PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McDonald, AJ; Dibble, JP; Evans, EGB; Millhauser, GL				McDonald, Alex J.; Dibble, Jessie P.; Evans, Eric G. B.; Millhauser, Glenn L.			A New Paradigm for Enzymatic Control of alpha-Cleavage and beta-Cleavage of the Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; COPPER-BINDING; IN-VIVO; TERMINAL FRAGMENT; OXIDATIVE STRESS; AMINO-TERMINUS; SCRAPIE PRION; ZINC; DOMAIN; BRAIN	The cellular form of the prion protein (PrPC) is found in both full-length and several different cleaved forms in vivo. Although the precise functions of the PrPC proteolytic products are not known, cleavage between the unstructured N-terminal domain and the structured C-terminal domain at Lys-109 down arrow His-110 (mouse sequence), termed alpha-cleavage, has been shown to produce the anti-apoptotic N1 and the scrapie-resistant C1 peptide fragments. beta-Cleavage, residing adjacent to the octarepeat domain and N-terminal to the alpha-cleavage site, is thought to arise from the action of reactive oxygen species produced from redox cycling of coordinated copper. We sought to elucidate the role of key members of the ADAM (a disintegrin and metalloproteinase) enzyme family, as well as Cu2+ redox cycling, in recombinant mouse PrP (MoPrP) cleavage through LC/MS analysis. Our findings show that although Cu2+ redox-generated reactive oxygen species do produce fragmentation corresponding to beta-cleavage, ADAM8 also cleaves MoPrP in the octarepeat domain in a Cu2+- and Zn2+-dependent manner. Additional cleavage by ADAM8 was observed at the previously proposed location of alpha-cleavage, Lys-109 down arrow His-110 (MoPrP sequencing); however, upon addition of Cu2+, the location of alpha-cleavage shifted by several amino acids toward the C terminus. ADAM10 and ADAM17 have also been implicated in alpha-cleavage at Lys109 down arrow His-110; however, we observed that they instead cleaved MoPrP at a novel location, Ala-119 down arrow Val-120, with additional cleavage by ADAM10 at Gly-227 down arrow Arg-228 near the C terminus. Together, our results show that MoPrP cleavage is far more complex than previously thought and suggest a mechanism by which PrPC fragmentation responds to Cu2+ and Zn2+.	[McDonald, Alex J.; Dibble, Jessie P.; Evans, Eric G. B.; Millhauser, Glenn L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Millhauser, GL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	glennm@ucsc.edu			National Institutes of Health [GM065790]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065790] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065790.	Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Budimir A, 2011, ACTA PHARMACEUT, V61, P1, DOI 10.2478/v10007-011-0006-6; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Faller P, 2012, FREE RADICAL BIO MED, V52, P747, DOI 10.1016/j.freeradbiomed.2011.11.005; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kenche VB, 2011, BRIT J PHARMACOL, V163, P211, DOI 10.1111/j.1476-5381.2011.01221.x; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liang JJ, 2012, J BIOL CHEM, V287, P16510, DOI 10.1074/jbc.M112.360891; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Oliveira-Martins JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009107; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; Thakur AK, 2011, J BIOL CHEM, V286, P38533, DOI 10.1074/jbc.M111.265645; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; Walter ED, 2009, CURR PROTEIN PEPT SC, V10, P529, DOI 10.2174/138920309789352056; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Watt NT, 2003, TRENDS BIOCHEM SCI, V28, P406, DOI 10.1016/S0968-0004(03)00166-X; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	41	80	80	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					803	813		10.1074/jbc.M113.502351	http://dx.doi.org/10.1074/jbc.M113.502351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24247244	hybrid, Green Published			2022-12-28	WOS:000330541200018
J	Busker, M; Neidhardt, I; Behrends, S				Busker, Mareike; Neidhardt, Inga; Behrends, Soenke			Nitric Oxide Activation of Guanylate Cyclase Pushes the alpha(1) Signaling Helix and the beta(1) Heme-binding Domain Closer to the Substrate-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Fluorescence Resonance Energy Transfer (FRET); Guanylate Cyclase (Guanylyl Cyclase); Nitric Oxide; Signal Transduction; Ciguate	CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; CATALYTIC DOMAINS; MECHANISM; SUBUNIT; RECEPTOR; NO; TRANSDUCTION; INHIBITION; EXPRESSION	The complete structure of the assembled domains of nitric oxide-sensitive guanylate cyclase (NOsGC) remains to be determined. It is also unknown how binding of NO to heme in guanylate cyclase is communicated to the catalytic domain. In the current study the conformational change of guanylate cyclase on activation by NO was studied using FRET. Endogenous tryptophan residues were used as donors, the substrate analog 2-Mant-3-dGTP as acceptor. The enzyme contains five tryptophan residues distributed evenly over all four functional domains. This provides a unique opportunity to detect the movement of the functional domains relative to the substrate-binding catalytic region. FRET measurements indicate that NO brings tryptophan 22 in the B helix of the (1) heme NO binding domain and tryptophan 466 in the second short helix of the (1) coiled-coil domain closer to the catalytic domain. We propose that the respective domains act as a pair of tongs forcing the catalytic domain into the nitric oxide-activated conformation.	[Busker, Mareike; Neidhardt, Inga; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Behrends, S (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Mendelssohnstr 1, D-38106 Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Behrends, Sönke/A-2551-2010	Behrends, Sönke/0000-0002-9068-0729	Deutsche Forschungsgemeinschaft [BE 1865/5-1]; European Cooperation in Science and Technology Program [BM1005]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Cooperation in Science and Technology Program	This work was supported by the Deutsche Forschungsgemeinschaft (BE 1865/5-1) and the European Cooperation in Science and Technology Program BM1005.	Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Gille A, 2004, J BIOL CHEM, V279, P19955, DOI 10.1074/jbc.M312560200; Gille A, 2003, J BIOL CHEM, V278, P12672, DOI 10.1074/jbc.M211292200; Goettle M, 2007, MOL PHARMACOL, V72, P526, DOI 10.1124/mol.107.034413; Haase N, 2010, BIOCHEM PHARMACOL, V80, P1676, DOI 10.1016/j.bcp.2010.08.007; Haase T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011617; Koglin M, 2000, BBA-GENE STRUCT EXPR, V1494, P286, DOI 10.1016/S0167-4781(00)00211-6; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; Kraehling JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025772; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P63; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Misono KS, 2011, FEBS J, V278, P1818, DOI 10.1111/j.1742-4658.2011.08083.x; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mou TC, 2005, J BIOL CHEM, V280, P7253, DOI 10.1074/jbc.M409076200; Mou TC, 2006, MOL PHARMACOL, V70, P878, DOI 10.1124/mol.106.026427; Newton M, 2010, ANAL BIOCHEM, V402, P129, DOI 10.1016/j.ab.2010.03.041; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; Padayatti PS, 2004, PHARMACOL THERAPEUT, V104, P83, DOI 10.1016/j.pharmthera.2004.08.003; Purohit R, 2013, PROTEIN SCI, V22, P1439, DOI 10.1002/pro.2331; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Schultz G., 1984, METHOD ENZYMAT AN, P379; Underbakke ES, 2013, P NATL ACAD SCI USA, V110, P6777, DOI 10.1073/pnas.1301934110; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Yoo BK, 2012, ACS CHEM BIOL, V7, P2046, DOI 10.1021/cb3003539; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1	34	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					476	484		10.1074/jbc.M113.504472	http://dx.doi.org/10.1074/jbc.M113.504472			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24220034	Green Published, hybrid			2022-12-28	WOS:000329370900041
J	Lyle, AN; Remus, EW; Fan, AE; Lassegue, B; Walter, GA; Kiyosue, A; Griendling, KK; Taylor, WR				Lyle, Alicia N.; Remus, Ebony W.; Fan, Aaron E.; Lassegue, Bernard; Walter, Grant A.; Kiyosue, Arihiro; Griendling, Kathy K.; Taylor, W. Robert			Hydrogen Peroxide Regulates Osteopontin Expression through Activation of Transcriptional and Translational Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Osteopontin; Reactive Oxygen Species (ROS); Transcription; Translation	SMOOTH-MUSCLE-CELLS; DEFICIENT MICE; ESSENTIAL-HYPERTENSION; DEPENDENT TRANSLATION; PROTEIN-SYNTHESIS; RECEPTOR; INITIATION; ATHEROSCLEROSIS; PHOSPHORYLATION	Recent in vivo studies establish that osteopontin (OPN) expression is hydrogen peroxide (H2O2)-dependent. However, the mechanisms by which H2O2 increases OPN expression remain poorly defined. OPN protein expression increased in an unusual biphasic pattern in response to H2O2. To investigate whether these increases were mediated through transcriptional and/or translational regulation of OPN, smooth muscle cells stimulated with 50 m H2O2 were used as an in vitro cell system. Early protein increases at 6 h were not preceded by increased mRNA, whereas later increases (18 h) were, suggesting multiple mechanisms of regulation by H2O2. Polyribosomal fractionation assays established that early increases (6 h) in OPN expression were due to increased translation. This increase in translation occurred through phosphorylation of 4E-BP1 at the reactive oxygen species-sensitive Ser-65, which allowed for release and activation of eukaryotic initiation factor eIF4E and subsequent OPN translation. This early increase (6 h) in OPN was blunted in cells expressing a phospho-deficient 4E-BP1 mutant. H2O2 stimulation increased rat OPN promoter activity at 8 and 18 h, and promoter truncation studies established that promoter region -2284 to -795 is crucial for H2O2-dependent OPN transcription. ChIP studies determined that H2O2-dependent transcription is mediated by the reactive oxygen species-sensitive transcription factors NF-B and AP-1. In conclusion, H2O2 stimulates OPN expression in a unique biphasic pattern, where early increases are translational and late increases are transcriptional.	[Lyle, Alicia N.; Remus, Ebony W.; Fan, Aaron E.; Lassegue, Bernard; Walter, Grant A.; Griendling, Kathy K.; Taylor, W. Robert] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Taylor, W. Robert] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Taylor, W. Robert] Atlanta Vet Affairs Med Ctr, Decatur, GA 30233 USA; [Kiyosue, Arihiro] Tokyo Univ Hosp, Dept Cardiovasc Med, Bungkyo Ku, Tokyo 1138655, Japan	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Tokyo	Taylor, WR (corresponding author), Emory Univ, Sch Med, Div Cardiol, 1639 Pierce Dr,Suite 319 WMB, Atlanta, GA 30322 USA.	wtaylor@emory.edu		Lassegue, Bernard/0000-0003-4924-6506; Lyle, Alicia/0000-0001-7527-9200; Griendling, Kathy/0000-0002-9456-8582	National Institutes of Health [P01 HL095070, R01 HL090584, R01HL062820]; American Heart Association [11POST7570026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092150, R01HL090584, P01HL095070, R01HL062820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL095070, R01 HL090584, and R01HL062820 (to W. R. T.). This work was also supported by American Heart Association Post-doctoral Grant 11POST7570026 (to A. N. L.).	Abe K, 2008, HYPERTENS RES, V31, P987, DOI 10.1291/hypres.31.987; Bidder M, 2002, J BIOL CHEM, V277, P44485, DOI 10.1074/jbc.M206235200; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Collins AR, 2004, J AM COLL CARDIOL, V43, P1698, DOI 10.1016/j.jacc.2003.11.058; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Duvall CL, 2008, ARTERIOSCL THROM VAS, V28, P290, DOI 10.1161/ATVBAHA.107.158485; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Gauer S, 2008, J CELL BIOCHEM, V103, P615, DOI 10.1002/jcb.21433; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Grant CM, 2011, ANTIOXID REDOX SIGN, V15, P191, DOI 10.1089/ars.2010.3699; GRIENDLING KK, 1991, J BIOL CHEM, V266, P15498; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Hu T, 2009, CLIN EXP PHARMACOL P, V36, P626, DOI 10.1111/j.1440-1681.2008.05124.x; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kurata M, 2011, J HUM HYPERTENS, V25, P334, DOI 10.1038/jhh.2010.73; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lorenzen JM, 2010, ATHEROSCLEROSIS, V209, P184, DOI 10.1016/j.atherosclerosis.2009.09.009; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Matsui Y, 2003, ARTERIOSCL THROM VAS, V23, P1029, DOI 10.1161/01.ATV.0000074878.29805.D0; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; REDPATH NT, 1989, BIOCHEM J, V262, P69, DOI 10.1042/bj2620069; Rocic P, 2003, J BIOL CHEM, V278, P36973, DOI 10.1074/jbc.M302099200; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Strom A, 2004, J VASC RES, V41, P314, DOI 10.1159/000079205; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Umekawa T, 2009, BJU INT, V104, P115, DOI 10.1111/j.1464-410X.2009.08374.x; Williams ES, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/496540; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626	37	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					275	285		10.1074/jbc.M113.489641	http://dx.doi.org/10.1074/jbc.M113.489641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247243	Green Published, hybrid			2022-12-28	WOS:000329370900024
J	Iqbal, J; McRae, S; Banaudha, K; Mai, T; Waris, G				Iqbal, Jawed; McRae, Steven; Banaudha, Krishna; Thi Mai; Waris, Gulam			RETRACTED: Mechanism of Hepatitis C Virus (HCV)-induced Osteopontin and Its Role in Epithelial to Mesenchymal Transition of Hepatocytes (Retracted article. See vol. 293, pg. 20010, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						Epithelial Mesenchymal Transition; Hepatitis C Virus; Metastasis; Osteopontin; Oxidative Stress	ENDOTHELIAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; OXIDATIVE STRESS; BETA-CATENIN; CORE PROTEIN; MOLECULAR PATHOGENESIS; ACTIVATES STAT-3; CELL MIGRATION; MOUSE MODEL; X-PROTEIN	Osteopontin (OPN) is a secreted phosphoprotein, originally characterized in malignant-transformed epithelial cells. OPN is associated with tumor metastasis of several tumors and is overexpressed in hepatocellular carcinoma (HCC) tissue involving HCC invasion and metastasis. Importantly, OPN is significantly up-regulated in liver injury, inflammation, and hepatitis C virus (HCV)-associated HCC. However, the underlying mechanisms of OPN activation and its role in HCV-mediated liver disease pathogenesis are not known. In this study, we investigated the mechanism of OPN activation in HCV-infected cells. We demonstrate that HCV-mediated Ca2+ signaling, elevation of reactive oxygen species, and activation of cellular kinases such as p38 MAPK, JNK, PI3K, and MEK1/2 are involved in OPN activation. Incubation of HCV-infected cells with the inhibitors of AP-1 and Sp1 and site-directed mutagenesis of AP-1- and Sp1-binding sites on the OPN promoter suggest the critical role of AP-1 and Sp1 in OPN promoter activation. In addition, we show the in vivo interactions of AP-1 and Sp1 with the OPN promoter using chromatin immunoprecipitation assay. We also show the calpain-mediated processing of precursor OPN (approximate to 75 kDa) into approximate to 55-, approximate to 42-, and approximate to 36-kDa forms of OPN in HCV-infected cells. Furthermore, we demonstrate the critical role of HCV-induced OPN in increased phosphorylation of Akt and GSK-3 followed by the activation of -catenin, which can lead to EMT of hepatocytes. Taken together, these studies provide an insight into the mechanisms of OPN activation that is relevant to the metastasis of HCV-associated HCC.	[Iqbal, Jawed; McRae, Steven; Thi Mai; Waris, Gulam] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, N Chicago, IL 60064 USA; [Banaudha, Krishna] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; George Washington University	Waris, G (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, N Chicago, IL 60064 USA.	gulam.waris@rosalindfranklin.edu			National Institutes of Health from NIAID [1R56AI089772-01A1]; American Cancer Society, Illinois Division [254976]; Rosalind Franklin University of Medicine and Science; H. M. Bligh Cancer Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089772] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society, Illinois Division(American Cancer Society); Rosalind Franklin University of Medicine and Science; H. M. Bligh Cancer Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI089772-01A1 from NIAID. This work was also supported by American Cancer Society, Illinois Division, Grant 254976 and by the Rosalind Franklin University of Medicine and Science, H. M. Bligh Cancer Research Fund (to G. W.).	Banaudha K, 2010, HEPATOLOGY, V51, P1922, DOI 10.1002/hep.23616; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bose SK, 2012, J VIROL, V86, P13621, DOI 10.1128/JVI.02016-12; Brown A, 2011, J NEUROVIROL, V17, P382, DOI 10.1007/s13365-011-0035-4; Burdette D, 2010, J GEN VIROL, V91, P681, DOI 10.1099/vir.0.014340-0; Bureau C, 2001, J BIOL CHEM, V276, P23077, DOI 10.1074/jbc.M100698200; Cao DX, 2012, WORLD J GASTROENTERO, V18, P3923, DOI 10.3748/wjg.v18.i30.3923; Cha MY, 2004, HEPATOLOGY, V39, P1683, DOI 10.1002/hep.20245; Colli A, 2006, AM J GASTROENTEROL, V101, P1939; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; HIJIYA N, 1994, BIOCHEM J, V303, P255, DOI 10.1042/bj3030255; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hsieh MJ, 2011, J CELL BIOCHEM, V112, P233, DOI 10.1002/jcb.22926; Hu T, 2009, CLIN EXP PHARMACOL P, V36, P626, DOI 10.1111/j.1440-1681.2008.05124.x; Huang YH, 2005, LIVER INT, V25, P236, DOI 10.1111/j.1478-3231.2005.01081.x; Kern MA, 2002, ADV CANCER RES, V86, P67, DOI 10.1016/S0065-230X(02)86003-1; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Li TY, 2010, ANN SURG ONCOL, V17, P1937, DOI 10.1245/s10434-010-0925-3; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Liu J., 2011, PLOS ONE, V6; Liu YN, 2004, ONCOGENE, V23, P278, DOI 10.1038/sj.onc.1207022; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Mamoune A, 2003, CANCER RES, V63, P4632; Mee CJ, 2010, GASTROENTEROLOGY, V138, P1134, DOI 10.1053/j.gastro.2009.11.047; Mochida S, 2004, BIOCHEM BIOPH RES CO, V317, P114, DOI 10.1016/j.bbrc.2004.02.180; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Moriya K, 2001, CANCER RES, V61, P4365; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Naas T, 2005, J GEN VIROL, V86, P2185, DOI 10.1099/vir.0.80969-0; Nishikawa Manabu, 2008, Masui, V57, P321; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679; Presser LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056367; Presser LD, 2011, VIROLOGY, V412, P284, DOI 10.1016/j.virol.2010.12.051; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Senger DR, 1996, AM J PATHOL, V149, P293; Standal T, 2004, EXP ONCOL, V26, P179; Stein GS, 2010, ADV ENZYME REGUL, V50, P160, DOI 10.1016/j.advenzreg.2009.10.026; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Whalen KA, 2008, J VIROL, V82, P4946, DOI 10.1128/JVI.02650-07; Wilson GK, 2012, J HEPATOL, V56, P803, DOI 10.1016/j.jhep.2011.11.018; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xiang ZH, 2010, BIOCHEM BIOPH RES CO, V402, P549, DOI 10.1016/j.bbrc.2010.10.081; Zhang J, 2010, LEUKEMIA RES, V34, P763, DOI 10.1016/j.leukres.2009.08.028; Zhang X, 2010, ACTA PHARMACOL SIN, V31, P593, DOI 10.1038/aps.2010.36; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	66	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36994	37009		10.1074/jbc.M113.492314	http://dx.doi.org/10.1074/jbc.M113.492314			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240095	Green Published, hybrid			2022-12-28	WOS:000329189700021
J	Smith, ES; Martinez-Velazquez, L; Ringstad, N				Smith, Ewan St. John; Martinez-Velazquez, Luis; Ringstad, Niels			A Chemoreceptor That Detects Molecular Carbon Dioxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Carbon Dioxide; Cyclic GMP (cGMP); Neurons; Receptors; Chemotransduction	GUANYLYL CYCLASE-D; C-ELEGANS; CAENORHABDITIS-ELEGANS; AVOIDANCE-BEHAVIOR; PRIMARY CULTURE; NEURONS; CO2; PH; OXYGEN; INTEGRATION	Animals from diverse phyla possess neurons that are activated by the product of aerobic respiration, CO2. It has long been thought that such neurons primarily detect the CO2 metabolites protons and bicarbonate. We have determined the chemical tuning of isolated CO2 chemosensory BAG neurons of the nematode Caenorhabditis elegans. We show that BAG neurons are principally tuned to detect molecular CO2, although they can be activated by acid stimuli. One component of the BAG transduction pathway, the receptor-type guanylate cyclase GCY-9, suffices to confer cellular sensitivity to both molecular CO2 and acid, indicating that it is a bifunctional chemoreceptor. We speculate that in other animals, receptors similarly capable of detecting molecular CO2 might mediate effects of CO2 on neural circuits and behavior.	[Smith, Ewan St. John; Martinez-Velazquez, Luis; Ringstad, Niels] NYU, Med Ctr, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; [Smith, Ewan St. John; Martinez-Velazquez, Luis; Ringstad, Niels] NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Smith, Ewan St. John] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	New York University; New York University; University of Cambridge	Smith, ES (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	es336@cam.ac.uk; Niels.Ringstad@med.nyu.edu	St. John Smith, Ewan/G-1776-2011	St. John Smith, Ewan/0000-0002-2699-1979	National Institutes of Health [R01-GM098320]; Max Kade Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS086750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Kade Foundation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM098320 ( to N. R.). This work was also supported by XXXXXX.; Supported by a Max Kade Foundation Fellowship.	Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bianchi L., 2006, CULTURE EMBRYONIC C, DOI 10.1895/wormbook.1.122.1; Brandt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034014; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Carrillo MA, 2013, J NEUROSCI, V33, P9675, DOI 10.1523/JNEUROSCI.4541-12.2013; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Dean JB, 2010, RESP PHYSIOL NEUROBI, V173, P274, DOI 10.1016/j.resp.2010.07.002; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Filosa JA, 2002, J PHYSIOL-LONDON, V541, P493, DOI 10.1113/jphysiol.2001.014142; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Frokjaer-Jensen C, 2006, J NEUROBIOL, V66, P1125, DOI 10.1002/neu.20261; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, CURR BIOL, V21, P377, DOI 10.1016/j.cub.2011.01.048; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3921, DOI 10.1113/jphysiol.2010.192096; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Huynh KT, 2011, J COMP PHYSIOL B, V181, P883, DOI 10.1007/s00360-011-0583-1; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Ma Dengke K, 2012, Front Biol (Beijing), V7, P246; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Scott K, 2011, NEURON, V69, P194, DOI 10.1016/j.neuron.2010.12.018; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; Supuran CT, 2010, CURR PHARM DESIGN, V16, P3233; Wang WG, 2002, J PHYSIOL-LONDON, V540, P951, DOI 10.1113/jphysiol.2001.013443; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	43	34	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37071	37081		10.1074/jbc.M113.517367	http://dx.doi.org/10.1074/jbc.M113.517367			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240097	Green Published, hybrid			2022-12-28	WOS:000329189700027
J	Olsen, JA; Kastrup, JS; Peters, D; Gajhede, M; Balle, T; Ahring, PK				Olsen, Jeppe A.; Kastrup, Jette S.; Peters, Dan; Gajhede, Michael; Balle, Thomas; Ahring, Philip K.			Two Distinct Allosteric Binding Sites at alpha 4 beta 2 Nicotinic Acetylcholine Receptors Revealed by NS206 and NS9283 Give Unique Insights to Binding Activity-associated Linkage at Cys-loop Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop Receptors; Drug Discovery; Electrophysiology; Nicotinic Acetylcholine Receptors; Xenopus; Allosteric; Modulation	SUBUNIT INTERFACES; ALTERNATE STOICHIOMETRIES; TRANSMEMBRANE SITE; IN-VIVO; MODULATOR; POTENTIATION; SENSITIVITY; SUBTYPES	Background: Positive allosteric modulators (PAMs) of 42 nicotinic acetylcholine receptors have significant therapeutic potential. Results: Two PAMs, NS206 and NS9283, were observed to have differential and additive pharmacological actions due to binding at distinct receptor sites. Conclusion: Modulator binding activity is linked to the specific binding position in Cys-loop receptors. Significance: Diverse PAM profiles increase possibilities for rational drug design and understanding of receptor function. Positive allosteric modulators (PAMs) of 42 nicotinic acetylcholine receptors have the potential to improve cognitive function and alleviate pain. However, only a few selective PAMs of 42 receptors have been described limiting both pharmacological understanding and drug-discovery efforts. Here, we describe a novel selective PAM of 42 receptors, NS206, and compare with a previously reported PAM, NS9283. Using two-electrode voltage-clamp electrophysiology in Xenopus laevis oocytes, NS206 was observed to positively modulate acetylcholine (ACh)-evoked currents at both known 42 stoichiometries (2:3 and 3:2). In the presence of NS206, peak current amplitudes surpassed those of maximal efficacious ACh stimulations (E-max(ACh)) with no or limited effects at potencies and current waveforms (as inspected visually). This pharmacological action contrasted with that of NS9283, which only modulated the 3:2 receptor and acted by left shifting the ACh concentration-response relationship. Interestingly, the two modulators can act simultaneously in an additive manner at 3:2 receptors, which results in current levels exceeding E-max(ACh) and a left-shifted ACh concentration-response relationship. Through use of chimeric and point-mutated receptors, the binding site of NS206 was linked to the 4-subunit transmembrane domain, whereas binding of NS9283 was shown to be associated with the -interface in 3:2 receptors. Collectively, these data demonstrate the existence of two distinct modulatory sites in 42 receptors with unique pharmacological attributes that can act additively. Several allosteric sites have been identified within the family of Cys-loop receptors and with the present data, a detailed picture of allosteric modulatory mechanisms of these important receptors is emerging.	[Olsen, Jeppe A.; Peters, Dan] NeuroSearch AS, DK-2750 Ballerup, Denmark; [Olsen, Jeppe A.; Kastrup, Jette S.; Gajhede, Michael] Univ Copenhagen, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Balle, Thomas; Ahring, Philip K.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Ahring, Philip K.] Aniona ApS, DK-2750 Ballerup, Denmark	University of Copenhagen; University of Sydney	Ahring, PK (corresponding author), Aniona ApS, Baltorpvej 154, DK-2750 Ballerup, Denmark.	pka@aniona.com		Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA research school at the University of Copenhagen, Denmark	NeuroSearch A/S; Danish Agency for Science, Technology and Innovation; DRA research school at the University of Copenhagen, Denmark	This work was supported in part by NeuroSearch A/S and the Danish Agency for Science, Technology and Innovation and the DRA research school at the University of Copenhagen, Denmark. J. A. O., D. P., and P. K. A. declare that they were employed by NeuroSearch A/S at the time the described work was carried out.	Anderson DJ, 2009, BIOCHEM PHARMACOL, V78, P844, DOI 10.1016/j.bcp.2009.06.024; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Livingstone PD, 2009, BIOCHEM PHARMACOL, V78, P744, DOI 10.1016/j.bcp.2009.06.004; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; MEHTA AK, 1987, J NEUROCHEM, V49, P1491, DOI 10.1111/j.1471-4159.1987.tb01019.x; Mihailescu S, 2000, ARCH MED RES, V31, P131, DOI 10.1016/S0188-4409(99)00087-9; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Pandya A, 2011, BIOCHEM PHARMACOL, V82, P952, DOI 10.1016/j.bcp.2011.04.020; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Rohde LAH, 2012, J BIOL CHEM, V287, P4248, DOI 10.1074/jbc.M111.292243; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Trattnig SM, 2012, J BIOL CHEM, V287, P25241, DOI 10.1074/jbc.M112.360370; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	32	36	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35997	36006		10.1074/jbc.M113.498618	http://dx.doi.org/10.1074/jbc.M113.498618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169695	Green Published, hybrid			2022-12-28	WOS:000329814700035
J	Shin, JN; Fattah, EA; Bhattacharya, A; Ko, S; Eissa, NT				Shin, Jin Na; Fattah, Elmoataz Abdel; Bhattacharya, Abhisek; Ko, Soyoung; Eissa, N. Tony			Inflammasome Activation by Altered Proteostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Inflammation; Lysosomes; Macrophages; Protein Misfolding; Inflammasome; Proteostasis	ENDOPLASMIC-RETICULUM STRESS; INDUCED CELL-DEATH; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; PLASMA-MEMBRANE; AUTOPHAGY; DISEASE; RECOGNITION; PROTEINS; CRYSTALS	Background: The mechanisms for association of altered proteostasis and inflammation are not known. Results: The deficiency of either autophagy or p62 led to inflammasome hyperactivation. Conclusion: Accumulation of misfolded proteins caused inflammasome activation by inducing generation of nonmitochondrial ROS and lysosomal damage. Significance: Our results suggest that altered proteostasis results in inflammasome activation and thus provide mechanisms for the association of altered proteostasis with inflammatory disorders. The association between altered proteostasis and inflammatory disorders has been increasingly recognized, but the underlying mechanisms are not well understood. In this study, we show that deficiency of either autophagy or sequestosome 1 (p62 or SQSTM) led to inflammasome hyperactivation in response to LPS and ATP in primary macrophages and in mice in vivo. Importantly, induction of protein misfolding by puromycin, thapsigargin, or geldanamycin resulted in inflammasome activation that was more pronounced in autophagy- or p62-deficient macrophages. Accumulation of misfolded proteins caused inflammasome activation by inducing generation of nonmitochondrial reactive oxygen species and lysosomal damage, leading to release of cathepsin B. Our results suggest that altered proteostasis results in inflammasome activation and thus provide mechanisms for the association of altered proteostasis with inflammatory disorders.	[Shin, Jin Na; Fattah, Elmoataz Abdel; Bhattacharya, Abhisek; Ko, Soyoung; Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Eissa, NT (corresponding author), Baylor Coll Med, One Baylor Plaza,BCM 285 Ste 535E, Houston, TX 77030 USA.	teissa@bcm.edu	Bhattacharya, Abhisek/AAN-6511-2020	Bhattacharya, Abhisek/0000-0002-1667-7169	National Institutes of Health grant from NHLBI; National Institutes of Health grant from NIAID;  [AI036211];  [CA125123];  [RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	National Institutes of Health grant from NHLBI; National Institutes of Health grant from NIAID; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants from NHLBI and NIAID and Grants AI036211, CA125123, and RR024574 (to the Cytometry and Cell Sorting Core at Baylor College of Medicine).	Atianand MK, 2013, CELL, V153, P272, DOI 10.1016/j.cell.2013.03.009; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu XD, 2012, J BIOL CHEM, V287, P19687, DOI 10.1074/jbc.M112.350934; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	33	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35886	35895		10.1074/jbc.M113.514919	http://dx.doi.org/10.1074/jbc.M113.514919			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178293	hybrid, Green Published			2022-12-28	WOS:000329814700025
J	Daus, ML; Wagenfuhr, K; Thomzig, A; Boerner, S; Hermann, P; Hermelink, A; Beekes, M; Lasch, P				Daus, Martin L.; Wagenfuehr, Katja; Thomzig, Achim; Boerner, Susann; Hermann, Peter; Hermelink, Antje; Beekes, Michael; Lasch, Peter			Infrared Microspectroscopy Detects Protein Misfolding Cyclic Amplification (PMCA)-induced Conformational Alterations in Hamster Scrapie Progeny Seeds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Biophysics; Neurodegenerative Diseases; Prions; Protein Misfolding; Infrared Microspectroscopy (IR-MSP); Prion Strains; Prion Structure; Protein Misfolding Cyclic Amplification (PMCA); Seeding Activity	PRION PROTEIN; SECONDARY STRUCTURE; SPECTROSCOPY; STRAINS; DISEASE; MODEL; BETA(2)-MICROGLOBULIN; INFECTIVITY; CONVERSION; INSIGHTS	Background: It is currently under discussion whether protein misfolding cyclic amplification (PMCA) alters strain properties of prions. Results: An improved infrared microspectroscopic approach combined with biochemical and bioassay data revealed altered strain properties of hamster 263K scrapie prions due to PMCA. Conclusion: PMCA can alter strain properties of 263K prions. Significance: Our analytical approach may help to improve the understanding of prion strain conversion. The self-replicative conformation of misfolded prion proteins (PrP) is considered a major determinant for the seeding activity, infectiousness, and strain characteristics of prions in different host species. Prion-associated seeding activity, which converts cellular prion protein (PrPC) into Proteinase K-resistant, infectious PrP particles (PrPTSE), can be monitored in vitro by protein misfolding cyclic amplification (PMCA). Thus, PMCA has been established as a valuable analytical tool in prion research. Currently, however, it is under discussion whether prion strain characteristics are preserved during PMCA when parent seeds are amplified in PrPC substrate from the identical host species. Here, we report on the comparative structural analysis of parent and progeny (PMCA-derived) PrP seeds by an improved approach of sensitive infrared microspectroscopy. Infrared microspectroscopy revealed that PMCA of native hamster 263K scrapie seeds in hamster PrPC substrate caused conformational alterations in progeny seeds that were accompanied by an altered resistance to Proteinase K, higher sedimentation velocities in gradient ultracentrifugations, and a longer incubation time in animal bioassays. When these progeny seeds were propagated in hamsters, misfolded PrP from brain extracts of these animals showed mixed spectroscopic and biochemical properties from both parental and progeny seeds. Thus, strain modifications of 263K prions induced by PMCA seem to have been partially reversed when PMCA products were reinoculated into the original host species.	[Daus, Martin L.; Wagenfuehr, Katja; Thomzig, Achim; Boerner, Susann; Beekes, Michael] Robert Koch Inst, FG Unconvent Pathogens & Their Inactivat Appl Inf, D-13353 Berlin, Germany; [Hermann, Peter; Hermelink, Antje; Lasch, Peter] Robert Koch Inst, ZBS Ctr Biol Threats & Special Pathogens Proteom, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Daus, ML (corresponding author), Robert Koch Inst, FG Unconvent Pathogens & Their Inactivat Appl Inf, Nordufer 20, D-13353 Berlin, Germany.	DausM@rki.de	Beekes, Michael/S-1975-2018	Beekes, Michael/0000-0002-6454-6657; Lasch, Peter/0000-0001-6193-3144	Alberta Prion Research Institute	Alberta Prion Research Institute	This work was supported by the Alberta Prion Research Institute, and the study was carried out within the project "Comprehensive Risk Assessment of CWD Transmission to Humans Using Non-human Primates" aiming at the typing and risk assessment of prion isolates. The technical progress described in this paper for the purification of PrP27-30 and IR-MSP provided a prerequisite for and has been transferred to the above mentioned project for the differentiation of CWD agents in white-tailed deer (manuscript in preparation).	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; Barria MA, 2012, METHODS MOL BIOL, V849, P199, DOI 10.1007/978-1-61779-551-0_14; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Baskakov IV, 2009, FEBS LETT, V583, P2618, DOI 10.1016/j.febslet.2009.05.044; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Colby D, 2011, COLD SPRING HARB PER, P3; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Daus ML, 2012, PRION, V6, P17, DOI 10.4161/pri.6.1.17776; Debelouchina GT, 2010, J AM CHEM SOC, V132, P17077, DOI 10.1021/ja107987f; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Diringer H, 1997, INTERVIROLOGY, V40, P238, DOI 10.1159/000150553; Everest SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019737; FABIAN H, 1994, BIOCHEMISTRY-US, V33, P10725, DOI 10.1021/bi00201a021; Fabian H, 2008, BIOCHEMISTRY-US, V47, P6895, DOI 10.1021/bi800279y; Gill AC, 2010, PRION, V4, P235, DOI 10.4161/pri.4.4.13394; Gonzalez-Montalban N, 2013, FASEB J, V27, P3702, DOI 10.1096/fj.13-230466; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lasch P, 1998, BIOPHYS J, V75, P840, DOI 10.1016/S0006-3495(98)77573-3; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Makarava N, 2009, J BIOL CHEM, V284, P14386, DOI 10.1074/jbc.M900533200; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2012, J VIROL, V86, P10494, DOI 10.1128/JVI.01286-12; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Suzuki SY, 2008, J VET MED SCI, V70, P159, DOI 10.1292/jvms.70.159; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tomzig A, 2004, J BIOL CHEM, V279, P33847, DOI 10.1074/jbc.M403730200; Wang F, 2012, J VIROL, V86, P1874, DOI 10.1128/JVI.06216-11; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809	49	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35068	35080		10.1074/jbc.M113.497131	http://dx.doi.org/10.1074/jbc.M113.497131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163371	Green Published, hybrid			2022-12-28	WOS:000329867600009
J	Gohil, VM; Zhu, L; Baker, CD; Cracan, V; Yaseen, A; Jain, M; Clish, CB; Brookes, PS; Bakovic, M; Mootha, VK				Gohil, Vishal M.; Zhu, Lin; Baker, Charli D.; Cracan, Valentin; Yaseen, Abbas; Jain, Mohit; Clish, Clary B.; Brookes, Paul S.; Bakovic, Marica; Mootha, Vamsi K.			Meclizine Inhibits Mitochondria! Respiration through Direct Targeting of Cytosolic Phosphoethanolamine Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Energy Metabolism; Metabolomics; Mitochondria; Phosphatidylethanolamine; Respiration; Meclizine; Phosphoethanolamine	PHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE; PHOSPHATIDYLSERINE; CARDIOLIPIN; CTP; PATHWAY; GENE; RNAI	We recently identified meclizine, an over-the-counter drug, as an inhibitor of mitochondrial respiration. Curiously, meclizine blunted respiration in intact cells but not in isolated mitochondria, suggesting an unorthodox mechanism. Using a metabolic profiling approach, we now show that treatment with meclizine leads to a sharp elevation of cellular phosphoethanolamine, an intermediate in the ethanolamine branch of the Kennedy pathway of phosphatidylethanolamine biosynthesis. Metabolic labeling and in vitro enzyme assays confirmed direct inhibition of the cytosolic enzyme CTP:phosphoethanolamine cytidylyltransferase (PCYT2). Inhibition of PCYT2 by meclizine led to rapid accumulation of its substrate, phosphoethanolamine, which is itself an inhibitor of mitochondrial respiration. Our work identifies the first pharmacologic inhibitor of the Kennedy pathway, demonstrates that its biosynthetic intermediate is an endogenous inhibitor of respiration, and provides key mechanistic insights that may facilitate repurposing meclizine for disorders of energy metabolism.	[Gohil, Vishal M.; Cracan, Valentin; Yaseen, Abbas; Jain, Mohit; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Dept Mol Biol, Boston, MA 02114 USA; [Gohil, Vishal M.; Cracan, Valentin; Yaseen, Abbas; Jain, Mohit; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Dept Med, Boston, MA 02114 USA; [Gohil, Vishal M.; Cracan, Valentin; Jain, Mohit; Clish, Clary B.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Gohil, Vishal M.; Cracan, Valentin; Jain, Mohit; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Gohil, Vishal M.; Baker, Charli D.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Zhu, Lin; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Texas A&M University System; Texas A&M University College Station; University of Guelph; University of Rochester	Gohil, VM (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, ILSB Rm 2146A,301 Old Main Dr, College Stn, TX 77843 USA.	vgohil@tamu.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Brookes, Paul/0000-0002-8639-8413; Cracan, Valentin/0000-0002-3280-0593; Gohil, Vishal/0000-0002-9920-2563	National Institutes of Health [5K08HL107451]; American Diabetes Association/Smith Family Foundation; Welch Foundation [A-1810]; Canadian Institutes of Health Research; Ontario President Research Excellence Award; Texas AM University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association/Smith Family Foundation(American Diabetes Association); Welch Foundation(The Welch Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario President Research Excellence Award; Texas AM University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K08HL107451 (to M. J.). This work was also supported by a grant from the American Diabetes Association/Smith Family Foundation (to V. K. M.). V. K. M. and V. M. G. are listed as inventors on a patent application filed by the Massachusetts General Hospital.; Supported by Welch Foundation Grant A-1810 and discretionary funds from Texas A&M University.; Supported by grants from the Canadian Institutes of Health Research and Ontario President Research Excellence Award.	Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bleijerveld OB, 2007, J BIOL CHEM, V282, P28362, DOI 10.1074/jbc.M703786200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; COHEN B, 1972, ARCH NEUROL-CHICAGO, V27, P129, DOI 10.1001/archneur.1972.00490140033006; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Ferreira AK, 2012, ANTICANCER RES, V32, P95; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Gohil VM, 2011, HUM MOL GENET, V20, P294, DOI 10.1093/hmg/ddq464; Gohil VM, 2010, J BIOL CHEM, V285, P13742, DOI 10.1074/jbc.M109.098400; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Huang WD, 2004, MOL ENDOCRINOL, V18, P2402, DOI 10.1210/me.2004-0046; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0; KUBO N, 1987, JPN J PHARMACOL, V43, P277, DOI 10.1254/jjp.43.277; Maheshwari S, 2013, BIOCHEM J, V450, P159, DOI 10.1042/BJ20121480; Modica-Napolitano JS, 2004, BIOL PSYCHIAT, V55, P273, DOI 10.1016/S0006-3223(03)00784-4; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Wang ZJ, 2012, J CLIN PHARMACOL, V52, P1343, DOI 10.1177/0091270011414575; Watkins SM, 2002, CURR OPIN MOL THER, V4, P224; Webhofer C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.56; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200	36	31	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35387	35395		10.1074/jbc.M113.489237	http://dx.doi.org/10.1074/jbc.M113.489237			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142790	Green Published, hybrid			2022-12-28	WOS:000329867600035
J	Sucharitakul, J; Tongsook, C; Pakotiprapha, D; van Berkel, WJH; Chaiyen, P				Sucharitakul, Jeerus; Tongsook, Chanakan; Pakotiprapha, Danaya; van Berkel, Willem J. H.; Chaiyen, Pimchai			The Reaction Kinetics of 3-Hydroxybenzoate 6-Hydroxylase from Rhodococcus jostii RHA1 Provide an Understanding of the para-Hydroxylation Enzyme Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Flavin; Flavoproteins; Hydroxylase	PARA-HYDROXYBENZOATE HYDROXYLASE; P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; 2-METHYL-3-HYDROXYPYRIDINE-5-CARBOXYLIC ACID OXYGENASE; STEADY-STATE; ORNITHINE HYDROXYLASE; VIBRIO-CAMPBELLII; CRYSTAL-STRUCTURE; GENTISIC ACID; IN-VITRO; MECHANISM	Background: 3-Hydroxybenzoate 6-hydroxylase (3HB6H) is a flavoprotein hydroxylase catalyzing the para-hydroxylation of 3-hydroxybenzoate. Results: The oxidative half-reaction was studied using transient kinetics. The enzyme reaction mechanism was elucidated. Conclusion: The product release and the hydroxylation limit the turnovers and the enzyme shows characteristics different from the ortho-hydroxylation enzymes. Significance: This is the first report on the oxygenation mechanism of a para-hydroxylating flavoenzyme. 3-Hydroxybenzoate 6-hydroxylase (3HB6H) from Rhodococcus jostii RHA1 is an NADH-specific flavoprotein monooxygenase that catalyzes the para-hydroxylation of 3-hydroxybenzoate (3HB) to form 2,5-dihydroxybenzoate (2,5-DHB). Based on results from stopped-flow spectrophotometry, the reduced enzyme-3HB complex reacts with oxygen to form a C4a-peroxy flavin with a rate constant of 1.13 +/- 0.01 x 10(6) m(-1) s(-1) (pH 8.0, 4 degrees C). This intermediate is subsequently protonated to form a C4a-hydroperoxyflavin with a rate constant of 96 +/- 3 s(-1). This step shows a solvent kinetic isotope effect of 1.7. Based on rapid-quench measurements, the hydroxylation occurs with a rate constant of 36 +/- 2 s(-1). 3HB6H does not exhibit substrate inhibition on the flavin oxidation step, a common characteristic found in most ortho-hydroxylation enzymes. The apparent k(cat) at saturating concentrations of 3HB, NADH, and oxygen is 6.49 +/- 0.02 s(-1). Pre-steady state and steady-state kinetic data were used to construct the catalytic cycle of the reaction. The data indicate that the steps of product release (11.7 s(-1)) and hydroxylation (36 +/- 2 s(-1)) partially control the overall turnover.	[Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Dent, Bangkok 10330, Thailand; [Tongsook, Chanakan; Pakotiprapha, Danaya; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Tongsook, Chanakan; Pakotiprapha, Danaya; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [van Berkel, Willem J. H.] Wageningen Univ, Lab Biochem, NL-6703 HA Wageningen, Netherlands	Chulalongkorn University; Mahidol University; Mahidol University; Wageningen University & Research	Sucharitakul, J (corresponding author), Chulalongkorn Univ, Dept Biochem, Fac Dent, Henri Dunant Rd, Bangkok 10330, Thailand.	jeerus.s@chula.ac.th	van Berkel, Willem J.H./O-2431-2014; Pakotiprapha, Danaya/B-1032-2013; Chaiyen, Pimchai/R-5052-2019	van Berkel, Willem J.H./0000-0002-6551-2782; Pakotiprapha, Danaya/0000-0002-5017-8283; Chaiyen, Pimchai/0000-0002-8533-1604	Thailand Research Fund [RSA5580050, RTA5680001, MRG5680043]; National Research University Project of CHE (to D. P.), and Chulalongkorn University through the Ratchadaphiseksomphot Endowment Fund,; Faculty of Dentistry, Chulalongkorn University through the Developing Research Unit: Cell Signaling and Protein Functions; Faculty of Science, Mahidol University; Netherlands Organization for Scientific Research (NWO) through the Integrated Biosynthesis Organic Synthesis (IBOS) programme	Thailand Research Fund(Thailand Research Fund (TRF)); National Research University Project of CHE (to D. P.), and Chulalongkorn University through the Ratchadaphiseksomphot Endowment Fund,; Faculty of Dentistry, Chulalongkorn University through the Developing Research Unit: Cell Signaling and Protein Functions; Faculty of Science, Mahidol University; Netherlands Organization for Scientific Research (NWO) through the Integrated Biosynthesis Organic Synthesis (IBOS) programme(Netherlands Organization for Scientific Research (NWO))	This work was supported by Thailand Research Fund Grants RSA5580050 (to J. S.), RTA5680001 (to P. C.), and MRG5680043 (to D. P.), and grants from the National Research University Project of CHE (to D. P.), and Chulalongkorn University through the Ratchadaphiseksomphot Endowment Fund, the Faculty of Dentistry, Chulalongkorn University through the Developing Research Unit: Cell Signaling and Protein Functions (to J. S.), the Faculty of Science, Mahidol University (to P. C.), and the Netherlands Organization for Scientific Research (NWO) through the Integrated Biosynthesis Organic Synthesis (IBOS) programme (to W. v. B.).	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; Ashidate K, 2005, EUR J PHARMACOL, V513, P173, DOI 10.1016/j.ejphar.2005.03.012; Ballou DP, 2013, HANDBOOK OF FLAVOPROTEINS: COMPLEX FLAVOPROTEINS, DEHYDROGENASES AND PHYSICAL METHODS, VOL 2, P1; CHA S, 1968, J BIOL CHEM, V243, P820; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Joshi R, 2012, FREE RADICAL RES, V46, P11, DOI 10.3109/10715762.2011.633518; Kallio P, 2011, BIOCHEMISTRY-US, V50, P5535, DOI 10.1021/bi200600k; Keitaro H., 1979, KINETICS FAST ENZYME; Kuby S. A., 2000, STUDY ENZYMES HIST I; MAEDAYORITA K, 1993, J BIOL CHEM, V268, P4134; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; Meneely KM, 2009, BIOCHEMISTRY-US, V48, P4371, DOI 10.1021/bi900442z; Montersino S, 2013, J BIOL CHEM, V288, P26235, DOI 10.1074/jbc.M113.479303; Montersino S, 2012, BBA-PROTEINS PROTEOM, V1824, P433, DOI 10.1016/j.bbapap.2011.12.003; Montersino S, 2011, ADV SYNTH CATAL, V353, P2301, DOI 10.1002/adsc.201100384; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; STEENNIS PJ, 1973, FEBS LETT, V36, P177, DOI 10.1016/0014-5793(73)80363-1; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2012, BIOCHEMISTRY-US, V51, P4309, DOI 10.1021/bi201823c; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tinikul R, 2012, J BIOTECHNOL, V162, P346, DOI 10.1016/j.jbiotec.2012.08.018; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Wang YL, 2002, FEMS MICROBIOL LETT, V208, P117, DOI 10.1016/S0378-1097(01)00591-2	41	24	24	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35210	35221		10.1074/jbc.M113.515205	http://dx.doi.org/10.1074/jbc.M113.515205			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24129570	Green Published, hybrid			2022-12-28	WOS:000329867600021
J	James, RG; Bosch, KA; Kulikauskas, RM; Yang, PTT; Robin, NC; Toroni, RA; Biechele, TL; Berndt, JD; von Haller, PD; Eng, JK; Wolf-Yadlin, A; Chien, AJ; Moon, RT				James, Richard G.; Bosch, Katherine A.; Kulikauskas, Rima M.; Yang, Peitzu T.; Robin, Nick C.; Toroni, Rachel A.; Biechele, Travis L.; Berndt, Jason D.; von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro; Chien, Andy J.; Moon, Randall T.			Protein Kinase PKN1 Represses Wnt/beta-Catenin Signaling in Human Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; -Catenin; Melanoma; Phosphorylation; Wnt Signaling; GSK3-; PKN1	C-RELATED KINASE; BETA-CATENIN; GENE-EXPRESSION; SMALL GTPASE; PHOSPHORYLATION; INHIBITION; LRP6; RECEPTOR; ACTIVATION; DOMAIN	Background: Wnt/-catenin signaling inhibits melanoma cell viability. Results: Integration of phosphoproteomics and RNA interference screens querying the Wnt/-catenin pathway reveals protein kinase N1 as an inhibitor of signaling. Conclusion: Protein kinase N1 inhibits Wnt/-catenin signaling and apoptosis in melanoma cells. Significance: This study identifies a kinase that inhibits Wnt/-catenin signaling, a pathway critical to melanoma cell viability. Advances in phosphoproteomics have made it possible to monitor changes in protein phosphorylation that occur at different steps in signal transduction and have aided the identification of new pathway components. In the present study, we applied this technology to advance our understanding of the responses of melanoma cells to signaling initiated by the secreted ligand WNT3A. We started by comparing the phosphopeptide patterns of cells treated with WNT3A for different periods of time. Next, we integrated these data sets with the results from a siRNA screen that targeted protein kinases. This integration of siRNA screening and proteomics enabled us to identify four kinases that exhibit altered phosphorylation in response to WNT3A and that regulate a luciferase reporter of -catenin-responsive transcription (-catenin-activated reporter). We focused on one of these kinases, an atypical PKC kinase, protein kinase N1 (PKN1). Reducing the levels of PKN1 with siRNAs significantly enhances activation of -catenin-activated reporter and increases apoptosis in melanoma cell lines. Using affinity purification followed by mass spectrometry, we then found that PKN1 is present in a protein complex with a WNT3A receptor, Frizzled 7, as well as with proteins that co-purify with Frizzled 7. These data establish that the protein kinase PKN1 inhibits Wnt/-catenin signaling and sensitizes melanoma cells to cell death stimulated by WNT3A.	[James, Richard G.; Bosch, Katherine A.; Kulikauskas, Rima M.; Yang, Peitzu T.; Robin, Nick C.; Toroni, Rachel A.; Biechele, Travis L.; Berndt, Jason D.; Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA; [von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro] Univ Washington, Dept Genome Sci, Seattle, WA 98109 USA; [James, Richard G.; Bosch, Katherine A.; Yang, Peitzu T.; Robin, Nick C.; Biechele, Travis L.; Berndt, Jason D.; Chien, Andy J.; Moon, Randall T.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Yang, Peitzu T.; Robin, Nick C.; Biechele, Travis L.; Moon, Randall T.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Kulikauskas, Rima M.; Toroni, Rachel A.; Chien, Andy J.] Univ Washington, Dept Med, Div Dermatol, Seattle, WA 98109 USA; [von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro] Univ Washington, Seattle, WA 98109 USA; [James, Richard G.; Bosch, Katherine A.; Kulikauskas, Rima M.; Yang, Peitzu T.; Robin, Nick C.; Toroni, Rachel A.; Biechele, Travis L.; Berndt, Jason D.; von Haller, Priska D.; Eng, Jimmy K.; Wolf-Yadlin, Alejandro; Chien, Andy J.; Moon, Randall T.] Univ Washington, Sch Med, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	James, RG (corresponding author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98115 USA.	rickerj@uw.edu; rtmoon@uw.edu	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Eng, Jimmy K/I-4202-2012; Wolf-Yadlin, Alejandro/E-6574-2011	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Eng, Jimmy K/0000-0001-6352-6737; Wolf-Yadlin, Alejandro/0000-0003-2909-3880; james, richard/0000-0002-2302-7367	National Institutes of Health from the NHLBI [K99/R00 1K99HL103768-01]; NCI [K08CA128565]; NIAMS [T32AR056969]; University of Washington's Proteomics Resource [UWPR 95794]; NATIONAL CANCER INSTITUTE [K08CA128565] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL103768, R00HL103768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Washington's Proteomics Resource; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant K99/R00 1K99HL103768-01 from the NHLBI (to R. G. J.), Grant K08CA128565 from the NCI (to A. J. C.), a grant from the NCI (to R. M. K.), and Training Grant T32AR056969 from the NIAMS (to T. L B.). This work was also supported by University of Washington's Proteomics Resource Grant UWPR 95794.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biechele TL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002274; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collazos A, 2011, BIOCHEM J, V438, P535, DOI 10.1042/BJ20110521; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hilger M, 2012, J PROTEOME RES, V11, P982, DOI 10.1021/pr200740a; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; James R. G., 2012, PLOS ONE, V7; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Jiang Y, 2012, EMBO J, V31, P2336, DOI 10.1038/emboj.2012.83; Kageshita T, 2001, BRIT J DERMATOL, V145, P210, DOI 10.1046/j.1365-2133.2001.04336.x; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Koh H, 2000, J BIOL CHEM, V275, P34451, DOI 10.1074/jbc.M001753200; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maelandsmo GM, 2003, CLIN CANCER RES, V9, P3383; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Mammen AL, 1997, J NEUROSCI, V17, P7351; Manser C, 2008, FEBS LETT, V582, P2303, DOI 10.1016/j.febslet.2008.05.034; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Meyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038222; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Miller BW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.72; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Rothberg BEG, 2009, J CLIN ONCOL, V27, P5772, DOI 10.1200/JCO.2009.22.8239; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sun WY, 2000, J BIOL CHEM, V275, P24421, DOI 10.1074/jbc.M003148200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Terabayashi T, 2009, J BIOL CHEM, V284, P26716, DOI 10.1074/jbc.M109.039313; Tiedemann RE, 2010, BLOOD, V115, P1594, DOI 10.1182/blood-2009-09-243980; Torbett NE, 2003, J BIOL CHEM, V278, P32344, DOI 10.1074/jbc.M303532200; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Yasui T, 2012, P NATL ACAD SCI USA, V109, P21022, DOI 10.1073/pnas.1218925110; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	65	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34658	34670		10.1074/jbc.M113.500314	http://dx.doi.org/10.1074/jbc.M113.500314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24114839	Green Published, hybrid			2022-12-28	WOS:000329812800033
J	Kraut, DA				Kraut, Daniel A.			Slippery Substrates Impair ATP-dependent Protease Function by Slowing Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent Protease; Enzyme Kinetics; Pre-steady-state Kinetics; Proteasome; Protein Degradation; Protein Denaturation; Protein Evolution; Protein Translocation; Protein Unfolding	NF-KAPPA-B; DEGRADATION; TRANSLOCATION; INHIBITION; REPEATS; MECHANISM; PROTEINS; PATHWAY; REGION; SIGNAL	Background: ATP-dependent proteases cannot fully degrade so-called slippery substrates. Results: Reanalysis indicates ClpXP has a reduced unfolding rate for slippery substrates, not a faster substrate release rate. Conclusion: The proteasome and ClpXP share a common mechanism of inhibition by slippery substrates. Significance: Comparison of the mechanisms of ATP-dependent proteases across species help explain how these unfolding machines work and evolve. ATP-dependent proteases are responsible for most energy-dependent protein degradation across all species. Proteases initially bind an unstructured region on a substrate and then translocate along the polypeptide chain, unfolding and degrading protein domains as they are encountered. Although this process is normally processive, resulting in the complete degradation of substrate proteins to small peptides, some substrates are released prematurely. Regions of low sequence complexity within the substrate such as the glycine-rich region (GRR) from p105 or glycine-alanine repeats (GAr) from the EBNA1 (Epstein-Barr virus nuclear antigen-1) protein, can trigger partial degradation and fragment release. Loss of processivity could be due to inability to hold on to the substrate (faster release) or inability to unfold and degrade a substrate domain (slower unfolding). I previously showed that the GRR slows domain unfolding by the proteasome (Kraut, D. A., Israeli, E., Schrader, E. K., Patil, A., Nakai, K., Nanavati, D., Inobe, T., and Matouschek, A. (2012) ACS Chem. Biol. 7, 1444-1453). In contrast, a recently published study concluded that GArs increase the rate of substrate release from ClpXP, a bacterial ATP-dependent protease (Too, P. H., Erales, J., Simen, J. D., Marjanovic, A., and Coffino, P. (2013) J. Biol. Chem. 288, 13243-13257). Here, I show that these apparently contradictory results can be reconciled through a reanalysis of the ClpXP GAr data. This reanalysis shows that, as with the proteasome, low complexity sequences in substrates slow their unfolding and degradation by ClpXP, with little effect on release rates. Thus, despite their evolutionary distance and limited sequence identity, both ClpXP and the proteasome share a common mechanism by which substrate sequences regulate the processivity of degradation.	Villanova Univ, Dept Chem, Villanova, PA 19085 USA	Villanova University	Kraut, DA (corresponding author), Villanova Univ, Dept Chem, 800 Lancaster Ave, Villanova, PA 19085 USA.	daniel.kraut@villanova.edu		Kraut, Daniel/0000-0002-4428-5832	Villanova University	Villanova University	Supported by a Summer Research Fellowship and Research Support Grant from Villanova University. To whom correspondence should be addressed: Dept. of Chemistry, Villanova University, 800 Lancaster Ave., Villanova, PA 19085. Tel.: 610-519-3910; Fax: 610-519-7167; E-mail: daniel.kraut@villanova.edu.	Daskalogianni C, 2008, J BIOL CHEM, V283, P30090, DOI 10.1074/jbc.M803290200; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; Fersht A. R., 1999, STRUCTURE MECH PROTE, P149; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gur E, 2012, PROTEIN SCI, V21, P268, DOI 10.1002/pro.2013; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Lander GC, 2013, CURR OPIN STRUC BIOL, V23, P243, DOI 10.1016/j.sbi.2013.02.004; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Lin L, 1996, MOL CELL BIOL, V16, P2248; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sharipo A, 2001, FEBS LETT, V499, P137, DOI 10.1016/S0014-5793(01)02542-X; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Too PHM, 2013, J BIOL CHEM, V288, P13243, DOI 10.1074/jbc.M113.452524	25	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34729	34735		10.1074/jbc.M113.512533	http://dx.doi.org/10.1074/jbc.M113.512533			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151080	Green Published, hybrid			2022-12-28	WOS:000329812800039
J	Zhu, H; Xu, BL; Liang, XL; Yang, YR; Tang, XF; Tang, B				Zhu, Hui; Xu, Bi-Lin; Liang, Xiaoliang; Yang, Yi-Ran; Tang, Xiao-Feng; Tang, Bing			Molecular Basis for Auto- and Hetero-catalytic Maturation of a Thermostable Subtilase from Thermophilic Bacillus sp WF146	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Enzyme Structure; Protein Processing; Protein Stability; Serine Protease; Maturation; Propeptide; Subtilase	SERINE-CARBOXYL PROTEINASE; ANGSTROM CRYSTAL-STRUCTURE; INTRAMOLECULAR CHAPERONE; HYPERTHERMOPHILIC ARCHAEON; SUBTILISIN; PROPEPTIDE; PROTEASE; MECHANISMS; ENZYMES; SITE	Background: The autocatalytic maturation mechanisms of subtilases are well known, but little is known about their hetero-catalytic maturation. Results: The N-terminal propeptide of the WF146 protease can be removed via both cis- and trans-processing reaction-initiated maturation pathways. Conclusion: The WF146 protease is intrinsically able to mature either autocatalytically or hetero-catalytically. Significance: Our work provides new insights into maturation mechanisms of subtilases. The proform of the WF146 protease, an extracellular subtilase produced by thermophilic Bacillus sp. WF146, matures efficiently at high temperatures. Here we report that the proform, which contains an N-terminal propeptide composed of a core domain (N*) and a linker peptide, is intrinsically able to mature via multiple pathways. One autocatalytic pathway is initiated by cis-processing of N* to generate an autoprocessed complex N*-I-WT, and this step is followed by truncation of the linker peptide and degradation of N*. Another autocatalytic pathway is initiated by trans-processing of the linker peptide followed by degradation of N*. Unlike most reported subtilases, the maturation of the WF146 protease occurs not only autocatalytically but also hetero-catalytically whereby heterogeneous proteases accelerate the maturation of the WF146 protease via trans-processing of the proform and N*-I-WT. Although N* acts as an intramolecular chaperone and an inhibitor of the mature enzyme, the linker peptide is susceptible to proteolysis, allowing the trans-processing reaction to occur auto- and hetero-catalytically. These studies also demonstrate that the WF146 protease undergoes subtle structural adjustments during the maturation process and that the binding of Ca2+ is required for routing the proform to mature properly at high temperatures. Interestingly, under Ca2+-free conditions, the proform is cis-processed into a unique propeptide-intermediate complex (N*-I-E) capable of re-synthesis of the proform. Based on the basic catalytic principle of serine proteases and these experimental results, a mechanism for the cis-processing/re-synthesis equilibrium of the proform and the role of the linker peptide in regulation of this equilibrium has been proposed.	[Zhu, Hui; Xu, Bi-Lin; Liang, Xiaoliang; Yang, Yi-Ran; Tang, Xiao-Feng; Tang, Bing] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Tang, B (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	tangb@whu.edu.cn			National Natural Science Foundation of China [30870052, 31270099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported the National Natural Science Foundation of China (30870052 and 31270099).	Almog O, 2003, J MOL BIOL, V332, P1071, DOI 10.1016/j.jmb.2003.07.011; Bian Y, 2006, FEBS LETT, V580, P6007, DOI 10.1016/j.febslet.2006.09.068; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brons-Poulsen J, 1998, MOL CELL PROBE, V12, P345, DOI 10.1006/mcpr.1998.0187; Cheng GY, 2009, MICROBIOL-SGM, V155, P3661, DOI 10.1099/mic.0.031336-0; Comellas-Bigler M, 2004, STRUCTURE, V12, P1313, DOI 10.1016/j.str.2004.04.013; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; EGNELL P, 1992, MOL MICROBIOL, V6, P1115, DOI 10.1111/j.1365-2958.1992.tb01549.x; Fang N, 2010, APPL MICROBIOL BIOT, V85, P1473, DOI 10.1007/s00253-009-2183-5; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; Han X, 2012, PLOS ONE, V7; Hu ZX, 1996, J BIOL CHEM, V271, P3375; JAMES GT, 1978, ANAL BIOCHEM, V86, P574, DOI 10.1016/0003-2697(78)90784-4; Khan AR, 1998, PROTEIN SCI, V7, P815; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Li YY, 1996, J MOL BIOL, V262, P591, DOI 10.1006/jmbi.1996.0537; Okubo A, 2006, FEBS J, V273, P2563, DOI 10.1111/j.1742-4658.2006.05266.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; Pulido M, 2006, APPL ENVIRON MICROB, V72, P4154, DOI 10.1128/AEM.02696-05; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Tanaka SI, 2007, J MOL BIOL, V372, P1055, DOI 10.1016/j.jmb.2007.07.027; Tanaka SI, 2007, J BIOL CHEM, V282, P8246, DOI 10.1074/jbc.M610137200; Tang B, 2002, BBA-PROTEIN STRUCT M, V1596, P16, DOI 10.1016/S0167-4838(01)00315-6; Tsuruoka N, 2003, APPL ENVIRON MICROB, V69, P162, DOI 10.1128/AEM.69.1.162-169.2003; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Volkov A, 1996, J MOL BIOL, V262, P595, DOI 10.1006/jmbi.1996.0538; Wu J, 2004, FEMS MICROBIOL LETT, V230, P251, DOI 10.1016/S0378-1097(03)00914-5; Yabuta Y, 2002, J BIOCHEM, V131, P31, DOI 10.1093/oxfordjournals.jbchem.a003074; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; Yang YR, 2008, FEBS LETT, V582, P2620, DOI 10.1016/j.febslet.2008.06.041	34	12	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34826	34838		10.1074/jbc.M113.498774	http://dx.doi.org/10.1074/jbc.M113.498774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145031	hybrid, Green Published			2022-12-28	WOS:000329812800050
J	Chahdi, A; Raufman, JP				Chahdi, Ahmed; Raufman, Jean-Pierre			The Cdc42/Rac Nucleotide Exchange Factor Protein beta(1) Pix (Pak-interacting Exchange Factor) Modulates beta-Catenin Transcriptional Activity in Colon Cancer Cells EVIDENCE FOR DIRECT INTERACTION OF beta(1) PIX WITH beta-CATENIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta -Catenin; Cell Proliferation; Colon Cancer; Guanine Nucleotide Exchange Factor (GEF); Small GTPases	SUBCELLULAR-LOCALIZATION; ADHERENS JUNCTIONS; COLORECTAL-CANCER; RAC1 GTPASE; ACTIVATION; WNT; PATHWAY; COMPLEX; APC; BINDING	Wnt/beta-catenin signaling is highly regulated and critical for intestinal epithelial development and repair; aberrant -catenin signaling is strongly associated with colon cancer. The small GTPase Rac1 regulates -catenin nuclear translocation and signaling. Here we tested the hypothesis that (1)Pix, a Cdc42/Rac guanine nucleotide exchange factor (GEF), regulates -catenin-dependent transcriptional activity and cell function. We report the novel observations that (1)Pix binds directly to -catenin, an action requiring both the (1)Pix DH and dimerization domains but not (1)Pix GEF activity. In human colon cancer cells, activation of -catenin signaling with LiCl decreased (1)Pix/-catenin association in the cytosol and increased nuclear binding of -catenin to (1)Pix. Nuclear association of (1)Pix and -catenin was independent of Rac1 expression and activation; down- and up-regulating Rac1 expression levels did not alter nuclear (1)Pix/-catenin association. Ectopic (1)Pix expression enhanced LiCl-induced -catenin transcriptional activity. Conversely, siRNA knockdown of (1)Pix attenuated both LiCl-induced -catenin transcriptional activity and colon cancer cell proliferation. Ectopic expression of (1)Pix stimulated -catenin transcriptional activity, whereas (1)Pix(602-611), which is unable to bind -catenin, had no effect. Altogether, these findings suggest that (1)Pix functions as a transcriptional regulator of -catenin signaling through direct interaction with -catenin, an action that may be functionally relevant to colon cancer biology.	[Chahdi, Ahmed; Raufman, Jean-Pierre] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Dept Med, Baltimore, MD 21210 USA; [Raufman, Jean-Pierre] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21210 USA; [Raufman, Jean-Pierre] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Raufman, JP (corresponding author), Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, 22 South Greene St,N3W62, Baltimore, MD 21210 USA.	jraufman@medicine.umaryland.edu			NCI [CA-107345, CA-120407]; NIDDK, National Institutes of Health [DK-093406]; NATIONAL CANCER INSTITUTE [R01CA107345, R01CA120407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK093406] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Public Health Service Grants CA-107345 and CA-120407 from the NCI and Grant DK-093406 from the NIDDK, National Institutes of Health.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Cerbone A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040149; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Chahdi A, 2008, MOL BIOL CELL, V19, P2609, DOI 10.1091/mbc.E07-05-0424; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chahdi A, 2010, BIOCHEM BIOPH RES CO, V391, P1330, DOI 10.1016/j.bbrc.2009.12.041; Chahdi A, 2010, CELL SIGNAL, V22, P325, DOI 10.1016/j.cellsig.2009.09.039; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Koh CG, 2001, J CELL SCI, V114, P4239; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liu L, 2005, WORLD J GASTROENTERO, V11, P705, DOI 10.3748/wjg.v11.i5.705; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Mendoza-Catalan MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-116; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pinto D, 2005, BIOL CELL, V97, P185; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sparks AB, 1998, CANCER RES, V58, P1130; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wiechens N, 2004, J BIOL CHEM, V279, P5263, DOI 10.1074/jbc.M307253200; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zurawel RH, 1998, CANCER RES, V58, P896	55	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34019	34029		10.1074/jbc.M113.480103	http://dx.doi.org/10.1074/jbc.M113.480103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129564	hybrid, Green Published			2022-12-28	WOS:000327250200043
J	Giang, AH; Raymond, T; Brookes, P; Bentley, KD; Schwarz, E; O'Keefe, R; Eliseev, R				Giang, An-Hoa; Raymond, Tamara; Brookes, Paul; Bentley, Karen de Mesy; Schwarz, Edward; O'Keefe, Regis; Eliseev, Roman			Mitochondrial Dysfunction and Permeability Transition in Osteosarcoma Cells Showing the Warburg Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Glycolysis; Mitochondria; Mitochondrial Permeability Transition; Osteosarcoma; Warburg Effect; Cyclophilin D	CYCLOPHILIN-D; CANCER-CELLS; REPERFUSION INJURY; CYCLING HYPOXIA; APOPTOSIS; PORE; P53; INHIBITION; GLYCOLYSIS; METABOLISM	Background: The Warburg effect in cancer is manifested by increased glycolysis and decreased respiration. Our goal was to determine how mitochondria are suppressed in osteosarcoma (OS). Results: OS cells showing the Warburg effect have markers of the mitochondrial permeability transition (MPT). Conclusion: MPT plays a possible role in suppression of mitochondrial function in OS. Significance: Our data implicate the MPT in metabolic reprogramming in cancer. Metabolic reprogramming in cancer is manifested by persistent aerobic glycolysis and suppression of mitochondrial function and is known as the Warburg effect. The Warburg effect contributes to cancer progression and is considered to be a promising therapeutic target. Understanding the mechanisms used by cancer cells to suppress their mitochondria may lead to development of new approaches to reverse metabolic reprogramming. We have evaluated mitochondrial function and morphology in poorly respiring LM7 and 143B osteosarcoma (OS) cell lines showing the Warburg effect in comparison with actively respiring Saos2 and HOS OS cells and noncancerous osteoblastic hFOB cells. In LM7 and 143B cells, we detected markers of the mitochondrial permeability transition (MPT), such as mitochondrial swelling, depolarization, and membrane permeabilization. In addition, we detected mitochondrial swelling in human OS xenografts in mice and archival human OS specimens using electron microscopy. The MPT inhibitor sanglifehrin A reversed MPT markers and increased respiration in LM7 and 143B cells. Our data suggest that the MPT may play a role in suppression of mitochondrial function, contributing to the Warburg effect in cancer.	[Giang, An-Hoa; Raymond, Tamara; Schwarz, Edward; O'Keefe, Regis; Eliseev, Roman] Univ Rochester, Ctr Musculoskeletal Res, Sch Med & Dent, Rochester, NY 14642 USA; [Brookes, Paul] Univ Rochester, Dept Anesthesiol, Sch Med & Dent, Rochester, NY 14642 USA; [Bentley, Karen de Mesy] Univ Rochester, Dept Pathol, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Eliseev, R (corresponding author), Univ Rochester, Sch Med & Dent, 575 Elmwood Ave,Rm 1-8541, Rochester, NY 14642 USA.	roman_eliseev@urmc.rochester.edu		Brookes, Paul/0000-0002-8639-8413	National Institutes of Health from the National Center for Research Resources [KL2 RR024136]; NIAMS [R03 AR061515, P30 AR061307]; Center for Musculoskeletal Research, BeatSarcoma; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061307, R03AR061515] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Center for Musculoskeletal Research, BeatSarcoma; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant KL2 RR024136 from the National Center for Research Resources and Grants R03 AR061515 and P30 AR061307 from NIAMS. This work was also supported by the Center for Musculoskeletal Research, BeatSarcoma, and the Karen D'Amico Foundation.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Czarnecka AM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-31; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gregory MA, 2011, ANTIMICROB AGENTS CH, V55, P1975, DOI 10.1128/AAC.01627-10; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Kimura H, 1996, CANCER RES, V56, P5522; Lafleur EA, 2004, CLIN CANCER RES, V10, P8114, DOI 10.1158/1078-0432.CCR-04-0353; Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Macho A, 1996, CYTOMETRY, V25, P333, DOI 10.1002/(SICI)1097-0320(19961201)25:4<333::AID-CYTO4>3.0.CO;2-E; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matsumoto S, 2010, CANCER RES, V70, P10019, DOI 10.1158/0008-5472.CAN-10-2821; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Schubert A, 2004, CANCER RES, V64, P85, DOI 10.1158/0008-5472.CAN-03-0476; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Shapovalov Y, 2010, INT J CANCER, V127, P67, DOI 10.1002/ijc.25024; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O. H., 1930, METABOLISM TUMOURS I; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wenner CE, 2012, J CELL PHYSIOL, V227, P450, DOI 10.1002/jcp.22788; Yasui H, 2010, CANCER RES, V70, P6427, DOI 10.1158/0008-5472.CAN-10-1350; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682	48	42	46	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33303	33311		10.1074/jbc.M113.507129	http://dx.doi.org/10.1074/jbc.M113.507129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100035	hybrid, Green Published			2022-12-28	WOS:000328841700044
J	Lai, WS; Perera, L; Hicks, SN; Blackshear, PJ				Lai, Wi S.; Perera, Lalith; Hicks, Stephanie N.; Blackshear, Perry J.			Mutational and Structural Analysis of the Tandem Zinc Finger Domain of Tristetraprolin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Inflammation; RNA-binding Protein; RNA Turnover; RNA-Protein Interaction; Tumor Necrosis Factor (TNF); AU-rich Elements	AU-RICH ELEMENT; CONTAINING MESSENGER-RNAS; PRIMARY RESPONSE GENE; GENOME-WIDE ANALYSIS; FORCE-FIELD; C-ELEGANS; PROTEINS; FAMILY; SEQUENCE; BINDING	Tristetraprolin (TTP), the best known member of a class of tandem (R/K)YKTELCX8CX5CX3H zinc finger proteins, can destabilize target mRNAs by first binding to AU-rich elements (AREs) in their 3-untranslated regions (UTRs) and subsequently promoting deadenylation and ultimate destruction of those mRNAs. This study sought to determine the roles of selected amino acids in the RNA binding domain, known as the tandem zinc finger (TZF) domain, in the ability of the full-length protein to bind to AREs within the tumor necrosis factor (TNF) mRNA 3-UTR. Within the CX8C region of the TZF domain, mutation of some of the residues specific to TTP, not found in other members of the TTP protein family, resulted in decreased binding to RNA as well as inhibited mRNA deadenylation and decay. Evaluation of simulation solution models revealed a distinct structure in the second zinc finger of TTP that was induced by the presence of these TTP-specific residues. In addition, mutations within the lead-in sequences preceding the first C of highly conserved residues within the CX5C or CX3H regions or within the linker region between the two fingers also perturbed both RNA binding and the simulation model of the TZF domain in complex with RNA. We conclude that, although the majority of conserved residues within the TZF domain of TTP are required for productive binding, not all residues at sequence-equivalent positions in the two zinc fingers of the TZF domain of TTP are functionally equivalent.	[Lai, Wi S.; Hicks, Stephanie N.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Perera, Lalith] NIEHS, Lab Struct Biol, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, F1-13 Bldg 101,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019; Perera, Lalith/ABB-9995-2021; perera, Lalith/B-6879-2012	Blackshear, Perry J./0000-0002-9561-8529; perera, Lalith/0000-0003-0823-1631	National Institutes of Health, NIEHS, Division of Intramural Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090080] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS, Division of Intramural Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health, NIEHS, Division of Intramural Research.	Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, BLOOD, V98, P2389, DOI 10.1182/blood.V98.8.2389; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Case D.A., 2010, AMBER VERSION 11; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Farley BM, 2008, RNA, V14, P2685, DOI 10.1261/rna.1256708; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; GOMPERTS M, 1990, ONCOGENE, V5, P1081; HEXIMER SP, 1993, DNA CELL BIOL, V12, P73, DOI 10.1089/dna.1993.12.73; Horner TJ, 2009, MOL CELL BIOL, V29, P1999, DOI 10.1128/MCB.00982-08; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jadhav S, 2008, DEVELOPMENT, V135, P1803, DOI 10.1242/dev.013656; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; MA QF, 1991, ONCOGENE, V6, P1277; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Shimada M, 2002, GENES CELLS, V7, P933, DOI 10.1046/j.1365-2443.2002.00570.x; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Tabara H, 1999, DEVELOPMENT, V126, P1; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44	48	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					565	580		10.1074/jbc.M113.466326	http://dx.doi.org/10.1074/jbc.M113.466326			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253039	Green Published, hybrid			2022-12-28	WOS:000329370900048
J	Baker, R; Wilkerson, EM; Sumita, K; Isom, DG; Sasaki, AT; Dohlman, HG; Campbell, SL				Baker, Rachael; Wilkerson, Emily M.; Sumita, Kazutaka; Isom, Daniel G.; Sasaki, Atsuo T.; Dohlman, Henrik G.; Campbell, Sharon L.			Differences in the Regulation of K-Ras and H-Ras Isoforms by Monoubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Oncogene; Post-translational Modification; Protein Chemical Modification; Ras; Signal Transduction; Ubiquitination; Monoubiquitination	SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; KRAS MUTATIONS; PROTEINS; BINDING; TRAFFICKING; EFFECTORS; SURFACE; GAPS; GEFS	Ras GTPases are signaling switches that control critical cellular processes including gene expression, differentiation, and apoptosis. The major Ras isoforms (K, H, and N) contain a conserved core GTPase domain, but have distinct biological functions. Among the three Ras isoforms there are clear differences in post-translational regulation, which contribute to differences in localization and signaling output. Modification by ubiquitination was recently reported to activate Ras signaling in cells, but the mechanisms of activation are not well understood. Here, we show that H-Ras is activated by monoubiquitination and that ubiquitination at Lys-117 accelerates intrinsic nucleotide exchange, thereby promoting GTP loading. This mechanism of Ras activation is distinct from K-Ras monoubiquitination at Lys-147, which leads to impaired regulator-mediated GTP hydrolysis. These findings reveal that different Ras isoforms are monoubiquitinated at distinct sites, with distinct mechanisms of action, but with a common ability to chronically activate the protein in the absence of a receptor signal or oncogenic mutation.	[Baker, Rachael; Isom, Daniel G.; Dohlman, Henrik G.; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Dohlman, Henrik G.; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilkerson, Emily M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Sumita, Kazutaka; Sasaki, Atsuo T.] Univ Cincinnati, Brain Tumor Ctr, Neurosci Inst, Div Hematol & Oncol,Dept Internal Med, Cincinnati, OH 45267 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Genet Med Bldg,Ste 3010, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu; campbesl@med.unc.edu	Sumita, Kazutaka/AAI-1553-2019	Dohlman, Henrik/0000-0003-2443-0729; campbell, sharon/0000-0003-0311-409X	National Institutes of Health [R01-GM106227A, R01-GM101560]; University Cancer Research Fund (UCRF); University of Cincinnati DNS/MERF; American Association of Neurological Surgeons fellowship; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073180, R01GM101560, R01GM106227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Research Fund (UCRF); University of Cincinnati DNS/MERF; American Association of Neurological Surgeons fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM106227A (to S. L. C.) and R01-GM101560 (to H. G. D.). This work was also supported by University Cancer Research Fund (UCRF) innovative grants (to S. L. C.) and by the University of Cincinnati DNS/MERF (to A. T. S.).; Partially supported by an American Association of Neurological Surgeons fellowship.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Colicelli J, 2010, CURR BIOL, V20, pR630, DOI 10.1016/j.cub.2010.06.019; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Denayer E, 2008, HUM MUTAT, V29, P232, DOI 10.1002/humu.20616; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Omerovic J, 2009, FEBS J, V276, P1817, DOI 10.1111/j.1742-4658.2009.06928.x; Pfleger CM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001874; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Schmidt G, 1996, ONCOGENE, V12, P87; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Sprang S, 2001, TRENDS BIOCHEM SCI, V26, P266, DOI 10.1016/S0968-0004(01)01818-7; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wolfman A., 2001, SCI STKE, V2001, ppe2; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; Zhang J, 1998, BIOCHEMISTRY-US, V37, P14881, DOI 10.1021/bi9811157	43	48	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36856	36862		10.1074/jbc.C113.525691	http://dx.doi.org/10.1074/jbc.C113.525691			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247240	Green Published, hybrid			2022-12-28	WOS:000329189700009
J	Matsumura, R; Matsubara, C; Node, K; Takumi, T; Akashi, M				Matsumura, Ritsuko; Matsubara, Chiaki; Node, Koichi; Takumi, Toru; Akashi, Makoto			Nuclear Receptor-mediated Cell-autonomous Oscillatory Expression of the Circadian Transcription Factor, Neuronal PAS Domain Protein 2 (NPAS2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Circadian Rhythms; Clock Genes; Nuclear Receptors; Transcription; Transcription Factors	CLOCK; COMPONENT; MAMMALS; GENE; MICE	Background: NPAS2 is a circadian transcription factor responsive to a wide range of intra- and extracellular stimuli. Results: Deficiency of ROR caused a damped transcriptional oscillation of Npas2 and functional depletion of an RORE resulted in a complete loss of the oscillation. Conclusion: Nuclear receptors elicit cell-autonomous circadian transcription of Npas2. Significance: Synchronous transcriptional oscillation of Npas2 with Bmal1 provides the foundation for efficient circadian input and robust oscillation. NPAS2 (MOP4) is a heme-containing sensor transcription factor responsive to a wide range of intra- and extracellular stimuli, which also functions as a circadian transcription factor. This molecule forms a heterodimer with another circadian transcription factor, BMAL1, and activates transcription via E-box elements, indicating that circadian phase synchronization between NPAS2 and BMAL1 expression is important for the efficient transcriptional activation of target genes. However, details of the mechanism of cell-autonomous circadian transcription of Npas2 remain unclear. Here, we show that one of the ROREs (retinoid-related orphan receptor response elements) in the upstream region of the transcription start site is essential for circadian transcription of the Npas2 gene. Furthermore, we also show that endogenous ROR indeed plays an essential role in cell-autonomous circadian transcription of Npas2, because a damped transcriptional oscillation was observed not only by introduction of a dominant negative form or small interfering RNA but also in embryonic fibroblasts obtained from ROR-mutant (sg/sg) mice. These results indicate that circadian transcription of Npas2 is synchronized with that of Bmal1 in a cell-autonomous nuclear receptor-mediated fashion.	[Matsumura, Ritsuko; Akashi, Makoto] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi 7538511, Japan; [Matsubara, Chiaki] Osaka City Univ, Grad Sch Med, Abeno Ku, Osaka 5450051, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 8498501, Japan; [Takumi, Toru] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Takumi, Toru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan	Yamaguchi University; Osaka Metropolitan University; Saga University; RIKEN; Japan Science & Technology Agency (JST)	Takumi, T (corresponding author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	toru.takumi@riken.jp; akashima@yamaguchi-u.ac.jp	Matsumura, Ritsuko/AAS-7122-2020		KAKENHI from Japan Society of Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Strategic International Cooperative Program (SICP) from Japan Science and Technology Agency (JST); Human Frontier Science Program (HFSP) [RPG 24/2012]; Uehara Memorial Foundation; Kanae Foundation; Takeda Science Foundation	KAKENHI from Japan Society of Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Cooperative Program (SICP) from Japan Science and Technology Agency (JST); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI from Japan Society of Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Strategic International Cooperative Program (SICP) from Japan Science and Technology Agency (JST), and Human Frontier Science Program (HFSP) Grant RPG 24/2012. This work was also supported by fellowships from the Uehara Memorial Foundation, the Kanae Foundation, and the Takeda Science Foundation.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2000, GENE DEV, V14, P645; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Partch CL, 2013, TRENDS CELL BIOL; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18	20	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36548	36553		10.1074/jbc.M113.517235	http://dx.doi.org/10.1074/jbc.M113.517235			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196956	Green Published, hybrid			2022-12-28	WOS:000328883400035
J	Casanal, A; Zander, U; Munoz, C; Dupeux, F; Luque, I; Botella, MA; Schwab, W; Valpuesta, V; Marquez, JA				Casanal, Ana; Zander, Ulrich; Munoz, Cristina; Dupeux, Florine; Luque, Irene; Angel Botella, Miguel; Schwab, Wilfried; Valpuesta, Victoriano; Marquez, Jose A.			The Strawberry Pathogenesis-related 10 (PR-10) Fra a Proteins Control Flavonoid Biosynthesis by Binding to Metabolic Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Flavonoids; Plant Biochemistry; Plant Molecular Biology; Secondary Metabolism	BET V 1; ALLERGIC CROSS-REACTIVITY; MEDICAGO-TRUNCATULA; X-RAY; PROANTHOCYANIDIN BIOSYNTHESIS; CRYSTAL-STRUCTURE; LIPID TRANSPORT; LIGAND-BINDING; START PROTEINS; DATA-BANK	Pathogenesis-related 10 (PR-10) proteins are involved in many aspects of plant biology but their molecular function is still unclear. They are related by sequence and structural homology to mammalian lipid transport and plant abscisic acid receptor proteins and are predicted to have cavities for ligand binding. Recently, three new members of the PR-10 family, the Fra a proteins, have been identified in strawberry, where they are required for the activity of the flavonoid biosynthesis pathway, which is essential for the development of color and flavor in fruits. Here, we show that Fra a proteins bind natural flavonoids with different selectivity and affinities in the low m range. The structural analysis of Fra a 1 E and a Fra a 3-catechin complex indicates that loops L3, L5, and L7 surrounding the ligand-binding cavity show significant flexibility in the apo forms but close over the ligand in the Fra a 3-catechin complex. Our findings provide mechanistic insight on the function of Fra a proteins and suggest that PR-10 proteins, which are widespread in plants, may play a role in the control of secondary metabolic pathways by binding to metabolic intermediates.	[Casanal, Ana; Munoz, Cristina; Angel Botella, Miguel; Valpuesta, Victoriano] Univ Malaga, Dept Biol Mol & Bioquim, IHSM UMA Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea, E-29071 Malaga, Spain; [Zander, Ulrich; Dupeux, Florine; Marquez, Jose A.] Grenoble Outstat, European Mol Biol Lab, F-38042 Grenoble, France; [Zander, Ulrich; Dupeux, Florine; Marquez, Jose A.] Univ Grenoble Alpes EMBL CNRS, Unit Virus Host Cell Interact, F-38042 Grenoble, France; [Luque, Irene] Univ Granada, Dept Phys Chem, E-18071 Granada, Spain; [Luque, Irene] Univ Granada, Inst Biotechnol, E-18071 Granada, Spain; [Schwab, Wilfried] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Granada; University of Granada; Technical University of Munich	Valpuesta, V (corresponding author), Univ Malaga, Dept Biol Mol & Bioquim, IHSM UMA Consejo Super Invest Cient, Inst Hortofruticultura Subtrop & Mediterranea, E-29071 Malaga, Spain.	valpuesta@uma.es; marquez@embl.fr	Botella, Miguel Ángel/S-3676-2019; Marquez, Jose/C-5826-2015; Botella, Miguel A/B-5734-2012; Luque, Inmaculada/K-9464-2014; Casañal, Ana/B-1002-2018; Luque, Irene/K-4758-2012; /R-5462-2019	Botella, Miguel Ángel/0000-0002-8867-1831; Botella, Miguel A/0000-0002-8867-1831; Luque, Inmaculada/0000-0003-1838-2636; Casañal, Ana/0000-0002-0334-0591; Luque, Irene/0000-0003-2757-4779; Valpuesta, Victoriano/0000-0003-0922-6615	European Commission [227764]; Ministerio de Ciencia e Innovacion (Spain) [BIO2010-15630]; Deutsche Forschungsgemeinschaft (Germany) [SFB 924]; Spanish government	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); Spanish government(Spanish GovernmentEuropean Commission)	This work was supported in part by the P-CUBE project of the European Commission (FP7/2007-2013; Grant 227764), Ministerio de Ciencia e Innovacion Grant BIO2010-15630 (Spain), and Deutsche Forschungsgemeinschaft SFB 924 (Germany).; Recipient of a Formacion de Personal Investigador (FPI) fellowship from the Spanish government.	Aaby K, 2007, J AGR FOOD CHEM, V55, P4395, DOI 10.1021/jf0702592; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beuning LL, 2004, PLANT MOL BIOL, V55, P369, DOI 10.1007/s11103-004-0904-9; Blount JW, 2000, PLANT PHYSIOL, V122, P107, DOI 10.1104/pp.122.1.107; Botton A, 2009, J AGR FOOD CHEM, V57, P724, DOI 10.1021/jf802709k; Casanal A, 2013, ACTA CRYSTALLOGR F, V69, P510, DOI 10.1107/S1744309113006945; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Fernandes H, 2009, FEBS J, V276, P1596, DOI 10.1111/j.1742-4658.2009.06892.x; Fraser C. M., 2011, ARABIDOPSIS BOOK, V9, pe0152; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Ghasemzadeh A, 2011, J MED PLANTS RES, V5, P6697, DOI 10.5897/JMPR11.1404; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Halbwirth H, 2006, J AGR FOOD CHEM, V54, P1479, DOI 10.1021/jf0524170; Hanhineva K, 2008, PHYTOCHEMISTRY, V69, P2463, DOI 10.1016/j.phytochem.2008.07.009; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hierno K, 2006, PROTEOMICS, V6, P1574, DOI 10.1002/pmic.200500469; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlsson AL, 2004, ALLERGY, V59, P1277, DOI 10.1111/j.1398-9995.2004.00585.x; Kobayashi H, 2004, MOL MICROBIOL, V51, P335, DOI 10.1046/j.1365-2958.2003.03841.x; Kosar M, 2004, J AGR FOOD CHEM, V52, P1586, DOI 10.1021/jf035093t; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Mahajan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028315; Marinova K, 2007, PLANT CELL, V19, P2023, DOI 10.1105/tpc.106.046029; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Munoz C, 2011, J AGR FOOD CHEM, V59, P12598, DOI 10.1021/jf203965j; Munoz C, 2010, MOL PLANT, V3, P113, DOI 10.1093/mp/ssp087; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Olsen KM, 2008, J PLANT PHYSIOL, V165, P1491, DOI 10.1016/j.jplph.2007.11.005; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Spangfort MD, 1997, INT ARCH ALLERGY IMM, V113, P243, DOI 10.1159/000237559; Spangfort MD, 1999, ALLERGY, V54, P23, DOI 10.1111/j.1398-9995.1999.tb05021.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; von Loetzen CS, 2012, BIOSCIENCE REP, V32, P567, DOI 10.1042/BSR20120058; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Yin R, 2012, J EXP BOT, V63, P2465, DOI 10.1093/jxb/err416; Zhao J, 2011, PLANT CELL, V23, P1536, DOI 10.1105/tpc.110.080804; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006; Zhao J, 2009, PLANT CELL, V21, P2323, DOI 10.1105/tpc.109.067819	71	55	63	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35322	35332		10.1074/jbc.M113.501528	http://dx.doi.org/10.1074/jbc.M113.501528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133217	Green Published, hybrid			2022-12-28	WOS:000329867600030
J	Congdon, EE; Gu, JP; Sait, HBR; Sigurdsson, EM				Congdon, Erin E.; Gu, Jiaping; Sait, Hameetha B. R.; Sigurdsson, Einar M.			Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fc gamma Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Antibodies; Endocytosis; Immunotherapy; Tau	MOUSE MODEL; A-BETA; ALZHEIMERS-DISEASE; IMMUNOGLOBULIN-G; NEUROFIBRILLARY TANGLES; PASSIVE-IMMUNIZATION; MEDIATED ENDOCYTOSIS; PATHOLOGY; PEPTIDE; IMMUNOTHERAPY	Background: How Tau immunotherapy clears Tau is not well known. Results: Tau antibody uptake correlates with Tau levels, is primarily via clathrin-dependent FcII/III endocytosis, and is required for acute Tau clearance. Conclusion: Following receptor-mediated uptake into neurons, antibodies co-localize with Tau aggregates and promote Tau clearance. Significance: Results support intracellular clearance as a viable route for immunotherapy and have major implications for future development. Tau immunotherapy is effective in transgenic mice, but the mechanisms of Tau clearance are not well known. To this end, Tau antibody uptake was analyzed in brain slice cultures and primary neurons. Internalization was rapid (<1 h), saturable, and substantial compared with control mouse IgG. Furthermore, temperature reduction to 4 degrees C, an excess of unlabeled mouse IgG, or an excess of Tau antibodies reduced uptake in slices by 63, 41, and 62%, respectively (p = 0.002, 0.04, and 0.005). Uptake strongly correlated with total and insoluble Tau levels (r(2) = 0.77 and 0.87 and p = 0.002 and 0.0002), suggesting that Tau aggregates influence antibody internalization and/or retention within neurons. Inhibiting phagocytosis did not reduce uptake in slices or neuronal cultures, indicating limited microglial involvement. In contrast, clathrin-specific inhibitors reduced uptake in neurons (78%, p < 0.0001) and slices (35%, p = 0.03), demonstrating receptor-mediated endocytosis as the primary uptake pathway. Fluid phase endocytosis accounted for the remainder of antibody uptake in primary neurons, based on co-staining with internalized dextran. The receptor-mediated uptake is to a large extent via low affinity FcII/III receptors and can be blocked in slices (43%, p = 0.04) and neurons (53%, p = 0.008) with an antibody against these receptors. Importantly, antibody internalization appears to be necessary for Tau reduction in primary neurons. Overall, these findings clarify that Tau antibody uptake is primarily receptor-mediated, that these antibodies are mainly found in neurons with Tau aggregates, and that their intracellular interaction leads to clearance of Tau pathology, all of which have major implications for therapeutic development of this approach.	[Congdon, Erin E.; Gu, Jiaping; Sait, Hameetha B. R.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Sigurdsson, Einar M.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	New York University; New York University	Sigurdsson, EM (corresponding author), NYU, Sch Med, Dept Neurosci & Physiol, 550 First Ave MSB 459, New York, NY 10016 USA.	Einar.Sigurdsson@nyumc.org		Congdon, Erin/0000-0001-8322-6176; Sigurdsson, Einar/0000-0003-1451-0952	National Institutes of Health [NS077239, AG032611, AG020197]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG020197, R01AG032611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS077239, AG032611, and AG020197. E. M. Sigurdsson is an inventor on NYU patents on Tau immunotherapy licensed to H. Lundbeck A/S.	Andoh T, 2004, FASEB J, V18, P182, DOI 10.1096/fj.02-1169fje; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; BOUTAJANGOUT A, 2011, ALZHEIMERS DEMENT, V7, pS480; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Callaway E, 2012, NATURE, V489, P13, DOI 10.1038/489013a; Cao SW, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-42; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2010, M S-MED SCI, V26, P121, DOI 10.1051/medsci/2010262121; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; Das P, 2003, J NEUROSCI, V23, P8532; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fernandez-Vizarra P, 2012, BRAIN, V135, P2826, DOI 10.1093/brain/aws195; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goebl NA, 2008, MOL BIOL CELL, V19, P5490, DOI 10.1091/mbc.E07-02-0101; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gong CX, 2001, BRAIN RES PROTOC, V6, P134, DOI 10.1016/S1385-299X(00)00046-5; Gu JP, 2013, J BIOL CHEM, V288, P33081, DOI 10.1074/jbc.M113.494922; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Krishnamurthy Pavan K, 2011, Front Psychiatry, V2, P59, DOI 10.3389/fpsyt.2011.00059; Lemere CA, 2000, ANN NY ACAD SCI, V920, P328; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu L, 2012, PLOS ONE, V7; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; PERESS NS, 1993, J NEUROIMMUNOL, V48, P71, DOI 10.1016/0165-5728(93)90060-C; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Punnonen EL, 1998, EUR J CELL BIOL, V75, P344, DOI 10.1016/S0171-9335(98)80067-8; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; Soto C, 2012, NEURON, V73, P621, DOI 10.1016/j.neuron.2012.02.006; Suemitsu S, 2010, NEUROSCIENCE, V166, P819, DOI 10.1016/j.neuroscience.2010.01.004; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; van der Kleij H, 2010, J ALLERGY CLIN IMMUN, V125, P757, DOI 10.1016/j.jaci.2009.10.054; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615	59	142	150	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35452	35465		10.1074/jbc.M113.491001	http://dx.doi.org/10.1074/jbc.M113.491001			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163366	Green Published, hybrid			2022-12-28	WOS:000329867600041
J	Hasse, D; Andersson, E; Carlsson, G; Masloboy, A; Hagemann, M; Bauwe, H; Andersson, I				Hasse, Dirk; Andersson, Evalena; Carlsson, Gunilla; Masloboy, Axel; Hagemann, Martin; Bauwe, Hermann; Andersson, Inger			Structure of the Homodimeric Glycine Decarboxylase P-protein from Synechocystis sp PCC 6803 Suggests a Mechanism for Redox Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Decarboxylase; Disulfide; Pyridoxal Phosphate; Redox Regulation; P-protein; Glycine Decarboxylase	CLEAVAGE SYSTEM; H-PROTEIN; T-PROTEIN; ANTISENSE REDUCTION; MULTIENZYME COMPLEX; CARBON METABOLISM; POTATO PLANTS; CLONING; CYANOBACTERIA; ENZYMES	Glycine decarboxylase, or P-protein, is a pyridoxal 5-phosphate (PLP)-dependent enzyme in one-carbon metabolism of all organisms, in the glycine and serine catabolism of vertebrates, and in the photorespiratory pathway of oxygenic phototrophs. P-protein from the cyanobacterium Synechocystis sp. PCC 6803 is an (2) homodimer with high homology to eukaryotic P-proteins. The crystal structure of the apoenzyme shows the C terminus locked in a closed conformation by a disulfide bond between Cys(972) in the C terminus and Cys(353) located in the active site. The presence of the disulfide bridge isolates the active site from solvent and hinders the binding of PLP and glycine in the active site. Variants produced by substitution of Cys(972) and Cys(353) by Ser using site-directed mutagenesis have distinctly lower specific activities, supporting the crucial role of these highly conserved redox-sensitive amino acid residues for P-protein activity. Reduction of the 353-972 disulfide releases the C terminus and allows access to the active site. PLP and the substrate glycine bind in the active site of this reduced enzyme and appear to cause further conformational changes involving a flexible surface loop. The observation of the disulfide bond that acts to stabilize the closed form suggests a molecular mechanism for the redox-dependent activation of glycine decarboxylase observed earlier.	[Hasse, Dirk; Carlsson, Gunilla; Andersson, Inger] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; [Andersson, Evalena] Swedish Univ Agr Sci, Dept Mol Biol, S-75124 Uppsala, Sweden; [Masloboy, Axel; Hagemann, Martin; Bauwe, Hermann] Univ Rostock, Dept Plant Physiol, D-18051 Rostock, Germany	Uppsala University; Swedish University of Agricultural Sciences; University of Rostock	Andersson, I (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden.	inger@xray.bmc.uu.se		Hasse, Dirk/0000-0001-8710-327X	Deutscher Akademischer Austauschdienst; Landesgraduiertenstipendium Mecklenburg-Vorpommern; Swedish Research Council FORMAS	Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Landesgraduiertenstipendium Mecklenburg-Vorpommern; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Deutscher Akademischer Austauschdienst and Landesgraduiertenstipendium Mecklenburg-Vorpommern and grants from the Swedish Research Council FORMAS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; BAUWE H, 1995, EUR J BIOCHEM, V234, P116, DOI 10.1111/j.1432-1033.1995.116_c.x; Bauwe H, 2010, TRENDS PLANT SCI, V15, P330, DOI 10.1016/j.tplants.2010.03.006; Beffa T, 1996, APPL ENVIRON MICROB, V62, P1723, DOI 10.1128/AEM.62.5.1723-1727.1996; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Bykova NV, 2005, PLANTA, V222, P130, DOI 10.1007/s00425-005-1505-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, FEMS MICROBIOL LETT, V277, P232, DOI 10.1111/j.1574-6968.2007.00960.x; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Faure M, 2000, EUR J BIOCHEM, V267, P2890, DOI 10.1046/j.1432-1033.2000.01330.x; FREUDENBERG W, 1989, J BACTERIOL, V171, P2209, DOI 10.1128/jb.171.4.2209-2215.1989; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guilhaudis L, 2000, BIOCHEMISTRY-US, V39, P4259, DOI 10.1021/bi992674w; Hagemann M, 2005, PLANT BIOLOGY, V7, P15, DOI 10.1055/s-2004-830445; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hasse D, 2007, FEBS LETT, V581, P1297, DOI 10.1016/j.febslet.2007.02.037; Hasse D, 2010, ACTA CRYSTALLOGR F, V66, P187, DOI 10.1107/S1744309109052828; Hasse D, 2009, FEBS J, V276, P6985, DOI 10.1111/j.1742-4658.2009.07406.x; Heineke D, 2001, PLANTA, V212, P880, DOI 10.1007/s004250000460; HIRAGA K, 1972, J BIOCHEM-TOKYO, V72, P1285, DOI 10.1093/oxfordjournals.jbchem.a130020; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorda J, 2011, ARCHAEA, V2011, DOI 10.1155/2011/409156; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanno J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.043448; KAWASAKI H, 1966, BIOCHEM BIOPH RES CO, V23, P227, DOI 10.1016/0006-291X(66)90532-8; Kern R, 2011, PHOTOSYNTH RES, V109, P103, DOI 10.1007/s11120-010-9615-z; KIKUCHI G, 1982, MOL CELL BIOCHEM, V45, P137; Kikuchi G, 2008, P JPN ACAD B-PHYS, V84, P246, DOI 10.2183/pjab/84.246; KLEIN SM, 1967, J BIOL CHEM, V242, P297; KUME A, 1991, J BIOL CHEM, V266, P3323; Kure S, 1998, HUM GENET, V102, P430, DOI 10.1007/s004390050716; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee HH, 2004, J BIOL CHEM, V279, P50514, DOI 10.1074/jbc.M409672200; Li M, 2007, ARCH BIOCHEM BIOPHYS, V458, P220, DOI 10.1016/j.abb.2006.12.010; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Lindahl M, 2009, J PROTEOMICS, V72, P416, DOI 10.1016/j.jprot.2009.01.003; Maaheimo H, 2001, EUR J BIOCHEM, V268, P2464, DOI 10.1046/j.1432-1327.2001.02126.x; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Marti MC, 2009, PLANT PHYSIOL, V150, P646, DOI 10.1104/pp.109.138073; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil JB, 1997, GENE, V186, P13, DOI 10.1016/S0378-1119(96)00670-1; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; MOTOKAWA Y, 1971, ARCH BIOCHEM BIOPHYS, V146, P461, DOI 10.1016/0003-9861(71)90149-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; Nakai T, 2003, ACTA CRYSTALLOGR D, V59, P1610, DOI 10.1107/S0907444903014975; NEUBURGER M, 1986, FEBS LETT, V207, P18, DOI 10.1016/0014-5793(86)80005-9; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; OLIVER DJ, 1990, PLANT PHYSIOL, V94, P833, DOI 10.1104/pp.94.2.833; OLIVER DJ, 1994, ANNU REV PLANT PHYS, V45, P323, DOI 10.1146/annurev.pp.45.060194.001543; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PASTERNACK LB, 1992, BIOCHEMISTRY-US, V31, P8713, DOI 10.1021/bi00152a005; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Timm S, 2012, FEBS LETT, V586, P3692, DOI 10.1016/j.febslet.2012.08.027; TURNER SR, 1992, J BIOL CHEM, V267, P5355; WALKER JL, 1986, J BIOL CHEM, V261, P2214; Yoshida K, 2013, PLANT CELL PHYSIOL, V54, P875, DOI 10.1093/pcp/pct037	70	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35333	35345		10.1074/jbc.M113.509976	http://dx.doi.org/10.1074/jbc.M113.509976			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24121504	Green Published, hybrid			2022-12-28	WOS:000329867600031
J	Shugg, RPP; Thomson, A; Tanabe, N; Kashishian, A; Steiner, BH; Puri, KD; Pereverzev, A; Lannutti, BJ; Jirik, FR; Dixon, SJ; Sims, SM				Shugg, Ryan P. P.; Thomson, Ashley; Tanabe, Natsuko; Kashishian, Adam; Steiner, Bart H.; Puri, Kamal D.; Pereverzev, Alexey; Lannutti, Brian J.; Jirik, Frank R.; Dixon, S. Jeffrey; Sims, Stephen M.			Effects of isoform-selective Phosphatidylinositol 3-Kinase Inhibitors on Osteoclasts ACTIONS ON CYTOSKELETAL ORGANIZATION, SURVIVAL, AND RESORPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Bone; Cytoskeleton; Osteoclast; Phosphatidylinositol 3-Kinase; GS-9820; Bone Resorption; Lamellipod	PHOSPHOINOSITIDE 3-KINASE; RAT OSTEOCLASTS; PI3K ISOFORMS; CLASS-I; ROLES; DELTA; RETRACTION; MECHANISMS; P110-ALPHA; PI3-KINASE	Phosphatidylinositol 3-kinases (PI3K) participate in numerous signaling pathways, and control distinct biological functions. Studies using pan-PI3K inhibitors suggest roles for PI3K in osteoclasts, but little is known about specific PI3K isoforms in these cells. Our objective was to determine effects of isoform-selective PI3K inhibitors on osteoclasts. The following inhibitors were investigated (targets in parentheses): wortmannin and LY294002 (pan-p110), PIK75 (), GDC0941 (, ), TGX221 (), AS252424 (), and IC87114 (). In addition, we characterized a new potent and selective PI3K inhibitor, GS-9820, and explored roles of PI3K isoforms in regulating osteoclast function. Osteoclasts were isolated from long bones of neonatal rats and rabbits. Wortmannin, LY294002, GDC0941, IC87114, and GS-9820 induced a dramatic retraction of osteoclasts within 15-20 min to 65-75% of the initial area. In contrast, there was no significant retraction in response to vehicle, PIK75, TGX221, or AS252424. Moreover, wortmannin and GS-9820, but not PIK75 or TGX221, disrupted actin belts. We examined effects of PI3K inhibitors on osteoclast survival. Whereas PIK75, TGX221, and GS-9820 had no significant effect on basal survival, all blocked RANKL-stimulated survival. When studied on resorbable substrates, osteoclastic resorption was suppressed by wortmannin and inhibitors of PI3K and PI3K, but not other isoforms. These data are consistent with a critical role for PI3K in regulating osteoclast cytoskeleton and resorptive activity. In contrast, multiple PI3K isoforms contribute to the control of osteoclast survival. Thus, the PI3K isoform, which is predominantly expressed in cells of hematopoietic origin, is an attractive target for anti-resorptive therapeutics.	[Shugg, Ryan P. P.; Thomson, Ashley; Pereverzev, Alexey; Dixon, S. Jeffrey; Sims, Stephen M.] Western Univ, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Tanabe, Natsuko] Nihon Univ, Sch Dent, Tokyo 101, Japan; [Kashishian, Adam; Steiner, Bart H.; Puri, Kamal D.; Lannutti, Brian J.] Gilead Sci Inc, Seattle, WA 98102 USA; [Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Western University (University of Western Ontario); Nihon University; Gilead Sciences; University of Calgary	Sims, SM (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	smsims@uwo.ca	Sims, Stephen/G-4510-2013; Dixon, S. Jeffrey/G-3657-2013	Dixon, S. Jeffrey/0000-0001-9162-1686	Canadian Institutes of Health Research [64453]; Alberta Cancer Research Institute [24428]; CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant 64453 and Alberta Cancer Research Institute Grant 24428.; Recipient of a Frederick Banting and Charles Best Canada Graduate Scholarship from the CIHR.	Adapala NS, 2010, J BIOL CHEM, V285, P36745, DOI 10.1074/jbc.M110.124628; Afonso PV, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002019; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Armstrong S, 2009, J CELL SCI, V122, P136, DOI 10.1242/jcs.031534; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Chellaiah MA, 2006, EUR J CELL BIOL, V85, P311, DOI 10.1016/j.ejcb.2006.01.008; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Golden LH, 2004, BONE, V34, P3, DOI 10.1016/j.bone.2003.09.005; Grey A, 2010, BIOCHEM BIOPH RES CO, V391, P564, DOI 10.1016/j.bbrc.2009.11.099; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hayakawa M, 2007, BIOORGAN MED CHEM, V15, P403, DOI 10.1016/j.bmc.2006.09.047; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Komarova SV, 2003, CALCIFIED TISSUE INT, V73, P265, DOI 10.1007/s00223-002-1051-4; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lakkakorpi PT, 1997, EXP CELL RES, V237, P296, DOI 10.1006/excr.1997.3797; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Lapierre DM, 2010, J BIOL CHEM, V285, P25792, DOI 10.1074/jbc.M110.109322; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Mouchemore KA, 2013, FEBS J, V280, P5228, DOI 10.1111/febs.12316; Naemsch LN, 1999, J CELL SCI, V112, P4425; Naemsch LN, 2001, J BIOL CHEM, V276, P39107, DOI 10.1074/jbc.M105881200; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Palacio S, 2001, EUR J ENDOCRINOL, V144, P431, DOI 10.1530/eje.0.1440431; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Pilkington MF, 1998, J BONE MINER RES, V13, P688, DOI 10.1359/jbmr.1998.13.4.688; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Shuttleworth SJ, 2011, CURR MED CHEM, V18, P2686; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WOOD DA, 1991, J BIOL CHEM, V266, P15369	48	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35346	35357		10.1074/jbc.M113.507525	http://dx.doi.org/10.1074/jbc.M113.507525			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133210	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000329867600032
J	Maeda, T; Lee, MJ; Palczewska, G; Marsili, S; Tesar, PJ; Palczewski, K; Takahashi, M; Maeda, A				Maeda, Tadao; Lee, Mee Jee; Palczewska, Grazyna; Marsili, Stefania; Tesar, Paul J.; Palczewski, Krzysztof; Takahashi, Masayo; Maeda, Akiko			Retinal Pigmented Epithelial Cells Obtained from Human Induced Pluripotent Stem Cells Possess Functional Visual Cycle Enzymes in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Induced Pluripotent Stem (iPS) Cell; Retinal Degeneration; Retinal Metabolism; Retinoid; Transplantation; LRAT; RPE; RPE65; Visual Cycle	LEBERS CONGENITAL AMAUROSIS; MACULAR DEGENERATION; RPE65; TRANSPLANTATION; EYE; DIFFERENTIATION; ACYLTRANSFERASE; EXPRESSION; MUTATIONS; INSIGHTS	Background: The visual (retinoid) cycle activity in human iPS-derived RPE (hiPS-RPE) cells has not been fully examined. Results: hiPS-RPE cells showed a functional visual cycle in both in vitro and in vivo. Conclusion: hiPS-RPE cell could provide potential treatment options for retinal degenerative diseases. Significance: hiPS-RPE cells with functional visual cycle proteins potentially could remedy certain degenerative retinal diseases. Differentiated retinal pigmented epithelial (RPE) cells have been obtained from human induced pluripotent stem (hiPS) cells. However, the visual (retinoid) cycle in hiPS-RPE cells has not been adequately examined. Here we determined the expression of functional visual cycle enzymes in hiPS-RPE cells compared with that of isolated wild-type mouse primary RPE (mpRPE) cells in vitro and in vivo. hiPS-RPE cells appeared morphologically similar to mpRPE cells. Notably, expression of certain visual cycle proteins was maintained during cell culture of hiPS-RPE cells, whereas expression of these same molecules rapidly decreased in mpRPE cells. Production of the visual chromophore, 11-cis-retinal, and retinosome formation also were documented in hiPS-RPE cells in vitro. When mpRPE cells with luciferase activity were transplanted into the subretinal space of mice, bioluminance intensity was preserved for >3 months. Additionally, transplantation of mpRPE into blind Lrat(-/-) and Rpe65(-/-) mice resulted in the recovery of visual function, including increased electrographic signaling and endogenous 11-cis-retinal production. Finally, when hiPS-RPE cells were transplanted into the subretinal space of Lrat(-/-) and Rpe65(-/-) mice, their vision improved as well. Moreover, histological analyses of these eyes displayed replacement of dysfunctional RPE cells by hiPS-RPE cells. Together, our results show that hiPS-RPE cells can exhibit a functional visual cycle in vitro and in vivo. These cells could provide potential treatment options for certain blinding retinal degenerative diseases.	[Maeda, Tadao; Lee, Mee Jee; Marsili, Stefania; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Maeda, Tadao; Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Tesar, Paul J.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Palczewska, Grazyna] Polgenix Inc, Cleveland, OH 44106 USA; [Takahashi, Masayo] RIKEN, Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo 6500047, Japan	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; RIKEN	Maeda, T (corresponding author), Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44106 USA.	txm88@case.edu; aam19@case.edu	Tesar, Paul J/C-9848-2014; marsili, stefania/AAY-9743-2020; Tesar, Paul/GPK-5942-2022	Tesar, Paul J/0000-0003-1532-3155; marsili, stefania/0000-0003-0117-8874; Tesar, Paul/0000-0003-1532-3155	National Institutes of Health [K08EY019031, K08EY019880, R01EY022658, R01EY009339, R24EY021126, R44AG043645, P30EY011373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Midwest Eye Banks; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, K08EY019031, K08EY019880, R24EY021126, R01EY022658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG043645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Midwest Eye Banks; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019031, K08EY019880, R01EY022658, R01EY009339, R24EY021126, R44AG043645, and P30EY011373. This work was also supported by the Research to Prevent Blindness Foundation, the Foundation Fighting Blindness, the Midwest Eye Banks, and the Ohio Lions Eye Research Foundation.	Ahmado A, 2011, INVEST OPHTH VIS SCI, V52, P7148, DOI 10.1167/iovs.10-6374; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Boulanger A, 2000, J BIOL CHEM, V275, P31274, DOI 10.1074/jbc.M003441200; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Carr AJF, 2013, TRENDS NEUROSCI, V36, P385, DOI 10.1016/j.tins.2013.03.006; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Cheung CMG, 2012, ARCH OPHTHALMOL-CHIC, V130, P480, DOI 10.1001/archophthalmol.2011.376; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Engelhardt M, 2012, VISUAL NEUROSCI, V29, P83, DOI 10.1017/S0952523812000041; Gearhart PM, 2010, ARCH OPHTHALMOL-CHIC, V128, P1442, DOI 10.1001/archophthalmol.2010.210; Golczak M, 2010, J BIOL CHEM, V285, P9667, DOI 10.1074/jbc.M109.063941; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kanemura H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02334; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Klein R, 2013, OPHTHALMOLOGY, V120, P1210, DOI 10.1016/j.ophtha.2012.11.041; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Nicoletti A, 1998, INVEST OPHTH VIS SCI, V39, P637; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rattner A, 2008, J NEUROSCI, V28, P9880, DOI 10.1523/JNEUROSCI.2401-08.2008; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Stanzel BV, 2005, EXP EYE RES, V80, P103, DOI 10.1016/j.exer.2004.06.032; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tezel TH, 2007, AM J OPHTHALMOL, V143, P584, DOI 10.1016/j.ajo.2006.12.007; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	40	64	65	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34484	34493		10.1074/jbc.M113.518571	http://dx.doi.org/10.1074/jbc.M113.518571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129572	Green Published, hybrid			2022-12-28	WOS:000329812800018
J	Ramon-Garcia, S; Ng, C; Jensen, PR; Dosanjh, M; Burian, J; Morris, RP; Folcher, M; Eltis, LD; Grzesiek, S; Nguyen, L; Thompson, CJ				Ramon-Garcia, Santiago; Ng, Carol; Jensen, Pernille R.; Dosanjh, Manisha; Burian, Jan; Morris, Rowan P.; Folcher, Marc; Eltis, Lindsay D.; Grzesiek, Stephan; Liem Nguyen; Thompson, Charles J.			WhiB7, an Fe-S-dependent Transcription Factor That Activates Species-specific Repertoires of Drug Resistance Determinants in Actinobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actinobacteria; Antibiotic Resistance; Gene Regulation; Iron-Sulfur Protein; Transcription; AT-hook; Iron-Sulfur Cluster; Regulation	MYCOBACTERIUM-TUBERCULOSIS H37RV; IRON-SULFUR CLUSTER; SP STRAIN RHA1; ESCHERICHIA-COLI; 4FE-4S CLUSTER; ANTIBIOTIC-RESISTANCE; EFFLUX PUMP; IN-VIVO; MOLECULAR-CLONING; BINDING PROTEIN	Background: WhiB7 is essential for antibiotic resistance in M. tuberculosis. Results: WhiB7 requires conserved residues, including a redox-sensitive center and DNA-binding motif, to coordinate transcription of species-specific drug resistance genes in diverse Actinobacteria. Conclusion: WhiB7 activates species-specific drug resistance genes in Actinobacteria. Significance: Understanding WhiB7 activity may allow the development of drugs that sensitize bacteria to antibiotics. WhiB-like (Wbl) proteins are well known for their diverse roles in actinobacterial morphogenesis, cell division, virulence, primary and secondary metabolism, and intrinsic antibiotic resistance. Gene disruption experiments showed that three different Actinobacteria (Mycobacterium smegmatis, Streptomyces lividans, and Rhodococcus jostii) each exhibited a different whiB7-dependent resistance profile. Heterologous expression of whiB7 genes showed these resistance profiles reflected the host's repertoire of endogenous whiB7-dependent genes. Transcriptional activation of two resistance genes in the whiB7 regulon, tap (a multidrug transporter) and erm(37) (a ribosomal methyltransferase), required interaction of WhiB7 with their promoters. Furthermore, heterologous expression of tap genes isolated from Mycobacterium species demonstrated that divergencies in drug specificity of homologous structural proteins contribute to the variation of WhiB7-dependent drug resistance. WhiB7 has a specific tryptophan/glycine-rich region and four conserved cysteine residues; it also has a peptide sequence (AT-hook) at its C terminus that binds AT-rich DNA sequence motifs upstream of the promoters it activates. Targeted mutagenesis showed that these motifs were required to provide antibiotic resistance in vivo. Anaerobically purified WhiB7 from S. lividans was dimeric and contained 2.1 +/- 0.3 and 2.2 +/- 0.3 mol of iron and sulfur, respectively, per protomer (consistent with the presence of a 2Fe-2S cluster). However, the properties of the dimer's absorption spectrum were most consistent with the presence of an oxygen-labile 4Fe-4S cluster, suggesting 50% occupancy. These data provide the first insights into WhiB7 iron-sulfur clusters as they exist in vivo, a major unresolved issue in studies of Wbl proteins.	[Ramon-Garcia, Santiago; Ng, Carol; Dosanjh, Manisha; Burian, Jan; Eltis, Lindsay D.; Thompson, Charles J.] Univ British Columbia, Dept Microbiol & Immunol, Ctr TB Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Jensen, Pernille R.; Folcher, Marc; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Morris, Rowan P.] Anim Hlth & Vet Labs Agcy, Starcross EX6 8PE, England; [Liem Nguyen] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	University of British Columbia; University of Basel; Case Western Reserve University	Nguyen, L (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	liem.nguyen@case.edu; charles.thompson@ubc.ca	Morris, Rowan/HGU-9105-2022; Jensen, Pernille Rose/J-8648-2016; Jensen, Pernille Rose/AAX-5696-2020; Eltis, Lindsay D/J-8272-2015; ramon, santi/C-6077-2013; Jensen, Pernille Rose/GQQ-6261-2022; Ramon Garcia, Santiago/V-8242-2017	Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Eltis, Lindsay D/0000-0002-6774-8158; ramon, santi/0000-0002-8480-0325; Jensen, Pernille Rose/0000-0003-4359-848X; Ramon Garcia, Santiago/0000-0002-8480-0325; Grzesiek, Stephan/0000-0003-1998-4225	National Institutes of Health [R01 AI087903]; Canadian Institute of Health Research [MOP-82855]; British Columbia Lung Association; Case Western Reserve University/University Hospitals Center for AIDS Research [P30 AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI087903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Case Western Reserve University/University Hospitals Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI087903 (to L. N.), Canadian Institute of Health Research Grant MOP-82855 (to C. J. T.), the British Columbia Lung Association (to C. J. T.), and Case Western Reserve University/University Hospitals Center for AIDS Research Grant P30 AI036219 (to L. N.).	Ainsa JA, 1996, GENE, V176, P23, DOI 10.1016/0378-1119(96)00202-8; Ainsa JA, 1998, J BACTERIOL, V180, P5836; Alam MS, 2007, MOL MICROBIOL, V63, P1414, DOI 10.1111/j.1365-2958.2007.05589.x; Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x; Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bentley SD, 2004, MOL MICROBIOL, V51, P1615, DOI 10.1111/j.1365-2958.2003.03949.x; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Burian J., 2013, NUCL ACIDS RES, DOI 10.1093/nar/gkt751; Burian J, 2012, EXPERT REV ANTI-INFE, V10, P1037, DOI [10.1586/eri.12.90, 10.1586/ERI.12.90]; Burian J, 2012, J BIOL CHEM, V287, P299, DOI 10.1074/jbc.M111.302588; Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004; Cayuela ML, 2003, J BACTERIOL, V185, P3527, DOI 10.1128/JB.185.12.3527-3537.2003; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Chawla M, 2012, MOL MICROBIOL, V85, P1148, DOI 10.1111/j.1365-2958.2012.08165.x; CHEN JS, 1977, ANAL BIOCHEM, V79, P157, DOI 10.1016/0003-2697(77)90390-6; CHENG H, 1994, BIOCHEMISTRY-US, V33, P3155, DOI 10.1021/bi00177a003; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; EVANS JNS, 1995, INT J PEPT PROT RES, V45, P554; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; Fowler-Goldsworthy K, 2011, MICROBIOL-SGM, V157, P1312, DOI 10.1099/mic.0.047555-0; Galbis-Martinez M, 2004, GENETICS, V167, P1585, DOI 10.1534/genetics.104.029207; Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Gostick DO, 1998, MICROBIOL-SGM, V144, P705, DOI 10.1099/00221287-144-3-705; HIDALGO E, 1995, J BIOL CHEM, V270, P20908, DOI 10.1074/jbc.270.36.20908; Himes SR, 2000, J IMMUNOL, V164, P3157, DOI 10.4049/jimmunol.164.6.3157; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Kang JG, 1999, EMBO J, V18, P4292, DOI 10.1093/emboj/18.15.4292; Kazda J, 2009, ECOLOGY OF MYCOBACTERIA: IMPACT ON ANIMAL'S AND HUMAN'S HEALTH, 2ND EDITION, P1, DOI 10.1007/978-1-4020-9413-2; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kim KH, 2012, P NATL ACAD SCI USA, V109, P7729, DOI 10.1073/pnas.1120251109; Konar M, 2012, FEBS J, V279, P2781, DOI 10.1111/j.1742-4658.2012.08662.x; Larsson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037516; Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200; Lee S, 2004, FEMS MICROBIOL LETT, V241, P271, DOI 10.1016/j.femsle.2004.10.032; LOFERER H, 1995, J BIOL CHEM, V270, P26178, DOI 10.1074/jbc.270.44.26178; McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142; Montoro E, 2005, J ANTIMICROB CHEMOTH, V55, P500, DOI 10.1093/jac/dki023; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; MURAKAMI T, 1986, MOL GEN GENET, V205, P42, DOI 10.1007/BF02428031; Nakashima N, 2004, APPL ENVIRON MICROB, V70, P5557, DOI 10.1128/AEM.70.9.5557-5568.2004; Nicolas FJ, 1996, P NATL ACAD SCI USA, V93, P6881, DOI 10.1073/pnas.93.14.6881; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Patrauchan MA, 2005, J BACTERIOL, V187, P4050, DOI 10.1128/JB.187.12.4050-4063.2005; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Ramon-Garcia S, 2006, J ANTIMICROB CHEMOTH, V57, P252, DOI 10.1093/jac/dki436; Ramon-Garcia S, 2012, ANTIMICROB AGENTS CH, V56, P2074, DOI 10.1128/AAC.05946-11; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 1999, METHOD ENZYMOL, V304, P155; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x; Saini V, 2012, CURR OPIN CHEM BIOL, V16, P45, DOI 10.1016/j.cbpa.2012.03.004; Sambrook J., 2001, MOL CLONING LAB MANU; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; Singh A., 2009, PLOS PATHOG, V5; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Smith LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040407; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Stapleton MR, 2012, TUBERCULOSIS, V92, P328, DOI 10.1016/j.tube.2012.03.001; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001; Warren R, 2004, J BACTERIOL, V186, P7783, DOI 10.1128/JB.186.22.7783-7795.2004; ZABINSKI R, 1972, BIOCHEMISTRY-US, V11, P3212, DOI 10.1021/bi00767a012; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106	83	38	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34514	34528		10.1074/jbc.M113.516385	http://dx.doi.org/10.1074/jbc.M113.516385			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24126912	hybrid, Green Published			2022-12-28	WOS:000329812800021
J	Stack, J; Hurst, TP; Flannery, SM; Brennan, K; Rupp, S; Oda, S; Khan, AR; Bowie, AG				Stack, Julianne; Hurst, Tara P.; Flannery, Sinead M.; Brennan, Kiva; Rupp, Sebastian; Oda, Shun-ichiro; Khan, Amir R.; Bowie, Andrew G.			Poxviral Protein A52 Stimulates p38 Mitogen-activated Protein Kinase (MAPK) Activation by Causing Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Self-association Leading to Transforming Growth Factor beta-activated Kinase 1 (TAK1) Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-kappa B (NF-KB); p38 MAPK; Pox Viruses; Signal Transduction; Viral Protein; TRAF6	NF-KAPPA-B; VACCINIA-VIRUS; MEDIATED ACTIVATION; GENE-PRODUCT; RECOGNITION; COMPLEX; TARGETS; BINDING; JNK; UBIQUITINATION	Vaccinia virus encodes a number of proteins that inhibit and manipulate innate immune signaling pathways that also have a role in virulence. These include A52, a protein shown to inhibit IL-1- and Toll-like receptor-stimulated NFB activation, via interaction with interleukin-1 receptor-associated kinase 2 (IRAK2). Interestingly, A52 was also found to activate p38 MAPK and thus enhance Toll-like receptor-dependent IL-10 induction, which was TRAF6-dependent, but the manner in which A52 manipulates TRAF6 to stimulate p38 activation was unclear. Here, we show that A52 has a non-canonical TRAF6-binding motif that is essential for TRAF6 binding and p38 activation but dispensable for NFB inhibition and IRAK2 interaction. Wild-type A52, but not a mutant defective in p38 activation and TRAF6 binding (F154A), caused TRAF6 oligomerization and subsequent TRAF6-TAK1 association. The crystal structure of A52 shows that it adopts a Bcl2-like fold and exists as a dimer in solution. Residue Met-65 was identified as being located in the A52 dimer interface, and consistent with that, A52-M65E was impaired in its ability to dimerize. A52-M65E although capable of interacting with TRAF6, was unable to cause either TRAF6 self-association, induce the TRAF6-TAK1 association, or activate p38 MAPK. The results suggest that an A52 dimer causes TRAF6 self-association, leading to TAK1 recruitment and p38 activation. This reveals a molecular mechanism whereby poxviruses manipulate TRAF6 to activate MAPKs (which can be proviral) without stimulating antiviral NFB activation.	[Stack, Julianne; Hurst, Tara P.; Flannery, Sinead M.; Brennan, Kiva; Rupp, Sebastian; Oda, Shun-ichiro; Khan, Amir R.; Bowie, Andrew G.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Immunol Res Ctr, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie	Oda, Shun-ichiro/P-1365-2015; Hurst, Tara/AAL-1296-2020	Oda, Shun-ichiro/0000-0001-9068-460X; Hurst, Tara/0000-0001-5474-7132; Brennan, Kiva/0000-0003-4960-7076; Khan, Amir/0000-0003-1176-6952; Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [07/IN1/B934, 08/RFP/BIC980]; Science Foundation Ireland-funded Immunology Research Centre [07/SRC/B1144]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Science Foundation Ireland-funded Immunology Research Centre(Science Foundation Ireland)	This work was supported by Science Foundation Ireland Grants 07/IN1/B934 and 08/RFP/BIC980 and as part of the Science Foundation Ireland-funded Immunology Research Centre (Grant 07/SRC/B1144).	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; de Motes CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002430; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Ember SWJ, 2012, J GEN VIROL, V93, P2098, DOI 10.1099/vir.0.045070-0; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Graham S. C., 2008, PLOS PATHOG, V4; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hu NJ, 2009, VACCINE, V27, P2994, DOI 10.1016/j.vaccine.2009.02.103; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; LaMonica R, 2001, J BIOL CHEM, V276, P19889, DOI 10.1074/jbc.M100499200; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Maloney G, 2005, J BIOL CHEM, V280, P30838, DOI 10.1074/jbc.M501917200; Mansur DS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003183; Meads MB, 2010, J IMMUNOL, V185, P1606, DOI 10.4049/jimmunol.0902026; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stack J, 2012, J BIOL CHEM, V287, P22672, DOI 10.1074/jbc.M112.349225; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Uemura N, 2006, J BIOL CHEM, V281, P7863, DOI 10.1074/jbc.M509834200; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345	48	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33642	33653		10.1074/jbc.M113.485490	http://dx.doi.org/10.1074/jbc.M113.485490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114841	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000327250200013
J	Zoghbi, ME; Altenberg, GA				Zoghbi, Maria E.; Altenberg, Guillermo A.			Hydrolysis at One of the Two Nucleotide-binding Sites Drives the Dissociation of ATP-binding Cassette Nucleotide-binding Domain Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; ATPases; CFTR; Fluorescence; Kinetics; Multidrug Transporters; LRET; Luminescence Resonance Energy Transfer; Thermophile	ABC TRANSPORTER MSBA; P-GLYCOPROTEIN; CATALYTIC CYCLE; ASSOCIATION/DISSOCIATION; DIMERIZATION; RESIDUES	Background: Nucleotide-binding domains (NBDs) of ABC proteins bind two ATPs, but it is unknown whether dissociation follows hydrolysis of one or both ATPs. Results: NBD dimers with one or two sites capable of ATP hydrolysis dissociate at the same rate. Conclusion: NBD dimers dissociate following a single ATP hydrolysis event. Significance: Understanding ABC proteins will help develop strategies to modify their function in disease. The functional unit of ATP-binding cassette (ABC) transporters consists of two transmembrane domains and two nucleotide-binding domains (NBDs). ATP binding elicits association of the two NBDs, forming a dimer in a head-to-tail arrangement, with two nucleotides sandwiched at the dimer interface. Each of the two nucleotide-binding sites is formed by residues from the two NBDs. We recently found that the prototypical NBD MJ0796 from Methanocaldococcus jannaschii dimerizes in response to ATP binding and dissociates completely following ATP hydrolysis. However, it is still unknown whether dissociation of NBD dimers follows ATP hydrolysis at one or both nucleotide-binding sites. Here, we used luminescence resonance energy transfer to study heterodimers formed by one active (donor-labeled) and one catalytically defective (acceptor-labeled) NBD. Rapid mixing experiments in a stop-flow chamber showed that NBD heterodimers with one functional and one inactive site dissociated at a rate indistinguishable from that of dimers with two hydrolysis-competent sites. Comparison of the rates of NBD dimer dissociation and ATP hydrolysis indicated that dissociation followed hydrolysis of one ATP. We conclude that ATP hydrolysis at one nucleotide-binding site drives NBD dimer dissociation.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Zoghbi, Maria/0000-0002-4206-4673; Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention and Research Institute of Texas [RP101073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1. This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP101073.	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Carrier I, 2008, FEBS J, V275, P3312, DOI 10.1111/j.1742-4658.2008.06479.x; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Mittal A, 2012, J BIOL CHEM, V287, P20395, DOI 10.1074/jbc.M112.359794; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nikaido K, 1999, J BIOL CHEM, V274, P26727, DOI 10.1074/jbc.274.38.26727; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Wen PC, 2008, BIOPHYS J, V95, P5100, DOI 10.1529/biophysj.108.139444; Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122; Zoghbi ME, 2012, J BIOL CHEM, V287, P14994, DOI 10.1074/jbc.M112.340281; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	33	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34259	34265		10.1074/jbc.M113.500371	http://dx.doi.org/10.1074/jbc.M113.500371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129575	Green Published, hybrid			2022-12-28	WOS:000327250200068
J	Williams, KA; Zhang, M; Xiang, SY; Hu, C; Wu, JY; Zhang, SP; Ryan, M; Cox, AD; Der, CJ; Fang, B; Koomen, J; Haura, E; Bepler, G; Nicosia, SV; Matthias, P; Wang, CG; Bai, WL; Zhang, XH				Williams, Kendra A.; Zhang, Mu; Xiang, Shengyan; Hu, Chen; Wu, Jheng-Yu; Zhang, Shengping; Ryan, Meagan; Cox, Adrienne D.; Der, Channing J.; Fang, Bin; Koomen, John; Haura, Eric; Bepler, Gerold; Nicosia, Santo V.; Matthias, Patrick; Wang, Chuangui; Bai, Wenlong; Zhang, Xiaohong			Extracellular Signal-regulated Kinase (ERK) Phosphorylates Histone Deacetylase 6 (HDAC6) at Serine 1035 to Stimulate Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; ERK; Histone Deacetylase; MAP Kinases (MAPKs); Protein Phosphorylation	MAP KINASES; ACETYLATION; ACTIVATION; MOTILITY; TUBULIN; POLYUBIQUITIN; CYTOSKELETON; DOMAIN; ALPHA	Background: HDAC6 plays an important role in cell migration. Results: ERK interacts with and phosphorylates HDAC6 to promote cell migration. Conclusion: ERK signaling pathway promotes cell migration, in part, through phosphorylating HDAC6. Significance: Inhibition of HDAC6 activity as well as the EGFR-Ras-Raf-MEK-ERK signaling pathway may cooperatively reduce cell migration. Histone deacetylase 6 (HDAC6) is well known for its ability to promote cell migration through deacetylation of its cytoplasmic substrates such as -tubulin. However, how HDAC6 itself is regulated to control cell motility remains elusive. Previous studies have shown that one third of extracellular signal-regulated kinase (ERK) is associated with the microtubule cytoskeleton in cells. Yet, no connection between HDAC6 and ERK has been discovered. Here, for the first time, we reveal that ERK binds to and phosphorylates HDAC6 to promote cell migration via deacetylation of -tubulin. We have identified two novel ERK-mediated phosphorylation sites: threonine 1031 and serine 1035 in HDAC6. Both sites were phosphorylated by ERK1 in vitro, whereas Ser-1035 was phosphorylated in response to the activation of EGFR-Ras-Raf-MEK-ERK signaling pathway in vivo. HDAC6-null mouse embryonic fibroblasts rescued by the nonphosphorylation mimicking mutant displayed significantly reduced cell migration compared with those rescued by the wild type. Consistently, the nonphosphorylation mimicking mutant exerted lower tubulin deacetylase activity in vivo compared with the wild type. These data indicate that ERK/HDAC6-mediated cell motility is through deacetylation of -tubulin. Overall, our results suggest that HDAC6-mediated cell migration could be governed by EGFR-Ras-Raf-MEK-ERK signaling.	[Williams, Kendra A.; Zhang, Mu; Xiang, Shengyan; Wu, Jheng-Yu; Nicosia, Santo V.; Bai, Wenlong; Zhang, Xiaohong] Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, Tampa, FL 33612 USA; [Hu, Chen; Zhang, Shengping; Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Coll Life Sci, Shanghai 200241, Peoples R China; [Ryan, Meagan; Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Fang, Bin; Koomen, John] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Prote Core Facil, Tampa, FL 33612 USA; [Haura, Eric; Nicosia, Santo V.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA; [Bai, Wenlong; Zhang, Xiaohong] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33612 USA; [Bepler, Gerold] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA; [Matthias, Patrick] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	State University System of Florida; University of South Florida; East China Normal University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Barbara Ann Karmanos Cancer Institute; Friedrich Miescher Institute for Biomedical Research	Zhang, XH (corresponding author), Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, 12901 Bruce B Downs Blvd,MDC 64, Tampa, FL 33612 USA.	xzhang1@health.usf.edu	XIANG, SHENGYAN/C-3176-2013; Bai, Wenlong/A-8977-2013	XIANG, SHENGYAN/0000-0002-6940-3559; Bai, Wenlong/0000-0002-9536-0556; Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health Grant from the NCI [R01CA164147]; James Esther King Biomedical Research Program [09KN-17]; a Moffitt Lung SPORE career development grant; Ovarian Cancer Research Fund; University of South Florida graduate student success diversity fellowship; NATIONAL CANCER INSTITUTE [R01CA164147, P50CA119997, P30CA076292, T32CA071341] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NCI; James Esther King Biomedical Research Program; a Moffitt Lung SPORE career development grant; Ovarian Cancer Research Fund; University of South Florida graduate student success diversity fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant R01CA164147 from the NCI. This work was also supported by New Investigator Grant 09KN-17 from the James Esther King Biomedical Research Program, a Moffitt Lung SPORE career development grant, and a grant from Ovarian Cancer Research Fund (to X. Z.) and a University of South Florida graduate student success diversity fellowship (to K. A. W.).	Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kekatpure VD, 2009, J BIOL CHEM, V284, P7436, DOI 10.1074/jbc.M808999200; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Lee H, 2000, MOL ENDOCRINOL, V14, P1882, DOI 10.1210/me.14.11.1882; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Shen Z, 2011, MOL CELL ENDOCRINOL, V338, P58, DOI 10.1016/j.mce.2011.02.023; Tanimura S, 2002, J BIOL CHEM, V277, P28256, DOI 10.1074/jbc.M202866200; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351	37	71	74	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33156	33170		10.1074/jbc.M113.472506	http://dx.doi.org/10.1074/jbc.M113.472506			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089523	hybrid, Green Published			2022-12-28	WOS:000328841700031
J	Petris, G; Casini, A; Sasset, L; Cesaratto, F; Bestagno, M; Cereseto, A; Burrone, OR				Petris, Gianluca; Casini, Antonio; Sasset, Linda; Cesaratto, Francesca; Bestagno, Marco; Cereseto, Anna; Burrone, Oscar R.			CD4 and BST-2/Tetherin Proteins Retro-translocate from Endoplasmic Reticulum to Cytosol as Partially Folded and Multimeric Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotin; Disulfide; ER-associated Degradation; ERAD; Oxidation-Reduction; BST-2; CD4; Biotinylation; Retro-translocation; Tetherin	MEMBRANE-PROTEIN; DISULFIDE REDUCTASE; MISFOLDED PROTEINS; SECRETORY PATHWAY; STRUCTURAL BASIS; CHOLERA-TOXIN; ERAD PATHWAY; BETA-TRCP; DEGRADATION; DISLOCATION	CD4 and BST-2/Tetherin are cellular membrane proteins targeted to degradation by the HIV-1 protein Vpu. In both cases proteasomal degradation following recruitment into the ERAD pathway has been described. CD4 is a type I transmembrane glycoprotein, with four extracellular immunoglobulin-like domains containing three intrachain disulfide bridges. BST-2/Tetherin is an atypical type II transmembrane glycoprotein with an N-terminal transmembrane domain and a C-terminal glycophosphatidylinositol anchor, which dimerizes through three interchain bridges. We investigated spontaneous and Vpu-induced retro-translocation of CD4 and BST-2/Tetherin using our novel biotinylation technique in living cells to determine ER-to-cytosol retro-translocation of proteins. We found that CD4 retro-translocates with oxidized intrachain disulfide bridges, and only upon proteasomal inhibition does it accumulate in the cytosol as already reduced and deglycosylated molecules. Similarly, BST-2/Tetherin is first exposed to the cytosol as a dimeric oxidized complex and then becomes deglycosylated and reduced to monomers. These results raise questions on the required features of the putative retro-translocon, suggesting alternative retro-translocation mechanisms for membrane proteins in which complete cysteine reduction and unfolding are not always strictly required before ER to cytosol dislocation.	[Petris, Gianluca; Sasset, Linda; Cesaratto, Francesca; Bestagno, Marco; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Casini, Antonio; Cereseto, Anna] Univ Trento, Ctr Integrat Biol CIBIO, I-38123 Mattarello, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trento	Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Immunol Grp, Padriciano 99, I-34149 Trieste, Italy.	burrone@icgeb.org	Petris, Gianluca/N-9754-2018; Sasset, Linda/AAC-3131-2020	Petris, Gianluca/0000-0002-2420-6359; Sasset, Linda/0000-0001-5298-2374; Cereseto, Anna/0000-0003-4453-2597; Casini, Antonio/0000-0001-7709-4955	International Centre for Genetic Engineering and Biotechnology predoctoral fellowships	International Centre for Genetic Engineering and Biotechnology predoctoral fellowships	Supported by International Centre for Genetic Engineering and Biotechnology predoctoral fellowships.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Brady RL, 1996, CURR TOP MICROBIOL, V205, P1; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Emerman AB, 2010, MOL BIOL CELL, V21, P4325, DOI 10.1091/mbc.E10-09-0742; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Geiger R, 2011, NAT CELL BIOL, V13, P1305, DOI 10.1038/ncb2339; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ng CL, 2010, EXP CELL RES, V316, P2113, DOI 10.1016/j.yexcr.2010.04.010; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olzmann JA, 2011, J BIOL CHEM, V286, P27872, DOI 10.1074/jbc.C111.266452; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Shamu CE, 2001, MOL BIOL CELL, V12, P2546, DOI 10.1091/mbc.12.8.2546; Sokolowska I, 2011, BIOCHEM J, V436, P371, DOI 10.1042/BJ20101493; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swiecki M, 2011, J BIOL CHEM, V286, P2987, DOI 10.1074/jbc.M110.190538; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vecchi L, 2012, J BIOL CHEM, V287, P20007, DOI 10.1074/jbc.M112.355107; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang XL, 2013, J BIOL CHEM, V288, P23295, DOI 10.1074/jbc.M113.482018; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278	69	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					1	12		10.1074/jbc.M113.512368	http://dx.doi.org/10.1074/jbc.M113.512368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257748	Green Published, hybrid			2022-12-28	WOS:000329370900001
J	Zhao, WN; Liu, Y; Timani, KA; He, JJ				Zhao, Weina; Liu, Ying; Timani, Khalid Amine; He, Johnny J.			Tip110 Protein Binds to Unphosphorylated RNA Polymerase II and Promotes Its Phosphorylation and HIV-1 Long Terminal Repeat Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; Phosphorylation; Promoters; RNA Polymerase II; Transcription; Viral Replication; Long Terminal Repeat; Tip110; Transcription Elongation; Transcription Initiation	VIRUS TYPE-1 TRANSCRIPTION; TUMOR-REJECTION ANTIGEN; TAT-INTERACTING PROTEIN; EMBRYONIC STEM-CELLS; P-TEFB; IN-VITRO; MESSENGER-RNA; 110 KDA; TETRATRICOPEPTIDE REPEAT; HISTONE METHYLATION	Transcription plays an important role in both HIV-1 gene expression and replication and mandates complicated but coordinated interactions between the host and virus. Our previous studies have shown that an HIV-1 Tat-interacting protein of 110 kDa, Tip110, binds to and enhances Tat function in Tat-mediated HIV-1 gene transcription and replication (Liu, Y., Li, J., Kim, B. O., Pace, B. S., and He, J. J. (2002) HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110. J. Biol. Chem. 277, 23854-23863). However, the underlying molecular mechanisms by which this takes place were not understood. In this study, we demonstrated that Tip110 bound to unphosphorylated RNA polymerase II (RNAPII) in a direct and specific manner. In addition, we detected Tip110 at the HIV-1 long terminal repeat (LTR) promoter and found that Tip110 expression was associated with increased phosphorylation of serine 2 of the heptapeptide repeats within the RNAPII C-terminal domain and increased recruitment of positive transcription elongation factor b to the LTR promoter. Consistent with these findings, we showed that Tip110 interaction with Tat directly enhanced transcription elongation of the LTR promoter. Taken together, these findings have provided additional and mechanistic evidence to support Tip110 function in HIV-1 transcription.	[Zhao, Weina; He, Johnny J.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Liu, Ying; Timani, Khalid Amine; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA	Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Health Science Center	He, JJ (corresponding author), Univ N Texas, Hlth Sci Ctr, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu		Timani, Khalid/0000-0002-4862-9348	National Institutes of Health, NINDS [R01NS065785]; National Institutes of Health, NIMH [R01092673]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065785] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01NS065785 and National Institutes of Health, NIMH, Grant R01092673 (to J. J. H.).	Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Brockman MA, 2006, J VIROL METHODS, V131, P134, DOI 10.1016/j.jviromet.2005.08.003; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chen D, 1999, MOL CELL BIOL, V19, P2863; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Garber ME, 2000, MOL CELL BIOL, V20, P6958, DOI 10.1128/MCB.20.18.6958-6969.2000; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Gu JA, 1998, BBA-GENE STRUCT EXPR, V1399, P1, DOI 10.1016/S0167-4781(98)00082-7; Harada K, 2001, INT J CANCER, V93, P623, DOI 10.1002/ijc.1391; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Herrmann CH, 2001, J CELL SCI, V114, P1491; Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187; Kawagoe N, 2000, J UROLOGY, V164, P2090, DOI 10.1016/S0022-5347(05)66975-3; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liu Y, 2004, J BIOL CHEM, V279, P21766, DOI 10.1074/jbc.M314321200; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu Y, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0271; Liu Y, 2012, STEM CELLS DEV, V21, P829, DOI 10.1089/scd.2011.0512; Medenbach J, 2004, MOL CELL BIOL, V24, P7392, DOI 10.1128/MCB.24.17.7392-7401.2004; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; ROBERTS S, 1992, GENE DEV, V6, P1562, DOI 10.1101/gad.6.8.1562; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Sasatomi T, 2002, CANCER, V94, P1636, DOI 10.1002/cncr.10421; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sundaravaradan V, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-126; Sune C, 2000, VIROLOGY, V274, P356, DOI 10.1006/viro.2000.0480; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; Vardabasso C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-8; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yang D, 1999, CANCER RES, V59, P4056; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhou MS, 2004, J VIROL, V78, P13522, DOI 10.1128/JVI.78.24.13522-13533.2004; Zhou MS, 2003, P NATL ACAD SCI USA, V100, P12666, DOI 10.1073/pnas.1835726100; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	53	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					190	202		10.1074/jbc.M113.529784	http://dx.doi.org/10.1074/jbc.M113.529784			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24217245	hybrid, Green Published			2022-12-28	WOS:000329370900017
J	Vance, DJ; Tremblay, JM; Mantis, NJ; Shoemaker, CB				Vance, David J.; Tremblay, Jacqueline M.; Mantis, Nicholas J.; Shoemaker, Charles B.			Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies That Passively Protect Mice from Ricin Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Immunology; Immunotherapy; Mouse; Toxins; VHH	MONOCLONAL-ANTIBODIES; ENZYMATIC SUBUNIT; BINDING-AGENTS; B-SUBUNIT; CHAIN; FRAGMENTS; INHIBITORS; CHALLENGE; KINETICS; IMMUNITY	Background: We sought to engineer highly efficacious agents that neutralize ricin toxin. Results: We identified monomeric single-chain camelid V-H domains (V(H)Hs) capable of neutralizing ricin in vitro and engineered heterodimeric V(H)Hs that neutralized ricin in vivo. Conclusion: Stepwise engineering of V(H)Hs resulted in highly potent ricin toxin-neutralizing antibodies. Significance: This study highlights the potential use of a VHH platform as a strategy for therapeutics against diverse biological toxins. In an effort to engineer countermeasures for the category B toxin ricin, we produced and characterized a collection of epitopic tagged, heavy chain-only antibody V-H domains (V(H)Hs) specific for the ricin enzymatic (RTA) and binding (RTB) subunits. Among the 20 unique ricin-specific V(H)Hs we identified, six had toxin-neutralizing activity: five specific for RTA and one specific for RTB. Three neutralizing RTA-specific V(H)Hs were each linked via a short peptide spacer to the sole neutralizing anti-RTB VHH to create VHH heterodimers. As compared with equimolar concentrations of their respective monovalent monomers, all three VHH heterodimers had higher affinities for ricin and, in the case of heterodimer D10/B7, a 6-fold increase in in vitro toxin-neutralizing activity. When passively administered to mice at a 4:1 heterodimer:toxin ratio, D10/B7 conferred 100% survival in response to a 10 x LD50 ricin challenge, whereas a 2:1 heterodimer:toxin ratio conferred 20% survival. However, complete survival was achievable when the low dose of D10/B7 was combined with an IgG1 anti-epitopic tag monoclonal antibody, possibly because decorating the toxin with up to four IgGs promoted serum clearance. The two additional ricin-specific heterodimers, when tested in vivo, provided equal or greater passive protection than D10/B7, thereby warranting further investigation of all three heterodimers as possible therapeutics.	[Vance, David J.; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12208 USA; [Tremblay, Jacqueline M.; Shoemaker, Charles B.] Tufts Univ, Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	State University of New York (SUNY) System; Wadsworth Center; Tufts University	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.	nmantis@wadsworth.org; charles.shoemaker@tufts.edu	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health [AI097688, U54-AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R03AI097688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI097688 (to N. J. M.) and U54-AI057159 (to C. B. S.).	Anderson GP, 2010, ANAL CHEM, V82, P7202, DOI 10.1021/ac100961x; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; FRANZ DR, 2004, DEFENSE TOXIN WEAPON; Gibbs WW, 2005, SCI AM, V293, P78, DOI 10.1038/scientificamerican0805-78; Jandhyala DM, 2012, CURR TOP MICROBIOL, V357, P41, DOI 10.1007/82_2011_181; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lebeda FJ, 1999, INT J BIOL MACROMOL, V24, P19, DOI 10.1016/S0141-8130(98)00059-2; LEMLEY PV, 1992, IMMUNOLOGY, V76, P511; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Mukherjee J., 2012, PLOS ONE, V7; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; O'Hara JM, 2013, J IMMUNOL METHODS, V395, P71, DOI 10.1016/j.jim.2013.06.004; O'Hara JM, 2013, CLIN VACCINE IMMUNOL, V20, P789, DOI 10.1128/CVI.00098-13; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Olsnes S, 1978, Methods Enzymol, V50, P330; Pincus SH, 2002, COMPARATIVE MED, V52, P530; Reisler R. B., 2012, ADV PREV MED, V2012; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; SIMMONS BM, 1986, J BIOL CHEM, V261, P7912; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vance DJ, 2012, TOXICON, V60, P874, DOI 10.1016/j.toxicon.2012.06.014; Wahome P.G., 2013, CURR PROTOC TOXICOL, V23, DOI DOI 10.1002/0471140856.TX0223S55; Wolfe DN, 2013, HUM VACC IMMUNOTHER, V9, P1591, DOI 10.4161/hv.24063; Yermakova A., 2012, PLOS ONE, V7; Yermakova A, 2013, TOXICON, V72, P29, DOI 10.1016/j.toxicon.2013.04.005; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075	36	50	52	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36538	36547		10.1074/jbc.M113.519207	http://dx.doi.org/10.1074/jbc.M113.519207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24202178	Green Published, hybrid			2022-12-28	WOS:000328883400034
J	Wu, HA; Balsbaugh, JL; Chandler, H; Georgilis, A; Zullow, H; Shabanowitz, J; Hunt, DF; Gil, J; Peters, G; Bernstein, E				Wu, Hsan-au; Balsbaugh, Jeremy L.; Chandler, Hollie; Georgilis, Athena; Zullow, Hayley; Shabanowitz, Jeffrey; Hunt, Donald F.; Gil, Jesus; Peters, Gordon; Bernstein, Emily			Mitogen-activated Protein Kinase Signaling Mediates Phosphorylation of Polycomb Ortholog Cbx7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; MAP Kinases (MAPKs); Phosphorylation; Polycomb; Post translational Modification; Senescence; Cbx7; Polycomb Repressive Complex 1	HISTONE METHYLTRANSFERASE ACTIVITY; E3 LIGASE ACTIVITY; CHROMOBOX PROTEIN; CHROMATIN-ASSOCIATION; MASS-SPECTROMETRY; TUMOR-SUPPRESSOR; ONCOGENIC RAS; MOUSE; H3; DROSOPHILA	Background: Post-translational modification of Polycomb protein Cbx7 remains poorly understood. Results: Here we identify and characterize a novel phosphorylation site at threonine 118 of mouse Cbx7. Conclusion: MAPK signaling induces Cbx7 threonine 118 phosphorylation and enhances PRC1 association. Significance: Mitogen signaling to Cbx7 confers an additional layer of PRC1 regulation. Cbx7 is one of five mammalian orthologs of the Drosophila Polycomb. Cbx7 recognizes methylated lysine residues on the histone H3 tail and contributes to gene silencing in the context of the Polycomb repressive complex 1 (PRC1). However, our knowledge of Cbx7 post-translational modifications remains limited. Through combined biochemical and mass spectrometry approaches, we report a novel phosphorylation site on mouse Cbx7 at residue Thr-118 (Cbx7T118ph), near the highly conserved Polycomb box. The generation of a site-specific antibody to Cbx7T118ph demonstrates that Cbx7 is phosphorylated via MAPK signaling. Furthermore, we find Cbx7T118 phosphorylation in murine mammary carcinoma cells, which can be blocked by MEK inhibitors. Upon EGF stimulation, Cbx7 interacts robustly with other members of PRC1. To test the role of Cbx7T118 phosphorylation in gene silencing, we employed a RAS-induced senescence model system. We demonstrate that Cbx7T118 phosphorylation moderately enhances repression of its target gene p16. In summary, we have identified and characterized a novel MAPK-mediated phosphorylation site on Cbx7 and propose that mitogen signaling to the chromatin template regulates PRC1 function.	[Wu, Hsan-au; Zullow, Hayley; Bernstein, Emily] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Wu, Hsan-au; Bernstein, Emily] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Chandler, Hollie; Peters, Gordon] London Res Inst, Canc Res UK, London WC2A 3LY, England; [Georgilis, Athena; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Med Res Council Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Virginia; University of Virginia; Cancer Research UK; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Bernstein, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, Box 1130, New York, NY 10029 USA.	Emily.bernstein@mssm.edu	Gil, Jesus/C-7739-2012	Gil, Jesus/0000-0002-4303-6260; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health [GM037537]; Cancer Research UK; New York State Stem Cell Science Innovative, Developmental or Exploratory Activities Award [C024285]; MRC [MC_U120085810] Funding Source: UKRI; Medical Research Council [MC_U120085810, 1229061] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); New York State Stem Cell Science Innovative, Developmental or Exploratory Activities Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM037537 (to D. F. H.), Cancer Research UK via core funding to the London Research Institute (to G. P. and H. C.), core support from the Medical Research Council (to J. G. and A. G.), and New York State Stem Cell Science Innovative, Developmental or Exploratory Activities Award C024285 (to E. B.).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Beuchle D, 2001, DEVELOPMENT, V128, P993; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; El Messaoudi-Aubert S, 2010, NAT STRUCT MOL BIOL, V17, P862, DOI 10.1038/nsmb.1824; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Fujisaki S, 2003, BIOCHEM BIOPH RES CO, V300, P135, DOI 10.1016/S0006-291X(02)02791-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Hall EH, 2010, MOL CELL PROTEOMICS, V9, P2853, DOI 10.1074/mcp.M110.003665; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003199; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tie F, 2005, BIOCHEM BIOPH RES CO, V332, P622, DOI 10.1016/j.bbrc.2005.04.157; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36398	36408		10.1074/jbc.M113.486266	http://dx.doi.org/10.1074/jbc.M113.486266			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194518	hybrid, Green Published			2022-12-28	WOS:000328883400021
J	Brandis, KA; Gale, S; Jinn, S; Langmade, SJ; Dudley-Rucker, N; Jiang, H; Sidhu, R; Ren, A; Goldberg, A; Schaffer, JE; Ory, DS				Brandis, Katrina A.; Gale, Sarah; Jinn, Sarah; Langmade, Stephen J.; Dudley-Rucker, Nicole; Jiang, Hui; Sidhu, Rohini; Ren, Aileen; Goldberg, Anna; Schaffer, Jean E.; Ory, Daniel S.			Box C/D Small Nucleolar RNA (snoRNA) U60 Regulates Intracellular Cholesterol Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Cholesterol Regulation; Intracellular Trafficking; Lipid Transport; Small Nucleolar RNA (snoRNA); Noncoding RNA	ENDOPLASMIC-RETICULUM CHOLESTEROL; PLASMA-MEMBRANE; STEROL TRANSPORT; ACCESSIBILITY; HOMEOSTASIS; SCREEN; MIR-33; GENES; CELLS; ER	Background: The mechanisms regulating internalization of plasma membrane cholesterol in mammalian cells are not well understood. Results: A cell line haploinsufficient for U60 snoRNA expression exhibits impaired plasma membrane to ER cholesterol trafficking and increased de novo cholesterol synthesis. Conclusion: U60 snoRNA expression regulates cholesterol homeostasis by affecting internalization of plasma membrane cholesterol. Significance: This is the first study to implicate a snoRNA in regulation of cholesterol homeostasis. Mobilization of plasma membrane (PM) cholesterol to the endoplasmic reticulum is essential for cellular cholesterol homeostasis. The mechanisms regulating this retrograde, intermembrane cholesterol transfer are not well understood. Because mutant cells with defects in PM to endoplasmic reticulum cholesterol trafficking can be isolated on the basis of resistance to amphotericin B, we conducted an amphotericin B loss-of-function screen in Chinese hamster ovary (CHO) cells using insertional mutagenesis to identify genes that regulate this trafficking mechanism. Mutant line A1 displayed reduced cholesteryl ester formation from PM-derived cholesterol and increased de novo cholesterol synthesis, indicating a deficiency in retrograde cholesterol transport. Genotypic analysis revealed that the A1 cell line contained one disrupted allele of the U60 small nucleolar RNA (snoRNA) host gene, resulting in haploinsufficiency of the box C/D snoRNA U60. Complementation and mutational studies revealed the U60 snoRNA to be the essential feature from this locus that affects cholesterol trafficking. Lack of alteration in predicted U60-mediated site-directed methylation of 28 S rRNA in the A1 mutant suggests that the U60 snoRNA modulates cholesterol trafficking by a mechanism that is independent of this canonical function. Our study adds to a growing body of evidence for participation of small noncoding RNAs in cholesterol homeostasis and is the first to implicate a snoRNA in this cellular function.	[Brandis, Katrina A.; Gale, Sarah; Jinn, Sarah; Langmade, Stephen J.; Dudley-Rucker, Nicole; Jiang, Hui; Sidhu, Rohini; Ren, Aileen; Goldberg, Anna; Schaffer, Jean E.; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA	Washington University (WUSTL)	Ory, DS (corresponding author), Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	dory@wustl.edu	Sidhu, Rohini/G-3547-2012	Sidhu, Rohini/0000-0003-1703-2167; Ren, Aileen/0000-0002-1116-900X	National Institutes of Health Grant [P30 DK020579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275, R01HL010330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK064989, R56DK064989] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Robyn Roth and John Heuser for assistance with electron microscopy experiments. Mass spectrometry analyses were performed in the Metabolomics Facility at Washington University (National Institutes of Health Grant P30 DK020579).	Baumann NA, 2005, BIOCHEMISTRY-US, V44, P5816, DOI 10.1021/bi048296z; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; DAHL NK, 1992, J BIOL CHEM, V267, P4889; DAHL NK, 1994, J LIPID RES, V35, P1839; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gale SE, 2009, J BIOL CHEM, V284, P1755, DOI 10.1074/jbc.M807210200; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hirose T, 2001, P NATL ACAD SCI USA, V98, P12914, DOI 10.1073/pnas.231490998; Jacobs NL, 1997, J LIPID RES, V38, P1973; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lange Y, 2013, BIOCHEMISTRY-US, V52, P6950, DOI 10.1021/bi400862q; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mesmin B, 2011, MOL BIOL CELL, V22, P4004, DOI 10.1091/mbc.E11-04-0372; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Norlin M, 2004, BIOCHEM BIOPH RES CO, V316, P158, DOI 10.1016/j.bbrc.2004.02.029; Olsen BN, 2013, BIOPHYS J, V105, P1838, DOI 10.1016/j.bpj.2013.08.042; Olsen BN, 2011, BIOPHYS J, V100, P948, DOI 10.1016/j.bpj.2010.12.3728; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; Urano Y, 2008, P NATL ACAD SCI USA, V105, P16513, DOI 10.1073/pnas.0807450105; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Xia J, 2013, HUM MOL GENET, V22, P737, DOI 10.1093/hmg/dds481; Yamauchi Y, 2007, J BIOL CHEM, V282, P34994, DOI 10.1074/jbc.M703653200	41	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35703	35713		10.1074/jbc.M113.488577	http://dx.doi.org/10.1074/jbc.M113.488577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174535	Green Published, hybrid			2022-12-28	WOS:000329814700009
J	Li, J; Yao, K; Yu, XN; Dong, XR; Gan, LS; Luo, CQ; Wu, YL				Li, Jie; Yao, Ke; Yu, Xiaoning; Dong, Xinran; Gan, Lishe; Luo, Chenqi; Wu, Yalin			Identification of a Novel Lipofuscin Pigment (iisoA2E) in Retina and Its Effects in the Retinal Pigment Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Phosphatidylethanolamine; Phospholipase D; Retina; Retinal Degeneration; Retinoid; Lipofuscin; Pigment	LIGHT-INDUCED DAMAGE; MACULAR DEGENERATION; STARGARDT-DISEASE; A2E; FLUOROPHORE; ABCR; RPE; OXIDATION; RHODOPSIN; PRODUCTS	Background: Macular degeneration implicates lipofuscin deposition in the retina. Results: Bisretinoid iisoA2E in the retina was characterized; excessive accumulation of iisoA2E was cytotoxic to retinal pigment epithelial cells. Conclusion: Pyridinium iisoA2E is a unique diretinal adduct and serves as a fluorescent biomarker of aberrant all-trans-retinal metabolism. Significance: Characterization of iisoA2E gives a more complete understanding of the biosynthesis of retinal bisretinoid lipofuscin. Lipofuscin accumulation in retinal pigment epithelial (RPE) cells of the eye implicates the etiologies of Stargardt disease and age-related macular degeneration, a leading cause of blindness in the elderly. Here, we have identified a previously unknown RPE lipofuscin component. By one- and two-dimensional NMR techniques and mass spectrometry, we confirmed that this compound is a new type of pyridinium bisretinoid presenting an unusual structure, in which two polyenic side chains are attached to adjacent carbons of a pyridinium ring. This pigment is a light-induced isomer of isoA2E, rather than A2E, referred to as iisoA2E. This pigment is a fluorescent lipofuscin compound with absorbance maxima at approximate to 430 and 352 nm detected in human, pig, mouse, and bovine eyes. Formation of iisoA2E was found in reaction mixtures of all-trans-retinal and ethanolamine. Excess intracellular accumulation of this adduct in RPE cells in vitro leads to a significant loss of cell viability and caused membrane damage. Phospholipase D-mediated phosphodiester cleavage of the A2PE series generated isoA2E and iisoA2E, in addition to A2E, thus corroborating the presence of isoA2PE and iisoA2PE that may serve as biosynthetic precursors of isoA2E and iisoA2E.	[Li, Jie; Gan, Lishe; Wu, Yalin] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Yao, Ke; Yu, Xiaoning; Dong, Xinran; Luo, Chenqi; Wu, Yalin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, YL (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310058, Zhejiang, Peoples R China.	yalinw@zju.edu.cn	Yao, Ke/AAM-6866-2021	Li, Jie/0000-0001-5463-3995; Yao, Ke/0000-0002-6764-7365	National Science Foundation of the People's Republic of China [21202146, 81271018]; Fundamental Research Funds for the Central Universities; Zhejiang Key Innovation Team Project of China Grant [2009R50039]; Zhejiang Key Laboratory Fund of China Grant [2011E10006]	National Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Key Innovation Team Project of China Grant; Zhejiang Key Laboratory Fund of China Grant	This work was supported in part by National Science Foundation of the People's Republic of China Grants 21202146 and 81271018 and by the Fundamental Research Funds for the Central Universities.; Supported by Zhejiang Key Innovation Team Project of China Grant 2009R50039 and Zhejiang Key Laboratory Fund of China Grant 2011E10006.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; ELDRED GE, 1988, EXP EYE RES, V47, P71, DOI 10.1016/0014-4835(88)90025-5; FEENEYBURNS L, 1988, INVEST OPHTH VIS SCI, V29, P708; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Honeyman B., 2005, NANOSCAPE, V2, P89; Jang YP, 2005, J BIOL CHEM, V280, P39732, DOI 10.1074/jbc.M504933200; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; LIU RSH, 1982, METHOD ENZYMOL, V88, P506; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Palczewska G, 2010, NAT MED, V16, P1444, DOI 10.1038/nm.2260; Pang JJ, 2005, MOL VIS, V11, P152; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Paxton JW, 2005, CLIN EXP PHARMACOL P, V32, P633, DOI 10.1111/j.0305-1870.2005.04243.x; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Sun H, 1997, NAT GENET, V17, P15, DOI 10.1038/ng0997-15; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; WADDELL WH, 1976, J AM CHEM SOC, V98, P238, DOI 10.1021/ja00417a041; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xi YM, 2013, ORG BIOMOL CHEM, V11, P2387, DOI 10.1039/c3ob40137e	47	11	11	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35671	35682		10.1074/jbc.M113.511386	http://dx.doi.org/10.1074/jbc.M113.511386			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169698	hybrid, Green Published			2022-12-28	WOS:000329814700006
J	Shibata, N; Carlin, AF; Spann, NJ; Saijo, K; Morello, CS; McDonald, JG; Romanoski, CE; Maurya, MR; Kaikkonen, MU; Lam, MT; Crotti, A; Reichart, D; Fox, JN; Quehenberger, O; Raetz, CRH; Sullards, MC; Murphy, RC; Merrill, AH; Brown, HA; Dennis, EA; Fahy, E; Subramaniam, S; Cavener, DR; Spector, DH; Russell, DW; Glass, CK				Shibata, Norihito; Carlin, Aaron F.; Spann, Nathanael J.; Saijo, Kaoru; Morello, Christopher S.; McDonald, Jeffrey G.; Romanoski, Casey E.; Maurya, Mano R.; Kaikkonen, Minna U.; Lam, Michael T.; Crotti, Andrea; Reichart, Donna; Fox, Jesse N.; Quehenberger, Oswald; Raetz, Christian R. H.; Sullards, M. Cameron; Murphy, Robert C.; Merrill, Alfred H., Jr.; Brown, H. Alex; Dennis, Edward A.; Fahy, Eoin; Subramaniam, Shankar; Cavener, Douglas R.; Spector, Deborah H.; Russell, David W.; Glass, Christopher K.			25-Hydroxycholesterol Activates the Integrated Stress Response to Reprogram Transcription and Translation in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Lipids; Macrophages; Oxidative Stress; Stress Response; Translation; 25-Hydroxycholesterol; GCN2; MCMV; eIF2-	UNFOLDED PROTEIN RESPONSE; GCN2 EIF2-ALPHA KINASE; AMINO-ACID; ENDOPLASMIC-RETICULUM; CELL-DEATH; OXIDATIVE STRESS; GENE-EXPRESSION; INNATE IMMUNITY; CHOLESTEROL; DEPRIVATION	Background: Interferons and viral infections stimulate the production of 25-hydroxycholesterol. Results: 25-Hydroxycholesterol significantly alters cholesterol ester and sphingolipid levels and activates the integrated stress response. Conclusion: 25-Hydroxycholesterol activates the GCN2/eIF2/ATF4 integrated stress response likely by causing cysteine depletion and/or by generating oxidative stress. Significance: Altering important membrane lipids and activating the integrated stress response may contribute to the antiviral activity of 25-hydroxycholesterol. 25-Hydroxycholesterol (25OHC) is an enzymatically derived oxidation product of cholesterol that modulates lipid metabolism and immunity. 25OHC is synthesized in response to interferons and exerts broad antiviral activity by as yet poorly characterized mechanisms. To gain further insights into the basis for antiviral activity, we evaluated time-dependent responses of the macrophage lipidome and transcriptome to 25OHC treatment. In addition to altering specific aspects of cholesterol and sphingolipid metabolism, we found that 25OHC activates integrated stress response (ISR) genes and reprograms protein translation. Effects of 25OHC on ISR gene expression were independent of liver X receptors and sterol-response element-binding proteins and instead primarily resulted from activation of the GCN2/eIF2/ATF4 branch of the ISR pathway. These studies reveal that 25OHC activates the integrated stress response, which may contribute to its antiviral activity.	[Shibata, Norihito; Spann, Nathanael J.; Saijo, Kaoru; Morello, Christopher S.; Romanoski, Casey E.; Kaikkonen, Minna U.; Lam, Michael T.; Crotti, Andrea; Reichart, Donna; Fox, Jesse N.; Subramaniam, Shankar; Spector, Deborah H.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Maurya, Mano R.; Fahy, Eoin; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dennis, Edward A.; Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Carlin, Aaron F.; Quehenberger, Oswald; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [McDonald, Jeffrey G.; Russell, David W.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Dept Pharmacol, Nashville, TN 37232 USA; [Raetz, Christian R. H.] Duke Univ, Med Ctr, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biochem, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Shibata, Norihito] Natl Inst Hlth Sci, Div Biochem & Mol Biol, Setagaya Ku, Tokyo 1588501, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute of Health Sciences - Japan	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Rooms 217 & 219,9500 Gilman Dr,MC 0651 CMM W, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Dennis, Edward A./M-5554-2019; Kaikkonen, Minna U/AAK-3612-2020; Glass, Christopher/AAI-3933-2021; Morello, Christopher/GRS-1025-2022; Murphy, Robert/AAO-5349-2020; Carlin, Aaron/AAK-3806-2021	Dennis, Edward A./0000-0003-3738-3140; Kaikkonen, Minna U/0000-0001-6294-0979; Glass, Christopher/0000-0003-4344-3592; Morello, Christopher/0000-0001-8113-1173; Murphy, Robert/0000-0002-9430-6515; Spector, Deborah/0000-0002-7605-6348; Russell, David/0000-0002-0277-403X; Merrill, Alfred/0000-0002-6673-968X; SHIBATA, NORIHITO/0000-0001-5792-8510; Romanoski, Casey/0000-0002-0149-225X	National Institutes of Health Grant [GM U54 069338]; Clayton Foundation for Research; American Heart Association; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM107784, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM U54 069338 (to the LIPID MAPS Consortium). This work was also supported by the Clayton Foundation for Research (to D. W. R.) and the American Heart Association (to N. S.).	Armas JCG, 1996, J VIROL, V70, P7921; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Budt M, 2009, J VIROL, V83, P1260, DOI 10.1128/JVI.01558-08; Chan RB, 2010, CHEM PHYS LIPIDS, V163, P449, DOI 10.1016/j.chemphyslip.2010.03.002; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; del Pino J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047272; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Gupte AA, 2013, CURR DIABETES REP, V13, P362, DOI 10.1007/s11892-013-0372-1; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hullin-Matsuda F, 2012, J BIOL CHEM, V287, P24397, DOI [10.1074/jbc.M112.344432, 10.1074/jbc.M112.356733]; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; LANGE Y, 1994, J BIOL CHEM, V269, P29371; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Li X, 2012, CELL PHYSIOL BIOCHEM, V30, P815, DOI 10.1159/000341460; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lorizate M., 2011, COLD SPRING HARBOR P, V3; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002908; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Morello CS, 2007, J VIROL, V81, P7766, DOI 10.1128/JVI.00633-07; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; RIDGWAY ND, 1995, J LIPID RES, V36, P1345; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; TABAS I, 1988, J BIOL CHEM, V263, P1266; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wilkins C, 2013, IMMUNITY, V38, P3, DOI 10.1016/j.immuni.2013.01.002; Won S, 2012, J VIROL, V86, P1802, DOI 10.1128/JVI.05660-11; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	67	44	45	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35812	35823		10.1074/jbc.M113.519637	http://dx.doi.org/10.1074/jbc.M113.519637			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189069	Green Published, hybrid			2022-12-28	WOS:000329814700019
J	Thrasivoulou, C; Millar, M; Ahmed, A				Thrasivoulou, Christopher; Millar, Michael; Ahmed, Aamir			Activation of Intracellular Calcium by Multiple Wnt Ligands and Translocation of beta-Catenin into the Nucleus A CONVERGENT MODEL OF Wnt Ca2+ AND Wnt/beta-CATENIN PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Calcium Signaling; Cell Signaling; Nuclear Membrane; Wnt Signaling; Canonical and Non-canonical Signaling; Intranuclear Calcium; Macromolecular Transport; Nuclear Membrane Potential	PORE COMPLEX; LOCALIZATION SIGNAL; TAIL FORMATION; TRANSPORT; ZEBRAFISH; DEPLETION; CELLS; TRANSFORMATION; DIFFUSION; INTERACTS	Background: Cellular transducers of Wnt signaling, -catenin and Ca2+, are considered to act via independent canonical and non-canonical pathways. Results: Six Wnt ligands activated cytosolic and intranuclear Ca2+ and nuclear translocation of -catenin. Conclusion: Wnt -catenin and Ca2+ signaling are coupled in mammalian cells. Significance: A coupled model of Wnt/Ca2+ and -catenin signaling that challenges the canonical and non-canonical categorization is proposed. Ca2+ and -catenin, a 92-kDa negatively charged transcription factor, transduce Wnt signaling via the non-canonical, Wnt/Ca2+ and canonical, Wnt/-catenin pathways independently. The nuclear envelope is a barrier to large protein entry, and this process is regulated by intracellular calcium [Ca2+](i) and trans-nuclear potential. How -catenin traverses the nuclear envelope is not well known. We hypothesized that Wnt/Ca2+ and Wnt/-catenin pathways act in a coordinated manner and that [Ca2+](i) release facilitates -catenin entry into the nucleus in mammalian cells. In a live assay using calcium dyes in PC3 prostate cancer cells, six Wnt peptides (3A, 4, 5A, 7A, 9B, and 10B) mobilized [Ca2+](i) but Wnt11 did not. Based upon dwell time (range = 15-30 s) of the calcium waveform, these Wnts could be classified into three classes: short, 3A and 5A; long, 7A and 10B; and very long, 4 and 9B. Wnt-activated [Ca2+](i) release was followed by an increase in intranuclear calcium and the depolarization of both the cell and nuclear membranes, determined by using FM4-64. In cells treated with Wnts 5A, 9B, and 10B, paradigm substrates for each Wnt class, increased [Ca2+](i) was followed by -catenin translocation into the nucleus in PC3, MCF7, and 253J, prostate, breast, and bladder cancer cell lines; both the increase in Wnt 5A, 9B, and 10B induced [Ca2+](i) release and -catenin translocation are suppressed by thapsigargin in PC3 cell line. We propose a convergent model of Wnt signaling network where Ca2+ and -catenin pathways may act in a coordinated, interdependent, rather than independent, manner.	[Thrasivoulou, Christopher] UCL, Res Dept Cell & Dev Biol, Ctr Cell & Mol Dynam, London WC1E 6JJ, England; [Millar, Michael] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Ahmed, Aamir] UCL, Prostate Canc Res Ctr, Div Surg, London W1W 7EJ, England	University of London; University College London; University of Edinburgh; University of London; University College London	Ahmed, A (corresponding author), UCL, Prostate Canc Res Ctr, Div Surg, 3rd Floor Labs,Charles Bell House,67 Riding House, London W1W 7EJ, England.	aamir.ahmed@ucl.ac.uk	Thrasivoulou, Christopher/F-7087-2010	Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	Prostate Cancer Research Centre Charity (UK Charity) [802545]	Prostate Cancer Research Centre Charity (UK Charity)	This work was supported by the Prostate Cancer Research Centre Charity (UK Charity 802545).	Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; ALLBRITTON NL, 1994, P NATL ACAD SCI USA, V91, P12458, DOI 10.1073/pnas.91.26.12458; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BUSTAMANTE JO, 1995, J MEMBRANE BIOL, V146, P253; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; GIULIAN D, 1977, J CELL BIOL, V72, P86, DOI 10.1083/jcb.72.1.86; GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jan CR, 1999, LIFE SCI, V65, P2513, DOI 10.1016/S0024-3205(99)00518-4; Ke JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033676; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; Lekven AC, 2003, DEV BIOL, V254, P172, DOI 10.1016/S0012-1606(02)00044-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MORLEY P, 1993, J CELL PHYSIOL, V156, P219, DOI 10.1002/jcp.1041560202; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011163; Ouko L, 2004, J BIOL CHEM, V279, P26707, DOI 10.1074/jbc.M402877200; PEIFER M, 1991, DEVELOPMENT, V111, P1029; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Perez-Terzic C, 1999, CIRC RES, V84, P1292, DOI 10.1161/01.RES.84.11.1292; PerezTerzic C, 1996, SCIENCE, V273, P1875, DOI 10.1126/science.273.5283.1875; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Rout MP, 2001, J BIOL CHEM, V276, P16593, DOI 10.1074/jbc.R100015200; Sarma A, 2011, PROTEIN CELL, V2, P291, DOI 10.1007/s13238-011-1038-x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma M, 2012, J BIOL CHEM, V287, P819, DOI 10.1074/jbc.M111.299099; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835; Suh EK, 2003, EXP CELL RES, V290, P447, DOI 10.1016/S0014-4827(03)00370-7; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119	57	80	84	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35651	35659		10.1074/jbc.M112.437913	http://dx.doi.org/10.1074/jbc.M112.437913			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158438	hybrid, Green Published			2022-12-28	WOS:000329814700004
J	Zhu, TG; Dou, Z; Qin, B; Jin, CJ; Wang, XH; Xu, LL; Wang, ZY; Zhu, LJ; Liu, FS; Gao, XJ; Ke, YW; Wang, ZY; Aikhionbare, F; Fu, CH; Ding, X; Yao, XB				Zhu, Tongge; Dou, Zhen; Qin, Bo; Jin, Changjiang; Wang, Xinghui; Xu, Leilei; Wang, Zhaoyang; Zhu, Lijuan; Liu, Fusheng; Gao, Xinjiao; Ke, Yuwen; Wang, Zhiyong; Aikhionbare, Felix; Fu, Chuanhai; Ding, Xia; Yao, Xuebiao			Phosphorylation of Microtubule-binding Protein Hec1 by Mitotic Kinase Aurora B Specifies Spindle Checkpoint Kinase Mps1 Signaling at the Kinetochore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; Kinetochore; Mitosis; Mitotic Spindle; Phosphorylation; Cenp-e; Checkpoint	CENP-E; ASSEMBLY CHECKPOINT; HELA-CELLS; ATTACHMENT; COMPLEX; BUBR1; MAD2; CDC20; LOCALIZATION; ARCHITECTURE	Background: Hec1 is a core component of outer kinetochore essential for chromosome segregation in mitosis. Results: Hec1 interacts with mitotic checkpoint kinase Mps1, and phosphorylation of Hec1 by Aurora B recruits Mps1 to kinetochore. Conclusion: Phosphorylation of Hec1 by Aurora B specifies Mps1 signaling at the kinetochore. Significance: Aurora B-Hec1-Mps1 axis orchestrates chromosome dynamics and stability in mitosis. The spindle assembly checkpoint (SAC) is a quality control device to ensure accurate chromosome attachment to spindle microtubule for equal segregation of sister chromatid. Aurora B is essential for SAC function by sensing chromosome bi-orientation via spatial regulation of kinetochore substrates. However, it has remained elusive as to how Aurora B couples kinetochore-microtubule attachment to SAC signaling. Here, we show that Hec1 interacts with Mps1 and specifies its kinetochore localization via its calponin homology (CH) domain and N-terminal 80 amino acids. Interestingly, phosphorylation of the Hec1 by Aurora B weakens its interaction with microtubules but promotes Hec1 binding to Mps1. Significantly, the temporal regulation of Hec1 phosphorylation orchestrates kinetochore-microtubule attachment and Mps1 loading to the kinetochore. Persistent expression of phosphomimetic Hec1 mutant induces a hyperactivation of SAC, suggesting that phosphorylation-elicited Hec1 conformational change is used as a switch to orchestrate SAC activation to concurrent destabilization of aberrant kinetochore attachment. Taken together, these results define a novel role for Aurora B-Hec1-Mps1 signaling axis in governing accurate chromosome segregation in mitosis.	[Zhu, Tongge; Dou, Zhen; Qin, Bo; Jin, Changjiang; Wang, Xinghui; Xu, Leilei; Wang, Zhaoyang; Zhu, Lijuan; Liu, Fusheng; Gao, Xinjiao; Ke, Yuwen; Wang, Zhiyong; Fu, Chuanhai; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230026, Peoples R China; [Zhu, Tongge; Dou, Zhen; Aikhionbare, Felix; Fu, Chuanhai] Morehouse Sch Med, Mol Imaging Ctr, Atlanta, GA 30310 USA; [Liu, Fusheng; Ding, Xia] Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Beijing University of Chinese Medicine	Ding, X (corresponding author), Beijing Univ Chinese Med, Sch Grad Studies, Beijing 100029, Peoples R China.	dingx@bucm.edu.cn; yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013; Fu, Chuanhai/G-8303-2016	Fu, Chuanhai/0000-0003-4354-3796; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA164133, 8G12MD007602, G12RR03034]; Chinese 973 Project [2010CB912103, 2012CB917204, 2014CB964800]; Anhui Province Key Project [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, 31271439]; Ministry of Education [20113402130010, WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, 8G12MD007602, and G12RR03034. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, and 2014CB964800; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 90508002, 91129714, 81270466, 90913016, 31000602, 31071184, 31171300, and 31271439; and Ministry of Education Grants 20113402130010, WK2060190018, and WK2340000021.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Caldas GV, 2013, MOL CELL, V51, P3, DOI 10.1016/j.molcel.2013.06.017; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2003, CURR BIOL, V13, P2103, DOI 10.1016/j.cub.2003.10.056; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Ding X, 2010, CELL RES, V20, P1386, DOI 10.1038/cr.2010.167; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dou Z, 2003, CELL RES, V13, P443, DOI 10.1038/sj.cr.7290186; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Fischer MS, 2004, J ZOOL SYST EVOL RES, V42, P1; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; He XW, 1998, J CELL SCI, V111, P1635; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lesage B, 2011, CURR BIOL, V21, pR898, DOI 10.1016/j.cub.2011.08.063; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Takeuchi K, 2012, EXP CELL RES, V318, P1367, DOI 10.1016/j.yexcr.2012.02.016; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009	50	45	47	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36149	36159		10.1074/jbc.M113.507970	http://dx.doi.org/10.1074/jbc.M113.507970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187132	Green Published, hybrid			2022-12-28	WOS:000329814700049
J	Chatelain, FC; Bichet, D; Feliciangeli, S; Larroque, MM; Braud, VM; Douguet, D; Lesage, F				Chatelain, Franck C.; Bichet, Delphine; Feliciangeli, Sylvain; Larroque, Marie-Madeleine; Braud, Veronique M.; Douguet, Dominique; Lesage, Florian			Silencing of the Tandem Pore Domain Halothane-inhibited K+ Channel 2 (THIK2) Relies on Combined Intracellular Retention and Low Intrinsic Activity at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Endoplasmic Reticulum (ER); Gating; Plasma Membrane; Potassium Channels; Protein Phosphorylation; Trafficking	POTASSIUM CHANNELS; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; ER RETENTION; BETA-SUBUNIT; SIGNAL; TRAFFICKING; PHOSPHORYLATION; LEAK; PROTEINS	Background: THIK2 does not generate macroscopic currents in heterologous systems. Results: THIK2 produces K+ currents when mutated in its pore region and/or in its cytoplasmic amino terminus. Conclusion: Silencing of THIK2 is due to low intrinsic activity and intracellular retention. Significance: THIK2 is a functional but silent channel. The tandem pore domain halothane-inhibited K+ channel 1 (THIK1) produces background K+ currents. Despite 62% amino acid identity with THIK1, THIK2 is not active upon heterologous expression. Here, we show that this apparent lack of activity is due to a unique combination of retention in the endoplasmic reticulum and low intrinsic channel activity at the plasma membrane. A THIK2 mutant containing a proline residue (THIK2-A155P) in its second inner helix (M2) produces K+-selective currents with properties similar to THIK1, including inhibition by halothane and insensitivity to extracellular pH variations. Another mutation in the M2 helix (I158D) further increases channel activity and affects current kinetics. We also show that the cytoplasmic amino-terminal region of THIK2 (Nt-THIK2) contains an arginine-rich motif (RRSRRR) that acts as a retention/retrieval signal. Mutation of this motif in THIK2 induces a relocation of the channel to the plasma membrane, resulting in measurable currents, even in the absence of mutations in the M2 helix. Cell surface delivery of a Nt-THIK2-CD161 chimera is increased by mutating the arginines of the retention motif but also by converting the serine embedded in this motif to aspartate, suggesting a phosphorylation-dependent regulation of THIK2 trafficking.	CNRS, Inst Pharmacol Mol & Cellulaire, Lab Excellence Ion Channel Sci & Therapeut, F-06560 Valbonne, France; Univ Nice Sophia Antipolis, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Lesage, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011; douguet, dominique/D-5644-2017; braud, veronique M/I-4597-2013; Feliciangeli, Sylvain/Q-1292-2016	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; braud, veronique M/0000-0001-8213-3947; Feliciangeli, Sylvain/0000-0003-3358-3719; Bichet, Delphine/0000-0002-9601-089X; CHATELAIN, Franck C./0000-0002-8426-8893	Fondation pour la Recherche Medicale Grant Equipe labellisee FRM; Agence Nationale de la Recherche Laboratory of Excellence "Ion Channel Science and Therapeutics" [ANR-11-LABX-0015-01]	Fondation pour la Recherche Medicale Grant Equipe labellisee FRM; Agence Nationale de la Recherche Laboratory of Excellence "Ion Channel Science and Therapeutics"(French National Research Agency (ANR))	The work was supported by Fondation pour la Recherche Medicale Grant Equipe labellisee FRM 2011 and by Agence Nationale de la Recherche Laboratory of Excellence "Ion Channel Science and Therapeutics" Grant ANR-11-LABX-0015-01.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Campanucci VA, 2003, J PHYSIOL-LONDON, V548, P731, DOI 10.1113/jphysiol.2002.035998; Chatelain FC, 2012, P NATL ACAD SCI USA, V109, P5499, DOI 10.1073/pnas.1201132109; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2010, J BIOL CHEM, V285, P4798, DOI 10.1074/jbc.M109.078535; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Kang D., 2013, PFLUEGERS ARCH, DOI 10.1007/s00424-013-1358-1; Kim D, 2001, BIOCHEM BIOPH RES CO, V284, P923, DOI 10.1006/bbrc.2001.5064; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2005, J GEN PHYSIOL, V125, P71, DOI 10.1085/jgp.200409194; Lazarenko RM, 2010, J NEUROSCI, V30, P9324, DOI 10.1523/JNEUROSCI.1956-10.2010; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Mant A, 2011, J BIOL CHEM, V286, P14110, DOI 10.1074/jbc.M110.190702; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Marsh B, 2012, MOL CELL NEUROSCI, V49, P375, DOI 10.1016/j.mcn.2012.01.002; Mathie A, 2010, CURR NEUROPHARMACOL, V8, P276, DOI 10.2174/157015910792246146; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Rajan S, 2001, J BIOL CHEM, V276, P7302, DOI 10.1074/jbc.M008985200; Ren Z, 2003, J NEUROSCI, V23, P6608; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Salinas M, 1999, J BIOL CHEM, V274, P11751, DOI 10.1074/jbc.274.17.11751; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Theilig F, 2008, CELL PHYSIOL BIOCHEM, V21, P63, DOI 10.1159/000113748; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	49	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35081	35092		10.1074/jbc.M113.503318	http://dx.doi.org/10.1074/jbc.M113.503318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163367	Green Published, hybrid			2022-12-28	WOS:000329867600010
J	Kopaskie, KS; Ligtenberg, KG; Schneewind, O				Kopaskie, Karyl S.; Ligtenberg, Katherine Given; Schneewind, Olaf			Translational Regulation of Yersinia enterocolitica mRNA Encoding a Type Ill Secretion Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; mRNA; Ribosomes; Secretion; Translation Regulation	III PROTEIN SECRETION; TARGET-CELL CONTACT; YOP PROTEINS; HELA-CELLS; POSTTRANSCRIPTIONAL MECHANISM; EUKARYOTIC CELLS; TIP COMPLEX; CHAPERONE; PSEUDOTUBERCULOSIS; EXPRESSION	Background:Yersinia enterocolitica yopD, lcrH, and yscM1 control the expression of yopQ encoding a secretion substrate. Results: YopD associates with 30 S ribosomal particles, and YopD, LcrH, and YscM1 block yopQ mRNA translation. Conclusion: In response to environmental signals, Yersinia prevent yopQ expression by blocking the translation of its transcripts. Significance: These results demonstrate translational regulation for the Yersinia type III secretion pathway. Yersinia enterocolitica type III secretion machines transport YopQ and other Yop effectors into host immune cells. YopD and its chaperone LcrH are essential components of the Yersinia type III pathway, enabling effector translocation into host cells. YopD, LcrH, and YscM1 also regulate yop expression post-transcriptionally in response to environmental signals; however, the molecular mechanisms for this regulation and Yop secretion are unknown. We show here that YopD associates with 30 S ribosomal particles in a manner requiring LcrH. When added to ribosomes, YopD, LcrH, and YscM1 block the translation of yopQ mRNA. We propose a model whereby LcrH-dependent association of YopD with 30 S ribosomal particles enables YscM1 to block yopQ translation unless type III machines are induced to secrete the effector.	Argonne Natl Lab, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA; [Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			NICHD, National Institutes of Health; Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health) [1-U54-AI-057153]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042797, U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Antoni P.A. Hendrickx for training in transmission electron microscopy and members of our laboratory for discussion and critical comments on the manuscript The S3 monoclonal antibody developed by L. Kahan was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD, National Institutes of Health, and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. O. S. acknowledges membership within and support from the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (National Institutes of Health Award 1-U54-AI-057153).	Amer AAA, 2011, J BACTERIOL, V193, P6683, DOI 10.1128/JB.00210-11; Anderson DM, 1999, MOL MICROBIOL, V31, P1139, DOI 10.1046/j.1365-2958.1999.01254.x; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blaylock B, 2008, MOL MICROBIOL, V70, P1210, DOI 10.1111/j.1365-2958.2008.06474.x; Broms JE, 2005, J BACTERIOL, V187, P7738, DOI 10.1128/JB.187.22.7738-7752.2005; Broms JE, 2007, J BACTERIOL, V189, P8417, DOI 10.1128/JB.00936-07; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004; Cambronne ED, 2002, J BACTERIOL, V184, P5880, DOI 10.1128/JB.184.21.5880-5893.2002; Chen YQ, 2011, MOL MICROBIOL, V80, P966, DOI 10.1111/j.1365-2958.2011.07623.x; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; Cheng LW, 2001, J BACTERIOL, V183, P5293, DOI 10.1128/JB.183.18.5293-5301.2001; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; CORNELIS G, 1975, J GEN MICROBIOL, V87, P285, DOI 10.1099/00221287-87-2-285; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2003, MOL MICROBIOL, V50, P1091, DOI 10.1046/j.1365-2958.2003.03812.x; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costa TRD, 2010, J BIOL CHEM, V285, P25269, DOI 10.1074/jbc.M110.144311; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Francis MS, 2000, MOL MICROBIOL, V38, P85, DOI 10.1046/j.1365-2958.2000.02112.x; Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Jackson MW, 1998, J BACTERIOL, V180, P4912, DOI 10.1128/JB.180.18.4912-4921.1998; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lee VT, 1999, MOL MICROBIOL, V31, P1619, DOI 10.1046/j.1365-2958.1999.01270.x; Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002; Ligtenberg KG, 2013, J BACTERIOL, V195, P777, DOI 10.1128/JB.02021-12; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Niemann GS, 2013, J BACTERIOL, V195, P2119, DOI 10.1128/JB.00024-13; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Ramamurthi KS, 2005, J BACTERIOL, V187, P707, DOI 10.1128/JB.187.2.707-715.2005; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x; Ramamurthi KS, 2002, ANNU REV CELL DEV BI, V18, P107, DOI 10.1146/annurev.cellbio.18.012502.105912; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sorg JA, 2005, J BACTERIOL, V187, P7090, DOI 10.1128/JB.187.20.7090-7102.2005; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493; Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998; Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08	66	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35478	35488		10.1074/jbc.M113.504811	http://dx.doi.org/10.1074/jbc.M113.504811			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158443	hybrid, Green Published			2022-12-28	WOS:000329867600043
J	Billington, N; Wang, AB; Mao, J; Adelstein, RS; Sellers, JR				Billington, Neil; Wang, Aibing; Mao, Jian; Adelstein, Robert S.; Sellers, James R.			Characterization of Three Full-length Human Nonmuscle Myosin II Paralogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; ATPases; Cytoskeleton; Electron Microscopy (EM); Molecular Motors; Myosin	LIGHT-CHAIN PHOSPHORYLATION; HUMAN PLATELET MYOSIN; SMOOTH-MUSCLE MYOSIN; VERTEBRATE NONMUSCLE; CELL-ADHESION; COILED-COILS; HEAD-HEAD; ACTIN; MEROMYOSIN; PURIFICATION	Nonmuscle myosin IIs (NM IIs) are a group of molecular motors involved in a wide variety of cellular processes including cytokinesis, migration, and control of cell morphology. There are three paralogs of the NM II heavy chain in humans (IIA, IIB, and IIC), each encoded by a separate gene. These paralogs are expressed at different levels according to cell type and have different roles and intracellular distributions in vivo. Most previous studies on NM II used tissue-purified protein or expressed fragments of the molecule, which presents potential drawbacks for characterizing individual paralogs of the intact protein in vitro. To circumvent current limitations and approach their native properties, we have successfully expressed and purified the three full-length human NM II proteins with their light chains, using the baculovirus/Sf9 system. The enzymatic and structural properties of the three paralogs were characterized. Although each NM II is capable of forming bipolar filaments, those formed by IIC tend to contain fewer constituent molecules than those of IIA and IIB. All paralogs adopt the compact conformation in the presence of ATP. Phosphorylation of the regulatory light chain leads to assembly into filaments, which bind to actin in the presence of ATP. The nature of interactions with actin filaments is shown with different paralogs exhibiting different actin binding behaviors under equivalent conditions. The data show that although NM IIA and IIB form filaments with similar properties, NM IIC forms filaments that are less well suited to roles such as tension maintenance within the cell.	[Billington, Neil; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Wang, Aibing; Mao, Jian; Adelstein, Robert S.] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Adelstein, RS (corresponding author), NHLBI, Mol Cardiol Lab, NIH, 10 Ctr Dr,10-6C103B, Bethesda, MD 20892 USA.	Adelster@nhlbi.nih.gov; sellersj@nhlbi.nih.gov		Adelstein, Robert/0000-0002-8683-2144; Billington, Neil/0000-0003-2306-0228; WANG, AIBING/0000-0002-0470-8220	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004216, ZIAHL001786] Funding Source: NIH RePORTER	Electron Microscopy Core Facility of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Electron Microscopy Core Facility of the NHLBI for support, advice, and use of facilities. We also thank Mary Anne Conti for critical reading of the manuscript.	Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Ben-Ya'acov A, 2003, J BIOL CHEM, V278, P40032, DOI 10.1074/jbc.M306948200; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; BURNS CG, 1995, J CELL BIOL, V130, P605, DOI 10.1083/jcb.130.3.605; BURRIDGE K, 1975, J MOL BIOL, V99, P1, DOI 10.1016/S0022-2836(75)80154-9; Butt T, 2010, J BIOL CHEM, V285, P4964, DOI 10.1074/jbc.M109.044792; COLLINS JH, 1981, J BIOL CHEM, V256, P2586; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; CRAIG R, 1977, J CELL BIOL, V75, P990, DOI 10.1083/jcb.75.3.990; DAVIS JS, 1986, BIOPHYS J, V50, P417, DOI 10.1016/S0006-3495(86)83477-4; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; Goeckeler ZM, 2008, AM J PHYSIOL-CELL PH, V295, pC994, DOI 10.1152/ajpcell.00318.2008; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; HODGE TP, 1992, J CELL BIOL, V118, P1085, DOI 10.1083/jcb.118.5.1085; Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Jana SS, 2009, J BIOL CHEM, V284, P11563, DOI 10.1074/jbc.M806574200; JOSEPHS R, 1966, BIOCHEMISTRY-US, V5, P3474, DOI 10.1021/bi00875a013; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Jung HS, 2008, P NATL ACAD SCI USA, V105, P6022, DOI 10.1073/pnas.0707846105; KAMINER B, 1966, J MOL BIOL, V20, P391, DOI 10.1016/0022-2836(66)90070-2; KAWAMOTO S, 1991, J CELL BIOL, V112, P915, DOI 10.1083/jcb.112.5.915; KENDRICKJONES J, 1987, J MOL BIOL, V198, P241, DOI 10.1016/0022-2836(87)90310-X; KENDRICKJONES J, 1982, METHOD ENZYMOL, V85, P364; Kiboku T, 2013, GENES CELLS, V18, P90, DOI 10.1111/gtc.12021; Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200; Kim KY, 2008, BIOCHEM BIOPH RES CO, V369, P124, DOI 10.1016/j.bbrc.2007.11.108; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kovacs M, 2004, BIOCHEMISTRY-US, V43, P4219, DOI 10.1021/bi036007l; Kuhne W., 1864, UNTERSUCHUNGEN PROTP; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; Li Y, 2008, DNA CELL BIOL, V27, P117, DOI 10.1089/dna.2007.0661; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; Ma XF, 2010, MOL BIOL CELL, V21, P3952, DOI 10.1091/mbc.E10-04-0293; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; ONISHI H, 1984, J BIOCHEM-TOKYO, V95, P903, DOI 10.1093/oxfordjournals.jbchem.a134686; Pato MD, 1996, J BIOL CHEM, V271, P2689, DOI 10.1074/jbc.271.5.2689; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLLARD TD, 1974, ANAL BIOCHEM, V60, P258, DOI 10.1016/0003-2697(74)90152-3; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; REISLER E, 1982, BIOCHEMISTRY-US, V21, P701, DOI 10.1021/bi00533a018; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Ricketson D, 2010, P NATL ACAD SCI USA, V107, P20964, DOI 10.1073/pnas.1007025107; Rosenberg MM, 2013, J BIOL CHEM, V288, P9779, DOI 10.1074/jbc.M112.430173; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; SCHOLEY JM, 1982, J BIOL CHEM, V257, P7737; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shutova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040814; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; TRYBUS KM, 1982, P NATL ACAD SCI-BIOL, V79, P6151, DOI 10.1073/pnas.79.20.6151; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; VERKHOVSKY AB, 1993, J CELL BIOL, V123, P637, DOI 10.1083/jcb.123.3.637; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, BIOCHEMISTRY-US, V39, P5555, DOI 10.1021/bi000133x; Wendt T, 1999, J CELL BIOL, V147, P1385, DOI 10.1083/jcb.147.7.1385; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	79	123	124	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33398	33410		10.1074/jbc.M113.499848	http://dx.doi.org/10.1074/jbc.M113.499848			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24072716	Green Published, hybrid			2022-12-28	WOS:000328841700053
J	Buhrman, JD; Jordan, KR; Munson, DJ; Moore, BL; Kappler, JW; Slansky, JE				Buhrman, Jonathan D.; Jordan, Kimberly R.; Munson, Daniel J.; Moore, Brandon L.; Kappler, John W.; Slansky, Jill E.			Improving Antigenic Peptide Vaccines for Cancer Immunotherapy Using a Dominant Tumor-specific T Cell Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen; Peptide Arrays; T Cell; T Cell Receptor; Tumor Immunology; Vaccines	MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I BINDING; SELF-ANTIGEN; ANTITUMOR IMMUNITY; MOLECULAR MIMICRY; CENTRAL TOLERANCE; MHC COMPLEXES; HIGH-AFFINITY; TCR-BINDING; RECOGNITION	Background: Vaccination with mimotopes, peptide mimics of epitopes, stimulates a range of T cell protection. Results: Mimotopes identified from peptide libraries by T cells with common receptors increased immunity more than those with rare high affinity receptors. Conclusion: T cell prevalence must be considered when designing peptide vaccines. Significance: Optimizing mimotopes will improve antigen-specific vaccines for applications including cancer immunotherapies. Vaccines that incorporate peptide mimics of tumor antigens, or mimotope vaccines, are commonly used in cancer immunotherapy and function by eliciting increased numbers of T cells that cross-react with the native tumor antigen. Unfortunately, they often elicit T cells that do not cross-react with or that have low affinity for the tumor antigen. Using a high affinity tumor-specific T cell clone, we identified a panel of mimotope vaccines for the dominant peptide antigen from a mouse colon tumor that elicits a range of tumor protection following vaccination. The TCR from this high affinity T cell clone was rarely identified in ex vivo evaluation of tumor-specific T cells elicited by mimotope vaccination. Conversely, a low affinity clone found in the tumor and following immunization was frequently identified. Using peptide libraries, we determined if this frequently identified TCR improved the discovery of efficacious mimotopes. We demonstrated that the representative TCR identified more protective mimotopes than the high affinity TCR. These results suggest that targeting a dominant fraction of tumor-specific T cells generates potent immunity and that consideration of the available T cell repertoire is necessary for targeted T cell therapy. These results have important implications when optimizing mimotope vaccines for cancer immunotherapy.	[Buhrman, Jonathan D.; Jordan, Kimberly R.; Munson, Daniel J.; Moore, Brandon L.; Kappler, John W.; Slansky, Jill E.] Univ Colorado, Sch Med, Integrated Dept Immunol, Aurora, CO 80045 USA; [Jordan, Kimberly R.] Univ Colorado, Sch Med, Dept Surg, Aurora, CO 80045 USA; [Kappler, John W.] Natl Jewish Hlth, Howard Hughes Med Inst, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute; National Jewish Health	Slansky, JE (corresponding author), Univ Colorado, Sch Med, Integrated Dept Immunol, Natl Jewish Hlth, 1400 Jackson St,Rm K511, Denver, CO 80206 USA.	Jill.Slansky@ucdenver.edu			National Institutes of Health [CA109560, P30CA046934]; American Cancer Society [RSG-08-184-01-L1B]; Cancer Research Institute Pre-doctoral Emphasis Pathway in Tumor Immunology Fellowship; NATIONAL CANCER INSTITUTE [R01CA109560, P30CA046934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Cancer Research Institute Pre-doctoral Emphasis Pathway in Tumor Immunology Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA109560 and P30CA046934. This work was also supported by American Cancer Society Grant RSG-08-184-01-L1B.; Both authors contributed equally to this work. Supported by the Cancer Research Institute Pre-doctoral Emphasis Pathway in Tumor Immunology Fellowship.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Appay V, 2006, EUR J IMMUNOL, V36, P1805, DOI 10.1002/eji.200535805; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Buhrman JD, 2013, CANCER RES, V73, P74, DOI 10.1158/0008-5472.CAN-12-1005; Chastain EML, 2012, IMMUNOL REV, V245, P227, DOI 10.1111/j.1600-065X.2011.01076.x; Clay TM, 1999, J IMMUNOL, V162, P1749; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Crawford F, 2006, IMMUNOL REV, V210, P156, DOI 10.1111/j.0105-2896.2006.00365.x; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; de Visser KE, 2003, J IMMUNOTHER, V26, P1, DOI 10.1097/00002371-200301000-00001; de Visser KE, 2001, J IMMUNOL, V167, P3818, DOI 10.4049/jimmunol.167.7.3818; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Ekeruche-Makinde J, 2012, J BIOL CHEM, V287, P37269, DOI 10.1074/jbc.M112.386409; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Hou YF, 2008, J IMMUNOL, V180, P1526, DOI 10.4049/jimmunol.180.3.1526; Iero M, 2007, CANCER IMMUNOL IMMUN, V56, P1979, DOI 10.1007/s00262-007-0342-z; Jordan KR, 2008, J IMMUNOL, V180, P188, DOI 10.4049/jimmunol.180.1.188; Jordan KR, 2012, CANCER IMMUNOL IMMUN, V61, P1627, DOI 10.1007/s00262-012-1217-5; Jordan KR, 2010, P NATL ACAD SCI USA, V107, P4652, DOI 10.1073/pnas.0914879107; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; KHILKO SN, 1993, J BIOL CHEM, V268, P15425; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; McMahan RH, 2006, J CLIN INVEST, V116, P2543, DOI 10.1172/JCI26936; McWilliams JA, 2008, VACCINE, V26, P1863, DOI 10.1016/j.vaccine.2008.01.052; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Miller JFAP, 1996, CURR OPIN IMMUNOL, V8, P815, DOI 10.1016/S0952-7915(96)80010-0; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; OZATO K, 1980, J IMMUNOL, V125, P2473; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Sanchez PJ, 2007, J IMMUNOL, V178, P1564, DOI 10.4049/jimmunol.178.3.1564; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Stuge TB, 2004, PLOS MED, V1, P149, DOI 10.1371/journal.pmed.0010028; Tam RC, 1996, J IMMUNOL, V156, P3765; Tang Y, 2007, CANCER IMMUNOL IMMUN, V56, P319, DOI 10.1007/s00262-006-0195-x; Truscott SM, 2007, J IMMUNOL, V178, P6280, DOI 10.4049/jimmunol.178.10.6280; Tumenjargal S, 2003, EUR J IMMUNOL, V33, P3175, DOI 10.1002/eji.200324244; Wang YB, 2005, P NATL ACAD SCI USA, V102, P2476, DOI 10.1073/pnas.0409798102; Wieckowski S, 2009, J IMMUNOL, V183, P5397, DOI 10.4049/jimmunol.0901460; WILSON RK, 1988, IMMUNOL REV, V101, P149, DOI 10.1111/j.1600-065X.1988.tb00736.x; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Zaremba S, 1997, CANCER RES, V57, P4570; Zugel U, 1998, J IMMUNOL, V161, P1705	59	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33213	33225		10.1074/jbc.M113.509554	http://dx.doi.org/10.1074/jbc.M113.509554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106273	Green Published, hybrid			2022-12-28	WOS:000328841700036
J	Inokuchi, H; Ito, R; Sekiguchi, T; Sekiguchi, M				Inokuchi, Hachiro; Ito, Riyoko; Sekiguchi, Takeshi; Sekiguchi, Mutsuo			Search for Proteins Required for Accurate Gene Expression under Oxidative Stress ROLES OF GUANYLATE KINASE AND RNA POLYMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Oxidative Stress; Protein Synthesis; RNA Polymerase; RNA Synthesis; Guanylate Kinase	ESCHERICHIA-COLI MUTT; RPOB GENE; MSBA GENE; MUTATIONS; GUANINE; DNA; MUTAGENESIS; NUCLEOTIDE; DEOXYGUANOSINE; TRANSCRIPTION	Background: Oxygen radicals, formed in aerobically growing cells, oxidize guanine to 8-oxo-7,8-dihydroguanine, which causes base mispairing. Results: Guanylate kinase and RNA polymerase are most responsible for preventing transcriptional errors caused by oxidative stress. Conclusion: Mutations in the genes responsible for preventing phenotypic suppression were identified. Significance: This study reveals a mechanism by which bacterial cells protect themselves against oxidative damage to RNA. In aerobically growing cells, in which reactive oxygen species are produced, the guanine base is oxidized to 8-oxo-7,8-dihydroguanine, which can pair with adenine as well as cytosine. This mispairing causes alterations in gene expression, and cells possess mechanisms to prevent such outcomes. In Escherichia coli, 8-oxo-7,8-dihydroguanine-related phenotypic suppression of lacZ amber is enhanced by mutations in genes related to the prevention of abnormal protein synthesis under oxidative stress. A genome-wide search for the genes responsible, followed by DNA sequence determination, revealed that specific amino acid changes in guanylate kinase and in the and subunits of RNA polymerase cause elevated levels of phenotypic suppression, specifically under aerobic conditions. The involvement of the DnaB, DnaN, and MsbA proteins, which are involved in DNA replication and in preserving the membrane structure, was also noted. Interactions of these proteins with each other and also with other molecules may be important for preventing errors in gene expression.	[Inokuchi, Hachiro; Ito, Riyoko; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan; [Inokuchi, Hachiro; Ito, Riyoko; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Dept Biochem, Fukuoka 8140193, Japan; [Sekiguchi, Takeshi] Kyushu Univ, Dept Mol Biol, Grad Sch Med Sci, Fukuoka 8128582, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Kyushu University	Sekiguchi, M (corresponding author), Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan.	mseki@college.fdcnet.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; MEXT	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, including the MEXT-supported Program for the Strategic Research Foundation at Private Universities and grants-in-aid for scientific research.	BERLYN MKB, 1996, ESCHERICHIA COLI SAL, P1715; BURGERS PMJ, 1981, P NATL ACAD SCI-BIOL, V78, P5391, DOI 10.1073/pnas.78.9.5391; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DEMPLE B, 1980, NATURE, V287, P203, DOI 10.1038/287203a0; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Fowler RG, 2003, DNA REPAIR, V2, P159, DOI 10.1016/S1568-7864(02)00193-3; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; GAIDAROV IO, 1993, FEBS LETT, V335, P81, DOI 10.1016/0014-5793(93)80444-Y; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Hayakawa H, 1999, BIOCHEMISTRY-US, V38, P3610, DOI 10.1021/bi982361l; Hayakawa H, 2001, BIOCHEMISTRY-US, V40, P9977, DOI 10.1021/bi010595q; Hible G, 2005, J MOL BIOL, V352, P1044, DOI 10.1016/j.jmb.2005.07.042; HOOPER ML, 1972, FEBS LETT, V22, P149, DOI 10.1016/0014-5793(72)80241-2; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KOMINE Y, 1990, J MOL BIOL, V212, P579, DOI 10.1016/0022-2836(90)90224-A; LAGERKVIST U, 1958, J BIOL CHEM, V233, P143; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; NAKAYAMA N, 1984, J BIOL CHEM, V259, P97; NINIO J, 1991, BIOCHIMIE, V73, P1517, DOI 10.1016/0300-9084(91)90186-5; OESCHGER MP, 1966, J BIOL CHEM, V241, P5452; OHMORI H, 1984, GENE, V28, P159, DOI 10.1016/0378-1119(84)90253-1; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Sakai A, 2006, GENES CELLS, V11, P767, DOI 10.1111/j.1365-2443.2006.00982.x; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Sekiguchi T, 2013, J BIOL CHEM, V288, P8128, DOI 10.1074/jbc.M112.418723; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Zhou YN, 2013, J BIOL CHEM, V288, P2700, DOI 10.1074/jbc.M112.429464	45	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32952	32962		10.1074/jbc.M113.507772	http://dx.doi.org/10.1074/jbc.M113.507772			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097971	Green Published, hybrid			2022-12-28	WOS:000328841700013
J	Tsitsanou, KE; Drakou, CE; Thireou, T; Gruber, AV; Kythreoti, G; Azem, A; Fessas, D; Eliopoulos, E; Iatrou, K; Zographos, SE				Tsitsanou, Katerina E.; Drakou, Christina E.; Thireou, Trias; Gruber, Anna Vitlin; Kythreoti, Georgia; Azem, Abdussalam; Fessas, Dimitrios; Eliopoulos, Elias; Iatrou, Kostas; Zographos, Spyros E.			Crystal and Solution Studies of the "Plus-C" Odorant-binding Protein 48 from Anopheles gambiae CONTROL OF BINDING SPECIFICITY THROUGH THREE-DIMENSIONAL DOMAIN SWAPPING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Calorimetry; Chromatography; Crystal Structure; Fluorescence; Molecular Docking	MALARIA-TRANSMITTING MOSQUITO; ANOPHELES-GAMBIAE; MAMESTRA-BRASSICAE; VECTOR MOSQUITO; GYPSY-MOTH; EXPRESSION; MECHANISM; GENES; TEMPERATURE; RELEASE	Much physiological and behavioral evidence has been provided suggesting that insect odorant-binding proteins (OBPs) are indispensable for odorant recognition and thus are appealing targets for structure-based discovery and design of novel host-seeking disruptors. Despite the fact that more than 60 putative OBP-encoding genes have been identified in the malaria vector Anopheles gambiae, the crystal structures of only six of them are known. It is therefore clear that OBP structure determination constitutes the bottleneck for structure-based approaches to mosquito repellent/attractant discovery. Here, we describe the three-dimensional structure of an A. gambiae Plus-C group OBP (AgamOBP48), which exhibits the second highest expression levels in female antennae. This structure represents the first example of a three-dimensional domain-swapped dimer in dipteran species. A combined binding site is formed at the dimer interface by equal contribution of each monomer. Structural comparisons with the monomeric AgamOBP47 revealed that the major structural difference between the two Plus-C proteins localizes in their N- and C-terminal regions, and their concerted conformational change may account for monomer-swapped dimer conversion and furthermore the formation of novel binding pockets. Using a combination of gel filtration chromatography, differential scanning calorimetry, and analytical ultracentrifugation, we demonstrate the AgamOBP48 dimerization in solution. Eventually, molecular modeling calculations were used to predict the binding mode of the most potent synthetic ligand of AgamOBP48 known so far, discovered by ligand- and structure-based virtual screening. The structure-aided identification of multiple OBP binders represents a powerful tool to be employed in the effort to control transmission of the vector-borne diseases.	[Tsitsanou, Katerina E.; Drakou, Christina E.; Zographos, Spyros E.] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens 11635, Greece; [Thireou, Trias; Eliopoulos, Elias] Agr Univ Athens, Dept Agr Biotechnol, GR-11855 Athens, Greece; [Gruber, Anna Vitlin; Azem, Abdussalam] Tel Aviv Univ, Dept Biochem & Mol Biol, George E Wise Fac Life Sci, IL-69978 Tel Aviv, Israel; [Kythreoti, Georgia; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol Grp, Athens 15310, Greece; [Fessas, Dimitrios] Univ Milan, Dept Food Environm & Nutr Sci, I-20133 Milan, Italy	National Hellenic Research Foundation; Agricultural University of Athens; Tel Aviv University; National Centre of Scientific Research "Demokritos"; University of Milan	Zographos, SE (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, 48 Vassileos Constantinou Ave, Athens 11635, Greece.	sez@eie.gr	Zographos, Spyros/H-9058-2013; Thireou, Trias/HCH-5951-2022	Zographos, Spyros/0000-0001-8455-2352; Eliopoulos, Elias/0000-0002-0919-0571; Thireou, Trias/0000-0002-6894-0774; Drakou, Christina/0000-0003-4793-0451; E. Tsitsanou, Katerina/0000-0001-9657-1390	European Community's Seventh Framework Programme under BioStruct-X Grant [283570]	European Community's Seventh Framework Programme under BioStruct-X Grant	We acknowledge the late Dr. Harald Biessmann and Dr. Marika F. Walter (Developmental Biology Center, University of California) for kindly providing the AgamOBP48 gene (GenBank (TM) accession number AF533512). Work at the Synchrotron Radiation Sources, MAX-lab, Lund, Sweden, and EMBL Hamburg Outstation, Germany, was supported by funding provided by the European Community's Seventh Framework Programme Grant FP7/2007-2013 under BioStruct-X Grant 283570.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; Ausili A, 2013, J PHOTOCH PHOTOBIO B, V118, P66, DOI 10.1016/j.jphotobiol.2012.11.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARONE G, 1992, J THERM ANAL, V38, P2779, DOI 10.1007/BF01979752; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1; Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2; Campanacci V, 1999, EUR J BIOCHEM, V264, P707, DOI 10.1046/j.1432-1327.1999.00666.x; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; DAuria S, 1997, BIOCHEM J, V323, P833, DOI 10.1042/bj3230833; Davrazou F, 2011, J BIOL CHEM, V286, P34175, DOI 10.1074/jbc.M111.274712; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fessa D, 2007, PROTEINS, V67, P1002, DOI 10.1002/prot.21383; Fessas D, 2001, EUR J BIOCHEM, V268, P5439, DOI 10.1046/j.0014-2956.2001.02484.x; FOSTER WA, 1994, J AM MOSQUITO CONTR, V10, P288; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leatherbarrow RJ., 2007, GRAFIT VERSION 6 0; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Medek P, 2007, JOURNAL WSCG, V15, P107; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Press WH, 1989, NUMERICAL RECIPES AR, P521; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schultze A, 2012, INSECT MOL BIOL, V21, P187, DOI 10.1111/j.1365-2583.2011.01125.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Tsitsanou KE, 2012, CELL MOL LIFE SCI, V69, P283, DOI 10.1007/s00018-011-0745-z; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179	60	28	33	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33427	33438		10.1074/jbc.M113.505289	http://dx.doi.org/10.1074/jbc.M113.505289			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097978	hybrid, Green Published			2022-12-28	WOS:000328841700055
J	Zhang, WX; Kou, YB; Xu, JT; Cao, YL; Zhao, GL; Shao, J; Wang, H; Wang, ZX; Bao, XM; Chen, GJ; Liu, WF				Zhang, Weixin; Kou, Yanbo; Xu, Jintao; Cao, Yanli; Zhao, Guolei; Shao, Jing; Wang, Hai; Wang, Zhixing; Bao, Xiaoming; Chen, Guanjun; Liu, Weifeng			Two Major Facilitator Superfamily Sugar Transporters from Trichoderma reesei and Their Roles in Induction of Cellulase Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Fungi; Gene Transcription; Sugar Transport; Transporters; Trichoderma reesei	DEGRADING ENZYMES; TRANSFORMATION; YEAST; GENE; SYSTEM; INVOLVEMENT; EXPRESSION; SOPHOROSE; ENCODES; SENSOR	Background: The molecular mechanism underlying the regulation of cellulase production by T. reesei is unclear. Results: The absence of sugar transporter Stp1 enhanced cellulase gene induction whereas the absence of Crt1 abolished cellulase gene expression. Conclusion: Crt1 is essential in cellulase gene induction independent of intracellular sugar delivery. Significance: These data shed light on the mechanism by which T. reesei senses and transmits cellulose signal. Proper perception of the extracellular insoluble cellulose is key to initiating the rapid synthesis of cellulases by cellulolytic Trichoderma reesei. Uptake of soluble oligosaccharides derived from cellulose hydrolysis represents a potential point of control in the induced cascade. In this study, we identified a major facilitator superfamily sugar transporter Stp1 capable of transporting cellobiose by reconstructing a cellobiose assimilation system in Saccharomyces cerevisiae. The absence of Stp1 in T. reesei resulted in differential cellulolytic response to Avicel versus cellobiose. Transcriptional profiling revealed a different expression profile in the stp1 strain from that of wild-type strain in response to Avicel and demonstrated that Stp1 somehow repressed induction of the bulk of major cellulase and hemicellulose genes. Two other putative major facilitator superfamily sugar transporters were, however, up-regulated in the profiling. Deletion of one of them identified Crt1 that was required for growth and enzymatic activity on cellulose or lactose, but was not required for growth or hemicellulase activity on xylan. The essential role of Crt1 in cellulase induction did not seem to rely on its transporting activity because the overall uptake of cellobiose or sophorose by T. reesei was not compromised in the absence of Crt1. Phylogenetic analysis revealed that orthologs of Crt1 exist in the genomes of many filamentous ascomycete fungi capable of degrading cellulose. These data thus shed new light on the mechanism by which T. reesei senses and transmits the cellulose signal and offers potential strategies for strain improvement.	[Zhang, Weixin; Kou, Yanbo; Xu, Jintao; Cao, Yanli; Zhao, Guolei; Wang, Zhixing; Bao, Xiaoming; Chen, Guanjun; Liu, Weifeng] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Shao, Jing; Wang, Hai] Qingdao Vland Biotech Grp Co Ltd, Qingdao 266061, Shandong, Peoples R China	Shandong University	Liu, WF (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	weifliu@sdu.edu.cn	Xu, Jintao/D-8308-2018	Xu, Jintao/0000-0002-9946-8601	National Basic Research Program of China [2011CB707402]; National Natural Science Foundation [31270116, 31300059]; New Century Excellent Talents in University [NCET-10-0546]; Shandong Provincial Funds for Distinguished Young Scientists [JQ201108]; Independent Innovation Foundation of Shandong University [2012GN021]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shandong Provincial Funds for Distinguished Young Scientists; Independent Innovation Foundation of Shandong University	This work was supported by National Basic Research Program of China Grant 2011CB707402, National Natural Science Foundation Grants 31270116 and 31300059, New Century Excellent Talents in University Grant NCET-10-0546, Shandong Provincial Funds for Distinguished Young Scientists Grant JQ201108, and Independent Innovation Foundation of Shandong University Grant 2012GN021.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; FRITSCHER C, 1990, EXP MYCOL, V14, P405, DOI 10.1016/0147-5975(90)90063-Y; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRUBER F, 1990, CURR GENET, V18, P447, DOI 10.1007/BF00309915; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; KUBICEK CP, 1993, J BIOL CHEM, V268, P19364; KUBICEK CP, 1988, J GEN MICROBIOL, V134, P1215; KUBICEK CP, 1993, ENZYME MICROB TECH, V15, P90, DOI 10.1016/0141-0229(93)90030-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MACH RL, 1995, MOL MICROBIOL, V16, P687, DOI 10.1111/j.1365-2958.1995.tb02430.x; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Porciuncula JD, 2013, BIOSCI BIOTECH BIOCH, V77, P1014, DOI 10.1271/bbb.120992; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Sambrook J., 2001, MOL CLONING LAB MANU, p[18, 54]; Stricker AR, 2006, EUKARYOT CELL, V5, P2128, DOI 10.1128/EC.00211-06; SZAKMARY K, 1991, J GEN MICROBIOL, V137, P2873, DOI 10.1099/00221287-137-12-2873; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VAHERI MP, 1979, EUR J APPL MICROBIOL, V8, P73, DOI 10.1007/BF00510268; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xie X, 2004, FUNGAL GENET BIOL, V41, P1104, DOI 10.1016/j.fgb.2004.08.009; Zhou QX, 2012, EUKARYOT CELL, V11, P1371, DOI 10.1128/EC.00170-12; Znameroski EA, 2012, P NATL ACAD SCI USA, V109, P6012, DOI 10.1073/pnas.1118440109	35	101	108	6	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32861	32872		10.1074/jbc.M113.505826	http://dx.doi.org/10.1074/jbc.M113.505826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085297	Green Published, hybrid			2022-12-28	WOS:000328841700005
J	Zhou, W; Jeyaraman, K; Yusoff, P; Shenolikar, S				Zhou, Wei; Jeyaraman, Krishna; Yusoff, Permeen; Shenolikar, Shirish			Phosphorylation at Tyrosine 262 Promotes GADD34 Protein Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Phosphotyrosine; Protein Turnover; Stress; Tyrosine Protein Phosphatase (Tyrosine Phosphatase); GADD34	ENDOPLASMIC-RETICULUM STRESS; INDUCED GENE-EXPRESSION; INITIATION-FACTOR 2; PHOSPHATASE 1B; GROWTH ARREST; TRANSCRIPTIONAL REGULATION; TRANSLATION; CANCER; PTP1B; SRC	Background: Proteasomal degradation of GADD34 dictates cell sensitivity to ER stress. Results: Phosphorylation at tyrosine 262 controls GADD34 protein turnover and cell fate following ER stress. Conclusion: Tyrosine 262 phosphorylation controls the cellular levels of GADD34, a key component of the stress-activated eIF2 phosphatase. Significance: Stress-induced GADD34 gene transcription and subsequent regulated GADD34 protein turnover control the feedback loop that ensures cell survival following ER stress. In mammalian cells, metabolic and environmental stress increases the phosphorylation of the eukaryotic translational initiation factor, eIF2, and attenuates global protein synthesis. Subsequent transcriptional activation of GADD34 assembles an eIF2 phosphatase that feeds back to restore mRNA translation. Active proteasomal degradation of GADD34 protein then reestablishes the sensitivity of cells to subsequent bouts of stress. Mass spectrometry established GADD34 phosphorylation on multiple serines, threonines, and tyrosines. Phosphorylation at tyrosine 262 enhanced the rate of the GADD34 protein turnover. Substrate-trapping studies identified TC-PTP (PTPN2) as a potential GADD34 phosphatase, recognizing phosphotyrosine 262. Reduced GADD34 protein levels in TC-PTP-null MEFs following ER stress emphasized the importance of TC-PTP in determining the cellular levels of GADD34 protein. The susceptibility of TC-PTP-null MEFs to ER stress-induced apoptosis was significantly ameliorated by ectopic expression of GADD34. The data suggested that GADD34 phosphorylation on tyrosine 262 modulates endoplasmic reticulum stress signaling and cell fate.	[Zhou, Wei; Jeyaraman, Krishna; Yusoff, Permeen; Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Shenolikar, Shirish] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University; Duke University	Shenolikar, S (corresponding author), Duke NUS Grad Med Sch, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	shirish.shenolikar@duke-nus.edu.sg			Duke-NUS Graduate Medical School, Singapore; IRG grant from the National Medical Research Council, Singapore	Duke-NUS Graduate Medical School, Singapore; IRG grant from the National Medical Research Council, Singapore	This work was supported by funds from the Duke-NUS Graduate Medical School, Singapore and an IRG grant (to S. S.) from the National Medical Research Council, Singapore.	B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Bettaieb A, 2011, J BIOL CHEM, V286, P9225, DOI 10.1074/jbc.M110.186148; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hollander MC, 2003, ONCOGENE, V22, P3827, DOI 10.1038/sj.onc.1206567; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Panzhinskiy E, 2013, DIABETOLOGIA, V56, P598, DOI 10.1007/s00125-012-2782-z; Prahlad V, 2009, TRENDS CELL BIOL, V19, P52, DOI 10.1016/j.tcb.2008.11.002; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Zhang HM, 2010, MOL CELL PROTEOMICS, V9, P635, DOI 10.1074/mcp.M900314-MCP200; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	36	7	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33146	33155		10.1074/jbc.M113.504407	http://dx.doi.org/10.1074/jbc.M113.504407			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092754	Green Published, hybrid			2022-12-28	WOS:000328841700030
J	Kaur, J; Olkhova, E; Malviya, VN; Grell, E; Michel, H				Kaur, Jagdeep; Olkhova, Elena; Malviya, Viveka Nand; Grell, Ernst; Michel, Hartmut			A L-Lysine Transporter of High Stereoselectivity of the Amino Acid-Polyamine-Organocation (APC) Superfamily PRODUCTION, FUNCTIONAL CHARACTERIZATION, AND STRUCTURE MODELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Homology Modeling; Isothermal Titration Calorimetry; Protein Purification; Site-directed Mutagenesis; APC Superfamily; Quantitative l-Lysine Binding; Secondary Active Transporter	ESCHERICHIA-COLI; PYROCOCCUS-HORIKOSHII; PROTEIN INTOLERANCE; MOLECULAR-BASIS; IDENTIFICATION; PERMEASE; GENE; MECHANISM; PURIFICATION; RECOGNITION	Background: LysP plays an important role in transport of lysine in bacteria. Results: Binding of lysine to purified STM2200 was investigated using ITC; key residues involved in binding are predicted by structure modeling and verified experimentally. Conclusion: l-Lysine binds to STM2200 selectively, and important residues were identified. Significance: Our findings provide a functional characterization of a lysine transporter. Membrane proteins of the amino acid-polyamine-organocation (APC) superfamily transport amino acids and amines across membranes and play an important role in the regulation of cellular processes. We report the heterologous production of the LysP-related transporter STM2200 from Salmonella typhimurium in Escherichia coli, its purification, and functional characterization. STM2200 is assumed to be a proton-dependent APC transporter of l-lysine. The functional interaction between basic amino acids and STM2200 was investigated by thermoanalytical methods, i.e. differential scanning and isothermal titration calorimetry. Binding of l-lysine to STM2200 in its solubilized monomer form is entropy-driven. It is characterized by a dissociation constant of 40 m at pH 5.9 and is highly selective; no evidence was found for the binding of l-arginine, l-ornithine, l-2,4-diaminobutyric acid, and l-alanine. d-Lysine is bound 45 times more weakly than its l-chiral form. We thus postulate that STM2200 functions as a specific transport protein. Based on the crystal structure of ApcT (Shaffer, P. L., Goehring, A., Shankaranarayanan, A., and Gouaux, E. (2009) Science 325, 1010-1014), a proton-dependent amino acid transporter of the APC superfamily, a homology model of STM2200 was created. Docking studies allowed identification of possible ligand binding sites. The resulting predictions indicated that Glu-222 and Arg-395 of STM2200 are markedly involved in ligand binding, whereas Lys-163 is suggested to be of structural and functional relevance. Selected variants of STM2200 where these three amino acid residues were substituted using single site-directed mutagenesis showed no evidence for l-lysine binding by isothermal titration calorimetry, which confirmed the predictions. Molecular aspects of the observed ligand specificity are discussed.	[Kaur, Jagdeep; Olkhova, Elena; Malviya, Viveka Nand; Grell, Ernst; Michel, Hartmut] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Max Planck Society	Michel, H (corresponding author), Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	hartmut.michel@biophys.mpg.de			European Membrane Protein Consortium (EMeP); Cluster of Excellence Frankfurt ("Macromolecular complexes"); Deutsche Forschungsgemeinschaft [SFB807]; Max-Planck-Gesellschaft	European Membrane Protein Consortium (EMeP); Cluster of Excellence Frankfurt ("Macromolecular complexes"); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by the European Membrane Protein Consortium (EMeP), the Cluster of Excellence Frankfurt ("Macromolecular complexes"), Deutsche Forschungsgemeinschaft Grant SFB807 (Transport and Communication across biological membranes), and Max-Planck-Gesellschaft.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; CLOSS EI, 1993, J BIOL CHEM, V268, P7538; Cosgriff AJ, 1997, J BACTERIOL, V179, P3317, DOI 10.1128/jb.179.10.3317-3323.1997; Cosgriff AJ, 2000, J BACTERIOL, V182, P2207, DOI 10.1128/JB.182.8.2207-2217.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Goswami D, 2012, BIOL CHEM, V393, P617, DOI 10.1515/hsz-2012-0101; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; Kim YM, 2002, J BIOCHEM, V132, P71, DOI 10.1093/oxfordjournals.jbchem.a003201; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Ruiz J, 2011, J BACTERIOL, V193, P2536, DOI 10.1128/JB.00815-10; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; SOPHIANOPOULOU V, 1995, FEMS MICROBIOL REV, V16, P53, DOI 10.1016/0168-6445(94)00091-C; STEFFES C, 1992, J BACTERIOL, V174, P3242, DOI 10.1128/jb.174.10.3242-3249.1992; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Vangelatos I, 2009, MOL MEMBR BIOL, V26, P356, DOI 10.1080/09687680903170546; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	40	10	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1377	1387		10.1074/jbc.M113.510743	http://dx.doi.org/10.1074/jbc.M113.510743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24257746	hybrid, Green Published			2022-12-28	WOS:000332401700016
J	Olsson, F; Schmidt, S; Althoff, V; Munter, LM; Jin, SB; Rosqvist, S; Lendahl, U; Multhaup, G; Lundkvist, J				Olsson, Fredrik; Schmidt, Staffan; Althoff, Veit; Munter, Lisa M.; Jin, Shaobo; Rosqvist, Susanne; Lendahl, Urban; Multhaup, Gerd; Lundkvist, Johan			Characterization of Intermediate Steps in Amyloid Beta (A beta) Production under Near-native Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Amyloid Precursor Protein; Intramembrane Proteolysis; Secretases	GAMMA-SECRETASE MODULATORS; AGE-OF-ONSET; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; A-BETA-42; TARGET; DEPOSITION; MUTATIONS; NSAIDS; MODEL	Background: The 42 amino acid long amyloid beta peptide (A42) plays a pivotal role in Alzheimer disease. Results: A novel assay was developed and enabled us to describe the process of 42 production and modulation. Conclusion: A42 is generated through different pathways, which are differently affected by disease causing mutations and anti-amyloidogenic drugs. Significance: The data provide key information for therapeutic development in Alzheimer disease. Processing of the amyloid precursor protein (APP) by -secretase results in generation of A peptides of different lengths ranging from 51 to 30 residues. Accumulation of A and in particular A42 is enhanced by familial Alzheimer disease (FAD) causing mutations in APP and is believed to play a pivotal role. The molecular mechanism underlying normal A production, the impact of FAD mutations on this process and how anti-amyloidogenic -secretase modulators (GSMs) cause a selective decrease in A40 and A42 and an increase in shorter A peptides, however, is poorly understood. By using a combined immuno- and LC-MS-based assay we identify several major intermediates, i.e. 3- and 4-peptides that line up head to head across the entire APP transmembrane sequence from A51 to A31/A30 and from A49 to A30/31. FAD APP mutations displayed a relative increase in 3- and 4-peptides from A48 to A38 compared with A49 to A37. These findings correlate with an increase in the A42/40 ratio. GSMs caused a decrease in A40 and A42 and an increase in A37 and A38 paralleled by an increase of the intermediates A40-38 and A42-39. Collectively, these data provide a thorough characterization of all intermediate steps in A production in native cell membranes and provide key mechanistic insights to genetic and pharmacological modulation of A generation.	[Olsson, Fredrik; Schmidt, Staffan; Rosqvist, Susanne; Lundkvist, Johan] AstraZeneca iMED CNS Pain, S-15185 Sodertalje, Sweden; [Althoff, Veit; Multhaup, Gerd] Free Univ Berlin, Berlin, Germany; [Munter, Lisa M.; Multhaup, Gerd] McGill Univ, Montreal, PQ, Canada; [Jin, Shaobo; Lendahl, Urban] Karolinska Inst, S-17177 Stockholm, Sweden	AstraZeneca; Free University of Berlin; McGill University; Karolinska Institutet	Multhaup, G (corresponding author), AstraZeneca iMED CNS Pain, S-15185 Sodertalje, Sweden.	gerhard.multhaup@mcgill.ca; johan.lundkvist@alzecure.org		Munter, Lisa/0000-0001-5736-1462; Lendahl, Urban/0000-0001-9543-8141	Deutsche Forschungsgemeinschaft (DFG) [MU901, SFB740]; Hans und Ilse Breuer foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Hans und Ilse Breuer foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (MU901; SFB740) and the Hans und Ilse Breuer foundation (to V. A.).	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Borgegard T, 2012, J BIOL CHEM, V287, P11810, DOI 10.1074/jbc.M111.305227; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Coric V, 2012, ARCH NEUROL-CHICAGO, V69, P1430, DOI 10.1001/archneurol.2012.2194; Duering M, 2005, NEUROBIOL AGING, V26, P785, DOI 10.1016/j.neurobiolaging.2004.08.002; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001	23	73	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1540	1550		10.1074/jbc.M113.498246	http://dx.doi.org/10.1074/jbc.M113.498246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24225948	Green Published, hybrid			2022-12-28	WOS:000332401700029
J	Cherry, AD; Suliman, HB; Bartz, RR; Piantadosi, CA				Cherry, Anne D.; Suliman, Hagir B.; Bartz, Raquel R.; Piantadosi, Claude A.			Peroxisome Proliferator-activated Receptor gamma Co-activator 1-alpha as a Critical Co-activator of the Murine Hepatic Oxidative Stress Response and Mitochondrial Biogenesis in Staphylococcus aureus Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antioxidants; Mitochondrial Metabolism; Oxidative Stress; Sepsis; Superoxide Dismutase (SOD); Co-immunoprecipitation; Peroxisome Proliferator-activated Receptor; Co-activator 1	SKELETAL-MUSCLE; EXPRESSION; METABOLISM; DAMAGE; SURVIVAL; PD-1; DYSFUNCTIONS; GLUTATHIONE; ADAPTATIONS; EXERCISE	A key transcriptional regulator of cell metabolism, the peroxisome proliferator-activated receptor co-activator 1- (PPARGC-1- or PGC-1), also regulates mitochondrial biogenesis, but its role in antioxidant gene regulation is not well understood. Here, we asked whether genetic heterozygosity of PGC-1 modulates gene expression for the mitochondrial antioxidant enzyme SOD-2 during hepatic inflammatory stress. Using Staphylococcus aureus peritonitis in mice, we found significant Sod2 gene induction in WT mice, whereas PGC-1 heterozygotes (PGC-1(+/-)) failed to augment Sod2 mRNA and protein levels. Impaired Sod2 regulation in PGC-1(+/-) mice was accompanied by oxidative stress shown by elevated mitochondrial GSSG/GSH and protein carbonyls. In silico analysis of the mouse proximal Sod2 promoter region revealed consensus binding sites for the Nfe2l2 (Nrf2) transcription factor. Chromatin immunoprecipitation demonstrated diminished Nfe2l2 protein binding to the antioxidant response element promoter site proximal to the Sod2 start site in PGC-1 heterozygous mice, implicating PGC-1 in facilitation of Nfe2l2 DNA binding. Nuclear protein co-immunoprecipitation demonstrated an interaction between hepatic Nfe2l2 and PGC-1 in WT mice that was greatly reduced in PGC-1(+/-) mice. The data indicate that PGC-1 promotes mitochondrial antioxidant enzyme expression through Nfe2l2-mediated SOD-2 expression in sepsis. The presence of this new PGC-1-dependent signaling axis indicates that PGC-1 opposes mitochondrial oxidative stress by means of selective induction of one or more antioxidant response element-driven genes. By implication, exploitation of this axis could lead to new pharmacological interventions to improve the antioxidant defenses during oxidative stress-induced mitochondrial damage.	Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Cherry, AD (corresponding author), Duke Univ, Dept Anesthesiol, DUMC Box 3094, Durham, NC 27710 USA.	anne.cherry@dm.duke.edu			National Institutes of Health [RO1-A1095424, R01-HL108801]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095424] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-A1095424 and R01-HL108801 (to C. A. P.).	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; CLARK JB, 1970, J BIOL CHEM, V245, P4724; Clayton CE, 2001, AM J PHYSIOL-LUNG C, V281, pL949, DOI 10.1152/ajplung.2001.281.4.L949; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Guidet B, 2005, CHEST, V127, P942, DOI 10.1378/chest.127.3.942; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Holley AK, 2011, INT J MOL SCI, V12, P7114, DOI 10.3390/ijms12107114; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Kantrow SP, 1997, ARCH BIOCHEM BIOPHYS, V345, P278, DOI 10.1006/abbi.1997.0264; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowes DA, 2011, BIOCHEM J, V436, P123, DOI 10.1042/BJ20102135; Lu ZB, 2010, ANTIOXID REDOX SIGN, V13, P1011, DOI 10.1089/ars.2009.2940; MacGarvey NC, 2012, AM J RESP CRIT CARE, V185, P851, DOI 10.1164/rccm.201106-1152OC; NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Russell AP, 2005, FASEB J, V19, P986, DOI 10.1096/fj.04-3168fje; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2004, CARDIOVASC RES, V64, P279, DOI 10.1016/j.cardiores.2004.07.005; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Sweeney T. E., 2010, PLOS ONE, V5; TAYLOR DE, 1995, ARCH BIOCHEM BIOPHYS, V316, P70, DOI 10.1006/abbi.1995.1011; VALCARCE C, 1988, J BIOL CHEM, V263, P7767; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang KQ, 2011, CARDIOVASC RES, V89, P426, DOI 10.1093/cvr/cvq296	49	54	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					41	52		10.1074/jbc.M113.512483	http://dx.doi.org/10.1074/jbc.M113.512483			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253037	hybrid, Green Published			2022-12-28	WOS:000329370900004
J	Feng, Y; Maity, R; Whitelegge, JP; Hadjikyriacou, A; Li, ZW; Zurita-Lopez, C; Al-Hadid, Q; Clark, AT; Bedford, MT; Masson, JY; Clarke, SG				Feng, You; Maity, Ranjan; Whitelegge, Julian P.; Hadjikyriacou, Andrea; Li, Ziwei; Zurita-Lopez, Cecilia; Al-Hadid, Qais; Clark, Amander T.; Bedford, Mark T.; Masson, Jean-Yves; Clarke, Steven G.			Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-rich Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Methylation; Mass Spectrometry (MS); Post-translational Modification; Protein Methylation; S-Adenosylmethionine (AdoMet); Methyltransferases; Protein-arginine Methyltransferases (PRMT)	HISTONE H4; POSTTRANSLATIONAL MODIFICATIONS; SYMMETRIC DIMETHYLATION; KINETIC MECHANISM; CRYSTAL-STRUCTURE; DNA-DAMAGE; IN-VIVO; METHYLATION; ACETYLATION; RESIDUES	The mammalian protein arginine methyltransferase 7 (PRMT7) has been implicated in roles of transcriptional regulation, DNA damage repair, RNA splicing, cell differentiation, and metastasis. However, the type of reaction that it catalyzes and its substrate specificity remain controversial. In this study, we purified a recombinant mouse PRMT7 expressed in insect cells that demonstrates a robust methyltransferase activity. Using a variety of substrates, we demonstrate that the enzyme only catalyzes the formation of -monomethylarginine residues, and we confirm its activity as the prototype type III protein arginine methyltransferase. This enzyme is active on all recombinant human core histones, but histone H2B is a highly preferred substrate. Analysis of the specific methylation sites within intact histone H2B and within H2B and H4 peptides revealed novel post-translational modification sites and a unique specificity of PRMT7 for methylating arginine residues in lysine- and arginine-rich regions. We demonstrate that a prominent substrate recognition motif consists of a pair of arginine residues separated by one residue (RXR motif). These findings will significantly accelerate substrate profile analysis, biological function study, and inhibitor discovery for PRMT7.	[Feng, You; Hadjikyriacou, Andrea; Zurita-Lopez, Cecilia; Al-Hadid, Qais; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Li, Ziwei; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Inst Mol Biol, Los Angeles, CA 90095 USA; [Maity, Ranjan; Masson, Jean-Yves] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec Res Ctr, Genome Stabil Lab, Quebec City, PQ G1R 2J6, Canada; [Whitelegge, Julian P.] Univ Calif Los Angeles, NPI Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Laval University; University of California System; University of California Los Angeles; University of Texas System; UTMD Anderson Cancer Center	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@chem.ucla.edu	Zurita-Lopez, Cecilia I./AAC-6509-2020	Feng, You/0000-0002-4710-7396; Masson, Jean Yves/0000-0002-4403-7169	National Institutes of Health [GM026020, S10 RR023045, DK62248]; Canadian Institute of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, P30DK063491, R01DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 (to S. G. C.), S10 RR023045 (to J. P. W.), and DK62248 (to M. T. B.). This work was also supported by the Canadian Institute of Health Research (to J. Y. M.).	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Auclair Y, 2013, DNA REPAIR, V12, P459, DOI 10.1016/j.dnarep.2013.04.006; Beck HC, 2006, MOL CELL PROTEOMICS, V5, P1314, DOI 10.1074/mcp.M600007-MCP200; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bleibel WK, 2009, HUM GENET, V125, P173, DOI 10.1007/s00439-008-0607-4; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Buhr N, 2008, ELECTROPHORESIS, V29, P2381, DOI 10.1002/elps.200700738; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Butler JS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202416; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dillon MBC, 2013, J BIOL CHEM, V288, P27872, DOI 10.1074/jbc.M113.491092; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Gros L, 2006, BBA-GEN SUBJECTS, V1760, P1646, DOI 10.1016/j.bbagen.2006.08.026; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lee JH, 2005, J BIOL CHEM, V280, P3656, DOI 10.1074/jbc.M405295200; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Siarheyeva A, 2012, STRUCTURE, V20, P1425, DOI 10.1016/j.str.2012.06.001; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Takahashi Y, 2011, J RECEPT SIG TRANSD, V31, P168, DOI 10.3109/10799893.2011.555768; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Thangaraj B, 2010, PROTEOMICS, V10, P3644, DOI 10.1002/pmic.201000190; Thomassen M, 2009, BREAST CANCER RES TR, V113, P239, DOI 10.1007/s10549-008-9927-2; Verbiest V, 2008, FEBS LETT, V582, P1483, DOI 10.1016/j.febslet.2008.03.031; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P1; Wang L, 2013, NUCLEIC ACIDS RES, V41, P6870, DOI 10.1093/nar/gkt415; Wyrick JJ, 2009, BBA-GENE REGUL MECH, V1789, P37, DOI 10.1016/j.bbagrm.2008.07.001; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323; Zoroddu MA, 2000, BBA-GEN SUBJECTS, V1475, P163, DOI 10.1016/S0304-4165(00)00066-0; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	56	113	115	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37010	37025		10.1074/jbc.M113.525345	http://dx.doi.org/10.1074/jbc.M113.525345			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247247	Green Published, hybrid			2022-12-28	WOS:000329189700022
J	Hoang, T; Smith, MD; Jelokhani-Niaraki, M				Hoang, Tuan; Smith, Matthew D.; Jelokhani-Niaraki, Masoud			Expression, Folding, and Proton Transport Activity of Human Uncoupling Protein-1 (UCP1) in Lipid Membranes EVIDENCE FOR ASSOCIATED FUNCTIONAL FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiolipin; Circular Dichroism (CD); Protein Folding; Protein Self-assembly; Proton Transport; Uncoupling Proteins; Mitochondrial Membrane Proteins; Protein Reconstitution; Proteoliposomes; Structure-Function Relationship	ESSENTIAL REQUIREMENT; OUTER-MEMBRANE; CARDIOLIPIN; CARRIER; TRANSMEMBRANE; CD; MITOCHONDRIA; CONFORMATION; TROPOMYOSIN; SURFACTANT	Background: UCP1 transports protons across the inner mitochondrial membrane and generates heat. Results: Oligomeric forms of UCP1 transported protons across phospholipid bilayers and the conformation and proton transport activity were affected by cardiolipin. Conclusion: UCP1 is functional in its monomeric and associated forms in membranes. Significance: Existence of functional associated forms of UCP1 provides insights into the mechanism of action of UCPs in mitochondria. Uncoupling protein-1 (UCP1) is abundantly expressed in the mitochondrial inner membrane of brown adipose tissues and has an important role in heat generation, mediated by its proton transport function. The structure and function of UCP1 are not fully understood, partially due to the difficulty in obtaining native-like folded proteins in vitro. In this study, using the auto-induction method, we have successfully expressed UCP1 in Escherichia coli membranes in high yield. Overexpressed UCP1 in bacterial membranes was extracted using mild detergents and reconstituted into phospholipid bilayers for biochemical studies. UCP1 was folded in octyl glucoside, as indicated by its high helical content and binding to ATP, a known UCP1 proton transport inhibitor. Reconstituted UCP1 in phospholipid vesicles also exhibited highly helical structures and proton transport that is activated by fatty acids and inhibited by purine nucleotides. Self-associated functional forms of UCP1 in lipid membranes were observed for the first time. The self-assembly of UCP1 into tetramers was unambiguously characterized by circular dichroism and fluorescence spectroscopy, analytical ultracentrifugation, and semi-native gel electrophoresis. In addition, the mitochondrial lipid cardiolipin stabilized the structure of associated UCP1 and enhanced the proton transport activity of the protein. The existence of the functional oligomeric states of UCP1 in the lipid membranes has important implications for understanding the structure and proton transport mechanism of this protein in brown adipose tissues as well as structure-function relationships of other mammalian UCPs in other tissues.	Wilfrid Laurier Univ, Dept Chem, Waterloo, ON N2L 3C5, Canada; [Smith, Matthew D.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada; [Hoang, Tuan; Smith, Matthew D.; Jelokhani-Niaraki, Masoud] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada	Wilfrid Laurier University; Wilfrid Laurier University; University of Guelph	Jelokhani-Niaraki, M (corresponding author), Wilfrid Laurier Univ, 75 Univ Ave West, Waterloo, ON N2L 3C5, Canada.	mjelokhani@wlu.ca	Smith, Matthew/M-4726-2014; Hoang, Tuan/E-7323-2015	Smith, Matthew/0000-0002-2855-5126; Hoang, Tuan/0000-0003-3204-0579	Canada Foundation for Innovation (CFI); Natural Sciences and Engineering Research Council of Canada (NSERC) [CFI 6786, NSERC 250119, CFI 11292, NSERC 312143]	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canada Foundation for Innovation (CFI) and the Natural Sciences and Engineering Research Council of Canada (NSERC) CFI 6786 and NSERC 250119 (to M. J. N.) and CFI 11292 and NSERC 312143 (to M. D. S.).	Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; DeLano W, 2002, PYMOL 0 99; Douette P, 2005, BIOCHEM BIOPH RES CO, V333, P686, DOI 10.1016/j.bbrc.2005.05.164; Douette P, 2004, BIOCHEM J, V380, P139, DOI 10.1042/BJ20031957; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; GREENFIELD NJ, 1993, PROTEIN SCI, V2, P1263, DOI 10.1002/pro.5560020809; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5; Hoang T, 2012, BIOCHEMISTRY-US, V51, P4004, DOI 10.1021/bi3003378; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; Jastroch M, 2012, METHODS MOL BIOL, V810, P153, DOI 10.1007/978-1-61779-382-0_10; Jelokhani-Niaraki M, 2008, BIOCHEM J, V411, P593, DOI 10.1042/bj20071326; KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Knyght I., 2012, J BIOL RES HONG KONG, V1, P12; Kozak LP, 2008, INT J OBESITY, V32, pS32, DOI 10.1038/ijo.2008.236; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Laue T.M., 1992, THEORY COMPUTER AIDE, P90; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; LIN CS, 1980, FEBS LETT, V113, P304, DOI 10.1016/0014-5793(80)80614-4; Nicholls D G, 1978, Experientia Suppl, V32, P89; NOEL H, 1986, EUR J BIOCHEM, V155, P99, DOI 10.1111/j.1432-1033.1986.tb09463.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zhou QJ, 2010, PROG BIOCHEM BIOPHYS, V37, P56, DOI 10.3724/SP.J.1206.2009.00531	46	32	36	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36244	36258		10.1074/jbc.M113.509935	http://dx.doi.org/10.1074/jbc.M113.509935			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196960	Green Published, hybrid			2022-12-28	WOS:000328883400007
J	Ranayhossaini, DJ; Rodriguez, AI; Sahoo, S; Chen, BB; Mallampalli, RK; Kelley, EE; Csanyi, G; Gladwin, MT; Romero, G; Pagano, PJ				Ranayhossaini, Daniel J.; Rodriguez, Andres I.; Sahoo, Sanghamitra; Chen, Beibei B.; Mallampalli, Rama K.; Kelley, Eric E.; Csanyi, Gabor; Gladwin, Mark T.; Romero, Guillermo; Pagano, Patrick J.			Selective Recapitulation of Conserved and Nonconserved Regions of Putative NOXA1 Protein Activation Domain Confers Isoform-specific Inhibition of Nox1 Oxidase and Attenuation of Endothelial Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Mechanisms; NADPH Oxidase; Peptides; Reactive Oxygen Species (ROS); Nox1	NADPH OXIDASE; SUPEROXIDE GENERATION; HYDROGEN-PEROXIDE; NITRIC-OXIDE; OXYGEN; PEROXYNITRITE; HYPERTENSION; PEPTIDE; DIPHENYLENEIODONIUM; EXPRESSION	Background: Nox1, an oxidant source in colon carcinoma and vascular disease, is activated by NOXA1. Results: A NOXA1 peptide blocked NOXA1-Nox1 binding and inhibited colon carcinoma and endothelial oxidants and migration. Conclusion: The findings identify a NOXA1-activating domain and an isoform-specific Nox1 inhibitor. Significance: The data provide insight into Nox1 regulation and present a potential therapy for suppressing oxidative stress-related disease. Excessive vascular and colon epithelial reactive oxygen species production by NADPH oxidase isoform 1 (Nox1) has been implicated in a number of disease states, including hypertension, atherosclerosis, and neoplasia. A peptide that mimics a putative activation domain of the Nox1 activator subunit NOXA1 (NOXA1 docking sequence, also known as NoxA1ds) potently inhibited Nox1-derived superoxide anion (O-radical anion) production in a reconstituted Nox1 cell-free system, with no effect on Nox2-, Nox4-, Nox5-, or xanthine oxidase-derived reactive oxygen species production as measured by cytochrome c reduction, Amplex Red fluorescence, and electron paramagnetic resonance. The ability of NoxA1ds to cross the plasma membrane was tested by confocal microscopy in a human colon cancer cell line exclusively expressing Nox1 (HT-29) using FITC-labeled NoxA1ds. NoxA1ds significantly inhibited whole HT-29 carcinoma cell-derived O-radical anion generation. ELISA and fluorescence recovery after photobleaching experiments indicate that NoxA1ds, but not its scrambled control, binds Nox1. FRET experiments conducted using Nox1-YFP and NOXA1-CFP illustrate that NoxA1ds disrupts the binding interaction between Nox1 and NOXA1, whereas a control peptide did not. Moreover, hypoxia-induced human pulmonary artery endothelial cell O-radical anion production was completely inhibited by NoxA1ds. Human pulmonary artery endothelial cell migration under hypoxic conditions was also reduced by pretreatment with NoxA1ds. Our data indicate that a peptide recapitulating a putative activation subdomain of NOXA1 (NoxA1ds) is a highly efficacious and selective inhibitor of Nox1 activity and establishes a critical interaction site for Nox1-NOXA1 binding required for enzyme activation.	[Ranayhossaini, Daniel J.; Rodriguez, Andres I.; Kelley, Eric E.; Csanyi, Gabor; Gladwin, Mark T.; Pagano, Patrick J.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Ranayhossaini, Daniel J.; Rodriguez, Andres I.; Sahoo, Sanghamitra; Kelley, Eric E.; Csanyi, Gabor; Romero, Guillermo; Pagano, Patrick J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Chen, Beibei B.; Mallampalli, Rama K.; Gladwin, Mark T.] Univ Pittsburgh, Dept Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Pagano, PJ (corresponding author), Univ Pittsburgh, BST E1247,200 Lothrop St, Pittsburgh, PA 15261 USA.	pagano@pitt.edu	Pagano, Patrick/GYO-2619-2022		National Institutes of Health [HL079207, HL096376, HL097376, HL098174, HL116472]; United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472, R01HL096376, R01HL079207, R01HL098174, P01HL114453, R01HL112914, P01HL103455, R01HL097376] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant HL079207; Grants HL096376, HL097376, and HL098174 (to R. K. M.); and Grant HL116472 (to B. B. C.). This work was also supported by a merit review award from the United States Department of Veterans Affairs. This work is the subject of a pending United States patent application No. 61/560,075 titled "Novel Inhibitors of Nox1," on which D. J. R. and P. J. P. are listed as inventors.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Ambasta RK, 2006, FREE RADICAL BIO MED, V41, P193, DOI 10.1016/j.freeradbiomed.2005.12.035; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Cardey B, 2007, J PHYS CHEM A, V111, P13046, DOI 10.1021/jp0731102; Cascino T, 2011, ANTIOXID REDOX SIGN, V15, P1507, DOI 10.1089/ars.2010.3631; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Corcionivoschi N, 2012, CELL HOST MICROBE, V12, P47, DOI 10.1016/j.chom.2012.05.018; Csanyi G, 2012, ARTERIOSCL THROM VAS, V32, P2966, DOI 10.1161/ATVBAHA.112.300031; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Dennis KE, 2009, AM J PHYSIOL-LUNG C, V297, pL596, DOI 10.1152/ajplung.90568.2008; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Gaggini F, 2011, BIOORGAN MED CHEM, V19, P6989, DOI 10.1016/j.bmc.2011.10.016; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Jacobson GM, 2003, CIRC RES, V92, P637, DOI 10.1161/01.RES.0000063423.94645.8A; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; KELLOGG EW, 1975, J BIOL CHEM, V250, P8812; Kinoshita M, 2005, PHARM RES-DORDR, V22, P716, DOI 10.1007/s11095-005-2586-7; Kuzkaya N, 2003, J BIOL CHEM, V278, P22546, DOI 10.1074/jbc.M302227200; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; LETO TL, 1991, J BIOL CHEM, V266, P19812; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Maehara Y, 2010, J BIOL CHEM, V285, P31435, DOI 10.1074/jbc.M110.161166; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCGUIRE JJ, 1994, J PHARMACOL EXP THER, V271, P708; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Molshanski-Mor Shahar, 2007, V412, P385, DOI 10.1007/978-1-59745-467-4_25; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Poillot C, 2012, J BIOL CHEM, V287, P17331, DOI 10.1074/jbc.M112.360628; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Roos D, 2010, BLOOD CELL MOL DIS, V44, P291, DOI 10.1016/j.bcmd.2010.01.009; Schroder K, 2009, CIRC RES, V105, P537, DOI 10.1161/CIRCRESAHA.109.205138; Sedeek M, 2009, CURR OPIN NEPHROL HY, V18, P122, DOI 10.1097/MNH.0b013e32832923c3; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	57	55	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36437	36450		10.1074/jbc.M113.521344	http://dx.doi.org/10.1074/jbc.M113.521344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24187133	Green Published, hybrid			2022-12-28	WOS:000328883400025
J	Honsho, M; Asaoku, S; Fukumoto, K; Fujiki, Y				Honsho, Masanori; Asaoku, Shunsuke; Fukumoto, Keiko; Fujiki, Yukio			Topogenesis and Homeostasis of Fatty Acyl-CoA Reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipid Ether; Peroxisomes; Plasmalogen; Protein Stability; Protein Targeting; Ether Lipid	OVARY CELL MUTANTS; MEMBRANE-PROTEIN; COMPLEMENTATION GROUP; DIHYDROXYACETONEPHOSPHATE ACYLTRANSFERASE; PLASMALOGEN DEFICIENCY; ZELLWEGER-SYNDROME; BIOSYNTHESIS; BIOGENESIS; LOCALIZATION; PEROXISOMES	Background: Stability of Far1, an essential enzyme for plasmalogen synthesis, is regulated by the cellular plasmalogen level. Results: Expression of a mutant Far1 harboring the mutation in its C-terminal membrane-flanking region increased plasmalogen synthesis because of the inhibition of its degradation. Conclusion: Elevation of plasmalogen synthesis is achieved by expression of Far1. Significance: Far1 is a rate-limiting enzyme for plasmalogen synthesis. Peroxisomal fatty acyl-CoA reductase 1 (Far1) is essential for supplying fatty alcohols required for ether bond formation in ether glycerophospholipid synthesis. The stability of Far1 is regulated by a mechanism that is dependent on cellular plasmalogen levels. However, the membrane topology of Far1 and how Far1 is targeted to membranes remain largely unknown. Here, Far1 is shown to be a peroxisomal tail-anchored protein. The hydrophobic C terminus of Far1 binds to Pex19p, a cytosolic receptor harboring a C-terminal CAAX motif, which is responsible for the targeting of Far1 to peroxisomes. Far1, but not Far2, was preferentially degraded in response to the cellular level of plasmalogens. Experiments in which regions of Far1 or Far2 were replaced with the corresponding region of the other protein showed that the region flanking the transmembrane domain of Far1 is required for plasmalogen-dependent modulation of Far1 stability. Expression of Far1 increased plasmalogen synthesis in wild-type Chinese hamster ovary cells, strongly suggesting that Far1 is a rate-limiting enzyme for plasmalogen synthesis.	[Honsho, Masanori; Fujiki, Yukio] Kyushu Univ, Dept Biol, Fac Sci, Higashi Ku, Fukuoka 8128581, Japan; [Honsho, Masanori; Asaoku, Shunsuke; Fukumoto, Keiko; Fujiki, Yukio] Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 8128581, Japan; [Fujiki, Yukio] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Grad Sch, Fac Sci, Dept Biol,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp		Honsho, Masanori/0000-0001-6165-4516	Science and Technology Agency of Japan CREST; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23570236] Funding Source: KAKEN	Science and Technology Agency of Japan CREST; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Science and Technology Agency of Japan CREST grant (to Y. F.); by grants-in-aid for scientific research (to M. H. and Y. F.); by the global COE program and grants for excellent graduate schools from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by grants from the Japan Foundation for Applied Enzymology (to Y. F.) and the Takeda Science Foundation (to M. H. and Y. F.).	BISHOP JE, 1981, J BIOL CHEM, V256, P9542; Brites P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028539; BURDETT K, 1991, J BIOL CHEM, V266, P12201; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Delille HK, 2008, J BIOL CHEM, V283, P31107, DOI 10.1074/jbc.M803332200; FUJIKI Y, 1984, P NATL ACAD SCI-BIOL, V81, P7127, DOI 10.1073/pnas.81.22.7127; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Ghaedi K, 2000, MOL BIOL CELL, V11, P2085, DOI 10.1091/mbc.11.6.2085; GINSBERG L, 1995, BRAIN RES, V698, P223, DOI 10.1016/0006-8993(95)00931-F; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2002, J BIOL CHEM, V277, P44513, DOI 10.1074/jbc.M206139200; Honsho M, 2001, J BIOL CHEM, V276, P9375, DOI 10.1074/jbc.M003304200; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; KAWAJIRI K, 1977, J BIOCHEM, V82, P1403, DOI 10.1093/oxfordjournals.jbchem.a131828; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; MIURA S, 1992, J BIOL CHEM, V267, P14405; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Nagan N, 1997, P NATL ACAD SCI USA, V94, P4475, DOI 10.1073/pnas.94.9.4475; Nagan N, 1998, BIOCHEM J, V332, P273, DOI 10.1042/bj3320273; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nishimukai M, 2003, LIPIDS, V38, P1227, DOI 10.1007/s11745-003-1183-9; Okumoto K, 1997, EXP CELL RES, V233, P11, DOI 10.1006/excr.1997.3552; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Rosenberger TA, 2002, J LIPID RES, V43, P59; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Weller S, 2003, ANNU REV GENOM HUM G, V4, P165, DOI 10.1146/annurev.genom.4.070802.110424; WELSH CJ, 1994, ARCH BIOCHEM BIOPHYS, V315, P41, DOI 10.1006/abbi.1994.1468; Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-102; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077	43	43	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34588	34598		10.1074/jbc.M113.498345	http://dx.doi.org/10.1074/jbc.M113.498345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24108123	Green Published, hybrid			2022-12-28	WOS:000329812800027
J	Shiou, SR; Yu, YY; Guo, YE; Westerhoff, M; Lu, L; Petrof, EO; Sun, J; Claud, EC				Shiou, Sheng-Ru; Yu, Yueyue; Guo, Yuee; Westerhoff, Maria; Lu, Lei; Petrof, Elaine O.; Sun, Jun; Claud, Erika C.			Oral Administration of Transforming Growth Factor-beta 1 (TGF-beta 1) Protects the Immature Gut from Injury via Smad Protein-dependent Suppression of Epithelial Nuclear Factor kappa B (NF-kappa B) Signaling and Proinflammatory Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChIP); Inflammation; Innate Immunity; Intestinal Epithelium; NF-kappa B (NF-KB); SMAD Transcription Factor; Transforming Growth Factor Beta (TGFbeta)	GROWTH-FACTOR-BETA; NEONATAL NECROTIZING ENTEROCOLITIS; TGF-BETA; INTERLEUKIN-6 GENE; HUMAN-MILK; CELL LINE; TNF-ALPHA; RAT MODEL; EXPRESSION; DISEASE	Background: Intestinal production of TGF- is decreased in neonatal necrotizing enterocolitis (NEC). Results: Oral administration of TGF- (TGF-1) inhibited inflammation in intestinal epithelium and systemic production of IL-6 and IFN- as well as NEC incidence in an animal model. Conclusion: Oral administration of TGF-1 can compensate for TGF-1 deficiency in gut diseases. Significance: TGF-1 can potentially be used to prevent and treat gut diseases. Inflammatory immune responses play an important role in mucosal homeostasis and gut diseases. Nuclear factor B (NF-B), central to the proinflammatory cascade, is activated in necrotizing enterocolitis (NEC), a devastating condition of intestinal injury with extensive inflammation in premature infants. TGF- is a strong immune suppressor and a factor in breast milk, which has been shown to be protective against NEC. In an NEC animal model, oral administration of the isoform TGF-1 activated the downstream effector Smad2 in intestine and significantly reduced NEC incidence. In addition, TGF-1 suppressed NF-B activation, maintained levels of the NF-B inhibitor IB in the intestinal epithelium, and systemically decreased serum levels of IL-6 and IFN-. The immature human fetal intestinal epithelial cell line H4 was used as a reductionistic model of the immature enterocyte to investigate mechanism. TGF-1 pretreatment inhibited the TNF--induced IB phosphorylation that targets the IB protein for degradation and inhibited NF-B activation. Chromatin immunoprecipitation (ChIP) assays demonstrated decreased NF-B binding to the promoters of IL-6, IL-8, and IB in response to TNF- with TGF-1 pretreatment. These TGF-1 effects appear to be mediated through the canonical Smad pathway as silencing of the TGF- central mediator Smad4 resulted in loss of the TGF-1 effects. Thus, TGF-1 is capable of eliciting anti-inflammatory effects by inhibiting NF-B specifically in the intestinal epithelium as well as by decreasing systemic IL-6 and IFN- levels. Oral administration of TGF-1 therefore can potentially be used to protect against gastrointestinal diseases.	[Shiou, Sheng-Ru; Yu, Yueyue; Guo, Yuee; Lu, Lei; Claud, Erika C.] Univ Chicago, Sect Neonatol, Dept Pediat, Chicago, IL 60637 USA; [Claud, Erika C.] Univ Chicago, Gastroenterol Sect, Dept Med, Chicago, IL 60637 USA; [Westerhoff, Maria] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98104 USA; [Petrof, Elaine O.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA	University of Chicago; University of Chicago; University of Washington; University of Washington Seattle; Queens University - Canada; Rush University	Claud, EC (corresponding author), Univ Chicago, Sect Neonatol, Dept Pediat, 5841 S Maryland Ave MC6060, Chicago, IL 60637 USA.	eclaud@peds.bsd.uchicago.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	National Institutes of Health National Research Service Award (NRSA) F32 Fellowship [HD062144, HD059123]; Digestive Disease Research Core Center of the University of Chicago; National Institutes of Health [DK42086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD062144, R01HD059123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health National Research Service Award (NRSA) F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Research Core Center of the University of Chicago(University of Chicago); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award (NRSA) F32 Fellowship Grants HD062144 (to S. S.) and HD059123 (to E. C. C.) and by the Digestive Disease Research Core Center of the University of Chicago (supported by National Institutes of Health Grant DK42086).	Azuma M, 1999, EXP CELL RES, V250, P213, DOI 10.1006/excr.1999.4503; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; CAPLAN MS, 1994, PEDIATR PATHOL, V14, P1017, DOI 10.3109/15513819409037698; Cavin LG, 2003, HEPATOLOGY, V38, P1540, DOI 10.1016/j.hep.2003.09.019; Cho ML, 2006, IMMUNOL LETT, V105, P159, DOI 10.1016/j.imlet.2006.02.003; Chung HL, 2002, J ALLERGY CLIN IMMUN, V109, P150, DOI 10.1067/mai.2002.120562; Claud EC, 2004, P NATL ACAD SCI USA, V101, P7404, DOI 10.1073/pnas.0401710101; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; Haller D, 2003, J BIOL CHEM, V278, P23851, DOI 10.1074/jbc.M300075200; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Kafetzis DA, 2003, CURR OPIN INFECT DIS, V16, P349, DOI 10.1097/00001432-200308000-00007; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Le YY, 2004, J IMMUNOL, V173, P962, DOI 10.4049/jimmunol.173.2.962; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; Li DH, 2004, GENE, V342, P157, DOI 10.1016/j.gene.2004.07.034; Mackinnon AC, 2011, J CLIN PATHOL, V64, P16, DOI 10.1136/jcp.2010.075853; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McKaig BC, 2002, AM J PHYSIOL-CELL PH, V282, pC172, DOI 10.1152/ajpcell.00048.2001; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Rautava S, 2012, J PEDIATR GASTR NUTR, V54, P630, DOI 10.1097/MPG.0b013e31823e7c29; Rupec RA, 1999, IMMUNOGENETICS, V49, P395, DOI 10.1007/s002510050512; SAITO S, 1993, CLIN EXP IMMUNOL, V94, P220, DOI 10.1111/j.1365-2249.1993.tb06004.x; SANDERSON IR, 1995, INT ARCH ALLERGY IMM, V107, P396, DOI 10.1159/000237051; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Yeganeh B, 2013, PULM PHARMACOL THER, V26, P50, DOI 10.1016/j.pupt.2012.07.006	36	34	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34757	34766		10.1074/jbc.M113.503946	http://dx.doi.org/10.1074/jbc.M113.503946			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129565	Green Published, hybrid			2022-12-28	WOS:000329812800044
J	Thapa, N; Choi, S; Hedman, A; Tan, XJ; Anderson, RA				Thapa, Narendra; Choi, Suyong; Hedman, Andrew; Tan, Xiaojun; Anderson, Richard A.			Phosphatidylinositol Phosphate 5-Kinase I gamma i2 in Association with Src Controls Anchorage-independent Growth of Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Biology; Cell Growth; Oncogene; Phosphatidylinositol; Src; Anchorage-independent Growth; Talin	KINASE; ADHESION; LOCALIZATION; TRAFFICKING; METASTASIS; ANOIKIS; PATHWAY; BINDING; TALIN; ACTIVATION	Background: PIPKI isoforms play roles in cell migration, polarization, and membrane trafficking and are overexpressed in triple-negative breast cancers, indicating protumorigenic functions. Results: PIPKIi2 associates with the C terminus of Src, and this interaction interdependently controls their functioning. Conclusion: PIPKIi2 and Src synergistically control anchorage-independent tumor cell growth. Significance: This study shows unexpected mechanisms for a phosphatidylinositol 4,5-biphosphate-generating enzyme that synergizes with the proto-oncogene Src to regulate oncogenic signaling. A fundamental property of tumor cells is to defy anoikis, cell death caused by a lack of cell-matrix interaction, and grow in an anchorage-independent manner. How tumor cells organize signaling molecules at the plasma membrane to sustain oncogenic signals in the absence of cell-matrix interactions remains poorly understood. Here, we describe a role for phosphatidylinositol 4-phosphate 5-kinase (PIPK) Ii2 in controlling anchorage-independent growth of tumor cells in coordination with the proto-oncogene Src. PIPKIi2 regulated Src activation downstream of growth factor receptors and integrins. PIPKIi2 directly interacted with the C-terminal tail of Src and regulated its subcellular localization in concert with talin, a cytoskeletal protein targeted to focal adhesions. Co-expression of PIPKIi2 and Src synergistically induced the anchorage-independent growth of nonmalignant cells. This study uncovers a novel mechanism where a phosphoinositide-synthesizing enzyme, PIPKIi2, functions with the proto-oncogene Src, to regulate oncogenic signaling.	[Thapa, Narendra; Choi, Suyong; Hedman, Andrew; Tan, Xiaojun; Anderson, Richard A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Med Sci Ctr 3750, 1300 Univ Ave, Madison, WI 53706 USA.	raanders@wisc.edu	Tan, Xiaojun/N-2142-2017	Tan, Xiaojun/0000-0003-3300-2240; Anderson, Richard/0000-0001-6265-8359	National Institutes of Health [CA104708, GM057549]; American Heart Association [10POST4290052, 13PRE14690057, PRE2280534]; Howard Hughes Medical Institute International Student Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA104708 and GM057549 (to R. A. A.). This work was also supported by American Heart Association Grants 10POST4290052 (to N. T.), 13PRE14690057 (to S. C.), and PRE2280534 (to A. H.) and a Howard Hughes Medical Institute International Student Research Fellowship (to X. T.).	Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; ANDERSON RA, 1985, NATURE, V318, P295, DOI 10.1038/318295a0; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Banno A, 2012, J BIOL CHEM, V287, P13799, DOI 10.1074/jbc.M112.341214; Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Choi S, 2013, EMBO J, V32, P2617, DOI 10.1038/emboj.2013.191; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Divecha N, 2010, CURR BIOL, V20, pR154, DOI 10.1016/j.cub.2010.01.016; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hemmings L, 1996, J CELL SCI, V109, P2715; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Lai MT, 2011, J PATHOL, V224, P367, DOI 10.1002/path.2867; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LIEBL EC, 1992, ONCOGENE, V7, P2417; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nakanishi K, 2002, CANCER RES, V62, P2971; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schramp M, 2011, CANCER RES, V71, P1282, DOI 10.1158/0008-5472.CAN-10-2480; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; SINGHAL RL, 1994, LIFE SCI, V55, P1487, DOI 10.1016/0024-3205(94)00690-3; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Thapa N, 2012, CELL ADHES MIGR, V6, P409, DOI 10.4161/cam.21192; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Tryfonopoulos D, 2011, ANN ONCOL, V22, P2234, DOI 10.1093/annonc/mdq757; Tsatsanis C, 2004, ANN NY ACAD SCI, V1028, P168, DOI 10.1196/annals.1322.019; Tu C, 2010, P NATL ACAD SCI USA, V107, P16107, DOI 10.1073/pnas.1009471107; Wang LH, 2004, MT SINAI J MED, V71, P361; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	49	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34707	34718		10.1074/jbc.M113.512848	http://dx.doi.org/10.1074/jbc.M113.512848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151076	Green Published, hybrid			2022-12-28	WOS:000329812800037
J	Larsson, M; Vorrsjo, E; Talmud, P; Lookene, A; Olivecrona, G				Larsson, Mikael; Vorrsjo, Evelina; Talmud, Philippa; Lookene, Aivar; Olivecrona, Gunilla			Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Dyslipidemia; Lipolysis; Lipoprotein; Lipoprotein Metabolism; Triglyceride; Apolipoprotein C-I; Apolipoprotein C-III; Lipoprotein Lipase	TRIACYLGLYCEROL-RICH LIPOPROTEINS; DENSITY-LIPOPROTEINS; TRANSGENIC MICE; FATTY-ACIDS; APOC-III; A-I; BINDING; PLASMA; HYPERTRIGLYCERIDEMIA; RECEPTOR	Apolipoproteins (apo) C-I and C-III are known to inhibit lipoprotein lipase (LPL) activity, but the molecular mechanisms for this remain obscure. We present evidence that either apoC-I or apoC-III, when bound to triglyceride-rich lipoproteins, prevent binding of LPL to the lipid/water interface. This results in decreased lipolytic activity of the enzyme. Site-directed mutagenesis revealed that hydrophobic amino acid residues centrally located in the apoC-III molecule are critical for attachment to lipid emulsion particles and consequently inhibition of LPL activity. Triglyceride-rich lipoproteins stabilize LPL and protect the enzyme from inactivating factors such as angiopoietin-like protein 4 (angptl4). The addition of either apoC-I or apoC-III to triglyceride-rich particles severely diminished their protective effect on LPL and rendered the enzyme more susceptible to inactivation by angptl4. These observations were seen using chylomicrons as well as the synthetic lipid emulsion Intralipid. In the presence of the LPL activator protein apoC-II, more of apoC-I or apoC-III was needed for displacement of LPL from the lipid/water interface. In conclusion, we show that apoC-I and apoC-III inhibit lipolysis by displacing LPL from lipid emulsion particles. We also propose a role for these apolipoproteins in the irreversible inactivation of LPL by factors such as angptl4.	[Larsson, Mikael; Vorrsjo, Evelina; Olivecrona, Gunilla] Umea Univ, Dept Med Biosciences Physiol Chem, SE-90187 Umea, Sweden; [Lookene, Aivar] Tallinn Univ Technol, Dept Chem, EE-12618 Tallinn, Estonia; [Larsson, Mikael; Vorrsjo, Evelina; Olivecrona, Gunilla] Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; [Talmud, Philippa] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London WC1E 6JF, England	Umea University; Tallinn University of Technology; Umea University; University of London; University College London	Olivecrona, G (corresponding author), Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden.	gunilla.olivecrona@medbio.umu.se		Talmud, Philippa/0000-0002-5560-1933	Swedish Science Council [12203]; Swedish Heart and Lung Foundation; British Heart Foundation [RG08/014]	Swedish Science Council; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by Swedish Science Council Grant 12203, The Swedish Heart and Lung Foundation, and British Heart Foundation Grant RG08/014.	ASTRUP HN, 1982, COMP BIOCHEM PHYS B, V72, P487, DOI 10.1016/0305-0491(82)90494-1; Attman PO, 2009, CURR OPIN LIPIDOL, V20, P293, DOI 10.1097/MOL.0b013e32832dd832; ATTMAN PO, 1987, KIDNEY INT, V32, P368, DOI 10.1038/ki.1987.219; Baranowski T, 2011, HORM METAB RES, V43, P117, DOI 10.1055/s-0030-1267917; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BENGTSSON G, 1977, EUR J BIOCHEM, V79, P225, DOI 10.1111/j.1432-1033.1977.tb11800.x; BENGTSSON G, 1979, BIOCHIM BIOPHYS ACTA, V575, P471, DOI 10.1016/0005-2760(79)90118-8; Bengtsson-Olivecrona G., 1992, LIPOPROTEIN ANAL PRA, P169; BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; BENSADOU.A, 1974, J BIOL CHEM, V249, P2220; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; BROWN WV, 1972, BIOCHEM BIOPH RES CO, V46, P375; Cohn JS, 2002, J LIPID RES, V43, P1680, DOI 10.1194/jlr.M200055-JLR200; CRAWFORD GA, 1979, CLIN SCI, V57, P155, DOI 10.1042/cs0570155; DEMEL RA, 1984, BIOCHIM BIOPHYS ACTA, V793, P399, DOI 10.1016/0005-2760(84)90255-8; Ding YY, 2011, TRANSGENIC RES, V20, P867, DOI 10.1007/s11248-010-9467-5; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; EKMAN R, 1975, CLIN CHIM ACTA, V63, P29, DOI 10.1016/0009-8981(75)90374-5; FIELDING CJ, 1976, J LIPID RES, V17, P419; FOJO SS, 1992, J INTERN MED, V231, P669, DOI 10.1111/j.1365-2796.1992.tb01256.x; FORMISANO S, 1978, J BIOL CHEM, V253, P354; Fredenrich A, 1997, J LIPID RES, V38, P1421; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Hansen JB, 2011, J LIPIDS, V2011, DOI 10.1155/2011/271062; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; Hultin M, 1996, J LIPID RES, V37, P1022; IBDAH JA, 1989, BIOCHIM BIOPHYS ACTA, V1004, P300, DOI 10.1016/0005-2760(89)90077-5; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; JACKSON RL, 1986, BIOCHIM BIOPHYS ACTA, V875, P203, DOI 10.1016/0005-2760(86)90169-4; JACKSON RL, 1986, BIOCHIM BIOPHYS ACTA, V875, P211, DOI 10.1016/0005-2760(86)90170-0; JACKSON RL, 1979, BIOCHIM BIOPHYS ACTA, V556, P369, DOI 10.1016/0005-2736(79)90126-3; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; KRAUSS RM, 1973, CIRC RES, V33, P403, DOI 10.1161/01.RES.33.4.403; KREBS KE, 1983, BIOCHIM BIOPHYS ACTA, V751, P470, DOI 10.1016/0005-2760(83)90308-9; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lambert DA, 1996, ATHEROSCLEROSIS, V127, P205, DOI 10.1016/S0021-9150(96)05955-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu HQ, 2000, J LIPID RES, V41, P1760; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; MAEDA N, 1994, J BIOL CHEM, V269, P23610; MASSEY JB, 1979, J BIOL CHEM, V254, P9359; Mattijssen F, 2012, BBA-MOL CELL BIOL L, V1821, P782, DOI 10.1016/j.bbalip.2011.10.010; Meyers NL, 2012, BIOCHEMISTRY-US, V51, P1238, DOI 10.1021/bi2015212; Nilsson SK, 2012, BBA-MOL CELL BIOL L, V1821, P1370, DOI 10.1016/j.bbalip.2012.06.003; Olivecrona G, 1997, ARTERIOSCL THROM VAS, V17, P1545, DOI 10.1161/01.ATV.17.8.1545; Olivecrona G, 1997, METHOD ENZYMOL, V286, P102; Olivecrona G, 2010, CURR OPIN LIPIDOL, V21, P409, DOI 10.1097/MOL.0b013e32833ded83; OSTLUNDLINDQVIST AM, 1975, BIOCHEM BIOPH RES CO, V65, P1447, DOI 10.1016/S0006-291X(75)80391-3; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Protter A. P., 1990, U.S. Patent, Patent No. [4,349,629, 4349629]; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shachter NS, 1996, J CLIN INVEST, V98, P846, DOI 10.1172/JCI118857; Shen Y, 2002, J BIOL CHEM, V277, P4334, DOI 10.1074/jbc.M105421200; SIMONET WS, 1991, J BIOL CHEM, V266, P8651; SPARROW JT, 1977, BIOCHEMISTRY-US, V16, P5427, DOI 10.1021/bi00644a004; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; van der Hoogt CC, 2006, BBA-MOL CELL BIOL L, V1761, P213, DOI 10.1016/j.bbalip.2006.01.002; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; WANG CS, 1985, J CLIN INVEST, V75, P384, DOI 10.1172/JCI111711; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang LB, 2003, J BIOL CHEM, V278, P37480, DOI 10.1074/jbc.M303133200; WASHINGTON C, 1988, INT J PHARM, V44, P169, DOI 10.1016/0378-5173(88)90113-5; Wei JY, 2012, FEBS J, V279, P91, DOI 10.1111/j.1742-4658.2011.08401.x; WEINBERG RB, 1992, J BIOL CHEM, V267, P8977; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102	74	108	116	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33997	34008		10.1074/jbc.M113.495366	http://dx.doi.org/10.1074/jbc.M113.495366			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121499	hybrid, Green Published			2022-12-28	WOS:000327250200041
J	Satou, R; Miyanaga, A; Ozawa, H; Funa, N; Katsuyama, Y; Miyazono, KI; Tanokura, M; Ohnishi, Y; Horinouchi, S				Satou, Ryutaro; Miyanaga, Akimasa; Ozawa, Hiroki; Funa, Nobutaka; Katsuyama, Yohei; Miyazono, Ken-ichi; Tanokura, Masaru; Ohnishi, Yasuo; Horinouchi, Sueharu			Structural Basis for Cyclization Specificity of Two Azotobacter Type III Polyketide Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Crystallography; Kinetics; Polyketides; Site-directed Mutagenesis	I FATTY-ACID; ALKYLRESORCYLIC ACID; CHALCONE SYNTHASE; BIOSYNTHESIS; LIPIDS	Background: Type III polyketide synthases (PKSs) show diverse cyclization specificity. Results: A single amino acid substitution in two Azotobacter type III PKSs reversed their cyclization specificity. Crystal structures were determined. Conclusion: The volume of the active site cavity is a crucial determinant of the cyclization specificity. Significance: An important insight into the cyclization specificity of type III PKSs was provided. Type III polyketide synthases (PKSs) show diverse cyclization specificity. We previously characterized two Azotobacter type III PKSs (ArsB and ArsC) with different cyclization specificity. ArsB and ArsC, which share a high sequence identity (71%), produce alkylresorcinols and alkylpyrones through aldol condensation and lactonization of the same polyketomethylene intermediate, respectively. Here we identified a key amino acid residue for the cyclization specificity of each enzyme by site-directed mutagenesis. Trp-281 of ArsB corresponded to Gly-284 of ArsC in the amino acid sequence alignment. The ArsB W281G mutant synthesized alkylpyrone but not alkylresorcinol. In contrast, the ArsC G284W mutant synthesized alkylresorcinol with a small amount of alkylpyrone. These results indicate that this amino acid residue (Trp-281 of ArsB or Gly-284 of ArsC) should occupy a critical position for the cyclization specificity of each enzyme. We then determined crystal structures of the wild-type and G284W ArsC proteins at resolutions of 1.76 and 1.99 , respectively. Comparison of these two ArsC structures indicates that the G284W substitution brings a steric wall to the active site cavity, resulting in a significant reduction of the cavity volume. We postulate that the polyketomethylene intermediate can be folded to a suitable form for aldol condensation only in such a relatively narrow cavity of ArsC G284W (and presumably ArsB). This is the first report on the alteration of cyclization specificity from lactonization to aldol condensation for a type III PKS. The ArsC G284W structure is significant as it is the first reported structure of a microbial resorcinol synthase.	[Ohnishi, Yasuo; Horinouchi, Sueharu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Miyazono, Ken-ichi; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ohnishi, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp	Miyanaga, Akimasa/C-1472-2015; Miyazono, Kenichi/P-9654-2019	Miyanaga, Akimasa/0000-0003-2219-6051; Miyazono, Kenichi/0000-0002-9354-2604; Tanokura, Masaru/0000-0001-5072-2480; Ohnishi, Yasuo/0000-0001-7633-9236; Katsuyama, Yohei/0000-0003-4905-5320	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Funding Program for Next Generation World-leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	This work was supported in part by the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan and a Funding Program for Next Generation World-leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan. This work was performed under the approval of the Photon Factory Program Advisory Committee (proposal 2008S2-001).	Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Austin MB, 2006, NAT CHEM BIOL, V2, P494, DOI 10.1038/nchembio811; Awakawa T, 2011, CHEMBIOCHEM, V12, P439, DOI 10.1002/cbic.201000628; DeLano W.L, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Funa N, 2002, BIOCHEM J, V367, P781, DOI 10.1042/BJ20020953; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; Funabashi M, 2008, J BIOL CHEM, V283, P13983, DOI 10.1074/jbc.M710461200; Goyal A, 2008, J STRUCT BIOL, V162, P411, DOI 10.1016/j.jsb.2008.02.009; Hayashi T, 2011, CHEMBIOCHEM, V12, P2166, DOI 10.1002/cbic.201100344; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Katsuyama Y, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P147; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matsuzawa M, 2010, PHYTOCHEMISTRY, V71, P1059, DOI 10.1016/j.phytochem.2010.02.012; Miyanaga A, 2008, P NATL ACAD SCI USA, V105, P871, DOI 10.1073/pnas.0709819105; Morita H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P171; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano C, 2009, J BACTERIOL, V191, P4916, DOI 10.1128/JB.00407-09; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Posehn SE, 2012, CHEMBIOCHEM, V13, P2212, DOI 10.1002/cbic.201200346; Rubin-Pitel SB, 2008, CHEM BIOL, V15, P1079, DOI 10.1016/j.chembiol.2008.08.011; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; Shimokawa Y, 2010, BIOORG MED CHEM LETT, V20, P5099, DOI 10.1016/j.bmcl.2010.07.022; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	32	19	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34146	34157		10.1074/jbc.M113.487272	http://dx.doi.org/10.1074/jbc.M113.487272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100027	hybrid, Green Published			2022-12-28	WOS:000327250200058
J	Cheng, JC; Chang, HM; Leung, PCK				Cheng, Jung-Chien; Chang, Hsun-Ming; Leung, Peter C. K.			Transforming Growth Factor-beta 1 Inhibits Trophoblast Cell Invasion by Inducing Snail-mediated Down-regulation of Vascular Endothelial-cadherin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cadherins; Invasion; SMAD Transcription Factor; Transforming Growth Factor- (TGF); Trophoblast; Snail; VE-cadherin	GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITIONS; PLASMINOGEN-ACTIVATOR SYSTEM; VE-CADHERIN; HUMAN CYTOTROPHOBLASTS; ENDOVASCULAR INVASION; EXPRESSION; ADHESION; PREECLAMPSIA; MIGRATION	Background: Transforming growth factor (TGF)-1 treatment decreases human trophoblast invasion. Results: Smad-dependent up-regulation of Snail mediates TGF-1-induced down-regulation of VE-cadherin. Conclusion: TGF-1 decreases human trophoblast invasion by down-regulating VE-cadherin. Significance: Our results provide important insights into the molecular mechanisms mediating TGF-1-induced down-regulation of VE-cadherin and decreased cell invasion in human trophoblast cells. Human trophoblast cells express transforming growth factor- (TGF-) and TGF- receptors. It has been shown that TGF-1 treatment decreases the invasiveness of trophoblast cells. However, the molecular mechanisms underlying TGF-1-decreased trophoblast invasion are still not fully understood. In the current study, we demonstrated that treatment of HTR-8/SVneo human trophoblast cells with TGF-1 decreased cell invasion and down-regulated the expression of vascular endothelial cadherin (VE-cadherin). In addition, the inhibitory effect of TGF-1 on VE-cadherin was confirmed in primary cultures of human trophoblast cells. Moreover, knockdown of VE-cadherin using siRNA decreased the invasiveness of HTR-8/SVneo cells and primary cultures of trophoblast cells. Treatment with TGF-1 induced the activation of Smad-dependent signaling pathways and the expression of Snail and Slug. Knockdown of Smads attenuated TGF-1-induced up-regulation of Snail and Slug and down-regulation of VE-cadherin. Interestingly, depletion of Snail, but not Slug, attenuated TGF-1-induced down-regulation of VE-cadherin. Furthermore, overexpression of Snail suppressed VE-cadherin expression. Chromatin immunoprecipitation analyses showed the direct binding of Snail to the VE-cadherin promoter. These results provide evidence that Snail mediates TGF-1-induced down-regulation of VE-cadherin, which subsequently contributed to TGF-1-decreased trophoblast cell invasion.	[Cheng, Jung-Chien; Chang, Hsun-Ming; Leung, Peter C. K.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V6H 3V5, Canada	Child & Family Research Institute; University of British Columbia	Leung, PCK (corresponding author), Rm 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca	Chang, Hsun-Ming/M-8584-2018; Cheng, Jung-Chien/T-4258-2019	Cheng, Jung-Chien/0000-0002-5399-9327; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (to P. C. K. L.).	Becker KF, 2007, CELLS TISSUES ORGANS, V185, P204, DOI 10.1159/000101321; Benian A, 2002, OBSTET GYNECOL, V100, P327, DOI 10.1016/S0029-7844(02)02077-X; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chen Y, 2013, BIOCHEM BIOPH RES CO, V432, P116, DOI 10.1016/j.bbrc.2013.01.075; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Gleeson LM, 2001, J CLIN ENDOCR METAB, V86, P2484, DOI 10.1210/jc.86.6.2484; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; GRAHAM CH, 1992, BIOL REPROD, V46, P561, DOI 10.1095/biolreprod46.4.561; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Graham CH, 1997, PLACENTA, V18, P137, DOI 10.1016/S0143-4004(97)90085-0; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HOLTING T, 1994, J CLIN ENDOCR METAB, V79, P806, DOI 10.1210/jc.79.3.806; Humbert L, 2013, CELL SIGNAL, V25, P490, DOI 10.1016/j.cellsig.2012.10.011; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jones RL, 2006, REPRODUCTION, V132, P217, DOI 10.1530/rep.1.01076; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; KRIEGLSTEIN K, 1995, INT J DEV NEUROSCI, V13, P301, DOI 10.1016/0736-5748(94)00062-8; Lala N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097881; Lala PK, 2001, PLACENTA, V22, P889, DOI 10.1053/plac.2001.0736; Lash GE, 2005, BIOL REPROD, V73, P374, DOI 10.1095/biolreprod.105.040337; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Li HW, 2003, INT J GYNECOL PATHOL, V22, P63, DOI 10.1097/00004347-200301000-00013; Li ZD, 2011, ARTHRITIS RHEUM-US, V63, P2473, DOI 10.1002/art.30317; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lim KH, 1997, AM J PATHOL, V151, P1809; Lopez D, 2009, ARCH BIOCHEM BIOPHYS, V482, P77, DOI 10.1016/j.abb.2008.11.016; Maroni D, 2011, J CELL SCI, V124, P2501, DOI 10.1242/jcs.084558; Meissner A, 1999, MOL HUM REPROD, V5, P252, DOI 10.1093/molehr/5.3.252; Muy-Rivera M, 2004, AM J HYPERTENS, V17, P334, DOI 10.1016/j.amjhyper.2003.12.010; Ng YH, 2012, ENDOCRINOLOGY, V153, P925, DOI 10.1210/en.2011-1488; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang XM, 2011, GENE, V485, P160, DOI 10.1016/j.gene.2011.06.023; Ward ST, 2011, J CELL BIOCHEM, V112, P2966, DOI 10.1002/jcb.23215; Woo MMM, 2007, IN VITRO CELL DEV-AN, V43, P7, DOI 10.1007/s11626-006-9002-4; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xuan YH, 2007, HISTOL HISTOPATHOL, V22, P227, DOI 10.14670/HH-22.227; Yang H, 2011, MED SCI MONITOR, V17, pBR55, DOI 10.12659/MSM.881439; Zhao MR, 2006, REPRODUCTION, V132, P333, DOI 10.1530/rep.1.01112; Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	53	76	77	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33181	33192		10.1074/jbc.M113.488866	http://dx.doi.org/10.1074/jbc.M113.488866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106276	hybrid, Green Published			2022-12-28	WOS:000328841700033
J	Glineburg, MR; Chavez, A; Agrawal, V; Brill, SJ; Johnson, FB				Glineburg, M. Rebecca; Chavez, Alejandro; Agrawal, Vishesh; Brill, Steven J.; Johnson, F. Brad			Resolution by Unassisted Top3 Points to Template Switch Recombination Intermediates during DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Replication; DNA Topoisomerase; DNA Topology; Homologous Recombination; Holliday Junction; Rec-X; Sgs1; Template Switch Recombination; Top3	DOUBLE HOLLIDAY JUNCTIONS; TOPOISOMERASE III-ALPHA; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; IN-VIVO; SUBSTRATE-SPECIFICITY; HYPER-RECOMBINATION; GENOME INSTABILITY; ESCHERICHIA-COLI	Background: The Sgs1/Top3/Rmi1 (STR) complex resolves DNA linkages formed during replication of methyl methanesulfonate (MMS)-damaged templates. Results: Even without Sgs1 and Rmi1, Top3 can provide some resistance to MMS and resolve linkages that have recombination-dependent X-molecule (Rec-X) topology. Conclusion: Rec-Xs form during replication of MMS-damaged DNA. Significance: The findings provide novel insight into replication, STR function, and genome maintenance. The evolutionarily conserved Sgs1/Top3/Rmi1 (STR) complex plays vital roles in DNA replication and repair. One crucial activity of the complex is dissolution of toxic X-shaped recombination intermediates that accumulate during replication of damaged DNA. However, despite several years of study the nature of these X-shaped molecules remains debated. Here we use genetic approaches and two-dimensional gel electrophoresis of genomic DNA to show that Top3, unassisted by Sgs1 and Rmi1, has modest capacities to provide resistance to MMS and to resolve recombination-dependent X-shaped molecules. The X-shaped molecules have structural properties consistent with hemicatenane-related template switch recombination intermediates (Rec-Xs) but not Holliday junction (HJ) intermediates. Consistent with these findings, we demonstrate that purified Top3 can resolve a synthetic Rec-X but not a synthetic double HJ in vitro. We also find that unassisted Top3 does not affect crossing over during double strand break repair, which is known to involve double HJ intermediates, confirming that unassisted Top3 activities are restricted to substrates that are distinct from HJs. These data help illuminate the nature of the X-shaped molecules that accumulate during replication of damaged DNA templates, and also clarify the roles played by Top3 and the STR complex as a whole during the resolution of replication-associated recombination intermediates.	[Glineburg, M. Rebecca; Chavez, Alejandro; Agrawal, Vishesh; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Glineburg, M. Rebecca; Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; [Chavez, Alejandro; Brill, Steven J.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick	Johnson, FB (corresponding author), Univ Penn, Stellar Chance Labs 405A, 422 Curie Blvd, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health from the NCI [R25 CA101871];  [sT32-AG000255];  [R01-GM071268];  [R01-AG021521];  [P01-AG031862]; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255, R01AG021521, P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R25 CA101871 from the NCI (to M. R. G.) and Grants sT32-AG000255 (to A. C.), R01-GM071268 (to S. J. B.), and R01-AG021521 and P01-AG031862 (to F. B. J.).	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ashton TM, 2011, MOL CELL BIOL, V31, P1921, DOI 10.1128/MCB.01130-10; Ashton TM, 2010, DNA REPAIR, V9, P303, DOI 10.1016/j.dnarep.2009.12.007; Bachrati CZ, 2009, METHODS MOL BIOL, V582, P91, DOI 10.1007/978-1-60761-340-4_8; Bennett RJ, 2000, J BIOL CHEM, V275, P26898; Bennett RJ, 2001, P NATL ACAD SCI USA, V98, P11108, DOI 10.1073/pnas.201387098; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Bolt EL, 2002, MOL CELL, V10, P187, DOI 10.1016/S1097-2765(02)00560-9; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Chakraverty RK, 2001, MOL CELL BIOL, V21, P7150, DOI 10.1128/MCB.21.21.7150-7162.2001; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chavez A, 2011, J BIOL CHEM, V286, P5119, DOI 10.1074/jbc.M110.201608; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chen YH, 2009, P NATL ACAD SCI USA, V106, P21252, DOI 10.1073/pnas.0908258106; Choi KY, 2010, MOL BIOL CELL, V21, P2306, DOI 10.1091/mbc.E10-01-0050; Fricke WM, 2005, DNA REPAIR, V4, P243, DOI 10.1016/j.dnarep.2004.10.001; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Fritsch O, 2010, DNA REPAIR, V9, P879, DOI 10.1016/j.dnarep.2010.05.003; FU TJ, 1994, BIOCHEMISTRY-US, V33, P3896, DOI 10.1021/bi00179a015; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; KIM RA, 1992, J BIOL CHEM, V267, P17178; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Liberi G, 2006, METHOD ENZYMOL, V409, P442, DOI 10.1016/S0076-6879(05)09026-9; Liberi G, 2010, CELL RES, V20, P611, DOI 10.1038/cr.2010.73; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Mankouri HW, 2007, MOL BIOL CELL, V18, P4062, DOI 10.1091/mbc.E07-05-0490; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Mankouri HW, 2011, P NATL ACAD SCI USA, V108, P4944, DOI 10.1073/pnas.1014240108; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Onodera R, 2002, GENES GENET SYST, V77, P11, DOI 10.1266/ggs.77.11; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Robert T, 2006, EMBO J, V25, P2837, DOI 10.1038/sj.emboj.7601158; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Szakal B, 2013, EMBO J, V32, P1155, DOI 10.1038/emboj.2013.67; Tay YD, 2010, NUCLEIC ACIDS RES, V38, P1889, DOI 10.1093/nar/gkp1199; Ui A, 2001, MOL GENET GENOMICS, V265, P837, DOI 10.1007/s004380100479; Vanoli F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001205; Wagner M, 2006, GENETICS, V174, P555, DOI 10.1534/genetics.104.036905; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Whitby MC, 1996, J MOL BIOL, V264, P878, DOI 10.1006/jmbi.1996.0684; Wilson TM, 2000, J BIOL CHEM, V275, P1533, DOI 10.1074/jbc.275.3.1533; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216	65	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33193	33204		10.1074/jbc.M113.496133	http://dx.doi.org/10.1074/jbc.M113.496133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100144	Green Published, hybrid			2022-12-28	WOS:000328841700034
J	Zippin, JH; Chen, YQ; Straub, SG; Hess, KC; Diaz, A; Lee, D; Tso, P; Holz, GG; Sharp, GWG; Levin, LR; Buck, J				Zippin, Jonathan H.; Chen, Yanqiu; Straub, Susanne G.; Hess, Kenneth C.; Diaz, Ana; Lee, Dana; Tso, Patrick; Holz, George G.; Sharp, Geoffrey W. G.; Levin, Lonny R.; Buck, Jochen			CO2/HCO3-- and Calcium-regulated Soluble Adenylyl Cyclase as a Physiological ATP Sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Cyclic AMP (cAMP); Glucose Metabolism; Metabolic Regulation; Pancreatic Islets	PANCREATIC BETA-CELLS; CYCLIC-AMP; INSULIN-SECRETION; CA2+ SENSOR; CAMP; GLUCOSE; BICARBONATE; PROTEIN; OSCILLATIONS; MITOCHONDRIA	Background: The affinity of soluble adenylyl cyclase (sAC) for its substrate ATP suggested that it might be sensitive to fluctuations in ATP. Results: In sAC-overexpressing and glucose-responsive cells, sAC-generated cAMP reflects intracellular ATP levels. Conclusion: sAC can be an ATP sensor inside cells. Significance: sAC serves as a metabolic sensor via regulation by three cellular metabolites: ATP, bicarbonate, and calcium. The second messenger molecule cAMP is integral for many physiological processes. In mammalian cells, cAMP can be generated from hormone- and G protein-regulated transmembrane adenylyl cyclases or via the widely expressed and structurally and biochemically distinct enzyme soluble adenylyl cyclase (sAC). sAC activity is uniquely stimulated by bicarbonate ions, and in cells, sAC functions as a physiological carbon dioxide, bicarbonate, and pH sensor. sAC activity is also stimulated by calcium, and its affinity for its substrate ATP suggests that it may be sensitive to physiologically relevant fluctuations in intracellular ATP. We demonstrate here that sAC can function as a cellular ATP sensor. In cells, sAC-generated cAMP reflects alterations in intracellular ATP that do not affect transmembrane AC-generated cAMP. In cells of the pancreas, glucose metabolism generates ATP, which corresponds to an increase in cAMP, and we show here that sAC is responsible for an ATP-dependent cAMP increase. Glucose metabolism also elicits insulin secretion, and we further show that sAC is necessary for normal glucose-stimulated insulin secretion in vitro and in vivo.	[Zippin, Jonathan H.; Chen, Yanqiu; Hess, Kenneth C.; Diaz, Ana; Levin, Lonny R.; Buck, Jochen] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Zippin, Jonathan H.] Cornell Univ, Weill Med Coll, Dept Dermatol, New York, NY 10065 USA; [Zippin, Jonathan H.] Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10065 USA; [Straub, Susanne G.; Sharp, Geoffrey W. G.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA; [Lee, Dana; Tso, Patrick] Univ Cincinnati, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Holz, George G.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA	Cornell University; Cornell University; Cornell University; Cornell University; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Levin, LR (corresponding author), Cornell Univ, Weill Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	llevin@med.cornell.edu	Hess, Kenneth/K-6546-2019; Levin, Lonny R/A-7215-2011; Holz, George G/A-3386-2012	Hess, Kenneth/0000-0003-1377-6070; Levin, Lonny/0000-0002-5204-6356; Holz, George/0000-0002-1781-3580	National Institutes of Health [GM62328, HD059913]; American Diabetes Association; Tri-Institutional Medical Scientist Training Program; Dermatology Foundation; La Roche-Posay; Woman's Dermatological Society; American Skin Association; Barbara and Stephen Friedman fellowship; University of Cincinnati Mouse Metabolic Phenotyping Center [U24 DK059630]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059913] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K08CA160657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, R01DK069575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Tri-Institutional Medical Scientist Training Program; Dermatology Foundation; La Roche-Posay; Woman's Dermatological Society; American Skin Association; Barbara and Stephen Friedman fellowship; University of Cincinnati Mouse Metabolic Phenotyping Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62328 and HD059913 (to L. R. L. and J. B.). This work was also supported by the American Diabetes Association (to L. R. L.); by the Tri-Institutional Medical Scientist Training Program, the Dermatology Foundation, La Roche-Posay, the Woman's Dermatological Society, the American Skin Association, and a Barbara and Stephen Friedman fellowship (to J. H. Z.); and by University of Cincinnati Mouse Metabolic Phenotyping Center Grant U24 DK059630 (to D. L. and P. T.). Drs. Zippin, Buck, and Levin own equity interest in CEP Biotech, which has licensed commercialization of a panel of monoclonal antibodies directed against sAC.	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Bitterman J. L., 2013, J PHARM EXP THER, DOI 10.1124/jpet.113.208496; BRAUN T, 1975, J CYCLIC NUCL PROT, V1, P271; BRAUN T, 1991, METHOD ENZYMOL, V195, P130; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; CHARLES MA, 1975, J BIOL CHEM, V250, P6134; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Chen J, 2013, BRAIN RES, V1518, P1, DOI 10.1016/j.brainres.2013.04.027; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Di Benedetto G, 2013, CELL METAB, V17, P965, DOI 10.1016/j.cmet.2013.05.003; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lee YS, 2011, J BIOL CHEM, V286, P41353, DOI 10.1074/jbc.M111.284679; Lefkimmiatis K, 2013, J CELL BIOL, V202, P453, DOI 10.1083/jcb.201303159; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Neer E J, 1978, Adv Cyclic Nucleotide Res, V9, P69; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Parkkila AK, 1998, J BIOL CHEM, V273, P24620, DOI 10.1074/jbc.273.38.24620; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shibasaki T, 2004, J BIOL CHEM, V279, P7956, DOI 10.1074/jbc.M309068200; Steegborn C, 2005, J BIOL CHEM, V280, P31754, DOI 10.1074/jbc.M507144200; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Tian G, 2011, DIABETES, V60, P1535, DOI 10.2337/db10-1087; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tresguerres M, 2010, PFLUG ARCH EUR J PHY, V460, P953, DOI 10.1007/s00424-010-0865-6; Wu KY, 2006, NAT NEUROSCI, V9, P1257, DOI 10.1038/nn1767; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4	55	81	82	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33283	33291		10.1074/jbc.M113.510073	http://dx.doi.org/10.1074/jbc.M113.510073			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100033	hybrid, Green Published			2022-12-28	WOS:000328841700042
J	Tseng, LTL; Lin, CL; Tzen, KY; Chang, SC; Chang, MF				Tseng, Linda Tzu-Ling; Lin, Chieh-Liang; Tzen, Kai-Yuan; Chang, Shin C.; Chang, Ming-Fu			LMBD1 Protein Serves as a Specific Adaptor for Insulin Receptor Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Antisense RNA; Cell Signaling; Cell Surface Receptor; Confocal Microscopy; Endocytosis; Flow Cytometry; Glucose Metabolism; In Vivo Imaging; Insulin	CLATHRIN-MEDIATED ENDOCYTOSIS; POSITRON-EMISSION-TOMOGRAPHY; GROWTH-FACTOR RECEPTOR; ENDOPLASMIC-RETICULUM; STRUCTURAL EXPLANATION; TRANSFERRIN RECEPTOR; PATHWAY; BINDING; CELLS; AP2	Energy homeostasis is crucial for maintaining normally functioning cells; disturbances in this balance often cause various diseases. The limb region 1 (LMBR1) domain containing 1 gene (lmbrd1) encodes the LMBD1 protein that possesses 9 putative transmembrane domains. LMBD1 has been suggested to be involved in the lysosome in aiding the export of cobalamin. In this study, we determined that LMBD1 plays a regulatory role in the plasma membrane. A micro-positron emission tomography analysis showed that a single-allele knock-out of lmbrd1 increased the F-18-fluorodeoxyglucose uptake in murine hearts. In addition, the knockdown of lmbrd1 resulted in an up-regulated signaling of the insulin receptor (IR) and its downstream signaling molecule, Akt. Confocal and live total internal reflection fluorescence microscopy showed that LMBD1 co-localized and co-internalized with clathrin and the IR, but not with the transferrin receptor. The results of the mutation analysis and phenotypic rescue experiments indicate that LMBD1 interacts with adaptor protein-2 and is involved in the unique clathrin-mediated endocytosis of the IR. LMBD1 selectively interacts with the IR. The knockdown of lmbrd1 attenuated IR endocytosis, resulting in the perturbation of the IR recycling pathway and consequential enhancement of the IR signaling cascade. In summary, LMBD1 plays an imperative role in mediating and regulating the endocytosis of the IR.	[Tseng, Linda Tzu-Ling; Lin, Chieh-Liang; Chang, Ming-Fu] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10051, Taiwan; [Chang, Shin C.] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 10051, Taiwan; [Tzen, Kai-Yuan] Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei 10041, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Chang, MF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, 1 Jen Ai Rd,Sect 1, Taipei 10051, Taiwan.	mfchang@ntu.edu.tw		TZEN, KAI-YUAN/0000-0002-5657-8579; CHANG, MING-FU/0000-0001-7062-3578	National Science Council, Republic of China;  [NSC98-2320-B-002-051-MY3];  [NSC101-2320-B-002-039]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); ; 	This work was supported by Research Grants NSC98-2320-B-002-051-MY3 and NSC101-2320-B-002-039 from the National Science Council, Republic of China.	BACKER JM, 1991, J CELL BIOL, V115, P1535, DOI 10.1083/jcb.115.6.1535; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Fang KM, 2008, CARDIOVASC RES, V78, P533, DOI 10.1093/cvr/cvn030; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hsu WC, 2009, ACTA OTO-LARYNGOL, V129, P423, DOI 10.1080/00016480802593497; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kukulski W, 2012, CELL, V150, P508, DOI 10.1016/j.cell.2012.05.046; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schafers KP, 2005, EUR J NUCL MED MOL I, V32, P383, DOI 10.1007/s00259-004-1628-4; Su MJ, 1997, BRIT J PHARMACOL, V122, P1285, DOI 10.1038/sj.bjp.0701510; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Wang YH, 2005, J VIROL, V79, P8113, DOI 10.1128/JVI.79.13.8113-8120.2005; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Warren RA, 1997, J BIOL CHEM, V272, P2116; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200	31	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32424	32432		10.1074/jbc.M113.479527	http://dx.doi.org/10.1074/jbc.M113.479527			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078630	Green Published, hybrid			2022-12-28	WOS:000328681700027
J	Papakostas, K; Botou, M; Frillingos, S				Papakostas, Konstantinos; Botou, Maria; Frillingos, Stathis			Functional Identification of the Hypoxanthine/Guanine Transporters YjcD and YgfQ and the Adenine Transporters PurP and YicO of Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Evolution; Homology Modeling; Membrane Transport; Nucleoside Nucleotide Analogs; Nucleoside Nucleotide Transport; Purine; Adenine; Guanine; Hypoxanthine; Purine Analogs; Substrate Selectivity	CYSTEINE-SCANNING ANALYSIS; XANTHINE PERMEASE; SIGNATURE MOTIF; ACID TRANSPORTER; PROTEIN; FAMILY; MECHANISM; RESIDUES; CLONING; GENE	The evolutionarily broad family nucleobase-cation symporter-2 (NCS2) encompasses transporters that are conserved in binding site architecture but diverse in substrate selectivity. Putative purine transporters of this family fall into one of two homology clusters: COG2233, represented by well studied xanthine and/or uric acid permeases, and COG2252, consisting of transporters for adenine, guanine, and/or hypoxanthine that remain unknown with respect to structure-function relationships. We analyzed the COG2252 genes of Escherichia coli K-12 with homology modeling, functional overexpression, and mutagenesis and showed that they encode high affinity permeases for the uptake of adenine (PurP and YicO) or guanine and hypoxanthine (YjcD and YgfQ). The two pairs of paralogs differ clearly in their substrate and ligand preferences. Of 25 putative inhibitors tested, PurP and YicO recognize with low micromolar affinity N-6-benzoyladenine, 2,6-diaminopurine, and purine, whereas YjcD and YgfQ recognize 1-methylguanine, 8-azaguanine, 6-thioguanine, and 6-mercaptopurine and do not recognize any of the PurP ligands. Furthermore, the permeases PurP and YjcD were subjected to site-directed mutagenesis at highly conserved sites of transmembrane segments 1, 3, 8, 9, and 10, which have been studied also in COG2233 homologs. Residues irreplaceable for uptake activity or crucial for substrate selectivity were found at positions occupied by similar role amino acids in the Escherichia coli xanthine- and uric acid-transporting homologs (XanQ and UacT, respectively) and predicted to be at or around the binding site. Our results support the contention that the distantly related transporters of COG2233 and COG2252 use topologically similar side chain determinants to dictate their function and the distinct purine selectivity profiles.	[Papakostas, Konstantinos; Botou, Maria; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALES; European Social Fund	European Union (European Social Fund)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALES(Thales Group); European Social Fund(European Social Fund (ESF))	This work was co-supported by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: THALES, investing in knowledge society through the European Social Fund.	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Burzle M, 2013, MOL ASPECTS MED, V34, P436, DOI 10.1016/j.mam.2012.12.002; BURTON K, 1983, J GEN MICROBIOL, V129, P3505; BURTON K, 1994, P ROY SOC B-BIOL SCI, V255, P153, DOI 10.1098/rspb.1994.0022; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; DANIELSEN S, 1992, MOL MICROBIOL, V6, P1335, DOI 10.1111/j.1365-2958.1992.tb00854.x; Frillingos Stathis, 2012, Int J Biochem Mol Biol, V3, P250; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2011, J BIOL CHEM, V286, P39595, DOI 10.1074/jbc.M111.299164; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kose M, 2009, FUTURE MED CHEM, V1, P303, DOI [10.4155/fmc.09.29, 10.4155/FMC.09.29]; Kosti V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041939; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Kozmin SG, 2013, MBIO, V4, DOI 10.1128/mBio.00661-13; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Madej MG, 2013, P NATL ACAD SCI USA, V110, P5870, DOI 10.1073/pnas.1303538110; Mansfield TA, 2009, FEBS LETT, V583, P481, DOI 10.1016/j.febslet.2008.12.048; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Papakostas K, 2012, J BIOL CHEM, V287, P15684, DOI 10.1074/jbc.M112.355818; ROYBURMAN S, 1975, J BIOL CHEM, V250, P9270; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	40	31	35	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36827	36840		10.1074/jbc.M113.523340	http://dx.doi.org/10.1074/jbc.M113.523340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214977	Green Published, hybrid			2022-12-28	WOS:000329189700006
J	Abe, K; Ohno, Y; Sassa, T; Taguchi, R; Caliskan, M; Ober, C; Kihara, A				Abe, Kensuke; Ohno, Yusuke; Sassa, Takayuki; Taguchi, Ryo; Caliskan, Minal; Ober, Carole; Kihara, Akio			Mutation for Nonsyndromic Mental Retardation in the trans-2-Enoyl-CoA Reductase TER Gene Involved in Fatty Acid Elongation Impairs the Enzyme Activity and Stability, Leading to Change in Sphingolipid Profile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; Fatty Acid Metabolism; Lipids; Membrane; Sphingolipid	IDENTIFICATION; ELOVL4; DELETION; SYSTEM; TSC13P	Background: The P182L mutation in the trans-2-enoyl-CoA reductase (TER) gene required for very long-chain fatty acid (VLCFA) synthesis causes nonsyndromic mental retardation. Results: This mutation reduces the activity and stability of the TER enzyme. Conclusion: The impaired TER function affects VLCFA synthesis and thereby alters the cellular sphingolipid profile. Significance: Maintenance of a proper VLCFA level may be important for neural function. Very long-chain fatty acids (VLCFAs, chain length >C20) exist in tissues throughout the body and are synthesized by repetition of the fatty acid (FA) elongation cycle composed of four successive enzymatic reactions. In mammals, the TER gene is the only gene encoding trans-2-enoyl-CoA reductase, which catalyzes the fourth reaction in the FA elongation cycle. The TER P182L mutation is the pathogenic mutation for nonsyndromic mental retardation. This mutation substitutes a leucine for a proline residue at amino acid 182 in the TER enzyme. Currently, the mechanism by which the TER P182L mutation causes nonsyndromic mental retardation is unknown. To understand the effect of this mutation on the TER enzyme and VLCFA synthesis, we have biochemically characterized the TER P182L mutant enzyme using yeast and mammalian cells transfected with the TER P182L mutant gene and analyzed the FA elongation cycle in the B-lymphoblastoid cell line with the homozygous TER P182L mutation (TERP182L/P182L B-lymphoblastoid cell line). We have found that TER P182L mutant enzyme exhibits reduced trans-2-enoyl-CoA reductase activity and protein stability, thereby impairing VLCFA synthesis and, in turn, altering the sphingolipid profile (i.e. decreased level of C24 sphingomyelin and C24 ceramide) in the TERP182L/P182L B-lymphoblastoid cell line. We have also found that in addition to the TER enzyme-catalyzed fourth reaction, the third reaction in the FA elongation cycle is affected by the TER P182L mutation. These findings provide new insight into the biochemical defects associated with this genetic mutation.	[Abe, Kensuke; Ohno, Yusuke; Sassa, Takayuki; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Taguchi, Ryo] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan; [Caliskan, Minal; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Hokkaido University; Chubu University; University of Chicago	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	SASSA, Takayuki/B-2519-2012; Ohno, Yusuke/B-5621-2014; KIHARA, AKIO/A-3802-2012; Ohno, Yusuke/Q-3285-2019	SASSA, Takayuki/0000-0003-3145-9829; Ohno, Yusuke/0000-0003-3702-1043; KIHARA, AKIO/0000-0001-5889-0788; Ohno, Yusuke/0000-0003-3702-1043; Caliskan, Minal/0000-0002-0942-7073; Ober, Carole/0000-0003-4626-9809	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [BY25598]; Grants-in-Aid for Scientific Research [25116701, 24619007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The yeast strain for the AID system (BY25598) was provided by the National Bio-Resource Project (NBRP) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. We are grateful to Dr. K. Obara for technical support and Dr. T. Toyokuni for scientific editing of the manuscript.	Agbaga MP, 2010, J LIPID RES, V51, P1624, DOI 10.1194/jlr.R005025; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Brachmann CB, 1998, YEAST, V14, P115; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Muhammad E., 2013, HUM MOL GEN IN PRESS; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Norton WT., 1984, MYELIN, P147, DOI DOI 10.1007/978-1-4757-1830-0_5; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Paul S, 2007, J BIOL CHEM, V282, P19237, DOI 10.1074/jbc.M701774200; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Potter KA, 2011, GLIA, V59, P1009, DOI 10.1002/glia.21172; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817	30	17	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36741	36749		10.1074/jbc.M113.493221	http://dx.doi.org/10.1074/jbc.M113.493221			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24220030	Green Published, hybrid			2022-12-28	WOS:000328883400051
J	Zhou, L; Lovell, KM; Frankowski, KJ; Slauson, SR; Phillips, AM; Streicher, JM; Stahl, E; Schmid, CL; Hodder, P; Madoux, F; Cameron, MD; Prisinzano, TE; Aube, J; Bohn, LM				Zhou, Lei; Lovell, Kimberly M.; Frankowski, Kevin J.; Slauson, Stephen R.; Phillips, Angela M.; Streicher, John M.; Stahl, Edward; Schmid, Cullen L.; Hodder, Peter; Madoux, Franck; Cameron, Michael D.; Prisinzano, Thomas E.; Aube, Jeffrey; Bohn, Laura M.			Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Brain; Drug Discovery; ERK; G Protein-coupled Receptors (GPCR); Opiate Opioid; Pain; Dysphoria; Kappa Opioid Receptor	PROTEIN-COUPLED RECEPTOR; BETA-ARRESTIN 2; OPIATE RECEPTORS; KINASE-C; ACTIVATION; ANALGESIA; ANTAGONIST; DYNORPHIN; STRESS; MICE	Background: Kappa opioid receptor (KOR) signaling may produce antinociception through G protein or dysphoria through arrestin pathways. Results: Two highly selective, brain penetrant agonist scaffolds bias KOR signaling toward G protein coupling and produce antinociception in mice. Conclusion: Described are first-in-class small molecule agonists that bias KOR signaling through G proteins. Significance: Functionally selective KOR agonists can now be used in vivo. The kappa opioid receptor (KOR) is widely expressed in the CNS and can serve as a means to modulate pain perception, stress responses, and affective reward states. Therefore, the KOR has become a prominent drug discovery target toward treating pain, depression, and drug addiction. Agonists at KOR can promote G protein coupling and arrestin2 recruitment as well as multiple downstream signaling pathways, including ERK1/2 MAPK activation. It has been suggested that the physiological effects of KOR activation result from different signaling cascades, with analgesia being G protein-mediated and dysphoria being mediated through arrestin2 recruitment. Dysphoria associated with KOR activation limits the therapeutic potential in the use of KOR agonists as analgesics; therefore, it may be beneficial to develop KOR agonists that are biased toward G protein coupling and away from arrestin2 recruitment. Here, we describe two classes of biased KOR agonists that potently activate G protein coupling but weakly recruit arrestin2. These potent and functionally selective small molecule compounds may prove to be useful tools for refining the therapeutic potential of KOR-directed signaling in vivo.	[Zhou, Lei; Lovell, Kimberly M.; Phillips, Angela M.; Streicher, John M.; Stahl, Edward; Schmid, Cullen L.; Cameron, Michael D.; Bohn, Laura M.] Scripps Res Inst, Dept Mol Therapeut & Neurosci, Jupiter, FL 33458 USA; [Hodder, Peter; Madoux, Franck] Scripps Res Inst, Dept Lead Identificat, Jupiter, FL 33458 USA; [Frankowski, Kevin J.; Slauson, Stephen R.; Prisinzano, Thomas E.; Aube, Jeffrey] Univ Kansas, Dept Med Chem, Lawrence, KS 66047 USA	Scripps Research Institute; Scripps Research Institute; University of Kansas	Aube, J (corresponding author), Univ Kansas, Dept Med Chem, 2034 Becker Dr, Lawrence, KS 66047 USA.	jaube@ku.edu; lbohn@scripps.edu	Prisinzano, Thomas E/B-7877-2010; Bohn, Laura M/A-7483-2014	Bohn, Laura M/0000-0002-6474-8179; Aube, Jeffrey/0000-0003-1049-5767; Slauson, Stephen/0000-0002-2811-2894; Prisinzano, Thomas/0000-0002-0649-8052; Schmid Mason, Cullen/0000-0002-2882-1842; Streicher, John/0000-0002-4173-7362	National Institutes of Health [R01 DA031927]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA031927 (to L. M. B. and J. A.).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ananthan S, 2012, J MED CHEM, V55, P8350, DOI 10.1021/jm300686p; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bohn Laura M, 2010, Drug Discov Today Technol, V7, pe37, DOI 10.1016/j.ddtec.2010.06.005; Bohn Laura M., 2009, P71, DOI 10.1007/978-1-60327-335-0_5; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; Breivogel CS, 2004, NEUROPHARMACOLOGY, V47, P81, DOI 10.1016/j.neuropharm.2004.02.017; Bruchas MR, 2008, NEUROREPORT, V19, P1417, DOI 10.1097/WNR.0b013e32830dd655; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Chavkin C, 2011, NEUROPSYCHOPHARMACOL, V36, P369, DOI 10.1038/npp.2010.137; Cox BM, 2013, MOL PHARMACOL, V83, P723, DOI 10.1124/mol.112.083279; DYKSTRA LA, 1987, J PHARMACOL EXP THER, V242, P413; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; Frankowski KJ, 2007, J COMB CHEM, V9, P1188, DOI 10.1021/cc700127f; Frankowski KJ, 2012, ACS CHEM NEUROSCI, V3, P221, DOI 10.1021/cn200128x; Frankowski KJ, 2010, ACS MED CHEM LETT, V1, P189, DOI 10.1021/ml100040t; Goicoechea C, 1999, NEUROSCI LETT, V273, P175, DOI 10.1016/S0304-3940(99)00640-0; Gullapalli S, 2002, BRAIN RES, V946, P191, DOI 10.1016/S0006-8993(02)02880-9; Hedrick M. P., 2010, PROBE REPORTS NIH MO; Jones RM, 2000, EUR J PHARMACOL, V396, P49, DOI 10.1016/S0014-2999(00)00208-9; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; LAHTI RA, 1985, EUR J PHARMACOL, V109, P281, DOI 10.1016/0014-2999(85)90431-5; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; LAWRENCE DMP, 1993, J PHARMACOL EXP THER, V266, P1678; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; MA GH, 1995, MOL PHARMACOL, V47, P1035; MACDONALD RL, 1986, J PHYSIOL-LONDON, V377, P237, DOI 10.1113/jphysiol.1986.sp016184; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; McGuinness R, 2007, CURR OPIN PHARMACOL, V7, P535, DOI 10.1016/j.coph.2007.08.004; McLaughlin JP, 2004, J BIOL CHEM, V279, P1810, DOI 10.1074/jbc.M305796200; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; MILLAN MJ, 1989, J PHARMACOL EXP THER, V251, P342; MINAMI M, 1995, NEUROSCI RES, V23, P121, DOI 10.1016/0168-0102(95)00933-K; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; PASTERNAK GW, 1980, P NATL ACAD SCI-BIOL, V77, P3691, DOI 10.1073/pnas.77.6.3691; Peters MF, 2009, J BIOMOL SCREEN, V14, P246, DOI 10.1177/1087057108330115; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; PRATHER PL, 1995, MOL BRAIN RES, V29, P336, DOI 10.1016/0169-328X(94)00264-F; Raehal KM, 2009, DRUG ALCOHOL DEPEN, V104, P187, DOI 10.1016/j.drugalcdep.2009.04.011; Raehal KM, 2005, AAPS J, V7, pE587, DOI 10.1208/aapsj070360; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Rives ML, 2012, J BIOL CHEM, V287, P27050, DOI 10.1074/jbc.C112.387332; Robinson J., 2013, ASSAY DRUG DEV TECHN, DOI 10.1089/adt.2013.526; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Schmid CL, 2013, J BIOL CHEM, V288, P22387, DOI 10.1074/jbc.M113.476234; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Thomas JB, 2001, J MED CHEM, V44, P2687, DOI 10.1021/jm015521r; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Valko K, 2001, CURR MED CHEM, V8, P1137, DOI 10.2174/0929867013372643; VONVOIGTLANDER PF, 1983, J PHARMACOL EXP THER, V224, P7; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	64	106	115	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36703	36716		10.1074/jbc.M113.504381	http://dx.doi.org/10.1074/jbc.M113.504381			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24187130	Green Published, hybrid			2022-12-28	WOS:000328883400048
J	Murata, JM; Behnke-Parks, WM; Major, J; Petersen, KJ; Goulet, A; Moores, CA; Thomas, DD; Rosenfeld, SS				Murata, Joseph M.; Behnke-Parks, William M.; Major, Jennifer; Petersen, Karl J.; Goulet, Adeline; Moores, Carolyn A.; Thomas, David D.; Rosenfeld, Steven S.			Loop L5 Assumes Three Distinct Orientations during the ATPase Cycle of the Mitotic Kinesin Eg5 A TRANSIENT AND TIME-RESOLVED FLUORESCENCE STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Fluorescence; Kinesin; Kinetics; Microtubules; Eg5; Anisotropy Decay; Cryo-EM; Stopped Flow; Time-resolved Fluorescence	INHIBITION; MECHANISM; MOTOR; CONFORMATION; ACTIVATION; MYOSIN	Background: Loop L5 shapes the enzymology of kinesin motors to meet specific physiologic roles. Results: L5 is in a dynamic equilibrium of three conformations whose relative proportions shift during the ATPase cycle. Conclusion: Interactions between L5 and helix 3 modulate the kinetics of microtubule binding. Significance: Combining transient kinetics with time-resolved fluorescence reveals important insights in the structural dynamics of molecular motors. Members of the kinesin superfamily of molecular motors differ in several key structural domains, which probably allows these molecular motors to serve the different physiologies required of them. One of the most variable of these is a stem-loop motif referred to as L5. This loop is longest in the mitotic kinesin Eg5, and previous structural studies have shown that it can assume different conformations in different nucleotide states. However, enzymatic domains often consist of a mixture of conformations whose distribution shifts in response to substrate binding or product release, and this information is not available from the static images that structural studies provide. We have addressed this issue in the case of Eg5 by attaching a fluorescent probe to L5 and examining its fluorescence, using both steady state and time-resolved methods. This reveals that L5 assumes an equilibrium mixture of three orientations that differ in their local environment and segmental mobility. Combining these studies with transient state kinetics demonstrates that there is a major shift in this distribution during transitions that interconvert weak and strong microtubule binding states. Finally, in conjunction with previous cryo-EM reconstructions of Eg5microtubule complexes, these fluorescence studies suggest a model in which L5 regulates both nucleotide and microtubule binding through a set of reversible interactions with helix 3. We propose that these features facilitate the production of sustained opposing force by Eg5, which underlies its role in supporting formation of a bipolar spindle in mitosis.	[Murata, Joseph M.; Petersen, Karl J.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Behnke-Parks, William M.] Columbia Univ, Dept Biol, New York, NY 10027 USA; [Major, Jennifer; Rosenfeld, Steven S.] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Goulet, Adeline; Moores, Carolyn A.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England	University of Minnesota System; University of Minnesota Twin Cities; Columbia University; Cleveland Clinic Foundation; University of London; Birkbeck University London	Rosenfeld, SS (corresponding author), Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave,NB40, Cleveland, OH 44195 USA.			Thomas, David D./0000-0002-8822-2040; Goulet, Adeline/0000-0002-5971-9488	National Institutes of Health [GM102875, AR032961, AR057220, AR056191]; Biotechnology and Biological Sciences Research Council [BB/H005137/1]; BBSRC [BB/H005137/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057220, R01AR032961, R37AR032961, F32AR056191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102875 (to S.S.R.), AR032961 and AR057220 (to D.D.T.), and AR056191 (to J.M.M.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/H005137/1 (to A.G. and C. M.).	BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Goulet A, 2012, J BIOL CHEM, V287, P44654, DOI 10.1074/jbc.M112.404228; Kaan HYK, 2013, J BIOL CHEM, V288, P18588, DOI 10.1074/jbc.M113.462648; KINOSITA K, 1982, BIOPHYS J, V37, P461, DOI 10.1016/S0006-3495(82)84692-4; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P134; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032	27	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34839	34849		10.1074/jbc.M113.518845	http://dx.doi.org/10.1074/jbc.M113.518845			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145034	Green Published, hybrid			2022-12-28	WOS:000329812800051
J	Zhang, QC; Flynn, GC				Zhang, Qingchun; Flynn, Gregory C.			Cysteine Racemization on IgG Heavy and Light Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Disulfide; Mass Spectrometry (MS); Post Translational Modification; Protein Chemical Modification; Chirality; Light Chain; Thioether	MONOCLONAL-ANTIBODY; HINGE REGION; CROSS-LINKS; FRAGMENTATION; SUBCLASSES; REDUCTION; ISOFORMS; STORAGE	Background: Cysteine racemization occurs at heavy chain position 220 of an IgG1under high pH stress. Results: d-Cysteine forms on both heavy and light chains of an IgGs under mild conditions. Conclusion: The terminal cysteine impairs racemization on the light chain. Significance: Because d-cysteine is naturally occurring on antibodies, its presence on therapeutic antibodies poses less of a safety concern. Under basic pH conditions, the heavy chain 220-light chain 214 (H220-L214) disulfide bond, found in the flexible hinge region of an IgG1, can convert to a thioether. Similar conditions also result in racemization of the H220 cysteine. Here, we report that racemization occurs on both H220 and L214 on an IgG1 with a light chain (IgG1) but almost entirely on H220 of an IgGl with a light chain (IgG1) under similar conditions. Likewise, racemization was detected at significant levels on H220 and L214 on endogenous human IgG1 but only at the H220 position on IgG1. Low but measurable levels of d-cysteines were found on IgG2 cysteines in the hinge region, both with monoclonal antibodies incubated under basic pH conditions and on antibodies isolated from human serum. A simplified reaction mechanism involving reversible -elimination on the cysteine is presented that accounts for both base-catalyzed racemization and thioether formation at the hinge disulfide.	[Zhang, Qingchun; Flynn, Gregory C.] Amgen Inc, Dept Proc & Prod Dev, Thousand Oaks, CA 91320 USA	Amgen	Flynn, GC (corresponding author), Amgen Inc, Mail Stop 30E-1-C,Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com						Alyanakian MA, 2003, VOX SANG, V84, P188, DOI 10.1046/j.1423-0410.2003.00278.x; Amano M, 2011, ANAL CHEM, V83, P3857, DOI 10.1021/ac200321v; BESSEMS GJH, 1987, EXP EYE RES, V44, P691, DOI 10.1016/S0014-4835(87)80139-2; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Cordoba AJ, 2005, J CHROMATOGR B, V818, P115, DOI 10.1016/j.jchromb.2004.12.033; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Eon-Duval A, 2012, BIOTECHNOL PROGR, V28, P608, DOI 10.1002/btpr.1548; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; Hutterer KM, 2013, MABS-AUSTIN, V5, P608, DOI 10.4161/mabs.24725; Linetsky M, 2004, EXP EYE RES, V79, P499, DOI 10.1016/j.exer.2004.06.026; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Maggon K, 2007, CURR MED CHEM, V14, P1978; Mozziconacci O, 2010, CHEM RES TOXICOL, V23, P1310, DOI 10.1021/tx100193b; OUT TA, 1984, CLIN CHIM ACTA, V144, P115, DOI 10.1016/0009-8981(84)90044-5; Pan H, 2009, ANAL BIOCHEM, V388, P273, DOI 10.1016/j.ab.2009.02.037; Tous GI, 2005, ANAL CHEM, V77, P2675, DOI 10.1021/ac0500582; VLUG A, 1994, ANN BIOL CLIN-PARIS, V52, P561; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; Yan BX, 2009, J BIOL CHEM, V284, P35390, DOI 10.1074/jbc.M109.064147; Zhang QC, 2013, J BIOL CHEM, V288, P16371, DOI 10.1074/jbc.M113.468397	23	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34325	34335		10.1074/jbc.M113.506915	http://dx.doi.org/10.1074/jbc.M113.506915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142697	hybrid, Green Published			2022-12-28	WOS:000329812800004
J	Arsenault, PR; Pei, F; Lee, R; Kerestes, H; Percy, MJ; Keith, B; Simon, MC; Lappin, TRJ; Khurana, TS; Lee, FS				Arsenault, Patrick R.; Pei, Fei; Lee, Rebecca; Kerestes, Heddy; Percy, Melanie J.; Keith, Brian; Simon, M. Celeste; Lappin, Terence R. J.; Khurana, Tejvir S.; Lee, Frank S.			A Knock-in Mouse Model of Human PHD2 Gene-associated Erythrocytosis Establishes a Haploinsufficiency Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Erythropoeisis; Erythropoietin; Hypoxia; Hypoxia-inducible Factor; Hypoxia-inducible Factor (HIF); Prolyl Hydroxylase Domain Protein	HYDROXYLASE DOMAIN PROTEIN-2; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; LINDAU TUMOR-SUPPRESSOR; PULMONARY-HYPERTENSION; HIF-ALPHA; MUTATION; MICE; POLYCYTHEMIA; HIF-2-ALPHA; HIF-1-ALPHA	The central pathway for controlling red cell mass is the PHD (prolyl hydroxylase domain protein):hypoxia-inducible factor (HIF) pathway. HIF, which is negatively regulated by PHD, activates numerous genes, including ones involved in erythropoiesis, such as the ERYTHROPOIETIN (EPO) gene. Recent studies have implicated PHD2 as the key PHD isoform regulating red cell mass. Studies of humans have identified erythrocytosis-associated, heterozygous point mutations in the PHD2 gene. A key question concerns the mechanism by which human mutations lead to phenotypes. In the present report, we generated and characterized a mouse line in which a P294R knock-in mutation has been introduced into the mouse Phd2 locus to model the first reported human PHD2 mutation (P317R). Phd2(P294R/+) mice display a degree of erythrocytosis equivalent to that seen in Phd2(+/-) mice. The Phd2(P294R/+)-associated erythrocytosis is reversed in a Hif2a(+/-), but not a Hif1a(+/-) background. Additional studies using various conditional knock-outs of Phd2 reveal that erythrocytosis can be induced by homozygous and heterozygous knock-out of Phd2 in renal cortical interstitial cells using a Pax3-Cre transgene or by homozygous knock-out of Phd2 in hematopoietic progenitors driven by a Vav1-Cre transgene. These studies formally prove that a missense mutation in PHD2 is the cause of the erythrocytosis, show that this occurs through haploinsufficiency, and point to multifactorial control of red cell mass by PHD2.	[Arsenault, Patrick R.; Pei, Fei; Lee, Rebecca; Kerestes, Heddy; Lee, Frank S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Keith, Brian] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Keith, Brian; Simon, M. Celeste] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Percy, Melanie J.] Belfast City Hosp, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; [Lappin, Terence R. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Belfast City Hospital; Queens University Belfast	Lee, FS (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021; Arsenault, Patrick/F-3429-2011	Arsenault, Patrick/0000-0001-6670-0809; Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-CA153347]; NATIONAL CANCER INSTITUTE [R01CA153347, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA153347 (to F.S.L.).	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Bushuev VI, 2006, HAEMATOLOGICA, V91, P744; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Degenhardt KR, 2010, DEV BIOL, V339, P519, DOI 10.1016/j.ydbio.2009.12.030; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Formenti F, 2011, FASEB J, V25, P2001, DOI 10.1096/fj.10-177378; Franke K, 2013, BLOOD, V121, P1436, DOI 10.1182/blood-2012-08-449181; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Mossuz P, 2004, HAEMATOLOGICA, V89, P1194; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Pappalardi MB, 2008, BIOCHEMISTRY-US, V47, P11165, DOI 10.1021/bi801624f; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; R Development Core Team, 2010, R ENV STAT COMP; Ryan HE, 2000, CANCER RES, V60, P4010; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Singh RP, 2013, BLOOD, V121, P5158, DOI 10.1182/blood-2012-12-471185; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Song DS, 2013, J BIOL CHEM, V288, P9662, DOI 10.1074/jbc.M112.440552; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu F, 2001, CANCER RES, V61, P4136	55	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33571	33584		10.1074/jbc.M113.482364	http://dx.doi.org/10.1074/jbc.M113.482364			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121508	hybrid, Green Published			2022-12-28	WOS:000327250200007
J	Amini, ZN; Muller, UF				Amini, Zhaleh N.; Mueller, Ulrich F.			Low Selection Pressure Aids the Evolution of Cooperative Ribozyme Mutations in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; Escherichia coli; Evolution; Ribozyme; RNA Catalysis	TERMINATION FACTOR-RHO; RNA INTERVENING SEQUENCE; IN-VITRO EVOLUTION; TRANSSPLICING RIBOZYMES; ESCHERICHIA-COLI; MESSENGER-RNA; SELF-CLEAVAGE; BENEFICIAL MUTATIONS; RIBONUCLEASE-P; VIVO SELECTION	Background: Ribozyme evolution experiments in cells can help our understanding of natural RNA evolution. Results: During an experimental RNA evolution, the emergence of four cooperative mutations was more efficient under low than under high selection pressure. Conclusion: Low selective pressure can facilitate the evolution of cooperative RNA mutations. Significance: Understanding RNA evolution in biology requires understanding the effects of evolutionary parameters in cells. Understanding the evolution of functional RNA molecules is important for our molecular understanding of biology. Here we tested experimentally how two evolutionary parameters, selection pressure and recombination, influenced the evolution of an evolving RNA population. This was done using four parallel evolution experiments that employed low or gradually increasing selection pressure, and recombination events either at the end or dispersed throughout the evolution. As model system, a trans-splicing group I intron ribozyme was evolved in Escherichia coli cells over 12 rounds of selection and amplification, including mutagenesis and recombination. The low selection pressure resulted in higher efficiency of the evolved ribozyme populations, whereas differences in recombination did not have a strong effect. Five mutations were responsible for the highest efficiency. The first mutation swept quickly through all four evolving populations, whereas the remaining four mutations accumulated later and more efficiently under low selection pressure. To determine why low selection pressure aided this evolution, all evolutionary intermediates between the wild type and the 5-mutation variant were constructed, and their activities at three different selection pressures were determined. The resulting fitness profiles showed a high cooperativity among the four late mutations, which can explain why high selection pressure led to inefficient evolution. These results show experimentally how low selection pressure can benefit the evolution of cooperative mutations in functional RNAs.	[Amini, Zhaleh N.; Mueller, Ulrich F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Muller, UF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ufmuller@ucsd.edu			National Institutes of Health Molecular Biophysics Training Grant [T32 GM008326]; Hellman Family Foundation [2011/12, 2012/13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326] Funding Source: NIH RePORTER	National Institutes of Health Molecular Biophysics Training Grant; Hellman Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Molecular Biophysics Training Grant T32 GM008326 (to Susan Taylor). This work was also supported by Grants 2011/12 and 2012/13 from the Hellman Family Foundation (to U. F. M.).	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Ayre BG, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf141; Ayre BG, 1999, P NATL ACAD SCI USA, V96, P3507, DOI 10.1073/pnas.96.7.3507; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BUZAYAN JM, 1986, P NATL ACAD SCI USA, V83, P8859, DOI 10.1073/pnas.83.23.8859; Byun J, 2003, RNA, V9, P1254, DOI 10.1261/rna.5450203; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chen X, 2009, RNA, V15, P2035, DOI 10.1261/rna.1635209; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Dayie KT, 2008, RNA, V14, P1697, DOI 10.1261/rna.1154408; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Fiskaa T, 2010, NEW BIOTECHNOL, V27, P194, DOI 10.1016/j.nbt.2010.02.013; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guo F, 2002, RNA, V8, P647, DOI 10.1017/S1355838202029011; Haugen P, 2004, RNA, V10, P1084, DOI 10.1261/rna.5202704; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; INOUE T, 1985, P NATL ACAD SCI USA, V82, P648, DOI 10.1073/pnas.82.3.648; Kastanos E, 2004, BIOCHEM BIOPH RES CO, V322, P930, DOI 10.1016/j.bbrc.2004.07.203; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kohler U, 1999, J MOL BIOL, V285, P1935, DOI 10.1006/jmbi.1998.2447; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lau MWL, 2009, CHEM BIOL, V16, P815, DOI 10.1016/j.chembiol.2009.07.005; Leconte AM, 2013, BIOCHEMISTRY-US, V52, P1490, DOI 10.1021/bi3016185; Lehman N, 2000, J MOL EVOL, V50, P481, DOI 10.1007/s002390010051; LEHMAN N, 1993, NATURE, V361, P182, DOI 10.1038/361182a0; Meluzzi D, 2012, RNA, V18, P590, DOI 10.1261/rna.029884.111; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Olson KE, 2012, RNA, V18, P581, DOI 10.1261/rna.028472.111; Ordoukhanian P, 1999, CHEM BIOL, V6, P881, DOI 10.1016/S1074-5521(00)80007-1; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Rogers CS, 2002, J CLIN INVEST, V110, P1783, DOI 10.1172/JCI200216481; Roth A., 2013, NAT CHEM BI IN PRESS; Ryu KJ, 2003, MOL THER, V7, P386, DOI 10.1016/S1525-0016(02)00063-1; SAVILLE BJ, 1990, CELL, V61, P685, DOI 10.1016/0092-8674(90)90480-3; Schmitt T, 1999, CHEM BIOL, V6, P857, DOI 10.1016/S1074-5521(00)80005-8; SHARMEEN L, 1988, J VIROL, V62, P2674, DOI 10.1128/JVI.62.8.2674-2679.1988; SHAW WV, 1967, J BIOL CHEM, V242, P687; Soll SJ, 2007, GENETICS, V175, P267, DOI 10.1534/genetics.106.066142; Song MS, 2006, FEBS LETT, V580, P5033, DOI 10.1016/j.febslet.2006.08.021; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; TRITTON TR, 1979, ARCH BIOCHEM BIOPHYS, V197, P10, DOI 10.1016/0003-9861(79)90212-1; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Unwalla HJ, 2008, MOL THER, V16, P1113, DOI 10.1038/mt.2008.54; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; Voytek SB, 2009, P NATL ACAD SCI USA, V106, P7780, DOI 10.1073/pnas.0903397106; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Walstrom KM, 1997, BIOCHEMISTRY-US, V36, P7993, DOI 10.1021/bi963180r; WANG Y, 1993, J BIOL CHEM, V268, P13947; Watanabe T, 2000, P NATL ACAD SCI USA, V97, P8490, DOI 10.1073/pnas.150104097; WEINER MP, 1994, PCR METH APPL, V4, pS131; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; Wieland M, 2008, ANGEW CHEM INT EDIT, V47, P2604, DOI 10.1002/anie.200703700; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	69	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33096	33106		10.1074/jbc.M113.511469	http://dx.doi.org/10.1074/jbc.M113.511469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089519	Green Published, hybrid			2022-12-28	WOS:000328841700025
J	Marzoq, AJ; Giese, N; Hoheisel, JD; Alhamdani, MSS				Marzoq, Aseel J.; Giese, Nathalia; Hoheisel, Joerg D.; Alhamdani, Mohamed Saiel Saeed			Proteome Variations in Pancreatic Stellate Cells upon Stimulation with Proinflammatory Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Microarray; Pancreatic Cancer; Proteomics; Stromal Cell; Tumor Necrosis Factor (TNF); Pancreatic Stellate Cell; Antibody Microarray	TUMOR-NECROSIS-FACTOR; CORNEAL NEOVASCULARIZATION; STROMA INTERACTIONS; MAMMALIAN TISSUE; MATRIX SYNTHESIS; CANCER; INTERLEUKIN-6; EXPRESSION; FIBROSIS; MICROENVIRONMENT	Pancreatic stellate cells are key mediators in chronic pancreatitis and play a central role in the development of pancreatic fibrosis, stromal formation, and progression of pancreatic cancer. This study was aimed at investigating molecular changes at the level of the proteome that are associated with the activation of pancreatic stellate cells by proinflammatory factors, namely TNF-, FGF2, IL6, and chemokine (C-C motif) ligand 4 (CCL4). They were added individually to cells growing in serum-free medium next to controls in medium supplemented with serum, thus containing a mixture of them all, or in serum-free medium alone. Variations were detected by means of a microarray of 810 antibodies targeting relevant proteins. All tested factors triggered increased proliferation and migration. Further analysis showed that TNF- is the prime factor responsible for the activation of pancreatic stellate cells. CCL4 is associated with cellular neovascularization, whereas FGF2 and IL6 induction led to better cellular survival and decreased apoptotic activity of the stellate cells. The identified direct effects of individual cytokines on human pancreatic stellate cells provide new insights about their contribution to pancreatic cancer promotion.	[Marzoq, Aseel J.; Hoheisel, Joerg D.; Alhamdani, Mohamed Saiel Saeed] Deutsch Krebsforschungszentrum DKFZ, Div Funct Genome Anal, D-69120 Heidelberg, Germany; [Giese, Nathalia] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Alhamdani, MSS (corresponding author), Deutsch Krebsforschungszentrum, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	m.alhamdani@dkfz.de			European Union as part of the Affinomics consortium; Deutscher Akademischer Austauschdienst (DAAD)	European Union as part of the Affinomics consortium; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by the European Union as part of the Affinomics consortium.; Recipient of a long-term fellowship from the Deutscher Akademischer Austauschdienst (DAAD).	ADAMSON GM, 1992, ARCH BIOCHEM BIOPHYS, V294, P223, DOI 10.1016/0003-9861(92)90161-O; Adebanjo OA, 1998, J CELL BIOL, V142, P1347, DOI 10.1083/jcb.142.5.1347; Alhamdani MSS, 2012, J PROTEOMICS, V75, P3747, DOI 10.1016/j.jprot.2012.04.042; Alhamdani MSS, 2010, PROTEOMICS, V10, P3203, DOI 10.1002/pmic.201000170; Alhamdani MSS, 2010, J PROTEOME RES, V9, P963, DOI 10.1021/pr900844q; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Campbell V, 2000, CYTOKINE, V12, P487, DOI 10.1006/cyto.1999.0584; Caruso JA, 2010, CANCER RES, V70, P7125, DOI 10.1158/0008-5472.CAN-10-1547; CATHCART R, 1984, METHOD ENZYMOL, V105, P352; Duner S, 2010, PANCREATOLOGY, V10, P673, DOI 10.1159/000320711; Edmonds C, 2008, CANCER BIOL THER, V7, P1816; EPSTEIN RJ, 1990, CORNEA, V9, P318; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Erkan M., 2010, Experimental Oncology, V32, P128; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; HILL HR, 1991, J EXP MED, V173, P767, DOI 10.1084/jem.173.3.767; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; Karayiannakis AJ, 2001, ANTICANCER RES, V21, P1355; Law HKW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-74; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li R, 2012, METAB BRAIN DIS, V27, P91, DOI 10.1007/s11011-011-9270-x; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mahali S, 2011, J BIOL CHEM, V286, P34903, DOI 10.1074/jbc.M111.279190; Martin B., 2012, PLOS ONE, V7; Masamune A, 2002, PANCREAS, V25, P78, DOI 10.1097/00006676-200207000-00018; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Matsubara J, 2010, MOL CELL PROTEOMICS, V9, P695, DOI 10.1074/mcp.M900234-MCP200; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Mroczko B, 2010, J CLIN LAB ANAL, V24, P256, DOI 10.1002/jcla.20395; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Paulo JA, 2011, J PROTEOMICS, V75, P708, DOI 10.1016/j.jprot.2011.09.009; Paulo JA, 2011, J PROTEOME RES, V10, P4835, DOI 10.1021/pr2006318; Poch B, 2007, LANGENBECK ARCH SURG, V392, P353, DOI 10.1007/s00423-006-0140-7; Reichenbach V, 2012, J PHARMACOL EXP THER, V340, P629, DOI 10.1124/jpet.111.188078; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Schroder C, 2011, METHODS MOL BIOL, V785, P203, DOI 10.1007/978-1-61779-286-1_14; Schroder C, 2010, MOL CELL PROTEOMICS, V9, P1271, DOI 10.1074/mcp.M900419-MCP200; Shi WY, 2010, CURR EYE RES, V35, P967, DOI 10.3109/02713683.2010.502294; Shimizu K, 2008, J GASTROENTEROL, V43, P823, DOI 10.1007/s00535-008-2249-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian XD, 2012, HEPATO-GASTROENTEROL, V59, P1604, DOI 10.5754/hge10366; Tomlins C, 2010, CARCINOGENESIS, V31, P2155, DOI 10.1093/carcin/bgq200; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wara AK, 2011, BLOOD, V118, P6450, DOI 10.1182/blood-2011-06-363713; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Yang F, 2010, OCUL IMMUNOL INFLAMM, V18, P390, DOI 10.3109/09273948.2010.483315; Yokoyama Y, 2009, SURG TODAY, V39, P466, DOI 10.1007/s00595-008-3904-6; Zeh H. J., 2005, Cancer Biomarkers, V1, P259; Zhou G, 2012, BIOTECHNOL LETT, V34, P1235, DOI 10.1007/s10529-012-0908-5	64	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32517	32527		10.1074/jbc.M113.488387	http://dx.doi.org/10.1074/jbc.M113.488387			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089530	hybrid, Green Published			2022-12-28	WOS:000328681700035
J	Diao, YR; Guo, X; Jiang, L; Wang, G; Zhang, C; Wan, J; Jin, Y; Wu, ZG				Diao, Yarui; Guo, Xing; Jiang, Lei; Wang, Gang; Zhang, Chao; Wan, Jun; Jin, Yan; Wu, Zhenguo			miR-203, a Tumor Suppressor Frequently Down-regulated by Promoter Hypermethylation in Rhabdomyosarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; JAK Kinase; Notch; p63; Proliferation; Rhabdomyosarcoma; Leukemia Inhibitory Factor Receptor; miR-203; Muscle Differentiation	LEUKEMIA INHIBITORY FACTOR; MUSCLE PROGENITOR CELLS; MYOGENIC DIFFERENTIATION; MICRORNA BIOGENESIS; NOTCH; EXPRESSION; PROLIFERATION; PROGRESS; PROTEIN; GENES	Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma found in children and young adults. It is characterized by the expression of a number of skeletal muscle-specific proteins, including MyoD and muscle -actin. However, unlike normal myoblasts, RMS cells differentiate poorly both in vivo and in culture. As microRNAs are known to regulate tumorigenesis, intensive efforts have been made to identify microRNAs that are involved in RMS development. In this work, we found that miR-203 was frequently down-regulated by promoter hypermethylation in both RMS cell lines and RMS biopsies and could be reactivated by DNA-demethylating agents. Re-expression of miR-203 in RMS cells inhibited their migration and proliferation and promoted terminal myogenic differentiation. Mechanistically, miR-203 exerts its tumor-suppressive effect by directly targeting p63 and leukemia inhibitory factor receptor in RMS cells, which promotes myogenic differentiation by inhibiting the Notch and the JAK1/STAT1/STAT3 pathways, respectively. Our work reveals that miR-203 functions as a tumor suppressor in RMS development.	[Diao, Yarui; Zhang, Chao; Wan, Jun; Wu, Zhenguo] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Med Ctr, Biomed Res Inst, Shenzhen 518036, Peoples R China; [Diao, Yarui; Guo, Xing; Jiang, Lei; Wang, Gang; Wu, Zhenguo] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Xian 710032, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Air Force Military Medical University	Wu, ZG (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	bczgwu@ust.hk	Jin, Yan/I-4204-2013	Wang, Gang/0000-0002-4066-5280; Wan, Jun/0000-0001-7308-0150; Wu, Zhenguo/0000-0003-3049-8324; Diao, Yarui/0000-0001-5842-4082	China Postdoctoral Science Foundation [20110490921]; Shenzhen Basic Research Program [JCYJ20120618172119166]; Hong Kong Research Grant Council [GRF663511]; State Key Laboratory of Molecular Neuroscience at Hong Kong University of Science and Technology	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shenzhen Basic Research Program; Hong Kong Research Grant Council(Hong Kong Research Grants Council); State Key Laboratory of Molecular Neuroscience at Hong Kong University of Science and Technology	This work was supported by China Postdoctoral Science Foundation Grant 20110490921 (to Y. D.), Shenzhen Basic Research Program Grant JCYJ20120618172119166 (to Y. D.), Hong Kong Research Grant Council Grant GRF663511 (to Z. W.), and the State Key Laboratory of Molecular Neuroscience at Hong Kong University of Science and Technology.	Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; Andrassy RJ, 1999, J PEDIATR SURG, V34, P731, DOI 10.1016/S0022-3468(99)90365-2; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Craig VJ, 2011, CANCER RES, V71, P3616, DOI 10.1158/0008-5472.CAN-10-3907; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dagher R, 1999, Oncologist, V4, P34; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Diao YR, 2012, CELL STEM CELL, V11, P231, DOI 10.1016/j.stem.2012.05.022; Diao YR, 2009, MOL CELL BIOL, V29, P5084, DOI 10.1128/MCB.00267-09; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Ecke I, 2009, CANCER RES, V69, P887, DOI 10.1158/0008-5472.CAN-08-0946; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kantlehner M, 2011, NUCLEIC ACIDS RES, V39, pE44, DOI 10.1093/nar/gkq1357; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lepper C, 2012, CELL STEM CELL, V11, P443, DOI 10.1016/j.stem.2012.09.010; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Mishra PJ, 2009, J CLIN INVEST, V119, P2119, DOI 10.1172/JCI40107; Missiaglia E, 2010, BRIT J CANCER, V102, P1769, DOI 10.1038/sj.bjc.6605684; Mourikis P, 2012, DEVELOPMENT, V139, P4536, DOI 10.1242/dev.084756; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Noguchi S, 2012, J BIOL CHEM, V287, P11769, DOI 10.1074/jbc.M111.325027; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Rota R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-120; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Wysoczynski M, 2007, CANCER RES, V67, P2131, DOI 10.1158/0008-5472.CAN-06-1021; Xiao F, 2011, CELL RES, V21, P350, DOI 10.1038/cr.2010.144; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	87	66	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					529	539		10.1074/jbc.M113.494716	http://dx.doi.org/10.1074/jbc.M113.494716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247238	Green Published, hybrid			2022-12-28	WOS:000329370900045
J	Jain, S; Prater, A; Pandey, V; Rana, A; Puri, N; Kumar, A				Jain, Sudhir; Prater, Alicia; Pandey, Varunkumar; Rana, Anita; Puri, Nitin; Kumar, Ashok			A Haplotype of Angiotensin Receptor Type 1 Associated with Human Hypertension Increases Blood Pressure in Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; G Protein-coupled receptors (GPCR); Gene Regulation; Genetic Polymorphism; Hypertension; Molecular Genetics; Transcription; Transgenic Mice	TRANSCRIPTION FACTOR USF; II RECEPTOR; GENE; EXPRESSION; UPSTREAM; SYSTEM; OVEREXPRESSION; POLYMORPHISMS; PROMOTER; ACCURATE	The renin-angiotensin system plays an important role in the regulation of blood pressure via angiotensin II and the angiotensin II receptor type 1 (AT(1)R). Human AT(1)R gene promoter has four SNPs: T/A at -777, T/G at -680, A/C at -214, and A/G at -119, that are in linkage disequilibrium. Variants -777T, -680T, -214A, and -119A almost always occur together (named haplotype I), and variants -777A, -680G, -214C, and -119G almost always occur together (named haplotype II) in Caucasian subjects. Genomic DNA analyses, from 388 normotensive and 374 hypertensive subjects, link haplotype I of the human AT(1)R (hAT(1)R) gene with hypertension in Caucasians (p = 0.004, (2) = 8.46). Our results show increased basal promoter activity of the hAT(1)R gene in cells (H295R and A7r5) transfected with reporter construct containing haplotype I. We also show increased binding of the transcription factor, USF2, to oligonucleotide containing nucleoside -214A as opposed to -214C. Recombineering of a 166-kb bacterial artificial chromosome containing 68 kb of the 5-flanking region, 45 kb of the coding sequence, and 53 kb of the 3-flanking region of the hAT(1)R gene was employed to generate transgenic mice with either haplotype. We show that (a) hAT(1)R mRNA level is increased in the kidney and heart of transgenic mice containing haplotype I as compared with haplotype II; (b) USF2 binds more strongly to the chromatin obtained from the kidney of transgenic mice containing haplotype I as compared with haplotype II; and (c) blood pressure and oxidative stress are increased in transgenic mice containing haplotype I as compared with haplotype II.	[Jain, Sudhir; Prater, Alicia; Pandey, Varunkumar; Rana, Anita; Puri, Nitin; Kumar, Ashok] Univ Toledo Hlth Sci Campus, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University of Toledo Health Science Campus	Kumar, A (corresponding author), Univ Toledo Hlth Sci Campus, Dept Physiol & Pharmacol, Rm 351,3000 Transverse Dr, Toledo, OH 43614 USA.	ashok.kumar2@utoledo.edu			National Institutes of Health [HL81752, HL105113, HL092558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092558, R01HL105113, R01HL081752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81752, HL105113, and HL092558.	BIRD IM, 1994, ENDOCRINOLOGY, V134, P2468, DOI 10.1210/en.134.6.2468; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ewens KG, 2005, DIABETES, V54, P3305, DOI 10.2337/diabetes.54.11.3305; Galis ZS, 2013, HYPERTENSION, V61, P757, DOI 10.1161/HYPERTENSIONAHA.111.00770; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; Griendling KK, 1997, HYPERTENSION, V29, P366, DOI 10.1161/01.HYP.29.1.366; GUTKIND JS, 1988, AM J PHYSIOL, V255, pH646, DOI 10.1152/ajpheart.1988.255.3.H646; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Jain S, 2010, J BIOL CHEM, V285, P41172, DOI 10.1074/jbc.M110.167585; Kainulainen K, 1999, HYPERTENSION, V33, P844, DOI 10.1161/01.HYP.33.3.844; Le TH, 2003, HYPERTENSION, V42, P507, DOI 10.1161/01.HYP.0000092000.07559.57; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; MENDELSOHN FAO, 1985, J HYPERTENS, V3, P307, DOI 10.1097/00004872-198508000-00002; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; PEACH MJ, 1990, J CARDIOVASC PHARM, V16, pS25, DOI 10.1097/00005344-199016004-00007; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; Veerasingham SJ, 2003, BRIT J PHARMACOL, V139, P191, DOI 10.1038/sj.bjp.0705262; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wu SL, 2010, HUM MOL GENET, V19, P597, DOI 10.1093/hmg/ddp526; Zhao YY, 1999, HYPERTENSION, V33, P108, DOI 10.1161/01.HYP.33.1.108	32	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37048	37056		10.1074/jbc.M113.520023	http://dx.doi.org/10.1074/jbc.M113.520023			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24202179	Green Published, hybrid			2022-12-28	WOS:000329189700025
J	Bause, AS; Matsui, MS; Haigis, MC				Bause, Alexandra S.; Matsui, Mary S.; Haigis, Marcia C.			The Protein Deacetylase SIRT3 Prevents Oxidative Stress-induced Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Keratinocytes; Mitochondria; Reactive Oxygen Species (ROS); Sirtuins; SIRT3	HUMAN EPIDERMAL-KERATINOCYTES; TERMINAL DIFFERENTIATION; SUPEROXIDE; MITOCHONDRIA; EXPRESSION	Background: SIRT3 plays a major role in protecting against mitochondrial oxidative stress. Results: Oxidative stress increases during keratinocyte differentiation, and SIRT3 can decrease differentiation by attenuating oxidative stress. Conclusion: SIRT3-induced down-regulation of mitochondrial oxidative stress attenuates keratinocyte differentiation. Significance: Understanding the regulation of keratinocyte differentiation is crucial for developing new therapies against dysregulated skin differentiation and aging. Keratinocyte differentiation is a key process in the formation and maintenance of the protective skin barrier. Dysregulation in the balance of reactive oxygen species homeostasis may play a role in keratinocyte differentiation. We have identified the mitochondrial deacetylase SIRT3 as a key regulator of mitochondrial reactive oxygen species in keratinocytes. Our studies demonstrate that SIRT3 expression is down-regulated during keratinocyte differentiation, consistent with an increase in mitochondrial superoxide levels. Importantly, loss of SIRT3 expression in keratinocytes increased superoxide levels and promoted the expression of differentiation markers, whereas overexpression decreased superoxide levels and reduced the expression of differentiation markers. These findings identify a new role for SIRT3 in the suppression of epidermal differentiation via lowering oxidative stress.	[Bause, Alexandra S.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Matsui, Mary S.] Estee Lauder Co Inc, Melville, NY 11747 USA	Harvard University; Harvard Medical School; Estee Lauder Companies	Haigis, MC (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, SGM 329C,250 Longwood Ave, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu			Estee Lauder Companies Inc.; German Academic Exchange Service; Glenn Foundation for Medical Research	Estee Lauder Companies Inc.; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Glenn Foundation for Medical Research	This work was supported by The Estee Lauder Companies Inc. (to M. C. H.), the German Academic Exchange Service (to A. S. B.), and the Glenn Foundation for Medical Research (to the Haigis laboratory).	Allombert-Blaise C, 2003, CELL DEATH DIFFER, V10, P850, DOI 10.1038/sj.cdd.4401245; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Bellizzi D, 2009, MOL CELLS, V28, P87, DOI 10.1007/s10059-009-0110-3; Benrahmoune M, 2000, FREE RADICAL BIO MED, V29, P775, DOI 10.1016/S0891-5849(00)00380-4; Bose A., 2012, PLOS ONE, V7; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hornig-Do HT, 2007, J INVEST DERMATOL, V127, P1084, DOI 10.1038/sj.jid.5700666; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Kalinin A, 2001, J CELL SCI, V114, P3069; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rutberg SE, 1996, ONCOGENE, V13, P167; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; STEVEN AC, 1994, J CELL SCI, V107, P693; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tamiji S, 2005, J INVEST DERMATOL, V125, P647, DOI 10.1111/j.0022-202X.2005.23885.x; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Velarde MC, 2012, AGING-US, V4, P3, DOI 10.18632/aging.100423; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206	26	26	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36484	36491		10.1074/jbc.M113.472324	http://dx.doi.org/10.1074/jbc.M113.472324			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194516	Green Published, hybrid			2022-12-28	WOS:000328883400029
J	Desquiret-Dumas, V; Gueguen, N; Leman, G; Baron, S; Nivet-Antoine, V; Chupin, S; Chevrollier, A; Vessieres, E; Ayer, A; Ferre, M; Bonneau, D; Henrion, D; Reynier, P; Procaccio, V				Desquiret-Dumas, Valerie; Gueguen, Naig; Leman, Geraldine; Baron, Stephanie; Nivet-Antoine, Valerie; Chupin, Stephanie; Chevrollier, Arnaud; Vessieres, Emilie; Ayer, Audrey; Ferre, Marc; Bonneau, Dominique; Henrion, Daniel; Reynier, Pascal; Procaccio, Vincent			Resveratrol Induces a Mitochondrial Complex I-dependent Increase in NADH Oxidation Responsible for Sirtuin Activation in Liver Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Mitochondrial Metabolism; NAD; Resveratrol; Sirtuins; Complex I; NADH Dehydrogenase	NICOTINAMIDE-ADENINE-DINUCLEOTIDE; FATTY-ACID OXIDATION; FLUORESCENCE SPECTROSCOPY; UBIQUINONE OXIDOREDUCTASE; METABOLISM; AMPK; PROTECTS; MICE; DEHYDROGENASE; PGC-1-ALPHA	Background: The mechanism of action of resveratrol on sirtuin and mitochondrial metabolism remains elusive. Results: Resveratrol increases the mitochondrial NAD(+) level by direct stimulation of complex I, leading to a SIRT3-dependent increase in substrate supplies. Conclusion: Our results link the direct stimulation by resveratrol of NADH oxidation to the SIRT3 activation. Significance: Mitochondrial NAD(+)/NADH ratio is a critical parameter mediating resveratrol effect on mitochondrial function. Resveratrol (RSV) has been shown to be involved in the regulation of energetic metabolism, generating increasing interest in therapeutic use. SIRT1 has been described as the main target of RSV. However, recent reports have challenged the hypothesis of its direct activation by RSV, and the signaling pathways remain elusive. Here, the effects of RSV on mitochondrial metabolism are detailed both in vivo and in vitro using murine and cellular models and isolated enzymes. We demonstrate that low RSV doses (1-5 m) directly stimulate NADH dehydrogenases and, more specifically, mitochondrial complex I activity (EC50 approximate to 1 m). In HepG2 cells, this complex I activation increases the mitochondrial NAD(+)/NADH ratio. This higher NAD(+) level initiates a SIRT3-dependent increase in the mitochondrial substrate supply pathways (i.e. the tricarboxylic acid cycle and fatty acid oxidation). This effect is also seen in liver mitochondria of RSV-fed animals (50 mg/kg/day). We conclude that the increase in NADH oxidation by complex I is a crucial event for SIRT3 activation by RSV. Our results open up new perspectives in the understanding of the RSV signaling pathway and highlight the critical importance of RSV doses used for future clinical trials.	[Desquiret-Dumas, Valerie; Gueguen, Naig; Leman, Geraldine; Chupin, Stephanie; Chevrollier, Arnaud; Vessieres, Emilie; Ayer, Audrey; Ferre, Marc; Bonneau, Dominique; Henrion, Daniel; Reynier, Pascal; Procaccio, Vincent] Univ Angers, F-49000 Angers, France; [Desquiret-Dumas, Valerie; Gueguen, Naig; Chupin, Stephanie; Chevrollier, Arnaud; Ferre, Marc; Bonneau, Dominique; Reynier, Pascal; Procaccio, Vincent] CHU Angers, Dept Biochim & Genet, F-49000 Angers, France; [Desquiret-Dumas, Valerie; Gueguen, Naig; Leman, Geraldine; Chupin, Stephanie; Chevrollier, Arnaud; Vessieres, Emilie; Ayer, Audrey; Ferre, Marc; Bonneau, Dominique; Henrion, Daniel; Reynier, Pascal; Procaccio, Vincent] CNRS, INSERM, UMR 6214, U1083, F-49000 Angers, France; [Baron, Stephanie; Nivet-Antoine, Valerie] Univ Paris 05, Fac Pharm, EA 4466, F-75270 Paris, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UDICE-French Research Universities; Universite Paris Cite	Procaccio, V (corresponding author), CHU Angers, Dept Biochim & Genet, 4 Rue Larrey, F-49933 Angers, France.	ViProcaccio@chu-angers.fr	Nivet-Antoine, Valerie/R-1981-2017; Bonneau, Dominique/K-6110-2015; Baron, Stephanie/AAY-5703-2020; Henrion, Daniel/N-7023-2015; FERRE, Marc/B-4103-2010; CHEVROLLIER, Arnaud/P-6630-2019; Reynier, Pascal/K-3677-2015; Ayer, Audrey/D-5384-2015; Desquiret-Dumas, Valérie/K-2695-2015; LENAERS, Guy/K-2421-2015; Henrion, Daniel/AAK-1995-2021; vessieres, emilie/K-1894-2015; CHEVROLLIER, Arnaud/K-2853-2015; Henrion, Daniel/J-8141-2015; CHEVROLLIER, Arnaud/GSD-3887-2022	Nivet-Antoine, Valerie/0000-0003-2490-0428; Baron, Stephanie/0000-0002-0375-6968; Henrion, Daniel/0000-0003-1094-0285; FERRE, Marc/0000-0001-8265-7249; CHEVROLLIER, Arnaud/0000-0002-5135-6643; LENAERS, Guy/0000-0003-2736-3349; Henrion, Daniel/0000-0003-1094-0285; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Henrion, Daniel/0000-0003-1094-0285; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Reynier, Pascal/0000-0003-0802-4608; procaccio, Vincent/0000-0002-1537-4684; Desquiret-Dumas, Valerie/0000-0001-9551-9400; Gueguen, Naig/0000-0002-3094-8121; Bonneau, Dominique/0000-0002-6886-0969	Region Pays de la Loire; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	Region Pays de la Loire(Region Pays de la Loire); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	This work was supported by grants from "Region Pays de la Loire," "Agence Nationale de la Recherche," "Fondation pour la Recherche Medicale," "Union Nationale des Aveugles et Deficients Visuels," "Retina France," "Ouvrir les Yeux," and "Association contre les Maladies Mitochondriales."	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bao JJ, 2010, CELL MOL LIFE SCI, V67, P3073, DOI 10.1007/s00018-010-0402-y; Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Calamini B, 2010, BIOCHEM J, V429, P273, DOI 10.1042/BJ20091857; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; DUCHEN MR, 1992, J PHYSIOL-LONDON, V450, P33, DOI 10.1113/jphysiol.1992.sp019115; ENG J, 1989, BIOPHYS J, V55, P621, DOI 10.1016/S0006-3495(89)82859-0; Flamment M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1162, DOI 10.1152/ajpendo.00169.2009; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Goncalves S, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-5; Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jiang YG, 2008, CHINESE MED J-PEKING, V121, P1204, DOI 10.1097/00029330-200807010-00010; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Kitson TM, 2001, CHEM-BIOL INTERACT, V130, P57, DOI 10.1016/S0009-2797(00)00222-2; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li XL, 2011, INT J BIOL SCI, V7, P575, DOI 10.7150/ijbs.7.575; Lopez-Nicolas JM, 2008, J AGR FOOD CHEM, V56, P7600, DOI 10.1021/jf800843e; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Menet MC, 2013, ANAL CHIM ACTA, V761, P128, DOI 10.1016/j.aca.2012.11.048; Mercader J, 2011, J NUTR BIOCHEM, V22, P828, DOI 10.1016/j.jnutbio.2010.07.007; MINEZAKI KK, 1994, J PHYSIOL-LONDON, V476, P459, DOI 10.1113/jphysiol.1994.sp020147; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Richard T., 2001, ANN NY ACAD SCI, V1215, P103; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Stefanatos R, 2011, CELL CYCLE, V10, P1528, DOI 10.4161/cc.10.10.15496; Sun F., 2012, PLOS ONE, V7; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Ungvari Z, 2011, EXERC SPORT SCI REV, V39, P128, DOI 10.1097/JES.0b013e3182141f80; Vinogradov AD, 2008, BBA-BIOENERGETICS, V1777, P729, DOI 10.1016/j.bbabio.2008.04.014; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514	57	97	102	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36662	36675		10.1074/jbc.M113.466490	http://dx.doi.org/10.1074/jbc.M113.466490			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24178296	Green Published, hybrid			2022-12-28	WOS:000328883400045
J	Giorgini, F; Huang, SY; Sathyasaikumar, KV; Notarangelo, FM; Thomas, MAR; Tararina, M; Wu, HQ; Schwarcz, R; Muchowski, PJ				Giorgini, Flaviano; Huang, Shao-Yi; Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Thomas, Marian A. R.; Tararina, Margarita; Wu, Hui-Qiu; Schwarcz, Robert; Muchowski, Paul J.			Targeted Deletion of Kynurenine 3-Monooxygenase in Mice A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Metabolism; Neurodegeneration; Neuroprotection; Schizophrenia; Tryptophan; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase	ARYL-HYDROCARBON RECEPTOR; QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE; CONVERT L-TRYPTOPHAN; 3-HYDROXYANTHRANILIC ACID; INDOLEAMINE 2,3-DIOXYGENASE; INHIBITION; SCHIZOPHRENIA; INFLAMMATION; 3-HYDROXYKYNURENINE; HYDROXYLASE	Background: Kynurenine 3-monooxygenase (KMO) is hypothesized to play a pivotal role in regulating tryptophan metabolism in health and disease. Results: Mice that were generated lacking KMO have alterations in the levels of several tryptophan metabolites. Conclusion: KMO is a critical regulator of tryptophan metabolism. Significance: KMO knock-out mice will be a useful research tool to dissect the biological and pathophysiological roles of tryptophan metabolism. Kynurenine 3-monooxygenase (KMO), a pivotal enzyme in the kynurenine pathway (KP) of tryptophan degradation, has been suggested to play a major role in physiological and pathological events involving bioactive KP metabolites. To explore this role in greater detail, we generated mice with a targeted genetic disruption of Kmo and present here the first biochemical and neurochemical characterization of these mutant animals. Kmo(-/-) mice lacked KMO activity but showed no obvious abnormalities in the activity of four additional KP enzymes tested. As expected, Kmo(-/-) mice showed substantial reductions in the levels of its enzymatic product, 3-hydroxykynurenine, in liver, brain, and plasma. Compared with wild-type animals, the levels of the downstream metabolite quinolinic acid were also greatly decreased in liver and plasma of the mutant mice but surprisingly were only slightly reduced (by approximate to 20%) in the brain. The levels of three other KP metabolites: kynurenine, kynurenic acid, and anthranilic acid, were substantially, but differentially, elevated in the liver, brain, and plasma of Kmo(-/-) mice, whereas the liver and brain content of the major end product of the enzymatic cascade, NAD(+), did not differ between Kmo(-/-) and wild-type animals. When assessed by in vivo microdialysis, extracellular kynurenic acid levels were found to be significantly elevated in the brains of Kmo(-/-) mice. Taken together, these results provide further evidence that KMO plays a key regulatory role in the KP and indicate that Kmo(-/-) mice will be useful for studying tissue-specific functions of individual KP metabolites in health and disease.	[Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Huang, Shao-Yi; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA 94158 USA; [Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Thomas, Marian A. R.; Tararina, Margarita; Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	University of Leicester; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore	Muchowski, PJ (corresponding author), Soteria Therapeut, 195 Beacon St, San Francisco, CA 94131 USA.	paulmuchowski@gmail.com	Schwarcz, Robert/P-3134-2018	Giorgini, Flaviano/0000-0001-7881-9508; Tararina, Margarita/0000-0003-4750-2289	National Institutes of Health from the United States Public Health Service [NS057715, AG022074]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS057715 and AG022074 from the United States Public Health Service.	AlberatiGiani D, 1996, ADV EXP MED BIOL, V398, P171; Amaral M, 2013, NATURE, V496, P382, DOI 10.1038/nature12039; Amori L, 2009, J NEUROCHEM, V109, P316, DOI 10.1111/j.1471-4159.2009.05893.x; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; BARAN H, 1990, J NEUROCHEM, V55, P738, DOI 10.1111/j.1471-4159.1990.tb04553.x; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Cannazza G, 2001, NEUROCHEM RES, V26, P511, DOI 10.1023/A:1010960812204; CARPENEDO R, 1994, NEUROSCIENCE, V61, P237, DOI 10.1016/0306-4522(94)90227-5; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Chess AC, 2007, SCHIZOPHRENIA BULL, V33, P797, DOI 10.1093/schbul/sbl033; Chess AC, 2009, BEHAV BRAIN RES, V201, P325, DOI 10.1016/j.bbr.2009.03.013; CHIARUGI A, 1995, J NEUROCHEM, V65, P1176; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Costantino G, 2009, EXPERT OPIN THER TAR, V13, P247, DOI [10.1517/14728220802665734, 10.1517/14728220802665734 ]; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; DECASTRO FT, 1957, J BIOL CHEM, V228, P777; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Erhardt S, 2004, BIOL PSYCHIAT, V56, P255, DOI 10.1016/j.biopsych.2004.06.006; Erhardt S, 2007, PHYSIOL BEHAV, V92, P203, DOI 10.1016/j.physbeh.2007.05.025; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FOSTER AC, 1985, J NEUROCHEM, V44, P446, DOI 10.1111/j.1471-4159.1985.tb05435.x; FOSTER AC, 1986, J NEUROCHEM, V47, P23; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; HEYES MP, 1992, J NEUROIMMUNOL, V40, P71, DOI 10.1016/0165-5728(92)90214-6; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; HEYES MP, 1988, J CHROMATOGR-BIOMED, V428, P340, DOI 10.1016/S0378-4347(00)83925-0; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; HIRAKU Y, 1995, CARCINOGENESIS, V16, P349, DOI 10.1093/carcin/16.2.349; Holtze M, 2012, J PSYCHIATR NEUROSCI, V37, P53, DOI 10.1503/jpn.100175; ISHII T, 1992, ARCH BIOCHEM BIOPHYS, V294, P616, DOI 10.1016/0003-9861(92)90733-D; Kaszaki J, 2012, J NEURAL TRANSM, V119, P211, DOI 10.1007/s00702-011-0658-x; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; LEKLEM JE, 1971, AM J CLIN NUTR, V24, P659; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller CL, 2008, NEUROCHEM INT, V52, P1297, DOI 10.1016/j.neuint.2008.01.013; MOFFETT JR, 1994, CELL TISSUE RES, V278, P461; Morita T, 2001, ANN CLIN BIOCHEM, V38, P242, DOI 10.1258/0004563011900461; Moroni F, 2012, J NEURAL TRANSM, V119, P133, DOI 10.1007/s00702-011-0763-x; Muller N, 2006, NEUROTOX RES, V10, P131; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Notarangelo FM, 2012, ANAL BIOCHEM, V421, P573, DOI 10.1016/j.ab.2011.12.032; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; RIOS C, 1991, NEUROCHEM RES, V16, P1139, DOI 10.1007/BF00966592; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Sathyasaikumar KV, 2011, SCHIZOPHRENIA BULL, V37, P1147, DOI 10.1093/schbul/sbq112; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Shepard PD, 2003, NEUROPSYCHOPHARMACOL, V28, P1454, DOI 10.1038/sj.npp.1300188; Speciale C, 1996, EUR J PHARMACOL, V315, P263, DOI 10.1016/S0014-2999(96)00613-9; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Stone TW, 2012, J NEURAL TRANSM, V119, P261, DOI 10.1007/s00702-011-0676-8; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Terakata M, 2013, J NUTR, V143, P1046, DOI 10.3945/jn.113.176875; Terakata M, 2012, J NUTR, V142, P2148, DOI 10.3945/jn.112.167569; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Thomas M., 2012, SOC NEUR ABSTR, V37; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Wejksza K, 2009, PHARMACOL REP, V61, P751, DOI 10.1016/S1734-1140(09)70130-6; Wonodi I, 2011, ARCH GEN PSYCHIAT, V68, P665, DOI 10.1001/archgenpsychiatry.2011.71; Wonodi I, 2010, SCHIZOPHRENIA BULL, V36, P211, DOI 10.1093/schbul/sbq002; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	81	81	82	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36554	36566		10.1074/jbc.M113.503813	http://dx.doi.org/10.1074/jbc.M113.503813			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189070	hybrid, Green Published			2022-12-28	WOS:000328883400036
J	Fernandez-Murray, JP; Ngo, MH; McMaster, CR				Fernandez-Murray, J. Pedro; Ngo, Michael H.; McMaster, Christopher R.			Choline Transport Activity Regulates Phosphatidylcholine Synthesis through Choline Transporter Hnm1 Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycerophospholipid; Membrane Transport; Phosphatidylcholine; Phospholipid Metabolism; Yeast Metabolism	YEAST SACCHAROMYCES-CEREVISIAE; UBIQUITIN-DEPENDENT TRAFFICKING; PHOSPHOLIPID-SYNTHESIS; TRANSFER PROTEIN; URACIL PERMEASE; ENDOCYTOSIS; GENE; BIOSYNTHESIS; PHOSPHORYLATION; PATHWAY	Background: Yeast cells grown in choline exhibit a reduction in the level of the choline transporter Hnm1. Results: Hnm1 transporter activity triggers its endocytosis by a mechanism dependent on the ubiquitin ligase Rsp5 and the casein kinases Yck1/2. Conclusion: Choline transport activity affects the stability of the Hnm1 choline transporter. Significance: Regulation of choline transporter activity constitutes an important regulatory node for phosphatidylcholine homeostasis. Choline is a precursor for the synthesis of phosphatidylcholine through the CDP-choline pathway. Saccharomyces cerevisiae expresses a single high affinity choline transporter at the plasma membrane, encoded by the HNM1 gene. We show that exposing cells to increasing levels of choline results in two different regulatory mechanisms impacting Hnm1 activity. Initial exposure to choline results in a rapid decrease in Hnm1-mediated transport at the level of transporter activity, whereas chronic exposure results in Hnm1 degradation through an endocytic mechanism that depends on the ubiquitin ligase Rsp5 and the casein kinase 1 redundant pair Yck1/Yck2. We present details of how the choline transporter is a major regulator of phosphatidylcholine synthesis.	[Fernandez-Murray, J. Pedro; Ngo, Michael H.; McMaster, Christopher R.] Dalhousie Univ, Fac Med, Dept Pharmacol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada	Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Fac Med, Dept Pharmacol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada.	Christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institutes of Health Research grant (to C. R. M.).	Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; COTTRELL SF, 1981, J BIOL CHEM, V256, P973; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Fernandez-Murray JP, 2009, J BIOL CHEM, V284, P36034, DOI 10.1074/jbc.M109.063958; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HOSAKA K, 1980, J BACTERIOL, V143, P176, DOI 10.1128/JB.143.1.176-181.1980; Howe AG, 2002, J BIOL CHEM, V277, P44100, DOI 10.1074/jbc.M206643200; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; LEE KS, 1994, J BIOL CHEM, V269, P19725; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rudge SA, 2002, GENETICS, V160, P1353; Sarri E, 2011, J BIOL CHEM, V286, P28632, DOI 10.1074/jbc.M111.267534; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346	42	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36106	36115		10.1074/jbc.M113.499855	http://dx.doi.org/10.1074/jbc.M113.499855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187140	Green Published, hybrid			2022-12-28	WOS:000329814700045
J	Joseph, J; Wang, S; Lee, J; Ro, JY; Chung, MK				Joseph, John; Wang, Sen; Lee, Jongseok; Ro, Jin Y.; Chung, Man-Kyo			Carboxyl-terminal Domain of Transient Receptor Potential Vanilloid 1 Contains Distinct Segments Differentially Involved in Capsaicin- and Heat-induced Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pain; Patch Clamp Electrophysiology; Receptor Desensitization; Transfection; TRP Channels; Heat	TRP CHANNELS; ION-CHANNEL; BODY-TEMPERATURE; PORE DOMAIN; ACTIVATION; SENSITIVITY; BINDING; THERMOSENSATION; KERATINOCYTES; DETERMINANT	Background: Mechanisms of TRPV1 desensitization by heat are not fully understood. Results: Distinct segments of the TRPV1 carboxyl-terminal domain are differentially involved in capsaicin- and heat-induced desensitization. Conclusion: Capsaicin and heat desensitizes TRPV1 through a distinct structural basis. Significances: Selective enhancement of desensitization could be a novel strategy for suppressing heat hyperalgesia. Multiple Ca2+-dependent processes are involved in capsaicin-induced desensitization of transient receptor potential vanilloid 1 (TRPV1), but desensitization of TRPV1 by heat occurs even in the absence of extracellular Ca2+, although the mechanisms are unknown. In this study, we tested the hypothesis that capsaicin and heat desensitize TRPV1 through distinct mechanisms involving distinct structural segments of TRPV1. In HEK293 cells that heterologously express TRPV1, we found that heat-induced desensitization was not affected by the inclusion of intracellular ATP or alanine mutation of Lys(155), both of which attenuate capsaicin-induced desensitization, suggesting that heat-induced desensitization occurs through mechanisms distinct from capsaicin-induced desensitization. To determine protein domains involved in heat-induced desensitization, we generated chimeric proteins between TRPV1 and TRPV3, a heat-gated channel lacking heat-induced desensitization. We found that TRPV1 with the carboxyl-terminal domain (CTD) of TRPV3 retained heat activation but was impaired in heat-induced desensitization. Further experiments using chimeric or deletion mutants within TRPV1 CTD indicated that the distal half of CTD regulates the activation and desensitization of TRPV1 in modality-specific manners. Within the distal CTD, we identified two segments that distinctly regulated capsaicin- and heat-induced desensitization. The results suggest that the activation and desensitization of TRPV1 by capsaicin and heat can be modulated differentially and disproportionally through different regions of TRPV1 CTD. Identifying the domains involved in thermal regulation of TRPV1 may facilitate the development of novel anti-hyperalgesic approaches aimed at attenuating activation and enhancing desensitization of TRPV1 by thermal stimuli.	[Joseph, John; Wang, Sen; Lee, Jongseok; Ro, Jin Y.; Chung, Man-Kyo] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chung, MK (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, 650 W Baltimore St,8 South, Baltimore, MD 21201 USA.	mchung@umaryland.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148	NIDCR, National Institutes of Health Grants [DE020866, DE016062]; University of Maryland Dental School start-up fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE020866, R01DE016062] Funding Source: NIH RePORTER	NIDCR, National Institutes of Health Grants; University of Maryland Dental School start-up fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by NIDCR, National Institutes of Health Grants DE020866 (to M.-K. C.) and DE016062 (to J. Y. R.). This work was also supported by the University of Maryland Dental School start-up fund (to M.-K. C.).	Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chaudhury S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-34; Chung MK, 2011, J DENT RES, V90, P1098, DOI 10.1177/0022034511412074; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Chung MK, 2011, ADV EXP MED BIOL, V704, P615, DOI 10.1007/978-94-007-0265-3_33; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; del Camino D, 2010, J NEUROSCI, V30, P15165, DOI 10.1523/JNEUROSCI.2580-10.2010; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huang Susan M, 2013, Open Pain J, V6, P119; Kohno K, 2010, J NEUROSCI, V30, P12219, DOI 10.1523/JNEUROSCI.2001-10.2010; Koplas PA, 1997, J NEUROSCI, V17, P3525; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lau SY, 2012, J GEN PHYSIOL, V140, P541, DOI 10.1085/jgp.201210810; Lee J, 2012, BIOCHEM BIOPH RES CO, V424, P358, DOI 10.1016/j.bbrc.2012.07.008; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Reilly RM, 2012, J PHARMACOL EXP THER, V342, P416, DOI 10.1124/jpet.111.190314; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Touska F, 2011, CURR PHARM BIOTECHNO, V12, P122, DOI 10.2174/138920111793937826; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Vyklicky L, 2008, PHYSIOL RES, V57, pS59, DOI 10.33549/physiolres.931478; Wang S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-22; Watabiki T, 2011, J PHARMACOL EXP THER, V336, P743, DOI 10.1124/jpet.110.175570; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941	48	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35690	35702		10.1074/jbc.M113.513374	http://dx.doi.org/10.1074/jbc.M113.513374			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174527	hybrid, Green Published			2022-12-28	WOS:000329814700008
J	Dias, FA; Gandara, ACP; Queiroz-Barros, FG; Oliveira, RLL; Sorgine, MHF; Braz, GRC; Oliveira, PL				Dias, Felipe A.; Gandara, Ana Caroline P.; Queiroz-Barros, Fernanda G.; Oliveira, Raquel L. L.; Sorgine, Marcos H. F.; Braz, Gloria R. C.; Oliveira, Pedro L.			Ovarian Dual Oxidase (Duox) Activity Is Essential for Insect Eggshell Hardening and Waterproofing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Insect; NADPH Oxidase; Protein Cross-linking; Reproduction; Eggshell; Waterproofing	TIME QUANTITATIVE PCR; DROSOPHILA-MELANOGASTER; RHODNIUS-PROLIXUS; AEDES-AEGYPTI; CROSS-LINKING; HUMAN MYELOPEROXIDASE; EXTRACELLULAR-MATRIX; HYDROGEN-PEROXIDE; CHORION PROTEINS; REACTIVE OXYGEN	Background: Hardening of the insect eggshell is due to peroxidases that promote protein cross-linking via H2O2, from an unknown source. Results: In Rhodnius prolixus, this H2O2 is produced by Duox, and it also contributes to waterproofing, preventing desiccation. Conclusion: H2O2 from Duox has a double role in protecting the Rhodnius eggshell. Significance: Duox activity is essential to insect reproduction. In insects, eggshell hardening involves cross-linking of chorion proteins via their tyrosine residues. This process is catalyzed by peroxidases at the expense of H2O2 and confers physical and biological protection to the developing embryo. Here, working with Rhodnius prolixus, the insect vector of Chagas disease, we show that an ovary dual oxidase (Duox), a NADPH oxidase, is the source of the H2O2 that supports dityrosine-mediated protein cross-linking and eggshell hardening. RNAi silencing of Duox activity decreased H2O2 generation followed by a failure in embryo development caused by a reduced resistance to water loss, which, in turn, caused embryos to dry out following oviposition. Phenotypes of Duox-silenced eggs were reversed by incubation in a water-saturated atmosphere, simultaneous silencing of the Duox and catalase genes, or H2O2 injection into the female hemocoel. Taken together, our results show that Duox-generated H2O2 fuels egg chorion hardening and that this process plays an essential role during eggshell waterproofing.	[Dias, Felipe A.; Gandara, Ana Caroline P.; Queiroz-Barros, Fernanda G.; Sorgine, Marcos H. F.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med Leopoldo De Meis, BR-21941590 Rio De Janeiro, Brazil; [Oliveira, Raquel L. L.; Braz, Gloria R. C.] Univ Fed Rio de Janeiro, Dept Bioquim, Inst Quim, BR-21945570 Rio De Janeiro, Brazil; [Dias, Felipe A.; Gandara, Ana Caroline P.; Queiroz-Barros, Fernanda G.; Oliveira, Raquel L. L.; Sorgine, Marcos H. F.; Braz, Gloria R. C.; Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol INCT EM, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Dias, FA (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.	felipe.dias@bioqmed.ufrj.br	Dias, Felipe/L-7390-2013; L. Oliveira, Pedro/A-9438-2010	Dias, Felipe/0000-0003-2074-1052; Gomes de Queiroz Barros-Aragao, Fernanda/0000-0002-1663-8346; Paiva Gandara, Ana Caroline/0000-0003-3194-4453; L. Oliveira, Pedro/0000-0003-0307-354X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ).	Andersen SA, 2005, INSECT BIOCHEM MOLEC, V35, P1181, DOI 10.1016/j.ibmb.2005.05.009; BEAMENT JWL, 1946, PROC R SOC SER B-BIO, V133, P407, DOI 10.1098/rspb.1946.0021; BEAMENT JWL, 1946, Q J MICROSC SCI, V87, P392; BEAMENT JWL, 1946, NATURE, V157, P370, DOI 10.1038/157370c0; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Konstandi OA, 2005, INSECT BIOCHEM MOLEC, V35, P1043, DOI 10.1016/j.ibmb.2005.04.005; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li JSS, 2006, INSECT BIOCHEM MOLEC, V36, P954, DOI 10.1016/j.ibmb.2006.09.006; Li JY, 1996, INSECT BIOCHEM MOLEC, V26, P309, DOI 10.1016/0965-1748(95)00099-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Margaritis L.H., 1985, COMPREHENSIVE INSECT, P151; MARGARITIS LH, 1985, TISSUE CELL, V17, P553, DOI 10.1016/0040-8166(85)90031-X; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; MINDRINOS MN, 1980, ROUX ARCH DEV BIOL, V189, P187, DOI 10.1007/BF00868677; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Moussian B, 2005, J MORPHOL, V264, P117, DOI 10.1002/jmor.10324; Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1; Nguyen TTA, 2011, J BIOL CHEM, V286, P33244, DOI 10.1074/jbc.M111.263178; OLIVEIRA PL, 1986, J INSECT PHYSIOL, V32, P859, DOI 10.1016/0022-1910(86)90101-0; PAPASSIDERI IS, 1993, TISSUE CELL, V25, P929, DOI 10.1016/0040-8166(93)90041-I; Papassideri IS, 1996, TISSUE CELL, V28, P401, DOI 10.1016/S0040-8166(96)80026-7; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82; Shaik KS, 2012, EUR J CELL BIOL, V91, P204, DOI 10.1016/j.ejcb.2011.11.005; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wong JL, 2005, DEV BIOL, V288, P317, DOI 10.1016/j.ydbio.2005.07.004; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Wong JL, 2008, DEVELOPMENT, V135, P431, DOI 10.1242/dev.015503; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200	41	26	27	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35058	35067		10.1074/jbc.M113.522201	http://dx.doi.org/10.1074/jbc.M113.522201			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24174530	hybrid, Green Published			2022-12-28	WOS:000329867600008
J	Chen, PC; Kryukova, YN; Shyng, SL				Chen, Pei-Chun; Kryukova, Yelena N.; Shyng, Show-Ling			Leptin Regulates K-ATP Channel Trafficking in Pancreatic beta-Cells by a Signaling Mechanism Involving AMP-activated Protein Kinase (AMPK) and cAMP-dependent Protein Kinase (PKA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Actin; AMP-activated kinase (AMPK); Endocytosis; Potassium Channels; cAMP-dependent Protein Kinase (PKA); Signal Transduction	SENSITIVE POTASSIUM CHANNELS; STIMULATED INSULIN-SECRETION; CONGENITAL HYPERINSULINISM; GLUCOSE-HOMEOSTASIS; ACTIN CYTOSKELETON; POMC NEURONS; FOOD-INTAKE; RAT; PHOSPHORYLATION; EXOCYTOSIS	Background: Leptin inhibits insulin secretion by increasing -cell K-ATP currents. Results: Leptin causes a transient increase in surface K-ATP channel density. This increase is dependent on AMPK and PKA and actin depolymerization. Conclusion: Leptin increases K-ATP currents by recruiting K-ATP channels to the -cell membrane. Significance: K-ATP channel trafficking is an important physiological mechanism to regulate channel activity. Pancreatic -cells secrete insulin in response to metabolic and hormonal signals to maintain glucose homeostasis. Insulin secretion is under the control of ATP-sensitive potassium (K-ATP) channels that play key roles in setting -cell membrane potential. Leptin, a hormone secreted by adipocytes, inhibits insulin secretion by increasing K-ATP channel conductance in -cells. We investigated the mechanism by which leptin increases K-ATP channel conductance. We show that leptin causes a transient increase in surface expression of K-ATP channels without affecting channel gating properties. This increase results primarily from increased channel trafficking to the plasma membrane rather than reduced endocytosis of surface channels. The effect of leptin on K-ATP channels is dependent on the protein kinases AMP-activated protein kinase (AMPK) and PKA. Activation of AMPK or PKA mimics and inhibition of AMPK or PKA abrogates the effect of leptin. Leptin activates AMPK directly by increasing AMPK phosphorylation at threonine 172. Activation of PKA leads to increased channel surface expression even in the presence of AMPK inhibitors, suggesting AMPK lies upstream of PKA in the leptin signaling pathway. Leptin signaling also leads to F-actin depolymerization. Stabilization of F-actin pharmacologically occludes, whereas destabilization of F-actin simulates, the effect of leptin on K-ATP channel trafficking, indicating that leptin-induced actin reorganization underlies enhanced channel trafficking to the plasma membrane. Our study uncovers the signaling and cellular mechanism by which leptin regulates K-ATP channel trafficking to modulate -cell function and insulin secretion.	[Chen, Pei-Chun; Kryukova, Yelena N.; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu		Chen, Pei-Chun/0000-0002-2550-6556	National Institutes of Health [DK57699, T32 DK007680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680, R01DK057699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK57699 (to S.-L.S.). This work was presented in abstract form at the 2013 American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting.; Supported by National Institutes of Health Grant T32 DK007680.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Chang TJ, 2009, DIABETOLOGIA, V52, P1112, DOI 10.1007/s00125-009-1337-4; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; CONGET JI, 1994, PANCREAS, V9, P157, DOI 10.1097/00006676-199403000-00003; Covey SD, 2006, CELL METAB, V4, P291, DOI 10.1016/j.cmet.2006.09.005; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Fehmann HC, 1997, PEPTIDES, V18, P1267, DOI 10.1016/S0196-9781(97)00135-6; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Harvey J, 1998, J PHYSIOL-LONDON, V510, P47, DOI 10.1111/j.1469-7793.1998.047bz.x; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Kulkarni RN, 1997, J CLIN INVEST, V100, P2729, DOI 10.1172/JCI119818; Lam NT, 2004, J MOL ENDOCRINOL, V32, P415, DOI 10.1677/jme.0.0320415; Lee YM, 2008, J BIOL CHEM, V283, P33969, DOI 10.1074/jbc.M804469200; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Liss B, 2001, TRENDS PHARMACOL SCI, V22, P599, DOI 10.1016/S0165-6147(00)01861-7; McCann CM, 2005, BIOTECHNIQUES, V38, P945, DOI 10.2144/05386IT02; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Ning K, 2009, J BIOL CHEM, V284, P9331, DOI 10.1074/jbc.M806774200; Niswender KD, 2007, J CLIN INVEST, V117, P2753, DOI 10.1172/JCI33528; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Schiemann J, 2012, NAT NEUROSCI, V15, P1272, DOI 10.1038/nn.3185; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tobin VA, 2007, BIOCHEM SOC T, V35, P1243, DOI 10.1042/BST0351243; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tomas A, 2010, TRAFFIC, V11, P123, DOI 10.1111/j.1600-0854.2009.00996.x; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Uotani S, 2006, BIOCHEM BIOPH RES CO, V351, P171, DOI 10.1016/j.bbrc.2006.10.015; Varadi A, 2006, DIABETOLOGIA, V49, P1567, DOI 10.1007/s00125-006-0257-9; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yoshida H, 2012, J MOL CELL CARDIOL, V52, P410, DOI 10.1016/j.yjmcc.2011.08.013	66	58	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34098	34109		10.1074/jbc.M113.516880	http://dx.doi.org/10.1074/jbc.M113.516880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100028	Green Published, hybrid			2022-12-28	WOS:000327250200053
J	Crist, SA; Elzey, BD; Ahmann, MT; Ratliff, TL				Crist, Scott A.; Elzey, Bennett D.; Ahmann, Michelle T.; Ratliff, Timothy L.			Early Growth Response-1 (EGR-1) and Nuclear Factor of Activated T Cells (NFAT) Cooperate to Mediate CD40L Expression in Megakaryocytes and Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Inflammation; Platelets; Signaling; Transcription; Megakaryocytes	GENE-EXPRESSION; TRANSCRIPTION FACTORS; LIGAND EXPRESSION; CD34(+) CELLS; DIFFERENTIATION; INDUCE; CD154; MECHANISMS	Increasing evidence implicates circulating platelets as mediators of chronic inflammatory and autoimmune diseases via the expression and release of CD40L, an important modulator of inflammation and adaptive immune responses traditionally associated with activated T cells. Emerging evidence suggests that platelet CD40L is dynamically regulated in several chronic inflammatory and autoimmune diseases and may mediate progression and secondary pathology associated with those disease states. The present study identifies NFATc2 as a key transcriptional modulator of CD40L expression in megakaryocytes and inflammatory activity of platelets. Furthermore, the current data show that EGR-1, a member of the early growth response family of zinc finger transcription factors, modulates NFATc2-dependent regulation of CD40L expression in megakaryocytes. Our novel demonstration that in vivo biochemical or genetic inhibition of NFATc2 activity in megakaryocyte diminishes platelet CD40L implicates the NFATc2/EGR-1 axis as a key regulatory pathway of inflammatory and immunomodulatory activity in platelets and represents a target for the development of therapeutics for the potential treatment of chronic inflammatory and autoimmune diseases.	[Crist, Scott A.; Elzey, Bennett D.; Ahmann, Michelle T.; Ratliff, Timothy L.] Purdue Univ, Dept Comparat Pathobiol, Sch Vet Med, W Lafayette, IN 47907 USA; [Crist, Scott A.; Elzey, Bennett D.; Ratliff, Timothy L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ratliff, TL (corresponding author), 239A Hansen Life Sci Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	scrist@purdue.edu			National Institutes of Health [R01-AI06924]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI06924.	Alfonso-Jaume MA, 2004, BIOCHEM J, V380, P735, DOI 10.1042/BJ20031281; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Arabanian LS, 2012, BRIT J HAEMATOL, V156, P523, DOI 10.1111/j.1365-2141.2011.08970.x; Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Balow JE, 2000, CURR OPIN NEPHROL HY, V9, P107, DOI 10.1097/00041552-200003000-00003; Bastian LS, 1999, BLOOD, V93, P2637, DOI 10.1182/blood.V93.8.2637.408k20_2637_2644; Cha JK, 2000, J KOREAN MED SCI, V15, P273, DOI 10.3346/jkms.2000.15.3.273; Crist SA, 2008, BLOOD, V111, P3553, DOI 10.1182/blood-2007-05-088161; Cron RQ, 2006, J IMMUNOL, V176, P811, DOI 10.4049/jimmunol.176.2.811; Crow MK, 2001, CURR OPIN RHEUMATOL, V13, P361, DOI 10.1097/00002281-200109000-00004; Danese S, 2005, CRIT REV IMMUNOL, V25, P103; Daub K, 2006, FASEB J, V20, P2559, DOI 10.1096/fj.06-6265fje; Day CJ, 2005, J CELL BIOCHEM, V95, P17, DOI 10.1002/jcb.20410; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Delmas Y, 2005, KIDNEY INT, V68, P2068, DOI 10.1111/j.1523-1755.2005.00663.x; Delmas Y, 2005, M S-MED SCI, V21, P825, DOI 10.1051/medsci/20052110825; Ertenli I, 2003, RHEUMATOL INT, V23, P49, DOI 10.1007/s00296-003-0289-0; Graff J, 2005, CLIN PHARMACOL THER, V78, P468, DOI 10.1016/j.clpt.2005.08.002; Harding SA, 2004, ATHEROSCLEROSIS, V176, P321, DOI 10.1016/j.atherosclerosis.2004.05.008; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Im SH, 2004, MOL CELLS, V18, P1; Jackers P, 2004, J BIOL CHEM, V279, P52183, DOI 10.1074/jbc.M407489200; Jalagadugula G, 2006, J THROMB HAEMOST, V4, P2678, DOI 10.1111/j.1538-7836.2006.02229.x; Kairaitis L, 2003, KIDNEY INT, V64, P1265, DOI 10.1046/j.1523-1755.2003.00223.x; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Kiani A, 2004, J LEUKOCYTE BIOL, V76, P1057, DOI 10.1189/jlb.0404259; Kiani A, 2007, EXP HEMATOL, V35, P757, DOI 10.1016/j.exphem.2007.02.001; Kyttala S, 2009, BRIT J HAEMATOL, V144, P395, DOI 10.1111/j.1365-2141.2008.07490.x; LEMARCHANDEL V, 1993, MOL CELL BIOL, V13, P668, DOI 10.1128/MCB.13.1.668; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Milovanovic A, 2004, CLIN CHIM ACTA, V343, P237, DOI 10.1016/j.cccn.2003.12.030; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Shelly C, 2000, CELL GROWTH DIFFER, V11, P501; Whalen AM, 1997, MOL CELL BIOL, V17, P1947, DOI 10.1128/MCB.17.4.1947; Yazdany J, 2004, LUPUS, V13, P377, DOI 10.1191/0961203304lu1030oa; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030	47	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33985	33996		10.1074/jbc.M113.511881	http://dx.doi.org/10.1074/jbc.M113.511881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106272	Green Published, hybrid			2022-12-28	WOS:000327250200040
J	Lander, N; Ulrich, PN; Docampo, R				Lander, Noelia; Ulrich, Paul N.; Docampo, Roberto			Trypanosoma brucei Vacuolar Transporter Chaperone 4 (TbVtc4) Is an Acidocalcisome Polyphosphate Kinase Required for in Vivo Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Parasite; Parasite Metabolism; Trypanosoma brucei; Vacuolar Acidification; Acidocalcisome; Osmoregulation; Polyphosphate; Vacuolar Transporter Chaperone	LEISHMANIA-MAJOR; GENE-EXPRESSION; PHOSPHOLIPASE-C; VTC PROTEINS; V-ATPASE; GROWTH; CRUZI; STRESS; EXOPOLYPHOSPHATASE; COMPLEX	Background: Polyphosphate (polyP) accumulates in an acidic calcium store named the acidocalcisome. Results: TbVtc4 is an acidocalcisome polyP kinase required for osmoregulation and virulence. Conclusion: TbVtc4 is a potential drug target in T. bruceiSignificance: This is the first demonstration of an essential polyP kinase in trypanosomes. Polyphosphate (polyP) is an anionic polymer of orthophosphate groups linked by high energy bonds that typically accumulates in acidic, calcium-rich organelles known as acidocalcisomes. PolyP synthesis in eukaryotes was unclear until it was demonstrated that the protein named Vtc4p (vacuolar transporter chaperone 4) is a long chain polyP kinase that localizes to the yeast vacuole. Here, we report that TbVtc4 (Vtc4 ortholog of Trypanosoma brucei) encodes, in contrast, a short chain polyP kinase that localizes to acidocalcisomes. The subcellular localization of TbVtc4 was demonstrated by fluorescence and electron microscopy of cell lines expressing TbVtc4 in its endogenous locus fused to an epitope tag and by purified polyclonal antibodies against TbVtc4. Recombinant TbVtc4 was expressed in bacteria, and polyP kinase activity was assayed in vitro. The in vitro growth of conditional knock-out bloodstream form trypanosomes (TbVtc4-KO) was significantly affected relative to the parental cell line. This mutant had reduced polyP kinase activity and short chain polyP content and was considerably less virulent in mice. The wild-type phenotype was recovered when an ectopic copy of the TbVtc4 gene was expressed in the presence of doxycycline. The mutant also exhibited a defect in volume recovery under osmotic stress conditions in vitro, underscoring the relevance of polyP in osmoregulation.	[Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, 350B Paul D Coverdell Ctr, Athens, GA 30602 USA.	rdocampo@uga.edu		Lander, Noelia/0000-0003-2178-381X	National Institutes of Health [AI077538]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077538 (to R.D.). This work was also supported by an American Heart Association predoctoral fellowship (to N.L.) and postdoctoral fellowship (to P.N.U.).	Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Docampo R, 2011, CELL CALCIUM, V50, P113, DOI 10.1016/j.ceca.2011.05.012; Docampo R, 2011, ADV PARASIT, V75, P307, DOI 10.1016/B978-0-12-385863-4.00014-9; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Fang JM, 2007, BIOCHEM J, V407, P161, DOI 10.1042/BJ20070612; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huang GZ, 2013, P NATL ACAD SCI USA, V110, P1887, DOI 10.1073/pnas.1216955110; Huang GZ, 2011, J BIOL CHEM, V286, P36619, DOI 10.1074/jbc.M111.284661; Kocic I, 2001, CARDIOVASC RES, V51, P59, DOI 10.1016/S0008-6363(01)00279-6; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; de Jesus TCL, 2010, J BIOL CHEM, V285, P24131, DOI 10.1074/jbc.M110.120212; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Li ZH, 2011, J BIOL CHEM, V286, P43959, DOI 10.1074/jbc.M111.311530; Martins VD, 2010, J BIOL CHEM, V285, P30906, DOI 10.1074/jbc.M110.142190; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Moreno SNJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003230; Moreno-Sanchez D, 2012, J BIOL CHEM, V287, P28435, DOI 10.1074/jbc.M112.385823; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Rodrigues CO, 2002, J BIOL CHEM, V277, P50899, DOI 10.1074/jbc.M208940200; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Rohloff P, 2008, EXP PARASITOL, V118, P17, DOI 10.1016/j.exppara.2007.04.013; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Scott DA, 1997, J BIOL CHEM, V272, P28020, DOI 10.1074/jbc.272.44.28020; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Ulrich PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018013; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995	49	51	53	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34205	34216		10.1074/jbc.M113.518993	http://dx.doi.org/10.1074/jbc.M113.518993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114837	Green Published, hybrid			2022-12-28	WOS:000327250200063
J	Franceschetti, T; Kessler, CB; Lee, SK; Delany, AM				Franceschetti, Tiziana; Kessler, Catherine B.; Lee, Sun-Kyeong; Delany, Anne M.			miR-29 Promotes Murine Osteoclastogenesis by Regulating Osteoclast Commitment and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cell Differentiation; Cell Migration; MicroRNA; Osteoclast; 3-UTR; miRNA; Post-transcriptional Regulation	TRANSCRIPTION FACTORS; DIFFERENTIATION; MICRORNA; BONE; EXPRESSION; PATHWAY; IDENTIFICATION; SUPPRESSION; OSTEOBLASTS; CELLS	Background: miR-29 is a positive regulator of osteoblastogenesis, but its role in osteoclastogenesis is undefined. Results: Expression of all miR-29 family members increased during osteoclastic differentiation. miR-29 knockdown impaired migration, osteoclast commitment, and formation. Six novel miR-29 targets were identified. Conclusion: miR-29 promotes osteoclastogenesis. Significance: These data expand our understanding of osteoclastogenesis, providing insight into miR-29 function in hematopoietic cells and other lineages. Osteoclast differentiation is regulated by transcriptional, post-transcriptional, and post-translational mechanisms. MicroRNAs are fundamental post-transcriptional regulators of gene expression. The function of the miR-29 (a/b/c) family in cells of the osteoclast lineage is not well understood. In primary cultures of mouse bone marrow-derived macrophages, inhibition of miR-29a, -29b, or -29c diminished formation of TRAP (tartrate-resistant acid phosphatase-positive) multinucleated osteoclasts, and the osteoclasts were smaller. Quantitative RT-PCR showed that all miR-29 family members increased during osteoclast differentiation, in concert with mRNAs for the osteoclast markers Trap (Acp5) and cathepsin K. Similar regulation was observed in the monocytic cell line RAW264.7. In stably transduced RAW264.7 cell lines expressing an inducible miR-29 competitive inhibitor (sponge construct), miR-29 knockdown impaired osteoclastic commitment and migration of pre-osteoclasts. However, miR-29 knockdown did not affect cell viability, actin ring formation, or apoptosis in mature osteoclasts. To better understand how miR-29 regulates osteoclast function, we validated miR-29 target genes using Luciferase 3-UTR reporter assays and specific miR-29 inhibitors. We demonstrated that miR-29 negatively regulates RNAs critical for cytoskeletal organization, including Cdc42 (cell division control protein 42) and Srgap2 (SLIT-ROBO Rho GTPase-activating protein 2). Moreover, miR-29 targets RNAs associated with the macrophage lineage: Gpr85 (G protein-coupled receptor 85), Nfia (nuclear factor I/A), and Cd93. In addition, Calcr (calcitonin receptor), which regulates osteoclast survival and resorption, is a novel miR-29 target. Thus, miR-29 is a positive regulator of osteoclast formation and targets RNAs important for cytoskeletal organization, commitment, and osteoclast function. We hypothesize that miR-29 controls the tempo and amplitude of osteoclast differentiation.	[Franceschetti, Tiziana; Kessler, Catherine B.; Delany, Anne M.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT 06030 USA; [Lee, Sun-Kyeong] Univ Connecticut, Ctr Hlth, Ctr Aging, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut	Delany, AM (corresponding author), Univ Connecticut, Ctr Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	adelany@uchc.edu		Franceschetti, Tiziana/0000-0002-8839-0247	National Institutes of Health [AR44877, AR055143]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044877, R01AR055143, R01AR044877, R56AR044877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR44877 (to A. M. D.) and AR055143 (to S.-K. L.).	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Beyer M, 2012, PLOS ONE, V7; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Cao JJ, 2005, J BONE MINER RES, V20, P1659, DOI 10.1359/JBMR.050503; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Danet GH, 2002, P NATL ACAD SCI USA, V99, P10441, DOI 10.1073/pnas.162104799; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; HE L, 2004, NAT REV GENET, V5, P522; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Huang YC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569034; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Jeon JW, 2010, J IMMUNOL, V185, P4921, DOI 10.4049/jimmunol.0904011; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kinugawa S, 2012, J IMMUNOL, V188, P1772, DOI 10.4049/jimmunol.1101174; Kuo YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040272; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee SK, 2006, J BONE MINER RES, V21, P695, DOI 10.1359/JBMR.060117; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liang MY, 2009, PHYSIOL GENOMICS, V38, P113, DOI 10.1152/physiolgenomics.00080.2009; Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107; Marzi MJ, 2012, J CELL BIOL, V199, P77, DOI 10.1083/jcb.201206033; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; Matsumoto M, 2008, P NATL ACAD SCI USA, V105, P6133, DOI 10.1073/pnas.0710717105; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Moreau V, 2006, EUR J CELL BIOL, V85, P319, DOI 10.1016/j.ejcb.2005.09.009; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Mughal MZ, 2009, ENDOCR DEV, V16, P191, DOI 10.1159/000223696; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Ostergaard M, 2008, BEST PRACT RES CL RH, V22, P1019, DOI 10.1016/j.berh.2008.09.014; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Rossi M, 2013, J CELL PHYSIOL, V228, P1506, DOI 10.1002/jcp.24306; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Sugatani T, 2003, J BIOL CHEM, V278, P5001, DOI 10.1074/jbc.M209299200; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; van Helden SFG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042563; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zhu CL, 2013, CLIN BIOCHEM, V46, P49, DOI 10.1016/j.clinbiochem.2012.09.002	65	90	96	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33347	33360		10.1074/jbc.M113.484568	http://dx.doi.org/10.1074/jbc.M113.484568			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085298	hybrid, Green Published			2022-12-28	WOS:000328841700049
J	Mavrommatis, E; Arslan, AD; Sassano, A; Hua, YJ; Kroczynska, B; Platanias, LC				Mavrommatis, Evangelos; Arslan, Ahmet Dirim; Sassano, Antonella; Hua, Youjia; Kroczynska, Barbara; Platanias, Leonidas C.			Expression and Regulatory Effects of Murine Schlafen (Slfn) Genes in Malignant Melanoma and Renal Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; Cell Death; Innate Immunity; Interferon; Signal Transduction; Signaling; Schlafen	ACTIVATED PROTEIN-KINASE; INTERFERON-ALPHA; GROWTH; FAMILY; INDUCTION	Background: The role of Slfn genes in antineoplastic responses is yet to be defined. Results: Murine Slfn genes are up-regulated in an IFN-dependent manner in melanoma, and RCC cells and members of this family differentially suppress proliferation and anchorage-independent malignant cell growth. Conclusion: Slfns play important roles in controlling malignant melanoma and RCC tumorigenesis. Significance: Modulation of Slfn expression may provide a novel approach for the treatment of malignancies. There is emerging evidence that the IFN-inducible family of Slfn genes and proteins play important roles in cell cycle progression and control of cellular proliferation, but the precise functional roles of different Slfn members in the regulation of tumorigenesis remain unclear. In the present study, we undertook a systematic analysis on the expression and functional relevance of different mouse Slfn genes in malignant melanoma and renal cell carcinoma cells. Our studies demonstrate that several mouse Slfn genes are up-regulated in response to IFN treatment of mouse melanoma and renal cell carcinoma cells, including Slfn1, Slfn2, Slfn4, Slfn5, and Slfn8. Our data show that Slfn2 and Slfn3 play essential roles in the control of mouse malignant melanoma cell proliferation and/or anchorage-independent growth, suggesting key and non-overlapping roles for these genes in the control of malignant melanoma tumorigenesis. In renal cell carcinoma cells, in addition to Slfn2 and Slfn3, Slfn5 also exhibits important antineoplastic effects. Altogether, our findings indicate important functions for distinct mouse Slfn genes in the control of tumorigenesis and provide evidence for differential involvement of distinct members of this gene family in controlling tumorigenesis. They also raise the potential of future therapeutic approaches involving modulation of expression of members of this family of genes in malignant melanoma and renal cell carcinoma.	[Mavrommatis, Evangelos; Arslan, Ahmet Dirim; Sassano, Antonella; Hua, Youjia; Kroczynska, Barbara; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Sch Med, Chicago, IL 60611 USA; [Mavrommatis, Evangelos; Sassano, Antonella; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Chicago, IL 60612 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA161796, CA155566, CA77816]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA161796, R01CA077816, R01CA155566, T32CA070085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA161796, CA155566, and CA77816. This work was also supported by a Merit Review grant from the Department of Veterans Affairs.	Ahmadi S, 2011, Pak J Biol Sci, V14, P1002; Ascierto PA, 2013, CRIT REV ONCOL HEMAT, V85, P149, DOI 10.1016/j.critrevonc.2012.07.004; Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Bukowski RM, 2010, EXPERT OPIN PHARMACO, V11, P2351, DOI 10.1517/14656566.2010.499126; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Condamine T, 2010, J LEUKOCYTE BIOL, V87, P451, DOI 10.1189/jlb.0609410; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Horton MR, 2010, NAT IMMUNOL, V11, P281, DOI 10.1038/ni0410-281; Katsoulidis E, 2010, J BIOL CHEM, V285, P40333, DOI 10.1074/jbc.M110.151076; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Lee NK, 2008, CELL SIGNAL, V20, P2302, DOI 10.1016/j.cellsig.2008.08.019; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Moschos S, 2005, CANC TREAT, V126, P207, DOI 10.1007/0-387-24361-5_9; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Patel BB, 2009, AM J PHYSIOL-GASTR L, V296, pG955, DOI 10.1152/ajpgi.90726.2008; Patel VB, 2009, BIOCHEM BIOPH RES CO, V388, P752, DOI 10.1016/j.bbrc.2009.08.094; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; van Zuylen WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015723; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Yuan LS, 2010, AM J PHYSIOL-GASTR L, V298, pG994, DOI 10.1152/ajpgi.00517.2009	28	26	26	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33006	33015		10.1074/jbc.M113.460741	http://dx.doi.org/10.1074/jbc.M113.460741			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089532	Green Published, hybrid			2022-12-28	WOS:000328841700017
J	Nakashima, M; Nandakumar, J; Sullivan, KD; Espinosa, JM; Cech, TR				Nakashima, Mai; Nandakumar, Jayakrishnan; Sullivan, Kelly D.; Espinosa, Joaquin M.; Cech, Thomas R.			Inhibition of Telomerase Recruitment and Cancer Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cell Biology; Telomerase; Telomeres; TPP1	TERT PROMOTER MUTATIONS; CATALYTIC SUBUNIT; TPP1; PROCESSIVITY; HOLOENZYME; MECHANISM; APOPTOSIS; MELANOMA; BIBR1532; GLIOMAS	Background: A specific surface of the TPP1 protein, called the TEL patch, mediates telomerase recruitment in human cells. Results: TEL patch deficiency caused cancer cell death, which was exacerbated by inhibition of telomerase enzymatic activity. Conclusion: TEL patch mutations are detrimental to cancer cell viability. Significance: This work encourages the development of new combinational cancer therapies that involve simultaneous inhibition of telomerase recruitment and telomerase activity. Continued proliferation of human cells requires maintenance of telomere length, usually accomplished by telomerase. Telomerase is recruited to chromosome ends by interaction with a patch of amino acids (the TEL patch, for TPP1 glutamate (E) and leucine (L)-rich patch) on the surface of telomere protein TPP1. In previous studies, interruption of this interaction by mutation prevented telomere extension in HeLa cells, but the cell culture continued to grow. We now show that the telomerase inhibitor BIBR1532 acts together with TEL patch mutations to inhibit the growth of HeLa cell lines and that apoptosis is a prominent mechanism of death of these cells. Survivor cells take over the population beginning around 40 days in culture. These cells no longer express the TEL patch mutant TPP1, apparently because of silencing of the expression cassette, a survival mechanism that would not be available to cancer cells. These results provide hope that inhibiting the binding of telomerase to the TEL patch of TPP1, perhaps together with a modest inhibition of the telomerase enzyme, could comprise an effective anticancer therapy for the approximate to 90% of human tumors that are telomerase-positive.	[Nakashima, Mai; Nandakumar, Jayakrishnan; Sullivan, Kelly D.; Espinosa, Joaquin M.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Nakashima, Mai; Nandakumar, Jayakrishnan; Cech, Thomas R.] Univ Colorado, Dept Chem & Biochem, BioFrontiers Inst, Boulder, CO 80309 USA; [Sullivan, Kelly D.; Espinosa, Joaquin M.; Cech, Thomas R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.	thomas.cech@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	Nandakumar, Jayakrishnan/0000-0001-9146-2785; SULLIVAN, KELLY/0000-0003-2725-0205	National Institutes of Health [K99CA167644, R01GM099705, R01CA117907]; NATIONAL CANCER INSTITUTE [R00CA167644, R01CA117907, K99CA167644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K99CA167644 (to J. N.), R01GM099705 (to T. R. C.), and R01CA117907 (to J. M. E.).	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Arita H, 2013, ACTA NEUROPATHOL, V126, P267, DOI 10.1007/s00401-013-1141-6; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cristofari G, 2007, MOL CELL, V27, P882, DOI 10.1016/j.molcel.2007.07.020; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; El-Daly H, 2005, BLOOD, V105, P1742, DOI 10.1182/blood-2003-12-4322; Eller MS, 2002, EXP CELL RES, V276, P185, DOI 10.1006/excr.2002.5531; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Liu XL, 2013, ENDOCR-RELAT CANCER, V20, P603, DOI 10.1530/ERC-13-0210; Liu XL, 2013, CELL CYCLE, V12, P1637, DOI 10.4161/cc.24662; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pascolo E, 2002, J BIOL CHEM, V277, P15566, DOI 10.1074/jbc.M201266200; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	27	35	38	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33171	33180		10.1074/jbc.M113.518175	http://dx.doi.org/10.1074/jbc.M113.518175			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097987	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000328841700032
J	Peng, M; Zhang, H; Jaafar, L; Risinger, JI; Huang, S; Mivechi, NF; Ko, L				Peng, Min; Zhang, Hao; Jaafar, Lahcen; Risinger, John I.; Huang, Shuang; Mivechi, Nahid F.; Ko, Lan			Human Ovarian Cancer Stroma Contains Luteinized Theca Cells Harboring Tumor Suppressor Gene GT198 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ovarian Cancer; Ovary; Steroid Hormone; Stromal Cell; Tumor Microenvironment; Tumor Suppressor Gene; Theca Cell	SURFACE EPITHELIUM; ENZYME-ACTIVITY; ORIGIN; PATHOGENESIS; BREAST; PROMOTERS; P450C17; BIOLOGY; PROTEIN; RAD51	Ovarian cancer is a highly lethal gynecological cancer, and its causes remain to be understood. Using a recently identified tumor suppressor gene, GT198 (PSMC3IP), as a unique marker, we searched for the identity of GT198 mutant cells in ovarian cancer. GT198 has germ line mutations in familial and early onset breast and ovarian cancers and recurrent somatic mutations in sporadic fallopian tube cancers. GT198 protein has been shown as a steroid hormone receptor coregulator and also as a crucial factor in DNA repair. In this study, using GT198 as a marker for microdissection, we find that ovarian tumor stromal cells harboring GT198 mutations are present in various types of ovarian cancer including high and low grade serous, endometrioid, mucinous, clear cell, and granulosa cell carcinomas and in precursor lesions such as inclusion cysts. The mutant stromal cells consist of a luteinized theca cell lineage at various differentiation stages including CD133(+), CD44(+), and CD34(+) cells, although the vast majority of them are differentiated overexpressing steroidogenic enzyme CYP17, a theca cell-specific marker. In addition, wild type GT198 suppresses whereas mutant GT198 protein stimulates CYP17 expression. The chromatin-bound GT198 on the human CYP17 promoter is decreased by overexpressing mutant GT198 protein, implicating the loss of wild type suppression in mutant cells. Together, our results suggest that GT198 mutant luteinized theca cells overexpressing CYP17 are common in ovarian cancer stroma. Because first hit cancer gene mutations would specifically mark cancer-inducing cells, the identification of mutant luteinized theca cells may add crucial evidence in understanding the cause of human ovarian cancer.	[Peng, Min; Jaafar, Lahcen; Mivechi, Nahid F.; Ko, Lan] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA; [Huang, Shuang] Georgia Regents Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Peng, Min] Wuhan Univ, Renmin Hosp, Ctr Oncol, Wuhan 430060, Hubei, Peoples R China; [Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou 515041, Guangdong, Peoples R China; [Risinger, John I.] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Wuhan University; Shantou University; Michigan State University	Ko, L (corresponding author), Georgia Regents Univ, Ctr Canc, 1410 Laney Walker Blvd,CN 3155, Augusta, GA 30912 USA.	LKO@gru.edu		Ko, Lan/0000-0002-0089-9090	Georgia Cancer Coalition Distinguished Cancer Scholar Award; National Nature Science Foundation of China [81102024]; National Institutes of Health [CA062130]; NATIONAL CANCER INSTITUTE [R01CA062130] Funding Source: NIH RePORTER	Georgia Cancer Coalition Distinguished Cancer Scholar Award; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Georgia Cancer Coalition Distinguished Cancer Scholar Award (to L. K.) and National Nature Science Foundation of China Grant 81102024 (to M. P.). This work was also supported, in whole or in part, by National Institutes of Health Grant CA062130 (to N. F. M.).	Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Auersperg N, 2011, INT J GYNECOL PATHOL, V30, P12, DOI 10.1097/PGP.0b013e3181f45f3e; Bapat SA, 2010, REPRODUCTION, V140, P33, DOI 10.1530/REP-09-0389; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Chodosh LA, 1998, J MAMMARY GLAND BIOL, V3, P389, DOI 10.1023/A:1018784031651; Dharia S, 2004, BIOL REPROD, V71, P83, DOI 10.1095/biolreprod.103.026732; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; EASTON DF, 1993, AM J HUM GENET, V52, P678; Enomoto R, 2004, J BIOL CHEM, V279, P35263, DOI 10.1074/jbc.M402481200; FIENBERG R, 1971, OBSTET GYNECOL, V37, P158; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Foster R, 2013, CANCER LETT, V338, P147, DOI 10.1016/j.canlet.2012.10.023; Furuya Mitsuko, 2012, Cancers (Basel), V4, P701, DOI 10.3390/cancers4030701; Gilep AA, 2011, BBA-PROTEINS PROTEOM, V1814, P200, DOI 10.1016/j.bbapap.2010.06.021; GODWIN AK, 1992, HEMATOL ONCOL CLIN N, V6, P829; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HELZLSOUER KJ, 1995, JAMA-J AM MED ASSOC, V274, P1926, DOI 10.1001/jama.274.24.1926; Ko L, 2002, MOL CELL BIOL, V22, P357, DOI 10.1128/MCB.22.1.357-369.2002; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Magoffin DA, 2005, INT J BIOCHEM CELL B, V37, P1344, DOI 10.1016/j.biocel.2005.01.016; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Mehrad M, 2010, ADV ANAT PATHOL, V17, P293, DOI 10.1097/PAP.0b013e3181ecdee1; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Orisaka M, 2006, BIOL REPROD, V75, P734, DOI 10.1095/biolreprod.105.050344; Peng Min, 2013, Genes Cancer, V4, P15, DOI 10.1177/1947601913486344; Peng Min, 2013, Genes Cancer, V4, P26, DOI 10.1177/1947601913486345; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Ponzone R, 1998, EUR J CANCER, V34, P966, DOI 10.1016/S0959-8049(98)00060-4; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; ROME RM, 1981, OBSTET GYNECOL, V57, P705; Satoh T, 2009, ENDOCRINOLOGY, V150, P3283, DOI 10.1210/en.2008-1122; SCULLY RE, 1964, OBSTET GYNECOL, V24, P667; Song ZJ, 2011, MED HYPOTHESES, V77, P356, DOI 10.1016/j.mehy.2011.05.014; Vicus D, 2010, GYNECOL ONCOL, V118, P299, DOI 10.1016/j.ygyno.2010.05.011; Wickenheisser JK, 2000, J CLIN ENDOCR METAB, V85, P2304, DOI 10.1210/jc.85.6.2304; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Zangen D, 2011, AM J HUM GENET, V89, P572, DOI 10.1016/j.ajhg.2011.09.006; Zhang PL, 1996, MOL ENDOCRINOL, V10, P147, DOI 10.1210/me.10.2.147	44	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33387	33397		10.1074/jbc.M113.485581	http://dx.doi.org/10.1074/jbc.M113.485581			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097974	Green Published, hybrid			2022-12-28	WOS:000328841700052
J	Datta, P; Li, GY; Yang, B; Zhao, X; Baik, JY; Gemmill, TR; Sharfstein, ST; Linhardt, RJ				Datta, Payel; Li, Guoyun; Yang, Bo; Zhao, Xue; Baik, Jong Youn; Gemmill, Trent R.; Sharfstein, Susan T.; Linhardt, Robert J.			Bioengineered Chinese Hamster Ovary Cells with Golgi-targeted 3-O-Sulfotransferase-1 Biosynthesize Heparan Sulfate with an Antithrombin-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antithrombin; Golgi; Heparan Sulfate; Heparin; Metabolic Engineering; Sulfotransferase	N-DEACETYLASE/N-SULFOTRANSFERASE; D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; PROTEIN LINKAGE REGION; MAST-CELLS; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; MICE DEFICIENT; CORE PROTEIN; EXPRESSION; PROTEOGLYCANS	HS3st1 (heparan sulfate 3-O-sulfotransferase isoform-1) is a critical enzyme involved in the biosynthesis of the antithrombin III (AT)-binding site in the biopharmaceutical drug heparin. Heparin is a highly sulfated glycosaminoglycan that shares a common biosynthetic pathway with heparan sulfate (HS). Although only granulated cells, such as mast cells, biosynthesize heparin, all animal cells are capable of biosynthesizing HS. As part of an effort to bioengineer CHO cells to produce heparin, we previously showed that the introduction of both HS3st1 and NDST2 (N-deacetylase/N-sulfotransferase isoform-2) afforded HS with a very low level of anticoagulant activity. This study demonstrated that untargeted HS3st1 is broadly distributed throughout CHO cells and forms no detectable AT-binding sites, whereas Golgi-targeted HS3st1 localizes in the Golgi and results in the formation of a single type of AT-binding site and high anti-factor Xa activity (137 +/- 36 units/mg). Moreover, stable overexpression of HS3st1 also results in up-regulation of 2-O-, 6-O-, and N-sulfo group-containing disaccharides, further emphasizing a previously unknown concerted interplay between the HS biosynthetic enzymes and suggesting the need to control the expression level of all of the biosynthetic enzymes to produce heparin in CHO cells.	[Datta, Payel; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Datta, Payel; Li, Guoyun; Yang, Bo; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Li, Guoyun; Yang, Bo; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Li, Guoyun; Zhao, Xue] Ocean Univ China, Coll Food Sci & Technol, Qingdao 266003, Peoples R China; [Baik, Jong Youn; Gemmill, Trent R.; Sharfstein, Susan T.] SUNY Albany, Coll Nanoscale Sci & Engn, Albany, NY 12203 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Ocean University of China; State University of New York (SUNY) System; State University of New York (SUNY) Albany; SUNY Polytechnic Institute	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	linhar@rpi.edu	Sharfstein, Susan T./AAF-2739-2020; Sharfstein, Susan T./M-5397-2018	Sharfstein, Susan T./0000-0002-0908-4197; Datta, Payel/0000-0001-5977-448X	National Institutes of Health [R01 GM090127]; Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090127. This work was also supported by a fellowship from the Rensselaer Polytechnic Institute (to P. D.).	Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Anower-E-Khuda MF, 2013, J BIOL CHEM, V288, P3705, DOI 10.1074/jbc.M112.416651; Baik JY, 2012, METAB ENG, V14, P81, DOI 10.1016/j.ymben.2012.01.008; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Carlsson Pernilla, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-23056-1_2; Chen JH, 2005, BBA-GEN SUBJECTS, V1725, P190, DOI 10.1016/j.bbagen.2005.06.012; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Datta P., 2013, THESIS RENSSLAER POL; Datta P, 2013, BIOTECHNOL BIOENG, V110, P1255, DOI 10.1002/bit.24841; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Duelli A, 2009, J IMMUNOL, V183, P7073, DOI 10.4049/jimmunol.0900309; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; ESKO JD, 1987, J BIOL CHEM, V262, P12189; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Fu L, 2013, J PHARM SCI-US, V102, P1447, DOI 10.1002/jps.23501; Girardin EP, 2005, J BIOL CHEM, V280, P38059, DOI 10.1074/jbc.M507997200; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; JACOBSSON I, 1984, J BIOL CHEM, V259, P1056; Jemth P, 2003, J BIOL CHEM, V278, P24371, DOI 10.1074/jbc.M212155200; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; MONTGOMERY RI, 1992, P NATL ACAD SCI USA, V89, P11327, DOI 10.1073/pnas.89.23.11327; Moon AF, 2012, P NATL ACAD SCI USA, V109, P5265, DOI 10.1073/pnas.1117923109; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Shworak NW, 2010, PROG MOL BIOL TRANSL, V93, P153, DOI [10.1016/S1877-1173(10)9.3008-1, 10.1016/S1877-1173(10)93008-1]; Shworak NW, 2002, GLYCOCONJUGATE J, V19, P355, DOI 10.1023/A:1025377206600; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Wang ZY, 2010, BIOTECHNOL BIOENG, V107, P964, DOI 10.1002/bit.22898; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yang B, 2012, J CHROMATOGR A, V1225, P91, DOI 10.1016/j.chroma.2011.12.063; Zhang FM, 2011, ANAL BIOANAL CHEM, V401, P2793, DOI 10.1007/s00216-011-5367-7; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9; Zhang LJ, 2001, J BIOL CHEM, V276, P28806, DOI 10.1074/jbc.M100204200; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200; Zhao WJ, 2011, FEBS LETT, V585, P2461, DOI 10.1016/j.febslet.2011.06.023; Zhao X, 2013, ANAL BIOCHEM, V434, P215, DOI 10.1016/j.ab.2012.12.009	54	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37308	37318		10.1074/jbc.M113.519033	http://dx.doi.org/10.1074/jbc.M113.519033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247246	hybrid, Green Published			2022-12-28	WOS:000329189700047
J	Yi, H; Dey, S; Kumaran, S; Lee, SG; Krishnan, HB; Jez, JM				Yi, Hankuil; Dey, Sanghamitra; Kumaran, Sangaralingam; Lee, Soon Goo; Krishnan, Hari B.; Jez, Joseph M.			Structure of Soybean Serine Acetyltransferase and Formation of the Cysteine Regulatory Complex as a Molecular Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Crystal Structure; Enzyme Structure; Plant Biochemistry; Plant Molecular Biology	O-ACETYLSERINE SULFHYDRYLASE; SULFUR ASSIMILATION PATHWAY; ARABIDOPSIS-THALIANA; GENE-FAMILY; SYNTHASE COMPLEX; ESCHERICHIA-COLI; HIGHER-PLANTS; GLUTATHIONE SYNTHESIS; CATALYTIC MECHANISM; EXPRESSION ANALYSIS	Background: Serine acetyltransferase (SAT) catalyzes the limiting step in cysteine biosynthesis. Results: Analysis of soybean SAT provides insight into catalysis and protein-protein interactions. Conclusion: Key structural features are required for catalysis and formation of a stable macromolecular complex. Significance: A new role for protein complex formation in plant cysteine biosynthesis is proposed. Serine acetyltransferase (SAT) catalyzes the limiting reaction in plant and microbial biosynthesis of cysteine. In addition to its enzymatic function, SAT forms a macromolecular complex with O-acetylserine sulfhydrylase. Formation of the cysteine regulatory complex (CRC) is a critical biochemical control feature in plant sulfur metabolism. Here we present the 1.75-3.0 resolution x-ray crystal structures of soybean (Glycine max) SAT (GmSAT) in apoenzyme, serine-bound, and CoA-bound forms. The GmSAT-serine and GmSAT-CoA structures provide new details on substrate interactions in the active site. The crystal structures and analysis of site-directed mutants suggest that His(169) and Asp(154) form a catalytic dyad for general base catalysis and that His(189) may stabilize the oxyanion reaction intermediate. Glu(177) helps to position Arg(203) and His(204) and the 1c-2c loop for serine binding. A similar role for ionic interactions formed by Lys(230) is required for CoA binding. The GmSAT structures also identify Arg(253) as important for the enhanced catalytic efficiency of SAT in the CRC and suggest that movement of the residue may stabilize CoA binding in the macromolecular complex. Differences in the effect of cold on GmSAT activity in the isolated enzyme versus the enzyme in the CRC were also observed. A role for CRC formation as a molecular chaperone to maintain SAT activity in response to an environmental stress is proposed for this multienzyme complex in plants.	[Yi, Hankuil] Chungnam Natl Univ, Dept Biol Sci, Taejon 305764, South Korea; [Dey, Sanghamitra] Presidency Univ, Dept Biol Sci, Kolkata 700073, W Bengal, India; [Kumaran, Sangaralingam] CSIR, Sect 39A, Inst Microbial Technol, Chandigarh 160036, India; [Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Krishnan, Hari B.] Univ Missouri, Plant Genet Res Unit, USDA, ARS,Dept Agron, Columbia, MO 65211 USA	Chungnam National University; Presidency University, Kolkata; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Washington University (WUSTL); United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Jez, JM (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Dey, Sanghamitra/AAV-7921-2021	Lee, Soon Goo/0000-0002-1541-8587	United States Department of Agriculture [NRI-2005-02518]; ARS [ARS-0424526] Funding Source: Federal RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture Grant NRI-2005-02518 (to J. M. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almog O, 2008, BIOPOLYMERS, V89, P354, DOI 10.1002/bip.20866; Amtmann A., 2009, Current Opinion in Plant Biology, V12, P275, DOI 10.1016/j.pbi.2009.04.014; Berkowitz O, 2002, J BIOL CHEM, V277, P30629, DOI 10.1074/jbc.M111632200; Blaszczyk A, 1999, PLANT J, V20, P237, DOI 10.1046/j.1365-313x.1999.00596.x; Bogdanova N, 1997, PLANT J, V11, P251, DOI 10.1046/j.1365-313X.1997.11020251.x; BOGDANOVA N, 1995, FEBS LETT, V358, P43, DOI 10.1016/0014-5793(94)01392-E; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; Chronis D, 2004, PLANTA, V218, P417, DOI 10.1007/s00425-003-1123-3; COOK PF, 1978, J BIOL CHEM, V253, P7874; Droux M, 2003, PLANT PHYSIOL BIOCH, V41, P619, DOI 10.1016/S0981-9428(03)00083-4; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Freeman JL, 2005, APPL ENVIRON MICROB, V71, P8627, DOI 10.1128/AEM.71.12.8627-8633.2005; Freeman JL, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-63; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gomez LD, 2004, PLANT PHYSIOL, V134, P1662, DOI 10.1104/pp.103.033027; Gorman J, 2004, ACTA CRYSTALLOGR D, V60, P1600, DOI 10.1107/S0907444904015240; Guan R, 2008, BIOCHEMISTRY-US, V47, P6322, DOI 10.1021/bi800075c; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Harms K, 2000, PLANT J, V22, P335, DOI 10.1046/j.1365-313x.2000.00743.x; Hindson VJ, 2000, J BIOL CHEM, V275, P461, DOI 10.1074/jbc.275.1.461; Hindson VJ, 2003, BIOCHEMISTRY-US, V42, P3113, DOI 10.1021/bi0267893; Howarth JR, 2003, PLANT MOL BIOL, V51, P589, DOI 10.1023/A:1022349623951; Howarth JR, 1997, BBA-GENE STRUCT EXPR, V1350, P123, DOI 10.1016/S0167-4781(96)00213-8; Hubberten HM, 2012, PLANT J, V70, P666, DOI 10.1111/j.1365-313X.2012.04905.x; Nguyen HC, 2012, J EXP BOT, V63, P5991, DOI 10.1093/jxb/ers253; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Jez JM, 2013, CURR OPIN STRUC BIOL, V23, P302, DOI 10.1016/j.sbi.2013.02.011; Johnson CM, 2004, BIOCHEMISTRY-US, V43, P15534, DOI 10.1021/bi048450h; Johnson CM, 2004, ARCH BIOCHEM BIOPHYS, V429, P115, DOI 10.1016/j.abb.2004.06.006; Kawashima CG, 2005, PLANT PHYSIOL, V137, P220, DOI 10.1104/pp.104.045377; Kim WS, 2012, PLANTA, V235, P13, DOI 10.1007/s00425-011-1487-8; Kocsy G, 2001, PHYSIOL PLANTARUM, V113, P158, DOI 10.1034/j.1399-3054.2001.1130202.x; Kocsy G, 2000, PLANTA, V210, P295, DOI 10.1007/PL00008137; Kocsy G, 2000, PLANTA, V211, P528, DOI 10.1007/s004250000308; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Kumar S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197376; Kumaran S, 2007, BIOCHEMISTRY-US, V46, P5586, DOI 10.1021/bi7001168; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; LEU LS, 1994, BIOCHEMISTRY-US, V33, P2667, DOI 10.1021/bi00175a040; Liu FL, 2006, J BIOL CHEM, V281, P27405, DOI 10.1074/jbc.M604548200; Marshall CJ, 1997, TRENDS BIOTECHNOL, V15, P359, DOI 10.1016/S0167-7799(97)01086-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McManus MT, 2005, PHYTOCHEMISTRY, V66, P1407, DOI 10.1016/j.phytochem.2005.04.034; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murillo M, 1995, CELL MOL BIOL RES, V41, P425; Na GN, 2011, J BIOL CHEM, V286, P40423, DOI 10.1074/jbc.M111.247411; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Noji M, 2001, PLANT CELL PHYSIOL, V42, P627, DOI 10.1093/pcp/pce078; Olivier NB, 2008, J BIOL CHEM, V283, P27937, DOI 10.1074/jbc.M801207200; Olsen LR, 2004, BIOCHEMISTRY-US, V43, P6013, DOI 10.1021/bi0358521; Phartiyal P, 2008, PHYTOCHEMISTRY, V69, P356, DOI 10.1016/j.phytochem.2007.07.013; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Pye VE, 2004, J BIOL CHEM, V279, P40729, DOI 10.1074/jbc.M403751200; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Roberts MA, 1996, PLANT MOL BIOL, V30, P1041, DOI 10.1007/BF00020814; RUFFET ML, 1994, PLANT PHYSIOL, V104, P597, DOI 10.1104/pp.104.2.597; RUFFET ML, 1995, EUR J BIOCHEM, V227, P500, DOI 10.1111/j.1432-1033.1995.tb20416.x; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Shin R, 2011, FEBS LETT, V585, P143, DOI 10.1016/j.febslet.2010.11.025; Sulzenbacher G, 2001, J BIOL CHEM, V276, P11844, DOI 10.1074/jbc.M011225200; Tabe L, 2010, J EXP BOT, V61, P721, DOI 10.1093/jxb/erp338; Taguchi S, 2000, APPL ENVIRON MICROB, V66, P1410, DOI 10.1128/AEM.66.4.1410-1415.2000; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Thoden JB, 2012, BIOCHEMISTRY-US, V51, P3433, DOI 10.1021/bi300197h; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P2699, DOI 10.1021/bi802313n; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Wirtz M, 2012, J BIOL CHEM, V287, P27941, DOI 10.1074/jbc.M112.372656; Wirtz M, 2010, J BIOL CHEM, V285, P32810, DOI 10.1074/jbc.M110.157446; Yi H, 2012, PHYTOCHEMISTRY, V83, P15, DOI 10.1016/j.phytochem.2012.08.003; Yi H, 2012, PLANT CELL, V24, P2696, DOI 10.1105/tpc.112.098954; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112	81	28	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36463	36472		10.1074/jbc.M113.527143	http://dx.doi.org/10.1074/jbc.M113.527143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24225955	Green Published, hybrid			2022-12-28	WOS:000328883400027
J	Smith, EC; Smith, SE; Carter, JR; Webb, SR; Gibson, KM; Hellman, LM; Fried, MG; Dutch, RE				Smith, Everett Clinton; Smith, Stacy E.; Carter, James R.; Webb, Stacy R.; Gibson, Kathleen M.; Hellman, Lance M.; Fried, Michael G.; Dutch, Rebecca Ellis			Trimeric Transmembrane Domain Interactions in Paramyxovirus Fusion Proteins ROLES IN PROTEIN FOLDING, STABILITY, AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fusion Protein; Membrane Fusion; Negative-strand RNA Viruses; Virus; Virus Entry; Transmembrane Domain	MEMBRANE-SPANNING DOMAIN; INFLUENZA-VIRUS HEMAGGLUTININ; F-PROTEIN; CYTOPLASMIC DOMAINS; DRIVE ASSOCIATION; CONSERVED REGION; GLYCOPROTEIN; SEQUENCE; POLAR; HEMIFUSION	Background: Mutations in transmembrane domains can affect activity of viral fusion proteins, but little is known about potential interactions between these domains. Results: Isolated paramyxovirus fusion protein transmembrane domains interact as trimers. Conclusion: Viral fusion protein transmembrane domains self-associate. Significance: Transmembrane domain associations may regulate stability of the prefusion conformation. Paramyxovirus fusion (F) proteins promote membrane fusion between the viral envelope and host cell membranes, a critical early step in viral infection. Although mutational analyses have indicated that transmembrane (TM) domain residues can affect folding or function of viral fusion proteins, direct analysis of TM-TM interactions has proved challenging. To directly assess TM interactions, the oligomeric state of purified chimeric proteins containing the Staphylococcal nuclease (SN) protein linked to the TM segments from three paramyxovirus F proteins was analyzed by sedimentation equilibrium analysis in detergent and buffer conditions that allowed density matching. A monomer-trimer equilibrium best fit was found for all three SN-TM constructs tested, and similar fits were obtained with peptides corresponding to just the TM region of two different paramyxovirus F proteins. These findings demonstrate for the first time that class I viral fusion protein TM domains can self-associate as trimeric complexes in the absence of the rest of the protein. Glycine residues have been implicated in TM helix interactions, so the effect of mutations at Hendra F Gly-508 was assessed in the context of the whole F protein. Mutations G508I or G508L resulted in decreased cell surface expression of the fusogenic form, consistent with decreased stability of the prefusion form of the protein. Sedimentation equilibrium analysis of TM domains containing these mutations gave higher relative association constants, suggesting altered TM-TM interactions. Overall, these results suggest that trimeric TM interactions are important driving forces for protein folding, stability and membrane fusion promotion.	[Smith, Everett Clinton; Smith, Stacy E.; Carter, James R.; Webb, Stacy R.; Gibson, Kathleen M.; Hellman, Lance M.; Fried, Michael G.; Dutch, Rebecca Ellis] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Dutch, RE (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	rdutc2@uky.edu		Carter, James/0000-0001-6905-1082; Hellman, Lance/0000-0002-4938-6296; Fried, Michael/0000-0002-5393-2640	National Institutes of Health (through the NIAID) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [R01AI051517, U54 AI057157, R01GM070662]; National Institutes of Health from National Center for Research Resources [2P20 RR020171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R01AI051517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070662] Funding Source: NIH RePORTER	National Institutes of Health (through the NIAID) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense; National Institutes of Health from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI051517 and U54 AI057157 (through the NIAID) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense (to R. E. D.), R01GM070662 (to M. G. F.), and 2P20 RR020171 from the National Center for Research Resources (to R. E. D and M. G. F.).	Adamian L, 2003, J MOL BIOL, V327, P251, DOI 10.1016/S0022-2836(03)00041-X; Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Armstrong RT, 2000, J CELL BIOL, V151, P425, DOI 10.1083/jcb.151.2.425; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Burgess NK, 2008, METHOD CELL BIOL, V84, P181, DOI 10.1016/S0091-679X(07)84007-6; Carter JR, 2005, J VIROL, V79, P7922, DOI 10.1128/JVI.79.12.7922-7925.2005; Chang DK, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-2; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Clancy EK, 2011, J VIROL, V85, P4707, DOI 10.1128/JVI.02223-10; Clancy EK, 2009, J VIROL, V83, P2941, DOI 10.1128/JVI.01869-08; Cleverley DZ, 1998, P NATL ACAD SCI USA, V95, P3425, DOI 10.1073/pnas.95.7.3425; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Donald JE, 2011, P NATL ACAD SCI USA, V108, P3958, DOI 10.1073/pnas.1019668108; Doura AK, 2004, J MOL BIOL, V343, P1487, DOI 10.1016/j.jmb.2004.09.011; Fleming KG, 1997, J MOL BIOL, V272, P266, DOI 10.1006/jmbi.1997.1236; Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10; Gardner AE, 2007, J VIROL, V81, P8303, DOI 10.1128/JVI.00366-07; Gardner AE, 2007, BIOCHEMISTRY-US, V46, P5094, DOI 10.1021/bi6025648; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Harrington W F, 1973, Methods Enzymol, V27, P306; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hayes D, 1995, PROGRAM SEDNTERP SED; Joshi SB, 1998, VIROLOGY, V248, P20, DOI 10.1006/viro.1998.9242; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kroch AE, 2006, J MOL BIOL, V357, P184, DOI 10.1016/j.jmb.2005.12.060; Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Li Z, 2008, J VIROL, V82, P3329, DOI 10.1128/JVI.02104-07; Lin XX, 2003, J VIROL, V77, P7067, DOI 10.1128/JVI.77.12.7067-7077.2003; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Melikyan GB, 2000, MOL BIOL CELL, V11, P3765, DOI 10.1091/mbc.11.11.3765; Melikyan GB, 1999, MOL BIOL CELL, V10, P1821, DOI 10.1091/mbc.10.6.1821; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Miyauchi K, 2006, JPN J INFECT DIS, V59, P77; Miyauchi K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-95; Molina-Garcia AD, 1999, PROG COLL POL SCI S, V113, P57; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Muhlebach MD, 2008, J VIROL, V82, P11437, DOI 10.1128/JVI.00779-08; Odell D, 1997, J VIROL, V71, P7996, DOI 10.1128/JVI.71.10.7996-8000.1997; Pager CT, 2005, J VIROL, V79, P12714, DOI 10.1128/JVI.79.20.12714-12720.2005; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Schowalter RM, 2006, J VIROL, V80, P10931, DOI 10.1128/JVI.01287-06; Schowalter RM, 2009, J VIROL, V83, P1511, DOI 10.1128/JVI.01381-08; SchrothDiez B, 1998, J VIROL, V72, P133, DOI 10.1128/JVI.72.1.133-141.1998; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Smith EC, 2012, J VIROL, V86, P3003, DOI 10.1128/JVI.05762-11; Stanley AM, 2005, J MOL BIOL, V347, P759, DOI 10.1016/j.jmb.2005.01.059; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tatulian SA, 2000, BIOCHEMISTRY-US, V39, P496, DOI 10.1021/bi991594p; Taylor GM, 1999, MOL BIOL CELL, V10, P2803, DOI 10.1091/mbc.10.9.2803; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vitu E, 2013, J MOL BIOL, V425, P2056, DOI 10.1016/j.jmb.2013.03.001; Welch BD, 2012, P NATL ACAD SCI USA, V109, P16672, DOI 10.1073/pnas.1213802109; Wilk T, 1996, VIROLOGY, V218, P269, DOI 10.1006/viro.1996.0190; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	69	27	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35726	35735		10.1074/jbc.M113.514554	http://dx.doi.org/10.1074/jbc.M113.514554			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178297	Green Published, hybrid			2022-12-28	WOS:000329814700011
J	Kang'ethe, W; Bernstein, HD				Kang'ethe, Wanyoike; Bernstein, Harris D.			Stepwise Folding of an Autotransporter Passenger Domain Is Not Essential for Its Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; Membrane Proteins; Protein Folding; Protein Translocation; Virulence Factors; Autotransporter	OUTER-MEMBRANE TRANSLOCATION; PARALLEL BETA-HELIX; ESCHERICHIA-COLI; BACTERIAL AUTOTRANSPORTER; CRYSTAL-STRUCTURE; RECOMBINANT PROTEINS; VIRULENCE FACTOR; SERINE-PROTEASE; P22 TAILSPIKE; BIOGENESIS	Background: It has been proposed that stepwise folding of the extracellular (passenger) domains of bacterial autotransporter proteins drives their secretion. Results: Mutations in N-terminal or medial segments of a passenger domain that severely impair folding only moderately reduce secretion efficiency. Conclusion: Stepwise folding only partially accounts for the energetics of autotransporter secretion. Significance: Autotransporter secretion may involve the use of a novel energy source. Autotransporters are a superfamily of virulence proteins produced by Gram-negative bacteria. They consist of an N-terminal -helical domain (passenger domain) that is secreted into the extracellular space and a C-terminal -barrel domain (-domain) that anchors the protein to the outer membrane. Because the periplasm lacks ATP, vectorial folding of the passenger domain in a C-to-N-terminal direction has been proposed to drive the secretion reaction. Consistent with this hypothesis, mutations that disrupt the folding of the C terminus of the passenger domain of the Escherichia coli O157:H7 autotransporter EspP have been shown to cause strong secretion defects. Here, we show that point mutations introduced at specific locations near the middle or N terminus of the EspP -helix that perturb folding also impair secretion, but to a lesser degree. Surprisingly, we found that even multiple mutations that potentially abolish the stability of several consecutive rungs of the -helix only moderately reduce secretion efficiency. Although these results provide evidence that the free energy derived from passenger domain folding contributes to secretion efficiency, they also suggest that a significant fraction of the energy required for secretion is derived from another source.	[Kang'ethe, Wanyoike; Bernstein, Harris D.] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, Bldg 5,Rm 201, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov			NIDDK Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052037] Funding Source: NIH RePORTER	NIDDK Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the NIDDK Intramural Research Program of the National Institutes of Health.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Betts S, 2004, PROTEIN SCI, V13, P2291, DOI 10.1110/ps.04676704; Brockmeyer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006100; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; Dautin N, 2011, J BACTERIOL, V193, P3748, DOI 10.1128/JB.05070-11; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jong WSP, 2010, CURR OPIN BIOTECH, V21, P646, DOI 10.1016/j.copbio.2010.07.009; Jose J, 2007, MICROBIOL MOL BIOL R, V71, P600, DOI 10.1128/MMBR.00011-07; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2010, PROTEINS, V78, P812, DOI 10.1002/prot.22609; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; Khan S, 2011, J MOL BIOL, V413, P985, DOI 10.1016/j.jmb.2011.09.028; KLAUSER T, 1992, EMBO J, V11, P2327, DOI 10.1002/j.1460-2075.1992.tb05292.x; LATTMAN EE, 1993, P NATL ACAD SCI USA, V90, P439, DOI 10.1073/pnas.90.2.439; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2012, CHEM BIOL, V19, P287, DOI 10.1016/j.chembiol.2011.11.009; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Sevastsyanovich YR, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-69; Shi LX, 2013, P NATL ACAD SCI USA, V110, P930, DOI 10.1073/pnas.1115886110; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	44	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35028	35038		10.1074/jbc.M113.515635	http://dx.doi.org/10.1074/jbc.M113.515635			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165126	hybrid, Green Published			2022-12-28	WOS:000329867600005
J	Meier, M; Patel, TR; Booy, EP; Marushchak, O; Okun, N; Deo, S; Howard, R; McEleney, K; Harding, SE; Stetefeld, J; McKenna, SA				Meier, Markus; Patel, Trushar R.; Booy, Evan P.; Marushchak, Oksana; Okun, Natalie; Deo, Soumya; Howard, Ryan; McEleney, Kevin; Harding, Stephen E.; Stetefeld, Joerg; McKenna, Sean A.			Binding of G-quadruplexes to the N-terminal Recognition Domain of the RNA Helicase Associated with AU-rich Element (RHAU)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; RNA-binding Protein; RNA Helicase; RNA-Protein Interaction; X-ray Scattering; DHX36; G-quadruplex; G4R1; RHAU	CRYSTAL-STRUCTURE; TETRAMOLECULAR QUADRUPLEX; RESOLUTION STRUCTURE; RESOLVING ACTIVITY; STRUCTURAL BASIS; MAJOR SOURCE; DNA; PROMOTER; REVEALS; GENE	Background: The helicase RHAU requires an N-terminal extension to bind quadruplex structures. Results: This extension adopts an elongated shape and interacts with the guanine tetrad face of quadruplexes. Conclusion: We provide a basis for the understanding of quadruplex binding by the N-terminal domain. Significance: The N-terminal region does not require the 2-OH of the ribose to mediate the protein-quadruplex interaction. Polynucleotides containing consecutive tracts of guanines can adopt an intramolecular G-quadruplex structure where multiple planar tetrads of hydrogen-bound guanines stack on top of each other. Remodeling of G-quadruplexes impacts numerous aspects of nucleotide biology including transcriptional and translational control. RNA helicase associated with AU-rich element (RHAU), a member of the ATP-dependent DEX(H/D) family of RNA helicases, has been established as a major cellular quadruplex resolvase. RHAU contains a core helicase domain responsible for ATP binding/hydrolysis/helicase activity and is flanked on either side by N- and C-terminal extensions. The N-terminal extension is required for quadruplex recognition, and we have previously demonstrated complex formation between this domain and a quadruplex from human telomerase RNA. Here we used an integrated approach that includes small angle x-ray scattering, nuclear magnetic resonance spectroscopy, circular dichroism, and dynamic light scattering methods to demonstrate the recognition of G-quadruplexes by the N-terminal domain of RHAU. Based on our results, we conclude that (i) quadruplex from the human telomerase RNA and its DNA analog both adopt a disc shape in solution, (ii) RHAU(53-105) adopts a defined and extended conformation in solution, and (iii) the N-terminal domain mediates an interaction with a guanine tetrad face of quadruplexes. Together, these data form the foundation for understanding the recognition of quadruplexes by the N-terminal domain of RHAU.	[Meier, Markus; Patel, Trushar R.; Booy, Evan P.; Marushchak, Oksana; Okun, Natalie; Deo, Soumya; Howard, Ryan; Stetefeld, Joerg; McKenna, Sean A.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Stetefeld, Joerg; McKenna, Sean A.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3T 2N2, Canada; [McEleney, Kevin] Univ Manitoba, Manitoba Inst Mat, Winnipeg, MB R3T 2N2, Canada; [Harding, Stephen E.] Univ Nottingham, Natl Ctr Macromol Hydrodynam Lab, Sch Biosci, Loughborough LE12 5RD, Notts, England	University of Manitoba; University of Manitoba; University of Manitoba; University of Nottingham	Stetefeld, J (corresponding author), Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.	Jorg.Stetefeld@umanitoba.ca; Sean.McKenna@umanitoba.ca	Krahn, Natalie/HHN-6747-2022; Meier, Markus/F-2798-2011; Patel, Trushar R/F-2776-2011; Stetefeld, Joerg/H-7630-2017; Patel, Trushar R./AAB-6250-2020	Krahn, Natalie/0000-0003-0696-433X; Meier, Markus/0000-0003-1068-746X; Patel, Trushar R/0000-0003-0627-2923; Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R./0000-0003-0627-2923; McKenna, Sean/0000-0002-9407-7257; Harding, Stephen E./0000-0002-7798-9692	Canadian Institutes of Health Research (CIHR)/Manitoba Health Research Council (MHRC) Regional Partnership Program [RPA-118069]; CIHR postdoctoral fellowship; MHRC postdoctoral fellowship; University of Manitoba Faculty of Science undergraduate student research award; University of Manitoba undergraduate research fellowship; University of Manitoba graduate fellowship; Canada Research Chair program	Canadian Institutes of Health Research (CIHR)/Manitoba Health Research Council (MHRC) Regional Partnership Program(Canadian Institutes of Health Research (CIHR)); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); MHRC postdoctoral fellowship; University of Manitoba Faculty of Science undergraduate student research award; University of Manitoba undergraduate research fellowship; University of Manitoba graduate fellowship; Canada Research Chair program(Canada Research Chairs)	This work was supported in part by Canadian Institutes of Health Research (CIHR)/Manitoba Health Research Council (MHRC) Regional Partnership Program Grant RPA-118069.; Supported by a CIHR postdoctoral fellowship.; Supported by an MHRC postdoctoral fellowship.; Supported by a University of Manitoba Faculty of Science undergraduate student research award and a University of Manitoba undergraduate research fellowship.; Supported by a University of Manitoba graduate fellowship; Supported by a University of Manitoba undergraduate research fellowship.; Supported by the Canada Research Chair program. .	Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Campbell NH, 2012, METAL IONS LIFE SCI, V10, P119, DOI 10.1007/978-94-007-2172-2_4; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Collie GW, 2012, J AM CHEM SOC, V134, P2723, DOI 10.1021/ja2102423; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Dzananovic E, 2013, RNA, V19, P333, DOI 10.1261/rna.035931.112; Gros J, 2008, CHEMBIOCHEM, V9, P2075, DOI 10.1002/cbic.200800300; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Kaushik M, 2011, CURR MOL MED, V11, P744, DOI 10.2174/156652411798062421; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; LAUGHLAN G, 1994, SCIENCE, V265, P520, DOI 10.1126/science.8036494; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; McKenna SA, 2007, J BIOL CHEM, V282, P11474, DOI 10.1074/jbc.M700301200; Meng H, 2012, J MOL BIOL, V422, P635, DOI 10.1016/j.jmb.2012.06.017; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Patel TR, 2010, MATRIX BIOL, V29, P565, DOI 10.1016/j.matbio.2010.07.004; Patel TR, 2008, MACROMOL BIOSCI, V8, P1108, DOI 10.1002/mabi.200800064; Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; Wei DG, 2012, NUCLEIC ACIDS RES, V40, P4691, DOI 10.1093/nar/gks023	49	42	43	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35014	35027		10.1074/jbc.M113.512970	http://dx.doi.org/10.1074/jbc.M113.512970			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151078	Green Published, hybrid			2022-12-28	WOS:000329867600004
J	Wang, YH; Zankovs, DP; Jiang, M; Zhang, M; Henderson, SC; Tseng, GN				Wang, Yuhong; Zankovs, Dimitar P.; Jiang, Min; Zhang, Mei; Henderson, Scott C.; Tseng, Gea-Ny			[Ca2+]i Elevation and Oxidative Stress Induce KCNQ1 Protein Trans location from the Cytosol to the Cell Surface and Increase Slow Delayed Rectifier (I-Ks) in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Endoplasmic Reticulum (ER); Potassium Channels; Stress Response; Trafficking; Confocal Microscopy; Stress Response; Trafficking	POTASSIUM CHANNEL; VENTRICULAR MYOCYTES; CURRENT AMPLITUDE; QT-SYNDROME; HERG; KCNE1; HEART; MUTATIONS; MINK; CARDIOMYOCYTES	Our goals are to simultaneously determine the three-dimensional distribution patterns of KCNQ1 and KCNE1 in cardiac myocytes and to study the mechanism and functional implications for variations in KCNQ1/KCNE1 colocalization in myocytes. We monitored the distribution patterns of KCNQ1, KCNE1, and markers for subcellular compartments/organelles using immunofluorescence/confocal microscopy and confirmed the findings in ventricular myocytes by directly observing fluorescently tagged KCNQ1-GFP and KCNE1-dsRed expressed in these cells. We also monitored the effects of stress on KCNQ1-GFP and endoplasmic reticulum (ER) remodeling during live cell imaging. The data showed that 1) KCNE1 maintained a stable cell surface localization, whereas KCNQ1 exhibited variations in the cytosolic compartment (striations versus vesicles) and the degree of presence on the cell surface; 2) the degree of cell surface KCNQ1/KCNE1 colocalization was positively correlated with slow delayed rectifier (I-Ks) current density; 3) KCNQ1 and calnexin (an ER marker) shared a cytosolic compartment; and 4) in response to stress ([Ca2+](i) elevation, oxidative overload, or AT1R stimulation), KCNQ1 exited the cytosolic compartment and trafficked to the cell periphery in vesicles. This was accompanied by partial ER fragmentation. We conclude that the cellular milieu regulates KCNQ1 distribution in cardiac myocytes and that stressful conditions can increase I-Ks by inducing KCNQ1 movement to the cell surface. This represents a hitherto unrecognized mechanism by which I-Ks fulfills its function as a repolarization reserve in ventricular myocytes.	[Wang, Yuhong; Zankovs, Dimitar P.; Jiang, Min; Zhang, Mei; Tseng, Gea-Ny] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Henderson, Scott C.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Tseng, GN (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, 1101 E Marshall St,Sanger Hall,3-042a, Richmond, VA 23298 USA.	gtseng@vcu.edu	Henderson, Scott/AAP-2785-2021	Henderson, Scott/0000-0002-1076-3867	National Institutes of Health [RO1 HL107294]; NINDS National Institutes of Health Center [5P30NS047463]; American Heart Association/Mid-Atlantic Affiliate Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS National Institutes of Health Center; American Heart Association/Mid-Atlantic Affiliate Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported, in whole or in part, by National Institutes of Health Grant RO1 HL107294 (to G. N. T.) and NINDS National Institutes of Health Center Core Grant 5P30NS047463 (for microscopy performed at the Virginia Commonwealth University Department of Neurobiology and Anatomy Microscopy Facility). This work was also supported by an American Heart Association/Mid-Atlantic Affiliate Postdoctoral Fellowship (to D. P. Z.).	Abraham RL, 2010, J MOL CELL CARDIOL, V48, P181, DOI 10.1016/j.yjmcc.2009.07.020; Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Borggrefe M, 2005, J ELECTROCARDIOL, V38, P75, DOI 10.1016/j.jelectrocard.2005.06.009; Delpon E, 2008, CIRC-ARRHYTHMIA ELEC, V1, P209, DOI 10.1161/CIRCEP.107.748103; Ehrlich JR, 2004, J BIOL CHEM, V279, P1233, DOI 10.1074/jbc.M309087200; ELLINGSEN O, 1993, AM J PHYSIOL, V265, pH747, DOI 10.1152/ajpheart.1993.265.2.H747; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Haitin Y, 2009, EMBO J, V28, P1994, DOI 10.1038/emboj.2009.157; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jiang M, 2009, J BIOL CHEM, V284, P16452, DOI 10.1074/jbc.M808262200; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Melnyk P, 2005, CARDIOVASC RES, V65, P104, DOI 10.1016/j.cardiores.2004.08.014; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; Nguyen N, 2013, AM J PHYSIOL-GASTR L, V304, pG157, DOI 10.1152/ajpgi.00346.2012; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; O'Rourke B, 1999, CIRC RES, V84, P562, DOI 10.1161/01.RES.84.5.562; Olesen MS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-24; Organ-Darling LE, 2013, AM J PHYSIOL-HEART C, V304, pH589, DOI 10.1152/ajpheart.00385.2012; Qu JH, 2001, CIRC RES, V89, pE8, DOI 10.1161/hh1301.094395; Rasmussen HB, 2004, AM J PHYSIOL-HEART C, V286, pH1300, DOI 10.1152/ajpheart.00344.2003; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; TOHSE N, 1990, AM J PHYSIOL, V258, pH1200, DOI 10.1152/ajpheart.1990.258.4.H1200; Wu DM, 2006, HEART RHYTHM, V3, P1469, DOI 10.1016/j.hrthm.2006.08.019; Zhang M, 2012, AM J PHYSIOL-HEART C, V302, pH910, DOI 10.1152/ajpheart.00691.2011	35	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35358	35371		10.1074/jbc.M113.504746	http://dx.doi.org/10.1074/jbc.M113.504746			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142691	hybrid, Green Published			2022-12-28	WOS:000329867600033
J	Vardy, E; Mosier, PD; Frankowski, KJ; Wu, HX; Katritch, V; Westkaemper, RB; Aube, J; Stevens, RC; Roth, BL				Vardy, Eyal; Mosier, Philip D.; Frankowski, Kevin J.; Wu, Huixian; Katritch, Vsevolod; Westkaemper, Richard B.; Aube, Jeffrey; Stevens, Raymond C.; Roth, Bryan L.			Chemotype-selective Modes of Action of kappa-Opioid Receptor Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); Mutagenesis Site-specific; Opiate Opioid; Pharmacology; Receptor Structure-Function	PROTEIN-COUPLED RECEPTOR; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; ADRENERGIC-RECEPTOR; SEROTONIN RECEPTORS; SALVINORIN-A; FQ RECEPTOR; ANTAGONIST; LIGANDS	Background: The -opioid receptor can be activated by structurally diverse agonists. Results: Four structurally diverse agonists differentially bound to and activated wild type and mutant -opioid receptors. Conclusion: The structural features of the agonists dictate how they interact with and stabilize G(i)-signaling receptor conformations. Significance: The results provide insights into the structural basis of opioid receptor ligand recognition and activation. The crystal structures of opioid receptors provide a novel platform for inquiry into opioid receptor function. The molecular determinants for activation of the -opioid receptor (KOR) were studied using a combination of agonist docking, functional assays, and site-directed mutagenesis. Eighteen positions in the putative agonist binding site of KOR were selected and evaluated for their effects on receptor binding and activation by ligands representing four distinct chemotypes: the peptide dynorphin A(1-17), the arylacetamide U-69593, and the non-charged ligands salvinorin A and the octahydroisoquinolinone carboxamide 1xx. Minimally biased docking of the tested ligands into the antagonist-bound KOR structure generated distinct binding modes, which were then evaluated biochemically and pharmacologically. Our analysis identified two types of mutations: those that affect receptor function primarily via ligand binding and those that primarily affect function. The shared and differential mechanisms of agonist binding and activation in KOR are further discussed. Usually, mutations affecting function more than binding were located at the periphery of the binding site and did not interact strongly with the various ligands. Analysis of the crystal structure along with the present results provide fundamental insights into the activation mechanism of the KOR and suggest that functional residues, along with water molecules detected in the crystal structure, may be directly involved in transduction of the agonist binding event into structural changes at the conserved rotamer switches, thus leading to receptor activation.	[Vardy, Eyal; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Mosier, Philip D.; Westkaemper, Richard B.] Virginia Commonwealth Univ, Sch Pharm, Dept Med Chem, Richmond, VA 23298 USA; [Frankowski, Kevin J.; Aube, Jeffrey] Univ Kansas, Sch Pharm, Dept Med Chem, Lawrence, KS 66047 USA; [Wu, Huixian; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University; University of Kansas; Scripps Research Institute	Roth, BL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	bryan_roth@med.unc.edu	Katritch, Vsevolod/Y-2721-2019; Roth, Bryan L/F-3928-2010; Wu, Huixian/N-6353-2014; Roth, Bryan/ABE-7032-2020; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016	Wu, Huixian/0000-0003-1357-9747; Roth, Bryan/0000-0002-0561-6520; Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; Aube, Jeffrey/0000-0003-1049-5767	National Institutes of Health (NIH) [R01 DA017204]; NIH, NIMH, Psychoactive Drug Screening Program (University of North Carolina at Chapel Hill); NIH PSI:Biology Grant [U54 GM094618]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIMH, Psychoactive Drug Screening Program (University of North Carolina at Chapel Hill); NIH PSI:Biology Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01 DA017204 (to B. L R.); the NIH, NIMH, Psychoactive Drug Screening Program (University of North Carolina at Chapel Hill) (to B. L R.); and NIH PSI:Biology Grant U54 GM094618 (to V. K. and R. C. S.).	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Ferguson DM, 2000, J MED CHEM, V43, P1251, DOI 10.1021/jm990583r; Filizola M, 2012, NATURE, V485, P314, DOI 10.1038/485314a; Frankowski KJ, 2010, ACS MED CHEM LETT, V1, P189, DOI 10.1021/ml100040t; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hjorth SA, 1996, MOL PHARMACOL, V50, P977; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Javitch JA, 1998, BIOCHEMISTRY-US, V37, P998, DOI 10.1021/bi972241y; Kane BE, 2008, J MED CHEM, V51, P1824, DOI 10.1021/jm701040v; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Katritch V, 2011, TRENDS PHARMACOL SCI, V32, P637, DOI 10.1016/j.tips.2011.08.001; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kenakin TP, 2009, PHARMACOLOGY PRIMER: THEORY, APPLICATIONS, AND METHODS, 3RD EDITION, P1; KONG HY, 1994, REGUL PEPTIDES, V54, P155; Kristiansen K, 2000, J PHARMACOL EXP THER, V293, P735; Larson DL, 2000, J MED CHEM, V43, P1573, DOI 10.1021/jm000059g; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Metzger TG, 2001, J MED CHEM, V44, P857, DOI 10.1021/jm000381r; Naqvi T, 1998, PEPTIDES, V19, P1277, DOI 10.1016/S0196-9781(98)00042-4; Negri A, 2013, J CHEM INF MODEL, V53, P521, DOI 10.1021/ci400019t; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; OHTA K, 1994, BIOCHEM BIOPH RES CO, V203, P1096, DOI 10.1006/bbrc.1994.2295; Owens CE, 2002, J PHARMACOL EXP THER, V300, P992, DOI 10.1124/jpet.300.3.992; Patkar KA, 2009, J MED CHEM, V52, P6814, DOI 10.1021/jm900715m; PORTOGHESE PS, 1989, TRENDS PHARMACOL SCI, V10, P230, DOI 10.1016/0165-6147(89)90267-8; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Sharma SK, 2001, J MED CHEM, V44, P2073, DOI 10.1021/jm010095v; Stevens CW, 2007, NEUROSCI LETT, V419, P189, DOI 10.1016/j.neulet.2007.04.014; STRADER CD, 1988, J BIOL CHEM, V263, P10267; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Vardy E, 2013, CELL, V152, P385, DOI 10.1016/j.cell.2013.01.025; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; WANG JB, 1994, J BIOL CHEM, V269, P25966; Weiss DR, 2013, ACS CHEM BIOL, V8, P1018, DOI 10.1021/cb400103f; Westkaemper RB, 1999, EUR J PHARMACOL, V380, pR5, DOI 10.1016/S0014-2999(99)00525-7; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yan F, 2005, BIOCHEMISTRY-US, V44, P8643, DOI 10.1021/bi050490d; Yan F, 2009, BIOCHEMISTRY-US, V48, P6898, DOI 10.1021/bi900605n	47	44	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34470	34483		10.1074/jbc.M113.515668	http://dx.doi.org/10.1074/jbc.M113.515668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121503	hybrid, Green Published			2022-12-28	WOS:000329812800017
J	Gao, XG; Zhi, Y; Sun, L; Peng, XX; Zhang, T; Xue, HT; Tai, GH; Zhou, YF				Gao, Xiaoge; Zhi, Yuan; Sun, Lin; Peng, Xiaoxia; Zhang, Tao; Xue, Huiting; Tai, Guihua; Zhou, Yifa			The Inhibitory Effects of a Rhamnogalacturonan I (RG-I) Domain from Ginseng Pectin on Galectin-3 and Its Structure-Activity Relationship	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Carbohydrate Structure; Galectin; Oligosaccharide; Polysaccharide; Galectin-3 Inhibitors; Ginseng Pectin; Rhamnogalacturonan I; Structure-Activity Relationship	CARBOHYDRATE-RECOGNITION DOMAIN; PROSTATE-CANCER CELLS; HUMAN BREAST; METASTASIS; POLYSACCHARIDES; AGGREGATION; ACTIVATION; APOPTOSIS; GCS-100; LECTIN	Pectin has been shown to inhibit the actions of galectin-3, a -galactoside-binding protein associated with cancer progression. The structural features of pectin involved in this activity remain unclear. We investigated the effects of different ginseng pectins on galectin-3 action. The rhamnogalacturonan I-rich pectin fragment, RG-I-4, potently inhibited galectin-3-mediated hemagglutination, cancer cell adhesion and homotypic aggregation, and binding of galectin-3 to T-cells. RG-I-4 specifically bound to the carbohydrate recognition domain of galectin-3 with a dissociation constant of 22.2 nm, which was determined by surface plasmon resonance analysis. The structure-activity relationship of RG-I-4 was investigated by modifying the structure through various enzymatic and chemical methods followed by activity tests. The results showed that (a) galactan side chains were essential to the activity of RG-I-4, whereas arabinan side chains positively or negatively regulated the activity depending on their location within the RG-I-4 molecule. (b) The activity of galactan chain was proportional to its length up to 4 Gal residues and largely unchanged thereafter. (c) The majority of galactan side chains in RG-I-4 were short with low activities. (d) The high activity of RG-I-4 resulted from the cooperative action of these side chains. (e) The backbone of the molecule was very important to RG-I-4 activity, possibly by maintaining a structural conformation of the whole molecule. (f) The isolated backbone could bind galectin-3, which was insensitive to lactose treatment. The novel discovery that the side chains and backbone play distinct roles in regulating RG-I-4 activity is valuable for producing highly active pectin-based galectin-3 inhibitors.	[Gao, Xiaoge; Zhi, Yuan; Sun, Lin; Peng, Xiaoxia; Zhang, Tao; Xue, Huiting; Tai, Guihua; Zhou, Yifa] NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China	Northeast Normal University - China	Tai, GH (corresponding author), NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China.	taigh477@nenu.edu.cn; zhouyf383@nenu.edu.cn			National Natural Science Foundation of China [31370805, 31170770]; Chinese New Drug Creation and Manufacturing Program [2012ZX09502001-001]; Fundamental Research Funds for the Central Universities [12SSXM005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese New Drug Creation and Manufacturing Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31370805 and 31170770, Chinese New Drug Creation and Manufacturing Program Grant 2012ZX09502001-001, and Fundamental Research Funds for the Central Universities Grant 12SSXM005.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Bi HT, 2009, CARBOHYD RES, V344, P1254, DOI 10.1016/j.carres.2009.04.009; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; Cheng HR, 2011, MED ONCOL, V28, P175, DOI 10.1007/s12032-010-9449-8; Clark MC, 2012, BLOOD, V120, P4635, DOI 10.1182/blood-2012-06-438234; Cumpstey I, 2005, ANGEW CHEM INT EDIT, V44, P5110, DOI 10.1002/anie.200500627; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Deng CH, 2009, CARBOHYD RES, V344, P1852, DOI 10.1016/j.carres.2008.11.011; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Fan YY, 2010, CARBOHYD POLYM, V81, P340, DOI 10.1016/j.carbpol.2010.02.028; Fukumori T, 2003, CANCER RES, V63, P8302; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Gao X, 2012, PLOS ONE, V7; Gao XG, 2012, GLYCOCONJUGATE J, V29, P159, DOI 10.1007/s10719-012-9382-5; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Glinsky VV, 2001, CANCER RES, V61, P4851; Glinsky VV, 2003, CANCER RES, V63, P3805; Gunning AP, 2009, FASEB J, V23, P415, DOI 10.1096/fj.08-106617; INOHARA H, 1994, GLYCOCONJUGATE J, V11, P527, DOI 10.1007/BF00731303; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; John CM, 2003, CLIN CANCER RES, V9, P2374; LEVI G, 1981, J BIOL CHEM, V256, P5735; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Maxwell EG, 2012, TRENDS FOOD SCI TECH, V24, P64, DOI 10.1016/j.tifs.2011.11.002; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Rabinovich GA, 2006, GLYCOBIOLOGY, V16, P210, DOI 10.1093/glycob/cwj056; Sathisha UV, 2007, GLYCOCONJUGATE J, V24, P497, DOI 10.1007/s10719-007-9042-3; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; Tejler J, 2007, CARBOHYD RES, V342, P1869, DOI 10.1016/j.carres.2007.03.012; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Vayssade M, 2010, PHYTOTHER RES, V24, P982, DOI 10.1002/ptr.3040; Wang Y, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.79; Yu L, 2011, PLANTA, V234, P487, DOI 10.1007/s00425-011-1417-9; Yu L, 2010, CARBOHYD POLYM, V79, P811, DOI 10.1016/j.carbpol.2009.08.028; Zhang X, 2009, CARBOHYD POLYM, V77, P544, DOI 10.1016/j.carbpol.2009.01.034; Zou J, 2005, CARCINOGENESIS, V26, P309, DOI 10.1093/carcin/bgh329	44	87	94	7	79	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33953	33965		10.1074/jbc.M113.482315	http://dx.doi.org/10.1074/jbc.M113.482315			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100038	Green Published, hybrid			2022-12-28	WOS:000327250200037
J	Linderoth, E; Pilia, G; Mahajan, NP; Ferby, I				Linderoth, Emma; Pilia, Giulia; Mahajan, Nupam P.; Ferby, Ingvar			Activated Cdc42-associated Kinase 1 (Ack1) Is Required for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor Recruitment to Lipid Rafts and Induction of Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cell Signaling; TRAIL; Tyrosine-Protein Kinase (Tyrosine Kinase); Lipid Rafts	NONRECEPTOR TYROSINE KINASE; COLON-CARCINOMA CELLS; EGF RECEPTOR; CANCER-CELLS; SIGNALING COMPLEX; PHOSPHORYLATION; CDC42; DR4; REDISTRIBUTION; PALMITOYLATION	Background: Activated TRAIL receptors accumulate in lipid raft membrane domains to trigger cell death. Results: Ack1 is required for ligand-induced TRAIL receptor recruitment to lipid rafts and induction of cell death. Conclusion: Ack1 is a novel key regulator of TRAIL receptor membrane dynamics. Significance: Insights gained into the spatiotemporal control of TRAIL receptors may help to predict or modulate therapeutic responsiveness to TRAIL. TNF-related apoptosis-inducing ligand (TRAIL) holds promise for treatment of cancer due to its ability to selectively kill cancer cells while sparing normal cells. Ligand-induced translocation of TRAIL receptors (TRAIL-R) 1 and 2 (also called DR4 and DR5, respectively) into lipid raft membrane microdomains is required for TRAIL-induced cell death by facilitating receptor clustering and formation of the death-inducing signaling complex, yet the underlying regulatory mechanisms remain largely unknown. We show here that the non-receptor tyrosine kinase Ack1, previously implicated in the spatiotemporal regulation of the EGF receptor, is required for TRAIL-induced cell death in multiple epithelial cell lines. TRAIL triggered a transient up-regulation of Ack1 and its recruitment to lipid rafts along with TRAIL-R1/2. siRNA-mediated depletion of Ack1 disrupted TRAIL-induced accumulation of TRAIL-R1/2 in lipid rafts and efficient recruitment of caspase-8 to the death-inducing signaling complex. Pharmacological inhibition of Ack1 did not affect TRAIL-induced cell death, indicating that Ack1 acts in a kinase-independent manner to promote TRAIL-R1/2 accumulation in lipid rafts. These findings identify Ack1 as an essential player in the spatial regulation of TRAIL-R1/2.	[Linderoth, Emma; Ferby, Ingvar] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Pilia, Giulia; Ferby, Ingvar] Ludwig Inst Canc Res, Sci Life Lab, S-75124 Uppsala, Sweden; [Mahajan, Nupam P.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University of London; University College London; Ludwig Institute for Cancer Research; H Lee Moffitt Cancer Center & Research Institute	Ferby, I (corresponding author), Ludwig Inst Canc Res, Uppsala Branch, Box 595, S-75124 Uppsala, Sweden.	ingvar.ferby@licr.uu.se		Pilia, Giulia/0000-0003-1311-4827; Ferby, Ingvar/0000-0002-3435-1728	Cancerfonden Grant [CAN 2012/581]; BBSRC; Ludwig Institute for Cancer Research; National Institutes of Health [1R01CA135328]; NATIONAL CANCER INSTITUTE [R01CA135328] Funding Source: NIH RePORTER	Cancerfonden Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ludwig Institute for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancerfonden Grant CAN 2012/581, BBSRC, and the Ludwig Institute for Cancer Research.; Supported by National Institutes of Health Grant 1R01CA135328.	Chua BT, 2010, MOL ONCOL, V4, P323, DOI 10.1016/j.molonc.2010.03.001; Colvin ES, 2013, ENDOCRINOLOGY, V154, P1039, DOI 10.1210/en.2012-1923; Delmas D, 2004, ONCOGENE, V23, P8979, DOI 10.1038/sj.onc.1208086; Dumitru CA, 2007, APOPTOSIS, V12, P1533, DOI 10.1007/s10495-007-0081-9; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Harper N, 2008, METHOD ENZYMOL, V446, P293, DOI 10.1016/S0076-6879(08)01618-2; Hopkins S, 2012, DEV CELL, V23, P547, DOI 10.1016/j.devcel.2012.08.001; Howlin J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2087; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Linseman DA, 2001, J BIOL CHEM, V276, P5622, DOI 10.1074/jbc.M006812200; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Martin S, 2005, CANCER RES, V65, P11447, DOI 10.1158/0008-5472.CAN-05-1494; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Pao-Chun L, 2009, J BIOL CHEM, V284, P34954, DOI 10.1074/jbc.M109.072660; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Rossin A, 2009, BIOCHEM J, V419, P185, DOI 10.1042/BJ20081212; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; VanOosten RL, 2005, MOL THER, V11, P542, DOI 10.1016/j.ymthe.2004.12.008; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yoshida T, 2007, ONCOL REP, V18, P1239	39	9	9	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32922	32931		10.1074/jbc.M113.481507	http://dx.doi.org/10.1074/jbc.M113.481507			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085293	Green Published, hybrid			2022-12-28	WOS:000328841700010
J	Merrins, MJ; Van Dyke, AR; Mapp, AK; Rizzo, MA; Satin, LS				Merrins, Matthew J.; Van Dyke, Aaron R.; Mapp, Anna K.; Rizzo, Mark A.; Satin, Leslie S.			Direct Measurements of Oscillatory Glycolysis in Pancreatic Islet beta-Cells Using Novel Fluorescence Resonance Energy Transfer (FRET) Biosensors for Pyruvate Kinase M2 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell; Flavin; Fluorescence Resonance Energy Transfer (FRET); Glycolysis; Mitochondrial Metabolism; NADH; Pancreatic Islets	METABOLIC OSCILLATIONS; FREE CA2+; OXYGEN-CONSUMPTION; INSULIN-SECRETION; PULSATILE INSULIN; YEAST-CELLS; GLUCOSE; MECHANISMS; CALCIUM; NAD(P)H	Background: Pyruvate kinase M2 controls glycolytic efflux. Results: Novel FRET sensors report PKM2 structural changes in response to activation by metabolites and phosphorylation events in pancreatic -cells. Conclusion: PKM2 activity is oscillatory and synchronized between islet -cells. Significance: This approach is broadly applicable for measuring pyruvate kinase M2 activity in living cells. Pulses of insulin released from pancreatic -cells maintain blood glucose in a narrow range, although the source of these pulses is unclear. We and others have proposed that positive feedback mediated by the glycolytic enzyme phosphofructokinase-1 (PFK1) enables -cells to generate metabolic oscillations via autocatalytic activation by its product fructose 1,6-bisphosphate (FBP). Although much indirect evidence has accumulated in favor of this hypothesis, a direct measurement of oscillating glycolytic intermediates has been lacking. To probe glycolysis directly, we engineered a family of inter- and intramolecular FRET biosensors based on the glycolytic enzyme pyruvate kinase M2 (PKAR; pyruvate kinase activity reporter), which multimerizes and is activated upon binding FBP. When introduced into Min6 -cells, PKAR FRET efficiency increased rapidly in response to glucose. Importantly, however, metabolites entering downstream of PFK1 (glyceraldehyde, pyruvate, and ketoisocaproate) failed to activate PKAR, consistent with sensor activation by FBP; the dependence of PKAR on FBP was further confirmed using purified sensor in vitro. Using a novel imaging modality for monitoring mitochondrial flavin fluorescence in mouse islets, we show that slow oscillations in mitochondrial redox potential stimulated by 10 mm glucose are in phase with glycolytic efflux through PKM2, measured simultaneously from neighboring islet -cells expressing PKAR. These results indicate that PKM2 activity in -cells is oscillatory and are consistent with pulsatile PFK1 being the mediator of slow glycolytic oscillations.	[Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48105 USA; [Merrins, Matthew J.; Satin, Leslie S.] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Ann Arbor, MI 48105 USA; [Van Dyke, Aaron R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48105 USA; [Mapp, Anna K.; Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore	Satin, LS (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48105 USA.	lsatin@umich.edu	, Dr Anna Mapp/GPX-8261-2022	Merrins, Matthew J./0000-0003-1599-9227	National Institutes of Health [R01DK46409, F32DK085960]; University of Michigan Diabetes Research and Training Center [5P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK046409, P60DK020572, F32DK085960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Diabetes Research and Training Center(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK46409 (to L. S. S.) and F32DK085960 (to M. J. M.). Additional support was provided by Dr. Steve Lentz and the Morphology and the Image Analysis Core of the University of Michigan Diabetes Research and Training Center (5P60 DK-20572).	Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertram R, 2009, ISLETS, V1, P87, DOI 10.4161/isl.1.2.9109; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; BRATUSCHMARRAIN PR, 1986, DIABETES, V35, P922, DOI 10.2337/diabetes.35.8.922; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; CHATTERTON TA, 1982, BIOCHEM J, V204, P605, DOI 10.1042/bj2040605; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; Dahgren GM, 2005, BBA-GEN SUBJECTS, V1724, P23, DOI 10.1016/j.bbagen.2005.04.007; Depry C., 2010, CURR PROTOC MOL BIOL, V18; Ewald JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028245; Fridlyand LE, 2009, BIOPHYS J, V96, P3126, DOI 10.1016/j.bpj.2009.01.029; Fridlyand LE, 2005, AM J PHYSIOL-ENDOC M, V289, pE839, DOI 10.1152/ajpendo.00595.2004; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; GILON P, 1993, J BIOL CHEM, V268, P22265; Heart E, 2007, AM J PHYSIOL-ENDOC M, V292, pE1295, DOI 10.1152/ajpendo.00648.2006; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Jung SK, 1999, BIOCHEM BIOPH RES CO, V259, P331, DOI 10.1006/bbrc.1999.0784; KEIZER J, 1989, BIOPHYS J, V56, P229, DOI 10.1016/S0006-3495(89)82669-4; Kennedy RT, 2002, DIABETES, V51, pS152, DOI 10.2337/diabetes.51.2007.S152; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; MACDONALD MJ, 1985, MOL CELL BIOCHEM, V68, P115; MacDonald MJ, 1997, DIABETES, V46, P1996, DOI 10.2337/diabetes.46.12.1996; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Martens GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014214; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Merrins MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034036; Merrins MJ, 2010, BIOPHYS J, V99, P76, DOI 10.1016/j.bpj.2010.04.012; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan HP, 2013, P NATL ACAD SCI USA, V110, P5881, DOI 10.1073/pnas.1217157110; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; Nunemaker CS, 2004, ENDOCRINE, V25, P61, DOI 10.1385/ENDO:25:1:61; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Quesada I, 2006, BIOPHYS J, V90, P2641, DOI 10.1529/biophysj.105.069906; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; RICHARD P, 1994, FEBS LETT, V341, P223, DOI 10.1016/0014-5793(94)80461-3; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; SCHNECKENBURGER H, 1992, J HISTOCHEM CYTOCHEM, V40, P1573, DOI 10.1177/40.10.1527376; TORNHEIM K, 1979, J THEOR BIOL, V79, P491, DOI 10.1016/0022-5193(79)90240-6; TORNHEIM K, 1991, J BIOL CHEM, V266, P15675; TORNHEIM K, 1988, J BIOL CHEM, V263, P2619; Tornheim K, 1997, DIABETES, V46, P1375, DOI 10.2337/diabetes.46.9.1375; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001	69	56	56	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33312	33322		10.1074/jbc.M113.508127	http://dx.doi.org/10.1074/jbc.M113.508127			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100037	Green Published, hybrid			2022-12-28	WOS:000328841700045
J	Xiong, YQ; Lee, HJ; Mariko, B; Lu, YC; Dannenberg, AJ; Haka, AS; Maxfield, FR; Camerer, E; Proia, RL; Hla, T				Xiong, Yuquan; Lee, Hyeuk Jong; Mariko, Boubacar; Lu, Yi-Chien; Dannenberg, Andrew J.; Haka, Abigail S.; Maxfield, Frederick R.; Camerer, Eric; Proia, Richard L.; Hla, Timothy			Sphingosine Kinases Are Not Required for Inflammatory Responses in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Ceramide; Inflammation; Lysosomes; Macrophages; Sphingolipid; Sphingosine 1-Phosphate	FUNCTIONAL-CHARACTERIZATION; LYMPHOCYTE EGRESS; MOLECULAR-CLONING; SPHINGOSINE-1-PHOSPHATE; AUTOPHAGY; TYPE-2; 1-PHOSPHATE; ACTIVATION; DISEASE; CELLS	Sphingosine kinases (Sphks), which catalyze the formation of sphingosine 1-phosphate (S1P) from sphingosine, have been implicated as essential intracellular messengers in inflammatory responses. Specifically, intracellular Sphk1-derived S1P was reported to be required for NFB induction during inflammatory cytokine action. To examine the role of intracellular S1P in the inflammatory response of innate immune cells, we derived murine macrophages that lack both Sphk1 and Sphk2 (M phi Sphk dKO). Compared with WT counterparts, M phi Sphk dKO cells showed marked suppression of intracellular S1P levels whereas sphingosine and ceramide levels were strongly up-regulated. Cellular proliferation and apoptosis were similar in M phi Sphk dKO cells compared with WT counterparts. Treatment of WT and M phi Sphk dKO with inflammatory mediators TNF or Escherichia coli LPS resulted in similar NFB activation and cytokine expression. Furthermore, LPS-induced inflammatory responses, mortality, and thioglycolate-induced macrophage recruitment to the peritoneum were indistinguishable between M phi Sphk dKO and littermate control mice. Interestingly, autophagic markers were constitutively induced in bone marrow-derived macrophages from Sphk dKO mice. Treatment with exogenous sphingosine further enhanced intracellular sphingolipid levels and autophagosomes. Inhibition of autophagy resulted in caspase-dependent cell death. Together, these data suggest that attenuation of Sphk activity, particularly Sphk2, leads to increased intracellular sphingolipids and autophagy in macrophages.	[Xiong, Yuquan; Lee, Hyeuk Jong; Lu, Yi-Chien; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Lee, Hyeuk Jong; Dannenberg, Andrew J.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Haka, Abigail S.; Maxfield, Frederick R.] Cornell Univ, Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Mariko, Boubacar] Paris Cardiovasc Res Ctr, INSERM, U970, F-75015 Paris, France; [Mariko, Boubacar; Camerer, Eric] Univ Paris 05, F-75015 Paris, France; [Proia, Richard L.] NIDDK, NIH, Bethesda, MD 20892 USA	Cornell University; Cornell University; Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hla, T (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	tih2002@med.cornell.edu	Proia, Richard L/A-7908-2012; Maxfield, Fred/M-6747-2019; Camerer, Eric/K-4161-2017; Hla, Timothy/G-5873-2012	Maxfield, Fred/0000-0003-4396-8866; Hla, Timothy/0000-0001-8355-4065; Proia, Richard/0000-0003-0456-1270	National Institutes of Health [HL67330, HL70694, HL89934]; INSERM Avenir; Marie Curie Actions; French National Research Agency; Fondation de France; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE [P20 RR017677]; NIDDK, National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R01HL093324, R37HL067330, R01HL089934, R01HL067330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083, ZIADK056015, ZIADK056014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); Marie Curie Actions(European Commission); French National Research Agency(French National Research Agency (ANR)); Fondation de France(Fondation de France); Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67330, HL70694, and HL89934 (to T. H). This work was also supported by INSERM Avenir, Marie Curie Actions, the French National Research Agency, Fondation de France, and the Ile-de-France Region (to E.C.). Sphingolipid measurements were supported by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313 and the Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant P20 RR017677.; Supported by the intramural funds of the NIDDK, National Institutes of Health.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bedia C, 2011, ANTI-CANCER AGENT ME, V11, P844, DOI 10.2174/187152011797655131; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Colie S, 2009, CANCER RES, V69, P9346, DOI 10.1158/0008-5472.CAN-09-2198; Coward J, 2009, AUTOPHAGY, V5, P184, DOI 10.4161/auto.5.2.7361; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Edmonds Y, 2011, PHARMACOL THERAPEUT, V132, P352, DOI 10.1016/j.pharmthera.2011.08.004; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Fyrst H, 2009, CANCER RES, V69, P9457, DOI 10.1158/0008-5472.CAN-09-2341; Grin'kina NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036475; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HLA T, 1990, J BIOL CHEM, V265, P9308; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kharel Y, 2012, BIOCHEM J, V447, P149, DOI 10.1042/BJ20120609; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Lavieu Gregory, 2008, V445, P159, DOI 10.1007/978-1-59745-157-4_11; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Limaye V, 2009, CELL MOL BIOL LETT, V14, P424, DOI 10.2478/s11658-009-0009-1; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; MATTIE M, 1994, J BIOL CHEM, V269, P3181; Mendelson K, 2013, J BIOL CHEM, V288, P2143, DOI 10.1074/jbc.M112.427344; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; O'Neill LAJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001299; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 2013, BBA-MOL CELL BIOL L, V1831, P193, DOI 10.1016/j.bbalip.2012.06.007; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Prakash H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010657; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; Worgall TS, 2004, ARTERIOSCL THROM VAS, V24, P943, DOI 10.1161/01.ATV.0000125703.20434.4d; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	58	53	54	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32563	32573		10.1074/jbc.M113.483750	http://dx.doi.org/10.1074/jbc.M113.483750			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24081141	Green Published, hybrid			2022-12-28	WOS:000328681700039
J	Cole, DK; Miles, KM; Madura, F; Holland, CJ; Schauenburg, AJA; Godkin, AJ; Bulek, AM; Fuller, A; Akpovwa, HJE; Pymm, PG; Liddy, N; Sami, M; Li, Y; Rizkallah, PJ; Jakobsen, BK; Sewell, AK				Cole, David K.; Miles, Kim M.; Madura, Florian; Holland, Christopher J.; Schauenburg, Andrea J. A.; Godkin, Andrew J.; Bulek, Anna M.; Fuller, Anna; Akpovwa, Hephzibah J. E.; Pymm, Phillip G.; Liddy, Nathaniel; Sami, Malkit; Li, Yi; Rizkallah, Pierre J.; Jakobsen, Bent K.; Sewell, Andrew K.			T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNATE PEPTIDE-MHC; CROSS-REACTIVITY; CLASS-I; ANTIGEN RECOGNITION; DIRECTED EVOLUTION; CRYSTAL-STRUCTURES; DISTINCT KINETICS; PHAGE DISPLAY; STOP SIGNAL; AMINO-ACIDS	alpha beta T-cell receptors (TCRs) engage antigens using complementarity-determining region (CDR) loops that are either germ line-encoded (CDR1 and CDR2) or somatically rearranged (CDR3). TCR ligands compose a presentation platform (major histocompatibility complex (MHC)) and a variable antigenic component consisting of a short "foreign" peptide. The sequence of events when the TCR engages its peptide-MHC (pMHC) ligand remains unclear. Some studies suggest that the germ line elements of the TCR engage the MHC prior to peptide scanning, but this order of binding is difficult to reconcile with some TCR-pMHC structures. Here, we used TCRs that exhibited enhanced pMHC binding as a result of mutations in either CDR2 and/or CDR3 loops, that bound to the MHC or peptide, respectively, to dissect the roles of these loops in stabilizing TCR-pMHC interactions. Our data show that TCR-peptide interactions play a strongly dominant energetic role providing a binding mode that is both temporally and energetically complementary with a system requiring positive selection by self-pMHC in the thymus and rapid recognition of non-self-pMHC in the periphery.	[Cole, David K.; Miles, Kim M.; Madura, Florian; Holland, Christopher J.; Schauenburg, Andrea J. A.; Godkin, Andrew J.; Bulek, Anna M.; Fuller, Anna; Akpovwa, Hephzibah J. E.; Pymm, Phillip G.; Rizkallah, Pierre J.; Sewell, Andrew K.] Cardiff Univ Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Pymm, Phillip G.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford 0X3 9DS, England; [Liddy, Nathaniel; Sami, Malkit; Li, Yi; Jakobsen, Bent K.] Immunocore Ltd, Abingdon OX14 4RX, Oxon, England	Cardiff University; University of Oxford	Cole, DK (corresponding author), Cardiff Univ Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk; sewellak@cf.ac.uk	Sewell, Andrew/GPT-4220-2022; Rizkallah, Pierre J/A-5367-2012	Sewell, Andrew/0000-0003-3194-3135; Rizkallah, Pierre J/0000-0002-9290-0369; Pymm, Phillip/0000-0003-2722-4621; Fuller, Anna/0000-0002-8655-6741; Godkin, Andrew/0000-0002-1910-7567; Cole, David/0000-0003-0028-9396	Royal Society Grant [RG080077]; Wellcome Trust Program Grant [WT086716MA]; Biotechnology and Biological Sciences Research Council Grant [BB/H001085/1]; Tenovus Ph.D. studentship;  [WT095767]; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish; Tenovus Cancer Care [PhD2009/L20] Funding Source: researchfish; BBSRC [BB/H001085/1] Funding Source: UKRI	Royal Society Grant(Royal Society of London); Wellcome Trust Program Grant(Wellcome Trust); Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Ph.D. studentship; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Tenovus Cancer Care; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Royal Society Grant RG080077, Wellcome Trust Program Grant WT086716MA, and Biotechnology and Biological Sciences Research Council Grant BB/H001085/1.; Wellcome Trust Research Career Development Fellow supported by Grant WT095767.; Supported by a Tenovus Ph.D. studentship.	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00168; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cole DK, 2006, EUR J IMMUNOL, V36, P170, DOI 10.1002/eji.200535424; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DeLano W.L, PYMOL MOL GRAPHICS S; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia K C, 1999, Rev Immunogenet, V1, P75; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Holland CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00629; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Laugel B, 2005, J BIOL CHEM, V280, P1882, DOI 10.1074/jbc.M409427200; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Persaud SP, 2010, MOL IMMUNOL, V47, P1793, DOI 10.1016/j.molimm.2010.02.013; Piepenbrink KH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2948; Purbhoo MA, 2007, MOL CANCER THER, V6, P2081, DOI 10.1158/1535-7163.MCT-07-0092; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	64	44	50	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					628	638		10.1074/jbc.M113.522110	http://dx.doi.org/10.1074/jbc.M113.522110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24196962	hybrid, Green Published			2022-12-28	WOS:000330541200004
J	Oliveira, IA; Goncalves, AS; Neves, JL; von Itzstein, M; Todeschini, AR				Oliveira, Isadora A.; Goncalves, Arlan S.; Neves, Jorge L.; von Itzstein, Mark; Todeschini, Adriane R.			Evidence of Ternary Complex Formation in Trypanosoma cruzi trans-Sialidase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Glycoconjugate; Enzyme Mechanisms; Enzyme Structure; Glycosidases; Molecular Dynamics; Sialic Acid; Nuclear Magnetic Resonance; Sialidase; Trypanosoma cruzi; trans-Sialidase	MOLECULAR-DYNAMICS SIMULATIONS; PING-PONG MECHANISM; SUBSTRATE-SPECIFICITY; RANGELI SIALIDASE; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; STRUCTURAL BASIS; INFLUENZA-VIRUS; ANIMAL LECTINS; FORCE-FIELD	Trypanosoma cruzi trans-sialidase (TcTS) is a key target protein for Chagas disease chemotherapy. In this study, we investigated the implications of active site flexibility on the biochemical mechanism of TcTS. Molecular dynamics studies revealed remarkable plasticity in the TcTS catalytic site, demonstrating, for the first time, how donor substrate engagement with the enzyme induces an acceptor binding site in the catalytic pocket that was not previously captured in crystal structures. Furthermore, NMR data showed cooperative binding between donor and acceptor substrates, supporting theoretical results. In summary, our data put forward a coherent dynamic framework to understand how a glycosidase evolved its highly efficient trans-glycosidase activity.	[Oliveira, Isadora A.; Todeschini, Adriane R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, BR-21941902 Rio De Janeiro, RJ, Brazil; [Goncalves, Arlan S.] Inst Fed Espirito Santo, BR-29106010 Vila Velha, ES, Brazil; [Neves, Jorge L.] Univ Fed Pernambuco, Dept Quim Fundamental, BR-50740560 Recife, PE, Brazil; [von Itzstein, Mark] Griffith Univ, Inst Glyc, Gold Coast, Qld 4222, Australia	Universidade Federal do Rio de Janeiro; Instituto Federal do Espirito Santo (IFES); Universidade Federal de Pernambuco; Griffith University	Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, Av Carlos Chagas Filho,373,Bloco D,Sala 3,Cidade, BR-21941902 Rio De Janeiro, RJ, Brazil.	adrianet@biof.ufrj.br	da Silva Goncalves, Arlan/J-4952-2017; von Itzstein, Mark/E-4823-2010; NEVES, JORGE LUIZ/AAK-7723-2021; Todeschini, Adriane/AAG-8128-2020; Neves, Jorge Luiz JL/F-8393-2010; Todeschini, Adriane Regina/ABC-9165-2020	Neves, Jorge Luiz JL/0000-0003-3853-4529; Todeschini, Adriane Regina/0000-0002-6049-2751; Oliveira, Isadora/0000-0003-0269-1450	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Instituto Nacional de Ciencia e Tecnologia de Vacinas	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Vacinas	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Instituto Nacional de Ciencia e Tecnologia de Vacinas.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blume A, 2007, CARBOHYD RES, V342, P1904, DOI 10.1016/j.carres.2007.05.037; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Buchini S, 2008, ANGEW CHEM INT EDIT, V47, P2700, DOI 10.1002/anie.200705435; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Carvalho ST, 2010, GLYCOBIOLOGY, V20, P1034, DOI 10.1093/glycob/cwq065; Chappuis F, 2010, J CLIN MICROBIOL, V48, P2948, DOI 10.1128/JCM.00774-10; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Clayton J, 2010, NATURE, V465, pS4, DOI 10.1038/nature09220; CREMONA ML, 1995, GENE, V160, P123, DOI 10.1016/0378-1119(95)00175-6; Cremona ML, 1999, GLYCOBIOLOGY, V9, P581, DOI 10.1093/glycob/9.6.581; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; Demir O, 2009, BIOCHEMISTRY-US, V48, P3398, DOI 10.1021/bi802230y; Dias WB, 2008, CELL MICROBIOL, V10, P88, DOI 10.1111/j.1462-5822.2007.01017.x; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Freire-De-Lima L, 2010, J BIOL CHEM, V285, P13388, DOI 10.1074/jbc.M109.096305; Goncalves AD, 2011, J BRAZIL CHEM SOC, V22, P155, DOI 10.1590/S0103-50532011000100021; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haselhorst T, 2004, GLYCOBIOLOGY, V14, P895, DOI 10.1093/glycob/cwh108; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; IOBST ST, 1994, J BIOL CHEM, V269, P15512; Jones C, 2004, BIOCHEMISTRY-US, V43, P11889, DOI 10.1021/bi048942u; Kawashima M, 2011, INT J RADIAT ONCOL, V79, P1479, DOI 10.1016/j.ijrobp.2009.12.048; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu S, 2009, BIOCHEMISTRY-US, V48, P11211, DOI 10.1021/bi9015154; Mendonca-Previato L, 2008, CURR ORG CHEM, V12, P926, DOI 10.2174/138527208784892187; Mitchell FL, 2013, BIOCHEMISTRY-US, V52, P3740, DOI 10.1021/bi301112p; Mitchell FL, 2010, BIOPHYS J, V98, pL38, DOI 10.1016/j.bpj.2010.01.006; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muenchhoff J, 2010, FEBS J, V277, P3844, DOI 10.1111/j.1742-4658.2010.07788.x; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Oppezzo P, 2011, BBA-PROTEINS PROTEOM, V1814, P1154, DOI 10.1016/j.bbapap.2011.04.012; Paris G, 2001, GLYCOBIOLOGY, V11, P305, DOI 10.1093/glycob/11.4.305; Pi NA, 2004, PROTEIN SCI, V13, P903, DOI 10.1110/ps.03581904; Pierdominici-Sottile G, 2011, BIOCHEMISTRY-US, V50, P836, DOI 10.1021/bi101648z; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; Ribeirao M, 1997, GLYCOBIOLOGY, V7, P1237, DOI 10.1093/glycob/7.8.1237; Ribeiro AAST, 2008, J BRAZIL CHEM SOC, V19, P1433, DOI 10.1590/S0103-50532008000700031; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Rizzo RC, 1999, J AM CHEM SOC, V121, P4827, DOI 10.1021/ja984106u; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Rogers MS, 2007, BIOCHEMISTRY-US, V46, P4606, DOI 10.1021/bi062139d; SCUDDER P, 1993, J BIOL CHEM, V268, P9886; Segel I. H., 1993, ENZYME KINETICS BEHA, p[273, 626, 660]; Smrcka AV, 2009, J PHYSIOL SCI, V59, P56; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sujatha MS, 2005, BIOCHEMISTRY-US, V44, P8554, DOI 10.1021/bi050298b; Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200; Todeschini AR, 2002, GLYCOBIOLOGY, V12, P668; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; VANDEKERCKHOVE F, 1992, GLYCOBIOLOGY, V2, P541, DOI 10.1093/glycob/2.6.541; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Wilson JC, 1999, ORG LETT, V1, P443, DOI 10.1021/ol990652w; Winger M, 2012, J AM CHEM SOC, V134, P18447, DOI 10.1021/ja3084658; WITHERS SG, 1987, J AM CHEM SOC, V109, P7530, DOI 10.1021/ja00258a047; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	72	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					423	436		10.1074/jbc.M112.399303	http://dx.doi.org/10.1074/jbc.M112.399303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24194520	hybrid, Green Published			2022-12-28	WOS:000329370900037
J	Ries, MI; Ali, H; Lankhorst, PP; Hankemeier, T; Bovenberg, RAL; Driessen, AJM; Vreeken, RJ				Ries, Marco I.; Ali, Hazrat; Lankhorst, Peter P.; Hankemeier, Thomas; Bovenberg, Roel A. L.; Driessen, Arnold J. M.; Vreeken, Rob J.			Novel Key Metabolites Reveal Further Branching of the Roquefortine/Meleagrin Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Anticancer Drug; Fungi; Natural Product Biosynthesis; Secondary Metabolism; Toxins	PENICILLIUM; ALKALOIDS; DIKETOPIPERAZINE; NEOXALINE; NITRONES	Metabolic profiling and structural elucidation of novel secondary metabolites obtained from derived deletion strains of the filamentous fungus Penicillium chrysogenum were used to reassign various previously ascribed synthetase genes of the roquefortine/meleagrin pathway to their corresponding products. Next to the structural characterization of roquefortine F and neoxaline, which are for the first time reported for P. chrysogenum, we identified the novel metabolite roquefortine L, including its degradation products, harboring remarkable chemical structures. Their biosynthesis is discussed, questioning the exclusive role of glandicoline A as key intermediate in the pathway. The results reveal that further enzymes of this pathway are rather unspecific and catalyze more than one reaction, leading to excessive branching in the pathway with meleagrin and neoxaline as end products of two branches.	[Ries, Marco I.; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Acad Ctr Drug Res, Div Analyt Biosci, NL-2333 CC Leiden, Netherlands; [Ali, Hazrat; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9747 AG Groningen, Netherlands; [Ali, Hazrat; Driessen, Arnold J. M.] Kluyver Ctr Genom Ind Fermentat, NL-2628 BC Delft, Netherlands; [Lankhorst, Peter P.; Bovenberg, Roel A. L.] DSM Biotechnol Ctr, NL-2613 AX Delft, Netherlands; [Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, NL-2333 CC Leiden, Netherlands; [Bovenberg, Roel A. L.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Synthet Biol & Cell Engn, NL-9747 AG Groningen, Netherlands	University of Groningen; DSM NV; Leiden University; Leiden University - Excl LUMC; University of Groningen	Vreeken, RJ (corresponding author), Leiden Acad Ctr Drug Res, Div Analyt Biosci, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.	vreekenrj@lacdr.leidenuniv.nl	Vreeken, Rob/AAA-4563-2021; Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019; Hankemeier, Thomas/V-5407-2019	Hankemeier, Thomas/0000-0001-7871-2073; Driessen, Arnold J.M./0000-0001-9258-9104; Vreeken, Rob/0000-0003-3568-1371; Lankhorst, Peter/0000-0002-0373-5673	Perspective Genbiotics program; Stichting toegepaste wetenschappen (STW); Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; STW	Perspective Genbiotics program; Stichting toegepaste wetenschappen (STW)(Technologiestichting STW); Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); STW(Technologiestichting STW)	This work was supported by the Perspective Genbiotics program subsidized by Stichting toegepaste wetenschappen (STW) and (co)financed by the Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.; Supported by the STW.	Ali H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065328; Cashman JR, 1999, J PHARMACOL EXP THER, V288, P1251; Clark B, 2005, J NAT PROD, V68, P1661, DOI 10.1021/np0503101; Du L, 2010, J ANTIBIOT, V63, P165, DOI 10.1038/ja.2010.11; Du L, 2009, TETRAHEDRON, V65, P1033, DOI 10.1016/j.tet.2008.11.078; Koolen HHF, 2012, NAT PROD RES, V26, P2013, DOI 10.1080/14786419.2011.639070; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Floyd RA, 2011, ANTI-CANCER AGENT ME, V11, P373; Garcia-Estrada C, 2011, CHEM BIOL, V18, P1499, DOI 10.1016/j.chembiol.2011.08.012; HIRANO A, 1979, J ANTIBIOT, V32, P781, DOI 10.7164/antibiotics.32.781; Kato N, 2009, CHEMBIOCHEM, V10, P920, DOI 10.1002/cbic.200800787; Koizumi Y, 2004, BBA-MOL CELL RES, V1693, P47, DOI 10.1016/j.bbamcr.2004.04.013; Kozlovsky AG, 1994, APPL BIOCHEM MICRO+, V30; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Maples KR, 2004, CNS DRUGS, V18, P1071, DOI 10.2165/00023210-200418150-00003; Overy DP, 2006, BIOCHEM SYST ECOL, V34, P345, DOI 10.1016/j.bse.2005.10.010; Overy DP, 2005, J CHEM ECOL, V31, P2373, DOI 10.1007/s10886-005-7107-y; Rodriguez RJ, 1999, DRUG METAB DISPOS, V27, P880; SCOTT PM, 1976, EXPERIENTIA, V32, P140, DOI 10.1007/BF01937728; STEYN PS, 1983, J CHEM SOC CHEM COMM, P560, DOI 10.1039/c39830000560; Sun H, 2007, J PHARMACOL EXP THER, V322, P843, DOI 10.1124/jpet.107.121723; Vinokurova NG, 2003, APPL BIOCHEM MICRO+, V39, P403, DOI 10.1023/A:1024576703367; Weber SS, 2012, APPL ENVIRON MICROB, V78, P7107, DOI 10.1128/AEM.01529-12	23	37	43	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37289	37295		10.1074/jbc.M113.512665	http://dx.doi.org/10.1074/jbc.M113.512665			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225953	Green Published, hybrid			2022-12-28	WOS:000329189700045
J	Zhou, Y; Paull, TT				Zhou, Yi; Paull, Tanya T.			DNA-dependent Protein Kinase Regulates DNA End Resection in Concert with Mre11-Rad50-Nbs1 (MRN) and Ataxia Telangiectasia-mutated (ATM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Damage Response; DNA Enzymes; DNA Recombination; DNA Repair; Protein Kinases	DOUBLE-STRAND BREAKS; CATALYTIC SUBUNIT; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; REPAIR; AUTOPHOSPHORYLATION; COMPLEX; BINDING; CTIP; EXO1	The resection of DNA double strand breaks initiates homologous recombination (HR) and is critical for genomic stability. Using direct measurement of resection in human cells and reconstituted assays of resection with purified proteins in vitro, we show that DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a classic nonhomologous end joining factor, antagonizes double strand break resection by blocking the recruitment of resection enzymes such as exonuclease 1 (Exo1). Autophosphorylation of DNA-PKcs promotes DNA-PKcs dissociation and consequently Exo1 binding. Ataxia telangiectasia-mutated kinase activity can compensate for DNA-PKcs autophosphorylation and promote resection under conditions where DNA-PKcs catalytic activity is inhibited. The Mre11-Rad50-Nbs1 (MRN) complex further stimulates resection in the presence of Ku and DNA-PKcs by recruiting Exo1 and enhancing DNA-PKcs autophosphorylation, and it also inhibits DNA ligase IV/XRCC4-mediated end rejoining. This work suggests that, in addition to its key role in nonhomologous end joining, DNA-PKcs also acts in concert with MRN and ataxia telangiectasia-mutated to regulate resection and thus DNA repair pathway choice.	Univ Texas Austin, Dept Mol Biosci, Howard Hughes Med Inst, Austin, TX 78712 USA; [Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Paull, TT (corresponding author), Univ Texas Austin, Dept Mol Biosci, 2500 Speedway,MBB 2-448, Austin, TX 78712 USA.	tpaull@utexas.edu	Zhou, Yi/P-1039-2015	Zhou, Yi/0000-0002-1650-4591; Paull, Tanya/0000-0002-2991-651X	CPRIT [RP110465-P4]	CPRIT	This work was supported by CPRIT Grant RP110465-P4.	Allen C, 2003, MOL CANCER RES, V1, P913; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Convery E, 2005, P NATL ACAD SCI USA, V102, P1345, DOI 10.1073/pnas.0406466102; Costanzo V, 2011, DNA REPAIR, V10, P1060, DOI 10.1016/j.dnarep.2011.07.009; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Davidson D, 2012, INVEST NEW DRUG, V30, P1248, DOI 10.1007/s10637-010-9626-9; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dobbs TA, 2010, DNA REPAIR, V9, P1307, DOI 10.1016/j.dnarep.2010.09.019; Dodson GE, 2010, CELL CYCLE, V9, P1516, DOI 10.4161/cc.9.8.11260; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lee BS, 2013, MOL CELL BIOL, V33, P3568, DOI 10.1128/MCB.00308-13; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Long MJC, 2012, CHEM BIOL, V19, P629, DOI 10.1016/j.chembiol.2012.04.008; Massip L, 2010, CELL CYCLE, V9, P2963, DOI 10.4161/cc.9.15.12412; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Merkle D, 2002, BIOCHEMISTRY-US, V41, P12706, DOI 10.1021/bi0263558; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Quennet V, 2011, NUCLEIC ACIDS RES, V39, P2144, DOI 10.1093/nar/gkq1175; Reddy YVR, 2004, J BIOL CHEM, V279, P39408, DOI 10.1074/jbc.M406432200; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Shrivastav M, 2009, DNA REPAIR, V8, P920, DOI 10.1016/j.dnarep.2009.05.006; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Trovesi C, 2013, J MOL BIOL, V425, P4756, DOI 10.1016/j.jmb.2013.04.013; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Wang H., 2013, PLOS GENET, V9; Weterings E, 2003, NUCLEIC ACIDS RES, V31, P7238, DOI 10.1093/nar/gkg889; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yuan JS, 2009, J BIOL CHEM, V284, P31746, DOI 10.1074/jbc.M109.023424; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	60	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37112	37125		10.1074/jbc.M113.514398	http://dx.doi.org/10.1074/jbc.M113.514398			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24220101	Green Published, hybrid			2022-12-28	WOS:000329189700031
J	Ezzeddine, R; Al-Banaw, A; Tovmasyan, A; Craik, JD; Batinic-Haberle, I; Benov, LT				Ezzeddine, Rima; Al-Banaw, Anwar; Tovmasyan, Artak; Craik, James D.; Batinic-Haberle, Ines; Benov, Ludmil T.			Effect of Molecular Characteristics on Cellular Uptake, Subcellular Localization, and Phototoxicity of Zn(II) N-Alkylpyridylporphyrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Fluorescence; Membrane Bilayer; Photodynamic Therapy; Porphyrin; Zn Porphyrin; Cellular Uptake; Photosensitizer; Phototoxicity; Subcellular Distribution	PHOTODYNAMIC THERAPY; PORPHYRIN DERIVATIVES; DEATH; PHOTOSENSITIZERS; MITOCHONDRIA; DERMATOLOGY; MECHANISMS; PATHWAYS; WATER	Background: Delivering molecules to selected cellular compartments is important for analytical and practical purposes. Results: Varying the length and positions of alkyl substituents results in preferential uptake of zinc porphyrins by particular cellular structures. Conclusion: Uptake, distribution, and phototoxicity of porphyrins depend on charge, lipophilicity, and molecular shape. Significance: Systematic chemical modification provides the basis for rational design of molecules targeting specific cellular compartments. Tetra-cationic Zn(II) meso-tetrakis(N-alkylpyridinium-2 (or -3 or -4)-yl)porphyrins (ZnPs) with progressively increased lipophilicity were synthesized to investigate how the tri-dimensional shape and lipophilicity of the photosensitizer (PS) affect cellular uptake, subcellular distribution, and photodynamic efficacy. The effect of the tri-dimensional shape of the molecule was studied by shifting the N-alkyl substituent attached to the pyridyl nitrogen from ortho to meta and para positions. Progressive increase of lipophilicity from shorter hydrophilic (methyl) to longer amphiphilic (hexyl) alkyl chains increased the phototoxicity of the ZnP PSs. PS efficacy was also increased for all derivatives when the alkyl substituents were shifted from ortho to meta, and from meta to para positions. Both cellular uptake and subcellular distribution of the PSs were affected by the lipophilicity and the position of the alkyl chains on the periphery of the porphyrin ring. Whereas the hydrophilic ZnPs demonstrated mostly lysosomal distribution, the amphiphilic hexyl derivatives were associated with mitochondria, endoplasmic reticulum, and plasma membrane. A comparison of hexyl isomers revealed that cellular uptake and partition into membranes followed the order para > meta > ortho. Varying the position and length of the alkyl substituents affects (i) the exposure of cationic charges for electrostatic interactions with anionic biomolecules and (ii) the lipophilicity of the molecule. The charge, lipophilicity, and the tri-dimensional shape of the PS are the major factors that determine cellular uptake, subcellular distribution, and as a consequence, the phototoxicity of the PSs.	[Ezzeddine, Rima; Craik, James D.; Benov, Ludmil T.] Kuwait Univ, Dept Biochem, Fac Med, Kuwait 13110, Kuwait; [Al-Banaw, Anwar] Kuwait Univ, Dept Med Lab Sci, Fac Allied Hlth Sci, Kuwait 13110, Kuwait; [Tovmasyan, Artak; Batinic-Haberle, Ines] Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC 27708 USA	Kuwait University; Kuwait University; Duke University	Benov, LT (corresponding author), Kuwait Univ, Fac Med, Dept Biochem, POB 24923, Safat 13110, Kuwait.	lbenov@hsc.edu.kw	Tovmasyan, Artak/D-9101-2014; Benov, Ludmil/AAD-3714-2020	Tovmasyan, Artak/0000-0002-8612-1676; Benov, Ludmil/0000-0002-0205-0146; Ezzeddine, Rima/0000-0003-3817-5394	College of Graduate Studies; Kuwait University [YM05/11, SRUL02/13]; Ines Batinic-Haberle General Research Fund	College of Graduate Studies; Kuwait University; Ines Batinic-Haberle General Research Fund	This work was supported by the College of Graduate Studies and by grants YM05/11 and SRUL02/13 from Kuwait University.; Supported by the Ines Batinic-Haberle General Research Fund.	Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Babilas P, 2010, PHOTODERMATOL PHOTO, V26, P118, DOI 10.1111/j.1600-0781.2010.00507.x; Batinic-Haberle I, 2002, J CHEM SOC DALTON, P2689, DOI 10.1039/b201057g; Benov L, 2011, ANTI-CANCER AGENT ME, V11, P233, DOI 10.2174/187152011795255975; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bonnett R, 2006, WATER RES, V40, P1269, DOI 10.1016/j.watres.2006.01.014; Boyle RW, 1996, PHOTOCHEM PHOTOBIOL, V64, P469, DOI 10.1111/j.1751-1097.1996.tb03093.x; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Ehrenberg B, 1998, PHOTOCHEM PHOTOBIOL, V68, P135, DOI 10.1111/j.1751-1097.1998.tb02479.x; Engelmann FM, 2007, J BIOENERG BIOMEMBR, V39, P175, DOI 10.1007/s10863-007-9075-0; Engelmann FM, 2007, INT J PHARM, V329, P12, DOI 10.1016/j.ijpharm.2006.08.008; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Jensen TJ, 2010, J PHOTOCH PHOTOBIO B, V100, P100, DOI 10.1016/j.jphotobiol.2010.05.007; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Kos I, 2009, J MED CHEM, V52, P7868, DOI 10.1021/jm900576g; Kos I, 2009, FREE RADICAL BIO MED, V47, P72, DOI 10.1016/j.freeradbiomed.2009.04.002; Kramer-Marek G, 2006, J PHOTOCH PHOTOBIO B, V84, P1, DOI 10.1016/j.jphotobiol.2005.12.011; Lee Y, 2011, SEMIN CUTAN MED SURG, V30, P199, DOI 10.1016/j.sder.2011.08.001; Lei WH, 2010, J PHOTOCH PHOTOBIO B, V98, P167, DOI 10.1016/j.jphotobiol.2009.12.003; Magaraggia M, 2006, J ENVIRON MONITOR, V8, P923, DOI 10.1039/b606975d; Meisel P, 2005, J PHOTOCH PHOTOBIO B, V79, P159, DOI 10.1016/j.jphotobiol.2004.11.023; Michels S, 2001, Semin Ophthalmol, V16, P201, DOI 10.1076/soph.16.4.201.10298; Ogilby PR, 2010, CHEM SOC REV, V39, P3181, DOI 10.1039/b926014p; Oleinick NL, 1998, RADIAT RES, V150, pS146, DOI 10.2307/3579816; Oleinick NL, 2002, PHOTOCH PHOTOBIO SCI, V1, P1, DOI 10.1039/b108586g; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Ricchelli F, 2005, INT J BIOCHEM CELL B, V37, P306, DOI 10.1016/j.biocel.2004.06.013; RODGERS MAJ, 1982, J AM CHEM SOC, V104, P5541, DOI 10.1021/ja00384a070; Silva JN, 2008, BIO-MED MATER ENG, V18, P319, DOI 10.3233/BME-2008-0546; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Spasojevic I, 2002, INORG CHEM, V41, P5874, DOI 10.1021/ic025556x; Szeimies RM, 2013, J DTSCH DERMATOL GES, V11, P632, DOI 10.1111/ddg.12119; Taub A. F., 2012, J COSMET DERMATOL, V25, P218; Wainwright M, 2002, CURR MED CHEM, V9, P127, DOI 10.2174/0929867023371355; Waksman R, 2008, J AM COLL CARDIOL, V52, P1024, DOI 10.1016/j.jacc.2008.06.023; Woodburn K W, 1996, J Clin Laser Med Surg, V14, P343	41	64	65	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36579	36588		10.1074/jbc.M113.511642	http://dx.doi.org/10.1074/jbc.M113.511642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214973	Green Published, hybrid			2022-12-28	WOS:000328883400038
J	Kim, Y; Park, D; Kim, H; Choi, M; Lee, H; Lee, YS; Choe, J; Kim, YM; Jeoung, D				Kim, Youngmi; Park, Deokbum; Kim, Hyuna; Choi, Munseon; Lee, Hansoo; Lee, Yun Sil; Choe, Jongseon; Kim, Young Myeong; Jeoung, Dooil			miR-200b and Cancer/Testis Antigen CAGE Form a Feedback Loop to Regulate the Invasion and Tumorigenic and Angiogenic Responses of a Cancer Cell Line to Microtubule-targeting Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Anticancer Drug; Cancer Biology; Invasion; MicroRNA; Angiogenic Potential; CAGE; Feedback Regulatory Loop; Tumorigenic Potential; miR-200b	EPITHELIAL-MESENCHYMAL TRANSITION; ENDOTHELIAL GROWTH-FACTOR; DOWN-REGULATION; UP-REGULATION; EXPRESSION; RESISTANCE; ASSOCIATION; METASTASIS; MICRORNAS; ZEB1	Background: The microRNA that regulates the expression of CAGE is unknown. Results: miR-200b and CAGE exert opposite regulations on the response to microtubule-targeting drugs, invasion, tumorigenic potential, and angiogenic potential. Conclusion: CAGE and miR-200b form a feedback regulatory loop. Significance: miR-200b may be a target for the treatment of CAGE-driven cancers. Cancer/testis antigen cancer-associated gene (CAGE) is known to be involved in various cellular processes, such as proliferation, cell motility, and anti-cancer drug resistance. However, the mechanism of the expression regulation of CAGE remains unknown. Target scan analysis predicted the binding of microRNA-200b (miR-200b) to CAGE promoter sequences. The expression of CAGE showed an inverse relationship with miR-200b in various cancer cell lines. miR-200b was shown to bind to the 3-UTR of CAGE and to regulate the expression of CAGE at the transcriptional level. miR-200b also enhanced the sensitivities to microtubule-targeting drugs in vitro. miR-200b and CAGE showed opposite regulations on invasion potential and responses to microtubule-targeting drugs. Xenograft experiments showed that miR-200b had negative effects on the tumorigenic and metastatic potential of cancer cells. The effect of miR-200b on metastatic potential involved the expression regulation of CAGE by miR-200b. miR-200b decreased the tumorigenic potential of a cancer cell line resistant to microtubule-targeting drugs in a manner associated with the down-regulation of CAGE. ChIP assays showed the direct regulation of miR-200b by CAGE. CAGE enhanced the invasion potential of a cancer cell line stably expressing miR-200b. miR-200b exerted a negative regulation on tumor-induced angiogenesis. The down-regulation of CAGE led to the decreased expression of plasminogen activator inhibitor-1, a TGF-responsive protein involved in angiogenesis, and VEGF. CAGE mediated tumor-induced angiogenesis and was necessary for VEGF-promoted angiogenesis. Human recombinant CAGE protein displayed angiogenic potential. Thus, miR-200b and CAGE form a feedback regulatory loop and regulate the response to microtubule-targeting drugs, as well as the invasion, tumorigenic potential, and angiogenic potential.	[Kim, Youngmi; Park, Deokbum; Kim, Hyuna; Choi, Munseon; Jeoung, Dooil] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea; [Lee, Hansoo] Kangwon Natl Univ, Dept Biol Sci, Coll Nat Sci, Chunchon 200701, South Korea; [Choe, Jongseon; Kim, Young Myeong] Kangwon Natl Univ, Grad Sch Med, Chunchon 200701, South Korea; [Lee, Yun Sil] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Ewha Womans University	Jeoung, D (corresponding author), Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chunchon 200701, South Korea.	jeoungd@kangwon.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	National Research Foundation [2010-0021357, 2011-0010867, 2012H1B8A2025495, C1008749-01-01]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1320160]	National Research Foundation; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by National Research Foundation Grants 2010-0021357, 2011-0010867, 2012H1B8A2025495, and C1008749-01-01 and by National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea Grant 1320160.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Aprelikova O, 2009, CANCER RES, V69, P616, DOI 10.1158/0008-5472.CAN-08-0811; Bai JX, 2013, ENDOCRINOLOGY, V154, P635, DOI 10.1210/en.2012-1607; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Basu A, 2009, INVEST OPHTH VIS SCI, V50, P4974, DOI 10.1167/iovs.09-3619; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chan YC, 2011, J BIOL CHEM, V286, P2047, DOI 10.1074/jbc.M110.158790; Chang SH, 2013, J BIOL CHEM, V288, P4908, DOI 10.1074/jbc.M112.423871; Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22; Cheng WW, 2012, FEBS J, V279, P2047, DOI 10.1111/j.1742-4658.2012.08589.x; Cho B, 2002, BIOCHEM BIOPH RES CO, V292, P715, DOI 10.1006/bbrc.2002.6701; Cho BS, 2003, BIOCHEM BIOPH RES CO, V307, P52, DOI 10.1016/S0006-291X(03)01121-5; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Gho YS, 1999, CANCER RES, V59, P5128; Glenn DJ, 2009, HYPERTENSION, V53, P549, DOI 10.1161/HYPERTENSIONAHA.108.125088; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Iwata T, 2005, CLIN CANCER RES, V11, P3949, DOI 10.1158/1078-0432.CCR-04-1702; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Jung SY, 2011, INT J ONCOL, V38, P571, DOI 10.3892/ijo.2010.859; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liggins Amanda P, 2010, Cancer Immun, V10, P8; Liu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051436; Lu L., 2012, PLOS ONE, V7; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Shen WG, 2007, MOL CELL BIOCHEM, V300, P89, DOI 10.1007/s11010-006-9373-6; Shim E, 2006, BIOTECHNOL LETT, V28, P515, DOI 10.1007/s10529-006-0008-5; Shintani S, 2004, ONCOLOGY-BASEL, V66, P316, DOI 10.1159/000078333; Sun L, 2012, ONCOGENE, V31, P432, DOI 10.1038/onc.2011.263; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Teng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033444; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Wang J, 2013, J BIOL CHEM, V288, P10418, DOI 10.1074/jbc.M112.444463; Wang R, 2010, J CELL MOL MED, V14, P206, DOI 10.1111/j.1582-4934.2009.00964.x; Wilson TJ, 2010, CANCER LETT, V288, P162, DOI 10.1016/j.canlet.2009.06.035; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Xu Q, 2013, CARCINOGENESIS, V34, P539, DOI 10.1093/carcin/bgs374; Yoshino H, 2013, J HUM GENET, V58, P508, DOI 10.1038/jhg.2013.31; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zolova OE, 2011, ASN NEURO, V3, P223, DOI 10.1042/AN20110021	52	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36502	36518		10.1074/jbc.M113.502047	http://dx.doi.org/10.1074/jbc.M113.502047			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24174534	Green Published, hybrid			2022-12-28	WOS:000328883400031
J	Ploier, B; Scharwey, M; Koch, B; Schmidt, C; Schatte, J; Rechberger, G; Kollroser, M; Hermetter, A; Daum, G				Ploier, Birgit; Scharwey, Melanie; Koch, Barbara; Schmidt, Claudia; Schatte, Jessica; Rechberger, Gerald; Kollroser, Manfred; Hermetter, Albin; Daum, Guenther			Screening for Hydrolytic Enzymes Reveals Ayr1p as a Novel Triacylglycerol Lipase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipase; Lipids; Lipid Droplets; Peroxisomes; Triacylglycerol; Yeast	STERYL ESTER SYNTHESIS; LIPID PARTICLES; HYDROLASE LDH1P; NONPOLAR LIPIDS; BETA-OXIDATION; GENES ENCODE; YEAST; PEROXISOMES; ACYLTRANSFERASE; PROTEINS	Background: Triacylglycerols are stored in lipid droplets and can be mobilized by lipases. Results: Ayr1p was identified as a novel triacylglycerol lipase. Conclusion: In addition to the known lipases Tgl3p, Tgl4p, and Tgl5p, further hydrolytic enzymes contribute to the mobilization of non-polar lipids in yeast. Significance: This study opens the view for a broader network of lipolytic enzymes in yeast. Saccharomyces cerevisiae, as well as other eukaryotes, preserves fatty acids and sterols in a biologically inert form, as triacylglycerols and steryl esters. The major triacylglycerol lipases of the yeast S. cerevisiae identified so far are Tgl3p, Tgl4p, and Tgl5p (Athenstaedt, K., and Daum, G. (2003) YMR313c/TGL3 encodes a novel triacylglycerol lipase located in lipid particles of Saccharomyces cerevisiae. J. Biol. Chem. 278, 23317-23323; Athenstaedt, K., and Daum, G. (2005) Tgl4p and Tgl5p, two triacylglycerol lipases of the yeast Saccharomyces cerevisiae, are localized to lipid particles. J. Biol. Chem. 280, 37301-37309). We observed that upon cultivation on oleic acid, triacylglycerol mobilization did not come to a halt in a yeast strain deficient in all currently known triacylglycerol lipases, indicating the presence of additional not yet characterized lipases/esterases. Functional proteome analysis using lipase and esterase inhibitors revealed a subset of candidate genes for yet unknown hydrolytic enzymes on peroxisomes and lipid droplets. Based on the conserved GXSXG lipase motif, putative functions, and subcellular localizations, a selected number of candidates were characterized by enzyme assays in vitro, gene expression analysis, non-polar lipid analysis, and in vivo triacylglycerol mobilization assays. These investigations led to the identification of Ayr1p as a novel triacylglycerol lipase of yeast lipid droplets and confirmed the hydrolytic potential of the peroxisomal Lpx1p in vivo. Based on these results, we discuss a possible link between lipid storage, lipid mobilization, and peroxisomal utilization of fatty acids as a carbon source.	[Ploier, Birgit; Scharwey, Melanie; Koch, Barbara; Schmidt, Claudia; Schatte, Jessica; Hermetter, Albin; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Rechberger, Gerald] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Kollroser, Manfred] Med Univ Graz, Inst Forens Med, A-8010 Graz, Austria	Graz University of Technology; University of Graz; Medical University of Graz	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at		Rechberger, Gerald N./0000-0002-0071-317X	Austrian Science Fund (FWF) [W901 DK, P23029]; Austrian Federal Ministry of Science and Research (bmwf); Austrian Science Funds, FWF [F3005 SFB LIPOTOX]; Austrian Science Fund (FWF) [P 23029, W 901] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research (bmwf); Austrian Science Funds, FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Projects W901 DK Molecular Enzymology and P23029 (to G. D.), the Austrian Federal Ministry of Science and Research (bmwf) (GOLD project in the framework of GEN-AU/Genome Research in Austria), and the Austrian Science Funds, FWF (Project F3005 SFB LIPOTOX).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2000, J BIOL CHEM, V275, P235, DOI 10.1074/jbc.275.1.235; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Birner-Gruenberger R, 2005, MOL CELL PROTEOMICS, V4, P1710, DOI 10.1074/mcp.M500062-MCP200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Connerth M, 2009, METHODS MOL BIOL, V579, P359, DOI 10.1007/978-1-60761-322-0_18; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Debelyy MO, 2011, EUKARYOT CELL, V10, P776, DOI 10.1128/EC.05040-11; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Heier C, 2010, BBA-MOL CELL BIOL L, V1801, P1063, DOI 10.1016/j.bbalip.2010.06.001; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; Jandrositz A, 2005, BBA-MOL CELL BIOL L, V1735, P50, DOI 10.1016/j.bbalip.2005.04.005; Koffel R, 2005, MOL CELL BIOL, V25, P1655, DOI 10.1128/MCB.25.5.1655-1668.2005; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; KUNAU WH, 1988, BIOCHEM SOC T, V16, P418, DOI 10.1042/bst0160418; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIGNERY GA, 1988, GENE, V62, P27, DOI 10.1016/0378-1119(88)90577-X; Mullner H, 2005, J BIOL CHEM, V280, P13321, DOI 10.1074/jbc.M409914200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oskolkova OV, 2003, CHEM PHYS LIPIDS, V125, P103, DOI 10.1016/S0009-3084(03)00085-9; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rosenberger S, 2009, BBA-MOL CELL BIOL L, V1791, P379, DOI 10.1016/j.bbalip.2009.01.015; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Schmidinger H, 2006, AMINO ACIDS, V30, P333, DOI 10.1007/s00726-006-0305-2; Schmidinger H, 2006, CHEMBIOCHEM, V7, P527, DOI 10.1002/cbic.200500276; Schmidinger H, 2005, CHEMBIOCHEM, V6, P1776, DOI 10.1002/cbic.200500013; Schmidt C, 2013, J BIOL CHEM, V288, P19939, DOI 10.1074/jbc.M113.459610; Schrag JD, 1997, METHOD ENZYMOL, V284, P85; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Thoms S, 2008, FEBS J, V275, P504, DOI 10.1111/j.1742-4658.2007.06217.x; Thoms S, 2011, EUKARYOT CELL, V10, P770, DOI 10.1128/EC.05038-11; Vico P, 2002, YEAST, V19, P873, DOI 10.1002/yea.882; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zahedi RP, 2006, MOL BIOL CELL, V17, P1436, DOI 10.1091/mbc.E05-08-0740; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	53	30	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36061	36072		10.1074/jbc.M113.509927	http://dx.doi.org/10.1074/jbc.M113.509927			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187129	Green Published, hybrid			2022-12-28	WOS:000329814700041
J	Gao, P; Yoo, SH; Lee, KJ; Rosensweig, C; Takahashi, JS; Chen, BP; Green, CB				Gao, Peng; Yoo, Seung-Hee; Lee, Kyung-Jong; Rosensweig, Clark; Takahashi, Joseph S.; Chen, Benjamin P.; Green, Carla B.			Phosphorylation of the Cryptochrome 1 C-terminal Tail Regulates Circadian Period Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Phosphorylation; Protein Kinases; Protein Stability; Transcription Repressor	DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; DNA-PK; POSTTRANSLATIONAL REGULATION; GENE-EXPRESSION; MAMMALIAN CRY1; CLOCK; IDENTIFICATION; DEGRADATION; DAMAGE	The Cryptochrome (CRY) proteins are critical components of the mammalian circadian clock and act to rhythmically repress the activity of the transcriptional activators CLOCK and BMAL1 at the heart of the clock mechanism. The CRY proteins are part of a large repressive complex, the components of which are not completely known. Using mass spectroscopy, we identified the catalytic subunit of DNA-dependent protein kinase as a CRY-interacting protein and found that loss or inhibition of this kinase results in circadian rhythms with abnormally long periods. We then identified serine 588 in the C-terminal tail of mouse CRY1 as a potential DNA-PK phosphorylation site but surprisingly found that the phosphomimetic mutation S588D also results in long period rhythms, similar to the loss of DNA-PK. Consistent with this, we found that phosphorylation of this site is increased in cells lacking DNA-PK, suggesting that DNA-PK negatively regulates the phosphorylation of this site most likely through indirect means. Furthermore, we found that phosphorylation of this site increases the stability of the CRY1 protein and prevents FBXL3-mediated degradation. The phosphorylation of this site is robustly rhythmic in mouse liver nuclei, peaking in the middle of the circadian day at a time when CRY1 levels are declining. Therefore, these data suggest a new role for the C-terminal tail of CRY1 in which phosphorylation rhythmically regulates CRY1 stability and contributes to the proper circadian period length.	[Gao, Peng; Yoo, Seung-Hee; Rosensweig, Clark; Takahashi, Joseph S.; Green, Carla B.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Lee, Kyung-Jong; Chen, Benjamin P.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Green, CB (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, ND4-124A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Carla.Green@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Rosensweig, Clark/0000-0001-6364-2025	National Institutes of Health [R01 GM090247, R01 CA166777]; NATIONAL CANCER INSTITUTE [R01CA166677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM090247 (to C. B. G.) and R01 CA166777 (to B. P. C.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Amatya PN, 2012, BBA-MOL CELL RES, V1823, P2099, DOI 10.1016/j.bbamcr.2012.08.022; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Chen Z, 2012, P NATL ACAD SCI USA, V109, P101, DOI 10.1073/pnas.1118034108; Cotta-Ramusino C, 2011, SCIENCE, V332, P1313, DOI 10.1126/science.1203430; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; Davis AJ, 2013, J BIOL CHEM, V288, P7037, DOI 10.1074/jbc.M112.434498; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Fan JY, 2009, GENETICS, V181, P139, DOI 10.1534/genetics.108.094805; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Khan SK, 2012, J BIOL CHEM, V287, P25917, DOI 10.1074/jbc.M112.368001; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108; Levy C, 2013, NATURE, V495, pE3, DOI 10.1038/nature11995; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCarthy EV, 2009, MOL CELL BIOL, V29, P5465, DOI 10.1128/MCB.00641-09; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Partch CL, 2006, P NATL ACAD SCI USA, V103, P10467, DOI 10.1073/pnas.0604138103; Peng YL, 2002, CANCER RES, V62, P6400; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Schwarz EM, 1996, MOL CELL BIOL, V16, P3554; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tamanini F, 2007, COLD SPRING HARB SYM, V72, P133, DOI 10.1101/sqb.2007.72.066; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhao SY, 1997, PHOTOCHEM PHOTOBIOL, V66, P727, DOI 10.1111/j.1751-1097.1997.tb03214.x; Zheng YL, 2010, MOL BIOL CELL, V21, P3601, DOI 10.1091/mbc.E10-01-0054; Zhu HS, 2003, CURR BIOL, V13, P1653, DOI 10.1016/j.cub.2003.08.033; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	69	48	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35277	35286		10.1074/jbc.M113.509604	http://dx.doi.org/10.1074/jbc.M113.509604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158435	hybrid, Green Published			2022-12-28	WOS:000329867600026
J	Goggs, R; Harper, MT; Pope, RJ; Savage, JS; Williams, CM; Mundell, SJ; Heesom, KJ; Bass, M; Mellor, H; Poole, AW				Goggs, Robert; Harper, Matthew T.; Pope, Robert J.; Savage, Joshua S.; Williams, Christopher M.; Mundell, Stuart J.; Heesom, Kate J.; Bass, Mark; Mellor, Harry; Poole, Alastair W.			RhoG Protein Regulates Platelet Granule Secretion and Thrombus Formation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Platelets; Proteomics; Rho GTPases; Secretion; Thrombosis; Transgenic Mice	NUCLEOTIDE EXCHANGE FACTOR; PHOSPHATIDYLSERINE EXPOSURE DOWNSTREAM; GLYCOPROTEIN-VI DEFICIENCY; ACTIN CYTOSKELETON; ACTIVATES RAC1; STABILITY; KINASE; GROWTH; PHOSPHORYLATION; MECHANISMS	Background: Rho family GTPases are essential for normal platelet function, but the role of RhoG in platelets has not been studied previously. Results: Platelets lacking RhoG have reduced granule secretion, and RhoG null mice have impaired thrombus formation. Conclusion: RhoG is required for normal platelet granule secretion. Significance: RhoG is a novel regulator of platelet function and thrombosis. Rho GTPases such as Rac, RhoA, and Cdc42 are vital for normal platelet function, but the role of RhoG in platelets has not been studied. In other cells, RhoG orchestrates processes integral to platelet function, including actin cytoskeletal rearrangement and membrane trafficking. We therefore hypothesized that RhoG would play a critical role in platelets. Here, we show that RhoG is expressed in human and mouse platelets and is activated by both collagen-related peptide (CRP) and thrombin stimulation. We used RhoG(-/-) mice to study the function of RhoG in platelets. Integrin activation and aggregation were reduced in RhoG(-/-) platelets stimulated by CRP, but responses to thrombin were normal. The central defect in RhoG(-/-) platelets was reduced secretion from -granules, dense granules, and lysosomes following CRP stimulation. The integrin activation and aggregation defects could be rescued by ADP co-stimulation, indicating that they are a consequence of diminished dense granule secretion. Defective dense granule secretion in RhoG(-/-) platelets limited recruitment of additional platelets to growing thrombi in flowing blood in vitro and translated into reduced thrombus formation in vivo. Interestingly, tail bleeding times were normal in RhoG(-/-) mice, suggesting that the functions of RhoG in platelets are particularly relevant to thrombotic disorders.	[Goggs, Robert; Harper, Matthew T.; Pope, Robert J.; Savage, Joshua S.; Williams, Christopher M.; Mundell, Stuart J.; Poole, Alastair W.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Heesom, Kate J.] Univ Bristol, Prote Facil, Bristol BS8 1TD, Avon, England; [Bass, Mark; Mellor, Harry] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol; University of Bristol	Poole, AW (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	a.poole@bris.ac.uk	Harper, Matthew T/G-5630-2013; Savage, Joshua/A-8738-2008	Harper, Matthew T/0000-0002-4740-637X; Savage, Joshua/0000-0003-0599-0245; Goggs, Robert/0000-0001-7446-6987; Mellor, Harry/0000-0003-3894-0623; Poole, Alastair/0000-0002-0868-297X; Mundell, Stuart/0000-0001-7754-3271	Wellcome Trust Clinical Research Training Fellowship Award [WT090093MA]; British Heart Foundation grants [RG/10/006/28299, RG/05/083]; Medical Research Council [G1000432]; MRC [G1000432] Funding Source: UKRI; British Heart Foundation [RG/10/006/28299, PG/11/68/29074] Funding Source: researchfish	Wellcome Trust Clinical Research Training Fellowship Award(Wellcome Trust); British Heart Foundation grants; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation)	This work was supported by Wellcome Trust Clinical Research Training Fellowship Award WT090093MA (to R.G., H.M., and A.W.P.). British Heart Foundation grants (to A.W.P.) supported M.T.H. and C.M.W. (Grant RG/10/006/28299) and J.S.S. (Grant RG/05/083), and Medical Research Council Grant G1000432 (to Stuart Mundell) supported R.J.P.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Bender M, 2011, J THROMB HAEMOST, V9, P1423, DOI 10.1111/j.1538-7836.2011.04328.x; Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001; Brass LF, 2011, J THROMB HAEMOST, V9, P66, DOI 10.1111/j.1538-7836.2011.04364.x; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chen D, 2000, BLOOD, V96, P1782, DOI 10.1182/blood.V96.5.1782.h8001782_1782_1788; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Daniel S, 2002, BIOCHEMISTRY-US, V41, P9663, DOI 10.1021/bi025604p; de Boer JD, 2012, BLOOD, V119, P3236, DOI 10.1182/blood-2011-11-391532; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Dubois C, 2006, BLOOD, V107, P3902, DOI 10.1182/blood-2005-09-3687; Eckly A, 2011, J THROMB HAEMOST, V9, P779, DOI 10.1111/j.1538-7836.2011.04218.x; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goggs R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054663; Harper MT, 2011, J THROMB HAEMOST, V9, P1599, DOI 10.1111/j.1538-7836.2011.04393.x; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Konopatskaya O, 2009, J CLIN INVEST, V119, P399, DOI 10.1172/JCI34665; Konstantinides S, 2006, J THROMB HAEMOST, V4, P2014, DOI 10.1111/j.1538-7836.2006.02086.x; Lenain N, 2003, J THROMB HAEMOST, V1, P1144, DOI 10.1046/j.1538-7836.2003.00144.x; Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Pearce AC, 2002, BLOOD, V100, P3561, DOI 10.1182/blood.V100.10.3561; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Savage JS, 2013, J THROMB HAEMOST, V11, P771, DOI 10.1111/jth.12138; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Schwer HD, 2001, CURR BIOL, V11, P579, DOI 10.1016/S0960-9822(01)00153-1; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; van Rijssel J, 2012, CELL ADHES MIGR, V6, P482, DOI 10.4161/cam.21418; Vignal E, 2001, MOL CELL BIOL, V21, P8022, DOI 10.1128/MCB.21.23.8022-8034.2001; Vigorito E, 2003, ONCOGENE, V22, P330, DOI 10.1038/sj.onc.1206116; Vigorito E, 2004, MOL CELL BIOL, V24, P719, DOI 10.1128/MCB.24.2.719-729.2004; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Woronowicz K, 2010, BIOCHEMISTRY-US, V49, P4533, DOI 10.1021/bi100541t; Yokoyama S, 2005, J AM COLL CARDIOL, V45, P1280, DOI 10.1016/j.jacc.2004.12.071	53	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34217	34229		10.1074/jbc.M113.504100	http://dx.doi.org/10.1074/jbc.M113.504100			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106270	Green Published, hybrid			2022-12-28	WOS:000327250200064
J	Liu, YF; Sun, LY; Singer, DV; Ginnan, R; Singer, HA				Liu, Yongfeng; Sun, Li-Yan; Singer, Diane V.; Ginnan, Roman; Singer, Harold A.			CaMKII delta-dependent Inhibition of cAMP-response Element-binding Protein Activity in Vascular Smooth Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; CaMKII; CREB; Thrombin; Vascular Smooth Muscle Cells; RGS2; SIK1	KINASE-II; ISOFORM REGULATION; CREB ACTIVATION; GENE-EXPRESSION; ANGIOTENSIN-II; TRANSCRIPTION; PHOSPHORYLATION; IDENTIFICATION; CA2+; IV	One transcription factor mediator of Ca2+-signals is cAMP response element-binding protein (CREB). CREB expression and/or activity negatively correlates with vascular smooth muscle (VSM) cell proliferation and migration. Multifunctional Ca2+/calmodulin-dependent protein kinases, including CaMKII, have been demonstrated to regulate CREB activity through both positive and negative phosphorylation events in vitro, but the function of CaMKII as a proximal regulator of CREB in intact cell systems, including VSM, is not clear. In this study, we used gain- and loss-of-function approaches to determine the function of CaMKII in regulating CREB phosphorylation, localization, and activity in VSM. Overexpression of constitutively active CaMKII specifically increased CREB phosphorylation on Ser(142) and silencing CaMKII expression by siRNA or blocking endogenous CaMKII activity with KN93 abolished thrombin- or ionomycin-induced CREB phosphorylation on Ser(142) without affecting Ser(133) phosphorylation. CREB-Ser(142) phosphorylation correlated with transient nucleocytoplasmic translocation of CREB. Thrombin-induced CREB promoter activity, CREB binding to Sik1 and Rgs2 promoters, and Sik1/Rgs2 transcription were enhanced by a kinase-negative CaMKII2 (K43A) mutant and inhibited by a constitutively active (T287D) mutant. Taken together, these studies establish negative regulation of CREB activity by endogenous CaMKII-dependent CREB-Ser(142) phosphorylation and suggest a potential mechanism for CaMKII/CREB signaling in modulating proliferation and migration in VSM cells.	[Liu, Yongfeng; Sun, Li-Yan; Singer, Diane V.; Ginnan, Roman; Singer, Harold A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Singer, HA (corresponding author), 47 New Scotland Ave, Albany, NY 12208 USA.	SingerH@mail.amc.edu			National Institutes of Health from the National Heart, Lung and Blood Institute [RO1-HL4942, RO1-HL092510]; Albany Medical College Candice Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092510, R01HL049426] Funding Source: NIH RePORTER	National Institutes of Health from the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Albany Medical College Candice Weir Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL4942 and RO1-HL092510 from the National Heart, Lung and Blood Institute (to H.A.S.) and the Albany Medical College Candice Weir Fund.	Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Bell KFS, 2013, J NEUROCHEM, V126, P274, DOI 10.1111/jnc.12176; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Cartin L, 2000, CIRC RES, V86, P760, DOI 10.1161/01.RES.86.7.760; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Garat CV, 2006, MOL CELL BIOL, V26, P4934, DOI 10.1128/MCB.02477-05; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Ginnan R, 2004, AM J PHYSIOL-CELL PH, V286, pC1281, DOI 10.1152/ajpcell.00202.2003; Ginnan R, 2012, BIOCHEM J, V444, P105, DOI 10.1042/BJ20120152; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Halees AS, 2003, NUCLEIC ACIDS RES, V31, P3554, DOI 10.1093/nar/gkg549; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Li J, 2012, ACTA PHARMACOL SIN, V33, P1030, DOI 10.1038/aps.2012.61; Li L., 2012, PLOS ONE, V7; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; Matchkov VV, 2012, BASIC CLIN PHARMACOL, V110, P42, DOI 10.1111/j.1742-7843.2011.00818.x; MAYER P, 1995, BASIC RES CARDIOL, V90, P372, DOI 10.1007/BF00788498; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Ono H, 2004, ARTERIOSCL THROM VAS, V24, P1634, DOI 10.1161/01.ATV.0000138052.86051.0d; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfleiderer PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1238, DOI 10.1152/ajpcell.00536.2003; Popov S, 2011, J HYPERTENS, V29, P2395, DOI 10.1097/HJH.0b013e32834d3d55; Sanchez-Munoz I, 2010, J NEUROSCI RES, V88, P825, DOI 10.1002/jnr.22264; Schauer IE, 2010, ARTERIOSCL THROM VAS, V30, P733, DOI 10.1161/ATVBAHA.109.199133; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; Scott JA, 2012, AM J PHYSIOL-HEART C, V302, pH1953, DOI 10.1152/ajpheart.00978.2011; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shetty PK, 2008, J BIOL CHEM, V283, P5389, DOI 10.1074/jbc.M708479200; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Stevenson AS, 2001, EXP CELL RES, V263, P118, DOI 10.1006/excr.2000.5107; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Takeda H, 2007, BRAIN RES, V1184, P306, DOI 10.1016/j.brainres.2007.09.055; Taub M, 2010, BIOCHEM BIOPH RES CO, V393, P339, DOI 10.1016/j.bbrc.2010.02.037; Tokunou T, 2001, ARTERIOSCL THROM VAS, V21, P1764, DOI 10.1161/hq2112.098770; Van Riper DA, 2000, MOL CELL BIOCHEM, V213, P83, DOI 10.1023/A:1007116231678; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026	51	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33519	33529		10.1074/jbc.M113.490870	http://dx.doi.org/10.1074/jbc.M113.490870			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106266	Green Published, hybrid			2022-12-28	WOS:000327250200003
J	Simandlova, J; Zagelbaum, J; Payne, MJ; Chu, WK; Shevelev, I; Hanada, K; Chatterjee, S; Reid, DA; Liu, Y; Janscak, P; Rothenberg, E; Hickson, ID				Simandlova, Jitka; Zagelbaum, Jennifer; Payne, Miranda J.; Chu, Wai Kit; Shevelev, Igor; Hanada, Katsuhiro; Chatterjee, Sujoy; Reid, Dylan A.; Liu, Ying; Janscak, Pavel; Rothenberg, Eli; Hickson, Ian D.			FBH1 Helicase Disrupts RAD51 Filaments in Vitro and Modulates Homologous Recombination in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Helicase; DNA Recombination; DNA Repair; DNA Replication	BOX DNA HELICASE; PROTEIN; INHIBITION; COMPLEX; REPAIR; TUMORS; ROLES	Background: Homologous recombination is regulated both positively and negatively in eukaryotic cells to suppress genomic instability. Results: FBH1 can disrupt RAD51 filaments in vitro and suppresses formation of spontaneous RAD51 foci in mammalian cells. In cells defective for FBH1, hyper-recombination is observed. Conclusion: FBH1 is a negative regulator of homologous recombination. Significance: RAD51 activity must be carefully controlled to preserve genomic integrity. Efficient repair of DNA double strand breaks and interstrand cross-links requires the homologous recombination (HR) pathway, a potentially error-free process that utilizes a homologous sequence as a repair template. A key player in HR is RAD51, the eukaryotic ortholog of bacterial RecA protein. RAD51 can polymerize on DNA to form a nucleoprotein filament that facilitates both the search for the homologous DNA sequences and the subsequent DNA strand invasion required to initiate HR. Because of its pivotal role in HR, RAD51 is subject to numerous positive and negative regulatory influences. Using a combination of molecular genetic, biochemical, and single-molecule biophysical techniques, we provide mechanistic insight into the mode of action of the FBH1 helicase as a regulator of RAD51-dependent HR in mammalian cells. We show that FBH1 binds directly to RAD51 and is able to disrupt RAD51 filaments on DNA through its ssDNA translocase function. Consistent with this, a mutant mouse embryonic stem cell line with a deletion in the FBH1 helicase domain fails to limit RAD51 chromatin association and shows hyper-recombination. Our data are consistent with FBH1 restraining RAD51 DNA binding under unperturbed growth conditions to prevent unwanted or unscheduled DNA recombination.	[Simandlova, Jitka; Shevelev, Igor; Janscak, Pavel] Acad Sci Czech Republ, Inst Mol Genet, Prague 14300, Czech Republic; [Zagelbaum, Jennifer; Chatterjee, Sujoy; Reid, Dylan A.; Rothenberg, Eli] NYU, Sch Med, Dept Mol Pharmacol & Biochem, New York, NY USA; [Payne, Miranda J.; Chu, Wai Kit; Hanada, Katsuhiro; Hickson, Ian D.] Univ Oxford, Weatherall Inst Mol Med, Dept Oncol, Oxford OX3 9DS, England; [Chu, Wai Kit; Liu, Ying; Hickson, Ian D.] Univ Copenhagen, Nordea Ctr Healthy Aging, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Janscak, Pavel] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; New York University; University of Oxford; University of Copenhagen; University of Zurich	Janscak, P (corresponding author), Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland.	pjanscak@imcr.uzh.ch; eli.rothenberg@nyumc.org; iandh@sund.ku.dk	Chu, Wai Kit/F-9405-2016; Janscak, Pavel/Q-3795-2018; Chatterjee, Sujoy/L-7325-2015; Hickson, Ian/AAJ-7548-2020; Janscak, Pavel/G-6189-2014	Chu, Wai Kit/0000-0003-2903-3247; Janscak, Pavel/0000-0002-1748-7789; Payne, Miranda/0000-0002-4908-5717; Hickson, Ian/0000-0002-0583-566X; Rothenberg, Eli/0000-0002-1382-1380; Hanada, Katsuhiro/0000-0003-0429-1899	Cancer Research UK; Nordea Foundation (Denmark); Czech Science Foundation [GAP305/10/0281]; Swiss National Science Foundation [31003A_129747]	Cancer Research UK(Cancer Research UK); Nordea Foundation (Denmark); Czech Science Foundation(Grant Agency of the Czech Republic); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Cancer Research UK, the Nordea Foundation (Denmark), Czech Science Foundation Grant GAP305/10/0281, and Swiss National Science Foundation Grant 31003A_129747.	Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2009, J BIOL CHEM, V284, P26349, DOI 10.1074/jbc.M109.029371; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fugger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2395; Fugger K, 2009, J CELL BIOL, V186, P655, DOI 10.1083/jcb.200812138; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Kim J, 2002, J BIOL CHEM, V277, P24530, DOI 10.1074/jbc.M201612200; Kim JH, 2004, NUCLEIC ACIDS RES, V32, P2287, DOI 10.1093/nar/gkh534; Kohzaki M, 2007, MOL CELL BIOL, V27, P2812, DOI 10.1128/MCB.02043-06; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Laulier C, 2010, DNA REPAIR, V9, P708, DOI 10.1016/j.dnarep.2010.03.011; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Lorenz A, 2009, MOL CELL BIOL, V29, P4742, DOI 10.1128/MCB.00471-09; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Morishita T, 2005, MOL CELL BIOL, V25, P8074, DOI 10.1128/MCB.25.18.8074-8083.2005; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Osman F, 2005, MOL CELL BIOL, V25, P8084, DOI 10.1128/MCB.25.18.8084-8096.2005; Pierce AJ, 2005, METH MOL B, V291, P373; Qiu YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3281; Rothenberg E, 2010, METHODS MOL BIOL, V587, P29, DOI 10.1007/978-1-60327-355-8_3; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Tan TLR, 2003, DNA REPAIR, V2, P787, DOI 10.1016/S1568-7864(03)00070-3; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Yodh JG, 2009, EMBO J, V28, P405, DOI 10.1038/emboj.2008.298; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646	39	55	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34168	34180		10.1074/jbc.M113.484493	http://dx.doi.org/10.1074/jbc.M113.484493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108124	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000327250200060
J	Rhein, VF; Carroll, J; Ding, SJ; Fearnley, IM; Walker, JE				Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.			NDUFAF7 Methylates Arginine 85 in the NDUFS2 Subunit of Human Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transport; Mitochondria; Protein Methylation; Respiratory Chain; Assembly; Complex I; Dimethylarginine; Methyltransferase	NUCLEAR-ENCODED SUBUNITS; AMINO-ACID-SEQUENCE; MITOCHONDRIAL COMPLEX; POSTTRANSLATIONAL MODIFICATIONS; FUNCTIONAL EXPRESSION; HISTONE DEMETHYLATION; LYSINE METHYLATION; PROTEIN; METHYLTRANSFERASE; IDENTIFICATION	Background: Arginine 85 of NDUFS2, a subunit of mitochondrial complex I, is symmetrically dimethylated. Results: NDUFAF7, a protein methylase in the matrix of mitochondria, modifies arginine 85 of NDUFS2 during assembly of complex I. Conclusion: Methylation of arginine 85 of NDUFS2 is required for assembly of complex I. Significance: The arginine protein methylase, NDUFAF7, is an assembly factor for human complex I. Complex I (NADH ubiquinone oxidoreductase) in mammalian mitochondria is an L-shaped assembly of 44 subunits. One arm is embedded in the inner membrane with the other protruding approximate to 100 into the matrix of the organelle. The extrinsic arm contains binding sites for NADH and the primary electron acceptor FMN, and it provides a scaffold for seven iron-sulfur clusters that form an electron pathway linking FMN to the terminal electron acceptor, ubiquinone, which is bound in the region of the junction between the arms. The membrane arm contains four antiporter-like domains, probably energetically coupled to the quinone site and involved in pumping protons from the matrix into the intermembrane space contributing to the proton motive force. Complex I is put together from preassembled subcomplexes. Their compositions have been characterized partially, and at least 12 extrinsic assembly factor proteins are required for the assembly of the complex. One such factor, NDUFAF7, is predicted to belong to the family of S-adenosylmethionine-dependent methyltransferases characterized by the presence in their structures of a seven--strand protein fold. In the present study, the presence of NDUFAF7 in the mitochondrial matrix has been confirmed, and it has been demonstrated that it is a protein methylase that symmetrically dimethylates the -N-G,N-G atoms of residue Arg-85 in the NDUFS2 subunit of complex I. This methylation step occurs early in the assembly of complex I and probably stabilizes a 400-kDa subcomplex that forms the initial nucleus of the peripheral arm and its juncture with the membrane arm.	[Rhein, Virginie F.; Carroll, Joe; Ding, Shujing; Fearnley, Ian M.; Walker, John E.] Med Res Council Mitochondrial Biol Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Walker, JE (corresponding author), Med Res Council Mitochondrial Biol Unit, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk		Walker, John/0000-0001-7929-2162	Medical Research Council; Swiss National Fund Stipendium [PBBSP3-130953]; Swiss Novartis Foundation; Medical Research Council [MC_U105663148] Funding Source: researchfish; MRC [MC_U105663148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Fund Stipendium; Swiss Novartis Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.; Recipient of a Medical Research Council Career Development Fellowship, Swiss National Fund Stipendium PBBSP3-130953, and a fellowship from the Swiss Novartis Foundation.	Angerer H, 2012, BBA-BIOENERGETICS, V1817, P1776, DOI 10.1016/j.bbabio.2012.03.021; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P894; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; BLOXHAM DP, 1982, BIOCHEMISTRY-US, V21, P2028, DOI 10.1021/bi00538a009; Bremang M, 2013, MOL BIOSYST, V9, P2231, DOI 10.1039/c3mb00009e; Brule H, 2004, BIOCHEMISTRY-US, V43, P9243, DOI 10.1021/bi049671q; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Carilla-Latorre S, 2010, J CELL SCI, V123, P1674, DOI 10.1242/jcs.066076; Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; Chen RM, 2004, J BIOL CHEM, V279, P21883, DOI 10.1074/jbc.M402074200; Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670; Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dibrov E, 1997, J BIOL CHEM, V272, P9175; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Efremov RG, 2011, CURR OPIN STRUC BIOL, V21, P532, DOI 10.1016/j.sbi.2011.07.002; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; EVANS CT, 1988, BIOCHEM BIOPH RES CO, V157, P1231, DOI 10.1016/S0006-291X(88)81006-4; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007; Hoefs SJG, 2011, EUR J HUM GENET, V19, P270, DOI 10.1038/ejhg.2010.204; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Jonassen T, 2000, J BIOL CHEM, V275, P12381, DOI 10.1074/jbc.275.17.12381; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Liu JM, 2000, NUCLEIC ACIDS RES, V28, P3445, DOI 10.1093/nar/28.18.3445; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; McKenzie M, 2011, J MOL BIOL, V414, P413, DOI 10.1016/j.jmb.2011.10.012; Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Polevoda B, 2000, J BIOL CHEM, V275, P20508, DOI 10.1074/jbc.M001891200; Rendon OZ, 2012, HUM MOL GENET, V21, P3815, DOI 10.1093/hmg/dds209; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Scacco S, 2003, J BIOL CHEM, V278, P44161, DOI 10.1074/jbc.M307615200; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith AC, 2009, MOL CELL PROTEOMICS, V8, P1324, DOI 10.1074/mcp.M800373-MCP200; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Vogel RO, 2007, GENE DEV, V21, P615, DOI 10.1101/gad.408407; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Young MJ, 2008, YEAST, V25, P903, DOI 10.1002/yea.1644; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	83	76	78	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33016	33026		10.1074/jbc.M113.518803	http://dx.doi.org/10.1074/jbc.M113.518803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089531	hybrid, Green Published			2022-12-28	WOS:000328841700018
J	Saito, T; Yano, M; Kawai, Y; Asada, A; Wada, M; Doi, H; Hisanaga, S				Saito, Taro; Yano, Masashi; Kawai, Yusei; Asada, Akiko; Wada, Mitsuhito; Doi, Hirofumi; Hisanaga, Shin-ichi			Structural Basis for the Different Stability and Activity between the Cdk5 Complexes with p35 and p39 Activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Computer Modeling; Cyclins; Neurons; Serine-Threonine Protein Kinase; Cdk5; Hydrogen Bond; p35; p39; Subunit Interaction	DEPENDENT KINASE-5 ACTIVATOR; TAU-PHOSPHORYLATION; ALZHEIMERS-DISEASE; BRAIN-DEVELOPMENT; CLEAVAGE; P25; LOCALIZATION; INHIBITORS; TOXICITY; CALPAIN	Cyclin-dependent kinase 5 (Cdk5) is a brain-specific membrane-bound protein kinase that is activated by binding to the p35 or p39 activator. Previous studies have focused on p35-Cdk5, and little is known regarding p39-Cdk5. The lack of functional understanding of p39-Cdk5 is due, in part, to the labile property of p39-Cdk5, which dissociates and loses kinase activity in nonionic detergent conditions. Here we investigated the structural basis for the instability of p39-Cdk5. p39 and p35 contain N-terminal p10 regions and C-terminal Cdk5 activation domains (AD). Although p35 and p39 show higher homology in the C-terminal AD than the N-terminal region, the difference in stability is derived from the C-terminal AD. Based on the crystal structures of the p25 (p35 C-terminal region including AD)-Cdk5 complex, we simulated the three-dimensional structure of the p39 AD-Cdk5 complex and found differences in the hydrogen bond network between Cdk5 and its activators. Three amino acids of p35, Asp-259, Asn-266, and Ser-270, which are involved in hydrogen bond formation with Cdk5, are changed to Gln, Gln, and Pro in p39. Because these three amino acids in p39 do not participate in hydrogen bond formation, we predicted that the number of hydrogen bonds between p39 and Cdk5 was reduced compared with p35 and Cdk5. Using substitution mutants, we experimentally validated that the difference in the hydrogen bond network contributes to the different properties between Cdk5 and its activators.	[Saito, Taro; Yano, Masashi; Kawai, Yusei; Asada, Akiko; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Wada, Mitsuhito; Doi, Hirofumi] Celestar Lexico Sci Inc, Mihama Ku, Chiba 2618501, Japan; [Doi, Hirofumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538914, Japan	Tokyo Metropolitan University; University of Tokyo	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp			MEXT of Japan	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Priority Area from MEXT of Japan (to S. H.).	Ahn JS, 2005, CHEM BIOL, V12, P811, DOI 10.1016/j.chembiol.2005.05.011; Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; Asada A, 2012, J CELL SCI, V125, P3421, DOI 10.1242/jcs.100503; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Ko J, 2001, J NEUROSCI, V21, P6758; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Ledee DR, 2005, J BIOL CHEM, V280, P21376, DOI 10.1074/jbc.M501215200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Mapelli M, 2005, J MED CHEM, V48, P671, DOI 10.1021/jm049323m; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Shukla V, 2012, ARCH MED RES, V43, P655, DOI 10.1016/j.arcmed.2012.10.015; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Takahashi S, 2003, J BIOL CHEM, V278, P10506, DOI 10.1074/jbc.M211964200; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zhu YS, 2005, J NEUROCHEM, V94, P1535, DOI 10.1111/j.1471-4159.2005.03301.x	30	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32433	32439		10.1074/jbc.M113.512293	http://dx.doi.org/10.1074/jbc.M113.512293			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085300	hybrid, Green Published			2022-12-28	WOS:000328681700028
J	Jacobson, JM; Yin, J; Kitov, PI; Mulvey, G; Griener, TP; James, MNG; Armstrong, G; Bundle, DR				Jacobson, Jared M.; Yin, Jiang; Kitov, Pavel I.; Mulvey, George; Griener, Tom P.; James, Michael N. G.; Armstrong, Glen; Bundle, David R.			The Crystal Structure of Shiga Toxin Type 2 with Bound Disaccharide Guides the Design of a Heterobifunctional Toxin Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; B-SUBUNIT; IN-VIVO; BINDING; VEROTOXIN-1; ASSOCIATION; TRANSPORT	Shiga toxin type 2 (Stx2a) is clinically most closely associated with enterohemorrhagic E. coli O157:H7-mediated hemorrhagic colitis that sometimes progresses to hemolytic-uremic syndrome. The ability to express the toxin has been acquired by other Escherichia coli strains, and outbreaks of food poisoning have caused significant mortality rates as, for example, in the 2011 outbreak in northern Germany. Stx2a, an AB(5) toxin, gains entry into human cells via the glycosphingolipid receptor Gb(3). We have determined the first crystal structure of a disaccharide analog of Gb(3) bound to the B-5 pentamer of Stx2a holotoxin. In this Gb(3) analog, alpha-GalNAc replaces the terminal alpha-Gal residue. This co-crystal structure confirms previous inferences that two of the primary binding sites identified in the B-5 pentamer of Stx1 are also functional in Stx2a. This knowledge provides a rationale for the synthesis and evaluation of heterobifunctional antagonists for E. coli toxins that target Stx2a. Incorporation of GalNAc Gb(3) trisaccharide in a heterobifunctional ligand with an attached pyruvate acetal, a ligand for human amyloid P component, and conjugation to poly[acrylamide-co-(3-azidopropylmethacrylamide)] produced a polymer that neutralized Stx2a in a mouse model of Shigatoxemia.	[Jacobson, Jared M.; Kitov, Pavel I.; Bundle, David R.] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Yin, Jiang; James, Michael N. G.] Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Mulvey, George; Griener, Tom P.; Armstrong, Glen] Univ Calgary, Alberta Glyc Ctr, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4Z6, Canada	University of Alberta; University of Alberta; University of Calgary	Bundle, DR (corresponding author), Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada.	dave.bundle@ualberta.ca	Kitov, Pavel/J-3714-2014	James, Michael/0000-0002-5978-4562	Centres Program grant from Alberta Innovates, Technology Futures; Alexander Graham Bell Canada Graduate Scholarship from the Natural Science and Engineering Research Council of Canada	Centres Program grant from Alberta Innovates, Technology Futures; Alexander Graham Bell Canada Graduate Scholarship from the Natural Science and Engineering Research Council of Canada	This work was supported by a Centres Program grant from Alberta Innovates, Technology Futures.; Supported by an Alexander Graham Bell Canada Graduate Scholarship from the Natural Science and Engineering Research Council of Canada.	ARMSTRONG GD, 1991, J INFECT DIS, V164, P1160, DOI 10.1093/infdis/164.6.1160; Armstrong GD, 2006, J INFECT DIS, V193, P1120, DOI 10.1086/501472; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dasgupta S, 2014, ANGEW CHEM INT EDIT, V53, P1510, DOI 10.1002/anie.201309436; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Flagler MJ, 2010, BIOCHEMISTRY-US, V49, P1649, DOI 10.1021/bi902084y; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; Griener TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021457; Hong SW, 2011, ARCH PHARM RES, V34, P127, DOI 10.1007/s12272-011-0115-2; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Jacobson JM, 2013, CARBOHYD RES, V378, P4, DOI 10.1016/j.carres.2013.05.010; Kale RR, 2008, ANGEW CHEM INT EDIT, V47, P1265, DOI 10.1002/anie.200703680; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Kitov PI, 2008, P NATL ACAD SCI USA, V105, P16837, DOI 10.1073/pnas.0804919105; Kitov PI, 2008, ANGEW CHEM INT EDIT, V47, P672, DOI 10.1002/anie.200704064; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Kitova EN, 2007, GLYCOBIOLOGY, V17, P1127, DOI 10.1093/glycob/cwm081; Kitova EN, 2001, GLYCOBIOLOGY, V11, P605, DOI 10.1093/glycob/11.7.605; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Matsuoka K, 1999, TETRAHEDRON LETT, V40, P7839, DOI 10.1016/S0040-4039(99)01632-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nishikawa K, 2005, J INFECT DIS, V191, P2097, DOI 10.1086/430388; Nishikawa K, 2002, P NATL ACAD SCI USA, V99, P7669, DOI 10.1073/pnas.112058999; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paton AW, 2006, NAT REV MICROBIOL, V4, P193, DOI 10.1038/nrmicro1349; Rojas RLG, 2010, CLIN VACCINE IMMUNOL, V17, P529, DOI 10.1128/CVI.00495-09; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Shimizu H, 1998, BIOCHEMISTRY-US, V37, P11078, DOI 10.1021/bi980946+; Snedeker KG, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-144; Solomon D, 2005, ORG LETT, V7, P4369, DOI 10.1021/ol051529+; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Watanabe M, 2006, INFECT IMMUN, V74, P1984, DOI 10.1128/IAI.74.3.1984-1988.2006; Watanabe-Takahashi M, 2010, INFECT IMMUN, V78, P177, DOI 10.1128/IAI.01022-09; ZHAO X, 1992, J BIOCHEM-TOKYO, V111, P736, DOI 10.1093/oxfordjournals.jbchem.a123828	48	20	21	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					885	894		10.1074/jbc.M113.518886	http://dx.doi.org/10.1074/jbc.M113.518886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24225957	Green Published, hybrid			2022-12-28	WOS:000330541200024
J	Chien, CY; Chen, RH				Chien, Chen-Ying; Chen, Rey-Huei			Cdc48 Chaperone and Adaptor Ubx4 Distribute the Proteasome in the Nucleus for Anaphase Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Cell Cycle; Mitosis; Molecular Chaperone; Proteasome	PROTEIN-DEGRADATION; AAA-ATPASE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; ENDOPLASMIC-RETICULUM; MITOTIC ANAPHASE; 26S PROTEASOME; AURORA B; YEAST; UBIQUITIN	Background: Anaphase progression requires efficient degradation of mitotic regulators. Results: Mutations in the chaperone Cdc48-Ubx4 perturb anaphase proteolysis and proteasome distribution. Conclusion: Cdc48-Ubx4 maintains an optimal level of proteasomes for anaphase proteolysis. Significance: The molecular chaperone Cdc48-Ubx4 links proteasome mobilization with mitosis. The cell cycle transition is driven by abrupt degradation of key regulators. While ubiquitylation of these proteins has been extensively studied, the requirement for the proteolytic step is less understood. By analyzing the cell cycle function of Cdc48 in the budding yeast Saccharomyces cerevisiae, we found that double mutations in Cdc48 and its adaptor Ubx4 cause mitotic arrest with sustained Clb2 and Cdc20 proteins that are normally degraded in anaphase. The phenotype is neither caused by spindle checkpoint activation nor a defect in the assembly or the activity of the ubiquitylation machinery and the proteasome. Interestingly, the 26S proteasome is mislocalized into foci, which are colocalized with nuclear envelope anchor Sts1 in cdc48-3 ubx4 cells. Moreover, genetic analysis reveals that ubx4 deletion mutant dies in the absence of Rpn4, a transcriptional activator for proteasome subunits, and the proteasome chaperone Ump1, indicating that an optimal level of the proteasome is required for survival. Overexpression of Rpn4 indeed can rescue cell growth and anaphase proteolysis in cdc48-3 ubx4 cells. Biochemical analysis further shows that Ubx4 interacts with the proteasome. Our data propose that Cdc48-Ubx4 acts on the proteasome and uses the chaperone activity to promote its nuclear distribution, thereby optimizing the proteasome level for efficient degradation of mitotic regulators.	[Chien, Chen-Ying; Chen, Rey-Huei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Chen, Rey-Huei] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Chen, RH (corresponding author), Acad Sinica, Inst Mol Biol, 128 Sec 2,Acad Rd, Taipei 11529, Taiwan.	rhchen@imb.sinica.edu.tw	Chen, Rey-Huei/AAA-5087-2021	Chen, Rey-Huei/0000-0002-6006-2137	Academia Sinica; National Science Council, Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from Academia Sinica and National Science Council, Taiwan.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Chen L, 2011, J BIOL CHEM, V286, P3104, DOI 10.1074/jbc.M110.135863; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; HOUMAN F, 1994, MOL CELL BIOL, V14, P6350, DOI 10.1128/MCB.14.9.6350; Ikai N, 2006, J STRUCT BIOL, V156, P50, DOI 10.1016/j.jsb.2006.04.003; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MOIR D, 1982, GENETICS, V100, P547; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; SAMEJIMA I, 1994, MOL CELL BIOL, V14, P6361, DOI 10.1128/MCB.14.9.6361; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Schuyler SC, 2009, METHODS MOL BIOL, V545, P271, DOI 10.1007/978-1-60327-993-2_17; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864	38	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37180	37191		10.1074/jbc.M113.513598	http://dx.doi.org/10.1074/jbc.M113.513598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225956	Green Published, hybrid			2022-12-28	WOS:000329189700036
J	Chung, H; Ramachandran, R; Hollenberg, MD; Muruve, DA				Chung, Hyunjae; Ramachandran, Rithwik; Hollenberg, Morley D.; Muruve, Daniel A.			Proteinase-activated Receptor-2 Transactivation of Epidermal Growth Factor Receptor and Transforming Growth Factor-beta Receptor Signaling Pathways Contributes to Renal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Fibrosis; Kidney; Receptors; Transforming Growth Factor (TGF); PAR2	ACUTE KIDNEY INJURY; MAST-CELL TRYPTASE; URINARY TRYPSIN-INHIBITOR; TUBULE EPITHELIAL-CELLS; TGF-BETA; CAMOSTAT MESILATE; INTESTINAL INFLAMMATION; INTERSTITIAL FIBROSIS; PROTEASE INHIBITOR; BLOOD-PRESSURE	Chronic kidney diseases cause significant morbidity and mortality in the population. During renal injury, kidney-localized proteinases can signal by cleaving and activating proteinase-activated receptor-2 (PAR2), a G-protein-coupled receptor involved in inflammation and fibrosis that is highly expressed in renal tubular cells. Following unilateral ureteric obstruction, PAR2-deficient mice displayed reduced renal tubular injury, fibrosis, collagen synthesis, connective tissue growth factor (CTGF), and -smooth muscle actin gene expression at 7 days, compared with wild-type controls. In human proximal tubular epithelial cells in vitro, PAR2 stimulation with PAR2-activating peptide (PAR2-AP) alone significantly up-regulated the expression of CTGF, a potent profibrotic cytokine. The induction of CTGF by PAR2-AP was synergistically increased when combined with transforming growth factor- (TGF-). Consistent with these findings, treating human proximal tubular epithelial cells with PAR2-AP induced Smad2/3 phosphorylation in the canonical TGF- signaling pathway. The Smad2 phosphorylation and CTGF induction required signaling via both the TGF-receptor and EGF receptor suggesting that PAR2 utilizes transactivation mechanisms to initiate fibrogenic signaling. Taken together, our data support the hypothesis that PAR2 synergizes with the TGF signaling pathway to contribute to renal injury and fibrosis.	[Chung, Hyunjae; Hollenberg, Morley D.; Muruve, Daniel A.] Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada; [Ramachandran, Rithwik; Hollenberg, Morley D.] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Muruve, DA (corresponding author), Univ Calgary, Fac Med, Dept Med, Calgary, AB T2N 4N1, Canada.	dmuruve@ucalgary.ca	Ramachandran, Rithwik/N-7815-2015; Hollenberg, Morley/AFV-6966-2022	Ramachandran, Rithwik/0000-0001-9557-9905; 	Canadian Institutes of Health Research (CIHR); University of Alberta; Snyder Institute for Chronic Diseases Live Cell Imaging Facility; Canadian Foundation Innovation (CFI); Alberta Science and Research Authority	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Alberta(University of Alberta); Snyder Institute for Chronic Diseases Live Cell Imaging Facility; Canadian Foundation Innovation (CFI)(Canada Foundation for Innovation); Alberta Science and Research Authority	This work was supported by Operating Grants from the Canadian Institutes of Health Research (CIHR), an Emerging Team Grant from the University of Alberta, and by the Snyder Institute for Chronic Diseases Live Cell Imaging Facility funded by an equipment and infrastructure grant from the Canadian Foundation Innovation (CFI) and the Alberta Science and Research Authority.	Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Borensztajn K, 2008, AM J PATHOL, V172, P309, DOI 10.2353/ajpath.2008.070347; Burch ML, 2010, J BIOL CHEM, V285, P26798, DOI 10.1074/jbc.M109.092767; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gui Y, 2003, AM J PHYSIOL-RENAL, V285, pF95, DOI 10.1152/ajprenal.00396.2002; Hao JM, 2000, AM J PHYSIOL-HEART C, V279, pH3020, DOI 10.1152/ajpheart.2000.279.6.H3020; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; Ishikura H, 2007, LIFE SCI, V80, P1999, DOI 10.1016/j.lfs.2007.02.044; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Katoh H, 2010, J RADIAT RES, V51, P325, DOI 10.1269/jrr.09108; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; Kondo S, 2001, J AM SOC NEPHROL, V12, P1668, DOI 10.1681/ASN.V1281668; Kono T, 2011, EXP BIOL MED, V236, P1314, DOI 10.1258/ebm.2011.011173; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li JH, 2004, FASEB J, V18, P176, DOI 10.1096/fj.02-1117fje; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Liu H, 2010, INFLAMM RES, V59, P551, DOI 10.1007/s00011-010-0159-7; Maekawa A, 2009, J HYPERTENS, V27, P181, DOI 10.1097/HJH.0b013e328317a762; Morinaga J, 2013, AM J PHYSIOL-RENAL, V305, pF173, DOI 10.1152/ajprenal.00586.2012; Morla L, 2013, J BIOL CHEM, V288, P10124, DOI 10.1074/jbc.M112.446393; Murray DB, 2012, J CELL COMMUN SIGNAL, V6, P45, DOI 10.1007/s12079-011-0146-y; Okuno M, 2001, GASTROENTEROLOGY, V120, P1784, DOI 10.1053/gast.2001.24832; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; Su X, 2009, ANAT REC, V292, P580, DOI 10.1002/ar.20846; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Vesey DA, 2007, AM J PHYSIOL-RENAL, V293, pF1441, DOI 10.1152/ajprenal.00088.2007; White LR, 2007, AM J PHYSIOL-RENAL, V292, pF567, DOI 10.1152/ajprenal.00212.2006; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Xiong Jing, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P523; Yu Q, 2000, GENE DEV, V14, P163; Zhang C, 2004, CELL BIOL INT, V28, P863, DOI 10.1016/j.cellbi.2004.09.003; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103	51	68	75	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37319	37331		10.1074/jbc.M113.492793	http://dx.doi.org/10.1074/jbc.M113.492793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24253040	hybrid, Green Published			2022-12-28	WOS:000329189700048
J	Su, JC; Gu, YC; Pruijn, FB; Smaill, JB; Patterson, AV; Guise, CP; Wilson, WR				Su, Jiechuang; Gu, Yongchuan; Pruijn, Frederik B.; Smaill, Jeff B.; Patterson, Adam V.; Guise, Christopher P.; Wilson, William R.			Zinc Finger Nuclease Knock-out of NADPH: Cytochrome P450 Oxidoreductase (POR) in Human Tumor Cell Lines Demonstrates That Hypoxia-activated Prodrugs Differ in POR Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Flavoproteins; Gene Knock-out; Hypoxia; Mass Spectrometry (MS); Molecular Cell Biology; Reductase; NADPH:Cytochrome P450 Oxidoreductase; Hypoxia-activated Prodrug; Proteotypic Peptides; Zinc Finger Nuclease	4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS; HAMSTER OVARY CELLS; C P450 REDUCTASE; MITOMYCIN-C; P-450 REDUCTASE; AEROBIC CONDITIONS; CANCER-THERAPY; GENE KNOCKOUT; TROG 02.02; CYTOTOXICITY	Hypoxia, a ubiquitous feature of tumors, can be exploited by hypoxia-activated prodrugs (HAP) that are substrates for one-electron reduction in the absence of oxygen. NADPH:cytochrome P450 oxidoreductase (POR) is considered one of the major enzymes responsible, based on studies using purified enzyme or forced overexpression in cell lines. To examine the role of POR in HAP activation at endogenous levels of expression, POR knock-outs were generated in HCT116 and SiHa cells by targeted mutation of exon 8 using zinc finger nucleases. Absolute quantitation by proteotypic peptide mass spectrometry of DNA sequence-confirmed multiallelic mutants demonstrated expression of proteins with residual one-electron reductase activity in some clones and identified two (Hko2 from HCT116 and S2ko1 from SiHa) that were functionally null by multiple criteria. Sensitivities of the clones to 11 HAP (six nitroaromatics, three benzotriazine N-oxides, and two quinones) were compared with wild-type and POR-overexpressing cells. All except the quinones were potentiated by POR overexpression. Knocking out POR had a marked effect on antiproliferative activity of the 5-nitroquinoline SN24349 in both genetic backgrounds after anoxic exposure but little or no effect on activity of most other HAP, including the clinical stage 2-nitroimidazole mustard TH-302, dinitrobenzamide mustard PR-104A, and benzotriazine N-oxide SN30000. Clonogenic cell killing and reductive metabolism of PR-104A and SN30000 under anoxia also showed little change in the POR knock-outs. Thus, although POR expression is a potential biomarker of sensitivity to some HAP, identification of other one-electron reductases responsible for HAP activation is needed for their rational clinical development.	[Su, Jiechuang; Gu, Yongchuan; Pruijn, Frederik B.; Smaill, Jeff B.; Patterson, Adam V.; Guise, Christopher P.; Wilson, William R.] Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc Res Ctr, Auckland, New Zealand	University of Auckland	Wilson, WR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc Res Ctr, Private Bag 92019, Auckland, New Zealand.	wr.wilson@auckland.ac.nz		Guise, Chris/0000-0001-8739-6682; Pruijn, Frederik/0000-0002-7354-5840; Gu, Yongchuan/0000-0001-5679-168X; Patterson, Adam/0000-0001-5138-1227	Health Research Council of New Zealand [11/1103]; University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland	This work was supported by Grant 11/1103 from the Health Research Council of New Zealand and a doctoral scholarship from the University of Auckland (to J. S.).	Bailey SM, 2001, BIOCHEM PHARMACOL, V62, P461, DOI 10.1016/S0006-2952(01)00674-8; Baumann RP, 2001, CANCER RES, V61, P7770; Belcourt MF, 1996, P NATL ACAD SCI USA, V93, P456, DOI 10.1073/pnas.93.1.456; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Chen Y, 2009, MED RES REV, V29, P29, DOI 10.1002/med.20137; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Denny WA, 2010, FUTURE ONCOL, V6, P419, DOI [10.2217/fon.10.1, 10.2217/FON.10.1]; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Elwell JH, 1997, BIOCHEM PHARMACOL, V54, P249, DOI 10.1016/S0006-2952(97)00171-8; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; Guise CP, 2007, BIOCHEM PHARMACOL, V74, P810, DOI 10.1016/j.bcp.2007.06.014; Guise CP, 2012, MOL PHARMACOL, V81, P31, DOI 10.1124/mol.111.073759; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Heine T, 2006, FREE RADICAL BIO MED, V40, P801, DOI 10.1016/j.freeradbiomed.2005.10.033; Henderson CJ, 2013, MOL PHARMACOL, V83, P1209, DOI 10.1124/mol.112.084616; Hendricksen K, 2012, J UROLOGY, V187, P1195, DOI 10.1016/j.juro.2011.11.101; HOBAN PR, 1990, CANCER RES, V50, P4692; Hunter FW, 2012, BIOCHEM PHARMACOL, V83, P574, DOI 10.1016/j.bcp.2011.12.005; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; KURZBAN GP, 1986, J BIOL CHEM, V261, P7824; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; MASON RP, 1975, BIOCHEM BIOPH RES CO, V67, P1267, DOI 10.1016/0006-291X(75)90163-1; McKeage MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-496; Meng FY, 2012, MOL CANCER THER, V11, P740, DOI 10.1158/1535-7163.MCT-11-0634; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Newton DC, 1998, ARCH BIOCHEM BIOPHYS, V359, P249, DOI 10.1006/abbi.1998.0917; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; PATTERSON AV, 1995, BRIT J CANCER, V72, P1144, DOI 10.1038/bjc.1995.478; Patterson AV, 1997, BRIT J CANCER, V76, P1338, DOI 10.1038/bjc.1997.558; Peters LJ, 2010, J CLIN ONCOL, V28, P2996, DOI 10.1200/JCO.2009.27.4498; Richter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065267; Riddick DS, 2013, DRUG METAB DISPOS, V41, P12, DOI 10.1124/dmd.112.048991; Rischin D, 2010, J CLIN ONCOL, V28, P2989, DOI 10.1200/JCO.2009.27.4449; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Saunders MP, 2000, BIOCHEM PHARMACOL, V59, P993, DOI 10.1016/S0006-2952(99)00405-0; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; SIIM BG, 1995, BIOCHEM PHARMACOL, V50, P75, DOI 10.1016/0006-2952(95)00112-D; SIIM BG, 1994, BRIT J CANCER, V70, P596, DOI 10.1038/bjc.1994.357; SIIM BG, 1994, BIOCHEM PHARMACOL, V48, P1593, DOI 10.1016/0006-2952(94)90204-6; SILVA JM, 1993, BRIT J CANCER, V68, P484, DOI 10.1038/bjc.1993.374; Singleton RS, 2009, CANCER RES, V69, P3884, DOI 10.1158/0008-5472.CAN-08-4023; Smaill J. B., 2010, U. S. Patent, Patent No. [2010/0173332 A1, 20100173332]; Su JC, 2013, BIOCHEM J, V452, P79, DOI 10.1042/BJ20121695; Tercel M, 2009, J MED CHEM, V52, P7258, DOI 10.1021/jm901202b; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vaupel P, 2009, ADV EXP MED BIOL, V645, P241, DOI 10.1007/978-0-387-85998-9_36; WALTON MI, 1992, BIOCHEM PHARMACOL, V44, P251, DOI 10.1016/0006-2952(92)90007-6; Wang JL, 2012, CLIN CANCER RES, V18, P1684, DOI 10.1158/1078-0432.CCR-11-2296; Wang YL, 2010, MOL CANCER THER, V9, P410, DOI 10.1158/1535-7163.MCT-09-0555; WARDMAN P, 1976, BIOCHEM BIOPH RES CO, V69, P942, DOI 10.1016/0006-291X(76)90464-2; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	68	21	21	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37138	37153		10.1074/jbc.M113.505222	http://dx.doi.org/10.1074/jbc.M113.505222			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196959	Green Published, hybrid			2022-12-28	WOS:000329189700033
J	Taib, B; Bouyakdan, K; Hryhorczuk, C; Rodaros, D; Fulton, S; Alquier, T				Taib, Bouchra; Bouyakdan, Khalil; Hryhorczuk, Cecile; Rodaros, Demetra; Fulton, Stephanie; Alquier, Thierry			Glucose Regulates Hypothalamic Long-chain Fatty Acid Metabolism via AMP-activated Kinase (AMPK) in Neurons and Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Astrocytes; Fatty Acid Oxidation; Glucose Metabolism; Hypothalamus; Neural Metabolism; Fatty Acid Esterification; Oleate; Palmitate	PROTEIN-KINASE; MALONYL-COA; CARNITINE PALMITOYLTRANSFERASE; FOOD-INTAKE; ENDOPLASMIC-RETICULUM; INSULIN-SECRETION; DEVELOPING BRAIN; MESSENGER-RNA; OLEIC-ACID; ENERGY	Hypothalamic controls of energy balance rely on the detection of circulating nutrients such as glucose and long-chain fatty acids (LCFA) by the mediobasal hypothalamus (MBH). LCFA metabolism in the MBH plays a key role in the control of food intake and glucose homeostasis, yet it is not known if glucose regulates LCFA oxidation and esterification in the MBH and, if so, which hypothalamic cell type(s) and intracellular signaling mechanisms are involved. The aim of this study was to determine the impact of glucose on LCFA metabolism, assess the role of AMP-activated Kinase (AMPK), and to establish if changes in LCFA metabolism and its regulation by glucose vary as a function of the kind of LCFA, cell type, and brain region. We show that glucose inhibits palmitate oxidation via AMPK in hypothalamic neuronal cell lines, primary hypothalamic astrocyte cultures, and MBH slices ex vivo but not in cortical astrocytes and slice preparations. In contrast, oleate oxidation was not affected by glucose or AMPK inhibition in MBH slices. In addition, our results show that glucose increases palmitate, but not oleate, esterification into neutral lipids in neurons and MBH slices but not in hypothalamic astrocytes. These findings reveal for the first time the metabolic fate of different LCFA in the MBH, demonstrate AMPK-dependent glucose regulation of LCFA oxidation in both astrocytes and neurons, and establish metabolic coupling of glucose and LCFA as a distinguishing feature of hypothalamic nuclei critical for the control of energy balance.	[Taib, Bouchra; Bouyakdan, Khalil; Hryhorczuk, Cecile; Rodaros, Demetra; Fulton, Stephanie; Alquier, Thierry] Ctr Hosp Univ Montreal, Ctr Rech, Montreal Diabet Res Ctr, Montreal, PQ H3T 1J4, Canada; [Taib, Bouchra; Alquier, Thierry] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Bouyakdan, Khalil; Alquier, Thierry] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Hryhorczuk, Cecile] Univ Montreal, Dept Physiol, Montreal, PQ H3T 1J4, Canada; [Fulton, Stephanie] Univ Montreal, Dept Nutr, Montreal, PQ H3T 1J4, Canada; [Alquier, Thierry] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Alquier, T (corresponding author), CRCHUM Tour Viger, 900 St Denis, Montreal, PQ H2X 0A9, Canada.	thierry.alquier@umontreal.ca	Alquier, Thierry/Z-1917-2019	Alquier, Thierry/0000-0001-8171-802X	Canadian Institutes of Health Research [MOP115042]; Fonds de Recherche Quebec-Sante; Societe Francophone du Diabete; Diabete Quebec; Canadian Foundation for Innovation; University of Montreal	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Quebec-Sante; Societe Francophone du Diabete; Diabete Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Montreal	This work was supported by grants from the Canadian Institutes of Health Research (MOP115042), Fonds de Recherche Quebec-Sante, Societe Francophone du Diabete, Diabete Quebec, and Canadian Foundation for Innovation (to T. A.).; Supported by a doctoral fellowship from Diabete Quebec and University of Montreal.	Alquier T, 2007, ENDOCRINOLOGY, V148, P1367, DOI 10.1210/en.2006-1039; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Beall C, 2012, DIABETOLOGIA, V55, P2432, DOI 10.1007/s00125-012-2617-y; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; BEVERLY JL, 1991, AM J PHYSIOL, V261, pR339, DOI 10.1152/ajpregu.1991.261.2.R339; Blazquez C, 1999, J NEUROCHEM, V73, P1674, DOI 10.1046/j.1471-4159.1999.731674.x; Borg ML, 2012, J PHYSIOL-LONDON, V590, P4377, DOI 10.1113/jphysiol.2012.233288; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cruciani-Guglielmacci C, 2004, DIABETOLOGIA, V47, P2032, DOI 10.1007/s00125-004-1569-2; Dai Y, 2007, BIOCHEM BIOPH RES CO, V359, P469, DOI 10.1016/j.bbrc.2007.05.161; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; EDMOND J, 1992, CAN J PHYSIOL PHARM, V70, pS118, DOI 10.1139/y92-253; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Fioramonti X, 2004, DIABETES, V53, P2767, DOI 10.2337/diabetes.53.11.2767; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Gao S, 2013, PHYSIOL BEHAV, V122, P17, DOI 10.1016/j.physbeh.2013.07.014; Gao S, 2013, PHYSIOL BEHAV, V118, P165, DOI 10.1016/j.physbeh.2013.03.030; Gao S, 2011, AM J PHYSIOL-REG I, V301, pR209, DOI 10.1152/ajpregu.00092.2011; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gavillet M, 2008, GLIA, V56, P975, DOI 10.1002/glia.20671; Guillod-Maximin E, 2004, J NEUROENDOCRINOL, V16, P464, DOI 10.1111/j.1365-2826.2004.01185.x; Han SM, 2005, DIABETOLOGIA, V48, P2170, DOI 10.1007/s00125-005-1913-1; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Karmi A, 2010, DIABETES, V59, P2171, DOI 10.2337/db09-0138; KASSER TR, 1985, AM J PHYSIOL, V248, pR447, DOI 10.1152/ajpregu.1985.248.4.R447; Kawashima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036335; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; KIMES AS, 1983, BRAIN RES, V274, P291, DOI 10.1016/0006-8993(83)90707-2; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lanfray D, 2013, DIABETES, V62, P801, DOI 10.2337/db11-0785; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Levin BE, 2011, ENDOCRINOLOGY, V152, P2552, DOI 10.1210/en.2011-0194; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Madadi G, 2008, BIOCHEM BIOPH RES CO, V376, P694, DOI 10.1016/j.bbrc.2008.09.054; Marty N, 2005, J CLIN INVEST, V115, P3545, DOI 10.1172/JCI26309; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Meegalla RL, 2002, BIOCHEM BIOPH RES CO, V298, P317, DOI 10.1016/S0006-291X(02)02466-X; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mountjoy PD, 2007, EXP PHYSIOL, V92, P311, DOI 10.1113/expphysiol.2006.036004; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Sanz C, 2007, J ENDOCRINOL, V193, P259, DOI 10.1677/JOE-06-0146; Schwinkendorf DR, 2011, INT J OBESITY, V35, P336, DOI 10.1038/ijo.2010.159; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Wang R, 2006, J NEUROPHYSIOL, V95, P1491, DOI 10.1152/jn.00697.2005; Wolfgang MJ, 2007, P NATL ACAD SCI USA, V104, P19285, DOI 10.1073/pnas.0709778104; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yi CX, 2011, NEUROENDOCRINOLOGY, V93, P143, DOI 10.1159/000324888	69	45	46	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37216	37229		10.1074/jbc.M113.506238	http://dx.doi.org/10.1074/jbc.M113.506238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240094	Green Published, hybrid			2022-12-28	WOS:000329189700039
J	Forbes, LV; Sjogren, T; Auchere, F; Jenkins, DW; Thong, B; Laughton, D; Hemsley, P; Pairaudeau, G; Turner, R; Eriksson, H; Unitt, JF; Kettle, AJ				Forbes, Louisa V.; Sjogren, Tove; Auchere, Francoise; Jenkins, David W.; Thong, Bob; Laughton, David; Hemsley, Paul; Pairaudeau, Garry; Turner, Rufus; Eriksson, Hakan; Unitt, John F.; Kettle, Anthony J.			Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Inhibitors; Neutrophil; Oxidative Stress; Surface Plasmon Resonance (SPR); Hydroxamate; Myeloperoxidase; Reversible Inhibition	RAY CRYSTAL-STRUCTURE; CHLORINATING ACTIVITY; MOLECULAR-MECHANISMS; REDOX PROPERTIES; OXIDATION; ENZYME; PROTEINS; KINETICS; COMPLEX; HEALTH	Background: Myeloperoxidase causes oxidative damage in many inflammatory diseases. Results: New substituted aromatic hydroxamates are identified as potent, selective, and reversible inhibitors of MPO. Conclusion: Binding affinities of hydroxamates to the heme pocket determine the potency of inhibition. Significance: Compounds that bind tightly to the active site of myeloperoxidase have potential as therapeutically useful inhibitors of oxidative stress. The neutrophil enzyme myeloperoxidase (MPO) promotes oxidative stress in numerous inflammatory pathologies by producing hypohalous acids. Its inadvertent activity is a prime target for pharmacological control. Previously, salicylhydroxamic acid was reported to be a weak reversible inhibitor of MPO. We aimed to identify related hydroxamates that are good inhibitors of the enzyme. We report on three hydroxamates as the first potent reversible inhibitors of MPO. The chlorination activity of purified MPO was inhibited by 50% by a 5 nm concentration of a trifluoromethyl-substituted aromatic hydroxamate, HX1. The hydroxamates were specific for MPO in neutrophils and more potent toward MPO compared with a broad range of redox enzymes and alternative targets. Surface plasmon resonance measurements showed that the strength of binding of hydroxamates to MPO correlated with the degree of enzyme inhibition. The crystal structure of MPO-HX1 revealed that the inhibitor was bound within the active site cavity above the heme and blocked the substrate channel. HX1 was a mixed-type inhibitor of the halogenation activity of MPO with respect to both hydrogen peroxide and halide. Spectral analyses demonstrated that hydroxamates can act variably as substrates for MPO and convert the enzyme to a nitrosyl ferrous intermediate. This property was unrelated to their ability to inhibit MPO. We propose that aromatic hydroxamates bind tightly to the active site of MPO and prevent it from producing hypohalous acids. This mode of reversible inhibition has potential for blocking the activity of MPO and limiting oxidative stress during inflammation.	[Forbes, Louisa V.; Auchere, Francoise; Turner, Rufus; Kettle, Anthony J.] Univ Otago, Dept Pathol, Ctr Free Rad Res, Christchurch 8140, New Zealand; [Sjogren, Tove] AstraZeneca Res & Dev, Discovery Sci, S-43181 Molndal, Sweden; [Jenkins, David W.; Thong, Bob; Laughton, David; Hemsley, Paul; Pairaudeau, Garry; Unitt, John F.] AstraZeneca Res & Dev Charnwood, Biosci & Med Chem, Loughborough LE11 5RH, Leics, England; [Eriksson, Hakan] AstraZeneca Res & Dev Sodertalje, SE-15185 Sodertalje, Sweden	University of Otago; AstraZeneca; AstraZeneca; AstraZeneca	Forbes, LV (corresponding author), Univ Otago, Dept Pathol, Ctr Free Rad Res, POB 4345, Christchurch 8140, New Zealand.	louisa.forbes@otago.ac.nz	Ashby, Louisa/GRN-9388-2022	Ashby, Louisa/0000-0001-8247-096X; Kettle, Tony/0000-0002-8218-7766	AstraZeneca	AstraZeneca(AstraZeneca)	Received financial support from AstraZeneca to conduct this research.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; ABUSOUD HM, 1995, J BIOL CHEM, V270, P22997, DOI 10.1074/jbc.270.39.22997; Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; Auchere F, 1999, BIOCHEM J, V343, P603, DOI 10.1042/0264-6021:3430603; AUERBACH BJ, 1992, ANAL BIOCHEM, V201, P375, DOI 10.1016/0003-2697(92)90354-A; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; BROOKS JL, 1983, BIOCHEM BIOPH RES CO, V116, P916, DOI 10.1016/S0006-291X(83)80229-0; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Connolly S, 2004, J MED CHEM, V47, P3320, DOI 10.1021/jm031035n; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Davey CA, 1996, BIOCHEMISTRY-US, V35, P10967, DOI 10.1021/bi960577m; DAVIES B, 1989, BIOCHEM J, V258, P801, DOI 10.1042/bj2580801; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Farmer PJ, 2005, J INORG BIOCHEM, V99, P166, DOI 10.1016/j.jinorgbio.2004.11.005; Ferrari RP, 1997, J INORG BIOCHEM, V68, P61, DOI 10.1016/S0162-0134(97)81617-0; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Forbes LV, 2012, BIOCHEM PHARMACOL, V84, P949, DOI 10.1016/j.bcp.2012.07.020; Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9; Halliwell B., 1999, FREE RADICALS BIOL M, P617; Hernandez-Mijares A, 2011, FREE RADICAL BIO MED, V50, P1215, DOI 10.1016/j.freeradbiomed.2011.01.019; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; Hsuanyu Y, 1999, ARCH BIOCHEM BIOPHYS, V368, P413, DOI 10.1006/abbi.1999.1328; IKEDASAITO M, 1991, J BIOL CHEM, V266, P3611; Jantschko W, 2005, BIOCHEM PHARMACOL, V69, P1149, DOI 10.1016/j.bcp.2005.02.006; JIANG XX, 1994, SCIENCE, V266, P810, DOI 10.1126/science.7973636; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; Koelsch M, 2010, BIOCHEM PHARMACOL, V79, P1156, DOI 10.1016/j.bcp.2009.11.024; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; NOGUCHI M, 1994, EUR J BIOCHEM, V222, P285, DOI 10.1111/j.1432-1033.1994.tb18867.x; Ochs RS, 2000, J CHEM EDUC, V77, P1453, DOI 10.1021/ed077p1453; Prutz WA, 2000, ARCH BIOCHEM BIOPHYS, V380, P181, DOI 10.1006/abbi.2000.1914; Queiroz RF, 2011, BIOCHEM J, V439, P423, DOI 10.1042/BJ20110555; Rees MD, 2009, BIOCHEM J, V421, P79, DOI 10.1042/BJ20090309; Reisz JA, 2010, DALTON T, V39, P5203, DOI 10.1039/c000980f; RICH PR, 1978, BIOCHIM BIOPHYS ACTA, V525, P325, DOI 10.1016/0005-2744(78)90227-9; Samuni Y, 2012, BBA-GEN SUBJECTS, V1820, P1560, DOI 10.1016/j.bbagen.2012.05.006; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; UETRECHT JP, 1992, DRUG METAB REV, V24, P299, DOI 10.3109/03602539208996297; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Weaver R, 2003, DRUG METAB DISPOS, V31, P955, DOI 10.1124/dmd.31.7.955; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182	52	76	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36636	36647		10.1074/jbc.M113.507756	http://dx.doi.org/10.1074/jbc.M113.507756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194519	Green Published, hybrid			2022-12-28	WOS:000328883400043
J	Islam, KN; Bae, JW; Gao, E; Koch, WJ				Islam, Kazi N.; Bae, Jang-Whan; Gao, Erhe; Koch, Walter J.			Regulation of Nuclear Factor kappa B (NF-kappa B) in the Nucleus of Cardiomyocytes by G Protein-coupled Receptor Kinase 5 (GRK5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); Gene Expression; Gene Regulation; NF-Kappa B (NF-KB); Transcription	HYPERTROPHY IN-VIVO; CARDIAC-HYPERTROPHY; TRANSCRIPTIONAL ACTIVITY; MYOCARDIAL HYPERTROPHY; GENE-EXPRESSION; ANGIOTENSIN-II; HEART-FAILURE; ACTIVATION; MICE; REQUIREMENT	Background: NF-B activation and GRK5 up-regulation have been shown to be associated with heart disease. Results: GRK5 induces NF-B signaling pathway both in cardiomyocytes and in mouse hearts. Conclusion: GRK5 triggers the binding of NF-B (p50/p65) to DNA in the nucleus and promotes gene transcription including hypertrophic gene. Significance: GRK5 up-regulation may lead to a significant increase in expression and activation of NF-B seen in heart disease. G protein-coupled receptor kinase 5 GRK5 plays a key role in regulating cardiac signaling and its expression is increased in heart failure. GRK5 activity in the nucleus of myocytes has been shown to be detrimental in the setting of pressure-overload hypertrophy. The ubiquitous nuclear transcription factor B (NF-B) is involved in the regulation of numerous genes in various tissues, and activation of NF-B has been shown to be associated with heart disease. Herein, we investigated whether GRK5 can specifically regulate the NF-B signaling pathway in myocytes. We found that overexpression of GRK5 increased the levels of NF-B -p50 and p65 in vitro and in vivo, whereas loss of GRK5 resulted in lower cardiac NF-B levels. Furthermore, increased GRK5 expression induced the phosphorylation status of p65, increased the activity of a NF-B reporter, and increased NF-B DNA binding activity in cultured neonatal rat ventricular myocytes. Importantly, siRNA against GRK5 presented with the opposite results in neonatal rat ventricular myocytes as p65 and p50 were decreased, and there was a loss of NF-B DNA binding activity. The influence of GRK5 on NF-B expression and activity was dependent on its nuclear localization as overexpression of a mutant GRK5 that cannot enter the nucleus was devoid of NF-B activation or DNA binding. Our study demonstrates that a novel pathological consequence of GRK5 up-regulation in the injured and failing heart is the induction of NF-B expression and activity.	[Islam, Kazi N.; Bae, Jang-Whan; Gao, Erhe; Koch, Walter J.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Islam, KN (corresponding author), LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, 533 Bolivar St,CSRB 401A, New Orleans, LA 70112 USA.	kisla1@lsuhsc.edu; walter.koch@temple.edu			National Institutes of Health Grants [PO1 HL 091799, PO1 HL 075443]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091799, P01HL075443] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 091799 (Project 1 to W. J. K. and Core B to E. G.) and PO1 HL 075443 (Project 2 to W. J. K.).	Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gold JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057324; Gold JI, 2012, CIRC RES, V111, P1048, DOI 10.1161/CIRCRESAHA.112.273367; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Islam KN, 2012, J BIOL CHEM, V287, P12771, DOI 10.1074/jbc.M111.324566; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Patial S, 2011, J CELL PHYSIOL, V226, P1323, DOI 10.1002/jcp.22460; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Yi YP, 2002, HYPERTENSION, V39, P1058, DOI 10.1161/01.HYP0000019130.09167.3B; Young D, 2008, J MOL BIOL, V381, P559, DOI 10.1016/j.jmb.2008.05.076; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	36	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35683	35689		10.1074/jbc.M113.529347	http://dx.doi.org/10.1074/jbc.M113.529347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174526	hybrid, Green Published			2022-12-28	WOS:000329814700007
J	Nabilsi, NH; Ryder, DJ; Peraza-Penton, AC; Poudyal, R; Loose, DS; Kladde, MP				Nabilsi, Nancy H.; Ryder, Daniel J.; Peraza-Penton, Ashley C.; Poudyal, Rosha; Loose, David S.; Kladde, Michael P.			Local Depletion of DNA Methylation Identifies a Repressive p53 Regulatory Region in the NEK2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Regulation; Chromatin Structure; DNA Methylation; Epigenetics; Nucleosome; p53; MAPit; NEK2	METHYLTRANSFERASE ACCESSIBILITY PROTOCOL; CELL-CYCLE; INDIVIDUAL TEMPLATES; CPG METHYLATION; PROTEIN-KINASE; SURVIVIN GENE; BREAST-CANCER; EXPRESSION; PATTERNS; TARGET	Background: NEK2 is a mammalian kinase that promotes centrosome separation during the cell cycle. Results: Agents that demethylate the NEK2 promoter or induce DNA damage repress NEK2 expression in a p53-dependent manner. Conclusion: p53 represses NEK2 expression and protects its binding region from accumulating DNA methylation. Significance: Knowledge regarding novel mechanisms of NEK2 regulation may help inform clinical application of NEK2-based anticancer therapeutics. Genome-scale mapping suggests that the function of DNA methylation varies with genomic context beyond transcriptional repression. However, the use of DNA-demethylating agents (e.g. 5-aza-2-deoxycytidine (5aza-dC)) to study epigenetic regulation often focuses on gene activation and ignores repression elicited by 5aza-dC. Here, we show that repression of NEK2, which encodes the never in mitosis A (NIMA)-related kinase, by 5aza-dC is context-specific as NEK2 transcript levels were reduced in HCT116 colon cancer cells but not in isogenic p53(-/-) cells. Bisulfite sequencing showed that DNA methylation was restricted to the distal region of the NEK2 promoter. Demethylation by 5aza-dC was associated with increased accessibility to micrococcal nuclease, i.e. nucleosome depletion. Conversely, methyltransferase accessibility protocol for individual templates (MAPit) methylation footprinting showed that nucleosome occupancy and DNA methylation at the distal promoter were significantly increased in p53(-/-) cells, suggesting dynamic regulation of chromatin structure at this region by p53 in HCT116 cells. Stabilization of endogenous p53 by doxorubicin or ectopic expression of p53, but not a p53 DNA-binding mutant, decreased NEK2 expression. Chromatin immunoprecipitation demonstrated direct and specific association of p53 with the distal NEK2 promoter, which was enhanced by doxorubicin. Luciferase reporters confirmed that this region is required for p53-mediated repression of NEK2 promoter activity. Lastly, modulation of p53 abundance altered nucleosome occupancy and DNA methylation at its binding region. These results identify NEK2 as a novel p53-repressed gene, illustrate that its repression by 5aza-dC is specific and associated with nucleosome reorganization, and provide evidence that identification of partially methylated regions can reveal novel p53 target genes.	[Nabilsi, Nancy H.; Peraza-Penton, Ashley C.; Poudyal, Rosha; Kladde, Michael P.] Univ Florida, Coll Med, Hlth Canc Ctr, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Ryder, Daniel J.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Phys Therapy, Gainesville, FL 32610 USA; [Loose, David S.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Health Science Center Houston	Loose, DS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	David.S.Loose@uth.tmc.edu; kladde@ufl.edu			National Institutes of Health [CA098258, CA155390]; Bankhead-Coley Florida Cancer Research Program Postdoctoral Fellowship [BD-03]; NATIONAL CANCER INSTITUTE [P50CA098258, P30CA016672, T32CA059365, R01CA155390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley Florida Cancer Research Program Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA098258 (to D. S. L.) and CA155390 (to M. P. K.). This work was also supported by Bankhead-Coley Florida Cancer Research Program Postdoctoral Fellowship BD-03 (to N. H. N.). We thank Dr. Lei Deng and Dr. Russell Broaddus for providing the p53-luciferase reporter and RNA from doxo-treated breast cancer cells and Dr. Lawrence Donehower for the p53-EGFP construct. We also thank Dr. Carolina Pardo for critical reading of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barbagallo F, 2009, J PATHOL, V217, P431, DOI 10.1002/path.2471; Barletta JM, 1997, CANCER RES, V57, P48; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Brendle A, 2009, EUR J CANCER, V45, P435, DOI 10.1016/j.ejca.2008.10.001; Broude EV, 2007, CELL CYCLE, V6, P1468; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Cui KR, 2012, METHODS MOL BIOL, V833, P413, DOI 10.1007/978-1-61779-477-3_24; Darst RP, 2012, METHOD ENZYMOL, V513, P185, DOI 10.1016/B978-0-12-391938-0.00008-2; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Fletcher L, 2004, RADIAT RES, V162, P128, DOI 10.1667/RR3211; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herbert BS, 2010, ONCOTARGET, V1, P405; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hsieh CL, 1999, MOL CELL BIOL, V19, P46; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kilgore JA, 2007, METHODS, V41, P320, DOI 10.1016/j.ymeth.2006.08.008; Kokuryo T, 2007, CANCER RES, V67, P9637, DOI 10.1158/0008-5472.CAN-07-1489; Lai AY, 2010, J EXP MED, V207, P1939, DOI 10.1084/jem.20100204; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Lin IG, 2000, MOL CELL BIOL, V20, P2343, DOI 10.1128/MCB.20.7.2343-2349.2000; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Nabilsi NH, 2010, J ENDOCRINOL, V207, P237, DOI 10.1677/JOE-10-0128; Pang LY, 2011, CELL CYCLE, V10, P932, DOI 10.4161/cc.10.6.15012; Pardo Carolina E, 2011, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2122s95; Pardo CE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq716; Peltonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012996; Petrovich M, 2009, J MOL BIOL, V386, P72, DOI 10.1016/j.jmb.2008.11.054; Qiu XL, 2009, J MED CHEM, V52, P1757, DOI 10.1021/jm8015969; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suzuki K, 2010, CANCER SCI, V101, P1163, DOI 10.1111/j.1349-7006.2010.01504.x; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wu GK, 2008, CANCER RES, V68, P8393, DOI 10.1158/0008-5472.CAN-08-1915; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie R, 2007, MODERN PATHOL, V20, P1045, DOI 10.1038/modpathol.3800940; Xu M, 1998, NUCLEIC ACIDS RES, V26, P3961, DOI 10.1093/nar/26.17.3961; Yang F, 2013, CURR BIOL, V23, P782, DOI 10.1016/j.cub.2013.03.043	58	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35940	35951		10.1074/jbc.M113.523837	http://dx.doi.org/10.1074/jbc.M113.523837			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24163369	Green Published, hybrid			2022-12-28	WOS:000329814700030
J	Sabit, I; Hashimoto, N; Matsumoto, Y; Yamaji, T; Furukawa, K; Furukawa, K				Sabit, Ilhamjan; Hashimoto, Noboru; Matsumoto, Yasuyuki; Yamaji, Toshiyuki; Furukawa, Keiko; Furukawa, Koichi			Binding of a Sialic Acid-recognizing Lectin Siglec-9 Modulates Adhesion Dynamics of Cancer Cells via Calpain-mediated Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Calpain; Focal Adhesion Kinase; Lectin; Protein Degradation; Sialic Acid	MALIGNANT PROPERTIES; GANGLIOSIDE GD3; MELANOMA-CELLS; KINASE FAK; MIGRATION; MECHANISMS; APOPTOSIS; PATHWAYS; PAXILLIN; INSIGHT	Although regulatory mechanisms for immune cells with inhibitory signals via immunoreceptor tyrosine-based inhibitory motifs are well known, signals transduced via interaction between Siglecs and sialyl compounds on their counterreceptors into target cells have not been reported to date. In this study, we found that an astrocytoma cell line, AS, showed detachment from culture plates when co-cultured with Siglec-9-expressing cells and/or soluble Siglec-9. Moreover, detached AS cells regrew as co-cultured cells with Siglec-9-deficient cells. They also showed increased motility and invasiveness upon Siglec-9 binding. In immunoblotting, rapid degradation of focal adhesion kinase (FAK) and related signaling molecules such as Akt, paxillin, and p130Cas was observed immediately after the co-culture. Despite degradation of these molecules, increased p-Akt was found at the front region of the cytoplasm, probably reflecting increased cell motility. Calpain was considered to be a responsible protease for the protein degradation by the inhibition experiments. These results suggest that protein degradation of FAK and related molecules was induced by Siglec-9 binding to its counterreceptors via sialylglycoconjugates, leading to the modulation of adhesion kinetics of cancer cells. Thus, this might be a mechanism by which cancer cells utilize Siglec-9-derived signals to escape from immunosurveillance.	[Sabit, Ilhamjan; Hashimoto, Noboru; Matsumoto, Yasuyuki; Furukawa, Keiko; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4660065, Japan; [Yamaji, Toshiyuki] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Furukawa, Keiko] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 4878501, Japan	Nagoya University; National Institute of Infectious Diseases (NIID); Chubu University	Furukawa, K (corresponding author), 65 Tsurumai,Showa Ku, Nagoya, Aichi 4660065, Japan.	koichi@med.nagoya-u.ac.jp	Shabiti, Yilihamujiang/E-9361-2015; Sabit, Ilhamjan/E-6002-2018	Shabiti, Yilihamujiang/0000-0002-6790-5141; Sabit, Ilhamjan/0000-0001-8983-9491	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [21390076, 24390078, 23590371, 23110008]; Toyoaki Shogaku-kai Foundation; Kobayashi Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toyoaki Shogaku-kai Foundation; Kobayashi Foundation	This work was supported by Grants-in-aid for Scientific Research 21390076, 24390078, and 23590371; Grant-in-aid for Scientific Research on Innovative Areas 23110008 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); and grants from the Toyoaki Shogaku-kai Foundation and Kobayashi Foundation.	Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Angata T, 2000, J BIOL CHEM, V275, P22127, DOI 10.1074/jbc.M002775200; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Golubovskaya VM, 2010, ANTI-CANCER AGENT ME, V10, P735; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hamamura K, 2008, BBA-GEN SUBJECTS, V1780, P513, DOI 10.1016/j.bbagen.2007.11.002; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Li B, 2002, GENE THER, V9, P233, DOI 10.1038/sj.gt.3301641; Mitsuki M, 2010, GLYCOBIOLOGY, V20, P395, DOI 10.1093/glycob/cwp195; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sieg DJ, 1999, J CELL SCI, V112, P2677; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; WATANABE T, 1982, J EXP MED, V156, P1884, DOI 10.1084/jem.156.6.1884; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	22	6	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35417	35427		10.1074/jbc.M113.513192	http://dx.doi.org/10.1074/jbc.M113.513192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145038	hybrid, Green Published			2022-12-28	WOS:000329867600038
J	Bryant, KL; Antonyak, MA; Cerione, RA; Baird, B; Holowka, D				Bryant, Kirsten L.; Antonyak, Marc A.; Cerione, Richard A.; Baird, Barbara; Holowka, David			Mutations in the Polybasic Juxtamembrane Sequence of Both Plasma Membrane- and Endoplasmic Reticulum-localized Epidermal Growth Factor Receptors Confer Ligand-independent Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Epidermal Growth Factor Receptor (EGFR); Oncogene; PI 3-Kinase (PI3K); Transformation	EGF RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SUBCELLULAR-LOCALIZATION; CONSTITUTIVE ACTIVATION; ENHANCED EXPRESSION; TYROSINE KINASES; EGFRVIII; DOMAIN; GENE; AMPLIFICATION	Background: Deregulation of EGF receptor (EGFR) signaling leads to cellular transformation. Results: Reduction of net charge in the EGFR juxtamembrane region generates constitutively active EGFR, and activity is maintained when this receptor is ER-retained. Conclusion: Wholly ER-retained, constitutively active EGFRs can drive transformation through PI3K activation. Significance: The polybasic juxtamembrane sequence plays an important role in regulating EGFR signaling leading to oncogenic transformation. Deregulation of ErbB receptor-tyrosine kinases is a hallmark of many human cancers. Conserved in the ErbB family is a cluster of basic amino acid residues in the cytoplasmic juxtamembrane region. We found that charge-silencing mutagenesis within this juxtamembrane region of the epidermal growth factor receptor (EGFR) results in the generation of a mutant receptor (EGFR Mut R1-6) that spontaneously transforms NIH 3T3 cells in a ligand-independent manner. A similar mutant with one additional basic residue, EGFR Mut R1-5, fails to exhibit ligand-independent transformation. The capacity of EGFR Mut R1-6 to mediate this transformation is maintained when this mutant is retained in the endoplasmic reticulum via a single point mutation, L393H, which we describe. We show that EGFR Mut R1-6 with or without L393H exhibits enhanced basal tyrosine phosphorylation when ectopically expressed, and the ligand-independent transforming activity of EGFR Mut R1-6 is sensitive to inhibition of EGFR kinase activity and is particularly dependent on PI3K and mTOR activity. Similar to EGFR Mut R1-6/L393H in NIH 3T3 cells, EGFR variant type III, a highly oncogenic mutant form of EGFR linked to human brain cancers, confers transforming activity while it is wholly endoplasmic reticulum-retained in U87 cells. Our findings highlight the importance of the polybasic juxtamembrane sequence in regulating the oncogenic potential of EGFR signaling.	[Bryant, Kirsten L.; Cerione, Richard A.; Baird, Barbara; Holowka, David] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, NYS Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Baird, B (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bab13@cornell.edu		Bryant, Kirsten/0000-0003-4026-0942	National Institutes of Health Chemistry/Biology Interface Training Grant [5T32GM008500, R01A1022449]; PhRMA Foundation Predoctoral Fellowship in Pharmacology/Toxicology; NATIONAL CANCER INSTITUTE [T32CA009156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, T32GM008500] Funding Source: NIH RePORTER	National Institutes of Health Chemistry/Biology Interface Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation Predoctoral Fellowship in Pharmacology/Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Chemistry/Biology Interface Training Grant 5T32GM008500 (to K.B.) and Grant R01A1022449 (NIAID). This work was also supported by a PhRMA Foundation Predoctoral Fellowship in Pharmacology/Toxicology (to K.B.).	Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Chu CT, 1997, BIOCHEM J, V324, P855, DOI 10.1042/bj3240855; Cvrljevic AN, 2011, J CELL SCI, V124, P2938, DOI 10.1242/jcs.083295; EKSTRAND AJ, 1995, ONCOGENE, V10, P1455; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; GAMOU S, 1989, EXP CELL RES, V183, P197, DOI 10.1016/0014-4827(89)90429-1; Gosse JA, 2005, J IMMUNOL, V175, P2123, DOI 10.4049/jimmunol.175.4.2123; Gupta P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-72; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; He C, 2002, J BIOL CHEM, V277, P38284, DOI 10.1074/jbc.M104646200; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; HUMPHREY PA, 1988, CANCER RES, V48, P2231; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8477, DOI 10.1093/nar/13.23.8477; Kong M, 2000, J BIOL CHEM, V275, P36035, DOI 10.1074/jbc.M005621200; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; Michailidis IE, 2011, PFLUG ARCH EUR J PHY, V461, P387, DOI 10.1007/s00424-010-0904-3; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Morrison P, 1996, BIOCHEMISTRY-US, V35, P14618, DOI 10.1021/bi961630+; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Moscatello DK, 1996, ONCOGENE, V13, P85; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; PRIVALSKY ML, 1984, VIROLOGY, V135, P356, DOI 10.1016/0042-6822(84)90192-2; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Sato T, 2006, BIOCHEMISTRY-US, V45, P12704, DOI 10.1021/bi061264m; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sengupta P, 2009, BIOPHYS J, V96, P4887, DOI 10.1016/j.bpj.2009.03.027; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; USHIRO H, 1980, J BIOL CHEM, V255, P8363; Ward CW, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-4; WIKSTRAND CJ, 1995, CANCER RES, V55, P3140; Wikstrand CJ, 1997, CANCER RES, V57, P4130; XU YH, 1984, P NATL ACAD SCI-BIOL, V81, P7308, DOI 10.1073/pnas.81.23.7308	55	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34930	34942		10.1074/jbc.M113.513333	http://dx.doi.org/10.1074/jbc.M113.513333			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142702	Green Published, hybrid			2022-12-28	WOS:000329812800059
J	Hu, LY; Pandey, AV; Eggimann, S; Rufenacht, V; Moslinger, D; Nuoffer, JM; Haberle, J				Hu, Liyan; Pandey, Amit V.; Eggimann, Sandra; Ruefenacht, Veronique; Moeslinger, Dorothea; Nuoffer, Jean-Marc; Haeberle, Johannes			Understanding the Role of Argininosuccinate Lyase Transcript Variants in the Clinical and Biochemical Variability of the Urea Cycle Disorder Argininosuccinic Aciduria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Metabolic Diseases; Recombinant Protein Expression; Transfection; Urea Cycle; Argininosuccinate Lyase (ASL); Argininosuccinic Aciduria (ASA); Homomeric; Heterotetrameric Protein; Transcript Variants	INTRAGENIC COMPLEMENTATION; MUTATION ANALYSIS; DELTA-CRYSTALLIN; GENE; DEFICIENCY; METABOLISM; ARGININE; ENZYMES; MUTANT; BRAIN	Background: The role of argininosuccinate lyase (ASL) transcripts in disease variability is unclear. Results: The most common ASL transcript variants decrease the functional enzymatic activity after co-expression with wild type or mutant ASL. Conclusion: ASL transcripts expressed at high levels can contribute to the variable phenotype in ASL-deficient patients. Significance: A new explanation of the molecular basis adds to our understanding of the clinical variability in patients. Argininosuccinic aciduria (ASA) is an autosomal recessive urea cycle disorder caused by deficiency of argininosuccinate lyase (ASL) with a wide clinical spectrum from asymptomatic to severe hyperammonemic neonatal onset life-threatening courses. We investigated the role of ASL transcript variants in the clinical and biochemical variability of ASA. Recombinant proteins for ASL wild type, mutant p.E189G, and the frequently occurring transcript variants with exon 2 or 7 deletions were (co-)expressed in human embryonic kidney 293T cells. We found that exon 2-deleted ASL forms a stable truncated protein with no relevant activity but a dose-dependent dominant negative effect on enzymatic activity after co-expression with wild type or mutant ASL, whereas exon 7-deleted ASL is unstable but seems to have, nevertheless, a dominant negative effect on mutant ASL. These findings were supported by structural modeling predictions for ASL heterotetramer/homotetramer formation. Illustrating the physiological relevance, the predominant occurrence of exon 7-deleted ASL was found in two patients who were both heterozygous for the ASL mutant p.E189G. Our results suggest that ASL transcripts can contribute to the highly variable phenotype in ASA patients if expressed at high levels. Especially, the exon 2-deleted ASL variant may form a heterotetramer with wild type or mutant ASL, causing markedly reduced ASL activity.	[Hu, Liyan; Ruefenacht, Veronique; Haeberle, Johannes] Univ Childrens Hosp Zurich, Div Metab, CH-8032 Zurich, Switzerland; [Hu, Liyan; Ruefenacht, Veronique; Haeberle, Johannes] Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Pandey, Amit V.] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Eggimann, Sandra; Nuoffer, Jean-Marc] Univ Bern, Univ Inst Clin Chem, CH-3010 Bern, Switzerland; [Eggimann, Sandra; Nuoffer, Jean-Marc] Univ Bern, Univ Childrens Hosp, CH-3010 Bern, Switzerland; [Moeslinger, Dorothea] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria	University Children's Hospital Zurich; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Medical University of Vienna	Haberle, J (corresponding author), Univ Childrens Hosp Zurich, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	Johannes.Haeberle@kispi.uzh.ch	Pandey, Amit V/AAO-6442-2020; Pandey, Amit V/A-7223-2008; Nuoffer, Jean-Marc/C-8936-2009	Pandey, Amit V/0000-0001-8331-5902; Pandey, Amit V/0000-0001-8331-5902; Nuoffer, Jean-Marc/0000-0003-3650-6153; Haberle, Johannes/0000-0003-0635-091X	Swiss National Science Foundation [310030_127184/1, 31003A-134926]; Schweizerische Mobiliar Genossenschaft Jubilaumsstiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schweizerische Mobiliar Genossenschaft Jubilaumsstiftung	This work was supported by Swiss National Science Foundation Grants 310030_127184/1 (to J. H.) and 31003A-134926 (to A. V. P.) and a grant from Schweizerische Mobiliar Genossenschaft Jubilaumsstiftung (to A. V. P.).	ABRAMSON RD, 1991, GENOMICS, V10, P126, DOI 10.1016/0888-7543(91)90492-W; ALLAN JD, 1958, LANCET, V1, P182; BARBOSA P, 1991, J BIOL CHEM, V266, P5286; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brusilow S., 2001, METABOLIC MOL BASES, V8th, P1909; Brusilow S W, 1996, Adv Pediatr, V43, P127; De Jonge WJ, 1998, PEDIATR RES, V43, P442, DOI 10.1203/00006450-199804000-00002; Doimo M, 2012, J INHERIT METAB DIS, V35, P557, DOI 10.1007/s10545-011-9402-9; Engel K, 2012, J INHERIT METAB DIS, V35, P133, DOI 10.1007/s10545-011-9357-x; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Erez A, 2011, AM J MED GENET C, V157C, P45, DOI 10.1002/ajmg.c.30289; Ficicioglu C, 2009, MOL GENET METAB, V98, P273, DOI 10.1016/j.ymgme.2009.06.011; Flynn NE, 1999, J NUTR, V129, P799, DOI 10.1093/jn/129.4.799; GLICK NR, 1976, AM J HUM GENET, V28, P22; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Howell PL, 1998, J INHERIT METAB DIS, V21, P72, DOI 10.1023/A:1005361724967; HUSSON A, 1990, EUR J BIOCHEM, V192, P677, DOI 10.1111/j.1432-1033.1990.tb19275.x; JONES ME, 1961, ARCH BIOCHEM BIOPHYS, V95, P499, DOI 10.1016/0003-9861(61)90182-5; Kretz R, 2012, MOL GENET METAB, V106, P375, DOI 10.1016/j.ymgme.2012.04.011; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsverk ML, 2011, MOL GENET METAB, V103, P148, DOI 10.1016/j.ymgme.2011.03.003; Linnebank M, 2000, J INHERIT METAB DIS, V23, P308, DOI 10.1023/A:1005690005439; Linnebank M, 2002, HUM GENET, V111, P350, DOI 10.1007/s00439-002-0793-4; Liu HY, 2001, PROTEINS, V44, P484, DOI 10.1002/prot.1114; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MATSUBASA T, 1989, P NATL ACAD SCI USA, V86, P592, DOI 10.1073/pnas.86.2.592; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; Mercimek-Mahmutoglu S, 2010, MOL GENET METAB, V100, P24, DOI 10.1016/j.ymgme.2010.01.013; NAYLOR SL, 1978, P NATL ACAD SCI USA, V75, P6159, DOI 10.1073/pnas.75.12.6159; Neill MA, 2009, MOL GENET METAB, V97, P121, DOI 10.1016/j.ymgme.2009.02.009; OBRIEN WE, 1981, BIOCHEMISTRY-US, V20, P2056, DOI 10.1021/bi00510a049; PERRY TL, 1980, CLIN CHIM ACTA, V105, P257, DOI 10.1016/0009-8981(80)90468-4; Piatigorsky J, 1996, BBA-PROTEIN STRUCT M, V1295, P158, DOI 10.1016/0167-4838(96)00030-1; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; PISARENKO SI, 1980, B EXP BIOL MED+, V89, P138; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RATNER S, 1960, ARCH BIOCHEM BIOPHYS, V91, P280, DOI 10.1016/0003-9861(60)90502-6; RATNER S, 1973, ADV ENZYMOL RAMB, V39, P1; RATNER S, 1953, J BIOL CHEM, V200, P175; Renouf S, 1998, BIOL NEONATE, V73, P190, DOI 10.1159/000013977; Sampaleanu LM, 2002, J BIOL CHEM, V277, P4166, DOI 10.1074/jbc.M107465200; SIMARD L, 1986, AM J HUM GENET, V39, P38; TODD S, 1989, GENOMICS, V4, P53, DOI 10.1016/0888-7543(89)90314-5; TOMLINSON S, 1964, CLIN SCI, V26, P261; Trevisson E, 2009, J BIOL CHEM, V284, P28926, DOI 10.1074/jbc.M109.050195; Turner MA, 1997, P NATL ACAD SCI USA, V94, P9063, DOI 10.1073/pnas.94.17.9063; Vallee F, 1999, BIOCHEMISTRY-US, V38, P2425, DOI 10.1021/bi982149h; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walker DC, 1997, J BIOL CHEM, V272, P6777, DOI 10.1074/jbc.272.10.6777; WALKER DC, 1990, P NATL ACAD SCI USA, V87, P9625, DOI 10.1073/pnas.87.24.9625; WALKER JB, 1958, P SOC EXP BIOL MED, V98, P7, DOI 10.3181/00379727-98-23922; WONG LTK, 1979, CLIN BIOCHEM, V12, P167, DOI 10.1016/S0009-9120(79)80083-1	55	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34599	34611		10.1074/jbc.M113.503128	http://dx.doi.org/10.1074/jbc.M113.503128			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24136197	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000329812800028
J	Dai, XM; She, PL; Chi, FT; Feng, Y; Liu, H; Jin, DQ; Zhao, YQ; Guo, XC; Jiang, DD; Guan, KL; Zhong, TP; Zhao, B				Dai, Xiaoming; She, Peilu; Chi, Fangtao; Feng, Ying; Liu, Huan; Jin, Daqing; Zhao, Yiqiang; Guo, Xiaocan; Jiang, Dandan; Guan, Kun-Liang; Zhong, Tao P.; Zhao, Bin			Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Angiogenesis; Cell Migration; Protein Kinases; Protein Phosphorylation; Lats; AMOT; Protein Kinase; the Hippo Pathway	HIPPO-YAP PATHWAY; TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; EMBRYONIC-DEVELOPMENT; PROLIFERATION ARREST; PROTEIN-KINASE; GROWTH-CONTROL; TISSUE-GROWTH; SIZE-CONTROL; CYCLE EXIT	The Hippo tumor suppressor pathway plays important roles in organ size control through Lats1/2 mediated phosphorylation of the YAP/TAZ transcription co-activators. However, YAP/TAZ independent functions of the Hippo pathway are largely unknown. Here we report a novel role of the Hippo pathway in angiogenesis. Angiomotin p130 isoform (AMOTp130) is phosphorylated on a conserved HXRXXS motif by Lats1/2 downstream of GPCR signaling. Phosphorylation disrupts AMOT interaction with F-actin and correlates with reduced F-actin stress fibers and focal adhesions. Furthermore, phosphorylation of AMOT by Lats1/2 inhibits endothelial cell migration in vitro and angiogenesis in zebrafish embryos in vivo. Thus AMOT is a direct substrate of Lats1/2 mediating functions of the Hippo pathway in endothelial cell migration and angiogenesis.	[Dai, Xiaoming; Chi, Fangtao; Feng, Ying; Liu, Huan; Zhao, Yiqiang; Guo, Xiaocan; Jiang, Dandan; Zhao, Bin] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Dai, Xiaoming; Chi, Fangtao; Feng, Ying; Liu, Huan; Zhao, Yiqiang; Guo, Xiaocan; Jiang, Dandan; Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [She, Peilu; Jin, Daqing; Zhong, Tao P.] Fudan Univ, Sch Life Sci, Dept Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Zhejiang University; Zhejiang University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhao, B (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	binzhao@zju.edu.cn	Guan, Kun-Liang/ADK-7088-2022; Liu, Huan/CAA-2351-2022	Dai, Xiaoming/0000-0001-9671-8137; /0000-0002-5730-2830	National Natural Science Foundation of China [31271508]; State Key Development Program for Basic Research of China [2013CB945303]; Natural Science Foundation of Zhejiang [LR12C07001]; Thousand Young Talents Plan of China; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province); Thousand Young Talents Plan of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants (to B. Z.) from the National Natural Science Foundation of China (31271508), State Key Development Program for Basic Research of China (2013CB945303), Natural Science Foundation of Zhejiang (LR12C07001), and the Thousand Young Talents Plan of China.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chiyoda T, 2012, J CELL BIOL, V197, P625, DOI 10.1083/jcb.201110110; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dutta S, 2008, CURR BIOL, V18, P1466, DOI 10.1016/j.cub.2008.08.052; Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Shah Kavita, 2003, Methods Mol Biol, V233, P253; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	53	115	124	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34041	34051		10.1074/jbc.M113.518019	http://dx.doi.org/10.1074/jbc.M113.518019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106267	hybrid, Green Published			2022-12-28	WOS:000327250200045
J	Loya, TJ; O'Rourke, TW; Degtyareva, N; Reines, D				Loya, Travis J.; O'Rourke, Thomas W.; Degtyareva, Natalya; Reines, Daniel			A Network of Interdependent Molecular Interactions Describes a Higher Order Nrd1-Nab3 Complex Involved in Yeast Transcription Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Polyglutamine; RNA; RNA-binding Protein; RNA Polymerase II; Transcription Elongation Factors; Transcription Termination; Nab3; Nrd1	RNA-BINDING PROTEINS; CELL-FREE FORMATION; HNRNP-C; SEQUENCE; NRD1; IDENTIFICATION; SNORNA; DOMAIN; AGGREGATION; RECOGNITION	Background: How the yeast proteins Nrd1 and Nab3 provoke transcription termination is poorly understood. Results: An essential part of Nab3 contains a self-assembly domain that appears unstructured. Nrd1/Nab3 double mutants disrupt the function of this higher order complex, causing lethality. Conclusion: A large network of molecular interactions is needed for termination. Significance: A new essential function of Nab3 has been identified. Nab3 and Nrd1 are yeast heterogeneous nuclear ribonucleoprotein (hnRNP)-like proteins that heterodimerize and bind RNA. Genetic and biochemical evidence reveals that they are integral to the termination of transcription of short non-coding RNAs by RNA polymerase II. Here we define a Nab3 mutation (nab3134) that removes an essential part of the protein's C terminus but nevertheless can rescue, in trans, the phenotype resulting from a mutation in the RNA recognition motif of Nab3. This low complexity region of Nab3 appears intrinsically unstructured and can form a hydrogel in vitro. These data support a model in which multiple Nrd1-Nab3 heterodimers polymerize onto substrate RNA to effect termination, allowing complementation of one mutant Nab3 molecule by another lacking a different function. The self-association property of Nab3 adds to the previously documented interactions between these hnRNP-like proteins, RNA polymerase II, and the nascent transcript, leading to a network of nucleoprotein interactions that define a higher order Nrd1-Nab3 complex. This was underscored from the synthetic phenotypes of yeast strains with pairwise combinations of Nrd1 and Nab3 mutations known to affect their distinct biochemical activities. The mutations included a Nab3 self-association defect, a Nab3-Nrd1 heterodimerization defect, a Nrd1-polymerase II binding defect, and an Nab3-RNA recognition motif mutation. Although no single mutation was lethal, cells with any two mutations were not viable for four such pairings, and a fifth displayed a synthetic growth defect. These data strengthen the idea that a multiplicity of interactions is needed to assemble a higher order Nrd1-Nab3 complex that coats specific nascent RNAs in preparation for termination.	[Loya, Travis J.; O'Rourke, Thomas W.; Degtyareva, Natalya; Reines, Daniel] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Rollins Res Ctr, Atlanta, GA 30322 USA.	dreines@emory.edu	excellency, Your/R-2357-2019; Degtyareva, Natalya/AAI-5500-2021	excellency, Your/0000-0003-0832-6243; Degtyareva, Natalya/0000-0002-7141-6308	National Institutes of Health, NIGMS [R01GM46331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM046331] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant R01GM46331.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; BARNETT SF, 1989, MOL CELL BIOL, V9, P492, DOI 10.1128/MCB.9.2.492; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Conrad NK, 2000, GENETICS, V154, P557; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Galea CA, 2006, J PROTEOME RES, V5, P2839, DOI 10.1021/pr060328c; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hobor F, 2011, J BIOL CHEM, V286, P3645, DOI 10.1074/jbc.M110.158774; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Johnson DE, 2012, J STRUCT BIOL, V180, P201, DOI 10.1016/j.jsb.2012.05.013; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kloimwieder A, 2011, G3-GENES GENOM GENET, V1, P143, DOI 10.1534/g3.111.000323; Loya TJ, 2013, J BIOL CHEM, V288, P2111, DOI 10.1074/jbc.M112.430678; Loya TJ, 2012, NUCLEIC ACIDS RES, V40, P7476, DOI 10.1093/nar/gks377; Lunde BM, 2011, NUCLEIC ACIDS RES, V39, P337, DOI 10.1093/nar/gkq751; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Petrakis S, 2013, BIOESSAYS, V35, P503, DOI 10.1002/bies.201300001; Porrua O, 2012, EMBO J, V31, P3935, DOI 10.1038/emboj.2012.237; REINES D, 1985, J BIOL CHEM, V260, P4248; Riordan DP, 2011, NUCLEIC ACIDS RES, V39, P1501, DOI 10.1093/nar/gkq920; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Whitson SR, 2005, J MOL BIOL, V350, P319, DOI 10.1016/j.jmb.2005.05.002; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	41	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34158	34167		10.1074/jbc.M113.516765	http://dx.doi.org/10.1074/jbc.M113.516765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100036	Green Published, hybrid			2022-12-28	WOS:000327250200059
J	Tumer, E; Broer, A; Balkrishna, S; Julich, T; Broer, S				Tuemer, Emrah; Broeer, Angelika; Balkrishna, Sarojini; Juelich, Torsten; Broeer, Stefan			Enterocyte-specific Regulation of the Apical Nutrient Transporter SLC6A19 (B(0)AT1) by Transcriptional and Epigenetic Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; DNA Methylation; Epithelial Cell; Histone Modification; HNF-4; Promoters; Transcription Regulation	HEPATOCYTE NUCLEAR FACTOR-1; INTESTINAL EPITHELIAL-CELLS; AMINO-ACID-TRANSPORT; GENE-EXPRESSION; DNA DEMETHYLATION; HARTNUP DISORDER; SELF-RENEWAL; ALPHA-GENE; DIFFERENTIATION; MUTATIONS	Enterocytes are specialized to absorb nutrients from the lumen of the small intestine by expressing a select set of genes to maximize the uptake of nutrients. They develop from stem cells in the crypt and differentiate into mature enterocytes while moving along the crypt-villus axis. Using the Slc6a19 gene as an example, encoding the neutral amino acid transporter B(0)AT1, we studied regulation of the gene by transcription factors and epigenetic factors in the intestine. To investigate this question, we used a fractionation method to separate mature enterocytes from crypt cells and analyzed gene expression. Transcription factors HNF1a and HNF4a activate transcription of the Slc6a19 gene in villus enterocytes, whereas high levels of SOX9 repress expression in the crypts. CpG dinucleotides in the proximal promoter were highly methylated in the crypt and fully de-methylated in the villus. Furthermore, histone modification H3K27Ac, indicating an active promoter, was prevalent in villus cells but barely detectable in crypt cells. The results suggest that Slc6a19 expression in the intestine is regulated at three different levels involving promoter methylation, histone modification, and opposing transcription factors.	[Tuemer, Emrah; Broeer, Angelika; Balkrishna, Sarojini; Juelich, Torsten; Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia	Australian National University	Broer, S (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	Stefan.broeer@anu.edu.au	Broer, Stefan/A-1286-2008	Broer, Stefan/0000-0002-8040-1634	National Health and Medical Research Council [525415]; Australian Research Council [DP0877897]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council Grant 525415 and Australian Research Council Grant DP0877897 (to S.B.).	BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Broer A, 2011, J BIOL CHEM, V286, P26638, DOI 10.1074/jbc.M111.241323; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Carey N, 2011, DRUG DISCOV TODAY, V16, P683, DOI 10.1016/j.drudis.2011.05.004; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; Eeckhoute J, 2004, NUCLEIC ACIDS RES, V32, P2586, DOI 10.1093/nar/gkh581; ENCODE Project Consortium, 2011, PLOS BIOL, V9; Fairweather S. J., 2012, BIOCH J; Fairweather SJ, 2012, BIOCHEM J, V446, P135, DOI 10.1042/BJ20120307; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Gracz AD, 2011, AM J PHYSIOL-GASTR L, V300, pG503, DOI 10.1152/ajpgi.00489.2010; Harries LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007855; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Kikuchi R, 2010, KIDNEY INT, V78, P569, DOI 10.1038/ki.2010.176; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Kowalczuk S, 2008, FASEB J, V22, P2880, DOI 10.1096/fj.08-107300; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Malakauskas SM, 2007, AM J PHYSIOL-RENAL, V292, pF533, DOI 10.1152/ajprenal.00325.2006; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Richmond CA, 2010, PROG MOL BIOL TRANSL, V96, P207, DOI 10.1016/S1877-1173(10)96009-2; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Suzuki T, 2008, BIOCHEM BIOPH RES CO, V369, P788, DOI 10.1016/j.bbrc.2008.02.101; TRABER PG, 1991, AM J PHYSIOL, V260, pG895, DOI 10.1152/ajpgi.1991.260.6.G895; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Weaver R. F., 2012, MOL BIOL, P259; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0	45	17	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33813	33823		10.1074/jbc.M113.482760	http://dx.doi.org/10.1074/jbc.M113.482760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121511	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000327250200026
J	Yang, D; Okamura, H; Nakashima, Y; Haneji, T				Yang, Di; Okamura, Hirohiko; Nakashima, Yoshiki; Haneji, Tatsuji			Histone Demethylase Jmjd3 Regulates Osteoblast Differentiation via Transcription Factors Runx2 and Osterix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Bone morphogenetic protein (BMP); Differentiation; Histone methylation; Osteoblasts	BONE MORPHOGENETIC PROTEIN-2; 2A C-ALPHA; GENE-EXPRESSION; PHOSPHATASE; OSTEOCALCIN; INDUCTION; CULTURES; FAMILY; MATRIX; CELLS	Post-translational modifications of histones including methylation play important roles in cell differentiation. Jumonji domain-containing 3 (Jmjd3) is a histone demethylase, which specifically catalyzes the removal of trimethylation of histone H3 at lysine 27 (H3K27me3). In this study, we examined the expression of Jmjd3 in osteoblasts and its roles in osteoblast differentiation. Jmjd3 expression in the nucleus was induced in response to the stimulation of osteoblast differentiation as well as treatment of bone morphogenetic protein-2 (BMP-2). Either treatment with Noggin, an inhibitor of BMP-2, or silencing of Smad1/5 suppressed Jmjd3 expression during osteoblast differentiation. Silencing of Jmjd3 expression suppressed osteoblast differentiation through the expression of bone-related genes including Runx2, osterix, osteopontin, bone sialoprotein (BSP), and osteocalcin (OCN). Silencing of Jmjd3 decreased the promoter activities of Runx2 and osterix and increased the level of H3K27me3 on the promoter regions of Runx2 and osterix. Introduction of the exogenous Runx2 and osterix partly rescued osteoblast differentiation in the shJmjd3 cells. The present results indicate that Jmjd3 plays important roles in osteoblast differentiation and regulates the expressions of BSP and OCN via transcription factors Runx2 and osterix.	[Yang, Di; Okamura, Hirohiko; Nakashima, Yoshiki; Haneji, Tatsuji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, Kuramoto, Tokushima 7708504, Japan; [Yang, Di] China Med Univ, Sch Stomatol, Dept Endodont, Shenyang 110002, Peoples R China	Tokushima University; China Medical University	Haneji, T (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	tat-hane@tokushima-u.ac.jp	Nakashima, Yoshiki/AAE-3808-2020; Okamura, Hirohiko/I-5917-2019	Okamura, Hirohiko/0000-0002-3254-5238; Nakashima, Yoshiki/0000-0003-1827-7609	Ministry of Education, Science, Sports, and Culture of Japan [21592330, 23592703, 25462859]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-aid for Scientific Research 21592330, 23592703, and 25462859 from the Ministry of Education, Science, Sports, and Culture of Japan.	Amorim BR, 2007, BIOCHEM BIOPH RES CO, V355, P347, DOI 10.1016/j.bbrc.2007.01.150; Canovas S, 2012, P NATL ACAD SCI USA, V109, P2400, DOI 10.1073/pnas.1119112109; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Chen SZ, 2013, CELL RES, V23, P326, DOI 10.1038/cr.2012.136; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Estaras C, 2012, DEVELOPMENT, V139, P2681, DOI 10.1242/dev.078345; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Fonseca M. B., 2012, PLOS ONE, V7; Ge WS, 2011, STEM CELLS, V29, P1112, DOI 10.1002/stem.663; Ghosh-Choudhury Nandini, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P345; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; HARRIS SE, 1994, J BONE MINER RES, V9, P855; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee SU, 2008, INT IMMUNOPHARMACOL, V8, P741, DOI 10.1016/j.intimp.2008.01.027; Lee SU, 2010, AMINO ACIDS, V38, P85, DOI 10.1007/s00726-008-0208-5; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Okamura H, 2013, J CELL PHYSIOL, V228, P1031, DOI 10.1002/jcp.24250; Okamura H, 2013, FEBS LETT, V587, P48, DOI 10.1016/j.febslet.2012.10.041; Okamura H, 2011, BONE, V49, P368, DOI 10.1016/j.bone.2011.06.004; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Rivenbark AG, 2007, SCIENCE, V318, P403, DOI 10.1126/science.1150321; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107	37	79	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33530	33541		10.1074/jbc.M113.497040	http://dx.doi.org/10.1074/jbc.M113.497040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106268	Green Published, hybrid			2022-12-28	WOS:000327250200004
J	Kofler, S; Ackaert, C; Samonig, M; Asam, C; Briza, P; Horejs-Hoeck, J; Cabrele, C; Ferreira, F; Duschl, A; Huber, C; Brandstetter, H				Kofler, Stefan; Ackaert, Chloe; Samonig, Martin; Asam, Claudia; Briza, Peter; Horejs-Hoeck, Jutta; Cabrele, Chiara; Ferreira, Fatima; Duschl, Albert; Huber, Christian; Brandstetter, Hans			Stabilization of the Dimeric Birch Pollen Allergen Bet v 1 Impacts Its Immunological Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergen; Crystal Structure; Mass Spectrometry (MS); Post-translational Modification; Protein Assembly; Dimerization; Noncanonical Amino Acid Incorporation; Polysulfide Linking; Position-specific Alteration of Genetic Code	SITE-DIRECTED MUTAGENESIS; IGE-BINDING; CRYSTAL-STRUCTURE; MAJOR ALLERGEN; X-RAY; MONOCLONAL-ANTIBODIES; PROTEIN STRUCTURES; CROSS-REACTIVITY; TYPE-2 RESPONSES; POTENTIAL USE	Many allergens share several biophysical characteristics, including the capability to undergo oligomerization. The dimerization mechanism in Bet v 1 and its allergenic properties are so far poorly understood. Here, we report crystal structures of dimeric Bet v 1, revealing a noncanonical incorporation of cysteine at position 5 instead of genetically encoded tyrosine. Cysteine polysulfide bridging stabilized different dimeric assemblies, depending on the polysulfide linker length. These dimers represent quaternary arrangements that are frequently observed in related proteins, reflecting their prevalence in unmodified Bet v 1. These conclusions were corroborated by characteristic immunologic properties of monomeric and dimeric allergen variants. Hereby, residue 5 could be identified as an allergenic hot spot in Bet v 1. The presented results refine fundamental principles in protein chemistry and emphasize the importance of protein modifications in understanding the molecular basis of allergenicity.	[Kofler, Stefan; Brandstetter, Hans] Salzburg Univ, Dept Mol Biol, Struct Biol Grp, A-5020 Salzburg, Austria; [Ackaert, Chloe; Asam, Claudia; Briza, Peter; Horejs-Hoeck, Jutta; Ferreira, Fatima; Duschl, Albert] Salzburg Univ, Dept Mol Biol, Div Allergy & Immunol, A-5020 Salzburg, Austria; [Samonig, Martin; Cabrele, Chiara; Huber, Christian] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria	Salzburg University; Salzburg University; Salzburg University	Brandstetter, H (corresponding author), Salzburg Univ, Dept Mol Biol, Struct Biol Grp, A-5020 Salzburg, Austria.	Hans.Brandstetter@sbg.ac.at	Ferreira, Fatima/E-4889-2011; Duschl, Albert/E-5872-2011; Briza, Peter/D-7309-2012; Horejs-Hoeck, Jutta/E-5010-2011; Brandstetter, Hans/E-6754-2011; Huber, Christian G./E-5445-2011; Horejs-Hoeck, Jutta/AAF-1735-2019; Cabrele, Chiara/B-8790-2015; Ferreira, Fatima/AAB-4321-2019	Ferreira, Fatima/0000-0003-0989-2335; Duschl, Albert/0000-0002-7034-9860; Briza, Peter/0000-0002-4941-6782; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Brandstetter, Hans/0000-0002-6089-3045; Huber, Christian G./0000-0001-8358-1880; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Cabrele, Chiara/0000-0002-7550-6896; Ferreira, Fatima/0000-0003-0989-2335	Austrian Science Fund [W_01213, P22236_B1]; Austrian Science Fund (FWF) [P 22236] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Projects W_01213 and P22236_B1.	Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Del Corno M, 2009, BLOOD, V114, P796, DOI 10.1182/blood-2009-01-199406; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira F, 1998, FASEB J, V12, P231, DOI 10.1096/fasebj.12.2.231; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gieras A, 2011, J IMMUNOL, V186, P5333, DOI 10.4049/jimmunol.1000804; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671; JAROLIM E, 1989, INT ARCH ALLER A IMM, V90, P54, DOI 10.1159/000235000; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kikuchi Y, 2006, J IMMUNOL, V177, P1609, DOI 10.4049/jimmunol.177.3.1609; Krebitz M, 2000, FASEB J, V14, P1279, DOI 10.1096/fj.14.10.1279; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Magler I, 2010, FEBS J, V277, P2598, DOI [10.1111/j.1742-464X.2010.07671.x, 10.1111/j.1742-4658.2010.07671.x]; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Michalska K, 2010, J STRUCT BIOL, V169, P161, DOI 10.1016/j.jsb.2009.10.008; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Mohr J, 2010, PROTEOMICS, V10, P3598, DOI 10.1002/pmic.201000341; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007245; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Niu XG, 2011, J MOL BIOL, V405, P479, DOI 10.1016/j.jmb.2010.11.007; PRECUP J, 1989, MOL GEN GENET, V218, P397, DOI 10.1007/BF00332401; Premstaller A, 2001, ANAL CHEM, V73, P2390, DOI 10.1021/ac010046q; Rouvinen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009037; Schein CH, 2010, BIOINFORM BIOL INSIG, V4, P113, DOI 10.4137/BBI.S5737; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; Sippl MJ, 2012, STRUCTURE, V20, P718, DOI 10.1016/j.str.2012.01.024; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verdino P, 2002, EMBO J, V21, P5007, DOI 10.1093/emboj/cdf526; Vogel L, 2005, ALLERGY, V60, P1021, DOI 10.1111/j.1398-9995.2005.00803.x; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Wellhausen A, 1996, Z ERNAHRUNGSWISS, V35, P348, DOI 10.1007/BF01610553; You Z, 2010, BIOCHEMISTRY-US, V49, P1191, DOI 10.1021/bi901844d; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	49	21	22	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					540	551		10.1074/jbc.M113.518795	http://dx.doi.org/10.1074/jbc.M113.518795			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253036	Green Published, hybrid			2022-12-28	WOS:000329370900046
J	Zapata-Morales, JR; Galicia-Cruz, OG; Franco, M; Morales, FMY				Zapata-Morales, Juan R.; Galicia-Cruz, Othir G.; Franco, Martha; Martinez y Morales, Flavio			Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) Protein Diminishes Sodium Glucose Transport 1 (SGLT1) and SGLT2 Protein Expression in Renal Epithelial Tubular Cells (LLC-PK1) under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucose Transport; Hypoxia; Hypoxia-inducible factor (HIF); Kidney Metabolism; Renal Physiology; GLUT1; Renal Glucose Transporters; SGLT1; SGLT2	NITRIC-OXIDE; OXYGEN-CONSUMPTION; GENE-EXPRESSION; FACTOR-ALPHA; FACTOR-I; COBALT; INJURY; ACTIVATION; KIDNEY; HIF-1	In this work, we demonstrated the regulation of glucose transporters by hypoxia inducible factor-1 (HIF-1) activation in renal epithelial cells. LLC-PK1 monolayers were incubated for 1, 3, 6, or 12 h with 0% or 5% O-2 or 300 m cobalt (CoCl2). We evaluated the effects of hypoxia on the mRNA and protein expression of HIF-1 and of the glucose transporters SGLT1, SGLT2, and GLUT1. The data showed an increase in HIF-1 mRNA and protein expression under the three evaluated conditions (p < 0.05 versus t = 0). An increase in GLUT1 mRNA (12 h) and protein expression (at 3, 6, and 12 h) was observed (p < 0.05 versus t = 0). SGLT1 and SGLT2 mRNA and protein expression decreased under the three evaluated conditions (p < 0.05 versus t = 0). In conclusion, our results suggest a clear decrease in the expression of the glucose transporters SGLT1 and SGLT2 under hypoxic conditions which implies a possible correlation with increased expression of HIF-1.	[Zapata-Morales, Juan R.; Galicia-Cruz, Othir G.; Martinez y Morales, Flavio] Univ San Luis Potosi, Sch Med, Dept Pharmacol, Los Filtros 78210, San Luis Potosi, Mexico; [Franco, Martha] Inst Nacl Cardiol Dr Ignacio Chavez, Dept Nephrol, Mexico City 14080, DF, Mexico	Universidad Autonoma de San Luis Potosi; National Institute of Cardiology - Mexico	Morales, FMY (corresponding author), Univ San Luis Potosi, Sch Med, Dept Pharmacol, 2405 V Carranza Ave, Los Filtros 78210, San Luis Potosi, Mexico.	martinej@uaslp.mx	Martinez, Flavio/E-9854-2011	Martinez, Flavio/0000-0003-0339-1089; Zapata-Morales, Juan Ramon/0000-0001-6523-5474; Franco, Martha/0000-0003-4073-524X	Programa para el Mejoramiento del Profesorado (PROMEP) [PROMEP/103.5/09/599]; Programa Integral de Fortalecimiento Institucional (PIFI) [2009-24MSU0011E-12]; CONACYT-Mx Fellowship [205614/200424]	Programa para el Mejoramiento del Profesorado (PROMEP); Programa Integral de Fortalecimiento Institucional (PIFI); CONACYT-Mx Fellowship	This work was supported by Programa para el Mejoramiento del Profesorado (PROMEP) Grant PROMEP/103.5/09/599 (to O. G. G.-C.) and Programa Integral de Fortalecimiento Institucional (PIFI) Grant 2009-24MSU0011E-12 (to F. M. M.).; Supported by CONACYT-Mx Fellowship 205614/200424.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; AUKLAND K, 1960, NATURE, V188, P671, DOI 10.1038/188671a0; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; BRUNDIN T, 1994, AM J PHYSIOL-ENDOC M, V267, pE648, DOI 10.1152/ajpendo.1994.267.5.E648; Chaudary N, 2004, CARDIOVASC RES, V61, P780, DOI 10.1016/j.cardiores.2003.11.031; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; Deng AH, 2005, KIDNEY INT, V68, P723, DOI 10.1111/j.1523-1755.2005.00450.x; Deng AH, 2010, AM J PHYSIOL-RENAL, V299, pF1365, DOI 10.1152/ajprenal.00153.2010; El Awad B, 2000, KIDNEY INT, V58, P43, DOI 10.1046/j.1523-1755.2000.00139.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Evans RG, 2008, AM J PHYSIOL-RENAL, V295, pF1259, DOI 10.1152/ajprenal.90230.2008; Friederich M, 2009, CURR DIABETES REV, V5, P120, DOI 10.2174/157339909788166800; Graven KK, 1999, BBA-GENE STRUCT EXPR, V1447, P208, DOI 10.1016/S0167-4781(99)00118-9; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; JONES DP, 1982, AM J PHYSIOL, V243, pC247, DOI 10.1152/ajpcell.1982.243.5.C247; Kles KA, 2002, AM J PHYSIOL-GASTR L, V283, pG1336, DOI 10.1152/ajpgi.00055.2002; Lang Florian, 2005, Clin Exp Nephrol, V9, P91, DOI 10.1007/s10157-005-0355-x; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Lison D, 2001, OCCUP ENVIRON MED, V58, P619, DOI 10.1136/oem.58.10.619; Lukiw WJ, 2003, INVEST OPHTH VIS SCI, V44, P4163, DOI 10.1167/iovs.02-0655; Maldonado-Cervantes MI, 2012, J PHYSIOL BIOCHEM, V68, P411, DOI 10.1007/s13105-012-0153-3; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; Nagy G, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-79; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; OHTA T, 1990, MOL CELL BIOL, V10, P6491, DOI 10.1128/MCB.10.12.6491; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Phillips AO, 1997, AM J PATHOL, V150, P1101; Pourgholami MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-143; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; TAKANO T, 1985, J CLIN INVEST, V76, P2377, DOI 10.1172/JCI112250; Takiyama Y, 2011, DIABETES, V60, P981, DOI 10.2337/db10-0655; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2001, CANCER RES, V61, P5215; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; YOU YD, 1992, J AM SOC NEPHROL, V3, P965; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	46	36	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					346	357		10.1074/jbc.M113.526814	http://dx.doi.org/10.1074/jbc.M113.526814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24196951	Green Published, hybrid			2022-12-28	WOS:000329370900030
J	Andersen, MN; Krzystanek, K; Petersen, F; Bomholtz, SH; Olesen, SP; Abriel, H; Jespersen, T; Rasmussen, HB				Andersen, Martin Nybo; Krzystanek, Katarzyna; Petersen, Frederic; Bomholtz, Sofia Hammami; Olesen, Soren-Peter; Abriel, Hugues; Jespersen, Thomas; Rasmussen, Hanne Borger			A Phosphoinositide 3-Kinase (PI3K)-serum- and glucocorticoid-inducible Kinase 1 (SGK1) Pathway Promotes Kv7.1 Channel Surface Expression by Inhibiting Nedd4-2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Endocytosis; Ion Channels; PI 3-Kinase (PI3K); Trafficking; KCNQ1	EPITHELIAL NA+ CHANNEL; POTASSIUM CHANNEL; CELL-SURFACE; K+ SECRETION; SERUM; KCNQ1; GENE; AKT; PHOSPHORYLATION; TRAFFICKING	Epithelial cell polarization involves several kinase signaling cascades that eventually divide the surface membrane into an apical and a basolateral part. One kinase, which is activated during the polarization process, is phosphoinositide 3-kinase (PI3K). In MDCK cells, the basolateral potassium channel Kv7.1 requires PI3K activity for surface-expression during the polarization process. Here, we demonstrate that Kv7.1 surface expression requires tonic PI3K activity as PI3K inhibition triggers endocytosis of these channels in polarized MDCK. Pharmacological inhibition of SGK1 gave similar results as PI3K inhibition, whereas overexpression of constitutively active SGK1 overruled it, suggesting that SGK1 is the primary downstream target of PI3K in this process. Furthermore, knockdown of the ubiquitin ligase Nedd4-2 overruled PI3K inhibition, whereas a Nedd4-2 interaction-deficient Kv7.1 mutant was resistant to both PI3K and SGK1 inhibition. Altogether, these data suggest that a PI3K-SGK1 pathway stabilizes Kv7.1 surface expression by inhibiting Nedd4-2-dependent endocytosis and thereby demonstrates that Nedd4-2 is a key regulator of Kv7.1 localization and turnover in epithelial cells.	[Andersen, Martin Nybo; Krzystanek, Katarzyna; Petersen, Frederic; Bomholtz, Sofia Hammami; Olesen, Soren-Peter; Jespersen, Thomas; Rasmussen, Hanne Borger] Univ Copenhagen, Dept Biomed Sci, Ctr Cardiac Arrhythmia, Danish Natl Res Fdn, DK-2200 Copenhagen N, Denmark; [Krzystanek, Katarzyna; Abriel, Hugues] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland	Danmarks Grundforskningsfond; University of Copenhagen; University of Bern	Rasmussen, HB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Panum Inst, Dept Biomed Sci, 12-5-32,Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	hannebr@sund.ku.dk	Rasmussen, Hanne B/N-9652-2016; Abriel, Hugues/B-9800-2009; Olesen, Soren-Peter/H-4206-2011	Rasmussen, Hanne B/0000-0002-2218-5646; Abriel, Hugues/0000-0003-0465-5138; Andersen, Martin Nybo/0000-0003-1125-1553; Jespersen, Thomas/0000-0001-6575-360X; Krzystanek, Katarzyna/0000-0001-8525-9705; Olesen, Soren-Peter/0000-0002-4381-5192; Bomholtz, Sofia Hammami/0000-0001-7221-4532	Danish National Research Foundation; Velux Foundation; Danish Council for Independent Research-Medical Sciences; Desiree and Niels Yde Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Aase og Ejnar Danielsens Fond; Danish Cardiovascular Research Academy; Swiss National Science Foundation [310030B_135693]	Danish National Research Foundation(Danmarks Grundforskningsfond); Velux Foundation(Velux Fonden); Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Desiree and Niels Yde Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Aase og Ejnar Danielsens Fond; Danish Cardiovascular Research Academy; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by The Danish National Research Foundation, The Velux Foundation, The Danish Council for Independent Research-Medical Sciences (to S.-P. O.), the Desiree and Niels Yde Foundation (to T. J.), The Novo Nordisk Foundation (to S.-P. O. and T. J.), the Lundbeck Foundation (to T. J.), the Aase og Ejnar Danielsens Fond (to H. B. R. and T. J.), the Danish Cardiovascular Research Academy (to K. K.), as well as the Swiss National Science Foundation (Grant 310030B_135693; to H. A.).	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Andersen Martin N, 2012, Commun Integr Biol, V5, P480, DOI 10.4161/cib.21200; Andersen MN, 2012, TRAFFIC, V13, P143, DOI 10.1111/j.1600-0854.2011.01295.x; Andersen MN, 2011, AM J PHYSIOL-CELL PH, V300, pC814, DOI 10.1152/ajpcell.00390.2010; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P591, DOI 10.1159/000185543; Busjahn A, 2004, CELL PHYSIOL BIOCHEM, V14, P135, DOI 10.1159/000078105; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Dahimene S, 2006, CIRC RES, V99, P1076, DOI 10.1161/01.RES.0000250262.12219.95; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Dunn EF, 2009, J VIROL, V83, P11665, DOI 10.1128/JVI.01092-09; Embark HM, 2003, PFLUG ARCH EUR J PHY, V445, P601, DOI 10.1007/s00424-002-0982-y; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Goldenberg I, 2008, CURR PROB CARDIOLOGY, V33, P629, DOI 10.1016/j.cpcardiol.2008.07.002; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jeanes A, 2009, J MOL HISTOL, V40, P395, DOI 10.1007/s10735-010-9253-y; Jespersen T, 2004, J CELL SCI, V117, P4517, DOI 10.1242/jcs.01318; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Krzystanek K, 2012, HEART RHYTHM, V9, P440, DOI 10.1016/j.hrthm.2011.10.026; Kuwahara K, 2000, J MOL CELL CARDIOL, V32, P1385, DOI 10.1006/jmcc.2000.1177; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Li YW, 2001, MOL CELL NEUROSCI, V17, P761, DOI 10.1006/mcne.2000.0967; Lu ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003623; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Rotte A, 2009, CELL PHYSIOL BIOCHEM, V23, P133, DOI 10.1159/000204102; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sandu C, 2007, PFLUG ARCH EUR J PHY, V455, P493, DOI 10.1007/s00424-007-0305-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2007, BIOCHEM BIOPH RES CO, V358, P304, DOI 10.1016/j.bbrc.2007.04.127; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Strutz-Seebohm N, 2009, CHANNELS, V3, P88, DOI 10.4161/chan.3.2.8086; Sunose H, 1997, HEARING RES, V114, P107, DOI 10.1016/S0378-5955(97)00152-4; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083	56	21	21	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36841	36854		10.1074/jbc.M113.525931	http://dx.doi.org/10.1074/jbc.M113.525931			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214981	Green Published, hybrid			2022-12-28	WOS:000329189700007
J	Gulshan, K; Brubaker, G; Wang, SH; Hazen, SL; Smith, JD				Gulshan, Kailash; Brubaker, Gregory; Wang, Shuhui; Hazen, Stanley L.; Smith, Jonathan D.			Sphingomyelin Depletion Impairs Anionic Phospholipid Inward Translocation and Induces Cholesterol Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Apolipoproteins; Phosphatidylcholine; Phosphatidylethanolamine; Phosphatidylserine; Sphingolipid; Sphingomyelinase	APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; CASSETTE TRANSPORTER A1; HAMSTER OVARY CELLS; APOE-DEFICIENT MICE; CELLULAR CHOLESTEROL; TANGIER-DISEASE; KNOCKOUT MICE; LIPID EFFLUX; ACCELERATES ATHEROSCLEROSIS	The phosphatidylserine (PS) floppase activity (outward translocation) of ABCA1 leads to plasma membrane remodeling that plays a role in lipid efflux to apolipoprotein A-I (apoAI) generating nascent high density lipoprotein. The Tangier disease W590S ABCA1 mutation has defective PS floppase activity and diminished cholesterol efflux activity. Here, we report that depletion of sphingomyelin by inhibitors or sphingomyelinase caused plasma membrane remodeling, leading to defective flip (inward translocation) of PS, higher PS exposure, and higher cholesterol efflux from cells by both ABCA1-dependent and ABCA1-independent mechanisms. Mechanistically, sphingomyelin was connected to PS translocation in cell-free liposome studies that showed that sphingomyelin increased the rate of spontaneous PS flipping. Depletion of sphingomyelin in stably transfected HEK293 cells expressing the Tangier disease W590S mutant ABCA1 isoform rescued the defect in PS exposure and restored cholesterol efflux to apoAI. Liposome studies showed that PS directly increased cholesterol accessibility to extraction by cyclodextrin, providing the mechanistic link between cell surface PS and cholesterol efflux. We conclude that altered plasma membrane environment conferred by depleting sphingomyelin impairs PS flip and promotes cholesterol efflux in ABCA1-dependent and -independent manners.	[Gulshan, Kailash; Brubaker, Gregory; Wang, Shuhui; Hazen, Stanley L.; Smith, Jonathan D.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.; Smith, Jonathan D.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Smith, JD (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Box NC10,9500 Euclid Ave, Cleveland, OH 44195 USA.	smithj4@ccf.org	Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health [PO1 HL098055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL098055 (to J. D. S. and S. L. H.).	Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Cary LA, 2000, NATURE, V404, P945, DOI 10.1038/35010257; Chakraborty M, 2013, J CLIN INVEST, V123, P1784, DOI 10.1172/JCI60415; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Chiantia Salvatore, 2013, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-7091-1368-4_2; Christian AE, 1997, J LIPID RES, V38, P2264; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Drobnik W, 2002, TRAFFIC, V3, P268, DOI 10.1034/j.1600-0854.2002.030404.x; Durbin DM, 1999, J LIPID RES, V40, P2293; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Ghering AB, 2006, J LIPID RES, V47, P2781, DOI 10.1194/jlr.M600380-JLR200; Glaros EN, 2008, J LIPID RES, V49, P324, DOI 10.1194/jlr.M700261-JLR200; Glaros EN, 2007, BIOCHEM PHARMACOL, V73, P1340, DOI 10.1016/j.bcp.2006.12.023; Grant AM, 2001, TRAFFIC, V2, P37, DOI 10.1034/j.1600-0854.2001.020106.x; HANADA K, 1995, J CELL BIOL, V128, P793, DOI 10.1083/jcb.128.5.793; Hidaka H, 2008, CLIN BIOCHEM, V41, P1211, DOI 10.1016/j.clinbiochem.2008.06.010; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Hojjati MR, 2006, J LIPID RES, V47, P673, DOI 10.1194/jlr.D500040-JLR200; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; Koseki M, 2007, J LIPID RES, V48, P299, DOI 10.1194/jlr.M600428-JLR200; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Li ZQ, 2009, BBA-MOL CELL BIOL L, V1791, P297, DOI 10.1016/j.bbalip.2009.01.010; Mendez AJ, 2001, J BIOL CHEM, V276, P3158, DOI 10.1074/jbc.M007717200; Nagao K, 2007, J BIOL CHEM, V282, P14868, DOI 10.1074/jbc.M611230200; Nagao K, 2010, FEBS LETT, V584, P2717, DOI 10.1016/j.febslet.2010.04.036; Nagao K, 2009, J LIPID RES, V50, P1165, DOI 10.1194/jlr.M800597-JLR200; Ohvo H, 1997, BBA-LIPID LIPID MET, V1349, P131, DOI 10.1016/S0005-2760(97)00126-4; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Park TS, 2008, PHARMACOL RES, V58, P45, DOI 10.1016/j.phrs.2008.06.005; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; POWNALL HJ, 1981, BIOCHEMISTRY-US, V20, P6630, DOI 10.1021/bi00526a017; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Rigot W, 2002, J LIPID RES, V43, P2077, DOI 10.1194/jlr.M200279-JLR200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Smith JD, 2002, J BIOL CHEM, V277, P17797, DOI 10.1074/jbc.M201594200; Tall AR, 2003, ARTERIOSCL THROM VAS, V23, P710, DOI 10.1161/01.ATV.0000068683.51375.59; Tamehiro N, 2008, BIOCHEMISTRY-US, V47, P6138, DOI 10.1021/bi800182t; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Ueda Y, 2013, FASEB J, V27, P3284, DOI 10.1096/fj.12-226548; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; WANG E, 1991, J BIOL CHEM, V266, P14486; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang SH, 2013, ARTERIOSCL THROM VAS, V33, P1197, DOI 10.1161/ATVBAHA.112.301195; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Worgall TS, 2011, ADV EXP MED BIOL, V721, P139, DOI 10.1007/978-1-4614-0650-1_9; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Yamauchi Y, 2003, J BIOL CHEM, V278, P47890, DOI 10.1074/jbc.M306258200; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372	64	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37166	37179		10.1074/jbc.M113.512244	http://dx.doi.org/10.1074/jbc.M113.512244			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24220029	Green Published, hybrid			2022-12-28	WOS:000329189700035
J	Kwak, Y; Jeong, J; Lee, S; Park, YU; Lee, SA; Han, DH; Kim, JH; Ohshima, T; Mikoshiba, K; Suh, YH; Cho, S; Park, SK				Kwak, Yongdo; Jeong, Jaehoon; Lee, Saebom; Park, Young-Un; Lee, Seol-Ae; Han, Dong-Hee; Kim, Joung-Hun; Ohshima, Toshio; Mikoshiba, Katsuhiko; Suh, Yoo-Hun; Cho, Sehyung; Park, Sang Ki			Cyclin-dependent Kinase 5 (Cdk5) Regulates the Function of CLOCK Protein by Direct Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CDK (Cyclin-dependent Kinase); Circadian Rhythms; Clock Genes; Neuroscience; Protein Phosphorylation; CLOCK; Cdk5; Molecular Clock	MAMMALIAN CIRCADIAN CLOCK; SEASONAL AFFECTIVE-DISORDER; SUPRACHIASMATIC NUCLEUS; DARK THERAPY; POSTTRANSLATIONAL REGULATION; CULTURED FIBROBLASTS; BIPOLAR DISORDER; GENE-EXPRESSION; ACTIVITY RHYTHM; TRANSCRIPTION	Circadian rhythm is a biological rhythm governing physiology and behavior with a period of approximate to 24 h. At the molecular level, circadian output is controlled by a molecular clock composed of positive and negative feedback loops in transcriptional and post-translational processes. CLOCK is a transcription factor known as a central component of the molecular clock feedback loops generating circadian oscillation. Although CLOCK is known to undergo multiple post-translational modifications, the knowledge of their entities remains limited. Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine-threonine kinase that is involved in various neuronal processes. Here, we report that Cdk5 is a novel regulator of CLOCK protein. Cdk5 phosphorylates CLOCK at the Thr-451 and Thr-461 residues in association with transcriptional activation of CLOCK. The Cdk5-dependent regulation of CLOCK function is mediated by alterations of its stability and subcellular distribution. These results suggest that Cdk5 is a novel regulatory component of the core molecular clock machinery.	[Kwak, Yongdo; Jeong, Jaehoon; Lee, Saebom; Park, Young-Un; Lee, Seol-Ae; Kim, Joung-Hun; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Suh, Yoo-Hun] Seoul Natl Univ, Ctr Alzheimers Dementia, Natl Creat Res Initiat, Dept Pharmacol,Coll Med, Seoul 110799, South Korea; [Suh, Yoo-Hun] Korea Brain Res Inst, Taegu 711873, South Korea; [Han, Dong-Hee; Cho, Sehyung] Kyung Hee Univ, Neurodegenerat Control Res Ctr, Seoul 130701, South Korea; [Han, Dong-Hee; Cho, Sehyung] Kyung Hee Univ, Dept Physiol, Seoul 130701, South Korea	Pohang University of Science & Technology (POSTECH); Waseda University; RIKEN; Seoul National University (SNU); Korea Brain Research Institute (KBRI); Kyung Hee University; Kyung Hee University	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	skpark@postech.ac.kr	Mikoshiba, Katsuhiko/N-7943-2015		Korean government (MSIP) [NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200]; NRF of Korea [2012K2A1A2033117]; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP [2031-415]	Korean government (MSIP); NRF of Korea; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP	This work was supported by grants (NRF-2012R1A2A2A01012923 and NRF-2012R1A4A1028200) from the Korean government (MSIP) and also supported under the framework of international cooperation program managed by the NRF of Korea (2012K2A1A2033117) and the Korea Brain Research Institute (KBRI) Basic Research Program of MSIP (2031-415).	Abe H, 2001, MOL BRAIN RES, V87, P92, DOI 10.1016/S0169-328X(00)00295-3; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Barbini B, 2005, BIPOLAR DISORD, V7, P98, DOI 10.1111/j.1399-5618.2004.00166.x; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Boivin DB, 2000, J PSYCHIATR NEUROSCI, V25, P446; Chen PC, 2005, NEUROPSYCHOPHARMACOL, V30, P538, DOI 10.1038/sj.npp.1300604; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Dalgleish T, 1996, BRIT J CLIN PSYCHOL, V35, P163, DOI 10.1111/j.2044-8260.1996.tb01174.x; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Engmann O, 2011, BRAIN, V134, P2408, DOI 10.1093/brain/awr155; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gomez-Bernal G, 2009, MED HYPOTHESES, V72, P105, DOI 10.1016/j.mehy.2008.08.008; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Honma K, 2009, EUR J NEUROSCI, V30, P1707, DOI 10.1111/j.1460-9568.2009.06976.x; Jung HS, 2003, NEUROREPORT, V14, P15, DOI 10.1097/00001756-200301200-00003; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko J, 2001, J NEUROSCI, V21, P6758; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li BS, 2001, P NATL ACAD SCI USA, V98, P12742, DOI 10.1073/pnas.211428098; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mongrain V., 2011, PLOS ONE, V6; Mukherjee S, 2010, BIOL PSYCHIAT, V68, P503, DOI 10.1016/j.biopsych.2010.04.031; Munoz JP, 2007, J CELL BIOCHEM, V100, P738, DOI 10.1002/jcb.21041; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Ohshima T, 2001, P NATL ACAD SCI USA, V98, P2764, DOI 10.1073/pnas.051628498; Phelps J, 2008, MED HYPOTHESES, V70, P224, DOI 10.1016/j.mehy.2007.05.026; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; ROSENTHAL NE, 1986, CLIN NEUROPHARMACOL, V9, P193; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sahar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008561; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; Sit D, 2007, BIPOLAR DISORD, V9, P918, DOI 10.1111/j.1399-5618.2007.00451.x; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tischkau SA, 2004, NEURON, V43, P539, DOI 10.1016/j.neuron.2004.07.027; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wang D, 2001, J VIROL, V75, P7266, DOI 10.1128/JVI.75.16.7266-7279.2001; Xing BM, 2012, J NEUROSCI, V32, P14709, DOI 10.1523/JNEUROSCI.1634-12.2012; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Zhao WN, 2007, NAT CELL BIOL, V9, P268, DOI 10.1038/ncb1539; Zhu WL, 2012, INT J NEUROPSYCHOPH, V15, P795, DOI 10.1017/S1461145711000915	59	20	28	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36878	36889		10.1074/jbc.M113.494856	http://dx.doi.org/10.1074/jbc.M113.494856			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235147	hybrid, Green Published			2022-12-28	WOS:000329189700011
J	Quintero, OA; Unrath, WC; Stevens, SM; Manor, U; Kachar, B; Yengo, CM				Quintero, Omar A.; Unrath, William C.; Stevens, Stanley M., Jr.; Manor, Uri; Kachar, Bechara; Yengo, Christopher M.			Myosin 3A Kinase Activity Is Regulated by Phosphorylation of the Kinase Domain Activation Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Hearing; Molecular Motors; Myosin; Phosphorylation	STATISTICAL-MODEL; MST1 KINASE; PROTEIN; ACTIN; MECHANISM; AUTOPHOSPHORYLATION; LOCALIZATION; BINDING; STEREOCILIA; INHIBITION	Class III myosins are unique members of the myosin superfamily in that they contain both a motor and kinase domain. We have found that motor activity is decreased by autophosphorylation, although little is known about the regulation of the kinase domain. We demonstrate by mass spectrometry that Thr-178 and Thr-184 in the kinase domain activation loop and two threonines in the loop 2 region of the motor domain are autophosphorylated (Thr-908 and Thr-919). The kinase activity of MYO3A 2IQ with the phosphomimic (T184E) or phosphoblock (T184A) mutations demonstrates that kinase activity is reduced 30-fold as a result of the T184A mutation, although the Thr-178 site only had a minor impact on kinase activity. Interestingly, the actin-activated ATPase activity of MYO3A 2IQ is slightly reduced as a result of the T178A and T184A mutations suggesting coupling between motor and kinase domains. Full-length GFP-tagged T184A and T184E MYO3A constructs transfected into COS7 cells do not disrupt the ability of MYO3A to localize to filopodia structures. In addition, we demonstrate that T184E MYO3A reduces filopodia elongation in the presence of espin-1, whereas T184A enhances filopodia elongation in a similar fashion to kinase-dead MYO3A. Our results suggest that as MYO3A accumulates at the tips of actin protrusions, autophosphorylation of Thr-184 enhances kinase activity resulting in phosphorylation of the MYO3A motor and reducing motor activity. The differential regulation of the kinase and motor activities allows for MYO3A to precisely self-regulate its concentration in the actin bundle-based structures of cells.	[Quintero, Omar A.; Unrath, William C.; Yengo, Christopher M.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Stevens, Stanley M., Jr.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Manor, Uri; Kachar, Bechara] NIDCD, Lab Cell Struct & Dynam, NIH, Bethesda, MD 20894 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	cmy11@psu.edu		Quintero-Carmona, Omar/0000-0002-9314-1704; Stevens, Stanley/0000-0002-1399-0256; Manor, Uri/0000-0002-9802-1955	National Institutes of Health [EY0181416, K01CA160667]; Penn State College of Medicine; NATIONAL CANCER INSTITUTE [K01CA160667] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants EY0181416 (to C. M. Y.) and K01CA160667 (to O. A. Q.). This work was also supported by start-up funds from Penn State College of Medicine.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Chung W, 2011, CANCER EPIDEM BIOMAR, V20, P1483, DOI 10.1158/1055-9965.EPI-11-0067; Dalal JS, 2011, J NEUROCHEM, V119, P772, DOI 10.1111/j.1471-4159.2011.07468.x; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Dose AC, 2003, MOL BIOL CELL, V14, P1058, DOI 10.1091/mbc.E02-06-0317; Dose AC, 2000, GENOMICS, V67, P333, DOI 10.1006/geno.2000.6256; Dose AC, 2007, J BIOL CHEM, V282, P216, DOI 10.1074/jbc.M605964200; Dose AC, 2008, BIOCHEMISTRY-US, V47, P2485, DOI 10.1021/bi7021574; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Joel PB, 2003, BIOCHEMISTRY-US, V42, P9160, DOI 10.1021/bi034415j; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Komaba S, 2003, J BIOL CHEM, V278, P21352, DOI 10.1074/jbc.M300757200; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Lin-Jones J, 2004, J CELL SCI, V117, P5825, DOI 10.1242/jcs.01512; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manor U, 2008, SEMIN CELL DEV BIOL, V19, P502, DOI 10.1016/j.semcdb.2008.07.006; Merritt RC, 2012, CURR BIOL, V22, P320, DOI 10.1016/j.cub.2011.12.053; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Odronitz F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-173; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Quintero OA, 2010, J BIOL CHEM, V285, P35770, DOI 10.1074/jbc.M110.144360; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Sasaki N, 2002, J MUSCLE RES CELL M, V23, P697, DOI 10.1023/A:1024415409406; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Tao ZH, 2010, BIOCHEMISTRY-US, V49, P8488, DOI 10.1021/bi100673c; Trivedi DV, 2012, BIOPHYS J, V102, P2545, DOI 10.1016/j.bpj.2012.04.025; Unschuld PG, 2009, AM J MED GENET B, V150B, P1100, DOI 10.1002/ajmg.b.30938; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Walsh VL, 2011, MAMM GENOME, V22, P170, DOI 10.1007/s00335-010-9310-6; Wang J, 2011, STRUCTURE, V19, P1752, DOI 10.1016/j.str.2011.10.013; Wang J, 2011, J BIOL CHEM, V286, P2689, DOI 10.1074/jbc.M110.156505; Wu H, 2003, J BIOL CHEM, V278, P41768, DOI 10.1074/jbc.M308196200; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhu GZ, 2005, J BIOL CHEM, V280, P36372, DOI 10.1074/jbc.M505031200	54	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37126	37137		10.1074/jbc.M113.511014	http://dx.doi.org/10.1074/jbc.M113.511014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214986	hybrid, Green Published			2022-12-28	WOS:000329189700032
J	Toda, Y; Nakagita, T; Hayakawa, T; Okada, S; Narukawa, M; Imai, H; Ishimaru, Y; Misaka, T				Toda, Yasuka; Nakagita, Tomoya; Hayakawa, Takashi; Okada, Shinji; Narukawa, Masataka; Imai, Hiroo; Ishimaru, Yoshiro; Misaka, Takumi			Two Distinct Determinants of Ligand Specificity in T1R1/T1R3 (the Umami Taste Receptor)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; G Protein-coupled Receptors (GPCR); Glutamate Receptors Metabotropic; Mutagenesis in Vitro; Receptor Structure-Function; Taste Receptor; Umami	METABOTROPIC GLUTAMATE-RECEPTOR; SWEET TASTE; MOLECULAR-MECHANISM; MONOSODIUM GLUTAMATE; PROTEIN; EXPRESSION; RESPONSES; BINDING; CLONING; VARIANT	Umami taste perception in mammals is mediated by a heteromeric complex of two G-protein-coupled receptors, T1R1 and T1R3. T1R1/T1R3 exhibits species-dependent differences in ligand specificity; human T1R1/T1R3 specifically responds to l-Glu, whereas mouse T1R1/T1R3 responds more strongly to other l-amino acids than to l-Glu. The mechanism underlying this species difference remains unknown. In this study we analyzed chimeric human-mouse receptors and point mutants of T1R1/T1R3 and identified 12 key residues that modulate amino acid recognition in the human- and mouse-type responses in the extracellular Venus flytrap domain of T1R1. Molecular modeling revealed that the residues critical for human-type acidic amino acid recognition were located at the orthosteric ligand binding site. In contrast, all of the key residues for the mouse-type broad response were located at regions outside of both the orthosteric ligand binding site and the allosteric binding site for inosine-5-monophosphate (IMP), a known natural umami taste enhancer. Site-directed mutagenesis demonstrated that the newly identified key residues for the mouse-type responses modulated receptor activity in a manner distinct from that of the allosteric modulation via IMP. Analyses of multiple point mutants suggested that the combination of two distinct determinants, amino acid selectivity at the orthosteric site and receptor activity modulation at the non-orthosteric sites, may mediate the ligand specificity of T1R1/T1R3. This hypothesis was supported by the results of studies using nonhuman primate T1R1 receptors. A complex molecular mechanism involving changes in the properties of both the orthosteric and non-orthosteric sites of T1R1 underlies the determination of ligand specificity in mammalian T1R1/T1R3.	[Toda, Yasuka; Nakagita, Tomoya; Okada, Shinji; Narukawa, Masataka; Ishimaru, Yoshiro; Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Hayakawa, Takashi; Imai, Hiroo] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Hayakawa, Takashi] Japan Soc Promot Sci, Tokyo 1020083, Japan	University of Tokyo; Kyoto University; Japan Society for the Promotion of Science	Misaka, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amisaka@mail.ecc.u-tokyo.ac.jp	Hayakawa, Takashi/U-9518-2018; Ishimaru, Yoshiro/AAI-3049-2020; OKADA, Shinji/AFS-7710-2022	Hayakawa, Takashi/0000-0002-1037-0350; OKADA, Shinji/0000-0002-4465-9961; Misaka, Takumi/0000-0002-9547-5767; Imai, Hiroo/0000-0003-0729-0322; Toda, Yasuka/0000-0001-5912-6730	Cooperation Research Program of the Primate Research Institute of Kyoto University; Japan Society for the Promotion of Science [LS037]; Korea Food Research Institute [E0111501]	Cooperation Research Program of the Primate Research Institute of Kyoto University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Korea Food Research Institute	The work was supported in part by the Cooperation Research Program of the Primate Research Institute of Kyoto University, by the Funding Program for Next Generation World-Leading Researchers of the Japan Society for the Promotion of Science (LS037 (to T. M.)), and by Korea Food Research Institute Grant E0111501 (to T. M.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Ikeda K, 2002, CHEM SENSES, V27, P847, DOI 10.1093/chemse/27.9.847; Inouye S, 2008, J BIOCHEM, V143, P711, DOI 10.1093/jb/mvn024; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kawai M, 2012, AMINO ACIDS, V43, P2349, DOI 10.1007/s00726-012-1315-x; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Koizumi A, 2011, P NATL ACAD SCI USA, V108, P16819, DOI 10.1073/pnas.1016644108; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kusuhara Y, 2013, J PHYSIOL-LONDON, V591, P1967, DOI 10.1113/jphysiol.2012.236604; Laska M, 2004, J EXP ZOOL PART A, V301A, P898, DOI 10.1002/jez.a.118; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Cascales JJL, 2010, BIOPHYS CHEM, V152, P139, DOI 10.1016/j.bpc.2010.09.001; Madsen U, 2005, PHARM DEV, P797, DOI 10.1002/0471728780.ch18; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Roura E, 2011, FLAVOUR FRAG J, V26, P282, DOI 10.1002/ffj.2057; San Gabriel A, 2005, CHEM SENSES, V30, pI25, DOI 10.1093/chemse/bjh095; Toda Y, 2011, J AGR FOOD CHEM, V59, P12131, DOI 10.1021/jf2029835; Toyono T, 2003, CELL TISSUE RES, V313, P29, DOI 10.1007/s00441-003-0740-2; Toyono T, 2002, ARCH HISTOL CYTOL, V65, P91, DOI 10.1679/aohc.65.91; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yamaguchi S, 2000, J NUTR, V130, p921S, DOI 10.1093/jn/130.4.921S; YAMAGUCHI S, 1971, J FOOD SCI, V36, P846, DOI 10.1111/j.1365-2621.1971.tb15541.x; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	37	65	69	8	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36863	36877		10.1074/jbc.M113.494443	http://dx.doi.org/10.1074/jbc.M113.494443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214976	Green Published, hybrid			2022-12-28	WOS:000329189700010
J	Okatsu, K; Uno, M; Koyano, F; Go, E; Kimura, M; Oka, T; Tanaka, K; Matsuda, N				Okatsu, Kei; Uno, Midori; Koyano, Fumika; Go, Etsu; Kimura, Mayumi; Oka, Toshihiko; Tanaka, Keiji; Matsuda, Noriyuki			A Dimeric PINK1-containing Complex on Depolarized Mitochondria Stimulates Parkin Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Parkin; Parkinson Disease; Phosphorylation; Pink1	PINK1/PARKIN-MEDIATED MITOPHAGY; NATIVE ELECTROPHORESIS; DAMAGED MITOCHONDRIA; KINASE DOMAIN; PINK1; MEMBRANE; DISEASE; TRANSLOCATION; MUTATIONS; NEURONS	Background: PINK1 functions on depolarized mitochondria. However, details regarding its mechanism remain limited. Results: We reveal the formation of a high molecular weight complex composed of two phosphorylated PINK1 molecules that stimulates Parkin recruitment. Conclusion: The dimeric PINK1-containing complex is important for mitochondrial quality control. Significance: The PINK1 molecular process is reminiscent of receptor kinase dimerization in signal transduction. Parkinsonism typified by sporadic Parkinson disease is a prevalent neurodegenerative disease. Mutations in PINK1 (PTEN-induced putative kinase 1), a mitochondrial Ser/Thr protein kinase, or PARKIN, a ubiquitin-protein ligase, cause familial parkinsonism. The accumulation and autophosphorylation of PINK1 on damaged mitochondria results in the recruitment of Parkin, which ultimately triggers quarantine and/or degradation of the damaged mitochondria by the proteasome and autophagy. However, the molecular mechanism of PINK1 in dissipation of the mitochondrial membrane potential (m) has not been fully elucidated. Here we show by fluorescence-based techniques that the PINK1 complex formed following a decrease in m is composed of two PINK1 molecules and is correlated with intermolecular phosphorylation of PINK1. Disruption of complex formation by the PINK1 S402A mutation weakened Parkin recruitment onto depolarized mitochondria. The most disease-relevant mutations of PINK1 inhibit the complex formation. Taken together, these results suggest that formation of the complex containing dyadic PINK1 is an important step for Parkin recruitment onto damaged mitochondria.	[Okatsu, Kei; Koyano, Fumika; Go, Etsu; Kimura, Mayumi; Tanaka, Keiji; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Okatsu, Kei; Koyano, Fumika] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Uno, Midori; Oka, Toshihiko] Rikkyo Univ, Dept Life Sci, Coll Sci, Tokyo 1718501, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Rikkyo University	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan.	tanaka-kj@igakuken.or.jp; matsuda-nr@igakuken.or.jp	Matsuda, Noriyuki/AAI-3156-2020	Matsuda, Noriyuki/0000-0001-8199-952X; Okatsu, Kei/0000-0001-8949-3750	Japan Society for the Promotion of Science (JSPS) KAKENHI [23687018]; MEXT KAKENHI [24111557, 25112522]; Takeda Science Foundation; Tomizawa Jun-ichi and Keiko Fund for Young Scientists; JSPS KAKENHI [23570232, 23'6061]; JST; KAKENHI [21000012]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tomizawa Jun-ichi and Keiko Fund for Young Scientists; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST(Japan Science & Technology Agency (JST)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 23687018 and MEXT KAKENHI Grants 24111557 and 25112522, the Takeda Science Foundation, and the Tomizawa Jun-ichi and Keiko Fund for Young Scientists (to N. M.); by JSPS KAKENHI Grant 23570232 and the grant for CREST from JST (to T. O.); by JSPS KAKENHI Grant 23'6061 (to K. O.); and by KAKENHI Grant 21000012 and the Takeda Science Foundation (to K. T.).	Amo T, 2011, NEUROBIOL DIS, V41, P111, DOI 10.1016/j.nbd.2010.08.027; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2013, GENES CELLS, V18, P672, DOI 10.1111/gtc.12066; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Narendra D, 2012, COLD SPRING HARB PER, V4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Swamy M, 2007, J IMMUNOL METHODS, V324, P74, DOI 10.1016/j.jim.2007.05.003; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang JY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3428; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	59	128	130	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36372	36384		10.1074/jbc.M113.509653	http://dx.doi.org/10.1074/jbc.M113.509653			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189060	hybrid, Green Published			2022-12-28	WOS:000328883400019
J	Paramo, T; Piggot, TJ; Bryant, CE; Bond, PJ				Paramo, Teresa; Piggot, Thomas J.; Bryant, Clare E.; Bond, Peter J.			The Structural Basis for Endotoxin-induced Allosteric Regulation of the Toll-like Receptor 4 (TLR4) Innate Immune Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Endotoxin; Lipopolysaccharide (LPS); Molecular Dynamics; Toll-like receptors (TLRs); Hydrophobic Collapse; Lipid A; Myeloid Differentiation Factor 2 (MD-2)	MOLECULAR-DYNAMICS SIMULATIONS; FORCE-FIELD; LIPID-A; LIPOPOLYSACCHARIDE RECOGNITION; HYDROPHOBIC COLLAPSE; TERTIARY STRUCTURE; TLR4-MD-2 COMPLEX; HUMAN MD-2; PROTEINS; ANTAGONIST	Background: Toll-like receptor 4 (TLR4) in complex with MD-2 stimulates innate immunological pathways in response to bacterial lipopolysaccharide (LPS). Results: Molecular simulations reveal the mechanism of TLR4 complex signaling in response to agonists or antagonists. Conclusion: Conserved clamshell motions in MD-2 allosterically signal ligand-bound state via the conserved phenylalanine 126 residue to TLR4. Significance: The structural basis for molecular switching during endotoxin-induced TLR4 activation is revealed in atomic detail. As part of the innate immune system, Toll-like receptor 4 (TLR4) recognizes bacterial cell surface lipopolysaccharide (LPS) by forming a complex with a lipid-binding co-receptor, MD-2. In the presence of agonist, TLR4MD-2 dimerizes to form an active receptor complex, leading to initiation of intracellular inflammatory signals. TLR4 is of great biomedical interest, but its pharmacological manipulation is complicated because even subtle variations in the structure of LPS can profoundly impact the resultant immunological response. Here, we use atomically detailed molecular simulations to gain insights into the nature of the molecular signaling mechanism. We first demonstrate that MD-2 is extraordinarily flexible. The clamshell-like motions of its -cup fold enable it to sensitively match the volume of its hydrophobic cavity to the size and shape of the bound lipid moiety. We show that MD-2 allosterically transmits this conformational plasticity, in a ligand-dependent manner, to a phenylalanine residue (Phe-126) at the cavity mouth previously implicated in TLR4 activation. Remarkably, within the receptor complex, we observe spontaneous transitions between active and inactive signaling states of Phe-126, and we confirm that Phe-126 is indeed the molecular switch in endotoxic signaling.	[Paramo, Teresa; Bond, Peter J.] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Piggot, Thomas J.] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; [Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of Cambridge; University of Southampton; University of Cambridge	Bond, PJ (corresponding author), Bioinformat Inst A STAR, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.	peterjb@bii.a-star.edu.sg	Kleinschmidt, Jörg H/G-3395-2012	Kleinschmidt, Jörg H/0000-0003-0986-334X; Bond, Peter/0000-0003-2900-098X	Unilever; MRC [G1000133] Funding Source: UKRI; Medical Research Council [G1000133] Funding Source: researchfish	Unilever(Unilever); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Unilever (to P. J. B. and T. P.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Casella CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062622; DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Figueiredo MD, 2008, AM J VET RES, V69, P796, DOI 10.2460/ajvr.69.6.796; Garate JA, 2013, PROTEINS, V81, P658, DOI 10.1002/prot.24223; Garzon D, 2013, J BIOL CHEM, V288, P19528, DOI 10.1074/jbc.M113.470179; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Godfroy JI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048875; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ichikawa S, 2005, J BIOCHEM, V137, P255, DOI 10.1093/jb/mvi039; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Nguyen TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004800; Nishiya T, 2006, BIOCHEM BIOPH RES CO, V341, P1128, DOI 10.1016/j.bbrc.2006.01.074; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Piggot TJ, 2011, J PHYS CHEM B, V115, P13381, DOI 10.1021/jp207013v; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Yu LP, 2012, J BIOL CHEM, V287, P16346, DOI 10.1074/jbc.M112.343467; ZAHRINGER U, 1994, ADV CARBOHYD CHEM BI, V50, P211, DOI 10.1016/S0065-2318(08)60152-3	41	46	47	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36215	36225		10.1074/jbc.M113.501957	http://dx.doi.org/10.1074/jbc.M113.501957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24178299	Green Published, hybrid			2022-12-28	WOS:000328883400004
J	Preuss, E; Hugle, M; Reimann, R; Schlecht, M; Fulda, S				Preuss, Ellen; Hugle, Manuela; Reimann, Romy; Schlecht, Marcel; Fulda, Simone			Pan-Mammalian Target of Rapamycin (mTOR) Inhibitor AZD8055 Primes Rhabdomyosarcoma Cells for ABT-737-induced Apoptosis by Down-regulating Mcl-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cancer; Cell Death; mTOR; Rhabdomyosarcoma	BH3 MIMETIC ABT-737; CANCER-THERAPY; BCL-2 FAMILY; IN-VITRO; RESISTANCE; SURVIVAL; NEUROBLASTOMA; ACTIVATION; MECHANISMS; CHILDREN	The PI3K/mammalian Target of Rapamycin (mTOR) pathway is often aberrantly activated in rhabdomyosarcoma (RMS) and represents a promising therapeutic target. Recent evaluation of AZD8055, an ATP-competitive mTOR inhibitor, by the Preclinical Pediatric Testing Program showed in vivo antitumor activity against childhood solid tumors, including RMS. Therefore, in the present study, we searched for AZD8055-based combination therapies. Here, we identify a new synergistic lethality of AZD8055 together with ABT-737, a BH3 mimetic that antagonizes Bcl-2, Bcl-x(L), and Bcl-w but not Mcl-1. AZD8055 and ABT-737 cooperate to induce apoptosis in alveolar and embryonal RMS cells in a highly synergistic fashion (combination index < 0.2). Synergistic induction of apoptosis by AZD8055 and ABT-737 is confirmed on the molecular level, as AZD8055 and ABT-737 cooperate to trigger loss of mitochondrial membrane potential, activation of caspases, and caspase-dependent apoptosis that is blocked by the pan-caspase inhibitor Z-VAD-fmk. Similar to AZD8055, the PI3K/mTOR inhibitor NVP-BEZ235, the PI3K inhibitor NVP-BKM120 and Akt inhibitor synergize with ABT-737 to trigger apoptosis, whereas no cooperativity is found for the mTOR complex 1 inhibitor RAD001. Interestingly, molecular studies reveal a correlation between the ability of different PI3K/mTOR inhibitors to potentiate ABT-737-induced apoptosis and to suppress Mcl-1 protein levels. Importantly, knockdown of Mcl-1 increases ABT-737-induced apoptosis similar to AZD8055/ABT-737 cotreatment. This indicates that AZD8055-mediated suppression of Mcl-1 protein plays an important role in the synergistic drug interaction. By identifying a novel synergistic interaction of AZD8055 and ABT-737, our findings have important implications for the development of molecular targeted therapies for RMS.	[Preuss, Ellen; Hugle, Manuela; Reimann, Romy; Schlecht, Marcel; Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany	Goethe University Frankfurt	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3a, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de		Fulda, Simone/0000-0002-0459-6417	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported in part by a grant from the Deutsche Krebshilfe (to S. F.).	Ackler S, 2008, MOL CANCER THER, V7, P3265, DOI 10.1158/1535-7163.MCT-08-0268; Armistead PM, 2007, CANCER, V110, P2293, DOI 10.1002/cncr.23038; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chou TC, 1991, SYNERGISM ANTAGONISM, P61; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; Dagher R, 1999, Oncologist, V4, P34; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S., 2012, SARCOMA, V2012; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Fulda S, 2008, CURR CANCER DRUG TAR, V8, P536, DOI 10.2174/156800908785699333; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Geoerger B, 2012, EUR J CANCER, V48, P253, DOI 10.1016/j.ejca.2011.09.021; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Houghton PJ, 2012, PEDIATR BLOOD CANCER, V58, P191, DOI 10.1002/pbc.22935; Kim KW, 2009, CLIN CANCER RES, V15, P6096, DOI 10.1158/1078-0432.CCR-09-0589; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pazzaglia L, 2009, HISTOL HISTOPATHOL, V24, P61, DOI 10.14670/HH-24.61; Petricoin EF, 2007, CANCER RES, V67, P3431, DOI 10.1158/0008-5472.CAN-06-1344; Thomas S, 2013, EXPERT OPIN THER TAR, V17, P61, DOI 10.1517/14728222.2013.733001; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wan XL, 2007, ONCOLOGIST, V12, P1007, DOI 10.1634/theoncologist.12-8-1007; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	34	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35287	35296		10.1074/jbc.M113.495986	http://dx.doi.org/10.1074/jbc.M113.495986			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133218	Green Published, hybrid			2022-12-28	WOS:000329867600027
J	Bode, A; Lynch, JW				Bode, Anna; Lynch, Joseph W.			Analysis of Hyperekplexia Mutations Identifies Transmembrane Domain Rearrangements That Mediate Glycine Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys Loop Receptors; Glycine Receptors; Patch Clamp; Receptor Structure-Function; Site-directed Mutagenesis	GATED ION-CHANNEL; X-RAY-STRUCTURE; GABA(A) RECEPTOR; CHLORIDE CHANNEL; AGONIST BINDING; OPEN STATE; PAIN; LOOP; MECHANISMS; GEPHYRIN	Pentameric ligand-gated ion channels (pLGICs) mediate numerous physiological processes and are therapeutic targets for a wide range of clinical indications. Elucidating the structural differences between their closed and open states may help in designing improved drugs that bias receptors toward the desired conformational state. We recently showed that two new hyperekplexia mutations, Q226E and V280M, induced spontaneous activity in 1 glycine receptors. Gln-226, located near the top of transmembrane (TM) 1, is closely apposed to Arg-271 at the top of TM2 in the neighboring subunit. Using mutant cycle analysis, we inferred that Q226E induces activation via an enhanced electrostatic attraction to Arg-271. This would tilt the top of TM2 toward TM1 and hence away from the pore axis to open the channel. We also concluded that the increased side chain volume of V280M, in the TM2-TM3 loop, exerts a steric repulsion against Ile-225 at the top of TM1 in the neighboring subunit. We infer that this steric repulsion would tilt the top of TM3 radially outwards against the stationary TM1 and thus provide space for TM2 to relax away from the pore axis to create an open channel. Because the transmembrane domain movements inferred from this functional analysis are consistent with the structural differences evident in the x-ray atomic structures of closed and open state bacterial pLGICs, we propyose that the model of pLGIC activation as outlined here may be broadly applicable across the eukaryotic pLGIC receptor family.	[Bode, Anna; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au			National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and the Australian Research Council.	Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Dutertre S, 2012, J BIOL CHEM, V287, P40216, DOI 10.1074/jbc.R112.408229; Eichler SA, 2008, J CELL MOL MED, V12, P2848, DOI 10.1111/j.1582-4934.2008.00357.x; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2001, J NEUROSCI, V21, P2589, DOI 10.1523/JNEUROSCI.21-08-02589.2001; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Manzke T, 2010, J CLIN INVEST, V120, P4118, DOI 10.1172/JCI43029; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Richardson BD, 2012, BRAIN RES, V1485, P77, DOI 10.1016/j.brainres.2012.02.014; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Thomas RH, 2010, J PEDIATR NEUROL, V8, P11, DOI 10.3233/JPN-2010-0359; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Xiong W, 2012, J EXP MED, V209, P1121, DOI 10.1084/jem.20120242; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2	36	19	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33760	33771		10.1074/jbc.M113.513804	http://dx.doi.org/10.1074/jbc.M113.513804			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097980	Green Published, hybrid			2022-12-28	WOS:000327250200022
J	Ngadjeua, F; Chiaravalli, J; Traincard, F; Raynal, B; Fontan, E; Agou, F				Ngadjeua, Flora; Chiaravalli, Jeanne; Traincard, Francois; Raynal, Bertrand; Fontan, Elisabeth; Agou, Fabrice			Two-sided Ubiquitin Binding of NF-kappa B Essential Modulator (NEMO) Zinc Finger Unveiled by a Mutation Associated with Anhidrotic Ectodermal Dysplasia with Immunodeficiency Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Immunodeficiency; NF-B; Ubiquitin; Zinc Finger; EDA-ID; IKK Complex; NEMO	IKK-GAMMA; LYS63-LINKED POLYUBIQUITIN; SEDIMENTATION-VELOCITY; LINEAR POLYUBIQUITIN; STRUCTURAL BASIS; MAP KINASE; ACTIVATION; DOMAIN; CHAINS; RECOGNITION	Hypomorphic mutations in the X-linked human NEMO gene result in various forms of anhidrotic ectodermal dysplasia with immunodeficiency. NEMO function is mediated by two distal ubiquitin binding domains located in the regulatory C-terminal domain of the protein: the coiled-coil 2-leucine zipper (CC2-LZ) domain and the zinc finger (ZF) domain. Here, we investigated the effect of the D406V mutation found in the NEMO ZF of an ectodermal dysplasia with immunodeficiency patients. This point mutation does not impair the folding of NEMO ZF or mono-ubiquitin binding but is sufficient to alter NEMO function, as NEMO-deficient fibroblasts and Jurkat T lymphocytes reconstituted with full-length D406V NEMO lead to partial and strong defects in NF-B activation, respectively. To further characterize the ubiquitin binding properties of NEMO ZF, we employed di-ubiquitin (di-Ub) chains composed of several different linkages (Lys-48, Lys-63, and linear (Met-1-linked)). We showed that the pathogenic mutation preferentially impairs the interaction with Lys-63 and Met-1-linked di-Ub, which correlates with its ubiquitin binding defect in vivo. Furthermore, sedimentation velocity and gel filtration showed that NEMO ZF, like other NEMO related-ZFs, binds mono-Ub and di-Ub with distinct stoichiometries, indicating the presence of a new Ub site within the NEMO ZF. Extensive mutagenesis was then performed on NEMO ZF and characterization of mutants allowed the proposal of a structural model of NEMO ZF in interaction with a Lys-63 di-Ub chain.	[Ngadjeua, Flora; Chiaravalli, Jeanne; Traincard, Francois; Fontan, Elisabeth; Agou, Fabrice] Inst Pasteur, Dept Struct Biol & Chem, CNRS, Unite Biochim Struct & Cellulaire,UMR 3528, F-75724 Paris 15, France; [Raynal, Bertrand] Inst Pasteur, Dept Struct Biol & Chem, CNRS, UMR 3528, F-75724 Paris 15, France; [Ngadjeua, Flora] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Agou, F (corresponding author), Inst Pasteur, Dept Struct Biol & Chem, CNRS, Unite Biochim Struct & Cellulaire,UMR 3528, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	fabrice.agou@pasteur.fr	, AGOU/GXA-2760-2022	raynal, Bertrand/0000-0001-5634-0408	Foundation BNP Paribas; Institut de Recherches SERVIER (Croissy sur Seine, France)	Foundation BNP Paribas; Institut de Recherches SERVIER (Croissy sur Seine, France)	This work was supported, in whole or in part, by Foundation BNP Paribas and the Institut de Recherches SERVIER (Croissy sur Seine, France).	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chiaravalli J, 2011, BIOCHEM PHARMACOL, V82, P1163, DOI 10.1016/j.bcp.2011.07.083; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Courtois G, 2011, CURR TOP MICROBIOL, V349, P73, DOI 10.1007/82_2010_98; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gautheron J, 2010, HUM MOL GENET, V19, P3138, DOI 10.1093/hmg/ddq222; Grubisha O, 2010, J MOL BIOL, V395, P89, DOI 10.1016/j.jmb.2009.10.018; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Harhaj EW, 2000, ONCOGENE, V19, P1448, DOI 10.1038/sj.onc.1203445; Hartwig A, 2010, METHODS MOL BIOL, V649, P399, DOI 10.1007/978-1-60761-753-2_25; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Hubeau M, 2011, BLOOD, V118, P926, DOI 10.1182/blood-2010-10-315234; Ivins FJ, 2009, BIOCHEM J, V421, P243, DOI 10.1042/BJ20090427; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kulathu Y, 2009, NAT STRUCT MOL BIOL, V16, P1328, DOI 10.1038/nsmb.1731; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; RICHARME G, 1982, BIOCHEM BIOPH RES CO, V105, P476, DOI 10.1016/0006-291X(82)91459-0; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Shifera AS, 2008, MOL IMMUNOL, V45, P1633, DOI 10.1016/j.molimm.2007.09.036; Sims JJ, 2012, NAT METHODS, V9, P303, DOI [10.1038/NMETH.1888, 10.1038/nmeth.1888]; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Vinolo E, 2006, J BIOL CHEM, V281, P6334, DOI 10.1074/jbc.M510118200; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028	52	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33722	33737		10.1074/jbc.M113.483305	http://dx.doi.org/10.1074/jbc.M113.483305			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100029	Green Published, hybrid			2022-12-28	WOS:000327250200019
J	Cai, JF; Guo, S; Lomasney, JW; Roberts, MF				Cai, Jingfei; Guo, Su; Lomasney, Jon W.; Roberts, Mary F.			Ca2+-independent Binding of Anionic Phospholipids by Phospholipase C delta 1 EF-hand Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzymes; Glycerophospholipid; Membrane Enzymes; NMR; Phospholipase C; Phospholipid Vesicle; Site-directed Mutagenesis	DEPENDENT PROTEIN-KINASE; CA2+ OSCILLATIONS; CRYSTAL-STRUCTURE; ACTIVATION; DIACYLGLYCEROL; HOMOLOGY; PLC; CALCIUM; ZETA; IDENTIFICATION	Recombinant EF-hand domain of phospholipase C 1 has a moderate affinity for anionic phospholipids in the absence of Ca2+ that is driven by interactions of cationic and hydrophobic residues in the first EF-hand sequence. This region of PLC 1 is missing in the crystal structure. The relative orientation of recombinant EF with respect to the bilayer, established with NMR methods, shows that the N-terminal helix of EF-1 is close to the membrane interface. Specific mutations of EF-1 residues in full-length PLC 1 reduce enzyme activity but not because of disturbing partitioning of the protein onto vesicles. The reduction in enzymatic activity coupled with vesicle binding studies are consistent with a role for this domain in aiding substrate binding in the active site once the protein is transiently anchored at its target membrane.	[Cai, Jingfei; Guo, Su; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Lomasney, Jon W.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Lomasney, Jon W.] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA	Boston College; Northwestern University; Northwestern University	Roberts, MF (corresponding author), Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu			National Institutes of Health [R01 GM60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM60418 (to M. F. R.).	Cheng JJ, 2013, J BIOL CHEM, V288, P14863, DOI 10.1074/jbc.M113.466532; ELLIS MV, 1993, EUR J BIOCHEM, V213, P339, DOI 10.1111/j.1432-1033.1993.tb17767.x; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Goo Rhee Sue, 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P35; Grobler JA, 1996, NAT STRUCT BIOL, V3, P788, DOI 10.1038/nsb0996-788; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jiang Y, 2000, J BIOL CHEM, V275, P34092, DOI 10.1074/jbc.M004914200; Kamat Asha, 1997, Cytokine and Growth Factor Reviews, V8, P109, DOI 10.1016/S1359-6101(97)00003-8; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Kobayashi M, 2005, ARCH BIOCHEM BIOPHYS, V440, P191, DOI 10.1016/j.abb.2005.06.014; Kobayashi M, 2004, BIOCHEMISTRY-US, V43, P7522, DOI 10.1021/bi035966c; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lomasney JW, 1999, J BIOL CHEM, V274, P21995, DOI 10.1074/jbc.274.31.21995; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; NAKASHIMA S, 1995, BIOCHEM BIOPH RES CO, V211, P364, DOI 10.1006/bbrc.1995.1822; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Redfield AG, 2012, J BIOMOL NMR, V52, P159, DOI 10.1007/s10858-011-9594-1; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Roberts M. F., 1998, PHOSPHOINOSITIDES CH, V718, P137; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; SAKANE F, 1990, NATURE, V344, P345, DOI 10.1038/344345a0; Saunders CM, 2002, DEVELOPMENT, V129, P3533; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Swann K, 2006, SEMIN CELL DEV BIOL, V17, P264, DOI 10.1016/j.semcdb.2006.03.009; TAKAI Y, 1979, BIOCHEM BIOPH RES CO, V91, P1218, DOI 10.1016/0006-291X(79)91197-5; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438	36	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37277	37288		10.1074/jbc.M113.512186	http://dx.doi.org/10.1074/jbc.M113.512186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235144	Green Published, hybrid			2022-12-28	WOS:000329189700044
J	Yang, HY; Lee, SM; Gao, BX; Zhang, JP; Fang, DY				Yang, Heeyoung; Lee, Sang-Myeong; Gao, Beixue; Zhang, Jinping; Fang, Deyu			Histone Deacetylase Sirtuin 1 Deacetylates IRF1 Protein and Programs Dendritic Cells to Control Th17 Protein Differentiation during Autoimmune Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; Dendritic Cells; Epigenetics; Sirt1; T Cell; IL-27; IRF1; Acetylation	T-CELLS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; IL-17 PRODUCTION; CUTTING EDGE; C-MAF; IL-27; ACTIVATION; INDUCTION; ALPHA	The type III histone deacetylase Sirt1 has recently emerged as a critical immune regulator by suppressing T cell immunity and macrophage activation during inflammation, but its role in dendritic cells (DCs) remains unknown. Here, we show that mice with genetic Sirt1 deletion specifically in DCs are resistant to MOG-induced experimental autoimmune encephalomyelitis. Loss of Sirt1 functions in DCs enhances their ability to produce IL-27 and interferon (IFN-). Co-cultivation of Sirt1-null DCs with CD4(+) T cells inhibited Th17 differentiation, which is reversed by anti-IL27 and anti-IFN- neutralization antibodies. Sirt1 antagonizes acetylation of IRF1, a transcription factor that drives IL-27 production. Genetic deletion of IRF1 in Sirt1-null DCs abolishes IL-27 production and suppresses Th17 differentiation. Our results show that the histone deacetylase Sirt1 programs DCs to regulate Th17 differentiation during inflammation.	[Yang, Heeyoung; Lee, Sang-Myeong; Gao, Beixue; Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Zhang, Jinping] Soochow Univ, Inst Biol Sci, Suzhou, Jiangsu, Peoples R China; [Zhang, Jinping] Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China	Northwestern University; Feinberg School of Medicine; Soochow University - China; Soochow University - China	Fang, DY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	fangd@northwestern.edu	zhang, jin/GXV-9154-2022; Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751	National Institutes of Health [R01AI079056, DP2DK083050]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK083050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI079056 and DP2DK083050 (to D. F.).	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Chen A, 2011, MOL CELL BIOL, V31, P3445, DOI 10.1128/MCB.05383-11; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Fraternale A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057866; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Genin P, 2003, J VIROL, V77, P7113, DOI 10.1128/JVI.77.12.7113-7119.2003; Gillum M. P., 2010, TRENDS MOL MED, V17, P22; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirahara K, 2012, IMMUNITY, V36, P1017, DOI 10.1016/j.immuni.2012.03.024; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Kemp KL, 2013, J BIOL CHEM, V288, P33272, DOI 10.1074/jbc.M113.493171; Kim HS, 2011, J IMMUNOL, V187, P4007, DOI 10.4049/jimmunol.1101654; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kryczek I, 2007, J IMMUNOL, V179, P1423, DOI 10.4049/jimmunol.179.3.1423; Kuroda S, 2011, P NATL ACAD SCI USA, V108, P14885, DOI 10.1073/pnas.1105133108; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; Masumi A, 1999, MOL CELL BIOL, V19, P1810; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mattei F, 2012, NEOPLASIA, V14, P1223, DOI 10.1593/neo.121444; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Molle C, 2007, J IMMUNOL, V178, P7607, DOI 10.4049/jimmunol.178.12.7607; Molle C, 2010, J IMMUNOL, V184, P1784, DOI 10.4049/jimmunol.0902005; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Remoli ME, 2007, EUR J IMMUNOL, V37, P3499, DOI 10.1002/eji.200737566; Schuetze N, 2005, INT IMMUNOL, V17, P649, DOI 10.1093/intimm/dxh247; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139	49	53	56	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37256	37266		10.1074/jbc.M113.527531	http://dx.doi.org/10.1074/jbc.M113.527531			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214980	Green Published, hybrid			2022-12-28	WOS:000329189700042
J	Zhang, ZP; Zha, YH; Hu, W; Huang, Z; Gao, ZF; Zang, YH; Chen, JN; Dong, L; Zhang, JF				Zhang, Zhengping; Zha, Yinhe; Hu, Wei; Huang, Zhen; Gao, Zhongfei; Zang, Yuhui; Chen, Jiangning; Dong, Lei; Zhang, Junfeng			The Autoregulatory Feedback Loop of MicroRNA-21/Programmed Cell Death Protein 4/Activation Protein-1 (MiR-21/PDCD4/AP-1) as a Driving Force for Hepatic Fibrosis Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibrosis; Hepatic Stellate Cells; Liver Injury; MicroRNA; Transforming Growth Factor (TGF)	STELLATE CELLS; MICRORNA EXPRESSION; LIVER FIBROSIS; UP-REGULATION; IN-VIVO; MIR-21; PDCD4; AP-1; RAT; ACTIVATION	Sustained activation of hepatic stellate cells (HSCs) leads to hepatic fibrosis, which is characterized by excessive collagen production, and for which there is no available drug clinically. Despite tremendous progress, the cellular activities underlying HSC activation, especially the driving force in the perpetuation stage, are only partially understood. Recently, microRNA-21 (miR-21) has been found to be prevalently up-regulated during fibrogenesis in different tissues, although its detailed role needs to be further elucidated. In the present study, miR-21 expression was examined in human cirrhotic liver samples and in murine fibrotic livers induced by thioacetamide or carbon tetrachloride. A dramatic miR-21 increase was noted in activated HSCs. We further found that miR-21 maintained itself at constant high levels by using a microRNA-21/programmed cell death protein 4/activation protein-1 (miR-21/PDCD4/AP-1) feedback loop. Disrupting this loop with miR-21 antagomir or AP-1 inhibitors significantly suppressed fibrogenic activities in HSCs and ameliorated liver fibrosis. In contrast, reinforcing this loop with small interfering RNA (siRNA) against PDCD4 promoted fibrogenesis in HSCs. Further analysis indicated that the up-regulated miR-21 promoted the central transforming growth factor- (TGF-) signaling pathway underlying HSC activation. In summary, we suggest that the miR-21/PDCD4/AP-1 autoregulatory loop is one of the main driving forces for hepatic fibrosis progression. Targeting this aberrantly activated feedback loop may provide a new therapeutic strategy and facilitate drug discovery against hepatic fibrosis.	[Zhang, Zhengping; Zha, Yinhe; Hu, Wei; Huang, Zhen; Gao, Zhongfei; Zang, Yuhui; Chen, Jiangning; Dong, Lei; Zhang, Junfeng] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Zhang, Junfeng] Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210000, Jiangsu, Peoples R China	Nanjing University	Dong, L (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.	leidong@nju.edu.cn; jfzhang@nju.edu.cn	Dong, Lei/J-3516-2013; zhang, zheng/HCH-9684-2022		National Science Fund for Distinguished Young Scholars Grant [81025019]; National Basic Research Program of China Grant [2012CB517603]; National Natural Science Foundation of China [J1103512, J1210026, 31070722, 31271013, 31071232, 31170751, 31200695, 51173076, 91129712, 81102489]; Chinese Ministry of Education [108059]; Ph.D. Programs Foundation of the Ministry of Education of China [20100091120020]; Fundamental Research Funds for the Central Universities	National Science Fund for Distinguished Young Scholars Grant(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Science Fund for Distinguished Young Scholars Grant 81025019; National Basic Research Program of China Grant 2012CB517603; National Natural Science Foundation of China Grants J1103512, J1210026, 31070722, 31271013, 31071232, 31170751, 31200695, 51173076, 91129712, and 81102489; Key Project of the Chinese Ministry of Education Grant 108059; Ph.D. Programs Foundation of the Ministry of Education of China Grant 20100091120020; and the Fundamental Research Funds for the Central Universities.	Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Chung ACK, 2013, MOL THER, V21, P388, DOI 10.1038/mt.2012.251; de Planell-Saguer M, 2010, NAT PROTOC, V5, P1061, DOI 10.1038/nprot.2010.62; Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Frezzetti D, 2011, ONCOGENE, V30, P275, DOI 10.1038/onc.2010.416; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006; Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lee JI, 2003, J HEPATOL, V39, P960, DOI 10.1016/S0168-8278(03)00411-2; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Marquez RT, 2010, LAB INVEST, V90, P1727, DOI 10.1038/labinvest.2010.126; Maubach G, 2011, WORLD J GASTROENTERO, V17, P2748, DOI [10.3748/wjg.v17.i22., 10.3748/wjg.v17.i22.2748]; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Ross KR, 2007, CELL SIGNAL, V19, P923, DOI 10.1016/j.cellsig.2006.11.008; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Thompson KC, 1998, HEPATOLOGY, V28, P1518, DOI 10.1002/hep.510280611; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737; Vogel S, 2000, J LIPID RES, V41, P882; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433	44	87	94	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37082	37093		10.1074/jbc.M113.517953	http://dx.doi.org/10.1074/jbc.M113.517953			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196965	hybrid, Green Published			2022-12-28	WOS:000329189700028
J	Broniowska, KA; Mathews, CE; Corbett, JA				Broniowska, Katarzyna A.; Mathews, Clayton E.; Corbett, John A.			Do beta-Cells Generate Peroxynitrite in Response to Cytokine Treatment?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Diabetes; Islet; Nitric Oxide; Reactive Oxygen Species (ROS); Nitric-oxide Synthase; Peroxynitrite	HUMAN PANCREATIC-ISLETS; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; OXYGEN SPECIES PRODUCTION; REACTIVE OXYGEN; INSULIN-SECRETION; SUPEROXIDE-PRODUCTION; NADPH OXIDASE; DNA-DAMAGE; RAT ISLETS	Background: The species that mediates cytokine-induced -cell death, be it nitric oxide or peroxynitrite, is unknown. Results: Cytokines stimulate the formation of nitric oxide but fail to stimulate peroxynitrite production by -cells. Conclusion: Terminally differentiated -cells, unlike macrophages, do not produce peroxynitrite. Significance: Peroxynitrite does not contribute to cytokine-induced -cell damage. The purpose of this study was to determine the reactive species that is responsible for cytokine-mediated -cell death. Inhibitors of inducible nitric oxide synthase prevent this death, and addition of exogenous nitric oxide using donors induces -cell death. The reaction of nitric oxide with superoxide results in the generation of peroxynitrite, and this powerful oxidant has been suggested to be the mediator of -cell death in response to cytokine treatment. Recently, coumarin-7-boronate has been developed as a probe for the selective detection of peroxynitrite. Using this reagent, we show that addition of the NADPH oxidase activator phorbol 12-myristate 13-acetate to nitric oxide-producing macrophages results in peroxynitrite generation. Using a similar approach, we demonstrate that cytokines fail to stimulate peroxynitrite generation by rat islets and insulinoma cells, either with or without phorbol 12-myristate 13-acetate treatment. When forced to produce superoxide using redox cyclers, this generation is associated with protection from nitric oxide toxicity. These findings indicate that: (i) nitric oxide is the likely mediator of the toxic effects of cytokines, (ii) -cells do not produce peroxynitrite in response to cytokines, and (iii) when forced to produce superoxide, the scavenging of nitric oxide by superoxide is associated with protection of -cells from nitric oxide-mediated toxicity.	[Broniowska, Katarzyna A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Mathews, Clayton E.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	Medical College of Wisconsin; State University System of Florida; University of Florida	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Broniowska, Katarzyna/0000-0002-8000-9093	National Institutes of Health [DK-052194, AI-44458, AI-056374, DK-074656]; American Heart Association [13POST16940076]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056374, R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104194, R01DK074656, R01DK052194, R56DK074656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-052194 and AI-44458 (to J. A. C.) and AI-056374 and DK-074656 (to C. E. M.). This work was also supported by American Heart Association Postdoctoral Fellowship 13POST16940076 (to K. A. B.).	BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; CADENAS E, 1995, BIOCHEM PHARMACOL, V49, P127, DOI 10.1016/S0006-2952(94)00333-5; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; COMBADIERE C, 1990, BIOCHEM BIOPH RES CO, V168, P65, DOI 10.1016/0006-291X(90)91675-I; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; CURNUTTE JT, 1994, J BIOL CHEM, V269, P10813; Delaney CA, 1997, ADV EXP MED BIOL, V426, P335; Delaney CA, 1997, MUTAT RES-FUND MOL M, V375, P137, DOI 10.1016/S0027-5107(97)00009-2; Delaney CA, 1996, FEBS LETT, V394, P300, DOI 10.1016/0014-5793(96)00977-5; DiMatteo MA, 1997, APOPTOSIS, V2, P164, DOI 10.1023/A:1026412414666; Eizirik DL, 1996, MOL CELL ENDOCRINOL, V118, P71, DOI 10.1016/0303-7207(96)03768-9; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1993, FEBS LETT, V317, P62, DOI 10.1016/0014-5793(93)81492-I; Graciano MFR, 2011, J CELL PHYSIOL, V226, P1110, DOI 10.1002/jcp.22432; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gunther MR, 2002, TOXICOLOGY, V177, P1, DOI 10.1016/S0300-483X(02)00191-9; Gurgul-Convey E, 2011, J MOL MED, V89, P785, DOI 10.1007/s00109-011-0747-1; Gusdon A.M., 2006, DRUG DISCOV TODAY DI, V3, P367, DOI [10.1016/j.ddmec.2006.09.010, DOI 10.1016/J.DDMEC.2006.09.010]; Gusdon AM, 2007, J BIOL CHEM, V282, P5171, DOI 10.1074/jbc.M609367200; Hadjivassiliou V, 1998, NITRIC OXIDE-BIOL CH, V2, P429, DOI 10.1006/niox.1998.0203; Halliwell B., 2007, FREE RADICALS BIOL M; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; Kohl R, 2006, FREE RADICAL BIO MED, V40, P1430, DOI 10.1016/j.freeradbiomed.2005.12.012; Lakey JRT, 2001, LAB INVEST, V81, P1683, DOI 10.1038/labinvest.3780381; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Mathews CE, 2002, FREE RADICAL BIO MED, V32, P744, DOI 10.1016/S0891-5849(02)00747-5; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2011, MOL CELL BIOL, V31, P4286, DOI 10.1128/MCB.05668-11; Miles AM, 1996, J BIOL CHEM, V271, P40, DOI 10.1074/jbc.271.1.40; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rebelato E, 2012, LIFE SCI, V91, P244, DOI 10.1016/j.lfs.2012.07.004; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907; Syed I, 2011, DIABETES, V60, P2843, DOI 10.2337/db11-0809; Syed I, 2011, AM J PHYSIOL-REG I, V300, pR756, DOI 10.1152/ajpregu.00786.2010; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Thayer TC, 2011, DIABETES, V60, P2144, DOI 10.2337/db10-1222; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Uchizono Y, 2006, LIFE SCI, V80, P133, DOI 10.1016/j.lfs.2006.08.031; Watanabe N, 2003, ARCH BIOCHEM BIOPHYS, V411, P145, DOI 10.1016/S0003-9861(02)00716-6; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	69	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36567	36578		10.1074/jbc.M113.522243	http://dx.doi.org/10.1074/jbc.M113.522243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194521	Green Published, hybrid			2022-12-28	WOS:000328883400037
J	Long, JY; Badal, SS; Wang, Y; Chang, BHJ; Rodriguez, A; Danesh, FR				Long, Jianyin; Badal, Shawn S.; Wang, Yin; Chang, Benny H. J.; Rodriguez, Antony; Danesh, Farhad R.			MicroRNA-22 Is a Master Regulator of Bone Morphogenetic Protein-7/6 Homeostasis in the Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Fibrosis; Gene Regulation; Kidney; MicroRNA	RENAL INTERSTITIAL FIBROSIS; UP-REGULATION; MESENCHYMAL TRANSITION; GENE-EXPRESSION; IDENTIFICATION; MECHANISMS; ID1; TESTOSTERONE; ACTIVATION; INHIBITION	Background: BMPs have emerged as key regulators of kidney fibrosis. Results: Deletion of miR-22 attenuated renal fibrosis via direct targeting of BMP-7/6. BMP-7/6 in turn transcriptionally regulates miR-22 expression. Conclusion: miR-22 and BMP-7/6 form a negative feedback circuit. Significance: The present study is the first to report the effect of miR-22 on BMP signaling and kidney fibrosis. Accumulating evidence suggests that microRNAs (miRNAs) contribute to a myriad of kidney diseases. However, the regulatory role of miRNAs on the key molecules implicated in kidney fibrosis remains poorly understood. Bone morphogenetic protein-7 (BMP-7) and its related BMP-6 have recently emerged as key regulators of kidney fibrosis. Using the established unilateral ureteral obstruction (UUO) model of kidney fibrosis as our experimental model, we examined the regulatory role of miRNAs on BMP-7/6 signaling. By analyzing the potential miRNAs that target BMP-7/6 in silica, we identified miR-22 as a potent miRNA targeting BMP-7/6. We found that expression levels of BMP-7/6 were significantly elevated in the kidneys of the miR-22 null mouse. Importantly, mice with targeted deletion of miR-22 exhibited attenuated renal fibrosis in the UUO model. Consistent with these in vivo observations, primary renal fibroblast isolated from miR-22-deficient UUO mice demonstrated a significant increase in BMP-7/6 expression and their downstream targets. This phenotype could be rescued when cells were transfected with miR-22 mimics. Interestingly, we found that miR-22 and BMP-7/6 are in a regulatory feedback circuit, whereby not only miR-22 inhibits BMP-7/6, but miR-22 by itself is induced by BMP-7/6. Finally, we identified two BMP-responsive elements in the proximal region of miR-22 promoter. These findings identify miR-22 as a critical miRNA that contributes to renal fibrosis on the basis of its pivotal role on BMP signaling cascade.	[Long, Jianyin; Badal, Shawn S.; Wang, Yin; Danesh, Farhad R.] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Houston, TX 77030 USA; [Badal, Shawn S.; Danesh, Farhad R.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Chang, Benny H. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Rodriguez, Antony] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Danesh, Farhad R.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Danesh, FR (corresponding author), Univ Texas MD Anderson Canc Ctr, Nephrol Sect, 1515 Holcombe Blvd, Houston, TX 77030 USA.	fdanesh@mdanderson.org		Danesh, Farhad/0000-0001-6849-5239	National Institutes of Health [RO1DK091310, RO1DK078900]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091310, R01DK078900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK091310 and RO1DK078900 (to F.R.D.).	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bar N., 2010, PLOS ONE, V5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Dov IZ, 2012, TRANSPLANTATION, V94, P1086, DOI 10.1097/TP.0b013e3182751efd; Blitz IL, 2009, DEV DYNAM, V238, P1321, DOI 10.1002/dvdy.21984; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Dey N, 2011, J BIOL CHEM, V286, P25586, DOI 10.1074/jbc.M110.208066; Du M, 2006, FEBS J, V273, P732, DOI 10.1111/j.1742-4658.2006.05106.x; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Grimwood Lauren, 2009, V466, P25, DOI 10.1007/978-1-59745-352-3_3; Gurha P, 2012, CIRCULATION, V125, P2751, DOI 10.1161/CIRCULATIONAHA.111.044354; Huang ZP, 2013, CIRC RES, V112, P1234, DOI 10.1161/CIRCRESAHA.112.300682; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jenkins RH, 2011, AM J PATHOL, V178, P964, DOI 10.1016/j.ajpath.2010.12.010; Jian P, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-20; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shepherd TG, 2008, GENE, V414, P95, DOI 10.1016/j.gene.2008.02.015; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718; Weiskirchen R, 2009, FRONT BIOSCI, V14, P4992, DOI 10.2741/3583; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Yan JD, 2009, ACTA PHARMACOL SIN, V30, P994, DOI 10.1038/aps.2009.56; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168	63	41	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36202	36214		10.1074/jbc.M113.498634	http://dx.doi.org/10.1074/jbc.M113.498634			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24163368	hybrid, Green Published			2022-12-28	WOS:000328883400003
J	Luo, DX; Bu, YW; Ma, J; Rajput, S; He, YC; Cai, GX; Liao, DF; Cao, DL				Luo, Dixian; Bu, Yiwen; Ma, Jun; Rajput, Sandeep; He, Yingchun; Cai, Guangxian; Liao, Duan-Fang; Cao, Deliang			Heat Shock Protein 90-alpha Mediates Aldo-Keto Reductase 1B10 (AKR1B10) Protein Secretion through Secretory Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; HSP90; Lysosomes; Protein Secretion; Tumor Marker; Chaperone	GROWTH-FACTOR-I; MOLECULAR CHAPERONES; ENDOPLASMIC-RETICULUM; CELL MOTILITY; CANCER CELLS; MEMBER B10; FAMILY 1; HSP90; OVEREXPRESSION; PURIFICATION	Background: Aldo-keto reductase 1B10 (AKR1B10) protein is a new tumor biomarker in humans. Results: Heat shock protein 90 (HSP90) is a chaperone molecule that mediates transportation to lysosomes and secretion of AKR1B10. Helix 10 of AKR1B10 protein mediates its interaction with HSP90. Conclusion: HSP90 mediates AKR1B10 secretion through binding to its helix 10 domain. Significance: This finding is significant in exploiting the use of AKR1B10 in cancer clinics. Aldo-keto reductase 1B10 (AKR1B10) protein is a new tumor biomarker in humans. Our previous studies have shown that AKR1B10 is secreted through a lysosome-mediated nonclassical pathway, leading to an increase in the serum of breast cancer patients. This study illuminates the regulatory mechanism of AKR1B10 secretion. The cytosolic AKR1B10 associates with and is translocated to lysosomes by heat shock protein 90 (HSP90), a chaperone molecule. Ectopic expression of HSP90 significantly increased the secretion of endogenous AKR1B10 and exogenous GFP-AKR1B10 fusion protein when cotransfected. Geldanamycin, a HSP90 inhibitor, dissociated AKR1B10-HSP90 complexes and significantly reduced AKR1B10 secretion in a dose-dependent manner. We characterized the functional domain in AKR1B10 and found that helix 10 (amino acids 233-240), located at the C terminus, regulates AKR1B10 secretion. Targeted point mutations recognized that amino acids Lys-233, Glu-236, and Lys-240 in helix 10 mediate the interaction of AKR1B10 with HSP90. Together, our data suggest that HSP90 mediates AKR1B10 secretion through binding to its helix 10 domain. This finding is significant in exploiting the use of AKR1B10 in cancer clinics.	[Luo, Dixian; Bu, Yiwen; Rajput, Sandeep; Cao, Deliang] So Illinois Univ, Simmons Canc Inst, Dept Med Microbiol Immunol & Cell Biol, Sch Med, Springfield, IL 62794 USA; [Luo, Dixian] First Peoples Hosp Chenzhou, Inst Translat Med, Chenzhou 423000, Hunan, Peoples R China; [Luo, Dixian] First Peoples Hosp Chenzhou, Dept Lab Med, Chenzhou 423000, Hunan, Peoples R China; [Ma, Jun; Cao, Deliang] Med Coll Guangdong, Affiliated Shenzhen Futian Hosp, Shenzhen 518033, Peoples R China; [Ma, Jun; Cao, Deliang] Shenzhen Third Peoples Hosp, Guangdong Med Coll, Shenzhen 518112, Peoples R China; [He, Yingchun; Cai, Guangxian; Liao, Duan-Fang; Cao, Deliang] Hunan Univ Chinese Med, State Key Lab Chinese Med Powder & Med Innovat Hu, Div Stem Cell Regulat & Applicat, Changsha 410208, Hunan, Peoples R China	Southern Illinois University System; Southern Illinois University; Guangdong Medical University; Hunan University of Chinese Medicine	Liao, DF (corresponding author), Hunan Univ Chinese Med, State Key Lab Chinese Med Powder & Med Innovat Hu, Div Stem Cell Regulat & Applicat, Changsha 410208, Hunan, Peoples R China.	dfliao66@aliyun.com; dcao@siumed.edu	rajput, sandeep/Q-5408-2019		Department of Defense Breast Cancer Research Program [BC083555]; National Natural Science Foundation of China [81372825, 81272918]; China Hunan Provincial Science and Technology Department [2012SK3065]; Health Department of China Hunan Province Grant [B2012-157]; China Hunan Provincial Education Department [13C882]	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Hunan Provincial Science and Technology Department; Health Department of China Hunan Province Grant; China Hunan Provincial Education Department	This work was supported by Department of Defense Breast Cancer Research Program Grant BC083555 (to D. C.), by National Natural Science Foundation of China Grants 81372825 (to D. L.) and 81272918 (to D. C.), by China Hunan Provincial Science and Technology Department Grant 2012SK3065 (to D. L.), by Health Department of China Hunan Province Grant B2012-157 (to D. L.), and by China Hunan Provincial Education Department Grant 13C882 (to D. L.).	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Balendiran GK, 2009, CHEM-BIOL INTERACT, V178, P134, DOI 10.1016/j.cbi.2008.10.044; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gross M, 1996, J BIOL CHEM, V271, P16833, DOI 10.1074/jbc.271.28.16833; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Luo DX, 2011, BIOCHEM J, V438, P71, DOI 10.1042/BJ20110111; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; Ma J, 2012, INT J CANCER, V131, pE862, DOI 10.1002/ijc.27618; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Martin HJO, 2006, DRUG METAB DISPOS, V34, P464, DOI 10.1124/dmd; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Quinn AM, 2008, CHEM RES TOXICOL, V21, P2207, DOI 10.1021/tx8002005; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Ruiz FX, 2009, CHEM-BIOL INTERACT, V178, P171, DOI 10.1016/j.cbi.2008.10.027; Shen Y, 2011, CHEM-BIOL INTERACT, V191, P192, DOI 10.1016/j.cbi.2011.02.004; Shen Y, 2010, BIOCHIMIE, V92, P530, DOI 10.1016/j.biochi.2010.02.001; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933; Yoshitake H, 2007, INT J GYNECOL CANCER, V17, P1300, DOI 10.1111/j.1525-1438.2007.00932.x; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhong LL, 2011, TOXICOL APPL PHARM, V255, P40, DOI 10.1016/j.taap.2011.05.014; Zhong LL, 2009, BIOCHEM BIOPH RES CO, V387, P245, DOI 10.1016/j.bbrc.2009.06.123; Zimmermann R, 1998, BIOL CHEM, V379, P275; Zu XY, 2007, TOXICOL SCI, V97, P562, DOI 10.1093/toxsci/kfm033	38	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36733	36740		10.1074/jbc.M113.514877	http://dx.doi.org/10.1074/jbc.M113.514877			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24217247	hybrid, Green Published			2022-12-28	WOS:000328883400050
J	Troeger, A; Chae, HD; Senturk, M; Wood, J; Williams, DA				Troeger, Anja; Chae, Hee-Don; Senturk, Mumine; Wood, Jenna; Williams, David A.			A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Protein Degradation; Protein Stability; Rho GTPases; T Cell; Atypical Rho GTPases; B-Cell Malignancies; RhoH; Carboxyl Terminus; Chaperone-mediated Autophagy	T-CELL-RECEPTOR; ABERRANT SOMATIC HYPERMUTATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; BINDING PROTEIN; GENE-TRANSFER; AUTOPHAGY; UBIQUITIN; DEGRADATION; INHIBITION; EXPRESSION	Background: RhoH is required for T cell development and non-coding RhoH mutations are found in B-cell lymphoma. Results: The C-terminal insert domain regulates RhoH protein stability via chaperone-mediated autophagy. Conclusion: Although the insert domain is required for lysosomal uptake, it is dispensable for T cell development. Significance: Targeting the insert domain may permit alteration of RhoH protein levels without impairing vital protein functions. RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family that was first identified as a hypermutable gene in human B lineage lymphomas. RhoH remains in a constitutively active state and thus its effects are regulated by expression levels or post-translational modifications. Similar to other small GTPases, intracellular localization of RhoH is dependent upon the conserved CAAX box and surrounding sequences within the carboxyl (C) terminus. However, RhoH also contains a unique C-terminal insert domain of yet undetermined function. RhoH serves as adaptor molecule in T cell receptor signaling and RhoH expression correlates with the unfavorable prognostic marker ZAP70 in human chronic lymphocytic leukemia. Disease progression is attenuated in a Rhoh(-/-) mouse model of chronic lymphocytic leukemia and treatment of primary human chronic lymphocytic leukemia cells with Lenalidomide results in reduced RhoH protein levels. Thus, RhoH is a potential therapeutic target in B cell malignancies. In the current studies, we demonstrate that deletion of the insert domain (LFSINE) results in significant cytoplasmic protein accumulation. Using inhibitors of degradation pathways, we show that LFSINE regulates lysosomal RhoH uptake and degradation via chaperone-mediated autophagy. Whereas the C-terminal prenylation site is critical for ZAP70 interaction, subcellular localization and rescue of the Rhoh(-/-) T cell defect in vivo, the insert domain appears dispensable for these functions. Taken together, our findings suggest that the insert domain regulates protein stability and activity without otherwise affecting RhoH function.	[Troeger, Anja; Wood, Jenna; Williams, David A.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Troeger, Anja; Wood, Jenna; Williams, David A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chae, Hee-Don] Stanford Univ, Sch Med, Div Hematol Oncol, Dept Pediat,CSCR 1210, Stanford, CA 94305 USA; [Senturk, Mumine] Baylor Coll Med, Dept Dev Biol, Houston, TX 77030 USA; [Troeger, Anja] Univ Dusseldorf, Clin Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Stanford University; Baylor College of Medicine; Heinrich Heine University Dusseldorf	Williams, DA (corresponding author), Karp Family Res Labs 08125 3, 300 Longwood Ave, Boston, MA 02115 USA.	DAWilliams@childrens.harvard.edu	Chae, Hee-Don/D-2620-2011	Wood, Jenna/0000-0001-6715-0626	National Institutes of Health [CA113969]; Deutsche Forschungsgemeinschaft [TR 1005/1-1]; NATIONAL CANCER INSTITUTE [R01CA113969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113969 (to D. A. W.) and Deutsche Forschungsgemeinschaft Grant TR 1005/1-1 (to A. T.).	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Benbrook D. M., 2012, Experimental Oncology, V34, P286; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blagosklonny MV, 1999, ONCOGENE, V18, P6460, DOI 10.1038/sj.onc.1203068; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; Chae HD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013970; Chang Xiu-Bao, 2011, Int J Biochem Mol Biol, V2, P287; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; Crul M, 2001, ANTI-CANCER DRUG, V12, P163, DOI 10.1097/00001813-200103000-00001; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DalleryPrudhomme E, 1997, GENOMICS, V43, P89, DOI 10.1006/geno.1997.4788; Delestre L, 2011, BIOCHEM J, V437, P75, DOI 10.1042/BJ20100829; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fueller Florian, 2008, Cell Commun Signal, V6, P6, DOI 10.1186/1478-811X-6-6; Gaidano G, 2003, BLOOD, V102, P1833, DOI 10.1182/blood-2002-11-3606; Galiegue-Zouitina S, 2008, CANCER RES, V68, P4531, DOI 10.1158/0008-5472.CAN-07-5661; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; Gu Y, 2005, CELL CYCLE, V4, P201; Gu Y, 2005, BLOOD, V105, P1467, DOI 10.1182/blood-2004-04-1604; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hiraga J, 2007, LEUKEMIA, V21, P1846, DOI 10.1038/sj.leu.2404717; Iwasaki T, 2008, EUR J HAEMATOL, V81, P454, DOI 10.1111/j.1600-0609.2008.01132.x; Jadhav Trafina, 2009, J Proteomics Bioinform, V2, P316; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lahousse S, 2004, GENE, V343, P55, DOI 10.1016/j.gene.2004.08.022; Li WM, 2011, CELL MOL LIFE SCI, V68, P749, DOI 10.1007/s00018-010-0565-6; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Montesinos-Rongen M, 2004, BLOOD, V103, P1869, DOI 10.1182/blood-2003-05-1465; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; Qiao LY, 2009, NEUROSCI LETT, V456, P15, DOI 10.1016/j.neulet.2009.03.085; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Sanchez-Aguilera A, 2010, LEUKEMIA, V24, P97, DOI 10.1038/leu.2009.217; Schmidt-Mende J, 2010, EUR J IMMUNOL, V40, P525, DOI 10.1002/eji.200939556; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Troeger A, 2012, BLOOD, V119, P4708, DOI 10.1182/blood-2011-12-395939; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Viana R, 2008, BIOCHEM BIOPH RES CO, V369, P964, DOI 10.1016/j.bbrc.2008.02.126; Wahlers A, 2001, GENE THER, V8, P477, DOI 10.1038/sj.gt.3301426; Wang H, 2011, CELL SIGNAL, V23, P249, DOI 10.1016/j.cellsig.2010.09.009; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Zungu M, 2011, AM J PATHOL, V178, P4, DOI 10.1016/j.ajpath.2010.11.030	57	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36451	36462		10.1074/jbc.M113.505727	http://dx.doi.org/10.1074/jbc.M113.505727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189071	Green Published, hybrid			2022-12-28	WOS:000328883400026
J	Zhou, X; Zheng, Y				Zhou, Xuan; Zheng, Yi			Cell Type-specific Signaling Function of RhoA GTPase: Lessons from Mouse Gene Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cellular Regulation; Gene Knock-out; Mouse Genetics; Rho GTPases; Signaling	VENTRAL BODY-WALL; PLATELET ACTIVATION; P190 RHOGAP; ROCK-I; PROTEIN; MIGRATION; SHAPE; ORGANIZATION; CYTOKINESIS; MICE	RhoA GTPase is a key intracellular regulator of actomyosin dynamics and other cell functions, including adhesion, proliferation, survival, and gene expression. Most of our knowledge of RhoA signaling function is from studies in immortalized cell lines utilizing inhibitors or dominant mutant overexpression, both of which are limited in terms of specificity, dosage, and clonal variation. Recent mouse gene targeting studies of rhoA and its regulators/effectors have revealed cell type-specific signaling mechanisms in the context of mammalian physiology. The new knowledge may present therapeutic opportunities for the rational targeting of RhoA signaling-mediated pathophysiologies.	[Zhou, Xuan; Zheng, Yi] Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Zheng, Y (corresponding author), Univ Cincinnati, Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	yi.zheng@cchmc.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	National Institutes of Health [R01 CA150547, R01 HL085362, P30 DK090971]; NATIONAL CANCER INSTITUTE [R01CA150547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 CA150547, R01 HL085362, and P30 DK090971.	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; Beltman J, 1999, J BIOL CHEM, V274, P3772, DOI 10.1074/jbc.274.6.3772; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Borges RM, 2011, GENESIS, V49, P368, DOI 10.1002/dvg.20723; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Chiba Y, 2010, J PHARMACOL SCI, V114, P239, DOI 10.1254/jphs.10R03CR; Cook Danielle R, 2011, Genes Cancer, V2, P932, DOI 10.1177/1947601912437035; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; FINDLATER GS, 1993, J ANAT, V183, P121; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Geh E, 2011, P NATL ACAD SCI USA, V108, P17349, DOI 10.1073/pnas.1102297108; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HENDRIX RW, 1974, NATURE, V247, P145, DOI 10.1038/247145a0; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Jackson B, 2011, MOL BIOL CELL, V22, P593, DOI 10.1091/mbc.E09-10-0859; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joseph B, 2010, EXP CELL RES, V316, P1415, DOI 10.1016/j.yexcr.2010.03.012; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Katayama KI, 2012, J NEUROSCI, V32, P10396, DOI 10.1523/JNEUROSCI.6474-11.2012; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Leslie JR, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00067; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Matheson SF, 2006, DEV NEUROSCI-BASEL, V28, P538, DOI 10.1159/000095116; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Melendez J, 2011, J BIOL CHEM, V286, P15132, DOI 10.1074/jbc.C111.229336; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Miller N. L., 2012, PLOS ONE, V7; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; MOHR C, 1992, FEBS LETT, V297, P95, DOI 10.1016/0014-5793(92)80335-E; Molli PR, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-16; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Nakano K, 1997, GENES CELLS, V2, P679, DOI 10.1046/j.1365-2443.1997.1540352.x; NEMOTO Y, 1992, J BIOL CHEM, V267, P20916; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pleines I, 2012, BLOOD, V119, P1054, DOI 10.1182/blood-2011-08-372193; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Shang X, 2013, P NATL ACAD SCI USA, V110, P3155, DOI 10.1073/pnas.1212324110; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Shinohara R, 2012, NAT NEUROSCI, V15, P373, DOI 10.1038/nn.3020; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Thumkeo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025465; Van de Putte T, 2001, MECH DEVELOP, V102, P33, DOI 10.1016/S0925-4773(01)00279-9; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Vidal A, 2002, J BIOL CHEM, V277, P16433, DOI 10.1074/jbc.M112090200; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Xu HM, 2009, BLOOD, V114, P3557, DOI 10.1182/blood-2009-02-205815; Yamada T, 2008, BIOCHEM BIOPH RES CO, V372, P941, DOI 10.1016/j.bbrc.2008.05.170; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zhang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033773; Zhou X, 2013, J EXP MED, V210, P2371, DOI 10.1084/jem.20122348; Zhou ZK, 2009, NEUROPHARMACOLOGY, V56, P81, DOI 10.1016/j.neuropharm.2008.07.031	93	34	37	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36179	36188		10.1074/jbc.R113.515486	http://dx.doi.org/10.1074/jbc.R113.515486			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24202176	hybrid, Green Published			2022-12-28	WOS:000328883400001
J	Matsuyama, M; Tanaka, H; Inoko, A; Goto, H; Yonemura, S; Kobori, K; Hayashi, Y; Kondo, E; Itohara, S; Izawa, I; Inagaki, M				Matsuyama, Makoto; Tanaka, Hiroki; Inoko, Akihito; Goto, Hidemasa; Yonemura, Shigenobu; Kobori, Kyoko; Hayashi, Yuko; Kondo, Eisaku; Itohara, Shigeyoshi; Izawa, Ichiro; Inagaki, Masaki			Defect of Mitotic Vimentin Phosphorylation Causes Microophthalmia and Cataract via Aneuploidy and Senescence in Lens Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cataract; Cell Division; Cytokinesis; Mitosis; Phosphorylation; Senescence; Aneuploidy; Chromosomal Instability; Vimentin	RHO-ASSOCIATED KINASE; INTERMEDIATE-FILAMENTS; CLEAVAGE FURROW; AURORA-B; PROTEIN; SITE; CYTOKINESIS; DYNAMICS; ROLES; SEGREGATION	Background: Vimentin, an intermediate filament (IF) protein, is phosphorylated in mitosis. Results: Disruption of vimentin phosphorylation during cell division leads to chromosomal instability (CIN) and premature aging in mouse lens tissue. Conclusion: Our data document the first physiological importance of vimentin phosphorylation during mitosis for organogenesis and tissue homeostasis. Significance: Our data suggest a possible causal relationship between CIN and premature aging. Vimentin, a type III intermediate filament (IF) protein, is phosphorylated predominantly in mitosis. The expression of a phosphorylation-compromised vimentin mutant in T24 cultured cells leads to cytokinetic failure, resulting in binucleation (multinucleation). The physiological significance of intermediate filament phosphorylation during mitosis for organogenesis and tissue homeostasis was uncertain. Here, we generated knock-in mice expressing vimentin that have had the serine sites phosphorylated during mitosis substituted by alanine residues. Homozygotic mice (VIMSA/SA) presented with microophthalmia and cataracts in the lens, whereas heterozygotic mice (VIMWT/SA) were indistinguishable from WT (VIMWT/WT) mice. In VIMSA/SA mice, lens epithelial cell number was not only reduced but the cells also exhibited chromosomal instability, including binucleation and aneuploidy. Electron microscopy revealed fiber membranes that were disorganized in the lenses of VIMSA/SA, reminiscent of similar characteristic changes seen in age-related cataracts. Because the mRNA level of the senescence (aging)-related gene was significantly elevated in samples from VIMSA/SA, the lens phenotype suggests a possible causal relationship between chromosomal instability and premature aging.	[Matsuyama, Makoto; Tanaka, Hiroki; Inoko, Akihito; Goto, Hidemasa; Kobori, Kyoko; Hayashi, Yuko; Izawa, Ichiro; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan; [Kondo, Eisaku] Aichi Canc Ctr, Res Inst, Div Oncol Pathol, Nagoya, Aichi 4648681, Japan; [Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4668550, Japan; [Kondo, Eisaku] Nagoya Univ, Grad Sch Med, Dept Epidemiol, Nagoya, Aichi 4668550, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo 6500047, Japan; [Itohara, Shigeyoshi] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan	Aichi Cancer Center; Aichi Cancer Center; Nagoya University; Nagoya University; RIKEN; RIKEN	Inagaki, M (corresponding author), Aichi Canc Ctr, Res Inst, Div Biochem, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	minagaki@aichi-cc.jp	Itohara, Shigeyoshi/I-8769-2012; Inagaki, Masaki/B-9920-2016	Itohara, Shigeyoshi/0000-0002-2410-9989; Goto, Hidemasa/0000-0002-6796-4467; TANAKA, HIROKI/0000-0003-3469-6555; Inoko, Akihito/0000-0002-6739-2948; Matsuyama, Makoto/0000-0003-2606-059X	Japan Society for the Promotion of Science; Ministry of Education, Science, Technology, Sports and Culture of Japan; Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan; Uehara Memorial Foundation; Naito Foundation; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23247035] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and from the Ministry of Education, Science, Technology, Sports and Culture of Japan, a grant-in-aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare, Japan, the Uehara Memorial Foundation, the Naito Foundation, a research grant from the Princess Takamatsu Cancer Research Fund, and the Takeda Science Foundation.	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Bassuk JA, 1999, EXP EYE RES, V68, P321, DOI 10.1006/exer.1998.0608; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; Boyle Daniel L, 2003, BMC Ophthalmol, V3, P3, DOI 10.1186/1471-2415-3-3; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chang B, 2002, HUM MOL GENET, V11, P507, DOI 10.1093/hmg/11.5.507; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2000, MICROSC RES TECHNIQ, V49, P173, DOI 10.1002/(SICI)1097-0029(20000415)49:2<173::AID-JEMT10>3.0.CO;2-A; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612; Kosako H, 1997, J BIOL CHEM, V272, P10333; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; MATSUOKA Y, 1992, EMBO J, V11, P2895, DOI 10.1002/j.1460-2075.1992.tb05358.x; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; NISHIZAWA K, 1991, J BIOL CHEM, V266, P3074; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Nowak RB, 2009, J CELL BIOL, V186, P915, DOI 10.1083/jcb.200905065; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; Ogawa K, 2004, GENES CELLS, V9, P471, DOI 10.1111/j.1356-9597.2004.00736.x; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010; Song SH, 2009, J CLIN INVEST, V119, P1837, DOI 10.1172/JCI38277; Tanaka H, 2011, CANCER SCI, V102, P784, DOI 10.1111/j.1349-7006.2011.01850.x; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]	47	47	47	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35626	35635		10.1074/jbc.M113.514737	http://dx.doi.org/10.1074/jbc.M113.514737			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24142690	hybrid, Green Published			2022-12-28	WOS:000329814700001
J	Valtcheva, N; Primorac, A; Jurisic, G; Hollmen, M; Detmar, M				Valtcheva, Nadejda; Primorac, Adriana; Jurisic, Giorgia; Hollmen, Maija; Detmar, Michael			The Orphan Adhesion G Protein-coupled Receptor GPR97 Regulates Migration of Lymphatic Endothelial Cells via the Small GTPases RhoA and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Adhesion; Cytoskeleton; Endothelial Cell; Integrin; Lymphangiogenesis; Pb99; Wound Healing Assay	GPCRS; LYMPHANGIOGENESIS; ACTIVATION; GPR56; ROLES; ANGIOGENESIS; PROGRESSION; MECHANISMS; VESSELS; PATHWAY	Background: The identification of G protein-coupled receptors (GPCRs) specific for the lymphatic endothelial cells (LECs) is essential for establishing drugs targeting the lymphatic system. Results: GPR97 is an orphan adhesion GPCR that regulates LEC migration. Conclusion: GPR97 is the first known adhesion GPCR involved in lymphatic remodeling. Significance: This first evidence that adhesion GPCRs govern LEC motility opens new possibilities for modulating lymphangiogenesis. The important role of the lymphatic vascular system in pathological conditions such as inflammation and cancer has been increasingly recognized, but its potential as a pharmacological target is poorly exploited. Our study aimed at the identification and molecular characterization of lymphatic-specific G protein-coupled receptors (GPCRs) to assess new targets for pharmacological manipulation of the lymphatic vascular system. We used a TaqMan quantitative RT-PCR-based low density array to determine the GPCR expression profiles of ex vivo isolated intestinal mouse lymphatic (LECs) and blood vascular endothelial cells (BECs). GPR97, an orphan adhesion GPCR of unknown function, was the most highly and specifically expressed GPCR in mouse lymphatic endothelium. Using siRNA silencing, we found that GPR97-deficient primary human LECs displayed increased adhesion and collective cell migration, whereas single cell migration was decreased as compared with nontargeting siRNA-transfected control LECs. Loss of GPR97 shifted the ratio of active Cdc42 and RhoA and initiated cytoskeletal rearrangements, including F-actin redistribution, paxillin and PAK4 phosphorylation, and 1-integrin activation. Our data suggest a possible role of GPR97 in lymphatic remodeling and furthermore provide the first insights into the biological functions of GPR97.	[Valtcheva, Nadejda; Primorac, Adriana; Jurisic, Giorgia; Hollmen, Maija; Detmar, Michael] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Detmar, M (corresponding author), ETH, Inst Pharmaceut Sci, Swiss Fed Inst Technol, Wolfgang Pauli Str 10,HCI H303, CH-8093 Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Hollmén, Maija/B-5831-2017	Hollmén, Maija/0000-0002-3250-7653; Jurisic Snijder, Giorgia/0000-0002-2102-8593	Swiss National Science Foundation Grant [31003A-130627]; European Research Council Grant LYVICAM; Oncosuisse, Krebsliga Zurich; Leducq Foundation	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); European Research Council Grant LYVICAM; Oncosuisse, Krebsliga Zurich; Leducq Foundation(Leducq Foundation)	This work was supported by Swiss National Science Foundation Grant 31003A-130627, European Research Council Grant LYVICAM, Oncosuisse, Krebsliga Zurich, and the Leducq Foundation.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Dunworth WP, 2009, ARTERIOSCL THROM VAS, V29, P650, DOI 10.1161/ATVBAHA.109.185066; Fredriksson R, 2002, FEBS LETT, V531, P407, DOI 10.1016/S0014-5793(02)03574-3; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Ispanovic E, 2008, AM J PHYSIOL-CELL PH, V295, pC600, DOI 10.1152/ajpcell.00460.2007; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; Jurisic G, 2009, CELL TISSUE RES, V335, P97, DOI 10.1007/s00441-008-0644-2; King SJ, 2011, EMBO J, V30, P1705, DOI 10.1038/emboj.2011.82; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Kong TQ, 2009, MOL BIOL CELL, V20, P4596, DOI 10.1091/mbc.E09-03-0220; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Mizuno N, 2010, ADV EXP MED BIOL, V706, P157; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Shum MSY, 2011, FASEB J, V25, P4423, DOI 10.1096/fj.11-185447; Sleckman BP, 2000, MOL CELL BIOL, V20, P4405, DOI 10.1128/MCB.20.12.4405-4410.2000; Takashima S, 2008, CARDIOVASC RES, V79, P689, DOI 10.1093/cvr/cvn118; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang LQ, 2011, CANCER RES, V71, P5558, DOI 10.1158/0008-5472.CAN-10-4543; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yona S, 2010, ADV EXP MED BIOL, V706, P121	45	42	45	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35736	35748		10.1074/jbc.M113.512954	http://dx.doi.org/10.1074/jbc.M113.512954			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178298	Green Published, hybrid			2022-12-28	WOS:000329814700012
J	Peden, EA; Boehm, M; Mulder, DW; Davis, R; Old, WM; King, PW; Ghirardi, ML; Dubini, A				Peden, Erin A.; Boehm, Marko; Mulder, David W.; Davis, ReAnna; Old, William M.; King, Paul W.; Ghirardi, Maria L.; Dubini, Alexandra			Identification of Global Ferredoxin Interaction Networks in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Chlamydomonas; Energy Metabolism; Protein-Protein Interactions; Redox; Ferredoxin; Network	AMINO-ACID SEQUENCE; GREEN-ALGA; STATE TRANSITIONS; ELECTRON-TRANSFER; ESCHERICHIA-COLI; PHOTOSYSTEM-I; PROTEINS; OXIDOREDUCTASE; DESATURATION; HYDROGENASE	Background:Chlamydomonas contains six chloroplast ferredoxins (FDXs) whose function is still unclear. Results: A global FDX interactome was obtained where FDX1 has a predominant role and is the most relevant electron donor to FNR1 and HYDA1. Conclusion: FDXs have distinct but also overlapping function. Significance: We discovered new FDX interaction partners and specific roles for each FDX isoform. Ferredoxins (FDXs) can distribute electrons originating from photosynthetic water oxidation, fermentation, and other reductant-generating pathways to specific redox enzymes in different organisms. The six FDXs identified in Chlamydomonas reinhardtii are not fully characterized in terms of their biological function. In this report, we present data from the following: (a) yeast two-hybrid screens, identifying interaction partners for each Chlamydomonas FDX; (b) pairwise yeast two-hybrid assays measuring FDX interactions with proteins from selected biochemical pathways; (c) affinity pulldown assays that, in some cases, confirm and even expand the interaction network for FDX1 and FDX2; and (d) in vitro NADP(+) reduction and H-2 photo-production assays mediated by each FDX that verify their role in these two pathways. Our results demonstrate new potential roles for FDX1 in redox metabolism and carbohydrate and fatty acid biosynthesis, for FDX2 in anaerobic metabolism, and possibly in state transition. Our data also suggest that FDX3 is involved in nitrogen assimilation, FDX4 in glycolysis and response to reactive oxygen species, and FDX5 in hydrogenase maturation. Finally, we provide experimental evidence that FDX1 serves as the primary electron donor to two important biological pathways, NADPH and H-2 photo-production, whereas FDX2 is capable of driving these reactions at less than half the rate observed for FDX1.	[Peden, Erin A.; Boehm, Marko; Mulder, David W.; Davis, ReAnna; King, Paul W.; Ghirardi, Maria L.; Dubini, Alexandra] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Old, William M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder	Dubini, A (corresponding author), Natl Renewable Energy Lab, Mail Stop 3313,15013 Denver West Pkwy, Golden, CO 80401 USA.	alexandra.dubini@nrel.gov	Mulder, David/AHC-0138-2022; dubini, alexandra/A-7252-2016; dubini, alexandra/Q-6277-2019; King, Paul W./D-9979-2011	Mulder, David/0000-0003-0559-0145; dubini, alexandra/0000-0001-8825-3915; dubini, alexandra/0000-0001-8825-3915; King, Paul W./0000-0001-5039-654X; OLD, WILLIAM/0000-0002-9499-8478	United States Department of Energy [DE-AC36-08GO28308]; National Renewable Energy Laboratory; Biological and Environmental Research program, Division of Energy Biosciences, Office of Science; United States Department of Energy; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy	United States Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); Biological and Environmental Research program, Division of Energy Biosciences, Office of Science; United States Department of Energy(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy under Contract DE-AC36-08GO28308 from the National Renewable Energy Laboratory, a grant from the Biological and Environmental Research program, Division of Energy Biosciences, Office of Science, the United States Department of Energy (to M. L G.), and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy (to P. W. K.).	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Allahverdiyeva Y, 2011, J BIOL CHEM, V286, P24007, DOI 10.1074/jbc.M111.223289; Baier M, 1999, PLANT PHYSIOL, V119, P1407, DOI 10.1104/pp.119.4.1407; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bertini I, 2002, PROTEINS, V46, P110, DOI 10.1002/prot.10009; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; BUCHANAN BB, 1964, P NATL ACAD SCI USA, V52, P839, DOI 10.1073/pnas.52.3.839; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; Chazarreta-Cifre L, 2011, J BACTERIOL, V193, P4043, DOI 10.1128/JB.05103-11; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; GarciaSanchez MI, 1997, EUR J BIOCHEM, V250, P364, DOI 10.1111/j.1432-1033.1997.0364a.x; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Ghirardi ML, 1997, APPL BIOCHEM BIOTECH, V63-5, P141, DOI 10.1007/BF02920420; Gou P, 2006, BIOCHEMISTRY-US, V45, P14389, DOI 10.1021/bi061779d; GUERRERO MG, 1981, ANNU REV PLANT PHYS, V32, P169, DOI 10.1146/annurev.pp.32.060181.001125; Hanke GT, 2011, BBA-PROTEINS PROTEOM, V1814, P366, DOI 10.1016/j.bbapap.2010.09.011; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Harris EH., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition; HASE T, 1991, PLANT PHYSIOL, V97, P1395, DOI 10.1104/pp.97.4.1395; HASE T, 1976, J BIOCHEM-TOKYO, V79, P329, DOI 10.1093/oxfordjournals.jbchem.a131076; Helman Y, 2003, CURR BIOL, V13, P230, DOI 10.1016/S0960-9822(03)00046-0; HEWITT EJ, 1975, ANNU REV PLANT PHYS, V26, P73, DOI 10.1146/annurev.pp.26.060175.000445; HUISMAN JG, 1978, BIOCHEM BIOPH RES CO, V82, P1121, DOI 10.1016/0006-291X(78)90303-0; HUTSON KG, 1978, BIOCHEM J, V172, P465, DOI 10.1042/bj1720465; Iwasaki T, 2011, J BIOL INORG CHEM, V16, P923, DOI 10.1007/s00775-011-0793-8; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jacquot JP, 1997, FEBS LETT, V401, P143, DOI 10.1016/S0014-5793(96)01459-7; Kameda H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021947; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kromer S, 1996, BIOCHEM SOC T, V24, P761; Lambertz C, 2010, EUKARYOT CELL, V9, P1747, DOI 10.1128/EC.00127-10; Lemaire SD, 2005, PLANT PHYSIOL, V137, P514, DOI 10.1104/pp.104.052670; Lemeille S, 2010, MOL CELL PROTEOMICS, V9, P1281, DOI 10.1074/mcp.M000020-MCP201; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Long H, 2008, BIOPHYS J, V95, P3753, DOI 10.1529/biophysj.107.127548; MATSUBARA H, 1968, J BIOL CHEM, V243, P1732; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meuser JE, 2012, BIOCHEM BIOPH RES CO, V417, P704, DOI 10.1016/j.bbrc.2011.12.002; Meyer-Arendt K, 2011, J PROTEOME RES, V10, P3060, DOI 10.1021/pr200039p; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; Noth J, 2013, J BIOL CHEM, V288, P4368, DOI 10.1074/jbc.M112.429985; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; ORMEJOHN.WH, 1973, ANNU REV BIOCHEM, V42, P159, DOI 10.1146/annurev.bi.42.070173.001111; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Peters JW, 2012, ANNU REV BIOCHEM, V81, P429, DOI 10.1146/annurev-biochem-052610-094911; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Scheibe R, 2012, PLANT CELL ENVIRON, V35, P202, DOI 10.1111/j.1365-3040.2011.02319.x; SCHMITTER JM, 1988, EUR J BIOCHEM, V172, P405, DOI 10.1111/j.1432-1033.1988.tb13901.x; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SMEEKENS S, 1990, TRENDS BIOCHEM SCI, V15, P73, DOI 10.1016/0968-0004(90)90180-J; TAKAHASHI Y, 1986, P NATL ACAD SCI USA, V83, P2434, DOI 10.1073/pnas.83.8.2434; Terashima M, 2012, P NATL ACAD SCI USA, V109, P17717, DOI 10.1073/pnas.1207118109; Terashima M, 2010, MOL CELL PROTEOMICS, V9, P1514, DOI 10.1074/mcp.M900421-MCP200; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Vallese F, 2012, J BIOL CHEM, V287, P36544, DOI 10.1074/jbc.M112.388900; van Lis R, 2013, PLANT PHYSIOL, V161, P57, DOI 10.1104/pp.112.208181; VandenKoornhuyse N, 1996, J BIOL CHEM, V271, P16281, DOI 10.1074/jbc.271.27.16281; WADA H, 1993, J BACTERIOL, V175, P544, DOI 10.1128/JB.175.2.544-547.1993; WADA K, 1974, J BIOCHEM-TOKYO, V76, P1217, DOI 10.1093/oxfordjournals.jbchem.a130674; Winkler M, 2010, EUR J CELL BIOL, V89, P998, DOI 10.1016/j.ejcb.2010.06.018; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; Yacoby I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035886; Yacoby I, 2011, P NATL ACAD SCI USA, V108, P9396, DOI 10.1073/pnas.1103659108; Yonekura-Sakakibara K, 2000, PLANT PHYSIOL, V122, P887, DOI 10.1104/pp.122.3.887	69	72	74	3	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35192	35209		10.1074/jbc.M113.483727	http://dx.doi.org/10.1074/jbc.M113.483727			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24100040	hybrid, Green Published			2022-12-28	WOS:000329867600020
J	Piontek, K; Strittmatter, E; Ullrich, R; Grobe, G; Pecyna, MJ; Kluge, M; Scheibner, K; Hofrichter, M; Plattner, DA				Piontek, Klaus; Strittmatter, Eric; Ullrich, Rene; Groebe, Glenn; Pecyna, Marek J.; Kluge, Martin; Scheibner, Katrin; Hofrichter, Martin; Plattner, Dietmar A.			Structural Basis of Substrate Conversion in a New Aromatic Peroxygenase CYTOCHROME P450 FUNCTIONALITY WITH BENEFITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Fungi; Glycoprotein; Heme; Magnesium; Oxyfunctionalization; Peroxygenase; Polycyclic Aromatic Hydrocarbons	CRYSTAL-STRUCTURE; PEROXIDASE; CYTOCHROME-P450; CHLOROPEROXIDASE; RESOLUTION; OXYFUNCTIONALIZATION; REFINEMENT; ACTIVATION; ENZYMES; BINDING	Background: Aromatic peroxygenases (APOs) are the missing link between heme peroxidases and P450-monooxygenases. Results: Based on two crystal structures the substrate conversion of APOs is elucidated. Conclusion: The specific design of the heme cavity and the distal heme access channel govern substrate specificity. Significance: APOs can be utilized in biotechnology and organic synthesis having significant advantages when compared with cytochrome P450 enzymes. Aromatic peroxygenases (APOs) represent a unique oxidoreductase sub-subclass of heme proteins with peroxygenase and peroxidase activity and were thus recently assigned a distinct EC classification (EC 1.11.2.1). They catalyze, inter alia, oxyfunctionalization reactions of aromatic and aliphatic hydrocarbons with remarkable regio- and stereoselectivities. When compared with cytochrome P450, APOs appear to be the choice enzymes for oxyfunctionalizations in organic synthesis due to their independence from a cellular environment and their greater chemical versatility. Here, the first two crystal structures of a heavily glycosylated fungal aromatic peroxygenase (AaeAPO) are described. They reveal different pH-dependent ligand binding modes. We model the fitting of various substrates in AaeAPO, illustrating the way the enzyme oxygenates polycyclic aromatic hydrocarbons. Spatial restrictions by a phenylalanine pentad in the active-site environment govern substrate specificity in AaeAPO.	[Piontek, Klaus; Strittmatter, Eric; Plattner, Dietmar A.] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany; [Ullrich, Rene; Pecyna, Marek J.; Kluge, Martin; Hofrichter, Martin] Int Grad Sch Zittau, Dept Bio & Environm Sci, D-02763 Zittau, Germany; [Groebe, Glenn; Scheibner, Katrin] Lausitz Univ Appl Sci, Dept Biotechnol, Fac Nat Sci, D-01968 Senftenberg, Germany	University of Freiburg; Technische Universitat Dresden; Brandenburg University of Technology Cottbus	Piontek, K (corresponding author), Univ Freiburg, Inst Organ Chem, Albertstr 21, D-79104 Freiburg, Germany.	Klaus.Piontek@ocbc.uni-freiburg.de; Dietmar.Plattner@chemie.uni-freiburg.de		Hofrichter, Martin/0000-0001-5174-7604	Commission of the European Communities [NMP2-CT-2006-026456]; 7th European Framework Programme (PEROXICATS) [KBBE-2010-4-265397]; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) within the program "Biolndustrie 2021-Cluster Integrierte Biotechnologie 2021" [0315877]; International Research Training Group (IRTG) "Catalysts and Catalytic Reactions for Organic Synthesis' (CCROS) of the Deutsche Forschungsgemeinschaft (DFG) [1038]	Commission of the European Communities(European Commission); 7th European Framework Programme (PEROXICATS); German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) within the program "Biolndustrie 2021-Cluster Integrierte Biotechnologie 2021"(Federal Ministry of Education & Research (BMBF)); International Research Training Group (IRTG) "Catalysts and Catalytic Reactions for Organic Synthesis' (CCROS) of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Commission of the European Communities (to K. P. and M. H.), within a project of the 6th European Framework Programme (BIORENEW Contract NMP2-CT-2006-026456) and a grant through the 7th European Framework Programme (PEROXICATS Contract KBBE-2010-4-265397) (to M. H.). This work was also supported by the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) within the program "Biolndustrie 2021-Cluster Integrierte Biotechnologie 2021" (Project 0315877 to K. P., K. S., M. H., and D. A. P.).; Supported by the International Research Training Group (IRTG) 1038 "Catalysts and Catalytic Reactions for Organic Synthesis' (CCROS) of the Deutsche Forschungsgemeinschaft (DFG).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Aranda E, 2010, BIODEGRADATION, V21, P267, DOI 10.1007/s10532-009-9299-2; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P91, DOI 10.1021/ar00051a001; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bordeaux M, 2012, ANGEW CHEM INT EDIT, V51, P10712, DOI 10.1002/anie.201203280; Casal S, 2002, J CHROMATOGR A, V976, P285, DOI 10.1016/S0021-9673(02)01154-8; Chan PC, 2008, ARCH TOXICOL, V82, P45, DOI 10.1007/s00204-007-0222-5; Choinowski T, 1999, J MOL BIOL, V286, P809, DOI 10.1006/jmbi.1998.2507; Churakova E, 2011, ANGEW CHEM INT EDIT, V50, P10716, DOI 10.1002/anie.201105308; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Grobe G, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-31; Guengerich FP, 2002, NAT REV DRUG DISCOV, V1, P359, DOI 10.1038/nrd792; Gutierrez A, 2011, ARCH BIOCHEM BIOPHYS, V514, P33, DOI 10.1016/j.abb.2011.08.001; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakiuchi F, 2003, ADV SYNTH CATAL, V345, P1077, DOI 10.1002/adsc.200303094; Kastner M, 1999, APPL ENVIRON MICROB, V65, P1834; Kinne M, 2009, J BIOL CHEM, V284, P29343, DOI 10.1074/jbc.M109.040857; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kuhnel K, 2006, J BIOL CHEM, V281, P23990, DOI 10.1074/jbc.M603166200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moon JK, 2011, J AGR FOOD CHEM, V59, P615, DOI 10.1021/jf104098a; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2013, TRENDS BIOCHEM SCI, V38, P140, DOI 10.1016/j.tibs.2012.11.006; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Peter S, 2011, FEBS J, V278, P3667, DOI 10.1111/j.1742-4658.2011.08285.x; Piontek K, 2010, ACTA CRYSTALLOGR F, V66, P693, DOI 10.1107/S1744309110013515; Poraj-Kobielska M, 2011, BIOCHEM PHARMACOL, V82, P789, DOI 10.1016/j.bcp.2011.06.020; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Sakaki T, 2012, BIOL PHARM BULL, V35, P844, DOI 10.1248/bpb.35.844; Samanta SK, 2002, TRENDS BIOTECHNOL, V20, P243, DOI 10.1016/S0167-7799(02)01943-1; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; SONO M, 1986, BIOCHEMISTRY-US, V25, P347, DOI 10.1021/bi00350a011; Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Ulrich R, 2004, APPL ENVIRON MICROB, V70, P4575, DOI 10.1128/AEM.70.8.4575-4581.2004; Verras A, 2006, PROTEIN ENG DES SEL, V19, P491, DOI 10.1093/protein/gzl035; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang XS, 2012, J AM CHEM SOC, V134, P12897, DOI 10.1021/ja3049223	51	90	90	9	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34767	34776		10.1074/jbc.M113.514521	http://dx.doi.org/10.1074/jbc.M113.514521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24126915	Green Published, hybrid			2022-12-28	WOS:000329812800045
J	Stephens, DN; Klein, RH; Salmans, ML; Gordon, W; Ho, H; Andersen, B				Stephens, Denise N.; Klein, Rachel Herndon; Salmans, Michael L.; Gordon, William; Ho, Hsiang; Andersen, Bogi			The Ets Transcription Factor EHF as a Regulator of Cornea Epithelial Cell Identity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Chromatin Immunoprecipitation (ChiP); Cornea; Development; DNA Transcription; Epithelium; Eye; Gene Expression; Transcription; Developmental Factors	GENE-EXPRESSION PATTERNS; AGE-RELATED-CHANGES; ADULT-MOUSE CORNEA; IN-VITRO; ORGANIZATION; MICROARRAY; FAMILY; MICE; REVEALS; CLONING	Background: Cornea development requires precise, coordinated gene expression; few regulators have been characterized. Results: Ets factor EHF collaborates with Kruppel-like factors to activate cornea epithelial genes while repressing non-epithelial genes. Conclusion: EHF, in collaboration with other transcription factors, promotes cornea epithelial identity. Significance: We generated a comprehensive data set on cornea gene expression over the lifetime of the mouse, identifying novel regulators of cornea epithelial identity. The cornea is the clear, outermost portion of the eye composed of three layers: an epithelium that provides a protective barrier while allowing transmission of light into the eye, a collagen-rich stroma, and an endothelium monolayer. How cornea development and aging is controlled is poorly understood. Here we characterize the mouse cornea transcriptome from early embryogenesis through aging and compare it with transcriptomes of other epithelial tissues, identifying cornea-enriched genes, pathways, and transcriptional regulators. Additionally, we profiled cornea epithelium and stroma, defining genes enriched in these layers. Over 10,000 genes are differentially regulated in the mouse cornea across the time course, showing dynamic expression during development and modest expression changes in fewer genes during aging. A striking transition time point for gene expression between postnatal days 14 and 28 corresponds with completion of cornea development at the transcriptional level. Clustering classifies co-expressed, and potentially co-regulated, genes into biologically informative categories, including groups that exhibit epithelial or stromal enriched expression. Based on these findings, and through loss of function studies and ChIP-seq, we show that the Ets transcription factor EHF promotes cornea epithelial fate through complementary gene activating and repressing activities. Furthermore, we identify potential interactions between EHF, KLF4, and KLF5 in promoting cornea epithelial differentiation. These data provide insights into the mechanisms underlying epithelial development and aging, identifying EHF as a regulator of cornea epithelial identity and pointing to interactions between Ets and KLF factors in promoting epithelial fate. Furthermore, this comprehensive gene expression data set for the cornea is a powerful tool for discovery of novel cornea regulators and pathways.	[Stephens, Denise N.; Klein, Rachel Herndon; Salmans, Michael L.; Gordon, William; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Ho, Hsiang; Andersen, Bogi] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Klein, Rachel Herndon; Salmans, Michael L.; Andersen, Bogi] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Andersen, B (corresponding author), Sprague Hall,Rm 250,839 Hlth Sci Dr, Irvine, CA USA.	bogi@uci.edu			National Institutes of Health [R01EY019413, RO1AR44882, T32-HD60555, T15LM00744]; California Institute for Regenerative Medicine [TG2-01152]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY019413 and RO1AR44882 (to B. A.), T32-HD60555 (to W. G.), and T15LM00744 (to R. H. K. and M. L. S.). This work was also supported by California Institute for Regenerative Medicine Grant TG2-01152 (to D. S. and M. L S.).	Adachi W, 2000, INVEST OPHTH VIS SCI, V41, P2900; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Arnaud-Dabernat S, 2007, DIABETES, V56, P96, DOI 10.2337/db05-1073; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Beggs ML, 2004, AGING CELL, V3, P353, DOI 10.1111/j.1474-9728.2004.00135.x; Berk RS, 2001, INVEST OPHTH VIS SCI, V42, P1561; Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bochert MA, 1998, BIOCHEM BIOPH RES CO, V246, P176, DOI 10.1006/bbrc.1998.8560; Brink TC, 2009, BIOGERONTOLOGY, V10, P549, DOI 10.1007/s10522-008-9197-8; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Cai L, 2010, J MOL BIOL, V401, P564, DOI 10.1016/j.jmb.2010.06.057; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cavallotti C., 2010, AGE RELATED CHANGES, P45; Chakravarti S, 2004, INVEST OPHTH VIS SCI, V45, P3475, DOI 10.1167/iovs.04-0343; Chu WM, 2013, CANCER LETT, V328, P222, DOI 10.1016/j.canlet.2012.10.014; Davis J, 2008, INVEST OPHTH VIS SCI, V49, P1814, DOI 10.1167/iovs.07-1057; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Dudoit S, 2003, BIOTECHNIQUES, P45; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Faragher RGA, 1997, BRIT J OPHTHALMOL, V81, P814, DOI 10.1136/bjo.81.10.814; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; FITCH KL, 1986, EXP GERONTOL, V21, P31, DOI 10.1016/0531-5565(86)90015-X; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; GIPSON IK, 1982, INVEST OPHTH VIS SCI, V23, P269; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Govindarajan V, 2001, DEVELOPMENT, V128, P1617; Grassel S, 1999, EUR J BIOCHEM, V263, P471, DOI 10.1046/j.1432-1327.1999.00523.x; Greiling TMS, 2008, SEMIN CELL DEV BIOL, V19, P94, DOI 10.1016/j.semcdb.2007.10.011; Gupta D, 2011, INVEST OPHTH VIS SCI, V52, P4951, DOI 10.1167/iovs.10-7068; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hanlon SD, 2011, EXP EYE RES, V93, P363, DOI 10.1016/j.exer.2011.04.013; Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; HIGBEE RG, 1983, EXP EYE RES, V36, P171, DOI 10.1016/0014-4835(83)90003-9; Hopkin AS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002829; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HW, 2012, BIOINFORMATICS, V28, P1182, DOI 10.1093/bioinformatics/bts096; Ida H, 2003, PHYSIOL GENOMICS, V15, P258, DOI 10.1152/physiolgenomics.00126.2003; Ikoma T, 2012, BIOCHEM BIOPH RES CO, V420, P217, DOI 10.1016/j.bbrc.2012.01.157; JESTER JV, 1994, INVEST OPHTH VIS SCI, V35, P730; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kayala MA, 2012, NUCLEIC ACIDS RES, V40, pW553, DOI 10.1093/nar/gks420; Kenchegowda D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044771; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kobberup S, 2007, DEV DYNAM, V236, P3100, DOI 10.1002/dvdy.21292; Kohman RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022654; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Lu R, 2012, STEM CELLS, V30, P753, DOI 10.1002/stem.1032; Lustig A, 2009, INT J MED SCI, V6, P51; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Marsden MD, 2005, FRONT BIOSCI-LANDMRK, V10, P1768; Mastropasqua L, 2006, AM J OPHTHALMOL, V142, P736, DOI 10.1016/j.ajo.2006.06.057; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Misra V, 2007, PHYSIOL GENOMICS, V31, P429, DOI 10.1152/physiolgenomics.00060.2007; Nakamura H, 2005, INVEST OPHTH VIS SCI, V46, P4092, DOI 10.1167/iovs.05-0324; Nakamura H, 2004, INVEST OPHTH VIS SCI, V45, P4327, DOI 10.1167/iovs.04-0353; Nakamura T, 2008, STEM CELLS, V26, P1265, DOI 10.1634/stemcells.2007-1067; Norman B, 2004, INVEST OPHTH VIS SCI, V45, P429, DOI 10.1167/iovs.03-0449; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; PEI YF, 1971, INVEST OPHTH VISUAL, V10, P811; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sax CM, 1996, J BIOL CHEM, V271, P33568, DOI 10.1074/jbc.271.52.33568; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Sevel D, 1988, Trans Am Ophthalmol Soc, V86, P178; SHELDON H, 1956, J BIOPHYS BIOCHEM CY, V2, P253, DOI 10.1083/jcb.2.3.253; Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090; Song J, 2003, INVEST OPHTH VIS SCI, V44, P548, DOI 10.1167/iovs.02-0592; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Swamynathan S, 2012, INVEST OPHTH VIS SCI, V53, P8433, DOI 10.1167/iovs.12-10759; Swindell W. R., 2012, PLOS ONE, V7; Tanifuji-Terai N, 2006, INVEST OPHTH VIS SCI, V47, P545, DOI 10.1167/iovs.05-1182; TOMASEK JJ, 1982, DEV BIOL, V92, P107, DOI 10.1016/0012-1606(82)90155-5; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Verbitsky M, 2004, LEARN MEMORY, V11, P253, DOI 10.1101/lm.68204; Verkman AS, 2008, PROG RETIN EYE RES, V27, P420, DOI 10.1016/j.preteyeres.2008.04.001; Weaving L, 2010, INVEST OPHTH VIS SCI, V51, P5561, DOI 10.1167/iovs.09-5123; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wu F, 2008, EXP EYE RES, V87, P214, DOI 10.1016/j.exer.2008.06.001; Yoshida N, 2000, MECH DEVELOP, V97, P27, DOI 10.1016/S0925-4773(00)00419-6; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	105	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34304	34324		10.1074/jbc.M113.504399	http://dx.doi.org/10.1074/jbc.M113.504399			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142692	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000329812800003
J	Cao, BY; Li, J; Zhu, JY; Shen, MY; Han, KK; Zhang, ZB; Yu, Y; Wang, YL; Wu, DP; Chen, SN; Sun, AN; Tang, XW; Zhao, Y; Qiao, CH; Hou, TJ; Mao, XL				Cao, Biyin; Li, Jie; Zhu, Jingyu; Shen, Mingyun; Han, Kunkun; Zhang, Zubin; Yu, Yang; Wang, Yali; Wu, Depei; Chen, Suning; Sun, Aining; Tang, Xiaowen; Zhao, Yun; Qiao, Chunhua; Hou, Tingjun; Mao, Xinliang			The Antiparasitic Clioquinol Induces Apoptosis in Leukemia and Myeloma Cells by Inhibiting Histone Deacetylase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Computer Modeling; Enzyme Inhibitors; Histone Deacetylase; Multiple Myeloma; Clioquinol	DISPLAYS PRECLINICAL ACTIVITY; CANCER-CELLS; THERAPEUTIC TARGETS; FORCE-FIELD; DNA-BINDING; PROTEASOME; P53; MALIGNANCIES; ACETYLATION; TRANSCRIPTION	Background: Clioquinol is a potent chelator of divalent metal ions including zinc. Results: Clioquinol fits the zinc-centered active pocket of HDACs and inhibits HDAC activity, which results in cell cycle arrest and cancer cell apoptosis. Conclusion: Clioquinol inhibits HDAC activity and induces blood cancer cell death. Significance: This is the first report to demonstrate that clioquinol inhibits HDAC activity. The antiparasitic clioquinol (CQ) represents a class of novel anticancer drugs by interfering with proteasome activity. In the present study, we found that CQ induced blood cancer cell apoptosis by inhibiting histone deacetylases (HDACs). CQ accumulated the acetylation levels of several key proteins including histone H3 (H3), p53, HSP90, and -tubulin. In the mechanistic study, CQ was found to down-regulate HDAC1, -3, -4, and -5 in both myeloma and leukemia cells. Computer modeling analysis revealed that CQ was well docked into the active pocket of the enzyme, where the oxygen and nitrogen atoms in CQ formed stable coordinate bonds with the zinc ion, and the hydroxyl group from CQ formed an effective hydrogen bond with Asp-267. Moreover, co-treatment with CQ and zinc/copper chloride led to decreased Ac-H3. Furthermore, CQ inhibited the activity of Class I and IIa HDACs in the cell-free assays, demonstrating that CQ interfered with HDAC activity. By inhibiting HDAC activity, CQ induced expression of p21, p27, and p53, cell cycle arrest at G(1) phase, and cell apoptosis. This study suggested that the HDAC enzymes are targets of CQ, which provided a novel insight into the molecular mechanism of CQ in the treatment of hematological malignancies.	[Cao, Biyin; Li, Jie; Zhu, Jingyu; Han, Kunkun; Zhang, Zubin; Wang, Yali; Zhao, Yun; Mao, Xinliang] Soochow Univ, Sch Pharm, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Shen, Mingyun; Hou, Tingjun] Soochow Univ, Sch Pharm, Inst Funct Nano & Soft Mat, Suzhou 215123, Peoples R China; [Yu, Yang; Qiao, Chunhua; Mao, Xinliang] Soochow Univ, Sch Pharm, Dept Pharmacol, Suzhou 215123, Peoples R China; [Wu, Depei; Chen, Suning; Sun, Aining; Tang, Xiaowen] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Mao, XL (corresponding author), Soochow Univ, Cyrus Tang Hematol Ctr, 199 Ren Ai Rd,Rm 703-507,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	xinliangmao@suda.edu.cn	Hou, Tingjun/D-7216-2012; Zhu, Jingyu/AAS-2410-2021; Hou, Tingjun/C-7492-2011	Zhu, Jingyu/0000-0002-9553-1765; Hou, Tingjun/0000-0001-7227-2580	National Natural Science Foundation of China [81272632, 81071935, 81101795, 81320108023]; Natural Science Foundation of Jiangsu Province [BK2011268, BK2010218]; National Basic Research Program of China Program 973 [2011CB933501]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Basic Research Program of China Program 973(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81272632, 81071935, 81101795, and 81320108023; Natural Science Foundation of Jiangsu Province Grants BK2011268 and BK2010218; National Basic Research Program of China Program 973 Grant 2011CB933501; and the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Bareggi SR, 2012, CNS NEUROSCI THER, V18, P41, DOI 10.1111/j.1755-5949.2010.00231.x; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Chen HL, 2009, BIOORGAN MED CHEM, V17, P7239, DOI 10.1016/j.bmc.2009.08.054; Chen JS, 2005, J CELL PHYSIOL, V202, P87, DOI 10.1002/jcp.20094; Chen PC, 2008, BIOORGAN MED CHEM, V16, P4839, DOI 10.1016/j.bmc.2008.03.050; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Claus R, 2003, ONCOGENE, V22, P6489, DOI 10.1038/sj.onc.1206814; Condorelli F, 2008, BRIT J PHARMACOL, V153, P657, DOI 10.1038/sj.bjp.0707608; Conti C, 2010, CANCER RES, V70, P4470, DOI 10.1158/0008-5472.CAN-09-3028; Daniel KG, 2005, BREAST CANCER RES, V7, pR897, DOI 10.1186/bcr1322; Du T, 2008, J PHARMACOL EXP THER, V324, P360, DOI 10.1124/jpet.107.130377; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Hu J, 2005, MOL CANCER RES, V3, P100, DOI 10.1158/1541-7786.MCR-04-0070; Hu XT, 2002, J BIOL CHEM, V277, P16528, DOI 10.1074/jbc.M109929200; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Kirschbaum M, 2011, J CLIN ONCOL, V29, P1198, DOI 10.1200/JCO.2010.32.1398; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Li XM, 2010, JNCI-J NATL CANCER I, V102, P1069, DOI 10.1093/jnci/djq198; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Mao X, 2009, LEUKEMIA, V23, P585, DOI 10.1038/leu.2008.232; Mao XL, 2008, BLOOD, V112, P760, DOI 10.1182/blood-2008-02-142687; Mao X, 2007, BLOOD, V110, P4047, DOI 10.1182/blood-2007-05-088666; Mao XL, 2011, MOL PHARMACOL, V79, P672, DOI 10.1124/mol.110.068122; Mao XL, 2011, BLOOD, V117, P1986, DOI 10.1182/blood-2010-05-284810; Mao XL, 2008, TOXICOL LETT, V182, P1, DOI 10.1016/j.toxlet.2008.08.015; Marquard L, 2008, HISTOPATHOLOGY, V53, P267, DOI [10.1111/j.1365-2559.2008.03109.x, 10.1111/j.0309-0167.2008.03109.x]; Melnick A, 2002, CURR OPIN HEMATOL, V9, P322, DOI 10.1097/00062752-200207000-00010; Mercurio C, 2010, PHARMACOL RES, V62, P18, DOI 10.1016/j.phrs.2010.02.010; Piekarz R, 2004, CURR PHARM DESIGN, V10, P2289, DOI 10.2174/1381612043383980; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; ROHDE W, 1976, ANTIMICROB AGENTS CH, V10, P234, DOI 10.1128/AAC.10.2.234; Schimmer AD, 2011, CURR CANCER DRUG TAR, V11, P325; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Shim JS, 2010, JNCI-J NATL CANCER I, V102, P1855, DOI 10.1093/jnci/djq457; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wood TE, 2010, MOL CANCER THER, V9, P246, DOI 10.1158/1535-7163.MCT-09-0495; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhai SM, 2010, J BIOL INORG CHEM, V15, P259, DOI 10.1007/s00775-009-0594-5; Zhang F., 2011, PLOS ONE, V6	48	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34181	34189		10.1074/jbc.M113.472563	http://dx.doi.org/10.1074/jbc.M113.472563			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114842	Green Published, hybrid			2022-12-28	WOS:000327250200061
J	Pradhan, A; Singh, TR; Ali, AM; Wahengbam, K; Meetei, AR				Pradhan, Arun; Singh, Thiyam Ramsing; Ali, Abdullah Mahmood; Wahengbam, Kebola; Meetei, Amom Ruhikanta			Monopolar Spindle 1 (MPS1) Protein-dependent Phosphorylation of RecQ-mediated Genome Instability Protein 2 (RMI2) at Serine 112 Is Essential for BLM-Topo III alpha-RMI1-RMI2 (BTR) Protein Complex Function upon Spindle Assembly Checkpoint (SAC) Activation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; Posttranslational Modification; Protein Phosphorylation; shRNA; Subcellular Fractionation; BTR Complex; Bloom Syndrome; RMI2; Genome Instability; Spindle Assembly Checkpoint (SAC)	ESSENTIAL COMPONENT; CORE-COMPLEX; REPAIR	Genomic instability and a predisposition to cancer are hallmarks of Bloom syndrome, an autosomal recessive disease arising from mutations in the BLM gene. BLM is a RecQ helicase component of the BLM-Topo III -RMI1-RMI2 (BTR) complex, which maintains chromosome stability at the spindle assembly checkpoint (SAC). Other members of the BTR complex include Topo IIIa, RMI1, and RMI2. All members of the BTR complex are essential for maintaining the stable genome. Interestingly, the BTR complex is posttranslationally modified upon SAC activation during mitosis, but its significance remains unknown. In this study, we show that two proteins that interact with BLM, RMI1 and RMI2, are phosphorylated upon SAC activation, and, like BLM, RMI1, and RMI2, are phosphorylated in an MPS1-dependent manner. An S112A mutant of RMI2 localized normally in cells and was found in SAC-induced coimmunoprecipitations of the BTR complex. However, in RMI2-depleted cells, an S112A mutant disrupted the mitotic arrest upon SAC activation. The failure of cells to maintain mitotic arrest, due to lack of phosphorylation at Ser-112, results in high genomic instability characterized by micronuclei, multiple nuclei, and a wide distribution of aberrantly segregating chromosomes. We found that the S112A mutant of RMI2 showed defects in redistribution between the nucleoplasm and nuclear matrix. The phosphorylation at Ser-112 of RMI2 is independent of BLM and is not required for the stability of the BTR complex, BLM focus formation, and chromatin targeting in response to replication stress. Overall, this study suggests that the phosphorylation of the BTR complex is essential to maintain a stable genome.	[Pradhan, Arun; Singh, Thiyam Ramsing; Ali, Abdullah Mahmood; Wahengbam, Kebola; Meetei, Amom Ruhikanta] Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol & Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Meetei, Amom Ruhikanta] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Singh, Thiyam Ramsing] Manipur Univ, Dept Biotechnol, Imphal 795003, India	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Manipur University	Meetei, AR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, 240 Albert Sabin Way, Cincinnati, OH 45229 USA.	Ruhikanta.Meetei@cchmc.org	Ali, Abdullah Mahmood/AAI-4094-2020	Ali, Abdullah Mahmood/0000-0002-4007-6769; singh, thiyam/0000-0002-0441-6818	National Institutes of Health Research [HL084082]; Ohio Cancer Research Associates Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084082] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Cancer Research Associates Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Research Grant HL084082. This work was also supported by a grant from the Ohio Cancer Research Associates Fund (to A.R.M.).	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; GERMAN J, 2002, GENETIC BASIS HUMAN, P267; Hoadley KA, 2010, STRUCTURE, V18, P1149, DOI 10.1016/j.str.2010.06.009; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Wang Y, 2000, GENE DEV, V14, P927; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	16	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33500	33508		10.1074/jbc.M113.470823	http://dx.doi.org/10.1074/jbc.M113.470823			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108125	hybrid, Green Published			2022-12-28	WOS:000327250200001
J	Park, M; Kim, HJ; Lim, B; Wylegala, A; Toborek, M				Park, Minseon; Kim, Hyun-Jung; Lim, Brian; Wylegala, Adam; Toborek, Michal			Methamphetamine-induced Occludin Endocytosis Is Mediated by the Arp2/3 Complex-regulated Actin Rearrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Brain; Cytoskeleton; Endocytosis; Endothelium; Tight Junctions; Methamphetamine; Arp2; 3 Complex; Actin; Nucleation; Blood-Brain Barrier; Occludin; Endocytosis; Endo	BLOOD-BRAIN-BARRIER; TIGHT JUNCTION PERMEABILITY; OXIDATIVE STRESS; CORONIN 1B; N-WASP; PROTEIN; BINDING; EXPRESSION; PHOSPHORYLATION; CYTOSKELETON	Background: Methamphetamine is a drug of abuse that disrupts the blood-brain barrier. Results: Blocking actin nucleation protects against methamphetamine-induced occludin internalization and disruption of blood-brain barrier integrity. Conclusion: Methamphetamine-induced transendothelial breaches may result from actin-mediated redistribution of occludin. Significance: Actin cytoskeletal dynamics modulates redistribution of occludin and blood-brain barrier integrity. Methamphetamine (METH) is a drug of abuse with neurotoxic and neuroinflammatory effects, which include disruption of the blood-brain barrier (BBB) and alterations of tight junction protein expression. This study focused on the actin cytoskeletal rearrangement as a modulator of METH-induced redistribution of tight junction protein occludin in brain endothelial cells. Exposure to METH resulted in a shift of occludin localization from plasma membranes to endosomes. These changes were accompanied by activation of the actin-related protein 2/3 (Arp2/3) complex, which stimulates actin polymerization by promoting actin nucleation. In addition, METH-induced coronin-1b phosphorylation diminishes the inhibitory effect of nonphosphorylated coronin-1b on actin nucleation. Blocking actin nucleation with CK-666, a specific inhibitor of the Arp2/3 complex, protected against METH-induced occludin internalization and increased transendothelial monocyte migration. Importantly, treatment with CK-666 attenuated a decrease in occludin levels in brain microvessels and BBB permeability of METH-injected mice. These findings indicate that actin cytoskeletal dynamics is detrimental to METH-induced BBB dysfunction by increasing internalization of occludin.	[Park, Minseon; Kim, Hyun-Jung; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Lim, Brian; Wylegala, Adam] Univ Kentucky, Dept Neurosurg, Lexington, KY 40536 USA	University of Miami; University of Kentucky	Park, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 1011 NW 15th St, Miami, FL 33136 USA.	mspark@med.miami.edu; mtoborek@med.miami.edu	Wylęgała, Adam/AAK-5951-2020	Wylegala, Adam/0000-0001-7295-4936	National Institutes of Health [DA027569, MH072567, MH098891, MH063022]; Miami Center for AIDS Research at the University of Miami [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098891, R01MH063022, R01MH072567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami Center for AIDS Research at the University of Miami; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA027569, MH072567, and MH098891 (to M. T.) and MH063022 (to M. P.). This work was also supported by Grant P30AI073961 (to M. P.) from the Miami Center for AIDS Research at the University of Miami.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Ayscough KR, 2000, CURR BIOL, V10, P1587, DOI 10.1016/S0960-9822(00)00859-9; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Chang FS, 2003, CURR BIOL, V13, P455, DOI 10.1016/S0960-9822(03)00131-3; Chen Jack P, 2007, J Invasive Cardiol, V19, pE89; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Colfax Grant, 2005, Curr HIV/AIDS Rep, V2, P194, DOI 10.1007/s11904-005-0016-4; Cunha-Oliveira T, 2008, BRAIN RES REV, V58, P192, DOI 10.1016/j.brainresrev.2008.03.002; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hirase T, 1997, J CELL SCI, V110, P1603; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Mahajan SD, 2008, BRAIN RES, V1203, P133, DOI 10.1016/j.brainres.2008.01.093; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Martins T, 2011, BRAIN RES, V1411, P28, DOI 10.1016/j.brainres.2011.07.013; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; Miki H, 1998, BIOCHEM BIOPH RES CO, V243, P73, DOI 10.1006/bbrc.1997.8064; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Ohta K, 2005, J EMERG MED, V28, P165, DOI 10.1016/j.jemermed.2004.06.015; Park M, 2012, J CELL MOL MED, V16, P362, DOI 10.1111/j.1582-4934.2011.01320.x; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Phares TW, 2006, J IMMUNOL, V176, P7666, DOI 10.4049/jimmunol.176.12.7666; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Seelbach M, 2010, ENVIRON HEALTH PERSP, V118, P479, DOI 10.1289/ehp.0901334; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Shen L, 2005, MOL BIOL CELL, V16, P3919, DOI 10.1091/mbc.E04-12-1089; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Srikanth S, 2008, CARDIOLOGY, V109, P188, DOI 10.1159/000106681; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Toborek M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-22; Torii H, 2007, PHARMACOL RES, V55, P104, DOI 10.1016/j.phrs.2006.10.010; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Zhong Y, 2008, J NEUROSCI, V28, P7788, DOI 10.1523/JNEUROSCI.0061-08.2008; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	64	49	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33324	33334		10.1074/jbc.M113.483487	http://dx.doi.org/10.1074/jbc.M113.483487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24081143	Green Published, hybrid			2022-12-28	WOS:000328841700047
J	Tawk, L; Lacroix, C; Gueirard, P; Kent, R; Gorgette, O; Thiberge, S; Mercereau-Puijalon, O; Menard, R; Barale, JC				Tawk, Lina; Lacroix, Celine; Gueirard, Pascale; Kent, Robyn; Gorgette, Olivier; Thiberge, Sabine; Mercereau-Puijalon, Odile; Menard, Robert; Barale, Jean-Christophe			A Key Role for Plasmodium Subtilisin-like SUB1 Protease in Egress of Malaria Parasites from Host Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatocyte; Malaria; Molecular Genetics; Plasmodium; Protease; Conditional Mutagenesis; Egress; Subtilisin	MEROZOITE SURFACE PROTEIN-1; CELL INVASION; CONDITIONAL MUTAGENESIS; ERYTHROCYTIC CYCLE; CYSTEINE PROTEASE; WESTERN CAMBODIA; FALCIPARUM; BERGHEI; LIVER; ARTEMISININ	Background: The subtilisin-like SUB1 is involved in Plasmodium egress from erythrocytes. Results: Using conditional mutagenesis, we show that SUB1 plays an essential role during Plasmodium hepatic stages. Conclusion: SUB1 has a dual pivotal role in parasite egress from host hepatocytes and erythrocytes. Significance: Its critical involvement in hepatic and erythrocytic parasite development qualifies SUB1 as a multistage drug target. In their mammalian host, Plasmodium parasites have two obligatory intracellular development phases, first in hepatocytes and subsequently in erythrocytes. Both involve an orchestrated process of invasion into and egress from host cells. The Plasmodium SUB1 protease plays a dual role at the blood stage by enabling egress of the progeny merozoites from the infected erythrocyte and priming merozoites for subsequent erythrocyte invasion. Here, using conditional mutagenesis in P. berghei, we show that SUB1 plays an essential role at the hepatic stage. Stage-specific sub1 invalidation during prehepatocytic development showed that SUB1-deficient parasites failed to rupture the parasitophorous vacuole membrane and to egress from hepatocytes. Furthermore, mechanically released parasites were not adequately primed and failed to establish a blood stage infection in vivo. The critical involvement of SUB1 in both pre-erythrocytic and erythrocytic developmental phases qualifies SUB1 as an attractive multistage target for prophylactic and therapeutic anti-Plasmodium intervention strategies.	[Tawk, Lina; Kent, Robyn; Gorgette, Olivier; Mercereau-Puijalon, Odile; Barale, Jean-Christophe] Inst Pasteur, Unite Immunol Mol Parasites, Dept Parasitol & Mycol, F-75015 Paris, France; [Tawk, Lina; Kent, Robyn; Gorgette, Olivier; Mercereau-Puijalon, Odile; Barale, Jean-Christophe] CNRS, URA2581, F-75015 Paris, France; [Lacroix, Celine; Gueirard, Pascale; Thiberge, Sabine; Menard, Robert] Inst Pasteur, Dept Parasitol & Mycol, Unite Biol & Genet Paludisme, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Barale, JC (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, URA CNRS 2581, Dept Parasitol & Mycol, 28 Rue Dr Roux, F-75724 Paris 15, France.	jean-christophe.barale@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020	Thiberge, Sabine/0000-0001-5507-0602; Kent, Robyn/0000-0002-2584-4694	Institut Carnot-Pasteur Maladies Infectieuses; gence Nationale pour la Recherche [ANR-11-RPIB-002]; "Fondation Roux" from the Pasteur Institute	Institut Carnot-Pasteur Maladies Infectieuses; gence Nationale pour la Recherche; "Fondation Roux" from the Pasteur Institute	This work was supported by grants from the "Institut Carnot-Pasteur Maladies Infectieuses" and "Agence Nationale pour la Recherche" Grant ANR-11-RPIB-002 (to J. C. B.).; Supported by the "Institut Carnot-Pasteur Maladies Infectieuses" and a fellow of the "Fondation Roux" from the Pasteur Institute.	Abkarian M, 2011, BLOOD, V117, P4118, DOI 10.1182/blood-2010-08-299883; Agarwal S, 2013, CELL MICROBIOL, V15, P910, DOI 10.1111/cmi.12086; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Baer K, 2007, PLOS PATHOG, V3, P1651, DOI 10.1371/journal.ppat.0030171; Barale JC, 1997, MOL BIOCHEM PARASIT, V87, P169, DOI 10.1016/S0166-6851(97)00065-0; Bastianelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021812; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Bouillon A, 2013, J BIOL CHEM, V288, P18561, DOI 10.1074/jbc.M113.456764; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Combe A, 2009, CELL HOST MICROBE, V5, P386, DOI 10.1016/j.chom.2009.03.008; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Falae A, 2010, J BIOL CHEM, V285, P3282, DOI 10.1074/jbc.M109.070367; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Girardin SE, 1998, FEBS LETT, V431, P333, DOI 10.1016/S0014-5793(98)00787-X; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Ishino T, 2009, CELL MICROBIOL, V11, P1329, DOI 10.1111/j.1462-5822.2009.01333.x; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kafsack Bjorn F.C., 2010, Communicative & Integrative Biology, V3, P18; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Lacroix C, 2011, NAT PROTOC, V6, P1412, DOI 10.1038/nprot.2011.363; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Roggwiller E, 1997, MOL BIOCHEM PARASIT, V86, P49, DOI 10.1016/S0166-6851(97)02848-X; Roiko MS, 2009, CELL MICROBIOL, V11, P1444, DOI 10.1111/j.1462-5822.2009.01357.x; Ruecker A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400820; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schmidt-Christensen A, 2008, CELL MICROBIOL, V10, P1723, DOI 10.1111/j.1462-5822.2008.01162.x; STAFFORD WHL, 1994, MOL BIOCHEM PARASIT, V66, P157, DOI 10.1016/0166-6851(94)90048-5; Sturm A, 2007, MED MICROBIOL IMMUN, V196, P127, DOI 10.1007/s00430-007-0044-3; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Sultan AA, 1999, INFECT IMMUN, V67, P2602, DOI 10.1128/IAI.67.5.2602-2606.1999; Thiberge S, 2007, NAT PROTOC, V2, P1811, DOI 10.1038/nprot.2007.257; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Uzureau P, 2004, CELL MICROBIOL, V6, P65, DOI 10.1046/j.1462-5822.2003.00343.x; WHO Global Malaria Programme, 2011, WORLD MALARIA REPORT; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhang M, 2012, P NATL ACAD SCI USA, V109, P3956, DOI 10.1073/pnas.1121567109	50	29	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33336	33346		10.1074/jbc.M113.513234	http://dx.doi.org/10.1074/jbc.M113.513234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089525	Green Published, hybrid			2022-12-28	WOS:000328841700048
J	Kang, GY; Pyun, BJ; Seo, HR; Jin, YB; Lee, HJ; Lee, YJ; Lee, YS				Kang, Ga-Young; Pyun, Bo-Jeong; Seo, Haeng Ran; Jin, Yeung Bae; Lee, Hae-June; Lee, Yoon-Jin; Lee, Yun-Sil			Inhibition of Snail1-DNA-PKcs Protein-Protein Interface Sensitizes Cancer Cells and Inhibits Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Migration; p53; Peptides; Phosphorylation; DNA-PKcs; Sensitization; Snail1; Snail1 Phosphorylation	EPITHELIAL-MESENCHYMAL TRANSITION; DNA-PK; TELOMERE LENGTH; CATALYTIC SUBUNIT; HISTONE H2AX; TGF-BETA; SNAIL; EXPRESSION; RESISTANCE; MICE	Our previous study suggested that the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) interacts with Snail1, which affects genomic instability, sensitivity to DNA-damaging agents, and migration of tumor cells by reciprocal regulation between DNA-PKcs and Snail1. Here, we further investigate that a peptide containing 7-amino acid sequences (amino acids 15-21) of Snail1 (KPNYSEL, SP) inhibits the endogenous interaction between DNA-PKcs and Snail1 through primary interaction with DNA-PKcs. SP restored the inhibited DNA-PKcs repair activity and downstream pathways. On the other hand, DNA-PKcs-mediated phosphorylation of Snail1 was inhibited by SP, which resulted in decreased Snail1 stability and Snail1 functions. However, these phenomena were only shown in p53 wild-type cells, not in p53-defective cells. From these results, it is suggested that interfering with the protein interaction between DNA-PKcs and Snail1 might be an effective strategy for sensitizing cancer cells and inhibiting tumor migration, especially in both Snail1-overexpressing and DNA-PKcs-overexpressing cancer cells with functional p53.	[Kang, Ga-Young; Pyun, Bo-Jeong; Lee, Yun-Sil] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul 120750, South Korea; [Seo, Haeng Ran; Lee, Hae-June; Lee, Yoon-Jin] Korea Inst Radiol & Med Sci, Div Radiat Effects, Seoul 139706, South Korea; [Jin, Yeung Bae] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Jeongeup Si 580185, Jeollabuk Do, South Korea	Ewha Womans University; Korea Institute of Radiological & Medical Sciences; Korea Atomic Energy Research Institute (KAERI)	Lee, YS (corresponding author), Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	yslee0425@ewha.ac.kr	Lee, Yun-Sil/AAP-1378-2020	Lee, Yun-Sil/0000-0002-7538-8850	Advanced Research Center for Nuclear Excellence [2011-0031696]; National Research Foundation of Korea (NRF) [2011-0013364]; Korean government (MEST); Ewha Womans University	Advanced Research Center for Nuclear Excellence; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ewha Womans University	This work was supported by a grant from the Advanced Research Center for Nuclear Excellence (2011-0031696), a grant from the Mid-career Researcher Program (2011-0013364) of the National Research Foundation of Korea (NRF), and funding by the Korean government (MEST). This work was also supported by an Ewha Global Top 5 Grant 2013 from Ewha Womans University.	ALLALUNISTURNER MJ, 1995, CANCER RES, V55, P5200; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Chiang C, 2013, CYTOKINE GROWTH F R, V24, P123, DOI 10.1016/j.cytogfr.2012.09.002; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Garcia-Barros M, 2010, CANCER RES, V70, P8179, DOI 10.1158/0008-5472.CAN-10-1871; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kajiyama H, 2007, INT J ONCOL, V31, P277; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kong XM, 2011, CELL SIGNAL, V23, P1273, DOI 10.1016/j.cellsig.2011.04.005; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; LEE KB, 1993, CARCINOGENESIS, V14, P2177, DOI 10.1093/carcin/14.10.2177; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pyun BJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.43; Reitsema T, 2005, DNA REPAIR, V4, P1172, DOI 10.1016/j.dnarep.2005.06.005; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Wong RHF, 2009, CELL CYCLE, V8, P1977; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Youn CK, 2004, CANCER RES, V64, P4849, DOI 10.1158/0008-5472.CAN-04-0348; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	43	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32506	32516		10.1074/jbc.M113.479840	http://dx.doi.org/10.1074/jbc.M113.479840			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085291	hybrid, Green Published			2022-12-28	WOS:000328681700034
J	Ma, JH; Nakagawa, Y; Kojima, I; Shibata, H				Ma, Jinhui; Nakagawa, Yuko; Kojima, Itaru; Shibata, Hiroshi			Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes (vol 289, pg 133, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]	1	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 29	2014	289	35					24030	24031		10.1074/jbc.A113.533240	http://dx.doi.org/10.1074/jbc.A113.533240			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AO7AY	24240093	Green Accepted, hybrid			2022-12-28	WOS:000341505600003
J	Kim, HJ; Kim, JG; Moon, MY; Park, SH; Park, JB				Kim, Hee-Jun; Kim, Jae-Gyu; Moon, Mi-Young; Park, Seol-Hye; Park, Jae-Bong			I kappa B Kinase gamma/Nuclear Factor-kappa B-Essential Modulator (IKK gamma/NEMO) Facilitates RhoA GTPase Activation, which, in Turn, Activates Rho-associated Kinase ( ROCK) to Phosphorylate IKK beta in Response to Transforming Growth Factor (TGF)-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Inflammation; NF-kB Transcription Factor; Rhoa; Transforming Growth Factor Beta (TGFbeta)	NUCLEAR FACTOR-KB; SIGNALING PATHWAYS; DISSOCIATION INHIBITOR; INDEPENDENT PATHWAYS; PROTEIN; FAMILY; APOPTOSIS; DOMAIN; NEMO; BINDING	Background: TGF-1 activates RhoA and nuclear factor-B (NF-B), but the activation mechanism was not clearly elucidated. Results: IKK disrupts RhoA-Rho guanine nucleotide dissociation inhibitor (RhoGDI) complex, facilitating GTP binding to RhoA, resulting in IKK phosphorylation by ROCK. Conclusion: IKK facilitates RhoA activation, which in turn activates NF-B. Significance: We found the new mechanism of IKK to activate RhoA and NF-B by TGF-1. Transforming growth factor (TGF)-1 plays several roles in a variety of cellular functions. TGF-1 transmits its signal through Smad transcription factor-dependent and -independent pathways. It was reported that TGF-1 activates NF-B and RhoA, and RhoA activates NF-B in several kinds of cells in a Smad-independent pathway. However, the activation molecular mechanism of NF-B by RhoA upon TGF-1 has not been clearly elucidated. We observed that RhoA-GTP level was increased by TGF-1 in RAW264.7 cells. RhoA-GDP and RhoGDI were bound to N- and C-terminal domains of IKK, respectively. Purified IKK facilitated GTP binding to RhoA complexed with RhoGDI. Furthermore, Dbs, a guanine nucletotide exchange factor of RhoA much more enhanced GTP binding to RhoA complexed with RhoGDI in the presence of IKK. Indeed, si-IKK abolished RhoA activation in response to TGF-1 in cells. However, TGF-1 stimulated the release of RhoA-GTP from IKK and Rho-associated kinase (ROCK), an active RhoA effector protein, directly phosphorylated IKK in vitro, whereas TGF-1-activated kinase 1 activated RhoA upon TGF-1 stimulation. Taken together, our data indicate that IKK facilitates RhoA activation via a guanine nucletotide exchange factor, which in turn activates ROCK to phosphorylate IKK, leading to NF-B activation that induced the chemokine expression and cell migration upon TGF-1.	[Kim, Hee-Jun; Kim, Jae-Gyu; Moon, Mi-Young; Park, Seol-Hye; Park, Jae-Bong] Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea	Hallym University	Park, JB (corresponding author), Hallym Univ, Coll Med, Dept Biochem, Chunchon 200702, Kangwon Do, South Korea.	jbpark@hallym.ac.kr			National Research Foundation of Korea; Ministry of Education; Ministry of Science, Information Communication Technology, and Future Planning [NRF-2013R1A1A2A10006114, MRC-2010-0009180]; Hallym University [HRF-S-41]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; Ministry of Science, Information Communication Technology, and Future Planning; Hallym University	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Education, the Ministry of Science, Information Communication Technology, and Future Planning (Grants NRF-2013R1A1A2A10006114 and MRC-2010-0009180) and Hallym University (Grant HRF-S-41).	Agou F, 2004, J BIOL CHEM, V279, P27861, DOI 10.1074/jbc.M314278200; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Cammarano MS, 2001, J BIOL CHEM, V276, P25876, DOI 10.1074/jbc.M011345200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Ear T, 2010, J IMMUNOL, V184, P3897, DOI 10.4049/jimmunol.0902958; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hippenstiel S, 2000, BLOOD, V95, P3044; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KIKUCHI A, 1989, J BIOL CHEM, V264, P9133; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; Kim O, 2002, J BIOL CHEM, V277, P30066, DOI 10.1074/jbc.M201713200; Kishida S, 2004, MOL CELL BIOL, V24, P4487, DOI 10.1128/MCB.24.10.4487-4501.2004; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Montaner S, 1999, J BIOL CHEM, V274, P8506, DOI 10.1074/jbc.274.13.8506; Moon MY, 2013, J CELL PHYSIOL, V228, P2119, DOI 10.1002/jcp.24383; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Papadimitriou E, 2011, CELL PHYSIOL BIOCHEM, V28, P229, DOI 10.1159/000331734; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shimizu S, 2007, MOL HUM REPROD, V13, P181, DOI 10.1093/molehr/gal113; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAKAI Y, 1995, TRENDS BIOCHEM SCI, V20, P227, DOI 10.1016/S0968-0004(00)89022-2; Thanbichler M, 2000, J BIOL CHEM, V275, P20458, DOI 10.1074/jbc.M002496200; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wiesner C, 2008, ONCOGENE, V27, P2159, DOI 10.1038/sj.onc.1210863; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yamamoto Y, 2001, J BIOL CHEM, V276, P36327, DOI 10.1074/jbc.M104090200; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yeh YY, 2008, BIOCHEM PHARMACOL, V75, P1292, DOI 10.1016/j.bcp.2007.11.017; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	54	29	30	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1429	1440		10.1074/jbc.M113.520130	http://dx.doi.org/10.1074/jbc.M113.520130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24240172	Green Published, hybrid			2022-12-28	WOS:000332401700020
J	Zubcevic, L; Bavro, VN; Muniz, JRC; Schmidt, MR; Wang, SZ; De Zorzi, R; Venien-Bryan, C; Sansom, MSP; Nichols, CG; Tucker, SJ				Zubcevic, Lejla; Bavro, Vassiliy N.; Muniz, Joao R. C.; Schmidt, Matthias R.; Wang, Shizhen; De Zorzi, Rita; Venien-Bryan, Catherine; Sansom, Mark S. P.; Nichols, Colin G.; Tucker, Stephen J.			Control of KirBac3.1 Potassium Channel Gating at the Interface between Cytoplasmic Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Ion Channels; Membrane Proteins; Molecular Dynamics; Potassium Channels; Channel Gating; Kir Channel; KirBac	RECTIFIER K+ CHANNEL; INWARD RECTIFICATION; KIR2.1 CHANNELS; PH SENSITIVITY; PORE; MUTATIONS; ELECTROSTATICS; SIMULATIONS; PERMEATION; CONDUCTION	KirBac channels are prokaryotic homologs of mammalian inwardly rectifying potassium (Kir) channels, and recent structures of KirBac3.1 have provided important insights into the structural basis of gating in Kir channels. In this study, we demonstrate that KirBac3.1 channel activity is strongly pH-dependent, and we used x-ray crystallography to determine the structural changes that arise from an activatory mutation (S205L) located in the cytoplasmic domain (CTD). This mutation stabilizes a novel energetically favorable open conformation in which changes at the intersubunit interface in the CTD also alter the electrostatic potential of the inner cytoplasmic cavity. These results provide a structural explanation for the activatory effect of this mutation and provide a greater insight into the role of the CTD in Kir channel gating.	[Zubcevic, Lejla; Bavro, Vassiliy N.; Tucker, Stephen J.] Univ Oxford, Clarendon Lab, Biol Phys Grp, Oxford OX1 3PU, England; [Bavro, Vassiliy N.] Univ Birmingham, Sch Immun & Infect, Birmingham B15 2TT, W Midlands, England; [Muniz, Joao R. C.] Univ Sao Paulo, Sao Carlos Inst Phys, BR-13560970 Sao Paulo, Brazil; [Schmidt, Matthias R.; Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Struct Bioinformat & Computat Biochem Unit, Oxford OX1 3QU, England; [Wang, Shizhen; Nichols, Colin G.] Washington, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Wang, Shizhen; Nichols, Colin G.] Washington, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [De Zorzi, Rita; Venien-Bryan, Catherine] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Venien-Bryan, Catherine] Univ Paris 06, CNRS UMR 7590, IMPMC, F-75005 Paris, France; [Sansom, Mark S. P.; Tucker, Stephen J.] Univ Oxford, OXION Initiat Ion Channels & Dis, Oxford OX1 3PT, England	University of Oxford; University of Birmingham; Universidade de Sao Paulo; University of Oxford; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); University of Oxford	Tucker, SJ (corresponding author), Univ Oxford, Clarendon Lab, Biol Phys Grp, Parks Rd, Oxford OX1 3PU, England.	stephen.tucker@physics.ox.ac.uk	Bavro, Vassiliy/I-4846-2019; Tucker, Stephen J./ABE-6741-2020; Zubcevic, Lejla/AAA-6713-2021; Tucker, Stephen J./ABE-7468-2020; Wang, Shizhen/N-6577-2017; Sansom, Mark S.P./C-5157-2009; Muniz, Joao R/B-7782-2016	Bavro, Vassiliy/0000-0003-2330-8924; Tucker, Stephen J./0000-0001-8996-2000; Zubcevic, Lejla/0000-0002-1884-9235; Tucker, Stephen J./0000-0001-8996-2000; Wang, Shizhen/0000-0003-1065-4756; Sansom, Mark S.P./0000-0001-6360-7959; Muniz, Joao R/0000-0003-2731-3966; Venien-Bryan, Catherine/0000-0002-7328-3764; DE ZORZI, Rita/0000-0001-7001-7498	National Institute of Health [HL54171]; Biotechnology and Biological Sciences Research Council; Wellcome Trust; BBSRC [BB/L002558/1, BB/I019855/1, BB/H000267/1, BB/F013035/1] Funding Source: UKRI; EPSRC [EP/J010421/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/16011, BB/F013035/1, B19456, BEP17032, BB/H000267/1, BB/L002558/1, BB/I019855/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J010421/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institute of Health Grant HL54171 (to C. G. N.). This work was also supported by grants from the Biotechnology and Biological Sciences Research Council (to S. J. T. and C. V.-B.) and the Wellcome Trust (to M. S. P. S.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; Bavro VN, 2012, NAT STRUCT MOL BIOL, V19, P158, DOI 10.1038/nsmb.2208; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Casamassima M, 2003, J BIOL CHEM, V278, P43533, DOI 10.1074/jbc.M306596200; Chang HK, 2005, BIOPHYS J, V88, P243, DOI 10.1529/biophysj.104.052217; Chang HK, 2007, J MEMBRANE BIOL, V215, P181, DOI 10.1007/s00232-007-9017-0; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Inanobe A, 2011, J BIOL CHEM, V286, P41801, DOI 10.1074/jbc.M111.278531; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas CM, 1998, AM J PHYSIOL-RENAL, V275, pF972, DOI 10.1152/ajprenal.1998.275.6.F972; Paynter JJ, 2010, J BIOL CHEM, V285, P40754, DOI 10.1074/jbc.M110.175687; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimomura K, 2009, EMBO MOL MED, V1, P166, DOI 10.1002/emmm.200900018; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu HX, 2000, J PHYSIOL-LONDON, V528, P267, DOI 10.1111/j.1469-7793.2000.00267.x; Xu YP, 2009, NAT STRUCT MOL BIOL, V16, P1252, DOI 10.1038/nsmb.1717; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7	40	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					143	151		10.1074/jbc.M113.501833	http://dx.doi.org/10.1074/jbc.M113.501833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257749	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000329370900013
J	dela Sena, C; Narayanasamy, S; Riedl, KM; Curley, RW; Schwartz, SJ; Harrison, EH				dela Sena, Carlo; Narayanasamy, Sureshbabu; Riedl, Kenneth M.; Curley, Robert W., Jr.; Schwartz, Steven J.; Harrison, Earl H.			Substrate Specificity of Purified Recombinant Human beta-Carotene 15,15 '-Oxygenase (BCO1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotenoid; Enzymes; Lipid Metabolism; Metabolism; Retinoid; Vitamin A; Acycloretinal; Apocarotenal; Lycopene; Retinal	ACYCLO-RETINOIC ACID; 9-CIS-RETINOIC ACID; IN-VITRO; GEOMETRICAL-ISOMERS; EXCENTRIC CLEAVAGE; INTESTINAL-MUCOSA; RABBIT INTESTINE; CANCER CELLS; HUMAN PLASMA; HUMAN SERUM	Humans cannot synthesize vitamin A and thus must obtain it from their diet. -Carotene 15,15-oxygenase (BCO1) catalyzes the oxidative cleavage of provitamin A carotenoids at the central 15-15 double bond to yield retinal (vitamin A). In this work, we quantitatively describe the substrate specificity of purified recombinant human BCO1 in terms of catalytic efficiency values (k(cat)/K-m). The full-length open reading frame of human BCO1 was cloned into the pET-28b expression vector with a C-terminal polyhistidine tag, and the protein was expressed in the Escherichia coli strain BL21-Gold(DE3). The enzyme was purified using cobalt ion affinity chromatography. The purified enzyme preparation catalyzed the oxidative cleavage of -carotene with a V-max = 197.2 nmol retinal/mg BCO1 x h, K-m = 17.2 m and catalytic efficiency k(cat)/K-m = 6098 m(-1) min(-1). The enzyme also catalyzed the oxidative cleavage of -carotene, -cryptoxanthin, and -apo-8-carotenal to yield retinal. The catalytic efficiency values of these substrates are lower than that of -carotene. Surprisingly, BCO1 catalyzed the oxidative cleavage of lycopene to yield acycloretinal with a catalytic efficiency similar to that of -carotene. The shorter -apocarotenals (-apo-10-carotenal, -apo-12-carotenal, -apo-14-carotenal) do not show Michaelis-Menten behavior under the conditions tested. We did not detect any activity with lutein, zeaxanthin, and 9-cis--carotene. Our results show that BCO1 favors full-length provitamin A carotenoids as substrates, with the notable exception of lycopene. Lycopene has previously been reported to be unreactive with BCO1, and our findings warrant a fresh look at acycloretinal and its alcohol and acid forms as metabolites of lycopene in future studies.	[dela Sena, Carlo; Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Riedl, Kenneth M.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), 314 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	harrison.304@osu.edu	riedl, ken/G-8621-2014; Harrison, Earl H/AAN-5378-2021; Riedl, Ken/K-1881-2019; NARAYANASAMY, SURESHBABU/AAN-6604-2021	riedl, ken/0000-0002-9020-3471; Schwartz, Steven/0000-0002-1427-5780; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health [R01-HL49879, R01-DK44498]; Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research Development Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01-HL49879 and R01-DK44498 and a grant from the Ohio Agricultural Research Development Center.	Ben-Dor A, 2001, ARCH BIOCHEM BIOPHYS, V391, P295, DOI 10.1006/abbi.2001.2412; BenAmotz A, 1996, AM J CLIN NUTR, V63, P729, DOI 10.1093/ajcn/63.5.729; CHANDLER LA, 1987, J FOOD SCI, V52, P669, DOI 10.1111/j.1365-2621.1987.tb06700.x; dePee S, 1996, EUR J CLIN NUTR, V50, pS38; DEVERY J, 1994, BRIT J NUTR, V72, P397, DOI 10.1079/BJN19940042; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; FIDGE NH, 1969, BIOCHEM J, V114, P689, DOI 10.1042/bj1140689; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Gajic M, 2006, J NUTR, V136, P1552, DOI 10.1093/jn/136.6.1552; GAZIANO JM, 1995, AM J CLIN NUTR, V61, P1248, DOI 10.1093/ajcn/61.6.1248; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; Grolier P, 1997, ARCH BIOCHEM BIOPHYS, V348, P233, DOI 10.1006/abbi.1997.0388; HANSEN S, 1988, BIOCHEMISTRY-US, V27, P200, DOI 10.1021/bi00401a030; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Ho CC, 2007, AM J CLIN NUTR, V85, P770, DOI 10.1093/ajcn/85.3.770; Kane MA, 2012, BBA-MOL CELL BIOL L, V1821, P10, DOI 10.1016/j.bbalip.2011.09.012; Khachik F, 1997, ANAL CHEM, V69, P1873, DOI 10.1021/ac961085i; KHACHIK F, 1995, J CELL BIOCHEM, P236; Kim YS, 2009, BIOTECHNOL LETT, V31, P403, DOI 10.1007/s10529-008-9873-4; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kopec RE, 2010, J AGR FOOD CHEM, V58, P3290, DOI 10.1021/jf100415z; Kotake-Nara E, 2002, ANTICANCER RES, V22, P689; KRINSKY NI, 1990, J NUTR, V120, P1654, DOI 10.1093/jn/120.12.1654; LAKSHMAN.MR, 1972, J LIPID RES, V13, P477; LAKSHMANAN MR, 1968, BIOCHEM BIOPH RES CO, V33, P347, DOI 10.1016/0006-291X(68)90791-2; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Liden M, 2005, EXP CELL RES, V310, P401, DOI 10.1016/j.yexcr.2005.08.002; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Maeda T, 2011, MOL PHARMACOL, V80, P943, DOI 10.1124/mol.111.074732; MINGUEZMOSQUERA MI, 1995, J AOAC INT, V78, P491; NAGAO A, 1994, FASEB J, V8, P968, DOI 10.1096/fasebj.8.12.8088462; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Park CS, 2008, BIOTECHNOL LETT, V30, P735, DOI 10.1007/s10529-007-9598-9; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Richelle M, 2010, BRIT J NUTR, V103, P1800, DOI 10.1017/S0007114510000103; STAHL W, 1993, J NUTR, V123, P847, DOI 10.1093/jn/123.5.847; Stahl W, 2000, ARCH BIOCHEM BIOPHYS, V373, P271, DOI 10.1006/abbi.1999.1510; Suzuki T, 1995, J NUTR SCI VITAMINOL, V41, P575, DOI 10.3177/jnsv.41.575; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; Tibaduiza EC, 2002, J NUTR, V132, P1368, DOI 10.1093/jn/132.6.1368; URBACH J, 1994, BIOCHEM J, V299, P459, DOI 10.1042/bj2990459; URBACH J, 1994, FEBS LETT, V351, P429, DOI 10.1016/0014-5793(94)00090-5; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; WANG XD, 1994, ARCH BIOCHEM BIOPHYS, V313, P150, DOI 10.1006/abbi.1994.1371; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; West CE, 1998, INT J VITAM NUTR RES, V68, P371; Wirtz GM, 2001, HELV CHIM ACTA, V84, P2301, DOI 10.1002/1522-2675(20010815)84:8<2301::AID-HLCA2301>3.0.CO;2-U; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476; Yeum KJ, 2000, FREE RADICAL BIO MED, V29, P105, DOI 10.1016/S0891-5849(00)00296-3; You CS, 1996, AM J CLIN NUTR, V64, P177, DOI 10.1093/ajcn/64.2.177; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	56	75	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37094	37103		10.1074/jbc.M113.507160	http://dx.doi.org/10.1074/jbc.M113.507160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24187135	Green Published, hybrid			2022-12-28	WOS:000329189700029
J	Filisetti, D; Theobald-Dietrich, A; Mahmoudi, N; Rudinger-Thirion, J; Candolfi, E; Frugier, M				Filisetti, Denis; Theobald-Dietrich, Anne; Mahmoudi, Nassira; Rudinger-Thirion, Joelle; Candolfi, Ermanno; Frugier, Magali			Aminoacylation of Plasmodium falciparum tRNA(Asn) and Insights in the Synthesis of Asparagine Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthesis; Plasmodium; Protein Folding; Transfer RNA (tRNA); Translation; Asparagine Repeats; Low Complexity Regions	TRANSFER-RNA-SYNTHETASE; LOW-COMPLEXITY REGIONS; N-TERMINAL EXTENSION; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; SEQUENCE; EVOLUTION; REVEALS; TRANSCRIPTS; EXPRESSION	Background: Proteins from the malaria parasite Plasmodium contain extensive asparagine repeats. Results:Plasmodium tRNA(Asn) concentration and in vitro asparaginylation catalytic parameters were analyzed to explain the frequency of asparagine repeats. Conclusion: The requirement for high levels of asparaginylated tRNAs hinders efficient protein translation. Significance: Limiting the availability of asparaginylated tRNAs represents a plausible regulatory mechanism for the production of properly folded proteins. Genome sequencing revealed an extreme AT-rich genome and a profusion of asparagine repeats associated with low complexity regions (LCRs) in proteins of the malarial parasite Plasmodium falciparum. Despite their abundance, the function of these LCRs remains unclear. Because they occur in almost all families of plasmodial proteins, the occurrence of LCRs cannot be associated with any specific metabolic pathway; yet their accumulation must have given selective advantages to the parasite. Translation of these asparagine-rich LCRs demands extraordinarily high amounts of asparaginylated tRNA(Asn). However, unlike other organisms, Plasmodium codon bias is not correlated to tRNA gene copy number. Here, we studied tRNA(Asn) accumulation as well as the catalytic capacities of the asparaginyl-tRNA synthetase of the parasite in vitro. We observed that asparaginylation in this parasite can be considered standard, which is expected to limit the availability of asparaginylated tRNA(Asn) in the cell and, in turn, slow down the ribosomal translation rate when decoding asparagine repeats. This observation strengthens our earlier hypothesis considering that asparagine rich sequences act as tRNA sponges and help cotranslational folding of parasite proteins. However, it also raises many questions about the mechanistic aspects of the synthesis of asparagine repeats and about their implications in the global control of protein expression throughout Plasmodium life cycle.	[Filisetti, Denis; Theobald-Dietrich, Anne; Mahmoudi, Nassira; Rudinger-Thirion, Joelle; Frugier, Magali] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, F-67084 Strasbourg, France; [Filisetti, Denis; Candolfi, Ermanno] Univ Strasbourg, Inst Parasitol & Pathol Trop, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Frugier, M (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	m.frugier@ibmc-cnrs.unistra.fr		Mahmoudi, Nassira/0000-0002-2351-8123; FILISETTI, Denis/0000-0001-9002-8151	European Community [223024]; Laboratoire d'Excellence NetRNA Grant [ANR-10-LABX-36]	European Community(European Commission); Laboratoire d'Excellence NetRNA Grant	This work was supported by the European Community's Seventh Framework Programme FP7/2007-2013 under Grant 223024 and the Laboratoire d'Excellence NetRNA Grant ANR-10-LABX-36.	Aguilo A, 2000, J NUTR BIOCHEM, V11, P81, DOI 10.1016/S0955-2863(99)00073-X; ANDRULIS IL, 1978, J BIOL CHEM, V253, P58; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bastien O, 2004, GENE, V336, P163, DOI 10.1016/j.gene.2004.04.029; Beaulande M, 1998, NUCLEIC ACIDS RES, V26, P521, DOI 10.1093/nar/26.2.521; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; Campanacci V, 2004, J MOL BIOL, V337, P273, DOI 10.1016/j.jmb.2004.01.027; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chayen N, 2004, ANN NY ACAD SCI, V1027, P20, DOI 10.1196/annals.1324.003; Cheong HK, 2003, INT J BIOCHEM CELL B, V35, P1548, DOI 10.1016/S1357-2725(03)00070-0; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Crepin T, 2011, J MOL BIOL, V405, P1056, DOI 10.1016/j.jmb.2010.11.049; Dalby AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006231; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Ferreira MU, 2003, GENE, V304, P65, DOI 10.1016/S0378-1119(02)01180-0; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frugier M, 2005, EMBO REP, V6, P860, DOI 10.1038/sj.embor.7400481; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Frugier M, 2010, FEBS LETT, V584, P448, DOI 10.1016/j.febslet.2009.11.004; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; GROSJEAN H, 1995, BIOCHIMIE, V77, P139, DOI 10.1016/0300-9084(96)88117-X; Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4; Huntley M, 2000, J MOL EVOL, V51, P131, DOI 10.1007/s002390010073; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kron MA, 2012, MOL BIOCHEM PARASIT, V185, P66, DOI 10.1016/j.molbiopara.2012.06.003; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; MADERN D, 1992, FEBS LETT, V299, P85, DOI 10.1016/0014-5793(92)80106-Q; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Marczinke B, 2000, J MOL BIOL, V295, P179, DOI 10.1006/jmbi.1999.3361; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Payne SH, 2006, EUKARYOT CELL, V5, P272, DOI 10.1128/EC.5.2.272-276.2006; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; Pizzi E, 2001, GENOME RES, V11, P218, DOI 10.1101/gr.GR-1522R; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; Ryckelynck M, 2005, BIOCHIMIE, V87, P835, DOI 10.1016/j.biochi.2005.02.014; Seignovert L, 1996, EUR J BIOCHEM, V239, P501, DOI 10.1111/j.1432-1033.1996.0501u.x; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wang LJ, 2001, PLANT PHYSIOL, V125, P1380, DOI 10.1104/pp.125.3.1380; Wayne N, 2010, J MOL BIOL, V401, P931, DOI 10.1016/j.jmb.2010.06.066; Xue HY, 2003, MOL BIOCHEM PARASIT, V128, P21, DOI 10.1016/S0166-6851(03)00039-2; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	57	15	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36361	36371		10.1074/jbc.M113.522896	http://dx.doi.org/10.1074/jbc.M113.522896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196969	Green Published, hybrid			2022-12-28	WOS:000328883400018
J	Sato, S; Fukagawa, T; Tachibanaki, S; Yamano, Y; Wada, A; Kawamura, S				Sato, Shinya; Fukagawa, Takashi; Tachibanaki, Shuji; Yamano, Yumiko; Wada, Akimori; Kawamura, Satoru			Substrate Specificity and Subcellular Localization of the Aldehyde-Alcohol Redox-coupling Reaction in Carp Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photoreceptors; Retinal Metabolism; Retinoid; Vision; Vitamin A; Cones; Muller Cells; Retinoid Cycle	VISUAL-PIGMENT; VITAMIN-A; CYCLE; ROD; REGENERATION; METABOLISM; OXIDATION; RPE65; ISOMEROHYDROLASE; PHOSPHORYLATION	Background: In carp cones, 11-cis-retinal and all-trans-retinol are formed with 11-cis-retinol and all-trans-retinal present. Results: The substrate specificity, reaction mechanism, and subcellular localization of this reaction were determined. Conclusion: Substrate specificity is high for retinol but low for retinal, and the activity is present in the cone inner segment. Significance: The possible contribution to efficient pigment regeneration in cones is suggested. Our previous study suggested the presence of a novel cone-specific redox reaction that generates 11-cis-retinal from 11-cis-retinol in the carp retina. This reaction is unique in that 1) both 11-cis-retinol and all-trans-retinal were required to produce 11-cis-retinal; 2) together with 11-cis-retinal, all-trans-retinol was produced at a 1:1 ratio; and 3) the addition of enzyme cofactors such as NADP(H) was not necessary. This reaction is probably part of the reactions in a cone-specific retinoid cycle required for cone visual pigment regeneration with the use of 11-cis-retinol supplied from Muller cells. In this study, using purified carp cone membrane preparations, we first confirmed that the reaction is a redox-coupling reaction between retinals and retinols. We further examined the substrate specificity, reaction mechanism, and subcellular localization of this reaction. Oxidation was specific for 11-cis-retinol and 9-cis-retinol. In contrast, reduction showed low specificity: many aldehydes, including all-trans-, 9-cis-, 11-cis-, and 13-cis-retinals and even benzaldehyde, supported the reaction. On the basis of kinetic studies of this reaction (aldehyde-alcohol redox-coupling reaction), we found that formation of a ternary complex of a retinol, an aldehyde, and a postulated enzyme seemed to be necessary, which suggested the presence of both the retinol- and aldehyde-binding sites in this enzyme. A subcellular fractionation study showed that the activity is present almost exclusively in the cone inner segment. These results suggest the presence of an effective production mechanism of 11-cis-retinal in the cone inner segment to regenerate visual pigment.	[Sato, Shinya; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 5650871, Japan; [Fukagawa, Takashi; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yamano, Yumiko; Wada, Akimori] Kobe Pharmaceut Univ, Dept Organ Chem Life Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Osaka University; Osaka University; Kobe Pharmaceutical University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp		Sato, Shinya/0000-0002-5978-0975	Japan Society for the Promotion of Science [20370060, 23227002, 22770150, 24570085]; Human Frontier Science Program grant; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program grant(Human Frontier Science Program); Naito Foundation(Naito Memorial Foundation)	This work was supported by Japan Society for the Promotion of Science Grants 20370060 and 23227002 (to S. K.) and 22770150 and 24570085 (to S. T.), a Human Frontier Science Program grant (to S. K.), and the Naito Foundation (to S. T.).	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; Bisswanger H., 2008, ENZYME KINETICS, P124; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Collery R, 2008, INVEST OPHTH VIS SCI, V49, P3812, DOI 10.1167/iovs.08-1957; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; HUBBARD R., 1971, Methods in Enzymology, V18C, P615, DOI 10.1016/S0076-6879(71)18045-7; Irie T, 2002, COMP BIOCHEM PHYS B, V131, P209, DOI 10.1016/S1096-4959(01)00496-1; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; LIU RSH, 1984, TETRAHEDRON, V40, P1931, DOI 10.1016/S0040-4020(01)88435-0; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Matsumoto H, 2003, J AGR FOOD CHEM, V51, P3560, DOI 10.1021/jf034132y; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; Pazos Y, 2001, J ORG CHEM, V66, P8483, DOI 10.1021/jo010711v; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reinheckel T, 1998, FREE RADICAL RES, V29, P297, DOI 10.1080/10715769800300331; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Schenkels P, 2000, MICROBIOL-SGM, V146, P775, DOI 10.1099/00221287-146-4-775; SUZUKI T, 1983, ANAL BIOCHEM, V129, P111, DOI 10.1016/0003-2697(83)90059-3; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; TREHAN A, 1990, BIOORG CHEM, V18, P30, DOI 10.1016/0045-2068(90)90013-U; Wada A, 2004, BIOORGAN MED CHEM, V12, P3931, DOI 10.1016/j.bmc.2004.04.047; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; ZONTA F, 1984, J CHROMATOGR, V301, P65, DOI 10.1016/S0021-9673(01)89179-2	39	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36589	36597		10.1074/jbc.M113.521153	http://dx.doi.org/10.1074/jbc.M113.521153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24217249	Green Published, hybrid			2022-12-28	WOS:000328883400039
J	Almenar-Queralt, A; Kim, SN; Benner, C; Herrera, CM; Kang, DE; Garcia-Bassets, I; Goldstein, LSB				Almenar-Queralt, Angels; Kim, Sonia N.; Benner, Christopher; Herrera, Cheryl M.; Kang, David E.; Garcia-Bassets, Ivan; Goldstein, Lawrence S. B.			Presenilins Regulate Neurotrypsin Gene Expression and Neurotrypsin-dependent Agrin Cleavage via Cyclic AMP Response Element-binding Protein (CREB) Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChIP); CREB; Presenilin; Promoters; Secretases; Drosophila Larval Brains; GSK3; MEFs; Tequila; Neurotrypsin	AMYLOID PRECURSOR PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; TRANSCRIPTIONAL ACTIVITY; SYNAPTIC FUNCTION; STEM-CELLS; ACTIVATION; DROSOPHILA; MUTATIONS	Background: Presenilins regulate multiple cellular pathways by controlling transcription. Results: Presenilins repress neurotrypsin expression by preventing CREB recruitment to its promoter. Conclusion: A new strategy utilized by presenilins to regulate CREB signaling relies on preventing CREB recruitment to gene promoters. Significance: Learning how presenilins control CREB signaling will help understanding their physiological/pathological roles. Presenilins, the catalytic components of the -secretase complex, are upstream regulators of multiple cellular pathways via regulation of gene transcription. However, the underlying mechanisms and the genes regulated by these pathways are poorly characterized. In this study, we identify Tequila and its mammalian ortholog Prss12 as genes negatively regulated by presenilins in Drosophila larval brains and mouse embryonic fibroblasts, respectively. Prss12 encodes the serine protease neurotrypsin, which cleaves the heparan sulfate proteoglycan agrin. Altered neurotrypsin activity causes serious synaptic and cognitive defects; despite this, the molecular processes regulating neurotrypsin expression and activity are poorly understood. Using -secretase drug inhibitors and presenilin mutants in mouse embryonic fibroblasts, we found that a mature -secretase complex was required to repress neurotrypsin expression and agrin cleavage. We also determined that PSEN1 endoproteolysis or processing of well known -secretase substrates was not essential for this process. At the transcriptional level, PSEN1/2 removal induced cyclic AMP response element-binding protein (CREB)/CREB-binding protein binding, accumulation of activating histone marks at the neurotrypsin promoter, and neurotrypsin transcriptional and functional up-regulation that was dependent on GSK3 activity. Upon PSEN1/2 reintroduction, this active epigenetic state was replaced by a methyl CpG-binding protein 2 (MeCP2)-containing repressive state and reduced neurotrypsin expression. Genome-wide analysis revealed hundreds of other mouse promoters in which CREB binding is similarly modulated by the presence/absence of presenilins. Our study thus identifies Tequila and neurotrypsin as new genes repressed by presenilins and reveals a novel mechanism used by presenilins to modulate CREB signaling based on controlling CREB recruitment.	[Almenar-Queralt, Angels; Kim, Sonia N.; Herrera, Cheryl M.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kang, David E.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Garcia-Bassets, Ivan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Almenar-Queralt, Angels; Kim, Sonia N.; Herrera, Cheryl M.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA; [Benner, Christopher] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Almenar-Queralt, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.	aalmenar@ucsd.edu; lgoldstein@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Kang, David E./E-5234-2012	Garcia-Bassets, Ivan/0000-0002-6941-9585; Kim, Sonia Nan/0000-0002-2998-2621; Benner, Christopher/0000-0002-4618-0719; Kang, David E./0000-0002-7132-821X	National Institutes of Health [1F32AG20039]; National Research Service Award from the NIA; NIA [5R01AG032180, 1R01AG033055]; Ovarian Cancer Research Fund; Estate of Agatha Fort (Liz Tilberis Scholar); NATIONAL INSTITUTE ON AGING [R01AG033055, R01AG032180, P50AG005131, F32AG020039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award from the NIA; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ovarian Cancer Research Fund; Estate of Agatha Fort (Liz Tilberis Scholar); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F32AG20039, a National Research Service Award from the NIA (to A. A. Q.); 5R01AG032180 from the NIA (to L S. B. G.); and 1R01AG033055 (to D. E. K.) and by the Ovarian Cancer Research Fund and the Estate of Agatha Fort (Liz Tilberis Scholar) (to I. G. B.).	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Barthet G, 2011, FASEB J, V25, P2937, DOI 10.1096/fj.11-183806; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boer U, 2008, NEUROPSYCHOPHARMACOL, V33, P2407, DOI 10.1038/sj.npp.1301640; Bogdanik LP, 2011, HUM MOL GENET, V20, P4617, DOI 10.1093/hmg/ddr396; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; Boulianne GL, 1997, NEUROREPORT, V8, P1025, DOI 10.1097/00001756-199703030-00041; Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen SZ, 2011, CANCER RES, V71, P6270, DOI 10.1158/0008-5472.CAN-11-0838; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Daniels MP, 2012, NEUROCHEM INT, V61, P848, DOI 10.1016/j.neuint.2012.02.028; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Espana J, 2010, J NEUROSCI, V30, P9402, DOI 10.1523/JNEUROSCI.2154-10.2010; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Francis YI, 2006, NEUROREPORT, V17, P917, DOI 10.1097/01.wnr.0000220137.06542.a0; Gadadhar A, 2011, J NEUROSCI, V31, P2615, DOI 10.1523/JNEUROSCI.4767-10.2011; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Garcia-Bassets I, 2012, CELL CYCLE, V11, P3199, DOI 10.4161/cc.21281; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gopisetty G, 2013, ONCOGENE, V32, P3119, DOI 10.1038/onc.2012.331; Gschwend TP, 1997, MOL CELL NEUROSCI, V9, P207, DOI 10.1006/mcne.1997.0616; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Handler M, 2000, DEVELOPMENT, V127, P2593; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Ho A, 2011, TRENDS MOL MED, V17, P617, DOI 10.1016/j.molmed.2011.06.002; Hong CS, 1997, NEUROREPORT, V8, P665, DOI 10.1097/00001756-199702100-00017; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Jayadev S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015743; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kawamura Y, 2001, EUR J BIOCHEM, V268, P3036, DOI 10.1046/j.1432-1327.2001.02197.x; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Li T, 2003, J NEUROSCI, V23, P3272; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Merdes G, 2004, EMBO J, V23, P4082, DOI 10.1038/sj.emboj.7600413; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; Raurell I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004080; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; St George-Hyslop P, 2012, J NEUROCHEM, V120, P84, DOI 10.1111/j.1471-4159.2011.07505.x; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tyson DR, 2002, ENDOCRINOLOGY, V143, P674, DOI 10.1210/en.143.2.674; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Watanabe H, 2009, J BIOL CHEM, V284, P13705, DOI 10.1074/jbc.M809168200; Wen PH, 2004, NEUROSCI LETT, V371, P249, DOI 10.1016/j.neulet.2004.09.038; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wolfe MS, 2012, J NEUROCHEM, V120, P89, DOI 10.1111/j.1471-4159.2011.07501.x; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wolfer DP, 2001, MOL CELL NEUROSCI, V18, P407, DOI 10.1006/mcne.2001.1029; Yang T, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-15; Yu G, 2000, J BIOL CHEM, V275, P27348; Zhong HB, 2009, MOL BIOSYST, V5, P1356, DOI 10.1039/b905752h; Zou K, 2008, BIOCHEMISTRY-US, V47, P3370, DOI 10.1021/bi7014508	83	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35222	35236		10.1074/jbc.M113.513705	http://dx.doi.org/10.1074/jbc.M113.513705			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145027	Green Published, hybrid			2022-12-28	WOS:000329867600022
J	Dejima, K; Takemura, M; Nakato, E; Peterson, J; Hayashi, Y; Kinoshita-Toyoda, A; Toyoda, H; Nakato, H				Dejima, Katsufumi; Takemura, Masahiko; Nakato, Eriko; Peterson, Jesse; Hayashi, Yoshiki; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Nakato, Hiroshi			Analysis of Drosophila Glucuronyl C5-Epimerase IMPLICATIONS FOR DEVELOPMENTAL ROLES OF HEPARAN SULFATE SULFATION COMPENSATION AND 2-O-SULFATED GLUCURONIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Fibroblast Growth Factor (FGF); Genetics; Heparan Sulfate; Immunohistochemistry; C5-Epimerase; Gagosome; Sulfation Compensation	MORPHOGEN GRADIENT FORMATION; HEXURONIC ACID 2-O-SULFOTRANSFERASE; INTEGRAL MEMBRANE PROTEOGLYCAN; L-IDURONIC ACID; IN-VIVO; CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; NERVOUS-SYSTEM; CELL-SURFACE; GENE	Background: The physiological significance of C5-epimerization of glucuronic acid (GlcA) remains elusive. Results:Drosophila Hsepi mutants are viable and fertile with only minor morphological defects, but they have a short lifespan. Conclusion: Sulfation compensation and 2-O-sulfated GlcA contribute to the mild phenotypes of Hsepi mutants. Significance: The findings suggest novel developmental roles of 2-O-sulfated GlcA. During the biosynthesis of heparan sulfate (HS), glucuronyl C5-epimerase (Hsepi) catalyzes C5-epimerization of glucuronic acid (GlcA), converting it to iduronic acid (IdoA). Because HS 2-O-sulfotransferase (Hs2st) shows a strong substrate preference for IdoA over GlcA, C5-epimerization is required for normal HS sulfation. However, the physiological significance of C5-epimerization remains elusive. To understand the role of Hsepi in development, we isolated Drosophila Hsepi mutants. Homozygous mutants are viable and fertile with only minor morphological defects, including the formation of an ectopic crossvein in the wing, but they have a short lifespan. We propose that two mechanisms contribute to the mild phenotypes of Hsepi mutants: HS sulfation compensation and possible developmental roles of 2-O-sulfated GlcA (GlcA2S). HS disaccharide analysis showed that loss of Hsepi resulted in a significant impairment of 2-O-sulfation and induced compensatory increases in N- and 6-O-sulfation. Simultaneous block of Hsepi and HS 6-O-sulfotransferase (Hs6st) activity disrupted tracheoblast formation, a well established FGF-dependent process. This result suggests that the increase in 6-O-sulfation in Hsepi mutants is critical for the rescue of FGF signaling. We also found that the ectopic crossvein phenotype can be induced by expression of a mutant form of Hs2st with a strong substrate preference for GlcA-containing units, suggesting that this phenotype is associated with abnormal GlcA 2-O-sulfation. Finally, we show that Hsepi formed a complex with Hs2st and Hs6st in S2 cells, raising the possibility that this complex formation contributes to the close functional relationships between these enzymes.	[Dejima, Katsufumi; Takemura, Masahiko; Nakato, Eriko; Peterson, Jesse; Hayashi, Yoshiki; Nakato, Hiroshi] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kinoshita-Toyoda, Akiko; Toyoda, Hidenao] Ritsumeikan Univ, Fac Pharmaceut Sci, Shiga 5258577, Japan	University of Minnesota System; University of Minnesota Twin Cities; Ritsumeikan University	Nakato, H (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	nakat003@umn.edu		Hayashi, Yoshiki/0000-0002-8966-8730; Takemura, Masahiko/0000-0003-3984-4481	National Institutes of Health [R01 HD042769]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HD042769 (to H. N.).	Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Chen J, 2012, DEVELOPMENT, V139, P2170, DOI 10.1242/dev.073817; Dejima K, 2013, J BIOL CHEM, V288, P6574, DOI 10.1074/jbc.M112.404830; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feyerabend TB, 2006, NAT CHEM BIOL, V2, P195, DOI 10.1038/nchembio777; Fujise M, 2001, DEV BIOL, V235, P433, DOI 10.1006/dbio.2001.0290; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; Ghiselli G, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-19; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hayashi Y, 2012, DEVELOPMENT, V139, P4162, DOI 10.1242/dev.078055; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kamimura K, 2011, GLYCOBIOLOGY, V21, P607, DOI 10.1093/glycob/cwq202; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kleinschmit A, 2010, DEV BIOL, V345, P204, DOI 10.1016/j.ydbio.2010.07.006; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li K, 2010, J BIOL CHEM, V285, P11106, DOI 10.1074/jbc.M109.081059; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Matsuda S, 2012, DEV BIOL, V366, P153, DOI 10.1016/j.ydbio.2012.04.009; Merry CLR, 2002, BIOCHEM SOC SYMP, V69, P47; Merry CLR, 2002, BBA-GEN SUBJECTS, V1573, P319, DOI 10.1016/S0304-4165(02)00399-9; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Ralston A, 2005, DEV BIOL, V280, P187, DOI 10.1016/j.ydbio.2005.01.018; Rong JH, 2001, BIOCHEMISTRY-US, V40, P5548, DOI 10.1021/bi002926p; Serpe M, 2005, DEVELOPMENT, V132, P2645, DOI 10.1242/dev.01838; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Smeds E, 2010, GLYCOBIOLOGY, V20, P1274, DOI 10.1093/glycob/cwq089; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Townley RA, 2011, J BIOL CHEM, V286, P16824, DOI 10.1074/jbc.M111.227926; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; White-Cooper H, 2004, METH MOL B, V247, P45; Xu D, 2007, J BIOL CHEM, V282, P8356, DOI 10.1074/jbc.M608062200	47	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34384	34393		10.1074/jbc.M113.499269	http://dx.doi.org/10.1074/jbc.M113.499269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133213	Green Published, hybrid			2022-12-28	WOS:000329812800010
J	Hu, JX; Hu, K; Liu, T; Stern, MK; Mistry, R; Challiss, RAJ; Costanzi, S; Wess, J				Hu, Jianxin; Hu, Kelly; Liu, Tong; Stern, Matthew K.; Mistry, Rajendra; Challiss, R. A. John; Costanzi, Stefano; Wess, Juergen			Novel Structural and Functional Insights into M-3 Muscarinic Receptor Dimer/Oligomer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholinergic Receptor; G Protein-coupled Receptors (GPCR); Neurotransmitter Receptors; Receptor Structure-function; Site-directed Mutagenesis	PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; ACETYLCHOLINE-RECEPTORS; OPIOID RECEPTOR; NATIVE MEMBRANES; MOLECULAR-BASIS; DRUG DISCOVERY; RHODOPSIN; ACTIVATION; TRANSDUCIN	Background: G protein-coupled receptors (GPCRs) exist in dimeric/oligomeric arrays but the structural basis underling this phenomenon is not well understood. Results: The M-3 muscarinic receptor, a prototypic GPCR, can form multiple, structurally distinct dimeric species. Conclusion: GPCRs may exist in a dynamic equilibrium of multiple dimers or oligomers. Significance: Our findings may facilitate efforts to target GPCR dimers for therapeutic purposes. Class A G protein-coupled receptors (GPCRs) are able to form homodimers and/or oligomeric arrays. We recently proposed, based on bioluminescence resonance energy transfer studies with the M-3 muscarinic receptor (M3R), a prototypic class A GPCR, that the M3R is able to form multiple, structurally distinct dimers that are probably transient in nature (McMillin, S. M., Heusel, M., Liu, T., Costanzi, S., and Wess, J. (2011) J. Biol. Chem. 286, 28584-28598). To provide more direct experimental support for this concept, we employed a disulfide cross-linking strategy to trap various M3R dimeric species present in a native lipid environment (transfected COS-7 cells). Disulfide cross-linking studies were carried out with many mutant M3Rs containing single cysteine (Cys) substitutions within two distinct cytoplasmic M3R regions, the C-terminal portion of the second intracellular loop (i2) and helix H8 (H8). The pattern of cross-links that we obtained, in combination with molecular modeling studies, was consistent with the existence of two structurally distinct M3R dimer interfaces, one involving i2/i2 contacts (TM4-TM5-i2 interface) and the other one characterized by H8-H8 interactions (TM1-TM2-H8 interface). Specific H8-H8 disulfide cross-links led to significant impairments in M3R-mediated G protein activation, suggesting that changes in the structural orientation or mobility of H8 are critical for efficient receptor-G protein coupling. Our findings provide novel structural and functional insights into the mechanisms involved in M3R dimerization (oligomerization). Because the M3R shows a high degree of sequence similarity with many other class A GPCRs, our findings should be of considerable general interest.	[Hu, Jianxin; Hu, Kelly; Liu, Tong; Stern, Matthew K.; Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Mistry, Rajendra; Challiss, R. A. John] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Costanzi, Stefano] Amer Univ, Dept Chem, Washington, DC 20016 USA; [Costanzi, Stefano] Amer Univ, Ctr Behav Neurosci, Washington, DC 20016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Leicester; American University; American University	Wess, J (corresponding author), Bldg 8A,Rm B1A-05,8 Ctr Dr MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov		Challiss, John/0000-0001-5506-2848; Costanzi, Stefano/0000-0003-3183-7332	National Institutes of Health, NIDDK; American University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031129] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institutes of Health, NIDDK, and the American University.	Akam EC, 2001, BRIT J PHARMACOL, V132, P950, DOI 10.1038/sj.bjp.0703892; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; [Anonymous], 2010, MOL OP ENV MOE VERS; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; GRIFFITH IP, 1972, BIOCHEM J, V126, P553, DOI 10.1042/bj1260553; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2010, REGUL PEPTIDES, V164, P113, DOI 10.1016/j.regpep.2010.06.001; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Javitch JA, 2004, MOL PHARMACOL, V66, P1077, DOI 10.1124/mol.104.006320; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lambert NA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115pe12; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Provasi D, 2010, BIOCHEMISTRY-US, V49, P6771, DOI 10.1021/bi100686t; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yang K, 1996, BIOCHEMISTRY-US, V35, P14040, DOI 10.1021/bi962113u; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng FY, 1999, J BIOL CHEM, V274, P16629, DOI 10.1074/jbc.274.23.16629	51	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34777	34790		10.1074/jbc.M113.503714	http://dx.doi.org/10.1074/jbc.M113.503714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133207	hybrid, Green Published			2022-12-28	WOS:000329812800046
J	Pham, TH; Gao, XF; Singh, G; Hardwidge, PR				Pham, Thanh H.; Gao, Xiaofei; Singh, Gyanendra; Hardwidge, Philip R.			Escherichia coli Virulence Protein NleH1 Interaction with the v-Crk Sarcoma Virus CT10 Oncogene-like Protein (CRKL) Governs NleH1 Inhibition of the Ribosomal Protein 53 (RPS3)/Nuclear Factor kappa B (NF-kappa B) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; Innate Immunity; NF-B; Type III Secretion System; Virulence factors; CRKL; IKK; NleH1	TYROSINE PHOSPHORYLATION; BACTERIAL EFFECTOR; SECRETION; APOPTOSIS; RECEPTOR; COMPLEX; LOCALIZATION; EXPRESSION; INFECTION; LIGATION	Background: Bacterial pathogens use virulence proteins to inhibit the host innate immune system. Results: The Escherichia coli O157:H7 NleH1 protein interacts with the host CRKL protein. Conclusion: CRKL may recruit NleH1 to a host kinase on which NleH1 performs its inhibitory function. Significance: These data clarify a mechanism by which E. coli inhibits innate immunity. Enterohemorrhagic Escherichia coli and other attaching/effacing bacterial pathogens cause diarrhea in humans. These pathogens use a type III secretion system to inject virulence proteins (effectors) into host cells, some of which inhibit the innate immune system. The enterohemorrhagic E. coli NleH1 effector prevents the nuclear translocation of RPS3 (ribosomal protein S3) to inhibit its participation as a nuclear specifier of NF-B binding to target gene promoters. NleH1 binds to RPS3 and inhibits its phosphorylation on Ser-209 by IB kinase- (IKK). However, the precise mechanism of this inhibition is unclear. NleH1 possesses a Ser/Thr protein kinase activity that is essential both for its ability to inhibit the RPS3/NF-B pathway and for full virulence of the attaching/effacing mouse pathogen Citrobacter rodentium. However, neither RPS3 nor IKK is a substrate of NleH1 kinase activity. We therefore screened approximate to 9,000 human proteins to identify NleH1 kinase substrates and identified CRKL (v-Crk sarcoma virus CT10 oncogene-like protein), a substrate of the BCR/ABL kinase. Knockdown of CRKL abundance prevented NleH1 from inhibiting RPS3 nuclear translocation and NF-B activity. CRKL residues Tyr-198 and Tyr-207 were required for interaction with NleH1. Lys-159, the kinase-active site of NleH1, was necessary for its interaction with CRKL. We also identified CRKL as an IKK interaction partner, mediated by CRKL Tyr-198. We propose that the CRKL interaction with IKK recruits NleH1 to the IKK complex, where NleH1 then inhibits the RPS3/NF-B pathway.	[Pham, Thanh H.; Singh, Gyanendra; Hardwidge, Philip R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Gao, Xiaofei] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Kansas State University; Massachusetts Institute of Technology (MIT); Whitehead Institute	Hardwidge, PR (corresponding author), Kansas State Univ, Manhattan, KS 66506 USA.	hardwidg@gmail.com		PHAM, THANH/0000-0001-8959-7947	National Institutes of Health from NIAID [AI099002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099002, R56AI099002] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI099002 from NIAID.	Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Gao XF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00137; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Garcia-Angulo VA, 2008, J BACTERIOL, V190, P2388, DOI 10.1128/JB.01602-07; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Koval AP, 1998, J BIOL CHEM, V273, P14780, DOI 10.1074/jbc.273.24.14780; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pham TH, 2012, INFECT IMMUN, V80, P2133, DOI 10.1128/IAI.06358-11; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Robinson KS, 2010, MICROBIOL-SGM, V156, P1815, DOI 10.1099/mic.0.037259-0; Ruchaud-Sparagano MH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002414; Sattler M, 1997, J BIOL CHEM, V272, P10248; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Sattler Martin, 1997, Cytokine and Growth Factor Reviews, V8, P63, DOI 10.1016/S1359-6101(96)00047-0; Sham HP, 2011, INFECT IMMUN, V79, P3552, DOI 10.1128/IAI.05033-11; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; Vossenkamper A, 2010, J IMMUNOL, V185, P4118, DOI 10.4049/jimmunol.1000500; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231	36	20	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34567	34574		10.1074/jbc.M113.512376	http://dx.doi.org/10.1074/jbc.M113.512376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145029	hybrid, Green Published			2022-12-28	WOS:000329812800025
J	Lu, Y; Liu, XJ; Zhou, JF; Huang, AJ; Zhou, JZ; He, C				Lu, Yan; Liu, Xiujie; Zhou, Jianfeng; Huang, Aijun; Zhou, Jiazhen; He, Cheng			TROY Interacts with Rho Guanine Nucleotide Dissociation Inhibitor alpha (RhoGDI alpha) to Mediate Nogo-induced Inhibition of Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Neurite Outgrowth; Neurons; RhoA; Signaling	FACTOR RECEPTOR SUPERFAMILY; FAMILY-MEMBER; GTPASES; CELLS; EXPRESSION; REGENERATION; CORECEPTOR; MORPHOLOGY; ADHESION; TAJ/TROY	Background: TROY, together with the Nogo receptor, mediates Nogo-66 induced neurite outgrowth inhibition. Results: TROY binds to RhoGDI to activate RhoA and inhibit neurite outgrowth after Nogo-66 stimulation in cerebellar granule neurons. Conclusion: TROY/RhoGDI interaction transduces the inhibitory effects of Nogo-66 on neurite extension by activating RhoA. Significance: TROY/RhoGDI interaction plays a key role in RhoA activation and neurite outgrowth inhibition by Nogo-66. TROY can functionally substitute p75 to comprise the Nogo receptor complex, which transduces the inhibitory signal of myelin-associated inhibitory factors on axon regeneration following CNS injury. The inhibition of neurite extension relies on TROY-dependent RhoA activation, but how TROY activates RhoA remains unclear. Here, we firstly identified Rho guanine nucleotide dissociation inhibitor (RhoGDI) as a binding partner of TROY using GST pull-down combined with two-dimensional gel electrophoresis and mass spectra analysis. The interaction was further confirmed by coimmunoprecipitation in vitro and in vivo. Deletion mutagenesis revealed that two regions of the TROY intracellular domain (amino acids 234-256 and 321-350) were essential for the interaction with RhoGDI. Secondly, TROY and RhoGDI were coexpressed in postnatal dorsal root ganglion neurons, cortex neurons, and cerebellar granule neurons (CGNs). Thirdly, TROY/RhoGDI association was potentiated by Nogo-66 and was independent of p75/RhoGDI interaction. Fourthly, TROY/RhoGDI interaction was still able to activate RhoA when p75 was deficient. Furthermore, RhoA activation was decreased dramatically when TROY was knocked down in p75-deficient CGNs cells. Finally, RhoGDI overexpression abolished RhoA activation and following neurite outgrowth inhibition by Nogo-66 in both wild-type and p75-deficient CGNs. These results showed that the association of RhoGDI with TROY contributed to TROY-dependent RhoA activation and neurite outgrowth inhibition after Nogo-66 stimulation.	Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn			National Key Basic Research Program [2011CB504401]; National Natural Science Foundation of China [31070922, 31130024]; Natural Science Foundation of Shanghai City [13ZR1448500]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai City(Natural Science Foundation of Shanghai)	This work was supported by National Key Basic Research Program Grant 2011CB504401, by National Natural Science Foundation of China Grants 31070922 and 31130024, and by Natural Science Foundation of Shanghai City Grant 13ZR1448500.	Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boulter Etienne, 2010, Small GTPases, V1, P65; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Chumbalkar VC, 2005, PROTEOMICS, V5, P1167, DOI 10.1002/pmic.200401202; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Deighton RF, 2010, BRAIN PATHOL, V20, P691, DOI 10.1111/j.1750-3639.2010.00376.x; Eby MT, 2000, J BIOL CHEM, V275, P15336, DOI 10.1074/jbc.275.20.15336; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harrington AW, 2008, J BIOL CHEM, V283, P24690, DOI 10.1074/jbc.M802188200; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hisaoka T, 2006, BRAIN RES, V1110, P81, DOI 10.1016/j.brainres.2006.06.068; Hisaoka T, 2006, EUR J NEUROSCI, V23, P3149, DOI 10.1111/j.1460-9568.2006.04851.x; Jacobs VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037955; Jiao L, 2011, CELL RES, V21, P327, DOI 10.1038/cr.2010.139; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Kojima T, 2000, J BIOL CHEM, V275, P20742, DOI 10.1074/jbc.M002691200; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Li X, 2012, ONCOGENE, V31, P595, DOI 10.1038/onc.2011.256; Liu XJ, 2012, J BIOL CHEM, V287, P17503, DOI 10.1074/jbc.M111.317610; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mandemakers WJ, 2005, CURR BIOL, V15, pR302, DOI 10.1016/j.cub.2005.04.002; McDonald CL, 2011, CURR MED CHEM, V18, P234; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2008, CYTOKINE GROWTH F R, V19, P245, DOI 10.1016/j.cytogfr.2008.04.007; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Morikawa Y, 2008, ANN NY ACAD SCI, V1126, pA1, DOI 10.1196/annals.1366.036; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Samuel F, 2010, MOL NEUROBIOL, V42, P133, DOI 10.1007/s12035-010-8144-2; Schwab JM, 2006, TRENDS MOL MED, V12, P293, DOI 10.1016/j.molmed.2006.05.001; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang Y, 2004, J CELL SCI, V117, P1525, DOI 10.1242/jcs.00994; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zhang Y, 2004, J MOL BIOL, V343, P1147, DOI 10.1016/j.jmb.2004.08.072; Zhang Y, 2009, J BIOL CHEM, V284, P12469, DOI 10.1074/jbc.M809214200	49	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34276	34286		10.1074/jbc.M113.519744	http://dx.doi.org/10.1074/jbc.M113.519744			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129566	hybrid, Green Published			2022-12-28	WOS:000327250200070
J	Luo, M; Lu, XP; Zhu, R; Zhang, ZH; Chow, CC; Li, R; Simons, SS				Luo, Min; Lu, Xinping; Zhu, Rong; Zhang, Zhenhuan; Chow, Carson C.; Li, Rong; Simons, S. Stoney, Jr.			A Conserved Protein Motif Is Required for Full Modulatory Activity of Negative Elongation Factor Subunits NELF-A and NELF-B in Modifying Glucocorticoid Receptor-regulated Gene Induction Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Transcription; Glucocorticoid Receptor; Mathematical Modeling; Steroid Hormone; Transcription Factors; EC50; Gene Induction; NELF-A and NELF-B; Cofactor Action; Competitive Decelerator	RNA-POLYMERASE; CHROMATIN ACCESSIBILITY; POL-II; TRANSCRIPTION; PROMOTER; IDENTIFICATION; EXPRESSION; BRCA1; COFACTOR; DOMAIN	NELF-B is a BRCA1-interacting protein and subunit (with NELF-A, -C/D, and -E) of the human negative elongation factor (NELF) complex, which participates in RNA polymerase II pausing shortly after transcription initiation, especially for synchronized gene expression. We now report new activities of NELF-B and other NELF complex subunits, which are to attenuate glucocorticoid receptor (GR)-mediated gene induction, reduce the partial agonist activity of an antagonist, and increase the EC50 of an agonist during nonsynchronized expression of exogenous and endogenous reporters. Stable knockdown of endogenous NELF-B has the opposite effects on an exogenous gene. The GR ligand-binding domain suffices for these biological responses. ChIP assays reveal that NELF-B diminishes GR recruitment to promoter regions of two endogenous genes. Using a new competition assay, NELF-A and NELF-B are each shown to act independently as competitive decelerators at two steps after the site of GR action and before or at the site of reporter gene activity. A common motif in each NELF was identified that is required for full activity of both NELF-A and NELF-B. These studies allow us to position the actions of two new modulators of GR-regulated transactivation, NELF-A and NELF-B, relative to other factors in the overall gene induction sequence.	[Luo, Min; Lu, Xinping; Zhu, Rong; Zhang, Zhenhuan; Simons, S. Stoney, Jr.] NIDDK, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA; [Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Simons, SS (corresponding author), NIDDK, LERB, NIH, Bldg 10,8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov			National Institutes of Health, the NIDDK; Voelcker Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057800, ZIADK047041, ZIADK075069] Funding Source: NIH RePORTER	National Institutes of Health, the NIDDK; Voelcker Scholar Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, the NIDDK, and a Voelcker Scholar Award (to R. L.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2007, INT J BIOL SCI, V3, P486; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Awasthi S, 2012, MOL CELL ENDOCRINOL, V355, P121, DOI 10.1016/j.mce.2012.02.001; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Blackford JA, 2012, J BIOL CHEM, V287, P40982, DOI 10.1074/jbc.M112.414805; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Chinenov Y, 2008, P NATL ACAD SCI USA, V105, P20185, DOI 10.1073/pnas.0810863105; Cho SY, 2005, MOL ENDOCRINOL, V19, P290, DOI 10.1210/me.2004-0134; Chow CC, 2011, METHOD ENZYMOL, P465, DOI [10.1016/S0076-6879(11)87016-3, 10.1016/B978-0-12-381270-4.00016-0]; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dougherty EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030225; Fromm HJ, 1975, INITIAL RATE ENZYME; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Ianculescu I, 2012, J BIOL CHEM, V287, P4000, DOI 10.1074/jbc.M111.300194; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim Y, 2006, J STEROID BIOCHEM, V100, P3, DOI 10.1016/j.jsbmb.2006.03.003; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Kunz S, 2003, MOL ENDOCRINOL, V17, P2566, DOI 10.1210/me.2003-0164; Lagha M, 2013, CELL, V153, P976, DOI 10.1016/j.cell.2013.04.045; LEACH KL, 1979, J BIOL CHEM, V254, P1884; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lee GS, 2011, BIOCHEMISTRY-US, V50, P356, DOI 10.1021/bi101792d; Luca F., 2013, PLOS ONE, V8; Luo M, 2009, HUM IMMUNOL, V70, P785, DOI 10.1016/j.humimm.2009.07.029; McChesney PA, 2006, CANCER RES, V66, P1346, DOI 10.1158/0008-5472.CAN-05-3593; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Segel IH., 1993, ENZYME KINETICS BEHA; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Simons SS, 2010, CURR OPIN PHARMACOL, V10, P613, DOI 10.1016/j.coph.2010.08.001; SIMONS SS, 1980, J ORG CHEM, V45, P3084, DOI 10.1021/jo01303a030; Simons SS, 2003, TRENDS PHARMACOL SCI, V24, P253, DOI 10.1016/S0165-6147(03)00101-9; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Sun JL, 2010, J BIOL CHEM, V285, P6443, DOI 10.1074/jbc.M109.084285; Sun YG, 2008, MOL CELL ENDOCRINOL, V295, P59, DOI 10.1016/j.mce.2008.05.008; Tao YG, 2008, BIOCHEMISTRY-US, V47, P7648, DOI 10.1021/bi800472w; Unden AL, 2005, CLIN ENDOCRINOL, V63, P94, DOI 10.1111/j.1365-2265.2005.02306.x; van der Laan S, 2008, ENDOCRINOLOGY, V149, P725, DOI 10.1210/en.2007-1234; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; WILLMANN T, 1986, NATURE, V324, P688, DOI 10.1038/324688a0; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Zhang ZH, 2013, J BIOL CHEM, V288, P42, DOI 10.1074/jbc.M112.427740; Zhao QH, 2003, INT IMMUNOPHARMACOL, V3, P1803, DOI 10.1016/j.intimp.2003.08.005	63	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34055	34072		10.1074/jbc.M113.512426	http://dx.doi.org/10.1074/jbc.M113.512426			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097989	Green Published, hybrid			2022-12-28	WOS:000327250200049
J	Bai, L; Livnat, I; Romanova, EV; Alexeeva, V; Yau, PM; Vilim, FS; Weiss, KR; Jing, J; Sweedler, JV				Bai, Lu; Livnat, Itamar; Romanova, Elena V.; Alexeeva, Vera; Yau, Peter M.; Vilim, Ferdinand S.; Weiss, Klaudiusz R.; Jing, Jian; Sweedler, Jonathan V.			Characterization of GdFFD, a D-Amino Acid-containing Neuropeptide That Functions as an Extrinsic Modulator of the Aplysia Feeding Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Chemistry; Invertebrates; Mass Spectrometry (MS); Peptides; Post-translational Modification; Aplysia; D-Amino Acid-containing peptides; Epimer; MALDI-TOF; TOF MS; Stereoselective	CONTAINING PEPTIDE; CARDIOACTIVE PEPTIDES; MASS-SPECTROMETRY; MOTOR PROGRAMS; NERVOUS-SYSTEM; AMPHIBIAN SKIN; HIGH-AFFINITY; ACHATIN-I; D-SERINE; RESIDUE	Background: l-to-d conversion of an amino acid in a neuropeptide can be required for bioactivity. Results: A new d-amino acid-containing peptide (DAACP), GdFFD, shows stereospecific bioactivity in the feeding circuit. Conclusion: Our findings broaden the importance of this unusual post-translational modification, providing new methods to accelerate DAACP discovery. Significance: GdFFD is the first DAACP showing bioactivity in a well defined circuit. During eukaryotic translation, peptides/proteins are created using l-amino acids. However, a d-amino acid-containing peptide (DAACP) can be produced through post-translational modification via an isomerase enzyme. General approaches to identify novel DAACPs and investigate their function, particularly in specific neural circuits, are lacking. This is primarily due to the difficulty in characterizing this modification and due to the limited information on neural circuits in most species. We describe a multipronged approach to overcome these limitations using the sea slug Aplysia californica. Based on bioinformatics and homology to known DAACPs in the land snail Achatina fulica, we targeted two predicted peptides in Aplysia, GFFD, similar to achatin-I (GdFAD versus GFAD, where dF stands for d-phenylalanine), and YAEFLa, identical to fulyal (YdAEFLa versus YAEFLa), using stereoselective analytical methods, i.e. MALDI MS fragmentation analysis and LC-MS/MS. Although YAEFLa in Aplysia was detected only in an all l-form, we found that both GFFD and GdFFD were present in the Aplysia CNS. In situ hybridization and immunolabeling of GFFD/GdFFD-positive neurons and fibers suggested that GFFD/GdFFD might act as an extrinsic modulator of the feeding circuit. Consistent with this hypothesis, we found that GdFFD induced robust activity in the feeding circuit and elicited egestive motor patterns. In contrast, the peptide consisting of all l-amino acids, GFFD, was not bioactive. Our data indicate that the modification of an l-amino acid-containing neuropeptide to a DAACP is essential for peptide bioactivity in a motor circuit, and thus it provides a functional significance to this modification.	[Bai, Lu; Livnat, Itamar; Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Bai, Lu; Livnat, Itamar; Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Alexeeva, Vera; Vilim, Ferdinand S.; Weiss, Klaudiusz R.; Jing, Jian] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Yau, Peter M.] Univ Illinois, Roy J Carver Biotechnol Ctr, Prot Sci Facil, Urbana, IL 61801 USA; [Jing, Jian] Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Urbana-Champaign; Nanjing University	Jing, J (corresponding author), Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China.	jingj01@gmail.com; jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Yau, Peter/0000-0002-1984-185X; Jing, Jian/0000-0003-1422-143X; Romanova, Elena/0000-0002-2040-3312	National Institutes of Health from NINDS [NS031609, NS066587, NS070583]; NIGMS [5T32-GM070421]; NIDA [P30 DA018310]; National Science Foundation of China [31371104]; National Science Foundation, Division of Chemistry [CHE-11-11705]; Division of Biological Infrastructure; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070583, R01NS031609, R29NS031609, R01NS066587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1111705] Funding Source: National Science Foundation	National Institutes of Health from NINDS; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation, Division of Chemistry(National Science Foundation (NSF)); Division of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS031609, NS066587, and NS070583 from NINDS, 5T32-GM070421 from NIGMS, and P30 DA018310 from NIDA. This work was also supported by Grant 31371104 from National Science Foundation of China and Grant CHE-11-11705 from the National Science Foundation, Division of Chemistry (with co-funding from the Division of Biological Infrastructure).	Adams CM, 2004, J AM SOC MASS SPECTR, V15, P1087, DOI 10.1016/j.jasms.2004.04.026; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bai Lu, 2009, Bioanal Rev, V1, P7; Bai L, 2011, ANAL CHEM, V83, P2794, DOI 10.1021/ac200142m; BARRA D, 1994, PEPTIDES, V15, P199, DOI 10.1016/0196-9781(94)90002-7; Blitz DM, 2012, J NEUROSCI, V32, P9182, DOI 10.1523/JNEUROSCI.1461-12.2012; BROCCARDO M, 1981, BRIT J PHARMACOL, V73, P625, DOI 10.1111/j.1476-5381.1981.tb16797.x; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Buczek O, 2008, TOXICON, V51, P218, DOI 10.1016/j.toxicon.2007.09.006; Cooks RG, 1998, ACCOUNTS CHEM RES, V31, P379, DOI 10.1021/ar960242x; Cropper EC, 2004, NEUROSIGNALS, V13, P70, DOI 10.1159/000076159; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; ERSPAMER V, 1989, P NATL ACAD SCI USA, V86, P5188, DOI 10.1073/pnas.86.13.5188; Ewing MA, 2008, ANAL CHEM, V80, P2874, DOI 10.1021/ac7025173; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; FUJISAWA Y, 1992, COMP BIOCHEM PHYS C, V102, P91, DOI 10.1016/0742-8413(92)90049-D; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; Furukawa Y, 2001, J NEUROSCI, V21, P8247, DOI 10.1523/JNEUROSCI.21-20-08247.2001; Han YH, 2008, FEBS J, V275, P1976, DOI 10.1111/j.1742-4658.2008.06352.x; Heck SD, 1996, P NATL ACAD SCI USA, V93, P4036, DOI 10.1073/pnas.93.9.4036; HECK SD, 1994, J AM CHEM SOC, V116, P10426, DOI 10.1021/ja00102a009; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Hummon AB, 2003, J PROTEOME RES, V2, P650, DOI 10.1021/pr034046d; Hurwitz I, 1997, J NEUROPHYSIOL, V78, P1305, DOI 10.1152/jn.1997.78.3.1305; Iwakoshi E, 2000, PEPTIDES, V21, P623, DOI 10.1016/S0196-9781(00)00201-1; Jacobsen R, 1998, J PEPT RES, V51, P173; Jacobsen RB, 1999, J PEPT RES, V54, P93, DOI 10.1034/j.1399-3011.1999.00093.x; Jimenez EC, 1997, BIOCHEMISTRY-US, V36, P989, DOI 10.1021/bi962840p; Jimenez EC, 1996, J BIOL CHEM, V271, P28002, DOI 10.1074/jbc.271.45.28002; Jimenez EC, 2001, TOXICON, V39, P803, DOI 10.1016/S0041-0101(00)00210-5; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Jing J, 2002, J NEUROSCI, V22, P6228; Jing J, 2001, J NEUROSCI, V21, P7349, DOI 10.1523/JNEUROSCI.21-18-07349.2001; Jing J, 2008, J NEUROSCI, V28, P12349, DOI 10.1523/JNEUROSCI.3855-08.2008; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; Jing J, 2011, J NEUROSCI, V31, P15438, DOI 10.1523/JNEUROSCI.3741-11.2011; Jing JA, 2010, J NEUROSCI, V30, P16545, DOI 10.1523/JNEUROSCI.4264-10.2010; Jing J, 2009, REV NEUROSCIENCE, V20, P405; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; KREIL G, 1989, EUR J PHARMACOL, V162, P123, DOI 10.1016/0014-2999(89)90611-0; KUPFERMANN I, 1974, BEHAV BIOL, V10, P89, DOI 10.1016/S0091-6773(74)91694-0; KUWADA M, 1994, MOL PHARMACOL, V46, P587; Li LJ, 2008, ANNU REV ANAL CHEM, V1, P451, DOI 10.1146/annurev.anchem.1.031207.113053; Li LJ, 2000, TRENDS BIOTECHNOL, V18, P151, DOI 10.1016/S0167-7799(00)01427-X; LLOYD PE, 1985, J NEUROSCI, V5, P1851; MIGNOGNA G, 1993, EMBO J, V12, P4829, DOI 10.1002/j.1460-2075.1993.tb06172.x; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; MOR A, 1989, FEBS LETT, V255, P269, DOI 10.1016/0014-5793(89)81104-4; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; Morishita F, 1997, BIOCHEM BIOPH RES CO, V240, P354, DOI 10.1006/bbrc.1997.7659; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; OHTA N, 1991, BIOCHEM BIOPH RES CO, V178, P486, DOI 10.1016/0006-291X(91)90133-R; Phares GA, 1996, J NEUROSCI, V16, P7841; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Predel R, 2007, BIOESSAYS, V29, P416, DOI 10.1002/bies.20571; Proekt A, 2005, J NEUROSCI, V25, P9637, DOI 10.1523/JNEUROSCI.2932-05.2005; Proekt A, 2007, J NEUROPHYSIOL, V97, P3046, DOI 10.1152/jn.01301.2006; RAJPARA SM, 1992, NEURON, V9, P505, DOI 10.1016/0896-6273(92)90188-J; Redeker V, 1998, ANAL CHEM, V70, P1805, DOI 10.1021/ac971309c; Romanova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048764; Sachon E, 2009, ANAL CHEM, V81, P4389, DOI 10.1021/ac9002886; Satake H, 1999, EUR J BIOCHEM, V261, P130, DOI 10.1046/j.1432-1327.1999.00252.x; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; Serafin SV, 2005, ANAL CHEM, V77, P5480, DOI 10.1021/ac050490j; SHIKATA Y, 1995, J BIOL CHEM, V270, P16719, DOI 10.1074/jbc.270.28.16719; SOSSIN WS, 1987, J NEUROSCI, V7, P671; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; Soyez D, 2011, J CHROMATOGR B, V879, P3102, DOI 10.1016/j.jchromb.2011.03.032; Strand F. L., 1999, NEUROPEPTIDES REGULA, P121; Sweedler JV, 2002, J NEUROSCI, V22, P7797; Taghert PH, 2012, NEURON, V76, P82, DOI 10.1016/j.neuron.2012.08.035; Torres AM, 2006, FEBS LETT, V580, P1587, DOI 10.1016/j.febslet.2006.01.089; Torres AM, 2005, BIOCHEM J, V391, P215, DOI 10.1042/BJ20050900; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; Vilim FS, 2010, J NEUROSCI, V30, P131, DOI 10.1523/JNEUROSCI.3282-09.2010; Vilim FS, 2001, PEPTIDES, V22, P2027, DOI 10.1016/S0196-9781(01)00561-7; Wu JS, 2010, J NEUROPHYSIOL, V103, P2174, DOI 10.1152/jn.01054.2009; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; YASUDAKAMATANI Y, 1995, J NEUROCHEM, V64, P2248; YasudaKamatani Y, 1997, PEPTIDES, V18, P347, DOI 10.1016/S0196-9781(96)00343-9	83	31	32	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32837	32851		10.1074/jbc.M113.486670	http://dx.doi.org/10.1074/jbc.M113.486670			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078634	Green Published, hybrid			2022-12-28	WOS:000328841700003
J	Faingold, O; Ashkenazi, A; Kaushansky, N; Ben-Nun, A; Shai, Y				Faingold, Omri; Ashkenazi, Avraham; Kaushansky, Nathali; Ben-Nun, Avraham; Shai, Yechiel			An Immunomodulating Motif of the HIV-1 Fusion Protein Is Chirality-independent IMPLICATIONS FOR ITS MODE OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; Immunosuppression; Membrane Fusion; Protein-Protein Interactions; T-cell; Viral Fusion Protein; Membrane Recognition	T-CELL-ACTIVATION; IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 LOOP REGION; TRANSMEMBRANE DOMAINS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; TCR-ALPHA; IN-VITRO; PEPTIDE; RECOGNITION	Background: Recently, an immunosuppressive motif was identified in the HIV-1 envelope glycoprotein complex. Results: Both d- and l-stereoisomers of the motif inhibit T-cell receptor activation and preferentially bind T-cells over B-cells. Conclusion: The motif immunomodulates T-cells through interactions occurring within the membrane milieu. Significance: This study provides new insights into the immunosuppressive activity of the envelope glycoprotein complex and the molecular recognition within the membrane. An immunosuppressive motif was recently found within the HIV-1 gp41 fusion protein (termed immunosuppressive loop-associated determinant core motif (ISLAD CM)). Peptides containing the motif interact with the T-cell receptor (TCR) complex; however, the mechanism by which the motif exerts its immunosuppressive activity is yet to be determined. Recent studies showed that interactions between protein domains in the membrane milieu are not always sterically controlled. Therefore, we utilized the unique membrane leniency toward association between d- and l-stereoisomers to investigate the detailed mechanism by which ISLAD CM inhibits T-cell activation. We show that a d-enantiomer of ISLAD CM (termed ISLAD d-CM) inhibited the proliferation of murine myelin oligodendrocyte glycoprotein (MOG)-(35-55)-specific line T-cells to the same extent as the l-motif form. Moreover, the d- and l-forms preferentially bound spleen-derived T-cells over B-cells by 13-fold. Furthermore, both forms of ISLAD CM co-localized with the TCR on activated T-cells and interacted with the transmembrane domain of the TCR. FRET experiments revealed the importance of basic residues for the interaction between ISLAD CM forms and the TCR transmembrane domain. Ex vivo studies demonstrated that ISLAD d-CM administration inhibited the proliferation (72%) and proinflammatory cytokine secretion of pathogenic MOG(35-55)-specific T-cells. This study provides insights into the immunosuppressive mechanism of gp41 and demonstrates that chirality-independent interactions in the membrane can take place in diverse biological systems. Apart from HIV pathogenesis, the d-peptide reported herein may serve as a potential tool for treating T-cell-mediated pathologies.	[Faingold, Omri; Ashkenazi, Avraham; Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kaushansky, Nathali; Ben-Nun, Avraham] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shai, Y (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	yechiel.shai@weizmann.ac.il		Ashkenazi, Avraham/0000-0002-1253-497X	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation.	Ashkenazi A, 2013, TRENDS BIOCHEM SCI, V38, P345, DOI 10.1016/j.tibs.2013.04.003; Ashkenazi A, 2013, BLOOD, V121, P2244, DOI 10.1182/blood-2012-11-468900; Ashkenazi A, 2012, BIOCHEMISTRY-US, V51, P6981, DOI 10.1021/bi300868f; Ashkenazi A, 2011, FASEB J, V25, P2156, DOI 10.1096/fj.10-175752; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; BENNUN A, 1983, J IMMUNOL, V130, P1205; Bloch I, 2007, FASEB J, V21, P393, DOI 10.1096/fj.06-7061com; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen LR, 2009, BIOPHYS J, V96, P4622, DOI 10.1016/j.bpj.2009.03.004; CHIRMULE N, 1995, J IMMUNOL, V155, P917; Cohen T, 2008, BIOCHEMISTRY-US, V47, P4826, DOI 10.1021/bi800100p; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Fernando K, 2007, BLOOD, V109, P2538, DOI 10.1182/blood-2006-08-038661; Fink A, 2013, J IMMUNOL, V190, P6410, DOI 10.4049/jimmunol.1202033; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; GALLAHER WR, 1989, AIDS RES HUM RETROV, V5, P431, DOI 10.1089/aid.1989.5.431; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Gerber D, 2002, J MOL BIOL, V322, P491, DOI 10.1016/S0022-2836(02)00807-0; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Kaushansky N, 2007, EUR J IMMUNOL, V37, P3281, DOI 10.1002/eji.200737438; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Maltez Fernando, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS21, DOI 10.1097/01.COH.0000410238.80894.81; Manolios N, 1997, NAT MED, V3, P84, DOI 10.1038/nm0197-84; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; Masci AM, 2003, J LEUKOCYTE BIOL, V74, P1117, DOI 10.1189/jlb.0503239; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; Pascual R, 2005, J VIROL, V79, P5142, DOI 10.1128/JVI.79.8.5142-5152.2005; Quintana FJ, 2005, J CLIN INVEST, V115, P2149, DOI 10.1172/JCI23956; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2007, BIOPOLYMERS, V88, P217, DOI 10.1002/bip.20668; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; Sackett K, 2003, J MOL BIOL, V333, P47, DOI 10.1016/j.jmb.2003.07.008; Sal-Man N, 2004, J MOL BIOL, V344, P855, DOI 10.1016/j.jmb.2004.09.066; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WEISS A, 1984, J IMMUNOL, V133, P123; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhang R, 2006, BLOOD, V107, P1989, DOI 10.1182/blood-2005-07-2731	57	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32852	32860		10.1074/jbc.M113.512038	http://dx.doi.org/10.1074/jbc.M113.512038			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078631	Green Published, hybrid			2022-12-28	WOS:000328841700004
J	Kemp, KL; Lin, ZH; Zhao, F; Gao, BX; Song, JX; Zhang, KZ; Fang, DY				Kemp, Kyeorda L.; Lin, Zhenghong; Zhao, Fang; Gao, Beixue; Song, Jianxun; Zhang, Kezhong; Fang, Deyu			The Serine-threonine Kinase Inositol-requiring Enzyme 1 alpha (IRE1 alpha) Promotes IL-4 Production in T Helper Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; ER Stress; Lymphocyte; Signal Transduction; T Cell Biology; IL-4; IRE1; T Cell Differentiation	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; GENE-EXPRESSION; STRESS-RESPONSE; ER STRESS; TH2 CELLS; C-THETA; ACTIVATION; DIFFERENTIATION	Background: IRE1 is a kinase important for the misfolded protein response. Results: IRE1 promotes IL-4 production by stabilizing IL-4 mRNA, and IRE1-specific inhibitor 48C suppresses IL-4 production. Conclusion: IRE1 is a positive regulator of IL-4 production by T helper cells. Significance: Cytokine IL-4 has been implicated in allergic response. Our discovery that IRE1 promotes IL-4 production implies that IRE1 inhibition has a therapeutic potential in allergic disease treatment. The inositol-requiring enzyme 1 (IRE1) is a serine-threonine kinase that plays crucial roles in activating the unfolded protein response. Studies suggest that IRE1 is activated during thymic T cell development and in effector CD8(+) T cells. However, its role in regulating T helper cell differentiation remains unknown. We find that IRE1 is up-regulated and activated upon CD4(+) T cell activation and plays an important role in promoting cytokine IL-4 production. CD4(+) T cells from IRE1 KO mice have reduced IL-4 protein expression, and this impaired IL-4 production is not due to the altered expression of Th2 lineage-specific transcription factors, such as GATA3. Instead, IL-4 mRNA stability is reduced in IRE1 KO T cells. Furthermore, treatment of T cells with an IRE1-specific inhibitor, 48C, leads to a block in IL-4, IL-5, and IL-13 production, confirming the role of IRE1 in the regulation of IL-4. This study identifies a regulatory function for IRE1 in the promotion of IL-4 in T cells.	[Kemp, Kyeorda L.; Lin, Zhenghong; Zhao, Fang; Gao, Beixue; Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Song, Jianxun] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA; [Zhang, Kezhong] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Wayne State University	Kemp, KL (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 3-754 Tarry Bldg,300 E Super St, Chicago, IL 60611 USA.	k-kemp@northwestern.edu; fangd@northwestern.edu	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751; Zhang, Kezhong/0000-0002-6062-235X; Lin, Zhenghong/0000-0002-6354-0042	National Institutes of Health [1 K12 GM088020, AI079056, DK083050, DK090313, ES017829]; American Heart Association [09GRNT2280479]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056, R56AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090313, DP2DK083050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants 1 K12 GM088020 (to K. K.), AI079056 (to D. F.), DK083050 (to D. F.), and National Institutes of Health Grants DK090313 and ES017829 and American Heart Association Grant 09GRNT2280479 (to K. Z.).	ALLEN JM, 1992, MOL CELL BIOL, V12, P2758, DOI 10.1128/MCB.12.6.2758; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109; Dodeller F, 2005, EUR J IMMUNOL, V35, P3631, DOI 10.1002/eji.200535029; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Guo LY, 2008, J IMMUNOL, V181, P3984, DOI 10.4049/jimmunol.181.6.3984; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kamimura D, 2008, J IMMUNOL, V181, P5433, DOI 10.4049/jimmunol.181.8.5433; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Khabar KSA, 2007, J LEUKOCYTE BIOL, V81, P1335, DOI 10.1189/jlb.0207109; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JHW, 2011, J HYDRO-ENVIRON RES, V5, P143, DOI 10.1016/j.jher.2011.07.001; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lee SM, 2009, OTOLARYNG HEAD NECK, V140, P197, DOI 10.1016/j.otohns.2008.08.016; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pino SC, 2008, CELL STRESS CHAPERON, V13, P421, DOI 10.1007/s12192-008-0038-0; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Scheu S, 2006, NAT IMMUNOL, V7, P644, DOI 10.1038/ni1338; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shirakawa T, 2011, J BIOL CHEM, V286, P4003, DOI 10.1074/jbc.M110.168435; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Stevens L, 2006, EUR J IMMUNOL, V36, P3305, DOI 10.1002/eji.200636400; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; WILDIN RS, 1991, J EXP MED, V173, P383, DOI 10.1084/jem.173.2.383; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yarovinsky TO, 2006, J IMMUNOL, V177, P4426, DOI 10.4049/jimmunol.177.7.4426; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	50	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33272	33282		10.1074/jbc.M113.493171	http://dx.doi.org/10.1074/jbc.M113.493171			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100031	Green Published, hybrid			2022-12-28	WOS:000328841700041
J	Uotila, LM; Aatonen, M; Gahmberg, CG				Uotila, Liisa M.; Aatonen, Maria; Gahmberg, Carl G.			Integrin CD11c/CD18 alpha-Chain Phosphorylation Is Functionally Important	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Integrins; Leukocyte; Phagocytosis; Phosphorylation	LEUKOCYTE ADHESION; BLOOD MONOCYTES; BETA-SUBUNIT; ACTIVATION; RECEPTOR; RECOGNITION; BINDING; LIGAND; DOMAIN; MAC-1	CD11c/CD18 ((X2), p150/95, or complement receptor 4, CR4) is a monocyte/macrophage-enriched integrin that has been reported to bind to a variety of ligands. These include cell surface proteins, extracellular matrix proteins, and soluble ligands. The regulation of ligand binding to CD11c/CD18 has remained poorly understood. Previous work has shown that both -chain and -chain phosphorylations of CD11a/CD18 and CD11b/CD18 are needed for activity, but no corresponding studies on CD11c/CD18 have been performed. In this study, we have identified the phosphorylation site of CD11c as Ser-1158 and show that it is pivotal for adherence and phagocytosis.	[Uotila, Liisa M.; Aatonen, Maria; Gahmberg, Carl G.] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Gahmberg, CG (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Div Biochem & Biotechnol, POB 56, FIN-00014 Helsinki, Finland.	Carl.Gahmberg@Helsinki.Fi	Gahmberg, Carl/AAE-1876-2019	Aatonen, Maria/0000-0002-4819-6722; Uotila, Liisa/0000-0003-4743-9013; Gahmberg, Carl/0000-0001-9892-9296	Academy of Finland; Sigrid Juselius Foundation; Finska Lakaresallskapet; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Wilhelm and Else Stockmann Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Liv och Halsa Foundation; Magnus Ehrnrooth Foundation; Wilhelm and Else Stockmann Foundation	This work was supported in part by grants from the Academy of Finland, the Sigrid Juselius Foundation, the Finska Lakaresallskapet, the Liv och Halsa Foundation, the Magnus Ehrnrooth Foundation, and the Wilhelm and Else Stockmann Foundation.	ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; BILSLAND CAG, 1994, J IMMUNOL, V152, P4582; Blackford J, 1996, EUR J IMMUNOL, V26, P525, DOI 10.1002/eji.1830260304; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; BUYON JP, 1990, J IMMUNOL, V144, P191; Castro FVV, 2008, EUR J IMMUNOL, V38, P2263, DOI 10.1002/eji.200838302; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chua GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041924; DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Faham A, 2011, INT J CANCER, V129, P1391, DOI 10.1002/ijc.25810; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Garnotel R, 2000, J IMMUNOL, V164, P5928, DOI 10.4049/jimmunol.164.11.5928; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Gronholm M, 2011, J IMMUNOL, V187, P3613, DOI 10.4049/jimmunol.1100704; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ihanus E, 2007, BLOOD, V109, P802, DOI 10.1182/blood-2006-04-014878; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; Lim J, 2010, J CELL BIOCHEM, V111, P999, DOI 10.1002/jcb.22788; LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; NORTAMO P, 1988, SCAND J IMMUNOL, V28, P537, DOI 10.1111/j.1365-3083.1988.tb01485.x; PETRUZZELLI L, 1995, J IMMUNOL, V155, P854; Sadhu C, 2007, J LEUKOCYTE BIOL, V81, P1395, DOI 10.1189/jlb.1106680; SUTHERLAND JA, 1986, J BIOL RESP MODIF, V5, P250; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Vorup-Jensen T, 2007, J BIOL CHEM, V282, P30869, DOI 10.1074/jbc.M706114200; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Ye F, 2012, BLOOD, V119, P26, DOI 10.1182/blood-2011-04-292128; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	42	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33494	33499		10.1074/jbc.C113.497446	http://dx.doi.org/10.1074/jbc.C113.497446			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24129562	Green Published, hybrid			2022-12-28	WOS:000328841700061
J	Xu, J; Xu, ZF; Zhou, JY; Zhuang, ZP; Wang, EH; Boerner, J; Wu, GS				Xu, Jing; Xu, Zhengfan; Zhou, Jun-Ying; Zhuang, Zhengping; Wang, Enhua; Boerner, Julie; Wu, Gen Sheng			Regulation of the Src-PP2A Interaction in Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Phosphorylation; PP2A; Src; Trail	PROTEIN PHOSPHATASE 2A; TRAIL-INDUCED APOPTOSIS; DEATH-RECEPTOR; LIPID RAFTS; SRC; FAMILY; MECHANISM; MEMBER; CELLS; IDENTIFICATION	Background: The mechanisms of TRAIL resistance in cancer cells are not fully understood. Results: TRAIL activates Src, which in turn phosphorylates caspase-8. Src inhibition increases TRAIL-induced apoptosis. TRAIL also relieves PP2A-mediated Src inhibition, leading to Src activation. Conclusion: The interaction between Src and PP2A plays an important role in TRAIL resistance. Significance: Inhibition of Src survival signaling may enhance TRAIL-induced apoptosis in cancer cells. TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in transformed and tumor cells but not in normal cells, making it a promising agent for cancer therapy. However, many cancer cells are resistant to TRAIL, and the underlying mechanisms are not fully understood. Here, we show that the regulation of the PP2A and Src interaction plays a critical role in TRAIL resistance. Specifically, we show that TRAIL treatment activates the tyrosine kinase Src, which subsequently phosphorylates caspase-8 at tyrosine 380, leading to the inhibition of caspase-8 activation. We also show that upon TRAIL treatment, Src, caspase-8, and PP2A/C (a catalytic subunit of the PP2A phosphatase) are redistributed into lipid rafts, a microdomain of the plasma membrane enriched with cholesterol, where PP2A dephosphorylates Src at tyrosine 418 and in turn inhibits caspase-8 phosphorylation. Furthermore, we find that TRAIL treatment causes PP2A/C degradation. These data suggest that the balance between Src-mediated caspase-8 phosphorylation and the inactivation of Src-mediated caspase-8 phosphorylation by PP2A determines the outcome of TRAIL treatment in breast cancer cells. Therefore, this work identifies a novel mechanism by which the interaction between PP2A and Src in the context of caspase-8 activation modulates TRAIL sensitivity in cancer cells.	[Xu, Jing; Xu, Zhengfan; Zhou, Jun-Ying; Boerner, Julie; Wu, Gen Sheng] Wayne State Univ, Sch Med, Depts Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Xu, Jing; Xu, Zhengfan; Zhou, Jun-Ying; Boerner, Julie; Wu, Gen Sheng] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA; [Xu, Zhengfan; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang 110001, Peoples R China; [Xu, Zhengfan; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang 110001, Peoples R China; [Zhuang, Zhengping] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; China Medical University; China Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, GS (corresponding author), Wayne State Univ, Sch Med, Depts Oncol, Karmanos Canc Inst, Detroit, MI 48201 USA.	wug@karmanos.org			Karmanos Cancer Institute Strategic Research Initiative grant; National Institutes of Health [P30 CA22453]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Karmanos Cancer Institute Strategic Research Initiative grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Karmanos Cancer Institute Strategic Research Initiative grant supported in part by National Institutes of Health Grant P30 CA22453.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Azijli K, 2012, J CELL SCI, V125, P4651, DOI 10.1242/jcs.109587; Burns TF, 2001, J BIOL CHEM, V276, P37879; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Eichhorn PJA, 2007, PLOS GENET, V3, P2381, DOI 10.1371/journal.pgen.0030218; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Hietakangas V, 2003, MOL CELL BIOL, V23, P1278, DOI 10.1128/MCB.23.4.1278-1291.2003; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Leong S, 2009, J CLIN ONCOL, V27, P4413, DOI 10.1200/JCO.2008.21.7422; Lu J, 2010, J NEUROSURG, V113, P225, DOI 10.3171/2009.11.JNS091272; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Mom CH, 2009, CLIN CANCER RES, V15, P5584, DOI 10.1158/1078-0432.CCR-09-0996; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Pai SI, 1998, CANCER RES, V58, P3513; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Pradhan S, 2010, J BIOL CHEM, V285, P29059, DOI 10.1074/jbc.M109.085167; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Screaton GR, 1997, CURR BIOL, V7, P693, DOI 10.1016/S0960-9822(06)00297-1; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Van Schaeybroeck S, 2008, CANCER RES, V68, P8312, DOI 10.1158/0008-5472.CAN-07-6736; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Wu GS, 1996, CLIN CANCER RES, V2, P623; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Xu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010306; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	39	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33263	33271		10.1074/jbc.M113.508093	http://dx.doi.org/10.1074/jbc.M113.508093			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100030	Green Published, hybrid			2022-12-28	WOS:000328841700040
J	Zhang, XM; Tan, FL; Skidgel, RA				Zhang, Xianming; Tan, Fulong; Skidgel, Randal A.			CarboxypeptidaseMIs a Positive Allosteric Modulator of the Kinin B1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Carboxypeptidase; G Protein-coupled Receptors (GPCR); Glycosyl Phosphatidylinositol Anchors; Peptidases; Peptide Hormones; Bradykinin; Kallidin	CONVERTING-ENZYME-INHIBITORS; MEMBRANE-BOUND CARBOXYPEPTIDASE; NITRIC-OXIDE PRODUCTION; 2ND EXTRACELLULAR LOOP; G-PROTEIN; BRADYKININ B1; B-1 RECEPTOR; CRYSTAL-STRUCTURE; ACTIVATION; GPCRS	Background: Carboxypeptidase M (CPM) generates agonist for the kinin B1 receptor (B1R). Results: CPM binds to B1R on the cell membrane and allosterically increases B1R agonist affinity. Conclusion: CPM is a positive allosteric modulator of the B1R, thereby increasing receptor signaling. Significance: Interfering with CPM binding to B1R could be a novel approach to inhibit deleterious effects of B1R signaling in inflammation. Ligand binding to extracellular domains of G protein-coupled receptors can result in novel and nuanced allosteric effects on receptor signaling. We previously showed that the protein-protein interaction of carboxypeptidase M (CPM) and kinin B1 receptor (B1R) enhances B1R signaling in two ways; 1) kinin binding to CPM causes a conformational activation of the B1R, and 2) CPM-generated des-Arg-kinin agonist is efficiently delivered to the B1R. Here, we show CPM is also a positive allosteric modulator of B1R signaling to its agonist, des-Arg(10)-kallidin (DAKD). In HEK cells stably transfected with B1R, co-expression of CPM enhanced DAKD-stimulated increases in intracellular Ca2+ or phosphoinositide turnover by a leftward shift of the dose-response curve without changing the maximum. CPM increased B1R affinity for DAKD by approximate to 5-fold but had no effect on basal B1R-dependent phosphoinositide turnover. Soluble, recombinant CPM bound to HEK cells expressing B1Rs without stimulating receptor signaling. CPM positive allosteric action was independent of enzyme activity but depended on interaction of its C-terminal domain with the B1R extracellular loop 2. Disruption of the CPM/B1R interaction or knockdown of CPM in cytokine-treated primary human endothelial cells inhibited the allosteric enhancement of CPM on B1R DAKD binding or ERK1/2 activation. CPM also enhanced the DAKD-induced B1R conformational change as detected by increased intramolecular fluorescence or bioluminescence resonance energy transfer. Thus, CPM binding to extracellular loop 2 of the B1R results in positive allosteric modulation of B1R signaling, and disruption of this interaction could provide a novel therapeutic approach to reduce pathological B1R signaling.	[Zhang, Xianming; Tan, Fulong; Skidgel, Randal A.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Skidgel, Randal A.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Skidgel, RA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol MC 868, 835 S Wolcott, Chicago, IL 60612 USA.	rskidgel@uic.edu	zhang, xian/GYA-0290-2022		National Institutes of Health [RO1 DK41431, PO1 HL60678]; American Heart Association Postdoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health B1R activation is also involved in the therapeutic effects of Grants RO1 DK41431 and PO1 HL60678.; Recipient of an American Heart Association Postdoctoral Fellowship.	Alhenc-Gelas F, 2011, CURR PHARM DESIGN, V17, P2654, DOI 10.2174/138161211797416002; Aloy P, 2001, J BIOL CHEM, V276, P16177, DOI 10.1074/jbc.M011457200; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Burford NT, 2011, BIOCHEM PHARMACOL, V81, P691, DOI 10.1016/j.bcp.2010.12.012; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; DEDDISH PA, 1990, J BIOL CHEM, V265, P15083; DEDDISH PA, 1989, BIOCHEM J, V261, P289, DOI 10.1042/bj2610289; Deiteren K, 2009, CLIN CHIM ACTA, V399, P24, DOI 10.1016/j.cca.2008.10.003; Duka A, 2008, HYPERTENSION, V51, P1352, DOI 10.1161/HYPERTENSIONAHA.107.108506; Duka I, 2003, HYPERTENSION, V42, P1021, DOI 10.1161/01.HYP.0000097550.98865.35; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Eng FJ, 1998, J BIOL CHEM, V273, P8382, DOI 10.1074/jbc.273.14.8382; Erdos EG, 2010, HYPERTENSION, V55, P214, DOI 10.1161/HYPERTENSIONAHA.109.144600; Hadkar V, 2004, AM J PHYSIOL-LUNG C, V287, pL35, DOI 10.1152/ajplung.00346.2003; Hagiwara M, 2004, HYPERTENS RES, V27, P399, DOI 10.1291/hypres.27.399; Hillmeister P, 2011, CIRC RES, V109, P524, DOI 10.1161/CIRCRESAHA.111.240986; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Ignjatovic T, 2002, J BIOL CHEM, V277, P16847, DOI 10.1074/jbc.M200355200; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Keil C, 2007, J MOL BIOL, V366, P504, DOI 10.1016/j.jmb.2006.11.025; Kenakin TP, 2009, TRENDS PHARMACOL SCI, V30, P460, DOI 10.1016/j.tips.2009.06.007; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Leeb-Lundberg LMF, 2001, J BIOL CHEM, V276, P8785, DOI 10.1074/jbc.M007396200; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Li JQ, 2002, GENE, V284, P189, DOI 10.1016/S0378-1119(01)00898-8; Li XY, 1999, BIOCHEM BIOPH RES CO, V258, P204, DOI 10.1006/bbrc.1999.0619; Marcic B, 2000, J BIOL CHEM, V275, P16110, DOI 10.1074/jbc.M909490199; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MCGWIRE GB, 1995, J BIOL CHEM, V270, P17154, DOI 10.1074/jbc.270.29.17154; Merino VF, 2008, J MOL MED, V86, P791, DOI 10.1007/s00109-008-0345-z; Moniwa N, 2006, BIOL CHEM, V387, P203, DOI 10.1515/BC.2006.027; Nakanishi J, 2006, BIOCHEM BIOPH RES CO, V343, P1191, DOI 10.1016/j.bbrc.2006.03.064; Pesquero JB, 2006, BIOL CHEM, V387, P119, DOI 10.1515/BC.2006.017; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Potier L, 2013, J PHARMACOL EXP THER, V346, P23, DOI 10.1124/jpet.113.203927; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schremmer-Danninger E, 1998, BIOCHEM BIOPH RES CO, V243, P246, DOI 10.1006/bbrc.1997.7999; Skidgel R. A., 1996, ZINC METALLOPROTEASE, P241; Skidgel RA, 1998, IMMUNOL REV, V161, P129, DOI 10.1111/j.1600-065X.1998.tb01577.x; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; SKIDGEL RA, 1984, BIOCHEM PHARMACOL, V33, P3471, DOI 10.1016/0006-2952(84)90122-9; SKIDGEL RA, 1998, LUNG BIOL HEALTH DIS, V112, P459; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Su JB, 2006, CURR PHARM DESIGN, V12, P3423; Talbot S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-36; TAN FL, 1995, METHOD ENZYMOL, V248, P663; TAN FL, 1989, J BIOL CHEM, V264, P13165; Tan FL, 2003, BIOCHEM J, V370, P567, DOI 10.1042/BJ20021495; Tan FL, 1997, BIOCHEM J, V327, P81, DOI 10.1042/bj3270081; Tschope C, 2004, CARDIOVASC RES, V61, P559, DOI 10.1016/j.cardiores.2003.10.018; Unal H, 2012, ADV EXP MED BIOL, V749, P187, DOI 10.1007/978-1-4614-3381-1_13; Unal H, 2012, TRENDS PHARMACOL SCI, V33, P79, DOI 10.1016/j.tips.2011.09.007; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Vijayaraghavan K, 2011, CARDIOL CLIN, V29, P137, DOI 10.1016/j.ccl.2010.11.003; Wang CIA, 2013, BIOCHEM PHARMACOL, V85, P153, DOI 10.1016/j.bcp.2012.09.001; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Xu J, 2009, EXP PHYSIOL, V94, P322, DOI 10.1113/expphysiol.2008.045583; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; Zhang XM, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1357, DOI 10.1016/B978-0-12-382219-2.00305-7; Zhang XM, 2013, BIOL CHEM, V394, P335, DOI 10.1515/hsz-2012-0290; Zhang XM, 2011, J BIOL CHEM, V286, P18547, DOI 10.1074/jbc.M110.214940	74	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33226	33240		10.1074/jbc.M113.520791	http://dx.doi.org/10.1074/jbc.M113.520791			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24108126	Green Published, hybrid			2022-12-28	WOS:000328841700037
J	Heo, DH; Yoo, I; Kong, J; Lidschreiber, M; Mayer, A; Choi, BY; Hahn, Y; Cramer, P; Buratowski, S; Kim, M				Heo, Dong-hyuk; Yoo, Inhea; Kong, Jiwon; Lidschreiber, Michael; Mayer, Andreas; Choi, Byung-Yi; Hahn, Yoonsoo; Cramer, Patrick; Buratowski, Stephen; Kim, Minkyu			The RNA Polymerase II C-terminal Domain-interacting Domain of Yeast Nrd1 Contributes to the Choice of Termination Pathway and Couples to RNA Processing by the Nuclear Exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; RNA Polymerase II; RNA Processing; Small Nucleolar RNA (snoRNA); Transcription Termination; C-terminal Domain; Nrd1	PROMOTES TRANSCRIPTION TERMINATION; DIFFERENT PHOSPHORYLATED FORMS; CTD; POLYADENYLATION; COMPLEX; PROTEIN; KINASE; THREONINE-4; DEGRADATION; TRANSITIONS	Background: Distinct termination pathways for yeast RNA polymerase II (RNApII) employ proteins (Nrd1 and Rtt103) recognizing different phospho-forms of the RNApII C-terminal domain (CTD). Results: Alteration of CTD-binding specificity of Nrd1 significantly affects RNApII termination. Conclusion: Differential interaction between RNApII CTD and termination factors is crucial in choosing a termination pathway. Significance: CTD-interacting domain of Nrd1 couples termination and RNA processing by the nuclear exosome. The RNA polymerase II (RNApII) C-terminal domain (CTD)-interacting domain (CID) proteins are involved in two distinct RNApII termination pathways and recognize different phosphorylated forms of CTD. To investigate the role of differential CTD-CID interactions in the choice of termination pathway, we altered the CTD-binding specificity of Nrd1 by domain swapping. Nrd1 with the CID from Rtt103 (Nrd1(CIDRtt103)) causes read-through transcription at many genes, but can also trigger termination where multiple Nrd1/Nab3-binding sites and the Ser(P)-2 CTD co-exist. Therefore, CTD-CID interactions target specific termination complexes to help choose an RNApII termination pathway. Interactions of Nrd1 with both CTD and nascent transcripts contribute to efficient termination by the Nrd1 complex. Surprisingly, replacing the Nrd1 CID with that from Rtt103 reduces binding to Rrp6/Trf4, and RNA transcripts terminated by Nrd1(CIDRtt103) are predominantly processed by core exosome. Thus, the Nrd1 CID couples Ser(P)-5 CTD not only to termination, but also to RNA processing by the nuclear exosome.	[Heo, Dong-hyuk; Choi, Byung-Yi; Kim, Minkyu] Seoul Natl Univ, Inst Basic Sci, Ctr RNA Res, Seoul 151742, South Korea; [Yoo, Inhea; Kong, Jiwon; Kim, Minkyu] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Lidschreiber, Michael; Mayer, Andreas; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lidschreiber, Michael; Mayer, Andreas; Cramer, Patrick] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Hahn, Yoonsoo] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Buratowski, Stephen] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); University of Munich; University of Munich; Chung Ang University; Harvard University; Harvard Medical School	Kim, M (corresponding author), Seoul Natl Univ, Inst Basic Sci, 1 Gwanak Ro, Seoul 151742, South Korea.	minkyu@snu.ac.kr	Kong, Jiwon/J-4912-2015; Kong, Jiwon/GXH-5761-2022; Mayer, Andreas/AAA-5173-2021	Kong, Jiwon/0000-0003-3990-5619; HAHN, YOONSOO/0000-0003-4273-9842; Mayer, Andreas/0000-0002-4532-9382	National Institutes of Health [GM56663]; Institute for Basic Science [EM1302]; National Research Foundation [NRF-2013R1A1A2A10013757]; Ministry of Education of Korea; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Basic Science; National Research Foundation; Ministry of Education of Korea(Ministry of Education (MOE), Republic of Korea); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56663 (to S. B.), Research Center Program Grant EM1302 from the Institute for Basic Science and Basic Science Research Program Grant NRF-2013R1A1A2A10013757 (to M. K.) through the National Research Foundation funded by the Ministry of Education of Korea.; Supported by the Deutsche Forschungsgemeinschaft Grants SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMUinnovativ project Bioimaging Network, the Jung-Stiftung, and the Vallee Foundation.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Becker R, 2008, J BIOL CHEM, V283, P22659, DOI 10.1074/jbc.M803540200; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chinchilla K, 2012, EUKARYOT CELL, V11, P417, DOI 10.1128/EC.05320-11; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; HEIDMANN S, 1994, MOL CELL BIOL, V14, P4633, DOI 10.1128/MCB.14.7.4633; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; MANDART E, 1995, MOL CELL BIOL, V15, P6979; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Porrua O, 2012, EMBO J, V31, P3935, DOI 10.1038/emboj.2012.237; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Sung MK, 2008, YEAST, V25, P301, DOI 10.1002/yea.1588; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Vo LTA, 2001, MOL CELL BIOL, V21, P8346, DOI 10.1128/MCB.21.24.8346-8356.2001; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	56	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36676	36690		10.1074/jbc.M113.508267	http://dx.doi.org/10.1074/jbc.M113.508267			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196955	Green Published, hybrid			2022-12-28	WOS:000328883400046
J	Barranco-Medina, S; Pozzi, N; Vogt, AD; Di Cera, E				Barranco-Medina, Sergio; Pozzi, Nicola; Vogt, Austin D.; Di Cera, Enrico			Histone H4 Promotes Prothrombin Autoactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Enzyme Mechanisms; Protein Conformation; Prothrombin; Thrombin	CONFORMATIONAL SELECTION; EXTRACELLULAR HISTONES; CRYSTAL-STRUCTURE; SERINE-PROTEASE; THROMBIN GENERATION; ENERGY-TRANSFER; ACTIVATION; BINDING; MECHANISM; COFACTOR	Background: The molecular origin of the prothrombotic properties of histones is unknown. Results: Histone H4 interacts with prothrombin and promotes autoactivation. Conclusion: The prothrombotic properties of histone H4 are due to direct interaction with prothrombin. Significance: Prothrombin autoactivation has pathophysiological relevance. Recent studies have documented the ability of prothrombin to spontaneously convert to the mature protease thrombin when Arg-320 becomes exposed to solvent for proteolytic attack upon mutation of residues in the activation domain. Whether prothrombin autoactivation occurs in the wild-type under conditions relevant to physiology remains unknown. Here, we report that binding of histone H4 to prothrombin under physiological conditions generates thrombin by autoactivation. The effect is abrogated by mutation of the catalytic Ser-525 and requires the presence of the Gla domain. Fluorescence titrations document direct binding of histone H4 to prothrombin with an affinity in the low nm range. Stopped flow data and luminescence resonance energy transfer measurements indicate that the binding mechanism obeys conformational selection. Among the two conformations of prothrombin, collapsed and fully extended, histone H4 binds selectively to the collapsed form and induces a transition toward a new conformation where the distance between Ser-101 in kringle-1 and Ser-210 in kringle-2 increases by 13 . These findings confirm the molecular plasticity of prothrombin emerged from recent structural studies and suggest that different conformations of the inter-kringle linker domain determine the functional behavior of prothrombin. The results also broaden our mechanistic understanding of the prothrombotic phenotype observed during cellular damage due to the release of histones in the blood stream. Prothrombin autoactivation induced by histone H4 emerges as a mechanism of pathophysiological relevance through which thrombin is generated independently of activation of the coagulation cascade.	[Barranco-Medina, Sergio; Pozzi, Nicola; Vogt, Austin D.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAE-4910-2020; Pozzi, Nicola/AAV-4876-2021	Pozzi, Nicola/0000-0003-2309-7100	National Institutes of Health Research Grants [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL112303, R29HL049413, R01HL073813, R01HL049413] Funding Source: NIH RePORTER	National Institutes of Health Research Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Research Grants HL49413, HL73813, and HL112303.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; Choi-Miura NH, 2001, BIOL PHARM BULL, V24, P221, DOI 10.1248/bpb.24.221; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; Etscheid M, 2000, BIOL CHEM, V381, P1223, DOI 10.1515/BC.2000.150; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gansler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050399; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; GONIAS SL, 1985, THROMB RES, V39, P97, DOI 10.1016/0049-3848(85)90125-2; GUINTO ER, 1995, P NATL ACAD SCI USA, V92, P11185, DOI 10.1073/pnas.92.24.11185; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Heyduk E, 1997, ANAL BIOCHEM, V248, P216, DOI 10.1006/abio.1997.2148; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Nakazawa F, 2005, BIOCHEM J, V385, P831, DOI 10.1042/BJ20041021; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; PAL PK, 1983, THROMB RES, V31, P69, DOI 10.1016/0049-3848(83)90008-7; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Pemberton AD, 2010, PROTEOMICS, V10, P1484, DOI 10.1002/pmic.200900818; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2012, BLOOD, V120, P664, DOI 10.1182/blood-2012-03-415323; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; ROSING J, 1980, J BIOL CHEM, V255, P274; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yamamichi S, 2010, J THROMB HAEMOST, V8, P559, DOI 10.1111/j.1538-7836.2009.03641.x; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Yamamoto E, 2011, BIOSCI BIOTECH BIOCH, V75, P2070, DOI 10.1271/bbb.110515	43	37	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35749	35757		10.1074/jbc.M113.509786	http://dx.doi.org/10.1074/jbc.M113.509786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24178300	Green Published, hybrid			2022-12-28	WOS:000329814700013
J	Francis, K; Stojkovic, V; Kohen, A				Francis, Kevin; Stojkovic, Vanja; Kohen, Amnon			Preservation of Protein Dynamics in Dihydrofolate Reductase Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Kinetics; Enzyme Mutation; Enzymes; Isotope Effects; Protein Dynamics; Protein Evolution; Marcus-like; Dihydofolate Reductase; Enzyme Dynamics	HYDRIDE TRANSFER; TEMPERATURE-DEPENDENCE; COUPLED MOTION; CHEMICAL STEP; ENZYME; MECHANISM; CATALYSIS; FLUCTUATIONS; KNOCKOUT	Background: Humanized mutants of bacterial dihydrofolate reductase were examined to relate protein dynamics with enzyme evolution. Results: Effects on enzyme dynamics alter the catalyzed C-HC step, but the nature of that step was retained along evolution. Conclusion: Protein dynamics evolved to optimize the catalyzed reaction. Significance: Evolutionary conservation of functional dynamics implicates their role in the catalyzed hydride transfer reaction. The hydride transfer reaction catalyzed by dihydrofolate reductase (DHFR) is a model for examining how protein dynamics contribute to enzymatic function. The relationship between functional motions and enzyme evolution has attracted significant attention. Recent studies on N23PP Escherichia coli DHFR (ecDHFR) mutant, designed to resemble parts of the human enzyme, indicated a reduced single turnover rate. NMR relaxation dispersion experiments with that enzyme showed rigidification of millisecond Met-20 loop motions (Bhabha, G., Lee, J., Ekiert, D. C., Gam, J., Wilson, I. A., Dyson, H. J., Benkovic, S. J., and Wright, P. E. (2011) Science 332, 234-238). A more recent study of this mutant, however, indicated that fast motions along the reaction coordinate are actually more dispersed than for wild-type ecDHFR (WT). Furthermore, a double mutant (N23PP/G51PEKN) that better mimics the human enzyme seems to restore both the single turnover rates and narrow distribution of fast dynamics (Liu, C. T., Hanoian, P., French, T. H., Hammes-Schiffer, S., and Benkovic, S. J. (2013) Proc. Natl. Acad. Sci. U.S.A. 110, 10159-11064). Here, we measured intrinsic kinetic isotope effects for both N23PP and N23PP/G51PEKN double mutant DHFRs over a temperature range. The findings indicate that although the C-HC transfer and dynamics along the reaction coordinate are impaired in the altered N23PP mutant, both seem to be restored in the N23PP/G51PEKN double mutant. This indicates that the evolution of G51PEKN, although remote from the Met-20 loop, alleviated the loop rigidification that would have been caused by N23PP, enabling WT-like H-tunneling. The correlation between the calculated dynamics, the nature of C-HC transfer, and a phylogenetic analysis of DHFR sequences are consistent with evolutionary preservation of the protein dynamics to enable H-tunneling from well reorganized active sites.	[Francis, Kevin; Stojkovic, Vanja; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	University of Iowa	Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	amnon-kohen@uiowa.edu	Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605	National Science Foundation [CHE 1149023]; National Institutes of Health [R01 GM65368]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065368] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (CHE 1149023) and National Institutes of Health (R01 GM65368).	Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Antoniou D, 2002, EUR J BIOCHEM, V269, P3103, DOI 10.1046/j.1432-1033.2002.03021.x; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BLAKLEY RL, 1960, NATURE, V188, P231, DOI 10.1038/188231a0; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Boekelheide N, 2011, P NATL ACAD SCI USA, V108, P16159, DOI 10.1073/pnas.1106397108; Cheatum CM, 2013, TOP CURR CHEM, V337, P1, DOI 10.1007/128_2012_407; Chen SX, 2012, J AM CHEM SOC, V134, P18883, DOI 10.1021/ja307179q; Cook P. F., 2007, ENZYME KINETICS MECH; Dametto M, 2012, MOL PHYS, V110, P531, DOI 10.1080/00268976.2012.655337; Fan Y, 2013, BIOCHEMISTRY-US, V52, P2036, DOI 10.1021/bi301559q; Ferrer S, 2003, J PHYS CHEM B, V107, P14036, DOI 10.1021/jp0354898; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Glowacki DR, 2012, NAT CHEM, V4, P169, DOI [10.1038/NCHEM.1244, 10.1038/nchem.1244]; Hammes-Schiffer S, 2006, ACCOUNTS CHEM RES, V39, P93, DOI 10.1021/ar040199a; Hay S, 2012, NAT CHEM, V4, P161, DOI [10.1038/NCHEM.1223, 10.1038/nchem.1223]; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Kanaan N, 2011, J AM CHEM SOC, V133, P6692, DOI 10.1021/ja1114369; Klinman JP, 2013, ANNU REV BIOCHEM, V82, P471, DOI 10.1146/annurev-biochem-051710-133623; Kohen A, 2003, PROG REACT KINET MEC, V28, P119, DOI 10.3184/007967403103165486; Kohen A., 2006, ISOTOPE EFFECTS CHEM, V28, P743; Kohen A., 2006, ISOTOPE EFFECTS CHEM; Liu CT, 2013, P NATL ACAD SCI USA, V110, P10159, DOI 10.1073/pnas.1307130110; Liu HB, 2007, J PHYS CHEM B, V111, P7852, DOI 10.1021/jp070938f; Loveridge EJ, 2012, NAT CHEM, V4, P292, DOI 10.1038/nchem.1296; Loveridge EJ, 2009, J AM CHEM SOC, V131, P6926, DOI 10.1021/ja901441k; Maglia G, 2003, J AM CHEM SOC, V125, P13372, DOI 10.1021/ja035692g; Markham KA, 2004, ANAL BIOCHEM, V325, P62, DOI 10.1016/j.ab.2003.10.027; Markham KA, 2003, ANAL BIOCHEM, V322, P26, DOI 10.1016/j.ab.2003.07.010; McCracken JA, 2004, ANAL BIOCHEM, V324, P131, DOI 10.1016/j.ab.2003.09.025; Melander L., 1987, REACTION RATES ISOTO; Miller GP, 1998, BIOCHEMISTRY-US, V37, P6336, DOI 10.1021/bi973065w; Nagel ZD, 2010, CHEM REV, V110, pPR41, DOI 10.1021/cr1001035; NORTHROP DB, 1981, BIOCHEMISTRY-US, V20, P4056, DOI 10.1021/bi00517a017; Pu JZ, 2005, J AM CHEM SOC, V127, P14879, DOI 10.1021/ja054170t; Radkiewicz JL, 2000, J AM CHEM SOC, V122, P225, DOI 10.1021/ja9913838; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; Roston D, 2012, BIOCHEMISTRY-US, V51, P6860, DOI 10.1021/bi300613e; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Sen A, 2011, BIOCHEMISTRY-US, V50, P6462, DOI 10.1021/bi2003873; Sikorski RS, 2004, J AM CHEM SOC, V126, P4778, DOI 10.1021/ja031683w; Stojkovic V, 2012, J AM CHEM SOC, V134, P1738, DOI 10.1021/ja209425w; Sutcliffe MJ, 2006, PHILOS T R SOC B, V361, P1375, DOI 10.1098/rstb.2006.1878; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wang LCH, 2006, J ETHNOPHARMACOL, V103, P103, DOI 10.1016/j.jep.2005.07.010; Wang Z, 2012, J AM CHEM SOC, V134, P17722, DOI 10.1021/ja307859m; Wang Z, 2012, ADV PROTEIN CHEM STR, V87, P155, DOI 10.1016/B978-0-12-398312-1.00006-8; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102	49	31	32	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35961	35968		10.1074/jbc.M113.507632	http://dx.doi.org/10.1074/jbc.M113.507632			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158440	Green Published, hybrid			2022-12-28	WOS:000329814700032
J	James, AD; Chan, A; Erice, O; Siriwardena, AK; Bruce, JIE				James, Andrew D.; Chan, Anthony; Erice, Oihane; Siriwardena, Ajith K.; Bruce, Jason I. E.			Glycolytic ATP Fuels the Plasma Membrane Calcium Pump Critical for Pancreatic Cancer Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Calcium ATPase; Calcium Signaling; Cell Death; Glycolysis; Metabolism; Pancreatic Cancer; PMCA; Warburg; Calcium Overload	ACINAR-CELLS; INTRACELLULAR CA2+; DEATH; 3-BROMOPYRUVATE; CA2+-ATPASE; METABOLISM; ACTIVATION; APOPTOSIS; SWITCH; PHOSPHATIDYLSERINE	Background: Pancreatic cancer cells exhibit up-regulated glycolysis. Results: Inhibition of glycolysis, but not mitochondrial metabolism, induced ATP depletion, plasma membrane calcium pump (PMCA) inhibition, Ca2+ overload, and cell death. Conclusion: Glycolytic ATP fuels the PMCA in pancreatic cancer. Significance: Glycolytic regulation of the PMCA may represent a novel chemotherapeutic target for pancreatic cancer. Pancreatic cancer is an aggressive cancer with poor prognosis and limited treatment options. Cancer cells rapidly proliferate and are resistant to cell death due, in part, to a shift from mitochondrial metabolism to glycolysis. We hypothesized that this shift is important in regulating cytosolic Ca2+ ([Ca2+](i)), as the ATP-dependent plasma membrane Ca2+ ATPase (PMCA) is critical for maintaining low [Ca2+](i) and thus cell survival. The present study aimed to determine the relative contribution of mitochondrial versus glycolytic ATP in fuelling the PMCA in human pancreatic cancer cells. We report that glycolytic inhibition induced profound ATP depletion, PMCA inhibition, [Ca2+](i) overload, and cell death in PANC1 and MIA PaCa-2 cells. Conversely, inhibition of mitochondrial metabolism had no effect, suggesting that glycolytic ATP is critical for [Ca2+](i) homeostasis and thus survival. Targeting the glycolytic regulation of the PMCA may, therefore, be an effective strategy for selectively killing pancreatic cancer while sparing healthy cells.	[James, Andrew D.; Erice, Oihane; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chan, Anthony; Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9NT, Lancs, England	University of Manchester; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	jason.bruce@manchester.ac.uk	Chan, Anthony K. C./AAR-8892-2021; Chan, Anthony/AAE-1234-2019; Erice, Oihane/C-7694-2018	Chan, Anthony K. C./0000-0003-1551-3995; Chan, Anthony/0000-0001-6380-3124; Erice, Oihane/0000-0002-9894-1356; James, Andrew/0000-0002-2432-5948; James, Andrew/0000-0002-6915-3975	Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant; Central Manchester Foundation Trust (CMFT)/National Institutes of Health Research (NIHR) Manchester Biological Research Centre (BRC) pump priming fund; BBSRC; AstraZeneca plc CASE Ph.D. studentship; Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Central Manchester Foundation Trust (CMFT)/National Institutes of Health Research (NIHR) Manchester Biological Research Centre (BRC) pump priming fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca plc CASE Ph.D. studentship(AstraZeneca); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Grant (to J. B.) and a Central Manchester Foundation Trust (CMFT)/National Institutes of Health Research (NIHR) Manchester Biological Research Centre (BRC) pump priming fund (to A. S. and J. B.).; Supported by a BBSRC and AstraZeneca plc CASE Ph.D. studentship.	Amin Z, 2006, CLIN RADIOL, V61, P996, DOI 10.1016/j.crad.2006.07.005; Ankorina-Stark I, 2002, J MEMBRANE BIOL, V186, P43, DOI 10.1007/s00232-001-0134-x; Baggaley E, 2007, J BIOL CHEM, V282, P37678, DOI 10.1074/jbc.M703416200; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Barrow SL, 2008, PFLUG ARCH EUR J PHY, V455, P1025, DOI 10.1007/s00424-007-0360-x; BERROZPE G, 1994, INT J CANCER, V58, P185, DOI 10.1002/ijc.2910580207; Bouron A, 2000, FEBS LETT, V470, P269, DOI 10.1016/S0014-5793(00)01340-5; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Bruce Jason Ie, 2010, World J Biol Chem, V1, P221, DOI 10.4331/wjbc.v1.i7.221; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Criddle DN, 2006, GASTROENTEROLOGY, V130, P781, DOI 10.1053/j.gastro.2005.12.031; Dong H, 2010, AM J PHYSIOL-CELL PH, V299, pC1493, DOI 10.1152/ajpcell.00242.2010; Duchen MR, 1999, J PHYSIOL-LONDON, V516, P1, DOI 10.1111/j.1469-7793.1999.001aa.x; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudjonsson B, 2009, EUR J GASTROEN HEPAT, V21, P1379, DOI 10.1097/MEG.0b013e328323aab7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen MR, 2009, CELL PHYSIOL BIOCHEM, V23, P387, DOI 10.1159/000218185; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hug M, 1996, FEBS LETT, V397, P298, DOI 10.1016/S0014-5793(96)01185-4; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Kim JS, 2008, J BIOENERG BIOMEMBR, V40, P607, DOI 10.1007/s10863-008-9188-0; Kim JS, 2003, GASTROENTEROLOGY, V124, P494, DOI 10.1053/gast.2003.50059; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Krejs GJ, 2010, DIGEST DIS, V28, P355, DOI 10.1159/000319414; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Maleth J, 2011, GUT, V60, P136, DOI 10.1136/gut.2009.192153; Mankad P, 2012, J BIOL CHEM, V287, P1823, DOI 10.1074/jbc.M111.326272; MILLIGAN LP, 1985, J NUTR, V115, P1374, DOI 10.1093/jn/115.10.1374; MUALLEM S, 1988, J MEMBRANE BIOL, V102, P153, DOI 10.1007/BF01870453; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; Nicotera P, 1998, TOXICOL LETT, V103, P139; Putney J. W., 2006, CALCIUM SIGNALING, P73; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; ROSSI JPFC, 1989, BIOCHIM BIOPHYS ACTA, V996, P153, DOI 10.1016/0167-4838(89)90241-0; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Shchepina LA, 2002, ONCOGENE, V21, P8149, DOI 10.1038/sj.onc.1206053; Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; TSAI IH, 1982, J BIOL CHEM, V257, P1438; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; WAKASUGI H, 1981, AM J PHYSIOL, V240, pG281, DOI 10.1152/ajpgi.1981.240.4.G281; WOLFF T, 1993, PFLUG ARCH EUR J PHY, V424, P423, DOI 10.1007/BF00374904; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]; Zhou WD, 2012, J PROTEOME RES, V11, P554, DOI 10.1021/pr2009274	56	20	20	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36007	36019		10.1074/jbc.M113.502948	http://dx.doi.org/10.1074/jbc.M113.502948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158437	hybrid, Green Published			2022-12-28	WOS:000329814700036
J	Symeonidou, IE; Kotsantis, P; Roukos, V; Rapsomaniki, MA; Grecco, HE; Bastiaens, P; Taraviras, S; Lygerou, Z				Symeonidou, Ioanna-Eleni; Kotsantis, Panagiotis; Roukos, Vassilis; Rapsomaniki, Maria-Anna; Grecco, Hernan E.; Bastiaens, Philippe; Taraviras, Stavros; Lygerou, Zoi			Multi-step Loading of Human Minichromosome Maintenance Proteins in Live Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Cycle; Chromatin; DNA Replication; Imaging; Fluorescence Recovery after Photobleaching; Licensing; Live-cell Imaging; Minichromosome Maintenance Complex; Genome Stability	EUKARYOTIC DNA-REPLICATION; ORIGIN RECOGNITION COMPLEX; MCM PROTEINS; S-PHASE; LICENSING FACTOR; BIND CHROMATIN; ATP-HYDROLYSIS; GEMININ; CDT1; HELICASE	Background: MCM2-7 loading onto chromatin licenses origins for replication. Results: MCMs exhibit transient interactions with chromatin in late mitosis, stable binding in G(1) phase and increased loading in late G(1) phase. Conclusion: Multilevel regulation of MCM2-7 loading to chromatin occurs during mitosis and preceding the G(1)/S phase transition. Significance: The dynamics of the DNA licensing system within live human cells reveal multiple control points. Once-per-cell cycle replication is regulated through the assembly onto chromatin of multisubunit protein complexes that license DNA for a further round of replication. Licensing consists of the loading of the hexameric MCM2-7 complex onto chromatin during G(1) phase and is dependent on the licensing factor Cdt1. In vitro experiments have suggested a two-step binding mode for minichromosome maintenance (MCM) proteins, with transient initial interactions converted to stable chromatin loading. Here, we assess MCM loading in live human cells using an in vivo licensing assay on the basis of fluorescence recovery after photobleaching of GFP-tagged MCM protein subunits through the cell cycle. We show that, in telophase, MCM2 and MCM4 maintain transient interactions with chromatin, exhibiting kinetics similar to Cdt1. These are converted to stable interactions from early G(1) phase. The immobile fraction of MCM2 and MCM4 increases during G(1) phase, suggestive of reiterative licensing. In late G(1) phase, a large fraction of MCM proteins are loaded onto chromatin, with maximal licensing observed just prior to S phase onset. Fluorescence loss in photobleaching experiments show subnuclear concentrations of MCM-chromatin interactions that differ as G(1) phase progresses and do not colocalize with sites of DNA synthesis in S phase.	[Symeonidou, Ioanna-Eleni; Kotsantis, Panagiotis; Roukos, Vassilis; Rapsomaniki, Maria-Anna; Lygerou, Zoi] Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece; [Taraviras, Stavros] Univ Patras, Sch Med, Physiol Lab, Patras 26500, Greece; [Grecco, Hernan E.; Bastiaens, Philippe] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany	University of Patras; University of Patras; Max Planck Society	Lygerou, Z (corresponding author), Univ Patras, Sch Med, Lab Gen Biol, Patras 26500, Greece.	lygerou@upatras.gr	Taraviras, Stavros/AAJ-4690-2020; Roukos, Vassilis/AAC-4827-2020; Kotsantis, Panagiotis/AGU-7131-2022; Kotsantis, Panagiotis/AGZ-3258-2022; Roukos, Vassilis/K-6248-2012	Taraviras, Stavros/0000-0002-7455-647X; Kotsantis, Panagiotis/0000-0002-6131-4009; Kotsantis, Panagiotis/0000-0002-6131-4009; Roukos, Vassilis/0000-0002-5065-3937; Rapsomaniki, Maria Anna/0000-0003-3883-4871	Association for International Cancer Research grant; European Research Council Grant [ERC281851_DYNACOM]	Association for International Cancer Research grant; European Research Council Grant(European Research Council (ERC))	This work was supported by an Association for International Cancer Research grant and by European Research Council Grant ERC281851_DYNACOM.	Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Bancaud Aurelien, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.top90; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Chagin VO, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000737; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Dimitrova DS, 1996, P NATL ACAD SCI USA, V93, P1498, DOI 10.1073/pnas.93.4.1498; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kimura H, 1996, GENES CELLS, V1, P977, DOI 10.1046/j.1365-2443.1996.840284.x; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Koster M, 2005, CURR OPIN BIOTECH, V16, P28, DOI 10.1016/j.copbio.2004.11.002; Krude T, 1996, J CELL SCI, V109, P309; Kuipers MA, 2011, J CELL BIOL, V192, P29, DOI 10.1083/jcb.201007111; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lygerou Z, 2000, SCIENCE, V290, P2271; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; McIntosh D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012955; McNairn AJ, 2005, EXP CELL RES, V308, P345, DOI 10.1016/j.yexcr.2005.05.009; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pefani DE, 2011, J BIOL CHEM, V286, P23234, DOI 10.1074/jbc.M110.207688; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rowles A, 1999, J CELL SCI, V112, P2011; Siddiqui K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012930; Somanathan S, 2001, J CELL BIOCHEM, V81, P56, DOI 10.1002/1097-4644(20010401)81:1<56::AID-JCB1023>3.0.CO;2-#; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Symeonidou IE, 2012, FEBS LETT, V586, P2803, DOI 10.1016/j.febslet.2012.07.042; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Xouri G, 2007, CELL CYCLE, V6, P1549, DOI 10.4161/cc.6.13.4455	68	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35852	35867		10.1074/jbc.M113.474825	http://dx.doi.org/10.1074/jbc.M113.474825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158436	Green Published, hybrid			2022-12-28	WOS:000329814700022
J	Hyde, AS; Thelen, AM; Barycki, JJ; Simpson, MA				Hyde, Annastasia S.; Thelen, Ashley M.; Barycki, Joseph J.; Simpson, Melanie A.			UDP-glucose Dehydrogenase Activity and Optimal Downstream Cellular Function Require Dynamic Reorganization at the Dimer-Dimer Subunit Interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dehydrogenase; Enzyme Catalysis; Glycobiology; Hyaluronate; Prostate Cancer; Protein Conformation; Protein Dynamics; Cardiac Defects; Human UGDH; Hyaluronan	URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; SITES REACTIVITY; LIVER; MECHANISM; 6-DEHYDROGENASE; BINDING; HYALURONAN; EXPRESSION; STABILITY; RESIDUES	Background: UDP-glucose dehydrogenase (UGDH) mutants were engineered to perturb hexamer:dimer quaternary structure equilibrium. Results: Dimeric species of UGDH have reduced activity in vitro and in supporting hyaluronan production by cultured cells. Conclusion: Only dynamic UGDH hexamers support robust cellular function. Significance: Manipulation of UGDH activity by hexamer stabilization may offer new therapeutic options in cancer and other pathologies. UDP-glucose dehydrogenase (UGDH) provides precursors for steroid elimination, hyaluronan production, and glycosaminoglycan synthesis. The wild-type UGDH enzyme purifies in a hexamer-dimer equilibrium and transiently undergoes dynamic motion that exposes the dimer-dimer interface during catalysis. In the current study we created and characterized point mutations that yielded exclusively dimeric species (obligate dimer, T325D), dimeric species that could be induced to form hexamers in the ternary complex with substrate and cofactor (T325A), and a previously described exclusively hexameric species (UGDH132) to investigate the role of quaternary structure in regulation of the enzyme. Characterization of the purified enzymes revealed a significant decrease in the enzymatic activity of the obligate dimer and hexamer mutants. Kinetic analysis of wild-type UGDH and the inducible hexamer, T325A, showed that upon increasing enzyme concentration, which favors the hexameric species, activity was modestly decreased and exhibited cooperativity. In contrast, cooperative kinetic behavior was not observed in the obligate dimer, T325D. These observations suggest that the regulation of the quaternary assembly of the enzyme is essential for optimal activity and allosteric regulation. Comparison of kinetic and thermal stability parameters revealed structurally dependent properties consistent with a role for controlled assembly and disassembly of the hexamer in the regulation of UGDH. Finally, both T325A and T325D mutants were significantly less efficient in promoting downstream hyaluronan production by HEK293 cells. These data support a model that requires an operational dimer-hexamer equilibrium to function efficiently and preserve regulated activity in the cell.	[Hyde, Annastasia S.; Thelen, Ashley M.; Barycki, Joseph J.; Simpson, Melanie A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Barycki, JJ (corresponding author), Univ Nebraska, Dept Biochem, N114 Beadle Ctr, Lincoln, NE 68588 USA.	jbarycki2@unl.edu; msimpson2@unl.edu			NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL CANCER INSTITUTE [R01CA165574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103489, P41GM103311, R01GM077289] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Chimera was supported by NIGMS, National Institutes of Health Grant P41-GM103311 (to the University of California at San Francisco).	Campbell RE, 1997, J BIOL CHEM, V272, P3416, DOI 10.1074/jbc.272.6.3416; Campbell RE, 1999, J ORG CHEM, V64, P9487, DOI 10.1021/jo991092h; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; Easley KE, 2007, BIOCHEMISTRY-US, V46, P369, DOI 10.1021/bi061537d; ECCLESTON ED, 1979, J BIOL CHEM, V254, P1399; Egger S, 2012, J BIOL CHEM, V287, P2119, DOI 10.1074/jbc.M111.313015; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; FRANZEN JS, 1983, BIOCHIM BIOPHYS ACTA, V746, P146, DOI 10.1016/0167-4838(83)90068-7; FRANZEN JS, 1973, BIOCHEM BIOPH RES CO, V50, P517, DOI 10.1016/0006-291X(73)90870-X; FRANZEN JS, 1980, BIOCHIM BIOPHYS ACTA, V614, P242, DOI 10.1016/0005-2744(80)90214-4; FRANZEN JS, 1980, BIOCHEMISTRY-US, V19, P6080, DOI 10.1021/bi00567a021; FRANZEN JS, 1976, BIOCHEMISTRY-US, V15, P5665, DOI 10.1021/bi00670a036; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ge X, 2004, EUR J BIOCHEM, V271, P14, DOI 10.1046/j.1432-1033.2003.03876.x; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Hyde AS, 2012, J BIOL CHEM, V287, P32708, DOI 10.1074/jbc.M112.395202; Kadirvelraj R, 2013, BIOCHEMISTRY-US, V52, P1456, DOI 10.1021/bi301593c; Kadirvelraj R, 2011, BIOCHEMISTRY-US, V50, P5780, DOI 10.1021/bi2005637; Nelsestuen G L, 1971, J Biol Chem, V246, P3824; ORDMAN AB, 1977, J BIOL CHEM, V252, P1320; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prydz K, 2000, J CELL SCI, V113, P193; SCHILLER JG, 1972, CARBOHYD RES, V25, P403, DOI 10.1016/S0008-6215(00)81651-1; Sennett NC, 2012, BIOCHEMISTRY-US, V51, P9364, DOI 10.1021/bi301067w; Sennett NC, 2011, BIOCHEMISTRY-US, V50, P9651, DOI 10.1021/bi201381e; Sommer BJ, 2004, J BIOL CHEM, V279, P23590, DOI 10.1074/jbc.M401928200; Spicer AP, 1998, J BIOL CHEM, V273, P25117, DOI 10.1074/jbc.273.39.25117; Stewart DC, 1998, PLANT PHYSIOL, V116, P349, DOI 10.1104/pp.116.1.349; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Turner W, 2002, ARCH BIOCHEM BIOPHYS, V407, P209, DOI 10.1016/S0003-9861(02)00500-3; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Wei Q, 2009, CANCER RES, V69, P2332, DOI 10.1158/0008-5472.CAN-08-3083	34	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35049	35057		10.1074/jbc.M113.519090	http://dx.doi.org/10.1074/jbc.M113.519090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145036	Green Published, hybrid			2022-12-28	WOS:000329867600007
J	Wertheimer, E; Krapf, D; de la Vega-Beltran, JL; Sanchez-Cardenas, C; Navarrete, F; Haddad, D; Escoffier, J; Salicioni, AM; Levin, LR; Buck, J; Mager, J; Darszon, A; Visconti, PE				Wertheimer, Eva; Krapf, Dario; de la Vega-Beltran, Jose L.; Sanchez-Cardenas, Claudia; Navarrete, Felipe; Haddad, Douglas; Escoffier, Jessica; Salicioni, Ana M.; Levin, Lonny R.; Buck, Jochen; Mager, Jesse; Darszon, Alberto; Visconti, Pablo E.			Compartmentalization of Distinct cAMP Signaling Pathways in Mammalian Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Calcium Imaging; Cell Signaling; Cyclic AMP (cAMP); Heterotrimeric G Proteins; Protein Kinase A (PKA); Signal Transduction; Acrosome Reaction; Forskolin; Sperm Capacitation	SOLUBLE ADENYLYL-CYCLASE; CYCLIC ADENINE RIBONUCLEOTIDE; MOUSE SPERM; G-PROTEINS; TYROSINE PHOSPHORYLATION; REGULATORY PROTEIN; HUMAN SPERMATOZOA; TISSUE PARTICLES; PERTUSSIS TOXIN; CATSPER CHANNEL	Fertilization competence is acquired in the female tract in a process known as capacitation. Capacitation is needed for the activation of motility (e.g. hyperactivation) and to prepare the sperm for an exocytotic process known as acrosome reaction. Although the HCO3--dependent soluble adenylyl cyclase Adcy10 plays a role in motility, less is known about the source of cAMP in the sperm head. Transmembrane adenylyl cyclases (tmACs) are another possible source of cAMP. These enzymes are regulated by stimulatory heterotrimeric G(s) proteins; however, the presence of G(s) or tmACs in mammalian sperm has been controversial. In this study, we used Western blotting and cholera toxin-dependent ADP-ribosylation to show the G(s) presence in the sperm head. Also, we showed that forskolin, a tmAC-specific activator, induces cAMP accumulation in sperm from both WT and Adcy10-null mice. This increase is blocked by the tmAC inhibitor SQ22536 but not by the Adcy10 inhibitor KH7. Although G(s) immunoreactivity and tmAC activity are detected in the sperm head, PKA is only found in the tail, where Adcy10 was previously shown to reside. Consistent with an acrosomal localization, G(s) reactivity is lost in acrosome-reacted sperm, and forskolin is able to increase intracellular Ca2+ and induce the acrosome reaction. Altogether, these data suggest that cAMP pathways are compartmentalized in sperm, with G(s) and tmAC in the head and Adcy10 and PKA in the flagellum.	[Wertheimer, Eva; Krapf, Dario; Navarrete, Felipe; Haddad, Douglas; Escoffier, Jessica; Salicioni, Ana M.; Mager, Jesse; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Wertheimer, Eva] Univ Buenos Aires, Ctr Estudios Farmacol & Bot, Fac Med, Consejo Nacl Invest Cient & Tecn, RA-1053 Buenos Aires, DF, Argentina; [Krapf, Dario] Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut, Inst Biol Celular & Mol Rosario, RA-2000 Rosario, Santa Fe, Argentina; [de la Vega-Beltran, Jose L.; Sanchez-Cardenas, Claudia; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Levin, Lonny R.; Buck, Jochen] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA	University of Massachusetts System; University of Massachusetts Amherst; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universidad Nacional Autonoma de Mexico; Cornell University	Darszon, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico.	darszon@ibt.unam.mx; pvisconti@vasci.umass.edu	Salicioni, Ana Maria/ABD-8384-2021; Escoffier, jessica/E-9498-2017; Escoffier, jessica/T-9857-2019; Levin, Lonny R/A-7215-2011	Salicioni, Ana Maria/0000-0002-8951-3587; Escoffier, jessica/0000-0001-8166-5845; Levin, Lonny/0000-0002-5204-6356; Darszon, Alberto/0000-0002-2502-0505; Krapf, Dario/0000-0001-7607-1954	National Institutes of Health [HD38082, HD44044, HD059913, GM62328]; CONACyT-Mexico Grant [49113]; DGAPA/UNAM Grants [IN211809, IN225406]; PICT-ANPCyT-Argentina Grant [2011-0540]; National Council of Science and Technology [2012-2263]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082, R01HD059913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT-Mexico Grant; DGAPA/UNAM Grants; PICT-ANPCyT-Argentina Grant; National Council of Science and Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD38082 and HD44044 (to P. E. V.) and Grants HD059913 and GM62328 (to J. B. and L R. L). This work was also supported by CONACyT-Mexico Grant 49113 (to A. D.), DGAPA/UNAM Grants IN211809 and IN225406 (to A. D.), PICT-ANPCyT-Argentina Grant 2011-0540 (to D. K.), and Postdoctoral Fellowship 2012-2263 from the National Council of Science and Technology (to E. W.). Drs. Levin and Buck own equity interest in CEP Biotech, which has licensed commercialization of a panel of monoclonal antibodies directed against sAC.	AITKEN RJ, 1986, J REPROD FERTIL, V78, P515; Alfano M, 2005, CURR PHARM DESIGN, V11, P2909, DOI 10.2174/1381612054546725; Bailey JL, 2010, SYST BIOL REPROD MED, V56, P334, DOI 10.3109/19396368.2010.512377; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baker MA, 2013, PROTEOMICS, V13, P61, DOI 10.1002/pmic.201200350; Battistone MA, 2013, MOL HUM REPROD, V19, P570, DOI 10.1093/molehr/gat033; Baxendale RW, 2003, MOL REPROD DEV, V66, P181, DOI 10.1002/mrd.10344; Baxendale RW, 2003, MOL REPROD DEV, V65, P104, DOI 10.1002/mrd.10295; BENTLEY JK, 1986, BIOCHEM BIOPH RES CO, V138, P728, DOI 10.1016/S0006-291X(86)80557-5; Bitterman J. L., 2013, J PHARM EXP THER, DOI 10.1124/jpet.113.208496; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; Brenker C, 2012, EMBO J, V31, P1654, DOI 10.1038/emboj.2012.30; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; CHENG CY, 1979, BIOCHEM BIOPH RES CO, V91, P1, DOI 10.1016/0006-291X(79)90574-6; DALY JW, 1984, ADV CYCLIC NUCL PROT, V17, P81; Duan BY, 2010, J IMMUNOL, V185, P335, DOI 10.4049/jimmunol.0903474; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; FORTE LR, 1983, MOL PHARMACOL, V24, P42; FRASER LR, 1993, J REPROD FERTIL, V98, P187; Fraser LR, 1999, BIOESSAYS, V21, P304, DOI 10.1002/(SICI)1521-1878(199904)21:4<304::AID-BIES6>3.0.CO;2-H; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; HANSKI E, 1983, FEBS LETT, V162, P447, DOI 10.1016/0014-5793(83)80805-9; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Helsel DR, 2006, CHEMOSPHERE, V65, P2434, DOI 10.1016/j.chemosphere.2006.04.051; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HILDEBRANDT JD, 1985, ENDOCRINOLOGY, V116, P1357, DOI 10.1210/endo-116-4-1357; Huston E, 2006, BIOCHEM SOC T, V34, P504, DOI 10.1042/BST0340504; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; KALAB P, 1994, J BIOL CHEM, V269, P3810; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; KEHLENBACH RH, 1994, NATURE, V372, P804; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Kim M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002084; KOPF GS, 1986, J BIOL CHEM, V261, P7327; Leclerc P, 1999, J ANDROL, V20, P126; LECLERC P, 1995, BIOL REPROD, V52, P1227, DOI 10.1095/biolreprod52.6.1227; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Lynch MJ, 2006, CURR TOP DEV BIOL, V75, P225, DOI 10.1016/S0070-2153(06)75007-4; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Merlet F, 1999, MOL HUM REPROD, V5, P38, DOI 10.1093/molehr/5.1.38; METZGER H, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1248; MONKS NJ, 1986, INT J ANDROL, V9, P67, DOI 10.1111/j.1365-2605.1986.tb00868.x; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; RALL TW, 1958, J BIOL CHEM, V232, P1065; ROBISHAW JD, 1986, J BIOL CHEM, V261, P9587; ROJAS FJ, 1992, HUM REPROD, V7, P1126, DOI 10.1093/oxfordjournals.humrep.a137806; SEAMON K, 1981, J BIOL CHEM, V256, P9799; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; Tresguerres M, 2011, KIDNEY INT, V79, P1277, DOI 10.1038/ki.2011.95; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 1998, J ANDROL, V19, P242; Wang D, 2007, P NATL ACAD SCI USA, V104, P9325, DOI 10.1073/pnas.0611296104; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; ZIGMAN JM, 1993, ENDOCRINOLOGY, V133, P2508, DOI 10.1210/en.133.6.2508	74	76	76	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35307	35320		10.1074/jbc.M113.489476	http://dx.doi.org/10.1074/jbc.M113.489476			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24129574	Green Published, hybrid			2022-12-28	WOS:000329867600029
J	Cook, KM; McNeil, HP; Hogg, PJ				Cook, Kristina M.; McNeil, H. Patrick; Hogg, Philip J.			Allosteric Control of beta 11-Tryptase by a Redox Active Disulfide Bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Disulfide; Mast Cell; Redox Regulation; Serine Protease	MAST-CELL TRYPTASE; HUMAN BETA-TRYPTASE; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; AIRWAY ACIDIFICATION; PROTEASE INHIBITORS; LAVAGE FLUID; INTERNAL-PH; THIOREDOXIN; TETRAMER	Background: The S1A serine proteases function in many biological processes and contain a conserved disulfide bond near the active site. Results: This disulfide in the S1A mast cell protease, II-tryptase, exists in oxidized and reduced states in the enzyme, which influences the specificity and efficiency of the enzyme. Conclusion: II-Tryptase is regulated by an allosteric disulfide bond. Significance: Other S1A proteases are likely similarly regulated. The S1A serine proteases function in many key biological processes such as development, immunity, and blood coagulation. S1A proteases contain a highly conserved disulfide bond (Cys(191)-Cys(220) in chymotrypsin numbering) that links two -loop structures that define the rim of the active site pocket. Mast cell II-tryptase is a S1A protease that is associated with pathological inflammation. In this study, we have found that the conserved disulfide bond (Cys(220)-Cys(248) in II-tryptase) exists in oxidized and reduced states in the enzyme stored and secreted by mast cells. The disulfide bond has a standard redox potential of -301 mV and is stoichiometrically reduced by the inflammatory mediator, thioredoxin, with a rate constant of 350 m(-1) s(-1). The oxidized and reduced enzymes have different substrate specificity and catalytic efficiency for hydrolysis of both small and macromolecular substrates. These observations indicate that II-tryptase activity is post-translationally regulated by an allosteric disulfide bond. It is likely that other S1A serine proteases are similarly regulated.	[Cook, Kristina M.; Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Cook, Kristina M.; Hogg, Philip J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [McNeil, H. Patrick] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Cook, Kristina/B-8012-2008	McNeil, Hugh Patrick/0000-0003-4336-2960; Cook, Kristina/0000-0002-0503-7166; Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council; New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by grants from the National Health and Medical Research Council. Mass spectrometric analysis for this work was carried out at the Bioanalytical Mass Spectrometry Facility, University of New South Wales and was supported in part by infrastructure funding from the New South Wales Government as part of its co-investment in the National Collaborative Research Infrastructure Strategy.	ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; Buckley MG, 1997, CLIN SCI, V93, P363, DOI 10.1042/cs0930363; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Cairns JA, 2005, PULM PHARMACOL THER, V18, P55, DOI 10.1016/j.pupt.2004.09.032; CASTELLS M, 1988, J ALLERGY CLIN IMMUN, V82, P348, DOI 10.1016/0091-6749(88)90005-X; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Fajardo I, 2003, BIOCHEM J, V369, P603, DOI 10.1042/BJ20021418; FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99; Fiorucci L, 2004, CELL MOL LIFE SCI, V61, P1278, DOI 10.1007/s00018-004-3400-0; Fukuoka Y, 2004, BIOCHEMISTRY-US, V43, P10757, DOI 10.1021/bi049486c; Fukuoka Y, 2006, J IMMUNOL, V176, P3165, DOI 10.4049/jimmunol.176.5.3165; Ganderton T, 2011, BLOOD, V118, P5312, DOI 10.1182/blood-2011-06-360297; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; GEBOREK P, 1989, J RHEUMATOL, V16, P468; Hallgren J, 2005, J MOL BIOL, V345, P129, DOI 10.1016/j.jmb.2004.10.029; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Huang CF, 1998, J IMMUNOL, V160, P1910; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; JARJOUR NN, 1991, AM REV RESPIR DIS, V144, P83, DOI 10.1164/ajrccm/144.1.83; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Jikimoto T, 2002, MOL IMMUNOL, V38, P765, DOI 10.1016/S0161-5890(01)00113-4; JOHNSON RG, 1980, FEBS LETT, V120, P75, DOI 10.1016/0014-5793(80)81050-7; Kodric M, 2007, AM J RESP CRIT CARE, V175, P905, DOI 10.1164/rccm.200607-940OC; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; LAGUNOFF D, 1983, EXP CELL RES, V144, P353, DOI 10.1016/0014-4827(83)90414-7; Lemarechal H, 2006, CLIN CHIM ACTA, V367, P156, DOI 10.1016/j.cca.2005.12.006; Liang GY, 2012, BIOORG MED CHEM LETT, V22, P1606, DOI 10.1016/j.bmcl.2011.12.127; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; McNeil HP, 2008, ARTHRITIS RHEUM-US, V58, P2338, DOI 10.1002/art.23639; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; MIYATA T, 1989, P NATL ACAD SCI USA, V86, P8319, DOI 10.1073/pnas.86.21.8319; NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ren S, 1997, J IMMUNOL, V159, P3540; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; Schwertassek U., 2007, SCI STKE, V2007, pl8; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Selwood T, 2002, BIOCHEMISTRY-US, V41, P3329, DOI 10.1021/bi015662v; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Torchinski M., 1974, THIOL DISULFIDE GROU; Trivedi NN, 2009, J ALLERGY CLIN IMMUN, V124, P1099, DOI 10.1016/j.jaci.2009.07.026; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Varallyay V, 1997, BIOCHEM BIOPH RES CO, V230, P592, DOI 10.1006/bbrc.1996.6009; Wang ECW, 1997, PROTEIN ENG, V10, P405, DOI 10.1093/protein/10.4.405; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yamada Y, 2003, IMMUNOL LETT, V86, P199, DOI 10.1016/S0165-2478(03)00006-3; Yousef GM, 2004, BBA-PROTEINS PROTEOM, V1698, P77, DOI 10.1016/j.bbapap.2003.10.008	62	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34920	34929		10.1074/jbc.M113.523506	http://dx.doi.org/10.1074/jbc.M113.523506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142694	hybrid, Green Published			2022-12-28	WOS:000329812800058
J	Sembongi, H; Miranda, M; Han, GS; Fakas, S; Grimsey, N; Vendrell, J; Carman, GM; Siniossoglou, S				Sembongi, Hiroshi; Miranda, Merce; Han, Gil-Soo; Fakas, Stylianos; Grimsey, Neil; Vendrell, Joan; Carman, George M.; Siniossoglou, Symeon			Distinct Roles of the Phosphatidate Phosphatases Lipin 1 and 2 during Adipogenesis and Lipid Droplet Biogenesis in 3T3-L1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Lipids; Mouse; Phosphatase; Phosphatidate; Triacylglycerol; Lipin	ACTIVATED RECEPTOR-GAMMA; SUBCELLULAR-LOCALIZATION; EXPRESSION; PROTEIN; ACID; TRIACYLGLYCEROL; LIPODYSTROPHY; MAINTENANCE; ADIPOCYTES; ISOFORMS	Background: Lipins are phosphatidate phosphatases that generate diacylglycerol for lipid synthesis. Results: Lipin 1 or lipin 2 depletion has distinct effects on differentiating adipocytes. Cells depleted of both lipins after initiation of adipogenesis accumulate triacylglycerol but display lipid droplet fragmentation. Conclusion: Lipins have a role in lipid droplet biogenesis after initiation of adipogenesis. Significance: Lipins play multiple roles during adipocyte differentiation. Lipins are evolutionarily conserved Mg2+-dependent phosphatidate phosphatase (PAP) enzymes with essential roles in lipid biosynthesis. Mammals express three paralogues: lipins 1, 2, and 3. Loss of lipin 1 in mice inhibits adipogenesis at an early stage of differentiation and results in a lipodystrophic phenotype. The role of lipins at later stages of adipogenesis, when cells initiate the formation of lipid droplets, is less well characterized. We found that depletion of lipin 1, after the initiation of differentiation in 3T3-L1 cells but before the loading of lipid droplets with triacylglycerol, results in a reciprocal increase of lipin 2, but not lipin 3. We generated 3T3-L1 cells where total lipin protein and PAP activity levels are down-regulated by the combined depletion of lipins 1 and 2 at day 4 of differentiation. These cells still accumulated triacylglycerol but displayed a striking fragmentation of lipid droplets without significantly affecting their total volume per cell. This was due to the lack of the PAP activity of lipin 1 in adipocytes after day 4 of differentiation, whereas depletion of lipin 2 led to an increase of lipid droplet volume per cell. We propose that in addition to their roles during early adipogenesis, lipins also have a role in lipid droplet biogenesis.	[Sembongi, Hiroshi; Grimsey, Neil; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Miranda, Merce; Vendrell, Joan] Univ Rovira & Virgili, Hosp Univ Joan 23, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Inst Invest Pere Virgili, E-43007 Tarragona, Spain; [Han, Gil-Soo; Fakas, Stylianos; Carman, George M.] Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Fakas, Stylianos; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Siniossoglou, S (corresponding author), Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	ss560@cam.ac.uk	Vendrell, Joan j/V-4034-2018; Grimsey, Neil/B-1634-2015; Fakas, Stylianos/AAQ-7594-2020; miranda, merce/H-7467-2017; Fakas, Stylianos/R-9908-2019; Grimsey, Neil/AAB-9153-2020	Vendrell, Joan j/0000-0002-6994-6115; Grimsey, Neil/0000-0002-0481-4920; Fakas, Stylianos/0000-0001-8692-1326; miranda, merce/0000-0001-6214-1042; Fakas, Stylianos/0000-0001-8692-1326; Grimsey, Neil/0000-0002-0481-4920	National Institutes of Health [GM-28140]; Medical Research Council [G0701446]; Instituto de Salud Carlos III; European Regional Development Fund [PI10/00967, CP11/00021, PI11/00085]; MRC [G0701446] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.). This work was also supported by Medical Research Council Grant G0701446 (to S. S.), funds from the Instituto de Salud Carlos III, and European Regional Development Fund Grants PI10/00967 and CP11/00021 (to M. M.) and PI11/00085 (to J. V.).	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Dwyer JR, 2012, P NATL ACAD SCI USA, V109, pE2486, DOI 10.1073/pnas.1205221109; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Haller JF, 2011, BBA-MOL BASIS DIS, V1812, P1393, DOI 10.1016/j.bbadis.2011.07.007; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Mylonis I, 2012, J CELL SCI, V125, P3485, DOI 10.1242/jcs.106682; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Stapleton CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018932; Swift S., 1999, CURRENT PROTOCOL S31; Valdearcos M, 2011, J IMMUNOL, V186, P6004, DOI 10.4049/jimmunol.1003279; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang HJ, 2011, FEBS LETT, V585, P1979, DOI 10.1016/j.febslet.2011.05.035; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012; Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681	40	35	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34502	34513		10.1074/jbc.M113.488445	http://dx.doi.org/10.1074/jbc.M113.488445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133206	Green Published, hybrid			2022-12-28	WOS:000329812800020
J	Shi, N; Chen, SY				Shi, Ning; Chen, Shi-You			Cell Division Cycle 7 Mediates Transforming Growth Factor-beta-induced Smooth Muscle Maturation through Activation of Myocardin Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Gene Regulation; Gene Transcription; Smooth Muscle; Transforming Growth Factor- (TGF-); Cell Division Cycle 7; Smooth Muscle Maturation	SERUM RESPONSE FACTOR; TGF-BETA; 10T1/2 CELLS; DIFFERENTIATION; EXPRESSION; REGULATOR; MARKER; PATHOGENESIS; SUFFICIENT; MODULATION	Background: Cell division cycle 7 (Cdc7) plays a role in cell fate determination in the early stage of smooth muscle (SM) differentiation. Results: Cdc7 activated myocardin gene transcription by interacting with Nkx2.5, leading to the induction of a mature SM marker smooth muscle myosin heavy chain (SMMHC). Conclusion: Cdc7 regulates SM maturation by activation of myocardin expression. Significance: Cdc7 regulates SM differentiation and maturation through different mechanisms. Smooth muscle (SM) development consists of several processes, including cell fate determination, differentiation, and maturation. The molecular mechanisms controlling SM early differentiation have been studied extensively. However, little is known about the mechanism underlying SM maturation. Cell division cycle 7 (Cdc7) has been shown to regulate cell fate determination in the initial phase of transforming growth factor- (TGF-)-induced SM differentiation. Our present study indicates that Cdc7 also regulates SM maturation. Knockdown of Cdc7 suppresses TGF--induced expression of SM myosin heavy chain, a late marker of SM differentiation. Cdc7 overexpression, on the other hand, enhances SM myosin heavy chain expression. Interestingly, Cdc7 activates the mRNA expression and promoter activity of myocardin (Myocd), a master regulator of SM differentiation, whose transcription is blocked in the initial phase of the differentiation because TGF- does not induce Myocd mRNA until after the early SM markers are induced. These data suggest that Cdc7 mediates TGF--induced SM maturation via activation of Myocd transcription. Mechanistically, Cdc7 physically and functionally interacts with Nkx2.5 to regulate Myocd promoter activity. Cdc7 appears to enhance Nkx2.5 binding to Myocd promoter, leading to Myocd activation. Taken together, our studies demonstrate that Cdc7 regulates the initial and late phase of SM differentiation through distinct mechanisms.	[Shi, Ning; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Shi, Ning/I-5631-2015		National Institutes of Health [HL093429, HL107526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093429, R01HL107526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL093429 and HL107526 (to S.-Y.C.).	AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Briones VR, 2006, BIOCHEM BIOPH RES CO, V345, P595, DOI 10.1016/j.bbrc.2006.04.052; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; GLUKHOVA MA, 1988, P NATL ACAD SCI USA, V85, P9542, DOI 10.1073/pnas.85.24.9542; Guo Xia, 2012, World J Biol Chem, V3, P41, DOI 10.4331/wjbc.v3.i3.41; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoofnagle MH, 2011, AM J PHYSIOL-HEART C, V300, pH1707, DOI 10.1152/ajpheart.01192.2010; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Ko YS, 1999, ARTERIOSCL THROM VAS, V19, P1669, DOI 10.1161/01.ATV.19.7.1669; KOCHER O, 1991, LAB INVEST, V65, P459; KOCHER O, 1986, HUM PATHOL, V17, P875, DOI 10.1016/S0046-8177(86)80637-2; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; MIANO JM, 1994, CIRC RES, V75, P803, DOI 10.1161/01.RES.75.5.803; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Raphel L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044052; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Yao YC, 2007, CARDIOVASC RES, V74, P279, DOI 10.1016/j.cardiores.2006.09.014; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	40	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34336	34342		10.1074/jbc.M113.498238	http://dx.doi.org/10.1074/jbc.M113.498238			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133205	Green Published, hybrid			2022-12-28	WOS:000329812800005
J	Tsou, WL; Burr, AA; Ouyang, M; Blount, JR; Scaglione, KM; Todi, SV				Tsou, Wei-Ling; Burr, Aaron A.; Ouyang, Michelle; Blount, Jessica R.; Scaglione, K. Matthew; Todi, Sokol V.			Ubiquitination Regulates the Neuroprotective Function of the Deubiquitinase Ataxin-3 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Drosophila; Neurodegeneration; Polyglutamine Disease; Protease; Ubiquitin; Machado-Joseph Disease; Neuroprotection; Ataxin-3	POLYGLUTAMINE DISEASE PROTEIN; SMALL-MOLECULE INHIBITOR; CELLULAR FUNCTIONS; MYOSIN-VIIA; NEURODEGENERATION; ENZYME; LOCALIZATION; SUPPRESSION; PROTEOLYSIS; DROSOPHILA	Background: Ubiquitination of ataxin-3 enhances its DUB activity in vitro, but it is unknown whether it controls its function in intact organisms. Results: Ubiquitination at lysine 117 regulates the neuroprotective function of ataxin-3 in Drosophila.Conclusion: Ataxin-3 ubiquitination is a critical regulator of its in vivo functions. Significance: Ubiquitination may constitute a general regulatory mechanism of DUB activities in vivo. Deubiquitinases (DUBs) are proteases that regulate various cellular processes by controlling protein ubiquitination. Cell-based studies indicate that the regulation of the activity of DUBs is important for homeostasis and is achieved by multiple mechanisms, including through their own ubiquitination. However, the physiological significance of the ubiquitination of DUBs to their functions in vivo is unclear. Here, we report that ubiquitination of the DUB ataxin-3 at lysine residue 117, which markedly enhances its protease activity in vitro, is critical for its ability to suppress toxic protein-dependent degeneration in Drosophila melanogaster. Compared with ataxin-3 with only Lys-117 present, ataxin-3 that does not become ubiquitinated performs significantly less efficiently in suppressing or delaying the onset of toxic protein-dependent degeneration in flies. According to further studies, the C terminus of Hsc70-interacting protein (CHIP), an E3 ubiquitin ligase that ubiquitinates ataxin-3 in vitro, is dispensable for its ubiquitination in vivo and is not required for the neuroprotective function of this DUB in Drosophila. Our work also suggests that ataxin-3 suppresses degeneration by regulating toxic protein aggregation rather than stability.	[Tsou, Wei-Ling; Burr, Aaron A.; Ouyang, Michelle; Blount, Jessica R.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Tsou, Wei-Ling; Burr, Aaron A.; Ouyang, Michelle; Blount, Jessica R.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Grad Program Canc Biol, Detroit, MI 48201 USA; [Scaglione, K. Matthew] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Scaglione, K. Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Wayne State University; Medical College of Wisconsin; Medical College of Wisconsin	Todi, SV (corresponding author), 540 E Canfield,Scott Hall Rm 3108, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Tsou, Wei-Ling/AAI-2655-2021	Tsou, Wei-Ling/0000-0001-9136-2581; TODI, SOKOL/0000-0003-4399-5549; Scaglione, Kenneth/0000-0002-3858-9418	National Institutes of Health from the NINDS [R00NS064097, NS073936]; NCI [T32-CA009531]; National Ataxia Foundation; NATIONAL CANCER INSTITUTE [T32CA009531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS073936, R00NS064097, R00NS073936] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Ataxia Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00NS064097 (to S. V. T.) and NS073936 (to K. M. S.) from the NINDS and an NCI T32-CA009531 slot (to A. A. B.). This work was also supported by awards from the National Ataxia Foundation (to W.-L.T. and S.V.T.).	Berke SJS, 2004, J NEUROCHEM, V89, P908, DOI 10.1111/j.1471-4159.2004.02369.x; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Cemal CK, 2002, HUM MOL GENET, V11, P1075, DOI 10.1093/hmg/11.9.1075; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Franca Marcondes C Jr, 2012, Front Neurol, V3, P164, DOI 10.3389/fneur.2012.00164; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Hubener J, 2010, NEUROBIOL DIS, V38, P116, DOI 10.1016/j.nbd.2010.01.005; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; LANG AE, 1994, ANN NEUROL, V36, P443, DOI 10.1002/ana.410360318; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li LB, 2007, J BIOL CHEM, V282, P37694, DOI 10.1074/jbc.M705211200; McGurk L, 2012, HUM MOL GENET, V21, P76, DOI 10.1093/hmg/ddr439; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pozzi C, 2008, NEUROBIOL DIS, V30, P190, DOI 10.1016/j.nbd.2008.01.011; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Seki T, 2013, J BIOL CHEM, V288, P17145, DOI 10.1074/jbc.M113.463406; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Todi S., 2012, CLIN PHARM BIOPHARMA, V1; Todi S.V., 2007, MOL NEUROLOGY, P257; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Todi SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002115; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	43	33	34	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34460	34469		10.1074/jbc.M113.513903	http://dx.doi.org/10.1074/jbc.M113.513903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24106274	hybrid, Green Published			2022-12-28	WOS:000329812800016
J	Ziemba, A; Hill, S; Sandoval, D; Webb, K; Bennett, EJ; Kleiger, G				Ziemba, Amy; Hill, Spencer; Sandoval, Danielle; Webb, Kristofor; Bennett, Eric J.; Kleiger, Gary			Multimodal Mechanism of Action for the Cdc34 Acidic Loop A CASE STUDY FOR WHY UBIQUITIN-CONJUGATING ENZYMES HAVE LOOPS AND TAILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinetics; Ubiquitin-conjugating Enzyme (Ubc); Ubiquitin Ligase; Ubiquitination; Yeast Genetics	POLYUBIQUITIN CHAINS; S-TRANSITION; LIGASE; DOMAIN; UBC3; PHOSPHORYLATION; COMPLEX; LYSINE; SCF; RECOGNITION	Background: Ubiquitin-mediated proteolysis is the principal mechanism for regulating protein half-lives in cells. Results: Cdc34 promotes ubiquitin chain assembly onto protein substrates and contains an essential acidic loop near the active site. Conclusion: The Cdc34 acidic loop promotes both protein-protein interactions and catalysis of ubiquitin chain formation. Significance: These results uncover specific biochemical activities for the Cdc34 acidic loop. Together with ubiquitin ligases (E3), ubiquitin-conjugating enzymes (E2) are charged with the essential task of synthesizing ubiquitin chains onto protein substrates. Some 75% of the known E2s in the human proteome contain unique insertions in their primary sequences, yet it is largely unclear what effect these insertions impart on the ubiquitination reaction. Cdc34 is an important E2 with prominent roles in cell cycle regulation and signal transduction. The amino acid sequence of Cdc34 contains an insertion distal to the active site that is absent in most other E2s, yet this acidic loop (named for its four invariably conserved acidic residues) is critical for Cdc34 function both in vitro and in vivo. Here we have investigated how the acidic loop in human Cdc34 promotes ubiquitination, identifying two key molecular events during which the acidic loop exerts its influence. First, the acidic loop promotes the interaction between Cdc34 and its ubiquitin ligase partner, SCF. Second, two glutamic acid residues located on the distal side of the loop collaborate with an invariably conserved histidine on the proximal side of the loop to suppress the pK(a) of an ionizing species on ubiquitin or Cdc34 which greatly contributes to Cdc34 catalysis. These results demonstrate that insertions can guide E2s to their physiologically relevant ubiquitin ligases as well as provide essential modalities that promote catalysis.	[Ziemba, Amy; Hill, Spencer; Sandoval, Danielle; Kleiger, Gary] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA; [Webb, Kristofor; Bennett, Eric J.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California San Diego	Kleiger, G (corresponding author), Univ Nevada, Dept Chem, 4505 S Maryland Pkwy,Box 454003, Las Vegas, NV 89154 USA.	gary.kleiger@unlv.edu		Webb, Kristofor/0000-0001-8111-9756	National Institutes of Health from NCRR [5P20RR016464-11]; National Institutes of Health from NIGMS [8P20GM103440-11]; Ellison Medical Foundation; Sidney Kimmel Cancer Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	National Institutes of Health from NCRR; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ellison Medical Foundation(Lawrence Ellison Foundation); Sidney Kimmel Cancer Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5P20RR016464-11 from NCRR and 8P20GM103440-11 from NIGMS (to A.Z. and G.K.). This work was also supported by the Ellison Medical Foundation and the Sidney Kimmel Cancer Research Foundation (both to E.J.B.).	Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Coccetti P, 2008, CELL CYCLE, V7, P1391, DOI 10.4161/cc.7.10.5825; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Deshaies RJ, 2009, NATURE, V458, P709, DOI 10.1038/458709a; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Fersht A., 1985, ENZYME STRUCTURE MEC, P157; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Huang H., 2013, NAT CHEM BI IN PRESS; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ju T., PROTEINS, V78, P1291; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Li T, 2005, METHOD ENZYMOL, V398, P125, DOI 10.1016/S0076-6879(05)98012-9; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; LIU Y, 1995, MOL CELL BIOL, V15, P5635; Mathias N, 1998, J BIOL CHEM, V273, P4040, DOI 10.1074/jbc.273.7.4040; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Papaleo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040786; Papaleo E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002056; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; PITLUK ZW, 1995, MOL CELL BIOL, V15, P1210; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	49	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34882	34896		10.1074/jbc.M113.509190	http://dx.doi.org/10.1074/jbc.M113.509190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129577	Green Published, hybrid			2022-12-28	WOS:000329812800055
J	Artamonov, MV; Momotani, K; Stevenson, A; Trentham, DR; Derewenda, U; Derewenda, ZS; Read, PW; Gutkind, JS; Somlyo, AV				Artamonov, Mykhaylo V.; Momotani, Ko; Stevenson, Andra; Trentham, David R.; Derewenda, Urszula; Derewenda, Zygmunt S.; Read, Paul W.; Gutkind, J. Silvio; Somlyo, Avril V.			Agonist-induced Ca2+ Sensitization in Smooth Muscle REDUNDANCY OF RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS (RhoGEFs) AND RESPONSE KINETICS, A CAGED COMPOUND STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Guanine Nucleotide Exchange Factor (GEF); Rho; Signal Transduction; Smooth Muscle	HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; PDZ-RHOGEF; MYOSIN PHOSPHATASE; ANGIOTENSIN-II; ADENOSINE-TRIPHOSPHATE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; FLASH-PHOTOLYSIS; LIVING CELLS	Many agonists, acting through G-protein-coupled receptors and G subunits of the heterotrimeric G-proteins, induce contraction of smooth muscle through an increase of [Ca2+](i) as well as activation of the RhoA/RhoA-activated kinase pathway that amplifies the contractile force, a phenomenon known as Ca2+ sensitization. G(12/13) subunits are known to activate the regulator of G-protein signaling-like family of guanine nucleotide exchange factors (RhoGEFs), which includes PDZ-RhoGEF (PRG) and leukemia-associated RhoGEF (LARG). However, their contributions to Ca2+-sensitized force are not well understood. Using permeabilized blood vessels from PRG(-/-) mice and a new method to silence LARG in organ-cultured blood vessels, we show that both RhoGEFs are activated by the physiologically and pathophysiologically important thromboxane A(2) and endothelin-1 receptors. The co-activation is the result of direct and independent activation of both RhoGEFs as well as their co-recruitment due to heterodimerization. The isolated recombinant C-terminal domain of PRG, which is responsible for heterodimerization with LARG, strongly inhibited Ca2+-sensitized force. We used photolysis of caged phenylephrine, caged guanosine 5-O-(thiotriphosphate) (GTPS) in solution, and caged GTPS or caged GTP loaded on the RhoARhoGDI complex to show that the recruitment and activation of RhoGEFs is the cause of a significant time lag between the initial Ca2+ transient and phasic force components and the onset of Ca2+-sensitized force.	[Artamonov, Mykhaylo V.; Momotani, Ko; Derewenda, Urszula; Derewenda, Zygmunt S.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Artamonov, Mykhaylo V.; Momotani, Ko; Derewenda, Urszula; Derewenda, Zygmunt S.; Somlyo, Avril V.] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA 22908 USA; [Stevenson, Andra] Merck Res Labs, Dept Cardiovasc Dis, Kenilworth, NJ 07033 USA; [Trentham, David R.] Kings Coll London, Sch Biomed Sci, Randall Div Cell & Mol Biophys, London SE1 1UK, England; [Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	University of Virginia; University of Virginia; Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Somlyo, AV (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, POB 736, Charlottesville, VA 22903 USA.	avs5u@virginia.edu	Artamonov, Mykhaylo/AAD-3488-2021; Gutkind, J. Silvio/J-1201-2016	Artamonov, Mykhaylo/0000-0002-0848-2054; Gutkind, J. Silvio/0000-0002-5150-4482	National Institutes of Health [GM086457, R01DK088905]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086457 and R01DK088905.	Adjobo-Hermans MJW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-32; Aittaleb M, 2011, J BIOL CHEM, V286, P34448, DOI 10.1074/jbc.M111.273342; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cario-Toumaniantz C, 2012, AM J PHYSIOL-CELL PH, V302, pC1394, DOI 10.1152/ajpcell.00423.2011; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; CORRIE JET, 1992, J CHEM SOC PERK T 1, P1015, DOI 10.1039/p19920001015; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P605, DOI 10.1113/jphysiol.1984.sp015395; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hong F, 2011, ARCH BIOCHEM BIOPHYS, V510, P135, DOI 10.1016/j.abb.2011.04.018; HORIUTI K, 1989, J GEN PHYSIOL, V94, P769, DOI 10.1085/jgp.94.4.769; Ichikawa K, 1996, J BIOL CHEM, V271, P4733; Jaiswal M, 2013, J BIOL CHEM, V288, P4486, DOI 10.1074/jbc.M112.429746; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; Medina F, 2013, J BIOL CHEM, V288, P11325, DOI 10.1074/jbc.M113.450056; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Momotani K, 2012, TRENDS CARDIOVAS MED, V22, P122, DOI 10.1016/j.tcm.2012.07.007; Momotani K, 2011, CIRC RES, V109, P993, DOI 10.1161/CIRCRESAHA.111.248898; Neppl RL, 2009, J BIOL CHEM, V284, P6348, DOI 10.1074/jbc.M807040200; Oleksy A, 2006, J BIOL CHEM, V281, P32891, DOI 10.1074/jbc.M606220200; Pfreimer M, 2012, CELL SIGNAL, V24, P652, DOI 10.1016/j.cellsig.2011.10.014; Read PW, 2000, PROTEIN SCI, V9, P376; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SCHEIDIG AJ, 1995, J MOL BIOL, V253, P132, DOI 10.1006/jmbi.1995.0541; Shankaranarayanan A, 2010, CELL SIGNAL, V22, P1114, DOI 10.1016/j.cellsig.2010.03.006; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; SOMLYO AV, 1992, J BIOL CHEM, V267, P22316; SOMLYO AV, 1988, J GEN PHYSIOL, V91, P165, DOI 10.1085/jgp.91.2.165; WALKER JW, 1988, BIOPHYS J, V53, pA596; WALKER JW, 1993, BIOCHEMISTRY-US, V32, P1338, DOI 10.1021/bi00056a020; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wuertz CM, 2010, FASEB J, V24, P4865, DOI 10.1096/fj.10-155499; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09	49	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34030	34040		10.1074/jbc.M113.514596	http://dx.doi.org/10.1074/jbc.M113.514596			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106280	hybrid, Green Published			2022-12-28	WOS:000327250200044
J	Kim, S; Dangelmaier, C; Bhavanasi, D; Meng, S; Wang, H; Goldfinger, LE; Kunapuli, SP				Kim, Soochong; Dangelmaier, Carol; Bhavanasi, Dheeraj; Meng, Shu; Wang, Hong; Goldfinger, Lawrence E.; Kunapuli, Satya P.			RhoG Protein Regulates Glycoprotein VI-Fc Receptor gamma-Chain Complex-mediated Platelet Activation and Thrombus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Fc Receptors; Platelets; Rho GTPases; Thrombosis; Glycoprotein VI	EXCHANGE FACTOR TRIO; COLLAGEN RECEPTOR; TYROSINE PHOSPHORYLATION; PHOSPHOLIPASE C-GAMMA-2; ACTIN CYTOSKELETON; APOPTOTIC CELLS; SMALL GTPASES; KINASE SYK; T-CELLS; RAC	Background: RhoG is a ubiquitously expressed member of the Rho family of GTPases. Results: RhoG-deficient platelets display severely impaired GPVI-dependent platelet activation. Conclusion: RhoG plays an important role in GPVI-FcR complex-mediated platelet activation and thrombus formation. Significance: Our study enhances the understanding of the molecular mechanisms of GPVI-FcR complex activation. We investigated the mechanism of activation and functional role of a hitherto uncharacterized signaling molecule, RhoG, in platelets. We demonstrate for the first time the expression and activation of RhoG in platelets. Platelet aggregation, integrin IIb3 activation, and -granule and dense granule secretion in response to the glycoprotein VI (GPVI) agonists collagen-related peptide (CRP) and convulxin were significantly inhibited in RhoG-deficient platelets. In contrast, 2-MeSADP- and AYPGKF-induced platelet aggregation and secretion were minimally affected in RhoG-deficient platelets, indicating that the function of RhoG in platelets is GPVI-specific. CRP-induced phosphorylation of Syk, Akt, and ERK, but not SFK (Src family kinase), was significantly reduced in RhoG-deficient platelets. CRP-induced RhoG activation was consistently abolished by a pan-SFK inhibitor but not by Syk or PI3K inhibitors. Interestingly, unlike CRP, platelet aggregation and Syk phosphorylation induced by fucoidan, a CLEC-2 agonist, were unaffected in RhoG-deficient platelets. Finally, RhoG(-/-) mice had a significant delay in time to thrombotic occlusion in cremaster arterioles compared with wild-type littermates, indicating the important in vivo functional role of RhoG in platelets. Our data demonstrate that RhoG is expressed and activated in platelets, plays an important role in GPVI-Fc receptor -chain complex-mediated platelet activation, and is critical for thrombus formation in vivo.	[Kim, Soochong; Bhavanasi, Dheeraj; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Meng, Shu; Wang, Hong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Goldfinger, Lawrence E.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Kim, Soochong; Dangelmaier, Carol; Bhavanasi, Dheeraj; Meng, Shu; Wang, Hong; Goldfinger, Lawrence E.; Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Goldfinger, LE (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, 3420 N Broad St, Philadelphia, PA 19140 USA.	goldfinger@temple.edu; spk@temple.edu			National Institutes of Health [HL93231, HL118593]; American Heart Association [12SDG8980013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093231, R01HL093416, R01HL118593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL93231 and HL118593 (to S.P.K.). This work was also supported by American Heart Association Grant 12SDG8980013 (to S.K.).	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Daniel JL, 2010, J BIOL CHEM, V285, P17282, DOI 10.1074/jbc.M109.080200; DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Goggs R, 2013, J BIOL CHEM, V288, P34217, DOI 10.1074/jbc.M113.504100; Gratacap MP, 2001, J BIOL CHEM, V276, P47906, DOI 10.1074/jbc.M104442200; Ichinohe T, 1997, J BIOL CHEM, V272, P63; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Manne BK, 2013, J BIOL CHEM, V288, P7717, DOI 10.1074/jbc.M112.424473; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; Obergfell A, 2001, J BIOL CHEM, V276, P5916, DOI 10.1074/jbc.M010639200; Patel KN, 2008, ARTERIOSCL THROM VAS, V28, P2225, DOI 10.1161/ATVBAHA.108.175679; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Pearce AC, 2002, BLOOD, V100, P3561, DOI 10.1182/blood.V100.10.3561; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Pollitt AY, 2010, BLOOD, V115, P2938, DOI 10.1182/blood-2009-12-257212; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quek LS, 2000, BLOOD, V96, P4246; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Soulet C, 2001, FEBS LETT, V507, P253, DOI 10.1016/S0014-5793(01)02984-2; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Takaya N, 2005, J MOL CELL CARDIOL, V39, P856, DOI 10.1016/j.yjmcc.2005.07.006; van Rijssel J, 2012, CELL ADHES MIGR, V6, P482, DOI 10.4161/cam.21418; Vignal E, 2001, MOL CELL BIOL, V21, P8022, DOI 10.1128/MCB.21.23.8022-8034.2001; Vigorito E, 2003, ONCOGENE, V22, P330, DOI 10.1038/sj.onc.1206116; Vigorito E, 2004, MOL CELL BIOL, V24, P719, DOI 10.1128/MCB.24.2.719-729.2004; VINCENT S, 1992, MOL CELL BIOL, V12, P3138, DOI 10.1128/MCB.12.7.3138; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010	51	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34230	34238		10.1074/jbc.M113.504928	http://dx.doi.org/10.1074/jbc.M113.504928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106269	Green Published, hybrid			2022-12-28	WOS:000327250200065
J	Xing, BW; Wang, LM; Guo, DG; Huang, JY; Espenel, C; Kreitzer, G; Zhang, JJ; Guo, L; Huang, XY				Xing, Bowen; Wang, Limin; Guo, Dagang; Huang, Jianyun; Espenel, Cedric; Kreitzer, Geri; Zhang, J. Jillian; Guo, Lin; Huang, Xin-Yun			Atypical Protein Kinase C lambda Is Critical for Growth Factor Receptor-induced Dorsal Ruffle Turnover and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Migration; Cell Signaling; Growth Factors; Protein Kinase C (PKC); Signal Transduction; Growth Factor Receptor	ASYMMETRIC DIVISION; DROSOPHILA RIC-8; MITOTIC SPINDLE; EXCHANGE FACTOR; ACTIN; SYNEMBRYN; COMPLEX; DIFFERENTIATION; REORGANIZATION; LOCALIZATION	Background: Growth factors induce actin cytoskeletal reorganization and cell migration in fibroblast cells. Results: Genetic inactivation of aPKC in mouse embryonic fibroblast cells inhibits PDGF-induced dorsal ruffle turnover and cell migration. Conclusion: Our results demonstrate a critical role for aPKC in PDGF-induced dorsal ruffle turnover and cell migration. Significance: These data will advance our understanding of the regulation of cell morphology induced by growth factors. G(13), a member of the heterotrimeric G proteins, is critical for actin cytoskeletal reorganization and cell migration. Previously we have shown that G(13) is essential for both G protein-coupled receptor and receptor tyrosine kinase-induced actin cytoskeletal reorganization such as dynamic dorsal ruffle turnover and cell migration. Ric-8A, a non-receptor guanine nucleotide exchange factor for some heterotrimeric G proteins, is critical for coupling receptor tyrosine kinases to G(13). Here, we show that PDGF can induce phosphorylation of Ric-8A. Atypical protein kinase C (aPKC) is required for Ric-8A phosphorylation. Furthermore, aPKC is required for PDGF-induced dorsal ruffle turnover and cell migration as demonstrated by both down-regulation of aPKC protein levels in cells by RNA interference and by studies in aPKC knock-out cells. Moreover, phosphorylation of Ric-8A modulates its subcellular localization. Hence, aPKC is critical for PDGF-induced actin cytoskeletal reorganization and cell migration.	[Xing, Bowen; Wang, Limin; Guo, Lin] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Wang, Limin; Guo, Dagang; Huang, Jianyun; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA; [Espenel, Cedric; Kreitzer, Geri] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA	Wuhan University; Cornell University; Cornell University	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA.	xyhuang@med.cornell.edu	Wang, Limin/AAX-4273-2020	Wang, Limin/0000-0001-5998-2609; espenel, cedric/0000-0002-8246-2879	National Institutes of Health [HL91525, GM087575]; 111 Project of China [B06018]; National Science Foundation of China [31028015, 31221061]; Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China(Ministry of Education, China - 111 Project); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Irma T. Hirschl Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant HL91525 (to X.-Y. H.) and was supported in part by the 111 Project of China (B06018), the National Science Foundation of China (Grants 31028015 and 31221061) (to L. G.), and National Institutes of Health Grant GM087575 and the Irma T. Hirschl Trust (to G. K.).	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Dhanasekaran Danny N, 2006, Sci STKE, V2006, ppe31, DOI 10.1126/stke.3472006pe31; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gu JL, 2002, P NATL ACAD SCI USA, V99, P9352, DOI 10.1073/pnas.102291599; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2004, METHOD ENZYMOL, V390, P377; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Tonissoo T, 2006, BEHAV BRAIN RES, V167, P42, DOI 10.1016/j.bbr.2005.08.025; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Wang CH, 2012, STRUCTURE, V20, P791, DOI 10.1016/j.str.2012.02.022; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wang LM, 2011, J BIOL CHEM, V286, P31055, DOI 10.1074/jbc.M111.253427; WARN R, 1993, SYM SOC EXP BIOL, V47, P325; Wooten MW, 2000, MOL CELL BIOL, V20, P4494, DOI 10.1128/MCB.20.13.4494-4504.2000; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200	46	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32827	32836		10.1074/jbc.M113.489427	http://dx.doi.org/10.1074/jbc.M113.489427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092753	hybrid, Green Published			2022-12-28	WOS:000328841700002
J	Guo, Z; Hou, XM; Goody, RS; Itzen, A				Guo, Zhong; Hou, Xiaomin; Goody, Roger S.; Itzen, Aymelt			Intermediates in the Guanine Nucleotide Exchange Reaction of Rab8 Protein Catalyzed by Guanine Nucleotide Exchange Factors Rabin8 and GRAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Guanine Nucleotide Exchange Factor (GEF); Intracellular Trafficking; Rab Proteins; Small GTPases; Intracellular Trafficking	POLARIZED MEMBRANE-TRANSPORT; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; GTPASE; COMPLEX; ACTIVATION; LEGIONELLA; DOMAIN; GDP; REGULATOR	Small G-proteins of the Ras superfamily control the temporal and spatial coordination of intracellular signaling networks by acting as molecular on/off switches. Guanine nucleotide exchange factors (GEFs) regulate the activation of these G-proteins through catalytic replacement of GDP by GTP. During nucleotide exchange, three distinct substrateenzyme complexes occur: a ternary complex with GDP at the start of the reaction (G-proteinGEFGDP), an intermediary nucleotide-free binary complex (G-proteinGEF), and a ternary GTP complex after productive G-protein activation (G-proteinGEFGTP). Here, we show structural snapshots of the full nucleotide exchange reaction sequence together with the G-protein substrates and products using Rabin8/GRAB (GEF) and Rab8 (G-protein) as a model system. Together with a thorough enzymatic characterization, our data provide a detailed view into the mechanism of Rabin8/GRAB-mediated nucleotide exchange.	[Guo, Zhong; Hou, Xiaomin; Goody, Roger S.; Itzen, Aymelt] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Hou, Xiaomin] Qingdao Agr Univ, Coll Life Sci, Qingdao 266109, Peoples R China; [Itzen, Aymelt] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany	Max Planck Society; Qingdao Agricultural University; Technical University of Munich	Goody, RS (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	roger.goody@mpi-dortmund.mpg.de; aymelt.itzen@tum.de	Itzen, Aymelt/F-5157-2014; GUO, Zhong/J-8723-2014; Goody, Roger S/J-8845-2014; GUO, Zhong/J-8723-2014	Itzen, Aymelt/0000-0002-4249-5617; GUO, Zhong/0000-0003-0285-5021; Goody, Roger S/0000-0002-0772-0444; GUO, Zhong/0000-0002-2277-0087	German Research Foundation (DFG) Sonderforschungsbereich [SFB1035, B05, SFB642, A4]; National Natural Science Foundation of China [31200554]	German Research Foundation (DFG) Sonderforschungsbereich(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by German Research Foundation (DFG) Sonderforschungsbereich SFB1035 (Projekt B05) and SFB642 (Projekt A4).; Supported by National Natural Science Foundation of China Grant 31200554.	Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bleimling N, 2009, PROTEIN EXPRES PURIF, V65, P190, DOI 10.1016/j.pep.2008.12.002; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; BURTON JL, 1994, EMBO J, V13, P5547, DOI 10.1002/j.1460-2075.1994.tb06892.x; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasper R, 2008, J MOL BIOL, V379, P51, DOI 10.1016/j.jmb.2008.03.011; Gazdag EM, 2013, EMBO REP, V14, P199, DOI 10.1038/embor.2012.211; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Luo HR, 2001, NEURON, V31, P439, DOI 10.1016/S0896-6273(01)00384-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Uejima T, 2010, J BIOL CHEM, V285, P36689, DOI 10.1074/jbc.M110.152132; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wixler V, 2011, BIOL CHEM, V392, P239, DOI 10.1515/BC.2011.022; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051	42	38	38	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32466	32474		10.1074/jbc.M113.498329	http://dx.doi.org/10.1074/jbc.M113.498329			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072714	Green Published, hybrid			2022-12-28	WOS:000328681700031
J	Basu, M; Mukhopadhyay, S; Chatterjee, U; Roy, SS				Basu, Moitri; Mukhopadhyay, Satinath; Chatterjee, Uttara; Roy, Sib Sankar			RETRACTED: FGF16 Promotes Invasive Behavior of SKOV-3 Ovarian Cancer Cells through Activation of Mitogen-activated Protein Kinase (MAPK) Signaling Pathway (Retracted article. See vol. 295, pg. 17381, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						-Catenin; Cell Proliferation; Fibroblast Growth Factor (FGF); Homeobox; Invasion; Ovarian Cancer	GROWTH-FACTOR; BETA-CATENIN; DIFFERENTIAL EXPRESSION; EPITHELIAL TUMORS; DOWNSTREAM TARGET; PITX2; PROLIFERATION; TRANSCRIPTION; INDUCTION; MECHANISMS	Background: The mechanism of FGF16-mediated invasions in ovarian cancer cells was not reported. Results: Through the activation of FGFR-MAPK-pathway, FGF16 regulates SNAI1/CDH1/MMP2/-MMP9, promoting invasion of ovarian cancer cells. Wnt-signaling and PITX2 synergistically regulates FGF16 expression. Conclusion: The oncogenic potential of FGF16 in ovarian cancer was established. Significance: Growth factor/signaling pathways leading to increased proliferation/invasion of ovarian cancer were identified. Uncontrolled cell growth and tissue invasion define the characteristic features of cancer. Several growth factors regulate these processes by inducing specific signaling pathways. We show that FGF16, a novel factor, is expressed in human ovary, and its expression is markedly increased in ovarian tumors. This finding indicated possible involvement of FGF16 in ovarian cancer progression. We observed that FGF16 stimulates the proliferation of human ovarian adenocarcinoma cells, SKOV-3 and OAW-42. Furthermore, through the activation of FGF receptor-mediated intracellular MAPK pathway, FGF16 regulates the expression of MMP2, MMP9, SNAI1, and CDH1 and thus facilitates cellular invasion. Inhibition of FGFR as well as MAPK pathway reduces the proliferative and invasive behavior of ovarian cancer cells. Moreover, ovarian tumors with up-regulated PITX2 expression also showed activation of Wnt/-catenin pathway that prompted us to investigate possible interaction among FGF16, PITX2, and Wnt pathway. We identified that PITX2 homeodomain transcription factor interacts with and regulates FGF16 expression. Furthermore, activation of the Wnt/-catenin pathway induces FGF16 expression. Moreover, FGF16 promoter possesses the binding elements of PITX2 as well as T-cell factor (Wnt-responsive), in close proximity, where PITX2 and -catenin binds to and synergistically activates the same. A detail study showed that both PITX2 and T-cell factor elements and the interaction with their binding partners are necessary for target gene expression. Taken together, our findings indicate that FGF16 in conjunction with Wnt pathway contributes to the cancer phenotype of ovarian cells and suggests that modulation of its expression in ovarian cells might be a promising therapeutic strategy for the treatment of invasive ovarian cancers.	[Basu, Moitri; Roy, Sib Sankar] Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, Kolkata 700032, India; [Mukhopadhyay, Satinath] Inst Post Grad Med Educ & Res, Dept Endocrinol & Metab, Kolkata 700020, India; [Chatterjee, Uttara] Inst Post Grad Med Educ & Res, Dept Pathol, Kolkata 700020, India; [Chatterjee, Uttara] Seth Sukhlal Karnani Mem Hosp, Kolkata 700020, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Roy, SS (corresponding author), Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	sibsankar@iicb.res.in		Mukhopadhyay, Satinath/0000-0001-8033-5748	Council of Scientific and Industrial Research, Government of India [BSC 0101, BSC 0206]; CSIR, Government of India [10-2(5)/2007(II)-E.UII]	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research projects BSC 0101 and BSC 0206, Government of India.; Recipient of a fellowship from CSIR, Government of India (award 10-2(5)/2007(II)-E.UII).	Ai D, 2007, MOL CELL BIOL, V27, P5765, DOI 10.1128/MCB.01848-06; Antoine M, 2006, BIOCHEM BIOPH RES CO, V346, P224, DOI 10.1016/j.bbrc.2006.05.105; Barbolina MV, 2011, BIOCHEM J, V437, P1, DOI 10.1042/BJ20110112; Basu M, 2013, J BIOL CHEM, V288, P4355, DOI 10.1074/jbc.M112.409102; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Birrer MJ, 2007, J CLIN ONCOL, V25, P2281, DOI 10.1200/JCO.2006.09.0795; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Cole C, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12585; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Giri D, 1999, CLIN CANCER RES, V5, P1063; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hirose H, 2011, ANN SURG ONCOL, V18, P3005, DOI 10.1245/s10434-011-1653-z; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Klint Peter, 1999, Frontiers in Bioscience, V4, pD165, DOI 10.2741/Klint; Konishi M, 2000, J BIOL CHEM, V275, P12119, DOI 10.1074/jbc.275.16.12119; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu SY, 2008, AM J PHYSIOL-CELL PH, V294, pC1242, DOI 10.1152/ajpcell.00529.2007; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; Miyake A, 1998, BIOCHEM BIOPH RES CO, V243, P148, DOI 10.1006/bbrc.1998.8073; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Nandi SS, 2011, CELL PHYSIOL BIOCHEM, V27, P159, DOI 10.1159/000325218; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; Nomura R, 2006, BIOCHEM BIOPH RES CO, V347, P340, DOI 10.1016/j.bbrc.2006.06.108; Ornitz DM, 2001, GENOME BIOL, V2; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Ropiquet F, 2000, CANCER RES, V60, P4245; Saha SK, 2005, ENDOCRINOLOGY, V146, P2963, DOI 10.1210/en.2004-1440; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; Shimokawa T, 2003, CANCER RES, V63, P6116; Steele IA, 2001, ONCOGENE, V20, P5878, DOI 10.1038/sj.onc.1204755; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583	53	44	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1415	1428		10.1074/jbc.M113.535427	http://dx.doi.org/10.1074/jbc.M113.535427			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24253043	Green Published, hybrid			2022-12-28	WOS:000332401700019
J	Farrand, L; Kim, JY; Byun, S; Im-aram, A; Lee, J; Suh, JY; Lee, KW; Lee, HJ; Tsang, BK				Farrand, Lee; Kim, Ji Young; Byun, Sanguine; Im-aram, Akechai; Lee, Jihoon; Suh, Jeong-Yong; Lee, Ki-Won; Lee, Hyong Joo; Tsang, Benjamin K.			The Diarylheptanoid Hirsutenone Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin via Modulation of Apoptosis-inducing Factor and X-linked Inhibitor of Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Chemoresistance; Ovarian Cancer; p53; XIAP; AIF; Hirsutenone	ALNUS-JAPONICA; IN-VITRO; PROTEIN; P53; UBIQUITINATION; PATHWAY; XIAP; FAMILY; TARGET	Background: Resistance of ovarian cancer cells to chemotherapy is a major therapeutic problem. Results: Hirsutenone induces cisplatin sensitivity via p53, X-linked inhibitor of apoptosis protein, and apoptosis-inducing factor. Conclusion: Hirsutenone sensitizes resistant ovarian cancer cells to cisplatin. Significance: Co-treatment with hirsutenone may have the potential to overcome chemoresistance. Cisplatin (CDDP) and its derivatives are considered first-line treatments for ovarian cancer (OVCA). However, despite initial results that often appear promising, in most cases patients will return with recurrent disease that fails to respond to further chemotherapy. We assayed a number of food phytochemicals with reported PI3K inhibitory ability to identify candidates that can influence CDDP treatment outcomes in chemoresistant OVCA cell lines. A direct comparison revealed that the diarylheptanoid hirsutenone from the tree bark of Alnus hirsuta var. sibirica was superior at inducing CDDP sensitivity in a number of chemoresistant cancer cell lines. Whereas hirsutenone treatment activated p53, its modest efficacy in p53-mutant and -null cell lines suggested the existence of a p53-independent mode of action. Further investigation revealed that hirsutenone causes CDDP-dependent apoptosis in chemoresistant cells by ubiquitin-proteasome-dependent X-linked inhibitor of apoptosis degradation and by enhancing the translocation of apoptosis-inducing factor from the mitochondria to the nucleus. This was found to be, at least in part, under the influence of upstream Akt activity, linking hirsutenone-dependent PI3K inhibition with downstream effects on apoptosis-inducing factor, X-linked inhibitor of apoptosis, and apoptosis. Our findings provide rationale for further investigation of the effects of hirsutenone on chemoresistant OVCA in clinical studies.	[Farrand, Lee; Kim, Ji Young; Byun, Sanguine; Im-aram, Akechai; Lee, Jihoon; Suh, Jeong-Yong; Lee, Ki-Won; Lee, Hyong Joo; Tsang, Benjamin K.] Seoul Natl Univ, World Class Univ Major Biomodulat, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151, South Korea; [Kim, Ji Young; Tsang, Benjamin K.] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON K1N 6N5, Canada; [Tsang, Benjamin K.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Kim, Ji Young; Tsang, Benjamin K.] Ottawa Hosp, Res Inst, Chron Dis Program, Ottawa, ON K1N 6N5, Canada	Seoul National University (SNU); University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Tsang, BK (corresponding author), Ottawa Hosp, Ottawa Hosp Res Inst, Gen Campus,Critical Care Wing,3rd Floor,Rm W3107, Ottawa, ON K1H 8L6, Canada.	btsang@ohri.ca	Byun, Sanguine/AAR-5451-2021; Lee, Ki Won/M-4114-2018	Tsang, Benjamin K./0000-0003-1213-3946; Byun, Sanguine/0000-0003-3903-5887	World Class University (WCU) through the National Research Foundation of Korea [R31-10056]; Ministry of Education, Science, and Technology; Canadian Institutes of Health Research [M0P-126144]	World Class University (WCU) through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the World Class University (WCU) program R31-10056 through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology, and by Canadian Institutes of Health Research Grant M0P-126144.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; American Cancer Society, 2012, CANC FACTS FIG 2012; Arafa ESA, 2009, CANCER RES, V69, P8910, DOI 10.1158/0008-5472.CAN-09-1543; Brown JM, 1999, CANCER RES, V59, P1391; Choi KH, 2010, CARDIOVASC RES, V85, P836, DOI 10.1093/cvr/cvp359; Covens A, 2002, GYNECOL ONCOL, V85, P71, DOI 10.1006/gyno.2001.6552; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fraser Michael, 2003, Reprod Biol Endocrinol, V1, P66, DOI 10.1186/1477-7827-1-66; Garrison JB, 2011, MOL CELL, V41, P107, DOI 10.1016/j.molcel.2010.12.002; Huang J, 2011, GENE CHROMOSOME CANC, V50, P606, DOI 10.1002/gcc.20883; Joo SS, 2009, EUR J PHARMACOL, V614, P98, DOI 10.1016/j.ejphar.2009.04.047; Lee CS, 2012, INVEST NEW DRUG, V30, P548, DOI 10.1007/s10637-010-9601-5; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; MARKS JR, 1991, CANCER RES, V51, P2979; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Sasaki H, 2000, CANCER RES, V60, P5659; Siddiqui IA, 2008, ONCOGENE, V27, P2055, DOI 10.1038/sj.onc.1210840; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wada H, 1998, CHEM PHARM BULL, V46, P1054, DOI 10.1248/cpb.46.1054; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Woo MG, 2012, J BIOL CHEM, V287, P3963, DOI 10.1074/jbc.M111.314765; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425	31	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1723	1731		10.1074/jbc.M113.513879	http://dx.doi.org/10.1074/jbc.M113.513879			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24247248	Green Published, hybrid			2022-12-28	WOS:000332401700043
J	Dancevic, CM; Fraser, FW; Smith, AD; Stupka, N; Ward, AC; McCulloch, DR				Dancevic, Carolyn M.; Fraser, Fiona W.; Smith, Adam D.; Stupka, Nicole; Ward, Alister C.; McCulloch, Daniel R.			Biosynthesis and Expression of a Disintegrin-like and Metalloproteinase Domain with Thrombospondin-1 Repeats-15 A NOVEL VERSICAN-CLEAVING PROTEOGLYCANASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Embryo; Extracellular Matrix; Extracellular Matrix Proteins; Metalloprotease; Proteoglycan; Skeletal Muscle	CELL-SURFACE; ADAMTS METALLOPROTEASES; IN-VIVO; CLEAVAGE; ACTIVATION; AGGRECANASE; MATRIX; GENE; LOCALIZATION; PROTEOLYSIS	The proteoglycanase clade of the ADAMTS superfamily shows preferred proteolytic activity toward the hyalectan/lectican proteoglycans as follows: aggrecan, brevican, neurocan, and versican. ADAMTS15, a member of this clade, was recently identified as a putative tumor suppressor gene in colorectal and breast cancer. However, its biosynthesis, substrate specificity, and tissue expression are poorly described. Therefore, we undertook a detailed study of this proteinase and its expression. We report propeptide processing of the ADAMTS15 zymogen by furin activity, identifying RAKR(212) as a major furin cleavage site within the prodomain. ADAMTS15 was localized on the cell surface, activated extracellularly, and required propeptide processing before cleaving V1 versican at position (441)EA(442). In the mouse embryo, Adamts15 was expressed in the developing heart at E10.5 and E11.5 days post-coitum and in the musculoskeletal system from E13.5 to E15.5 days post-coitum, where it was co-localized with hyaluronan. Adamts15 was also highly expressed in several structures within the adult mouse colon. Our findings show overlapping sites of Adamts15 expression with other members of ADAMTS proteoglycanases during embryonic development, suggesting possible cooperative roles during embryogenesis, consistent with other ADAMTS proteoglycanase combinatorial knock-out mouse models. Collectively, these data suggest a role for ADAMTS15 in a wide range of biological processes that are potentially mediated through the processing of versican.	[McCulloch, Daniel R.] Deakin Univ, Fac Hlth, Sch Med, Waurn Ponds, Vic 3216, Australia; Deakin Univ, Mol & Med Res SRC, Waurn Ponds, Vic 3216, Australia	Deakin University; Deakin University	McCulloch, DR (corresponding author), Deakin Univ, Fac Hlth, Sch Med, 75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.	daniel.mcculloch@deakin.edu.au		, Carolyn/0000-0002-1529-8060; Ward, Alister/0000-0001-7945-7975; Stupka, Nicole/0000-0002-1000-1707; McCulloch, Daniel/0000-0003-0269-5857	Financial Markets Foundation for Children [162-10]; Deakin University Faculty of Health, Faculty Development Research Grant [FDRG-2009]; Commonwealth Government; National Health and Medical Research Council	Financial Markets Foundation for Children; Deakin University Faculty of Health, Faculty Development Research Grant; Commonwealth Government; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Financial Markets Foundation for Children Grant 162-10 (to D. McC., N. S., and A. W.) and the Deakin University Faculty of Health, Faculty Development Research Grant FDRG-2009 (to D. McC.).; Supported by a Commonwealth Government-funded Australian postgraduate award.; Supported in part by a National Health and Medical Research Council Peter Doherty Fellowship.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Cross NA, 2005, PROSTATE, V63, P269, DOI 10.1002/pros.20182; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dunn JR, 2006, BRIT J CANCER, V94, P1186, DOI 10.1038/sj.bjc.6603006; Dupuis LE, 2013, J MOL CELL CARDIOL, V60, P50, DOI 10.1016/j.yjmcc.2013.03.010; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Enomoto H, 2010, DEVELOPMENT, V137, P4029, DOI 10.1242/dev.050591; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hsu YP, 2012, INT J EXP PATHOL, V93, P70, DOI 10.1111/j.1365-2613.2011.00802.x; Jungers KA, 2005, GENE EXPR PATTERNS, V5, P609, DOI 10.1016/j.modgep.2005.03.004; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Kintakas C, 2011, MATRIX BIOL, V30, P311, DOI 10.1016/j.matbio.2011.05.004; Kischel P, 2010, INT J CANCER, V126, P640, DOI 10.1002/ijc.24812; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Koo BH, 2010, AM J PATHOL, V176, P1494, DOI 10.2353/ajpath.2010.090655; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Longpre JM, 2004, J BIOL CHEM, V279, P33237, DOI 10.1074/jbc.M313151200; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; McCulloch DR, 2010, OSTEOARTHR CARTILAGE, V18, P455, DOI 10.1016/j.joca.2009.10.014; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Molokwu CN, 2010, CANCER INVEST, V28, P698, DOI 10.3109/07357907.2010.489538; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Porter S, 2006, INT J CANCER, V118, P1241, DOI 10.1002/ijc.21476; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Silver DL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000003; Snow HE, 2005, ANAT REC PART A, V282A, P95, DOI 10.1002/ar.a.20151; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stupka N, 2013, J BIOL CHEM, V288, P1907, DOI 10.1074/jbc.M112.429647; Thai SNM, 2002, MECH DEVELOP, V115, P181, DOI 10.1016/S0925-4773(02)00115-6; Tsai HM, 2002, INT J HEMATOL, V76, P132, DOI 10.1007/BF03165103; Viloria CG, 2009, CANCER RES, V69, P4926, DOI 10.1158/0008-5472.CAN-08-4155; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Ween MP, 2011, CLIN EXP METASTAS, V28, P113, DOI 10.1007/s10585-010-9363-7; Westling J, 2002, J BIOL CHEM, V277, P16059, DOI 10.1074/jbc.M108607200; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Yokoyama H, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_9.39; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	51	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37267	37276		10.1074/jbc.M112.418624	http://dx.doi.org/10.1074/jbc.M112.418624			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24220035	Green Published, hybrid			2022-12-28	WOS:000329189700043
J	Ma, PX; Schwarten, M; Schneider, L; Boeske, A; Henke, N; Lisak, D; Weber, S; Mohrluder, J; Stoldt, M; Strodel, B; Methner, A; Hoffmann, S; Weiergraber, OH; Willbold, D				Ma, Peixiang; Schwarten, Melanie; Schneider, Lars; Boeske, Alexandra; Henke, Nadine; Lisak, Dmitrij; Weber, Stephan; Mohrlueder, Jeannine; Stoldt, Matthias; Strodel, Birgit; Methner, Axel; Hoffmann, Silke; Weiergraeber, Oliver H.; Willbold, Dieter			Interaction of Bcl-2 with the Autophagy-related GABA(A) Receptor-associated Protein (GABARAP) BIOPHYSICAL CHARACTERIZATION AND FUNCTIONAL IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Bcl-2; NMR; Protein-Protein Interactions; GABARAP; LC3; Lipidation	CELL-DEATH; JNK1-MEDIATED PHOSPHORYLATION; NMR-SPECTROSCOPY; BREAST-CANCER; BINDING MODE; BH4 DOMAIN; APOPTOSIS; MITOCHONDRIAL; SYSTEM; LC3	Apoptosis and autophagy are fundamental homeostatic processes in eukaryotic organisms fulfilling essential roles in development and adaptation. Recently, the anti-apoptotic factor Bcl-2 has been reported to also inhibit autophagy, thus establishing a potential link between these pathways, but the mechanistic details are only beginning to emerge. Here we show that Bcl-2 directly binds to the phagophore-associated protein GABARAP. NMR experiments revealed that the interaction critically depends on a three-residue segment (EWD) of Bcl-2 adjacent to the BH4 region, which is anchored to one of the two hydrophobic pockets on the GABARAP molecule. This is at variance with the majority of GABARAP interaction partners identified previously, which occupy both hydrophobic pockets simultaneously. Bcl-2 affinity could also be detected for GEC1, but not for other mammalian Atg8 homologs. Finally, we provide evidence that overexpression of Bcl-2 inhibits lipidation of GABARAP, a key step in autophagosome formation, possibly via competition with the lipid conjugation machinery. These results support the regulatory role of Bcl-2 in autophagy and define GABARAP as a novel interaction partner involved in this intricate connection.	[Weber, Stephan; Mohrlueder, Jeannine; Stoldt, Matthias; Strodel, Birgit; Hoffmann, Silke; Weiergraeber, Oliver H.; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany; [Ma, Peixiang; Schwarten, Melanie; Stoldt, Matthias; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Ma, Peixiang; Schwarten, Melanie; Stoldt, Matthias; Willbold, Dieter] Univ Dusseldorf, BMFZ, D-40225 Dusseldorf, Germany; [Schneider, Lars; Henke, Nadine; Lisak, Dmitrij; Methner, Axel] Univ Dusseldorf, Neurol Klin, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Weiergraber, OH (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany.	o.h.weiergraeber@fz-juelich.de; d.willbold@fz-juelich.de	Schwarten, Melanie/G-6407-2013; Stoldt, Matthias/G-5738-2013; Weiergräber, Oliver H./G-8940-2013; Willbold, Dieter/A-6280-2013; Strodel, Birgit/H-5449-2013; Ma, Peixiang/AAU-4825-2021; Mohrlüder, Jeannine/G-9458-2013; Hoffmann, Silke/H-5059-2013	Schwarten, Melanie/0000-0001-8920-9668; Stoldt, Matthias/0000-0002-5060-4844; Weiergräber, Oliver H./0000-0002-2410-3691; Willbold, Dieter/0000-0002-0065-7366; Strodel, Birgit/0000-0002-8734-7765; Mohrlüder, Jeannine/0000-0002-9922-2986; Hoffmann, Silke/0000-0003-1414-8957; Nickel, Nadine/0000-0002-0609-0735; ma, peixiang/0000-0001-6794-1663; Methner, Axel/0000-0002-8774-0057	Deutscher Akademischer Austauschdienst (DAAD); International Helmholtz Research School BioSoft; Deutsche Forschungsgemeinschaft (DFG) [Me 1922/9-1, Wi 1472/5]	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); International Helmholtz Research School BioSoft; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a fellowship of the Deutscher Akademischer Austauschdienst (DAAD) (to P. M.), a fellowship of the International Helmholtz Research School BioSoft (to M. Schwarten), and Deutsche Forschungsgemeinschaft (DFG) Grants Me 1922/9-1 (to A. M.) and Wi 1472/5 (to D. W.).	Bassik MC, 2004, EMBO J, V23, P1207, DOI 10.1038/sj.emboj.7600104; Conus S, 2000, EMBO J, V19, P1534, DOI 10.1093/emboj/19.7.1534; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gotow T, 2000, CELL DEATH DIFFER, V7, P666, DOI 10.1038/sj.cdd.4400694; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hallin U, 2006, NEUROBIOL DIS, V21, P478, DOI 10.1016/j.nbd.2005.08.013; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Imazu T, 1999, ONCOGENE, V18, P4523, DOI 10.1038/sj.onc.1202722; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Keller R., 2004, COMPUTER AIDED RESON, V1; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klebig C, 2005, CANCER RES, V65, P394; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Ma PX, 2010, CHEMBIOCHEM, V11, P1967, DOI 10.1002/cbic.201000354; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mohrluder J, 2007, BIOCHEMISTRY-US, V46, P14537, DOI 10.1021/bi7018145; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Mohrluder J, 2009, FEBS J, V276, P4989, DOI 10.1111/j.1742-4658.2009.07207.x; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oh S, 2011, CELL DEATH DIFFER, V18, P452, DOI 10.1038/cdd.2010.116; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Otter I, 1998, J BIOL CHEM, V273, P6110, DOI 10.1074/jbc.273.11.6110; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Roberts SS, 2009, PATHOL ONCOL RES, V15, P645, DOI 10.1007/s12253-009-9165-x; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Stangler T, 2002, J BIOL CHEM, V277, P13363, DOI 10.1074/jbc.C200050200; Stangler T, 2001, J BIOMOL NMR, V21, P183, DOI 10.1023/A:1012416810974; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thielmann Y, 2008, CHEMBIOCHEM, V9, P1767, DOI 10.1002/cbic.200800117; Thielmann Y, 2009, PROTEINS, V77, P637, DOI 10.1002/prot.22477; Thielmann Y, 2009, MOL BIOSYST, V5, P575, DOI 10.1039/b900425d; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Trisciuoglio D, 2013, NEOPLASIA, V15, P315, DOI 10.1593/neo.121392; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wales D. J., 2003, ENERGY LANDSCAPES; Wales DJ, 1997, J PHYS CHEM A, V101, P5111, DOI 10.1021/jp970984n; Wang NS, 2001, J BIOL CHEM, V276, P44117, DOI 10.1074/jbc.M101958200; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Weiergraber OH, 2008, J MOL BIOL, V381, P1320, DOI 10.1016/j.jmb.2008.06.086; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	64	25	25	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37204	37215		10.1074/jbc.M113.528067	http://dx.doi.org/10.1074/jbc.M113.528067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240096	hybrid, Green Published			2022-12-28	WOS:000329189700038
J	Ormsby, AR; Ramdzan, YM; Mok, YF; Jovanoski, KD; Hatters, DM				Ormsby, Angelique R.; Ramdzan, Yasmin M.; Mok, Yee-Foong; Jovanoski, Kristijan D.; Hatters, Danny M.			A Platform to View Huntingtin Exon 1 Aggregation Flux in the Cell Reveals Divergent Influences from Chaperones hsp40 and hsp70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Analytical Ultracentrifugation; Chaperone Chaperonin; Flow Cytometry; Protein Aggregation; PulSA; huntingtin; Oligomers; Polyglutamine	MUTANT HUNTINGTIN; TRINUCLEOTIDE REPEAT; PROTEIN; OLIGOMERS; SUPPRESSION; LENGTH; CONFORMATION; PATHOGENESIS; SUFFICIENT; INCLUSIONS	Our capacity for tracking how misfolded proteins aggregate inside a cell and how different aggregation states impact cell biology remains enigmatic. To address this, we built a new toolkit that enabled the high throughput tracking of individual cells enriched with polyglutamine-expanded Htt exon 1 (Httex1) monomers, oligomers, and inclusions using biosensors of aggregation state and flow cytometry pulse shape analysis. Supplemented with gel filtration chromatography and fluorescence-adapted sedimentation velocity analysis of cell lysates, we collated a multidimensional view of Httex1 aggregation in cells with respect to time, polyglutamine length, expression levels, cell survival, and overexpression of protein quality control chaperones hsp40 (DNAJB1) and hsp70 (HSPA1A). Cell death rates trended higher for Neuro2a cells containing Httex1 in inclusions than with Httex1 dispersed through the cytosol at time points of expression over 2 days. hsp40 stabilized monomers and suppressed inclusion formation but did not otherwise change Httex1 toxicity. hsp70, however, had no major effect on aggregation of Httex1 but increased the survival rate of cells with inclusions. hsp40 and hsp70 also increased levels of a second bicistronic reporter of Httex1 expression, mKate2, and increased total numbers of cells in culture, suggesting these chaperones partly rectify Httex1-induced deficiencies in quality control and growth rates. Collectively, these data suggest that Httex1 overstretches the protein quality control resources and that the defects can be partly rescued by overexpression of hsp40 and hsp70. Importantly, these effects occurred in a pronounced manner for soluble Httex1, which points to Httex1 aggregation occurring subsequently to more acute impacts on the cell.	[Ormsby, Angelique R.; Ramdzan, Yasmin M.; Mok, Yee-Foong; Jovanoski, Kristijan D.; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Melbourne	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Melbourne, Vic 3010, Australia.	dhatters@unimelb.edu.au		Hatters, Danny/0000-0002-9965-2847; , Angelique/0000-0002-2780-9550	National Health and Medical Research Council [566640, APP1049458, APP1049459]; Australian Research Council [DP120102763]; Hereditary Disease Foundation, New York; Miegunyah Trust	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Hereditary Disease Foundation, New York; Miegunyah Trust	This work was supported by National Health and Medical Research Council Project Grants 566640, APP1049458, and APP1049459 (to D. M. H.), Australian Research Council Discovery Grant DP120102763, and the Hereditary Disease Foundation, New York.; Grimwade Fellow supported by the Miegunyah Trust and is currently an Australian Research Council Future Fellow.	ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gong B, 2008, BRAIN RES BULL, V75, P146, DOI 10.1016/j.brainresbull.2007.08.005; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Harvey KJ, 2001, CYTOMETRY, V43, P273, DOI 10.1002/1097-0320(20010401)43:4<273::AID-CYTO1059>3.0.CO;2-3; Hatters DM, 2012, CURR TOP MED CHEM, V12, P2611; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; NOZAKI Y, 1982, SCIENCE, V217, P366, DOI 10.1126/science.7089571; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Peters-Libeu C, 2012, J MOL BIOL, V421, P587, DOI 10.1016/j.jmb.2012.01.034; Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]; Ramdzan YM, 2010, CHEM BIOL, V17, P371, DOI 10.1016/j.chembiol.2010.03.011; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Singh VR, 2008, J PHYS CHEM B, V112, P13172, DOI 10.1021/jp805636p; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200	61	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37192	37203		10.1074/jbc.M113.486944	http://dx.doi.org/10.1074/jbc.M113.486944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196953	hybrid, Green Published			2022-12-28	WOS:000329189700037
J	Wiencek, JR; Na, M; Hirbawi, J; Kalafatis, M				Wiencek, Joesph R.; Na, Mahesheema; Hirbawi, Jamila; Kalafatis, Michael			Amino Acid Region 1000-1008 of Factor V Is a Dynamic Regulator for the Emergence of Procoagulant Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Coagulation Factors; Phospholipid Vesicle; Protein Chemistry; Prothrombin; Thrombin; Factor V; Factor Va; Factor Xa; Prothrombinase; Prothrombin	ACTIVATED PROTEIN-C; XA-BINDING-SITE; THROMBIN-CATALYZED ACTIVATION; PEPTIDE-BOND CLEAVAGES; COAGULATION FACTOR XA; HEAVY-CHAIN; DIRECTED MUTAGENESIS; FACTOR VA(R506Q); PROTHROMBIN; INACTIVATION	Single chain factor V (fV) circulates as an M-r 330,000 quiescent pro-cofactor. Removal of the B domain and generation of factor Va (fVa) are vital for procoagulant activity. We investigated the role of the basic amino acid region 1000-1008 within the B domain of fV by constructing a recombinant mutant fV molecule with all activation cleavage sites (Arg(709)/Arg(1018)/Arg(1545)) mutated to glutamine (fV(Q3)), a mutant fV molecule with region 1000-1008 deleted (fV(B9)), and a mutant fV molecule containing the same deletion with activation cleavage sites changed to glutamine (fV(B9/Q3)). The recombinant molecules along with wild type fV (fV(WT)) were transiently expressed in COS-7L cells, purified, and assessed for their ability to bind factor Xa (fXa) prior to and following incubation with thrombin. The data showed that fV(Q3) was severely impaired in its interaction with fXa before and after incubation with thrombin. In contrast, K-D(app) values for fV(B9) (0.9 nm), fVa(B9) (0.4 nm), and fV(B9/Q3) (0.7 nm) were similar to the affinity of fVa(WT) for fXa (0.3 nm). Two-stage clotting assays revealed that although fV(Q3) was deficient in its clotting activity, fV(B9/Q3) had clotting activity comparable with fVa(WT). The k(cat) value of prothrombinase assembled with fV(B9/Q3) was minimally affected, whereas the K-m value of the reaction was increased 57-fold compared with the K-m value obtained with prothrombinase assembled with fVa(WT). These findings strongly suggest that amino acid region 1000-1008 of fV is a regulatory sequence protecting the organisms from spontaneous binding to fXa and unnecessary prothrombinase complex formation, which in turn results in catastrophic physiological consequences.	[Wiencek, Joesph R.; Na, Mahesheema; Kalafatis, Michael] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Hirbawi, Jamila; Kalafatis, Michael] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Kalafatis, Michael] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Kalafatis, Michael] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA	Cleveland State University; Cleveland Clinic Foundation; Cleveland State University; Cleveland Clinic Foundation	Kalafatis, M (corresponding author), Cleveland State Univ, Dept Chem, 2351 Euclid Ave,Sci & Res Ctr SR370, Cleveland, OH 44115 USA.	m.kalafatis@csuohio.edu			National Institutes of Health from the NHLBI [R01 HL-73343]; Ohio Department of Development; Center for Gene Regulation in Health and Disease; Doctoral Dissertation Research Expense Award and Fellowship Program (DDREAFP) at Cleveland State University;  [T32 HL 007914]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073343, T32HL007914] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ohio Department of Development; Center for Gene Regulation in Health and Disease; Doctoral Dissertation Research Expense Award and Fellowship Program (DDREAFP) at Cleveland State University; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL-73343 from the NHLBI (to M. K.) by a Third frontier grant from the Ohio Department of Development, and T32 HL 007914. This work was also supported by Funds from the Center for Gene Regulation in Health and Disease. A preliminary report of this work was presented at the 52nd Annual Meeting of the American Society of Hematology, December 4-7, 2010, Orlando, FL. (2010) Blood 116, 2221a.; Supported in part by Doctoral Dissertation Research Expense Award and Fellowship Program (DDREAFP) at Cleveland State University (to JRW).	ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Barhoover MA, 2008, BIOCHEMISTRY-US, V47, P6840, DOI 10.1021/bi800057r; Barhoover MA, 2008, BIOCHEMISTRY-US, V47, P12835, DOI 10.1021/bi801241r; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Bukys MA, 2005, J BIOL CHEM, V280, P27393, DOI 10.1074/jbc.M503435200; Bukys MA, 2008, THROMB HAEMOSTASIS, V99, P511, DOI 10.1160/TH07-08-0532; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; Copeland R, 2000, ENZYMES PRACTICAL IN, P120; COTE HCF, 1994, J BIOL CHEM, V269, P11374; Erdogan E, 2008, J THROMB HAEMOST, V6, P118; Erdogan E, 2007, THROMB HAEMOSTASIS, V98, P998, DOI 10.1160/TH07-06-0431; ESMON CT, 1979, J BIOL CHEM, V254, P964; FERSHT A, 1985, ENZYME STRUCTURE MEC, P324; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1577, DOI 10.1021/bi00405a027; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; Hirbawi J, 2008, BIOCHEMISTRY-US, V47, P7963, DOI 10.1021/bi800593k; Hirbawi J, 2010, BIOCHEMISTRY-US, V49, P8520, DOI 10.1021/bi101097t; Hockin MF, 1999, BIOCHEMISTRY-US, V38, P6918, DOI 10.1021/bi981966e; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; Kalafatis M, 2003, J BIOL CHEM, V278, P33550, DOI 10.1074/jbc.M303153200; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; KALAFATIS M, 1994, BIOCHEMISTRY-US, V33, P6538, DOI 10.1021/bi00187a022; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KANE WH, 1981, J BIOL CHEM, V256, P1002; KELLER FG, 1995, BIOCHEMISTRY-US, V34, P4118, DOI 10.1021/bi00012a030; Khan AR, 1999, P NATL ACAD SCI USA, V96, P10968, DOI 10.1073/pnas.96.20.10968; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P9684; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P23696; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mann K, 2003, CHEST, V124, P4; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; MANN KG, 1981, BIOCHEMISTRY-US, V20, P28, DOI 10.1021/bi00504a005; Mann KG, 2000, THROMB HAEMOSTASIS, V83, P3; Mathur A, 1997, J BIOL CHEM, V272, P23418, DOI 10.1074/jbc.272.37.23418; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; NESHEIM ME, 1983, J BIOL CHEM, V258, P5386; NESHEIM ME, 1984, J BIOL CHEM, V259, P3187; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; ROSING J, 1980, J BIOL CHEM, V255, P274; Singh LS, 2003, J BIOL CHEM, V278, P28335, DOI 10.1074/jbc.M300233200; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2008, J BIOL CHEM, V283, P20805, DOI 10.1074/jbc.M802703200; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200	57	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37026	37038		10.1074/jbc.M113.462374	http://dx.doi.org/10.1074/jbc.M113.462374			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24178294	Green Published, hybrid			2022-12-28	WOS:000329189700023
J	Baldwin, HM; Pallas, K; King, V; Jamieson, T; McKimmie, CS; Nibbs, RJB; Carballido, JM; Jaritz, M; Rot, A; Graham, GJ				Baldwin, Helen M.; Pallas, Kenneth; King, Vicky; Jamieson, Thomas; McKimmie, Clive S.; Nibbs, Robert J. B.; Carballido, Jose M.; Jaritz, Marcus; Rot, Antal; Graham, Gerard J.			Microarray Analyses Demonstrate the Involvement of Type I Interferons in Psoriasiform Pathology Development in D6-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Cytokines; Interferon; Inflammation; Mouse; Psoriasis	CHEMOKINE RECEPTOR D6; DECOY RECEPTOR; RHEUMATOID-ARTHRITIS; IMMUNE; INFLAMMATION; CYTOKINE; CELLS; SYSTEM; EXPRESSION; DELETION	Background: D6 regulates resolution of inflammatory responses. Its mode of action has not been molecularly defined. Results: Microarray analysis of inflamed D6-deficient mouse skin identifies dysregulated type I interferon responses as underpinning exaggerated inflammatory responses in D6-deficient mice. Conclusion: D6 is important for regulating type I interferon-based responses in inflammation. Significance: The study provides novel insights into roles for D6 in the resolution of inflammatory responses. The inflammatory response is normally limited by mechanisms regulating its resolution. In the absence of resolution, inflammatory pathologies can emerge, resulting in substantial morbidity and mortality. We have been studying the D6 chemokine scavenging receptor, which played an indispensable role in the resolution phase of inflammatory responses and does so by facilitating removal of inflammatory CC chemokines. In D6-deficient mice, otherwise innocuous cutaneous inflammatory stimuli induce a grossly exaggerated inflammatory response that bears many similarities to human psoriasis. In the present study, we have used transcriptomic approaches to define the molecular make up of this response. The data presented highlight potential roles for a number of cytokines in initiating and maintaining the psoriasis-like pathology. Most compellingly, we provide data indicating a key role for the type I interferon pathway in the emergence of this pathology. Neutralizing antibodies to type I interferons are able to ameliorate the psoriasis-like pathology, confirming a role in its development. Comparison of transcriptional data generated from this mouse model with equivalent data obtained from human psoriasis further demonstrates the strong similarities between the experimental and clinical systems. As such, the transcriptional data obtained in this preclinical model provide insights into the cytokine network active in exaggerated inflammatory responses and offer an excellent tool to evaluate the efficacy of compounds designed to therapeutically interfere with inflammatory processes.	[Baldwin, Helen M.; Pallas, Kenneth; King, Vicky; McKimmie, Clive S.; Nibbs, Robert J. B.; Graham, Gerard J.] Univ Glasgow, Chemokine Res Grp, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Jamieson, Thomas] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Carballido, Jose M.; Jaritz, Marcus; Rot, Antal] Novartis Inst Biomed Res, A-1235 Vienna, Austria; [Carballido, Jose M.] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Rot, Antal] Univ Birmingham, Birmingham B15 2TT, W Midlands, England	University of Glasgow; Beatson Institute; Novartis; Novartis; University of Birmingham	Graham, GJ (corresponding author), Univ Glasgow, Chemokine Res Grp, Glasgow Biomed Res Ctr, Rm B3-27, Glasgow G12 8TA, Lanark, Scotland.	gerard.graham@glasgow.ac.uk	McKimmie, Clive/AAD-9509-2019	McKimmie, Clive/0000-0002-7694-9509; Rot, Antal/0000-0002-9730-6166; Nibbs, Robert/0000-0002-8150-0044; Graham, Gerard/0000-0002-7801-204X	Medical Research Council; Oliver Bird Ph.D. Programme; Arthritis Research UK Foundation Fellowship; MRC [G1001724, G0802838, G0901113] Funding Source: UKRI; Medical Research Council [G0901113, G0802838, G1001724] Funding Source: researchfish; Versus Arthritis [19656] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oliver Bird Ph.D. Programme; Arthritis Research UK Foundation Fellowship(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was supported by grants from the Medical Research Council and Oliver Bird Ph.D. Programme.; Recipient of an Arthritis Research UK Foundation Fellowship.	Albanesi C, 2010, AUTOIMMUNITY, V43, P215, DOI 10.3109/08916930903510906; Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Bazzan E, 2013, CHEST, V143, P98, DOI 10.1378/chest.11-3220; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bordon Y, 2009, J IMMUNOL, V182, P5032, DOI 10.4049/jimmunol.0802802; Ciocon DH, 2007, BRIT J DERMATOL, V157, P850, DOI 10.1111/j.1365-2133.2007.08148.x; Cochain C, 2012, ARTERIOSCL THROM VAS, V32, P2206, DOI 10.1161/ATVBAHA.112.254409; Codullo V, 2011, ANN RHEUM DIS, V70, P1115, DOI 10.1136/ard.2010.137349; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Graham GJ, 2013, J PATHOL, V229, P168, DOI 10.1002/path.4123; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Homey B, 2008, CLIN DERMATOL, V26, P539, DOI 10.1016/j.clindermatol.2007.11.003; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Lee KM, 2013, TRENDS IMMUNOL, V34, P7, DOI 10.1016/j.it.2012.08.001; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; McKimmie CS, 2013, BLOOD, V121, P3768, DOI 10.1182/blood-2012-04-425314; Molin S, 2011, J INVEST ALLERG CLIN, V21, P472; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Savino B, 2009, J BIOL CHEM, V284, P26207, DOI 10.1074/jbc.M109.029249; Singh MD, 2012, AM J PATHOL, V181, P1158, DOI 10.1016/j.ajpath.2012.06.042; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	41	6	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36473	36483		10.1074/jbc.M113.491563	http://dx.doi.org/10.1074/jbc.M113.491563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194523	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000328883400028
J	Woo, SK; Kwon, MS; Ivanov, A; Geng, ZH; Gerzanich, V; Simard, JM				Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Geng, Zhihua; Gerzanich, Volodymyr; Simard, J. Marc			Complex N-Glycosylation Stabilizes Surface Expression of Transient Receptor Potential Melastatin 4b Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Glycoprotein; Ion Channels; Protein Stability; TRP Channels	NONSELECTIVE CATION CHANNEL; ADULT-RAT BRAIN; LINKED GLYCOSYLATION; TRPM8 CHANNEL; REACTIVE ASTROCYTES; COLD; GLYCOPROTEINS; TRAFFICKING; SENSITIVITY; OLIGOSACCHARIDES	Background:N-Glycosylation is important for the function and regulation of ion channels but has not been examined for Trpm4. Results:N-Glycosylation is not required for surface expression, but complex N-glycosylation stabilizes Trpm4b surface expression. Conclusion: Complex N-glycosylation of Trpm4b has important functional implications. Significance: By promoting surface expression, N-glycosylation contributes importantly to calcium regulation byTrpm4b. N-Glycosylation is important for the function and regulation of ion channels. We examined the role of N-glycosylation of transient receptor potential melastatin (Trpm) 4b, a membrane glycoprotein that regulates calcium influx. Trpm4b was expressed in vivo in all rat tissues examined. In each tissue, Trpm4b had a different molecular mass, between approximate to 129 and approximate to 141 kDa, but all reverted to approximate to 120 kDa following treatment with peptide:N-glycosidase F, consistent with N-glycosylation being the principal form of post-translational modification of Trpm4b in vivo. In six stable isogenic cell lines that express different levels of Trpm4b, two forms were found, high mannose, core-glycosylated and complex, highly glycosylated (HG), with HG-Trpm4b comprising 85% of the total Trpm4b expressed. For both forms, surface expression was directly proportional to the total Trpm4b expressed. Complex N-glycosylation doubled the percentage of Trpm4b at the surface, compared with high mannose N-glycosylation. Mutation of the single N-glycosylation consensus sequence at Asn-988 (Trpm4b-N988Q), located near the pore-forming loop between transmembrane helices 5 and 6, prevented glycosylation, but did not prevent surface expression, impair formation of functional membrane channels, or alter channel conductance. In transfection experiments, the time courses for appearance of HG-Trpm4b and Trpm4b-N988Q on the surface were similar. In experiments with cycloheximide inhibition of protein synthesis, the time course for disappearance of HG-Trpm4b from the surface was much slower than that for Trpm4b-N988Q. We conclude that N-glycosylation is not required for surface expression or channel function, but that complex N-glycosylation plays a crucial role in stabilizing surface expression of Trpm4b.	[Woo, Seung Kyoon; Kwon, Min Seong; Ivanov, Alexander; Geng, Zhihua; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Dept Neurosurg, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@smail.umaryland.edu			National Institutes of Health from the NINDS [NS060801, NS061808, NS061934, NS072501]; National Institutes of Health from the NHLBI [HL082517]; Department of Veterans Affairs (Baltimore); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072501, R01NS061934, R01NS061808, R01NS060801] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs (Baltimore); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS060801 and NS061808 from the NINDS and HL082517 from the NHLBI (to J. M. S.) and NS061934 and NS072501 from the NINDS (to V. G.). This work was also supported by a Department of Veterans Affairs (Baltimore) grant (to J. M. S.).	Banerjee DK, 2012, BBA-GEN SUBJECTS, V1820, P1338, DOI 10.1016/j.bbagen.2012.01.013; BENALLAL M, 1995, BIOSCIENCE REP, V15, P21, DOI 10.1007/BF01200212; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Cohen DM, 2006, SEMIN CELL DEV BIOL, V17, P630, DOI 10.1016/j.semcdb.2006.11.007; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Fozzard Harry A, 2002, Sci STKE, V2002, ppe19, DOI 10.1126/stke.2002.130.pe19; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liman Emily R., 2007, P203; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Vennekens R., 2007, V179, P269; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xu HS, 2006, AM J PHYSIOL-RENAL, V290, pF1103, DOI 10.1152/ajprenal.00245.2005	42	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36409	36417		10.1074/jbc.M113.530584	http://dx.doi.org/10.1074/jbc.M113.530584			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214984	Green Published, hybrid			2022-12-28	WOS:000328883400022
J	Pascual, F; Soto-Cardalda, A; Carman, GM				Pascual, Florencia; Soto-Cardalda, Anibal; Carman, George M.			PAH1-encoded Phosphatidate Phosphatase Plays a Role in the Growth Phase-and Inositol-mediated Regulation of Lipid Synthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Lipids; Phosphatase; Phosphatidate; Phospholipid; Phospholipid Metabolism; Triacylglycerol; Yeast	DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; CYTIDINE DIPHOSPHATE CHOLINE; PHOSPHATIDYLSERINE SYNTHASE ACTIVITY; PROTEIN-INTERACTION NETWORKS; PHOSPHOLIPASE-D ACTIVITY; NUCLEAR-MEMBRANE GROWTH; ENZYMATIC-SYNTHESIS; ESCHERICHIA-COLI; BUDDING YEAST; TRANSCRIPTIONAL REGULATION	Background: Yeast Pah1p phosphatidate phosphatase produces diacylglycerol for triacylglycerol synthesis and controls phosphatidate content for phospholipid synthesis. Results:PAH1 expression was induced throughout growth, stimulated by inositol supplementation, and mediated by the Ino2p/Ino4p/Opi1p regulatory circuit and transcription factors Gis1p and Rph1p. Conclusion: Growth phase- and inositol-mediated expression of PAH1 regulates lipid synthesis. Significance: Pah1p phosphatidate phosphatase is regulated by a transcriptional mechanism throughout growth. In the yeast Saccharomyces cerevisiae, the synthesis of phospholipids in the exponential phase of growth occurs at the expense of the storage lipid triacylglycerol. As exponential phase cells progress into the stationary phase, the synthesis of triacylglycerol occurs at the expense of phospholipids. Early work indicates a role of the phosphatidate phosphatase (PAP) in this metabolism; the enzyme produces the diacylglycerol needed for the synthesis of triacylglycerol and simultaneously controls the level of phosphatidate for the synthesis of phospholipids. Four genes (APP1, DPP1, LPP1, and PAH1) encode PAP activity in yeast, and it has been unclear which gene is responsible for the synthesis of triacylglycerol throughout growth. An analysis of lipid synthesis and composition, as well as PAP activity in various PAP mutant strains, showed the essential role of PAH1 in triacylglycerol synthesis throughout growth. Pah1p is a phosphorylated enzyme whose in vivo function is dependent on its dephosphorylation by the Nem1p-Spo7p protein phosphatase complex. nem1 mutant cells exhibited defects in triacylglycerol synthesis and lipid metabolism that mirrored those imparted by the pah1 mutation, substantiating the importance of Pah1p dephosphorylation throughout growth. An analysis of cells bearing P-PAH1-lacZ and P-PAH1-DPP1 reporter genes showed that PAH1 expression was induced throughout growth and that the induction in the stationary phase was stimulated by inositol supplementation. A mutant analysis indicated that the Ino2p/Ino4p/Opi1p regulatory circuit and transcription factors Gis1p and Rph1p mediated this regulation.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health Grant from the USPHS [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health Grant from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 from the USPHS.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; CULBERTSON MR, 1975, GENETICS, V80, P23; DAVIDSON JB, 1971, BIOCHEM BIOPH RES CO, V42, P1191, DOI 10.1016/0006-291X(71)90032-5; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; HOSHIZAKI DK, 1990, J BIOL CHEM, V265, P4736; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENNEDY EP, 1961, FED PROC, V20, P934; KIYASU JY, 1963, J BIOL CHEM, V238, P2293; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kocsis MG, 1996, LIPIDS, V31, P785, DOI 10.1007/BF02522974; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; LIAO MJ, 1979, BIOCHIM BIOPHYS ACTA, V550, P157, DOI 10.1016/0005-2736(79)90204-9; LIN YP, 1989, J BIOL CHEM, V264, P8641; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Murray M, 1997, MOL MICROBIOL, V25, P541, DOI 10.1046/j.1365-2958.1997.4881840.x; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Quinn J. E., 2001, THESIS RUTGERS U NEW; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P4460, DOI 10.1093/nar/28.22.4460; Rose MD., 1990, METHODS YEAST GENETI; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Stukey J, 1997, PROTEIN SCI, V6, P469; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; van Kuilenburg ABP, 2000, BBA-GENE STRUCT EXPR, V1492, P548, DOI 10.1016/S0167-4781(00)00141-X; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; WEISS SB, 1958, J BIOL CHEM, V231, P53; WEISS SB, 1960, J BIOL CHEM, V235, P40; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	142	44	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35781	35792		10.1074/jbc.M113.525766	http://dx.doi.org/10.1074/jbc.M113.525766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24196957	Green Published, hybrid			2022-12-28	WOS:000329814700016
J	Wong, LY; Hatfield, JK; Brown, MA				Wong, Larry Y.; Hatfield, Julianne K.; Brown, Melissa A.			Ikaros Sets the Potential for Th17 Lineage Gene Expression through Effects on Chromatin State in Early T Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Immunology; T Cell; Transcription Factors; Transcription Regulation	ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; RETRACTED ARTICLE. SEE; TRANSCRIPTION FACTORS; T(H)17 DIFFERENTIATION; CUTTING EDGE; T-H-17 CELLS; HISTONE H3; ACTIVATION; CYTOKINE	Th17 cells are important effectors of immunity to extracellular pathogens, particularly at mucosal surfaces, but they can also contribute to pathologic tissue inflammation and autoimmunity. Defining the multitude of factors that influence their development is therefore of paramount importance. Our previous studies using Ikaros(-/-) CD4+ T cells implicated Ikaros in Th1 versus Th2 lineage decisions. Here we demonstrate that Ikaros also regulates Th17 differentiation through its ability to promote expression of multiple Th17 lineage-determining genes, including Ahr, Runx1, Rorc, Il17a, and Il22. Ikaros exerts its influence on the chromatin remodeling of these loci at two distinct stages in CD4+ T helper cell development. In naive cells, Ikaros is required to limit repressive chromatin modifications at these gene loci, thus maintaining the potential for expression of the Th17 gene program. Subsequently, Ikaros is essential for the acquisition of permissive histone marks in response to Th17 polarizing signals. Additionally, Ikaros represses the expression of genes that limit Th17 development, including Foxp3 and Tbx21. These data define new targets of the action of Ikaros and indicate that Ikaros plays a critical role in CD4+ T cell differentiation by integrating specific cytokine cues and directing epigenetic modifications that facilitate activation or repression of relevant genes that drive T cell lineage choice.	[Wong, Larry Y.; Hatfield, Julianne K.; Brown, Melissa A.] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Brown, MA (corresponding author), Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, 303 E Chicago Ave,Tarry 6-701, Chicago, IL 60611 USA.	m-brown12@northwestern.edu			National Institutes of Health [R21 NS047578, R56 AI082407]; MS Society grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MS Society grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS047578 and R56 AI082407 (to M. A. B.). This work was also supported by an MS Society grant.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brembilla NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018741; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Funatake CJ, 2005, J IMMUNOL, V175, P4184, DOI 10.4049/jimmunol.175.7.4184; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koipally J, 2002, J BIOL CHEM, V277, P23143, DOI 10.1074/jbc.M202079200; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Koipally J, 1999, COLD SPRING HARB SYM, V64, P79, DOI 10.1101/sqb.1999.64.79; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Marks BR, 2009, NAT IMMUNOL, V10, P1125, DOI 10.1038/ni.1783; McGeachy MJ, 2012, J IMMUNOL, V189, P3285, DOI 10.4049/jimmunol.1201834; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Nakahama T, 2011, P NATL ACAD SCI USA, V108, P14222, DOI 10.1073/pnas.1111786108; Nichogiannopoulou A, 1998, SEMIN IMMUNOL, V10, P119, DOI 10.1006/smim.1998.0113; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Oukka M, 2007, ANN RHEUM DIS, V66, P87, DOI 10.1136/ard.2007.078527; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Ramirez JM, 2010, EUR J IMMUNOL, V40, P2450, DOI 10.1002/eji.201040461; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2010, J BIOL CHEM, V285, P2545, DOI 10.1074/jbc.M109.038794; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Umetsu SE, 2009, J IMMUNOL, V183, P5518, DOI 10.4049/jimmunol.0901284; Urban JA, 2004, J IMMUNOL, V173, P4470, DOI 10.4049/jimmunol.173.7.4470; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2010, CURR OPIN IMMUNOL, V22, P747, DOI 10.1016/j.coi.2010.09.001; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036; Zygmunt B, 2011, ADV IMMUNOL, V109, P159, DOI 10.1016/B978-0-12-387664-5.00005-4	68	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35170	35179		10.1074/jbc.M113.481440	http://dx.doi.org/10.1074/jbc.M113.481440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145030	Green Published, hybrid			2022-12-28	WOS:000329867600018
J	Blattler, A; Farnham, PJ				Blattler, Adam; Farnham, Peggy J.			Cross-talk between Site-specific Transcription Factors and DNA Methylation States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						DNA-binding Protein; DNA Methylation; Epigenetics; Gene Regulation; Transcription Factors	ZINC-FINGER PROTEINS; CPG-BINDING; CHROMATIN-STRUCTURE; STRUCTURAL BASIS; TARGET GENES; SRA DOMAIN; HISTONE H3; METHYLTRANSFERASE; ISLANDS; DEMETHYLATION	DNA methylation, which occurs predominantly at CpG dinucleotides, is a potent epigenetic repressor of transcription. Because DNA methylation is reversible, there is much interest in understanding the mechanisms by which it can be regulated by DNA-binding transcription factors. We discuss several models that, by incorporating sequence motifs, CpG density, and methylation levels, attempt to link the binding of a transcription factor with the acquisition or loss of DNA methylation at promoters and distal regulatory elements. Additional in vivo genome-wide characterization of transcription factor binding patterns and high-resolution DNA methylation analyses are clearly required for stronger support of each model.	[Blattler, Adam; Farnham, Peggy J.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90089 USA; [Blattler, Adam] Univ Calif Davis, Genet Grad Grp, Davis, CA 95676 USA	University of Southern California; University of California System; University of California Davis	Farnham, PJ (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, 1450 Biggy St,NRT 6503, Los Angeles, CA 90089 USA.	peggy.farnham@med.usc.edu		Blattler, Adam/0000-0002-4682-7201; Farnham, Peggy/0000-0003-4469-7914	National Institutes of Health through the United States Public Health Service [HG006996]; National Institutes of Health Predoctoral Training Fellowship [F3100HG6114]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F31HG006114, U54HG006996] Funding Source: NIH RePORTER	National Institutes of Health through the United States Public Health Service; National Institutes of Health Predoctoral Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grant HG006996 through the United States Public Health Service.; Supported in part by National Institutes of Health Predoctoral Training Fellowship F3100HG6114.	Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bartels SJJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025884; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Blattler A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-13; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Campanero MR, 2000, P NATL ACAD SCI USA, V97, P6481, DOI 10.1073/pnas.100340697; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; de la Rica L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r99; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Franchini DM, 2012, ANNU REV GENET, V46, P419, DOI 10.1146/annurev-genet-110711-155451; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Fujiki K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3262; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; Lee DH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001224; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Lienert F, 2011, NAT GENET, V43, P1091, DOI 10.1038/ng.946; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu YW, 2013, TRENDS BIOCHEM SCI, V38, P177, DOI 10.1016/j.tibs.2012.12.005; Long HK, 2013, BIOCHEM SOC T, V41, P727, DOI 10.1042/BST20130028; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Mann IK, 2013, GENOME RES, V23, P988, DOI 10.1101/gr.146654.112; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Moss TJ, 2007, MUTAT RES-FUND MOL M, V618, P163, DOI 10.1016/j.mrfmmm.2006.05.038; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Qian CM, 2008, J BIOL CHEM, V283, P34490, DOI 10.1074/jbc.C800169200; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Statham AL, 2012, GENOME RES, V22, P1120, DOI 10.1101/gr.132076.111; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Verschure PJ, 2005, MOL CELL BIOL, V25, P4552, DOI 10.1128/MCB.25.11.4552-4564.2005; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Zhou JC, 2012, MOL CELL BIOL, V32, P479, DOI 10.1128/MCB.06332-11	79	130	132	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34287	34294		10.1074/jbc.R113.512517	http://dx.doi.org/10.1074/jbc.R113.512517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151070	Green Published, hybrid			2022-12-28	WOS:000329812800001
J	Chen, YC; Pristera, A; Ayub, M; Swanwick, RS; Karu, K; Hamada, Y; Rice, ASC; Okuse, K				Chen, Ya-Chun; Pristera, Alessandro; Ayub, Mahmood; Swanwick, Richard S.; Karu, Kersti; Hamada, Yosuke; Rice, Andrew S. C.; Okuse, Kenji			Identification of a Receptor for Neuropeptide VGF and Its Role in Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Intracellular Release; Macrophages; Neurons; Neuropeptide; Pain; VGF; gC1qR; Neuropathic Pain; Sensory Neurons	DORSAL-ROOT GANGLION; GENE-EXPRESSION; PEPTIDE TLQP-21; IN-VITRO; PROTEIN; MACROPHAGES; ACTIVATION; CALCIUM; BINDING; C1Q	Background: VGF is a neuropeptide involved in chronic pain. Results: VGF-derived peptide TLQP-21 activates macrophages. We identified gC1qR as a receptor for TLQP-21. Conclusion: TLQP-21 and gC1qR are involved in chronic pain pathways. Significance: TLQP-21 and gC1qR may be drug targets for chronic pain treatment. VGF (nonacronymic) is a neuropeptide precursor that plays multiple roles in regulation of energy balance, reproduction, hippocampal synaptic plasticity, and pain. Data from a number of pain models showed significant up-regulation of VGF in sensory neurons. TLQP-21, one of the VGF-derived neuropeptides, has been shown to induce a hyperalgesic response when injected subcutaneously into the hind paw of mice. However, the precise role of VGF-derived neuropeptides in neuropathic pain and the molecular identity of the receptor for VGF-derived peptides are yet to be investigated. Here we identified gC1qR, the globular heads of the C1q receptor, as the receptor for TLQP-21 using chemical cross-linking combined with mass spectrometry analysis. TLQP-21 caused an increase in intracellular Ca2+ levels in rat macrophages and microglia. Inoculation of TLQP-21-stimulated macrophages into rat hind paw caused mechanical hypersensitivity. The increase in intracellular Ca2+ levels in macrophages was attenuated by either siRNA or neutralizing antibodies against gC1qR. Furthermore, application of the gC1qR-neutralizing antibody to rats with partial sciatic nerve ligation resulted in a delayed onset of nerve injury-associated mechanical hypersensitivity. These results indicate that gC1qR is the receptor for TLQP-21 and plays an important role in chronic pain through activation of macrophages. Because direct association between TLQP-21 and gC1qR is required for activation of macrophages and causes hypersensitivity, disrupting this interaction may be a useful new approach to develop novel analgesics.	[Chen, Ya-Chun; Pristera, Alessandro; Ayub, Mahmood; Swanwick, Richard S.; Karu, Kersti; Hamada, Yosuke; Okuse, Kenji] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England; [Rice, Andrew S. C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW10 9NH, England	Imperial College London; Imperial College London	Okuse, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England.	k.okuse@imperial.ac.uk	Rice, Andrew/I-7501-2012; Ayub, Mahmood/V-8792-2019	Ayub, Mahmood/0000-0002-2096-2704	Wellcome Trust United Kingdom; BBSRC; EU-IMI	Wellcome Trust United Kingdom(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU-IMI	This work was supported by the Wellcome Trust United Kingdom (to Y.-C. C., A. P., R. S. S., A. S. C. R., and K. O.), BBSRC (to M. A.), and EU-IMI (to K. K, A. S. C. R., and K. O.).	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Baker MD, 2011, MOL CELL NEUROSCI, V48, P258, DOI 10.1016/j.mcn.2011.08.007; Barbasz A, 2008, INT IMMUNOPHARMACOL, V8, P211, DOI 10.1016/j.intimp.2007.08.002; Bordin S, 1998, J PERIODONTOL, V69, P642, DOI 10.1902/jop.1998.69.6.642; Brown DM, 2004, AM J PHYSIOL-LUNG C, V286, pL344, DOI 10.1152/ajplung.00139.2003; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Cassina V, 2013, BBA-BIOMEMBRANES, V1828, P455, DOI 10.1016/j.bbamem.2012.10.023; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Duus K, 2010, FEBS J, V277, P3526, DOI 10.1111/j.1742-4658.2010.07762.x; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Garlatti V, 2010, J IMMUNOL, V185, P808, DOI 10.4049/jimmunol.1000184; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Hannedouche S, 2013, J BIOL CHEM, V288, P27434, DOI 10.1074/jbc.M113.497214; Kim KB, 2009, PROTEOMICS, V9, P2373, DOI 10.1002/pmic.200800811; Korhonen R, 2001, BIOCHEM J, V354, P351, DOI 10.1042/0264-6021:3540351; Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Maratou K, 2009, EUR J PAIN, V13, P387, DOI 10.1016/j.ejpain.2008.05.011; Mert T, 2009, N-S ARCH PHARMACOL, V379, P445, DOI 10.1007/s00210-008-0387-3; Moss A, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-62; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Prakash M, 2011, CELL SIGNAL, V23, P1563, DOI 10.1016/j.cellsig.2011.04.009; Pristera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040079; Riedl MS, 2009, J NEUROSCI, V29, P13377, DOI 10.1523/JNEUROSCI.1127-09.2009; Rizzi R, 2008, NEUROSCI LETT, V441, P129, DOI 10.1016/j.neulet.2008.06.018; Roumenina LT, 2006, BIOCHEMISTRY-US, V45, P4093, DOI 10.1021/bi052646f; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Shao D, 2009, MOL CELL NEUROSCI, V42, P219, DOI 10.1016/j.mcn.2009.07.003; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Storz P, 2000, J BIOL CHEM, V275, P24601, DOI 10.1074/jbc.M002964200; Tan LA, 2010, PROTEIN CELL, V1, P1033, DOI 10.1007/s13238-010-0125-8; Tange TO, 1996, J BIOL CHEM, V271, P10066, DOI 10.1074/jbc.271.17.10066; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Vulchanova L., 2012, SOC NEUR ABSTR, V267; Wallace VCJ, 2007, BRAIN, V130, P2688, DOI 10.1093/brain/awm195; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Xiao S, 2001, CLIN EXP IMMUNOL, V125, P360, DOI 10.1046/j.1365-2249.2001.01597.x; Zutter MM, 2007, IMMUNOBIOLOGY, V212, P343, DOI 10.1016/j.imbio.2006.11.013	39	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34638	34646		10.1074/jbc.M113.510917	http://dx.doi.org/10.1074/jbc.M113.510917			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24106277	Green Published, hybrid			2022-12-28	WOS:000329812800031
J	Nagae, M; Yamanaka, K; Hanashima, S; Ikeda, A; Morita-Matsumoto, K; Satoh, T; Matsumoto, N; Yamamoto, K; Yamaguchi, Y				Nagae, Masamichi; Yamanaka, Kousuke; Hanashima, Shinya; Ikeda, Akemi; Morita-Matsumoto, Kana; Satoh, Tadashi; Matsumoto, Naoki; Yamamoto, Kazuo; Yamaguchi, Yoshiki			Recognition of Bisecting N-Acetylglucosamine STRUCTURAL BASIS FOR ASYMMETRIC INTERACTION WITH THE MOUSE LECTIN DENDRITIC CELL INHIBITORY RECEPTOR 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Crystal Structure; Dendritic Cells; Lectin; Receptors; C-type Lectin; DCIR2; Bisecting N-Acetylglucosamine; Glycan	IMMUNOGLOBULIN-G; SUGAR CHAINS; DC-SIGN; LINKED OLIGOSACCHARIDES; IMMUNE-RESPONSES; INHIBITORY MOTIF; SURFACE-RECEPTOR; LIGAND-BINDING; COMPLEX; AFFINITY	Dendritic cell inhibitory receptor 2 (DCIR2) is a C-type lectin expressed on classical dendritic cells. We recently identified the unique ligand specificity of mouse DCIR2 (mDCIR2) toward biantennary complex-type glycans containing bisecting N-acetylglucosamine (GlcNAc). Here, we report the crystal structures of the mDCIR2 carbohydrate recognition domain in unliganded form as well as in complex with an agalactosylated complex-type N-glycan unit carrying a bisecting GlcNAc residue. Bisecting GlcNAc and the 1-3 branch of the biantennary oligosaccharide asymmetrically interact with canonical and non-canonical mDCIR2 residues. Ligand-protein interactions occur directly through mDCIR2-characteristic amino acid residues as well as via a calcium ion and water molecule. Our structural and biochemical data elucidate for the first time the unique binding mode of mDCIR2 for bisecting GlcNAc-containing glycans, a mode that contrasts sharply with that of other immune C-type lectin receptors such as DC-SIGN.	[Nagae, Masamichi; Hanashima, Shinya; Ikeda, Akemi; Morita-Matsumoto, Kana; Satoh, Tadashi; Yamaguchi, Yoshiki] RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Struct Glycobiol Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Yamanaka, Kousuke; Matsumoto, Naoki; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	RIKEN; University of Tokyo	Yamaguchi, Y (corresponding author), RIKEN, Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Struct Glycobiol Team,Syst Glycobiol Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yyoshiki@riken.jp	Hanashima, Shinya/AGN-0921-2022; Yamaguchi, Yoshiki/N-5246-2015; Satoh, Tadashi/M-5157-2017	Hanashima, Shinya/0000-0003-3102-7890; Yamaguchi, Yoshiki/0000-0003-0100-5439; Satoh, Tadashi/0000-0002-4493-4978; Nagae, Masamichi/0000-0002-5470-3807	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460054, 24770111]; Grants-in-Aid for Scientific Research [24770102, 25460054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Scientific Research (C) 25460054 (to Y. Y.) and for Young Scientists (B) 24770111 (to M. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bates EEM, 1999, J IMMUNOL, V163, P1973; Benevides RG, 2012, J BIOL CHEM, V287, P26352, DOI 10.1074/jbc.M112.375816; Bhattacharyya R, 2002, J BIOL CHEM, V277, P26300, DOI 10.1074/jbc.M202276200; BHAUMIK M, 1995, GENE, V164, P295, DOI 10.1016/0378-1119(95)00260-D; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; FUJII S, 1990, J BIOL CHEM, V265, P6009; Futakawa S, 2012, NEUROBIOL AGING, V33, P1807, DOI 10.1016/j.neurobiolaging.2011.02.023; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HOFFMANN A, 1995, FEBS LETT, V359, P164, DOI 10.1016/0014-5793(95)00034-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Igarashi T, 2007, FEBS LETT, V581, P2416, DOI 10.1016/j.febslet.2007.04.057; IRIMURA T, 1981, BIOCHEMISTRY-US, V20, P560, DOI 10.1021/bi00506a018; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Kaden SA, 2009, J IMMUNOL, V183, P5069, DOI 10.4049/jimmunol.0900908; Kanazawa N, 2002, J INVEST DERMATOL, V118, P261, DOI 10.1046/j.0022-202x.2001.01633.x; Kasahara S, 2012, J LEUKOCYTE BIOL, V91, P437, DOI 10.1189/jlb.0711384; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; MIZUOCHI T, 1990, J IMMUNOL, V145, P1794; MIZUOCHI T, 1987, ARCH BIOCHEM BIOPHYS, V257, P387, DOI 10.1016/0003-9861(87)90581-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; NAKAGAWA H, 1995, ANAL BIOCHEM, V226, P130, DOI 10.1006/abio.1995.1200; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Nishima W, 2012, J PHYS CHEM B, V116, P8504, DOI 10.1021/jp212550z; NUSSENZWEIG MC, 1982, P NATL ACAD SCI-BIOL, V79, P161, DOI 10.1073/pnas.79.1.161; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Qin SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394288; Re S, 2011, BIOPHYS J, V101, pL44, DOI 10.1016/j.bpj.2011.10.019; Riboldi E, 2011, J BIOL CHEM, V286, P35329, DOI 10.1074/jbc.C111.290494; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Shibukawa Y, 2003, J BIOL CHEM, V278, P3197, DOI 10.1074/jbc.M207870200; Shigeta M, 2006, GLYCOBIOLOGY, V16, P564, DOI 10.1093/glycob/cwj100; SHIMIZU H, 1993, J BIOCHEM-TOKYO, V114, P334, DOI 10.1093/oxfordjournals.jbchem.a124177; Stanley P, 2002, BBA-GEN SUBJECTS, V1573, P363, DOI 10.1016/S0304-4165(02)00404-X; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; TAKAHASHI N, 1987, BIOCHEMISTRY-US, V26, P1137, DOI 10.1021/bi00378a023; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017; YAMASHITA K, 1983, J BIOL CHEM, V258, P4753; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	60	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33598	33610		10.1074/jbc.M113.513572	http://dx.doi.org/10.1074/jbc.M113.513572			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108122	hybrid, Green Published			2022-12-28	WOS:000327250200009
J	Sheridan, JT; Gilmore, RC; Watson, MJ; Archer, CB; Tarran, R				Sheridan, John T.; Gilmore, Rodney C.; Watson, Michael J.; Archer, Christopher B.; Tarran, Robert			17 beta-Estradiol Inhibits Phosphorylation of Stromal Interaction Molecule 1 (STIM1) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Cystic Fibrosis; Epithelial Cell; Estrogen; Phosphorylation	SURFACE LIQUID VOLUME; CYSTIC-FIBROSIS; CRAC CHANNEL; CALCIUM-ENTRY; CA2+ STORE; ORAI1; OLIGOMERIZATION; ACTIVATION; RECEPTOR; CYTOSKELETON	Sex plays a significant role in the development of lung diseases including asthma, cancer, chronic bronchitis, and cystic fibrosis. In cystic fibrosis, 17-estradiol (E2) may inhibit store-operated Ca2+ entry (SOCE) to impinge upon airway secretions, leaving females at greater risk of contracting lung infections. Stromal interaction molecule 1 (STIM1)-mediated SOCE is essential for cell homeostasis and regulates numerous processes including cell proliferation, smooth muscle contraction, and secretion. E2 can signal nongenomically to modulate Ca2+ signaling, but little is known of the underlying mechanisms. We found that E2 exposure inhibited STIM1 translocation in airway epithelia, preventing SOCE. This correlated with a decrease in STIM1-STIM1 FRET and STIM1 mobility in E2-exposed HEK293T cells co-expressing estrogen receptor . We also examined the role of STIM1 phosphorylation in E2-mediated inhibition of STIM1 mobility. STIM1 is basally phosphorylated at serine 575, which is required for SOCE. Exposure to E2 significantly decreased STIM1 serine phosphorylation. Mutating serine 575 to an alanine blocked STIM1 phosphorylation, reduced basal STIM1 mobility, and rendered STIM1 insensitive to E2. These data indicate that E2 can signal nongenomically by inhibiting basal phosphorylation of STIM1, leading to a reduction in SOCE.	[Sheridan, John T.; Tarran, Robert] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Gilmore, Rodney C.; Watson, Michael J.; Archer, Christopher B.; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tarran, R (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA.	tarran@med.unc.edu		Watson, Michael/0000-0002-3715-3153	Cystic Fibrosis Foundation; British American Tobacco; National Institutes of Health [RO1 HL-10927, PPG HL-034322]; Howard Hughes Medical Institute Med-into-Grad University of North Carolina program; Dr. Susan Fellner physiology graduate student research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108927, P01HL034322] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); British American Tobacco; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Med-into-Grad University of North Carolina program; Dr. Susan Fellner physiology graduate student research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Cystic Fibrosis Foundation, British American Tobacco, and National Institutes of Health Grants RO1 HL-10927 and PPG HL-034322.; Supported by the Dr. Susan Fellner physiology graduate student research fellowship and the Howard Hughes Medical Institute Med-into-Grad University of North Carolina program in translational medicine.	Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Block JK, 2006, THORAX, V61, P969, DOI 10.1136/thx.2006.061366; Chotirmall SH, 2012, NEW ENGL J MED, V366, P1978, DOI 10.1056/NEJMoa1106126; Cioffi DL, 2012, CIRC RES, V110, P1435, DOI 10.1161/CIRCRESAHA.112.269506; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; DEMKO CA, 1995, J CLIN EPIDEMIOL, V48, P1041, DOI 10.1016/0895-4356(94)00230-N; Di Capite JL, 2011, CURR OPIN ALLERGY CL, V11, P33, DOI 10.1097/ACI.0b013e32834232b0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Kilch T, 2013, J BIOL CHEM, V288, P1653, DOI 10.1074/jbc.M112.417246; Lai HY, 2010, CURR OPIN ALLERGY CL, V10, P67, DOI 10.1097/ACI.0b013e328334643a; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; PARADISO AM, 1995, NATURE, V377, P643, DOI 10.1038/377643a0; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Randell SH, 2011, METHODS MOL BIOL, V742, P285, DOI 10.1007/978-1-61779-120-8_18; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2004, J BIOL CHEM, V279, P29231, DOI 10.1074/jbc.M403509200; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23; Schatz M, 2003, ANN ALLERG ASTHMA IM, V91, P553, DOI 10.1016/S1081-1206(10)61533-5; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Siegfried JM, 2001, LANCET ONCOL, V2, P506, DOI 10.1016/S1470-2045(01)00457-0; Silverman EK, 2000, AM J RESP CRIT CARE, V162, P2152, DOI 10.1164/ajrccm.162.6.2003112; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Smyth JT, 2012, CURR BIOL, V22, P1487, DOI 10.1016/j.cub.2012.05.057; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Townsend EA, 2012, AM J PHYSIOL-LUNG C, V303, pL923, DOI 10.1152/ajplung.00023.2012; Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang MJ, 2006, AM J PHYSIOL-HEART C, V290, pH2204, DOI 10.1152/ajpheart.01219.2005; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Wu Q, 2011, J BIOL CHEM, V286, P14737, DOI 10.1074/jbc.R110.191791; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	47	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33509	33518		10.1074/jbc.M113.486662	http://dx.doi.org/10.1074/jbc.M113.486662			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114840	hybrid, Green Published			2022-12-28	WOS:000327250200002
J	Van Cor-Hosmer, SK; Kim, DH; Daly, MB; Daddacha, W; Kim, B				Van Cor-Hosmer, Sarah K.; Kim, Dong-Hyun; Daly, Michele B.; Daddacha, Waaqo; Kim, Baek			Restricted 5 '-End Gap Repair of HIV-1 Integration Due to Limited Cellular dNTP Concentrations in Human Primary Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; DNA Repair; HIV-1; Macrophages; Monocytes; DNA Gap Filling; Integration; dNTP	IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL DNA INTEGRATION; CENTRAL POLYPURINE TRACT; REVERSE-TRANSCRIPTASE; POLYMERASE-BETA; IN-VITRO; REPLICATION; PROTEIN; SAMHD1; INFECTION	Background: The cellular DNA repair machinery completes the 5-end gap repair of HIV-1 integration. Results: The 5-end DNA gap repair of HIV-1 integration depends on dNTP availability in macrophages, monocytes, and CD4(+) T cells. Conclusion: 5-End DNA gap repair is a rate-limiting step in HIV-1 integration in macrophages and monocytes due to limited cellular dNTPs. Significance: Availability of cellular dNTP and polymerase controls HIV-1 integration kinetics. HIV-1 proviral DNA integration into host chromosomal DNA is only partially completed by the viral integrase, leaving two single-stranded DNA gaps with 5-end mismatched viral DNA flaps. It has been inferred that these gaps are repaired by the cellular DNA repair machinery. Here, we investigated the efficiency of gap repair at integration sites in different HIV-1 target cell types. First, we found that the general gap repair machinery in macrophages was attenuated compared with that in dividing CD4(+) T cells. In fact, the repair in macrophages was heavily reliant upon host DNA polymerase (Pol ). Second, we tested whether the poor dNTP availability found in macrophages is responsible for the delayed HIV-1 proviral DNA integration in this cell type because the K-m value of Pol is much higher than the dNTP concentrations found in macrophages. Indeed, with the use of a modified quantitative AluI PCR assay, we demonstrated that the elevation of cellular dNTP concentrations accelerated DNA gap repair in macrophages at HIV-1 proviral DNA integration sites. Finally, we found that human monocytes, which are resistant to HIV-1 infection, exhibited severely restricted gap repair capacity due not only to the very low levels of dNTPs detected but also to the significantly reduced expression of Pol . Taken together, these results suggest that the low dNTP concentrations found in macrophages and monocytes can restrict the repair steps necessary for HIV-1 integration.	[Van Cor-Hosmer, Sarah K.; Daddacha, Waaqo] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Coll Pharm, Seoul 130701, South Korea; [Daly, Michele B.; Kim, Baek] Emory Univ, Ctr Drug Discovery, Dept Pediat, Emory Ctr AIDS Res, Atlanta, GA 30322 USA	University of Rochester; Kyung Hee University; Emory University	Kim, B (corresponding author), Emory Univ, Ctr Drug Discovery, Dept Pediat, Hlth Sci Res Bldg,1760 Haygood Dr, Atlanta, GA 30322 USA.	baek.kim@emory.edu			National Institutes of Health [AI049781, F31 GM095190]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815, R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to B. K.) and F31 GM095190 (to W. D.).	Akbari M, 2009, DNA REPAIR, V8, P834, DOI 10.1016/j.dnarep.2009.04.002; Albright AV, 2000, AIDS RES HUM RETROV, V16, P1527, DOI 10.1089/088922200750006056; Amie SM, 2013, VIROLOGY, V436, P247, DOI 10.1016/j.virol.2012.11.010; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; BUSHMAN FD, 1991, P NATL ACAD SCI USA, V88, P1339, DOI 10.1073/pnas.88.4.1339; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; Clapham PR, 2002, J GEN VIROL, V83, P1809, DOI 10.1099/0022-1317-83-8-1809; COLLIN M, 1994, VIROLOGY, V200, P114, DOI 10.1006/viro.1994.1169; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Espeseth AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017612; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; Gavegnano C., 2012, MOL BIOL INT, V2012; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Imoto S, 2008, BIOCHEMISTRY-US, V47, P4306, DOI 10.1021/bi7021427; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Johnson A, 2005, CURR BIOL, V15, pR90, DOI 10.1016/j.cub.2005.01.025; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MASTRO AM, 1986, CELL TISSUE KINET, V19, P557, DOI 10.1111/j.1365-2184.1986.tb00756.x; Michelini Z, 2010, J VIROL METHODS, V168, P272, DOI 10.1016/j.jviromet.2010.06.004; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; OBRIEN WA, 1994, J LEUKOCYTE BIOL, V56, P273, DOI 10.1002/jlb.56.3.273; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Simsek D, 2011, CELL CYCLE, V10, P3636, DOI 10.4161/cc.10.21.18094; Singh J, 1996, J BIOL CHEM, V271, P28391, DOI 10.1074/jbc.271.45.28391; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Van Cor-Hosmer SK, 2012, VIROLOGY, V422, P393, DOI 10.1016/j.virol.2011.11.004; Van Cor-Hosmer SK, 2010, VIROLOGY, V406, P253, DOI 10.1016/j.virol.2010.07.028; Vatakis DN, 2007, J VIROL, V81, P3574, DOI 10.1128/JVI.02569-06; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yoder KE, 2000, J VIROL, V74, P11191, DOI 10.1128/JVI.74.23.11191-11200.2000; Yoder KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017862	48	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33253	33262		10.1074/jbc.M113.486787	http://dx.doi.org/10.1074/jbc.M113.486787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097986	hybrid, Green Published			2022-12-28	WOS:000328841700039
J	Rather, MI; Swamy, S; Gopinath, KS; Kumar, A				Rather, Mohammad Iqbal; Swamy, Shivananda; Gopinath, Kodaganur S.; Kumar, Arun			Transcriptional Repression of Tumor Suppressor CDC73, Encoding an RNA Polymerase II Interactor, by Wilms Tumor 1 Protein (WT1) Promotes Cell Proliferation IMPLICATION FOR CANCER THERAPEUTICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE WT1; HRPT2 GENE; PARAFIBROMIN EXPRESSION; PARATHYROID CARCINOMA; PROGENITOR CELLS; PAF1 COMPLEX; METHYLATION; INVOLVEMENT; GROWTH; HYPERPARATHYROIDISM	The Wilms tumor 1 gene (WT1) can either repress or induce the expression of genes. Inconsistent with its tumor suppressor role, elevated WT1 levels have been observed in leukemia and solid tumors. WT1 has also been suggested to act as an oncogene by inducing the expression of MYC and BCL-2. However, these are only the correlational studies, and no functional study has been performed to date. Consistent with its tumor suppressor role, CDC73 binds to RNA polymerase II as part of a PAF1 transcriptional regulatory complex and causes transcriptional repression of oncogenes MYC and CCND1. It also represses beta-catenin-mediated transcription. Based on the reduced level of CDC73 in oral squamous cell carcinoma (OSCC) samples in the absence of loss-of-heterozygosity, promoter methylation, and mutations, we speculated that an inhibitory transcription factor is regulating its expression. The bioinformatics analysis predicted WT1 as an inhibitory transcription factor to regulate the CDC73 level. Our results showed that overexpression of WT1 decreased CDC73 levels and promoted proliferation of OSCC cells. ChIP and EMSA results demonstrated binding of WT1 to the CDC73 promoter. The 5-azacytidine treatment of OSCC cells led to an up-regulation of WT1 with a concomitant down-regulation of CDC73, further suggesting regulation of CDC73 by WT1. Exogenous CDC73 attenuated the protumorigenic activity of WT1 by apoptosis induction. An inverse correlation between expression levels of CDC73 and WT1 was observed in OSCC samples. These observations indicated that WT1 functions as an oncogene by repressing the expression of CDC73 in OSCC. We suggest that targeting WT1 could be a therapeutic strategy for cancer, including OSCC.	[Rather, Mohammad Iqbal; Kumar, Arun] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Swamy, Shivananda; Gopinath, Kodaganur S.] HCG Bangalore Inst Oncol, Dept Surg Oncol, Bangalore 560027, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kumar, A (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	karun@mrdg.iisc.ernet.in	Kumar, Arun/C-9149-2009	Kumar, Arun/0000-0001-8422-0219	Department of Science and Technology, New Delhi, India	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, New Delhi, India.	Bajaj V, 2008, GENE, V424, P40, DOI 10.1016/j.gene.2008.07.032; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cetani F, 2004, J CLIN ENDOCR METAB, V89, P5583, DOI 10.1210/jc.2004-0294; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Hahn MA, 2010, ENDOCR-RELAT CANCER, V17, P273, DOI 10.1677/ERC-09-0291; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; Hewitt KM, 2007, ANN OTO RHINOL LARYN, V116, P928, DOI 10.1177/000348940711601210; Inoue K, 1998, BLOOD, V91, P2969, DOI 10.1182/blood.V91.8.2969.2969_2969_2976; James RG, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000230; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeb DM, 2001, CANCER RES, V61, P921; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; Mikami T, 2013, J ORAL PATHOL MED, V42, P133, DOI 10.1111/j.1600-0714.2012.01182.x; Oji Y, 1999, JPN J CANCER RES, V90, P194, DOI 10.1111/j.1349-7006.1999.tb00733.x; Oka Y, 2000, IMMUNOGENETICS, V51, P99, DOI 10.1007/s002510050018; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Osaka M, 1997, INT J CANCER, V72, P696, DOI 10.1002/(SICI)1097-0215(19970807)72:4<696::AID-IJC23>3.0.CO;2-8; Pannone G, 2010, ONCOL REP, V24, P1035, DOI 10.3892/or_00000952; Rather MI, 2013, J BIOL CHEM, V288, P608, DOI 10.1074/jbc.M112.425736; REDDY JC, 1995, J BIOL CHEM, V270, P29976; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Satoh Y, 2003, J BIOCHEM, V133, P303, DOI 10.1093/jb/mvg041; Selvarajan S, 2008, J CLIN PATHOL, V61, P64, DOI 10.1136/jcp.2007.048694; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Tsuboi A, 1999, LEUKEMIA RES, V23, P499, DOI 10.1016/S0145-2126(99)00037-5; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yamagami T, 1996, BLOOD, V87, P2878, DOI 10.1182/blood.V87.7.2878.bloodjournal8772878; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zhang C, 2006, BIOCHEM BIOPH RES CO, V350, P17, DOI 10.1016/j.bbrc.2006.08.169; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zheng HC, 2008, VIRCHOWS ARCH, V452, P147, DOI 10.1007/s00428-007-0551-z	34	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					968	976		10.1074/jbc.M113.483255	http://dx.doi.org/10.1074/jbc.M113.483255			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24257751	Green Published, hybrid			2022-12-28	WOS:000330541200031
J	Joshi, M; Duan, D; Drew, D; Jia, ZM; Davis, D; Campbell, RL; Allingham, JS				Joshi, Monika; Duan, Da; Drew, Doran; Jia, Zhimeng; Davis, Darlene; Campbell, Robert L.; Allingham, John S.			Kar3Vik1 Mechanochemistry Is Inhibited by Mutation or Deletion of the C Terminus of the Vik1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinesin; Mechanotransduction; Microtubules; Molecular Dynamics; Molecular Motors; ATPase; Kar3; Motility; Neck Mimic; Vik1	KINESIN MOTOR PROTEIN; END-DIRECTED KINESIN; CRYSTAL-STRUCTURE; FORCE GENERATION; DRIVES MOTILITY; ONE HEAD; MICROTUBULES; PROCESSIVITY; MECHANISM; DOMAIN	Force production by kinesins has been linked to structural rearrangements of the N and C termini of their motor domain upon nucleotide binding. In recent crystal structures, the Kar3-associated protein Vik1 shows unexpected homology to these conformational states even though it lacks a nucleotide-binding site. This conservation infers a degree of commonality in the function of the N- and C-terminal regions during the mechanochemical cycle of all kinesins and kinesin-related proteins. We tested this inference by examining the functional effects on Kar3Vik1 of mutating or deleting residues in Vik1 that are involved in stabilizing the C terminus against the core and N terminus of the Vik1 motor homology domain (MHD). Point mutations at two moderately conserved residues near the Vik1 C terminus impaired microtubule gliding and microtubule-stimulated ATP turnover by Kar3Vik1. Deletion of the seven C-terminal residues inhibited Kar3Vik1 motility much more drastically. Interestingly, none of the point mutants seemed to perturb the ability of Kar3Vik1 to bind microtubules, whereas the C-terminal truncation mutant did. Molecular dynamics simulations of these C-terminal mutants showed distinct root mean square fluctuations in the N-terminal region of the Vik1 MHD that connects it to Kar3. Here, the degree of motion in the N-terminal portion of Vik1 highly correlated with that in the C terminus. These observations suggest that the N and C termini of the Vik1 MHD form a discrete folding motif that is part of a communication pathway to the nucleotide-binding site of Kar3.	[Joshi, Monika; Duan, Da; Drew, Doran; Jia, Zhimeng; Davis, Darlene; Campbell, Robert L.; Allingham, John S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Allingham, JS (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Rm 652, Kingston, ON K7L 3N6, Canada.	allinghj@queensu.ca	Jia, Zhimeng/GRI-9437-2022; Allingham, John/AAW-9262-2020; Jia, Zhimeng/AAS-9450-2021	Jia, Zhimeng/0000-0001-8156-5553; Jia, Zhimeng/0000-0001-8156-5553; Campbell, Robert/0000-0002-5473-5876	Natural Sciences and Engineering Research Council (NSERC); Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council (NSERC) and the Canadian Institutes of Health Research (CIHR; to J. S. A.).	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Ambrose JC, 2005, MOL BIOL CELL, V16, P1584, DOI 10.1091/mbc.e04-10-0935; Amos LA, 2007, J CELL SCI, V120, P3919, DOI 10.1242/jcs.016931; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Chen CJ, 2012, J BIOL CHEM, V287, P36673, DOI 10.1074/jbc.M112.395590; Cope J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053792; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Duan D, 2012, J BIOL CHEM, V287, P40292, DOI 10.1074/jbc.M112.416529; Duan D, 2012, PROTEINS, V80, P1016, DOI 10.1002/prot.24004; Ebbing B, 2008, HUM MOL GENET, V17, P1245, DOI 10.1093/hmg/ddn014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Gonzalez MA, 2013, J STRUCT BIOL, V184, P335, DOI 10.1016/j.jsb.2013.09.020; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hesse WR, 2013, BIOPHYS J, V104, P1969, DOI 10.1016/j.bpj.2013.03.051; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin DS, 2010, P NATL ACAD SCI USA, V107, P5453, DOI 10.1073/pnas.0914924107; Rank KC, 2013, BIOL CELL, V105, P1, DOI 10.1111/boc.201200044; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Subramanian R, 2007, J GEN PHYSIOL, V130, P445, DOI 10.1085/jgp.200709866; Szczesna E, 2012, FEBS LETT, V586, P854, DOI 10.1016/j.febslet.2012.02.011; Thoresen T, 2008, BIOCHEMISTRY-US, V47, P9514, DOI 10.1021/bi800747e; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vinogradova MV, 2009, P NATL ACAD SCI USA, V106, P8175, DOI 10.1073/pnas.0811131106; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	55	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36957	36970		10.1074/jbc.M113.492264	http://dx.doi.org/10.1074/jbc.M113.492264			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24240171	Green Published, hybrid			2022-12-28	WOS:000329189700018
J	Liu, X; Xiao, W; Wang, XD; Li, YF; Han, JH; Li, YQ				Liu, Xin; Xiao, Wei; Wang, Xu-Dong; Li, Yue-Fang; Han, Jiahuai; Li, Yingqiu			The p38-interacting Protein (p38IP) Regulates G(2)/M Progression by Promoting alpha-Tubulin Acetylation via Inhibiting Ubiquitination-induced Degradation of the Acetyltransferase GCN5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Cycle; Cell Signaling; Gene Silencing; Molecular Cell Biology; Protein Degradation; -Tubulin; Acetylation; gcn5; p38IP	TATA-BINDING PROTEIN; HISTONE ACETYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; CYTOPLASMIC DYNEIN; CELL-CYCLE; YEAST; COMPLEX; ACTIVATION; ATAC	Background: The role of p38IP in cell cycle regulation remains unclear. Results: p38IP inhibits ubiquitination-induced GCN5 degradation and therefore promotes -tubulin acetylation, facilitating spindle formation and G(2)/M progression. Conclusion: p38IP is required for G(2)/M progression. Significance: This study reveals the necessity of p38IP for GCN5 stability and for G(2)/M progression. p38-interacting protein (p38IP) is a component of the GCN5 histone acetyltransferase-containing coactivator complex (GCN5-SAGA complex). It remains unclear whether p38IP or GCN5-SAGA is involved in cell cycle regulation. Using RNA interference to knock down p38IP, we observed that cells were arrested at the G(2)/M phase, exhibiting accumulation of cyclins, shrunken spindles, and hypoacetylation of -tubulin. Further analysis revealed that knockdown of p38IP led to proteasome-dependent degradation of GCN5. GCN5 associated with and acetylated -tubulin, and recovering GCN5 protein levels in p38IP knockdown cells by ectopic expression of GCN5 efficiently reversed -tubulin hypoacetylation and G(2)/M arrest. During the G(2)/M transition, the association of -tubulin with GCN5 increased, and the acetylation of -tubulin reached a peak. Biochemical analyses demonstrated that the interaction between p38IP and GCN5 depended on the p38IP N terminus (1-381 amino acids) and GCN5 histone acetyltransferase domain and bromodomain. The p38IP N terminus could effectively reverse p38IP depletion-induced GCN5 degradation, thus recovering -tubulin acetylation and G(2)/M progression. p38IP-mediated suppression of GCN5 ubiquitination most likely occurs via nuclear sequestration of GCN5. Our data indicate that the GCN5-SAGA complex is required for G(2)/M progression, mainly because p38IP promotes the acetylation of -tubulin by preventing the degradation of GCN5, in turn facilitating the formation of the mitotic spindle.	[Liu, Xin; Xiao, Wei; Wang, Xu-Dong; Li, Yue-Fang; Li, Yingqiu] Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Han, Jiahuai] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361005, Peoples R China	Sun Yat Sen University; Xiamen University	Li, YQ (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ,Sch Life Sci, 135 Xingang Xi Rd, Guangzhou 510275, Guangdong, Peoples R China.	lsslyq@mail.sysu.edu.cn	Han, J/G-4671-2010; Wang, Xu-Dong/Z-1721-2019	Wang, Xu-Dong/0000-0002-8265-1485	Ministry of Science and Technology of China [2009CB522200, 2013CB835300]; National Natural Science Foundation of China [31170846]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (Grants 2009CB522200 and 2013CB835300) and the National Natural Science Foundation of China (Grant 31170846).	Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Candau R, 1996, MOL CELL BIOL, V16, P593; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; HINNEBUSCH AG, 1983, P NATL ACAD SCI-BIOL, V80, P5374, DOI 10.1073/pnas.80.17.5374; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Lin W, 2007, DEV DYNAM, V236, P1547, DOI 10.1002/dvdy.21160; LUCCHINI G, 1984, MOL CELL BIOL, V4, P1326, DOI 10.1128/MCB.4.7.1326; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Nagy Z, 2009, MOL CELL BIOL, V29, P1649, DOI 10.1128/MCB.01076-08; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Wang LA, 1997, MOL CELL BIOL, V17, P519, DOI 10.1128/MCB.17.1.519; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Welihinda AA, 1997, P NATL ACAD SCI USA, V94, P4289, DOI 10.1073/pnas.94.9.4289; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zohn IE, 2006, CELL, V125, P957, DOI 10.1016/j.cell.2006.03.048	41	21	21	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36648	36661		10.1074/jbc.M113.486910	http://dx.doi.org/10.1074/jbc.M113.486910			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24220028	Green Published, hybrid			2022-12-28	WOS:000328883400044
J	Singh, H; Dai, YY; Outten, FW; Busenlehner, LS				Singh, Harsimran; Dai, Yuyuan; Outten, F. Wayne; Busenlehner, Laura S.			Escherichia coli SufE Sulfur Transfer Protein Modulates the SufS Cysteine Desulfurase through Allosteric Conformational Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Structure; Iron-Sulfur Protein; Mass Spectrometry (MS); Protein Complexes; Protein Conformation; Protein-Protein Interactions; Cysteine Desulfurase; Hydrogen; Deuterium Exchange	FE-S CLUSTER; CSDB; BIOGENESIS; IDENTIFICATION; COUNTERPART; MECHANISMS; HOMOLOG; SYSTEM; GENE	Background: SufS cysteine desulfurase mobilizes sulfur for stress-responsive iron-sulfur cluster biogenesis in bacteria. Results: Interaction with the sulfur transfer protein SufE triggers conformational changes in the SufS active site. Conclusion: SufE participates in allosteric regulation of SufS activity in addition to being a sulfur acceptor. Significance: New insight into sulfur mobilization and transfer during iron-sulfur cluster metallocofactor assembly is provided. Fe-S clusters are critical metallocofactors required for cell function. Fe-S cluster biogenesis is carried out by assembly machinery consisting of multiple proteins. Fe-S cluster biogenesis proteins work together to mobilize sulfide and iron, form the nascent cluster, traffic the cluster to target metalloproteins, and regulate the assembly machinery in response to cellular Fe-S cluster demand. A complex series of protein-protein interactions is required for the assembly machinery to function properly. Despite considerable progress in obtaining static three-dimensional structures of the assembly proteins, little is known about transient protein-protein interactions during cluster assembly or the role of protein dynamics in the cluster assembly process. The Escherichia coli cysteine desulfurase SufS (EC 2.8.1.7) and its accessory protein SufE work together to mobilize persulfide from l-cysteine, which is then donated to the SufB Fe-S cluster scaffold. Here we use amide hydrogen/deuterium exchange mass spectrometry (HDX-MS) to characterize SufS-SufE interactions and protein dynamics in solution. HDX-MS analysis shows that SufE binds near the SufS active site to accept persulfide from Cys-364. Furthermore, SufE binding initiates allosteric changes in other parts of the SufS structure that likely affect SufS catalysis and alter SufS monomer-monomer interactions. SufE enhances the initial l-cysteine substrate binding to SufS and formation of the external aldimine with pyridoxal phosphate required for early steps in SufS catalysis. Together, these results provide a new picture of the SufS-SufE sulfur transferase pathway and suggest a more active role for SufE in promoting the SufS cysteine desulfurase reaction for Fe-S cluster assembly.	[Singh, Harsimran; Busenlehner, Laura S.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA; [Dai, Yuyuan; Outten, F. Wayne] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of Alabama System; University of Alabama Tuscaloosa; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Outten, FW (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St, Columbia, SC 29208 USA.	outtenf@mailbox.sc.edu; LSBusenlehner@bama.ua.edu	Dai, Yuyuan/D-6485-2016	Outten, Franklin/0000-0002-9095-0194	Chemistry Research Instrumentation and Facilities Program (CRIF) [CHE 0639003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081706] Funding Source: NIH RePORTER	Chemistry Research Instrumentation and Facilities Program (CRIF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Qiaoli Liang (The University of Alabama) for maintenance and help with the mass spectrometer and Dr. Leslie Lovelace and Dr. Lukasz Lebioda (The University of South Carolina) for assistance with use of their ITC instrument. The University of Alabama Mass Spectrometry Facility was supported by Chemistry Research Instrumentation and Facilities Program (CRIF) Grant CHE 0639003.	Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Busenlehner LS, 2007, BIOCHEMISTRY-US, V46, P2812, DOI 10.1021/bi6023385; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; Ehring H, 1999, ANAL BIOCHEM, V267, P252, DOI 10.1006/abio.1998.3000; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Engen JR, 1999, BIOCHEMISTRY-US, V38, P8926, DOI 10.1021/bi982611y; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Goldsmith-Fischman S, 2004, J MOL BIOL, V344, P549, DOI 10.1016/j.jmb.2004.08.074; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Mandell J. G., 2005, CURRENT PROTOCOLS PR, V40; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Selbach B, 2010, BIOCHEMISTRY-US, V49, P8794, DOI 10.1021/bi101358k; Selbach BP, 2013, BIOCHEMISTRY-US, V52, P4089, DOI 10.1021/bi4001479; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Singh H, 2014, METHODS MOL BIOL, V1084, P81, DOI 10.1007/978-1-62703-658-0_5; Tawfik D.S., 2002, PROTEIN PROTOCOLS HD, P483; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	35	28	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36189	36200		10.1074/jbc.M113.525709	http://dx.doi.org/10.1074/jbc.M113.525709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196966	Green Published, hybrid			2022-12-28	WOS:000328883400002
J	Seo, HS; Minasov, G; Seepersaud, R; Doran, KS; Dubrovska, I; Shuvalova, L; Anderson, WF; Iverson, TM; Sullam, PM				Seo, Ho Seong; Minasov, George; Seepersaud, Ravin; Doran, Kelly S.; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Anderson, Wayne F.; Iverson, Tina M.; Sullam, Paul M.			Characterization of Fibrinogen Binding by Glycoproteins Srr1 and Srr2 of Streptococcus agalactiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Bacterial Pathogenesis; Fibrinogen; Protein Crystallization; Streptococcus; Streptococcus agalactiae; Prot	GROUP-B-STREPTOCOCCUS; MICROVASCULAR ENDOTHELIAL-CELLS; RICH REPEAT PROTEINS; STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; LIGAND-BINDING; PROMOTES ADHERENCE; EXPRESSION; MSCRAMM; GSPB	Background: The serine-rich repeat glycoproteins Srr1 and Srr2 are surface adhesins of Streptococcus agalactiae important for pathogenicity. Results: Both Srrs bind tandem repeats of the fibrinogen A chain, but Srr2 has greater affinity explained by structure-function analysis of the Srrs. Conclusion: A dock, lock, and latch mechanism describes the Srr-fibrinogen interaction. Significance: The higher affinity of Srr2 may contribute to the hypervirulence of Srr2-expressing strains. The serine-rich repeat glycoproteins of Gram-positive bacteria comprise a large family of cell wall proteins. Streptococcus agalactiae (group B streptococcus, GBS) expresses either Srr1 or Srr2 on its surface, depending on the strain. Srr1 has recently been shown to bind fibrinogen, and this interaction contributes to the pathogenesis of GBS meningitis. Although strains expressing Srr2 appear to be hypervirulent, no ligand for this adhesin has been described. We now demonstrate that Srr2 also binds human fibrinogen and that this interaction promotes GBS attachment to endothelial cells. Recombinant Srr1 and Srr2 bound fibrinogen in vitro, with affinities of K-D = 2.1 x 10(-5) and 3.7 x 10(-6) m, respectively, as measured by surface plasmon resonance spectroscopy. The binding site for Srr1 and Srr2 was localized to tandem repeats 6-8 of the fibrinogen A chain. The structures of both the Srr1 and Srr2 binding regions were determined and, in combination with mutagenesis studies, suggest that both Srr1 and Srr2 interact with a segment of these repeats via a dock, lock, and latch mechanism. Moreover, properties of the latch region may account for the increased affinity between Srr2 and fibrinogen. Together, these studies identify how greater affinity of Srr2 for fibrinogen may contribute to the increased virulence associated with Srr2-expressing strains.	[Seo, Ho Seong; Seepersaud, Ravin; Sullam, Paul M.] Univ Calif San Francisco, Vet Affairs Med Ctr, Div Infect Dis, San Francisco, CA 94121 USA; [Seo, Ho Seong; Seepersaud, Ravin; Sullam, Paul M.] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Seo, Ho Seong] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup Si 580185, South Korea; [Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Ctr Struct Genom Infect Dis, Chicago, IL 60611 USA; [Minasov, George; Dubrovska, Ievgeniia; Shuvalova, Ludmilla; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Doran, Kelly S.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Doran, Kelly S.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Northern California Institute for Research & Education; Korea Atomic Energy Research Institute (KAERI); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego; Vanderbilt University; Vanderbilt University	Sullam, PM (corresponding author), Vet Affairs Med Ctr 111W, Div Infect Dis, 4150 Clement St, San Francisco, CA 94121 USA.	paul.sullam@ucsf.edu	Seo, Ho Seong/V-1806-2019	Seo, Ho Seong/0000-0002-7103-1344	United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057433, R01AI041513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001653] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Peter Hwang (University of California at San Francisco) for assistance with the SPR studies, Wendy Thomas (University of Washington) for valuable suggestions, and Jeannine Brady (University of Florida) and Craig Rubens (Seattle Children's Hospital) for providing GBS isolates. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817.	Al Safadi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014658; Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, INFECT IMMUN, V72, P6528, DOI 10.1128/IAI.72.11.6528-6537.2004; Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; BOLYARD MG, 1988, GENE, V66, P183, DOI 10.1016/0378-1119(88)90355-1; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Davies HD, 2004, J INFECT DIS, V189, P1097, DOI 10.1086/382087; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Devi AS, 2010, PROTEIN EXPRES PURIF, V74, P148, DOI 10.1016/j.pep.2010.07.004; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Dramsi S, 2012, MICROBES INFECT, V14, P1044, DOI 10.1016/j.micinf.2012.07.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganesh VK, 2011, J BIOL CHEM, V286, P25963, DOI 10.1074/jbc.M110.217414; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hartford OM, 2001, J BIOL CHEM, V276, P2466, DOI 10.1074/jbc.M007979200; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Jonsson IM, 2005, J INFECT DIS, V192, P1456, DOI 10.1086/491478; King NP, 2011, MICROBIOL-SGM, V157, P1161, DOI 10.1099/mic.0.047639-0; Lamy MC, 2006, MICROBES INFECT, V8, P1714, DOI 10.1016/j.micinf.2006.02.008; LANCEFIELD RC, 1975, J EXP MED, V142, P165, DOI 10.1084/jem.142.1.165; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; LORD ST, 1985, DNA-J MOLEC CELL BIO, V4, P33, DOI 10.1089/dna.1985.4.33; Lord ST, 1996, BIOCHEMISTRY-US, V35, P2342, DOI 10.1021/bi952353u; Margarit I, 2009, FASEB J, V23, P3100, DOI 10.1096/fj.09-131458; MARTIN TR, 1988, J INFECT DIS, V157, P91, DOI 10.1093/infdis/157.1.91; Matsuoka E, 2011, PROTEIN SCI, V20, P406, DOI 10.1002/pro.573; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierno M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028108; Pietrocola G, 2006, BIOCHEMISTRY-US, V45, P12840, DOI 10.1021/bi060696u; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Pyburn TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002112; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Samen U, 2011, MICROBIOL-SGM, V157, P2319, DOI 10.1099/mic.0.044933-0; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Seo HS, 2011, INFECT IMMUN, V79, P3518, DOI 10.1128/IAI.05088-11; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Sheen TR, 2011, J BACTERIOL, V193, P6834, DOI 10.1128/JB.00094-11; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Sillanpaa J, 2009, MICROBIOL-SGM, V155, P2390, DOI 10.1099/mic.0.027821-0; Sunkara B, 2012, INT J INFECT DIS, V16, pE182, DOI 10.1016/j.ijid.2011.11.008; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tazi A, 2012, CURR OPIN MICROBIOL, V15, P44, DOI 10.1016/j.mib.2011.12.002; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; WESSELS MR, 1992, INFECT IMMUN, V60, P392, DOI 10.1128/IAI.60.2.392-400.1992; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183; Xiang H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002751; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004	72	59	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35982	35996		10.1074/jbc.M113.513358	http://dx.doi.org/10.1074/jbc.M113.513358			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24165132	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000329814700034
J	Gallo-Ebert, C; Donigan, M; Liu, HY; Pascual, F; Manners, M; Pandya, D; Swanson, R; Gallagher, D; Chen, WW; Carman, GM; Nickels, JT				Gallo-Ebert, Christina; Donigan, Melissa; Liu, Hsing-Yin; Pascual, Florencia; Manners, Melissa; Pandya, Devanshi; Swanson, Robert; Gallagher, Denise; Chen, WeiWei; Carman, George M.; Nickels, Joseph T., Jr.			The Yeast Anaerobic Response Element AR1(b) Regulates Aerobic Antifungal Drug-dependent Sterol Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Lipids; Sterol; Transcription; Yeast; Aerobic; Anaerobic; Azole; Lipid; Promoter	PHOSPHATIDATE PHOSPHATASE ENZYME; SQUALENE SYNTHASE GENE; COENZYME-A REDUCTASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; CANDIDA-ALBICANS; FLUCONAZOLE RESISTANCE; SENSING DOMAIN; MANNOPROTEIN GENES; LIPIN HOMOLOG	Background:Saccharomyces cerevisiae sterol gene expression is regulated by a consensus sterol-response promoter element (SRE/AR1(c)). Results: The anaerobic AR1(b) promoter element regulates global antifungal-dependent sterol gene expression. Conclusion: Yeast sterol gene expression is regulated by multiple SRE-like elements. Significance: Understanding sterol gene expression will yield valuable information concerning antifungal drug resistance. Saccharomyces cerevisiae ergosterol biosynthesis, like cholesterol biosynthesis in mammals, is regulated at the transcriptional level by a sterol feedback mechanism. Yeast studies defined a 7-bp consensus sterol-response element (SRE) common to genes involved in sterol biosynthesis and two transcription factors, Upc2 and Ecm22, which direct transcription of sterol biosynthetic genes. The 7-bp consensus SRE is identical to the anaerobic response element, AR1(c). Data indicate that Upc2 and Ecm22 function through binding to this SRE site. We now show that it is two novel anaerobic AR1(b) elements in the UPC2 promoter that direct global ERG gene expression in response to a block in de novo ergosterol biosynthesis, brought about by antifungal drug treatment. The AR1(b) elements are absolutely required for auto-induction of UPC2 gene expression and protein and require Upc2 and Ecm22 for function. We further demonstrate the direct binding of recombinant expressed S. cerevisiae ScUpc2 and pathogenic Candida albicans CaUpc2 and Candida glabrata CgUpc2 to AR1(b) and SRE/AR1(c) elements. Recombinant endogenous promoter studies show that the UPC2 anaerobic AR1(b) elements act in trans to regulate ergosterol gene expression. Our results indicate that Upc2 must occupy UPC2 AR1(b) elements in order for ERG gene expression induction to take place. Thus, the two UPC2-AR1(b) elements drive expression of all ERG genes necessary for maintaining normal antifungal susceptibility, as wild type cells lacking these elements have increased susceptibility to azole antifungal drugs. Therefore, targeting these specific sites for antifungal therapy represents a novel approach to treat systemic fungal infections.	[Gallo-Ebert, Christina; Donigan, Melissa; Liu, Hsing-Yin; Pandya, Devanshi; Chen, WeiWei; Nickels, Joseph T., Jr.] Inst Metab Disorders, Genesis Biotechnol Grp, Hamilton, NJ 08691 USA; [Pascual, Florencia; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; [Pascual, Florencia; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Manners, Melissa; Swanson, Robert; Gallagher, Denise] Venenum Biodesign, Genesis Biotechnol Grp, Hamilton, NJ 08690 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Nickels, JT (corresponding author), Inst Metab Disorders LLC, 1000 Waterview Dr, Hamilton, NJ 08691 USA.	jnickels@venenumbiodesign.com		Gallo-Ebert, Christina/0000-0003-0985-3547	National Institutes of Health from USPHS [HL67401, GM28140]; American Heart Association [0615426U]; Genesis Biotechnology Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; American Heart Association(American Heart Association); Genesis Biotechnology Group; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67401 (to J. T. N.) and GM28140 (to G. M. C.) from USPHS. This work was also supported by American Heart Association Predoctoral Grant 0615426U (to C. G.-E.) and the Genesis Biotechnology Group.	Abramova NE, 2001, GENETICS, V157, P1169; ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; BACHHAWAT N, 1995, J BIOL CHEM, V270, P25087, DOI 10.1074/jbc.270.42.25087; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Carman GM, 2007, METHOD ENZYMOL, V434, P305, DOI 10.1016/S0076-6879(07)34017-2; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Cohen BD, 2001, NUCLEIC ACIDS RES, V29, P799, DOI 10.1093/nar/29.3.799; Costa M, 2001, THROMB HAEMOSTASIS, V86, P672, DOI 10.1055/s-0037-1616103; Crowley JH, 1998, J BACTERIOL, V180, P4177, DOI 10.1128/JB.180.16.4177-4183.1998; Datta S, 2006, J BIOL CHEM, V281, P807, DOI 10.1074/jbc.M511050200; Davies BSJ, 2005, MOL CELL BIOL, V25, P7375, DOI 10.1128/MCB.25.16.7375-7385.2005; Dimster-Denk D, 1999, J LIPID RES, V40, P850; DimsterDenk D, 1996, MOL CELL BIOL, V16, P3981; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Flowers SA, 2012, EUKARYOT CELL, V11, P1289, DOI 10.1128/EC.00215-12; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Fu LY, 2009, J HYPERTENS, V27, P991, DOI 10.1097/HJH.0b013e3283294bec; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Germann M, 2005, J BIOL CHEM, V280, P35904, DOI 10.1074/jbc.M504978200; Guan GM, 1997, J BIOL CHEM, V272, P10295; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hach A, 1999, MOL CELL BIOL, V19, P4324; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Harendza S, 2009, CELL MOL BIOL LETT, V14, P679, DOI 10.2478/s11658-009-0026-0; Heilmann CJ, 2010, ANTIMICROB AGENTS CH, V54, P353, DOI 10.1128/AAC.01102-09; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Hoot SJ, 2011, ANTIMICROB AGENTS CH, V55, P940, DOI 10.1128/AAC.00995-10; Hoot SJ, 2010, EUKARYOT CELL, V9, P1354, DOI 10.1128/EC.00130-10; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JOLLOW D, 1968, J CELL BIOL, V37, P221, DOI 10.1083/jcb.37.2.221; Kennedy MA, 1999, BBA-GENE STRUCT EXPR, V1445, P110, DOI 10.1016/S0167-4781(99)00035-4; Leber R, 2001, EUR J BIOCHEM, V268, P914, DOI 10.1046/j.1432-1327.2001.01940.x; Li L, 2007, J DENT RES, V86, P204, DOI 10.1177/154405910708600304; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; Marie C, 2008, FUNGAL GENET BIOL, V45, P1430, DOI 10.1016/j.fgb.2008.07.004; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Nagi M, 2011, GENES CELLS, V16, P80, DOI 10.1111/j.1365-2443.2010.01470.x; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; OSBORNE TF, 1991, J BIOL CHEM, V266, P13947; Pam VK, 2012, INT J MOL EPIDEMIOL, V3, P84; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; PFEIFER K, 1987, CELL, V49, P9, DOI 10.1016/0092-8674(87)90750-1; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Samaranayake YH, 2013, J MED MICROBIOL, V62, P303, DOI 10.1099/jmm.0.044123-0; Sasse C, 2012, MOL MICROBIOL, V86, P539, DOI 10.1111/j.1365-2958.2012.08210.x; Sasse C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025623; Schiavoni G, 2010, BBA-MOL CELL BIOL L, V1801, P587, DOI 10.1016/j.bbalip.2010.01.013; Shen Yin-zhong, 2010, Zhonghua Nei Ke Za Zhi, V49, P245; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Smith SJ, 1996, MOL CELL BIOL, V16, P5427; STARR PR, 1962, J BACTERIOL, V83, P1042, DOI 10.1128/JB.83.5.1042-1046.1962; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399	69	8	11	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35466	35477		10.1074/jbc.M113.526087	http://dx.doi.org/10.1074/jbc.M113.526087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163365	hybrid, Green Published			2022-12-28	WOS:000329867600042
J	Matczuk, AK; Kunec, D; Veit, M				Matczuk, Anna Karolina; Kunec, Dusan; Veit, Michael			Co-translational Processing of Glycoprotein 3 from Equine Arteritis Virus N-GLYCOSYLATION ADJACENT TO THE SIGNAL PEPTIDE PREVENTS CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Glycosylation; Protein Translocation; Signal Peptidase; Virology; Arterivirus; Gp3; N-Glycosylation; Signal Peptide Cleavage	ENDOPLASMIC-RETICULUM; GP(3); COMPLEXES; SEQUENCE; ENCODES; CELLS; GP(4); YEAST; SITE	Signal peptide cleavage and N-glycosylation of proteins are co-translational processes, but little is known about their interplay if they compete for adjacent sites. Here we report two unique findings for processing of glycoprotein 3 of equine arteritis virus. Glycoprotein 3 (Gp3) contains an N-terminal signal peptide, which is not removed, although bioinformatics predicts cleavage with high probability. There is an overlapping sequon, NNTT, adjacent to the signal peptide that we show to be glycosylated at both asparagines. Exchanging the overlapping sequon and blocking glycosylation allows signal peptide cleavage, indicating that carbohydrate attachment inhibits processing of a potentially cleavable signal peptide. Bioinformatics analyses suggest that a similar processing scheme may exist for some cellular proteins. Membrane fractionation and secretion experiments revealed that the signal peptide of Gp3 does not act as a membrane anchor, indicating that it is completely translocated into the lumen of the endoplasmic reticulum. Membrane attachment is caused by the hydrophobic C terminus of Gp3, which, however, does not span the membrane but rather attaches the protein peripherally to endoplasmic reticulum membranes.	[Matczuk, Anna Karolina; Kunec, Dusan; Veit, Michael] Free Univ Berlin, Inst Virol, D-14163 Berlin, Germany	Free University of Berlin	Veit, M (corresponding author), Free Univ Berlin, Zentrum Infekt Med Robert von Ostertag Haus, Inst Virol, Fachbereich Vet Med, D-14163 Berlin, Germany.	mveit@zedat.fu-berlin.de		Veit, Michael/0000-0002-7638-1829; Matczuk, Anna/0000-0002-7282-6560; Kunec, Dusan/0000-0001-6697-7621	European Union (FP7, Initial Training network "Virus entry"); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER	European Union (FP7, Initial Training network "Virus entry"); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the European Union (FP7, Initial Training network "Virus entry").	Balasuriya U. B., 2013, VET MICROBIOL, DOI 10.1016/j.vetmic.2013.06.015; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Chen XM, 2001, J BIOL CHEM, V276, P2411, DOI 10.1074/jbc.M007723200; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; DEVRIES AAF, 1995, J VIROL, V69, P3441, DOI 10.1128/JVI.69.6.3441-3448.1995; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ernst AM, 2013, FEBS LETT, V587, P1411, DOI 10.1016/j.febslet.2013.03.019; Faaberg KS, 1997, VIROLOGY, V227, P245, DOI 10.1006/viro.1996.8310; GAROFF H, 1990, J CELL BIOL, V111, P867, DOI 10.1083/jcb.111.3.867; Hedges JF, 1999, VIROLOGY, V264, P92, DOI 10.1006/viro.1999.9982; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Jose J, 2009, FUTURE MICROBIOL, V4, P837, DOI [10.2217/fmb.09.59, 10.2217/FMB.09.59]; Karamyshev AL, 2005, J BIOL CHEM, V280, P40489, DOI 10.1074/jbc.M509168200; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Mardassi H, 1998, J VIROL, V72, P6298, DOI 10.1128/JVI.72.8.6298-6306.1998; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nitschke M, 2008, VIROLOGY, V377, P248, DOI 10.1016/j.virol.2008.04.041; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reddy A, 1999, GLYCOBIOLOGY, V9, P547, DOI 10.1093/glycob/9.6.547; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Thaa B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065548; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Veit Michael, 2008, V446, P163, DOI 10.1007/978-1-60327-084-7_12; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wieringa R, 2004, J VIROL, V78, P13019, DOI 10.1128/JVI.78.23.13019-13027.2004; Wieringa R, 2003, J VIROL, V77, P6216, DOI 10.1128/JVI.77.11.6216-6226.2003; Wieringa R, 2002, J VIROL, V76, P10829, DOI 10.1128/JVI.76.21.10829-10840.2002; Yan AX, 2005, GLYCOBIOLOGY, V15, P1407, DOI 10.1093/glycob/cwj026; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200	35	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35396	35405		10.1074/jbc.M113.505420	http://dx.doi.org/10.1074/jbc.M113.505420			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142700	Green Published, hybrid			2022-12-28	WOS:000329867600036
J	Rohman, A; van Oosterwijk, N; Thunnissen, AMWH; Dijkstra, BW				Rohman, Ali; van Oosterwijk, Niels; Thunnissen, Andy-Mark W. H.; Dijkstra, Bauke W.			Crystal Structure and Site-directed Mutagenesis of 3-Ketosteroid Delta(1)-Dehydrogenase from Rhodococcus erythropolis SQ1 Explain Its Catalytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol Metabolism; Crystal Structure; Dehydrogenase; Enzyme Mechanisms; Flavoproteins; Mycobacterium tuberculosis; 3-Ketosteroid; Rhodococcus erythropolis; Rossmann Fold	GENE; 3-KETOSTEROID-DELTA-1-DEHYDROGENASE; STEROIDS; RING	Background: 3-Ketosteroid (1)-dehydrogenases catalyze the 1,2-desaturation of 3-ketosteroids. Results: First structures of the enzyme from Rhodococcus erythropolis SQ1, combined with site-directed mutagenesis, clarify its catalytic mechanism. Conclusion: Tyr(487) and Gly(491) promote keto-enol tautomerization, whereas Tyr(318)/Tyr(119) and FAD abstract a proton and hydride ion, respectively. Significance: This study is an important step toward tailoring the enzyme for steroid biotransformation applications. 3-Ketosteroid (1)-dehydrogenases are FAD-dependent enzymes that catalyze the 1,2-desaturation of 3-ketosteroid substrates to initiate degradation of the steroid nucleus. Here we report the 2.0 resolution crystal structure of the 56-kDa enzyme from Rhodococcus erythropolis SQ1 ((1)-KSTD1). The enzyme contains two domains: an FAD-binding domain and a catalytic domain, between which the active site is situated as evidenced by the 2.3 resolution structure of (1)-KSTD1 in complex with the reaction product 1,4-androstadiene-3,17-dione. The active site contains four key residues: Tyr(119), Tyr(318), Tyr(487), and Gly(491). Modeling of the substrate 4-androstene-3,17-dione at the position of the product revealed its interactions with these residues and the FAD. The C1 and C2 atoms of the substrate are at reaction distance to the N5 atom of the isoalloxazine ring of FAD and the hydroxyl group of Tyr(318), respectively, whereas the C3 carbonyl group is at hydrogen bonding distance from the hydroxyl group of Tyr(487) and the backbone amide of Gly(491). Site-directed mutagenesis of the tyrosines to phenylalanines confirmed their importance for catalysis. The structural features and the kinetic properties of the mutants suggest a catalytic mechanism in which Tyr(487) and Gly(491) work in tandem to promote keto-enol tautomerization and increase the acidity of the C2 hydrogen atoms of the substrate. With assistance of Tyr(119), the general base Tyr(318) abstracts the axial -hydrogen from C2 as a proton, whereas the FAD accepts the axial -hydrogen from the C1 atom of the substrate as a hydride ion.	[Rohman, Ali] Airlangga Univ, Dept Chem, Fac Sci & Technol, Surabaya 60115, Indonesia; [Rohman, Ali] Airlangga Univ, Inst Trop Dis, Surabaya 60115, Indonesia; [Rohman, Ali; van Oosterwijk, Niels; Thunnissen, Andy-Mark W. H.; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, NL-9747 AG Groningen, Netherlands	Airlangga University; Airlangga University; University of Groningen	Dijkstra, BW (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019; Rohman, Ali/GWV-1736-2022; Thunnissen, Andy-Mark/A-1777-2010	Dijkstra, Bauke W./0000-0001-9731-6586; Thunnissen, Andy-Mark/0000-0002-1915-9850; Rohman, Ali/0000-0002-8177-5881	Directorate General of Higher Education; Ministry of Education and Culture, Republic of Indonesia; Ministry of Research and Technology, Republic of Indonesia	Directorate General of Higher Education; Ministry of Education and Culture, Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Ministry of Research and Technology, Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	Recipient of a scholarship from the Directorate General of Higher Education, the Ministry of Education and Culture, Republic of Indonesia, and a research assistance grant from the Ministry of Research and Technology, Republic of Indonesia.	ABULHAJJ YJ, 1978, J BIOL CHEM, V253, P2356; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brzezinska M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-43; Donova MV, 2007, APPL BIOCHEM MICRO+, V43, P1, DOI 10.1134/S0003683807010012; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujii C, 1999, J BIOCHEM-TOKYO, V126, P662, DOI 10.1093/oxfordjournals.jbchem.a022500; GALE PH, 1962, BIOCHEMISTRY-US, V1, P788, DOI 10.1021/bi00911a010; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; HAYANO M, 1961, BIOCHEM BIOPH RES CO, V4, P454, DOI 10.1016/0006-291X(61)90307-2; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horinouchi M, 2003, APPL ENVIRON MICROB, V69, P2139, DOI 10.1128/AEM.69.4.2139-2152.2003; ITAGAKI E, 1990, J BIOCHEM-TOKYO, V108, P122, DOI 10.1093/oxfordjournals.jbchem.a123150; ITAGAKI E, 1990, BIOCHIM BIOPHYS ACTA, V1038, P60, DOI 10.1016/0167-4838(90)90010-D; JERUSSI ROBERT, 1965, BIOCHEMISTRY, V4, P2113, DOI 10.1021/bi00886a028; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knol J, 2008, BIOCHEM J, V410, P339, DOI 10.1042/BJ20071130; LEVY HR, 1959, J BIOL CHEM, V234, P2014; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; MATSUSHITA H, 1992, J BIOCHEM-TOKYO, V111, P594, DOI 10.1093/oxfordjournals.jbchem.a123803; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RINGOLD HJ, 1963, J BIOL CHEM, V238, P1960; Rohman A, 2012, ACTA CRYSTALLOGR F, V68, P551, DOI 10.1107/S1744309112011025; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; van der Geize R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002181; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; van Oosterwijk N, 2012, J BIOL CHEM, V287, P30975, DOI 10.1074/jbc.M112.374306; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOVCHA MG, 1979, BIOCHIM BIOPHYS ACTA, V574, P471, DOI 10.1016/0005-2760(79)90243-1	38	39	42	0	40	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35559	35568		10.1074/jbc.M113.522771	http://dx.doi.org/10.1074/jbc.M113.522771			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165124	Green Published, hybrid			2022-12-28	WOS:000329867600050
J	Du, X; Chen, NLH; Wong, A; Craik, CS; Bromme, D				Du, Xin; Chen, Nelson L. H.; Wong, Andre; Craik, Charles S.; Broemme, Dieter			Elastin Degradation by Cathepsin V Requires Two Exosites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cysteine Protease; Elastin; Extracellular Matrix Proteins; Protein Degradation; Site-directed Mutagenesis; Elastase; Cathepsin V; Exosite; Substrate Specificity	LYSOSOMAL CYSTEINE PROTEASES; MATRIX METALLOPROTEINASE-12; TROPOELASTIN; SPECIFICITY; EXPRESSION; INHIBITOR	Background: Elastin degradation is a key event in various pathologies of the skin, lung, and the vascular system. Results: Elastin degradation by cathepsin V requires two exosites. Conclusion: Cathepsin exosites support the recognition of and binding to insoluble elastin. Significance: Exosites may represent novel target sites for the selective inhibition of the elastase activity of cathepsins. Cathepsin V is a highly effective elastase and has been implicated in physiological and pathological extracellular matrix degradation. However, its mechanism of action remains elusive. Whereas human cathepsin V exhibits a potent elastolytic activity, the structurally homologous cathepsin L, which shares a 78% amino acid sequence, has only a minimal proteolytic activity toward insoluble elastin. This suggests that there are distinct structural domains that play an important role in elastinolysis. In this study, a total of 11 chimeras of cathepsins V and L were generated to identify elastin-binding domains in cathepsin V. Evaluation of these chimeras revealed two exosites contributing to the elastolytic activity of cathepsin V that are distant from the active cleft of the protease and are located in surface loop regions. Replacement of exosite 1 or 2 with analogous residues from cathepsin L led to a 75 and 43% loss in the elastolytic activity, respectively. Replacement of both exosites yielded a non-elastase variant similar to that of cathepsin L. Identification of these exosites may contribute to the design of inhibitors that will only affect the elastolytic activity of cysteine cathepsins without interfering with other physiological protease functions.	[Du, Xin; Chen, Nelson L. H.; Broemme, Dieter] Univ British Columbia, Fac Med, Ctr Blood Res, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wong, Andre; Broemme, Dieter] Univ British Columbia, Fac Dent, Life Sci Ctr, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Craik, Charles S.] Univ Calif San Francisco, Program Chem & Chem Biol, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Craik, Charles S.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	University of British Columbia; University of British Columbia; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bromme, D (corresponding author), Univ British Columbia, 2350 Hlth Sci Mall,Rm 4558, Vancouver, BC V6T 1Z3, Canada.	dbromme@dentistry.ubc.ca			Canadian Institutes of Health [MOP89974]; National Institutes of Health [R01 CA128765]; NATIONAL CANCER INSTITUTE [R01CA128765] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work supported by Canadian Institutes of Health Research Grant MOP89974 (to D.B.) and National Institutes of Health Grant R01 CA128765 (to C.S.C.).	BROMME D, 1995, BIOL CHEM H-S, V376, P379, DOI 10.1515/bchm3.1995.376.6.379; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Fulcher YG, 2011, BIOCHEMISTRY-US, V50, P9488, DOI 10.1021/bi2009807; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005; Hornebeck W, 2011, FRONT BIOSCI-LANDMRK, V16, P707, DOI 10.2741/3714; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Brun AP, 2012, BIOMACROMOLECULES, V13, P379, DOI 10.1021/bm201404x; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Ma DHK, 2007, INVEST OPHTH VIS SCI, V48, P644, DOI 10.1167/iovs.06-0884; Makrantonaki E, 2007, DERMATOLOGY, V214, P352, DOI 10.1159/000100890; Matsumoto S, 1998, AM J PATHOL, V153, P109, DOI 10.1016/S0002-9440(10)65551-4; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Novinec M, 2007, J BIOL CHEM, V282, P7893, DOI 10.1074/jbc.M610107200; Palmier MO, 2010, J BIOL CHEM, V285, P30918, DOI 10.1074/jbc.M110.136903; Puzer L, 2004, ARCH BIOCHEM BIOPHYS, V430, P274, DOI 10.1016/j.abb.2004.07.006; Robert L, 2008, BIOGERONTOLOGY, V9, P119, DOI 10.1007/s10522-007-9122-6; Robert L, 1998, ATHEROSCLEROSIS, V140, P281, DOI 10.1016/S0021-9150(98)00171-3; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200	30	33	34	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34871	34881		10.1074/jbc.M113.510008	http://dx.doi.org/10.1074/jbc.M113.510008			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121514	hybrid, Green Published			2022-12-28	WOS:000329812800054
J	Watanabe, Y; Katayama, N; Takeuchi, K; Togano, T; Itoh, R; Sato, M; Yamazaki, M; Abe, M; Sato, T; Oda, K; Yokoyama, M; Takao, K; Fukaya, M; Miyakawa, T; Watanabe, M; Sakimura, K; Manabe, T; Igarashi, M				Watanabe, Yumi; Katayama, Norikazu; Takeuchi, Kosei; Togano, Tetsuya; Itoh, Rieko; Sato, Michiko; Yamazaki, Maya; Abe, Manabu; Sato, Toshiya; Oda, Kanako; Yokoyama, Minesuke; Takao, Keizo; Fukaya, Masahiro; Miyakawa, Tsuyoshi; Watanabe, Masahiko; Sakimura, Kenji; Manabe, Toshiya; Igarashi, Michihiro			Point Mutation in Syntaxin-1A Causes Abnormal Vesicle Recycling, Behaviors, and Short Term Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calmodulin-dependent Protein Kinase (CaMK); Exocytosis; SNARE Proteins; Synaptic Plasticity; Synaptosomes	PROTEIN-KINASE-II; GENETICALLY-ENGINEERED MICE; NEUROPSYCHIATRIC DISORDERS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC PLASTICITY; CONFORMATIONAL SWITCH; CA1 REGION; SYNAPSIN-I; EXOCYTOSIS; COMPLEXIN	Background: Roles of the syntaxin-1ACaMKII interaction are not physiologically understood in vivo.Results: A point mutation in syntaxin-1A caused abnormal plasticity, recycling, and behaviors in mice. Conclusion: The CaMKII/syntaxin-1A interaction is essential for maintenance of neuronal plasticity. Significance: Syntaxin-1A is involved in regulatory pathways in higher brain functions. Syntaxin-1A is a t-SNARE that is involved in vesicle docking and vesicle fusion; it is important in presynaptic exocytosis in neurons because it interacts with many regulatory proteins. Previously, we found the following: 1) that autophosphorylated Ca2+/calmodulin-dependent protein kinase II (CaMKII), an important modulator of neural plasticity, interacts with syntaxin-1A to regulate exocytosis, and 2) that a syntaxin missense mutation (R151G) attenuated this interaction. To determine more precisely the physiological importance of this interaction between CaMKII and syntaxin, we generated mice with a knock-in (KI) syntaxin-1A (R151G) mutation. Complexin is a molecular clamp involved in exocytosis, and in the KI mice, recruitment of complexin to the SNARE complex was reduced because of an abnormal CaMKII/syntaxin interaction. Nevertheless, SNARE complex formation was not inhibited, and consequently, basal neurotransmission was normal. However, the KI mice did exhibit more enhanced presynaptic plasticity than wild-type littermates; this enhanced plasticity could be associated with synaptic response than did wild-type littermates; this pronounced response included several behavioral abnormalities. Notably, the R151G phenotypes were generally similar to previously reported CaMKII mutant phenotypes. Additionally, synaptic recycling in these KI mice was delayed, and the density of synaptic vesicles was reduced. Taken together, our results indicated that this single point mutation in syntaxin-1A causes abnormal regulation of neuronal plasticity and vesicle recycling and that the affected syntaxin-1A/CaMKII interaction is essential for normal brain and synaptic functions in vivo.	[Watanabe, Yumi; Takeuchi, Kosei; Togano, Tetsuya; Itoh, Rieko; Sato, Michiko; Igarashi, Michihiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Neurochem & Mol Cell Biol, Niigata 9518510, Japan; [Togano, Tetsuya] Niigata Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Niigata 9518510, Japan; [Watanabe, Yumi; Takeuchi, Kosei; Igarashi, Michihiro] Niigata Univ, Transdisciplinary Res Program, Niigata 9518510, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata 9518510, Japan; [Sato, Toshiya; Oda, Kanako; Yokoyama, Minesuke] Niigata Univ, Dept Expt Anim Resource, Brain Res Inst, Niigata 9518510, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 4448585, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi 4701192, Japan; [Katayama, Norikazu; Manabe, Toshiya] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Neuronal Network, Tokyo 1088639, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2520374, Japan; Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Watanabe, Yumi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Niigata University; Niigata University; Niigata University; Niigata University; Niigata University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University; University of Tokyo; Kitasato University; Hokkaido University; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST)	Igarashi, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Cellular Biol, Chuo Ku, 1-757 Asahimachi, Niigata 9518510, Japan.	tarokaja@med.niigata-u.ac.jp	Yamazaki, Maya/C-6952-2012; Watanabe, Masahiko/S-3614-2019; Miyakawa, Tsuyoshi/A-7741-2008; Takeuchi, Kosei/AAV-3577-2021; Takao, Keizo/B-9527-2008	Watanabe, Masahiko/0000-0001-5037-7138; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Takeuchi, Kosei/0000-0001-6397-2243; Takao, Keizo/0000-0002-4734-3583; Togano, Tetsuya/0000-0003-2853-1308; Sato, Toshiya/0000-0001-7844-9930	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Sciences KAKENHI [17023019, 22040040, 24111515, 11J40157, 23220008, 25116505, 25640005]; Comprehensive Center of Education and Research for Chemical Biology of Diseases (Global COE Program); Strategic Research Program for Brain Sciences from the MEXT; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [24111515, 23220008] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Sciences KAKENHI; Comprehensive Center of Education and Research for Chemical Biology of Diseases (Global COE Program); Strategic Research Program for Brain Sciences from the MEXT; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Sciences KAKENHI 17023019, 22040040, and 24111515 (to M.I.), 11J40157 (to Y.W.), 23220008, 25116505, and 25640005 (to T. Manabe), the Comprehensive Center of Education and Research for Chemical Biology of Diseases (Global COE Program) (to T. Manabe), the Strategic Research Program for Brain Sciences from the MEXT (to T. Manabe), and a grant from the Uehara Memorial Foundation (to T. Manabe).	BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Ertunc M, 2007, J NEUROSCI, V27, P341, DOI 10.1523/JNEUROSCI.4051-06.2007; Fioravante D, 2011, CURR OPIN NEUROBIOL, V21, P269, DOI 10.1016/j.conb.2011.02.003; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Igarashi M, 2007, NEUROSCI RES, V58, P226, DOI 10.1016/j.neures.2007.03.005; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kitayama K, 2001, BIOCHEM BIOPH RES CO, V281, P1134, DOI 10.1006/bbrc.2001.4492; Krishnakumar SS, 2011, NAT STRUCT MOL BIOL, V18, P934, DOI 10.1038/nsmb.2103; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Nomura K, 2003, J NEUROSCI RES, V72, P198, DOI 10.1002/jnr.10563; Ohyama A, 2002, J NEUROSCI, V22, P3342; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Takao K, 2009, J TOXICOL SCI, V34, pSP293, DOI 10.2131/jts.34.SP293; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Weninger KR, 2011, NAT STRUCT MOL BIOL, V18, P861, DOI 10.1038/nsmb.2118; Xue MS, 2008, P NATL ACAD SCI USA, V105, P7875, DOI 10.1073/pnas.0803012105; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342	35	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34906	34919		10.1074/jbc.M113.504050	http://dx.doi.org/10.1074/jbc.M113.504050			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24136198	hybrid, Green Published			2022-12-28	WOS:000329812800057
J	Dumarieh, R; D'Antonio, J; Deliz-Liang, A; Smirnova, T; Svistunenko, DA; Ghiladi, RA				Dumarieh, Rania; D'Antonio, Jennifer; Deliz-Liang, Alexandria; Smirnova, Tatyana; Svistunenko, Dimitri A.; Ghiladi, Reza A.			Tyrosyl Radicals in Dehaloperoxidase HOW NATURE DEALS WITH EVOLVING AN OXYGEN-BINDING GLOBIN TO A BIOLOGICALLY RELEVANT PEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hemoglobin; Iron; Peroxidase; Radicals; Tyrosine; Compound ES; Compound I; Compound II; Dehaloperoxidase; Ferryl	AMPHITRITE-ORNATA DEHALOPEROXIDASE; CATALASE-PEROXIDASE KATG; NOTOMASTUS-LOBATUS CHLOROPEROXIDASE; TRP CROSS-LINK; COMPOUND-I; HORSERADISH-PEROXIDASE; DISTAL HISTIDINE; SPECTROSCOPIC CHARACTERIZATION; OXIDATIVE DEHALOGENATION; ELECTRONIC-STRUCTURE	Dehaloperoxidase (DHP) from Amphitrite ornata, having been shown to catalyze the hydrogen peroxide-dependent oxidation of trihalophenols to dihaloquinones, is the first oxygen binding globin that possesses a biologically relevant peroxidase activity. The catalytically competent species in DHP appears to be Compound ES, a reactive intermediate that contains both a ferryl heme and a tyrosyl radical. By simulating the EPR spectra of DHP activated by H2O2, Thompson et al. (Thompson, M. K., Franzen, S., Ghiladi, R. A., Reeder, B. J., and Svistunenko, D. A. (2010) J. Am. Chem. Soc. 132, 17501-17510) proposed that two different radicals, depending on the pH, are formed, one located on either Tyr-34 or Tyr-28 and the other on Tyr-38. To provide additional support for these simulation-based assignments and to deduce the role(s) that tyrosyl radicals play in DHP, stopped-flow UV-visible and rapid-freeze-quench EPR spectroscopic methods were employed to study radical formation in DHP when three tyrosine residues, Tyr-28, Tyr-34, and Tyr-38, were replaced either individually or in combination with phenylalanines. The results indicate that radicals form on all three tyrosines in DHP. Evidence for the formation of DHP Compound I in several tyrosine mutants was obtained. Variants that formed Compound I showed an increase in the catalytic rate for substrate oxidation but also an increase in heme bleaching, suggesting that the tyrosines are necessary for protecting the enzyme from oxidizing itself. This protective role of tyrosines is likely an evolutionary adaptation allowing DHP to avoid self-inflicted damage in the oxidative environment.	[Dumarieh, Rania; D'Antonio, Jennifer; Deliz-Liang, Alexandria; Smirnova, Tatyana; Ghiladi, Reza A.] N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA; [Svistunenko, Dimitri A.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	University of North Carolina; North Carolina State University; University of Essex	Svistunenko, DA (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	svist@essex.ac.uk; Reza_Ghiladi@ncsu.edu	Ghiladi, Reza/J-8492-2017	Ghiladi, Reza/0000-0002-6450-9311; Liang, Alexandria Deliz/0000-0002-9897-2822; Svistunenko, Dimitri/0000-0001-8060-2738; Smirnova, Tatyana/0000-0001-7867-7116	National Institutes of Health [S10RR023614]; National Science Foundation [CHE-0840501]; North Carolina Biotechnology Center [2009-IDG-1015]; Division Of Chemistry [1150709] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); North Carolina Biotechnology Center; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	EPR instrumentation employed in this work was supported by National Institutes of Health Grant S10RR023614, National Science Foundation Grant CHE-0840501, and North Carolina Biotechnology Center Grant 2009-IDG-1015. Mass spectra were obtained at the Mass Spectrometry Facility for Biotechnology at North Carolina State University. Partial funding for the facility was obtained from the North Carolina Biotechnology Center and the National Science Foundation.	ADEDIRAN SA, 1984, J PROTEIN CHEM, V3, P437, DOI 10.1007/BF01025062; Ayala M, 2007, BIOCHEM BIOPH RES CO, V357, P804, DOI 10.1016/j.bbrc.2007.04.020; Battistuzzi G, 2007, J BIOL INORG CHEM, V12, P951, DOI 10.1007/s00775-007-0267-1; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; BEERS RF, 1952, J BIOL CHEM, V195, P133; Belyea J, 2006, BIOCHEMISTRY-US, V45, P14275, DOI 10.1021/bi0609218; CHEN YP, 1991, J BIOL CHEM, V266, P23909; Chen YP, 1996, J BIOL CHEM, V271, P4609; Chen Z, 2009, ACTA CRYSTALLOGR D, V65, P34, DOI 10.1107/S0907444908036548; CHIANCONE E, 1981, BIOCHIM BIOPHYS ACTA, V670, P84, DOI 10.1016/0005-2795(81)90052-0; CHIANCONE E, 1980, BIOCHIM BIOPHYS ACTA, V623, P146, DOI 10.1016/0005-2795(80)90017-3; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Conant JB, 1932, J BIOL CHEM, V98, P0057; D'Antonio EL, 2012, J ELECTROANAL CHEM, V668, P37, DOI 10.1016/j.jelechem.2011.12.015; D'Antonio J, 2011, BIOCHEMISTRY-US, V50, P5999, DOI 10.1021/bi200311u; D'Antonio J, 2010, BIOCHEMISTRY-US, V49, P6600, DOI 10.1021/bi100407v; Davis MF, 2009, BIOCHEMISTRY-US, V48, P2164, DOI 10.1021/bi801568s; Davydov R, 2010, J AM CHEM SOC, V132, P14995, DOI 10.1021/ja1059747; de Serrano V, 2007, ACTA CRYSTALLOGR D, V63, P1094, DOI 10.1107/S0907444907043417; de Serrano V, 2010, ACTA CRYSTALLOGR D, V66, P529, DOI 10.1107/S0907444910004580; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; Du J, 2010, BIOCHEMISTRY-US, V49, P6064, DOI 10.1021/bi100741z; Egawa T, 2000, J BIOL CHEM, V275, P34858, DOI 10.1074/jbc.M004026200; FARHANGRAZI ZS, 1994, BIOCHEMISTRY-US, V33, P5647, DOI 10.1021/bi00184a038; Feducia J, 2009, BIOCHEMISTRY-US, V48, P995, DOI 10.1021/bi801916j; FIELMAN KT, 1995, MAR ECOL PROG SER, V116, P125, DOI 10.3354/meps116125; Franzen S, 2007, BBA-PROTEINS PROTEOM, V1774, P121, DOI 10.1016/j.bbapap.2006.09.019; Franzen S, 2006, BIOCHEMISTRY-US, V45, P9085, DOI 10.1021/bi060020z; Franzen S, 2006, J PHYS CHEM B, V110, P14483, DOI 10.1021/jp056790m; Franzen S, 2012, BBA-PROTEINS PROTEOM, V1824, P578, DOI 10.1016/j.bbapap.2011.12.008; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Han KP, 2001, MAR BIOTECHNOL, V3, P287, DOI 10.1007/s10126-001-0003-8; Heineman W. R., 1979, J ELECTROANAL CHEM, V104, P577; HEWSON WD, 1979, J BIOL CHEM, V254, P3182; KING GM, 1986, NATURE, V323, P257, DOI 10.1038/323257a0; LaCount MW, 2000, J BIOL CHEM, V275, P18712, DOI 10.1074/jbc.M001194200; Lebioda L, 1999, NATURE, V401, P445, DOI 10.1038/46728; Lincoln DE, 2005, BIOCHEM SYST ECOL, V33, P559, DOI 10.1016/j.bse.2004.12.006; Ma HA, 2010, J PHYS CHEM B, V114, P13823, DOI 10.1021/jp1014516; MARANON MJR, 1994, BIOCHEM J, V301, P335, DOI 10.1042/bj3010335; Matsui T, 1997, J BIOL CHEM, V272, P32735, DOI 10.1074/jbc.272.52.32735; McKinley AB, 2004, SPECTROSC LETT, V37, P275, DOI 10.1081/SL-120038763; Miksovska J, 2008, BIOCHEMISTRY-US, V47, P11510, DOI 10.1021/bi8012033; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nicoletti FP, 2010, BIOCHEMISTRY-US, V49, P1903, DOI 10.1021/bi9020567; Nienhaus K, 2008, BIOCHEMISTRY-US, V47, P12985, DOI 10.1021/bi801564r; Nilges M. J., 2007, ESR SPECTROSCOPY MEM, P379; Nissum M, 2001, BBA-PROTEIN STRUCT M, V1545, P339, DOI 10.1016/S0167-4838(00)00295-8; Osborne RL, 2004, BIOCHEM BIOPH RES CO, V324, P1194, DOI 10.1016/j.bbrc.2004.09.174; Osborne RL, 2006, J AM CHEM SOC, V128, P1036, DOI 10.1021/ja056213b; Osborne RL, 2007, BIOCHEMISTRY-US, V46, P9823, DOI 10.1021/bi700684u; Osborne RL, 2006, J INORG BIOCHEM, V100, P1100, DOI 10.1016/j.jinorgbio.2006.02.008; Osborne RL, 2009, BIOCHEMISTRY-US, V48, P4231, DOI 10.1021/bi900367e; POULOS TL, 1980, J BIOL CHEM, V255, P8199; Reeder BJ, 2012, J AM CHEM SOC, V134, P7741, DOI 10.1021/ja211745g; Roach MP, 1997, BIOCHEMISTRY-US, V36, P2197, DOI 10.1021/bi9621371; Singh R, 2010, BIOCHEMISTRY-US, V49, P8857, DOI 10.1021/bi100499a; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Smirnova TI, 2008, J AM CHEM SOC, V130, P2128, DOI 10.1021/ja0772952; Svistunenko D, 2004, TYROSINE RESIDUES DI; Svistunenko DA, 2004, BIOPHYS J, V87, P582, DOI 10.1529/biophysj.104.041046; Tanaka M, 1997, BIOCHEMISTRY-US, V36, P9791, DOI 10.1021/bi9706172; Thompson MK, 2010, J AM CHEM SOC, V132, P17501, DOI 10.1021/ja106620q; Wang CX, 2013, BIOCHEMISTRY-US, V52, P6203, DOI 10.1021/bi400627w; WEBER RE, 1977, COMP BIOCHEM PHYS A, V56, P179, DOI 10.1016/0300-9629(77)90182-7; WOODIN SA, 1987, J EXP MAR BIOL ECOL, V107, P209, DOI 10.1016/0022-0981(87)90038-4; WOODIN SA, 1991, AM ZOOL, V31, P797; Zhang E, 1996, ACTA CRYSTALLOGR D, V52, P1191, DOI 10.1107/S0907444996007974; Zhao J, 2013, BIOCHEMISTRY-US, V52, P2427, DOI 10.1021/bi301307f	73	18	19	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33470	33482		10.1074/jbc.M113.496497	http://dx.doi.org/10.1074/jbc.M113.496497			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100039	Green Published, hybrid			2022-12-28	WOS:000328841700059
J	Goda, S; Isagawa, T; Chikaoka, Y; Kawamura, T; Aburatani, H				Goda, Satoshi; Isagawa, Takayuki; Chikaoka, Yoko; Kawamura, Takeshi; Aburatani, Hiroyuki			Control of Histone H3 Lysine 9 (H3K9) Methylation State via Cooperative Two-step Demethylation by Jumonji Domain Containing 1A (JMJD1A) Homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Enzyme Mechanisms; Histone Methylation; Mass Spectrometry (MS); Surface Plasmon Resonance (SPR); JMJD1A; Chromatin Biology; Dimerization; Histone Lysine Demethylase	HYPOXIA-INDUCIBLE FACTOR-1; STRUCTURAL INSIGHTS; GENE-EXPRESSION; BINDING; DIMERIZATION; JHDM2A; PHOSPHORYLATION; TRANSCRIPTION; REVEALS; OBESITY	Post-translational histone methylation is a dynamic and reversible process that is involved in the spatio-temporal regulation of gene transcription and contributes to various cellular phenotypes. Methylation of histone H3 at lysine 9 (H3K9), which is generally a transcriptional repression mark, is demethylated by H3K9-specific demethylases, leading to transcriptional activation. However, how multiple demethylases with the same substrate specificity differ in their chromatin targeting mechanisms has not been well understood. Unlike other H3K9-specific demethylases, it has been reported that JMJD1A likely forms a homodimer, but a detailed mode of dimerization and the possible link between structure and enzymatic activity have remained unresolved. Here, we report the structure-function relationship of JMJD1A in detail. First, JMJD1A forms a homodimer through its catalytic domains, bringing the two active sites close together. Second, increasing the concentration of JMJD1A facilitates efficient production of unmethylated product from dimethyl-H3K9 and decreases the release of the monomethylated intermediate. Finally, substituting one of the two active sites with an inactive mutant results in a significant reduction of the demethylation rate without changing the affinity to the intermediate. Given this evidence, we propose a substrate channeling model for the efficient conversion of dimethylated H3K9 into the unmethylated state. Our study provides valuable information that will help in understanding the redundancy of H3K9-specific demethylases and the complementary activity of their unique structures and enzymatic properties for appropriate control of chromatin modification patterns.	[Goda, Satoshi; Isagawa, Takayuki; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan; [Isagawa, Takayuki] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1538904, Japan; [Chikaoka, Yoko; Kawamura, Takeshi] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Aburatani, H (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Tokyo 1538904, Japan.	haburata-tky@umin.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a grant for the New Energy and Industrial Technology Development Organization (NEDO) (to H. A. and T. N.), Japan.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartke T, 2013, BRIEF FUNCT GENOMICS, V12, P205, DOI 10.1093/bfgp/elt002; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Brauchle M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060549; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cheng Y, 2011, J MOL BIOL, V414, P106, DOI 10.1016/j.jmb.2011.09.040; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Krishnan S, 2011, CHEMBIOCHEM, V12, P254, DOI 10.1002/cbic.201000545; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Leung IKH, 2010, CHEM BIOL, V17, P1316, DOI 10.1016/j.chembiol.2010.09.016; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Osawa T, 2013, CANCER RES, V73, P3019, DOI 10.1158/0008-5472.CAN-12-3231; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sar A, 2009, CELL TISSUE RES, V337, P223, DOI 10.1007/s00441-009-0805-y; Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395; Shiau C, 2013, CHEM BIOL, V20, P494, DOI 10.1016/j.chembiol.2013.03.008; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Uemura M, 2010, CLIN CANCER RES, V16, P4636, DOI 10.1158/1078-0432.CCR-10-0407; Watson AA, 2012, J MOL BIOL, V422, P3, DOI 10.1016/j.jmb.2012.04.031; Wei H, 2010, P NATL ACAD SCI USA, V107, P18433, DOI 10.1073/pnas.1009911107; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yamada D, 2012, ANN SURG ONCOL, V19, pS355, DOI 10.1245/s10434-011-1797-x; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang YHP, 2011, BIOTECHNOL ADV, V29, P715, DOI 10.1016/j.biotechadv.2011.05.020	49	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36948	36956		10.1074/jbc.M113.492595	http://dx.doi.org/10.1074/jbc.M113.492595			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24214985	hybrid, Green Published			2022-12-28	WOS:000329189700017
J	Gosein, V; Miller, GJ				Gosein, Varin; Miller, Gregory J.			Conformational Stability of Inositol 1,3,4,5,6-Pentakisphosphate 2-Kinase (IPK1) Dictates Its Substrate Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Enzyme Structure; Inositol Phosphates; Protein Crystallization; Protein Structure; IPK1; Differential Scanning Fluorometry; Kinase Activation; Substrate Recognition	CRYSTAL-STRUCTURE; BINDING; SPECIFICITY	Inositol 1,3,4,5,6-pentakisphosphate 2-kinase (IPK1) converts inositol 1,3,4,5,6-pentakisphosphate(IP5) to inositol hexakisphosphate (IP6). IPK1 shares structural similarity with protein kinases and is suspected to employ a similar mechanism of activation. Previous studies revealed roles for the 1- and 3-phosphates of IP5 in IPK1 activation and revealed that the N-lobe of IPK1 is unstable in the absence of inositol phosphate (IP). Here, we demonstrate the link between IPK1 substrate specificity and the stability of its N-lobe. Limited proteolysis of IPK1 revealed that N-lobe stability is dependent on the presence of the 1-phosphate of the substrate, whereas overall stability of IPK1 was increased in ternary complexes with nucleotide and IPs possessing 1- and 3-phosphates that engage the N-lobe of IPK1. Thus, the 1- and 3-phosphates possess dual roles in both IPK1 activation and IPK1 stability. To test whether kinase stability directly contributed to substrate selectivity of the kinase, we engineered IPK1 mutants with disulfide bonds that artificially stabilized the N-lobe in an IP-independent manner thereby mimicking its substrate-bound state in the absence of IP. IPK1 E82C/S142C exhibited a DTT-sensitive 5-fold increase in k(cat) for 3,4,5,6-inositol tetrakisphosphate (3,4,5,6-IP4) as compared with wild-type IPK1. The crystal structure of the IPK1 E82C/S142C mutant confirmed the presence of the disulfide bond and revealed a small shift in the N-lobe. Finally, we determined that IPK1 E82C/S142C is substantially more stable than wild-type IPK1 under nonreducing conditions, revealing that increased stability of IPK1 E82C/S142C correlates with changes in substrate specificity by allowing IPs lacking the stabilizing 1-phosphate to be used. Taken together, our results show that IPK1 substrate selection is linked to the ability of each potential substrate to stabilize IPK1.	[Gosein, Varin; Miller, Gregory J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Miller, Gregory J.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Miller, Gregory J.] Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA	McGill University; McGill University; Catholic University of America	Miller, GJ (corresponding author), Catholic Univ Amer, Dept Chem, Washington, DC 20064 USA.	millergj@cua.edu			Canadian Institutes of Health (CIHR) [MOP-93687]; CIHR Strategic Training Initiative in Chemical Biology	Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health (CIHR) Research Operating Grant MOP-93687 (to G. J. M.) and a CIHR Strategic Training Initiative in Chemical Biology (to V. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agarwal R, 2009, MOL CELL BIOCHEM, V328, P155, DOI 10.1007/s11010-009-0085-6; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Gosein V, 2013, J BIOL CHEM, V288, P26908, DOI 10.1074/jbc.M113.487777; Gosein V, 2012, PROTEIN SCI, V21, P737, DOI 10.1002/pro.2049; Holmes W, 2006, J BIOL CHEM, V281, P38109, DOI 10.1074/jbc.M606883200; Banos-Sanz JI, 2012, J BIOL CHEM, V287, P29237, DOI 10.1074/jbc.M112.363671; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Miller GJ, 2005, MOL CELL, V18, P201, DOI 10.1016/j.molcel.2005.03.016; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sweetman D, 2006, BIOCHEM J, V394, P95, DOI 10.1042/BJ20051331; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Verbsky J, 2005, J BIOL CHEM, V280, P29263, DOI 10.1074/jbc.M503366200; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733	27	4	4	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36788	36795		10.1074/jbc.M113.512731	http://dx.doi.org/10.1074/jbc.M113.512731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24165122	Green Published, hybrid			2022-12-28	WOS:000329189700003
J	Hayes, ML; Giang, K; Berhane, B; Mulligan, RM				Hayes, Michael L.; Giang, Karolyn; Berhane, Beniam; Mulligan, R. Michael			Identification of Two Pentatricopeptide Repeat Genes Required for RNA Editing and Zinc Binding by C-terminal Cytidine Deaminase-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloroplast; Gene Expression; Mass Spectrometry (MS); Metalloenzymes; RNA Modification	CRYSTAL-STRUCTURE; PPR PROTEINS; MESSENGER-RNA; DYW PROTEIN; ARABIDOPSIS; SITE; MITOCHONDRIA; TRANSCRIPTS; MUTANTS; REVEALS	Background: Many pentatricopeptide repeat (PPR) proteins are RNA site specificity factors and include C-terminal DYW deaminase domains. Results: ELI1 and DOT4 are required for editing single sites. The DYW deaminase domain binds two zinc atoms. Conclusion: The C terminus of PLS-type PPR proteins shares molecular characteristics with cytidine deaminase. Significance: This study provides the first evidence that DYW deaminase domains bind zinc. Many transcripts expressed from plant organelle genomes are modified by C-to-U RNA editing. Nuclear encoded pentatricopeptide repeat (PPR) proteins are required as RNA binding specificity determinants in the RNA editing mechanism. Bioinformatic analysis has shown that most of the Arabidopsis PPR proteins necessary for RNA editing events include a C-terminal portion that shares structural characteristics with a superfamily of deaminases. The DYW deaminase domain includes a highly conserved zinc binding motif that shares characteristics with cytidine deaminases. The Arabidopsis PPR genes, ELI1 and DOT4, both have DYW deaminase domains and are required for single RNA editing events in chloroplasts. The ELI1 DYW deaminase domain was expressed as a recombinant protein in Escherichia coli and was shown to bind two zinc atoms per polypeptide. Thus, the DYW deaminase domain binds a zinc metal ion, as expected for a cytidine deaminase, and is potentially the catalytic component of an editing complex. Genetic complementation experiments demonstrate that large portions of the DYW deaminase domain of ELI1 may be eliminated, but the truncated genes retain the ability to restore editing site conversion in a mutant plant. These results suggest that the catalytic activity can be supplied in trans by uncharacterized protein(s) of the editosome.	[Hayes, Michael L.; Giang, Karolyn; Mulligan, R. Michael] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Berhane, Beniam] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Mulligan, RM (corresponding author), Univ Calif Irvine, 5219 McGaugh Hall, Irvine, CA 92697 USA.	rmmullig@uci.edu		Berhane, Beniam/0000-0002-1963-376X	National Science Foundation [MCB-0929423]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0929423 (to R. M. M.).	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bersoult A., 2010, 20 INT C AR RES ED U, P54; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; FRALEY RT, 1985, BIO-TECHNOL, V3, P629, DOI 10.1038/nbt0785-629; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Hall JC, 2002, AM J BOT, V89, P1826, DOI 10.3732/ajb.89.11.1826; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-66; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Miyamoto T, 2004, P NATL ACAD SCI USA, V101, P48, DOI 10.1073/pnas.0307163101; Namuswe F, 2012, J INORG BIOCHEM, V111, P146, DOI 10.1016/j.jinorgbio.2011.10.018; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Petricka JJ, 2008, PLANT J, V56, P251, DOI 10.1111/j.1365-313X.2008.03595.x; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2011, RNA, V17, P2058, DOI 10.1261/rna.02962911; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schallenberg-Rudinger M., 2013, RNA BIOL, V10, P1343; Serrano-Cartagena J, 1999, MOL GEN GENET, V261, P725, DOI 10.1007/s004380050016; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Verbitskiy D, 2012, PLANT CELL PHYSIOL, V53, P358, DOI 10.1093/pcp/pcr182; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	56	54	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36519	36529		10.1074/jbc.M113.485755	http://dx.doi.org/10.1074/jbc.M113.485755			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194514	hybrid, Green Published			2022-12-28	WOS:000328883400032
J	Mukund, S; Shang, YL; Clarke, HJ; Madjidi, A; Corn, JE; Kates, L; Kolumam, G; Chiang, V; Luis, E; Murray, J; Zhang, YN; Hotzel, I; Koth, CM; Allan, BB				Mukund, Susmith; Shang, Yonglei; Clarke, Holly J.; Madjidi, Azadeh; Corn, Jacob E.; Kates, Lance; Kolumam, Ganesh; Chiang, Vicky; Luis, Elizabeth; Murray, Jeremy; Zhang, Yingnan; Hoetzel, Isidro; Koth, Christopher M.; Allan, Bernard B.			Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Diabetes; G Protein-coupled Receptors (GPCR); Glucose Metabolism; Structural Biology	MOLECULAR RECOGNITION; GLY40SER MUTATION; PHAGE DISPLAY; BINDING-SITE; B GPCRS; GENE; HORMONE; DOMAIN; ANTAGONIST; MODULATORS	Elevated glucagon levels and increased hepatic glucagon receptor (GCGR) signaling contribute to hyperglycemia in type 2 diabetes. We have identified a monoclonal antibody that inhibits GCGR, a class B G-protein coupled receptor (GPCR), through a unique allosteric mechanism. Receptor inhibition is mediated by the binding of this antibody to two distinct sites that lie outside of the glucagon binding cleft. One site consists of a patch of residues that are surface-exposed on the face of the extracellular domain (ECD) opposite the ligand-binding cleft, whereas the second binding site consists of residues in the A helix of the ECD. A docking model suggests that the antibody does not occlude the ligand-binding cleft. We solved the crystal structure of GCGR ECD containing a naturally occurring G40S mutation and found a shift in the register of the A helix that prevents antibody binding. We also found that alterations in the A helix impact the normal function of GCGR. We present a model for the allosteric inhibition of GCGR by a monoclonal antibody that may form the basis for the development of allosteric modulators for the treatment of diabetes and other class B GPCR-related diseases.	[Mukund, Susmith; Murray, Jeremy; Koth, Christopher M.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Shang, Yonglei; Chiang, Vicky; Hoetzel, Isidro] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Clarke, Holly J.; Madjidi, Azadeh; Allan, Bernard B.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kates, Lance; Kolumam, Ganesh] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Luis, Elizabeth] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Corn, Jacob E.; Zhang, Yingnan] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Koth, CM (corresponding author), Genentech Inc, Dept Biol Struct, 1 DNA Way, San Francisco, CA 94080 USA.	kothc@gene.com; allanb2@gene.com		Koth, Christopher/0000-0003-3939-8856; Hotzel, Isidro/0000-0001-6910-7840	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE))	We are grateful to the Structural Biology Expression Group for the generation of critical reagents to support this work. Portions of this work were carried out at the Advanced Light Source, Lawrence Berkeley National Laboratory. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy (Contract Number DE-AC02-05CH11231).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barwell J, 2012, BRIT J PHARMACOL, V166, P51, DOI 10.1111/j.1476-5381.2011.01525.x; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Cascieri MA, 1999, J BIOL CHEM, V274, P8694, DOI 10.1074/jbc.274.13.8694; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conner AC, 2004, BIOCHEM SOC T, V32, P843, DOI 10.1042/BST0320843; Dallas-Yang Q, 2004, EUR J PHARMACOL, V501, P225, DOI 10.1016/j.ejphar.2004.08.023; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dennis MS, 2010, BIOTECHNOL PHARM ASP, V11, P9, DOI 10.1007/978-0-387-76643-0_2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOUGH SCL, 1995, HUM MOL GENET, V4, P1609, DOI 10.1093/hmg/4.9.1609; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Gu W, 2009, J PHARMACOL EXP THER, V331, P871, DOI 10.1124/jpet.109.157685; HAGER J, 1995, NAT GENET, V9, P299, DOI 10.1038/ng0395-299; Hansen LH, 1996, DIABETES, V45, P725, DOI 10.2337/diabetes.45.6.725; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoare SRJ, 2007, CURR NEUROPHARMACOL, V5, P168, DOI 10.2174/157015907781695928; Ke JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033676; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Patterson JT, 2013, MOL METAB, V2, P86, DOI 10.1016/j.molmet.2013.01.003; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ravn P, 2013, J BIOL CHEM, V288, P19760, DOI 10.1074/jbc.M112.426288; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Strazzullo P, 2001, J MOL MED, V79, P574, DOI 10.1007/s001090100257; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Tonolo G, 1997, DIABETOLOGIA, V40, P89, DOI 10.1007/s001250050647; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Willard FS, 2012, MOL PHARMACOL, V82, P1066, DOI 10.1124/mol.112.080432; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	39	28	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36168	36178		10.1074/jbc.M113.496984	http://dx.doi.org/10.1074/jbc.M113.496984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189067	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000329814700051
J	Ranaghan, MJ; Kumar, RP; Chakrabarti, KS; Buosi, V; Kern, D; Oprian, DD				Ranaghan, Matthew J.; Kumar, Ramasamy P.; Chakrabarti, Kalyan S.; Buosi, Vanessa; Kern, Dorothee; Oprian, Daniel D.			A Highly Conserved Cysteine of Neuronal Calcium-sensing Proteins Controls Cooperative Binding of Ca2+ to Recoverin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Calcium-binding Proteins; Calcium Signaling; Cooperativity; Mutant; Protein Myristoylation; Cysteine; Neuronal Calcium Sensor; Sulfenic Acid	RHODOPSIN KINASE; TERMINAL MYRISTOYLATION; SENSOR; PHOSPHORYLATION; INHIBITION; MODULATION; TRANSITION; SYSTEM	Background: Recoverin contains a cysteine (Cys-39) that is highly conserved in neuronal calcium-sensing (NCS) proteins. Results: The C39A mutation shifts the conformational equilibrium from the R to T state, inducing cooperative calcium binding. Conclusion: Cys-39 controls the conformational equilibrium of calcium-free recoverin. Significance: This mutation assigns a previously unknown function to the conserved cysteine in recoverin and possibly all NCS proteins. Recoverin, a 23-kDa Ca2+-binding protein of the neuronal calcium sensing (NCS) family, inhibits rhodopsin kinase, a Ser/Thr kinase responsible for termination of photoactivated rhodopsin in rod photoreceptor cells. Recoverin has two functional EF hands and a myristoylated N terminus. The myristoyl chain imparts cooperativity to the Ca2+-binding sites through an allosteric mechanism involving a conformational equilibrium between R and T states of the protein. Ca2+ binds preferentially to the R state; the myristoyl chain binds preferentially to the T state. In the absence of myristoylation, the R state predominates, and consequently, binding of Ca2+ to the non-myristoylated protein is not cooperative. We show here that a mutation, C39A, of a highly conserved Cys residue among NCS proteins, increases the apparent cooperativity for binding of Ca2+ to non-myristoylated recoverin. The binding data can be explained by an effect on the T/R equilibrium to favor the T state without affecting the intrinsic binding constants for the two Ca2+ sites.	[Ranaghan, Matthew J.; Kumar, Ramasamy P.; Chakrabarti, Kalyan S.; Buosi, Vanessa; Kern, Dorothee; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Chakrabarti, Kalyan S.; Buosi, Vanessa; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	dkern@brandeis.edu; oprian@brandeis.edu	Ramasamy, Prem Kumar/I-6801-2019; chakrabarti, kalyan s/A-4583-2013	Ramasamy, Prem Kumar/0000-0002-6555-8289; Chakrabarti, Kalyan S/0000-0003-4864-9477	NIGMS, National Institutes of Health; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY009514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Doug Theobald, Chris Miller, and Benjamin Nickle for insightful discussions and Adelajda Zorba for help with HPLC experiments. The Berkeley Center for Structural Biology is supported in part by the NIGMS, National Institutes of Health. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 2002, BIOCHEMISTRY-US, V41, P5776, DOI 10.1021/bi012153k; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Baldwin AN, 1998, BIOCHEMISTRY-US, V37, P17408, DOI 10.1021/bi980928s; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Desmeules P, 2006, ANAL BIOCHEM, V349, P25, DOI 10.1016/j.ab.2005.11.023; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gensch T, 2007, PROTEINS, V66, P492, DOI 10.1002/prot.21231; Higgins MK, 2006, J BIOL CHEM, V281, P19426, DOI 10.1074/jbc.M602203200; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; Permyakov SE, 2007, J PROTEOME RES, V6, P1855, DOI 10.1021/pr070015x; Permyakov SE, 2012, AMINO ACIDS, V42, P1435, DOI 10.1007/s00726-011-0843-0; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; Senin II, 2002, J BIOL CHEM, V277, P50365, DOI 10.1074/jbc.M204338200; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Weiergraber OH, 2003, J BIOL CHEM, V278, P22972, DOI 10.1074/jbc.M300447200; Weiergraber OH, 2006, J BIOL CHEM, V281, P37594, DOI 10.1074/jbc.M603700200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	35	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36160	36167		10.1074/jbc.M113.524355	http://dx.doi.org/10.1074/jbc.M113.524355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189072	Green Published, hybrid			2022-12-28	WOS:000329814700050
J	Gault, VA; Bhat, VK; Irwin, N; Flatt, PR				Gault, Victor A.; Bhat, Vikas K.; Irwin, Nigel; Flatt, Peter R.			A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1 and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Glucose; Insulin; Insulin Secretion; Obesity	ZUCKER RATS; IN-VITRO; DB/DB MICE; GIP; HOMEOSTASIS; EXENDIN-4; HORMONES; WEIGHT; ACTIVATION; THERAPIES	Glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon bind to related members of the same receptor superfamily and exert important effects on glucose homeostasis, insulin secretion, and energy regulation. The present study assessed the biological actions and therapeutic utility of novel GIP/glucagon/GLP-1 hybrid peptides. Nine novel peptides were synthesized and exhibited complete DPP-IV resistance and enhanced in vitro insulin secretion. The most promising peptide, [dA(2)]GLP-1/GcG, stimulated cAMP production in GIP, GLP-1, and glucagon receptor-transfected cells. Acute administration of [dA(2)]GLP-1/GcG in combination with glucose significantly lowered plasma glucose and increased plasma insulin in normal and obese diabetic (ob/ob) mice. Furthermore, [dA(2)]GLP-1/GcG elicited a protracted glucose-lowering and insulinotropic effect in high fat-fed mice. Twice daily administration of [dA(2)]GLP-1/GcG for 21 days decreased body weight and nonfasting plasma glucose and increased circulating plasma insulin concentrations in high fat-fed mice. Furthermore, [dA(2)]GLP-1/GcG significantly improved glucose tolerance and insulin sensitivity by day 21. Interestingly, locomotor activity was increased in [dA(2)]GLP-1/GcG mice, without appreciable changes in aspects of metabolic rate. Studies in knock-out mice confirmed the biological action of [dA(2)]GLP-1/GcG via multiple targets including GIP, GLP-1, and glucagon receptors. The data suggest significant promise for novel triple-acting hybrid peptides as therapeutic options for obesity and diabetes.	[Gault, Victor A.; Bhat, Vikas K.; Irwin, Nigel; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Ulster University	Irwin, N (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	n.irwin@ulster.ac.uk	Irwin, Nigel/H-9696-2019	Irwin, Nigel/0000-0003-4855-964X; Flatt, Peter/0000-0001-8548-7943; Gault, Victor/0000-0001-8501-1013	University of Ulster; Diabetes Research and Wellness Foundation	University of Ulster; Diabetes Research and Wellness Foundation	This work was supported by University of Ulster Strategy Research Funding, a Vice-Chancellors Research Scholarship (to V. B.), and a research grant from Diabetes Research and Wellness Foundation.	Al-Barazanji KA, 2000, OBES RES, V8, P317, DOI 10.1038/oby.2000.38; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Baggio LL, 2004, DIABETES, V53, P2492, DOI 10.2337/diabetes.53.9.2492; Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; BAILEY CJ, 1982, INT J OBESITY, V6, P11; Bhat VK, 2013, DIABETOLOGIA, V56, P1417, DOI 10.1007/s00125-013-2892-2; Brubaker PL, 2002, RECEPTOR CHANNEL, V8, P179, DOI 10.1080/1060682020005155; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Deacon CF, 2005, REGUL PEPTIDES, V128, P117, DOI 10.1016/j.regpep.2004.06.007; Delmeire D, 2004, BIOCHEM PHARMACOL, V68, P33, DOI 10.1016/j.bcp.2004.02.035; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Flatt PR, 2009, CURR DRUG METAB, V10, P125, DOI 10.2174/138920009787522124; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Gault VA, 2011, J ENDOCRINOL, V208, P265, DOI 10.1530/JOE-10-0419; Gault VA, 2011, CLIN SCI, V121, P107, DOI 10.1042/CS20110006; Gelling RW, 2009, AM J PHYSIOL-ENDOC M, V297, pE695, DOI 10.1152/ajpendo.00082.2009; Greig NH, 1999, DIABETOLOGIA, V42, P45, DOI 10.1007/s001250051111; Gribble FM, 2012, P NUTR SOC, V71, P456, DOI 10.1017/S0029665112000705; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Hinke SA, 2002, DIABETES, V51, P652, DOI 10.2337/diabetes.51.3.652; Ionut V, 2013, OBESITY, V21, P1093, DOI 10.1002/oby.20364; Irwin N, 2013, DIABETES OBES METAB, V15, P650, DOI 10.1111/dom.12079; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Parker JA, 2013, INT J OBESITY, V37, P1391, DOI 10.1038/ijo.2012.227; Parlevliet ET, 2010, AM J PHYSIOL-ENDOC M, V299, pE318, DOI 10.1152/ajpendo.00191.2010; Pospisilik JA, 2001, REGUL PEPTIDES, V96, P133, DOI 10.1016/S0167-0115(00)00170-1; Sadry SA, 2013, NAT REV ENDOCRINOL, V9, P425, DOI 10.1038/nrendo.2013.47; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Xiao Q, 2001, BIOCHEMISTRY-US, V40, P2860, DOI 10.1021/bi0014498; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026	33	95	104	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35581	35591		10.1074/jbc.M113.512046	http://dx.doi.org/10.1074/jbc.M113.512046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165127	Green Published, hybrid			2022-12-28	WOS:000329867600052
J	Woskowicz, AM; Weaver, SA; Shitomi, Y; Ito, N; Itoh, Y				Woskowicz, Anna M.; Weaver, Sarah A.; Shitomi, Yasuyuki; Ito, Noriko; Itoh, Yoshifumi			MT-LOOP-dependent Localization of Membrane Type I Matrix Metalloproteinase (MT1-MMP) to the Cell Adhesion Complexes Promotes Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Surface Enzymes; Integrin; Invasion; Matrix Metalloproteinase (MMP); MT-LOOP; MT1-MMP; Focal Adhesion	3-DIMENSIONAL EXTRACELLULAR-MATRIX; HEMOPEXIN-LIKE DOMAIN; TUMOR-GROWTH; RHEUMATOID-ARTHRITIS; PROMMP-2 ACTIVATION; TISSUE INHIBITOR; CYTOPLASMIC TAIL; FOCAL ADHESIONS; SURFACE; MIGRATION	Background: MT1-MMP promotes cancer cell invasion. Results: Deletion of the MT-LOOP region of MT1-MMP or an antibody to the MT-LOOP inhibits cellular invasion. Conclusion: MT-LOOP-dependent MT1-MMP localization to the cell adhesion complex promotes cellular invasion. Significance: Our work reveals a novel mechanism of MT1-MMP regulation during cellular invasion and identifies the MT-LOOP as a novel target region to develop specific inhibitors. Localization of membrane type I matrix metalloproteinase (MT1-MMP) to the leading edge is thought to be a crucial step during cancer cell invasion. However, its mechanisms and functional impact on cellular invasion have not been clearly defined. In this report, we have identified the MT-LOOP, a loop region in the catalytic domain of MT1-MMP ((163)PYAYIREG(170)), as an essential region for MT1-MMP to promote cellular invasion. Deletion of the MT-LOOP effectively inhibited functions of MT1-MMP on the cell surface, including proMMP-2 activation, degradation of gelatin and collagen films, and cellular invasion into a collagen matrix. This is not due to loss of the catalytic function of MT1-MMP but due to inefficient localization of the enzyme to 1-integrin-rich cell adhesion complexes at the plasma membrane. We also found that an antibody that specifically recognizes the MT-LOOP region of MT1-MMP (LOOPAb) inhibited MT1-MMP functions, fully mimicking the phenotype of the MT-LOOP deletion mutant. We therefore propose that the MT-LOOP region is an interface for molecular interactions that mediate enzyme localization to cell adhesion complexes and regulate MT1-MMP functions. Our findings have revealed a novel mechanism regulating MT1-MMP during cellular invasion and have identified the MT-LOOP as a potential exosite target region to develop selective MT1-MMP inhibitors.	[Woskowicz, Anna M.; Weaver, Sarah A.; Shitomi, Yasuyuki; Ito, Noriko; Itoh, Yoshifumi] Univ Oxford, Kennedy Inst Rheumatol, NDORMS, Oxford OX3 7FY, England	University of Oxford	Itoh, Y (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, NDORMS, Roosevelt Dr, Oxford OX3 7FY, England.	yoshi.itoh@kennedy.ox.ac.uk		Itoh, Yoshifumi/0000-0002-2128-2823	Cancer Research UK Project [C1507/A5541]; Medical Research Council Research [G0802007]; Arthritis Research UK core grant; Kennedy Trust Ph.D. studentship; Medical Research Council [G0802007] Funding Source: researchfish; Versus Arthritis [19797] Funding Source: researchfish; MRC [G0802007] Funding Source: UKRI	Cancer Research UK Project(Cancer Research UK); Medical Research Council Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK core grant(Versus Arthritis); Kennedy Trust Ph.D. studentship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK Project Grant C1507/A5541, by Medical Research Council Research Grant G0802007, by an Arthritis Research UK core grant (to the Kennedy Institute of Rheumatology), and by a Kennedy Trust Ph.D. studentship.	Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; English WR, 2001, J BIOL CHEM, V276, P42018, DOI 10.1074/jbc.M107783200; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Ingvarsen S, 2013, J BIOL CHEM, V288, P10195, DOI 10.1074/jbc.M112.447169; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2011, BIOCHEM J, V440, P319, DOI 10.1042/BJ20110424; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Mori H, 2013, DEVELOPMENT, V140, P343, DOI 10.1242/dev.084236; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Nakada M, 2001, CANCER RES, V61, P8896; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Palmisano R, 2010, METHODS MOL BIOL, V622, P379, DOI 10.1007/978-1-60327-299-5_23; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Sabeh F, 2010, J IMMUNOL, V184, P6396, DOI 10.4049/jimmunol.0904068; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato T, 1997, J CELL SCI, V110, P589; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Wang Y, 2012, J CELL BIOL, V196, P375, DOI 10.1083/jcb.201105153; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52	57	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35126	35137		10.1074/jbc.M113.496067	http://dx.doi.org/10.1074/jbc.M113.496067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165131	Green Published, hybrid			2022-12-28	WOS:000329867600014
J	Chu, BW; Kovary, KM; Guillaume, J; Chen, LC; Teruel, MN; Wandless, TJ				Chu, Bernard W.; Kovary, Kyle M.; Guillaume, Johan; Chen, Ling-chun; Teruel, Mary N.; Wandless, Thomas J.			The E3 Ubiquitin Ligase UBE3C Enhances Proteasome Processivity by Ubiquitinating Partially Proteolyzed Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Proteasome; Protein Degradation; Protein Processing; Protein Stability	DNA-REPAIR; PLASMODIUM-FALCIPARUM; MOLECULAR CHAPERONES; PROTEIN; DEGRADATION; CHAINS; RECOGNITION; CHIP; HUL5; PROMOTES	Background: An RNAi screen identified UBE3C as a key player in degradation of a model unfolded protein. Results: UBE3C knockdown results in incomplete degradation of relatively stable substrates. Conclusion: UBE3C enhances proteasome processivity to prevent the accumulation of potentially harmful protein fragments. Significance: This advances our understanding of proteasome processivity and the consequences of defects therein. To maintain protein homeostasis, cells must balance protein synthesis with protein degradation. Accumulation of misfolded or partially degraded proteins can lead to the formation of pathological protein aggregates. Here we report the use of destabilizing domains, proteins whose folding state can be reversibly tuned using a high affinity ligand, as model substrates to interrogate cellular protein quality control mechanisms in mammalian cells using a forward genetic screen. Upon knockdown of UBE3C, an E3 ubiquitin ligase, a reporter protein consisting of a destabilizing domain fused to GFP is degraded more slowly and incompletely by the proteasome. Partial proteolysis is also observed when UBE3C is present but cannot ubiquitinate substrates because its active site has been mutated, it is unable to bind to the proteasome, or the substrate lacks lysine residues. UBE3C knockdown also results in less substrate polyubiquitination. Finally, knockdown renders cells more susceptible to the Hsp90 inhibitor 17-AAG, suggesting that UBE3C protects against the harmful accumulation of protein fragments arising from incompletely degraded proteasome substrates.	[Chu, Bernard W.; Kovary, Kyle M.; Guillaume, Johan; Chen, Ling-chun; Teruel, Mary N.; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Wandless, TJ (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu		Kovary, Kyle/0000-0002-7616-2968; Teruel, Mary/0000-0002-2854-3598	National Institutes of Health [GM073046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM073046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073046.	Aviram S, 2010, MOL CELL BIOL, V30, P985, DOI 10.1128/MCB.00909-09; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bennett EJ, 2008, NAT STRUCT MOL BIOL, V15, P20, DOI 10.1038/nsmb0108-20; Berko D, 2012, MOL CELL, V48, P601, DOI 10.1016/j.molcel.2012.08.029; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dolan BP, 2012, P NATL ACAD SCI USA, V109, P7025, DOI 10.1073/pnas.1112387109; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glass M, 2009, NAT METHODS, V6, P577, DOI 10.1038/nmeth.1346; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Hagai T, 2010, P NATL ACAD SCI USA, V107, P2001, DOI 10.1073/pnas.0912335107; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kohlmann S, 2008, J BIOL CHEM, V283, P16374, DOI 10.1074/jbc.M801702200; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Martinez-Noel G, 2012, MOL CELL BIOL, V32, P3095, DOI 10.1128/MCB.00201-12; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; Mocciaro A, 2012, J CELL SCI, V125, P255, DOI 10.1242/jcs.091199; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SLAVIK J, 1981, FOLIA MICROBIOL, V26, P176, DOI 10.1007/BF02927419; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; You JX, 2003, J BIOL CHEM, V278, P23369, DOI 10.1074/jbc.M212887200; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027	67	48	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34575	34587		10.1074/jbc.M113.499350	http://dx.doi.org/10.1074/jbc.M113.499350			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24158444	hybrid, Green Published			2022-12-28	WOS:000329812800026
J	Krauson, AJ; Rued, AC; Carattino, MD				Krauson, Aram J.; Rued, Anna C.; Carattino, Marcelo D.			Independent Contribution of Extracellular Proton Binding Sites to ASIC1a Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid Sensing Ion Channels (ASIC); Enac; Gating; Ion Channels; Site-directed Mutagenesis	SENSING ION CHANNELS; SENSORY NEURONS; SODIUM-CHANNEL; SELECTIVITY; PLASTICITY; SENSATION; ISCHEMIA; DOMAIN; PAIN; 1A	Background: Protons activate ASIC1a by an unknown mechanism. Results: E79K and D345K mutants showed shifted biphasic proton activation curves. The introduction of Lys residues at both of these sites restrained to a large extent proton gating. Conclusion: Two independent proton binding sites in the extracellular region of each subunit contribute to ASIC1a activation. Significance: These findings are relevant to understand the process of activation of ASIC1a. Acid-sensing ion channels (ASICs) are a group of trimeric cation permeable channels gated by extracellular protons that are mainly expressed in the nervous system. Despite the structural information available for ASIC1, there is limited understanding of the molecular mechanism that allows these channels to sense and respond to drops in extracellular pH. In this report, we employed the substituted cysteine accessibility method and site-directed mutagenesis to examine the mechanism of activation of ASIC1a by extracellular protons. We found that the modification of E238C and D345C channels by MTSET reduced proton apparent affinity for activation. Furthermore, the introduction of positively charged residues at position 345 rendered shifted biphasic proton activation curves. Likewise, channels bearing mutations at positions 79 and 416 in the palm domain of the channel showed reduced proton apparent affinity and biphasic proton activation curves. Of significance, the effect of the mutations at positions 79 and 345 on channel activation was additive. E79K-D345K required a change to a pH lower than 2 for maximal activation. In summary, this study provides direct evidence for the presence of two distinct proton coordination sites in the extracellular region of ASIC1a, which jointly facilitate pore opening in response to extracellular acidification.	[Krauson, Aram J.; Rued, Anna C.; Carattino, Marcelo D.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu	Krauson, Aram J/M-4866-2013; Krauson, Aram/ABH-1593-2021	Krauson, Aram J/0000-0001-7948-5730; Krauson, Aram/0000-0001-7948-5730	National Institutes of Health [R01 DK084060, T32 DK061296, P30 DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061296, R01DK084060, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health R01 DK084060 (to M. D. C.), T32 DK061296, and P30 DK079307.	Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Carattino MD, 2012, J BIOL CHEM, V287, P12927, DOI 10.1074/jbc.M111.329284; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Duan B, 2011, J NEUROSCI, V31, P2101, DOI 10.1523/JNEUROSCI.4351-10.2011; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gautam M, 2013, FASEB J, V27, P793, DOI 10.1096/fj.12-220400; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	26	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34375	34383		10.1074/jbc.M113.504324	http://dx.doi.org/10.1074/jbc.M113.504324			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142696	hybrid, Green Published			2022-12-28	WOS:000329812800009
J	Schumacher, MA; Chinnam, N; Ohashi, T; Shah, RS; Erickson, HP				Schumacher, Maria A.; Chinnam, Nagababu; Ohashi, Tomoo; Shah, Riddhi Sanjay; Erickson, Harold P.			The Structure of Irisin Reveals a Novel Intersubunit beta-Sheet Fibronectin Type III (FNIII) Dimer IMPLICATIONS FOR RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exercise; Hormones; Muscle; Receptors; X-ray Crystallography	SKELETAL-MUSCLE; ADIPOSE-TISSUE; EXERCISE; FNDC5; DIFFERENTIATION; EXPRESSION; MARKERS; PROTEIN; OBESITY; DOMAIN	Irisin was recently identified as a putative myokine that is induced by exercise. Studies suggest that it is produced by cleavage of the FNDC5 (fibronectin domain-containing protein 5) receptor; irisin corresponds to the extracellular receptor ectodomain. Data suggesting that irisin stimulates white-to-brown fat conversion have led to the hypothesis that it does so by binding an unknown receptor, thus functioning as a myokine. As brown fat promotes energy dissipation, myokines that elicit the transformation of white to brown fat have potentially profound benefits in the treatment of obesity and metabolic disorders. Understanding the molecular basis for such exercise-induced phenomena is thus of considerable interest. Moreover, FNDC5-like receptors are highly conserved and have been shown to be critical for neuronal development. However, the structural and molecular mechanisms utilized by these proteins are currently unknown. Here, we describe the crystal structure and biochemical characterization of the FNDC5 ectodomain, corresponding to the irisin myokine. The 2.28 structure shows that irisin consists of an N-terminal fibronectin III (FNIII)-like domain attached to a flexible C-terminal tail. Strikingly, the FNIII-like domain forms a continuous intersubunit -sheet dimer, previously unobserved for any FNIII protein. Biochemical data confirm that irisin is a dimer and that dimerization is unaffected by glycosylation. This finding suggests a possible mechanism for receptor activation by the irisin domain as a preformed myokine dimer ligand or as a paracrine or autocrine dimerization module on FNDC5-like receptors.	[Schumacher, Maria A.; Chinnam, Nagababu; Erickson, Harold P.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Ohashi, Tomoo; Shah, Riddhi Sanjay; Erickson, Harold P.] Duke Univ, Sch Med, Dept Cell Biol & Biochem, Durham, NC 27710 USA	Duke University; Duke University	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, DUMC, 255 Nanaline H Duke,POB 3711, Durham, NC 27710 USA.	maria.schumacher@duke.edu	Chinnam, Nagababu/ABF-5512-2021; chinnam, Nagababu/AFS-2420-2022	Chinnam, Nagababu/0000-0001-8925-5365; chinnam, Nagababu/0000-0001-8925-5365	Office of Science, Office of Basic Energy Sciences, and Material Science Division of the United States Department of Energy at the Lawrence Berkeley National Laboratory; NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, and Material Science Division of the United States Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Advanced Light Source (ALS) and the support staff. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, and Material Science Division of the United States Department of Energy at the Lawrence Berkeley National Laboratory.	Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050; Elbelt U, 2013, CURR OPIN CLIN NUTR, V16, P541, DOI 10.1097/MCO.0b013e328363bc65; Erickson HP, 2013, ADIPOCYTE, V2, P289, DOI 10.4161/adip.26082; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hashemi MS, 2013, NEUROSCIENCE, V231, P296, DOI 10.1016/j.neuroscience.2012.11.041; HOLLENBERG MD, 1991, FASEB J, V5, P178, DOI 10.1096/fasebj.5.2.1848518; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Ohashi T, 2011, J BIOL CHEM, V286, P39188, DOI 10.1074/jbc.M111.262337; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Pekkala S., 2013, J PHYSL IN PRESS; Pinto A, 2012, CURR PHARM DESIGN, V18, P4326, DOI 10.2174/138161212802481192; Raschke S., 2013, PLOS ONE, V8; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Santiveri CM, 2010, BIOPOLYMERS, V94, P779, DOI 10.1002/bip.21436; Schiefner A, 2012, J BIOL CHEM, V287, P17578, DOI 10.1074/jbc.M111.303131; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Timmons JA, 2012, NATURE, V488, pE9, DOI 10.1038/nature11364; Wang SS, 2002, ACTA CRYSTALLOGR D, V58, P571, DOI 10.1107/S0907444902001191; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	35	149	160	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33738	33744		10.1074/jbc.M113.516641	http://dx.doi.org/10.1074/jbc.M113.516641			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114836	Green Published, hybrid			2022-12-28	WOS:000327250200020
J	Abou-Saleh, H; Pathan, AR; Daalis, A; Hubrack, S; Abou-Jassoum, H; Al-Naeimi, H; Rusch, NJ; Machaca, K				Abou-Saleh, Haissam; Pathan, Asif R.; Daalis, Arwa; Hubrack, Satanay; Abou-Jassoum, Hamda; Al-Naeimi, Hamda; Rusch, Nancy J.; Machaca, Khaled			Inositol 1,4,5-Trisphosphate (IP3) Receptor Up-regulation in Hypertension Is Associated with Sensitization of Ca2+ Release and Vascular Smooth Muscle Contractility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium Signaling; Hypertension; NFAT Transcription Factor; Vascular Smooth Muscle Cells; A7r5; IP3 Receptor	HIGH BLOOD-PRESSURE; CEREBRAL-ARTERIES; MYOGENIC RESPONSE; CALCIUM-CHANNELS; PHOSPHOLIPASE-C; ION CHANNELS; CELLS; ENTRY; TRISPHOSPHATE; EXPRESSION	Background: The role of the vascular IP3 receptor (IP3R) in hypertension is unknown. Results: IP3R are up-regulated in vascular smooth muscle (VSM) in hypertension through the calcineurin-NFAT pathway. Conclusion: Up-regulated IP3R in VSM sensitize Ca2+ release and enhance contraction. Significance: Up-regulated vascular IP3R may contribute to vascular resistance in hypertension. Resistance arteries show accentuated responsiveness to vasoconstrictor agonists in hypertension, and this abnormality relies partly on enhanced Ca2+ signaling in vascular smooth muscle (VSM). Although inositol 1,4,5-triphosphate receptors (IP(3)Rs) are abundant in VSM, their role in the molecular remodeling of the Ca2+ signaling machinery during hypertension has not been addressed. Therefore, we compared IP3R expression and function between mesenteric arteries of normotensive and hypertensive animals. Levels of IP3R transcript and protein were significantly increased in mesenteric arteries of hypertensive animals, and pharmacological inhibition of the IP3R revealed a higher contribution of IP3-dependent Ca2+ release to vascular contraction in these arteries. Subsequently, we established cultured aortic VSM A7r5 cells as a cellular model that replicates IP3R up-regulation during hypertension by depolarizing the VSM cell membrane. IP3R up-regulation requires Ca2+ influx through L-type Ca2+ channels, followed by activation of the calcineurin-NFAT axis, resulting in IP3R transcription. Functionally, IP3R up-regulation in VSM is associated with enhancement and sensitization of IP3-dependent Ca2+ release, resulting in increased VSM contraction in response to agonist stimulation.	[Abou-Saleh, Haissam; Daalis, Arwa; Hubrack, Satanay; Machaca, Khaled] Qatar Fdn, Dept Physiol & Biophys, Weill Cornell Med Coll Qatar, Doha 24144, Qatar; [Pathan, Asif R.; Rusch, Nancy J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Abou-Jassoum, Hamda; Al-Naeimi, Hamda] Qatar Univ, Dept Biol & Environm Sci, Doha 2713, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Arkansas System; University of Arkansas Medical Sciences; Qatar University	Machaca, K (corresponding author), Qatar Fdn, Dept Physiol & Biophys, Weill Cornell Med Coll Qatar, Doha 24144, Qatar.	khm2002@qatar-med.cornell.edu	Machaca, Khaled/AAF-3579-2019	Hubrack, Satanay/0000-0003-1095-7386; Aboujassoum, Hamda/0000-0003-0778-9481	Qatar National Research Fund, National Priority Research Program Grant [NPRP 08-392-3-087]; Biomedical Research Program at Weill Cornell Medical College in Qatar; Qatar Foundation	Qatar National Research Fund, National Priority Research Program Grant(Qatar National Research Fund (QNRF)); Biomedical Research Program at Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was supported by a grant from the Qatar National Research Fund, National Priority Research Program Grant NPRP 08-392-3-087. The laboratory of K. M. is also supported by the Biomedical Research Program at Weill Cornell Medical College in Qatar, a program funded by Qatar Foundation.	Baek Eun Bok, 2011, Journal of Smooth Muscle Research, V47, P55; Bergdahl A, 2005, AM J PHYSIOL-CELL PH, V288, pC872, DOI 10.1152/ajpcell.00334.2004; Bergdahl A, 2003, CIRC RES, V93, P839, DOI 10.1161/01.RES.0000100367.45446.A3; BERNIER S, 1993, AM J HYPERTENS, V6, P217; BOSNJAK ZJ, 1993, ANESTHESIOLOGY, V79, P1392, DOI 10.1097/00000542-199312000-00031; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chockalingam A, 2008, CAN J CARDIOL, V24, P441, DOI 10.1016/S0828-282X(08)70617-2; Cox RH, 2002, MICROCIRCULATION, V9, P243, DOI 10.1038/sj.mn.7800140; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Grayson TH, 2004, CELL CALCIUM, V36, P447, DOI 10.1016/j.ceca.2004.04.005; HASHIMOTO T, 1986, J PHYSIOL-LONDON, V370, P605, DOI 10.1113/jphysiol.1986.sp015953; Hill MA, 2001, J APPL PHYSIOL, V91, P973, DOI 10.1152/jappl.2001.91.2.973; HIRST GDS, 1989, PHYSIOL REV, V69, P546, DOI 10.1152/physrev.1989.69.2.546; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Inscho EW, 1998, HYPERTENSION, V31, P421, DOI 10.1161/01.HYP.31.1.421; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Kharade SV, 2013, HYPERTENSION, V61, P137, DOI 10.1161/HYPERTENSIONAHA.112.197863; KULIK TJ, 1991, BIOCHEM BIOPH RES CO, V180, P982, DOI 10.1016/S0006-291X(05)81162-3; Lee CH, 2001, J PHYSIOL-LONDON, V534, P641, DOI 10.1111/j.1469-7793.2001.t01-1-00641.x; Lemarie CA, 2010, J MOL CELL CARDIOL, V48, P433, DOI 10.1016/j.yjmcc.2009.09.018; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATSUMOTO H, 1995, AM J PHYSIOL-CELL PH, V268, pC458, DOI 10.1152/ajpcell.1995.268.2.C458; Miriel VA, 1999, J PHYSIOL-LONDON, V518, P815, DOI 10.1111/j.1469-7793.1999.0815p.x; Monkawa T, 1998, KIDNEY INT, V53, P296, DOI 10.1046/j.1523-1755.1998.00763.x; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NARAYANAN J, 1994, AM J PHYSIOL, V266, pH1840, DOI 10.1152/ajpheart.1994.266.5.H1840; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; OSOL G, 1993, AM J PHYSIOL, V265, pH415, DOI 10.1152/ajpheart.1993.265.1.H415; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perez JF, 2005, J GEN PHYSIOL, V125, P555, DOI 10.1085/jgp.200409217; Pesic A, 2004, CIRC RES, V94, pE97, DOI 10.1161/01.RES.0000131495.93500.3c; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Pratt PF, 2002, HYPERTENSION, V40, P214, DOI 10.1161/01.HYP.0000025877.23309.36; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rizzoni D, 2012, INTERN EMERG MED, V7, P205, DOI 10.1007/s11739-011-0548-0; RUSCH NJ, 1991, ADV EXP MED BIOL, V308, P1; Schubert R, 2008, CARDIOVASC RES, V77, P8, DOI 10.1016/j.cardiores.2007.07.018; SMITH JB, 1986, AM J PHYSIOL, V250, pF759, DOI 10.1152/ajprenal.1986.250.5.F759; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; SOMLYO AV, 1985, P NATL ACAD SCI USA, V82, P5231, DOI 10.1073/pnas.82.15.5231; STEKIEL WJ, 1993, HYPERTENSION, V21, P1005, DOI 10.1161/01.HYP.21.6.1005; STEKIEL WJ, 1986, AM J PHYSIOL, V250, pC547, DOI 10.1152/ajpcell.1986.250.4.C547; STEKIEL WJ, 1991, HYPERTENSION, V17, P1185, DOI 10.1161/01.HYP.17.6.1185; TAKATA Y, 1983, CLIN EXP HYPERTENS A, V5, P827, DOI 10.3109/10641968309081811; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Wang YP, 2001, CIRC RES, V88, P202; WATANABE J, 1993, CIRC RES, V73, P465, DOI 10.1161/01.RES.73.3.465; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Xu SZ, 2001, CIRC RES, V88, P84, DOI 10.1161/01.RES.88.1.84; ZIEGLER MG, 1991, AM J HYPERTENS, V4, P586, DOI 10.1093/ajh/4.7.586	55	38	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32941	32951		10.1074/jbc.M113.496802	http://dx.doi.org/10.1074/jbc.M113.496802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097979	Green Published, hybrid			2022-12-28	WOS:000328841700012
J	Brown, KC; Perry, HE; Lau, JK; Jones, DV; Pulliam, JF; Thornhill, BA; Crabtree, CM; Luo, HT; Chen, YC; Dasgupta, P				Brown, Kathleen C.; Perry, Haley E.; Lau, Jamie K.; Jones, Dennie V.; Pulliam, Joseph F.; Thornhill, Brent A.; Crabtree, Clayton M.; Luo, Haitao; Chen, Yi. Charlie; Dasgupta, Piyali			Nicotine Induces the Up-regulation of the alpha 7-Nicotinic Receptor (alpha 7-nAChR) in Human Squamous Cell Lung Cancer Cells via the Sp1/GATA Protein Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GATA; Lung Cancer; Nicotinic Acetylcholine Receptors; Proliferation; Sp1	ACETYLCHOLINE-RECEPTOR; SUBUNIT GENE; GROWTH-FACTOR; E-BOX; ACTIVATION; EXPRESSION; SMOKING; TRANSCRIPTION; PROMOTER; TARGET	Background: Nicotine promotes the proliferation of human squamous cell lung cancer (SCC-L) via the 7-nicotinic receptor (nAChR). Results: Nicotine increases 7-nAChR expression via transcriptional mechanisms involving Sp1 and GATA proteins. Conclusion: Nicotine-induced up-regulation of 7-nAChR accelerates the growth of human SCC-L. Significance: SCC-L patients exposed to nicotine display fast growing lung tumors and worse clinical outcomes. Nicotine, the addictive component of cigarettes, promotes lung cancer proliferation via the 7-nicotinic acetylcholine receptor (7-nAChR) subtype. The present manuscript explores the effect of nicotine exposure on 7-nAChR levels in squamous cell carcinoma of the lung (SCC-L) in vitro and in vivo. Nicotine (at concentrations present in the plasma of average smokers) increased 7-nAChR levels in human SCC-L cell lines. Nicotine-induced up-regulation of 7-nAChR was confirmed in vivo by chicken chorioallantoic membrane models. We also observed that the levels of 7-nAChR in human SCC-L tumors (isolated from patients who are active smokers) correlated with their smoking history. Nicotine increased the levels of 7-nAChR mRNA and 7-nAChR transcription in human SCC-L cell lines and SCC-L tumors. Nicotine-induced up-regulation of 7-nAChR required GATA4 and GATA6. ChIP assays showed that nicotine induced the binding of GATA4 or GATA6 to Sp1 on the 7-nAChR promoter, thereby inducing its transcription and increasing its levels in human SCC-L. Our data are clinically relevant because SCC-L patients smoked for decades before being diagnosed with cancer. It may be envisaged that continuous exposure to nicotine (in such SCC-L patients) causes up-regulation of 7-nAChRs, which facilitates tumor growth and progression. Our results will also be relevant to many SCC-L patients exposed to nicotine via second-hand smoke, electronic cigarettes, and patches or gums to quit smoking.	[Brown, Kathleen C.; Perry, Haley E.; Lau, Jamie K.; Thornhill, Brent A.; Crabtree, Clayton M.; Dasgupta, Piyali] Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA; [Jones, Dennie V.] Univ Kentucky, Div Oncol, Dept Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Pulliam, Joseph F.] Univ Kentucky, Div Pathol, Dept Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Luo, Haitao; Chen, Yi. Charlie] Alderson Broaddus Univ, Dept Biol, Philippi, WV 26416 USA	Marshall University; University of Kentucky; University of Kentucky	Dasgupta, P (corresponding author), Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, 1700 3rd Ave, Huntington, WV 25755 USA.	dasgupta@marshall.edu			National Institutes of Health [1R15CA161491-01A1]; Flight Attendant Medical Association, Miami, FL [82115]; PhRMA Foundation; Sigma-Xi-GIAR undergraduate research grant, NASA; West Virginia IDeA Network of Biomedical Research Excellence Grants [P20RR016477, P20GM103434]; NATIONAL CANCER INSTITUTE [R15CA161491] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Association, Miami, FL; PhRMA Foundation; Sigma-Xi-GIAR undergraduate research grant, NASA; West Virginia IDeA Network of Biomedical Research Excellence Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health R15 AREA Grant 1R15CA161491-01A1 (to P. D.). This work was also supported by Young Clinical Scientist Award #82115 from the Flight Attendant Medical Association, Miami, FL, and a Research Starter Grant from the PhRMA Foundation (to P. D.).; Recipient of the Sigma-Xi-GIAR undergraduate research grant, NASA.; Supported by West Virginia IDeA Network of Biomedical Research Excellence Grants P20RR016477 and P20GM103434.	Al-Wadei HAN, 2009, INT J ONCOL, V34, P1093, DOI 10.3892/ijo_00000236; Al-Wadei MH, 2012, CARCINOGENESIS, V33, P1745, DOI 10.1093/carcin/bgs229; Arredondo J, 2008, FASEB J, V22, P1356, DOI 10.1096/fj.07-9965.com; Brown KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010243; Buisson B, 2002, TRENDS PHARMACOL SCI, V23, P130, DOI 10.1016/S0165-6147(00)01979-9; Carrasco-Serrano C, 2004, FEBS LETT, V566, P247, DOI 10.1016/j.febslet; Carrasco-Serrano C, 1998, J BIOL CHEM, V273, P20021, DOI 10.1074/jbc.273.32.20021; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Drilon A, 2012, LANCET ONCOL, V13, pE418, DOI 10.1016/S1470-2045(12)70291-7; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Egleton RD, 2009, PHARMACOL THERAPEUT, V121, P205, DOI 10.1016/j.pharmthera.2008.10.007; Fenster CP, 1997, J NEUROSCI, V17, P5747; Finlay-Schultz J, 2011, J BIOL CHEM, V286, P42123, DOI 10.1074/jbc.M111.276014; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Ito H, 2011, BBA-MOL CELL BIOL L, V1811, P119, DOI 10.1016/j.bbalip.2010.12.005; Johnson BE, 1997, SEMIN ONCOL, V24, P492; Jones RM, 1996, MOL CELL BIOL, V16, P4754; Kawahara M, 1998, BRIT J CANCER, V78, P409, DOI 10.1038/bjc.1998.507; Kawai H, 2001, J NEUROCHEM, V78, P1367, DOI 10.1046/j.1471-4159.2001.00526.x; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Leonard S, 2002, ARCH GEN PSYCHIAT, V59, P1085, DOI 10.1001/archpsyc.59.12.1085; Mexal S, 2010, J MOL NEUROSCI, V40, P185, DOI 10.1007/s12031-009-9233-4; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Nuutinen S, 2006, EUR J PHARMACOL, V544, P21, DOI 10.1016/j.ejphar.2006.06.038; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Pillai S, 2012, CURR DRUG TARGETS, V13, P671, DOI 10.2174/138945012800398847; Pillai S, 2010, CANCER RES, V70, P4931, DOI 10.1158/0008-5472.CAN-10-0501; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Schuller HM, 2012, CURR DRUG TARGETS, V13, P680, DOI 10.2174/138945012800398883; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Singhal S, 2011, J NANOTECHNOL, V2011, DOI [10.1155/2011/930243, 10.1155/2011/456743]; Song PF, 2003, CANCER RES, V63, P214; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; van der Zanden EP, 2012, NEUROIMMUNOMODULAT, V19, P255, DOI 10.1159/000335185; Videtic GMM, 2003, J CLIN ONCOL, V21, P1544, DOI 10.1200/JCO.2003.10.089; Wada T, 2007, ENDOCRINOLOGY, V148, P790, DOI 10.1210/en.2006-0907; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223; Zhou BY, 2008, AM J PHYSIOL-CELL PH, V295, pC1141, DOI 10.1152/ajpcell.00120.2008	50	64	68	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33049	33059		10.1074/jbc.M113.501601	http://dx.doi.org/10.1074/jbc.M113.501601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089524	hybrid, Green Published			2022-12-28	WOS:000328841700021
J	DeBerg, HA; Blehm, BH; Sheung, J; Thompson, AR; Bookwalter, CS; Torabi, SF; Schroer, TA; Berger, CL; Lu, Y; Trybus, KM; Selvin, PR				DeBerg, Hannah A.; Blehm, Benjamin H.; Sheung, Janet; Thompson, Andrew R.; Bookwalter, Carol S.; Torabi, Seyed F.; Schroer, Trina A.; Berger, Christopher L.; Lu, Yi; Trybus, Kathleen M.; Selvin, Paul R.			Motor Domain Phosphorylation Modulates Kinesin-1 Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Jun N-terminal Kinase (JNK); Kinesin; Molecular Motors; Phosphorylation; Single-molecule Biophysics	AXONAL-TRANSPORT; ANDROGEN RECEPTOR; LIGHT-CHAINS; TAIL DOMAIN; DYNEIN; PURIFICATION; HUNTINGTIN; PROTEINS; BINDING; EXPRESSION	Disruptions in microtubule motor transport are associated with a variety of neurodegenerative diseases. Post-translational modification of the cargo-binding domain of the light and heavy chains of kinesin has been shown to regulate transport, but less is known about how modifications of the motor domain affect transport. Here we report on the effects of phosphorylation of a mammalian kinesin motor domain by the kinase JNK3 at a conserved serine residue (Ser-175 in the B isoform and Ser-176 in the A and C isoforms). Phosphorylation of this residue has been implicated in Huntington disease, but the mechanism by which Ser-175 phosphorylation affects transport is unclear. The ATPase, microtubule-binding affinity, and processivity are unchanged between a phosphomimetic S175D and a nonphosphorylatable S175A construct. However, we find that application of force differentiates between the two. Placement of negative charge at Ser-175, through phosphorylation or mutation, leads to a lower stall force and decreased velocity under a load of 1 piconewton or greater. Sedimentation velocity experiments also show that addition of a negative charge at Ser-175 favors the autoinhibited conformation of kinesin. These observations imply that when cargo is transported by both dynein and phosphorylated kinesin, a common occurrence in the cell, there may be a bias that favors motion toward the minus-end of microtubules. Such bias could be used to tune transport in healthy cells when properly regulated but contribute to a disease state when misregulated.	[DeBerg, Hannah A.; Blehm, Benjamin H.; Sheung, Janet; Selvin, Paul R.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [DeBerg, Hannah A.; Blehm, Benjamin H.; Sheung, Janet; Selvin, Paul R.] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Torabi, Seyed F.; Lu, Yi] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Lu, Yi] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Thompson, Andrew R.; Bookwalter, Carol S.; Berger, Christopher L.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Schroer, Trina A.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Vermont; Johns Hopkins University	Selvin, PR (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	selvin@illinois.edu	liu, yi/GXE-9662-2022; Lu, Yi/GQQ-1069-2022; Lu, Yi/B-5461-2010	Lu, Yi/0000-0003-1221-6709; Lu, Yi/0000-0003-1221-6709; Thompson, Andrew/0000-0001-8537-6776; Schroer, Trina/0000-0002-5065-1835	National Institutes of Health [GM068625, GM078097, GM101066, ES016865, GM044589]; National Science Foundation [1063188, 0822613]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044589, R01GM068625, R01GM101066, R56GM044589, R01GM078097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068625 (to P.R.S.), GM078097 (to K.M.T.), GM101066 (to C.L.B.), ES016865 (to Y.L.), and GM044589 (to T.A.S.). This work was also supported by National Science Foundation Grants 1063188 and 0822613 (to P.R.S.).	Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Blehm BH, 2013, P NATL ACAD SCI USA, V110, P3381, DOI 10.1073/pnas.1219961110; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Crowe J., 1992, QIAEXPRESSIONIST, p[79, 81, 82]; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Li MH, 2011, BIOCHEMISTRY-US, V50, P8645, DOI 10.1021/bi2008257; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Piccioni F, 2001, BRAIN RES BULL, V56, P215, DOI 10.1016/S0361-9230(01)00652-9; Pierce DW, 1998, METHOD ENZYMOL, V298, P154, DOI 10.1016/S0076-6879(98)98016-8; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	39	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32612	32621		10.1074/jbc.M113.515510	http://dx.doi.org/10.1074/jbc.M113.515510			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072715	Green Published, hybrid			2022-12-28	WOS:000328681700043
J	Boivin, B; Chaudhary, F; Dickinson, BC; Haque, A; Pero, SC; Chang, CJ; Tonks, NK				Boivin, Benoit; Chaudhary, Fauzia; Dickinson, Bryan C.; Haque, Aftabul; Pero, Stephanie C.; Chang, Christopher J.; Tonks, Nicholas K.			Receptor Protein-tyrosine Phosphatase alpha Regulates Focal Adhesion Kinase Phosphorylation and ErbB2 Oncoprotein-mediated Mammary Epithelial Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Motility; Oncogene; Phosphatase; Phosphorylation; Protein Kinases; ErbB2; FAK; PTP; Dephosphorylation	ENDOTHELIAL GROWTH-FACTOR; HUMAN BREAST-CANCER; SRC-FAMILY KINASES; PTP-ALPHA; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; RPTP-ALPHA; IN-VIVO; REVERSIBLE OXIDATION; FLUORESCENT-PROBES	We investigated the role of protein-tyrosine phosphatase (PTP) in regulating signaling by the ErbB2 oncoprotein in mammary epithelial cells. Using this model, we demonstrated that activation of ErbB2 led to the transient inactivation of PTP, suggesting that attenuation of PTP activity may contribute to enhanced ErbB2 signaling. Furthermore, RNAi-induced suppression of PTP led to increased cell migration in an ErbB2-dependent manner. The ability of ErbB2 to increase cell motility in the absence of PTP was characterized by prolonged interaction of GRB7 with ErbB2 and increased association of ErbB2 with a 1-integrin-rich complex, which depended on GRB7-SH2 domain interactions. Finally, suppression of PTP resulted in increased phosphorylation of focal adhesion kinase on Tyr-407, which induced the recruitment of vinculin and the formation of a novel focal adhesion kinase complex in response to ErbB2 activation in mammary epithelial cells. Collectively, these results reveal a new role for PTP in the regulation of motility of mammary epithelial cells in response to ErbB2 activation.	[Boivin, Benoit; Chaudhary, Fauzia; Haque, Aftabul; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Pero, Stephanie C.] Univ Vermont, Coll Med, Vermont Comprehens Canc Ctr, Dept Surg, Burlington, VT 05405 USA	Cold Spring Harbor Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Vermont	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu		Boivin, Benoit/0000-0003-3306-5970	National Institutes of Health [CA53840, GM55989, GM79465]; Cold Spring Harbor Laboratory Cancer Centre [CA45508]; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE [R37CA053840, R01CA053840, P30CA045508, R01CA080790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, R01GM055989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Centre; Gladowsky Breast Cancer Foundation; Don Monti Memorial Research Foundation; Hansen Memorial Foundation; West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri; Robertson Research Fund; Masthead Cove Yacht Club Carol Marcincuk Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53840 and GM55989 (to N. K. T.) and GM79465 (to C. J. C.). This work was also supported by Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508 and by The Gladowsky Breast Cancer Foundation, The Don Monti Memorial Research Foundation, the Hansen Memorial Foundation, the West Islip Breast Cancer Coalition for Long Island, Glen Cove CARES, Find a Cure Today (FACT), Constance Silveri, the Robertson Research Fund, and the Masthead Cove Yacht Club Carol Marcincuk Fund (to N. K. T.).	Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Berndt A, 1999, HISTOCHEM CELL BIOL, V111, P399, DOI 10.1007/s004180050373; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boivin B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137pl2; Boivin B, 2010, METHOD ENZYMOL, V474, P35, DOI 10.1016/S0076-6879(10)74003-9; Buist A, 2000, J BIOL CHEM, V275, P20754, DOI 10.1074/jbc.M001626200; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chu PY, 2009, J BIOL CHEM, V284, P20215, DOI 10.1074/jbc.M109.018259; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Hauck CR, 2002, IUBMB LIFE, V53, P115, DOI 10.1080/15216540211470; Hauck CR, 2002, J BIOL CHEM, V277, P12487, DOI 10.1074/jbc.C100760200; Helmke S, 1998, J CELL SCI, V111, P2465; Huang J, 2011, EMBO J, V30, P3200, DOI 10.1038/emboj.2011.212; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Lahlou H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2905; Lammers R, 2000, J BIOL CHEM, V275, P3391, DOI 10.1074/jbc.275.5.3391; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Lim Y, 2007, J BIOL CHEM, V282, P10398, DOI 10.1074/jbc.M609302200; Lin G, 2011, GENE DEV, V25, P1412, DOI 10.1101/gad.2018911; Lin VS, 2013, METHOD ENZYMOL, V526, P19, DOI 10.1016/B978-0-12-405883-5.00002-8; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; MANGEAT P, 1984, J CELL BIOL, V99, pS95, DOI 10.1083/jcb.99.1.95s; Matkowskyj KA, 2003, J HISTOCHEM CYTOCHEM, V51, P1041, DOI 10.1177/002215540305100807; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meyer D.S., 2013, ONCOGENE IN PRESS; Miller EW, 2007, CURR OPIN CHEM BIOL, V11, P620, DOI 10.1016/j.cbpa.2007.09.018; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Persson C, 2004, P NATL ACAD SCI USA, V101, P1886, DOI 10.1073/pnas.0304403101; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Porter CJ, 2005, EUR BIOPHYS J BIOPHY, V34, P454, DOI [10.1007/s00249-005-0480-1, 10.1007/s00249-005-0480-l]; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; Shen TL, 2004, FRONT BIOSCI-LANDMRK, V9, P192, DOI 10.2741/1229; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; TABITI K, 1995, CANCER LETT, V93, P239, DOI 10.1016/0304-3835(95)03816-F; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tran KT, 2003, EXP CELL RES, V289, P359, DOI 10.1016/S0014-4827(03)00287-8; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Wu CW, 2006, CANCER LETT, V242, P95, DOI 10.1016/j.canlet.2005.10.046; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	78	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36926	36935		10.1074/jbc.M113.527564	http://dx.doi.org/10.1074/jbc.M113.527564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217252	Green Published, hybrid			2022-12-28	WOS:000329189700015
J	Gruning, CSR; Klinker, S; Wolff, M; Schneider, M; Toksoz, K; Klein, AN; Nagel-Steger, L; Willbold, D; Hoyer, W				Gruening, Clara S. R.; Klinker, Stefan; Wolff, Martin; Schneider, Mario; Toksoez, Kuepra; Klein, Antonia N.; Nagel-Steger, Luitgard; Willbold, Dieter; Hoyer, Wolfgang			The Off-rate of Monomers Dissociating from Amyloid-beta Protofibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Fluorescence; Kinetics; Protein Aggregation; Protein Engineering; Protein Misfolding; Scaffold Proteins; Spectroscopy	PROTEIN FIBRILLOGENESIS; PEPTIDE; A-BETA-40; THERMODYNAMICS; FLUORESCENCE; MECHANISMS; OLIGOMERS; KINETICS; BINDING	The interconversion of monomers, oligomers, and amyloid fibrils of the amyloid- peptide (A) has been implicated in the pathogenesis of Alzheimer disease. The determination of the kinetics of the individual association and dissociation reactions is hampered by the fact that forward and reverse reactions to/from different aggregation states occur simultaneously. Here, we report the kinetics of dissociation of A monomers from protofibrils, prefibrillar high molecular weight oligomers previously shown to possess pronounced neurotoxicity. An engineered binding protein sequestering specifically monomeric A was employed to follow protofibril dissociation by tryptophan fluorescence, precluding confounding effects of reverse or competing reactions. A protofibril dissociation into monomers follows exponential decay kinetics with a time constant of approximate to 2 h at 25 degrees C and an activation energy of 80 kJ/mol, values typical for high affinity biomolecular interactions. This study demonstrates the high kinetic stability of A protofibrils toward dissociation into monomers and supports the delineation of the A folding and assembly energy landscape.	[Gruening, Clara S. R.; Klinker, Stefan; Wolff, Martin; Schneider, Mario; Toksoez, Kuepra; Nagel-Steger, Luitgard; Willbold, Dieter; Hoyer, Wolfgang] Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany; [Wolff, Martin; Klein, Antonia N.; Nagel-Steger, Luitgard; Willbold, Dieter; Hoyer, Wolfgang] Res Ctr Julich, Inst Struct Biochem ICS 6, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Hoyer, W (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40204 Dusseldorf, Germany.	wolfgang.hoyer@uni-duesseldorf.de	Hoyer, Wolfgang/H-6193-2013; Willbold, Dieter/A-6280-2013; Nagel-Steger, Luitgard/H-6415-2013	Hoyer, Wolfgang/0000-0003-4301-5416; Willbold, Dieter/0000-0002-0065-7366; Nagel-Steger, Luitgard/0000-0001-5232-2149	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	This work was supported by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen.	Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gronwall C, 2007, J BIOTECHNOL, V128, P162, DOI 10.1016/j.jbiotec.2006.09.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hoyer W, 2008, J MOL BIOL, V378, P398, DOI 10.1016/j.jmb.2008.02.040; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Kheterpal I, 2003, BIOCHEMISTRY-US, V42, P14092, DOI 10.1021/bi0357816; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Macao B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-82; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; OJCIUS DM, 1993, BIOCHEM BIOPH RES CO, V197, P1216, DOI 10.1006/bbrc.1993.2606; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Sanchez L, 2011, J AM CHEM SOC, V133, P6505, DOI 10.1021/ja1117123; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	40	22	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37104	37111		10.1074/jbc.M113.513432	http://dx.doi.org/10.1074/jbc.M113.513432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24247242	hybrid, Green Published			2022-12-28	WOS:000329189700030
J	Buonvicino, D; Formentini, L; Cipriani, G; Chiarugi, A				Buonvicino, Daniela; Formentini, Laura; Cipriani, Giulia; Chiarugi, Alberto			Glucose Deprivation Converts Poly(ADP-ribose) Polymerase-1 Hyperactivation into a Transient Energy-producing Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP; AMP; ATP; Glucose; Mitochondria; Adenine Nucleotides; Adenylate Kinases; Poly(ADP-ribose) Polymerase-1	CELL-DEATH; NAD(+) DEPLETION; ADENYLATE KINASE; PAR POLYMER; MITOCHONDRIAL; IDENTIFICATION; TRANSPORTER; CATABOLISM; EXPRESSION; REPAIR	Background: Excessive activation of enzyme poly(ADP-ribose) polymerase-1 (PARP-1) causes ATP depletion and kills cells. Results: We found that in the absence of glucose PARP-1 triggers an adenylate kinase-dependent increase of ATP. Conclusion: PARP-1 hyperactivation is not invariantly related to ATP loss. Significance: This study adds to the complexity of PARP-1 hyperactivity and energy derangement. Massive poly(ADP-ribose) formation by poly(ADP-ribose) polymerase-1 (PARP-1) triggers NAD depletion and cell death. These events have been invariantly related to cellular energy failure due to ATP shortage. The latter occurs because of both ATP consumption for NAD resynthesis and impairment of mitochondrial ATP formation caused by an increase of the AMP/ADP ratio. ATP depletion is therefore thought to be an inevitable consequence of NAD loss and a hallmark of PARP-1 activation. Here, we challenge this scenario by showing that PARP-1 hyperactivation in cells cultured in the absence of glucose (Glu(-) cells) is followed by NAD depletion and an unexpected PARP-1 activity-dependent ATP increase. We found increased ADP content in resting Glu(-) cells, a condition that counteracts the increase of the AMP/ADP ratio during hyperpoly(ADP-ribosyl)ation and preserves mitochondrial coupling. We also show that the increase of ATP in Glu(-) cells is due to adenylate kinase activity, transforming AMP into ADP which, in turn, is converted into ATP by coupled mitochondria. Interestingly, PARP-1-dependent mitochondrial release of apoptosis-inducing factor (AIF) and cytochrome complex (Cyt c) is reduced in Glu(-) cells, even though cell death eventually occurs. Overall, the present study identifies basal ADP content and adenylate kinase as key determinants of bioenergetics during PARP-1 hyperactivation and unequivocally demonstrates that ATP loss is not metabolically related to NAD depletion.	[Buonvicino, Daniela; Cipriani, Giulia; Chiarugi, Alberto] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, I-50139 Florence, Italy; [Formentini, Laura] Hosp 12 Octubre, Ctr Invest Biomed Red Enfermedades Raras, Dept Biol Mol, Ctr Biol Mol Severo Ochoa,Ctr Invest, E-28041 Madrid, Spain	University of Florence; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario 12 de Octubre	Buonvicino, D (corresponding author), Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Viale Pieraccini 6, I-50139 Florence, Italy.	daniela.buonvicino@unifi.it	Buonvicino, Daniela/AAC-4978-2022	buonvicino, daniela/0000-0003-0435-8475; Formentini, Laura/0000-0001-5641-821X	Associazione Ricerca Sclerosi Laterale Amiotrofica (ARISLA); Regione Toscana "Progetto Salute"; Associazione Italiana Sclerosi Multipla; Ente Cassa di Risparmio di Firenze	Associazione Ricerca Sclerosi Laterale Amiotrofica (ARISLA); Regione Toscana "Progetto Salute"(Regione Toscana); Associazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the Associazione Ricerca Sclerosi Laterale Amiotrofica (ARISLA), Regione Toscana "Progetto Salute 2009," Associazione Italiana Sclerosi Multipla, and Ente Cassa di Risparmio di Firenze.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BROWNSON C, 1972, BIOCHEM J, V130, P797, DOI 10.1042/bj1300797; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Ethier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047978; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Maruta H, 1997, BIOCHEM BIOPH RES CO, V236, P265, DOI 10.1006/bbrc.1997.6910; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Oei SL, 2000, J BIOL CHEM, V275, P23234, DOI 10.1074/jbc.M002429200; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Panayiotou C, 2011, BIOCHEM J, V433, P527, DOI 10.1042/BJ20101443; Pellegrini-Giampietro DE, 1999, NEUROPHARMACOLOGY, V38, P1607, DOI 10.1016/S0028-3908(99)00097-0; Rapizzi E, 2004, MOL PHARMACOL, V66, P890, DOI 10.1124/mol.104.000968; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; ROSE IA, 1968, P NATL ACAD SCI USA, V61, P1079, DOI 10.1073/pnas.61.3.1079; Rossi L, 2002, BIOCHIMIE, V84, P1229; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	38	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36530	36537		10.1074/jbc.M113.506378	http://dx.doi.org/10.1074/jbc.M113.506378			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194524	hybrid, Green Published			2022-12-28	WOS:000328883400033
J	Yazawa, K; Furusawa, H; Okahata, Y				Yazawa, Kenjiro; Furusawa, Hiroyuki; Okahata, Yoshio			Real-time Monitoring of Intermediates Reveals the Reaction Pathway in the Thiol-Disulfide Exchange between Disulfide Bond Formation Protein A (DsbA) and B (DsbB) on a Membrane-immobilized Quartz Crystal Microbalance (QCM) System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Kinetics; Membrane Lipids; Membrane Proteins; Protein Chemistry; Disulfide Bond Formation Protein; Quartz Crystal Microbalance; Supported Lipid Bilayer; Transient Kinetic Analysis	ESCHERICHIA-COLI; KINETIC MEASUREMENTS; REDOX PROPERTIES; CATALYST DSBB; ENZYME DSBB; MECHANISM; GENERATION; HYDROLYZES; CELLS	Background: A device of QCM can be used in the transient kinetics of oxidation of a pair of cysteine residues in DsbA by DsbB. Results: The obtained kinetic parameters indicate that the two pairs of cysteine residues in DsbB are important. Conclusion: The reaction pathway of almost all DsbA oxidation processes would proceed through the stable intermediate. Significance: The transient kinetics of the reaction intermediate is important. Disulfide bond formation protein B (DsbB(S-S,S-S)) is an inner membrane protein in Escherichia coli that has two disulfide bonds (S-S, S-S) that play a role in oxidization of a pair of cysteine residues (SH, SH) in disulfide bond formation protein A (DsbA(SH,SH)). The oxidized DsbA(S-S), with one disulfide bond (S-S), can oxidize proteins with SH groups for maturation of a folding preprotein. Here, we have described the transient kinetics of the oxidation reaction between DsbA(SH,SH) and DsbB(S-S,S-S). We immobilized DsbB(S-S,S-S) embedded in lipid bilayers on the surface of a 27-MHz quartz crystal microbalance (QCM) device to detect both formation and degradation of the reaction intermediate (DsbA-DsbB), formed via intermolecular disulfide bonds, as a mass change in real time. The obtained kinetic parameters (intermediate formation, reverse, and oxidation rate constants (k(f), k(r), and k(cat), respectively) indicated that the two pairs of cysteine residues in DsbB(S-S,S-S) were more important for the stability of the DsbA-DsbB intermediate than ubiquinone, an electron acceptor for DsbB(S-S,S-S). Our data suggested that the reaction pathway of almost all DsbA(SH,SH) oxidation processes would proceed through this stable intermediate, avoiding the requirement for ubiquinone.	Yamagata Univ, Innovat Flex Course Frontier Organ Mat Syst iFron, Yonezawa, Yamagata 9928510, Japan; Tokyo Inst Technol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan	Yamagata University; Tokyo Institute of Technology	Okahata, Y (corresponding author), Yamagata Univ, Grad Sch Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	yokahata@yz.yamagata-u.ac.jp	Yazawa, Kenjiro/C-7423-2017	Yazawa, Kenjiro/0000-0001-7268-5983	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22225005] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science.	Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Becker B, 2011, J MOL RECOGNIT, V24, P754, DOI 10.1002/jmr.1117; BUTTRY DA, 1992, CHEM REV, V92, P1355, DOI 10.1021/cr00014a006; Furusawa H, 2008, ANAL CHEM, V80, P1005, DOI 10.1021/ac702290z; Furusawa H, 2008, ORG BIOMOL CHEM, V6, P727, DOI 10.1039/b717171d; Furusawa H, 2009, ANAL CHEM, V81, P1841, DOI 10.1021/ac8022229; Furusawa H, 2009, ANAL CHEM, V81, P2268, DOI 10.1021/ac802412t; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P4004, DOI 10.1002/1521-3773(20001117)39:22<4004::AID-ANIE4004>3.0.CO;2-2; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i; Matsuno H, 2004, CHEM-EUR J, V10, P6172, DOI 10.1002/chem.200400030; Niikura K, 1998, J AM CHEM SOC, V120, P8537, DOI 10.1021/ja980967r; Okahata Y, 1998, ANAL CHEM, V70, P1288, DOI 10.1021/ac970584w; Okahata Y, 2000, ANAL SCI, V16, P1113, DOI 10.2116/analsci.16.1113; Ozeki T, 2007, ANAL CHEM, V79, P79, DOI 10.1021/ac060873x; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Takahashi S, 2007, ANAL BIOCHEM, V361, P210, DOI 10.1016/j.ab.2006.11.030; Tang M, 2011, J AM CHEM SOC, V133, P4359, DOI 10.1021/ja107775w; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; Watson J.D., 2014, MOL BIOL GENE, V5, P657; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Yazawa K, 2013, CHEM LETT, V42, P241, DOI 10.1246/cl.2013.241; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	34	7	7	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35969	35981		10.1074/jbc.M113.519876	http://dx.doi.org/10.1074/jbc.M113.519876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24145032	Green Published, hybrid			2022-12-28	WOS:000329814700033
J	Banerjee, S; Cui, HC; Xie, N; Tan, Z; Yang, SZ; Icyuz, M; Thannickal, VJ; Abraham, E; Liu, G				Banerjee, Sami; Cui, Huachun; Xie, Na; Tan, Zheng; Yang, Shanzhong; Icyuz, Mert; Thannickal, Victor John; Abraham, Edward; Liu, Gang			miR-125a-5p Regulates Differential Activation of Macrophages and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Kruppel-like Factor (KLF); Macrophages; MicroRNA; Toll-like Receptors (TLR); KLF13; Macrophage Polarization; Phagocytosis	TRANSCRIPTION FACTOR; RANTES EXPRESSION; GENE-EXPRESSION; POLARIZATION; MICRORNAS; LIPOPOLYSACCHARIDE; RECEPTOR; SUPPRESSOR; CLEARANCE; MONOCYTES	Macrophage activation is a central event in immune responses. Macrophages undergoing classical activation (M1 macrophages) are proinflammatory, whereas alternatively activated macrophages (M2 macrophages) are generally anti-inflammatory. miRNAs play important regulatory roles in inflammatory response. However, the manner in which miRNAs regulate macrophage activation in response to different environmental cues has not been well defined. In this study, we found that M-BMM macrophages (M2) express greater levels of miR-125a-5p than do GM-BMM macrophages (M1). Stimulation of macrophages through TLR2 and TLR4 but not through TLR3 enhanced miR-125a-5p expression. Up-regulation of miR-125a-5p after TLR2/4 activation requires the adaptor MYD88 but not TRIF. Overexpression of miR-125a-5p diminished M1 phenotype expression induced by LPS but promoted M2 marker expression induced by IL-4. In contrast, knockdown of miR-125a-5p promoted M1 polarization and diminished IL-4-induced M2 marker expression. We found that miR-125a-5p targets KLF13, a transcriptional factor that has an important role in T lymphocyte activation and inflammation. KLF13 knockdown had similar effects on M1 activation as did miR-125a-5p overexpression. In addition, miR-125a-5p regulates phagocytic and bactericidal activities of macrophages. Our data suggest that miR-125a-5p has an important role in suppressing classical activation of macrophages while promoting alternative activation.	[Banerjee, Sami; Cui, Huachun; Xie, Na; Tan, Zheng; Yang, Shanzhong; Icyuz, Mert; Thannickal, Victor John; Liu, Gang] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Abraham, Edward] Wake Forest Sch Med, Winston Salem, NC 27157 USA	University of Alabama System; University of Alabama Birmingham; Wake Forest University	Liu, G (corresponding author), Univ Alabama Birmingham, Dept Med, 901 19th St So,BMR 233 2, Birmingham, AL 35294 USA.	gliu@uab.edu	Icyuz, Mert/J-6598-2013	Icyuz, Mert/0000-0003-1681-0115; , Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	National Institutes of Health [HL114470, amd HL105473, HL076206]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470, R01HL076206, R01HL105473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants HL114470 (to V. J. T.) amd HL105473 and HL076206 (to G. L)	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Banerjee S, 2013, J IMMUNOL, V190, P6542, DOI 10.4049/jimmunol.1202496; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chaudhuri AA, 2011, J IMMUNOL, V187, P5062, DOI 10.4049/jimmunol.1102001; de Freitas A, 2012, J IMMUNOL, V188, P6381, DOI 10.4049/jimmunol.1200020; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; Escribese MM, 2012, J IMMUNOL, V189, P1946, DOI 10.4049/jimmunol.1201064; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Huang HC, 2012, J LEUKOCYTE BIOL, V92, P171, DOI 10.1189/jlb.1211593; Kim DS, 2012, BLOOD, V120, P1658, DOI 10.1182/blood-2012-03-415968; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Song A, 1999, IMMUNITY, V10, P93, DOI 10.1016/S1074-7613(00)80010-2; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang DZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063659; Zhao X, 2010, ARTHRITIS RHEUM-US, V62, P3425, DOI 10.1002/art.27632; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	51	168	184	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35428	35436		10.1074/jbc.M112.426866	http://dx.doi.org/10.1074/jbc.M112.426866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151079	hybrid, Green Published			2022-12-28	WOS:000329867600039
J	Zhang, Y; Evans, GB; Clinch, K; Crump, DR; Harris, LD; Frohlich, RFG; Tyler, PC; Hazleton, KZ; Cassera, MB; Schramm, VL				Zhang, Yong; Evans, Gary B.; Clinch, Keith; Crump, Douglas R.; Harris, Lawrence D.; Froehlich, Richard F. G.; Tyler, Peter C.; Hazleton, Keith Z.; Cassera, Maria B.; Schramm, Vern L.			Transition State Analogues of Plasmodium falciparum and Human Orotate Phosphoribosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Enzyme Catalysis; Malaria; Plasmodium; Pyrimidine; Inhibitor Design; N-Ribosyltransferases; Orotidine 5-Monophosphate	PURINE NUCLEOSIDE PHOSPHORYLASE; NOVO NUCLEOTIDE BIOSYNTHESIS; HUMAN UMP SYNTHASE; DIHYDROOROTATE DEHYDROGENASE; SELECTIVE ACTIVITY; IMMUCILLIN-H; EADOCK DSS; INHIBITORS; HYDROLASES; MALARIA	Background: Human and malaria orotate phosphoribosyltransferases (OPRTs) in the de novo pyrimidine biosynthesis pathway are characterized by ribocation transition states with fully dissociated leaving orotate groups. Results: Transition state analogues with varied ribocation substitutions, different linkers, and distinct leaving groups exhibited nanomolar binding affinities for the OPRT enzymes. Conclusion: Components crucial for inhibitor binding to the OPRT active sites have been identified, and powerful inhibitors were characterized. Significance: Transition state analogues of OPRTs provide new insights into the nature of potential antimalarials and anticancer agents. The survival and proliferation of Plasmodium falciparum parasites and human cancer cells require de novo pyrimidine synthesis to supply RNA and DNA precursors. Orotate phosphoribosyltransferase (OPRT) is an indispensible component in this metabolic pathway and is a target for antimalarials and antitumor drugs. P. falciparum (Pf) and Homo sapiens (Hs) OPRTs are characterized by highly dissociative transition states with ribocation character. On the basis of the geometrical and electrostatic features of the PfOPRT and HsOPRT transition states, analogues were designed, synthesized, and tested as inhibitors. Iminoribitol mimics of the ribocation transition state in linkage to pyrimidine mimics using methylene or ethylene linkers gave dissociation constants (K-d) as low as 80 nm. Inhibitors with pyrrolidine groups as ribocation mimics displayed slightly weaker binding affinities for OPRTs. Interestingly, p-nitrophenyl riboside 5-phosphate bound to OPRTs with K-d values near 40 nm. Analogues designed with a C5-pyrimidine carbon-carbon bond to ribocation mimics gave K-d values in the range of 80-500 nm. Acyclic inhibitors with achiral serinol groups as the ribocation mimics also displayed nanomolar inhibition against OPRTs. In comparison with the nucleoside derivatives, inhibition constants of their corresponding 5-phosphorylated transition state analogues are largely unchanged, an unusual property for a nucleotide-binding site. In silico docking of the best inhibitor into the HsOPRT active site supported an extensive hydrogen bond network associated with the tight binding affinity. These OPRT transition state analogues identify crucial components of potent inhibitors targeting OPRT enzymes. Despite their tight binding to the targets, the inhibitors did not kill cultured P. falciparum.	[Zhang, Yong; Hazleton, Keith Z.; Cassera, Maria B.; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Evans, Gary B.; Clinch, Keith; Crump, Douglas R.; Harris, Lawrence D.; Froehlich, Richard F. G.; Tyler, Peter C.] Callaghan Innovat, Carbohydrate Chem Team, Lower Hutt 5040, New Zealand	Yeshiva University; Albert Einstein College of Medicine; Callaghan Innovation	Schramm, VL (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	vern.schramm@einstein.yu.edu	Evans, Gary/B-8343-2011; Evans, Gary/I-4123-2019; Hazleton, Keith Z./AAD-3979-2019	Evans, Gary/0000-0002-6973-2002; Evans, Gary/0000-0002-6973-2002; Hazleton, Keith Z./0000-0003-4098-3411; Harris, Lawrence/0000-0002-4214-1018; Clinch, Keith/0000-0002-3300-4396	National Institutes of Health [AI049512, GM041916, GM007288]; New Zealand Foundation for Research Science and Technology [C08X0701]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041916, R01GM041916, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grants AI049512 and GM041916 and Training Grant GM007288. This work was also supported by New Zealand Foundation for Research Science and Technology Contract C08X0701.	Abdo M, 2010, ORG LETT, V12, P2982, DOI 10.1021/ol1010032; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Bantia S, 2010, INT IMMUNOPHARMACOL, V10, P784, DOI 10.1016/j.intimp.2010.04.009; Breda A, 2012, EUR J MED CHEM, V54, P113, DOI 10.1016/j.ejmech.2012.04.031; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Clinch K, 2006, ORG BIOMOL CHEM, V4, P1131, DOI 10.1039/b517883e; Clinch K, 2007, ORG BIOMOL CHEM, V5, P2800, DOI 10.1039/b708796a; Clinch K, 2009, J MED CHEM, V52, P1126, DOI 10.1021/jm801421q; Evans GB, 2004, J ORG CHEM, V69, P2217, DOI 10.1021/jo035744k; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Furneaux RH, 1997, TETRAHEDRON, V53, P2915, DOI 10.1016/S0040-4020(96)01172-6; Furneaux RH, 1999, BIOORGAN MED CHEM, V7, P2599, DOI 10.1016/S0968-0896(99)00210-2; GERO AM, 1990, BLOOD CELLS, V16, P467; GOITEIN RK, 1978, J BIOL CHEM, V253, P2963; Gonzalez-Segura L, 2007, BIOCHEMISTRY-US, V46, P14075, DOI 10.1021/bi701023z; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; Huang M, 2008, LEUKEMIA RES, V32, P1268, DOI 10.1016/j.leukres.2007.12.015; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Kicska GA, 2002, J BIOL CHEM, V277, P3219, DOI 10.1074/jbc.M105905200; KRUNGKRAI J, 1992, BIOCHEM PHARMACOL, V43, P1295, DOI 10.1016/0006-2952(92)90506-E; Krungkrai SR, 2004, MOL BIOCHEM PARASIT, V134, P245, DOI 10.1016/j.molbiopara.2003.12.006; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lewandowicz A, 2003, BIOCHEMISTRY-US, V42, P6057, DOI 10.1021/bi0343830; Longshaw AI, 2010, J MED CHEM, V53, P6730, DOI 10.1021/jm100898v; Mazzella LJ, 1996, J AM CHEM SOC, V118, P2111, DOI 10.1021/ja953537z; Parkin DW, 1997, BIOCHEMISTRY-US, V36, P3528, DOI 10.1021/bi962319v; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; QUEEN SA, 1990, ANTIMICROB AGENTS CH, V34, P1393, DOI 10.1128/AAC.34.7.1393; Quemeneur L, 2004, J IMMUNOL, V173, P4945, DOI 10.4049/jimmunol.173.8.4945; RATHOD PK, 1989, ANTIMICROB AGENTS CH, V33, P1090, DOI 10.1128/AAC.33.7.1090; Schramm V. L., 2003, NUCL ACIDS RES S, V3, P107; Schramm VL, 2007, J BIOL CHEM, V282, P28297, DOI 10.1074/jbc.R700018200; Schramm VL, 2005, ARCH BIOCHEM BIOPHYS, V433, P13, DOI 10.1016/j.abb.2004.08.035; Schramm VL, 2003, ACCOUNTS CHEM RES, V36, P588, DOI 10.1021/ar0200495; SEYMOUR KK, 1994, BIOCHEMISTRY-US, V33, P5268, DOI 10.1021/bi00183a033; Singh V, 2005, J BIOL CHEM, V280, P18265, DOI 10.1074/jbc.M414472200; Suchi M, 1997, AM J HUM GENET, V60, P525; Weber G, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1164, DOI 10.1023/A:1012493232344; Witte JF, 2006, BIOORG MED CHEM LETT, V16, P6112, DOI 10.1016/j.bmcl.2006.08.109; WOLFENDE.R, 1969, NATURE, V223, P704, DOI 10.1038/223704a0; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704; Zhang Y, 2010, J AM CHEM SOC, V132, P17023, DOI 10.1021/ja107806j; Zhang Y, 2010, J AM CHEM SOC, V132, P8787, DOI 10.1021/ja102849w; Zhang Y, 2009, J AM CHEM SOC, V131, P4685, DOI 10.1021/ja808346y	52	18	19	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34746	34754		10.1074/jbc.M113.521955	http://dx.doi.org/10.1074/jbc.M113.521955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24158442	Green Published, hybrid			2022-12-28	WOS:000329812800041
J	Clayton, GM; Klein, DJ; Rickert, KW; Patel, SB; Kornienko, M; Zugay-Murphy, J; Reid, JC; Tummala, S; Sharma, S; Singh, SB; Miesel, L; Lumb, KJ; Soisson, SM				Clayton, Gina M.; Klein, Daniel J.; Rickert, Keith W.; Patel, Sangita B.; Kornienko, Maria; Zugay-Murphy, Joan; Reid, John C.; Tummala, Srivanya; Sharma, Sujata; Singh, Sheo B.; Miesel, Lynn; Lumb, Kevin J.; Soisson, Stephen M.			Structure of the Bacterial Deacetylase LpxC Bound to the Nucleotide Reaction Product Reveals Mechanisms of Oxyanion Stabilization and Proton Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Escherichia coli; Lipopolysaccharide (LPS); Protein Structure; X-ray Crystallography; LpxC; UDP	ZINC-DEPENDENT DEACETYLASE; SUBSTRATE-ANALOG INHIBITOR; ESCHERICHIA-COLI; HYDROXAMIC ACIDS; UDP-3-O-(R-3-HYDROXYMYRISTOYL)-N-ACETYLGLUCOSAMINE DEACETYLASE; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; BINDING; BIOSYNTHESIS; ENDOTOXIN	The emergence of antibiotic-resistant strains of pathogenic bacteria is an increasing threat to global health that underscores an urgent need for an expanded antibacterial armamentarium. Gram-negative bacteria, such as Escherichia coli, have become increasingly important clinical pathogens with limited treatment options. This is due in part to their lipopolysaccharide (LPS) outer membrane components, which dually serve as endotoxins while also protecting Gram-negative bacteria from antibiotic entry. The LpxC enzyme catalyzes the committed step of LPS biosynthesis, making LpxC a promising target for new antibacterials. Here, we present the first structure of an LpxC enzyme in complex with the deacetylation reaction product, UDP-(3-O-(R-3-hydroxymyristoyl))-glucosamine. These studies provide valuable insight into recognition of substrates and products by LpxC and a platform for structure-guided drug discovery of broad spectrum Gram-negative antibiotics.	[Clayton, Gina M.; Klein, Daniel J.; Patel, Sangita B.; Reid, John C.; Soisson, Stephen M.] Merck Res Labs, Global Struct Chem, West Point, PA 19486 USA; [Rickert, Keith W.; Kornienko, Maria; Zugay-Murphy, Joan; Tummala, Srivanya; Sharma, Sujata; Lumb, Kevin J.] Merck Res Labs, Screening & Prot Sci, West Point, PA 19486 USA; [Singh, Sheo B.] Merck Res Labs, Discovery Chem, Kenilworth, NJ 07033 USA; [Miesel, Lynn] Merck Res Labs, Infect Dis, Kenilworth, NJ 07033 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Soisson, SM (corresponding author), Merck Res Labs, Global Struct Chem, West Point, PA 19486 USA.	stephen_soisson@merck.com		Lumb, Kevin/0000-0003-2778-9956	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Hauptman-Woodward Medical Research Institute; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Paul McNicolas, Max Deng, Jun Lu, Gopal Parthasarathy, and Hua Su for helpful discussions; Lisa Keefe and the staff at the IMCA-CAT (Advanced Photon Source), and Joe Brunzelle for assistance with data collection. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Buetow L, 2006, ACTA CRYSTALLOGR F, V62, P1082, DOI 10.1107/S1744309106041893; Clements JM, 2002, ANTIMICROB AGENTS CH, V46, P1793, DOI 10.1128/AAC.46.6.1793-1799.2002; Coggins BE, 2003, NAT STRUCT BIOL, V10, P645, DOI 10.1038/nsb948; Coggins BE, 2005, BIOCHEMISTRY-US, V44, P1114, DOI 10.1021/bi047820z; Coggins BE, 2004, J BIOMOL NMR, V28, P201, DOI 10.1023/B:JNMR.0000013817.29493.87; Cole K. E., BIOCHEMISTRY, V50, P258; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gennadios HA, 2006, BIOCHEMISTRY-US, V45, P7940, DOI 10.1021/bi060823m; Gennadios HA, 2006, BIOCHEMISTRY-US, V45, P15216, DOI 10.1021/bi0619021; Hale MR, 2013, BIOORG MED CHEM LETT, V23, P2362, DOI 10.1016/j.bmcl.2013.02.055; Hernick M, 2005, J BIOL CHEM, V280, P16969, DOI 10.1074/jbc.M413560200; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee CJ, 2011, CHEM BIOL, V18, P38, DOI 10.1016/j.chembiol.2010.11.011; Liang XF, 2011, BIOORGAN MED CHEM, V19, P852, DOI 10.1016/j.bmc.2010.12.017; LOTLIKAR PD, 1971, BIOCHEM J, V124, P69, DOI 10.1042/bj1240069; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P1106, DOI 10.1021/bi048001h; Metzger LE, 2009, BIOCHEMISTRY-US, V48, P11559, DOI 10.1021/bi901750f; Mochalkin I, 2008, PROTEIN SCI, V17, P450, DOI 10.1110/ps.073324108; Montgomery JI, 2012, J MED CHEM, V55, P1662, DOI 10.1021/jm2014875; MULDER GJ, 1983, ENVIRON HEALTH PERSP, V49, P27, DOI 10.2307/3429577; Norrby R, 2001, Expert Opin Pharmacother, V2, P293, DOI 10.1517/14656566.2.2.293; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Pirrung MC, 2003, J AM CHEM SOC, V125, P1575, DOI 10.1021/ja0209114; Pirrung MC, 2002, J MED CHEM, V45, P4359, DOI 10.1021/jm020183v; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Roversi P, 2000, ACTA CRYSTALLOGR D, V56, P1316, DOI 10.1107/S0907444900008490; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; WEISBURGER JH, 1973, PHARMACOL REV, V25, P1; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543; Whittington DA, 2003, P NATL ACAD SCI USA, V100, P8146, DOI 10.1073/pnas.1432990100	42	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34073	34080		10.1074/jbc.M113.513028	http://dx.doi.org/10.1074/jbc.M113.513028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108127	hybrid, Green Published			2022-12-28	WOS:000327250200050
J	Nagae, M; Ikeda, A; Hane, M; Hanashima, S; Kitajima, K; Sato, C; Yamaguchi, Y				Nagae, Masamichi; Ikeda, Akemi; Hane, Masaya; Hanashima, Shinya; Kitajima, Ken; Sato, Chihiro; Yamaguchi, Yoshiki			Crystal Structure of Anti-polysialic Acid Antibody Single Chain Fv Fragment Complexed with Octasialic Acid INSIGHT INTO THE BINDING PREFERENCE FOR POLYSIALIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Crystal Structure; Oligosaccharide; Sialic Acid; Site-directed Mutagenesis	CELL-ADHESION MOLECULE; CARBOHYDRATE-BINDING; DENDRITIC CELLS; LIGAND-BINDING; PEANUT LECTIN; POLYSACCHARIDE; BRAIN; GLYCOPROTEINS; RESIDUES; OLIGO	Polysialic acid is a linear homopolymer of 2-8-linked sialic acids attached mainly onto glycoproteins. Cell surface polysialic acid plays roles in cell adhesion and differentiation events in a manner that is often dependent on the degree of polymerization (DP). Anti-oligo/polysialic acid antibodies have DP-dependent antigenic specificity, and such antibodies are widely utilized in biological studies for detecting and distinguishing between different oligo/polysialic acids. A murine monoclonal antibody mAb735 has a unique preference for longer polymers of polysialic acid (DP >10), yet the mechanism of recognition at the atomic level remains unclear. Here, we report the crystal structure of mAb735 single chain variable fragment (scFv735) in complex with octasialic acid at 1.8 resolution. In the asymmetric unit, two scFv735 molecules associate with one octasialic acid. In both complexes of the unit, all the complementarity-determining regions except for L3 interact with three consecutive sialic acid residues out of the eight. A striking feature of the complex is that 11 ordered water molecules bridge the gap between antibody and ligand, whereas the direct antibody-ligand interaction is less extensive. The dihedral angles of the trisialic acid unit directly interacting with scFv735 are not uniform, indicating that mAb735 does not strictly favor the previously proposed helical conformation. Importantly, both reducing and nonreducing ends of the bound ligand are completely exposed to solvent. We suggest that mAb735 gains its apparent high affinity for a longer polysialic acid chain by recognizing every three sialic acid units in a paired manner.	[Nagae, Masamichi; Ikeda, Akemi; Hanashima, Shinya; Yamaguchi, Yoshiki] RIKEN Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr, Wako, Saitama 3510198, Japan; [Hane, Masaya; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Hane, Masaya; Kitajima, Ken; Sato, Chihiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	RIKEN; Nagoya University; Nagoya University	Yamaguchi, Y (corresponding author), RIKEN Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, RIKEN Max Planck Joint Res Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yyoshiki@riken.jp	Hanashima, Shinya/AGN-0921-2022; Yamaguchi, Yoshiki/N-5246-2015; Naganawa, Shinji/I-1572-2012; SATO, Chihiro/B-7396-2014	Hanashima, Shinya/0000-0003-3102-7890; Yamaguchi, Yoshiki/0000-0003-0100-5439; Naganawa, Shinji/0000-0002-0214-613X; Nagae, Masamichi/0000-0002-5470-3807	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24110506, 24110520]; Grants-in-Aid for Scientific Research [23570133, 25460054] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Innovative Areas (deciphering sugar chain-based signals regulating integrative neuronal functions) 24110506 and 24110520 (to M. N. and C. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; EVANS SV, 1995, BIOCHEMISTRY-US, V34, P6737, DOI 10.1021/bi00020a019; FINNE J, 1982, J BIOL CHEM, V257, P1966; FINNE J, 1983, LANCET, V2, P355; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hanashima S, 2013, BIOORGAN MED CHEM, V21, P6069, DOI 10.1016/j.bmc.2013.07.023; Hane M, 2012, PURE APPL CHEM, V84, P1895, DOI 10.1351/PAC-CON-11-12-10; Henderson TJ, 2003, J AM CHEM SOC, V125, P2930, DOI 10.1021/ja0210087; Imberty A, 1997, CURR OPIN STRUC BIOL, V7, P617, DOI 10.1016/S0959-440X(97)80069-3; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Kanato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P2735, DOI 10.1271/bbb.90637; KLEBERT S, 1993, BIOL CHEM H-S, V374, P993, DOI 10.1515/bchm3.1993.374.7-12.993; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; Ono S, 2012, J BIOL CHEM, V287, P3710, DOI 10.1074/jbc.M111.276618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Ravishankar R, 1999, ACTA CRYSTALLOGR D, V55, P1375, DOI 10.1107/S0907444999006587; Ravishankar R, 1997, CURR SCI INDIA, V72, P855; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 1998, J BIOL CHEM, V273, P2575, DOI 10.1074/jbc.273.5.2575; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; VAESEN M, 1991, BIOL CHEM H-S, V372, P451, DOI 10.1515/bchm3.1991.372.1.451; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P851, DOI 10.1021/bi00217a039; Yongye AB, 2008, BIOCHEMISTRY-US, V47, P12493, DOI 10.1021/bi800431c	42	45	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33784	33796		10.1074/jbc.M113.496224	http://dx.doi.org/10.1074/jbc.M113.496224			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24100042	Green Published, hybrid			2022-12-28	WOS:000327250200024
J	Bleicken, S; Landeta, O; Landajuela, A; Basanez, G; Garcia-Saez, AJ				Bleicken, Stephanie; Landeta, Olatz; Landajuela, Ane; Basanez, Gorka; Garcia-Saez, Ana J.			Proapoptotic Bax and Bak Proteins Form Stable Protein-permeable Pores of Tunable Size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Proteins; Confocal Microscopy; Membrane Biophysics; Vesicles	BCL-2 FAMILY-MEMBERS; CYTOCHROME-C RELEASE; MITOCHONDRIAL-MEMBRANE; APOPTOSIS; OLIGOMERIZATION; ACTIVATION; PERMEABILIZATION; BCL-X(L); PEPTIDE; CYTOSOL	Background: During apoptosis Bax/Bak release differently sized proteins out of the mitochondria. Results: The size of Bax/Bak pores depends on protein concentration. Conclusion: Bax/Bak form stable toroidal pores tunable in size. Significance: Pore size-tuning constitutes a new level for the regulation of Bax/Bak activity. The Bcl-2 proapoptotic proteins Bax and Bak mediate the permeabilization of the mitochondrial outer membrane during apoptosis. Current models consider that Bax and Bak form pores at the mitochondrial outer membrane that are responsible for the release of cytochrome c and other larger mitochondrial apoptotic factors (i.e. Smac/DIABLO, AIF, and endoglycosidase G). However, the properties and nature of Bax/Bak apoptotic pores remain enigmatic. Here, we performed a detailed analysis of the membrane permeabilizing activity of Bax and Bak at the single vesicle level. We directly visualized that cBid-activated Bax and BakC21 can form membrane pores large enough to release not only cytochrome c, but also allophycocyanine, a protein of 104 kDa. Interestingly, the size of Bax and BakC21 pores is not constant, as typically observed in purely proteinaceous channels, but evolves with time and depends on protein concentration. We found that Bax and BakC21 formed long-lived pores, whose areas changed with the amount of Bax/BakC21 but not with cardiolipin concentration. Altogether, our results demonstrate that Bax and BakC21 follow similar mechanisms of membrane permeabilization characterized by the formation of protein-permeable pores of dynamic size, in agreement with the proteolipidic nature of these apoptotic pores.	[Bleicken, Stephanie; Garcia-Saez, Ana J.] BioQuant, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Bleicken, Stephanie; Garcia-Saez, Ana J.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany; [Landeta, Olatz; Landajuela, Ane; Basanez, Gorka] Univ Basque Country, CSIC, Unidad Biofis, Leioa 48940, Bizkaia, Spain	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Basanez, G (corresponding author), Univ Basque Country, CSIC, Unidad Biofis, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain.	gorka_basanez@ehu.es; ajegarsa@mf.mpg.de	Basanez, Gorka/L-9509-2014; Saez, Ana J. Garcia/U-1611-2019	Basanez, Gorka/0000-0002-7475-7861; Bleicken, Stephanie/0000-0002-4789-0974; Landeta, Olatz/0000-0002-5494-0271	Max Planck Society; German Cancer Research Center; Bundesministerium fur Bildung und Forschung Grant [0312040]; Basque Government; Ministerio de Economia y Competitividad [BFU2011-28566]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Cancer Research Center; Bundesministerium fur Bildung und Forschung Grant(Federal Ministry of Education & Research (BMBF)); Basque Government(Basque Government); Ministerio de Economia y Competitividad(Spanish Government)	Supported by the Max Planck Society, the German Cancer Research Center, and Bundesministerium fur Bildung und Forschung Grant 0312040.; Recipient of predoctoral fellowship from the Basque Government.; Supported by Grant BFU2011-28566 from the Ministerio de Economia y Competitividad. To whom correspondence may be addressed: Unidad de Biofisica (CSIC-UPV/EHU), Barrio Sarriena s/n, Leioa 48940. Tel.: 34-946013355, Fax: 34-94-6013360; E-mail: gorka_basanez@ehu.es.	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bender T., 2013, COLD SPRING HARBOR P, V5; Bhola PD, 2009, BIOPHYS J, V97, P2222, DOI 10.1016/j.bpj.2009.07.056; Bleicken S, 2013, BIOPHYS J, V104, P421, DOI 10.1016/j.bpj.2012.12.010; Bleicken S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035910; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Bleicken S, 2009, J BIOENERG BIOMEMBR, V41, P29, DOI 10.1007/s10863-009-9202-1; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Danial NN, 2010, ADV EXP MED BIOL, V687, P1; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Epand RF, 2003, BIOCHEMISTRY-US, V42, P14576, DOI 10.1021/bi035348w; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Etxebarria A, 2008, BIOCHEM PHARMACOL, V76, P1563, DOI 10.1016/j.bcp.2008.08.003; Ferrer PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031510; Flanagan L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.26; Fuertes G., 2011, THESIS U VALENCIA VA; Fuertes G, 2011, EUR BIOPHYS J BIOPHY, V40, P399, DOI 10.1007/s00249-011-0693-4; Fuertes G, 2010, BIOPHYS J, V99, P2917, DOI 10.1016/j.bpj.2010.08.068; Garcia-Saez AJ, 2012, CELL DEATH DIFFER, V19, P1733, DOI 10.1038/cdd.2012.105; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Garcia-Saez AJ, 2010, ADV EXP MED BIOL, V677, P91; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Huang HW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198304; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Landeta O, 2011, J BIOL CHEM, V286, P8213, DOI 10.1074/jbc.M110.165852; Leshchiner ES, 2013, P NATL ACAD SCI USA, V110, pE986, DOI 10.1073/pnas.1214313110; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Matsuzaki K, 1997, BIOPHYS J, V73, P831, DOI 10.1016/S0006-3495(97)78115-3; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Mirkin N, 2008, PROTEINS, V70, P83, DOI 10.1002/prot.21452; Moldoveanu T, 2013, NAT STRUCT MOL BIOL, V20, P589, DOI 10.1038/nsmb.2563; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Phillips DC, 2007, CANCER RES, V67, P756, DOI 10.1158/0008-5472.CAN-06-2374; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Schellenberg B, 2013, MOL CELL, V49, P959, DOI 10.1016/j.molcel.2012.12.022; Tamba Y, 2009, J PHYS CHEM B, V113, P4846, DOI 10.1021/jp8109622; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	63	100	101	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33241	33252		10.1074/jbc.M113.512087	http://dx.doi.org/10.1074/jbc.M113.512087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100034	hybrid, Green Published			2022-12-28	WOS:000328841700038
J	Carlson, AE; Rosenbaum, JC; Brelidze, TI; Klevit, RE; Zagotta, WN				Carlson, Anne E.; Rosenbaum, Joel C.; Brelidze, Tinatin I.; Klevit, Rachel E.; Zagotta, William N.			Flavonoid Regulation of HCN2 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic AMP (cAMP); Electrophysiology; Flavonoids; Fluorescence Resonance Energy Transfer (FRET); Ion Channels; NMR; HCN; Fluorescence Anisotropy; Purine Ring	CARBOXY-TERMINAL REGION; STRUCTURAL BASIS; CAMP MODULATION; HEART-DISEASE; BINDING; INHIBITOR; EXCITABILITY; DROSOPHILA; GENISTEIN; FAMILY	Background: HCN2 channels are regulated by membrane potential and by the direct binding of cyclic nucleotides to their carboxyl-terminal region. Results: The flavonoid fisetin potentiates HCN2 channel activation. Conclusion: Fisetin acts as a partial agonist for HCN2 channels by binding to the channel's cyclic nucleotide-binding site. Significance: HCN2 may be a target for the physiologic action of flavonoids such as fisetin. The hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels are pacemaker channels whose currents contribute to rhythmic activity in the heart and brain. HCN channels open in response to hyperpolarizing voltages, and the binding of cAMP to their cyclic nucleotide-binding domain (CNBD) facilitates channel opening. Here, we report that, like cAMP, the flavonoid fisetin potentiates HCN2 channel gating. Fisetin sped HCN2 activation and shifted the conductance-voltage relationship to more depolarizing potentials with a half-maximal effective concentration (EC50) of 1.8 m. When applied together, fisetin and cAMP regulated HCN2 gating in a nonadditive fashion. Fisetin did not potentiate HCN2 channels lacking their CNBD, and two independent fluorescence-based binding assays reported that fisetin bound to the purified CNBD. These data suggest that the CNBD mediates the fisetin potentiation of HCN2 channels. Moreover, binding assays suggest that fisetin and cAMP partially compete for binding to the CNBD. NMR experiments demonstrated that fisetin binds within the cAMP-binding pocket, interacting with some of the same residues as cAMP. Together, these data indicate that fisetin is a partial agonist for HCN2 channels.	[Carlson, Anne E.; Brelidze, Tinatin I.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Rosenbaum, Joel C.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	zagotta@uw.edu	Klevit, Rachel/AAI-7038-2021; Carlson, Anne/I-9495-2019	Klevit, Rachel/0000-0002-3476-969X; Carlson, Anne/0000-0003-2724-1325; Brelidze, Tinatin/0000-0003-3046-8184	National Institutes of Health [R01 EY010329, F32 HL095241, 5T32CA080416-14, R01 EY017370]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010329, R01EY017370] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL095241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY010329 (to W. N. Z.), F32 HL095241 (to A. E. C.), 5T32CA080416-14 (to J. C. R.), and R01 EY017370 (to R. E. K.).	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012523; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Cavanagh J., 2005, PROTEIN NMR SPECTROS, P540; Chen GQ, 1997, PROTEIN ENG, V10, P1061, DOI 10.1093/protein/10.9.1061; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Cui Y, 2008, CANCER-AM CANCER SOC, V112, P2241, DOI 10.1002/cncr.23398; Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Echalier A, 2012, CHEM BIOL, V19, P1028, DOI 10.1016/j.chembiol.2012.06.015; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Galli RL, 2002, ANN NY ACAD SCI, V959, P128, DOI 10.1111/j.1749-6632.2002.tb02089.x; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haque AM, 2006, J NUTR, V136, P1043, DOI 10.1093/jn/136.4.1043; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Inanami O, 1998, FREE RADICAL RES, V29, P359, DOI 10.1080/10715769800300401; Jacobson KA, 2002, ADV EXP MED BIOL, V505, P163; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P56; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Lu HS, 2005, J MED CHEM, V48, P737, DOI 10.1021/jm049353p; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Middleton E, 2000, PHARMACOL REV, V52, P673; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rozario AO, 2009, BBA-BIOMEMBRANES, V1788, P1939, DOI 10.1016/j.bbamem.2009.06.003; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	51	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33136	33145		10.1074/jbc.M113.501759	http://dx.doi.org/10.1074/jbc.M113.501759			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085296	Green Published, hybrid			2022-12-28	WOS:000328841700029
J	Takahashi, M; Hasegawa, Y; Ikeda, Y; Wada, Y; Tajiri, M; Ariki, S; Takamiya, R; Nishitani, C; Araki, M; Yamaguchi, Y; Taniguchi, N; Kuroki, Y				Takahashi, Motoko; Hasegawa, Yoshihiro; Ikeda, Yoshitaka; Wada, Yoshinao; Tajiri, Michiko; Ariki, Shigeru; Takamiya, Rina; Nishitani, Chiaki; Araki, Motoko; Yamaguchi, Yoshiki; Taniguchi, Naoyuki; Kuroki, Yoshio			Suppression of Heregulin beta Signaling by the Single N-Glycan Deletion Mutant of Soluble ErbB3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Glycosylation; Growth Factors; Mass Spectrometry (MS); Receptors	EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; NEU DIFFERENTIATION FACTOR; EXTRACELLULAR REGION; CORE FUCOSYLATION; BISECTING GLCNAC; TUMOR PROMOTION; CELL-ADHESION; UP-REGULATION; HELAS3 CELLS	Background: Extracellular domain of ErbBs (sErbBs) down-regulates growth factor signaling. Results: sErbB3 acts on ErbB3-containing heterodimers to suppress heregulin signaling, and the effects are enhanced by single N-glycan deletion. Conclusion:N-Glycan on Asn-418 controls the ability of sErbB3 to suppress heregulin signaling. Significance: Provides new insights toward understanding the mechanisms by which N-glycan regulates ErbB receptors. Heregulin signaling is involved in various tumor proliferations and invasions; thus, receptors of heregulin are targets for the cancer therapy. In this study we examined the suppressing effects of extracellular domains of ErbB2, ErbB3, and ErbB4 (soluble ErbB (sErbB)) on heregulin signaling in human breast cancer cell line MCF7. It was found that sErbB3 suppresses ligand-induced activation of ErbB receptors, PI3K/Akt and Ras/Erk pathways most effectively; sErbB2 scarcely suppresses ligand-induced signaling, and sErbB4 suppresses receptor activation at approximate to 10% efficiency of sErbB3. It was revealed that sErbB3 does not decrease the effective ligands but decreases the effective receptors. By using small interfering RNA (siRNA) for ErbB receptors, we determined that sErbB3 suppresses the heregulin signaling by interfering ErbB3-containing heterodimers including ErbB2/ErbB3. By introducing the mutation of N418Q to sErbB3, the signaling-inhibitory effects were increased by 2-3-fold. Moreover, the sErbB3 N418Q mutant enhanced anticancer effects of lapatinib more effectively than the wild type. We also determined the structures of N-glycan on Asn-418. Results suggested that the N-glycan-deleted mutant of sErbB3 suppresses heregulin signaling via ErbB3-containing heterodimers more effectively than the wild type. Thus, we demonstrated that the sErbB3 N418Q mutant is a potent inhibitor for heregulin signaling.	[Takahashi, Motoko; Hasegawa, Yoshihiro; Ariki, Shigeru; Takamiya, Rina; Nishitani, Chiaki; Araki, Motoko; Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido 0608556, Japan; [Ikeda, Yoshitaka] Saga Univ, Mol Cell Biol Div, Dept Biomol Sci, Fac Med, Saga 8498501, Japan; [Wada, Yoshinao; Tajiri, Michiko] Osaka Med Ctr, Dept Mol Med, Osaka 5941101, Japan; [Wada, Yoshinao; Tajiri, Michiko] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Yamaguchi, Yoshiki; Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Max Planck Joint Res Ctr, Global Res Cluster, Wako, Saitama 3510198, Japan	Sapporo Medical University; Saga University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN	Takahashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	takam@sapmed.ac.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014; Ariki, Shigeru/E-3861-2014; Yamaguchi, Yoshiki/N-5246-2015; Takahashi, Motoko/I-3154-2013	Taniguchi, Naoyuki/0000-0001-5889-5968; Ariki, Shigeru/0000-0001-5838-499X; Yamaguchi, Yoshiki/0000-0003-0100-5439; Takahashi, Motoko/0000-0002-2112-6142	Japan Society for the Promotion of Science [21590342]; Takeda Science Foundation; Suhara Foundation; Grants-in-Aid for Scientific Research [24591173] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suhara Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Science Research from the Japan Society for the Promotion of Science 21590342, the Takeda Science Foundation, and the Suhara Foundation.	Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Azios NG, 2001, ONCOGENE, V20, P5199, DOI 10.1038/sj.onc.1204555; Baselga J, 1998, CANCER RES, V58, P2825; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Doherty JK, 1999, P NATL ACAD SCI USA, V96, P10869, DOI 10.1073/pnas.96.19.10869; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; HORAN T, 1995, J BIOL CHEM, V270, P24604, DOI 10.1074/jbc.270.41.24604; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Lee H, 2001, CANCER RES, V61, P4467; Lee SH, 2006, J BIOCHEM, V139, P391, DOI 10.1093/jb/mvj039; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Li W, 2007, GLYCOBIOLOGY, V17, P655, DOI 10.1093/glycob/cwm022; Lindzen M, 2012, ONCOGENE, V31, P3505, DOI 10.1038/onc.2011.518; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Rusnak DW, 2001, CANCER RES, V61, P7196; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Shibukawa Y, 2003, J BIOL CHEM, V278, P3197, DOI 10.1074/jbc.M207870200; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Tajiri M, 2005, GLYCOBIOLOGY, V15, P1332, DOI 10.1093/glycob/cwj019; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wada Y, 2010, J PROTEOME RES, V9, P1367, DOI 10.1021/pr900913k; WARD WHJ, 1994, BIOCHEM PHARMACOL, V48, P659, DOI 10.1016/0006-2952(94)90042-6; Watty A, 2002, J BIOL CHEM, V277, P50457, DOI 10.1074/jbc.M208664200; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Xu JG, 2003, J BIOL CHEM, V278, P10770, DOI 10.1074/jbc.M207968200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109	51	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32910	32921		10.1074/jbc.M113.491902	http://dx.doi.org/10.1074/jbc.M113.491902			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097984	Green Published, hybrid			2022-12-28	WOS:000328841700009
J	Wunderlich, P; Glebov, K; Kemmerling, N; Tien, NT; Neumann, H; Walter, J				Wunderlich, Patrick; Glebov, Konstantin; Kemmerling, Nadja; Tien, Nguyen T.; Neumann, Harald; Walter, Jochen			Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and gamma-Secretase-dependent Intramembranous Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Intramembrane Proteolysis; Membrane; Presenilin; Protein Phosphorylation; Secretases; Signaling	AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; A-BETA; PRESENILIN; MUTATIONS; DAP12; METALLOPROTEINASES; MICROGLIA; TRAFFICKING; NEUTROPHILS	Background: TREM2 is a microglial receptor, recently identified as a genetic risk factor for late onset AD. Results: Sequential proteolytic processing of TREM2 involves ectodomain shedding and intramembranous cleavage by -secretase and affects signaling via its adaptor protein DAP12. Conclusion: -Secretase-mediated intramembranous proteolysis modulates TREM2 signaling. Significance: Inhibition of -secretase could impair TREM2 function in neuroinflammation. Triggering receptor expressed on myeloid cells-2 (TREM2) and its signaling adaptor protein TYROBP/DAP12 play important roles in signal transduction in dendritic cells, osteoclasts, tissue macrophages, and microglia. Recently, TREM2 variants have been shown to be linked to late onset Alzheimer disease. Here, we demonstrate that TREM2 undergoes sequential proteolytic processing by ectodomain shedding and intramembrane proteolysis. The C-terminal fragment (CTF) of TREM2 generated by ectodomain shedding is cleaved by -secretase. Importantly, pharmacologic and genetic -secretase inhibition resulted in accumulation of TREM2 CTF at the plasma membrane that also interacts with the signaling adaptor protein DAP12. Thus, the accumulated TREM2 CTF thereby might limit the interaction of DAP12 with the functional full-length receptor, resulting in decreased DAP12 phosphorylation and impaired metabolism of phosphatidylinositol 4,5-bisphosphate. Together, these data demonstrate -secretase-mediated intramembranous proteolysis of TREM2 and functionally link two Alzheimer disease-associated proteins in one signaling pathway.	[Wunderlich, Patrick; Glebov, Konstantin; Kemmerling, Nadja; Tien, Nguyen T.; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Neumann, Harald] Univ Bonn, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany	University of Bonn; University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	jochen.walter@ukb.uni-bonn.de	Walter, Jochen/B-3677-2014; Neumann, Harald/A-9718-2010; Wang, Caihong/T-5837-2019	Neumann, Harald/0000-0002-5071-5202; Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912	Deutsche Forschungsgemeinschaft [SFB695, KFO177, FOR1336, SFB704]; Hertie-Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie-Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB695 and KFO177 to J. W.; FOR1336, SFB704, and KFO177 to H. N.) and by the Hertie-Foundation (to H. N.).	Benitez BA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.018; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Farfara D, 2011, ANN NEUROL, V69, P170, DOI 10.1002/ana.22191; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gingras MC, 2002, MOL IMMUNOL, V38, P817, DOI 10.1016/S0161-5890(02)00004-4; Gomez-Pina V, 2007, J IMMUNOL, V179, P4065, DOI 10.4049/jimmunol.179.6.4065; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hemming ML, 2008, PLOS BIOL, V6, P2314, DOI 10.1371/journal.pbio.0060257; Hernandez-Pando R, 2000, INT J EXP PATHOL, V81, P199, DOI 10.1046/j.1365-2613.2000.00152.x; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Jiang T, 2013, MOL NEUROBIOL, V48, P180, DOI 10.1007/s12035-013-8424-8; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lee J, 2002, NEUROMOL MED, V2, P29; Lowell CA, 2011, COLD SPRING HARB PER, V3; Mahdy AM, 2006, CLIN VACCINE IMMUNOL, V13, P492, DOI 10.1128/CVI.13.4.492-495.2006; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Melchior B, 2010, ASN NEURO, V2, P157, DOI 10.1042/AN20100010; Mendez Mario F, 2006, Am J Alzheimers Dis Other Demen, V21, P281, DOI 10.1177/1533317506290448; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Peraus GC, 1997, J NEUROSCI, V17, P7714; Piccio L, 2008, BRAIN, V131, P3081, DOI 10.1093/brain/awn217; Pottier C, 2013, J ALZHEIMERS DIS, V35, P45, DOI 10.3233/JAD-122311; Prada I, 2006, NEUROSCIENCE, V140, P1139, DOI 10.1016/j.neuroscience.2006.03.058; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zompi S, 2003, NAT IMMUNOL, V4, P565, DOI 10.1038/ni930	49	162	166	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33027	33036		10.1074/jbc.M113.517540	http://dx.doi.org/10.1074/jbc.M113.517540			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078628	Green Published, hybrid			2022-12-28	WOS:000328841700019
J	Malenczyk, K; Jazurek, M; Keimpema, E; Silvestri, C; Janikiewicz, J; Mackie, K; Di Marzo, V; Redowicz, MJ; Harkany, T; Dobrzyn, A				Malenczyk, Katarzyna; Jazurek, Magdalena; Keimpema, Erik; Silvestri, Cristoforo; Janikiewicz, Justyna; Mackie, Ken; Di Marzo, Vincenzo; Redowicz, Maria J.; Harkany, Tibor; Dobrzyn, Agnieszka			CB1 Cannabinoid Receptors Couple to Focal Adhesion Kinase to Control Insulin Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cannabinoid Receptors; Cytoskeleton; Endocannabinoids; Exocytosis; Focal Adhesion Kinase; Insulin Release	DIACYLGLYCEROL LIPASE-ALPHA; BETA-CELL; MOLECULAR CHARACTERIZATION; ENDOCANNABINOID SYSTEM; INTRACELLULAR CALCIUM; CYTOSOLIC CA2+; SECRETION; ACTIN; ANANDAMIDE; MOBILIZATION	Background: Endocannabinoids can affect pancreatic cell physiology. Results: Anandamide and 2-arachidonoylglycerol binding to CB1 receptors induces focal adhesion kinase phosphorylation, which is a prerequisite of insulin release. Conclusion: Focal adhesion kinase activation downstream from CB1 receptors couples cytoskeletal reorganization to insulin release. Significance: Identifies the molecular blueprint of 2-arachidonoylglycerol signaling in the endocrine pancreas, and outlines a kinase activation cascade linking endocannabinoid signals to insulin release. Endocannabinoid signaling has been implicated in modulating insulin release from cells of the endocrine pancreas. Cells express CB1 cannabinoid receptors (CB(1)Rs), and the enzymatic machinery regulating anandamide and 2-arachidonoylglycerol bioavailability. However, the molecular cascade coupling agonist-induced cannabinoid receptor activation to insulin release remains unknown. By combining molecular pharmacology and genetic tools in INS-1E cells and in vivo, we show that CB1R activation by endocannabinoids (anandamide and 2-arachidonoylglycerol) or synthetic agonists acutely or after prolonged exposure induces insulin hypersecretion. In doing so, CB(1)Rs recruit Akt/PKB and extracellular signal-regulated kinases 1/2 to phosphorylate focal adhesion kinase (FAK). FAK activation induces the formation of focal adhesion plaques, multimolecular platforms for second-phase insulin release. Inhibition of endocannabinoid synthesis or FAK activity precluded insulin release. We conclude that FAK downstream from CB(1)Rs mediates endocannabinoid-induced insulin release by allowing cytoskeletal reorganization that is required for the exocytosis of secretory vesicles. These findings suggest a mechanistic link between increased circulating and tissue endocannabinoid levels and hyperinsulinemia in type 2 diabetes.	[Malenczyk, Katarzyna; Jazurek, Magdalena; Janikiewicz, Justyna; Redowicz, Maria J.; Dobrzyn, Agnieszka] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; [Malenczyk, Katarzyna; Keimpema, Erik; Harkany, Tibor] Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Silvestri, Cristoforo; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, Ist Chim Biomol, I-80078 Naples, Italy; [Mackie, Ken] Indiana Univ, Gill Ctr Neurosci, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Harkany, Tibor] Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Indiana University System; Indiana University Bloomington; University of Aberdeen	Harkany, T (corresponding author), Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, Scheeles Vag 1,A1,2nd Floor, SE-17177 Stockholm, Sweden.	Tibor.Harkany@ki.se; a.dobrzyn@nencki.gov.pl	Redowicz, Maria Jolanta/R-4083-2016; Dobrzyn, Agnieszka/R-4073-2016; Redowicz, Maria Jolanta/AAM-8020-2020; Silvestri, Cristoforo/Y-2504-2019; Di Marzo, Vincenzo/AAD-7742-2019	Redowicz, Maria Jolanta/0000-0001-5834-471X; Dobrzyn, Agnieszka/0000-0002-6331-9460; Silvestri, Cristoforo/0000-0001-5635-1545; Di Marzo, Vincenzo/0000-0002-1490-3070; Keimpema, Erik/0000-0002-7555-6762; Jazurek-Ciesiolka, Magdalena/0000-0001-7403-7218; Malenczyk, Katarzyna/0000-0002-4818-238X; Janikiewicz, Justyna/0000-0002-6484-9164	National Institutes of Health [DA023214, DA011322, DA021696]; Foundation for Polish Science [TEAM/2010-5/2, MPD/2009/4]; National Science Center (NCN) [UMO-2011/03/B/NZ4/03055]; Scottish Universities Life Science Alliance; Vetenskapsradet; Hjarnfonden; European Commission [HEALTH-F2-2007-201159]; Novo Nordisk Foundation; Visby international mobility scholarship; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021696, R01DA011322, R01DA023214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Science Center (NCN)(National Science Centre, Poland); Scottish Universities Life Science Alliance; Vetenskapsradet(Swedish Research Council); Hjarnfonden; European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Visby international mobility scholarship; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA023214 (to T. H.), DA011322 (to K. Mac.), and DA021696 (to K. Mac.), Foundation for Polish Science Grants TEAM/2010-5/2 (to A. D.) and MPD/2009/4 (to A. D.), National Science Center (NCN) Grant UMO-2011/03/B/NZ4/03055 (to A. D.), Scottish Universities Life Science Alliance (to T. H.), Vetenskapsradet (to T. H.), Hjarnfonden (to T. H.), European Commission Grant HEALTH-F2-2007-201159 (to T. H.), and the Novo Nordisk Foundation (to T. H.).; Recipient of a Visby international mobility scholarship to study in Sweden.	Arous C, 2013, DIABETOLOGIA, V56, P792, DOI 10.1007/s00125-012-2800-1; Begg M, 2005, PHARMACOL THERAPEUT, V106, P133, DOI 10.1016/j.pharmthera.2004.11.005; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Bisht B, 2008, J PHYSIOL-LONDON, V586, P3825, DOI 10.1113/jphysiol.2008.157107; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Cai EP, 2012, DIABETES, V61, P1708, DOI 10.2337/db11-1344; Cheung AT, 2000, DIABETES, V49, P810, DOI 10.2337/diabetes.49.5.810; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Dalton GD, 2013, CELL SIGNAL, V25, P1665, DOI 10.1016/j.cellsig.2013.03.020; Daval M, 2011, DIABETES, V60, P1186, DOI 10.2337/db10-1048; De Marchi Nicola, 2003, Lipids Health Dis, V2, P5, DOI 10.1186/1476-511X-2-5; De Petrocellis L, 1998, P NATL ACAD SCI USA, V95, P8375, DOI 10.1073/pnas.95.14.8375; De Petrocellis L, 2007, EXP CELL RES, V313, P2993, DOI 10.1016/j.yexcr.2007.05.012; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Derkinderen P, 1996, SCIENCE, V273, P1719, DOI 10.1126/science.273.5282.1719; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Getty-Kaushik L, 2009, OBESITY, V17, P1856, DOI 10.1038/oby.2009.234; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; GOMEZ DP, 2000, BIOCHEM J, V347, P369; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Henquin JC, 2012, FEBS LETT, V586, P89, DOI 10.1016/j.febslet.2011.11.030; Higuchi M, 2013, J CELL SCI, V126, P745, DOI 10.1242/jcs.112722; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Huang DS, 2006, ENDOCRINOLOGY, V147, P3333, DOI 10.1210/en.2005-0382; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Keimpema E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02093; Keimpema E, 2013, P NATL ACAD SCI USA, V110, P1935, DOI 10.1073/pnas.1212563110; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Laezza C, 2008, ENDOCR-RELAT CANCER, V15, P965, DOI 10.1677/ERC-08-0030; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Li C, 2010, CELL PHYSIOL BIOCHEM, V26, P187, DOI 10.1159/000320527; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Matias I, 2006, J Endocrinol Invest, V29, P15; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Matias I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042399; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Melck D, 1999, BIOCHEM BIOPH RES CO, V262, P275, DOI 10.1006/bbrc.1999.1105; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mombouli JV, 1999, BRIT J PHARMACOL, V126, P1593, DOI 10.1038/sj.bjp.0702483; Muccioli GG, 2008, CHEMBIOCHEM, V9, P2704, DOI 10.1002/cbic.200800428; Mulder J, 2011, BRAIN, V134, P1041, DOI 10.1093/brain/awr046; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Obara Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024284; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Rasmussen I, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-44; Ren XD, 2000, J CELL SCI, V113, P3673; Rondas D, 2012, J BIOL CHEM, V287, P2423, DOI 10.1074/jbc.M111.279885; Rondas D, 2011, DIABETES, V60, P1146, DOI 10.2337/db10-0946; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; Sato Y, 1998, FEBS LETT, V421, P115, DOI 10.1016/S0014-5793(97)01547-0; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Simon GM, 2008, J BIOL CHEM, V283, P9341, DOI 10.1074/jbc.M707807200; SLIPETZ DM, 1995, MOL PHARMACOL, V48, P352; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Vilches-Flores A, 2013, CLIN SCI, V124, P467, DOI 10.1042/CS20120447; Vilches-Flores A, 2010, REGUL PEPTIDES, V163, P81, DOI 10.1016/j.regpep.2010.04.013; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200; Zhou D, 2002, FEBS LETT, V525, P164, DOI 10.1016/S0014-5793(02)03091-0; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	84	53	55	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32685	32699		10.1074/jbc.M113.478354	http://dx.doi.org/10.1074/jbc.M113.478354			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089517	hybrid, Green Published			2022-12-28	WOS:000328681700053
J	Shim, JY; Ahn, KH; Kendall, DA				Shim, Joong-Youn; Ahn, Kwang H.; Kendall, Debra A.			Molecular Basis of Cannabinoid CB1 Receptor Coupling to the G Protein Heterotrimer G alpha(i)beta gamma IDENTIFICATION OF KEY CB1 CONTACTS WITH THE C-TERMINAL HELIX alpha(5) OF G alpha(i)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cannabinoid Receptors; Computer Modeling; G Protein-coupled Receptors (GPCR); G Proteins; Molecular Dynamics; Mutagenesis; Protein-Protein Interactions; Signaling	BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; INTRACELLULAR LOOP; BETA(2)-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; STRUCTURAL REQUIREMENTS; FORCE-FIELD; ACTIVATION; RHODOPSIN; DYNAMICS	The cannabinoid (CB1) receptor is a member of the rhodopsin-like G protein-coupled receptor superfamily. The human CB1 receptor, which is among the most expressed receptors in the brain, has been implicated in several disease states, including drug addiction, anxiety, depression, obesity, and chronic pain. Different classes of CB1 agonists evoke signaling pathways through the activation of specific subtypes of G proteins. The molecular basis of CB1 receptor coupling to its cognate G protein is unknown. As a first step toward understanding CB1 receptor-mediated G protein signaling, we have constructed a ternary complex structural model of the CB1 receptor and G(i) heterotrimer (CB1-G(i)), guided by the x-ray structure of (2)-adrenergic receptor ((2)AR) in complex with G(s) ((2)AR-G(s)), through 824-ns duration molecular dynamics simulations in a fully hydrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine bilayer environment. We identified a group of residues at the juxtamembrane regions of the intracellular loops 2 and 3 (IC2 and IC3) of the CB1 receptor, including Ile-218(3.54), Tyr-224(IC2), Asp-338(6.30), Arg-340(6.32), Leu-341(6.33), and Thr-344(6.36), as potential key contacts with the extreme C-terminal helix (5) of G(i). Ala mutations of these residues at the receptor-G(i) interface resulted in little G protein coupling activity, consistent with the present model of the CB1-G(i) complex, which suggests tight interactions between CB1 and the extreme C-terminal helix (5) of G(i). The model also suggests that unique conformational changes in the extreme C-terminal helix (5) of G play a crucial role in the receptor-mediated G protein activation.	[Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Ahn, Kwang H.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of North Carolina; North Carolina Central University; University of Connecticut	Shim, JY (corresponding author), N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	jyshim@nccu.edu			National Institutes of Health [DA020663, DA020763]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763, K01DA020663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA020663 (to J.Y.S.) and DA020763 (to D.A.K.).	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Berg J. M., 2010, BIOCHEMISTRY-US, P7; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen XP, 2010, BRIT J PHARMACOL, V161, P1817, DOI 10.1111/j.1476-5381.2010.01006.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Costanzi S, 2009, CURR PHARM DESIGN, V15, P3994, DOI 10.2174/138161209789824795; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; GERARD CM, 1991, BIOCHEM J, V279, P129, DOI 10.1042/bj2790129; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P1953, DOI 10.1021/jp0750708; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kapur A, 2008, J PHARMACOL EXP THER, V325, P341, DOI 10.1124/jpet.107.133256; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lei S, 2002, J BIOL CHEM, V277, P40989, DOI 10.1074/jbc.M206801200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; Meschler JP, 2000, BIOCHEM PHARMACOL, V60, P1315, DOI 10.1016/S0006-2952(00)00447-0; MORO O, 1993, J BIOL CHEM, V268, P22273; Mukhopadhyay S, 1999, BIOCHEMISTRY-US, V38, P3447, DOI 10.1021/bi981767v; Nebane NM, 2006, FEBS LETT, V580, P5392, DOI 10.1016/j.febslet.2006.09.001; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Nordstrom KJV, 2011, MOL BIOL EVOL, V28, P2471, DOI 10.1093/molbev/msr061; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PFEUFFER T, 1988, CURR TOP CELL REGUL, V29, P129; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roche JP, 1999, MOL PHARMACOL, V56, P611, DOI 10.1124/mol.56.3.611; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scott CE, 2013, PROTEIN SCI, V22, P101, DOI 10.1002/pro.2192; Shan JF, 2010, BIOCHEMISTRY-US, V49, P10691, DOI 10.1021/bi100580s; Shim JY, 2013, METHOD ENZYMOL, V520, P337, DOI 10.1016/B978-0-12-391861-1.00016-2; Shim JY, 2012, J BIOL CHEM, V287, P38741, DOI 10.1074/jbc.M112.390955; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Smaby JM, 1997, BIOPHYS J, V73, P1492, DOI 10.1016/S0006-3495(97)78181-5; Stadel R, 2011, J NEUROCHEM, V117, P1, DOI 10.1111/j.1471-4159.2011.07186.x; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Ulfers AL, 2002, BIOCHEMISTRY-US, V41, P11344, DOI 10.1021/bi0259610; Van Eps N, 2010, BIOCHEMISTRY-US, V49, P6877, DOI 10.1021/bi100846c; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White S. H., 1996, MEMBRANE STRUCTURE D, P127	97	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32449	32465		10.1074/jbc.M113.489153	http://dx.doi.org/10.1074/jbc.M113.489153			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24092756	hybrid, Green Published			2022-12-28	WOS:000328681700030
J	Dahiya, V; Chaudhuri, TK				Dahiya, Vinay; Chaudhuri, Tapan K.			Chaperones GroEL/GroES Accelerate the Refolding of a Multidomain Protein through Modulating On-pathway Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggregation; Molecular Chaperone; Protein Conformation; Protein Dynamics; Protein Folding; GroEL; Malate Synthase G; Folding Intermediates; Large Protein Folding; Refolding Kinetics	THERMODYNAMIC COUPLING MECHANISM; ESCHERICHIA-COLI PROTEINS; IN-VIVO; MOLECULAR CHAPERONES; FOLDING REACTION; GROEL; BINDING; ATP; POLYPEPTIDE; RECONSTITUTION	Despite a vast amount information on the interplay of GroEL, GroES, and ATP in chaperone-assisted folding, the molecular details on the conformational dynamics of folding polypeptide during its GroEL/GroES-assisted folding cycle is quite limited. Practically no such studies have been reported to date on large proteins, which often have difficulty folding in vitro. The effect of the GroEL/GroES chaperonin system on the folding pathway of an 82-kDa slow folding protein, malate synthase G (MSG), was investigated. GroEL bound to the burst phase intermediate of MSG and accelerated the slowest kinetic phase associated with the formation of native topology in the spontaneous folding pathway. GroEL slowly induced conformational changes on the bound burst phase intermediate, which was then transformed into a more folding-compatible form. Subsequent addition of ATP or GroES/ATP to the GroEL-MSG complex led to the formation of the native state via a compact intermediate with the rate several times faster than that of spontaneous refolding. The presence of GroES doubled the ATP-dependent reactivation rate of bound MSG by preventing multiple cycles of its GroEL binding and release. Because GroES bound to the trans side of GroEL-MSG complex, it may be anticipated that confinement of the substrate underneath the co-chaperone is not required for accelerating the rate in the assisted folding pathway. The potential role of GroEL/GroES in assisted folding is most likely to modulate the conformation of MSG intermediates that can fold faster and thereby eliminate the possibility of partial aggregation caused by the slow folding intermediates during its spontaneous refolding pathway.	[Dahiya, Vinay; Chaudhuri, Tapan K.] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Chaudhuri, TK (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ac.in		Dahiya, Vinay/0000-0003-1900-0468	Council of Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Recipient of the Council of Scientific and Industrial Research, Government of India Senior Research Fellowship.; Recipient of financial assistance from the Department of Biotechnology, Government of India.	Bhutani N, 2000, J MOL BIOL, V297, P1037, DOI 10.1006/jmbi.2000.3648; Bhutani N, 2001, J MOL BIOL, V314, P1167, DOI 10.1006/jmbi.2000.5193; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Dahiya V, 2013, BIOCHEMISTRY-US, V52, P4517, DOI 10.1021/bi400328a; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Fenton WA, 1997, PROTEIN SCI, V6, P743; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Gervasoni P, 1996, P NATL ACAD SCI USA, V93, P12189, DOI 10.1073/pnas.93.22.12189; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GULUKOTA K, 1994, P NATL ACAD SCI USA, V91, P9292, DOI 10.1073/pnas.91.20.9292; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lau CK, 1999, BBA-PROTEIN STRUCT M, V1431, P282, DOI 10.1016/S0167-4838(99)00050-3; LILIE H, 1995, P NATL ACAD SCI USA, V92, P8100, DOI 10.1073/pnas.92.18.8100; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MATTINGLY JR, 1995, J BIOL CHEM, V270, P1138, DOI 10.1074/jbc.270.3.1138; Noivirt-Brik O, 2007, BIOINFORMATICS, V23, P3276, DOI 10.1093/bioinformatics/btm513; Paul S, 2007, FASEB J, V21, P2874, DOI 10.1096/fj.06-7958com; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Zahn R, 1996, J MOL BIOL, V261, P43, DOI 10.1006/jmbi.1996.0440; ZAHN R, 1994, J MOL BIOL, V242, P150, DOI 10.1006/jmbi.1994.1566	48	17	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					286	298		10.1074/jbc.M113.518373	http://dx.doi.org/10.1074/jbc.M113.518373			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247249	Green Published, hybrid			2022-12-28	WOS:000329370900025
J	Neuhaus, A; Kooshapur, H; Wolf, J; Meyer, NH; Madl, T; Saidowsky, J; Hambruch, E; Lazam, A; Jung, M; Sattler, M; Schliebs, W; Erdmann, R				Neuhaus, Alexander; Kooshapur, Hamed; Wolf, Janina; Meyer, N. Helge; Madl, Tobias; Saidowsky, Juergen; Hambruch, Eva; Lazam, Anissa; Jung, Martin; Sattler, Michael; Schliebs, Wolfgang; Erdmann, Ralf			A Novel Pex14 Protein-interacting Site of Human Pex5 Is Critical for Matrix Protein Import into Peroxisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Peroxisomes; Protein Dynamics; Protein Motifs; Protein Structure; Protein Targeting; Protein-Protein Interactions; Subcellular Organelles	PTS1 RECEPTOR PEX5P; N-TERMINAL DOMAIN; BINDING-SITES; SH3 DOMAIN; STRUCTURAL BASIS; MEMBRANE; BIOGENESIS; ASSOCIATION; MACHINERY; COMPLEXES	Protein import into peroxisomes relies on the import receptor Pex5, which recognizes proteins with a peroxisomal targeting signal 1 (PTS1) in the cytosol and directs them to a docking complex at the peroxisomal membrane. Receptor-cargo docking occurs at the membrane-associated protein Pex14. In human cells, this interaction is mediated by seven conserved diaromatic penta-peptide motifs (WXXX(F/Y) motifs) in the N-terminal half of Pex5 and the N-terminal domain of Pex14. A systematic screening of a Pex5 peptide library by ligand blot analysis revealed a novel Pex5-Pex14 interaction site of Pex5. The novel motif composes the sequence LVAEF with the evolutionarily conserved consensus sequence LVXEF. Replacement of the amino acid LVAEF sequence by alanines strongly affects matrix protein import into peroxisomes in vivo. The NMR structure of a complex of Pex5-(57-71) with the Pex14-N-terminal domain showed that the novel motif binds in a similar -helical orientation as the WXXX(F/Y) motif but that the tryptophan pocket is now occupied by a leucine residue. Surface plasmon resonance analyses revealed 33 times faster dissociation rates for the LVXEF ligand when compared with a WXXX(F/Y) motif. Surprisingly, substitution of the novel motif with the higher affinity WXXX(F/Y) motif impairs protein import into peroxisomes. These data indicate that the distinct kinetic properties of the novel Pex14-binding site in Pex5 are important for processing of the peroxisomal targeting signal 1 receptor at the peroxisomal membrane. The novel Pex14-binding site may represent the initial tethering site of Pex5 from which the cargo-loaded receptor is further processed in a sequential manner.	[Neuhaus, Alexander; Wolf, Janina; Saidowsky, Juergen; Hambruch, Eva; Lazam, Anissa; Schliebs, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Abt Syst Biochem, Inst Physiol Chem, D-44780 Bochum, Germany; [Kooshapur, Hamed; Meyer, N. Helge; Madl, Tobias; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Kooshapur, Hamed; Meyer, N. Helge; Madl, Tobias; Sattler, Michael] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, Chair Biomol NMR, D-85747 Garching, Germany; [Jung, Martin] Univ Saarland, D-66421 Homburg, Germany	Ruhr University Bochum; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Saarland University	Sattler, M (corresponding author), Helmholtz Zentrum, Inst Biol Struct, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	sattler@helmholtz-muenchen.de; ralf.erdmann@rub.de	Jung, Martin/D-2207-2012; Madl, Tobias/B-1682-2012; Sattler, Michael/A-2407-2012; Kooshapur, Hamed/H-4622-2019; Jung, Martin/AAM-4547-2021	Jung, Martin/0000-0002-1482-7020; Madl, Tobias/0000-0002-9725-5231; Sattler, Michael/0000-0002-1594-0527; Jung, Martin/0000-0002-1482-7020; Meyer, Niels Helge/0000-0003-1018-4942; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft [FOR1905, GRK1721, SFB594]; European Commission [FP7 NMI3, 226507]; Technische Universitat Munchen Graduate School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Technische Universitat Munchen Graduate School	This work was supported in part by Deutsche Forschungsgemeinschaft Grants FOR1905 (to R. E. and M. S.), GRK1721 (to M. S.), and SFB594 (to M. S.) and European Commission Grant FP7 NMI3, 226507 (to M. S.).; Supported by the Technische Universitat Munchen Graduate School.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Bharti P, 2011, J CELL SCI, V124, P1759, DOI 10.1242/jcs.079368; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Choe J, 2003, BIOCHEMISTRY-US, V42, P10915, DOI 10.1021/bi034248n; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Goddard TD, 2007, SPARKY VERSION 3; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Huybrechts SJ, 2008, J MED GENET, V45, P376, DOI 10.1136/jmg.2007.056697; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Madrid KP, 2005, BIOCHEM J, V391, P105, DOI 10.1042/BJ20050328; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Neufeld C, 2009, EMBO J, V28, P745, DOI 10.1038/emboj.2009.7; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pires JR, 2003, J MOL BIOL, V326, P1427, DOI 10.1016/S0022-2836(03)00039-1; Platta HW, 2013, CELL MOL LIFE SCI, V70, P1393, DOI 10.1007/s00018-012-1136-9; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Saidowsky J, 2001, J BIOL CHEM, V276, P34524, DOI 10.1074/jbc.M104647200; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; Simon B, 2010, ANGEW CHEM INT EDIT, V49, P1967, DOI 10.1002/anie.200906147; Stanley WA, 2004, J SYNCHROTRON RADIAT, V11, P490, DOI 10.1107/S090904950402504X; Su JR, 2009, P NATL ACAD SCI USA, V106, P417, DOI 10.1073/pnas.0808681106; Williams C, 2005, FEBS LETT, V579, P3416, DOI 10.1016/j.febslet.2005.05.011	33	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					437	448		10.1074/jbc.M113.499707	http://dx.doi.org/10.1074/jbc.M113.499707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235149	hybrid, Green Published			2022-12-28	WOS:000329370900038
J	Ramadasan-Nair, R; Gayathri, N; Mishra, S; Sunitha, B; Mythri, RB; Nalini, A; Subbannayya, Y; Harsha, HC; Kolthur-Seetharam, U; Bharath, MMS				Ramadasan-Nair, Renjini; Gayathri, Narayanappa; Mishra, Sudha; Sunitha, Balaraju; Mythri, Rajeswara Babu; Nalini, Atchayaram; Subbannayya, Yashwanth; Harsha, Hindalahalli Chandregowda; Kolthur-Seetharam, Ullas; Bharath, Muchukunte Mukunda Srinivas			Mitochondrial Alterations and Oxidative Stress in an Acute Transient Mouse Model of Muscle Degeneration IMPLICATIONS FOR MUSCULAR DYSTROPHY AND RELATED MUSCLE PATHOLOGIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Muscular Dystrophy; Oxidative Stress; Proteomics; Skeletal Muscle; Muscle Pathology; Cardiotoxin	SQUAMOUS-CELL CARCINOMA; NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; PERMEABILITY TRANSITION; PROTEOMIC ANALYSIS; PROTEIN OXIDATION; CALCIUM INFLUX; EXPRESSION; GLUTATHIONE; CARDIOTOXIN	Muscular dystrophies (MDs) and inflammatory myopathies (IMs) are debilitating skeletal muscle disorders characterized by common pathological events including myodegeneration and inflammation. However, an experimental model representing both muscle pathologies and displaying most of the distinctive markers has not been characterized. We investigated the cardiotoxin (CTX)-mediated transient acute mouse model of muscle degeneration and compared the cardinal features with human MDs and IMs. The CTX model displayed degeneration, apoptosis, inflammation, loss of sarcolemmal complexes, sarcolemmal disruption, and ultrastructural changes characteristic of human MDs and IMs. Cell death caused by CTX involved calcium influx and mitochondrial damage both in murine C2C12 muscle cells and in mice. Mitochondrial proteomic analysis at the initial phase of degeneration in the model detected lowered expression of 80 mitochondrial proteins including subunits of respiratory complexes, ATP machinery, fatty acid metabolism, and Krebs cycle, which further decreased in expression during the peak degenerative phase. The mass spectrometry (MS) data were supported by enzyme assays, Western blot, and histochemistry. The CTX model also displayed markers of oxidative stress and a lowered glutathione reduced/oxidized ratio (GSH/GSSG) similar to MDs, human myopathies, and neurogenic atrophies. MS analysis identified 6 unique oxidized proteins from Duchenne muscular dystrophy samples (n = 6) (versus controls; n = 6), including two mitochondrial proteins. Interestingly, these mitochondrial proteins were down-regulated in the CTX model thereby linking oxidative stress and mitochondrial dysfunction. We conclude that mitochondrial alterations and oxidative damage significantly contribute to CTX-mediated muscle pathology with implications for human muscle diseases.	[Bharath, Muchukunte Mukunda Srinivas] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurochem, Bangalore 560029, Karnataka, India; [Gayathri, Narayanappa; Sunitha, Balaraju] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore 560029, Karnataka, India; [Mishra, Sudha] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Biophys, Bangalore 560029, Karnataka, India; [Nalini, Atchayaram] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore 560029, Karnataka, India; [Subbannayya, Yashwanth; Harsha, Hindalahalli Chandregowda] Inst Bioinformat, Bangalore 560066, Karnataka, India; [Kolthur-Seetharam, Ullas] Tata Inst Fundamental Res, Div Biol Sci, Bombay 400005, Maharashtra, India	National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; National Institute of Mental Health & Neurosciences - India; Tata Institute of Fundamental Research (TIFR)	Bharath, MMS (corresponding author), Natl Inst Mental Hlth & Neurosci, 2900 Hosur Rd, Bangalore 560029, Karnataka, India.	bharath@nimhans.kar.nic.in	R, Mythri/ABE-8212-2020; Nalini, Atchayaram/AAT-2469-2021; Gowda, Harsha/A-8526-2011; Subbannayya, Yashwanth/A-7796-2012	Nalini, Atchayaram/0000-0001-9791-3639; Gowda, Harsha/0000-0002-4118-6855; Subbannayya, Yashwanth/0000-0002-3885-3514	Indian Council of Medical Research (ICMR) [54/8/2011-HUM-BMS]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research (ICMR) Grant 54/8/2011-HUM-BMS (to M. M. S. B.).	Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Banerjee KK, 2012, AGING-US, V4, P206, DOI 10.18632/aging.100435; Baron D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026952; Barreiro E, 2010, ANTIOXID REDOX SIGN, V12, P417, DOI 10.1089/ars.2009.2808; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395; BHATTACHARYA SK, 1991, ANAL BIOCHEM, V192, P344, DOI 10.1016/0003-2697(91)90546-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown S., 1997, DYSTROPHIN GENE PROT, P79; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; BURR IM, 1987, MUSCLE NERVE, V10, P150, DOI 10.1002/mus.880100208; Carberry S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/691641; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Chien CM, 2010, TOXICON, V56, P508, DOI 10.1016/j.toxicon.2010.05.007; Choi Angela O., 2007, Journal of Nanobiotechnology, V5, P1, DOI 10.1186/1477-3155-5-1; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; Cotgreave IA, 2002, FASEB J, V16, P435, DOI 10.1096/fj.01-0685fje; Dalle-Donne I, 2005, MASS SPECTROM REV, V24, P55, DOI 10.1002/mas.20006; Degl'Innocenti D, 1999, BIOCHIMIE, V81, P1025, DOI 10.1016/S0300-9084(99)00334-X; Dimitri D, 2009, PRESSE MED, V38, P1141, DOI 10.1016/j.lpm.2009.01.013; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI, P293; Dudley RWR, 2006, AM J PHYSIOL-REG I, V291, pR704, DOI 10.1152/ajpregu.00031.2006; EMERY AEH, 1977, NATURE, V266, P472, DOI 10.1038/266472a0; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Enwere EK, 2013, HUM MOL GENET, V22, P867, DOI 10.1093/hmg/dds493; Fadic R, 2005, BIOL RES, V38, P375, DOI 10.4067/S0716-97602005000400010; Fairclough RJ, 2012, CURR GENE THER, V12, P206; FITZPATRICK DR, 1995, GENOMICS, V27, P457, DOI 10.1006/geno.1995.1077; Fraysse B, 2004, NEUROBIOL DIS, V17, P144, DOI 10.1016/j.nbd.2004.06.002; Fraysse B, 2010, AM J PHYSIOL-CELL PH, V299, pC706, DOI 10.1152/ajpcell.00545.2009; Ghosh AK, 2011, MEM I OSWALDO CRUZ, V106, P85, DOI 10.1590/S0074-02762011000900011; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hoffman EP, 2001, DISORDERS VOLUNTARY, P385; Hopf F. W., 2007, V45, P429; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; JACOBSON EL, 1976, ARCH BIOCHEM BIOPHYS, V175, P627, DOI 10.1016/0003-9861(76)90553-1; Jongpiputvanich S, 2005, J CLIN NEUROSCI, V12, P426, DOI 10.1016/j.jocn.2004.06.014; Kherif S, 1999, DEV BIOL, V205, P158, DOI 10.1006/dbio.1998.9107; Kovalyov LI, 2006, BIOCHEMISTRY-MOSCOW+, V71, P448, DOI 10.1134/S0006297906040146; Kudryashova E, 2012, J CLIN INVEST, V122, P1764, DOI 10.1172/JCI59581; Kuru S, 2003, ACTA NEUROPATHOL, V105, P217, DOI 10.1007/s00401-002-0632-4; Lopez-Alemany R, 2005, FRONT BIOSCI-LANDMRK, V10, P30, DOI 10.2741/1503; Lopez-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Marshall JL, 2012, J CELL BIOL, V197, P1009, DOI 10.1083/jcb.201110032; MATSUDA R, 1984, DEV BIOL, V103, P276, DOI 10.1016/0012-1606(84)90315-4; Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339; Messina S, 2007, FASEB J, V21, P3737, DOI 10.1096/fj.07-8459com; Moller IM, 2004, PHOTOCH PHOTOBIO SCI, V3, P730, DOI 10.1039/b315561g; Nahleh Z, 2012, FUTURE MED CHEM, V4, P927, DOI [10.4155/FMC.12.50, 10.4155/fmc.12.50]; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Ng R, 2012, PROG MOL BIOL TRANSL, V105, P83, DOI 10.1016/B978-0-12-394596-9.00004-4; Oikawa S, 2009, FREE RADICAL BIO MED, V46, P1472, DOI 10.1016/j.freeradbiomed.2009.02.029; Onofre-Oliveira PCG, 2012, NEUROMOL MED, V14, P74, DOI 10.1007/s12017-012-8172-3; Owen JB, 2008, BRAIN RES, V1240, P22, DOI 10.1016/j.brainres.2008.09.001; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Parker MH, 2012, SKELET MUSCLE, V2, DOI [10.1186/2044-5040-2-4, 10.1186/2044-5040-2-6]; Patel HV, 1997, J BIOL CHEM, V272, P1484, DOI 10.1074/jbc.272.32.20185; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Pawar H, 2011, CANCER BIOL THER, V12, P510, DOI 10.4161/cbt.12.6.16833; Peng TI, 1998, MOL PHARMACOL, V53, P974; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Renjini R, 2012, INDIAN J MED RES, V135, P878; Renjini R, 2012, NEUROCHEM RES, V37, P885, DOI 10.1007/s11064-011-0683-z; Robin G, 2012, J GEN PHYSIOL, V139, P209, DOI 10.1085/jgp.201110738; Sabatelli P, 2012, NEUROL INDIA, V60, P510, DOI 10.4103/0028-3886.103200; Sandri M, 1998, LAB INVEST, V78, P1005; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Smith JP, 1995, J NEUROSCI METH, V62, P15, DOI 10.1016/0165-0270(95)00049-6; Spencer MJ, 1997, J CLIN INVEST, V99, P2745, DOI 10.1172/JCI119464; Sultana R, 2011, FREE RADICAL BIO MED, V50, P487, DOI 10.1016/j.freeradbiomed.2010.11.021; Szoke D, 2012, CLIN CHIM ACTA, V413, P1184, DOI 10.1016/j.cca.2012.04.021; Tews DS, 1998, CLIN IMMUNOL IMMUNOP, V87, P240, DOI 10.1006/clin.1998.4527; Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5; Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1046/j.1523-1755.2002.00565.x; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tsai PC, 2012, TOXICON, V60, P734, DOI 10.1016/j.toxicon.2012.05.019; Turki A, 2012, FREE RADICAL BIO MED, V53, P1068, DOI 10.1016/j.freeradbiomed.2012.06.041; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Wagner AE, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/835970; Wang CH, 2005, TOXICON, V46, P430, DOI 10.1016/j.toxicon.2005.06.012; Wang CH, 2005, FEBS LETT, V579, P3169, DOI 10.1016/j.febslet.2005.05.006; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wanschitz JV, 2013, NEUROMUSCULAR DISORD, V23, P75, DOI 10.1016/j.nmd.2012.09.003; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Yamashima T, 2012, J NEUROCHEM, V120, P477, DOI 10.1111/j.1471-4159.2011.07596.x; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yugeta Naoko, 2006, BMC Cardiovasc Disord, V6, P47, DOI 10.1186/1471-2261-6-47	97	48	48	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					485	509		10.1074/jbc.M113.493270	http://dx.doi.org/10.1074/jbc.M113.493270			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24220031	Green Published, hybrid			2022-12-28	WOS:000329370900042
J	Kannenberg, F; Gorzelniak, K; Jager, K; Fobker, M; Rust, S; Repa, J; Roth, M; Bjorkhem, I; Walter, M				Kannenberg, Frank; Gorzelniak, Kerstin; Jaeger, Kathrin; Fobker, Manfred; Rust, Stephan; Repa, Joyce; Roth, Mike; Bjorkhem, Ingemar; Walter, Michael			Characterization of Cholesterol Homeostasis in Telomerase-immortalized Tangier Disease Fibroblasts Reveals Marked Phenotype Variability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cholesterol; Cholesterol Metabolism; High Density Lipoprotein (HDL); Telomerase; Oxysterols	APOLIPOPROTEIN-A-I; PERFORMANCE LIQUID-CHROMATOGRAPHY; DENSITY-LIPOPROTEIN DEFICIENCY; BINDING PROTEIN-1C GENE; CASSETTE TRANSPORTER 1; CELLULAR CHOLESTEROL; LXR-ALPHA; INTRACELLULAR CHOLESTEROL; EFFLUX; ATHEROSCLEROSIS	We compared the consequences of an ABCA1 mutation that produced an apparent lack of atherosclerosis (Tangier family 1, N935S) with an ABCA1 mutation with functional ABCA1 knockout that was associated with severe atherosclerosis (Tangier family 2, Leu(548):Leu(575)-End), using primary and telomerase-immortalized fibroblasts. Telomerase-immortalized Tangier fibroblasts of family 1 (TT1) showed 30% residual cholesterol efflux capacity in response to apolipoprotein A-I, whereas telomerase-immortalized Tangier fibroblasts of family 2 (TT2) showed only 20%. However, there were a number of secondary differences that were often stronger and may help to explain the more rapid development of atherosclerosis in family 2. First, the total cellular cholesterol content increase was 2-3-fold and 3-5-fold in TT1 and TT2 cells, respectively. The corresponding increase in esterified cholesterol concentration was 10- and 40-fold, respectively. Second, 24-, 25-, and 27-hydroxycholesterol concentrations were moderately increased in TT1 cells, but were increased as much as 200-fold in TT2 cells. Third, cholesterol biosynthesis was moderately decreased in TT1 cells, but was markedly decreased in TT2 cells. Fourth, potentially atheroprotective LXR-dependent SREBP1c signaling was normal in TT1, but was rather suppressed in TT2 cells. Cultivated primary Tangier fibroblasts were characterized by premature aging in culture and were associated with less obvious biochemical differences. In summary, these results may help to understand the differential atherosclerotic susceptibility in Tangier disease and further demonstrate the usefulness of telomerase-immortalized cells in studying this cellular phenotype. The data support the contention that side chain-oxidized oxysterols are strong suppressors of cholesterol biosynthesis under specific pathological conditions in humans.	[Kannenberg, Frank; Fobker, Manfred] Univ Munster, Ctr Lab Med, D-48149 Munster, Germany; [Gorzelniak, Kerstin] Unfallkrankenhaus, D-12683 Berlin, Germany; [Jaeger, Kathrin; Walter, Michael] Charite, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; [Rust, Stephan] Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Repa, Joyce] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Roth, Mike] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bjorkhem, Ingemar] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, S-14186 Stockholm, Sweden; [Walter, Michael] Lab Berlin Charite Vivantes Serv GmbH, D-13353 Berlin, Germany	University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Karolinska University Hospital; Labor Berlin - Charite Vivantes GmbH	Walter, M (corresponding author), Campus Virchow Klinikum, Inst Lab Med Clin Chem & Pathobiochem, Augustenburger Pl 1, D-13353 Berlin, Germany.	m.walter@charite.de		Bjorkhem, Ingemar/0000-0001-6087-9190; Bjorkhem, Ingemar/0000-0002-0575-9425; Repa, Joyce/0000-0001-5740-1954; Roth, Michael/0000-0002-9056-332X	Landesversicherungsanstalt Rheinprovinz (LVA); Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL; Bonn, Germany); Swedish Research Council	Landesversicherungsanstalt Rheinprovinz (LVA); Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL; Bonn, Germany); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by grants from the "Landesversicherungsanstalt Rheinprovinz (LVA)" (to M. W.), the Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL; Bonn, Germany) (to M. W.), and a grant from the Swedish Research Council (to I. B.).	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; ASSMANN G, 1995, METABOLIC MOL BASES, P2053; AXELSON M, 1995, J BIOL CHEM, V270, P15102, DOI 10.1074/jbc.270.25.15102; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 1999, CURR OPIN LIPIDOL, V10, P161, DOI 10.1097/00041433-199904000-00010; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cullen P, 1997, J LIPID RES, V38, P401; Cullen P, 1997, ANAL BIOCHEM, V251, P39, DOI 10.1006/abio.1997.2227; Drobnik W, 1999, ARTERIOSCL THROM VAS, V19, P28, DOI 10.1161/01.ATV.19.1.28; Engel T, 2007, FEBS LETT, V581, P1673, DOI 10.1016/j.febslet.2007.03.038; ESTERMAN AL, 1983, J LIPID RES, V24, P1304; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KANDUTSCH AA, 1975, J CELL PHYSIOL, V85, P415, DOI 10.1002/jcp.1040850408; KLANSEK JJ, 1995, J LIPID RES, V36, P2261; Landau JM, 1997, BBA-LIPID LIPID MET, V1345, P349, DOI 10.1016/S0005-2760(97)00010-6; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lund E, 1996, ARTERIOSCL THROM VAS, V16, P208, DOI 10.1161/01.ATV.16.2.208; LUND E, 1993, BIOCHIM BIOPHYS ACTA, V1166, P177, DOI 10.1016/0005-2760(93)90094-P; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Oram JF, 1999, J LIPID RES, V40, P1769; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; RADER DJ, 1993, LANCET, V342, P1455, DOI 10.1016/0140-6736(93)92933-K; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Rust S, 1998, NAT GENET, V20, P96, DOI 10.1038/1770; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Utech M, 2001, BIOCHEM BIOPH RES CO, V280, P229, DOI 10.1006/bbrc.2000.4061; WALTER M, 1995, ARTERIOSCL THROM VAS, V15, P1975, DOI 10.1161/01.ATV.15.11.1975; Walter M, 1996, J CLIN INVEST, V98, P2315, DOI 10.1172/JCI119043; Walter M, 2004, J BIOL CHEM, V279, P20866, DOI 10.1074/jbc.M401714200; WALTER M, 1994, ATHEROSCLEROSIS, V110, P203, DOI 10.1016/0021-9150(94)90205-4; WALTER M, 1994, BIOCHEM BIOPH RES CO, V205, P850, DOI 10.1006/bbrc.1994.2742; Walter M, 2009, ARTERIOSCL THROM VAS, V29, P1244, DOI 10.1161/ATVBAHA.108.181438; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200	51	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36936	36947		10.1074/jbc.M113.500256	http://dx.doi.org/10.1074/jbc.M113.500256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196952	Green Published, hybrid			2022-12-28	WOS:000329189700016
J	Mercer, RCC; Ma, L; Watts, JC; Strome, R; Wohlgemuth, S; Yang, J; Cashman, NR; Coulthart, MB; Schmitt-Ulms, G; Jhamandas, JH; Westaway, D				Mercer, Robert C. C.; Ma, Li; Watts, Joel C.; Strome, Robert; Wohlgemuth, Serene; Yang, Jing; Cashman, Neil R.; Coulthart, Michael B.; Schmitt-Ulms, Gerold; Jhamandas, Jack H.; Westaway, David			The Prion Protein Modulates A-type K+ Currents Mediated by Kv4.2 Complexes through Dipeptidyl Aminopeptidase-like Protein 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Membrane Proteins; Potassium Channels; Prions; Protein Cross-linking	STRESS-INDUCIBLE PROTEIN-1; CELLULAR PRION; POTASSIUM CHANNELS; NULL MICE; PRP; DPP6; EXCITABILITY; RECEPTOR; ASSOCIATION; EXPRESSION	Widely expressed in the adult central nervous system, the cellular prion protein (PrPC) is implicated in a variety of processes, including neuronal excitability. Dipeptidyl aminopeptidase-like protein 6 (DPP6) was first identified as a PrPC interactor using in vivo formaldehyde cross-linking of wild type (WT) mouse brain. This finding was confirmed in three cell lines and, because DPP6 directs the functional assembly of K+ channels, we assessed the impact of WT and mutant PrPC upon Kv4.2-based cell surface macromolecular complexes. Whereas a Gerstmann-Straussler-Scheinker disease version of PrP with eight extra octarepeats was a loss of function both for complex formation and for modulation of Kv4.2 channels, WT PrPC, in a DPP6-dependent manner, modulated Kv4.2 channel properties, causing an increase in peak amplitude, a rightward shift of the voltage-dependent steady-state inactivation curve, a slower inactivation, and a faster recovery from steady-state inactivation. Thus, the net impact of wt PrPC was one of enhancement, which plays a critical role in the down-regulation of neuronal membrane excitability and is associated with a decreased susceptibility to seizures. Insofar as previous work has established a requirement for WT PrPC in the A-dependent modulation of excitability in cholinergic basal forebrain neurons, our findings implicate PrPC regulation of Kv4.2 channels as a mechanism contributing to the effects of oligomeric A upon neuronal excitability and viability.	[Mercer, Robert C. C.; Wohlgemuth, Serene; Yang, Jing; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Mercer, Robert C. C.; Ma, Li; Wohlgemuth, Serene; Jhamandas, Jack H.; Westaway, David] Univ Alberta, Dept Med Neurol, Edmonton, AB T6G 2M8, Canada; [Ma, Li; Jhamandas, Jack H.; Westaway, David] Univ Alberta, Ctr Neurosci, Edmonton, AB T6G 2M8, Canada; [Westaway, David] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2M8, Canada; [Watts, Joel C.; Strome, Robert; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Cashman, Neil R.] Univ British Columbia, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Coulthart, Michael B.] Publ Hlth Agcy Canada, Canadian Creutzfeldt Jakob Dis Surveillance Syst, Ottawa, ON K1A0K9, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Toronto; University of British Columbia; Public Health Agency of Canada	Jhamandas, JH (corresponding author), Univ Alberta, Heritage Med Res Ctr 530, Edmonton, AB T6G 2S2, Canada.	jack.jhamandas@ualberta.ca; david.westaway@ualberta.ca	Mercer, Robert/E-1973-2016	Watts, Joel/0000-0002-2604-2925; Mercer, Robert/0000-0001-6029-511X; Wohlgemuth, Serene/0000-0001-7287-0935	PrioNet Network Centres of Excellence; Alberta Prion Research Institute [APRI 200600070]; Alberta Innovates-Health Solutions [AHFMR 201000628, AHFMR 201100104]; Canadian Institutes of Health Research [MOP36377, 93601]; Canadian Foundation for Innovation	PrioNet Network Centres of Excellence; Alberta Prion Research Institute; Alberta Innovates-Health Solutions; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by grants from the PrioNet Network Centres of Excellence, Alberta Prion Research Institute Grant APRI 200600070, Alberta Innovates-Health Solutions Grant AHFMR 201000628, Canadian Institutes of Health Research Grants MOP36377 and 93601, and the Canadian Foundation for Innovation.; Recipient of Alberta Innovates-Health Solutions Scholarship AHFMR 201100104.	Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; Carleton A, 2001, PFLUG ARCH EUR J PHY, V442, P223, DOI 10.1007/s004240100523; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Fogh I, 2011, NEUROBIOL AGING, V32, P966, DOI 10.1016/j.neurobiolaging.2009.05.014; Fransen E, 2010, HIPPOCAMPUS, V20, P877, DOI 10.1002/hipo.20694; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; Hinnell C, 2011, NEUROLOGY, V76, P485, DOI 10.1212/WNL.0b013e31820a0ab2; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; Hough RB, 1998, P NATL ACAD SCI USA, V95, P13800, DOI 10.1073/pnas.95.23.13800; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Khosravani Houman, 2008, J Gen Physiol, V131, pi5, DOI 10.1085/JGP1316OIA5; Kim J, 2008, J NEUROPHYSIOL, V100, P1835, DOI 10.1152/jn.90261.2008; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Laplanche JL, 1999, BRAIN, V122, P2375, DOI 10.1093/brain/122.12.2375; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Maffie J, 2009, NEUROSCI LETT, V449, P189, DOI 10.1016/j.neulet.2008.10.098; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1995, NEURODEGENERATION, V4, P113; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Marionneau C, 2009, CHANNELS, V3, P284; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McHugh PC, 2012, NEUROCHEM INT, V61, P672, DOI 10.1016/j.neuint.2012.07.002; Mo HP, 2001, P NATL ACAD SCI USA, V98, P2352, DOI 10.1073/pnas.051627998; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Powell AD, 2008, J NEUROSCI, V28, P3877, DOI 10.1523/JNEUROSCI.0675-08.2008; Prestori F, 2008, J NEUROSCI, V28, P7091, DOI 10.1523/JNEUROSCI.0409-08.2008; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Rangel A, 2007, J NEUROSCI RES, V85, P2741, DOI 10.1002/jnr.21215; Ren XM, 2005, MOL CELL NEUROSCI, V29, P320, DOI 10.1016/j.mcn.2005.02.003; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Seikel E, 2009, BIOCHEMISTRY-US, V48, P5721, DOI 10.1021/bi802316m; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Watt NT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2135; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; WHITTINGTON MA, 1995, NAT GENET, V9, P197, DOI 10.1038/ng0295-197; Witzel K, 2012, NEUROPHARMACOLOGY, V63, P1389, DOI 10.1016/j.neuropharm.2012.08.017; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	76	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37241	37255		10.1074/jbc.M113.488650	http://dx.doi.org/10.1074/jbc.M113.488650			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225951	hybrid, Green Published			2022-12-28	WOS:000329189700041
J	Colvin, SC; Maier, B; Morris, DL; Tersey, SA; Mirmira, RG				Colvin, Stephanie C.; Maier, Bernhard; Morris, David L.; Tersey, Sarah A.; Mirmira, Raghavendra G.			Deoxyhypusine Synthase Promotes Differentiation and Proliferation of T Helper Type 1 (Th1) Cells in Autoimmune Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Immunology; Islet; Mouse; T Cell	ENDOPLASMIC-RETICULUM STRESS; NITRIC-OXIDE SYNTHASE; NOD MOUSE; EIF5A; INHIBITION; TRANSLATION; ACTIVATION; EXPRESSION; ONSET; INTERLEUKIN-2	Background: Deoxyhypusine synthase promotes mRNA translation by catalyzing the hypusine modification of eIF5A. Results: Inhibition of deoxyhypusine synthase reduced accumulation and proliferation of Th1 cells in type 1 diabetic mice and in vitro by reducing CD25 expression in T cells. Conclusion: Deoxyhypusine synthase promotes Th1 cell proliferation and differentiation. Significance: Inhibition of deoxyhypusine synthase may provide a novel strategy for reducing diabetogenic Th1 cells in type 1 diabetes. In type 1 diabetes, cytokines arising from immune cells cause islet cell dysfunction even before overt hyperglycemia. Deoxyhypusine synthase catalyzes the crucial hypusine modification of the factor eIF5A, which promotes the translation of a subset of mRNAs involved in cytokine responses. Here, we tested the hypothesis that deoxyhypusine synthase and, secondarily, hypusinated eIF5A contribute to the pathogenesis of type 1 diabetes using the non-obese diabetic (NOD) mouse model. Pre-diabetic NOD mice that received injections of the deoxyhypusine inhibitor N1-guanyl-1,7-diaminoheptane (GC7) demonstrated significantly improved glucose tolerance, more robust insulin secretion, and reduced insulitis compared with control animals. Analysis of tissues from treated mice revealed selective reductions in diabetogenic T helper type 1 (Th1) cells in the pancreatic lymph nodes, a primary site of antigen presentation. Isolated mouse CD90.2(+) splenocytes stimulated in vitro with anti-CD3/anti-CD28 and IL-2 to mimic autoimmune T cell activation exhibited proliferation and differentiation of CD4(+) T cell subsets (Th1, Th17, and Treg), but those treated with the deoxyhypusine synthase inhibitor GC7 showed a dose-dependent block in T cell proliferation with selective reduction in Th1 cells, similar to that observed in NOD mice. Inhibition of deoxyhypusine synthase blocked post-transcriptional expression of CD25, the high affinity IL-2 receptor chain. Our results suggest a previously unrecognized role for deoxyhypusine synthase in promoting T cell proliferation and differentiation via regulation of CD25. Inhibition of deoxyhypusine synthase may provide a strategy for reducing diabetogenic Th1 cells and preserving cell function in type 1 diabetes.	[Colvin, Stephanie C.; Maier, Bernhard; Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Colvin, Stephanie C.; Maier, Bernhard; Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Morris, David L.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Mirmira, RG (corresponding author), Indiana Univ Sch Med, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	rmirmira@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Tersey, Sarah/0000-0003-0667-2361	National Institutes of Health [R01 DK60581, F32 DK094489, F32 DK091976]; Juvenile Diabetes Research Foundation; institutional Clinical and Translational Sciences Institute KL2 award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060581, F32DK091976, F32DK094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); institutional Clinical and Translational Sciences Institute KL2 award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK60581 (to R. G. M.), F32 DK094489 (to S. C. C.), and F32 DK091976 (to D. L. M.). This work was also supported by a grant from the Juvenile Diabetes Research Foundation (to R. G. M.), an institutional Clinical and Translational Sciences Institute KL2 award (to S. A. T.), and gifts from the George and Frances Ball Foundation and the Ball Brothers Foundation (to R. G. M.).	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Berchtold S, 1999, FEBS LETT, V461, P211, DOI 10.1016/S0014-5793(99)01465-9; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Cabrera SM, 2012, CURR MOL MED, V12, P1261, DOI 10.2174/156652412803833634; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dias CAO, 2012, AMINO ACIDS, V42, P697, DOI 10.1007/s00726-011-0985-0; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Guo ZY, 2013, J IMMUNOL, V190, P3153, DOI 10.4049/jimmunol.1200751; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Keskinen P, 2002, DIABETOLOGIA, V45, P1639, DOI 10.1007/s00125-002-0981-8; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LEITER EH, 1987, AM J PATHOL, V128, P380; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Maier B, 2010, DISCOV MED, V10, P18; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Nishiki Y, 2013, MOL ENDOCRINOL, V27, P336, DOI 10.1210/me.2012-1230; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; O'Sullivan-Murphy B, 2012, DIABETES, V61, P780, DOI 10.2337/db12-0091; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; PARK MH, 1994, J BIOL CHEM, V269, P27827; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schlee M, 2004, J VIROL, V78, P3941, DOI 10.1128/JVI.78.8.3941-3952.2004; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; STRANDELL E, 1990, J CLIN INVEST, V85, P1944, DOI 10.1172/JCI114657; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494	48	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36226	36235		10.1074/jbc.M113.473942	http://dx.doi.org/10.1074/jbc.M113.473942			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196968	Green Published, hybrid			2022-12-28	WOS:000328883400005
J	Mascle, XH; Lussier-Price, M; Cappadocia, L; Estephan, P; Raiola, L; Omichinski, JG; Aubry, M				Mascle, Xavier H.; Lussier-Price, Mathieu; Cappadocia, Laurent; Estephan, Patricia; Raiola, Luca; Omichinski, James G.; Aubry, Muriel			Identification of a Non-covalent Ternary Complex Formed by PIAS1, SUMO1, and UBC9 Proteins Involved in Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioluminescence Resonance Energy Transfer (BRET); Calorimetry; Gene Regulation; Nuclear Magnetic Resonance; Phosphorylation; Protein Complexes; Sumoylation; E2 SUMO Conjugating Enzyme; E3 SUMO Ligase; SUMO Interacting Motif	UBIQUITIN-LIKE PROTEIN; RESONANCE ENERGY-TRANSFER; NUCLEAR-PORE COMPLEX; E3 LIGASE ACTIVITY; NF-KAPPA-B; CONJUGATING ENZYME; RING DOMAIN; SUBNUCLEAR LOCALIZATION; TUMOR-SUPPRESSOR; YEAST SEPTINS/	Background: Covalent coupling of SUMO by the E2 and E3 enzymes confers repression activity to transcriptional regulators. Results: Identification of a non-covalent E2SUMOE3 complex that can also function in transcriptional repression. Conclusion: SUMO participates in repression as both a covalent modification and through non-covalent interactions with E2 and E3 enzymes. Significance: Similar interaction interfaces in other ubiquitin-like proteins and their cognate enzymes suggest they form analogous ternary complexes. Post-translational modifications with ubiquitin-like proteins require three sequentially acting enzymes (E1, E2, and E3) that must unambiguously recognize each other in a coordinated fashion to achieve their functions. Although a single E2 (UBC9) and few RING-type E3s (PIAS) operate in the SUMOylation system, the molecular determinants regulating the interactions between UBC9 and the RING-type E3 enzymes are still not well defined. In this study we use biochemical and functional experiments to characterize the interactions between PIAS1 and UBC9. Our results reveal that UBC9 and PIAS1 are engaged both in a canonical E2E3 interaction as well as assembled into a previously unidentified non-covalent ternary complex with SUMO as evidenced by bioluminescence resonance energy transfer, nuclear magnetic resonance spectroscopy, and isothermal titration calorimetry studies. In this ternary complex, SUMO functions as a bridge by forming non-overlapping interfaces with UBC9 and PIAS1. Moreover, our data suggest that phosphorylation of serine residues adjacent to the PIAS1 SUMO-interacting motif favors formation of the non covalent PIAS1SUMOUBC9 ternary complex. Finally, our results also indicate that the non-covalent ternary complex is required for the known transcriptional repression activities mediated by UBC9 and SUMO1. Taken together, the data enhance our knowledge concerning the mode of interaction of enzymes of the SUMOylation machinery as well as their role in transcriptional regulation and establishes a framework for investigations of other ubiquitin-like protein systems.	[Mascle, Xavier H.; Lussier-Price, Mathieu; Cappadocia, Laurent; Estephan, Patricia; Raiola, Luca; Omichinski, James G.; Aubry, Muriel] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Omichinski, JG (corresponding author), Univ Montreal, Dept Biochim, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	jg.omichinski@umontreal.ca; muriel.aubry@umontreal.ca		Cappadocia, Laurent/0000-0001-7348-1982	Canadian Cancer Society; Canadian Institutes for Health Research [MOP-74739]; Natural Sciences and Engineering Research Council of Canada	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Canadian Cancer Society (to J. G. O.), the Canadian Institutes for Health Research (to J. G. O.; MOP-74739), and the Natural Sciences and Engineering Research Council of Canada (to M. A.).	Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bentley ML, 2011, EMBO J, V30, P3285, DOI 10.1038/emboj.2011.243; Boddy MN, 1996, ONCOGENE, V13, P971; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chen A, 1998, BIOCHEM MOL BIOL INT, V46, P1161; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Garner TP, 2011, BIOCHEMISTRY-US, V50, P9076, DOI 10.1021/bi201137e; Germain-Desprez D, 2003, J BIOL CHEM, V278, P22367, DOI 10.1074/jbc.M302234200; Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Levin I, 2010, P NATL ACAD SCI USA, V107, P2848, DOI 10.1073/pnas.0914821107; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Merrill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008794; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Okura T, 1996, J IMMUNOL, V157, P4277; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Purbeck C, 2010, BIOCHEMISTRY-US, V49, P1361, DOI 10.1021/bi9014693; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rytinki MM, 2008, J BIOL CHEM, V283, P11586, DOI 10.1074/jbc.M709359200; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schulman BA, 2011, PROTEIN SCI, V20, P1941, DOI 10.1002/pro.750; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P3168, DOI 10.1021/bi026861x; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Tolkunova E, 2007, J MOL BIOL, V374, P1200, DOI 10.1016/j.jmb.2007.09.081; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	94	16	18	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36312	36327		10.1074/jbc.M113.486845	http://dx.doi.org/10.1074/jbc.M113.486845			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24174529	hybrid, Green Published			2022-12-28	WOS:000328883400014
J	Yamamoto, H; Shikanai, T				Yamamoto, Hiroshi; Shikanai, Toshiharu			In Planta Mutagenesis of Src Homology 3 Domain-like Fold of NdhS, a Ferredoxin-binding Subunit of the Chloroplast NADH Dehydrogenase-like Complex in Arabidopsis A CONSERVED ARG-193 PLAYS A CRITICAL ROLE IN FERREDOXIN BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Chloroplast; Electron Transport; Photosynthesis; Protein-Protein Interactions	CYCLIC ELECTRON-TRANSPORT; PHOTOSYSTEM-I; RESPIRATORY COMPLEX; SUPERCOMPLEX FORMATION; EFFICIENT OPERATION; QUANTUM YIELD; FLOW; PGR5; IDENTIFICATION; FLUORESCENCE	Background: NdhS is a ferredoxin-binding subunit of chloroplast NADH dehydrogenase-like (NDH) complex. Results: Mutagenesis of the Src homology 3-like domain of NdhS revealed that its positively charged pocket is required for high affinity binding of ferredoxin. Conclusion: The positive charge of Arg-193 plays a critical role in electrostatic interaction with ferredoxin. Significance: Our results provide insights into the evolution of the electron input module of chloroplast NDH. Chloroplast NADH dehydrogenase-like (NDH) complex mediates cyclic electron transport around photosystem I and chlororespiration in angiosperms. The Src homology 3 domain (SH3)-like fold protein NdhS/CRR31 is an NDH subunit that is necessary for high affinity binding of ferredoxin, indicating that chloroplast NDH functions as a ferredoxin:plastoquinone oxidoreductase. However, the mechanism of the interaction between NdhS and ferredoxin is unclear. In this study, we analyzed their interaction in planta by using site-directed mutagenesis of NdhS. In general, binding of ferredoxin to its target proteins depends on electrostatic interaction. In silico analysis predicted the presence of a positively charged pocket in the SH3-like domain of NdhS, where nine charged residues are highly conserved among plants. Systematic alteration of these sites with neutral glutamine revealed that only arginine 193 was required for high NDH activity in vivo. Further replacement of arginine 193 with negatively charged aspartate or glutamate or hydrophobic alanine significantly decreased the efficiency of ferredoxin-dependent plastoquinone reduction by NDH in ruptured chloroplasts. Similar results were obtained in in vivo analyses of NDH activity and electron transport. From these results, we propose that the positive charge of arginine 193 in the SH3-like domain of NdhS is critical for electrostatic interaction with ferredoxin in vivo.	[Yamamoto, Hiroshi; Shikanai, Toshiharu] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Yamamoto, Hiroshi; Shikanai, Toshiharu] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Shikanai, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan.	shikanai@pmg.bot.kyoto-u.ac.jp	Shikanai, Toshiharu/AAK-9112-2020	Yamamoto, Hiroshi/0000-0002-1739-1226	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22114509, 22247005]; Grants-in-Aid for Scientific Research [25251032] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants 22114509 and 22247005 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akashi T, 1999, J BIOL CHEM, V274, P29399, DOI 10.1074/jbc.274.41.29399; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Barth P, 1998, BIOCHEMISTRY-US, V37, P16233, DOI 10.1021/bi981379t; Barth P, 2000, J BIOL CHEM, V275, P7030, DOI 10.1074/jbc.275.10.7030; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Finel M, 1998, TRENDS BIOCHEM SCI, V23, P412, DOI 10.1016/S0968-0004(98)01276-6; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Hase Toshiharu, 2006, V24, P477; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hertle AP, 2013, MOL CELL, V49, P511, DOI 10.1016/j.molcel.2012.11.030; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Kishan KVR, 2005, CURR PROTEIN PEPT SC, V6, P143, DOI 10.2174/1389203053545444; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; MATSUBAYASHI T, 1987, MOL GEN GENET, V210, P385, DOI 10.1007/BF00327187; Miyake C, 2009, PLANT CELL PHYSIOL, V50, P730, DOI 10.1093/pcp/pcp032; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Okegawa Y, 2008, PLANT CELL PHYSIOL, V49, P825, DOI 10.1093/pcp/pcn055; Peng LW, 2011, PLANT PHYSIOL, V155, P1629, DOI 10.1104/pp.110.171264; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Sugimoto K, 2013, PLANT CELL PHYSIOL, V54, P1525, DOI 10.1093/pcp/pct098; Suorsa M, 2012, PLANT CELL, V24, P2934, DOI 10.1105/tpc.112.097162; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Weerakoon DR, 2008, J BACTERIOL, V190, P915, DOI 10.1128/JB.01647-07; XU Q, 1994, J BIOL CHEM, V269, P21512; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; YU L, 1993, PLANT PHYSIOL, V103, P171, DOI 10.1104/pp.103.1.171	46	50	53	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36328	36337		10.1074/jbc.M113.511584	http://dx.doi.org/10.1074/jbc.M113.511584			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24225949	Green Published, hybrid			2022-12-28	WOS:000328883400015
J	Du, JH; Cleghorn, WM; Contreras, L; Lindsay, K; Rountree, AM; Chertov, AO; Turner, SJ; Sahaboglu, A; Linton, J; Sadilek, M; Satrustegui, J; Sweet, IR; Paquet-Durand, F; Hurley, JB				Du, Jianhai; Cleghorn, Whitney M.; Contreras, Laura; Lindsay, Ken; Rountree, Austin M.; Chertov, Andrei O.; Turner, Sally J.; Sahaboglu, Ayse; Linton, Jonathan; Sadilek, Martin; Satrustegui, Jorgina; Sweet, Ian R.; Paquet-Durand, Franois; Hurley, James B.			Inhibition of Mitochondrial Pyruvate Transport by Zaprinast Causes Massive Accumulation of Aspartate at the Expense of Glutamate in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aspartate; Glutamate; Metabolism; Phosphodiesterases; Pyruvate; Retina	CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; MICE LACKING; BETA-SUBUNIT; AMINO-ACIDS; DEGENERATION; IDENTIFICATION; CHANNELS; GLUCOSE; SPECIFICITY; ACTIVATION	Background: Pyruvate transport into mitochondria is a key step in energy metabolism. Zaprinast is a well known phosphodiesterase inhibitor. Results: Zaprinast has a strong influence on pyruvate transport into mitochondria. Conclusion: Inhibition of the mitochondrial pyruvate carrier by Zaprinast causes accumulation of aspartate at the expense of glutamate. Significance: Maintenance of normal amino acid levels in the retina relies on pyruvate transport into mitochondria. Transport of pyruvate into mitochondria by the mitochondrial pyruvate carrier is crucial for complete oxidation of glucose and for biosynthesis of amino acids and lipids. Zaprinast is a well known phosphodiesterase inhibitor and lead compound for sildenafil. We found Zaprinast alters the metabolomic profile of mitochondrial intermediates and amino acids in retina and brain. This metabolic effect of Zaprinast does not depend on inhibition of phosphodiesterase activity. By providing C-13-labeled glucose and glutamine as fuels, we found that the metabolic profile of the Zaprinast effect is nearly identical to that of inhibitors of the mitochondrial pyruvate carrier. Both stimulate oxidation of glutamate and massive accumulation of aspartate. Moreover, Zaprinast inhibits pyruvate-driven O-2 consumption in brain mitochondria and blocks mitochondrial pyruvate carrier in liver mitochondria. Inactivation of the aspartate glutamate carrier in retina does not attenuate the metabolic effect of Zaprinast. Our results show that Zaprinast is a potent inhibitor of mitochondrial pyruvate carrier activity, and this action causes aspartate to accumulate at the expense of glutamate. Our findings show that Zaprinast is a specific mitochondrial pyruvate carrier (MPC) inhibitor and may help to elucidate the roles of MPC in amino acid metabolism and hypoglycemia.	[Du, Jianhai; Cleghorn, Whitney M.; Lindsay, Ken; Chertov, Andrei O.; Turner, Sally J.; Linton, Jonathan; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Rountree, Austin M.; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98195 USA; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Contreras, Laura; Satrustegui, Jorgina] Univ Autonoma Madrid, Consejo Super Invest Cient, CIBER Rare Dis CIBERER, Ctr Mol Biol Severo Ochoa,Dept Mol Biol, E-28049 Madrid, Spain; [Contreras, Laura; Satrustegui, Jorgina] Autonomous Univ Madrid, Fdn Jimenez Diaz, Hlth Res Inst, E-28049 Madrid, Spain; [Sahaboglu, Ayse; Paquet-Durand, Franois] Ctr Ophthalmol, Inst Ophthalm Res, Div Expt Ophthalmol, D-72076 Tubingen, Germany	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	jbhhh@u.washington.edu	Du, Jianhai/J-6197-2014; Contreras, Laura/A-2296-2015; Paquet-Durand, Francois/G-6709-2015; Satrustegui, Jorgina/R-6732-2019; Contreras, Laura/ABG-7620-2021	Du, Jianhai/0000-0002-5612-4091; Paquet-Durand, Francois/0000-0001-7355-5742; Contreras, Laura/0000-0003-1157-4942; Sahaboglu, Ayse/0000-0003-3241-0672; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667	National Institutes of Health [P30DK017047]; NATIONAL EYE INSTITUTE [F32EY006641, R01EY017863, R01EY006641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Cngb1<SUP>-/-</SUP> mice were kindly provided by Stylianos Michalakis and Martin Biel, Center for Integrated Protein Science CIPS-M and Department of Pharmacy, Ludwig-Maximilians Universitat Munchen. Oxygen consumption and pyruvate uptake experiments were carried out by Diabetes Research Center Cell Function Analysis Core (National Institutes of Health Grant P30DK017047).	Biel Martin, 2009, V191, P111, DOI 10.1007/978-3-540-68964-5_7; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brivet M, 2003, MOL GENET METAB, V78, P186, DOI 10.1016/S1096-7192(03)00016-7; BUTTERWORTH RF, 1982, J NEUROCHEM, V38, P1483, DOI 10.1111/j.1471-4159.1982.tb07929.x; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gibson A, 2001, EUR J PHARMACOL, V411, P1, DOI 10.1016/S0014-2999(00)00824-4; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Guo JA, 2008, J PHARMACOL EXP THER, V324, P342, DOI 10.1124/jpet.107.127266; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Janke R, 2010, BIOTECHNOL BIOENG, V107, P566, DOI 10.1002/bit.22817; LaNoue KF, 2001, J NEUROSCI RES, V66, P914, DOI 10.1002/jnr.10064; Mackenzie A E, 2011, Front Endocrinol (Lausanne), V2, P68, DOI 10.3389/fendo.2011.00068; de la Camara CMF, 2013, EXP EYE RES, V111, P122, DOI 10.1016/j.exer.2013.03.015; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Pardo B, 2011, J CEREBR BLOOD F MET, V31, P90, DOI 10.1038/jcbfm.2010.146; Peng L, 2007, J NEUROSCI RES, V85, P3480, DOI 10.1002/jnr.21262; PROUDLOVE MO, 1987, BIOCHEM J, V247, P441, DOI 10.1042/bj2470441; ROMIJN HJ, 1988, BIOL CELL, V63, P263, DOI 10.1016/0248-4900(88)90116-5; Sahaboglu A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.12; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; SANDBERG M, 1985, J NEUROSCI RES, V13, P489, DOI 10.1002/jnr.490130403; Sweet IR, 2004, BIOCHEM BIOPH RES CO, V314, P976, DOI 10.1016/j.bbrc.2003.12.182; SZERB JC, 1987, SYNAPSE, V1, P265, DOI 10.1002/syn.890010308; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; THOMPSON WJ, 1991, PHARMACOL THERAPEUT, V51, P13, DOI 10.1016/0163-7258(91)90039-O; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; Vallazza-Deschamps G, 2005, EUR J NEUROSCI, V22, P1013, DOI 10.1111/j.1460-9568.2005.04306.x; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	49	49	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36129	36140		10.1074/jbc.M113.507285	http://dx.doi.org/10.1074/jbc.M113.507285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187136	Green Published, hybrid			2022-12-28	WOS:000329814700047
J	Hartmann, T; Zhang, B; Baronian, G; Schulthess, B; Homerova, D; Grubmuller, S; Kutzner, E; Gaupp, R; Bertram, R; Powers, R; Eisenreich, W; Kormanec, J; Herrmann, M; Molle, V; Somerville, GA; Bischoff, M				Hartmann, Torsten; Zhang, Bo; Baronian, Gregory; Schulthess, Bettina; Homerova, Dagmar; Grubmueller, Stephanie; Kutzner, Erika; Gaupp, Rosmarie; Bertram, Ralph; Powers, Robert; Eisenreich, Wolfgang; Kormanec, Jan; Herrmann, Mathias; Molle, Virginie; Somerville, Greg A.; Bischoff, Markus			Catabolite Control Protein E (CcpE) Is a LysR-type Transcriptional Regulator of Tricarboxylic Acid Cycle Activity in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Metabolic Regulation; Staphylococcus aureus; Transcription Regulation; Tricarboxylic Acid (TCA) Cycle	GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; VIRULENCE GENES; REPRESSION; ACONITASE; IDENTIFICATION; GROWTH; INACTIVATION; METABOLISM; ACTIVATION	Background: The TCA cycle is a central metabolic pathway that facilitates the adaption of bacteria to a nutrient-limited environment. Results: Inactivation of CcpE in Staphylococcus aureus resulted in a decreased transcription of the aconitase encoding gene citB, and reduced TCA cycle activity. Conclusion: CcpE affects the TCA cycle via direct transcriptional control of citB.Significance: This is the first positive regulator of TCA cycle activity identified in this pathogen. The tricarboxylic acid cycle (TCA cycle) is a central metabolic pathway that provides energy, reducing potential, and biosynthetic intermediates. In Staphylococcus aureus, TCA cycle activity is controlled by several regulators (e.g. CcpA, CodY, and RpiRc) in response to the availability of sugars, amino acids, and environmental stress. Developing a bioinformatic search for additional carbon catabolite-responsive regulators in S. aureus, we identified a LysR-type regulator, catabolite control protein E (CcpE), with homology to the Bacillus subtilis CcpC regulator. Inactivation of ccpE in S. aureus strain Newman revealed that CcpE is a positive transcriptional effector of the first two enzymes of the TCA cycle, aconitase (citB) and to a lesser extent citrate synthase (citZ). Consistent with the transcriptional data, aconitase activity dramatically decreased in the ccpE mutant relative to the wild-type strain. The effect of ccpE inactivation on citB transcription and the lesser effect on citZ transcription were also reflected in electrophoretic mobility shift assays where CcpE bound to the citB promoter but not the citZ promoter. Metabolomic studies showed that inactivation of ccpE resulted in increased intracellular concentrations of acetate, citrate, lactate, and alanine, consistent with a redirection of carbon away from the TCA cycle. Taken together, our data suggest that CcpE is a major direct positive regulator of the TCA cycle gene citB.	[Hartmann, Torsten; Herrmann, Mathias; Bischoff, Markus] Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany; [Zhang, Bo; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68583 USA; [Gaupp, Rosmarie; Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Baronian, Gregory; Molle, Virginie] Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34090 Montpellier, France; [Schulthess, Bettina] Univ Zurich, Inst Med Microbiol, CH-8006 Zurich, Switzerland; [Homerova, Dagmar; Kormanec, Jan] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia; [Grubmueller, Stephanie; Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Dept Biochem, D-85748 Garching, Germany; [Bertram, Ralph] Univ Tubingen, Dept Microbial Genet, D-72076 Tubingen, Germany	Universitatsklinikum des Saarlandes; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Zurich; Slovak Academy of Sciences; Technical University of Munich; Eberhard Karls University of Tubingen	Bischoff, M (corresponding author), Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany.	markus.bischoff@uniklinikum-saarland.de	Eisenreich, Wolfgang/A-1258-2013; Schulthess, Bettina/ABA-8795-2021; Bischoff, Markus/D-2130-2014; MOLLE, Virginie/D-4050-2019; Somerville, Greg A/B-1326-2013; Powers, Robert/AAK-3431-2020; Kormanec, Jan/AAA-7446-2019; Herrmann, Mathias/B-6475-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Schulthess, Bettina/0000-0002-1562-4583; Bischoff, Markus/0000-0001-6734-2732; MOLLE, Virginie/0000-0002-6573-3411; Somerville, Greg A/0000-0002-0991-8737; Powers, Robert/0000-0001-9948-6837; Herrmann, Mathias/0000-0003-2638-2257; Kormanec, Jan/0000-0003-0377-6413; Zhang, Bo/0000-0001-8858-1425	National Institutes of Health [AI087668]; Deutsche Forschungsgemeinschaft (DFG) [BI 1350/1-1, BI 1350/1-2, BE 4038/1, BE 4038/2, EI-384/5-1, EI-384/5-2]; region Languedoc-Roussillon-Chercheur d'Avenir grant; Swiss National Science Foundation [31-117707]; Slovak Academy of Sciences [2/0028/12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); region Languedoc-Roussillon-Chercheur d'Avenir grant(Region Occitanie); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Slovak Academy of Sciences(Slovak Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI087668 (to G. A. S. and R. P.) and Grants BI 1350/1-1 and BI 1350/1-2 from the Deutsche Forschungsgemeinschaft (DFG).; Supported by the region Languedoc-Roussillon-Chercheur d'Avenir grant.; Supported by Swiss National Science Foundation Grant 31-117707.; Supported by Grant 2/0028/12 from the Slovak Academy of Sciences.; Supported by DFG Grants BE 4038/1 and BE 4038/2.; Supported by the DFG Grants EI-384/5-1 and EI-384/5-2.	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; CHEUNG AL, 1994, ANAL BIOCHEM, V222, P511, DOI 10.1006/abio.1994.1528; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deora R, 1996, J BIOL CHEM, V271, P21828, DOI 10.1074/jbc.271.36.21828; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DUTHIE ES, 1952, J GEN MICROBIOL, V7, P320, DOI 10.1099/00221287-7-3-4-320; Fiegler H, 1999, J BACTERIOL, V181, P4929, DOI 10.1128/JB.181.16.4929-4936.1999; FOUET A, 1990, J BACTERIOL, V172, P835, DOI 10.1128/jb.172.2.835-844.1990; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Halouska S, 2006, J MAGN RESON, V178, P88, DOI 10.1016/j.jmr.2005.08.016; Halouska S., 2013, J INTEGR OMICS, DOI 10.5584/jiomics.v2013i2013.139; Hu KF, 2011, J AM CHEM SOC, V133, P1662, DOI 10.1021/ja1095304; JIN SF, 1994, J BACTERIOL, V176, P4680, DOI 10.1128/JB.176.15.4680-4690.1994; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jourlin-Castelli C, 2000, J MOL BIOL, V295, P865, DOI 10.1006/jmbi.1999.3420; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim HJ, 2003, J BACTERIOL, V185, P1672, DOI 10.1128/JB.185.5.1672-1680.2003; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Leibig M, 2008, APPL ENVIRON MICROB, V74, P1316, DOI 10.1128/AEM.02424-07; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Nguyen BD, 2007, J MAGN RESON, V184, P263, DOI 10.1016/j.jmr.2006.10.014; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Rossi J, 2003, ANTIMICROB AGENTS CH, V47, P2558, DOI 10.1128/AAC.47.8.2558-2564.2003; Sadykov MR, 2010, J BACTERIOL, V192, P1459, DOI 10.1128/JB.01377-09; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Somerville G. A., 2009, STAPHYLOCOCCI HUMAN, V3-18; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; STRASTERS KC, 1963, J GEN MICROBIOL, V33, P213, DOI 10.1099/00221287-33-2-213; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Valihrach L, 2012, J MICROBIOL METH, V90, P214, DOI 10.1016/j.mimet.2012.05.008; Werth MT, 2010, ANAL BIOCHEM, V399, P58, DOI 10.1016/j.ab.2009.12.022; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Worley B, 2013, ANAL BIOCHEM, V433, P102, DOI 10.1016/j.ab.2012.10.011; Zhang B, 2011, J PROTEOME RES, V10, P3743, DOI 10.1021/pr200360w; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	59	28	29	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36116	36128		10.1074/jbc.M113.516302	http://dx.doi.org/10.1074/jbc.M113.516302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24194525	hybrid, Green Published			2022-12-28	WOS:000329814700046
J	Seldin, MM; Lei, X; Tan, SY; Stanson, KP; Wei, ZK; Wong, GW				Seldin, Marcus M.; Lei, Xia; Tan, Stefanie Y.; Stanson, Kevin P.; Wei, Zhikui; Wong, G. William			Skeletal Muscle-derived Myonectin Activates the Mammalian Target of Rapamycin (mTOR) Pathway to Suppress Autophagy in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Liver; Liver Metabolism; mTOR; Skeletal Muscle	IN-VIVO; ADIPOSE-TISSUE; AMINO-ACIDS; CELL-DEATH; GLUCOSE; MICE; PROTEOLYSIS; METABOLISM; DEPRIVATION; HOMEOSTASIS	Background: Liver autophagy is dynamically regulated in fed and fasted states. Results: Myonectin is secreted by skeletal muscle in response to nutrient availability, and it activates the mTOR signaling pathway to suppress autophagy in liver. Conclusion: Myonectin is a novel regulator of liver autophagy. Significance: Myonectin mediates muscle-liver cross-talk to control energy balance. Cells turn on autophagy, an intracellular recycling pathway, when deprived of nutrients. How autophagy is regulated by hormonal signals in response to major changes in metabolic state is not well understood. Here, we provide evidence that myonectin (CTRP15), a skeletal muscle-derived myokine, is a novel regulator of cellular autophagy. Starvation activated liver autophagy, whereas nutrient supplementation following food deprivation suppressed it; the former and latter correlated with reduced and increased expression and circulating levels of myonectin, respectively, suggestive of a causal link. Indeed, recombinant myonectin administration suppressed starvation-induced autophagy in mouse liver and cultured hepatocytes, as indicated by the inhibition of LC3-dependent autophagosome formation, p62 degradation, and expression of critical autophagy-related genes. Reduction in protein degradation is mediated by the PI3K/Akt/mTOR signaling pathway; inhibition of this pathway abrogated the ability of myonectin to suppress autophagy in cultured hepatocytes. Together, our results reveal a novel skeletal muscle-liver axis controlling cellular autophagy, underscoring the importance of hormone-mediated tissue cross-talk in maintaining energy homeostasis.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu		Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.).; Supported by a postdoctoral grant from the American Heart Association.; Supported by a predoctoral grant from the American Heart Association.	Addis T, 1936, J BIOL CHEM, V115, P111; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Byerly M. S., 2013, PLOS ONE, V8; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kotoulas OB, 2004, MICROSC RES TECHNIQ, V64, P10, DOI 10.1002/jemt.20046; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; TOKUYAMA K, 1982, PHYSIOL BEHAV, V28, P899, DOI 10.1016/0031-9384(82)90211-6; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	49	73	78	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36073	36082		10.1074/jbc.M113.500736	http://dx.doi.org/10.1074/jbc.M113.500736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187137	Green Published, hybrid			2022-12-28	WOS:000329814700042
J	Aihara, E; Hentz, CL; Korman, AM; Perry, NPJ; Prasad, V; Shull, GE; Montrose, MH				Aihara, Eitaro; Hentz, Courtney L.; Korman, Abraham M.; Perry, Nicholas P. J.; Prasad, Vikram; Shull, Gary E.; Montrose, Marshall H.			In Vivo Epithelial Wound Repair Requires Mobilization of Endogenous Intracellular and Extracellular Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Imaging; Calcium Signaling; Cell Migration; Fluorescence Resonance Energy Transfer (FRET); Fura Red; Yellow Cameleon; Photodamage; Two-photon Microscopy	PLASMA-MEMBRANE CA2+-ATPASE; BICARBONATE SECRETION; ACID-SECRETION; ISOFORM 4; CA2+; MOUSE; CELLS; HOMEOSTASIS; DISRUPTION; TRANSPORT	We report that a localized intracellular and extracellular Ca2+ mobilization occurs at the site of microscopic epithelial damage in vivo and is required to mediate tissue repair. Intravital confocal/two-photon microscopy continuously imaged the surgically exposed stomach mucosa of anesthetized mice while photodamage of gastric epithelial surface cells created a microscopic lesion that healed within 15 min. Transgenic mice with an intracellular Ca2+-sensitive protein (yellow cameleon 3.0) report that intracellular Ca2+ selectively increases in restituting gastric epithelial cells adjacent to the damaged cells. Pretreatment with U-73122, indomethacin, 2-aminoethoxydiphenylborane, or verapamil inhibits repair of the damage and also inhibits the intracellular Ca2+ increase. Confocal imaging of Fura-Red dye in luminal superfusate shows a localized extracellular Ca2+ increase at the gastric surface adjacent to the damage that temporally follows intracellular Ca2+ mobilization. Indomethacin and verapamil also inhibit the luminal Ca2+ increase. Intracellular Ca2+ chelation (1,2-bis(o-aminophenoxy)ethane-N,N,N,N-tetraacetic acid/acetoxymethyl ester, BAPTA/AM) fully inhibits intracellular and luminal Ca2+ increases, whereas luminal calcium chelation (N-(2-hydroxyetheyl)-ethylendiamin-N,N,N-triacetic acid trisodium, HEDTA) blocks the increase of luminal Ca2+ and unevenly inhibits late-phase intracellular Ca2+ mobilization. Both modes of Ca2+ chelation slow gastric repair. In plasma membrane Ca-ATPase 1(+/-) mice, but not plasma membrane Ca-ATPase 4(-/-) mice, there is slowed epithelial repair and a diminished gastric surface Ca2+ increase. We conclude that endogenous Ca2+, mobilized by signaling pathways and transmembrane Ca2+ transport, causes increased Ca2+ levels at the epithelial damage site that are essential to gastric epithelial cell restitution in vivo.	[Aihara, Eitaro; Hentz, Courtney L.; Korman, Abraham M.; Perry, Nicholas P. J.; Montrose, Marshall H.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA; [Prasad, Vikram; Shull, Gary E.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Cincinnati; University of Cincinnati	Montrose, MH (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, ML 0576,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	mhm@uc.edu			National Institutes of Health [RO1-DK-54940, R01-DK050594, P30-DK078392]; University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050594, P30DK078392, R01DK054940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-DK-54940 (to M. H. M.), R01-DK050594 (to G. E. S.), and P30-DK078392. This work was also supported by university research council funding from the University of Cincinnati (to E. A.).	ALLEN A, 1993, PHYSIOL REV, V73, P823, DOI 10.1152/physrev.1993.73.4.823; Baumgartner HK, 2002, J PHYSIOL-LONDON, V544, P871, DOI 10.1113/jphysiol.2002.024620; Belkacemi L, 2005, CELL CALCIUM, V37, P1, DOI 10.1016/j.ceca.2004.06.010; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Caroppo R, 2004, J CELL BIOL, V166, P111, DOI 10.1083/jcb.200310145; Caroppo R, 2001, EMBO J, V20, P6316, DOI 10.1093/emboj/20.22.6316; Cheng AM, 2001, AM J PHYSIOL-CELL PH, V281, pC430, DOI 10.1152/ajpcell.2001.281.2.C430; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; CRITCHLOW J, 1985, GASTROENTEROLOGY, V88, P236, DOI 10.1016/S0016-5085(85)80177-3; deFoneska A, 2010, CURR OPIN GASTROEN, V26, P604, DOI 10.1097/MOG.0b013e32833f1222; DelValle J, 1996, AM J PHYSIOL-GASTR L, V270, pG897, DOI 10.1152/ajpgi.1996.270.6.G897; Demitrack ES, 2012, GUT, V61, P804, DOI 10.1136/gutjnl-2011-300420; Demitrack ES, 2010, AM J PHYSIOL-GASTR L, V299, pG255, DOI 10.1152/ajpgi.00037.2010; Dong X, 2009, AM J PHYSIOL-GASTR L, V296, pG424, DOI 10.1152/ajpgi.90314.2008; Dreval V, 2005, CELL PHYSIOL BIOCHEM, V16, P119, DOI 10.1159/000087738; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705; Hou CF, 2004, J PHARMACOL EXP THER, V309, P697, DOI 10.1124/jpet.103.060574; Ishihara T, 2010, BIOCHEM PHARMACOL, V79, P1622, DOI 10.1016/j.bcp.2010.01.030; KOO MWL, 1994, PHARMACOL RES, V29, P217, DOI 10.1016/1043-6618(94)80045-6; Lindstrom E, 2001, J PHYSIOL-LONDON, V535, P663, DOI 10.1111/j.1469-7793.2001.00663.x; Liu L, 2006, AM J PHYSIOL-CELL PH, V290, pC1239, DOI 10.1152/ajpcell.00440.2005; Liu L, 2007, AM J PHYSIOL-CELL PH, V292, pC423, DOI 10.1152/ajpcell.00313.2006; Lohr C, 2003, CELL CALCIUM, V34, P295, DOI 10.1016/S0143-4160(03)00105-2; Miller TA, 2001, LIFE SCI, V69, P3091, DOI 10.1016/S0024-3205(01)01415-1; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; NEGULESCU PA, 1993, AM J PHYSIOL, V264, pC843, DOI 10.1152/ajpcell.1993.264.4.C843; Nyqvist D, 2005, J ENDOCRINOL, V186, P333, DOI 10.1677/joe.1.06204; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Peng T, 2008, CARDIOVASC RES, V78, P90, DOI 10.1093/cvr/cvm100; Prasad V, 2007, ANN NY ACAD SCI, V1099, P276, DOI 10.1196/annals.1387.029; Ranta-Knuuttila T, 2002, DIGEST DIS SCI, V47, P1008, DOI 10.1023/A:1015025704589; Ray JM, 1997, AM J PHYSIOL-GASTR L, V273, pG281, DOI 10.1152/ajpgi.1997.273.2.G281; Shi TJS, 2008, P NATL ACAD SCI USA, V105, P20004, DOI 10.1073/pnas.0810899105; Starodub OT, 2008, AM J PHYSIOL-CELL PH, V294, pC223, DOI 10.1152/ajpcell.00395.2006; Takeuchi K, 1997, GASTROENTEROLOGY, V113, P1553, DOI 10.1053/gast.1997.v113.pm9352857; TAKEUCHI K, 1985, DIGEST DIS SCI, V30, P1072, DOI 10.1007/BF01315605; Takeuchi K, 1999, DIGEST DIS SCI, V44, P515, DOI 10.1023/A:1026645004918; Talarico EF, 2010, MOL VIS, V16, P2259; Tsien Roger Y, 2003, Harvey Lect, V99, P77; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Xue L, 2010, GUT, V59, P1184, DOI 10.1136/gut.2009.205625	43	23	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33585	33597		10.1074/jbc.M113.488098	http://dx.doi.org/10.1074/jbc.M113.488098			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121509	Green Published, hybrid			2022-12-28	WOS:000327250200008
J	Schiebel, J; Kapilashrami, K; Fekete, A; Bommineni, GR; Schaefer, CM; Mueller, MJ; Tonge, PJ; Kisker, C				Schiebel, Johannes; Kapilashrami, Kanishk; Fekete, Agnes; Bommineni, Gopal R.; Schaefer, Christin M.; Mueller, Martin J.; Tonge, Peter J.; Kisker, Caroline			Structural Basis for the Recognition of Mycolic Acid Precursors by KasA, a Condensing Enzyme and Drug Target from Mycobacterium Tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Mechanisms; Enzyme Structure; Lipid Synthesis; Mycobacterium tuberculosis; Phospholipid; KasA; Condensing Enzyme; Enzyme Dynamics; Induced Fit Substrate Recognition	ACYL CARRIER PROTEIN; FATTY-ACIDS; POSITIONAL DISTRIBUTION; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; RESIDENCE TIME; SYNTHASE-II; INHIBITOR; THIOLACTOMYCIN; BIOSYNTHESIS	Background: Although induced fit binding is central to molecular recognition, in most cases, the structural basis for this process remains to be elucidated. Results: We determined structural snapshots along the substrate binding reaction coordinate for the drug target Mycobacterium tuberculosis KasA. Conclusion: KasA binds acyl substrates via the induced fit concerted opening of a hydrophobic cavity. Significance: Improved understanding of induced fit binding is crucial for inhibitor design. The survival of Mycobacterium tuberculosis depends on mycolic acids, very long -alkyl--hydroxy fatty acids comprising 60-90 carbon atoms. However, despite considerable efforts, little is known about how enzymes involved in mycolic acid biosynthesis recognize and bind their hydrophobic fatty acyl substrates. The condensing enzyme KasA is pivotal for the synthesis of very long (C38-42) fatty acids, the precursors of mycolic acids. To probe the mechanism of substrate and inhibitor recognition by KasA, we determined the structure of this protein in complex with a mycobacterial phospholipid and with several thiolactomycin derivatives that were designed as substrate analogs. Our structures provide consecutive snapshots along the reaction coordinate for the enzyme-catalyzed reaction and support an induced fit mechanism in which a wide cavity is established through the concerted opening of three gatekeeping residues and several -helices. The stepwise characterization of the binding process provides mechanistic insights into the induced fit recognition in this system and serves as an excellent foundation for the development of high affinity KasA inhibitors.	[Schiebel, Johannes; Schaefer, Christin M.; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Schiebel, Johannes] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany; [Kapilashrami, Kanishk; Bommineni, Gopal R.; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Fekete, Agnes; Mueller, Martin J.] Univ Wurzburg, Dept Pharmaceut Biol, Bioctr, Julius von Sachs Inst Biosci, D-97082 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Kisker, C (corresponding author), Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany.	caroline.kisker@virchow.uni-wuerzburg.de	mueller, martin j/C-7616-2019; Fekete, Agnes/C-8048-2019; Tonge, Peter J/A-7443-2009	Fekete, Agnes/0000-0003-3058-7570; Tonge, Peter J/0000-0003-1606-3471; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [GM102864]; Deutsche Forschungsgemeinschaft [SFB630]; Forschungszentrum [FZ82]; German Excellence Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungszentrum; German Excellence Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102864 (to P.J.T.). This work was also supported by Deutsche Forschungsgemeinschaft SFB630 and Forschungszentrum FZ82 (to C.K.).; Supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg.	Alhamadsheh MM, 2007, CHEM BIOL, V14, P513, DOI 10.1016/j.chembiol.2007.03.013; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Borgaro JG, 2011, BIOCHEMISTRY-US, V50, P10678, DOI 10.1021/bi201199x; Brown MS, 2003, J AM CHEM SOC, V125, P10166, DOI 10.1021/ja034540i; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; Choi KH, 2000, J BIOL CHEM, V275, P28201; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fieulaine S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001066; FRENCH GL, 1987, LANCET, V2, P117; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kapilashrami K, 2013, J BIOL CHEM, V288, P6045, DOI 10.1074/jbc.M112.414516; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Lee W, 2011, BIOCHEMISTRY-US, V50, P5743, DOI 10.1021/bi200006t; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; LI Y, 1990, J ORG CHEM, V55, P481, DOI 10.1021/jo00289a020; Lu C., 2012, PLOS ONE, V7; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; Machutta CA, 2010, J BIOL CHEM, V285, P6161, DOI 10.1074/jbc.M109.077909; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFadden JM, 2005, J MED CHEM, V48, P946, DOI 10.1021/jm049389h; McFadden JM, 2002, ORG LETT, V4, P3859, DOI 10.1021/ol026685k; Milletti F, 2007, J CHEM INF MODEL, V47, P2172, DOI 10.1021/ci700018y; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; Muller P, 2003, ACTA CRYSTALLOGR D, V59, P32, DOI 10.1107/S0907444902018000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OKUYAMA H, 1967, J BIOCHEM-TOKYO, V61, P732, DOI 10.1093/oxfordjournals.jbchem.a128607; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Price AC, 2003, J BACTERIOL, V185, P4136, DOI 10.1128/JB.185.14.4136-4143.2003; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Qiu XY, 2001, J MOL BIOL, V307, P341, DOI 10.1006/jmbi.2000.4457; Richard JP, 2013, BIOCHEMISTRY-US, V52, P2009, DOI 10.1021/bi3017119; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sachdeva S, 2008, CHEM BIOL, V15, P402, DOI 10.1016/j.chembiol.2008.03.007; Schaefer B, 2011, J COMPUT AID MOL DES, V25, P1053, DOI 10.1007/s10822-011-9483-4; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schramm VL, 2011, ANNU REV BIOCHEM, V80, P703, DOI 10.1146/annurev-biochem-061809-100742; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Sridharan S, 2007, J MOL BIOL, V366, P469, DOI 10.1016/j.jmb.2006.11.006; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Swanson S, 2009, STRUCTURE, V17, P914, DOI 10.1016/j.str.2009.06.006; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; von Wettstein-Knowles P, 2006, FEBS J, V273, P695, DOI 10.1111/j.1742-4658.2005.05101.x; WALKER RW, 1970, LIPIDS, V5, P684, DOI 10.1007/BF02531435; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wilmouth RC, 1997, NAT STRUCT BIOL, V4, P456, DOI 10.1038/nsb0697-456; Witkowski A, 2002, BIOCHEMISTRY-US, V41, P10877, DOI 10.1021/bi0259047; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Zhang HN, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P231; Zhang YM, 2006, J BIOL CHEM, V281, P17390, DOI 10.1074/jbc.M513199200	66	27	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34190	34204		10.1074/jbc.M113.511436	http://dx.doi.org/10.1074/jbc.M113.511436			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108128	hybrid, Green Published			2022-12-28	WOS:000327250200062
J	Yang, FC; Lin, YH; Chen, WH; Huang, JY; Chang, HY; Su, SH; Wang, HT; Chiang, CY; Hsu, PH; Tsai, MD; Tan, BCM; Lee, SC				Yang, Fu-Chia; Lin, Ya-Huei; Chen, Wei-Hao; Huang, Jing-Yi; Chang, Hsin-Yun; Su, Su-Hui; Wang, Hsiao-Ting; Chiang, Chun-Yi; Hsu, Pang-Hung; Tsai, Ming-Daw; Tan, Bertrand Chin-Ming; Lee, Sheng-Chung			Interaction between Salt-inducible Kinase 2 (SIK2) and p97/Valosin-containing Protein (VCP) Regulates Endoplasmic Reticulum (ER)-associated Protein Degradation in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ER Stress; ER-associated Degradation; ERAD; Protein Degradation; Unfolded Protein Response; SIK2; p97; VCP	VALOSIN-CONTAINING-PROTEIN; ER-ASSOCIATED DEGRADATION; TYROSINE PHOSPHORYLATION; P97-UFD1-NPL4 COMPLEX; INCREASED EXPRESSION; P97; INVOLVEMENT; PROTEASOME; ATPASE; TRANSCRIPTION	Salt-inducible kinase 2 (SIK2) is an important regulator of cAMP response element-binding protein-mediated gene expression in various cell types and is the only AMP-activated protein kinase family member known to interact with the p97/valosin-containing protein (VCP) ATPase. Previously, we have demonstrated that SIK2 can regulate autophagy when proteasomal function is compromised. Here we report that physical and functional interactions between SIK2 and p97/VCP underlie the regulation of endoplasmic reticulum (ER)-associated protein degradation (ERAD). SIK2 co-localizes with p97/VCP in the ER membrane and stimulates its ATPase activity through direct phosphorylation. Although the expression of wild-type recombinant SIK2 accelerated the degradation and removal of ERAD substrates, the kinase-deficient variant conversely had no effect. Furthermore, down-regulation of endogenous SIK2 or mutation of the SIK2 target site on p97/VCP led to impaired degradation of ERAD substrates and disruption of ER homeostasis. Collectively, these findings highlight a mechanism by which the interplay between SIK2 and p97/VCP contributes to the regulation of ERAD in mammalian cells.	[Yang, Fu-Chia; Lin, Ya-Huei; Chen, Wei-Hao; Huang, Jing-Yi; Chang, Hsin-Yun; Su, Su-Hui; Wang, Hsiao-Ting; Chiang, Chun-Yi; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 100, Taiwan; [Lee, Sheng-Chung] Natl Taiwan Univ, Inst Clin Med, Taipei 100, Taiwan; [Hsu, Pang-Hung; Tsai, Ming-Daw] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Tsai, Ming-Daw; Lee, Sheng-Chung] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 33302, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Chang Gung University	Lee, SC (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10051, Taiwan.	slee@ntu.edu.tw	Hsu, Pang-Hung/C-5587-2018; Kisker, Caroline/T-1724-2019	Hsu, Pang-Hung/0000-0001-6873-6434; Tan, Bertrand/0000-0002-2218-7115	National Science Council [NSC96-2321-B-002-008, NSC100-2320-B-002-008, NSC99-2632-B-182-011MY3, NSC101-2320-B-182-036-MY3, NSC102-2321-B-182-007]; National Health Research Institute [NHRI-EX102-9923SC]; Academia Sinica; Institute of Biological Chemistry, Academia Sinica, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); Academia Sinica(Academia Sinica - Taiwan); Institute of Biological Chemistry, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by National Science Council Grants NSC96-2321-B-002-008andNSC100-2320-B-002-008 (to S.-C. L.) and NSC99-2632-B-182-011MY3, NSC101-2320-B-182-036-MY3, and NSC102-2321-B-182-007(to B.C.-M.T.); National Health Research Institute Grant NHRI-EX102-9923SC; Academia Sinica (to M.-D.T.); and the Institute of Biological Chemistry (to S.-C.L.), Academia Sinica, Taiwan.	Ahmed AA, 2010, CANCER CELL, V18, P109, DOI 10.1016/j.ccr.2010.06.018; Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Alzayady KJ, 2005, J BIOL CHEM, V280, P34530, DOI 10.1074/jbc.M508890200; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Bug M, 2012, J STRUCT BIOL, V179, P78, DOI 10.1016/j.jsb.2012.03.003; Chapman E, 2011, MOL BIOSYST, V7, P700, DOI 10.1039/c0mb00176g; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dargemont C, 2012, BBA-MOL CELL RES, V1823, P138, DOI 10.1016/j.bbamcr.2011.07.011; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Imamura S, 2003, FEBS LETT, V549, P14, DOI 10.1016/S0014-5793(03)00723-3; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Liu Y, 2012, ENDOCRINOLOGY, V153, P223, DOI 10.1210/en.2011-1404; Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Qiu Y, 2007, AM J PATHOL, V170, P152, DOI 10.2353/ajpath.2007.060722; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002; Yamamoto S, 2004, ANN SURG ONCOL, V11, P165, DOI 10.1245/ASO.2004.05.012; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yang FC, 2013, J BIOL CHEM, V288, P6227, DOI 10.1074/jbc.M112.431239; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	61	11	11	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33861	33872		10.1074/jbc.M113.492199	http://dx.doi.org/10.1074/jbc.M113.492199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129571	Green Published, hybrid			2022-12-28	WOS:000327250200030
J	Lee, THY; Mitchell, A; Lau, SL; An, HY; Rajeaskariah, P; Wasinger, V; Raftery, M; Bryant, K; Tedla, N				Lee, Terry H. Y.; Mitchell, Ainslie; Lau, Sydney Liu; An, Hongyan; Rajeaskariah, Poornima; Wasinger, Valerie; Raftery, Mark; Bryant, Katherine; Tedla, Nicodemus			Glycosylation in a Mammalian Expression System Is Critical for the Production of Functionally Active Leukocyte Immunoglobulin-like Receptor A3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycoprotein; Glycosylation; Leukocyte; Mass Spectrometry (MS); Monocytes; Protein Deamidation; Protein Expression; Protein Purification; Recombinant Protein Expression; Tumor Necrosis Factor (TNF)	RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; CRYSTAL-STRUCTURE; N-GLYCOSYLATION; LIGAND-BINDING; ASSOCIATION; CELLS; GLYCOPROTEOME; STABILITY; GLYCANS	Background: LILRA3 is a soluble receptor with unknown functions that is abundantly present in human serum. Results: Optimally glycosylated recombinant LILRA3 protein produced only in a mammalian system binds potential ligands and suppresses monocyte function. Conclusion: LILRA3 suppresses LPS-mediated TNF production, suggesting that it is a new anti-inflammatory protein. Significance: This work provides first insight into the biochemical characteristics and functions of LILRA3. The leukocyte immunoglobulin-like receptor (LILR) A3 is a member of the highly homologous activating and inhibitory receptors expressed on leukocytes. LILRA3 is a soluble receptor of unknown functions but is predicted to act as a broad antagonist to other membrane-bound LILRs. Functions of LILRA3 are unclear primarily because of the lack of high quality functional recombinant protein and insufficient knowledge regarding its ligand(s). Here, we expressed and characterized recombinant LILRA3 (rLILRA3) proteins produced in 293T cells, Escherichia coli, and Pichia pastoris. We found that the purified rLILRA3 produced in the mammalian system was the same size as a 70-kDa native macrophage LILRA3. This is 20 kDa larger than the calculated size, suggesting significant post-translational modifications. In contrast, rLILRA3 produced in E. coli was similar in size to the unprocessed protein, but yeast-produced protein was 2-4 times larger than the unprocessed protein. Treatment with peptide-N-glycosidase F reduced the size of the mammalian cell- and yeast-produced rLILRA3 to 50 kDa, suggesting that most modifications are due to glycosylation. Consistent with this, mass spectrometric analysis of the mammalian rLILRA3 revealed canonical N-glycosylation at the predicted Asn(140), Asn(281), Asn(302), Asn(341), and Asn(431) sites. Functionally, only mammalian cell-expressed rLILRA3 bound onto the surface of monocytes with high affinity, and importantly, only this significantly abrogated LPS-induced TNF production by monocytes. Binding to monocytes was partially blocked by -lactose, indicating that optimally glycosylated LILRA3 might be critical for ligand binding and function. Overall, our data demonstrated for the first time that LILRA3 is a potential new anti-inflammatory protein, and optimal glycosylation is required for its functions.	[Lee, Terry H. Y.; Mitchell, Ainslie; An, Hongyan; Rajeaskariah, Poornima; Bryant, Katherine; Tedla, Nicodemus] Univ New S Wales, Inflammat & Infect Res Ctr, Sch Med Sci, Sydney, NSW 2052, Australia; [Bryant, Katherine] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [Lau, Sydney Liu; Wasinger, Valerie; Raftery, Mark] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Mark Wainwright Analyt Ctr, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Bryant, K (corresponding author), Univ New S Wales, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia.	katherine.bryant@unsw.edu.au; n.tedla@unsw.edu.au	Wasinger, Valerie/AAC-5004-2021; Bryant, Katherine/E-8574-2010	Wasinger, Valerie/0000-0001-5338-0869; Bryant, Katherine/0000-0002-8686-623X				Alavi A, 2000, J RHEUMATOL, V27, P1379; An HY, 2010, J RHEUMATOL, V37, P1596, DOI 10.3899/jrheum.091119; Arck PC, 1997, AM J REPROD IMMUNOL, V37, P262; Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chapman TL, 2000, IMMUNITY, V13, P727, DOI 10.1016/S1074-7613(00)00071-6; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; GEETHAHABIB M, 1990, J BIOL CHEM, V265, P13655; Guo MJ, 2008, ENZYME MICROB TECH, V42, P340, DOI 10.1016/j.enzmictec.2007.10.013; Guseva NV, 2010, EUR J IMMUNOL, V40, P2618, DOI 10.1002/eji.200940134; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jones DC, 2011, J IMMUNOL, V186, P2990, DOI 10.4049/jimmunol.1003078; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kabalak G, 2009, ARTHRITIS RHEUM-US, V60, P2923, DOI 10.1002/art.24804; Kalli A, 2008, J PROTEOME RES, V7, P2834, DOI 10.1021/pr800038y; Koch S, 2005, GENES IMMUN, V6, P445, DOI 10.1038/sj.gene.6364187; Kunicki TJ, 2005, BLOOD, V106, P2744, DOI 10.1182/blood-2005-04-1454; Margraf-Schonfeld S, 2011, J BIOL CHEM, V286, P24142, DOI 10.1074/jbc.M111.225334; Martinez-Donato G, 2006, BIOCHEM BIOPH RES CO, V342, P625, DOI 10.1016/j.bbrc.2006.01.157; Nakajima H, 1999, J IMMUNOL, V162, P5; Ordonez D, 2009, GENES IMMUN, V10, P579, DOI 10.1038/gene.2009.34; Palmisano G, 2012, J PROTEOME RES, V11, P1949, DOI 10.1021/pr2011268; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shiroishi M, 2006, J BIOL CHEM, V281, P19536, DOI 10.1074/jbc.M603076200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Tedla N, 2011, TISSUE ANTIGENS, V77, P305, DOI 10.1111/j.1399-0039.2011.01633.x; Tedla N, 2003, P NATL ACAD SCI USA, V100, P1174, DOI 10.1073/pnas.0337567100; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Uchibori-Iwaki H, 2000, GLYCOBIOLOGY, V10, P865, DOI 10.1093/glycob/10.9.865; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Vitale M, 1999, INT IMMUNOL, V11, P29, DOI 10.1093/intimm/11.1.29; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Wormald MR, 1999, STRUCTURE, V7, pR155, DOI 10.1016/S0969-2126(99)80095-1; Zheng JK, 2012, NATURE, V485, P656, DOI 10.1038/nature11095; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; Zou SP, 2013, J BIOTECHNOL, V164, P75, DOI 10.1016/j.jbiotec.2012.12.015	42	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32873	32885		10.1074/jbc.M113.478578	http://dx.doi.org/10.1074/jbc.M113.478578			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085305	hybrid, Green Published			2022-12-28	WOS:000328841700006
J	Sasaki-Osugi, K; Imoto, C; Takahara, T; Shibata, H; Maki, M				Sasaki-Osugi, Kanae; Imoto, Chiaki; Takahara, Terunao; Shibata, Hideki; Maki, Masatoshi			Nuclear ALG-2 Protein Interacts with Ca2+ Homeostasis Endoplasmic Reticulum Protein (CHERP) Ca2+-dependently and Participates in Regulation of Alternative Splicing of Inositol Trisphosphate Receptor Type 1 (IP(3)R1) Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium; Calcium-binding Proteins; Calcium Signaling; Protein-Protein Interactions; RNA Polymerase II; Subcellular Organelles; SR Proteins; Nuclear Speckles	1,4,5-TRISPHOSPHATE RECEPTORS; BINDING PROTEIN; SR PROTEINS; EXIT SITES; CA2+-BINDING PROTEINS; CELL-PROLIFERATION; II TRANSCRIPTION; POLYMERASE-II; CALCIUM; IDENTIFICATION	Background: ALG-2 is present both in the cytoplasm and nucleus, but little is known about its nuclear function. Results: ALG-2 interacts with the SR superfamily protein CHERP and accumulates at nuclear speckles in a Ca2+-dependent manner. Conclusion: ALG-2 and CHERP participate in alternative splicing. Significance: We propose a new role of ALG-2 and CHERP in post-transcriptional processing in the nucleus. The intracellular Ca2+ signaling pathway is important for the control of broad cellular processes from fertilization to cell death. ALG-2 is a Ca2+-binding protein that contains five serially repeated EF-hand motifs and interacts with various proteins in a Ca2+-dependent manner. Although ALG-2 is present both in the cytoplasm and in the nucleus, little is known about its nuclear function. Ca2+ homeostasis endoplasmic reticulum protein (CHERP) was first identified as an endoplasmic reticulum protein that regulates intracellular Ca2+ mobilization in human cells, but recent proteomics data suggest an association between CHERP and spliceosomes. Here, we report that CHERP, containing a Pro-rich region and a phosphorylated Ser/Arg-rich RS-like domain, is a novel Ca2+-dependent ALG-2-interactive target in the nucleus. Immunofluorescence microscopic analysis revealed localization of CHERP to the nucleoplasm with prominent accumulation at nuclear speckles, which are the sites of storage and modification for pre-mRNA splicing factors. Live cell time-lapse imaging showed that nuclear ALG-2 was recruited to the CHERP-localizing speckles upon Ca2+ mobilization. Results of co-immunoprecipitation assays revealed binding of CHERP to a phosphorylated form of RNA polymerase II. Knockdown of CHERP or ALG-2 in HT1080 cells resulted in generation of alternatively spliced isoforms of the inositol 1,4,5-trisphosphate receptor 1 (IP(3)R1) pre-mRNA that included exons 41 and 42 in addition to the major isoform lacking exons 40-42. Furthermore, binding between CHERP and IP(3)R1 RNA was detected by an RNA immunoprecipitation assay using a polyclonal antibody against CHERP. These results indicate that CHERP and ALG-2 participate in regulation of alternative splicing of IP(3)R1 pre-mRNA and provide new insights into post-transcriptional regulation of splicing variants in Ca2+ signaling pathways.	[Sasaki-Osugi, Kanae; Imoto, Chiaki; Takahara, Terunao; Shibata, Hideki; Maki, Masatoshi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Maki, M (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	mmaki@agr.nagoya-u.ac.jp	Maki, Masatoshi/AAM-6839-2021	Maki, Masatoshi/0000-0001-9144-5491	Japan Society for the Promotion of Science [23380056]; Japan Society for the Promotion of Science Fellows Project [25-3584]; Japan Society for the Promotion of Science research fellowship	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science Fellows Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science research fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research (B) Project No. 23380056 from the Japan Society for the Promotion of Science (to M. M.) and Grant-in-aid from the Japan Society for the Promotion of Science Fellows Project No. 25-3584 (to K. S.).; Recipient of a Japan Society for the Promotion of Science research fellowship for young scientists (DC2).	Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Becker R, 2008, J BIOL CHEM, V283, P22659, DOI 10.1074/jbc.M803540200; Choi JY, 2004, AM J PHYSIOL-CELL PH, V287, pC971, DOI 10.1152/ajpcell.00571.2003; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Draeby I, 2007, ARCH BIOCHEM BIOPHYS, V467, P87, DOI 10.1016/j.abb.2007.07.028; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Krebs J, 2011, NEUROCHEM RES, V36, P1198, DOI 10.1007/s11064-011-0431-4; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; Lamond AI, 2011, COLD SPRING HARB PER, V3; LaPlante JM, 2000, BIOCHEM J, V348, P189, DOI 10.1042/0264-6021:3480189; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Lin-Moshier Y, 2013, J BIOL CHEM, V288, P355, DOI 10.1074/jbc.M112.405761; Mahul-Mellier AL, 2008, J BIOL CHEM, V283, P34954, DOI 10.1074/jbc.M803140200; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M, 1997, BIOCHEM J, V328, P718; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mathew R, 2008, NAT STRUCT MOL BIOL, V15, P435, DOI 10.1038/nsmb.1415; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Montaville P, 2006, BBA-MOL CELL RES, V1763, P1335, DOI 10.1016/j.bbamcr.2006.09.003; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; NAKAGAWA T, 1991, J NEUROCHEM, V57, P1807, DOI 10.1111/j.1471-4159.1991.tb06385.x; Neugebauer KM, 1997, GENE DEV, V11, P1148, DOI 10.1101/gad.11.9.1148; NUCIFORA FC, 1995, MOL BRAIN RES, V32, P291, DOI 10.1016/0169-328X(95)00089-B; O'Rourke FA, 2003, BIOCHEM J, V373, P133, DOI 10.1042/BJ20030013; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; OROURKE F, 1994, BIOCHEM J, V300, P673, DOI 10.1042/bj3000673; Osugi Kanae, 2013, Methods Mol Biol, V963, P187, DOI 10.1007/978-1-62703-230-8_12; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Rasche N, 2012, EMBO J, V31, P1591, DOI 10.1038/emboj.2011.502; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Ryan T, 2011, J BIOL CHEM, V286, P17060, DOI 10.1074/jbc.M110.197186; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; SCHELL MJ, 1993, MOL BRAIN RES, V17, P212, DOI 10.1016/0169-328X(93)90004-9; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; Wagner LE, 2003, J BIOL CHEM, V278, P45811, DOI 10.1074/jbc.M306270200; Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	54	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33361	33375		10.1074/jbc.M113.497479	http://dx.doi.org/10.1074/jbc.M113.497479			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078636	Green Published, hybrid			2022-12-28	WOS:000328841700050
J	Alibaud, L; Pawelczyk, J; Gannoun-Zaki, L; Singh, VK; Rombouts, Y; Drancourt, M; Dziadek, J; Guerardel, Y; Kremer, L				Alibaud, Laeticia; Pawelczyk, Jakub; Gannoun-Zaki, Laila; Singh, Vipul K.; Rombouts, Yoann; Drancourt, Michel; Dziadek, Jaroslaw; Guerardel, Yann; Kremer, Laurent			Increased Phagocytosis of Mycobacterium marinum Mutants Defective in Lipooligosaccharide Production A STRUCTURE-ACTIVITY RELATIONSHIP STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Glycolipid Structure; Macrophages; Mass Spectrometry (MS); Mycobacterium; Phagocytosis; Acanthamoeba; Lipooligosaccharide; Thin Layer Chromatography	TREHALOSE-CONTAINING LIPOOLIGOSACCHARIDES; CELL-WALL; TUBERCULOSIS; BIOSYNTHESIS; ANTIGENS; GLYCOPEPTIDOLIPIDS; IDENTIFICATION; INACTIVATION; PATHOGENESIS; MANNOSIDES	Mycobacterium marinum is a waterborne pathogen responsible for tuberculosis-like infections in ectotherms and is an occasional opportunistic human pathogen. In the environment, M. marinum also interacts with amoebae, which may serve as a natural reservoir for this microorganism. However, the description of mycobacterial determinants in the early interaction with macrophages or amoebae remains elusive. Lipooligosaccharides (LOSs) are cell surface-exposed glycolipids capable of modulating the host immune system, suggesting that they may be involved in the early interactions of M. marinum with macrophages. Herein, we addressed whether LOS composition affects the uptake of M. marinum by professional phagocytes. Mutants with various truncated LOS variants were generated, leading to the identification of several previously uncharacterized biosynthetic genes (wbbL2, MMAR_2321, and MMAR_2331). Biochemical and structural approaches allowed resolving the structures of LOS precursors accumulating in this set of mutants. These strains with structurally defined LOS profiles were then used to infect both macrophages and Acanthamoebae. An inverse correlation between LOS completeness and uptake of mycobacteria by phagocytes was found, allowing the proposal of three mutant classes: class I (papA4), devoid of LOS and highly efficiently phagocytosed; class II, accumulating only early LOS intermediates (wbbL2 and MMAR_2331) and efficiently phagocytosed but less than class I mutants; class III, lacking LOS-IV (losA, MMAR_2319, and MMAR_2321) and phagocytosed similarly to the control strain. These results indicate that phagocytosis is conditioned by the LOS pattern and that the LOS pathway used by M. marinum in macrophages is conserved during infection of amoebae.	[Kremer, Laurent] Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France; [Pawelczyk, Jakub; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, PL-93231 Lodz, Poland; [Singh, Vipul K.; Drancourt, Michel] Fac Med Marseille, INSERM 1095, IRD 198, Unite Rech Malad Infect & Trop Emergentes,UMR CNR, F-13005 Marseille, France; [Rombouts, Yoann; Guerardel, Yann] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Rombouts, Yoann; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Kremer, L (corresponding author), Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	laurent.kremer@univ-montp2.fr	Singh, Vipul Kumar/AAA-9302-2020; Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Dziadek, Jaroslaw/0000-0003-1427-884X; Gannoun, Laila/0000-0002-9644-1083; Rombouts, Yoann/0000-0003-4482-2199; Guerardel, Yann/0000-0003-4967-9512; Singh, Vipul Kumar/0000-0002-7146-7279	French National Research Agency [ANR-10-MIDI-009]; InfectioPole Sud Foundation; European Regional Development Fund under Operational Programme Innovative Economy Grant [POIG.01.01.02-10-107/09]	French National Research Agency(French National Research Agency (ANR)); InfectioPole Sud Foundation; European Regional Development Fund under Operational Programme Innovative Economy Grant	This work was supported by French National Research Agency Grant ANR-10-MIDI-009 (ZebraFlam) (to L. K.), the InfectioPole Sud Foundation (to V. K. S.), and the European Regional Development Fund under Operational Programme Innovative Economy Grant POIG.01.01.02-10-107/09 (to J. D. and J. P.).	Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Alexander DC, 2004, J BIOL CHEM, V279, P18824, DOI 10.1074/jbc.M400791200; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; Chavadi SS, 2011, J BIOL CHEM, V286, P24616, DOI 10.1074/jbc.M111.247601; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; GILLERON M, 1995, GLYCOCONJUGATE J, V12, P298, DOI 10.1007/BF00731333; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; HERMANSSON K, 1993, CARBOHYD RES, V248, P199, DOI 10.1016/0008-6215(93)84127-R; HUNTER SW, 1985, BIOCHEMISTRY-US, V24, P2798, DOI 10.1021/bi00332a030; HUNTER SW, 1988, BIOCHEMISTRY-US, V27, P1549, DOI 10.1021/bi00405a023; HUNTER SW, 1983, J BIOL CHEM, V258, P481; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kennedy GM, 2012, APPL ENVIRON MICROB, V78, P2049, DOI 10.1128/AEM.06965-11; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; Medie FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020499; Mills JA, 2004, J BIOL CHEM, V279, P43540, DOI 10.1074/jbc.M407782200; Nessar R, 2011, MICROBIOL-SGM, V157, P1187, DOI 10.1099/mic.0.046557-0; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Rombouts Y, 2011, J BIOL CHEM, V286, P33678, DOI 10.1074/jbc.M111.273920; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Roux AL, 2011, CELL MICROBIOL, V13, P692, DOI 10.1111/j.1462-5822.2010.01565.x; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461; Villeneuve C, 2003, J BIOL CHEM, V278, P51291, DOI 10.1074/jbc.M306554200	44	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					215	228		10.1074/jbc.M113.525550	http://dx.doi.org/10.1074/jbc.M113.525550			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235141	Green Published, hybrid			2022-12-28	WOS:000329370900019
J	Ma, JH; Nakagawa, Y; Kojima, I; Shibata, H				Ma, Jinhui; Nakagawa, Yuko; Kojima, Itaru; Shibata, Hiroshi			Prolonged Insulin Stimulation Down-regulates GLUT4 through Oxidative Stress-mediated Retromer Inhibition by a Protein Kinase CK2-dependent Mechanism in 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Glut4; Insulin; Membrane Trafficking; Signal Transduction; Retromer	TYROSINE-PHOSPHATASE 1B; HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; GLUCOSE TRANSPORTERS; ADIPOSE CONVERSION; STORAGE-VESICLES; TRANSLOCATION; SORTILIN; ACTIVATION; MEMBRANE	Although insulin acutely stimulates glucose uptake by promotion of GLUT4 translocation from intracellular compartments to the plasma membrane in adipocytes and muscles, long term insulin stimulation causes GLUT4 depletion that is particularly prominent in the insulin-responsive GLUT4 storage compartment. This effect is caused mainly by accelerated lysosomal degradation of GLUT4, although the mechanism is not fully defined. Here we show that insulin acutely induced dissociation of retromer components from the low density microsomal membranes of 3T3-L1 adipocytes that was accompanied by disruption of the interaction of Vps35 with sortilin. This insulin effect was dependent on the activity of protein kinase CK2 but not phosphatidylinositol 3-kinase or extracellular signal-regulated kinase 1/2. Knockdown of Vps26 decreased GLUT4 to a level comparable with that with insulin stimulation for 4 h. Vps35 with a mutation in the CK2 phosphorylation motif (Vps35-S7A) was resistant to insulin-induced dissociation from the low density microsomal membrane, and its overexpression attenuated GLUT4 down-regulation with insulin. Furthermore, insulin-generated hydrogen peroxide was an upstream mediator of the insulin action on retromer and GLUT4. These results suggested that insulin-generated oxidative stress switches the GLUT4 sorting direction to lysosomes through inhibition of the retromer function in a CK2-dependent manner.	[Ma, Jinhui; Nakagawa, Yuko; Kojima, Itaru; Shibata, Hiroshi] Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gunma 3718512, Japan	Gunma University	Shibata, H (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan.	hshibata@gunma-u.ac.jp			Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan [23591295]	Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders"; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Global Centers of Excellence Program "Signal Transduction in the Regulatory System and Its Disorders" and Grant-in-aid 23591295 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. S.). Parts of this study were presented in abstract form at the 69th Scientific Sessions of the American Diabetes Association, New Orleans, LA, June 5-9, 2009.	ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1974, P NATL ACAD SCI USA, V71, P4173, DOI 10.1073/pnas.71.10.4173; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; FLORESRIVEROS JR, 1993, P NATL ACAD SCI USA, V90, P512, DOI 10.1073/pnas.90.2.512; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; GUY GR, 1993, J BIOL CHEM, V268, P2141; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KONO T, 1977, J BIOL CHEM, V252, P2226; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu LB, 2003, J BIOL CHEM, V278, P30157, DOI 10.1074/jbc.M301511200; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Maier VH, 2000, DIABETOLOGIA, V43, P1273, DOI 10.1007/s001250051523; MAY JM, 1979, J BIOL CHEM, V254, P2214; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SHIBATA H, 1995, J BIOL CHEM, V270, P11489, DOI 10.1074/jbc.270.19.11489; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; Tamori Y, 1996, BIOCHEM BIOPH RES CO, V220, P740, DOI 10.1006/bbrc.1996.0474; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595	50	41	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					133	142		10.1074/jbc.M113.533240	http://dx.doi.org/10.1074/jbc.M113.533240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24240093	Green Published, hybrid			2022-12-28	WOS:000329370900012
J	Cheng, SW; Cao, DF; Hottman, DA; Yuan, LL; Bergo, MO; Li, L				Cheng, Shaowu; Cao, Dongfeng; Hottman, David A.; Yuan, LiLian; Bergo, Martin O.; Li, Ling			Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimers Disease; Amyloid; Isoprenoid; Neuroinflammation; Transgenic Mice; Learning and Memory; Protein Prenylation	AMYLOID PRECURSOR PROTEIN; LONG-TERM POTENTIATION; A-BETA; REDUCTASE INHIBITORS; NEURONAL PLASTICITY; GAMMA-SECRETASE; H-RAS; ISOPRENOIDS; DEFICITS; GERANYLGERANYLATION	Background: Protein prenylation may play an important role in Alzheimer disease. Results: Haplodeficiency in farnesyltransferase and geranylgeranyltransferase-1 attenuates neuropathology, but only reduction of farnesyltransferase rescues cognitive function in Alzheimer mice. Conclusion: Protein farnesylation and geranylgeranylation differentially affect the course of Alzheimer disease. Significance: Specific inhibition of protein farnesylation might be a potential strategy for effectively treating Alzheimer disease. Isoprenoids and prenylated proteins have been implicated in the pathophysiology of Alzheimer disease (AD), including amyloid- precursor protein metabolism, Tau phosphorylation, synaptic plasticity, and neuroinflammation. However, little is known about the relative importance of the two protein prenyltransferases, farnesyltransferase (FT) and geranylgeranyltransferase-1 (GGT), in the pathogenesis of AD. In this study, we defined the impact of deleting one copy of FT or GGT on the development of amyloid- (A)-associated neuropathology and learning/memory impairments in APPPS1 double transgenic mice, a well established model of AD. Heterozygous deletion of FT reduced A deposition and neuroinflammation and rescued spatial learning and memory function in APPPS1 mice. Heterozygous deletion of GGT reduced the levels of A and neuroinflammation but had no impact on learning and memory. These results document that farnesylation and geranylgeranylation play differential roles in AD pathogenesis and suggest that specific inhibition of protein farnesylation could be a potential strategy for effectively treating AD.	[Cheng, Shaowu; Cao, Dongfeng; Hottman, David A.; Li, Ling] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Yuan, LiLian] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Bergo, Martin O.] Univ Gothenburg, Inst Med, Sahlgrenska Canc Ctr, S-41390 Gothenburg, Sweden	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Gothenburg	Li, L (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, 2001 6th St SE,MTRF 4-208, Minneapolis, MN 55455 USA.	lil@umn.edu		Li, Ling/0000-0002-9245-7387; cheng, shaowu/0000-0001-9059-4727	National Institutes of Health [AG031846]; Alzheimer's Association [IIRG-09-131791]; American Health Assistance Foundation/Bright Focus Foundation [A2010328]; Academic Health Center of the University of Minnesota; NATIONAL INSTITUTE ON AGING [R01AG031846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation/Bright Focus Foundation(BrightFocus Foundation); Academic Health Center of the University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG031846. This work was also supported by Alzheimer's Association Grant IIRG-09-131791, American Health Assistance Foundation/Bright Focus Foundation Grant A2010328, and the Academic Health Center of the University of Minnesota (to L. L.).	Bi XN, 2004, J BIOL CHEM, V279, P48238, DOI 10.1074/jbc.M405442200; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boo JH, 2008, BIOCHEM BIOPH RES CO, V372, P913, DOI 10.1016/j.bbrc.2008.05.153; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cespedes-Rubio A, 2010, J NEUROSCI RES, V88, P3621, DOI 10.1002/jnr.22511; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Cole SL, 2006, NEUROBIOL DIS, V22, P209, DOI 10.1016/j.nbd.2005.11.007; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Eckert GP, 2009, NEUROBIOL DIS, V35, P251, DOI 10.1016/j.nbd.2009.05.005; Franke C, 2007, NEUROBIOL DIS, V25, P438, DOI 10.1016/j.nbd.2006.10.004; Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020; Holstein SA, 2002, BIOCHEMISTRY-US, V41, P13698, DOI 10.1021/bi026251x; Holtzman D.M., 2012, COLD SPRING HARB PER, V2; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Lee M, 2002, BIOCHEM J, V366, P937, DOI 10.1042/BJ20020453; Leuchtenberger S, 2006, J NEUROCHEM, V96, P355, DOI 10.1111/j.1471-4159.2005.03553.x; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Li L, 2012, MOL NEUROBIOL, V46, P64, DOI 10.1007/s12035-012-8253-1; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Liu M, 2010, P NATL ACAD SCI USA, V107, P6471, DOI 10.1073/pnas.0908396107; Luo Z, 2003, NEURON, V40, P703, DOI 10.1016/S0896-6273(03)00695-0; Manabe T, 2000, J NEUROSCI, V20, P2504; Mans RA, 2012, NEUROSCIENCE, V202, P1, DOI 10.1016/j.neuroscience.2011.12.007; Mans RA, 2010, NEUROSCIENCE, V166, P435, DOI 10.1016/j.neuroscience.2009.12.062; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; ten Klooster JP, 2007, BIOL CELL, V99, P1, DOI 10.1042/BC20060071; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Wang PL, 2009, J NEUROSCI RES, V87, P2105, DOI 10.1002/jnr.22039; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Ye XJ, 2010, NEURON, V68, P340, DOI 10.1016/j.neuron.2010.09.013; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com	48	33	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35952	35960		10.1074/jbc.M113.503904	http://dx.doi.org/10.1074/jbc.M113.503904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24136196	Green Published, hybrid			2022-12-28	WOS:000329814700031
J	Hao, W; Collier, SM; Moffett, P; Chai, JJ				Hao, Wei; Collier, Sarah M.; Moffett, Peter; Chai, Jijie			Structural Basis for the Interaction between the Potato Virus X Resistance Protein (Rx) and Its Cofactor Ran GTPase-activating Protein 2 (RanGAP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Plant Molecular Biology; Protein Structure; Protein; Protein Interactions; Structural Biology; X-ray Crystallography; RanGAP; Rx; Coiled-coil Domain; Plant Resistance Protein	RICH REPEAT PROTEIN; DISEASE RESISTANCE; CRYSTAL-STRUCTURE; COILED-COIL; LRR PROTEIN; BINDING; DOMAIN; UNIQUE; GENE; ASSOCIATION	Background: The interaction of the potato disease resistance protein Rx with RanGAP2 is important for virus resistance. Results: The crystal structure of the complex of the Rx and RanGAP2 N-terminal domains was determined. Conclusion: The two proteins bind primarily through hydrophobic interactions. Significance: This work reveals the distinct surfaces of the Rx coiled-coil domain involved in intra- and intermolecular interactions. The potato (Solanum tuberosum) disease resistance protein Rx has a modular arrangement that contains coiled-coil (CC), nucleotide-binding (NB), and leucine-rich repeat (LRR) domains and mediates resistance to potato virus X. The Rx N-terminal CC domain undergoes an intramolecular interaction with the Rx NB-LRR region and an intermolecular interaction with the Rx cofactor RanGAP2 (Ran GTPase-activating protein 2). Here, we report the crystal structure of the Rx CC domain in complex with the Trp-Pro-Pro (WPP) domain of RanGAP2. The structure reveals that the Rx CC domain forms a heterodimer with RanGAP2, in striking contrast to the homodimeric structure of the CC domain of the barley disease resistance protein MLA10. Structure-based mutagenesis identified residues from both the Rx CC domain and the RanGAP2 WPP domain that are crucial for their interaction and function in vitro and in vivo. Our results reveal the molecular mechanism underlying the interaction of Rx with RanGAP2 and identify the distinct surfaces of the Rx CC domain that are involved in intramolecular and intermolecular interactions.	[Hao, Wei] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China; [Hao, Wei] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Collier, Sarah M.; Moffett, Peter] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Collier, Sarah M.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA; [Moffett, Peter] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of Sherbrooke; Tsinghua University; Tsinghua University	Moffett, P (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	peter.moffett@usherbrooke.ca; chaijj@mail.tsinghua.edu.cn		Moffett, Peter/0000-0003-0678-4531; Collier, Sarah/0000-0002-8834-5075; Chai, Jijie/0000-0001-7591-3873	National Outstanding Young Scholar Science Foundation of China Grant [20101331722]; National Science Foundation Grant [IOB-0343327]; National Science Foundation graduate research fellowship	National Outstanding Young Scholar Science Foundation of China Grant; National Science Foundation Grant(National Science Foundation (NSF)); National Science Foundation graduate research fellowship(National Science Foundation (NSF))	This work was supported by National Outstanding Young Scholar Science Foundation of China Grant 20101331722 (to J. C.), National Science Foundation Grant IOB-0343327 (to P. M.), and a National Science Foundation graduate research fellowship (to S. M. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frost D, 2004, MOL PLANT MICROBE IN, V17, P224, DOI 10.1094/MPMI.2004.17.2.224; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KOHM BA, 1993, PLANT CELL, V5, P913, DOI 10.1105/tpc.5.8.913; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Lewis J. D., 2013, P NATL ACAD IN PRESS; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Meier I, 2008, J MICROSC-OXFORD, V231, P225, DOI 10.1111/j.1365-2818.2008.02038.x; Meier I, 2010, BIOCHEM SOC T, V38, P733, DOI 10.1042/BST0380733; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Rose A, 2001, P NATL ACAD SCI USA, V98, P15377, DOI 10.1073/pnas.261459698; Sacco MA, 2007, PLANT J, V52, P82, DOI 10.1111/j.1365-313X.2007.03213.x; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461	34	77	83	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35868	35876		10.1074/jbc.M113.517417	http://dx.doi.org/10.1074/jbc.M113.517417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24194517	Green Published, hybrid			2022-12-28	WOS:000329814700023
J	Lu, L; Hu, SH; Wei, RF; Qiu, X; Lu, KF; Fu, YS; Li, HC; Xing, GC; Li, D; Peng, RY; He, FC; Zhang, LQ				Lu, Li; Hu, Shaohua; Wei, Rongfei; Qiu, Xiao; Lu, Kefeng; Fu, Yesheng; Li, Hongchang; Xing, Guichun; Li, Dong; Peng, Ruiyun; He, Fuchu; Zhang, Lingqiang			The HECT Type Ubiquitin Ligase NEDL2 Is Degraded by Anaphase-promoting Complex/Cyclosome (APC/C)-Cdh1, and Its Tight Regulation Maintains the Metaphase to Anaphase Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Mitosis; Protein Degradation; Tumor; Ubiquitin Ligase; APC; C	SPINDLE CHECKPOINT; CHROMOSOMAL INSTABILITY; FAMILY-MEMBERS; COMPLEX; CELL; CDC20; IDENTIFICATION; BOX; PROTEOLYSIS; ACTIVATION	Background: NEDL2 is a member of the HECT type ubiquitin ligase NEDD4 family, but its function remains largely unknown. Results: NEDL2 is degraded by APC/C-Cdh1 during mitotic exit and regulates metaphase to anaphase transition. Conclusion: NEDL2 appears to dynamically modulate regulation of mitosis. Significance: Our data provide a novel substrate of APC/C-Cdh1 and reveal an additional protein by which HECT type ubiquitin ligase can regulate mitosis. NEDD4-like ubiquitin ligase 2 (NEDL2) is a HECT type ubiquitin ligase. NEDL2 enhances p73 transcriptional activity and degrades ATR kinase in lamin misexpressed cells. Compared with the important functions of other HECT type ubiquitin ligase, there is less study concerning the function and regulation of NEDL2. Using primary antibody immunoprecipitation and mass spectrometry, we identify a list of potential proteins that are putative NEDL2-interacting proteins. The candidate list contains many of mitotic proteins, especially including several subunits of anaphase-promoting complex/cyclosome (APC/C) and Cdh1, an activator of APC/C. Cdh1 can interact with NEDL2 in vivo and in vitro. Cdh1 recognizes one of the NEDL2 destruction boxes (R(740)GSL(743)) and targets it for degradation in an APC/C-dependent manner during mitotic exit. Overexpression of Cdh1 reduces the protein level of NEDL2, whereas knockdown of Cdh1 increases the protein level of NEDL2 but has no effect on the NEDL2 mRNA level. NEDL2 associates with mitotic spindles, and its protein level reaches a maximum in mitosis. The function of NEDL2 during mitosis is essential because NEDL2 depletion prolongs metaphase, and overexpression of NEDL2 induces chromosomal lagging. Elevated expression of NEDL2 protein and mRNA are both found in colon cancer and cervix cancer. We conclude that NEDL2 is a novel substrate of APC/C-Cdh1 as cells exit mitosis and functions as a regulator of the metaphase to anaphase transition. Its overexpression may contribute to tumorigenesis.	[Lu, Li; Wei, Rongfei; Qiu, Xiao; Lu, Kefeng; Fu, Yesheng; Li, Hongchang; Xing, Guichun; Li, Dong; He, Fuchu; Zhang, Lingqiang] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China; [Zhang, Lingqiang] Dalian Med Univ, Inst Canc Stem Cells, Dalian 116023, Liaoning Provin, Peoples R China; [Lu, Li; He, Fuchu] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China; [Hu, Shaohua; Peng, Ruiyun] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing 100850, Peoples R China; [Wei, Rongfei; Qiu, Xiao; He, Fuchu] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China	Academy of Military Medical Sciences - China; Dalian Medical University; Beijing University of Technology; Academy of Military Medical Sciences - China; Tsinghua University	He, FC (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.	hefc@nic.bmi.ac.cn; zhanglq@nic.bmi.ac.cn		Lu, Kefeng/0000-0001-8200-9380	National Basic Research Programs [2012CB910304, 2011CB910602, 2011CB910802]; National Natural Science Foundation Projects [31125010, 81221004]	National Basic Research Programs(National Basic Research Program of China); National Natural Science Foundation Projects(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Programs 2012CB910304, 2011CB910602, and 2011CB910802 and National Natural Science Foundation Projects 31125010 and 81221004.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fujita T, 2008, AM J PATHOL, V173, P217, DOI 10.2353/ajpath.2008.070957; Gieffers C, 1999, P NATL ACAD SCI USA, V96, P11317, DOI 10.1073/pnas.96.20.11317; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Kannan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050735; Kannan M, 2012, DEVELOPMENT, V139, P3600, DOI 10.1242/dev.081786; Kim AH, 2007, MOL CELL NEUROSCI, V34, P281, DOI 10.1016/j.mcn.2006.11.019; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lengauer C, 2004, NAT GENET, V36, P1144, DOI 10.1038/ng1104-1144; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Li Y, 2008, ONCOGENE, V27, P3700, DOI 10.1038/sj.onc.1211032; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Michor F, 2005, PHILOS T R SOC B, V360, P631, DOI 10.1098/rstb.2004.1617; Miyazaki K, 2004, J BIOL CHEM, V279, P11327, DOI 10.1074/jbc.M312389200; Miyazaki K, 2003, BIOCHEM BIOPH RES CO, V308, P106, DOI 10.1016/S0006-291X(03)01347-0; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Weaver BA, 2008, CANCER CELL, V14, P431, DOI 10.1016/j.ccr.2008.11.011; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhang L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/831092	38	37	39	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35637	35650		10.1074/jbc.M113.472076	http://dx.doi.org/10.1074/jbc.M113.472076			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24163370	Green Published, hybrid			2022-12-28	WOS:000329814700003
J	Kim, H; Falet, H; Hoffmeister, KM; Hartwig, JH				Kim, Hugh; Falet, Herve; Hoffmeister, Karin M.; Hartwig, John H.			Wiskott-Aldrich Syndrome Protein (WASp) Controls the Delivery of Platelet Transforming Growth Factor-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Extracellular Matrix; Platelets; Signal Transduction; Signaling	FILAMENT BARBED ENDS; GROWTH-FACTOR-BETA; COLLAGEN RECEPTOR; MEMBRANE SKELETON; ACTIVATION; SECRETION; DOWNSTREAM; GELSOLIN; BINDING; CDC42	Background: The mechanisms that regulate cytokine secretion from platelets are undefined. Results: Inhibiting the expression or function of the Wiskott-Aldrich syndrome protein (WASp) increases TGF-1 release from platelets. Conclusion: WASp curtails the secretion of TGF-1 from human and mouse platelets. Significance: Identifying the biochemical mechanisms of cytokine secretion will improve our understanding of platelets vis-a-vis the host immune response. Platelets are immunologically competent cells containing cytokines such as TGF-1 that regulate cell-mediated immunity. However, the mechanisms underlying cytokine secretion from platelets are undefined. The Wiskott-Aldrich syndrome protein (WASp) regulates actin polymerization in nucleated hematopoietic cells but has other role(s) in platelets. WASp-null (WASp(-/-)) platelets stimulated with a PAR-4 receptor agonist had increased TGF-1 release compared with WT platelets; inhibiting WASp function with wiskostatin augmented TRAP-induced TGF-1 release in human platelets. TGF-1 release is dissociated from -granule secretion (P-selectin up-regulation) and occurs more gradually, with approximate to 10-15% released after 30-60 min. Blockade of Src family kinase-mediated WASp Tyr-291/Tyr-293 phosphorylation increased TGF-1 release, with no additive effect in WASp(-/-) platelets, signifying that phosphorylation is critical for WASp-limited TGF-1 secretion. Inhibiting F-actin assembly with cytochalasin D enhanced secretion in WT platelets and further increased TGF-1 release in WASp(-/-) platelets, indicating that WASp and actin assembly independently regulate TGF-1 release. A permeabilized platelet model was used to test the role of upstream small GTPases in TGF-1 release. N17Cdc42, but not Rac1 mutants, increased TGF-1 secretion and abrogated WASp phosphorylation. We conclude that WASp function restricts TGF-1 secretion in a Cdc42- and Src family kinase-dependent manner and independently of actin assembly.	[Kim, Hugh] Brigham & Womens Hosp, Div Translat Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kim, H (corresponding author), Brigham & Womens Hosp, Div Translat Med, 1 Blackfan Circle,Karp 6, Boston, MA 02115 USA.	hkim28@rics.bwh.harvard.edu		Falet, Herve/0000-0003-0788-9204	National Institutes of Health [HL059561-11, HL107146]; Canadian Institutes of Health Research Clinician-Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059561, P01HL107146, R01HL104145, R01HL089224] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Clinician-Scientist Award(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL059561-11 (to J. H. H. and H. F.) and HL107146 (to K. M. H.). This work was also supported by a Canadian Institutes of Health Research Clinician-Scientist Award (to H. K.).	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Barkalow K, 1996, J CELL BIOL, V134, P389, DOI 10.1083/jcb.134.2.389; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Calaminus SDJ, 2007, J THROMB HAEMOST, V5, P535, DOI 10.1111/j.1538-7836.2007.02377.x; Catucci M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00209; Cleland SY, 2011, FEBS LETT, V585, P3710, DOI 10.1016/j.febslet.2011.10.031; Derry JM, 1994, CELL, V79, P922; Dovas Athanassios, 2010, Commun Integr Biol, V3, P101; Falet H, 2000, BLOOD, V96, P3786, DOI 10.1182/blood.V96.12.3786.h8003786_3786_3792; Falet H, 2005, AM J PHYSIOL-CELL PH, V289, pC819, DOI 10.1152/ajpcell.00587.2004; Falet H, 2002, P NATL ACAD SCI USA, V99, P16782, DOI 10.1073/pnas.222652499; Falet H, 2002, BLOOD, V100, P2113, DOI 10.1182/blood.V100.6.2113.h81802002113_2113_2122; Falet H, 2009, BLOOD, V114, P4729, DOI 10.1182/blood-2009-02-202721; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Feng SJ, 2003, BLOOD, V102, P2122, DOI 10.1182/blood-2002-12-3805; Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392; Flaumenhaft R, 2003, ARTERIOSCL THROM VAS, V23, P1152, DOI 10.1161/01.ATV.0000075965.88456.48; Gerdes N, 2011, THROMB HAEMOSTASIS, V106, P353, DOI 10.1160/TH11-01-0020; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; Gross BS, 1999, BLOOD, V94, P4166, DOI 10.1182/blood.V94.12.4166.424k36_4166_4176; Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Hoffmeister KM, 2001, J BIOL CHEM, V276, P24751, DOI 10.1074/jbc.M011642200; Humblet-Baron S, 2007, J CLIN INVEST, V117, P407, DOI 10.1172/JCI29539; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kim S, 2011, J BIOL CHEM, V286, P24170, DOI 10.1074/jbc.M110.212274; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lutskiy MI, 2007, BRIT J HAEMATOL, V139, P98, DOI 10.1111/j.1365-2141.2007.06745.x; Oda A, 2000, BLOOD, V95, P1663; Pandey D, 2009, BLOOD, V114, P415, DOI 10.1182/blood-2008-10-183582; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; Rutledge Tara W, 2004, Methods Mol Biol, V272, P109; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; VOSTAL JG, 1993, BIOCHEM J, V294, P675, DOI 10.1042/bj2940675; Westerberg LS, 2008, BLOOD, V112, P4139, DOI 10.1182/blood-2008-02-140715; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	53	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34352	34363		10.1074/jbc.M113.459750	http://dx.doi.org/10.1074/jbc.M113.459750			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133214	Green Published, hybrid			2022-12-28	WOS:000329812800007
J	Quazi, F; Molday, RS				Quazi, Faraz; Molday, Robert S.			Differential Phospholipid Substrates and Directional Transport by ATP-binding Cassette Proteins ABCA1, ABCA7, and ABCA4 and Disease-causing Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cholesterol Metabolism; High Density Lipoprotein (HDL); Lipid Transport; Membrane Reconstitution; Phospholipid; ABCA1; ABCA4; Stargardt Disease; Tangier Disease	APOLIPOPROTEIN-A-I; N-RETINYLIDENE-PHOSPHATIDYLETHANOLAMINE; CELLULAR LIPID EFFLUX; CHOLESTEROL EFFLUX; TANGIER-DISEASE; RIM PROTEIN; APOA-I; MUTATIONS; IDENTIFICATION; PURIFICATION	Background: Lipid transport by the A-subfamily of ATP-binding cassette (ABC) transporters implicated in human disorders is poorly understood. Results: ABCA1 and ABCA7 export phosphatidylcholine and phosphatidylserine across membranes, whereas ABCA4 imports phosphatidylethanolamine. Conclusion: ABCA transporters actively flip phospholipids across membranes, a function severely reduced for disease-causing mutants. Significance: ABCA-dependent phospholipid transport plays a crucial role in cellular lipid homeostasis. ABCA1, ABCA7, and ABCA4 are members of the ABCA subfamily of ATP-binding cassette transporters that share extensive sequence and structural similarity. Mutations in ABCA1 cause Tangier disease characterized by defective cholesterol homeostasis and high density lipoprotein (HDL) deficiency. Mutations in ABCA4 are responsible for Stargardt disease, a degenerative disorder associated with severe loss in central vision. Although cell-based studies have implicated ABCA proteins in lipid transport, the substrates and direction of transport have not been firmly established. We have purified and reconstituted ABCA1, ABCA7, and ABCA4 into liposomes for fluorescent-lipid transport studies. ABCA1 actively exported or flipped phosphatidylcholine, phosphatidylserine, and sphingomyelin from the cytoplasmic to the exocytoplasmic leaflet of membranes, whereas ABCA7 preferentially exported phosphatidylserine. In contrast, ABCA4 transported phosphatidylethanolamine in the reverse direction. The same phospholipids stimulated the ATPase activity of these ABCA transporters. The transport and ATPase activities of ABCA1 and ABCA4 were reduced by 25% in the presence of 20% cholesterol. Nine ABCA1 Tangier mutants and the corresponding ABCA4 Stargardt mutants showed significantly reduced phospholipid transport activity and subcellular mislocalization. These studies provide the first direct evidence for ABCA1 and ABCA7 functioning as phospholipid transporters and suggest that this activity is an essential step in the loading of apoA-1 with phospholipids for HDL formation.	[Quazi, Faraz; Molday, Robert S.] Univ British Columbia, Dept Biochem & Mol Biol, Ctr Macular Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Molday, RS (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	molday@mail.ubc.ca			National Institutes of Health [EY002422]; Natural Sciences and Engineering Research Council of Canada; NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY002422.; Supported by a predoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada.	Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Ahn J, 2000, J BIOL CHEM, V275, P20399, DOI 10.1074/jbc.M000555200; Ahn JH, 2003, J BIOL CHEM, V278, P39600, DOI 10.1074/jbc.M304236200; Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Beharry S, 2004, J BIOL CHEM, V279, P53972, DOI 10.1074/jbc.M405216200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Coleman JA, 2013, BBA-MOL CELL BIOL L, V1831, P555, DOI 10.1016/j.bbalip.2012.10.006; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Hassan HH, 2007, J LIPID RES, V48, P2428, DOI 10.1194/jlr.M700206-JLR200; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hozoji M, 2009, J BIOL CHEM, V284, P11293, DOI 10.1074/jbc.M900580200; Iatan I, 2011, J LIPID RES, V52, P2043, DOI 10.1194/jlr.M016196; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Kim WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.wnr.0000221833.41340.cd; LAKOWICZ JR, 1980, J BIOCHEM BIOPH METH, V2, P91, DOI 10.1016/0165-022X(80)90077-9; Linsel-Nitschke P, 2005, J LIPID RES, V46, P86, DOI 10.1194/jlr.M400247-JLR200; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Molday RS, 2009, BBA-MOL CELL BIOL L, V1791, P573, DOI 10.1016/j.bbalip.2009.02.004; Nagao K, 2012, BBA-MOL CELL BIOL L, V1821, P530, DOI 10.1016/j.bbalip.2011.06.024; Nagao K, 2011, FEBS J, V278, P3190, DOI 10.1111/j.1742-4658.2011.08170.x; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Nasonkin I, 1998, HUM GENET, V102, P21, DOI 10.1007/s004390050649; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Piehler Armin P, 2012, Front Psychiatry, V3, P17, DOI 10.3389/fpsyt.2012.00017; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Rajasekharan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028401; Reboul E, 2013, BIOCHIMIE, V95, P957, DOI 10.1016/j.biochi.2012.11.009; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2006, CIRC RES, V99, P389, DOI 10.1161/01.RES.0000237920.70451.ad; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Szakacs G, 2001, BIOCHEM BIOPH RES CO, V288, P1258, DOI 10.1006/bbrc.2001.5905; Takahashi K, 2006, J BIOL CHEM, V281, P10760, DOI 10.1074/jbc.M513783200; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3177, DOI 10.2741/2305; Wong JP, 2009, J PROTEOME RES, V8, P2388, DOI 10.1021/pr801008c; Zhong M, 2009, J BIOL CHEM, V284, P3640, DOI 10.1074/jbc.M806580200	59	130	134	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34414	34426		10.1074/jbc.M113.508812	http://dx.doi.org/10.1074/jbc.M113.508812			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24097981	Green Published, hybrid			2022-12-28	WOS:000329812800013
J	Shiryaev, SA; Remacle, AG; Chernov, AV; Golubkov, VS; Motamedchaboki, K; Muranaka, N; Dambacher, CM; Capek, P; Kukreja, M; Kozlov, IA; Perucho, M; Cieplak, P; Strongin, AY				Shiryaev, Sergey A.; Remacle, Albert G.; Chernov, Andrei V.; Golubkov, Vladislav S.; Motamedchaboki, Khatereh; Muranaka, Norihito; Dambacher, Corey M.; Capek, Petr; Kukreja, Muskan; Kozlov, Igor A.; Perucho, Manuel; Cieplak, Piotr; Strongin, Alex Y.			Substrate Cleavage Profiling Suggests a Distinct Function of Bacteroides fragilis Metalloproteinases (Fragilysin and Metalloproteinase II) at the Microbiome-Inflammation-Cancer Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Enzymes; Metalloprotease; Microbial Pathogenesis; Toxins; Bacteroides; Fragilysin	IN-VITRO SELECTION; PATHOGENICITY ISLAND; KAPPA-B; HUMAN COMMENSAL; ENTEROTOXIN; PROTEIN; TOXIN; INHIBITORS; GENE; COLITIS	Background: Two distinct metalloproteinase types (fragilysin and metalloproteinase II/MPII) are encoded by the Bacteroides fragilis pathogenicity island. Results: Our assays determined substrate cleavage characteristics of fragilysin and MPII. Conclusion: MPII is the first zinc metalloproteinase with the dibasic cleavage preferences. Significance: Our results are important for understanding B. fragilis virulence and fundamental roles of the microbiome in human health and disease. Enterotoxigenic anaerobic Bacteroides fragilis is a significant source of inflammatory diarrheal disease and a risk factor for colorectal cancer. Two distinct metalloproteinase types (the homologous 1, 2, and 3 isoforms of fragilysin (FRA1, FRA2, and FRA3, respectively) and metalloproteinase II (MPII)) are encoded by the B. fragilis pathogenicity island. FRA was demonstrated to be important to pathogenesis, whereas MPII, also a potential virulence protein, remained completely uncharacterized. Here, we, for the first time, extensively characterized MPII in comparison with FRA3, a representative of the FRA isoforms. We employed a series of multiplexed peptide cleavage assays to determine substrate specificity and proteolytic characteristics of MPII and FRA. These results enabled implementation of an efficient assay of MPII activity using a fluorescence-quenched peptide and contributed to structural evidence for the distinct substrate cleavage preferences of MPII and FRA. Our data imply that MPII specificity mimics the dibasic ArgArg cleavage motif of furin-like proprotein convertases, whereas the cleavage motif of FRA (Pro-X-X-Leu-(Arg/Ala/Leu)) resembles that of human matrix metalloproteinases. To the best of our knowledge, MPII is the first zinc metalloproteinase with the dibasic cleavage preferences, suggesting a high level of versatility of metalloproteinase proteolysis. Based on these data, we now suggest that the combined (rather than individual) activity of MPII and FRA is required for the overall B. fragilis virulence in vivo.	[Shiryaev, Sergey A.; Remacle, Albert G.; Chernov, Andrei V.; Golubkov, Vladislav S.; Motamedchaboki, Khatereh; Perucho, Manuel; Cieplak, Piotr; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Muranaka, Norihito; Dambacher, Corey M.; Capek, Petr; Kukreja, Muskan; Kozlov, Igor A.] Prognosys Biosci Inc, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Chernov, Andrei/I-1623-2019; Golubkov, Vladislav/L-6828-2017; Capek, Petr/G-1303-2012; Strongin, Alex/R-6609-2019	Chernov, Andrei/0000-0002-3294-5418; Strongin, Alex/0000-0003-3765-3016; Perucho, Manuel/0000-0002-2169-2662	National Institutes of Health [R01CA83017, R01CA157328, R01DE022757, R44GM085884, R01GM098835]; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM085884, R01GM098835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA83017, R01CA157328, and R01DE022757 (to A.Y.S) R44GM085884 (to I.A.K.), and R01GM098835 (to P. Cieplak).	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2012, AMBER 12; Chan AT, 2012, CANCER PREV RES, V5, P164, DOI 10.1158/1940-6207.CAPR-11-0391; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Claros MC, 2006, ANAEROBE, V12, P17, DOI 10.1016/j.anaerobe.2005.06.005; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dejea C, 2013, FUTURE MICROBIOL, V8, P445, DOI [10.2217/fmb.13.17, 10.2217/FMB.13.17]; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Foulon I, 2003, J CLIN MICROBIOL, V41, P4428, DOI 10.1128/JCM.41.9.4428-4430.2003; Franco AA, 1999, J BACTERIOL, V181, P6623, DOI 10.1128/JB.181.21.6623-6633.1999; Franco AA, 2004, J BACTERIOL, V186, P6077, DOI 10.1128/jb.186.18.6077-6092.2004; GALARDY RE, 1994, ANN NY ACAD SCI, V732, P315, DOI 10.1111/j.1749-6632.1994.tb24746.x; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Holton John, 2008, Curr Infect Dis Rep, V10, P99, DOI 10.1007/s11908-008-0018-7; Housseau F, 2010, CELL CYCLE, V9, P3, DOI 10.4161/cc.9.1.10352; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kling JJ, 1997, FEMS MICROBIOL LETT, V146, P279, DOI 10.1016/S0378-1097(96)00488-0; Kozlov IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037441; Kurz M, 2001, CHEMBIOCHEM, V2, P666, DOI 10.1002/1439-7633(20010903)2:9<666::AID-CBIC666>3.0.CO;2-#; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Levy DE, 1998, J MED CHEM, V41, P199, DOI 10.1021/jm970494j; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175, DOI 10.1128/IAI.63.1.175-181.1995; Noto Jennifer M, 2012, Methods Mol Biol, V921, P7; Obiso RJ, 1997, INFECT IMMUN, V65, P1431, DOI 10.1128/IAI.65.4.1431-1439.1997; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Remacle AG, 2013, J BIOL CHEM, V288, P20568, DOI 10.1074/jbc.M113.471508; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Riegler M, 1999, GUT, V44, P504, DOI 10.1136/gut.44.4.504; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Saidi RF, 1997, CELL MOTIL CYTOSKEL, V37, P159, DOI 10.1002/(SICI)1097-0169(1997)37:2<159::AID-CM8>3.3.CO;2-N; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sanchez E, 2012, APPL ENVIRON MICROB, V78, P6507, DOI 10.1128/AEM.00563-12; Sears CL, 2008, CLIN INFECT DIS, V47, P797, DOI 10.1086/591130; Sears CL, 2006, INFECT IMMUN, V74, P5595, DOI 10.1128/IAI.00135-06; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shalinsky DR, 1999, ANN NY ACAD SCI, V878, P236, DOI 10.1111/j.1749-6632.1999.tb07689.x; Shiryaev SA, 2012, PLOS ONE, V7; Shiryaev SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054290; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; Trinchieri G., 2011, F1000 MED REP, V3, P11; VANTASSELL RL, 1992, INFECT IMMUN, V60, P1343, DOI 10.1128/IAI.60.4.1343-1350.1992; Vines RR, 2000, VACCINE, V19, P655, DOI 10.1016/S0264-410X(00)00254-1; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wells CL, 1996, GASTROENTEROLOGY, V110, P1429, DOI 10.1053/gast.1996.v110.pm8613048; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wick EC, 2010, CURR OPIN INFECT DIS, V23, P470, DOI 10.1097/QCO.0b013e32833da1eb; Woessner JF, 1999, ANN NY ACAD SCI, V878, P388, DOI 10.1111/j.1749-6632.1999.tb07697.x; Wu SG, 2004, INFECT IMMUN, V72, P5832, DOI 10.1128/IAI.72.10.5832-5839.2004; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455; Wu SG, 2006, INFECT IMMUN, V74, P5382, DOI 10.1128/IAI.00060-06; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yiotakis A, 2008, MOL ASPECTS MED, V29, P329, DOI 10.1016/j.mam.2008.06.001; Yoon YM, 2010, INFECT IMMUN, V78, P2024, DOI 10.1128/IAI.00118-10	73	19	20	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34956	34967		10.1074/jbc.M113.516153	http://dx.doi.org/10.1074/jbc.M113.516153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145028	Green Published, hybrid			2022-12-28	WOS:000329812800061
J	Zhang, YJ; Zhang, LY; Wu, JH; Di, CX; Xia, ZW				Zhang, Yanjie; Zhang, Liya; Wu, Jinhong; Di, Caixia; Xia, Zhenwei			Heme Oxygenase-1 Exerts a Protective Role in Ovalbumin-induced Neutrophilic Airway Inflammation by Inhibiting Th17 Cell-mediated Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Asthma; Heme Oxygenase; Immunology; Inflammation; T Cell; Th17; Treg	REGULATORY T-CELLS; RECEPTOR TRANSGENIC MICE; OXIDATIVE STRESS; UP-REGULATION; T(H)17 CELLS; IN-VIVO; ASTHMA; STAT3; HYPERREACTIVITY; PROLIFERATION	Background: Heme oxygenase-1 (HO-1) is an inducible enzyme that exerts multiple physiological functions. Results: Induction of HO-1 inhibits Th17-mediated neutrophilic airway inflammation in vivo and suppresses Th17 cell differentiation in vitro. Conclusion: HO-1 exhibits anti-inflammatory activity in non-eosinophilic asthma (NEA) by inhibiting Th17 responses. Significance: HO-1 may become a novel therapeutic target in NEA. Allergic asthma is conventionally considered as a Th2 immune response characterized by eosinophilic inflammation. Recent investigations revealed that Th17 cells play an important role in the pathogenesis of non-eosinophilic asthma (NEA), resulting in steroid-resistant neutrophilic airway inflammation. Heme oxygenase-1 (HO-1) has anti-inflammation, anti-oxidation, and anti-apoptosis functions. However, its role in NEA is still unclear. Here, we explore the role of HO-1 in a mouse model of NEA. HO-1 inducer hemin or HO-1 inhibitor tin protoporphyrin IX was injected intraperitoneally into ovalbumin-challenged DO11.10 mice. Small interfering RNA (siRNA) was delivered into mice to knock down HO-1 expression. The results show that induction of HO-1 by hemin attenuated airway inflammation and decreased neutrophil infiltration in bronchial alveolar lavage fluid and was accompanied by a lower proportion of Th17 cells in mediastinal lymph nodes and spleen. More importantly, induction of HO-1 down-regulated Th17-related transcription factor retinoic acid-related orphan receptor t (RORt) expression and decreased IL-17A levels, all of which correlated with a decrease in phosphorylated STAT3 (p-STAT3) level and inhibition of Th17 cell differentiation. Consistently, the above events could be reversed by tin protoporphyrin IX. Also, HO-1 siRNA transfection abolished the effect of hemin induced HO-1 in vivo. Meanwhile, the hemin treatment promoted the level of Foxp3 expression and enhanced the proportion of regulatory T cells (Tregs). Collectively, our findings indicate that HO-1 exhibits anti-inflammatory activity in the mouse model of NEA via inhibition of the p-STAT3-RORt pathway, regulating kinetics of RORt and Foxp3 expression, thus providing a possible novel therapeutic target in asthmatic patients.	[Zhang, Yanjie; Zhang, Liya; Wu, Jinhong; Di, Caixia; Xia, Zhenwei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pediat, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Xia, ZW (corresponding author), Ruijin Hosp, Dept Pediat, Ruijin 2nd Rd 197, Shanghai 200025, Peoples R China.	xzw63@hotmail.com			National Natural Science Foundation of China [81070022, 81128001, 81270084]; Shanghai Municipal Science and Technology Commission Foundation [13XD1402800, 10410701000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission Foundation	This work was supported by National Natural Science Foundation of China Grants 81070022, 81128001, and 81270084 and Shanghai Municipal Science and Technology Commission Foundation Grants 13XD1402800 and 10410701000.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Almolki A, 2004, AM J PHYSIOL-LUNG C, V287, pL26, DOI 10.1152/ajplung.00237.2003; Almolki A, 2008, AM J PATHOL, V173, P981, DOI 10.2353/ajpath.2008.070863; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chang TJ, 2008, AM J PHYSIOL-HEART C, V295, pH999, DOI 10.1152/ajpheart.01289.2007; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Chen HL, 2012, INFLAMMATION, V35, P1087, DOI 10.1007/s10753-011-9415-4; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Desbuards N, 2007, THROMB HAEMOSTASIS, V98, P614, DOI 10.1160/TH06-12-0717; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Elguero B, 2012, NEOPLASIA, V14, P1043, DOI 10.1593/neo.121358; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gao HW, 2007, EXPERT OPIN THER TAR, V11, P869, DOI 10.1517/14728222.11.7.869; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jia YX, 1999, INT ARCH ALLERGY IMM, V120, P141, DOI 10.1159/000024232; Kikuchi S, 2005, INT ARCH ALLERGY IMM, V137, P7, DOI 10.1159/000085425; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Knott PG, 2000, AM J RESP CRIT CARE, V161, P1340, DOI 10.1164/ajrccm.161.4.9906078; Kobayashi H, 2006, ARTHRITIS RHEUM-US, V54, P1132, DOI 10.1002/art.21754; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin TH, 2010, J CELL PHYSIOL, V222, P757, DOI 10.1002/jcp.22008; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128; Nakagome K, 2011, J IMMUNOL, V186, P5975, DOI 10.4049/jimmunol.1001274; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Presser K, 2008, J IMMUNOL, V181, P7751, DOI 10.4049/jimmunol.181.11.7751; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Scott MJ, 2002, CLIN DIAGN LAB IMMUN, V9, P1153, DOI 10.1128/CDLI.9.6.1153-1159.2002; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Song RP, 2004, J IMMUNOL, V172, P1220, DOI 10.4049/jimmunol.172.2.1220; Tae YM, 2012, J IMMUNOL, V188, P1799, DOI 10.4049/jimmunol.1102481; Takeda Y, 2004, CLIN EXP IMMUNOL, V138, P237, DOI 10.1111/j.1365-2249.2004.02594.x; Tanaka S, 2009, J IMMUNOL, V183, P7523, DOI 10.4049/jimmunol.0803828; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Varga C, 2007, EUR J PHARMACOL, V561, P164, DOI 10.1016/j.ejphar.2006.12.022; Wilder JA, 2001, J LEUKOCYTE BIOL, V69, P538; Wong CK, 2009, IMMUNOL INVEST, V38, P652, DOI 10.1080/08820130903062756; Wu JY, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-77; Xia ZW, 2007, AM J PATHOL, V171, P1904, DOI 10.2353/ajpath.2007.070096; Xia ZW, 2006, J IMMUNOL, V177, P5936, DOI 10.4049/jimmunol.177.9.5936; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Ye JA, 2011, EUR J IMMUNOL, V41, P936, DOI 10.1002/eji.201040682; Yoriki H, 2013, J GASTROEN HEPATOL, V28, P632, DOI 10.1111/jgh.12074; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	59	51	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34612	34626		10.1074/jbc.M113.494369	http://dx.doi.org/10.1074/jbc.M113.494369			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24097973	Green Published, hybrid			2022-12-28	WOS:000329812800029
J	Amengual, J; Widjaja-Adhi, MAK; Rodriguez-Santiago, S; Hessel, S; Golczak, M; Palczewski, K; von Lintig, J				Amengual, Jaume; Widjaja-Adhi, M. Airanthi K.; Rodriguez-Santiago, Susana; Hessel, Susanne; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes			Two Carotenoid Oxygenases Contribute to Mammalian Provitamin A Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carotenoid; Enzymes; Liver; Metabolism; Vitamin A	LECITHIN-RETINOL ACYLTRANSFERASE; BETA-CAROTENE; VITAMIN-A; IN-VITRO; ENZYMATIC CLEAVAGE; OXIDATIVE CLEAVAGE; STRUCTURAL BASIS; CELLULAR UPTAKE; ACID; IDENTIFICATION	Background: Mammalian genomes encode two carotenoid oxygenases, but their contributions to vitamin A homeostasis remain undefined. Results: Mammals employ symmetric and eccentric cleaving carotenoid oxygenases to convert different provitamin A carotenoids to vitamin A. Conclusion: Both carotenoid oxygenases contribute to vitamin A production. Significance: Carotenoids are the major source for vitamin A in the human diet. Mammalian genomes encode two provitamin A-converting enzymes as follows: the -carotene-15,15-oxygenase (BCO1) and the -carotene-9,10-oxygenase (BCO2). Symmetric cleavage by BCO1 yields retinoids (-15-apocarotenoids, C-20), whereas eccentric cleavage by BCO2 produces long-chain (>C-20) apocarotenoids. Here, we used genetic and biochemical approaches to clarify the contribution of these enzymes to provitamin A metabolism. We subjected wild type, Bco1(-/-), Bco2(-/-), and Bco1(-/-)Bco2(-/-) double knock-out mice to a controlled diet providing -carotene as the sole source for apocarotenoid production. This study revealed that BCO1 is critical for retinoid homeostasis. Genetic disruption of BCO1 resulted in -carotene accumulation and vitamin A deficiency accompanied by a BCO2-dependent production of minor amounts of -apo-10-carotenol (APO10ol). We found that APO10ol can be esterified and transported by the same proteins as vitamin A but with a lower affinity and slower reaction kinetics. In wild type mice, APO10ol was converted to retinoids by BCO1. We also show that a stepwise cleavage by BCO2 and BCO1 with APO10ol as an intermediate could provide a mechanism to tailor asymmetric carotenoids such as -cryptoxanthin for vitamin A production. In conclusion, our study provides evidence that mammals employ both carotenoid oxygenases to synthesize retinoids from provitamin A carotenoids.	[Amengual, Jaume; Widjaja-Adhi, M. Airanthi K.; Rodriguez-Santiago, Susana; Hessel, Susanne; Golczak, Marcin; Palczewski, Krzysztof; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol W341, 10900 Euclid Ave, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		von Lintig, Johannes/0000-0002-2079-2143; Widjaja-Adhi, Made Airanthi K./0000-0002-0589-2605	National Institutes of Health from NEI [RO1EY019641, RO1EY020551]; NATIONAL EYE INSTITUTE [R01EY019641, R01EY020551] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1EY019641 and RO1EY020551 from the NEI.	Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golczak M, 2012, J BIOL CHEM, V287, P23790, DOI 10.1074/jbc.M112.361550; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GRISCAVAGE JM, 1995, BIOCHEM BIOPH RES CO, V215, P721, DOI 10.1006/bbrc.1995.2523; Grune T., 2010, JOUNRAL NUTR, V140, P2268; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; HANDELMAN GJ, 1991, FREE RADICAL BIO MED, V10, P427, DOI 10.1016/0891-5849(91)90051-4; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kowatz T., 2013, ARCH BIOCH BIOPHYS, DOI 10.1016/j.abb.2013.05.007; Lietz G, 2010, ARCH BIOCHEM BIOPHYS, V502, P8, DOI 10.1016/j.abb.2010.06.032; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Liu LM, 2008, BIOCHEM PHARMACOL, V75, P2316, DOI 10.1016/j.bcp.2008.03.012; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Mein JR, 2011, ARCH BIOCHEM BIOPHYS, V506, P109, DOI 10.1016/j.abb.2010.11.005; Messing SAJ, 2010, PLANT CELL, V22, P2970, DOI 10.1105/tpc.110.074815; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Oberhauser V, 2008, P NATL ACAD SCI USA, V105, P19000, DOI 10.1073/pnas.0807805105; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; SHARMA RV, 1976, BIOCHEM J, V158, P377, DOI 10.1042/bj1580377; SHARMA RV, 1977, BIOCHIM BIOPHYS ACTA, V486, P183, DOI 10.1016/0005-2760(77)90083-2; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; Sommer A, 2012, AM J CLIN NUTR, V96, p1204S, DOI 10.3945/ajcn.112.034868; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; van Helden YGJ, 2010, CELL MOL LIFE SCI, V67, P2039, DOI 10.1007/s00018-010-0341-7; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang XD, 1996, J BIOL CHEM, V271, P26490, DOI 10.1074/jbc.271.43.26490; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; WOLF G, 1995, NUTR REV, V53, P134, DOI 10.1111/j.1753-4887.1995.tb01537.x; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619	54	113	116	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34081	34096		10.1074/jbc.M113.501049	http://dx.doi.org/10.1074/jbc.M113.501049			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106281	Green Published, hybrid			2022-12-28	WOS:000327250200051
J	Banerjee, S; Sangwan, V; McGinn, O; Chugh, R; Dudeja, V; Vickers, SM; Saluja, AK				Banerjee, Sulagna; Sangwan, Veena; McGinn, Olivia; Chugh, Rohit; Dudeja, Vikas; Vickers, Selwyn M.; Saluja, Ashok K.			Triptolide-induced Cell Death in Pancreatic Cancer Is Mediated by O-GlcNAc Modification of Transcription Factor Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat Shock Protein; O-GlcNAc; Pancreas; Pancreatic Cancer; Sp1; Minnelide; Triptolide	N-ACETYLGLUCOSAMINE TRANSFERASE; IN-VITRO; KAPPA-B; TUMOR-GROWTH; APOPTOSIS; INHIBITION; EXPRESSION; GENE; ACTIVATION; PATHWAYS	Pancreatic cancer, the fourth most prevalent cancer-related cause of death in the United States, is a disease with a dismal survival rate of 5% 5 years after diagnosis. One of the survival proteins responsible for its extraordinary ability to evade cell death is HSP70. A naturally derived compound, triptolide, and its water-soluble prodrug, Minnelide, down-regulate the expression of this protein in pancreatic cancer cells, thereby causing cell death. However, the mechanism of action of triptolide has not been elucidated. Our study shows that triptolide-induced down-regulation of HSP70 expression is associated with a decrease in glycosylation of the transcription factor Sp1. We further show that triptolide inhibits glycosylation of Sp1, inhibiting the hexosamine biosynthesis pathway, particularly the enzyme O-GlcNAc transferase. Inhibition of O-GlcNAc transferase prevents nuclear localization of Sp1 and affects its DNA binding activity. This in turn down-regulates prosurvival pathways like NF-B, leading to inhibition of HSF1 and HSP70 and eventually to cell death. In this study, we evaluated the mechanism by which triptolide affects glycosylation of Sp1, which in turn affects downstream pathways controlling survival of pancreatic cancer cells.	[Banerjee, Sulagna; Sangwan, Veena; McGinn, Olivia; Chugh, Rohit; Dudeja, Vikas; Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Div Basic & Translat Res, Dept Surg, Minneapolis, MN 55455 USA; [Vickers, Selwyn M.; Saluja, Ashok K.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Saluja, AK (corresponding author), Univ Minnesota, Div Basic & Translat Res, Dept Surg, 515 Delaware St SE, Minneapolis, MN 55455 USA.	asaluja@umn.edu	McGinn, Olivia/J-8337-2015	McGinn, Olivia/0000-0003-0769-5581	National Institutes of Health UAB/UMN SPORE in Pancreatic Cancer Grant from NCI [P50 CA101955];  [T32CA132715];  [R01 CA170946];  [CA124723]; NATIONAL CANCER INSTITUTE [P50CA101955, R01CA170946, R01CA124723, T32CA132715] Funding Source: NIH RePORTER	National Institutes of Health UAB/UMN SPORE in Pancreatic Cancer Grant from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health UAB/UMN SPORE in Pancreatic Cancer Grant P50 CA101955 from NCI (to S. M. V.), Training Grant T32CA132715 (to R. C.), and Grants R01 CA170946 and CA124723 (to A. K. S.). University of Minnesota has filed a patent for Minnelide, which has been licensed to Minneamrita Therapeutics, LLC. A. K. S. and S. M. V. have financial interests in this company. A. K. S., S. M. V., and R. C. are inventors on this patent.	Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Antonoff MB, 2009, SURGERY, V146, P282, DOI 10.1016/j.surg.2009.04.023; Banerjee S., 2012, PLOS ONE, V7; Banerjee S, 2013, CANCER LETT, V335, P412, DOI 10.1016/j.canlet.2013.02.050; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Blasco F, 2004, ONCOLOGY-BASEL, V67, P277, DOI 10.1159/000081329; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Dudeja V, 2009, GASTROENTEROLOGY, V136, P1772, DOI 10.1053/j.gastro.2009.01.070; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Krosch TCK, 2013, AM J SURG, V205, P387, DOI 10.1016/j.amjsurg.2013.01.008; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Majumdar G, 2004, DIABETES, V53, P3184, DOI 10.2337/diabetes.53.12.3184; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Sclabas GM, 2005, CANCER-AM CANCER SOC, V103, P2485, DOI 10.1002/cncr.21075; Shi Q, 2001, CANCER RES, V61, P4143; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Tengchaisri T, 1998, CANCER LETT, V133, P169, DOI 10.1016/S0304-3835(98)00222-5; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yang M, 2008, INT J MOL MED, V22, P489, DOI 10.3892/ijmm_00000047; Yang SM, 2003, MOL CANCER THER, V2, P65; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	39	86	89	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33927	33938		10.1074/jbc.M113.500983	http://dx.doi.org/10.1074/jbc.M113.500983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129563	Green Published, hybrid			2022-12-28	WOS:000327250200035
J	Burke, TL; Miller, JL; Grant, PA				Burke, Tara L.; Miller, Jaime L.; Grant, Patrick A.			Direct Inhibition of Gcn5 Protein Catalytic Activity by Polyglutamine-expanded Ataxin-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Expression; Histone Acetylase; Histone Modification; Neurodegeneration; Polyglutamine Disease; Protein Complexes; Spinocerebellar Ataxia Type 7	HISTONE ACETYLTRANSFERASE ACTIVITY; IN-VIVO; RETINAL DEGENERATION; REPEAT EXPANSION; HAT COMPLEXES; SAGA; ACETYLATION; RECRUITMENT; DEUBIQUITINATION; IDENTIFICATION	Background: Polyglutamine expansion of the ataxin-7 protein, a subunit of the SAGA (Spt-Ada-Gcn5-acetyltransferase) complex, causes spinocerebellar ataxia type 7. Results: Polyglutamine-expanded ataxin-7 aberrantly binds to SAGA, affecting Gcn5 acetyltransferase activity at SAGA-regulated genes. Conclusion: Ataxin-7 exhibits a dominant-negative effect on Gcn5 catalytic activity in vivo. Significance: We show a direct dominant effect of polyglutamine-expanded ataxin-7 on SAGA acetyltransferase function. Spinocerebellar ataxia type 7 (SCA7) is a neurodegenerative disease caused by polyglutamine (polyQ) expansion within the N-terminal region of the ataxin-7 protein, a known subunit of the SAGA complex. Although the mechanisms of SCA7 pathogenesis remain poorly understood, previous studies have shown perturbations in SAGA histone acetyltransferase function and transcriptional alterations. We sought to determine whether and how polyQ-expanded ataxin-7 affects SAGA catalytic activity. Here, we determined that polyQ-expanded ataxin-7 directly bound the Gcn5 catalytic core of SAGA while in association with its regulatory proteins, Ada2 and Ada3. This caused a significant decrease in Gcn5 histone acetyltransferase activity in vitro and in vivo at two SAGA-regulated galactose genes, GAL1 and GAL7. However, Gcn5 occupancy at the GAL1 and GAL7 promoters was increased in these cells, revealing a dominant-negative phenotype of the polyQ-expanded ataxin-7-incorporated, catalytically inactive SAGA. These findings suggest a dominant mechanism of polyQ-mediated SAGA inhibition that potentially contributes to SCA7 disease pathogenesis.	[Burke, Tara L.; Miller, Jaime L.; Grant, Patrick A.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Grant, PA (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	pag9n@virginia.edu		Miller, Jaime/0000-0001-8589-9892	National Institutes of Health [R01 NS049065]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS049065 (to P.A.G.).	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Burke T. L., 2011, REGULATION ORGANELLE, P109; Chen YC, 2012, HUM MOL GENET, V21, P394, DOI 10.1093/hmg/ddr474; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; McCullough SD, 2012, P NATL ACAD SCI USA, V109, P21319, DOI 10.1073/pnas.1218331110; McCullough SD, 2010, ADV PROTEIN CHEM STR, V79, P165, DOI 10.1016/S1876-1623(10)79005-2; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; McMahon SJ, 2004, METHOD ENZYMOL, V377, P154; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Roberts SM, 1997, GENETICS, V147, P451; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108	32	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34266	34275		10.1074/jbc.M113.487538	http://dx.doi.org/10.1074/jbc.M113.487538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129567	Green Published, hybrid			2022-12-28	WOS:000327250200069
J	Li, X; Nooh, MM; Bahouth, SW				Li, Xin; Nooh, Mohammed M.; Bahouth, Suleiman W.			Role of AKAP79/150 Protein in beta(1)-Adrenergic Receptor Trafficking and Signaling in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenergic Receptor; AKAP; Cyclic AMP (cAMP); Fluorescence Resonance Energy Transfer (FRET); G-protein-coupled Receptors (GPCR); Protein Kinase A (PKA); Receptor Recycling; Trafficking	KINASE-ANCHORING PROTEINS; GLUTAMATE RECEPTORS; IN-VIVO; PKA; CARDIOMYOCYTES; CALCINEURIN; ASSOCIATION; MEMBRANE; SCAFFOLD; BETA(1)	Protein kinase A-anchoring proteins (AKAPs) participate in the formation of macromolecular signaling complexes that include protein kinases, ion channels, effector enzymes, and G-protein-coupled receptors. We examined the role of AKAP79/150 (AKAP5) in trafficking and signaling of the (1)-adrenergic receptor ((1)-AR). shRNA-mediated down-regulation of AKAP5 in HEK-293 cells inhibited the recycling of the (1)-AR. Recycling of the (1)-AR in AKAP5 knockdown cells was rescued by shRNA-resistant AKAP5. However, truncated mutants of AKAP5 with deletions in the domains involved in membrane targeting or in binding to calcineurin or PKA failed to restore the recycling of the (1)-AR, indicating that full-length AKAP5 was required. Furthermore, recycling of the (1)-AR in rat neonatal cardiac myocytes was dependent on targeting the AKAP5-PKA complex to the C-terminal tail of the (1)-AR. To analyze the role of AKAP5 more directly, recycling of the (1)-AR was determined in ventricular myocytes from AKAP5(-/-) mice. In AKAP5(-/-) myocytes, the agonist-internalized (1)-AR did not recycle, except when full-length AKAP5 was reintroduced. These data indicate that AKAP5 exerted specific and profound effects on (1)-AR recycling in mammalian cells. Biochemical or real time FRET-based imaging of cyclic AMP revealed that deletion of AKAP5 sensitized the cardiac (1)-AR signaling pathway to isoproterenol. Moreover, isoproterenol-mediated increase in contraction rate, surface area, or expression of -myosin heavy chains was significantly greater in AKAP5(-/-) myocytes than in AKAP5(+/+) myocytes. These results indicate a significant role for the AKAP5 scaffold in signaling and trafficking of the (1)-AR in cardiac myocytes and mammalian cells.	[Li, Xin; Nooh, Mohammed M.; Bahouth, Suleiman W.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Bahouth, SW (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	sbahouth@uthsc.edu		Nooh, Mohammed/0000-0001-9794-4099	National Institutes of Health [HL-085848]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-085848 (to S. W. B.).	Bahouth SW, 1997, J MOL CELL CARDIOL, V29, P3223, DOI 10.1006/jmcc.1997.0549; Baker JG, 2011, FASEB J, V25, P4486, DOI 10.1096/fj.11-192435; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bisognano JD, 2000, J MOL CELL CARDIOL, V32, P817, DOI 10.1006/jmcc.2000.1123; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; COHN JN, 1989, AM J HYPERTENS, V2, pS353; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Delos Santos NM, 2006, J BIOL CHEM, V281, P12896, DOI 10.1074/jbc.M508500200; Devic E, 2001, MOL PHARMACOL, V60, P577; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Faul C, 2007, MOL CELL BIOL, V27, P8215, DOI 10.1128/MCB.00950-07; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gooch JL, 2006, J CELL SCI, V119, P2468, DOI 10.1242/jcs.02971; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Horvat SJ, 2012, FASEB J, V26, P3670, DOI 10.1096/fj.11-201020; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Jo IH, 2001, AM J PHYSIOL-RENAL, V281, pF958; Jones BW, 2012, P NATL ACAD SCI USA, V109, P17099, DOI 10.1073/pnas.1215219109; Kapiloff MS, 2002, MOL PHARMACOL, V62, P193, DOI 10.1124/mol.62.2.193; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KOWALSKI MT, 1990, BRIT J PHARMACOL, V99, P27, DOI 10.1111/j.1476-5381.1990.tb14648.x; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Logue JS, 2010, FEBS J, V277, P4370, DOI 10.1111/j.1742-4658.2010.07866.x; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Nooh MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063379; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Schafer M, 2000, AM J PHYSIOL-CELL PH, V279, pC495, DOI 10.1152/ajpcell.2000.279.2.C495; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; YU SS, 1993, J BIOL CHEM, V268, P337	56	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33797	33812		10.1074/jbc.M113.470559	http://dx.doi.org/10.1074/jbc.M113.470559			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121510	Green Published, hybrid			2022-12-28	WOS:000327250200025
J	Yan, YL; Shapiro, AP; Haller, S; Katragadda, V; Liu, LJ; Tian, J; Basrur, V; Malhotra, D; Xie, ZJ; Abraham, NG; Shapiro, JI; Liu, J				Yan, Yanling; Shapiro, Anna P.; Haller, Steven; Katragadda, Vinai; Liu, Lijun; Tian, Jiang; Basrur, Venkatesha; Malhotra, Deepak; Xie, Zi-jian; Abraham, Nader G.; Shapiro, Joseph I.; Liu, Jiang			Involvement of Reactive Oxygen Species in a Feed-forward Mechanism of Na/K-ATPase-mediated Signaling Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hypertension; NAK-ATPase; Reactive Oxygen Species (ROS); Signal Transduction; Sodium Transport; Na; K-ATPase Signaling	ENDOGENOUS CARDIOTONIC STEROIDS; SALT-SENSITIVE RATS; NA+/K+-ATPASE; STATISTICAL-MODEL; OXIDATIVE STRESS; LLC-PK1 CELLS; SODIUM-PUMP; K+-ATPASE; OUABAIN; SRC	Background: Na/K-ATPase signaling regulates sodium reabsorption in renal proximal tubules. Results: Carbonylation modification of the Na/K-ATPase 1 subunit regulates Na/K-ATPase signaling and subsequent transepithelial sodium transport. Conclusion: ROS is involved in the Na/K-ATPase signaling transduction in a feed-forward mechanism. Significance: ROS regulates Na/K-ATPase signaling and sodium transport in LLC-PK1 cells. Cardiotonic steroids (such as ouabain) signaling through Na/K-ATPase regulate sodium reabsorption in the renal proximal tubule. We report here that reactive oxygen species are required to initiate ouabain-stimulated Na/K-ATPasec-Src signaling. Pretreatment with the antioxidant N-acetyl-l-cysteine prevented ouabain-stimulated Na/K-ATPasec-Src signaling, protein carbonylation, redistribution of Na/K-ATPase and sodium/proton exchanger isoform 3, and inhibition of active transepithelial Na-22(+) transport. Disruption of the Na/K-ATPasec-Src signaling complex attenuated ouabain-stimulated protein carbonylation. Ouabain-stimulated protein carbonylation is reversed after removal of ouabain, and this reversibility is largely independent of de novo protein synthesis and degradation by either the lysosome or the proteasome pathways. Furthermore, ouabain stimulated direct carbonylation of two amino acid residues in the actuator domain of the Na/K-ATPase 1 subunit. Taken together, the data indicate that carbonylation modification of the Na/K-ATPase 1 subunit is involved in a feed-forward mechanism of regulation of ouabain-mediated renal proximal tubule Na/K-ATPase signal transduction and subsequent sodium transport.	[Yan, Yanling; Abraham, Nader G.; Shapiro, Joseph I.; Liu, Jiang] Marshall Univ, JCE Sch Med, Dept Pharmacol Physiol & Toxicol, Huntington, WV 25755 USA; [Shapiro, Anna P.; Haller, Steven; Katragadda, Vinai; Tian, Jiang; Malhotra, Deepak; Xie, Zi-jian; Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA; [Liu, Lijun; Tian, Jiang; Xie, Zi-jian] Univ Toledo, Coll Med, Dept Pharmacol, Toledo, OH 43614 USA; [Yan, Yanling] Yanshan Univ, Inst Biomed Engn, Qinhuangdao 066004, Peoples R China; [Basrur, Venkatesha] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Marshall University; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Yanshan University; University of Michigan System; University of Michigan	Liu, J (corresponding author), Marshall Univ, Joan C Edwards Sch Med, Dept Pharmacol Physiol & Toxicol, 1 John Marshall Dr, Huntington, WV 25755 USA.	liuj@marshall.edu	Liu, Jiang/AAF-2742-2021; Yan, Yanling/AAX-1691-2020; Yan, Yanling/AAE-8460-2021	Yan, Yanling/0000-0001-6549-3393; 	National Institutes of Health [RO1 HL-109015, RO1 HL-105649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105649, R01HL109015, P01HL034300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-109015 (to Z.X. and J.I.S.) and RO1 HL-105649 (to J.T.).	Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Bizzozero OA, 2006, J NEUROSCI RES, V83, P656, DOI 10.1002/jnr.20771; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; Dasgupta A, 2012, ASN NEURO, V4, DOI 10.1042/AN20110064; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Fedorova OV, 2010, BBA-MOL BASIS DIS, V1802, P1230, DOI 10.1016/j.bbadis.2010.03.011; Fedorova OV, 2000, CIRCULATION, V102, P3009; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; GROSS CL, 1993, CELL BIOL TOXICOL, V9, P259, DOI 10.1007/BF00755604; Han HJ, 2005, AM J PHYSIOL-RENAL, V288, pF988, DOI 10.1152/ajprenal.00327.2004; HUANG WH, 1992, INT J BIOCHEM, V24, P621; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kennedy DJ, 2006, AM J PHYSIOL-HEART C, V291, pH3003, DOI 10.1152/ajpheart.00603.2006; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Liu J, 2002, KIDNEY INT, V62, P2118, DOI 10.1046/j.1523-1755.2002.00672.x; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu J, 2004, FEBS LETT, V577, P175, DOI 10.1016/j.febslet.2004.09.079; Liu J, 2000, J BIOL CHEM, V275, P27838; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu J, 2011, J BIOL CHEM, V286, P22806, DOI 10.1074/jbc.M111.246249; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Liu LJ, 2006, FREE RADICAL BIO MED, V41, P1548, DOI 10.1016/j.freeradbiomed.2006.08.018; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Mokry M, 2008, HYPERTENSION, V51, P922, DOI 10.1161/HYPERTENSIONAHA.107.108415; Nesher M, 2009, AM J PHYSIOL-HEART C, V297, pH2026, DOI 10.1152/ajpheart.00734.2009; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NISHI A, 1993, ACTA PHYSIOL SCAND, V149, P377, DOI 10.1111/j.1748-1716.1993.tb09633.x; Panico C, 2009, HYPERTENSION, V54, P1291, DOI 10.1161/HYPERTENSIONAHA.109.134783; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Periyasamy SM, 2005, KIDNEY INT, V67, P1868, DOI 10.1111/j.1523-1755.2005.00285.x; Petrushanko IY, 2012, J BIOL CHEM, V287, P32195, DOI 10.1074/jbc.M112.391094; Qiang W, 1999, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V21, P175; Schoner W, 2008, NEPHROL DIAL TRANSPL, V23, P2723, DOI 10.1093/ndt/gfn325; Schreck C, 2011, AM J PHYSIOL-REG I, V300, pR1023, DOI 10.1152/ajpregu.00618.2010; Thevenod F, 1999, FASEB J, V13, P1751, DOI 10.1096/fasebj.13.13.1751; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; Yan YL, 2012, MOL CELL BIOCHEM, V367, P175, DOI 10.1007/s11010-012-1331-x; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zanetti M, 2005, METH MOLEC MED, V108, P65; Zhang CJ, 2002, NITRIC OXIDE-BIOL CH, V7, P30, DOI 10.1016/S1089-8603(02)00003-4; Zheng J, 2010, FREE RADICAL RES, V44, P258, DOI 10.3109/10715760903456092	50	68	71	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34249	34258		10.1074/jbc.M113.461020	http://dx.doi.org/10.1074/jbc.M113.461020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121502	Green Published, hybrid			2022-12-28	WOS:000327250200067
J	Ghorpade, DS; Sinha, AY; Holla, S; Singh, V; Balaji, KN				Ghorpade, Devram Sampat; Sinha, Akhuri Yash; Holla, Sahana; Singh, Vikas; Balaji, Kithiganahalli Narayanaswamy			NOD2-Nitric Oxide-responsive MicroRNA-146a Activates Sonic Hedgehog Signaling to Orchestrate Inflammatory Responses in Murine Model of Inflammatory Bowel Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Inflammatory Bowel Disease; Innate Immunity; Macrophages; MicroRNA; Nitric Oxide; NOD-like Receptors (NLR); Signal Transduction; Signaling	NITRIC-OXIDE; CROHNS-DISEASE; INTESTINAL EPITHELIUM; UP-REGULATION; BOVIS BCG; NOD2; EXPRESSION; SYNTHASE; DIFFERENTIATION; MACROPHAGES	Background: Genetic variants of NOD2 are linked to inflammatory bowel disease (IBD) etiology. Results: DSS model of colitis in wild-type and inducible nitric-oxide synthase (iNOS) null mice revealed that NOD2-iNOS/NO-responsive microRNA-146a targets NUMB gene facilitating Sonic hedgehog (SHH) signaling. Conclusion: miR-146a-mediated NOD2-SHH signaling regulates gut inflammation. Significance: Identification of novel regulators of IBD provides new insights into pathophysiology and development of new therapy concepts. Inflammatory bowel disease (IBD) is a debilitating chronic inflammatory disorder of the intestine. The interactions between enteric bacteria and genetic susceptibilities are major contributors of IBD etiology. Although genetic variants with loss or gain of NOD2 functions have been linked to IBD susceptibility, the mechanisms coordinating NOD2 downstream signaling, especially in macrophages, during IBD pathogenesis are not precisely identified. Here, studies utilizing the murine dextran sodium sulfate model of colitis revealed the crucial roles for inducible nitric-oxide synthase (iNOS) in regulating pathophysiology of IBDs. Importantly, stimulation of NOD2 failed to activate Sonic hedgehog (SHH) signaling in iNOS null macrophages, implicating NO mediated cross-talk between NOD2 and SHH signaling. NOD2 signaling up-regulated the expression of a NO-responsive microRNA, miR-146a, that targeted NUMB gene and alleviated the suppression of SHH signaling. In vivo and ex vivo studies confirmed the important roles for miR-146a in amplifying inflammatory responses. Collectively, we have identified new roles for miR-146a that established novel cross-talk between NOD2-SHH signaling during gut inflammation. Potential implications of these observations in therapeutics could increase the possibility of defining and developing better regimes to treat IBD pathophysiology.	[Ghorpade, Devram Sampat; Sinha, Akhuri Yash; Holla, Sahana; Singh, Vikas; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	Singh, Vikas/AAQ-2841-2021	Singh, Vikas/0000-0003-3102-4286; Holla, Sahana/0000-0001-5186-0180	Department of Biotechnology (DBT); Department of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR), Government of India; Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); Indian Institute of Science (IISc)	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); Indian Institute of Science (IISc)(Indian Institute of Science (IISC) - Bangalore)	This study was supported by funds from the Department of Biotechnology (DBT), Department of Science and Technology (DST), Council for Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR), Government of India, and the Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA) and by infrastructure support from the ICMR (Center for advanced study in Molecular Medicine), DST (FIST), and UGC (special assistance) (to K. N. B.).; Supported by a fellowship from the Indian Institute of Science (IISc).	Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414; Bansal K, 2011, J BIOL CHEM, V286, P5823, DOI 10.1074/jbc.M110.192393; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Bauersachs J, 2011, CIRC RES, V109, P334, DOI 10.1161/CIRCRESAHA.110.228676; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Blantz RC, 2002, NEPHRON, V90, P373, DOI 10.1159/000054723; Brooks MN, 2011, CELL MICROBIOL, V13, P402, DOI 10.1111/j.1462-5822.2010.01544.x; Cho JH, 2007, ANNU REV MED, V58, P401, DOI 10.1146/annurev.med.58.061705.145024; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; El-Zaatari M, 2009, CURR OPIN ENDOCRINOL, V16, P60, DOI 10.1097/MED.0b013e328320a821; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68; Hehlio T, 2003, GUT, V52, P558, DOI 10.1136/gut.52.4.558; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Kolios G, 2004, IMMUNOLOGY, V113, P427, DOI 10.1111/j.1365-2567.2004.01984.x; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kufer TA, 2008, MOL BIOSYST, V4, P380, DOI 10.1039/b718948f; Kufer TA, 2006, ANN NY ACAD SCI, V1072, P19, DOI 10.1196/annals.1326.020; Laroux FS, 2000, ANTIOXID REDOX SIGN, V2, P391, DOI 10.1089/15230860050192161; Lees CW, 2008, PLOS MED, V5, P1761, DOI 10.1371/journal.pmed.0050239; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nielsen CM, 2004, LAB INVEST, V84, P1631, DOI 10.1038/labinvest.3700197; Ozturk H, 2007, RENAL FAILURE, V29, P249, DOI 10.1080/08860220601166289; Pan QL, 2006, INFECT IMMUN, V74, P2121, DOI 10.1128/IAI.74.4.2121-2127.2006; Pere M., 2012, J BIOMED BIOTECHNOL, V2012; Pilichos CJ, 2004, IN VIVO, V18, P513; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Rumbo M, 2005, FEBS J, V272, P444, DOI 10.1111/j.1742-4658.2004.04484.x; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Sohn JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044156; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Waldner Maximilian J, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0555s46; Wang ZW, 2011, WORLD J GASTROENTERO, V17, P118, DOI 10.3748/wjg.v17.i1.118; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	45	68	73	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33037	33048		10.1074/jbc.M113.492496	http://dx.doi.org/10.1074/jbc.M113.492496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092752	Green Published, hybrid			2022-12-28	WOS:000328841700020
J	Lo, NC; Turner, NA; Cruz, MA; Moake, J				Lo, Nathan C.; Turner, Nancy A.; Cruz, Miguel A.; Moake, Joel			Interaction of Shiga Toxin with the A-domains and Multimers of von Willebrand Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adamts13; Platelets; Thrombosis; Toxins; Von Willebrand Factor; Hemolytic Uremia; Shiga Toxin	HEMOLYTIC-UREMIC SYNDROME; FACTOR-CLEAVING PROTEASE; GLYCOPROTEIN IB-ALPHA; ESCHERICHIA-COLI; THROMBOTIC MICROANGIOPATHIES; ENDOTHELIAL-CELLS; PRIMATE MODEL; PLATELET; SECRETION; COLLAGEN	Background: VWF is a multimeric glycoprotein that causes platelet adherence and aggregation and is cleaved by ADAMTS-13. Results: Shiga toxin binds to VWF multimers, specifically the A1 and A2 domains, and decreases ADAMTS-13 cleavage rate at Tyr(1605)-Met(1606) of the A2 domain. Conclusion: Shiga toxin binding to VWF impairs ADAMTS-13 cleavage. Significance: Delayed VWF cleavage may contribute to renal thrombotic microangiopathy in Shiga toxin-induced hemolytic uremic syndrome. Shiga toxin (Stx) produced by enterohemorrhagic Escherichia coli causes diarrhea-associated hemolytic-uremic syndrome (DHUS), a severe renal thrombotic microangiopathy. We investigated the interaction between Stx and von Willebrand Factor (VWF), a multimeric plasma glycoprotein that mediates platelet adhesion, activation, and aggregation. Stx bound to ultra-large VWF (ULVWF) secreted from and anchored to stimulated human umbilical vein endothelial cells, as well as to immobilized VWF-rich human umbilical vein endothelial cell supernatant. This Stx binding was localized to the A1 and A2 domain of VWF monomeric subunits and reduced the rate of ADAMTS-13-mediated cleavage of the Tyr(1605)-Met(1606) peptide bond in the A2 domain. Stx-VWF interaction and the associated delay in ADAMTS-13-mediated cleavage of VWF may contribute to the pathophysiology of DHUS.	[Lo, Nathan C.; Turner, Nancy A.; Moake, Joel] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Cruz, Miguel A.] Baylor Coll Med, Cardiovasc Res Sect, Dept Med, Houston, TX 77030 USA; [Cruz, Miguel A.] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA	Rice University; Baylor College of Medicine; Baylor College of Medicine	Cruz, MA (corresponding author), Baylor Coll Med, Cardiovasc Res Sect, 1 Baylor Plaza,N1319, Houston, TX 77030 USA.	miguelc@bcm.edu			Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund; Alkek Foundation	Mary R. Gibson Foundation; Mabel and Everett Hinkson Memorial Fund; Alkek Foundation	This work was supported by grants from the Mary R. Gibson Foundation, the Mabel and Everett Hinkson Memorial Fund, and the Alkek Foundation.	Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2010, J BIOL CHEM, V285, P22829, DOI 10.1074/jbc.M110.103358; CLEARY TG, 1988, PEDIATR CLIN N AM, V35, P485; COURTECUISSE V, 1967, EXP MOL PATHOL, V7, P327, DOI 10.1016/0014-4800(67)90044-5; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; Foster GH, 2002, J LEUKOCYTE BIOL, V71, P107; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Habib R, 1982, ADV NEPHROL, V11, P99; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; Huang J, 2010, BLOOD, V116, P3653, DOI 10.1182/blood-2010-02-271957; Hughes AK, 2001, NEPHRON, V88, P14, DOI 10.1159/000045953; INBAL A, 1989, THROMB RES, V56, P347, DOI 10.1016/0049-3848(89)90247-8; KATZ J, 1973, J PEDIATR-US, V83, P739, DOI 10.1016/S0022-3476(73)80364-6; Keir LS, 2012, DRUG DES DEV THER, V6, P195, DOI 10.2147/DDDT.S25757; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Liu F, 2011, BLOOD, V118, P3392, DOI 10.1182/blood-2011-06-363648; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Matussek A, 2003, BLOOD, V102, P1323, DOI 10.1182/blood-2002-10-3301; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x; Nolasco LH, 2005, BLOOD, V106, P4199, DOI 10.1182/blood-2005-05-2111; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Pysher TJ, 2002, PEDIATR DEVEL PATHOL, V5, P472, DOI 10.1007/s10024-001-0204-1; Siegler RL, 2001, J AM SOC NEPHROL, V12, P1458, DOI 10.1681/ASN.V1271458; Studt JD, 2003, SWISS MED WKLY, V133, P325; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; Tsai HM, 2001, PEDIATR RES, V49, P653, DOI 10.1203/00006450-200105000-00008; Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753; Veyradier A, 2001, BLOOD, V98, P1765, DOI 10.1182/blood.V98.6.1765	32	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33118	33123		10.1074/jbc.M113.487413	http://dx.doi.org/10.1074/jbc.M113.487413			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097977	Green Published, hybrid			2022-12-28	WOS:000328841700027
J	Wientjes, E; Drop, B; Kouril, R; Boekema, EJ; Croce, R				Wientjes, Emilie; Drop, Bartlomiej; Kouril, Roman; Boekema, Egbert J.; Croce, Roberta			During State 1 to State 2 Transition in Arabidopsis thaliana, the Photosystem II Supercomplex Gets Phosphorylated but Does Not Disassemble	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photosynthesis; Photosystem II; Plant; Plant Biochemistry; Protein Phosphorylation; State Transitions; Supramolecular Organization	LIGHT-HARVESTING COMPLEX; EXCITATION-ENERGY DISTRIBUTION; PROTEIN-PHOSPHORYLATION; MEMBRANE ORGANIZATION; CHARGE SEPARATION; QUANTUM YIELD; ANTENNA; PHOTOSYNTHESIS; FLUORESCENCE; DYNAMICS	Background: State transition balances the excitation pressure between the two photosystems of plants. Results: The organization of photosystem II supercomplexes and megacomplexes is the same in state 1 and state 2. Conclusion: Phosphorylation is not sufficient to induce the disassembly of the supercomplexes. Significance: This work helps to understand how plants optimize light harvesting under ever changing light conditions. Plants are exposed to continuous changes in light quality and quantity that challenge the performance of the photosynthetic apparatus and have evolved a series of mechanisms to face this challenge. In this work, we have studied state transitions, the process that redistributes the excitation pressure between photosystems I and II (PSI/PSII) by the reversible association of LHCII, the major antenna complex of higher plants, with either one of them upon phosphorylation/dephosphorylation. By combining biochemical analysis and electron microscopy, we have studied the effect of state transitions on the composition and organization of photosystem II in Arabidopsis thaliana. Two LHCII trimers (called trimers M and S) are part of the PSII supercomplex, whereas up to two more are loosely associated with PSII in state 1 in higher plants (called extra trimers). Here, we show that the LHCII from the extra pool migrates to PSI in state 2, thus leaving the PSII supercomplex and the semicrystalline PSII arrays intact. In state 2, not only is the mobile LHCII phosphorylated, but also the LHCII in the PSII supercomplexes. This demonstrates that PSII phosphorylation is not sufficient for disconnecting LHCII trimers S and M from PSII and for their migration to PSI.	[Wientjes, Emilie; Drop, Bartlomiej; Croce, Roberta] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Kouril, Roman; Boekema, Egbert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Fac Math & Nat Sci, NL-9747 AG Groningen, Netherlands; [Kouril, Roman] Palacky Univ, Dept Biophys, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Olomouc 78371, Czech Republic	Vrije Universiteit Amsterdam; University of Groningen; Palacky University Olomouc	Croce, R (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/ABG-3595-2021; Croce, Roberta/F-1174-2014; Wientjes, Emilie/AAC-8491-2019; KOUŘIL, Roman/A-9587-2018; Croce, Roberta/N-4067-2014; Croce, Roberta/HGU-9554-2022; Wientjes, Emilie/M-6387-2014	Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045; KOUŘIL, Roman/0000-0001-8211-3348; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045	Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences; Vici grant; European Research Council (ERC) [281341, ED0007/01/01]	Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Vici grant; European Research Council (ERC)(European Research Council (ERC))	This work was supported by the Netherlands Organization for Scientific Research (NWO), Earth and Life Sciences (ALW), through a Vici grant and the European Research Council (ERC) starting/consolidator Grant 281341 (to R. C.), and Grant ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research (to R. K.).	Allen JF, 2000, PHILOS T R SOC B, V355, P1351, DOI 10.1098/rstb.2000.0697; ALLEN JF, 1992, TRENDS BIOCHEM SCI, V17, P12, DOI 10.1016/0968-0004(92)90418-9; ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Allen JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026372; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V935, P152, DOI 10.1016/0005-2728(88)90212-5; BASSI R, 1992, EUR J BIOCHEM, V204, P317, DOI 10.1111/j.1432-1033.1992.tb16640.x; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BENNETT J, 1991, ANNU REV PLANT PHYS, V42, P281, DOI 10.1146/annurev.pp.42.060191.001433; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; Broess K, 2008, BBA-BIOENERGETICS, V1777, P404, DOI 10.1016/j.bbabio.2008.02.003; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; CHOW WS, 1990, P NATL ACAD SCI USA, V87, P7502, DOI 10.1073/pnas.87.19.7502; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Dietzel L, 2011, PLANT CELL, V23, P2964, DOI 10.1105/tpc.111.087049; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; Grieco M, 2012, PLANT PHYSIOL, V160, P1896, DOI 10.1104/pp.112.206466; Hankamer B, 1997, EUR J BIOCHEM, V243, P422, DOI 10.1111/j.1432-1033.1997.0422a.x; Hogewoning SW, 2012, PLANT CELL, V24, P1921, DOI 10.1105/tpc.112.097972; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kouril R, 2013, BBA-BIOENERGETICS, V1827, P411, DOI 10.1016/j.bbabio.2012.12.003; Kouril R, 2011, BBA-BIOENERGETICS, V1807, P368, DOI 10.1016/j.bbabio.2010.11.007; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KYLE DJ, 1983, ARCH BIOCHEM BIOPHYS, V222, P527, DOI 10.1016/0003-9861(83)90551-9; LARSSON UK, 1987, BIOCHIM BIOPHYS ACTA, V894, P59, DOI 10.1016/0005-2728(87)90212-X; LARSSON UK, 1983, EUR J BIOCHEM, V136, P25, DOI 10.1111/j.1432-1033.1983.tb07700.x; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; MELIS A, 1991, BIOCHIM BIOPHYS ACTA, V1058, P87, DOI 10.1016/S0005-2728(05)80225-7; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; PETER GF, 1991, J BIOL CHEM, V266, P16745; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; TELFER A, 1983, BIOCHIM BIOPHYS ACTA, V722, P176, DOI 10.1016/0005-2728(83)90171-8; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P425, DOI 10.1016/j.bbabio.2008.02.001; Wientjes E, 2013, J PHYS CHEM B, V117, P11200, DOI 10.1021/jp401663w; Wientjes E, 2013, BBA-BIOENERGETICS, V1827, P420, DOI 10.1016/j.bbabio.2012.12.009	48	57	59	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32821	32826		10.1074/jbc.M113.511691	http://dx.doi.org/10.1074/jbc.M113.511691			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097972	hybrid, Green Published			2022-12-28	WOS:000328841700001
J	Liu, XR; Yang, XR; Lee, CA; Moustafa, IM; Smidansky, ED; Lum, D; Arnold, JJ; Cameron, CE; Boehr, DD				Liu, Xinran; Yang, Xiaorong; Lee, Cheri A.; Moustafa, Ibrahim M.; Smidansky, Eric D.; Lum, David; Arnold, Jamie J.; Cameron, Craig E.; Boehr, David D.			Vaccine-derived Mutation in Motif D of Poliovirus RNA-dependent RNA Polymerase Lowers Nucleotide Incorporation Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; NMR; Positive-strand RNA Viruses; Protein Dynamics; Viral Polymerase	STATE KINETIC-ANALYSIS; SABIN TYPE-1 SEQUENCE; DNA-POLYMERASE; O-HELIX; RIBONUCLEOTIDE INCORPORATION; MOLECULAR-DYNAMICS; ACTIVE-SITE; CONFORMATIONAL DYNAMICS; ATTENUATION PHENOTYPE; LETHAL MUTAGENESIS	Background: The motif D loop in poliovirus RNA-dependent RNA polymerase is important for catalysis and fidelity. Results: A vaccine-derived mutation in motif D decreases RdRp fidelity by changing motif D conformational dynamics. Conclusion: Non-conserved residues of motif D can alter RdRp function. Significance: Motif D of the RdRp may be a universal target permitting creation of enzymes with perturbed fidelity and viruses with reduced virulence. All viral RNA-dependent RNA polymerases (RdRps) have a conserved structural element termed motif D. Studies of the RdRp from poliovirus (PV) have shown that a conformational change of motif D leads to efficient and faithful nucleotide addition by bringing Lys-359 into the active site where it serves as a general acid. The RdRp of the Sabin I vaccine strain has Thr-362 changed to Ile. Such a drastic change so close to Lys-359 might alter RdRp function and contribute in some way to the attenuated phenotype of Sabin type I. Here we present our characterization of the T362I RdRp. We find that the T362I RdRp exhibits a mutator phenotype in biochemical experiments in vitro. Using NMR, we show that this change in nucleotide incorporation fidelity correlates with a change in the structural dynamics of motif D. A recombinant PV expressing the T362I RdRp exhibits normal growth properties in cell culture but expresses a mutator phenotype in cells. For example, the T362I-containing PV is more sensitive to the mutagenic activity of ribavirin than wild-type PV. Interestingly, the T362I change was sufficient to cause a statistically significant reduction in viral virulence. Collectively, these studies suggest that residues of motif D can be targeted when changes in nucleotide incorporation fidelity are desired. Given the observation that fidelity mutants can serve as vaccine candidates, it may be possible to use engineering of motif D for this purpose.	[Liu, Xinran; Yang, Xiaorong; Lum, David; Boehr, David D.] Penn State Univ, Dept Chem, University Pk, PA USA; [Lee, Cheri A.; Moustafa, Ibrahim M.; Smidansky, Eric D.; Arnold, Jamie J.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, 107 Chem Bldg, University Pk, PA USA.	ddb12@psu.edu	Liu, Xinran/GON-4955-2022	Liu, Xinran/0000-0002-3732-6632	National Institutes of Health [R01 AI45818]; Pennsylvania State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045818, R01AI104878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI45818 (to C. E. C.). This work was also supported by startup funds from Pennsylvania State University (to D. D. B.).	Arnold JJ, 2006, ANAL BIOCHEM, V350, P214, DOI 10.1016/j.ab.2005.11.001; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; BAKER S, 1995, J GEN VIROL, V76, P2081, DOI 10.1099/0022-1317-76-8-2081; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Bell JB, 1997, J BIOL CHEM, V272, P7345, DOI 10.1074/jbc.272.11.7345; Berdis AJ, 2009, CHEM REV, V109, P2862, DOI 10.1021/cr800530b; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cameron CE, 2001, CURR OPIN INFECT DIS, V14, P757, DOI 10.1097/00001432-200112000-00015; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castro C, 2007, P NATL ACAD SCI USA, V104, P4267, DOI 10.1073/pnas.0608952104; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, J GEN VIROL, V83, P1707, DOI 10.1099/0022-1317-83-7-1707; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garriga D, 2013, J MOL BIOL, V425, P2279, DOI 10.1016/j.jmb.2013.03.034; GEORGESCU MM, 1995, J VIROL, V69, P5278, DOI 10.1128/JVI.69.9.5278-5286.1995; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hayden FG, 2006, CURR OPIN INFECT DIS, V19, P169, DOI 10.1097/01.qco.0000216628.51563.b1; Hayden FG, 1999, ADV EXP MED BIOL, V458, P55; Hayden FG, 2006, ANTIVIR RES, V71, P372, DOI 10.1016/j.antiviral.2006.05.016; Howard RS, 2005, BMJ-BRIT MED J, V330, P1314, DOI 10.1136/bmj.330.7503.1314; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P7256, DOI 10.1021/bi960537i; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Korneeva VS, 2007, J BIOL CHEM, V282, P16135, DOI 10.1074/jbc.M610090200; Lang DM, 2013, NUCLEIC ACIDS RES, V41, P1464, DOI 10.1093/nar/gks1251; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Ogawa M, 2001, MUTAT RES-DNA REPAIR, V485, P197, DOI 10.1016/S0921-8777(00)00081-1; Paul AV, 2000, VIROLOGY, V272, P72, DOI 10.1006/viro.2000.0354; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Racaniello VR, 2006, VIROLOGY, V344, P9, DOI 10.1016/j.virol.2005.09.015; Ren Z, 2011, BIOCHEMISTRY-US, V50, P1875, DOI 10.1021/bi101863g; Ren Z, 2010, NUCLEIC ACIDS RES, V38, P5105, DOI 10.1093/nar/gkq210; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Suzuki M, 1997, J BIOL CHEM, V272, P11228; Svarovskaia ES, 2003, FRONT BIOSCI-LANDMRK, V8, pD117, DOI 10.2741/957; TARDYPANIT M, 1993, J VIROL, V67, P4630, DOI 10.1128/JVI.67.8.4630-4638.1993; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zamyatkin DF, 2009, J MOL BIOL, V390, P10, DOI 10.1016/j.jmb.2009.04.069; Zemla AT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-226	72	33	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32753	32765		10.1074/jbc.M113.484428	http://dx.doi.org/10.1074/jbc.M113.484428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085299	Green Published, hybrid			2022-12-28	WOS:000328681700059
J	Sultan, A; Raman, B; Rao, CM; Tangirala, R				Sultan, Abdullah; Raman, Bakthisaran; Rao, Ch. Mohan; Tangirala, Ramakrishna			The Extracellular Chaperone Haptoglobin Prevents Serum Fatty Acid-promoted Amyloid Fibril Formation of beta(2)-Microglobulin, Resistance to Lysosomal Degradation, and Cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acidosis; Inflammation; Lysosomes; Molecular Chaperone; Protein Degradation; Amyloidosis; 2-Microglobulin; Cytotoxicity; Haptoglobin	PROTEIN; HEMOGLOBIN; EXTENSION; PH; BETA-2-MICROGLOBULIN; FLUORESCENCE; MACROPHAGES; PRODUCT; INDUCE; GROWTH	Fibril formation of (2)-microglobulin and associated inflammation occur in patients on long term dialysis. We show that the plasma protein haptoglobin prevents the fatty acid-promoted de novo fibril formation of (2)-microglobulin even at substoichiometric concentration. The fibrils are cytotoxic, and haptoglobin abolishes the cytotoxicity by preventing fibril formation. Haptoglobin does not alleviate the cytotoxicity of preformed fibrils. Fibrillar (2)-microglobulin is resistant to lysosomal degradation. However, the species of (2)-microglobulin populated in the presence of haptoglobin is susceptible to degradation. We observed that haptoglobin interacts with oligomeric prefibrillar species of (2)-microglobulin but not with monomeric or fibrillar (2)-microglobulin that may underlie the molecular mechanism. 1,1-Bis(4-anilino)naphthalene-5,5-disulfonic acid cross-linking to haptoglobin significantly compromises its chaperone activity, suggesting the involvement of hydrophobic surfaces. Haptoglobin is an acute phase protein whose level increases severalfold during inflammation, where local acidosis can occur. Our data show that haptoglobin prevents fibril formation of (2)-microglobulin under conditions of physiological acidosis (between pH 5.5 and 6.5) but with relatively decreased efficiency. However, compromise in its chaperone activity under these conditions is more than compensated by its increased level of expression under inflammation. Erythrolysis is known to release hemoglobin into the plasma. Haptoglobin forms a 1:1 (mol/mol) complex with hemoglobin. This complex, like haptoglobin, interacts with the prefibrillar species of (2)-microglobulin, preventing its fibril formation and the associated cytotoxicity and resistance to intracellular degradation. Thus, our study demonstrates that haptoglobin is a potential extracellular chaperone for (2)-microglobulin even in moderately acidic conditions relevant during inflammation, with promising therapeutic implications in (2)-microglobulin amyloid-related diseases.	[Sultan, Abdullah; Raman, Bakthisaran; Rao, Ch. Mohan; Tangirala, Ramakrishna] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rao, CM (corresponding author), Dept Sci & Technol, New Delhi, India.	mohan@ccmb.res.in; trk@ccmb.res.in	SULTAN, ABDULLAH/U-2028-2017	SULTAN, ABDULLAH/0000-0001-8203-4391	Department of Biotechnology (New Delhi, India); Department of Science and Technology (New Delhi, India)	Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India); Department of Science and Technology (New Delhi, India)(Department of Science & Technology (India))	Recipient of a Senior Research Fellowship from the Department of Biotechnology (New Delhi, India).; Recipient of the J. C. Bose National Fellowship of the Department of Science and Technology (New Delhi, India). To whom correspondence may be addressed. E-mail: mohan@ccmb.res.in.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Arredouani MS, 2005, IMMUNOLOGY, V114, P263, DOI 10.1111/j.1365-2567.2004.02071.x; Asleh R, 2003, CIRC RES, V92, P1193, DOI 10.1161/01.RES.0000076889.23082.F1; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; BENESCH RE, 1976, J BIOL CHEM, V251, P465; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; BUCCI E, 1988, J BIOL CHEM, V263, P6972; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Dobryszycka W, 1997, EUR J CLIN CHEM CLIN, V35, P647; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Engstrom G, 2003, DIABETES, V52, P442, DOI 10.2337/diabetes.52.2.442; Fujimoto N, 2002, J INVEST DERMATOL, V118, P479, DOI 10.1046/j.0022-202x.2001.01695.x; Fujimoto N, 2002, BRIT J DERMATOL, V147, P549, DOI 10.1046/j.1365-2133.2002.04940.x; Garcia-Garcia M, 1999, KIDNEY INT, V55, P899, DOI 10.1046/j.1523-1755.1999.055003899.x; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hou FF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351296; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lee HG, 2004, J ALZHEIMERS DIS, V6, P137; Liau CY, 2003, J CHROMATOGR B, V790, P209, DOI 10.1016/S1570-0232(03)00128-4; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Morten IJ, 2007, J BIOL CHEM, V282, P29691, DOI 10.1074/jbc.M705004200; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Naiki H, 2005, AMYLOID, V12, P15, DOI 10.1080/13506120500032352; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; Ozawa D, 2011, J BIOL CHEM, V286, P9668, DOI 10.1074/jbc.M110.167965; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sadrzadeh S.M., 2004, AM J CLIN PATHOL, V121, P97; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; TAKAMI M, 1993, J BIOL CHEM, V268, P20335; Uji Y, 1987, Biomed Chromatogr, V2, P110, DOI 10.1002/bmc.1130020306; WEJMAN JC, 1984, J MOL BIOL, V174, P343, DOI 10.1016/0022-2836(84)90342-5; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yerbury JJ, 2005, EMBO REP, V6, P1131, DOI 10.1038/sj.embor.7400586; Yerbury JJ, 2005, BIOCHEMISTRY-US, V44, P10914, DOI 10.1021/bi050764x; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200; Zhang PY, 2010, AMYLOID, V17, P50, DOI 10.3109/13506129.2010.483116	51	13	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32326	32342		10.1074/jbc.M113.498337	http://dx.doi.org/10.1074/jbc.M113.498337			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078632	hybrid, Green Published			2022-12-28	WOS:000328681700019
J	Ju, R; Zhuang, ZW; Zhang, JS; Lanahan, AA; Kyriakides, T; Sessa, WC; Simons, M				Ju, Rong; Zhuang, Zhen W.; Zhang, Jiasheng; Lanahan, Anthony A.; Kyriakides, Themis; Sessa, William C.; Simons, Michael			Angiopoietin-2 Secretion by Endothelial Cell Exosomes REGULATION BY THE PHOSPHATIDYLINOSITOL 3-KINASE (PI3K)/Akt/ENDOTHELIAL NITRIC OXIDE SYNTHASE (eNOS) AND SYNDECAN-4/SYNTENIN PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Endothelium; Exocytosis; Exosomes; Vascular Biology	PDZ PROTEIN; PKC-ALPHA; TIE2; ANGIOGENESIS; HOMEOSTASIS; ACTIVATION; SYNTENIN; PATHWAY; LIGAND	Angiopoietin-2 (Ang2) is an extracellular protein and one of the principal ligands of Tie2 receptor that is involved in the regulation of vascular integrity, quiescence, and inflammation. The mode of secretion of Ang2 has never been established, however. Here, we provide evidence that Ang2 is secreted from endothelial cells via exosomes and that this process is inhibited by the PI3K/Akt/endothelial nitric oxide synthase (eNOS) signaling pathway, whereas it is positively regulated by the syndecan-4/syntenin pathway. Vascular defects in Akt1 null mice arise, in part, because of excessive Ang2 secretion and can be rescued by the syndecan-4 knock-out that reduces extracellular Ang2 levels. This novel mechanism connects three critical signaling pathways: angiopoietin/Tie2, PI3K/Akt/eNOS, and syndecan/syntenin, which play important roles in vascular growth and stabilization.	[Ju, Rong; Zhuang, Zhen W.; Zhang, Jiasheng; Lanahan, Anthony A.; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovasc Med, New Haven, CT 06520 USA; [Kyriakides, Themis] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Simons, M (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Sect Cardiovasc Med, 300 Cedar St, New Haven, CT 06520 USA.	michael.simons@yale.edu	Sessa, William C/B-6844-2011; Simons, Michael/G-8553-2014	Sessa, William C/0000-0001-5759-1938; Simons, Michael/0000-0003-0348-7734	National Institutes of Health [R01 HL062289, PO1 HL107205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062289, P01HL107205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants R01 HL062289 (to M. S.) and PO1 HL107205 (to M. S., T. K., and W. C. S.)	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Ju R, 2013, CELL SIGNAL, V25, P101, DOI 10.1016/j.cellsig.2012.09.007; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Morgan MR, 2013, DEV CELL, V24, P472, DOI 10.1016/j.devcel.2013.01.027; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tang MX, 2010, CARDIOVASC RES, V88, P424, DOI 10.1093/cvr/cvq217; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tkachenko E, 2006, CIRC RES, V98, P1398, DOI 10.1161/01.RES.0000225283.71490.5a; Tsigkos S, 2006, J CELL PHYSIOL, V207, P506, DOI 10.1002/jcp.20592; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zagorchev Lyubomir, 2010, J Angiogenes Res, V2, P7, DOI 10.1186/2040-2384-2-7; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	33	65	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					510	519		10.1074/jbc.M113.506899	http://dx.doi.org/10.1074/jbc.M113.506899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235146	hybrid, Green Published			2022-12-28	WOS:000329370900043
J	Wang, Y; Tjandra, N				Wang, Yu; Tjandra, Nico			Structural Insights of tBid, the Caspase-8-activated Bid, and Its BH3 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2; NMR; Protein Dynamics; Protein Structure; LPPG Micelles; tBid	BCL-2 FAMILY-MEMBER; CYTOCHROME-C; MEMBRANE-BINDING; MITOCHONDRIAL-MEMBRANE; CONFORMATIONAL-CHANGES; BACKBONE DYNAMICS; PROTEIN FAMILY; ACTIVATE BAX; DEATH; CARDIOLIPIN	Background: The membrane-associated tBid promotes Bax membrane insertion and activation. Results: tBid adopts an extended structure in 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] (LPPG) micelles with its six helices including the BH3 domain interacting with the micelles. Conclusion: An on the membrane binding mode was suggested for tBid interaction with Bax. Significance: Revealing tBid structure on the membrane is key to the understanding of tBid-mediated Bax activation. The Bcl-2 family proteins regulate mitochondria-mediated apoptosis through intricate molecular mechanisms. One of the pro-apoptotic proteins, tBid, can induce apoptosis by promoting Bax activation, Bax homo-oligomerization, and mitochondrial outer membrane permeabilization. Association of tBid on the mitochondrial outer membrane is key to its biological function. Therefore knowing the conformation of tBid on the membrane will be the first step toward understanding its crucial role in triggering apoptosis. Here, we present NMR characterization of the structure and dynamics of human tBid in 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] micelles. Our data showed that tBid is monomeric with six well defined -helices in the micelles. Compared with the full-length Bid structure, a longer flexible loop between tBid helix (4) and (5) was observed. Helices in tBid do not pack into a compact-fold but form an extended structure with a C-shape configuration in the micelles. All six tBid helices were shown to interact with LPPG micelles, with helix (6) and (7) being more embedded. Of note, the BH3-containing helix (3), which was previously believed to be exposed above the membrane surface, is also membrane associated, suggesting an on the membrane binding mode for tBid interaction with Bax. Our data provided structural details on the membrane-associated state of tBid and the functional implications of its membrane-associated BH3 domain.	[Wang, Yu; Tjandra, Nico] NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tjandra, N (corresponding author), NHLBI, Lab Mol Biophys, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	tjandran@nhlbi.nih.gov			National Institutes of Health grant from the Intramural Research Program of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064] Funding Source: NIH RePORTER	National Institutes of Health grant from the Intramural Research Program of the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Intramural Research Program of the NHLBI (to N. T.).	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Bleicken S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035910; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cho EY, 2012, MOL CELL BIOCHEM, V363, P395, DOI 10.1007/s11010-011-1192-8; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gobl C, 2010, J PHYS CHEM B, V114, P4717, DOI 10.1021/jp9114089; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P659, DOI 10.1038/sj.cdd.4401585; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; Krueger-Koplin RD, 2004, J BIOMOL NMR, V28, P43, DOI 10.1023/B:JNMR.0000012875.80898.8f; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Manara A, 2009, BBA-MOL CELL BIOL L, V1791, P997, DOI 10.1016/j.bbalip.2009.05.003; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Oh KJ, 2006, J BIOL CHEM, V281, P36999, DOI 10.1074/jbc.M602341200; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Petit PX, 2009, FEBS J, V276, P6338, DOI 10.1111/j.1742-4658.2009.07345.x; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Ryabov Y, 2011, J AM CHEM SOC, V133, P6154, DOI 10.1021/ja201020c; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shamas-Din A, 2013, J BIOL CHEM, V288, P22111, DOI 10.1074/jbc.M113.482109; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tyurin VA, 2007, CELL DEATH DIFFER, V14, P872, DOI 10.1038/sj.cdd.4402068; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yao Y, 2009, BIOCHEMISTRY-US, V48, P8704, DOI 10.1021/bi901171n; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	79	53	53	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35840	35851		10.1074/jbc.M113.503680	http://dx.doi.org/10.1074/jbc.M113.503680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158446	hybrid, Green Published			2022-12-28	WOS:000329814700021
J	Blazevic, T; Schwaiberger, AV; Schreiner, CE; Schachner, D; Schaible, AM; Grojer, CS; Atanasov, AG; Werz, O; Dirsch, VM; Heiss, EH				Blazevic, Tina; Schwaiberger, Andrea V.; Schreiner, Cornelia E.; Schachner, Daniel; Schaible, Anja M.; Grojer, Christoph S.; Atanasov, Atanas G.; Werz, Oliver; Dirsch, Verena M.; Heiss, Elke H.			12/15-Lipoxygenase Contributes to Platelet-derived Growth Factor-induced Activation of Signal Transducer and Activator of Transcription 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemical Biology; Lipoxygenase Pathway; Redox Regulation; Signal Transduction; STAT3; Vascular Smooth Muscle Cells; Indirubin-3-monoxime; Platelet-derived Growth Factor	SMOOTH-MUSCLE-CELLS; PDGF-BETA-RECEPTOR; TYROSINE PHOSPHORYLATION; NEOINTIMA FORMATION; IN-VIVO; OXIDATIVE STRESS; SRC; KINASE; PROLIFERATION; INVOLVEMENT	We showed previously that the small molecule indirubin-3-monoxime (I3MO) prevents vascular smooth muscle cell (VSMC) proliferation by selectively inhibiting signal transducer and activator of transcription 3 (STAT3). Looking for the underlying upstream molecular mechanism, we here reveal the important role of reactive oxygen species (ROS) for PDGF-induced STAT3 activation in VSMC. We show that neither NADPH-dependent oxidases (Noxes) nor mitochondria, but rather 12/15-lipoxygenase (12/15-LO) are pivotal ROS sources involved in the redox-regulated signal transduction from PDGFR to STAT3. Accordingly, pharmacological and genetic interference with 12/15-LO activity selectively inhibited PDGF-induced Src activation and STAT3 phosphorylation. I3MO is able to blunt PDGF-induced ROS and 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) production, indicating an inhibitory action of I3MO on 12/15-LO and consequently on STAT3. We identify 12/15-LO as a hitherto unrecognized signaling hub in PDGF-triggered STAT3 activation and show for the first time a negative impact of I3MO on 12/15-LO.	[Blazevic, Tina; Schwaiberger, Andrea V.; Schreiner, Cornelia E.; Schachner, Daniel; Grojer, Christoph S.; Atanasov, Atanas G.; Dirsch, Verena M.; Heiss, Elke H.] Univ Vienna, Dept Pharmacognosy, A-1090 Vienna, Austria; [Schaible, Anja M.; Werz, Oliver] Univ Jena, Chair Pharmaceut Med Chem, D-07743 Jena, Germany	University of Vienna; Friedrich Schiller University of Jena	Heiss, EH (corresponding author), Univ Vienna, Dept Pharmacognosy, Althanstr 14, A-1090 Vienna, Austria.	elke.heiss@univie.ac.at	Blazevic, Tina/AAD-4212-2020; Atanasov, Atanas G./C-5535-2013; Heiss, Elke/B-6086-2015	Atanasov, Atanas G./0000-0003-2545-0967; Dirsch, Verena/0000-0002-9261-5293; Blazevic, Tina/0000-0002-2084-9074; Heiss, Elke/0000-0001-7618-5505	Austrian Science Fund (FWF) [P23317, S10704]; Austrian Science Fund (FWF) [P 23317] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grants P23317 (to E. H. H.) and S10704 (to V. M. D.).	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bartosz G, 2009, BIOCHEM PHARMACOL, V77, P1303, DOI 10.1016/j.bcp.2008.11.009; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bronas UG, 2010, AM J LIFESTYLE MED, V4, P521, DOI 10.1177/1559827610375534; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Chen K, 2003, FREE RADICAL BIO MED, V35, P117, DOI 10.1016/S0891-5849(03)00239-9; Chiarugi P, 2008, MOL CELLS, V26, P329; Claesson-Welsh Lena, 1994, Progress in Growth Factor Research, V5, P37, DOI 10.1016/0955-2235(94)90016-7; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Daniel JM, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0261-9; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]; Funk CD, 2001, TRENDS CARDIOVAS MED, V11, P116; Heldin CH, 1997, FEBS LETT, V410, P17, DOI 10.1016/S0014-5793(97)00318-9; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; INUI H, 1993, J BIOL CHEM, V268, P17045; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; KNOSPE J, 1988, J CHROMATOGR, V442, P444, DOI 10.1016/S0021-9673(00)94498-4; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lennartsson J, 2013, J BIOL CHEM, V288, P15736, DOI 10.1074/jbc.M113.476424; Maheswaranathan M, 2011, J BIOL CHEM, V286, P35430, DOI 10.1074/jbc.M111.268284; Manea A, 2010, CELL TISSUE RES, V342, P325, DOI 10.1007/s00441-010-1060-y; Maziere C, 1999, FEBS LETT, V448, P49, DOI 10.1016/S0014-5793(99)00324-5; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Natarajan R, 1996, J CELL PHYSIOL, V169, P391, DOI 10.1002/(SICI)1097-4652(199611)169:2<391::AID-JCP19>3.3.CO;2-Q; Natarajan R, 2002, DIABETOLOGIA, V45, P125, DOI 10.1007/s125-002-8253-x; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Ramachandran A, 2002, FREE RADICAL BIO MED, V33, P1465, DOI 10.1016/S0891-5849(02)01142-5; Reddy MA, 2003, HYPERTENSION, V41, P1294, DOI 10.1161/01.HYP.0000069011.18333.08; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sachsenmaier C, 1999, ONCOGENE, V18, P3583, DOI 10.1038/sj.onc.1202694; SCHEWE T, 1995, GEN PHARMACOL-VASC S, V26, P1153, DOI 10.1016/0306-3623(95)00003-J; Schreiner CE, 2011, CARDIOVASC RES, V90, P140, DOI 10.1093/cvr/cvq355; Schwaiberger AV, 2010, ARTERIOSCL THROM VAS, V30, P2475, DOI 10.1161/ATVBAHA.110.212654; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Smith SME, 2012, CHEM BIOL, V19, P752, DOI 10.1016/j.chembiol.2012.04.015; Smith WL, 2008, N COMP BIOC, P331, DOI 10.1016/B978-044453219-0.50014-3; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Sroka IM, 2010, MOL PHARMACOL, V77, P255, DOI 10.1124/mol.109.060327; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	53	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35592	35603		10.1074/jbc.M113.489013	http://dx.doi.org/10.1074/jbc.M113.489013			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165129	hybrid, Green Published			2022-12-28	WOS:000329867600053
J	Carey, M; Kehlenbrink, S; Hawkins, M				Carey, Michelle; Kehlenbrink, Sylvia; Hawkins, Meredith			Evidence for Central Regulation of Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Brain; Glucose Metabolism; Hypothalamus; Insulin; Lipid Metabolism; Central Nervous System	FASTING PLASMA-GLUCOSE; SENSITIVE K+ CHANNELS; BRAIN-INSULIN ACTION; BODY-WEIGHT; VENTROMEDIAL HYPOTHALAMUS; CENTRAL LEPTIN; FOOD-INTAKE; OBESE GENE; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIAL SENSITIVITY	Evidence for central regulation of glucose homeostasis is accumulating from both animal and human studies. Central nutrient and hormone sensing in the hypothalamus appears to coordinate regulation of whole body metabolism. Central signals activate ATP-sensitive potassium (K-ATP) channels, thereby down-regulating glucose production, likely through vagal efferent signals. Recent human studies are consistent with this hypothesis. The contributions of direct and central inputs to metabolic regulation are likely of comparable magnitude, with somewhat delayed central effects and more rapid peripheral effects. Understanding central regulation of glucose metabolism could promote the development of novel therapeutic approaches for such metabolic conditions as diabetes mellitus.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hawkins, M (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	hawkins@aecom.yu.edu			National Institutes of Health [DK69861, DK79974]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK069861, R01DK069861, R01DK079974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK69861 and DK79974 (to M. H.).This work was also supported by a grant from the American Diabetes Association.	Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Asilmaz E, 2004, J CLIN INVEST, V113, P414, DOI 10.1172/JCI200419511; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Benedict C, 2008, J CLIN ENDOCR METAB, V93, P1339, DOI 10.1210/jc.2007-2606; Benedict C, 2011, DIABETES, V60, P114, DOI 10.2337/db10-0329; Bernard C., 1855, LECONS PHYSL EXPT AP, P296; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Borg MA, 2003, DIABETES, V52, P663, DOI 10.2337/diabetes.52.3.663; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Edgerton DS, 2006, J CLIN INVEST, V116, P521, DOI 10.1172/JCI27073; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Filippi BM, 2012, CELL METAB, V16, P500, DOI 10.1016/j.cmet.2012.09.005; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Gelling RW, 2006, CELL METAB, V3, P67, DOI 10.1016/j.cmet.2005.11.013; GIDDINGS AE, 1974, P ROY SOC MED, V67, P833, DOI 10.1177/003591577406700905; Guo S, 2009, MOL CELL BIOL, V29, P5070, DOI 10.1128/MCB.00138-09; Gutierrez-Juarez R, 2004, J BIOL CHEM, V279, P49704, DOI 10.1074/jbc.M408665200; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Hawkins M, 1999, J BIOL CHEM, V274, P31312, DOI 10.1074/jbc.274.44.31312; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hill JW, 2009, ENDOCRINOLOGY, V150, P4874, DOI 10.1210/en.2009-0454; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Kishore P, 2011, J CLIN INVEST, V121, P4916, DOI 10.1172/JCI58035; Kishore P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000292; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lam TKT, 2005, SCIENCE, V309, P943, DOI 10.1126/science.1112085; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Liu YJ, 2000, NATURE, V405, P1058, DOI 10.1038/35016590; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Matsuda M, 1999, DIABETES, V48, P1801, DOI 10.2337/diabetes.48.9.1801; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Ono H, 2008, J CLIN INVEST, V118, P2959, DOI 10.1172/JCI34277; Paranjape SA, 2010, DIABETES, V59, P1521, DOI 10.2337/db10-0014; Park S, 2009, NEUROENDOCRINOLOGY, V89, P387, DOI 10.1159/000197974; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Prigeon RL, 2003, AM J PHYSIOL-ENDOC M, V285, pE701, DOI 10.1152/ajpendo.00024.2003; Radtke MA, 2010, DIABETES CARE, V33, P589, DOI 10.2337/dc09-1436; Ramnanan CJ, 2013, DIABETES, V62, P74, DOI 10.2337/db12-0148; Ramnanan CJ, 2011, J CLIN INVEST, V121, P3713, DOI 10.1172/JCI45472; Riddle M, 2011, DIABETES CARE, V34, P2508, DOI 10.2337/dc11-0632; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Ross R, 2008, DIABETES, V57, P2061, DOI 10.2337/db08-0206; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; SARA VR, 1982, NEUROSCI LETT, V34, P39; Satoh F, 2000, ENDOCRINOLOGY, V141, P1301, DOI 10.1210/en.141.4.1301; Scherer T, 2011, CELL METAB, V13, P183, DOI 10.1016/j.cmet.2011.01.008; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Smeets PAM, 2005, NEUROIMAGE, V24, P363, DOI 10.1016/j.neuroimage.2004.07.073; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Vidarsdottir S, 2007, DIABETES, V56, P2547, DOI 10.2337/db07-0193; Villareal DT, 2009, DIABETES, V58, P1869, DOI 10.2337/db09-0025; Vinik A, 2007, CLIN THER, V29, P1236, DOI 10.1016/j.clinthera.2007.07.005; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Warne JP, 2011, CELL METAB, V14, P791, DOI 10.1016/j.cmet.2011.11.001; Yue JTY, 2012, CIRC RES, V110, P1345, DOI [10.1161/CIRCRESAHA.112.268276, 10.1161/circresaha.112.268276]; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	95	36	36	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					34981	34988		10.1074/jbc.R113.506782	http://dx.doi.org/10.1074/jbc.R113.506782			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142701	Green Published, hybrid			2022-12-28	WOS:000329867600001
J	Sibilski, C; Mueller, T; Kollipara, L; Zahedi, RP; Rapp, UR; Rudel, T; Baljuls, A				Sibilski, Claudia; Mueller, Thomas; Kollipara, Laxmikanth; Zahedi, Rene P.; Rapp, Ulf R.; Rudel, Thomas; Baljuls, Angela			Tyr(728) in the Kinase Domain of the Murine Kinase Suppressor of RAS 1 Regulates Binding and Activation of the Mitogen-activated Protein Kinase Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MAP Kinases (MAPKs); Mass Spectrometry (MS); Molecular Modeling; Raf; Signal Transduction; KSR1; Src Family Kinases; Tyrosine Phosphorylation	KSR-1 GENE ENCODES; GROWTH-FACTOR; PHOSPHORYLATION SITES; ONCOGENIC RAS; A-RAF; SCAFFOLD; AUTOPHOSPHORYLATION; IDENTIFICATION; INTERACTS; QUALITY	Background: KSR1 coordinates the assembly of RAF-MEK-ERK complexes and regulates signal transduction. Results: LCK-dependent phosphorylation of KSR1 on Tyr(728) regulates MEK binding and activation. Conclusion: Tyr(728) phosphorylation may coordinate the transition between the scaffolding and catalytic function of KSR1 to fine-tune cellular responses. Significance: Tyrosine phosphorylation of KSR1 is a new regulatory link between Src family kinases and RAF/MEK/ERK signaling. In metazoans, the highly conserved MAPK signaling pathway regulates cell fate decision. Aberrant activation of this pathway has been implicated in multiple human cancers and some developmental disorders. KSR1 functions as an essential scaffold that binds the individual components of the cascade and coordinates their assembly into multiprotein signaling platforms. The mechanism of KSR1 regulation is highly complex and not completely understood. In this study, we identified Tyr(728) as a novel regulatory phosphorylation site in KSR1. We show that Tyr(728) is phosphorylated by LCK, uncovering an additional and unexpected link between Src kinases and MAPK signaling. To understand how phosphorylation of Tyr(728) may regulate the role of KSR1 in signal transduction, we integrated structural modeling and biochemical studies. We demonstrate that Tyr(728) is involved in maintaining the conformation of the KSR1 kinase domain required for binding to MEK. It also affects phosphorylation and activation of MEK by RAF kinases and consequently influences cell proliferation. Moreover, our studies suggest that phosphorylation of Tyr(728) may affect the intrinsic kinase activity of KSR1. Together, we propose that phosphorylation of Tyr(728) may regulate the transition between the scaffolding and the catalytic function of KSR1 serving as a control point used to fine-tune cellular responses.	[Sibilski, Claudia; Rapp, Ulf R.; Rudel, Thomas; Baljuls, Angela] Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst Biosci, D-97074 Wurzburg, Germany; [Kollipara, Laxmikanth; Zahedi, Rene P.] ISAS eV, Leibniz Inst Analyt Wissensch, D-44139 Dortmund, Germany; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Div Mol Mech Lung Canc, D-61231 Bad Nauheim, Germany; [Baljuls, Angela] Univ Coll Dublin, Conway Inst, Syst Biol Ireland, Dublin 4, Ireland	University of Wurzburg; University of Wurzburg; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Max Planck Society; University College Dublin	Rudel, T (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de; angela.baljuls@ucd.ie	Zahedi, Rene/HGU-5710-2022; Zahedi, René/A-9148-2012	Zahedi, René/0000-0002-4960-5460; Laxmikanth, Kollipara/0000-0002-2673-0488; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft [SFB 487]; Project C3; Project B2; University of Wuerzburg Fellowship; Deutsche Forschungsgemeinschaft Fellowship; Science Foundation Ireland [06/CE/B1129]; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; NATIONAL INSTITUTE ON AGING [R01AG032180, F32AG020039, R01AG033055] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Project C3; Project B2; University of Wuerzburg Fellowship; Deutsche Forschungsgemeinschaft Fellowship(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487, under Project C3 (to U. R. R.) and Project B2 (to T. M.), by University of Wuerzburg Fellowship "Chancengleichheit fur Frauen in Forschung und Lehre" (to C. S.), by a Deutsche Forschungsgemeinschaft Fellowship (to A. B.), and by the Science Foundation Ireland under Grant 06/CE/B1129.; Supported by the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen.	Abe MK, 2001, J BIOL CHEM, V276, P21272, DOI 10.1074/jbc.M100026200; AMREIN KE, 1994, BBA-MOL CELL RES, V1222, P441, DOI 10.1016/0167-4889(94)90052-3; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Beck F, 2011, PROTEOMICS, V11, P1099, DOI 10.1002/pmic.201000562; Bell B, 1999, J BIOL CHEM, V274, P7982, DOI 10.1074/jbc.274.12.7982; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Burkhart JM, 2012, J PROTEOMICS, V75, P1454, DOI 10.1016/j.jprot.2011.11.016; Burkhart JM, 2011, PROTEOMICS, V11, P1049, DOI 10.1002/pmic.201000604; Cabeza-Arvelaiz Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044700; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Channavajhala PL, 2003, J BIOL CHEM, V278, P47089, DOI 10.1074/jbc.M306002200; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Goettel JA, 2011, EXP CELL RES, V317, P452, DOI 10.1016/j.yexcr.2010.11.018; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jimenez JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r90; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kilkenny DM, 2003, J BIOL CHEM, V278, P17448, DOI 10.1074/jbc.M209698200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lozano J, 2003, CANCER RES, V63, P4232; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mckay MM, 2007, J BIOL CHEM, V282, P26225, DOI 10.1074/jbc.M702692200; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; PARK S, 1992, J BIOL CHEM, V267, P17194; Qiao YF, 2006, SCIENCE, V311, P1293, DOI 10.1126/science.1122224; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; Vaudel M, 2013, PROTEOMICS, V13, P1036, DOI 10.1002/pmic.201200408; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Winkler C, 2007, ELECTROPHORESIS, V28, P2095, DOI 10.1002/elps.200600670; Xia F, 2008, PLOS BIOL, V6, P1115, DOI 10.1371/journal.pbio.0060128; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Yan F, 2001, CANCER RES, V61, P963; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	57	3	3	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35237	35252		10.1074/jbc.M113.490235	http://dx.doi.org/10.1074/jbc.M113.490235			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158441	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000329867600023
J	Verma, SK; Deshmukh, V; Liu, P; Nutter, CA; Espejo, R; Hung, ML; Wang, GS; Yeo, GW; Kuyumcu-Martinez, MN				Verma, Sunil K.; Deshmukh, Vaibhav; Liu, Patrick; Nutter, Curtis A.; Espejo, Rosario; Hung, Ming-Lung; Wang, Guey-Shin; Yeo, Gene W.; Kuyumcu-Martinez, Muge N.			Reactivation of Fetal Splicing Programs in Diabetic Hearts Is Mediated by Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Diabetes; Heart Development; Protein Kinase C (PKC); RNA-binding Protein; Signal Transduction	CORONARY-ARTERY-DISEASE; PLASMA-MEMBRANE CA2+; GENE-EXPRESSION; MESSENGER-RNA; SARCOPLASMIC-RETICULUM; MYOTONIC-DYSTROPHY; CARDIAC MYOCYTES; GROWTH-FACTOR; PKC-BETA; CARDIOMYOPATHY	Diabetic cardiomyopathy is one of the complications of diabetes that eventually leads to heart failure and death. Aberrant activation of PKC signaling contributes to diabetic cardiomyopathy by mechanisms that are poorly understood. Previous reports indicate that PKC is implicated in alternative splicing regulation. Therefore, we wanted to test whether PKC activation in diabetic hearts induces alternative splicing abnormalities. Here, using RNA sequencing we identified a set of 22 alternative splicing events that undergo a developmental switch in splicing, and we confirmed that splicing reverts to an embryonic pattern in adult diabetic hearts. This network of genes has important functions in RNA metabolism and in developmental processes such as differentiation. Importantly, PKC isozymes / control alternative splicing of these genes via phosphorylation and up-regulation of the RNA-binding proteins CELF1 and Rbfox2. Using a mutant of CELF1, we show that phosphorylation of CELF1 by PKC is necessary for regulation of splicing events altered in diabetes. In summary, our studies indicate that activation of PKC/ in diabetic hearts contributes to the genome-wide splicing changes through phosphorylation and up-regulation of CELF1/Rbfox2 proteins. These findings provide a basis for PKC-mediated cardiac pathogenesis under diabetic conditions.	[Verma, Sunil K.; Deshmukh, Vaibhav; Nutter, Curtis A.; Espejo, Rosario; Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Kuyumcu-Martinez, Muge N.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Liu, Patrick; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92037 USA; [Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92037 USA; [Hung, Ming-Lung; Wang, Guey-Shin] Acad Sinica, Inst Biomed Sci, Taipei 11528, Taiwan	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Academia Sinica - Taiwan	Kuyumcu-Martinez, MN (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	nmmartin@utmb.edu	Verma, Sunil Kumar/J-8838-2019; Yeo, Gene/AAE-7676-2019; Wang, Guey-Shin/Q-3968-2018	Verma, Sunil Kumar/0000-0001-9443-2493; Yeo, Gene/0000-0002-0799-6037; Wang, Guey-Shin/0000-0003-4485-1811	National Institutes of Health [HG004659, 3NS075449]; American Heart Association [SDG-093022N]; March of Dimes Basil O'Connor Starter Scholar Award [5 FY12-21]; University of Texas Medical Branch; National Science Council, Taiwan; Institute of Biomedical Sciences, Academia Sinica; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107294] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449, P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Basil O'Connor Starter Scholar Award(March of Dimes); University of Texas Medical Branch; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HG004659 and NS075449 (to G. W. Y.). This work was also supported by American Heart Association Grant SDG-093022N, March of Dimes Basil O'Connor Starter Scholar Award 5 FY12-21, and University of Texas Medical Branch start up funds (to M. N. K.-M.). This work was also supported in part by National Science Council, Taiwan, and Institute of Biomedical Sciences, Academia Sinica (to G.-S. W.). We thank Dr. David Konkel for critically editing the manuscript, Drs. Thai Ho and Rajalaxmi Natarajan for critically reading the manuscript, Dr. Thomas Wood for technical help in RNA-sequencing, and Dr. Adriana Paulucci for help in confocal microscopy. We also thank Dr. Nisha Garg for kindly providing control human heart tissues.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Alzugaray ME, 2009, ARCH BIOCHEM BIOPHYS, V490, P17, DOI 10.1016/j.abb.2009.07.022; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Arrington CB, 2012, EUR J MED GENET, V55, P235, DOI 10.1016/j.ejmg.2012.02.002; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blackwell E, 2010, HUM MOL GENET, V19, P1314, DOI 10.1093/hmg/ddq007; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Connelly KA, 2009, CIRC-HEART FAIL, V2, P129, DOI 10.1161/CIRCHEARTFAILURE.108.765750; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Depre C, 2000, J MOL CELL CARDIOL, V32, P985, DOI 10.1006/jmcc.2000.1139; Ding H, 2005, AM J PHYSIOL-HEART C, V289, pH206, DOI 10.1152/ajpheart.00037.2005; DISATNIK MH, 1995, J MOL CELL CARDIOL, V27, P2473, DOI 10.1006/jmcc.1995.0235; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; Feng T, 2010, HUM GENET, V128, P269, DOI 10.1007/s00439-010-0849-9; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gallagher TL, 2011, DEV BIOL, V359, P251, DOI 10.1016/j.ydbio.2011.08.025; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Guzzo RM, 2005, AM J PHYSIOL-HEART C, V288, pH1810, DOI 10.1152/ajpheart.01015.2004; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Harcourt BE, 2013, NAT REV ENDOCRINOL, V9, P113, DOI 10.1038/nrendo.2012.236; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INOGUCHI T, 1992, P NATL ACAD SCI USA, V89, P11059, DOI 10.1073/pnas.89.22.11059; JAMES G, 1992, J CELL BIOL, V116, P863, DOI 10.1083/jcb.116.4.863; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Kobayashi Y, 2012, HYPERTENSION, V59, P854, DOI 10.1161/HYPERTENSIONAHA.110.165068; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lin WH, 2001, HUM MOL GENET, V10, P1753, DOI 10.1093/hmg/10.17.1753; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Liu YN, 2012, CLIN SCI, V122, P161, DOI 10.1042/CS20110176; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore SF, 2013, J BIOL CHEM, V288, P3918, DOI 10.1074/jbc.M112.429936; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Moraes KCM, 2006, RNA, V12, P1084, DOI 10.1261/rna.59606; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Oppelt A, 2013, EMBO REP, V14, P57, DOI 10.1038/embor.2012.183; Ramirez-Correa GA, 2010, J MOL CELL CARDIOL, V48, P943, DOI 10.1016/j.yjmcc.2010.01.004; Ramsdell AF, 2005, DEV BIOL, V288, P1, DOI 10.1016/j.ydbio.2005.07.038; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Revil T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-399; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Salsali Afshin, 2006, Am J Ther, V13, P349, DOI 10.1097/00045391-200607000-00012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Terenzi F, 2010, RNA BIOL, V7, P43, DOI 10.4161/rna.7.1.10401; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; TOCHINO Y, 1988, CRIT REV IMMUNOL, V8, P49; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Van Belle T L, 2009, Drug Discov Today Dis Models, V6, P41; van't Padje S, 2009, J EXP BIOL, V212, P2564, DOI 10.1242/jeb.032532; Walker DM, 2001, CURR BIOL, V11, P1600, DOI 10.1016/S0960-9822(01)00501-2; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2009, J CLIN INVEST, V119, P3797, DOI 10.1172/JCI37976; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Xia XB, 2008, MOL VIS, V14, P1965; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; YTREHUS K, 1994, AM J PHYSIOL, V266, pH1145, DOI 10.1152/ajpheart.1994.266.3.H1145; Yu XC, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-6; Zhao YM, 2012, BIOCHEM BIOPH RES CO, V423, P212, DOI 10.1016/j.bbrc.2012.05.033; Zhou ZH, 2012, MOL CELL, V47, P422, DOI 10.1016/j.molcel.2012.05.014	88	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35372	35386		10.1074/jbc.M113.507426	http://dx.doi.org/10.1074/jbc.M113.507426			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151077	hybrid, Green Published			2022-12-28	WOS:000329867600034
J	Binici, J; Hartmann, J; Herrmann, J; Schreiber, C; Beyer, S; Guler, G; Vogel, V; Tumulka, F; Abele, R; Mantele, W; Koch, J				Binici, Janina; Hartmann, Jessica; Herrmann, Julia; Schreiber, Christine; Beyer, Steffen; Gueler, Guennur; Vogel, Vitali; Tumulka, Franz; Abele, Rupert; Maentele, Werner; Koch, Joachim			A Soluble Fragment of the Tumor Antigen BCL2-associated Athanogene 6 (BAG-6) Is Essential and Sufficient for Inhibition of NKp30 Receptor-dependent Cytotoxicity of Natural Killer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Immunosuppression; Innate Immunity; Natural Killer (NK) Cell; Tumor Immunology; Tumor Marker; BAG-6; BAT3; NKp30; Natural Killer Cell Receptors (NCR); Tumor Immune Escape	B-ASSOCIATED TRANSCRIPT-3; ACUTE MYELOID-LEUKEMIA; NKG2D LIGANDS; EXPRESSION; BINDING; BAT3; APOPTOSIS; SCYTHE; RECOGNITION; MECHANISMS	Background: Cellular ligands of the activating natural killer (NK) cell receptor NKp30 are poorly characterized. Results: The identified domain of the cellular ligand BCL2-associated athanogene 6 (BAG-6) is essential and sufficient to bind NKp30 and inhibits NK cell function. Conclusion: The BAG-6 domain from amino acid 686 to 936 is an important element of BAG-6-dependent tumor immune escape. Significance: This study gives the first molecular insights into BAG-6-mediated inhibition of NKp30-dependent NK cell cytotoxicity. Immunosurveillance of tumor cells depends on NKp30, a major activating receptor of human natural killer (NK) cells. The human BCL2-associated athanogene 6 (BAG-6, also known as BAT3; 1126 amino acids) is a cellular ligand of NKp30. To date, little is known about the molecular details of this receptor ligand system. Within the current study, we have located the binding site of NKp30 to a sequence stretch of 250 amino acids in the C-terminal region of BAG-6 (BAG-6(686-936)). BAG-6(686-936) forms a noncovalent dimer of 57-59 kDa, which is sufficient for high affinity interaction with NKp30 (K-D < 100 nm). As our most important finding, BAG-6(686-936) inhibits NKp30-dependent signaling, interferon- release, and degranulation of NK cells in the presence of malignantly transformed target cells. Based on these data, we show for the first time that BAG-6(686-936) comprises a subdomain of BAG-6, which is sufficient for receptor docking and inhibition of NKp30-dependent NK cell cytotoxicity as part of a tumor immune escape mechanism. These molecular insights provide an access point to restore tumor immunosurveillance by NK cells and to increase the efficacy of cellular therapies.	[Binici, Janina; Hartmann, Jessica; Herrmann, Julia; Schreiber, Christine; Beyer, Steffen; Koch, Joachim] Georg Speyer Haus, Inst Biomed Res, D-60596 Frankfurt, Germany; [Gueler, Guennur; Vogel, Vitali; Maentele, Werner] Goethe Univ Frankfurt, Inst Biophys, Bioctr, D-60438 Frankfurt, Germany; [Tumulka, Franz; Abele, Rupert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany	Octapharma; Goethe University Frankfurt; Goethe University Frankfurt	Koch, J (corresponding author), Georg Speyer Haus, Inst Biomed Res, Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	joachim.koch@em.uni-frankfurt.de	Vogel, Vitali R/I-4767-2013; Vogel, Vitali/F-9126-2011; Güler, Günnur/GLQ-7527-2022; Hartmann, Jessica/AAL-8849-2021	Hartmann, Jessica/0000-0001-9372-8954; Guler, Gunnur/0000-0002-8485-7372	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK)	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK)	We thank Carsten Watzl (Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany) for critical review of the manuscript and helpful discussions and Elke Pogge von Strandmann (Medical School University of Cologne, Germany) for helpful discussions and technical advice. The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research and the Arts of the State of Hessen (HMWK).	Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Cerwenka A, 2003, TISSUE ANTIGENS, V61, P335, DOI 10.1034/j.1399-0039.2003.00070.x; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Fernandez-Messina L, 2010, J BIOL CHEM, V285, P8543, DOI 10.1074/jbc.M109.045906; Funke J, 2011, AIDS REV, V13, P67; Hammond T, 2010, CELL IMMUNOL, V264, P150, DOI 10.1016/j.cellimm.2010.06.001; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hilpert K, 2007, NAT PROTOC, V2, P1333, DOI 10.1038/nprot.2007.160; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; Reiners KS, 2013, BLOOD, V121, P3658, DOI 10.1182/blood-2013-01-476606; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wu W, 2012, J CELL SCI, V125, P4219, DOI 10.1242/jcs.086553; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	34	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34295	34303		10.1074/jbc.M113.483602	http://dx.doi.org/10.1074/jbc.M113.483602			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133212	hybrid, Green Published			2022-12-28	WOS:000329812800002
J	Li, L; Carter, CW				Li, Li; Carter, Charles W., Jr.			Full Implementation of the Genetic Code by Tryptophanyl-tRNA Synthetase Requires Intermodular Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthesis; Aminoacyl tRNA Synthetase; Cooperativity; Enzyme Kinetics; Protein Evolution; Protein Synthesis; Antidocon-binding Domain; Connecting Peptide 1; Factorial Design; Urzymes	CLASS-I; MG2+-ASSISTED CATALYSIS; DOMAIN; TRPRS; AMINOACYLATION; EVOLUTION; BINDING	Background: Aminoacyl-tRNA synthetases evolved from Urzymes with reduced amino acid specificity. Results: Independent restoration of either the catalytic insertion domain or the anticodon-binding domain greatly reduces both amino acid specificity and tRNA aminoacylation. Conclusion: Amino acid selectivity and tRNA acylation require interdomain cooperativity. Significance: Independent recruitment of either module would have significantly reduced evolutionary fitness as Class I aaRS evolved. Tryptophanyl-tRNA Synthetase (TrpRS) Urzyme (fragments A and C), a 130-residue construct containing only secondary structures positioning the HIGH and KMSKS active site signatures and the specificity helix, accelerates tRNA(Trp) aminoacylation with approximate to 10-fold specificity toward tryptophan, relative to structurally related tyrosine. We proposed that including the 76-residue connecting peptide 1 insertion (Fragment B) might enhance tryptophan affinity and hence amino acid specificity, because that subdomain constrains the orientation of the specificity helix. We test that hypothesis by characterizing two new constructs: the catalytic domain (fragments A-C) and the Urzyme supplemented with the anticodon-binding domain (fragments A, C, and D). The three constructs, together with the full-length enzyme (fragments A-D), comprise a factorial experiment from which we deduce individual and combined contributions of the two modules to the steady-state kinetics parameters for tryptophan-dependent (PPi)-P-32 exchange, specificity for tryptophan versus tyrosine, and aminoacylation of tRNA(Trp). Factorial design directly measures the energetic coupling between the two more recent modules in the contemporary enzyme and demonstrates its functionality. Combining the TrpRS Urzyme individually in cis with each module affords an analysis of long term evolution of amino acid specificity and tRNA aminoacylation, both essential for expanding the genetic code. Either module significantly enhances tryptophan activation but unexpectedly eliminates amino acid specificity for tryptophan, relative to tyrosine, and significantly reduces tRNA aminoacylation. Exclusive dependence of both enhanced functionalities of full-length TrpRS on interdomain coupling energies between the two new modules argues that independent recruitment of connecting peptide 1 and the anticodon-binding domain during evolutionary development of Urzymes would have entailed significant losses of fitness.	[Li, Li; Carter, Charles W., Jr.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Carter, CW (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7270, Chapel Hill, NC 27599 USA.	carter@med.unc.edu			National Institutes of Health [NIGMS 78227, NIGMS 40906]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078227, R01GM090406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants NIGMS 78227 and NIGMS 40906.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5; Bullock TL, 2003, J MOL BIOL, V328, P395, DOI 10.1016/S0022-2836(03)00305-X; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Cammer S, 2010, BIOINFORMATICS, V26, P709, DOI 10.1093/bioinformatics/btq039; CARTER C W JR, 1990, Methods (Orlando), V1, P12, DOI 10.1016/S1046-2023(05)80142-2; Chopra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2421; Cleland W. W, 1970, ENZYMES, V2, P1; Cleland WW, 1999, METHOD ENZYMOL, V308, P3; Corigliano EM, 2009, BIOCHEMISTRY-US, V48, P676, DOI 10.1021/bi801552y; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; Ilyin VA, 2000, PROTEIN SCI, V9, P218; JAHN M, 1991, NATURE, V352, P258, DOI 10.1038/352258a0; Johnson JM, 2013, BIOCHEMISTRY-US, V52, P4399, DOI 10.1021/bi400079h; Kapustina M, 2007, STRUCTURE, V15, P1272, DOI 10.1016/j.str.2007.08.010; Laowanapiban P, 2009, P NATL ACAD SCI USA, V106, P1790, DOI 10.1073/pnas.0812752106; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Li L, 2013, J BIOL CHEM, V288, P26856, DOI 10.1074/jbc.M113.496125; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Perona JJ, 2012, BIOCHEMISTRY-US, V51, P8705, DOI 10.1021/bi301180x; Pham Y, 2007, MOL CELL, V25, P851, DOI 10.1016/j.molcel.2007.02.010; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Praetorius-Ibba M, 2000, BIOCHEMISTRY-US, V39, P13136; SAS, 2004, JMP STAT GRAPH GUID; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Weimer KME, 2009, J BIOL CHEM, V284, P10088, DOI 10.1074/jbc.M807361200; Weinreb V, 2012, STRUCTURE, V20, P128, DOI 10.1016/j.str.2011.10.020; Weinreb V, 2009, STRUCTURE, V17, P952, DOI 10.1016/j.str.2009.05.007; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200	35	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34736	34745		10.1074/jbc.M113.510958	http://dx.doi.org/10.1074/jbc.M113.510958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142809	hybrid, Green Published			2022-12-28	WOS:000329812800040
J	Stavrum, AK; Heiland, I; Schuster, S; Puntervoll, P; Ziegler, M				Stavrum, Anne-Kristin; Heiland, Ines; Schuster, Stefan; Puntervoll, Pal; Ziegler, Mathias			Model of Tryptophan Metabolism, Readily Scalable Using Tissue-specific Gene Expression Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain Metabolism; Liver Metabolism; Mathematical Modeling; Neurodegenerative Diseases; Tryptophan; Tumor Metabolism	INDOLEAMINE 2,3-DIOXYGENASE; KYNURENINE; PATHWAY; BRAIN; FLUX; SEROTONIN; NEURODEGENERATION; QUANTIFICATION; COMPETITION; INHIBITION	Background: Changes in tryptophan metabolism are associated with various diseases. Results: A comprehensive model of human tryptophan metabolism was constructed and verified with existing experimental data. Conclusion: The subtle balance of tryptophan derivatives required for proper brain function is sensitive to alterations in peripheral tissues. Significance: The model is applicable as a diagnostic tool to study disease related changes in tryptophan metabolism. Tryptophan is utilized in various metabolic routes including protein synthesis, serotonin, and melatonin synthesis and the kynurenine pathway. Perturbations in these pathways have been associated with neurodegenerative diseases and cancer. Here we present a comprehensive kinetic model of the complex network of human tryptophan metabolism based upon existing kinetic data for all enzymatic conversions and transporters. By integrating tissue-specific expression data, modeling tryptophan metabolism in liver and brain returned intermediate metabolite concentrations in the physiological range. Sensitivity and metabolic control analyses identified expected key enzymes to govern fluxes in the branches of the network. Combining tissue-specific models revealed a considerable impact of the kynurenine pathway in liver on the concentrations of neuroactive derivatives in the brain. Moreover, using expression data from a cancer study predicted metabolite changes that resembled the experimental observations. We conclude that the combination of the kinetic model with expression data represents a powerful diagnostic tool to predict alterations in tryptophan metabolism. The model is readily scalable to include more tissues, thereby enabling assessment of organismal tryptophan metabolism in health and disease.	[Stavrum, Anne-Kristin] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Heiland, Ines] Arctic Univ Norway, Dept Arctic & Marine Biol, UiT, N-9037 Tromso, Norway; [Schuster, Stefan] Univ Jena, Dept Bioinformat, D-07743 Jena, Germany; [Puntervoll, Pal] Uni Res, Computat Biol Unit, Uni Comp, N-5008 Bergen, Norway; [Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5008 Bergen, Norway	University of Bergen; UiT The Arctic University of Tromso; Friedrich Schiller University of Jena; University of Bergen	Heiland, I (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Dramsveien 201, N-9037 Tromso, Norway.	ines.heiland@uit.no	Heiland, Ines/B-9212-2014	Heiland, Ines/0000-0002-9124-5112; Ziegler, Mathias/0000-0001-6961-2396	German Federal Ministry of Education and Research (BMBF) within the Research Initiative in Systems Biology of Aging (GerontoSys) [0315591D, 0315890C]; German academic exchange service (DAAD) within the German-Norwegian Collaborative Research Support Scheme; Norwegian Cancer Society; Research Council of Norway [178885, 191721]	German Federal Ministry of Education and Research (BMBF) within the Research Initiative in Systems Biology of Aging (GerontoSys)(Federal Ministry of Education & Research (BMBF)); German academic exchange service (DAAD) within the German-Norwegian Collaborative Research Support Scheme(Deutscher Akademischer Austausch Dienst (DAAD)); Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway)	This work was supported by German Federal Ministry of Education and Research (BMBF) Projects 0315591D and 0315890C within the Research Initiative in Systems Biology of Aging (GerontoSys), the German academic exchange service (DAAD) within the German-Norwegian Collaborative Research Support Scheme, the Norwegian Cancer Society, and Research Council of Norway Grants 178885 and 191721.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BENDER DA, 1983, MOL ASPECTS MED, V6, P101, DOI 10.1016/0098-2997(83)90005-5; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carretti N, 2005, HUM REPROD, V20, P1548, DOI 10.1093/humrep/deh795; Chen YG, 2009, INT J COMPUT INT SYS, V2, P1, DOI 10.2991/jnmp.2009.2.1.1; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Dolusic E, 2011, J MED CHEM, V54, P5320, DOI 10.1021/jm2006782; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Fell DA, 1998, BIOTECHNOL BIOENG, V58, P121, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<121::AID-BIT2>3.3.CO;2-F; Fujigaki S, 1998, ARCH BIOCHEM BIOPHYS, V358, P329, DOI 10.1006/abbi.1998.0861; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Heinmets F, 1974, Comput Biol Med, V1, P323; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kincses ZT, 2010, J CELL MOL MED, V14, P2045, DOI 10.1111/j.1582-4934.2010.01123.x; Klipp E, 1999, BIOSYSTEMS, V54, P1, DOI 10.1016/S0303-2647(99)00059-3; Klipp Edda, 2004, Genome Inform, V15, P125; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Liu QY, 2008, J PHARMACOL EXP THER, V325, P47, DOI 10.1124/jpet.107.132670; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pawlak D, 2001, J PHYSIOL PHARMACOL, V52, P755; Sahle S, 2008, PHILOS T R SOC A, V366, P3619, DOI 10.1098/rsta.2008.0108; SALTER M, 1986, BIOCHEM J, V234, P635, DOI 10.1042/bj2340635; Schauble S, 2013, FEBS LETT, V587, P2818, DOI 10.1016/j.febslet.2013.06.025; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schuster S., 1996, REGULATION CELLULAR, P138; Schuster S., 2006, BIOINFORMATICS GENOM, P755; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; SPECIALE C, 1989, J NEUROSCI, V9, P2066; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; Stansberg C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-94; Stavrum A. K., 2008, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi0703s21; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vogt AM, 2002, FEBS LETT, V517, P245, DOI 10.1016/S0014-5793(02)02632-7; Zadori D, 2012, J NEURAL TRANSM, V119, P275, DOI 10.1007/s00702-011-0697-3; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	46	38	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34555	34566		10.1074/jbc.M113.474908	http://dx.doi.org/10.1074/jbc.M113.474908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129579	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000329812800024
J	Bishop, AC; Ganguly, S; Solis, NV; Cooley, BM; Jensen-Seaman, MI; Filler, SG; Mitchell, AP; Patton-Vogt, J				Bishop, Andrew C.; Ganguly, Shantanu; Solis, Norma V.; Cooley, Benjamin M.; Jensen-Seaman, Michael I.; Filler, Scott G.; Mitchell, Aaron P.; Patton-Vogt, Jana			Glycerophosphocholine Utilization by Candida albicans ROLE OF THE Git3 TRANSPORTER IN VIRULENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Pathogenesis; Phosphatidylcholine; Phospholipid Turnover; Transport; Yeast Genetics; Glycerophosphocholine; Phospholipid Metabolite	PHOSPHOLIPASE-B ACTIVITY; MOLECULAR CHARACTERIZATION; H-1-NMR SPECTROSCOPY; CHOLINE; PHOSPHODIESTERASE; GENE; GLYCEROPHOSPHOINOSITOL; PHOSPHATIDYLCHOLINE; TRANSPORT; GLYCEROPHOSPHODIESTERS	Candida albicans contains four ORFs (GIT1,2,3,4) predicted to encode proteins involved in the transport of glycerophosphodiester metabolites. Previously, we reported that Git1, encoded by ORF 19.34, is responsible for the transport of intact glycerophosphoinositol but not glycerophosphocholine (GroPCho). Here, we report that a strain lacking both GIT3 (ORF 19.1979) and GIT4 (ORF 19.1980) is unable to transport [H-3]GroPCho into the cell. In the absence of a GroPCho transporter, C. albicans can utilize GroPCho via a mechanism involving extracellular hydrolysis. Upon reintegration of either GIT3 or GIT4 into the genome, measurable uptake of [H-3]GroPCho is observed. Transport assays and kinetic analyses indicate that Git3 has the greater transport velocity. We present evidence that GDE1 (ORF 19.3936) codes for an enzyme with glycerophosphodiesterase activity against GroPCho. Homozygous deletion of GDE1 results in a buildup of internal GroPCho that is restored to wild type levels by reintegration of GDE1 into the genome. The transcriptional regulator, Pho4, is shown to regulate the expression of GIT3, GIT4, and GDE1. Finally, Git3 is shown to be required for full virulence in a mouse model of disseminated candidiasis, and Git3 sequence orthologs are present in other pathogenic Candida species. In summary, we have characterized multiple aspects of GroPCho utilization by C. albicans and have demonstrated that GroPCho transport plays a key role in the growth of the organism in the host.	[Bishop, Andrew C.; Cooley, Benjamin M.; Jensen-Seaman, Michael I.; Patton-Vogt, Jana] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Ganguly, Shantanu; Mitchell, Aaron P.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Solis, Norma V.; Filler, Scott G.] Harbor UCLA Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Filler, Scott G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA	Duquesne University; Carnegie Mellon University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Patton-Vogt, J (corresponding author), Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA.	pattonvogt@duq.edu		Mitchell, Aaron/0000-0002-0868-4000	National Institutes of Health [R15GM104876, R01AI070272, R01AI054928]; National Science Foundation [BCS-0922525]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054928, R01AI070272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104876] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [0922525] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported, in whole or in part, by National Institutes of Health Grants R15GM104876 (to J.P.-V.), R01AI070272 (to A. P. M.), and R01AI054928 (to S. G. F.). This work was also supported by National Science Foundation Grant BCS-0922525 (to M. J. S.).	Almaguer C, 2004, J BIOL CHEM, V279, P31937, DOI 10.1074/jbc.M403648200; Backshall A, 2009, J PROTEOME RES, V8, P1423, DOI 10.1021/pr800793w; Bishop AC, 2011, EUKARYOT CELL, V10, P1618, DOI 10.1128/EC.05160-11; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; BRZOSKA P, 1988, J BACTERIOL, V170, P4125, DOI 10.1128/jb.170.9.4125-4135.1988; Cheng LY, 2011, PLANT PHYSIOL, V156, P1131, DOI 10.1104/pp.111.173724; Cheng YX, 2011, PLANT J, V66, P781, DOI 10.1111/j.1365-313X.2011.04538.x; Chrisman CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002047; COOK SJ, 1989, BIOCHEM J, V263, P581, DOI 10.1042/bj2630581; Davis DA, 2002, GENETICS, V162, P1573; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; ELION EA, 1984, CELL, V39, P663, DOI 10.1016/0092-8674(84)90473-2; Farn JL, 2001, J BACTERIOL, V183, P6717, DOI 10.1128/JB.183.22.6717-6720.2001; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Fisher JF, 2011, CLIN INFECT DIS, V52, pS437, DOI 10.1093/cid/cir110; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; Ganguly Shantanu, 2012, Methods Mol Biol, V845, P19, DOI 10.1007/978-1-61779-539-8_2; Gaur M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-579; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Ghosh S, 2012, J PROTEOME RES, V11, P4992, DOI 10.1021/pr300562m; Hama H, 2000, METHODS, V20, P465, DOI 10.1006/meth.2000.0959; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; Heimburger DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010687; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ilcol YO, 2005, J NUTR BIOCHEM, V16, P489, DOI 10.1016/j.jnutbio.2005.01.011; Jiang FY, 2012, BIORESOURCE TECHNOL, V104, P518, DOI 10.1016/j.biortech.2011.09.112; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KLEIN J, 1993, NEUROCHEM INT, V22, P293, DOI 10.1016/0197-0186(93)90058-D; Kohler GA, 2006, BBA-MOL CELL BIOL L, V1761, P1391, DOI 10.1016/j.bbalip.2006.09.011; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leidich SD, 1998, J BIOL CHEM, V273, P26078, DOI 10.1074/jbc.273.40.26078; Mariggio S, 2006, FEBS LETT, V580, P6789, DOI 10.1016/j.febslet.2006.11.039; Moran GP, 2011, EUKARYOT CELL, V10, P34, DOI 10.1128/EC.00242-10; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; OVERDUIN P, 1988, MOL MICROBIOL, V2, P767, DOI 10.1111/j.1365-2958.1988.tb00088.x; Paban V, 2010, EUR J NEUROSCI, V31, P1063, DOI 10.1111/j.1460-9568.2010.07126.x; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; PATTON JL, 1995, J BACTERIOL, V177, P3379, DOI 10.1128/jb.177.12.3379-3385.1995; Patton-Vogt J, 2007, BBA-MOL CELL BIOL L, V1771, P337, DOI 10.1016/j.bbalip.2006.04.013; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Romanowski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030119; Santos MAS, 1997, MOL MICROBIOL, V26, P423, DOI 10.1046/j.1365-2958.1997.5891961.x; SENAR S, 1994, CELL SIGNAL, V6, P433, DOI 10.1016/0898-6568(94)90090-6; Taff HT, 2012, MED MYCOL, V50, P214, DOI 10.3109/13693786.2011.580016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theiss S, 2006, INT J MED MICROBIOL, V296, P405, DOI 10.1016/j.ijmm.2006.03.003; Walter A, 2004, NEUROBIOL AGING, V25, P1299, DOI 10.1016/j.neurobiolaging.2004.02.016; Wang YL, 2005, J PROTEOME RES, V4, P1324, DOI 10.1021/pr050032r; Wang Y, 2007, J PROTEOME RES, V6, P3944, DOI 10.1021/pr0702565; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xu SY, 2009, FEBS J, V276, P175, DOI 10.1111/j.1742-4658.2008.06771.x; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062	59	16	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33939	33952		10.1074/jbc.M113.505735	http://dx.doi.org/10.1074/jbc.M113.505735			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114876	Green Published, hybrid			2022-12-28	WOS:000327250200036
J	Gan, XQ; Wang, C; Patel, M; Kreutz, B; Zhou, M; Kozasa, T; Wu, DQ				Gan, Xiaoqing; Wang, Chen; Patel, Maulik; Kreutz, Barry; Zhou, Maggie; Kozasa, Tohru; Wu, Dianqing			Different Raf Protein Kinases Mediate Different Signaling Pathways to Stimulate E3 Ligase RFFL Gene Expression in Cell Migration Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Cell Signaling; G Proteins; Raf; Signal Transduction; Signaling	P115 RHOGEF; A-RAF; G-ALPHA(13); DEGRADATION; COMPLEX; G(13); ALPHA	We previously characterized a G12-specific signaling pathway that stimulates the transcription of the E3 ligase RFFL via the protein kinase ARAF and ERK. This pathway leads to persistent PKC activation and is important for sustaining fibroblast migration. However, questions remain regarding how G12 specifically activates ARAF, which transcription factor is involved in G12-mediated RFFL expression, and whether RFFL is important for cell migration stimulated by other signaling mechanisms that can activate ERK. In this study, we show that replacement of the G12 residue Arg-264 with Gln, which is the corresponding G13 residue, abrogates the ability of G12 to interact with or activate ARAF. We also show that G12 can no longer interact with and activate an ARAF mutant with its C-terminal sequence downstream of the kinase domain being replaced with the corresponding CRAF sequence. These results explain why G12, but not G13, specifically activates ARAF but not CRAF. Together with our finding that recombinant G12 is sufficient for stimulating the kinase activity of ARAF, this study reveals an ARAF activation mechanism that is different from that of CRAF. In addition, we show that this G12-ARAF-ERK pathway stimulates RFFL transcription through the transcription factor c-Myc. We further demonstrate that EGF, which signals through CRAF, and an activated BRAF mutant also activate PKC and stimulate cell migration through up-regulating RFFL expression. Thus, RFFL-mediated PKC activation has a broad significance in cell migration regulation.	[Gan, Xiaoqing; Wang, Chen; Zhou, Maggie; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Gan, Xiaoqing; Wang, Chen; Zhou, Maggie; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Patel, Maulik; Kreutz, Barry; Kozasa, Tohru] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Kozasa, Tohru] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 153, Japan	Yale University; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tokyo	Wu, DQ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.	dan.wu@yale.edu	zhou, Maggie/GWQ-6970-2022	Zhou, Maggie/0000-0001-5308-0014	National Institutes of Health [HL070694, HL080706, GM061454]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R01HL080706, R01HL120465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070694 and HL080706 (to D. W.) and GM061454 (to T. K.).	Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Herroeder S, 2009, IMMUNITY, V30, P708, DOI 10.1016/j.immuni.2009.02.010; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Sivaraj KK, 2013, DEV CELL, V25, P427, DOI 10.1016/j.devcel.2013.04.008; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; Won HY, 2010, BIOCHEM BIOPH RES CO, V394, P811, DOI 10.1016/j.bbrc.2010.03.079; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002	22	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33978	33984		10.1074/jbc.M113.477406	http://dx.doi.org/10.1074/jbc.M113.477406			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114843	Green Published, hybrid			2022-12-28	WOS:000327250200039
J	Suhanovsky, MM; Teschke, CM				Suhanovsky, Margaret M.; Teschke, Carolyn M.			An Intramolecular Chaperone Inserted in Bacteriophage P22 Coat Protein Mediates Its Chaperonin-independent Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteriophage; Protein Folding; Protein Self-assembly; Protein Stability; Virus Assembly	CIRCULAR-DICHROISM; UNFOLDING KINETICS; POLYHEAD FORMATION; PULSE PROTEOLYSIS; RIBONUCLEASE-A; PHAGE-P22; MECHANISM; MUTANTS; MATURATION; STABILITY	The bacteriophage P22 coat protein has the common HK97-like fold but with a genetically inserted domain (I-domain). The role of the I-domain, positioned at the outermost surface of the capsid, is unknown. We hypothesize that the I-domain may act as an intramolecular chaperone because the coat protein folds independently, and many folding mutants are localized to the I-domain. The function of the I-domain was investigated by generating the coat protein core without its I-domain and the isolated I-domain. The core coat protein shows a pronounced folding defect. The isolated I-domain folds autonomously and has a high thermodynamic stability and fast folding kinetics in the presence of a peptidyl prolyl isomerase. Thus, the I-domain provides thermodynamic stability to the full-length coat protein so that it can fold reasonably efficiently while still allowing the HK97-like core to retain the flexibility required for conformational switching during procapsid assembly and maturation.	[Suhanovsky, Margaret M.; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Teschke, Carolyn M.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Teschke, CM (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	teschke@uconn.edu			National Institutes of Health [GMS 076661]; IDeA Networks of Biomedical Research Program, NIGMS, National Institutes of Health [8P20GM103449]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449, R01GM076661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDeA Networks of Biomedical Research Program, NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMS 076661 (to C. M. T.) and the IDeA Networks of Biomedical Research Program, NIGMS, National Institutes of Health Grant 8P20GM103449 (to the Vermont Genetics Network).	Aksyuk AA, 2012, P NATL ACAD SCI USA, V109, P14001, DOI 10.1073/pnas.1207730109; Anderson E, 2003, VIROLOGY, V313, P184, DOI 10.1016/S0042-6822(03)00240-X; Aramli LA, 1999, J BIOL CHEM, V274, P22217, DOI 10.1074/jbc.274.32.22217; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; Bowman BR, 2003, EMBO J, V22, P757, DOI 10.1093/emboj/cdg086; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen DH, 2011, P NATL ACAD SCI USA, V108, P1355, DOI 10.1073/pnas.1015739108; Creighton T. E., 1992, PROTEINS STRUCTURES, P5; Dodge RW, 1996, BIOCHEMISTRY-US, V35, P1548, DOI 10.1021/bi952348q; Dornan J, 2003, CURR TOP MED CHEM, V3, P1392, DOI 10.2174/1568026033451899; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Gloss LM, 1998, BIOCHEMISTRY-US, V37, P15990, DOI 10.1021/bi981511p; GORDON CL, 1993, J BIOL CHEM, V268, P9358; GORDON CL, 1994, GENETICS, V136, P427; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Inouye K, 1998, BBA-PROTEIN STRUCT M, V1388, P209, DOI 10.1016/S0167-4838(98)00189-7; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kang SB, 2005, J MOL BIOL, V347, P935, DOI 10.1016/j.jmb.2005.02.021; Kang S, 2010, BIOMACROMOLECULES, V11, P2804, DOI 10.1021/bm100877q; KIEFHABER T, 1992, J MOL BIOL, V224, P231, DOI 10.1016/0022-2836(92)90586-9; KING J, 1976, PHILOS T ROY SOC B, V276, P37, DOI 10.1098/rstb.1976.0096; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498; MAYR LM, 1994, J MOL BIOL, V240, P288, DOI 10.1006/jmbi.1994.1446; McKinney J, 2002, J BACTERIOL, V184, P6056, DOI 10.1128/JB.184.21.6056-6059.2002; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Na YR, 2009, PROTEIN SCI, V18, P268, DOI 10.1002/pro.29; Nakonechny WS, 1998, J BIOL CHEM, V273, P27236, DOI 10.1074/jbc.273.42.27236; OCHMAN H, 1988, GENETICS, V120, P621; Parent KN, 2007, MOL MICROBIOL, V65, P1300, DOI 10.1111/j.1365-2958.2007.05868.x; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Pierre B, 2011, BIOTECHNOL BIOENG, V108, P1011, DOI 10.1002/bit.23039; PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; PREVELIGE PE, 1993, PROG MED VIROL, V40, P206; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rizzo AA, 2013, BIOMOL NMR ASSIGN, V7, P257, DOI 10.1007/s12104-012-9422-x; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Suhanovsky MM, 2010, MOL MICROBIOL, V77, P1568, DOI 10.1111/j.1365-2958.2010.07311.x; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	59	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33772	33783		10.1074/jbc.M113.515312	http://dx.doi.org/10.1074/jbc.M113.515312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126914	Green Published, hybrid			2022-12-28	WOS:000327250200023
J	Chen, SF; Wu, CH; Lee, YM; Tam, K; Tsai, YC; Liou, JY; Shyue, SK				Chen, Shu-Fen; Wu, Chun-Hu; Lee, Yen-Ming; Tam, Kabik; Tsai, Yi-Chen; Liou, Jun-Yang; Shyue, Song-Kun			Caveolin-1 Interacts with Derlin-1 and Promotes Ubiquitination and Degradation of Cyclooxygenase-2 via Collaboration with p97 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caveolin; Cyclooxygenase (COX) Pathway; ER-associated Degradation; Protein Degradation; Ubiquitination; Derlin-1; Caveolin-1; Cyclooxygenase-2; p97	RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; AAA-ATPASE; MEMBRANE; PATHWAY; ACTIVATION; EXPRESSION; DISEASE; VCP	Caveolin-1 (Cav-1) interacts with and mediates protein trafficking and various cellular functions. Derlin-1 is a candidate for the retrotranslocation channel of endoplasmic reticulum proteins. However, little is known about how Derlin-1 mediates glycosylated protein degradation. Here, we identified Cav-1 as a key player in Derlin-1- and p97-mediated cyclooxygenase 2 (COX-2) ubiquitination and degradation. Derlin-1 augmented the interaction of Cav-1 and COX-2 and mediated the degradation of COX-2 in a COX-2 C terminus-dependent manner. Suppression of Cav-1 decreased the ubiquitination of COX-2, and mutation of Asn-594 to Ala to disrupt N-glycosylation at the C terminus of COX-2 reduced the interaction of COX-2 with Cav-1 but not Derlin-1. Moreover, suppression of p97 increased the ubiquitination of COX-2 and up-regulated COX-2 but not COX-1. Cav-1 enhanced the interaction of p97 with Ufd1 and Derlin-1 and collaborated with p97 to interact with COX-2. Cav-1 may be a cofactor in the interaction of Derlin-1 and N-glycosylated COX-2 and may facilitate Derlin-1- and p97 complex-mediated COX-2 ubiquitination, retrotranslocation, and degradation.	[Chen, Shu-Fen; Wu, Chun-Hu; Lee, Yen-Ming; Tam, Kabik; Tsai, Yi-Chen; Shyue, Song-Kun] Acad Sinica, Inst Biomed Sci, Cardiovasc Div, Taipei 11529, Taiwan; [Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan; [Shyue, Song-Kun] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan	Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Shyue, SK (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	skshyue@ibms.sinica.edu.tw	Liou, Jun-Yang/B-1065-2010; Shyue, Song-Kun/Q-2583-2018; WU, CHUN-HU/P-3958-2018	Shyue, Song-Kun/0000-0002-1057-8696; WU, CHUN-HU/0000-0001-6851-7936	National Science Council, Taiwan [NSC 94-2320-B-001-038, NSC 99-2628-B-001-013-MY3]; Institute of Biomedical Sciences, Academia Sinica	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan)	This study was supported by National Science Council, Taiwan, Grants NSC 94-2320-B-001-038 and NSC 99-2628-B-001-013-MY3 and by the Institute of Biomedical Sciences, Academia Sinica.	Al-Hourani BJ, 2011, EXPERT OPIN THER PAT, V21, P1339, DOI 10.1517/13543776.2011.593510; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bonuccelli G, 2009, AM J PATHOL, V174, P1650, DOI 10.2353/ajpath.2009.080648; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chang TC, 2005, J BIOL CHEM, V280, P36567, DOI 10.1074/jbc.M504280200; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Gaudreault SB, 2004, NEUROBIOL AGING, V25, P753, DOI 10.1016/j.neurobiolaging.2003.07.004; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Kirchner P, 2013, J BIOL CHEM, V288, P7363, DOI 10.1074/jbc.M112.429076; Lass A, 2007, ARCH BIOCHEM BIOPHYS, V462, P62, DOI 10.1016/j.abb.2007.04.010; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sato M, 2012, J BIOL CHEM, V287, P20674, DOI 10.1074/jbc.M111.280651; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; Sugiyama T, 2011, BIOCHEM BIOPH RES CO, V404, P853, DOI 10.1016/j.bbrc.2010.12.074; Tsai TH, 2011, SHOCK, V35, P92, DOI 10.1097/SHK.0b013e3181ea45ca; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang F, 2012, J BIOL CHEM, V287, P10482, DOI 10.1074/jbc.M111.312223; Wu KK, 2005, PROSTAG LEUKOTR ESS, V72, P89, DOI 10.1016/j.plefa.2004.11.001; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	42	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33462	33469		10.1074/jbc.M113.521799	http://dx.doi.org/10.1074/jbc.M113.521799			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089527	hybrid, Green Published			2022-12-28	WOS:000328841700058
J	Patel, A; Vought, VE; Swatkoski, S; Viggiano, S; Howard, B; Dharmarajan, V; Monteith, KE; Kupakuwana, G; Namitz, KE; Shinsky, SA; Cotter, RJ; Cosgrove, MS				Patel, Anamika; Vought, Valarie E.; Swatkoski, Stephen; Viggiano, Susan; Howard, Benny; Dharmarajan, Venkatasubramanian; Monteith, Kelsey E.; Kupakuwana, Gillian; Namitz, Kevin E.; Shinsky, Stephen A.; Cotter, Robert J.; Cosgrove, Michael S.			Automethylation Activities within the Mixed Lineage Leukemia-1 (MLL1) Core Complex Reveal Evidence Supporting a "Two-active Site" Model for Multiple Histone H3 Lysine 4 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI ADA; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; METHYLTRANSFERASE ACTIVITY; DROSOPHILA-TRITHORAX; 11Q23 TRANSLOCATIONS; MOLECULAR REGULATION; PRODUCT SPECIFICITY; GENE-EXPRESSION; KABUKI SYNDROME	The mixed lineage leukemia-1 (MLL1) core complex predominantly catalyzes mono-and dimethylation of histone H3 at lysine 4 (H3K4) and is frequently altered in aggressive acute leukemias. The molecular mechanisms that account for conversion of mono-to dimethyl H3K4 (H3K4me1,2) are not well understood. In this investigation, we report that the suppressor of variegation, enhancer of zeste, trithorax (SET) domains from human MLL1 and Drosophila Trithorax undergo robust intramolecular automethylation reactions at an evolutionarily conserved cysteine residue in the active site, which is inhibited by unmodified histone H3. The location of the automethylation in the SET-I subdomain indicates that the MLL1 SET domain possesses significantly more conformational plasticity in solution than suggested by its crystal structure. We also report that MLL1 methylates Ash2L in the absence of histone H3, but only when assembled within a complex with WDR5 and RbBP5, suggesting a restraint for the architectural arrangement of subunits within the complex. Using MLL1 and Ash2L automethylation reactions as probes for histone binding, we observed that both automethylation reactions are significantly inhibited by stoichiometric amounts of unmethylated histone H3, but not by histones previously mono-, di-, or trimethylated at H3K4. These results suggest that the H3K4me1 intermediate does not significantly bind to the MLL1 SET domain during the dimethylation reaction. Consistent with this hypothesis, we demonstrate that the MLL1 core complex assembled with a catalytically inactive SET domain variant preferentially catalyzes H3K4 dimethylation using the H3K4me1 substrate. Taken together, these results are consistent with a "two-active site" model for multiple H3K4 methylation by the MLL1 core complex.	[Patel, Anamika; Viggiano, Susan; Namitz, Kevin E.; Shinsky, Stephen A.; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Vought, Valarie E.; Howard, Benny; Dharmarajan, Venkatasubramanian; Monteith, Kelsey E.; Kupakuwana, Gillian] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Swatkoski, Stephen; Cotter, Robert J.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21202 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Syracuse University; Johns Hopkins University; Johns Hopkins Medicine	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 East Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu		Namitz, Kevin/0000-0003-4434-1475; Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health Grant from NCI [R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health Grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA140522 from NCI (to M. S. C.).	Atkinson D. E., 1977, CELLULAR ENERGY META, P32; BAILEY E, 1981, CANCER RES, V41, P2514; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cosgrove MS, 2010, FEBS J, V277, P1832, DOI 10.1111/j.1742-4658.2010.07609.x; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HANCK T, 1993, NUCLEIC ACIDS RES, V21, P303, DOI 10.1093/nar/21.2.303; Hannibal MC, 2011, AM J MED GENET A, V155A, P1511, DOI 10.1002/ajmg.a.34074; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Kuhn P, 2009, PROTEIN SCI, V18, P1272, DOI 10.1002/pro.139; Lapko VN, 2002, BIOCHEMISTRY-US, V41, P14645, DOI 10.1021/bi0267700; Li Y, 2011, HUM GENET, V130, P715, DOI 10.1007/s00439-011-1004-y; Lin YX, 2001, BIOCHEMISTRY-US, V40, P4261, DOI 10.1021/bi002109p; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; MYERS LC, 1995, J BIOL CHEM, V270, P6664, DOI 10.1074/jbc.270.12.6664; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; OLSSON M, 1980, J BIOL CHEM, V255, P569; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Paulussen ADC, 2011, HUM MUTAT, V32, pE2018, DOI 10.1002/humu.21416; Pawson T, 2002, EUR J CANCER, V38, pS3, DOI 10.1016/S0959-8049(02)80597-4; PEGG AE, 1992, FASEB J, V6, P2302, DOI 10.1096/fasebj.6.6.1544541; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; SZILAK L, 1995, GENE, V157, P105, DOI 10.1016/0378-1119(94)00635-6; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	61	19	21	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					868	884		10.1074/jbc.M113.501064	http://dx.doi.org/10.1074/jbc.M113.501064			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24235145	Green Published, hybrid			2022-12-28	WOS:000330541200023
J	Schureck, MA; Maehigashi, T; Miles, SJ; Marquez, J; Cho, SE; Erdman, R; Dunham, CM				Schureck, Marc A.; Maehigashi, Tatsuya; Miles, Stacey J.; Marquez, Jhomar; Cho, Shein Ei; Erdman, Rachel; Dunham, Christine M.			Structure of the Proteus vulgaris HigB-(HigA)(2)-HigB Toxin-Antitoxin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER GENE SYSTEM; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REPRESSION; MULTIDRUG TOLERANCE; SECONDARY-STRUCTURE; LON PROTEASE; DNA-BINDING; YOEB TOXIN; RNA	Bacterial toxin-antitoxin (TA) systems regulate key cellular processes to promote cell survival during periods of stress. During steady-state cell growth, antitoxins typically interact with their cognate toxins to inhibit activity presumably by preventing substrate recognition. We solved two x-ray crystal structures of the Proteus vulgaris tetrameric HigB-(HigA)(2)-HigB TA complex and found that, unlike most other TA systems, the antitoxin HigA makes minimal interactions with toxin HigB. HigB adopts a RelE family tertiary fold containing a highly conserved concave surface where we predict its active site is located. HigA does not cover the solvent-exposed HigB active site, suggesting that, in general, toxin inhibition is not solely mediated by active site hindrance by its antitoxin. Each HigA monomer contains a helix-turn-helix motif that binds to its own DNA operator to repress transcription during normal cellular growth. This is distinct from antitoxins belonging to other superfamilies that typically only form DNA-binding motifs upon dimerization. We further show that disruption of the HigB-(HigA)(2)-HigB tetramer to a HigBA heterodimer ablates operator binding. Taken together, our biochemical and structural studies elucidate the novel molecular details of the HigBA TA system.	[Schureck, Marc A.; Maehigashi, Tatsuya; Miles, Stacey J.; Marquez, Jhomar; Cho, Shein Ei; Erdman, Rachel; Dunham, Christine M.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Emory University	Dunham, CM (corresponding author), Emory Univ, Dept Biochem, Sch Med, 1510 Clifton Rd NE,Ste G223, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu			National Science Foundation CAREER [MCB0953714]; National Institutes of Health NCRR [RR-15301]; United States Department of Energy [DE-AC02-06CH11357]; Biochemistry, Cellular and Molecular Biology (BCMB) Graduate Training Grant [5T32GM8367]; National Institutes of Health National Research Service [GM108351]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, F31GM108351] Funding Source: NIH RePORTER	National Science Foundation CAREER(National Science Foundation (NSF)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); Biochemistry, Cellular and Molecular Biology (BCMB) Graduate Training Grant; National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER Award MCB0953714 (to C. M. D.). This work is based on research conducted at the Advanced Photon Source on the NE-CAT beamlines, which is supported by National Institutes of Health NCRR Award RR-15301, and at the SER-CAT beamline. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.; Supported by Biochemistry, Cellular and Molecular Biology (BCMB) Graduate Training Grant 5T32GM8367 and National Institutes of Health National Research Service Award Fellowship GM108351.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bauerova-Hlinkova V, 2009, FEBS J, V276, P4156, DOI 10.1111/j.1742-4658.2009.07125.x; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Boggild A, 2012, STRUCTURE, V20, P1641, DOI 10.1016/j.str.2012.08.017; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francuski D, 2009, J MOL BIOL, V393, P898, DOI 10.1016/j.jmb.2009.08.048; Francuski M, 2009, TRANSPL INT, V22, P482, DOI 10.1111/j.1432-2277.2008.00776.x; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Goeders N, 2013, J BACTERIOL, V195, P2541, DOI 10.1128/JB.02266-12; Harrison JJ, 2009, ANTIMICROB AGENTS CH, V53, P2253, DOI 10.1128/AAC.00043-09; Heaton BE, 2012, J BIOL CHEM, V287, P12098, DOI 10.1074/jbc.M111.332163; HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hurley JM, 2011, J BIOL CHEM, V286, P14770, DOI 10.1074/jbc.M110.108969; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Luscombe NM, 2000, GENOME BIOL, V1; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2013, STRUCTURE, V21, P627, DOI 10.1016/j.str.2013.02.008; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; SHIMON LJW, 1993, J MOL BIOL, V232, P826, DOI 10.1006/jmbi.1993.1434; Stella S, 2010, GENE DEV, V24, P814, DOI 10.1101/gad.1900610; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; TERAWAKI Y, 1967, J BACTERIOL, V94, P687, DOI 10.1128/JB.94.3.687-690.1967; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tian QB, 2001, PLASMID, V45, P63, DOI 10.1006/plas.2000.1506; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	72	55	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1060	1070		10.1074/jbc.M113.512095	http://dx.doi.org/10.1074/jbc.M113.512095			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24257752	hybrid, Green Published			2022-12-28	WOS:000330541200038
J	Park, HJ; Guariento, M; Maciejewski, M; Hauhart, R; Tham, WH; Cowman, AF; Schmidt, CQ; Mertens, HDT; Liszewski, MK; Hourcade, DE; Barlow, PN; Atkinson, JP				Park, Hyon Ju; Guariento, Mara; Maciejewski, Mateusz; Hauhart, Richard; Tham, Wai-Hong; Cowman, Alan F.; Schmidt, Christoph Q.; Mertens, Haydyn D. T.; Liszewski, M. Kathryn; Hourcade, Dennis E.; Barlow, Paul N.; Atkinson, John P.			Using Mutagenesis and Structural Biology to Map the Binding Site for the Plasmodium falciparum Merozoite Protein PfRh4 on the Human Immune Adherence Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Complement System; Convertases; Malaria; NMR; Plasmodium; Protein Structure; Surface Plasmon Resonance (SPR); Reticulocyte-binding Homologue Proteins	MALARIA PARASITE INVASION; PAPUA-NEW-GUINEA; 2 ACTIVE-SITES; COMPLEMENT RECEPTOR; C3B/C4B RECEPTOR; ERYTHROCYTE INVASION; FACTOR-H; LIGAND-BINDING; GLYCOPHORIN-C; C3B BINDING	To survive and replicate within the human host, malaria parasites must invade erythrocytes. Invasion can be mediated by the P. falciparum reticulocyte-binding homologue protein 4 (PfRh4) on the merozoite surface interacting with complement receptor type 1 (CR1, CD35) on the erythrocyte membrane. The PfRh4 attachment site lies within the three N-terminal complement control protein modules (CCPs 1-3) of CR1, which intriguingly also accommodate binding and regulatory sites for the key complement activation-specific proteolytic products, C3b and C4b. One of these regulatory activities is decay-accelerating activity. Although PfRh4 does not impact C3b/C4b binding, it does inhibit this convertase disassociating capability. Here, we have employed ELISA, co-immunoprecipitation, and surface plasmon resonance to demonstrate that CCP 1 contains all the critical residues for PfRh4 interaction. We fine mapped by homologous substitution mutagenesis the PfRh4-binding site on CCP 1 and visualized it with a solution structure of CCPs 1-3 derived by NMR and small angle x-ray scattering. We cross-validated these results by creating an artificial PfRh4-binding site through substitution of putative PfRh4-interacting residues from CCP 1 into their homologous positions within CCP 8; strikingly, this engineered binding site had an approximate to 30-fold higher affinity for PfRh4 than the native one in CCP 1. These experiments define a candidate site on CR1 by which P. falciparum merozoites gain access to human erythrocytes in a non-sialic acid-dependent pathway of merozoite invasion.	[Park, Hyon Ju; Hauhart, Richard; Liszewski, M. Kathryn; Hourcade, Dennis E.; Atkinson, John P.] Washington Univ, Sch Med, Dept Internal Med, Div Rheumatol, St Louis, MO 63110 USA; [Guariento, Mara; Maciejewski, Mateusz; Schmidt, Christoph Q.; Barlow, Paul N.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland; [Guariento, Mara; Maciejewski, Mateusz; Schmidt, Christoph Q.; Barlow, Paul N.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JJ, Midlothian, Scotland; [Tham, Wai-Hong; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Div Infect & Immun, Parkville, Vic 3052, Australia; [Tham, Wai-Hong; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Mertens, Haydyn D. T.] Australian Natl Synchrotron, Melbourne, Vic 3168, Australia	Washington University (WUSTL); University of Edinburgh; University of Edinburgh; University of Melbourne; Walter & Eliza Hall Institute	Barlow, PN (corresponding author), Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland.	paul.barlow@ed.ac.uk; jatkinso@dom.wustl.edu	Tham, Wai-Hong/P-6474-2019; Tham, Wai-Hong/L-3173-2018	Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699; Atkinson, John/0000-0002-2514-3441; Mertens, Haydyn/0000-0002-5664-744X	National Institutes of Health [R01 AI041592, P30 AR48335, T32 AR07279, R01 AI051436]; Wellcome Trust [081179, 085025]; National Health and Medical Research Council [1026581]; Australian Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041592, R01AI051436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335, T32AR007279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI041592, P30 AR48335, and T32 AR07279 (to J. P. A.) and R01 AI051436 (to D. H.). This work was also supported by Wellcome Trust Grants 081179 (to P. N. B., C. Q. S., and M. G.) and 085025 (to M. M.), National Health and Medical Research Council Grant 1026581 (to W.-H. T.), and an Australian Research Council Future Fellowship (to W.-H. T.).	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Alonso P. L., 2011, PLOS MED, V8; [Anonymous], 2010, WHO GLOB MAL PROGR; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Black G, 2004, J BIOMOL NMR, V30, P227, DOI 10.1023/B:JNMR.0000048853.72652.9a; CARROLL MC, 1988, J EXP MED, V167, P1271, DOI 10.1084/jem.167.4.1271; COLE JL, 1985, P NATL ACAD SCI USA, V82, P859, DOI 10.1073/pnas.82.3.859; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Daniels G. L., 2003, Vox Sanguinis, V84, P244, DOI 10.1046/j.1423-0410.2003.00282.x; DECORDOBA SR, 1985, J EXP MED, V161, P1189, DOI 10.1084/jem.161.5.1189; DECORDOBA SR, 1984, P NATL ACAD SCI-BIOL, V81, P7890, DOI 10.1073/pnas.81.24.7890; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; FEARON DT, 1979, P NATL ACAD SCI USA, V76, P5867, DOI 10.1073/pnas.76.11.5867; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Hocking HG, 2008, J BIOL CHEM, V283, P9475, DOI 10.1074/jbc.M709587200; HOURCADE D, 1992, GENOMICS, V12, P289, DOI 10.1016/0888-7543(92)90376-4; HOURCADE D, 1988, J EXP MED, V168, P1255, DOI 10.1084/jem.168.4.1255; HOURCADE D, 1990, J BIOL CHEM, V265, P974; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Ko WY, 2011, AM J HUM GENET, V88, P741, DOI 10.1016/j.ajhg.2011.05.005; KRYCH M, 1991, P NATL ACAD SCI USA, V88, P4353, DOI 10.1073/pnas.88.10.4353; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; KRYCH M, 1994, J BIOL CHEM, V269, P13273; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Krych-Goldberg M, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P179; Krych-Goldberg M, 2005, J IMMUNOL, V175, P4528, DOI 10.4049/jimmunol.175.7.4528; Krych-Goldberg M, 2002, TRENDS MOL MED, V8, P531, DOI 10.1016/S1471-4914(02)02419-X; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Makou E, 2012, J MOL BIOL, V424, P295, DOI 10.1016/j.jmb.2012.09.013; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moulds JM, 1998, EXP CLIN IMMUNOGENET, V15, P291, DOI 10.1159/000019084; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Patel SS, 2004, AM J HEMATOL, V75, P1, DOI 10.1002/ajh.10448; Peterson DS, 2000, MOL BIOCHEM PARASIT, V105, P105, DOI 10.1016/S0166-6851(99)00173-5; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schrodinger L., 2011, PYMOL MOL GRAPHICS S; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Smith BO, 2002, CELL, V108, P769, DOI 10.1016/S0092-8674(02)00672-4; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Subramanian VB, 1996, J IMMUNOL, V157, P1242; Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123; Tetteh-Quarcoo PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034820; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Zimmerman PA, 2003, TRENDS PARASITOL, V19, P250, DOI 10.1016/S1471-4922(03)00112-0	67	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					450	463		10.1074/jbc.M113.520346	http://dx.doi.org/10.1074/jbc.M113.520346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24214979	Green Published, hybrid			2022-12-28	WOS:000329370900039
J	Wu, J; Puppala, D; Feng, XD; Monetti, M; Lapworth, AL; Geoghegan, KF				Wu, Jiang; Puppala, Dinesh; Feng, Xidong; Monetti, Mara; Lapworth, Amanda Lee; Geoghegan, Kieran F.			Chemoproteomic Analysis of Intertissue and Interspecies Isoform Diversity of AMP-activated Protein Kinase (AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Chemical Biology; Chemical Modification; Drug Discovery; Mass Spectrometry (MS)	GAMMA-SUBUNIT ISOFORMS; HUMAN SKELETAL-MUSCLE; LABEL-FREE; CHEMICAL PROTEOMICS; ENERGY SENSOR; DRUG TARGET; EXPRESSION; METFORMIN; EXERCISE; IDENTIFICATION	Background: AMPK is a heterotrimeric enzyme targeted for drug discovery (activation) in diabetes. Results: Diversity of AMPK was studied by chemical capture and proteomic LC-MS. Conclusion: AMPK of human and rat livers differs with respect to the chain. Certain direct activators only activate AMPK containing the 1 form. Significance: Interspecies divergence could compromise the translatability of preclinical data. AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that senses and governs changes in the cellular energy balance represented by concentrations of AMP, ADP, and ATP. Each of its three chains (, , and ) exists as either two or three subtypes, theoretically allowing up to 12 different forms of the complete enzyme. Tissue specificity in the distribution of AMPK subtypes is believed to underpin a range of biological functions for AMPK, a central regulator of metabolic function and response. It is of particular interest for drug discovery purposes to compare AMPK isoforms that are most prevalent in human liver and muscle with isoforms present in key preclinical species. To complement immunocapture/immunodetection methods, which for AMPK are challenged by sequence similarities and difficulties of obtaining accurate relative quantitation, AMPK was captured from lysates of a range of cells and tissues using the ActivX ATP probe. This chemical probe covalently attaches desthiobiotin to one or more conserved lysyl residues in the ATP-binding sites of protein kinases, including AMPK, while also labeling a wide range of ATP-utilizing proteins. Affinity-based recovery of labeled proteins followed by gel-based fractionation of the captured sample was followed by proteomic characterization of AMPK polypeptides. In agreement with transcript-based analysis and previous indications from immunodetection, the results indicated that the predominant AMPK heterotrimer in human liver is 121 but that dog and rat livers mainly contain the 111 and 211 forms, respectively. Differences were not detected between the AMPK profiles of normal and diabetic human liver tissues.	[Wu, Jiang; Puppala, Dinesh; Feng, Xidong; Geoghegan, Kieran F.] Pfizer Worldwide Res, Groton, CT 06340 USA; [Monetti, Mara; Lapworth, Amanda Lee] Pfizer Worldwide Res, Cambridge, MA 02139 USA	Pfizer; Pfizer	Geoghegan, KF (corresponding author), Pfizer Worldwide Res, Groton, CT 06340 USA.	kieran.f.geoghegan@pfizer.com						Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Balgley BM, 2008, ELECTROPHORESIS, V29, P3047, DOI 10.1002/elps.200800050; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Borg Jacques, 2011, Clin Proteomics, V8, P6, DOI 10.1186/1559-0275-8-6; Boyle JG, 2010, DIABETIC MED, V27, P1097, DOI 10.1111/j.1464-5491.2010.03098.x; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cooney JM, 2012, J PROTEOME RES, V11, P1065, DOI 10.1021/pr200807p; Cooper B, 2010, J AM SOC MASS SPECTR, V21, P1534, DOI 10.1016/j.jasms.2010.05.001; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Drewes G, 2012, METHODS MOL BIOL, V803, P15, DOI 10.1007/978-1-61779-364-6_2; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gruzman Arie, 2009, Rev Diabet Stud, V6, P13, DOI 10.1900/RDS.2009.6.13; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Houston NL, 2011, J PROTEOME RES, V10, P763, DOI 10.1021/pr100913w; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hwang GW, 2010, J TOXICOL SCI, V35, P601, DOI 10.2131/jts.35.601; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; McAllister FE, 2013, ANAL CHEM, V85, P4666, DOI 10.1021/ac303478g; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Miao Q, 2012, EXPERT REV PROTEOMIC, V9, P281, DOI [10.1586/EPR.12.22, 10.1586/epr.12.22]; Mosley AL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000687; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Nielsen JN, 2003, J APPL PHYSIOL, V94, P631, DOI 10.1152/japplphysiol.00642.2002; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piersma SR, 2010, J PROTEOME RES, V9, P1913, DOI 10.1021/pr901072h; Pinter K, 2012, CELL CYCLE, V11, P917, DOI 10.4161/cc.11.5.19412; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Rajamohan F, 2010, PROTEIN EXPRES PURIF, V73, P189, DOI 10.1016/j.pep.2010.04.022; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Van Summeren A, 2012, TOXICOL IN VITRO, V26, P373, DOI 10.1016/j.tiv.2012.01.012; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Vogel Christine, 2012, Methods Mol Biol, V893, P321, DOI 10.1007/978-1-61779-885-6_20; Wadley GD, 2006, AM J PHYSIOL-ENDOC M, V290, pE694, DOI 10.1152/ajpendo.00464.2005; Wierzba K, 2011, CURR OPIN CHEM BIOL, V15, P57, DOI 10.1016/j.cbpa.2010.10.009; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223; Zanders ED, 2012, METHODS MOL BIOL, V800, P3, DOI 10.1007/978-1-61779-349-3_1; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	60	35	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35904	35912		10.1074/jbc.M113.508747	http://dx.doi.org/10.1074/jbc.M113.508747			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187138	Green Published, hybrid			2022-12-28	WOS:000329814700027
J	Gamsjaeger, R; O'Connell, MR; Cubeddu, L; Shepherd, NE; Lowry, JA; Kwan, AH; Vandevenne, M; Swanton, MK; Matthews, JM; Mackay, JP				Gamsjaeger, Roland; O'Connell, Mitchell R.; Cubeddu, Liza; Shepherd, Nicholas E.; Lowry, Jason A.; Kwan, Ann H.; Vandevenne, Marylene; Swanton, Michael K.; Matthews, Jacqueline M.; Mackay, Joel P.			A Structural Analysis of DNA Binding by Myelin Transcription Factor 1 Double Zinc Fingers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Myelin; Nuclear Magnetic Resonance; Protein Structure; Zinc Finger	NUCLEIC-ACID STRUCTURES; CENTRAL-NERVOUS-SYSTEM; NEURONAL DIFFERENTIATION; OLIGODENDROCYTE LINEAGE; DIRECT CONVERSION; PROTEIN; GENE; FAMILY; CELLS; FIBROBLASTS	Background: Myelin transcription factor 1 (MyT1) contains seven similar zinc finger domains that bind DNA specifically. Results: A three-dimensional structural model explains how a double zinc finger unit is able to recognize DNA. Conclusion: DNA-binding residues are conserved among all MyT1 zinc fingers, suggesting an identical DNA binding mode. Significance: Determination of the molecular details of DNA interaction will be crucial in understanding MyT1 function. Myelin transcription factor 1 (MyT1/NZF2), a member of the neural zinc-finger (NZF) protein family, is a transcription factor that plays a central role in the developing central nervous system. It has also recently been shown that, in combination with two other transcription factors, the highly similar paralog MyT1L is able to direct the differentiation of murine and human stem cells into functional neurons. MyT1 contains seven zinc fingers (ZFs) that are highly conserved throughout the protein and throughout the NZF family. We recently presented a model for the interaction of the fifth ZF of MyT1 with a DNA sequence derived from the promoter of the retinoic acid receptor (RARE) gene. Here, we have used NMR spectroscopy, in combination with surface plasmon resonance and data-driven molecular docking, to delineate the mechanism of DNA binding for double ZF polypeptides derived from MyT1. Our data indicate that a two-ZF unit interacts with the major groove of the entire RARE motif and that both fingers bind in an identical manner and with overall two-fold rotational symmetry, consistent with the palindromic nature of the target DNA. Several key residues located in one of the irregular loops of the ZFs are utilized to achieve specific binding. Analysis of the human and mouse genomes based on our structural data reveals three putative MyT1 target genes involved in neuronal development.	[Gamsjaeger, Roland; O'Connell, Mitchell R.; Cubeddu, Liza; Shepherd, Nicholas E.; Kwan, Ann H.; Vandevenne, Marylene; Matthews, Jacqueline M.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Gamsjaeger, Roland; Cubeddu, Liza] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 2751, Australia; [Swanton, Michael K.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	University of Sydney; Western Sydney University; Victor Chang Cardiac Research Institute	Gamsjaeger, R (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Locked Bag 1797, Penrith, NSW 2751, Australia.	r.gamsjaeger@uws.edu.au; joel.mackay@sydney.edu.au	Shepherd, Nicholas/H-6781-2016; Mackay, Joel/D-6834-2011	Shepherd, Nicholas/0000-0001-6234-4456; Mackay, Joel/0000-0001-7508-8033; O'Connell, Mitchell/0000-0002-8642-3973; Kwan, Ann/0000-0002-1506-2226; Vandevenne, Marylene/0000-0002-4492-2635; Matthews, Jacqueline/0000-0001-8518-3472; Gamsjaeger, Roland/0000-0003-1095-2569	National Health and Medical Council of Australia (NHMRC); Australian Research Council (ARC); NHMRC	National Health and Medical Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Council of Australia (NHMRC) and the Australian Research Council (ARC).; Recipients of Senior Research Fellowships from the NHMRC.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Berkovits HJ, 1999, BIOCHEMISTRY-US, V38, P16826, DOI 10.1021/bi991433l; Berkovits-Cymet HJ, 2004, BIOCHEMISTRY-US, V43, P898, DOI 10.1021/bi035159d; Besold AN, 2010, J BIOL INORG CHEM, V15, P583, DOI 10.1007/s00775-010-0626-1; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gamsjaeger R, 2008, J BIOL CHEM, V283, P5158, DOI 10.1074/jbc.M703772200; Goddard T. D, 2007, SPARKY 3; Hagiwara T, 1996, GENOMICS, V33, P508, DOI 10.1006/geno.1996.0226; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; Kameyama T, 2011, NEUROSCI LETT, V497, P74, DOI 10.1016/j.neulet.2011.04.033; Kim EJ, 2011, J COMP NEUROL, V519, P1355, DOI 10.1002/cne.22574; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Macke TJ, 1998, ACS SYM SER, V682, P379; MACKLIN WB, 1987, J NEUROSCI RES, V18, P383, DOI 10.1002/jnr.490180302; Murray RC, 2000, DEV DYNAM, V218, P189, DOI 10.1002/(SICI)1097-0177(200005)218:1<189::AID-DVDY16>3.0.CO;2-4; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Von Wilmsdorff M, 2013, WORLD J BIOL PSYCHIA, V14, P490, DOI 10.3109/15622975.2011.645877; WOLF P, 1983, ANAL BIOCHEM, V129, P145, DOI 10.1016/0003-2697(83)90062-3; Yang JL, 2008, FASEB J, V22, P3956, DOI 10.1096/fj.08-111013; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Zweckstetter M, 2004, BIOPHYS J, V86, P3444, DOI 10.1529/biophysj.103.035790	37	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35180	35191		10.1074/jbc.M113.482075	http://dx.doi.org/10.1074/jbc.M113.482075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24097990	Green Published, hybrid			2022-12-28	WOS:000329867600019
J	Kiani, FA; Fischer, S				Kiani, Farooq Ahmad; Fischer, Stefan			Stabilization of the ADP/Metaphosphate Intermediate during ATP Hydrolysis in Pre-power Stroke Myosin QUANTITATIVE ANATOMY OF AN ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; ATPases; Bioenergetics; Biophysics; Computational Biology; Computer Modeling; Enzyme Catalysis; Enzyme Mechanisms; Myosin; Quantum Chemistry	ADENOSINE-TRIPHOSPHATE HYDROLYSIS; OXYGEN-EXCHANGE; MOLECULAR-DYNAMICS; MOTOR DOMAIN; SALT-BRIDGE; MECHANISM; COMPLEX; ACTIVATION; SIMULATION; PROTEINS	It has been proposed recently that ATP hydrolysis in ATPase enzymes proceeds via an initial intermediate in which the dissociated gamma-phosphate of ATP is bound in the protein as a metaphosphate (P gamma O3-). A combined quantum/classical analysis of this dissociated nucleotide state inside myosin provides a quantitative understanding of how the enzyme stabilizes this unusual metaphosphate. Indeed, in vacuum, the energy of the ADP(3-)center dot P gamma O3-center dot Mg2+ complex is much higher than that of the undissociated ATP(4-). The protein brings it to a surprisingly low value. Energy decomposition reveals how much each interaction in the protein stabilizes the metaphosphate state; backbone peptides of the P-loop contribute 50% of the stabilization energy, and the side chain of Lys-185(+) contributes 25%. This can be explained by the fact that these groups make strong favorable interactions with the alpha- and beta-phosphates, thus favoring the charge distribution of the metaphosphate state over that of the ATP state. Further stabilization (16%) is achieved by a hydrogen bond between the backbone C=O of Ser-237 (on loop Switch-1) and a water molecule perfectly positioned to attack the P gamma O3- in the subsequent hydrolysis step. The planar and singly negative P gamma O3- is a much better target for the subsequent nucleophilic attack by a negatively charged OH- than the tetrahedral and doubly negative P gamma O3- group of ATP. Therefore, we argue that the present mechanism of metaphosphate stabilization is common to the large family of nucleotide-hydrolyzing enzymes. Methodologically, this work presents a computational approach that allows us to obtain a truly quantitative conception of enzymatic strategy.	[Kiani, Farooq Ahmad; Fischer, Stefan] Heidelberg Univ, Computat Biochem Grp, Interdisciplinary Ctr Sci Comp, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fischer, S (corresponding author), Heidelberg Univ, Computat Biochem Grp, Interdisciplinary Ctr Sci Comp, Neuenheimerfeld 368, D-69120 Heidelberg, Germany.	Stefan.Fischer@iwr.uni-heidelberg.de		Kiani, Farooq/0000-0001-8773-3634	German Science Foundation (DFG) [SFB 623]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG) through the module "SFB 623, Molecular Catalysis: Structure and Function Design."	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Akola J, 2003, J PHYS CHEM B, V107, P11774, DOI 10.1021/jp035538g; BAGSHAW CR, 1975, P NATL ACAD SCI USA, V72, P2592, DOI 10.1073/pnas.72.7.2592; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Boyer P. D, 2003, NOBEL LECT CHEM 1996, P120; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; DEMPSEY ME, 1963, J BIOL CHEM, V238, P2708; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Gao J., 1996, REV COMP CH, P119; Grigorenko BL, 2007, P NATL ACAD SCI USA, V104, P7057, DOI 10.1073/pnas.0701727104; Grigorenko BL, 2011, J MOL GRAPH MODEL, V31, P1, DOI 10.1016/j.jmgm.2011.07.005; Guo H, 2000, J PHYS CHEM B, V104, P9746, DOI 10.1021/jp0012247; Hayashi S, 2012, J AM CHEM SOC, V134, P8447, DOI 10.1021/ja211027m; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Koppole S, 2007, STRUCTURE, V15, P825, DOI 10.1016/j.str.2007.06.008; Kuhner S, 2011, P NATL ACAD SCI USA, V108, P7793, DOI 10.1073/pnas.1018420108; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LEVY HM, 1960, J BIOL CHEM, V235, P2628; LEVY HM, 1959, J BIOL CHEM, V234, P1102; LEVY HM, 1958, J AM CHEM SOC, V80, P3164, DOI 10.1021/ja01545a066; Li GH, 2004, J PHYS CHEM B, V108, P3342, DOI 10.1021/jp0371783; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; LYBRAND TP, 1985, J CHEM PHYS, V83, P2923, DOI 10.1063/1.449246; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; McGrath MJ, 2013, J AM CHEM SOC, V135, P8908, DOI 10.1021/ja401540g; MILLER DL, 1966, J AM CHEM SOC, V88, P1507, DOI 10.1021/ja00959a034; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Onishi H, 1998, P NATL ACAD SCI USA, V95, P6653, DOI 10.1073/pnas.95.12.6653; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; ROUX B, 1991, BIOPHYS J, V59, P961, DOI 10.1016/S0006-3495(91)82311-6; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schwarzl S. M, 2006, THESIS RUPRECHT KARL; Schwarzl SM, 2005, J COMPUT CHEM, V26, P1359, DOI 10.1002/jcc.20274; Schwarzl SM, 2006, BIOCHEMISTRY-US, V45, P5830, DOI 10.1021/bi052433q; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; SHUKLA KK, 1977, BIOCHEMISTRY-US, V16, P132, DOI 10.1021/bi00620a022; SLEEP JA, 1978, BIOCHEMISTRY-US, V17, P5417, DOI 10.1021/bi00618a015; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SWANSON JR, 1966, BIOCHEM Z, V345, P395; TRENTHAM DR, 1976, Q REV BIOPHYS, V9, P217, DOI 10.1017/S0033583500002419; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; VANBELLE D, 1987, J MOL BIOL, V198, P721, DOI 10.1016/0022-2836(87)90213-0; WEBB MR, 1981, J BIOL CHEM, V256, P910; Yang Y, 2008, J MOL BIOL, V381, P1407, DOI 10.1016/j.jmb.2008.06.071; Yu HB, 2007, PLOS COMPUT BIOL, V3, P199, DOI 10.1371/journal.pcbi.0030021	57	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35569	35580		10.1074/jbc.M113.500298	http://dx.doi.org/10.1074/jbc.M113.500298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165121	hybrid, Green Published			2022-12-28	WOS:000329867600051
J	Lukacs, V; Rives, JM; Sun, XH; Zakharian, E; Rohacs, T				Lukacs, Viktor; Rives, Jan-Michael; Sun, Xiaohui; Zakharian, Eleonora; Rohacs, Tibor			Promiscuous Activation of Transient Receptor Potential Vanilloid 1 (TRPV1) Channels by Negatively Charged Intracellular Lipids THE KEY ROLE OF ENDOGENOUS PHOSPHOINOSITIDES IN MAINTAINING CHANNEL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Inositol Phospholipid; Ion Channels; Phosphoinositides; TRP Channels; TRPV1	PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; POTASSIUM CHANNELS; TRPM8 CHANNELS; MEMBRANE PHOSPHOINOSITIDES; CAPSAICIN RECEPTOR; PLASMA-MEMBRANE; PIP2 ACTIVATION; KIR CHANNELS; BETA-GAMMA; ATP	Background: Regulation of TRPV1 by phosphoinositides is controversial. Results: ATP reactivates TRPV1 after run-down in excised inside-out patches by generating phosphoinositides; many other negatively charged lipids may also support TRPV1 activity. Conclusion: Despite its promiscuous activation, phosphoinositides are the key endogenous cofactors for TRPV1 activity. Significance: Our data may reconcile discordant data obtained in different experimental settings. The regulation of the heat- and capsaicin-activated transient receptor potential vanilloid 1 (TRPV1) channels by phosphoinositides is controversial. Data in cellular systems support the dependence of TRPV1 activity on phosphoinositides. The purified TRPV1, however, was recently shown to be fully functional in artificial liposomes in the absence of phosphoinositides. Here, we show that several other negatively charged phospholipids, including phosphatidylglycerol, can also support TRPV1 activity in excised patches at high concentrations. When we incorporated TRPV1 into planar lipid bilayers consisting of neutral lipids, capsaicin-induced activity depended on phosphatidylinositol 4,5-bisphosphate. We also found that TRPV1 activity in excised patches ran down and that MgATP reactivated the channel. Inhibition of phosphatidylinositol 4-kinases or enzymatic removal of phosphatidylinositol abolished this effect of MgATP, suggesting that it activated TRPV1 by generating endogenous phosphoinositides. We conclude that endogenous phosphoinositides are positive cofactors for TRPV1 activity. Our data highlight the importance of specificity in lipid regulation of ion channels and may reconcile discordant data obtained in various experimental settings.	[Lukacs, Viktor; Rives, Jan-Michael; Rohacs, Tibor] Rutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Sun, Xiaohui; Zakharian, Eleonora] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Peoria	Rohacs, T (corresponding author), Rutgers New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA.	tibor.rohacs@rutgers.edu	Sun, Xiaohui/G-5146-2013	Sun, Xiaohui/0000-0003-0294-6855; Lukacs, Viktor/0000-0003-3652-5469	National Institutes of Health [RO1NS055159, RO1GM093290, RO1GM098052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093290, R01GM098052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS055159 and RO1GM093290 (to T. R.) and RO1GM098052 (to E. Z.).	Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; El-Arabi AM, 2012, LAB CHIP, V12, P2409, DOI [10.1039/c2lc40087a, 10.1039/c21c40087a]; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gamper Nikita, 2012, Subcell Biochem, V59, P289, DOI 10.1007/978-94-007-3015-1_10; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 2012, J GEN PHYSIOL, V140, P245, DOI 10.1085/jgp.201210874; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hui KK, 2003, BIOPHYS J, V84, P2957, DOI 10.1016/S0006-3495(03)70022-8; Imai Y, 2012, J PHYSIOL-LONDON, V590, P1101, DOI 10.1113/jphysiol.2011.221358; Jeske NA, 2011, J NEUROSCI, V31, P8681, DOI 10.1523/JNEUROSCI.0020-11.2011; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Krauter T, 2001, MOL PHARMACOL, V59, P1086, DOI 10.1124/mol.59.5.1086; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Lemonnier L, 2008, CELL CALCIUM, V43, P506, DOI 10.1016/j.ceca.2007.09.001; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J NEUROSCI, V33, P11451, DOI 10.1523/JNEUROSCI.5637-12.2013; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Raisinghani M, 2005, J PHYSIOL-LONDON, V567, P771, DOI 10.1113/jphysiol.2005.087874; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T., 2013, HDB EXP PHA IN PRESS; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rohacs Tibor, 2013, Advances in Biological Regulation, V53, P341, DOI 10.1016/j.jbior.2013.07.004; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Trebak M, 2009, PFLUG ARCH EUR J PHY, V457, P757, DOI 10.1007/s00424-008-0550-1; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; White D.A., 1973, FORM FUNCTION PHOSPH; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Yudin Y, 2011, J PHYSIOL-LONDON, V589, P6007, DOI 10.1113/jphysiol.2011.220228; Zakharian E, 2011, FASEB J, V25, P3915, DOI 10.1096/fj.11-184630; Zakharian E, 2010, J NEUROSCI, V30, P12526, DOI 10.1523/JNEUROSCI.3189-10.2010; Zakharian E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005404; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	55	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35003	35013		10.1074/jbc.M113.520288	http://dx.doi.org/10.1074/jbc.M113.520288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158445	Green Published, hybrid			2022-12-28	WOS:000329867600003
J	Meng, L; Forouhar, F; Thieker, D; Gao, ZW; Ramiah, A; Moniz, H; Xiang, Y; Seetharaman, J; Milaninia, S; Su, M; Bridger, R; Veillon, L; Azadi, P; Kornhaber, G; Wells, L; Montelione, GT; Woods, RJ; Tong, L; Moremen, KW				Meng, Lu; Forouhar, Farhad; Thieker, David; Gao, Zhongwei; Ramiah, Annapoorani; Moniz, Heather; Xiang, Yong; Seetharaman, Jayaraman; Milaninia, Sahand; Su, Min; Bridger, Robert; Veillon, Lucas; Azadi, Parastoo; Kornhaber, Gregory; Wells, Lance; Montelione, Gaetano T.; Woods, Robert J.; Tong, Liang; Moremen, Kelley W.			Enzymatic Basis for N-Glycan Sialylation STRUCTURE OF RAT alpha 2,6-SIALYLTRANSFERASE (ST6GAL1) REVEALS CONSERVED AND UNIQUE FEATURES FOR GLYCAN SIALYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Carbohydrate Glycoprotein; Enzyme Structure; Glycobiology; Glycoprotein Biosynthesis; Molecular Dynamics; AMBER; GLYCAM	MOLECULAR-DYNAMICS SIMULATIONS; SUBSTRATE-SPECIFICITY; LINKED OLIGOSACCHARIDES; CONFORMATIONAL-CHANGES; CAMPYLOBACTER-JEJUNI; GENERALIZED BORN; BINDING; SIALYLTRANSFERASE; PROTEIN; GLYCOSYLTRANSFERASES	Background: Specificity and enzymology of glycan sialylation is poorly understood, despite its importance in biological recognition. Results: ST6GAL1 structure was determined, and substrate binding was modeled to probe active site specificity. Conclusion: The structure provides insights into the enzymatic basis of glycan sialylation. Significance: Knowledge of the enzyme structure can lead to broader understanding of enzymatic sialylation and selective inhibitor design. Glycan structures on glycoproteins and glycolipids play critical roles in biological recognition, targeting, and modulation of functions in animal systems. Many classes of glycan structures are capped with terminal sialic acid residues, which contribute to biological functions by either forming or masking glycan recognition sites on the cell surface or secreted glycoconjugates. Sialylated glycans are synthesized in mammals by a single conserved family of sialyltransferases that have diverse linkage and acceptor specificities. We examined the enzymatic basis for glycan sialylation in animal systems by determining the crystal structures of rat ST6GAL1, an enzyme that creates terminal 2,6-sialic acid linkages on complex-type N-glycans, at 2.4 resolution. Crystals were obtained from enzyme preparations generated in mammalian cells. The resulting structure revealed an overall protein fold broadly resembling the previously determined structure of pig ST3GAL1, including a CMP-sialic acid-binding site assembled from conserved sialylmotif sequence elements. Significant differences in structure and disulfide bonding patterns were found outside the sialylmotif sequences, including differences in residues predicted to interact with the glycan acceptor. Computational substrate docking and molecular dynamics simulations were performed to predict and evaluate the CMP-sialic acid donor and glycan acceptor interactions, and the results were compared with kinetic analysis of active site mutants. Comparisons of the structure with pig ST3GAL1 and a bacterial sialyltransferase revealed a similar positioning of donor, acceptor, and catalytic residues that provide a common structural framework for catalysis by the mammalian and bacterial sialyltransferases.	[Meng, Lu; Thieker, David; Gao, Zhongwei; Ramiah, Annapoorani; Moniz, Heather; Xiang, Yong; Bridger, Robert; Veillon, Lucas; Azadi, Parastoo; Wells, Lance; Woods, Robert J.; Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Forouhar, Farhad; Seetharaman, Jayaraman; Milaninia, Sahand; Su, Min; Tong, Liang] Columbia Univ, Dept Biol Sci, Northeast Struct Genom Consortium, New York, NY 10027 USA; [Kornhaber, Gregory; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Northeast Struct Genom Consortium, Piscataway, NJ 08854 USA; [Kornhaber, Gregory; Montelione, Gaetano T.] Rutgers State Univ, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Woods, Robert J.] Natl Univ Ireland, Sch Chem, Galway, Ireland	University System of Georgia; University of Georgia; Columbia University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Ollscoil na Gaillimhe-University of Galway	Woods, RJ (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	rwoods@ccrc.uga.edu; ltong@columbia.edu; moremen@uga.edu	Meng, Lu/GXN-0092-2022; Wells, Lance/H-3118-2013; Moremen, Kelley/AAD-4661-2019	Thieker, David/0000-0003-0786-8278; Montelione, Gaetano/0000-0002-9440-3059; Tong, Liang/0000-0002-0563-6468; Wells, Lance/0000-0003-4956-5363; Woods, Robert/0000-0002-2400-6293; Bridger, Robert/0000-0003-2653-8813	National Institutes of Health [P41GM103390, P41RR005351, R01GM094919, U54 GM094597]; Science Foundation of Ireland [08/IN.1/B2070]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, U54GM094597, R01GM094919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation of Ireland(Science Foundation Ireland); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41GM103390 (to K. W. M.), P41RR005351 (to Dr. James Prestegard), R01GM094919 (EUREKA) (to R. J. W.), and Grant U54 GM094597 for work performed in part as a community nominated project of the Protein Structure Initiative of the National Institutes of Health (to G. T. M. and L. T.). This work was also supported by Science Foundation of Ireland Grant 08/IN.1/B2070 (to R. J. W.).	Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Backliwal G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn423; Barb AW, 2012, BIOCHEMISTRY-US, V51, P4618, DOI 10.1021/bi300319q; Barton WA, 2006, PROTEIN SCI, V15, P2008, DOI 10.1110/ps.062244206; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; Blume A, 2006, J BIOL CHEM, V281, P32728, DOI 10.1074/jbc.M600424200; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryce RA, 2001, BIOPHYS J, V81, P1373, DOI 10.1016/S0006-3495(01)75793-1; BUEHNER M, 1973, P NATL ACAD SCI USA, V70, P3052, DOI 10.1073/pnas.70.11.3052; Chen C, 2000, GLYCOBIOLOGY, V10, P531, DOI 10.1093/glycob/10.5.531; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Clark GF, 2013, HUM REPROD, V28, P566, DOI 10.1093/humrep/des447; Coutinho PM, 1999, ROY SOC CH, P3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Drickamer K, 1997, STRUCTURE, V5, P465, DOI 10.1016/S0969-2126(97)00202-5; Duke R.E., 2012, AMBER 10; FAST DG, 1993, BIOCHIM BIOPHYS ACTA, V1202, P325, DOI 10.1016/0167-4838(93)90023-K; Frisch M.J, 2009, GAUSSIAN 09; FUKUDA MN, 1989, BLOOD, V73, P84; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirano Y, 2012, J BIOCHEM, V151, P197, DOI 10.1093/jb/mvr133; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Kadirvelraj R, 2006, P NATL ACAD SCI USA, V103, P8149, DOI 10.1073/pnas.0602815103; Kadirvelraj R, 2011, GLYCOBIOLOGY, V21, P973, DOI 10.1093/glycob/cwr030; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuhn B, 2013, ACTA CRYSTALLOGR D, V69, P1826, DOI 10.1107/S0907444913015412; Kwan EM, 2005, PROTEIN ENG DES SEL, V18, P497, DOI 10.1093/protein/gzi055; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee HJ, 2011, J BIOL CHEM, V286, P35922, DOI 10.1074/jbc.M111.261172; Lehmann F, 2006, CELL MOL LIFE SCI, V63, P1331, DOI 10.1007/s00018-005-5589-y; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Li YH, 2012, APPL MICROBIOL BIOT, V94, P887, DOI 10.1007/s00253-012-4040-1; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; Lutteke Thomas, 2009, V534, P293, DOI 10.1007/978-1-59745-022-5_21; Ma JY, 1997, J BIOL CHEM, V272, P672; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nairn AV, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405233; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel RY, 2006, GLYCOBIOLOGY, V16, P108, DOI 10.1093/glycob/cwj046; PAULSON JC, 1984, EUR J BIOCHEM, V140, P523, DOI 10.1111/j.1432-1033.1984.tb08133.x; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qian R, 2001, J BIOL CHEM, V276, P28641, DOI 10.1074/jbc.M103664200; Rakic B, 2013, GLYCOBIOLOGY, V23, P536, DOI 10.1093/glycob/cwt001; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Rao FV, 2009, NAT STRUCT MOL BIOL, V16, P1186, DOI 10.1038/nsmb.1685; Rauvolfova J, 2008, CARBOHYD RES, V343, P1605, DOI 10.1016/j.carres.2008.05.002; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rillahan CD, 2011, ANGEW CHEM INT EDIT, V50, P12534, DOI 10.1002/anie.201105065; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tozser J, 2005, FEBS J, V272, P514, DOI 10.1111/j.1742-4658.2004.04493.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 2008, ESSENTIALS GLYCOBIOL; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; Wu XD, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/591923; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187; Yan HM, 2013, INT IMMUNOPHARMACOL, V16, P353, DOI 10.1016/j.intimp.2013.04.013; Yang WH, 2012, BLOOD, V120, P1015, DOI 10.1182/blood-2012-04-424366	95	90	90	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34680	34698		10.1074/jbc.M113.519041	http://dx.doi.org/10.1074/jbc.M113.519041			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24155237	hybrid, Green Published			2022-12-28	WOS:000329812800035
J	Turnbull, J; Tiberia, E; Pereira, S; Zhao, XC; Pencea, N; Wheeler, AL; Yu, WQ; Ivovic, A; Naranian, T; Israelian, N; Draginov, A; Piliguian, M; Frankland, PW; Wang, PX; Ackerley, CA; Giacca, A; Minassian, BA				Turnbull, Julie; Tiberia, Erica; Pereira, Sandra; Zhao, Xiaochu; Pencea, Nela; Wheeler, Anne L.; Yu, Wen Qin; Ivovic, Alexander; Naranian, Taline; Israelian, Nyrie; Draginov, Arman; Piliguian, Mark; Frankland, Paul W.; Wang, Peixiang; Ackerley, Cameron A.; Giacca, Adria; Minassian, Berge A.			Deficiency of a Glycogen Synthase-associated Protein, Epm2aip1, Causes Decreased Glycogen Synthesis and Hepatic Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Diabetes; Glycogen Synthase; Mouse Genetics; Obesity; Lafora Disease; Mouse Model; Glycogen Metabolism	PROGRESSIVE MYOCLONUS EPILEPSY; DEPENDENT DIABETES-MELLITUS; MUSCLE GLYCOGEN; SKELETAL-MUSCLE; GLUCOSE-TOLERANCE; LAFORA DISEASE; METABOLISM; MICE; LIVER; IDENTIFICATION	Background: Impaired activation of glycogen synthesis is a major component of insulin resistance. Results: We identified a protein, Epm2aip1, that associates with glycogen synthase (GS) and whose absence impairs allosteric activation of GS and causes hepatic insulin resistance. Conclusion: Epm2aip1 is a modulator of GS activity under insulin control. Significance: This study uncovers a novel component of glycogen regulation and hepatic insulin resistance. Glycogen synthesis is a major component of the insulin response, and defective glycogen synthesis is a major portion of insulin resistance. Insulin regulates glycogen synthase (GS) through incompletely defined pathways that activate the enzyme through dephosphorylation and, more potently, allosteric activation. We identify Epm2aip1 as a GS-associated protein. We show that the absence of Epm2aip1 in mice impairs allosteric activation of GS by glucose 6-phosphate, decreases hepatic glycogen synthesis, increases liver fat, causes hepatic insulin resistance, and protects against age-related obesity. Our work identifies a novel GS-associated GS activity-modulating component of insulin resistance.	[Turnbull, Julie; Tiberia, Erica; Zhao, Xiaochu; Pencea, Nela; Naranian, Taline; Israelian, Nyrie; Draginov, Arman; Piliguian, Mark; Wang, Peixiang; Minassian, Berge A.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Pencea, Nela; Ackerley, Cameron A.] Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada; [Wheeler, Anne L.; Frankland, Paul W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Minassian, Berge A.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Turnbull, Julie] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Pereira, Sandra; Ivovic, Alexander; Giacca, Adria] Univ Toronto, Dept Physiol & Med, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Minassian, BA (corresponding author), Univ Toronto, 100 Coll St, Toronto, ON M5S 1A1, Canada.	berge.minassian@sickkids.ca	Wheeler, Anne/V-1215-2019	Wheeler, Anne/0000-0002-1103-0526	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	ACHESON KJ, 1988, AM J CLIN NUTR, V48, P240, DOI 10.1093/ajcn/48.2.240; Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Bouskila M, 2010, CELL METAB, V12, P456, DOI 10.1016/j.cmet.2010.10.006; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruno C, 2004, NEUROLOGY, V63, P1053, DOI 10.1212/01.WNL.0000138429.11433.0D; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; CHEN CB, 1993, AM J PHYSIOL, V265, pE743, DOI 10.1152/ajpendo.1993.265.5.E743; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; Daniele N, 1999, J BIOL CHEM, V274, P3597, DOI 10.1074/jbc.274.6.3597; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Duez H, 2009, ENDOCRINOLOGY, V150, P56, DOI 10.1210/en.2008-1137; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Ganesh S, 2002, HUM MOL GENET, V11, P1251, DOI 10.1093/hmg/11.11.1251; Golay A, 2005, BEST PRACT RES CL EN, V19, P649, DOI 10.1016/j.beem.2005.07.010; Golay A, 2002, METABOLISM, V51, P549, DOI 10.1053/meta.2002.31972; Henry RR, 1996, J CLIN INVEST, V98, P1231, DOI 10.1172/JCI118906; Hojlund K, 2009, J CLIN ENDOCR METAB, V94, P4547, DOI 10.1210/jc.2009-0897; Ianzano L, 2003, GENOMICS, V81, P579, DOI 10.1016/S0888-7543(03)00094-6; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jensen Jorgen, 2009, Archives of Physiology and Biochemistry, V115, P13, DOI 10.1080/13813450902778171; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kadotani A, 2007, ARCH BIOCHEM BIOPHYS, V466, P283, DOI 10.1016/j.abb.2007.08.006; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; NEWGARD CB, 1984, DIABETES, V33, P192, DOI 10.2337/diabetes.33.2.192; Niederwanger A, 2005, J CHROMATOGR B, V820, P143, DOI 10.1016/j.jchromb.2005.02.019; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Petersen KF, 1998, J CLIN INVEST, V101, P1203, DOI 10.1172/JCI579; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Skurat A. V., 2004, DIABETES MELLITUS FU; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Taylor R., 2011, HDB PHYSL ENDOCRINE, P787; THORBURN AW, 1991, J CLIN INVEST, V87, P489, DOI 10.1172/JCI115022; THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468; Tourlakis ME, 2012, GASTROENTEROLOGY, V143, P481, DOI 10.1053/j.gastro.2012.04.012; Turnbull J, 2012, BRAIN, V135, P2684, DOI 10.1093/brain/aws205; Turnbull J, 2010, ANN NEUROL, V68, P925, DOI 10.1002/ana.22156; Valles-Ortega J, 2011, EMBO MOL MED, V3, P667, DOI 10.1002/emmm.201100174; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998	52	12	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34627	34637		10.1074/jbc.M113.483198	http://dx.doi.org/10.1074/jbc.M113.483198			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142699	Green Published, hybrid			2022-12-28	WOS:000329812800030
J	Shnitsar, V; Li, J; Li, XY; Calmettes, C; Basu, A; Casey, JR; Moraes, TF; Reithmeier, RAF				Shnitsar, Volodymyr; Li, Jing; Li, Xuyao; Calmettes, Charles; Basu, Arghya; Casey, Joseph R.; Moraes, Trevor F.; Reithmeier, Reinhart A. F.			A Substrate Access Tunnel in the Cytosolic Domain Is Not an Essential Feature of the Solute Carrier 4 (SLC4) Family of Bicarbonate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Membrane Proteins; Protein Folding; Site-directed Mutagenesis; Trafficking; Transporters; X-ray Crystallography; Anion Exchanger 1 (AE1); Band 3; SLC4	RENAL TUBULAR-ACIDOSIS; HEREDITARY SPHEROCYTOSIS MUTANTS; REVERSIBLE CONFORMATIONAL EQUILIBRIUM; ERYTHROCYTE ANION-EXCHANGER; REACTIVE SULFHYDRYL-GROUPS; CYTOPLASMIC DOMAIN; STRUCTURAL-CHARACTERIZATION; KIDNEY ANION-EXCHANGER-1; TRAFFICKING DEFECTS; BAND-3 POLYPEPTIDE	Anion exchanger 1 (AE1; Band 3; SLC4A1) is the founding member of the solute carrier 4 (SLC4) family of bicarbonate transporters that includes chloride/bicarbonate AEs and Na+-bicarbonate co-transporters (NBCs). These membrane proteins consist of an amino-terminal cytosolic domain involved in protein interactions and a carboxyl-terminal membrane domain that carries out the transport function. Mutation of a conserved arginine residue (R298S) in the cytosolic domain of NBCe1 (SLC4A4) is linked to proximal renal tubular acidosis and results in impaired transport function, suggesting that the cytosolic domain plays a role in substrate permeation. Introduction of single and double mutations at the equivalent arginine (Arg(283)) and at an interacting glutamate (Glu(85)) in the cytosolic domain of human AE1 (cdAE1) had no effect on the cell surface expression or the transport activity of AE1 expressed in HEK-293 cells. In addition, the membrane domain of AE1 (mdAE1) efficiently mediated anion transport. A 2.1- resolution crystal structure of cd54AE1 (residues 55-356 of cdAE1) lacking the amino-terminal and carboxyl-terminal disordered regions, produced at physiological pH, revealed an extensive hydrogen-bonded network involving Arg(283) and Glu(85). Mutations at these residues affected the pH-dependent conformational changes and stability of cd54AE1. As these structural alterations did not impair functional expression of AE1, the cytosolic and membrane domains operate independently. A substrate access tunnel within the cytosolic domain is not present in AE1 and therefore is not an essential feature of the SLC4 family of bicarbonate transporters.	[Shnitsar, Volodymyr; Li, Jing; Li, Xuyao; Calmettes, Charles; Moraes, Trevor F.; Reithmeier, Reinhart A. F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Basu, Arghya; Casey, Joseph R.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Basu, Arghya; Casey, Joseph R.] Univ Alberta, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada	University of Toronto; University of Alberta; University of Alberta	Reithmeier, RAF (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	r.reithmeier@utoronto.ca		calmettes, charles/0000-0002-2542-4382; Basu, Arghya/0000-0002-0826-5359; Casey, Joseph/0000-0002-9890-5056	National Center for Research Resources at the National Institutes of Health [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Michael Jennings (Arkansas) for providing the IVF-12 monoclonal anti-AE1 antibody. This work is based upon research conducted at the Northeastern Collaborative Access Team beam lines of the Advanced Photon Source, which is supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alper S L, 2001, JOP, V2, P171; ALPER SL, 1988, J BIOL CHEM, V263, P17092; Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; Alper SL, 2002, J NEPHROL, V15, pS41; Alper SL, 2002, CELL BIOCHEM BIOPHYS, V36, P123, DOI 10.1385/CBB:36:2-3:123; APPELL KC, 1981, J BIOL CHEM, V256, P1104; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; Bruce LJ, 2000, BIOCHEM J, V350, P41, DOI 10.1042/0264-6021:3500041; BRUCE LJ, 1993, BIOCHEM J, V293, P317, DOI 10.1042/bj2930317; BRUCE LJ, 1994, BLOOD, V84, P916; Bruce LJ, 1999, BEST PRACT RES CL HA, V12, P637, DOI 10.1053/beha.1999.0046; Bustos SP, 2006, BIOCHEMISTRY-US, V45, P1026, DOI 10.1021/bi051692c; Bustos SP, 2011, BIOCHEM J, V433, P313, DOI 10.1042/BJ20101375; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CASEY JR, 1995, J BIOL CHEM, V270, P8521, DOI 10.1074/jbc.270.15.8521; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Chernova MN, 2008, AM J PHYSIOL-CELL PH, V295, pC302, DOI 10.1152/ajpcell.00109.2008; Chernova MN, 1997, J GEN PHYSIOL, V109, P345, DOI 10.1085/jgp.109.3.345; Cheung JC, 2005, BIOCHEM J, V392, P425, DOI 10.1042/BJ20051076; Cordat E, 2006, TRAFFIC, V7, P117, DOI 10.1111/j.1600-0854.2005.00366.x; Cordat E, 2003, TRAFFIC, V4, P642, DOI 10.1034/j.1600-0854.2003.00123.x; Cordat E, 2006, BIOCHEM CELL BIOL, V84, P949, DOI 10.1139/O06-200; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GRINSTEIN S, 1978, BIOCHIM BIOPHYS ACTA, V507, P294, DOI 10.1016/0005-2736(78)90424-8; GROVES JD, 1994, J MEMBRANE BIOL, V140, P81; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; JENNINGS ML, 1986, J BIOL CHEM, V261, P9002; JENNINGS ML, 1987, J BIOL CHEM, V262, P1691; JENNINGS ML, 1992, J BIOL CHEM, V267, P13964; Johnson DE, 2011, J PHYSIOL-LONDON, V589, P1551, DOI 10.1113/jphysiol.2010.201483; KAY MMB, 1988, P NATL ACAD SCI USA, V85, P492, DOI 10.1073/pnas.85.2.492; KIYATKIN AB, 1995, PROTEINS, V22, P293, DOI 10.1002/prot.340220312; Kurschat CE, 2006, J BIOL CHEM, V281, P1885, DOI 10.1074/jbc.M509734200; Li J, 2000, BIOCHEM J, V349, P51, DOI 10.1042/0264-6021:3490051; Loiselle Frederick B, 2003, Methods Mol Biol, V227, P259, DOI 10.1385/1-59259-387-9:259; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; LOW PS, 1984, J BIOL CHEM, V259, P3070; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pang AJ, 2008, BIOCHEMISTRY-US, V47, P4510, DOI 10.1021/bi702149b; Patterson ST, 2010, J BIOL CHEM, V285, P33423, DOI 10.1074/jbc.M110.144261; Popov M, 1999, J BIOL CHEM, V274, P17635, DOI 10.1074/jbc.274.25.17635; Quilty JA, 2002, AM J PHYSIOL-RENAL, V282, pF810, DOI 10.1152/ajprenal.00216.2001; Quilty JA, 2000, TRAFFIC, V1, P987, DOI 10.1034/j.1600-0854.2000.011208.x; RAO A, 1979, J BIOL CHEM, V254, P6144; REITHMEIER RAF, 1979, J BIOL CHEM, V254, P6151; Romero MF, 2005, CURR OPIN NEPHROL HY, V14, P495, DOI 10.1097/01.mnh.0000168333.01831.2c; STECK TL, 1972, J MOL BIOL, V66, P295, DOI 10.1016/0022-2836(72)90481-0; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 2004, J BIOL CHEM, V279, P52664, DOI 10.1074/jbc.M408108200; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; THEVENIN BJM, 1989, J BIOL CHEM, V264, P15886; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Toye AM, 2002, BLOOD, V99, P342, DOI 10.1182/blood.V99.1.342; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; WALDER JA, 1984, J BIOL CHEM, V259, P238; WANG CC, 1992, PROTEIN SCI, V1, P1206, DOI 10.1002/pro.5560010913; WANG CC, 1995, J BIOL CHEM, V270, P17892, DOI 10.1074/jbc.270.30.17892; Yenchitsomanus Pa-Thai, 2005, J Mol Genet Med, V1, P49; Zhang DC, 2000, BLOOD, V96, P2925; Zhou JZ, 2001, J BIOL CHEM, V276, P38147	70	25	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33848	33860		10.1074/jbc.M113.511865	http://dx.doi.org/10.1074/jbc.M113.511865			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121512	hybrid, Green Published			2022-12-28	WOS:000327250200029
J	van Straaten, KE; Ko, JB; Jagdhane, R; Anjum, S; Palmer, DRJ; Sanders, DAR				van Straaten, Karin E.; Ko, Jong Bum; Jagdhane, Rajendra; Anjum, Shazia; Palmer, David R. J.; Sanders, David A. R.			The Structure of NtdA, a Sugar Aminotransferase Involved in the Kanosamine Biosynthetic Pathway in Bacillus subtilis, Reveals a New Subclass of Aminotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Carbohydrate; Cell Wall; Crystal Structure; Enzymes; X-ray Crystallography; Kanosamine; Transaminase	3,3'-NEOTREHALOSADIAMINE BMY-28251; 3-AMINO-3-DEOXY-D-GLUCOSE; MECHANISM; ALIGNMENT; SYSTEM	Background: NtdA represents a novel aminotransferase recognizing a sugar 6-phosphate. Results: We have determined the structure of NtdA with pyridoxamine phosphate (the internal and external aldimines), identifying determinants of substrate specificity. Conclusion: The structures suggest a canonical aminotransferase chemical mechanism, but features exclude the binding of sugar nucleotides. Significance: A new subfamily of sugar aminotransferases is revealed, enhancing our understanding of antibiotic biosynthesis. NtdA from Bacillus subtilis is a sugar aminotransferase that catalyzes the pyridoxal phosphate-dependent equatorial transamination of 3-oxo-alpha-D-glucose 6-phosphate to form alpha-D-kanosamine 6-phosphate. The crystal structure of NtdA shows that NtdA shares the common aspartate aminotransferase fold (Type 1) with residues from both monomers forming the active site. The crystal structures of NtdA alone, co-crystallized with the product alpha-D-kanosamine 6-phosphate, and incubated with the amine donor glutamate reveal three key structures in the mechanistic pathway of NtdA. The structure of NtdA alone reveals the internal aldimine form of NtdA with the cofactor pyridoxal phosphate covalently attached to Lys-247. The addition of glutamate results in formation of pyridoxamine phosphate. Co-crystallization with kanosamine 6-phosphate results in the formation of the external aldimine. Only alpha-D-kanosamine 6-phosphate is observed in the active site of NtdA, not the beta-anomer. Acomparison of the structure and sequence of NtdA with other sugar aminotransferases enables us to propose that the VI beta family of aminotransferases should be divided into subfamilies based on the catalytic lysine motif.	[van Straaten, Karin E.; Ko, Jong Bum; Jagdhane, Rajendra; Anjum, Shazia; Palmer, David R. J.; Sanders, David A. R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada	University of Saskatchewan	Sanders, DAR (corresponding author), Univ Saskatchewan, Dept Chem, 110 Sci Pl, Saskatoon, SK S7N 5C9, Canada.	david.sanders@usask.ca	Sanders, David A.R./I-5668-2016; Palmer, David R J/F-1934-2010	Palmer, David R J/0000-0001-9300-7460	Saskatchewan Health Research Foundation Team grant; University of Saskatchewan	Saskatchewan Health Research Foundation Team grant; University of Saskatchewan	This work was supported by a Saskatchewan Health Research Foundation Team grant to the Molecular Design Research Group and by the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa K, 2002, J AM CHEM SOC, V124, P10644, DOI 10.1021/ja0206339; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Burgie ES, 2007, PROTEIN SCI, V16, P887, DOI 10.1110/ps.062711007; DOLAK LA, 1980, J ANTIBIOT, V33, P900, DOI 10.7164/antibiotics.33.900; Floss HG, 2011, J ANTIBIOT, V64, P35, DOI 10.1038/ja.2010.139; Fodje M. N., 2010, P 8 INT WORKSH PERS, P130; FUSETANI N, 1987, EXPERIENTIA, V43, P464, DOI 10.1007/BF01940457; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo JT, 2002, J AM CHEM SOC, V124, P10642, DOI 10.1021/ja026628m; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hwang BY, 2005, J MOL CATAL B-ENZYM, V37, P47, DOI 10.1016/j.molcatb.2005.09.004; Hwang BY, 2004, CHEM BIOL, V11, P915, DOI 10.1016/j.chembiol.2004.04.015; Inaoka T, 2004, J BIOL CHEM, V279, P3885, DOI 10.1074/jbc.M309925200; Inaoka T, 2007, J BACTERIOL, V189, P65, DOI 10.1128/JB.01478-06; Janiak AM, 2001, MED MYCOL, V39, P401, DOI 10.1080/mmy.39.5.401.408; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Larkin A, 2010, BIOCHEMISTRY-US, V49, P7227, DOI 10.1021/bi100805b; Milner JL, 1996, APPL ENVIRON MICROB, V62, P3061, DOI 10.1128/AEM.62.8.3061-3065.1996; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUMATA KI, 1986, J ANTIBIOT, V39, P1346, DOI 10.7164/antibiotics.39.1346; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shang HZ, 1999, CURR MICROBIOL, V38, P199, DOI 10.1007/PL00006787; Thoden JB, 2009, BIOCHEMISTRY-US, V48, P1553, DOI 10.1021/bi8022015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUNO T, 1986, J ANTIBIOT, V39, P1001, DOI 10.7164/antibiotics.39.1001; UMEZAWA S, 1967, B CHEM SOC JPN, V40, P2419, DOI 10.1246/bcsj.40.2419; UMEZAWA S, 1968, J ANTIBIOT, V21, P485, DOI 10.7164/antibiotics.21.485; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Straaten KE, 2009, ACTA CRYSTALLOGR F, V65, P426, DOI 10.1107/S1744309109009038; Vetter ND, 2013, J AM CHEM SOC, V135, P5970, DOI 10.1021/ja4010255	36	19	20	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34121	34130		10.1074/jbc.M113.500637	http://dx.doi.org/10.1074/jbc.M113.500637			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097983	Green Published, hybrid			2022-12-28	WOS:000327250200056
J	Abdalla, M; Goc, A; Segar, L; Somanath, PR				Abdalla, Maha; Goc, Anna; Segar, Lakshman; Somanath, Payaningal R.			Akt1 Mediates alpha-Smooth Muscle Actin Expression and Myofibroblast Differentiation via Myocardin and Serum Response Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Differentiation; Fibronectin; Fibrosis; Myofibroblast; Myocardin; Serum Response Factor	TRANSFORMING GROWTH-FACTOR-BETA-1; GRANULATION-TISSUE; FIBROBLAST DIFFERENTIATION; GENE-EXPRESSION; IN-VITRO; ACTIVATION; KINASE; GROWTH; TRANSCRIPTION; MATRIX	Myofibroblast (MF) differentiation, marked by the de novo expression of smooth muscle -actin (SMA) stress fibers, plays a central role in wound healing and its persistence is a hallmark of fibrotic diseases. We have previously shown that Akt1 is necessary for wound healing through matrix regulation. However, the role of Akt1 in regulating MF differentiation with implications in fibrosis remains poorly defined. Here, we show that sustained activation of Akt1 was associated with a 6-fold increase in SMA expression and assembly; an effect that is blunted in cells expressing inactive Akt1 despite TGF stimulation. Mechanistically, Akt1 mediated TGF-induced SMA synthesis through the contractile gene transcription factors myocardin and serum response factor (SRF), independent of mammalian target of rapamycin in mouse embryonic fibroblasts and fibroblasts overexpressing active Akt1. Akt1 deficiency was associated with decreased myocardin, SRF, and SMA expressions in vivo. Furthermore, sustained Akt1-induced SMA synthesis markedly decreased upon RNA silencing of SRF and myocardin. In addition to its integral role in SMA synthesis, we also show that Akt1 mediates fibronectin splice variant expression, which is required for MF differentiation, as well as total fibronectin, which generates the contractile force that promotes MF differentiation. In summary, our results constitute evidence that sustained Akt1 activation is crucial for TGF-induced MF formation and persistent differentiation. These findings highlight Akt1 as a novel potential therapeutic target for fibrotic diseases.	[Abdalla, Maha; Goc, Anna; Segar, Lakshman; Somanath, Payaningal R.] Univ Georgia, Coll Pharm, Ctr Pharm & Expt Therapeut, Augusta, GA 30912 USA; [Abdalla, Maha; Goc, Anna; Segar, Lakshman; Somanath, Payaningal R.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Somanath, Payaningal R.] Georgia Regents Univ, Dept Med, Augusta, GA 30912 USA; [Somanath, Payaningal R.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; Augusta University; University System of Georgia; Augusta University	Somanath, PR (corresponding author), Georgia Regents Univ, Univ Georgia, Coll Pharm, Ctr Pharm & Expt Therapeut, HM1200, Augusta, GA 30912 USA.	sshenoy@gru.edu		Rammohan Shenoy, Somanath/0000-0003-3017-0230; Abdalla, Maha/0000-0002-5644-3383	National Institutes of Health [R01HL103952]; American Heart Association Scientist Development Grant [0830326N]; American Heart Association Predoctoral Fellowship [13PRE17100070]; University of Georgia Research Foundation, University of Georgia College of Pharmacy Dean's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); American Heart Association Predoctoral Fellowship(American Heart Association); University of Georgia Research Foundation, University of Georgia College of Pharmacy Dean's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL103952, American Heart Association Scientist Development Grant 0830326N (to P. R. S.), American Heart Association Predoctoral Fellowship 13PRE17100070 (to M. A.), and grants from the University of Georgia Research Foundation, University of Georgia College of Pharmacy Dean's Foundation (to P. R. S.).	Akhmetshina A, 2008, ARTHRITIS RHEUM-US, V58, P2553, DOI 10.1002/art.23677; Anderson S, 2004, EXP CELL RES, V298, P574, DOI 10.1016/j.yexcr.2004.05.005; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Goc A, 2011, J CELL PHYSIOL, V226, P3004, DOI 10.1002/jcp.22648; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Jun JB, 2005, J INVEST DERMATOL, V124, P298, DOI 10.1111/j.0022-202X.2004.23559.x; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Kohan M, 2010, FASEB J, V24, P4503, DOI 10.1096/fj.10-154435; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; MAJNO G, 1971, SCIENCE, V173, P548, DOI 10.1126/science.173.3996.548; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Sandbo N, 2005, MOL PHARMACOL, V67, P789, DOI 10.1124/mol.104.006874; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Short M, 2004, AM J PHYSIOL-CELL PH, V286, pC416, DOI 10.1152/ajpcell.00169.2003; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; White ES, 2010, EXP CELL RES, V316, P2644, DOI 10.1016/j.yexcr.2010.06.028; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	50	42	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33483	33493		10.1074/jbc.M113.504290	http://dx.doi.org/10.1074/jbc.M113.504290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106278	hybrid, Green Published			2022-12-28	WOS:000328841700060
J	Horiuchi, K; Kawamura, T; Iwanari, H; Ohashi, R; Naito, M; Kodama, T; Hamakubo, T				Horiuchi, Keiko; Kawamura, Takeshi; Iwanari, Hiroko; Ohashi, Riuko; Naito, Makoto; Kodama, Tatsuhiko; Hamakubo, Takao			Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Cell Cycle; Nuclear RNA; Protein Complexes; Proteomics	HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; SEX-LETHAL; PROTEOMIC ANALYSIS; DOSAGE COMPENSATION; MOLECULAR PARTNER; HUMAN ENHANCER; CROSS-LINKING; GENE; RNA; DROSOPHILA	Background: WTAP is a ubiquitously expressed nuclear protein that is required for mammalian early embryo development and cell cycle progression. Results: WTAP forms a complex with several splicing regulators. Conclusion: WTAP regulates both the cell cycle and alternative splicing by the formation of a protein complex. Significance: Characterization of this protein complex will help to elucidate the critically important function of WTAP in alternative splicing and cell proliferation. Wilms' tumor 1-associating protein (WTAP) is a putative splicing regulator that is thought to be required for cell cycle progression through the stabilization of cyclin A2 mRNA and mammalian early embryo development. To further understand how WTAP acts in the context of the cellular machinery, we identified its interacting proteins in human umbilical vein endothelial cells and HeLa cells using shotgun proteomics. Here we show that WTAP forms a novel protein complex including Hakai, Virilizer homolog, KIAA0853, RBM15, the arginine/serine-rich domain-containing proteins BCLAF1 and THRAP3, and certain general splicing regulators, most of which have reported roles in post-transcriptional regulation. The depletion of these respective components of the complex resulted in reduced cell proliferation along with G(2)/M accumulation. Double knockdown of the serine/arginine-rich (SR)-like proteins BCLAF1 and THRAP3 by siRNA resulted in a decrease in the nuclear speckle localization of WTAP, whereas the nuclear speckles were intact. Furthermore, we found that the WTAP complex regulates alternative splicing of the WTAP pre-mRNA by promoting the production of a truncated isoform, leading to a change in WTAP protein expression. Collectively, these findings show that the WTAP complex is a novel component of the RNA processing machinery, implying an important role in both posttranscriptional control and cell cycle regulation.	[Horiuchi, Keiko; Kawamura, Takeshi; Iwanari, Hiroko; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo 1538904, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo 1538904, Japan; [Ohashi, Riuko; Naito, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Niigata 9518510, Japan	University of Tokyo; University of Tokyo; Niigata University	Hamakubo, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo 1538904, Japan.	hamakubo@qbm.rcast.u-tokyo.ac.jp	Ohashi, Riuko/AAH-1415-2019	Ohashi, Riuko/0000-0001-5820-7870; HORIUCHI, KEIKO/0000-0003-4811-5133	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20221010, 08104737]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20221010 and 08104737 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Amente S, 2005, FEBS LETT, V579, P683, DOI 10.1016/j.febslet.2004.12.045; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cook D, 2013, DEV NEUROBIOL, DOI 10.1002/dneu.22096; Daigo K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015073; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Figueroa A, 2009, MOL BIOL CELL, V20, P3533, DOI 10.1091/mbc.E08-08-0845; FLICKINGER TW, 1994, GENE DEV, V8, P914, DOI 10.1101/gad.8.8.914; Forch P, 2001, RNA, V7, P1185, DOI 10.1017/S1355838201010536; Fujimura A, 2012, BIOCHEM BIOPH RES CO, V423, P588, DOI 10.1016/j.bbrc.2012.06.018; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; He X, 2011, ONCOGENE, V30, P356, DOI 10.1038/onc.2010.426; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; HORABIN JI, 1993, MOL CELL BIOL, V13, P7734, DOI 10.1128/MCB.13.12.7734; Horiuchi K, 2006, P NATL ACAD SCI USA, V103, P17278, DOI 10.1073/pnas.0608357103; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; Jin DI, 2012, CANCER SCI, V103, P2102, DOI 10.1111/cas.12022; Jo H.J., 2013, J GASTROENTEROL; Kaido M, 2009, GENES CELLS, V14, P1067, DOI 10.1111/j.1365-2443.2009.01335.x; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Kim KM, 2012, METHODS, V56, P161, DOI 10.1016/j.ymeth.2011.10.013; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Lukasik A, 2008, FEBS J, V275, P332, DOI 10.1111/j.1742-4658.2007.06203.x; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Onyango P, 2011, P NATL ACAD SCI USA, V108, P16759, DOI 10.1073/pnas.1110904108; Ortega A, 2003, J BIOL CHEM, V278, P3040, DOI 10.1074/jbc.M210737200; Penn JKM, 2008, GENETICS, V178, P737, DOI 10.1534/genetics.107.081679; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Saitoh N, 2004, MOL BIOL CELL, V15, P3876, DOI 10.1091/mbc.E04-03-0253; SAKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P5533, DOI 10.1093/nar/20.21.5533; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Small TW, 2006, CIRC RES, V99, P1338, DOI 10.1161/01.RES.0000252289.79841.d3; Small TW, 2009, J BIOL CHEM, V284, P24684, DOI 10.1074/jbc.M109.034629; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; Weng MT, 2012, P NATL ACAD SCI USA, V109, pE3659, DOI 10.1073/pnas.1207673110; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Zafrakas M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-145; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	62	201	233	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33292	33302		10.1074/jbc.M113.500397	http://dx.doi.org/10.1074/jbc.M113.500397			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24100041	Green Published, hybrid			2022-12-28	WOS:000328841700043
J	Li, D; Jin, LT; Alesi, GN; Kim, YM; Fan, J; Seo, JH; Wang, DS; Tucker, M; Gu, TL; Lee, BH; Taunton, J; Magliocca, KR; Chen, ZG; Shin, DM; Khuri, FR; Kang, SM				Li, Dan; Jin, Lingtao; Alesi, Gina N.; Kim, Young-Mee; Fan, Jun; Seo, Jae Ho; Wang, Dongsheng; Tucker, Meghan; Gu, Ting-Lei; Lee, Benjamin H.; Taunton, Jack; Magliocca, Kelly R.; Chen, Zhuo G.; Shin, Dong M.; Khuri, Fadlo R.; Kang, Sumin			The Prometastatic Ribosomal S6 Kinase 2-cAMP Response Element-binding Protein (RSK2-CREB) Signaling Pathway Up-regulates the Actin-binding Protein Fascin-1 to Promote Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Migration; Metastasis; Serine Threonine Protein Kinase; Signal Transduction; Fascin-1; Ribosomal S6 Kinase 2; cAMP Response Element-binding; Filopodia	PLASMINOGEN-ACTIVATOR INHIBITOR-1; CANCER METASTASIS; CELL INVASION; BETA-CATENIN; TYROSINE PHOSPHORYLATION; GENE-EXPRESSION; COLON-CANCER; IN-VITRO; CREB; TARGET	Metastasis is the leading cause of death in patients with breast, lung, and head and neck cancers. However, the molecular mechanisms underlying metastases in these cancers remain unclear. We found that the p90 ribosomal S6 kinase 2 (RSK2)-cAMP response element-binding protein (CREB) pathway is commonly activated in diverse metastatic human cancer cells, leading to up-regulation of a CREB transcription target Fascin-1. We also observed that the protein expression patterns of RSK2 and Fascin-1 correlate in primary human tumor tissue samples from head and neck squamous cell carcinoma patients. Moreover, knockdown of RSK2 disrupts filopodia formation and bundling in highly invasive cancer cells, leading to attenuated cancer cell invasion in vitro and tumor metastasis in vivo, whereas expression of Fascin-1 significantly rescues these phenotypes. Furthermore, targeting RSK2 with the small molecule RSK inhibitor FMK-MEA effectively attenuated the invasive and metastatic potential of cancer cells in vitro and in vivo, respectively. Taken together, our findings for the first time link RSK2-CREB signaling to filopodia formation and bundling through the up-regulation of Fascin-1, providing a proinvasive and prometastatic advantage to human cancers. Therefore, protein effectors of the RSK2-CREB-Fascin-1 pathway represent promising biomarkers and therapeutic targets in the clinical prognosis and treatment of metastatic human cancers.	[Li, Dan; Jin, Lingtao; Alesi, Gina N.; Kim, Young-Mee; Fan, Jun; Seo, Jae Ho; Wang, Dongsheng; Chen, Zhuo G.; Shin, Dong M.; Khuri, Fadlo R.; Kang, Sumin] Emory Univ Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Tucker, Meghan; Gu, Ting-Lei] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Lee, Benjamin H.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; [Magliocca, Kelly R.] Emory Univ Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Novartis; University of California System; University of California San Francisco; Emory University	Kang, SM (corresponding author), Emory Univ Sch Med, Winship Canc Inst, 1365-C Clifton Rd NE, Atlanta, GA 30322 USA.	smkang@emory.edu	Shin, Dong Moon/G-9649-2013; Khuri, Fadlo R./AAU-4942-2020; Jin, Lingtao/O-4316-2014	Shin, Dong Moon/0000-0002-8245-4174; Khuri, Fadlo R./0000-0002-8638-7618; 	American Cancer Society [RSG-11-081-01]; National Institutes of Health/NCI SPORE in Head and Neck Cancer Career Development Program Award [P50CA128613]; Robbins Scholar Award; National Institutes of Health [GM071434]; NATIONAL CANCER INSTITUTE [P50CA128613, R01CA175316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071434] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health/NCI SPORE in Head and Neck Cancer Career Development Program Award; Robbins Scholar Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the American Cancer Society Grant RSG-11-081-01 (to S.K.), the National Institutes of Health/NCI SPORE in Head and Neck Cancer P50CA128613 Career Development Program Award (to S.K.), and a Robbins Scholar Award (to S.K.). M.T. and T.-L.G. are employees of Cell Signaling Technology, Inc. J.T. is as an inventor on a patent application filed by the University of California that describes the RSK inhibitor FMK.; Supported by National Institutes of Health Grant GM071434.	Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089; Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Aucoin R, 2004, J CELL BIOCHEM, V93, P215, DOI 10.1002/jcb.20231; Baldassarre M, 2006, EUR J CELL BIOL, V85, P1217, DOI 10.1016/j.ejcb.2006.08.003; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Dimova EY, 2010, ANTIOXID REDOX SIGN, V13, P413, DOI 10.1089/ars.2009.2999; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Elf S, 2011, BLOOD, V117, P6885, DOI 10.1182/blood-2010-10-315721; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gutierrez LS, 2000, CANCER RES, V60, P5839; Hashimoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005130; Hayashi Y, 2008, CELL TISSUE RES, V334, P219, DOI 10.1007/s00441-008-0683-8; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Jalvy S, 2007, CIRC RES, V100, P1292, DOI 10.1161/01.RES.0000266609.28312.de; Jiang H, 2012, MOL BIOL REP, V39, P2773, DOI 10.1007/s11033-011-1035-4; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2011, EXPERT OPIN THER TAR, V15, P11, DOI 10.1517/14728222.2010.531013; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kim SJ, 2010, GASTROENTEROLOGY, V138, P1035, DOI 10.1053/j.gastro.2009.09.061; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Small J V, 1988, Electron Microsc Rev, V1, P155; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smith JA, 2005, CANCER RES, V65, P1027; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang X, 2002, CANCER-AM CANCER SOC, V95, P1663, DOI 10.1002/cncr.10837	46	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32528	32538		10.1074/jbc.M113.500561	http://dx.doi.org/10.1074/jbc.M113.500561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085294	Green Published, hybrid			2022-12-28	WOS:000328681700036
J	van Hateren, A; Carter, R; Bailey, A; Kontouli, N; Williams, AP; Kaufman, J; Elliott, T				van Hateren, Andy; Carter, Rachel; Bailey, Alistair; Kontouli, Nasia; Williams, Anthony P.; Kaufman, Jim; Elliott, Tim			A Mechanistic Basis for the Co-evolution of Chicken Tapasin and Major Histocompatibility Complex Class I (MHC I) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antigen Presentation; Evolution; Immunology; Major Histocompatibility Complex (MHC); Protein-Protein Interactions; Chicken MHC; Co-evolution; Peptide Selection; Tapasin	ANTIGEN PRESENTATION; PEPTIDE BINDING; REVEALS POLYMORPHISM; CELL LINE; MOLECULES; SELECTION; TAP; GENES; HETERODIMER; EXPRESSION	Background: Tapasin edits the MHC I peptide repertoire and is highly polymorphic in birds but not mammals. Results: Two chicken MHC I alleles differ in peptide binding properties and participate in an allele-specific interaction with tapasin. Conclusion: Tapasin-MHC alleles have co-evolved by balancing interaction characteristics against MHC peptide-binding ability. Significance: Variations in the functional attributes of tapasin and MHC I alleles determine effective antigen presentation. MHC class I molecules display peptides at the cell surface to cytotoxic T cells. The co-factor tapasin functions to ensure that MHC I becomes loaded with high affinity peptides. In most mammals, the tapasin gene appears to have little sequence diversity and few alleles and is located distal to several classical MHC I loci, so tapasin appears to function in a universal way to assist MHC I peptide loading. In contrast, the chicken tapasin gene is tightly linked to the single dominantly expressed MHC I locus and is highly polymorphic and moderately diverse in sequence. Therefore, tapasin-assisted loading of MHC I in chickens may occur in a haplotype-specific way, via the co-evolution of chicken tapasin and MHC I. Here we demonstrate a mechanistic basis for this co-evolution, revealing differences in the ability of two chicken MHC I alleles to bind and release peptides in the presence or absence of tapasin, where, as in mammals, efficient self-loading is negatively correlated with tapasin-assisted loading. We found that a polymorphic residue in the MHC I 3 domain thought to bind tapasin influenced both tapasin function and intrinsic peptide binding properties. Differences were also evident between the MHC alleles in their interactions with tapasin. Last, we show that a mismatched combination of tapasin and MHC alleles exhibit significantly impaired MHC I maturation in vivo and that polymorphic MHC residues thought to contact tapasin influence maturation efficiency. Collectively, this supports the possibility that tapasin and BF2 proteins have co-evolved, resulting in allele-specific peptide loading in vivo.	[van Hateren, Andy; Carter, Rachel; Bailey, Alistair; Kontouli, Nasia; Williams, Anthony P.; Elliott, Tim] Univ Southampton, Fac Med, Southampton SO16 6YD, Hants, England; [van Hateren, Andy; Carter, Rachel; Bailey, Alistair; Kontouli, Nasia; Williams, Anthony P.; Elliott, Tim] Univ Southampton, Inst Life Sci, Southampton SO16 6YD, Hants, England; [Kaufman, Jim] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Kaufman, Jim] Univ Cambridge, Dept Vet Med, Cambridge CB2 1QP, England	University of Southampton; University of Southampton; University of Cambridge; University of Cambridge	Kaufman, J (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	jfk31@cam.ac.uk; tje@soton.ac.uk	van Hateren, Andy/GZL-0129-2022	Kaufman, Jim/0000-0002-7216-8422; van Hateren, Andy/0000-0002-3915-0239; Elliott, Tim/0000-0003-1097-0222; Bailey, Alistair/0000-0003-0023-8679	Cancer Research UK Program Grant [C7056A]	Cancer Research UK Program Grant(Cancer Research UK)	This work was supported by Cancer Research UK Program Grant C7056A (to T. E.).	Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bennett EM, 1999, J IMMUNOL, V162, P5049; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Copeman J, 1998, EUR J IMMUNOL, V28, P3783, DOI 10.1002/(SICI)1521-4141(199811)28:11<3783::AID-IMMU3783>3.0.CO;2-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Furukawa H, 1998, TISSUE ANTIGENS, V52, P279, DOI 10.1111/j.1399-0039.1998.tb03044.x; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Hee CS, 2013, IMMUNOGENETICS, V65, P157, DOI 10.1007/s00251-012-0667-4; Herberg JA, 1998, EUR J IMMUNOL, V28, P459, DOI 10.1002/(SICI)1521-4141(199802)28:02<459::AID-IMMU459>3.3.CO;2-Q; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Rizvi SM, 2006, P NATL ACAD SCI USA, V103, P18220, DOI 10.1073/pnas.0605131103; Rizvi SM, 2010, TRAFFIC, V11, P332, DOI 10.1111/j.1600-0854.2009.01025.x; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; Shaw I, 2007, J IMMUNOL, V178, P5744, DOI 10.4049/jimmunol.178.9.5744; Suh WK, 1999, J IMMUNOL, V162, P1530; van Hateren A, 2010, TISSUE ANTIGENS, V76, P259, DOI 10.1111/j.1399-0039.2010.01550.x; VANHATEREN A, 2006, THESIS U SOUTHAMPTON; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287	37	35	37	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32797	32808		10.1074/jbc.M113.474031	http://dx.doi.org/10.1074/jbc.M113.474031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078633	Green Published, hybrid			2022-12-28	WOS:000328681700063
J	Temme, S; Zacharias, M; Neumann, J; Wohlfromm, S; Konig, A; Temme, N; Springer, S; Trowsdale, J; Koch, N				Temme, Sebastian; Zacharias, Martin; Neumann, Juergen; Wohlfromm, Sebastian; Koenig, Angelika; Temme, Nadine; Springer, Sebastian; Trowsdale, John; Koch, Norbert			A Novel Family of Human Leukocyte Antigen Class II Receptors May Have Its Origin in Archaic Human Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; MHC PROTEIN HLA-DR1; HLA-DR MOLECULES; INVARIANT-CHAIN; PEPTIDE BINDING; ENDOGENOUS PEPTIDE; CRYSTAL-STRUCTURE; DP MOLECULES; IA MOLECULE; ALPHA-CHAIN	HLA class II alpha and beta chains form receptors for antigen presentation to CD4(+) T cells. Numerous pairings of class II alpha and beta subunits from the wide range of haplotypes and isotypes may form, but most of these combinations, in particular those produced by isotype mixing, yielded mismatched dimers. It is unclear how selection of functional receptors is achieved. At the atomic level, it is not known which interactions of class II residues regulate selection of matched alpha beta heterodimers and the evolutionary origin of matched isotype mixed dimer formation. In this study we investigated assembly of isotype-mixed HLA class II alpha and beta heterodimers. Assembly and carbohydrate maturation of various HLA-class II isotype-mixed alpha and beta subunits was dependent on the groove binding section of the invariant chain (Ii). By mutation of polymorphic DP beta sequences, we identified two motifs, Lys-69 and GGPM-(8487), that are engaged in Ii-dependent assembly of DP beta with DR alpha. We identified five members of a family of DP beta chains containing Lys-69 and GGPM 84-87, which assemble with DR alpha. The Lys/GGPM motif is present in the DP beta sequence of the Neanderthal genome, and this ancient sequence is related to the human allele DPB1*0401. By site-directed mutagenesis, we inspected Neanderthal amino acid residues that differ from the DPB1*0401 allele and aimed to determine whether matched heterodimers are formed by assembly of DP beta mutants with DR alpha. Because the *0401 allele is rare in the sub-Saharan population but frequent in the European population, it may have arisen in modern humans by admixture with Neanderthals in Europe.	[Temme, Sebastian; Neumann, Juergen; Koenig, Angelika; Temme, Nadine] Univ Bonn, Immunobiol Sect, Inst Genet, D-53115 Bonn, Germany; [Temme, Sebastian] Univ Dusseldorf, Dept Mol Cardiol, D-40225 Dusseldorf, Germany; [Zacharias, Martin] Tech Univ Munich, Dept Phys, D-85747 Garching, Germany; [Wohlfromm, Sebastian] Univ Dusseldorf, Biol Med Forschungszentrum, D-40225 Dusseldorf, Germany; [Temme, Nadine] Forschungszentrum Caesar, D-53175 Bonn, Germany; [Springer, Sebastian] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Trowsdale, John] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Bonn; Heinrich Heine University Dusseldorf; Technical University of Munich; Heinrich Heine University Dusseldorf; Center of Advanced European Studies & Research (CAESAR); Jacobs University; University of Cambridge	Koch, N (corresponding author), Univ Bonn, Abt Immunbiol, Inst Genet, Endenicher Allee 11-13, D-53115 Bonn, Germany.	norbert.koch@uni-bonn.de	Springer, Sebastian/AAJ-7036-2021	Springer, Sebastian/0000-0002-5527-6149	Deutsche Forschungsgemeinschaft; Wellcome Trust; Medical Research Council; National Institute of Health Cambridge Biomedical Research Centre; MRC [G0901682] Funding Source: UKRI; Medical Research Council [G0901682] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Cambridge Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft.; Supported by grants from the Wellcome Trust and the Medical Research Council with partial funding from the National Institute of Health Cambridge Biomedical Research Centre.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; ADAMS TE, 1983, IMMUNOLOGY, V50, P613; ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; ARROYO J, 1995, HUM IMMUNOL, V43, P219, DOI 10.1016/0198-8859(95)00022-V; BIKOFF EK, 1993, J EXP MED, V177, P1699, DOI 10.1084/jem.177.6.1699; BIKOFF EK, 1995, IMMUNITY, V2, P301, DOI 10.1016/1074-7613(95)90054-3; BRAUNSTEIN NS, 1987, P NATL ACAD SCI USA, V84, P2921, DOI 10.1073/pnas.84.9.2921; BUERSTEDDE JM, 1988, J EXP MED, V168, P823, DOI 10.1084/jem.168.3.823; Charron D. J., 1980, J EXP MED, V152, p127s; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; DeLano W.L, PYMOL MOL GRAPHICS S; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Diaz G, 2003, INT IMMUNOL, V15, P565, DOI 10.1093/intimm/dxg057; GERMAIN RN, 1986, NATURE, V320, P72, DOI 10.1038/320072a0; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gruneberg U, 1997, HUM IMMUNOL, V53, P34, DOI 10.1016/S0198-8859(97)00025-6; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; KARP DR, 1990, J EXP MED, V171, P615, DOI 10.1084/jem.171.3.615; Koch N, 2000, IMMUNOL TODAY, V21, P546, DOI 10.1016/S0167-5699(00)01717-5; Koch N, 2007, TRENDS BIOCHEM SCI, V32, P532, DOI 10.1016/j.tibs.2007.09.007; Koch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017257; KOCH S, 1987, J IMMUNOL METHODS, V103, P211, DOI 10.1016/0022-1759(87)90292-4; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Lancaster Alex, 2003, Pac Symp Biocomput, P514; LAYET C, 1991, P NATL ACAD SCI USA, V88, P2346, DOI 10.1073/pnas.88.6.2346; LECHLER RI, 1990, J IMMUNOL, V144, P329; LOTTEAU V, 1987, NATURE, V329, P339, DOI 10.1038/329339a0; MALISSEN B, 1986, P NATL ACAD SCI USA, V83, P3958, DOI 10.1073/pnas.83.11.3958; MARKS MS, 1995, J BIOL CHEM, V270, P10475, DOI 10.1074/jbc.270.18.10475; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Nagaraj S, 2008, PANCREAS, V37, P321, DOI 10.1097/MPA.0b013e318166722e7; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Neumann J, 2005, J IMMUNOL METHODS, V301, P66, DOI 10.1016/j.jim.2005.03.014; Neumann J, 2005, FEBS LETT, V579, P6055, DOI 10.1016/j.febslet.2005.09.070; Neumann J, 2006, J CELL SCI, V119, P4207, DOI 10.1242/jcs.03177; NORCROSS MA, 1986, J IMMUNOL, V137, P1714; PESANDO JM, 1986, J IMMUNOL, V136, P4311; RUBERTI G, 1992, J EXP MED, V175, P157, DOI 10.1084/jem.175.1.157; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SANDERSON S, 1995, P NATL ACAD SCI USA, V92, P7217, DOI 10.1073/pnas.92.16.7217; SANT AJ, 1991, J EXP MED, V174, P799, DOI 10.1084/jem.174.4.799; SANT AJ, 1989, CELL, V57, P797, DOI 10.1016/0092-8674(89)90794-0; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; SCHAIFF WT, 1991, J IMMUNOL, V147, P603; SHACKELFORD DA, 1983, J IMMUNOL, V130, P274; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Silk JD, 2005, MOL IMMUNOL, V42, P1129, DOI 10.1016/j.molimm.2004.11.024; SPENCER JS, 1989, J EXP MED, V169, P625, DOI 10.1084/jem.169.3.625; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; TEMPONI M, 1993, J IMMUNOL METHODS, V161, P239, DOI 10.1016/0022-1759(93)90300-V; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078	54	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					639	653		10.1074/jbc.M113.515767	http://dx.doi.org/10.1074/jbc.M113.515767			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24214983	Green Published, hybrid			2022-12-28	WOS:000330541200005
J	Basu, N; Saha, S; Khan, I; Ramachandra, SG; Visweswariah, SS				Basu, Nirmalya; Saha, Sayanti; Khan, Imran; Ramachandra, Subbaraya G.; Visweswariah, Sandhya S.			Intestinal Cell Proliferation and Senescence Are Regulated by Receptor Guanylyl Cyclase C and p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Intestinal Epithelium; Microarray; Protein Kinase G (PKG); Senescence; Sp1; GCC Knock-out mice; T84 Cell; p21; Receptor Guanylyl Cyclase C	DEPENDENT PROTEIN-KINASE; HEAT-STABLE ENTEROTOXIN; P53-MEDIATED G(1) ARREST; ABERRANT CRYPT FOCI; COLON-CANCER CELLS; COLORECTAL-CANCER; ESCHERICHIA-COLI; BACTERIAL ENTEROTOXINS; GENE-TRANSCRIPTION; CYCLIC-GMP	Guanylyl cyclase C (GC-C) is expressed in intestinal epithelial cells and serves as the receptor for bacterial heat-stable enterotoxin (ST) peptides and the guanylin family of gastrointestinal hormones. Activation of GC-C elevates intracellular cGMP, which modulates intestinal fluid-ion homeostasis and differentiation of enterocytes along the crypt-villus axis. GC-C activity can regulate colonic cell proliferation by inducing cell cycle arrest, and mice lacking GC-C display increased cell proliferation in colonic crypts. Activation of GC-C by administration of ST to wild type, but not Gucy2c(-/-), mice resulted in a reduction in carcinogen-induced aberrant crypt foci formation. In p53-deficient human colorectal carcinoma cells, ST led to a transcriptional up-regulation of p21, the cell cycle inhibitor, via activation of the cGMP-responsive kinase PKGII and p38 MAPK. Prolonged treatment of human colonic carcinoma cells with ST led to nuclear accumulation of p21, resulting in cellular senescence and reduced tumorigenic potential. Our results, therefore, identify downstream effectors for GC-C that contribute to regulating intestinal cell proliferation. Thus, genomic responses to a bacterial toxin can influence intestinal neoplasia and senescence.	[Basu, Nirmalya; Saha, Sayanti; Khan, Imran; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Ramachandra, Subbaraya G.] Indian Inst Sci, Cent Anim Facil, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Visweswariah, Sandhya/Q-7500-2019; khan, imran/K-9921-2013	Visweswariah, Sandhya/0000-0003-2786-7344; khan, imran/0000-0001-6888-7347; Gudde, Ramachandra/0000-0002-0744-3627; Basu, Nirmalya/0000-0003-3041-2826	Central Animal Facility in the Indian Institute of Science	Central Animal Facility in the Indian Institute of Science	We thank Prof. P. Kondaiah and Neeraj Rana for help with the microarray and Pavithra Kumar, Vani R. Iyer, and members of the laboratory for useful discussions. We acknowledge the assistance of the late Prof. Parag P. Sadhale in early transcriptomic studies. Support from the Central Animal Facility in the Indian Institute of Science is acknowledged.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basu N, 2010, MOL CELL BIOCHEM, V334, P67, DOI 10.1007/s11010-009-0324-x; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Bigler D, 2007, PROSTATE, V67, P1590, DOI 10.1002/pros.20644; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Camici M, 2008, BIOMED PHARMACOTHER, V62, P70, DOI 10.1016/j.biopha.2007.04.010; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carrithers SL, 1996, P NATL ACAD SCI USA, V93, P14827, DOI 10.1073/pnas.93.25.14827; Cen B, 2008, CANCER RES, V68, P5355, DOI 10.1158/0008-5472.CAN-07-6869; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; DWARAKANATH P, 1989, GENE, V81, P219, DOI 10.1016/0378-1119(89)90182-0; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Ghosh AR, 1996, EUR J EPIDEMIOL, V12, P81, DOI 10.1007/BF00144433; Gu MF, 2000, J BIOL CHEM, V275, P11389, DOI 10.1074/jbc.275.15.11389; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; HARPER JW, 1993, CELL, V75, P805; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kagawa S, 1999, CELL DEATH DIFFER, V6, P765, DOI 10.1038/sj.cdd.4400549; Kanthan R., 2012, PATHOLOG RES INT, V2012; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kazerounian S, 2005, J PHARMACOL EXP THER, V314, P1013, DOI 10.1124/jpet.105.089052; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lembo AJ, 2011, NEW ENGL J MED, V365, P527, DOI 10.1056/NEJMoa1010863; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MILLER JP, 1973, BIOCHEMISTRY-US, V12, P5310, DOI 10.1021/bi00750a014; Mohandas KM, 2011, INDIAN J GASTROENTER, V30, P3, DOI 10.1007/s12664-010-0076-2; Nandi A, 1997, J CELL BIOCHEM, V66, P500, DOI 10.1002/(SICI)1097-4644(19970915)66:4<500::AID-JCB9>3.0.CO;2-P; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; Pasz-Walczak G, 2001, PATHOL RES PRACT, V197, P683, DOI 10.1078/0344-0338-00146; Pitari GM, 2003, P NATL ACAD SCI USA, V100, P2695, DOI 10.1073/pnas.0434905100; Pitari GM, 2001, P NATL ACAD SCI USA, V98, P7846, DOI 10.1073/pnas.141124698; PRETLOW TP, 1991, CANCER RES, V51, P1564; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; Saha S, 2008, J APPL TOXICOL, V28, P475, DOI 10.1002/jat.1297; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shailubhai K, 2000, CANCER RES, V60, P5151; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Steinbrecher KA, 2000, BIOCHEM BIOPH RES CO, V273, P225, DOI 10.1006/bbrc.2000.2917; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang R, 2012, AM J PHYSIOL-GASTR L, V303, pG209, DOI 10.1152/ajpgi.00500.2011; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wu Y, 2012, ONCOL REP, V27, P553, DOI 10.3892/or.2011.1507; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	70	40	40	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					581	593		10.1074/jbc.M113.511311	http://dx.doi.org/10.1074/jbc.M113.511311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24217248	Green Published, hybrid			2022-12-28	WOS:000329370900049
J	Kirchhefer, U; Heinick, A; Konig, S; Kristensen, T; Muller, FU; Seidl, MD; Boknik, P				Kirchhefer, Uwe; Heinick, Alexander; Koenig, Simone; Kristensen, Torsten; Mueller, Frank U.; Seidl, Matthias D.; Boknik, Peter			Protein Phosphatase 2A Is Regulated by Protein Kinase C alpha (PKC alpha)-dependent Phosphorylation of Its Targeting Subunit B56 alpha at Ser(41)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Intracellular Release; Heart Failure; Protein Kinase C (PKC); Protein Phosphorylation; Serine; Threonine Protein Phosphatase	HEART; PP2A; DEPHOSPHORYLATION; CONTRACTILITY; HYPERTROPHY; EXPRESSION; SUBSTRATE; FAMILY; CREB	Protein phosphatase 2A (PP2A) is a family of multifunctional serine/threonine phosphatases consisting of a catalytic C, a structural A, and a regulatory B subunit. The substrate and therefore the functional specificity of PP2A are determined by the assembly of the enzyme complex with the appropriate regulatory B subunit families, namely B55, B56, PR72, or PR93/PR110. It has been suggested that additional levels of regulating PP2A function may result from the phosphorylation of B56 isoforms. In this study, we identified a novel phosphorylation site at Ser(41) of B56. This phosphoamino acid residue was efficiently phosphorylated in vitro by PKC. We detected a 7-fold higher phosphorylation of B56 in failing human hearts compared with nonfailing hearts. Purified PP2A dimeric holoenzyme (subunits C and A) was able to dephosphorylate PKC-phosphorylated B56. The potency of B56 for PP2A inhibition was markedly increased by PKC phosphorylation. PP2A activity was also reduced in HEK293 cells transfected with a B56 mutant, where serine 41 was replaced by aspartic acid, which mimics phosphorylation. More evidence for a functional role of PKC-dependent phosphorylation of B56 was derived from Fluo-4 fluorescence measurements in phenylephrine-stimulated Flp293 cells. The endoplasmic reticulum Ca2+ release was increased by 23% by expression of the pseudophosphorylated form compared with wild-type B56. Taken together, our results suggest that PKC can modify PP2A activity by phosphorylation of B56 at Ser(41). This interplay between PKC and PP2A represents a new mechanism to regulate important cellular functions like cellular Ca2+ homeostasis.	[Kirchhefer, Uwe; Heinick, Alexander; Mueller, Frank U.; Seidl, Matthias D.; Boknik, Peter] Univ Klinikum Munster, Inst Pharmakol & Toxikol, D-48149 Munster, Germany; [Koenig, Simone] Univ Munster, Interdisziplinares Zentrum Klin Forsch, D-48149 Munster, Germany; [Kristensen, Torsten] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	University of Munster; University of Munster; Aarhus University	Kirchhefer, U (corresponding author), Univ Klinikum Munster, Inst Pharmakol & Toxikol, Domagkstr 12, D-48149 Munster, Germany.	kirchhef@uni-muenster.de	König, Simone/B-6504-2008	König, Simone/0000-0003-0672-7246; Heinick, Alexander/0000-0002-3770-105X	Innovative Medizinische Forschung Munster Grant [KI 2 1 10 10]; Deutsche Forschungsgemeinschaft [Mu1376/11-1]	Innovative Medizinische Forschung Munster Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Innovative Medizinische Forschung Munster Grant KI 2 1 10 10 and Deutsche Forschungsgemeinschaft Grant Mu1376/11-1.	Ahn J., 2011, PLOS ONE, V6; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Boudreau RTM, 2002, J BIOL CHEM, V277, P5322, DOI 10.1074/jbc.M108623200; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Braman J, 1996, Methods Mol Biol, V57, P31; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; DeGrande ST, 2013, J BIOL CHEM, V288, P1032, DOI 10.1074/jbc.M112.426957; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; deSouza N, 2002, J BIOL CHEM, V277, P39397, DOI 10.1074/jbc.M207059200; Dodge-Kafka KL, 2010, J BIOL CHEM, V285, P11078, DOI 10.1074/jbc.M109.034868; Dozier C, 2004, BIOL CELL, V96, P509, DOI 10.1016/j.biolcel.2004.04.010; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiffar T, 2004, LEUKEMIA, V18, P505, DOI 10.1038/sj.leu.2403275; Jin ZG, 2010, J BIOL CHEM, V285, P34493, DOI 10.1074/jbc.M110.169581; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kirchhefer U, 2001, J BIOL CHEM, V276, P4142, DOI 10.1074/jbc.M006443200; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Lu Q, 2003, J BIOL CHEM, V278, P15727, DOI 10.1074/jbc.M300546200; Ludowyke RI, 2000, J BIOL CHEM, V275, P6144, DOI 10.1074/jbc.275.9.6144; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; NEUMANN J, 1993, AM J PHYSIOL, V265, pH257, DOI 10.1152/ajpheart.1993.265.1.H257; Nourian Z, 2008, EUR J PHARMACOL, V596, P32, DOI 10.1016/j.ejphar.2008.08.014; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; Ricciarelli R, 1998, ARCH BIOCHEM BIOPHYS, V355, P197, DOI 10.1006/abbi.1998.0732; Rudrabhatla P, 2011, CURR ALZHEIMER RES, V8, P623, DOI 10.2174/156720511796717168; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Saraf A, 2010, BIOCHEMISTRY-US, V49, P986, DOI 10.1021/bi902160t; Seidl M. D., 2013, FASEB J, DOI 10.1096/fj.13-231977; Servillo G, 1997, ONCOGENE, V14, P1601, DOI 10.1038/sj.onc.1200996; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tang TS, 2003, J NEUROSCI, V23, P403, DOI 10.1523/JNEUROSCI.23-02-00403.2003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wijnker PJM, 2011, J MUSCLE RES CELL M, V32, P221, DOI 10.1007/s10974-011-9261-x; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200	53	33	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					163	176		10.1074/jbc.M113.507996	http://dx.doi.org/10.1074/jbc.M113.507996			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24225947	hybrid, Green Published			2022-12-28	WOS:000329370900015
J	Takayama, H; Misu, H; Iwama, H; Chikamoto, K; Saito, Y; Murao, K; Teraguchi, A; Lan, F; Kikuchi, A; Saito, R; Tajima, N; Shirasaki, T; Matsugo, S; Miyamoto, K; Kaneko, S; Takamura, T				Takayama, Hiroaki; Misu, Hirofumi; Iwama, Hisakazu; Chikamoto, Keita; Saito, Yoshiro; Murao, Koji; Teraguchi, Atsushi; Lan, Fei; Kikuchi, Akihiro; Saito, Reina; Tajima, Natsumi; Shirasaki, Takayoshi; Matsugo, Seiichi; Miyamoto, Ken-ichi; Kaneko, Shuichi; Takamura, Toshinari			Metformin Suppresses Expression of the Selenoprotein P Gene via an AMP-activated Kinase (AMPK)/FoxO3a Pathway in H4IIEC3 Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Gene Expression; Hepatocyte; Insulin Resistance; Transcription Promoter; FoxO3a; Hepatokine; Metformin; Selenoprotein P	FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; OXIDATIVE STRESS; FOXO; LIVER; SELENIUM; MOUSE; CELLS	Selenoprotein P (SeP; encoded by SEPP1 in humans) is a liver-derived secretory protein that induces insulin resistance in type 2 diabetes. Suppression of SeP might provide a novel therapeutic approach to treating type 2 diabetes, but few drugs that inhibit SEPP1 expression in hepatocytes have been identified to date. The present findings demonstrate that metformin suppresses SEPP1 expression by activating AMP-activated kinase (AMPK) and subsequently inactivating FoxO3a in H4IIEC3 hepatocytes. Treatment with metformin reduced SEPP1 promoter activity in a concentration- and time-dependent manner; this effect was cancelled by co-administration of an AMPK inhibitor. Metformin also suppressed Sepp1 gene expression in the liver of mice. Computational analysis of transcription factor binding sites conserved among the species resulted in identification of the FoxO-binding site in the metformin-response element of the SEPP1 promoter. A luciferase reporter assay showed that metformin suppresses Forkhead-response element activity, and a ChIP assay revealed that metformin decreases binding of FoxO3a, a direct target of AMPK, to the SEPP1 promoter. Transfection with siRNAs for Foxo3a, but not for Foxo1, cancelled metformin-induced luciferase activity suppression of the metformin-response element of the SEPP1 promoter. The overexpression of FoxO3a stimulated SEPP1 promoter activity and rescued the suppressive effect of metformin. Metformin did not affect FoxO3a expression, but it increased its phosphorylation and decreased its nuclear localization. These data provide a novel mechanism of action for metformin involving improvement of systemic insulin sensitivity through the regulation of SeP production and suggest an additional approach to the development of anti-diabetic drugs.	[Takayama, Hiroaki; Misu, Hirofumi; Chikamoto, Keita; Lan, Fei; Kikuchi, Akihiro; Saito, Reina; Tajima, Natsumi; Shirasaki, Takayoshi; Kaneko, Shuichi; Takamura, Toshinari] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan; [Chikamoto, Keita] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Nat Syst, Kanazawa, Ishikawa 9201192, Japan; [Saito, Yoshiro] Doshisha Univ, Fac Med & Life Sci, Dept Med Life Syst, Kyoto 6100394, Japan; [Murao, Koji] Kagawa Univ, Dept Adv Med, Miki, Kagawa 7610793, Japan; [Teraguchi, Atsushi] Kanazawa Univ, Dept Hosp Pharm, Kanazawa, Ishikawa 9208641, Japan; [Shirasaki, Takayoshi] Kanazawa Univ, Grad Sch Hlth Med, Dept Adv Med Technol, Kanazawa, Ishikawa 9208641, Japan; [Matsugo, Seiichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Engn, Kanazawa, Ishikawa 9201192, Japan; [Matsugo, Seiichi] Kanazawa Univ, Fac Nat Syst, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Hosp Pharm, Kanazawa, Ishikawa 9208641, Japan; [Miyamoto, Ken-ichi] Kanazawa Univ, Grad Sch Med Sci, Dept Med Informat, Kanazawa, Ishikawa 9208641, Japan	Kanazawa University; Kagawa University; Kanazawa University; Doshisha University; Kagawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	ttakamura@m-kanazawa.jp	Takayama, Hiroaki/C-4694-2015; Saito, Yoshiro/H-4597-2019	Takayama, Hiroaki/0000-0003-4792-3868; Saito, Yoshiro/0000-0002-0559-5889; Kikuchi, Akihiro/0000-0001-9332-1273	Ministry of Education, Culture, Sports, Science and Technology, Japan; Dainippon Sumitomo Pharma; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24591352] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. M., T. T., and S. K.) and research grants from Dainippon Sumitomo Pharma (to S. K.) and Takeda Science Foundation (to H. M.).	Boyle JG, 2010, DIABETIC MED, V27, P1097, DOI 10.1111/j.1464-5491.2010.03098.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Eckers A, 2011, ARCH BIOCHEM BIOPHYS, V516, P138, DOI 10.1016/j.abb.2011.10.006; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Honda M, 2011, GASTROENTEROLOGY, V141, P128, DOI 10.1053/j.gastro.2011.03.051; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; Lutzner N., 2012, PLOS ONE, V7; Magwere T, 1997, FREE RADICAL BIO MED, V22, P321, DOI 10.1016/S0891-5849(96)00285-7; Malin SK, 2012, DIABETES CARE, V35, P131, DOI 10.2337/dc11-0925; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Shargorodsky M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-61; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Singh S, 2012, DIABETES METAB SYND, V6, P207, DOI 10.1016/j.dsx.2012.05.013; Speckmann B, 2009, BIOCHEM BIOPH RES CO, V387, P158, DOI 10.1016/j.bbrc.2009.06.143; Speckmann B, 2008, HEPATOLOGY, V48, P1998, DOI 10.1002/hep.22526; Takebe G, 2002, J BIOL CHEM, V277, P41254, DOI 10.1074/jbc.M202773200; ukaszewicz-Hussain A., 2004, POL J ENVIRON STUD, V13, P303; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	44	57	59	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					335	345		10.1074/jbc.M113.479386	http://dx.doi.org/10.1074/jbc.M113.479386			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257750	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000329370900029
J	Kurushima, J; Hayashi, I; Sugai, M; Tomita, H				Kurushima, Jun; Hayashi, Ikue; Sugai, Motoyuki; Tomita, Haruyoshi			Bacteriocin Protein BacL(1) of Enterococcus faecalis Is a Peptidoglycan D-Isoglutamyl-L-lysine Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Cell Wall; Enzymes; Hydrolases; Peptidoglycan; Enterococcus faecalis; Bacteriocin	COMPLETE GENOME SEQUENCE; STREPTOCOCCUS-FAECALIS; N-ACETYLGLUCOSAMINIDASE; GENETIC ORGANIZATION; LYTIC ENZYME; DETERMINANT; HEMOLYSIN; IDENTIFICATION; PLASMIDS; CLONING	Enterococcus faecalis strains are commensal bacteria in humans and other animals, and they are also the causative agent of opportunistic infectious diseases. Bacteriocin 41 (Bac41) is produced by certain E. faecalis clinical isolates, and it is active against other E. faecalis strains. Our genetic analyses demonstrated that the extracellular products of the bacL(1) and bacA genes, which are encoded in the Bac41 operon, coordinately express the bacteriocin activity against E. faecalis. In this study, we investigated the molecular functions of the BacL(1) and BacA proteins. Immunoblotting and N-terminal amino acid sequence analysis revealed that BacL(1) and BacA are secreted without any processing. The coincidental treatment with the recombinant BacL(1) and BacA showed complete bacteriocin activity against E. faecalis, but neither BacL(1) nor BacA protein alone showed the bacteriocin activity. Interestingly, BacL(1) alone demonstrated substantial degrading activity against the cell wall fraction of E. faecalis in the absence of BacA. Furthermore, MALDI-TOF MS analysis revealed that BacL(1) has a peptidoglycan d-isoglutamyl-l-lysine endopeptidase activity via a NlpC/P60 homology domain. These results collectively suggest that BacL(1) serves as a peptidoglycan hydrolase and, when BacA is present, results in the lysis of viable E. faecalis cells.	[Kurushima, Jun; Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Dept Bacteriol, Maebashi, Gunma 3718511, Japan; [Tomita, Haruyoshi] Gunma Univ, Grad Sch Med, Lab Bacterial Drug Resistance, Maebashi, Gunma 3718511, Japan; [Hayashi, Ikue] Hiroshima Univ, Fac Dent, Res Facil, Hiroshima 7348551, Japan; [Sugai, Motoyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Project Res Ctr Nosocomial Infect Dis, Minami Ku, Hiroshima 7348551, Japan; [Sugai, Motoyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Minami Ku, Hiroshima 7348551, Japan	Gunma University; Gunma University; Hiroshima University; Hiroshima University; Hiroshima University	Tomita, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Bacteriol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	tomitaha@med.gunma-u.ac.jp		Kurushima, Jun/0000-0002-8573-6169	Japanese Ministry of Education, Culture, Sport, Science, and Technology (Gunma University Operation Grants); Japanese Ministry of Health, Labor, and Welfare [H24-Shinkou-Ippan-010, H24-Shokuhin-Ippan-008]; Japanese Ministry of Education, Culture, Sport, Science, and Technology [25870116]; Grants-in-Aid for Scientific Research [25870116] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sport, Science, and Technology (Gunma University Operation Grants); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sport, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Ministry of Education, Culture, Sport, Science, and Technology (Grant-in-Aid for Young Scientists (B) 25870116, Gunma University Operation Grants) and the Japanese Ministry of Health, Labor, and Welfare (Grants H24-Shinkou-Ippan-010 and H24-Shokuhin-Ippan-008).	Arai R, 2012, J BIOL CHEM, V287, P44736, DOI 10.1074/jbc.M112.414763; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; CLEWELL DB, 1981, MICROBIOL REV, V45, P409, DOI 10.1128/MMBR.45.3.409-436.1981; DUNNY GM, 1979, PLASMID, V2, P454, DOI 10.1016/0147-619X(79)90029-5; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Franz CMAP, 2007, FEMS MICROBIOL REV, V31, P293, DOI 10.1111/j.1574-6976.2007.00064.x; FUJIMOTO S, 1995, J BACTERIOL, V177, P5574, DOI 10.1128/jb.177.19.5574-5581.1995; Fujimoto S, 2001, APPL ENVIRON MICROB, V67, P1262, DOI 10.1128/AEM.67.3.1262-1267.2001; IKE Y, 1992, J BACTERIOL, V174, P8172, DOI 10.1128/JB.174.24.8172-8177.1992; IKE Y, 1990, J BACTERIOL, V172, P155, DOI 10.1128/JB.172.1.155-163.1990; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; IKE Y, 1987, J CLIN MICROBIOL, V25, P1524, DOI 10.1128/JCM.25.8.1524-1528.1987; Inoue T, 2006, ANTIMICROB AGENTS CH, V50, P1202, DOI 10.1128/AAC.50.4.1202-1212.2006; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; JETT BD, 1992, INFECT IMMUN, V60, P2445, DOI 10.1128/IAI.60.6.2445-2452.1992; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Martinez-Fleites C, 2009, CARBOHYD RES, V344, P1753, DOI 10.1016/j.carres.2009.06.001; MARTINEZBUENO M, 1994, J BACTERIOL, V176, P6334, DOI 10.1128/jb.176.20.6334-6339.1994; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Pecenkova T, 1997, GENE, V199, P157; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; Sambrook J., 2001, MOL CLONING LAB MANU; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; SUGAI M, 1991, ZBL BAKT-INT J MED M, V275, P156; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Todokoro D, 2006, APPL ENVIRON MICROB, V72, P6955, DOI 10.1128/AEM.00934-06; Tomita H, 1997, J BACTERIOL, V179, P7843, DOI 10.1128/jb.179.24.7843-7855.1997; Tomita H, 1996, J BACTERIOL, V178, P3585, DOI 10.1128/jb.178.12.3585-3593.1996; Tomita H., 2010, 3 INT ASM C ENT, P37; Tomita H, 2008, J BACTERIOL, V190, P2075, DOI 10.1128/JB.01056-07; Uchiyama J, 2011, APPL ENVIRON MICROB, V77, P580, DOI 10.1128/AEM.01540-10; WIRTH R, 1986, J BACTERIOL, V165, P831, DOI 10.1128/jb.165.3.831-836.1986; Yamashita H, 2011, ANTIMICROB AGENTS CH, V55, P4352, DOI 10.1128/AAC.01274-10; Zheng B, 2009, ANTIMICROB AGENTS CH, V53, P735, DOI 10.1128/AAC.00754-08	39	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36915	36925		10.1074/jbc.M113.506618	http://dx.doi.org/10.1074/jbc.M113.506618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235140	hybrid, Green Published			2022-12-28	WOS:000329189700014
J	Kevany, BM; Tsybovsky, Y; Campuzano, IDG; Schnier, PD; Engel, A; Palczewski, K				Kevany, Brian M.; Tsybovsky, Yaroslav; Campuzano, Iain D. G.; Schnier, Paul D.; Engel, Andreas; Palczewski, Krzysztof			Structural and Functional Analysis of the Native Peripherin-ROM1 Complex Isolated from Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Retina; Retinal Degeneration; Retinal Metabolism; Vision; Vitamin A	OUTER SEGMENT MORPHOGENESIS; RETINAL DEGENERATION; ELECTRON-MICROSCOPY; 3-DIMENSIONAL ARCHITECTURE; TETRASPANIN FUNCTIONS; EXTRACELLULAR DOMAIN; RETINITIS-PIGMENTOSA; 2D CRYSTALLIZATION; MEMBRANE-PROTEINS; MASS-SPECTROMETRY	Background: The tetraspanins peripherin and ROM1 interact and localize to the rim structures of vertebrate photoreceptor disc membranes. Results: Native peripherin-ROM1 complex displays a tetrameric structure with a 2-fold symmetry and induces membrane curvature. Conclusion: Biochemical and structural analyses confirm the tetrameric state of the complex. Significance: Analyses provide evidence for the role of the peripherin-ROM1 complex in the rim structure. Peripherin and its homologue ROM1 are retina-specific members of the tetraspanin family of integral membrane proteins required for morphogenesis and maintenance of photoreceptor outer segments, regions that collect light stimuli. Over 100 pathogenic mutations in peripherin cause inherited rod- and cone-related dystrophies in humans. Peripherin and ROM1 interact in vivo and are predicted to form a core heterotetrameric complex capable of creating higher order oligomers. However, structural analysis of tetraspanin proteins has been hampered by their resistance to crystallization. Here we present a simplified methodology for high yield purification of peripherin-ROM1 from bovine retinas that permitted its biochemical and biophysical characterization. Using size exclusion chromatography and blue native gel electrophoresis, we confirmed that the core native peripherin-ROM1 complex exists as a tetramer. Peripherin, but not ROM1, is glycosylated and we examined the glycosylation site and glycan composition of ROM1 by liquid chromatographic tandem mass spectrometry. Mass spectrometry was used to analyze the native complex in detergent micelles, demonstrating its tetrameric state. Our electron microscopy-generated structure solved to 18 displayed the tetramer as an elongated structure with an apparent 2-fold symmetry. Finally, we demonstrated that peripherin-ROM1 tetramers induce membrane curvature when reconstituted in lipid vesicles. These results provide critical insights into this key retinal component with a poorly defined function.	[Kevany, Brian M.; Tsybovsky, Yaroslav; Engel, Andreas; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Campuzano, Iain D. G.; Schnier, Paul D.] Amgen Inc, Dept Mol Struct, Thousand Oaks, CA 91320 USA	Case Western Reserve University; Amgen	Palczewski, K (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY008061, EY019478]; Transcontinental EM Initiative for Membrane Protein Structure; National Institutes of Health Protein Structure Initiative [U54GM094598]; NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061, R01EY019478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transcontinental EM Initiative for Membrane Protein Structure; National Institutes of Health Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and EY019478. This work was also supported by the Transcontinental EM Initiative for Membrane Protein Structure, which is a center for membrane protein structure determination funded by the National Institutes of Health Protein Structure Initiative under Grant U54GM094598.	Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; BoeszeBattaglia K, 1997, BIOCHEMISTRY-US, V36, P6835, DOI 10.1021/bi9627370; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; DONOHO DL, 1992, J ROY STAT SOC B MET, V54, P41; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Farjo R, 2006, OPHTHALMIC GENET, V27, P117, DOI 10.1080/13816810600976806; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Iacovache I, 2010, J STRUCT BIOL, V169, P370, DOI 10.1016/j.jsb.2009.12.001; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193; Kedzierski W, 1999, J NEUROCHEM, V72, P430, DOI 10.1046/j.1471-4159.1999.0720430.x; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Muller-Weeks S, 2002, EXP EYE RES, V75, P143, DOI 10.1006/exer.2002.2013; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; VAHEDIFARIDI A, 2013, J ELECTRON MICROSC, V62, P95, DOI DOI 10.1093/JMICRO/DFS091; Wrigley JDJ, 2000, J BIOL CHEM, V275, P13191, DOI 10.1074/jbc.C900853199; WU XR, 1990, J BIOL CHEM, V265, P19170; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	47	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36272	36284		10.1074/jbc.M113.520700	http://dx.doi.org/10.1074/jbc.M113.520700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196967	hybrid, Green Published			2022-12-28	WOS:000328883400011
J	Shen, K; Wang, YQ; Fu, YHH; Zhang, Q; Feigon, J; Shan, SO				Shen, Kuang; Wang, Yaqiang; Fu, Yu-Hsien Hwang; Zhang, Qi; Feigon, Juli; Shan, Shu-ou			Molecular Mechanism of GTPase Activation at the Signal Recognition Particle (SRP) RNA Distal End	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Proteins; Nuclear Magnetic Resonance; Protein Targeting; Protein-Nucleic Acid Interaction; RNA; Single Molecule Biophysics	RESIDUAL DIPOLAR COUPLINGS; ENDOPLASMIC-RETICULUM; PROTEIN TRANSLOCATION; TRANSLATING RIBOSOME; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; 4.5S RNA; RECEPTOR; MEMBRANE; DYNAMICS	Background: A large GTPase movement on the signal recognition particle (SRP) RNA activates GTP hydrolysis to complete protein targeting. Results: GTPase activation requires distinct primary and secondary docking sites and catalytic bases, optimally positioned on the SRP RNA. Conclusion: The SRP RNA forms a preorganized surface to mediate specific GTPase activation. Significance: Study of the SRP RNA broadens our understanding of RNA-protein recognition and protein targeting. The signal recognition particle (SRP) RNA is a universally conserved and essential component of the SRP that mediates the co-translational targeting of proteins to the correct cellular membrane. During the targeting reaction, two functional ends in the SRP RNA mediate distinct functions. Whereas the RNA tetraloop facilitates initial assembly of two GTPases between the SRP and SRP receptor, this GTPase complex subsequently relocalizes approximate to 100 to the 5,3-distal end of the RNA, a conformation crucial for GTPase activation and cargo handover. Here we combined biochemical, single molecule, and NMR studies to investigate the molecular mechanism of this large scale conformational change. We show that two independent sites contribute to the interaction of the GTPase complex with the SRP RNA distal end. Loop E plays a crucial role in the precise positioning of the GTPase complex on these two sites by inducing a defined bend in the RNA helix and thus generating a preorganized recognition surface. GTPase docking can be uncoupled from its subsequent activation, which is mediated by conserved bases in the next internal loop. These results, combined with recent structural work, elucidate how the SRP RNA induces GTPase relocalization and activation at the end of the protein targeting reaction.	[Shen, Kuang; Fu, Yu-Hsien Hwang; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Wang, Yaqiang; Zhang, Qi; Feigon, Juli] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Wang, Yaqiang/C-4705-2008; Zhang, Qi/B-5869-2014; Shen, Kuang/H-9441-2016	Wang, Yaqiang/0000-0002-6822-4778; Zhang, Qi/0000-0003-1754-4058; Hwang-Fu, Yu-Hsien/0000-0002-2861-4843	National Institutes of Health [GM078024, GM048123, GM45162]; Caltech Matching Fund [350270]; David and Lucile Packard Fellowship in Science and Engineering; Henry Dreyfus teacher-scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045162, R37GM045162, R01GM078024, R01GM048123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech Matching Fund; David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Henry Dreyfus teacher-scholar award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078024 (to S.-o. S.) and GM048123 (to J. F.) and a National Institutes of Health instrument supplement to Grant GM45162 (to D. C. Rees). This work was also supported by Caltech Matching Fund 350270 for the single molecule instruments, the David and Lucile Packard Fellowship in Science and Engineering (to S.-o. S.), and a Henry Dreyfus teacher-scholar award (to S.-o. S.).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Akopian D, 2013, J CELL BIOL, V200, P397, DOI 10.1083/jcb.201208045; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Bailor MH, 2007, NAT PROTOC, V2, P1536, DOI 10.1038/nprot.2007.221; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batey RT, 2001, J MOL BIOL, V307, P229, DOI 10.1006/jmbi.2000.4454; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dieckmann T, 1997, J BIOMOL NMR, V9, P259, DOI 10.1023/A:1018622708674; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Flinders J, 2006, PROG NUCL MAG RES SP, V48, P137, DOI 10.1016/j.pnmrs.2006.03.001; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Guillerez J, 2005, P NATL ACAD SCI USA, V102, P5958, DOI 10.1073/pnas.0407141102; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hansen AL, 2006, J MAGN RESON, V179, P299, DOI 10.1016/j.jmr.2005.12.012; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lentzen G, 1996, RNA, V2, P244; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Meissner A, 1999, J MAGN RESON, V139, P439, DOI 10.1006/jmre.1999.1788; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; Peluso P, 2000, SCIENCE, V288, P1640, DOI 10.1126/science.288.5471.1640; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shen K, 2012, NATURE, V492, P271, DOI 10.1038/nature11726; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Stelzer AC, 2010, ANGEW CHEM INT EDIT, V49, P5731, DOI 10.1002/anie.201000814; Voigts-Hoffmann F, 2013, MOL CELL; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WILSON C, 1988, J CELL BIOL, V107, P69, DOI 10.1083/jcb.107.1.69; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	48	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36385	36397		10.1074/jbc.M113.513614	http://dx.doi.org/10.1074/jbc.M113.513614			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24151069	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000328883400020
J	Zhou, TBT; King, GD; Chen, CD; Abraham, CR				Zhou, Tracey B. Tucker; King, Gwendalyn D.; Chen, CiDi; Abraham, Carmela R.			Biochemical and Functional Characterization of the Klotho-VS Polymorphism Implicated in Aging and Disease Risk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Cell Signaling; Fibroblast Growth Factor Receptor (FGFR); Genetic Polymorphism; Protein Complexes; Shedding; Dimerizaion	CORONARY-ARTERY-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; AGED POSTMENOPAUSAL WOMEN; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; GENE POLYMORPHISMS; ENDOPLASMIC-RETICULUM; GLUCOSE-METABOLISM; HORMONE KLOTHO; BLOOD-PRESSURE	Background: The mechanism by which polymorphisms in the anti-aging protein klotho lead to increased disease risk is unknown. Results:In vitro, klotho-VS decreases homodimerization and increases heterodimerization with and activation of FGFR1c. Conclusion: Altered dimerization explains klotho-VS association with increased disease risk. Significance: Understanding how the VS variant leads to changes in klotho function will elucidate the role klotho plays in disease and lifespan. Klotho (KL) is an age-regulating protein named after the Greek goddess who spins the thread of life. Mice deficient in KL are normal throughout development, but rapidly degenerate and display a variety of aging-associated abnormalities that eventually lead to decreased life expectancy. While multiple genetic association studies have identified KL polymorphisms linked with changes in disease risk, there is a paucity of concrete mechanistic data to explain how these amino acid substitutions alter KL protein function. The KLVS polymorphism is suggested to lead to changes in protein trafficking although the mechanism is unclear. Our studies have sought to further investigate the functional differences in the KLVS variant that result in increased risk of many age-related diseases. Our findings suggest that the F352V and C370S substitutions lead to alterations in processing as seen by differences in shedding and half-life. Their co-expression in KLVS results in a phenotype resembling wild-type, but despite this intragenic complementation there are still changes in homodimerization and interactions with FGFR1c. Taken together, these studies suggest that KLVS leads to altered homodimerization that indirectly leads to changes in processing and FGFR1c interactions. These findings help elucidate the functional differences that result from the VS polymorphism, which will help clarify how alterations in KL function can lead to human disease and affect cognition and lifespan.	[Zhou, Tracey B. Tucker; King, Gwendalyn D.; Chen, CiDi; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Zhou, Tracey B. Tucker; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Abraham, CR (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio O Conte Bldg K304, Boston, MA 02118 USA.	cabraham@bu.edu			National Institutes of Health-NIA [AG 00001, 5T32GM008541-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000001] Funding Source: NIH RePORTER	National Institutes of Health-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health-NIA Grants AG 00001 (to C. R. A.) and 5T32GM008541-15 (to T. B. T. Z.).	Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Brownstein CA, 2008, P NATL ACAD SCI USA, V105, P3455, DOI 10.1073/pnas.0712361105; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P1999, DOI 10.1681/ASN.2007020143; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; FIMBEL S, 1995, STEROIDS, V60, P686, DOI 10.1016/0039-128X(95)00092-5; Freathy RM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-51; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Ichikawa S., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P318; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Invidia L, 2010, BIOGERONTOLOGY, V11, P67, DOI 10.1007/s10522-009-9229-z; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; King GD, 2012, AGE, V34, P1405, DOI 10.1007/s11357-011-9315-4; Ko GJ, 2012, KIDNEY BLOOD PRESS R, V36, P191, DOI 10.1159/000343408; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Laitman Y, 2012, BREAST CANCER RES TR, V132, P1119, DOI 10.1007/s10549-011-1938-8; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Low AF, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-38; Lu L, 2008, CANCER INVEST, V26, P185, DOI 10.1080/07357900701638343; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Majumdar V, 2011, CLIN CHIM ACTA, V412, P1116, DOI 10.1016/j.cca.2011.02.034; Majumdar V, 2010, BIOCHEM BIOPH RES CO, V403, P412, DOI 10.1016/j.bbrc.2010.11.045; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Mullin BH, 2005, CALCIFIED TISSUE INT, V77, P145, DOI 10.1007/s00223-004-0291-x; Nolan VG, 2005, BRIT J HAEMATOL, V128, P266, DOI 10.1111/j.1365-2141.2004.05295.x; Ogata N, 2002, BONE, V31, P37, DOI 10.1016/S8756-3282(02)00786-X; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Rhee EJ, 2006, J ENDOCRINOL INVEST, V29, P613, DOI 10.1007/BF03344160; Rhee EJ, 2006, METABOLISM, V55, P1344, DOI 10.1016/j.metabol.2006.05.020; Riancho JA, 2007, BIOGERONTOLOGY, V8, P121, DOI 10.1007/s10522-006-9039-5; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Shimoyama Y, 2009, AM J NEPHROL, V30, P383, DOI 10.1159/000235686; Shimoyama Y, 2009, CLIN CHIM ACTA, V406, P134, DOI 10.1016/j.cca.2009.06.011; Sopjani M, 2011, FEBS LETT, V585, P1759, DOI 10.1016/j.febslet.2011.05.021; Tangri N, 2011, NEPHROL DIAL TRANSPL, V26, P3998, DOI 10.1093/ndt/gfr188; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wolf I, 2010, ONCOGENE, V29, P26, DOI 10.1038/onc.2009.301; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zarrabeitia MT, 2007, CALCIFIED TISSUE INT, V80, P10, DOI 10.1007/s00223-006-0233-x	62	26	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36302	36311		10.1074/jbc.M113.490052	http://dx.doi.org/10.1074/jbc.M113.490052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24217253	Green Published, hybrid			2022-12-28	WOS:000328883400013
J	Anders, K; Daminelli-Widany, G; Mroginski, MA; von Stetten, D; Essen, LO				Anders, Katrin; Daminelli-Widany, Grazia; Mroginski, Maria Andrea; von Stetten, David; Essen, Lars-Oliver			Structure of the Cyanobacterial Phytochrome 2 Photosensor Implies a Tryptophan Switch for Phytochrome Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Protein Conformation; Signal Transduction; Signaling; Structural Biology; Biliprotein; c-di-GMP Signaling; Photochromicity; Phytochrome; Red Light Photoreceptor	PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; CHROMOPHORE; PHOTOCONVERSION; STATE; PHOTOTAXIS; HOLOPHYTOCHROME; TRANSITION; LINKAGE; DOMAIN	Background: Phytochromes are red/far-red photoreceptors using a bilin chromophore. Results: Compared with Cph1, the Cph2 bilin-binding site differs around the propionates, but utilizes an otherwise conserved tongue for sealing the chromophore from solvent. Conclusion: The tongue signals via a tryptophan switch within the tongue-GAF domain interface. Significance: The first structure of a Cph2-type phytochrome indicates a common mechanism for photoswitching in all canonical phytochromes. Phytochromes are highly versatile photoreceptors, which occur ubiquitously in plants as well as in many light-responsive microorganisms. Here, photosynthetic cyanobacteria utilize up to three different phytochrome architectures, where only the plant-like and the single-domain cyanobacteriochromes are structurally characterized so far. Cph2 represents a third group in Synechocystis species and affects their capability of phototaxis by controlling c-di-GMP synthesis and degradation. The 2.6- crystal structure of its red/far-red responsive photosensory module in the P-r state reveals a tandem-GAF bidomain that lacks the figure-of-eight knot of the plant/cph1 subfamily. Its covalently attached phycocyanobilin chromophore adopts a highly tilted ZZZssa conformation with a novel set of interactions between its propionates and the GAF1 domain. The tongue-like protrusion from the GAF2 domain interacts with the GAF1-bound chromophore via its conserved PRXSF, WXE, and W(G/A)G motifs. Mutagenesis showed that the integrity of the tongue is indispensable for P-r P-fr photoconversion and involves a swap of the motifs' tryptophans within the tongue-GAF1 interface. This Trp switch is supposed to be a crucial element for the photochromicity of all multidomain phytochromes.	[Anders, Katrin; Essen, Lars-Oliver] Univ Marburg, Biomed Res Ctr, Dept Chem, D-35032 Marburg, Germany; [Daminelli-Widany, Grazia; Mroginski, Maria Andrea] Tech Univ Berlin, Dept Chem, D-10623 Berlin, Germany; [von Stetten, David] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Philipps University Marburg; Technical University of Berlin; European Synchrotron Radiation Facility (ESRF)	Essen, LO (corresponding author), Univ Marburg, Biomed Res Ctr FB15, Hans Meerwein Str, D-35032 Marburg, Germany.	essen@chemie.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026; von Stetten, David/0000-0001-7906-9788	Deutsche Forschungsgemeinschaft Grants [ES152/9-1, MR81/3-1]; LOEWE Center for Synthetic Microbiology	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); LOEWE Center for Synthetic Microbiology	This work was supported by Deutsche Forschungsgemeinschaft Grants ES152/9-1 and MR81/3-1 and the LOEWE Center for Synthetic Microbiology (to L.-O. E.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anders K, 2011, PHOTOCHEM PHOTOBIOL, V87, P160, DOI 10.1111/j.1751-1097.2010.00845.x; Bakowies D, 1996, J PHYS CHEM-US, V100, P10580, DOI 10.1021/jp9536514; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Billeter SR, 2000, PHYS CHEM CHEM PHYS, V2, P2177, DOI 10.1039/a909486e; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; BUTLER WL, 1959, P NATL ACAD SCI USA, V45, P1703, DOI 10.1073/pnas.45.12.1703; Carpentier P, 2007, J APPL CRYSTALLOGR, V40, P1113, DOI 10.1107/S0021889807044202; DeLano W.L, PYMOL MOL GRAPHICS S; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Fiedler B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1481, DOI 10.1562/2005-06-28-RA-592; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jain R, 2012, J BACTERIOL, V194, P4285, DOI 10.1128/JB.00803-12; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; Landgraf FT, 2001, FEBS LETT, V508, P459, DOI 10.1016/S0014-5793(01)02988-X; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mailliet J, 2011, J MOL BIOL, V413, P115, DOI 10.1016/j.jmb.2011.08.023; Mailliet J, 2009, ACTA CRYSTALLOGR D, V65, P1232, DOI 10.1107/S0907444909034106; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Park CM, 2000, BIOCHEMISTRY-US, V39, P6349, DOI 10.1021/bi992916s; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; Shang LX, 2010, BIOCHEMISTRY-US, V49, P6070, DOI 10.1021/bi100756x; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Vierstra RD, 2011, TRENDS PLANT SCI, V16, P417, DOI 10.1016/j.tplants.2011.05.011; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wilde A, 2002, MOL MICROBIOL, V44, P981, DOI 10.1046/j.1365-2958.2002.02923.x; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105	44	66	67	4	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35714	35725		10.1074/jbc.M113.510461	http://dx.doi.org/10.1074/jbc.M113.510461			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174528	Green Published, hybrid			2022-12-28	WOS:000329814700010
J	Chakravartty, V; Cronan, JE				Chakravartty, Vandana; Cronan, John E.			The Wing of a Winged Helix-Turn-Helix Transcription Factor Organizes the Active Site of BirA, a Bifunctional Repressor/Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; Bacterial Genetics; Bacterial Metabolism; Enzyme Catalysis; Enzyme Mutation; Microbiology; Promoters; Transcription Factors; Transcription Regulation; Transcription Target Genes	BIOTIN HOLOENZYME SYNTHETASE; ESCHERICHIA-COLI REPRESSOR; DNA-BINDING; PROTEIN; BIOSYNTHESIS; OPERON; GENE; LIGASE; MUTANT; DOMAIN	Background:E. coli BirA is a both transcriptional repressor of the biotin operon and the biotin protein ligase. Results: Structural and sequence integrity of the wing domain is important in both biotinylation and regulatory activities of BirA. Conclusion: DNA-binding domain wing coordinates the two functions of BirA. Significance: This is the first example of a wing domain that has a role in an enzymatic activity. The BirA biotin protein ligase of Escherichia coli belongs to the winged helix-turn-helix (wHTH) family of transcriptional regulators. The N-terminal BirA domain is required for both transcriptional regulation of biotin synthesis and biotin protein ligase activity. We addressed the structural and functional role of the wing of the wHTH motif in both BirA functions. A panel of N-terminal deletion mutant proteins including a discrete deletion of the wing motif were unable to bind DNA. However, all the N-terminal deletion mutants weakly complemented growth of a birA strain at low biotin concentrations, indicating compromised ligase activity. A wing domain chimera was constructed by replacing the BirA wing with the nearly isosteric wing of the E. coli OmpR transcription factor. Although this chimera BirA was defective in operator binding, it was much more efficient in complementation of a birA strain than was the wing-less protein. The enzymatic activities of the wing deletion and chimera proteins in the in vitro synthesis of biotinoyl-5-AMP differed greatly. The wing deletion BirA accumulated an off pathway compound, ADP, whereas the chimera protein did not. Finally, we report that a single residue alteration in the wing bypasses the deleterious effects caused by mutations in the biotin-binding loop of the ligase active site. We believe that the role of the wing in the BirA enzymatic reaction is to orient the active site and thereby protect biotinoyl-5-AMP from attack by solvent. This is the first evidence that the wing domain of a wHTH protein can play an important role in enzymatic activity.	[Chakravartty, Vandana; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI15650.	BARKER DF, 1980, J BACTERIOL, V143, P789, DOI 10.1128/JB.143.2.789-800.1980; BARKER DF, 1981, J MOL BIOL, V146, P469, DOI 10.1016/0022-2836(81)90043-7; Beckett D, 2007, ANNU REV GENET, V41, P443, DOI 10.1146/annurev.genet.41.042007.170450; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BUONCRISTIANI MR, 1986, GENE, V44, P255, DOI 10.1016/0378-1119(86)90189-7; CAMPBELL A, 1972, P NATL ACAD SCI USA, V69, P676, DOI 10.1073/pnas.69.3.676; Chakravartty V, 2012, J BACTERIOL, V194, P1113, DOI 10.1128/JB.06549-11; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; CRONAN JE, 1995, FEMS MICROBIOL LETT, V130, P221, DOI 10.1016/0378-1097(95)00210-V; CRONAN JE, 1988, J BIOL CHEM, V263, P10332; KATO N, 1995, MOL GEN GENET, V248, P399, DOI 10.1007/BF02191639; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Maeda Y, 2010, APPL ENVIRON MICROB, V76, P5785, DOI 10.1128/AEM.00916-10; Miller J. H, 1972, EXPT MOL GENETICS; Mukhopadhyay B, 2001, J BACTERIOL, V183, P3804, DOI 10.1128/JB.183.12.3804-3810.2001; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRAKASH O, 1979, P NATL ACAD SCI USA, V76, P5592, DOI 10.1073/pnas.76.11.5592; Solbiati J, 2010, CHEM BIOL, V17, P11, DOI 10.1016/j.chembiol.2009.12.007; Streaker ED, 1998, J MOL BIOL, V278, P787, DOI 10.1006/jmbi.1998.1733; Streaker ED, 1999, J MOL BIOL, V292, P619, DOI 10.1006/jmbi.1999.3086; Streaker ED, 2002, BIOCHEMISTRY-US, V41, P14263, DOI 10.1021/bi0203839; Teichmann M, 2012, TRANSCR-AUSTIN, V3, P2, DOI 10.4161/trns.3.1.18917; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200	30	17	18	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36029	36039		10.1074/jbc.M113.525618	http://dx.doi.org/10.1074/jbc.M113.525618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189073	hybrid, Green Published			2022-12-28	WOS:000329814700038
J	Li, M; Khambu, B; Zhang, H; Kang, JH; Chen, XY; Chen, DH; Vollmer, L; Liu, PQ; Vogt, A; Yin, XM				Li, Min; Khambu, Bilon; Zhang, Hao; Kang, Jeong-Han; Chen, Xiaoyun; Chen, Daohong; Vollmer, Laura; Liu, Pei-Qing; Vogt, Andreas; Yin, Xiao-Ming			Suppression of Lysosome Function Induces Autophagy via a Feedback Down-regulation of MTOR Complex 1 (MTORC1) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Cell Biology; Lysosomes; mTOR; Signal Transduction	RAG GTPASES; ATG12-ATG5 CONJUGATE; CHEMICAL MODULATORS; NICLOSAMIDE; MECHANISM; PROTEIN; TFEB; ACTIVATION; RAGULATOR; MEMBRANE	Background: Lysosomes are required for autophagic degradation, which can be suppressed by lysosome inhibitors. Results: Inhibition of lysosome function resulted in autophagy activation via down-regulation of MTORC1. Conclusion: Lysosomes can affect autophagy initiation in addition to its role in autophagy degradation. Significance: The finding expands lysosome function to include regulation of autophagy activation and indicates a dual effect of lysosome inhibitors in autophagy. Autophagy can be activated via MTORC1 down-regulation by amino acid deprivation and by certain chemicals such as rapamycin, torin, and niclosamide. Lysosome is the degrading machine for autophagy but has also been linked to MTORC1 activation through the Rag/RRAG GTPase pathway. This association raises the question of whether lysosome can be involved in the initiation of autophagy. Toward this end, we found that niclosamide, an MTORC1 inhibitor, was able to inhibit lysosome degradation and increase lysosomal permeability. Niclosamide was ineffective in inhibiting MTORC1 in cells expressing constitutively activated Rag proteins, suggesting that its inhibitory effects were targeted to the Rag-MTORC1 signaling system. This places niclosamide in the same category of bafilomycin A(1) and concanamycin A, inhibitors of the vacuolar H+-ATPase, for its dependence on Rag GTPase in suppression of MTORC1. Surprisingly, classical lysosome inhibitors such as chloroquine, E64D, and pepstatin A were also able to inhibit MTORC1 in a Rag-dependent manner. These lysosome inhibitors were able to activate early autophagy events represented by ATG16L1 and ATG12 puncta formation. Our work established a link between the functional status of the lysosome in general to the Rag-MTORC1 signaling axis and autophagy activation. Thus, the lysosome is not only required for autophagic degradation but also affects autophagy activation. Lysosome inhibitors can have a dual effect in suppressing autophagy degradation and in initiating autophagy.	[Li, Min; Khambu, Bilon; Zhang, Hao; Chen, Xiaoyun; Chen, Daohong; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Li, Min; Liu, Pei-Qing] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Kang, Jeong-Han] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Vollmer, Laura; Vogt, Andreas] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Sun Yat Sen University; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yin, XM (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, W 350 11th St, Indianapolis, IN 46202 USA.	xmyin@iupui.edu	Khambu, Bilon/P-6148-2019; Kang, Jeong-Han/J-3541-2019; Li, Min/B-1281-2011	Kang, Jeong-Han/0000-0002-9693-0696; Khambu, Bilon/0000-0002-9432-2064; li, min/0000-0002-5657-8675	NCI; NIMH, National Institutes of Health [R03MH083154, R01CA111456, R01CA 83817]; NCI, National Institutes of Health Grant [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA083817, P30CA047904, R01CA111456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH083154] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI, National Institutes of Health Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NCI and NIMH, National Institutes of Health Grants R03MH083154, R01CA111456, and R01CA 83817 (to X.-M. Y.). This work used the UPCI Chemical Biology facility that is supported in part by NCI, National Institutes of Health Grant P30CA047904.	Baek KH, 2012, CHEM SOC REV, V41, P3245, DOI 10.1039/c2cs15328a; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2012, ANTIOXID REDOX SIGN, V17, P766, DOI 10.1089/ars.2011.4405; Cho YS, 2010, ARCH PHARM RES, V33, P1881, DOI 10.1007/s12272-010-1201-6; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; DITZEL J, 1967, ACTA MED SCAND, V182, P663; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Juhasz G, 2012, AUTOPHAGY, V8, P1875, DOI 10.4161/auto.21544; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Pan JX, 2012, CHIN J CANCER, V31, P178, DOI 10.5732/cjc.011.10290; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yin X.-M., 2010, PUBCHEM BIOASSAY; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhang Y., 2012, PLOS ONE, V7; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	45	125	127	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35769	35780		10.1074/jbc.M113.511212	http://dx.doi.org/10.1074/jbc.M113.511212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174532	Green Published, hybrid			2022-12-28	WOS:000329814700015
J	Ramaswamy, SS; MacLean, DM; Gorfe, AA; Jayaraman, V				Ramaswamy, Swarna S.; MacLean, David M.; Gorfe, Alemayehu A.; Jayaraman, Vasanthi			Proton-mediated Conformational Changes in an Acid-sensing Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channels (ASICs); Fluorescence Resonance Energy Transfer (FRET); Ligand-binding Protein; Receptor Desensitization; Receptor Structure-Function; Ligand-gated Ion Channels; Receptor Activation	BINDING DOMAIN; ASIC1; DESENSITIZATION; SELECTIVITY; ACTIVATION; DECREASES; LINKER	Background: Protons activate acid-sensing ion channels (ASICs). Results: Proton binding leads to a movement involving the thumb and finger subdomains. Mutation of carboxylates lining the finger leads to loss of activation and loss of this movement. Conclusion: The carboxylates lining the finger domain are essential for the movement of the thumb and finger domains and in activation. Significance: This study provides insight into proton-induced conformational changes in ASICs. Acid-sensing ion channels are cation channels activated by external protons and play roles in nociception, synaptic transmission, and the physiopathology of ischemic stroke. Using luminescence resonance energy transfer (LRET), we show that upon proton binding, there is a conformational change that increases LRET efficiency between the probes at the thumb and finger subdomains in the extracellular domain of acid-sensing ion channels. Additionally, we show that this conformational change is lost upon mutating Asp-238, Glu-239, and Asp-260, which line the finger domains, to alanines. Electrophysiological studies showed that the single mutant D260A shifted the EC50 by 0.2 pH units, the double mutant D238A/E239A shifted the EC50 by 2.5 pH units, and the triple mutant D238A/E239A/D260A exhibited no response to protons despite surface expression. The LRET experiments on D238A/E239A/D260A showed no changes in LRET efficiency upon reduction in pH from 8 to 6. The LRET and electrophysiological studies thus suggest that the three carboxylates, two of which are involved in carboxyl/carboxylate interactions, are essential for proton-induced conformational changes in the extracellular domain, which in turn are necessary for receptor activation.	[Ramaswamy, Swarna S.; MacLean, David M.; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Gorfe, Alemayehu A.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu		MacLean, David/0000-0001-8294-6075	National Science Foundation [MCB-1110501]; Harry S. and Isabel C. Cameron Foundation fellowship; American Heart Association postdoctoral fellowship	National Science Foundation(National Science Foundation (NSF)); Harry S. and Isabel C. Cameron Foundation fellowship; American Heart Association postdoctoral fellowship(American Heart Association)	This work was supported in part by National Science Foundation Grant MCB-1110501 (to V. J), a Harry S. and Isabel C. Cameron Foundation fellowship (to S. S. R.), and an American Heart Association postdoctoral fellowship (to D. M. M.)	Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Li T, 2011, THEOR APPL MECH LETT, V1, DOI 10.1063/2.1104102; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Selvin S, 1996, PAEDIATR PERINAT EP, V10, P220, DOI 10.1111/j.1365-3016.1996.tb00045.x; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	24	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35896	35903		10.1074/jbc.M113.478982	http://dx.doi.org/10.1074/jbc.M113.478982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24196950	hybrid, Green Published			2022-12-28	WOS:000329814700026
J	Al-Khalaf, HH; Mohideen, P; Nallar, SC; Kalvakolanu, DV; Aboussekhra, A				Al-Khalaf, Huda H.; Mohideen, Peer; Nallar, Shreeram C.; Kalvakolanu, Dhananjaya V.; Aboussekhra, Abdelilah			The Cyclin-dependent Kinase Inhibitor p16(INK4a) Physically Interacts with Transcription Factor Sp1 and Cyclin-dependent Kinase 4 to Transactivate MicroRNA-141 and MicroRNA-146b-5p Spontaneously and in Response to Ultraviolet Light-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Complexes; Protein-DNA Interaction; shRNA; Signaling; Tumor suppressor gene	PROMOTES CELL-SURVIVAL; TUMOR-SUPPRESSOR; MIR-200 FAMILY; CANCER; GENE; EXPRESSION; SENESCENCE; IDENTIFICATION; INDUCTION; REGULATOR	Background: The cyclin-dependent kinase inhibitor p16(INK4a) is also a modulator of gene expression through an unknown mechanism. Results: p16(INK4a)-CDK4 forms a heterocomplex with Sp1, which induces the expression and UV-dependent up-regulation of miR-141 and miR-146b-5p. Conclusion: p16(INK4a)-CDK4 complex has transcriptional activity through interaction with the transcription factor Sp1. Significance: The microRNAs are novel effectors of the p16(INK4a)-CDK4 complex. p16(INK4a) is a tumor suppressor protein involved in several stress-related cellular responses, including apoptosis. Recent lines of evidence indicate that p16(INK4a) is also a modulator of gene expression. However, the molecular mechanisms underlying this novel function are still obscure. Here, we present clear evidence that p16(INK4a) modulates the levels of various microRNAs, with marked positive effect on miR-141 and miR-146b-5p. This effect is mediated through the formation of the p16-CDK4-Sp1 heterocomplex, which binds to Sp1 consensus-binding motifs present in the promoters of miR-141 and miR-146b-5p, and it enables their transcription. In addition, we have shown that p16(INK4a) interacts with Sp1 through the fourth ankyrin repeat, which is crucial for Sp1 binding to the miR-141 and miR-146b-5p promoters and their transcriptional activation. The physiological importance of this association was revealed by the inability of cancer-related p16(INK4a) mutants to interact with Sp1. Moreover, we have shown p16-CDK4-Sp1-dependent up-regulation of miR-141 and miR-146b-5p following UV light-induced DNA damage and the role of these two microRNAs in mediating p16-related induction of apoptosis in response to this genotoxic stress. Together, these results indicate that p16(INK4a) associates with CDK4 not only to inhibit the cell cycle but also to enable the transcription of two important onco-microRNAs, which act as downstream effectors.	[Al-Khalaf, Huda H.; Mohideen, Peer; Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh 11211, Saudi Arabia; [Al-Khalaf, Huda H.] King Abdulaziz City Sci & Technol, Joint Ctr Genom Res, Riyadh 11211, Saudi Arabia; [Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	King Faisal Specialist Hospital & Research Center; University System of Maryland; University of Maryland Baltimore	Aboussekhra, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, MBC 03,POB 3354, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Alkhalaf, Huda/Z-5701-2019	Abubucker, Peer Mohideen/0000-0002-1895-3585	National Institutes of Health [CA105005]; Research Advisory Council [2090027]; NATIONAL CANCER INSTITUTE [R01CA105005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Advisory Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA105005 (to D. V. K). This work was also supported by Research Advisory Council Proposal 2090027.	Al-Khalaf HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070133; Al-Khalaf HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021111; Al-Khalaf HH, 2011, MOL CANCER RES, V9, P311, DOI 10.1158/1541-7786.MCR-10-0506; Al-Mohanna MA, 2004, ONCOGENE, V23, P201, DOI 10.1038/sj.onc.1206927; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Arslan AA, 2012, BREAST CANCER RES TR, V134, P981, DOI 10.1007/s10549-012-2017-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bond JA, 1999, MOL CELL BIOL, V19, P3103; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chien WW, 2011, ONCOGENE, V30, P1880, DOI 10.1038/onc.2010.570; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Katakowski M, 2010, CANCER INVEST, V28, P1024, DOI 10.3109/07357907.2010.512596; KOH J, 1995, NATURE, V375, P506, DOI 10.1038/375506a0; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P94, DOI 10.1016/j.mrgentox.2010.05.006; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lovat F, 2011, SEMIN ONCOL, V38, P724, DOI 10.1053/j.seminoncol.2011.08.006; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Mansilla S, 2008, BIOCHIMIE, V90, P976, DOI 10.1016/j.biochi.2007.12.008; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Oleaga C, 2012, BIOCHEM PHARMACOL, V84, P1581, DOI 10.1016/j.bcp.2012.09.014; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sabir M, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-11; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shapiro GI, 1998, MOL CELL BIOL, V18, P378, DOI 10.1128/MCB.18.1.378; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Sun P, 2010, J BIOL CHEM, V285, P27545, DOI 10.1074/jbc.M110.105767; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan GY, 2012, J BIOL CHEM, V287, P33036, DOI 10.1074/jbc.M112.383273; Tan GY, 2012, BIOCHEM BIOPH RES CO, V417, P546, DOI 10.1016/j.bbrc.2011.11.160; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Wouters MD, 2011, MUTAT RES-FUND MOL M, V717, P54, DOI 10.1016/j.mrfmmm.2011.03.012; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108; Zhou XF, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100143	51	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35511	35525		10.1074/jbc.M113.512640	http://dx.doi.org/10.1074/jbc.M113.512640			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24163379	Green Published, hybrid			2022-12-28	WOS:000329867600046
J	Brahme, NN; Harburger, DS; Kemp-O'Brien, K; Stewart, R; Raghavan, S; Parsons, M; Calderwood, DA				Brahme, Nina N.; Harburger, David S.; Kemp-O'Brien, Karl; Stewart, Rachel; Raghavan, Srikala; Parsons, Maddy; Calderwood, David A.			Kindlin Binds Migfilin Tandem LIM Domains and Regulates Migfilin Focal Adhesion Localization and Recruitment Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesion; Cell Adhesion; Cytoskeleton; Fluorescence Resonance Energy Transfer (FRET); Integrin; LIM Domain; Focal Adhesion; Kindlin; Migfilin	INTEGRIN-BETA TAILS; FILAMIN-BINDING; CELL; ACTIVATION; MIGRATION; PROTEIN; COACTIVATOR; COMPETITION; MIG-2; TALIN	Focal adhesions (FAs), sites of tight adhesion to the extracellular matrix, are composed of clusters of transmembrane integrin adhesion receptors and intracellular proteins that link integrins to the actin cytoskeleton and signaling pathways. Two integrin-binding proteins present in FAs, kindlin-1 and kindlin-2, are important for integrin activation, FA formation, and signaling. Migfilin, originally identified in a yeast two-hybrid screen for kindlin-2-interacting proteins, is a LIM domain-containing adaptor protein found in FAs and implicated in control of cell adhesion, spreading, and migration. By binding filamin, migfilin provides a link between kindlin and the actin cytoskeleton. Here, using a combination of kindlin knockdown, biochemical pulldown assays, fluorescence microscopy, fluorescence resonance energy transfer (FRET), and fluorescence recovery after photobleaching (FRAP), we have established that the C-terminal LIM domains of migfilin dictate its FA localization, shown that these domains mediate an interaction with kindlin in vitro and in cells, and demonstrated that kindlin is important for normal migfilin dynamics in cells. We also show that when the C-terminal LIM domain region is deleted, then the N-terminal filamin-binding region of the protein, which is capable of targeting migfilin to actin-rich stress fibers, is the predominant driver of migfilin localization. Our work details a correlation between migfilin domains that drive kindlin binding and those that drive FA localization as well as a kindlin dependence on migfilin FA recruitment and mobility. We therefore suggest that the kindlin interaction with migfilin LIM domains drives migfilin FA recruitment, localization, and mobility.	[Brahme, Nina N.; Stewart, Rachel; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Harburger, David S.; Raghavan, Srikala; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kemp-O'Brien, Karl; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Raghavan, Srikala] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India	Yale University; Yale University; University of London; King's College London; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Calderwood, DA (corresponding author), 333 Cedar St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Parsons, Maddy/B-2203-2013; Calderwood, David A/AAC-6954-2019	Parsons, Maddy/0000-0002-2021-8379; Calderwood, David A/0000-0002-0791-4142; Stewart, Rachel/0000-0001-5864-3277	National Institutes of Health [RO1 GM-068600, RO1 GM088240, T32 GM-007223]; American Cancer Society [RSG-12-053-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600, R01GM088240, T32GM007223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM-068600, RO1 GM088240, and T32 GM-007223 and American Cancer Society Grant RSG-12-053-01.	Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; Gkretsi V, 2005, J CELL SCI, V118, P697, DOI 10.1242/jcs.01638; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morton PE, 2011, METHODS MOL BIOL, V769, P403, DOI 10.1007/978-1-61779-207-6_27; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Ou YW, 2012, J BIOL CHEM, V287, P32394, DOI 10.1074/jbc.M112.393900; Papachristou DJ, 2007, HISTOPATHOLOGY, V51, P499, DOI 10.1111/j.1365-2559.2007.02791.x; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Petricca G, 2009, EUR J ORAL SCI, V117, P518, DOI 10.1111/j.1600-0722.2009.00651.x; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	39	17	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35604	35616		10.1074/jbc.M113.483016	http://dx.doi.org/10.1074/jbc.M113.483016			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165133	hybrid, Green Published			2022-12-28	WOS:000329867600054
J	Dmitriev, P; Stankevicins, L; Ansseau, E; Petrov, A; Barat, A; Dessen, P; Robert, T; Turki, A; Lazar, V; Labourer, E; Belayew, A; Carnac, G; Laoudj-Chenivesse, D; Lipinski, M; Vassetzky, YS				Dmitriev, Petr; Stankevicins, Luiza; Ansseau, Eugenie; Petrov, Andrei; Barat, Ana; Dessen, Philippe; Robert, Thomas; Turki, Ahmed; Lazar, Vladimir; Labourer, Emmanuel; Belayew, Alexandra; Carnac, Gilles; Laoudj-Chenivesse, Dalila; Lipinski, Marc; Vassetzky, Yegor S.			Defective Regulation of MicroRNA Target Genes in Myoblasts from Facioscapulohumeral Dystrophy Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetic Diseases; MicroRNA; Muscular Dystrophy; Transcription; Transcription Regulation; Facioscapulohumeral Dystrophy	LONG NONCODING RNA; MUSCULAR-DYSTROPHY; DNA REARRANGEMENTS; MYOGENIC FACTORS; FSHD MYOBLASTS; CANDIDATE GENE; 4Q35 REGION; EXPRESSION; MUSCLE; DIFFERENTIATION	Background: FSHD is characterized by the overexpression of double homeobox genes DUX4 and DUX4c. Results: We found 29 miRNAs differentially expressed between FSHD and normal myoblasts. Twelve of these miRNAs were up-regulated in myoblasts ectopically expressing DUX4c. Conclusion:DUX4c is linked to the abnormal miRNA expression profile observed in FSHD. Significance: We observe a defective gene regulation by miRNAs in FSHD. Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant hereditary neuromuscular disorder linked to the deletion of an integral number of 3.3-kb-long macrosatellite repeats (D4Z4) within the subtelomeric region of chromosome 4q. Most genes identified in this region are overexpressed in FSHD myoblasts, including the double homeobox genes DUX4 and DUX4c. We have carried out a simultaneous miRNome/transcriptome analysis of FSHD and control primary myoblasts. Of 365 microRNAs (miRNAs) analyzed in this study, 29 were found to be differentially expressed between FSHD and normal myoblasts. Twenty-one microRNAs (miR-1, miR-7, miR-15a, miR-22, miR-30e, miR-32, miR-107, miR-133a, miR-133b, miR-139, miR-152, miR-206, miR-223, miR-302b, miR-331, miR-362, miR-365, miR-382, miR-496, miR-532, miR-654, and miR-660) were up-regulated, and eight were down-regulated (miR-15b, miR-20b, miR-21, miR-25, miR-100, miR-155, miR-345, and miR-594). Twelve of the miRNAs up-regulated in FHSD were also up-regulated in the cells ectopically expressing DUX4c, suggesting that this gene could regulate miRNA gene transcription. The myogenic miRNAs miR-1, miR-133a, miR-133b, and miR-206 were highly expressed in FSHD myoblasts, which nonetheless did not prematurely enter myogenic differentiation. This could be accounted for by the fact that in FSHD myoblasts, functionally important target genes, including cell cycle, DNA damage, and ubiquitination-related genes, escape myogenic microRNA-induced repression.	[Dmitriev, Petr; Stankevicins, Luiza; Barat, Ana; Lipinski, Marc; Vassetzky, Yegor S.] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR 8126, F-94805 Villejuif, France; [Dmitriev, Petr; Turki, Ahmed; Carnac, Gilles; Laoudj-Chenivesse, Dalila] INSERM, U1046, F-34295 Montpellier, France; [Dessen, Philippe; Robert, Thomas; Lazar, Vladimir] Inst Cancerol Gustave Roussy, Funct Genom Unit, F-94805 Villejuif, France; [Labourer, Emmanuel] Ambion Inc, Austin, TX 78744 USA; [Petrov, Andrei] IBC Generium, Volginsky 601125, Russia; [Ansseau, Eugenie; Belayew, Alexandra] Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Gustave Roussy; University of Mons	Vassetzky, YS (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, UMR 8126, F-94805 Villejuif, France.	vassetzky@igr.fr	Lazar, Vladimir/AAQ-2086-2020; BELAYEW, Alexandra/D-5205-2013; Stankevicins, Luiza/K-1858-2014; Vassetzky, Yegor S/C-6447-2008; Lazar, Vladimir/AAV-2087-2020; Vassetzky, Yegor/M-3383-2019; Carnac, Gilles/N-6744-2018; Laoudj-Chenivesse, dalila/N-7097-2018	BELAYEW, Alexandra/0000-0001-5115-2424; Vassetzky, Yegor S/0000-0003-3101-7043; Vassetzky, Yegor/0000-0003-3101-7043; Turki, Ahmed/0000-0003-4559-3105; Carnac, Gilles/0000-0002-3518-8774; Laoudj-Chenivesse, dalila/0000-0003-4356-9187	Association Francaise contre les Myopathies; Association de Recherche Contre le Cancer; Association Amis FSH; University of Montpellier I; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior - Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB) felllowship	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association de Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Amis FSH; University of Montpellier I; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior - Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB) felllowship	This work was supported by grants from the Association Francaise contre les Myopathies (to Y. S. V. and D. L).; Supported by the Association de Recherche Contre le Cancer, the Association Amis FSH, and the University of Montpellier I.; Recipient of a Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior - Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (CAPES-COFECUB) felllowship.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ansseau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007482; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Block GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035532; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bosnakovski D, 2008, EXP NEUROL, V214, P87, DOI 10.1016/j.expneurol.2008.07.022; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020966; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Ciarapica R, 2009, CELL CYCLE, V8, P172, DOI 10.4161/cc.8.1.7292; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Deak KL, 2007, NEUROLOGY, V68, P578, DOI 10.1212/01.wnl.0000254991.21818.f3; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2011, J BIOL CHEM, V286, P44620, DOI 10.1074/jbc.M111.254052; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harafuji N, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-55; HITI AL, 1989, MOL CELL BIOL, V9, P4722, DOI 10.1128/MCB.9.11.4722; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A., 2003, Genetika, V39, P202; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sharma V., 2013, PLOS ONE, V8; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tsumagari K, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-67; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van Geel M, 1999, GENOMICS, V61, P55, DOI 10.1006/geno.1999.5942; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Vanderplanck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026820; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Vizoso M, 2012, CELL RES, V22, P1413, DOI 10.1038/cr.2012.93; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	66	49	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					34989	35002		10.1074/jbc.M113.504522	http://dx.doi.org/10.1074/jbc.M113.504522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145033	Green Published, hybrid			2022-12-28	WOS:000329867600002
J	Lim, D; Gold, DA; Julien, L; Rosowski, EE; Niedelman, W; Yaffe, MB; Saeij, JPJ				Lim, Daniel; Gold, Daniel A.; Julien, Lindsay; Rosowski, Emily E.; Niedelman, Wendy; Yaffe, Michael B.; Saeij, Jeroen P. J.			Structure of the Toxoplasma gondii ROP18 Kinase Domain Reveals a Second Ligand Binding Pocket Required for Acute Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Protein Kinases; Protein Phosphorylation; Protozoan; Signal Transduction; Toxoplasma Gondii; Rhoptry Protein	AUTOMATED STRUCTURE SOLUTION; WIDE PREDICTION; PROTEIN; PHOSPHORYLATION; INFECTION; SUBUNIT; CRYSTALLOGRAPHY; THREONINE; IMMUNITY; XTALVIEW	Background: ROP18 is a Toxoplasma secreted Ser/Thr protein kinase important for acute virulence. Results: The crystal structure of the unphosphorylated ROP18 kinase domain was determined in complex with an ATP analog. Conclusion: The structure is inconsistent with a previously proposed model of autoinhibition and identifies an additional ligand binding site important for virulence. Significance: Structure-function studies of ROP18 will aid development of novel drugs against toxoplasmosis. At least a third of the human population is infected with the intracellular parasite Toxoplasma gondii, which contributes significantly to the disease burden in immunocompromised and neutropenic hosts and causes serious congenital complications when vertically transmitted to the fetus. Genetic analyses have identified the Toxoplasma ROP18 Ser/Thr protein kinase as a major factor mediating acute virulence in mice. ROP18 is secreted into the host cell during the invasion process, and its catalytic activity is required for the acute virulence phenotype. However, its precise molecular function and regulation are not fully understood. We have determined the crystal structure of the ROP18 kinase domain, which is inconsistent with a previously proposed autoinhibitory mechanism of regulation. Furthermore, a sucrose molecule bound to our structure identifies an additional ligand-binding pocket outside of the active site cleft. Mutational analysis confirms an important role for this pocket in virulence.	[Lim, Daniel; Gold, Daniel A.; Julien, Lindsay; Rosowski, Emily E.; Niedelman, Wendy; Yaffe, Michael B.; Saeij, Jeroen P. J.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lim, Daniel; Yaffe, Michael B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yaffe, MB (corresponding author), 77 Massachusetts Ave,Bldg 76-353, Cambridge, MA 02139 USA.	myaffe@mit.edu; jsaeij@mit.edu	Rosowski, Emily E./U-9654-2019	Rosowski, Emily E./0000-0002-6761-1098; Saeij, Jeroen/0000-0003-0289-7109	National Institutes of Health [R01-A1080621, R01-GM52981, P50GM68762, R01-GM104047]; Massachusetts Life Sciences Center New Investigator Award; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104047, T32GM007287, P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Life Sciences Center New Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-A1080621 (to J.P.J.S.) and R01-GM52981, P50GM68762, and R01-GM104047 (to M.B.Y.) and a Massachusetts Life Sciences Center New Investigator Award (to J.P.J.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexander J, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001796; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Dar A.C., 2005, EUKARYOTIC PROTEIN K, DOI 10. 1002/3527603611. ch9; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; DeLano W.L, PYMOL MOL GRAPHICS S; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Fentress SJ, 2012, CELL MICROBIOL, V14, P1921, DOI 10.1111/cmi.12022; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Filhol O, 2003, MOL CELL BIOL, V23, P975, DOI 10.1128/MCB.23.3.975-987.2003; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Howard JC, 2011, CURR OPIN MICROBIOL, V14, P414, DOI 10.1016/j.mib.2011.07.002; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; JOINER KA, 1993, INFECT IMMUN, V61, P1169, DOI 10.1128/IAI.61.4.1169-1172.1993; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ku SY, 2007, ACTA CRYSTALLOGR D, V63, P493, DOI 10.1107/S0907444907006592; Labesse G, 2009, STRUCTURE, V17, P139, DOI 10.1016/j.str.2008.11.005; Laudet B, 2008, MOL CELL BIOCHEM, V316, P63, DOI 10.1007/s11010-008-9821-6; Lim DC, 2012, INT J PARASITOL, V42, P21, DOI 10.1016/j.ijpara.2011.11.007; Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mcree DE, 2008, J STRUCT BIOL, V163, P208, DOI 10.1016/j.jsb.2008.02.004; MEGGIO F, 1992, EUR J BIOCHEM, V205, P939, DOI 10.1111/j.1432-1033.1992.tb16860.x; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Niedelman W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002784; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Qiu W, 2009, EMBO J, V28, P969, DOI 10.1038/emboj.2009.24; Raaf J, 2008, CHEM BIOL, V15, P111, DOI 10.1016/j.chembiol.2007.12.012; Raaf J, 2009, J MOL BIOL, V386, P1212, DOI 10.1016/j.jmb.2009.01.033; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Reese ML, 2011, J BIOL CHEM, V286, P29366, DOI 10.1074/jbc.M111.253435; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Selleck EM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003320; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660	67	12	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34968	34980		10.1074/jbc.M113.523266	http://dx.doi.org/10.1074/jbc.M113.523266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129568	Green Published, hybrid			2022-12-28	WOS:000329812800062
J	MacLean, JA; Hu, ZY; Welborn, JP; Song, HW; Rao, MK; Wayne, CM; Wilkinson, MF				MacLean, James A., II; Hu, Zhiying; Welborn, Joshua P.; Song, Hye-Won; Rao, Manjeet K.; Wayne, Chad M.; Wilkinson, Miles F.			The RHOX Homeodomain Proteins Regulate the Expression of Insulin and Other Metabolic Regulators in the Testis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Homeobox; Insulin; Spermatogenesis; Testis; Sertoli Cells	PEM HOMEOBOX GENE; TRANSCRIPTION FACTOR PDX-1; AKITA DIABETIC MICE; HUMAN SERTOLI-CELLS; MALE GERM-CELLS; IN-VITRO; ANDROGEN RECEPTOR; RAPID EVOLUTION; RAT TESTIS; SPERMATOGENIC CELLS	Background: RHOX5 is a transcription factor important for spermatogenesis. Results: Using Rhox5-null mice, we demonstrate that RHOX5 regulates key metabolism genes, including insulin (Ins), resistin (Retn), and adiponectin (Adipoq) in specific cell types and developmental stages in the testis. Conclusion: RHOX5 is a crucial regulator of metabolism genes in the testis. Significance: This work provides a framework for understanding why metabolism defects cause male infertility. Defects in cellular metabolism have been widely implicated in causing male infertility, but there has been little progress in understanding the underlying mechanism. Here we report that several key metabolism genes are regulated in the testis by Rhox5, the founding member of a large X-linked homeobox gene cluster. Among these Rhox5-regulated genes are insulin 2 (Ins2), resistin (Retn), and adiponectin (Adipoq), all of which encode secreted proteins that have profound and wide-ranging effects on cellular metabolism. The ability of Rhox5 to regulate their levels in the testis has the potential to dictate metabolism locally in this organ, given the existence of the blood-testes barrier. We demonstrate that Ins2 is a direct target of Rhox5 in Sertoli cells, and we show that this regulation is physiologically significant, because Rhox5-null mice fail to up-regulate Ins2 expression during the first wave of spermatogenesis and have insulin-signaling defects. We identify other Rhox family members that induce Ins2 transcription, define protein domains and homeodomain amino acid residues crucial for this property, and demonstrate that this regulation is conserved. Rhox5-null mice also exhibit altered expression of other metabolism genes, including those encoding the master transcriptional regulators of metabolism, PPARG and PPARGC1A, as well as SCD1, the rate-limiting enzyme for fatty acid metabolism. These results, coupled with the known roles of RHOX5 and its target metabolism genes in spermatogenesis in vivo, lead us to propose a model in which RHOX5 is a central transcription factor that promotes the survival of male germ cells via its effects on cellular metabolism.	[MacLean, James A., II; Welborn, Joshua P.] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Wayne, Chad M.] Univ Houston, Dept Biol, Houston, TX 77004 USA; [Song, Hye-Won; Wilkinson, Miles F.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [MacLean, James A., II; Hu, Zhiying; Song, Hye-Won; Rao, Manjeet K.; Wayne, Chad M.; Wilkinson, Miles F.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Song, Hye-Won; Wilkinson, Miles F.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Southern Illinois University System; Southern Illinois University; University of Texas System; University of Texas Health San Antonio; University of Houston System; University of Houston; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego	Wilkinson, MF (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	mfwilkinson@ucsd.edu			National Institutes of Health [R01 HD045595, HD053808, R03 HD55268, R15 HD65584]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053808, R03HD055268, R15HD065584] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD045595 and HD053808 (to M. F. W.) and R03 HD55268 and R15 HD65584 (to J. A. M.).	ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Agbaje IM, 2007, HUM REPROD, V22, P1871, DOI 10.1093/humrep/dem077; Ahuja HS, 2001, MOL PHARMACOL, V59, P765, DOI 10.1124/mol.59.4.765; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Alves MG, 2012, BBA-MOL CELL RES, V1823, P1389, DOI 10.1016/j.bbamcr.2012.06.002; Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Barbulescu K, 2001, MOL ENDOCRINOL, V15, P1803, DOI 10.1210/me.15.10.1803; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Bhardwaj A, 2012, MOL ENDOCRINOL, V26, P538, DOI 10.1210/me.2011-1059; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Bobes RJ, 2001, POULTRY SCI, V80, P637, DOI 10.1093/ps/80.5.637; Bouma GJ, 2010, BIOL REPROD, V82, P380, DOI 10.1095/biolreprod.109.079822; Brown RM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103267; Caminos JE, 2008, ENDOCRINOLOGY, V149, P3390, DOI 10.1210/en.2007-1582; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Daggag H, 2008, BIOL REPROD, V79, P468, DOI 10.1095/biolreprod.107.067348; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DUBOULE D, 1994, GUIDEBOOK HOMEBOX GE; Fleenor DE, 2001, ENDOCRINOLOGY, V142, P2805, DOI 10.1210/en.142.7.2805; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Geserick C, 2002, BIOCHEM J, V366, P367, DOI 10.1042/bj20020399; Geyer CB, 2008, GENE, V423, P194, DOI 10.1016/j.gene.2008.06.031; Goulis DG, 2008, GYNECOL ENDOCRINOL, V24, P33, DOI 10.1080/09513590701582273; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; HALES DB, 1987, J BIOL CHEM, V262, P11200; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; Hu ZY, 2007, ANN NY ACAD SCI, V1120, P72, DOI 10.1196/annals.1411.011; Hu ZY, 2010, MOL ENDOCRINOL, V24, P60, DOI 10.1210/me.2009-0303; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kim ST, 2008, REPRODUCTION, V136, P313, DOI 10.1530/REP-08-0167; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; LIN TP, 1994, DEV BIOL, V166, P170, DOI 10.1006/dbio.1994.1305; Lindsey JS, 1996, DEV BIOL, V179, P471, DOI 10.1006/dbio.1996.0276; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; MacLean JA, 2005, BIOL REPROD, V73, P1126, DOI 10.1095/biolreprod.105.042747; MacLean JA, 2013, FRONT BIOSCI-LANDMRK, V18, P474, DOI 10.2741/4115; MacLean JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099184; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; MacLean JA, 2010, REPRODUCTION, V140, P195, DOI 10.1530/REP-10-0100; Maiti S, 1996, GENOMICS, V34, P304, DOI 10.1006/geno.1996.0291; Monaco L, 2004, INT J ANDROL, V27, P322, DOI 10.1111/j.1365-2605.2004.00494.x; Morris L, 2006, MAMM GENOME, V17, P178, DOI 10.1007/s00335-005-0138-4; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; Nakayama Y, 1999, INT J DEV BIOL, V43, P343; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Niu AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-298; Nogueiras R, 2004, J CELL SCI, V117, P3247, DOI 10.1242/jcs.01196; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Oliveira PF, 2012, BBA-GEN SUBJECTS, V1820, P84, DOI 10.1016/j.bbagen.2011.11.006; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pitetti JL, 2013, MOL ENDOCRINOL, V27, P814, DOI 10.1210/me.2012-1258; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Rao MK, 2002, J BIOL CHEM, V277, P48771, DOI 10.1074/jbc.M209417200; Reul BA, 1997, BIOCHEM J, V324, P605, DOI 10.1042/bj3240605; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; Saether T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035; Saether T, 2007, REPRODUCTION, V133, P467, DOI 10.1530/REP-06-00294; SAEZ JM, 1988, REPROD NUTR DEV, V28, P989, DOI 10.1051/rnd:19880701; SAKKAS D, 1993, BIOL REPROD, V49, P1288, DOI 10.1095/biolreprod49.6.1288; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schoeller EL, 2012, CELL TISSUE RES, V349, P839, DOI 10.1007/s00441-012-1387-7; Schoeller EL, 2012, DIABETES, V61, P1869, DOI 10.2337/db11-1527; Song HW, 2013, HUM REPROD, V28, P1635, DOI 10.1093/humrep/det043; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Su LL, 2009, INT J BIOCHEM CELL B, V41, P2578, DOI 10.1016/j.biocel.2009.08.015; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; VITALE R, 1973, ANAT REC, V176, P333, DOI 10.1002/ar.1091760309; Wang J, 2000, BIOTECHNIQUES, V29, P976, DOI 10.2144/00295bm09; Wang J, 2001, BIOTECHNIQUES, V31, P722, DOI 10.2144/01314bm01; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Wayne CM, 2002, ENDOCRINOLOGY, V143, P4875, DOI 10.1210/en.2002-220558; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Wiecek A, 2002, NEPHROL DIAL TRANSPL, V17, P191, DOI 10.1093/ndt/17.2.191; WILKINSON M, 2000, ESSENTIAL MOL BIOL, P69; Winzell MS, 2007, METABOLISM, V56, P122, DOI 10.1016/j.metabol.2006.09.008; Woods SC, 2001, INT J OBESITY, V25, pS35, DOI 10.1038/sj.ijo.0801909; Wu HT, 2003, REPROD DOMEST ANIM, V38, P470, DOI 10.1046/j.0936-6768.2003.00465.x; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	100	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34809	34825		10.1074/jbc.M113.486340	http://dx.doi.org/10.1074/jbc.M113.486340			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121513	Green Published, hybrid			2022-12-28	WOS:000329812800049
J	Moller-Hackbarth, K; Dewitz, C; Schweigert, O; Trad, A; Garbers, C; Rose-John, S; Scheller, J				Moeller-Hackbarth, Katja; Dewitz, Christin; Schweigert, Olga; Trad, Ahmad; Garbers, Christoph; Rose-John, Stefan; Scheller, Juergen			A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM ADAMTS; Cell Culture; Cell Surface; Shedding; Signaling	KIDNEY INJURY MOLECULE-1; CHRONIC VIRAL-INFECTION; EPIDERMAL-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; L-SELECTIN; IL-6 RECEPTOR; ANTITUMOR IMMUNITY; EXPRESSION; TACE; PROTEINS	Background: Membrane-bound Tim-3 regulates immune responses. Results: Soluble Tim-3 is generated by A disintegrin and metalloprotease (ADAM) 10 and ADAM17. Conclusion: ADAM proteases are involved in Tim-3 processing. Significance: Shedding of Tim-3 influences immune cell activation. T cell immunoglobulin and mucin domain 3 (Tim-3) dampens the response of CD4(+) and CD8(+) effector T cells via induction of cell death and/or T cell exhaustion and enhances the ability of macrophages to clear pathogens via binding to galectin 9. Here we provide evidence that human Tim-3 is a target of A disintegrin and metalloprotease (ADAM)-mediated ectodomain shedding resulting in a soluble form of Tim-3. We identified ADAM10 and ADAM17 as major sheddases of Tim-3 as shown by ADAM-specific inhibitors and the ADAM10 pro-domain in HEK293 cells and ADAM10/ADAM17-deficient murine embryonic fibroblasts. PMA-induced shedding of Tim-3 was abrogated by deletion of amino acids Glu(181)-Asp(190) of the stalk region and Tim-3 lacking the intracellular domain was not efficiently cleaved after PMA stimulation. Surprisingly, a single lysine residue within the intracellular domain rescues shedding of Tim-3. Shedding of endogenous Tim-3 was found in primary human CD14(+) monocytes after PMA and ionomycin stimulation. Importantly, the recently described down-regulation of Tim-3 from Toll-like receptor-activated CD14(+) monocytes was caused by ADAM10- and ADAM17-mediated shedding. Inhibition of Tim-3 shedding from lipopolysaccharide-induced monocytes did not influence lipopolysaccharide-induced TNF and IL-6 but increases IL-12 expression. In summary, we describe Tim-3 as novel target for ADAM-mediated ectodomain shedding and suggest a role of Tim-3 shedding in TLR-mediated immune responses of CD14(+) monocytes.	[Moeller-Hackbarth, Katja; Dewitz, Christin; Schweigert, Olga; Trad, Ahmad; Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, D-24098 Kiel, Germany; [Garbers, Christoph; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany	University of Kiel; Heinrich Heine University Dusseldorf	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Garbers, Christoph/D-9932-2015; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279	Deutsche Forschungsgemeinschaft [DFG SCHE 907/2-1, SFB654, C8, SFB877]; Cluster of Excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"	This work was supported in part by Deutsche Forschungsgemeinschaft Grant DFG SCHE 907/2-1, SFB654, C8, and SFB877 projects A1 and Z3, and the Cluster of Excellence "Inflammation at Interfaces."	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Ali N, 2007, J BIOL CHEM, V282, P37378, DOI 10.1074/jbc.M702170200; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Canobbio I, 2011, BBA-MOL CELL RES, V1813, P500, DOI 10.1016/j.bbamcr.2010.12.002; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Gifford JL, 2012, J BIOL CHEM, V287, P26513, DOI 10.1074/jbc.M112.373373; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Gomez-Gaviro M, 2007, J IMMUNOL, V178, P8053, DOI 10.4049/jimmunol.178.12.8053; Gonzales PE, 2008, BIOCHEMISTRY-US, V47, P9911, DOI 10.1021/bi801049v; Guo LY, 2012, J BIOCHEM, V152, P425, DOI 10.1093/jb/mvs082; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kenny PA, 2007, DIFFERENTIATION, V75, P800, DOI 10.1111/j.1432-0436.2007.00198.x; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Lim AI, 2012, INT J BIOCHEM CELL B, V44, P1040, DOI 10.1016/j.biocel.2012.03.015; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Yoshiyama K, 1997, GENOMICS, V41, P56, DOI 10.1006/geno.1997.4607; Zhang Y, 2012, J LEUKOCYTE BIOL, V91, P189, DOI 10.1189/jlb.1010591; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	53	74	80	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34529	34544		10.1074/jbc.M113.488478	http://dx.doi.org/10.1074/jbc.M113.488478			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24121505	hybrid, Green Published			2022-12-28	WOS:000329812800022
J	Zemoura, K; Schenkel, M; Acuna, MA; Yevenes, GE; Zeilhofer, HU; Benke, D				Zemoura, Khaled; Schenkel, Marisa; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar			Endoplasmic Reticulum-associated Degradation Controls Cell Surface Expression of gamma-Aminobutyric Acid, Type B Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER-associated Degradation; GABA Receptors; Neurons; Proteasome; Ubiquitination	SMALL-MOLECULE INHIBITOR; GABA(B) RECEPTORS; LYSOSOMAL DEGRADATION; SYNAPTIC PLASTICITY; PROXIMITY LIGATION; MEMBRANE-PROTEINS; UBIQUITINATION; PROTEASOME; PATHWAY; EEYARESTATIN	Background: The amount of cell surface GABA(B) receptors determines the strength of GABA(B)-mediated inhibition of neuronal excitability. Results: GABA(B) receptors are Lys(48)-linked polyubiquitinated and degraded by proteasomes via ERAD. Conclusion: ERAD constitutively degrades GABA(B) receptors and thereby determines the number of functional receptors available for signaling. Significance: Modulation of ERAD activity may be a mechanism to adjust the level of functional GABA(B) receptors. Metabotropic GABA(B) receptors are crucial for controlling the excitability of neurons by mediating slow inhibition in the CNS. The strength of receptor signaling depends on the number of cell surface receptors, which is thought to be regulated by trafficking and degradation mechanisms. Although the mechanisms of GABA(B) receptor trafficking are studied to some extent, it is currently unclear whether receptor degradation actively controls the number of GABA(B) receptors available for signaling. Here we tested the hypothesis that proteasomal degradation contributes to the regulation of GABA(B) receptor expression levels. Blocking proteasomal activity in cultured cortical neurons considerably enhanced total and cell surface expression of GABA(B) receptors, indicating the constitutive degradation of the receptors by proteasomes. Proteasomal degradation required Lys(48)-linked polyubiquitination of lysines 767/771 in the C-terminal domain of the GABA(B2) subunit. Inactivation of these ubiquitination sites increased receptor levels and GABA(B) receptor signaling in neurons. Proteasomal degradation was mediated by endoplasmic reticulum-associated degradation (ERAD) as shown by the accumulation of receptors in the endoplasmic reticulum upon inhibition of proteasomes, by the increase of receptor levels, as well as receptor signaling upon blocking ERAD function, and by the interaction of GABA(B) receptors with the essential ERAD components Hrd1 and p97. In conclusion, the data support a model in which the fraction of GABA(B) receptors available for plasma membrane trafficking is regulated by degradation via the ERAD machinery. Thus, modulation of ERAD activity by changes in physiological conditions may represent a mechanism to adjust receptor numbers and thereby signaling strength.	[Zemoura, Khaled; Schenkel, Marisa; Acuna, Mario A.; Yevenes, Gonzalo E.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Acuna, Mario A.; Zeilhofer, Hanns Ulrich; Benke, Dietmar] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Schenkel, Marisa; Zeilhofer, Hanns Ulrich] Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	University of Zurich; University of Zurich; ETH Zurich; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch	Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629; Acuna, Mario A./0000-0002-0673-5150	Swiss National Science Foundation [31003A_121963, 31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A_121963 and 31003A_138382 (to D.B.).	Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Huang L, 2007, FEBS LETT, V581, P4955, DOI 10.1016/j.febslet.2007.09.031; Kantamneni S, 2008, J NEUROCHEM, V107, P86, DOI 10.1111/j.1471-4159.2008.05580.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Saliba RS, 2009, J BIOL CHEM, V284, P32544, DOI 10.1074/jbc.M109.040071; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002	33	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34897	34905		10.1074/jbc.M113.514745	http://dx.doi.org/10.1074/jbc.M113.514745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24114844	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000329812800056
J	Jensen, AB; Hoestgaard-Jensen, K; Jensen, AA				Jensen, Anne B.; Hoestgaard-Jensen, Kirsten; Jensen, Anders A.			Elucidation of Molecular Impediments in the alpha 6 Subunit for in Vitro Expression of Functional alpha 6 beta 4* Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Cys-loop Receptors; Ion Channels; Neurotransmitter Receptors; Nicotinic Acetylcholine Receptors	SINGLE-CHANNEL CONDUCTANCE; DOPAMINE RELEASE; PARTIAL AGONIST; SAZETIDINE-A; NEURONS; ALPHA-4-BETA-2; DETERMINANTS; PHARMACOLOGY; ACTIVATION; SUBTYPES	Explorations into the 6-containing nicotinic acetylcholine receptors (6* nAChRs) as putative drug targets have been severely hampered by the inefficient functional expression of the receptors in heterologous expression systems. In this study, the molecular basis for the problem was investigated through the construction of chimeric 6/3 and mutant 3 and 6 subunits and functional characterization of these co-expressed with 4 or 43 subunits in tsA201 cells in a fluorescence-based assay and in Xenopus oocytes using two-electrode voltage clamp electrophysiology. Substitution of a small C-terminal segment in the second intracellular loop or the Phe(223) residue in transmembrane helix 1 of 6 with the corresponding 3 segment or residue was found to enhance 64 functionality in tsA201 cells significantly, in part due to increased cell surface expression of the receptors. The gain-of-function effects of these substitutions appeared to be additive since incorporation of both 3 elements into 6 resulted in assembly of 64* receptors exhibiting robust functional responses to acetylcholine. The pharmacological properties exhibited by 643 receptors comprising one of these novel 6/3 chimeras in oocytes were found to be in good agreement with those from previous studies of 6* nAChRs formed from other surrogate 6 subunits or concatenated subunits and studies of other heteromeric nAChRs. In contrast, co-expression of this 6/3 chimera with 2 or 23 subunits in oocytes did not result in efficient formation of functional receptors, indicating that the identified molecular elements in 6 could be specific impediments for the expression of functional 64* nAChRs.	[Jensen, Anne B.; Hoestgaard-Jensen, Kirsten; Jensen, Anders A.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark	University of Copenhagen	Jensen, AA (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Univ Pk 2, DK-2100 Copenhagen, Denmark.	aaj@sund.ku.dk	Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052	Lundbeck Foundation; Aase and Ejner Danielsen Foundation; Carlsberg Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R9-2007-928, R77-2010-6692] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Aase and Ejner Danielsen Foundation; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation, The Aase and Ejner Danielsen Foundation, the Carlsberg Foundation, and the Novo Nordisk Foundation. Part of this work was presented in the form of a poster at the Society of Neuroscience conference in New Orleans on October 15, 2012.	Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Broadbent S, 2006, MOL PHARMACOL, V70, P1350, DOI 10.1124/mol.106.026682; CACHELIN AB, 1995, PFLUG ARCH EUR J PHY, V429, P449, DOI 10.1007/BF00374164; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Dash B, 2011, J BIOL CHEM, V286, P37976, DOI 10.1074/jbc.M111.263673; Dash B, 2011, J BIOL CHEM, V286, P37905, DOI 10.1074/jbc.M111.264044; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Drenan RM, 2010, J NEUROSCI, V30, P9877, DOI 10.1523/JNEUROSCI.2056-10.2010; Evans NM, 2003, EUR J PHARMACOL, V466, P31, DOI 10.1016/S0014-2999(03)01540-1; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Hansen KB, 2009, METHODS MOL BIOL, V552, P343, DOI 10.1007/978-1-60327-317-6_25; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; Krzywkowski K, 2007, PHARMACOGENET GENOM, V17, P255, DOI 10.1097/FPC.0b013e3280117269; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Letchworth SR, 2011, BIOCHEM PHARMACOL, V82, P862, DOI 10.1016/j.bcp.2011.06.022; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Perez XA, 2010, MOL PHARMACOL, V78, P971, DOI 10.1124/mol.110.067561; Perez-Alvarez A, 2012, FASEB J, V26, P346, DOI 10.1096/fj.11-190223; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Quik M, 2011, PHARMACOL REV, V63, P938, DOI 10.1124/pr.110.003269; Quik M, 2011, BIOCHEM PHARMACOL, V82, P873, DOI 10.1016/j.bcp.2011.06.001; Rezvani K, 2009, J NEUROSCI, V29, P6883, DOI 10.1523/JNEUROSCI.4723-08.2009; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tsetlin V, 2011, J NEUROCHEM, V116, P734, DOI 10.1111/j.1471-4159.2010.07060.x; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Williams BM, 1998, NAT NEUROSCI, V1, P557, DOI 10.1038/2792; Xiao YX, 2006, MOL PHARMACOL, V70, P1454, DOI 10.1124/mol.106.027318; Zhang J, 1999, MOL PHARMACOL, V55, P970, DOI 10.1124/mol.55.6.970; Zoli M, 2002, J NEUROSCI, V22, P8785; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	54	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33708	33721		10.1074/jbc.M113.509356	http://dx.doi.org/10.1074/jbc.M113.509356			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24085295	hybrid, Green Published			2022-12-28	WOS:000327250200018
J	Patel, N; Exell, JC; Jardine, E; Ombler, B; Finger, LD; Ciani, B; Grasby, JA				Patel, Nikesh; Exell, Jack C.; Jardine, Emma; Ombler, Ben; Finger, L. David; Ciani, Barbara; Grasby, Jane A.			Proline Scanning Mutagenesis Reveals a Role for the Flap Endonuclease-1 Helical Cap in Substrate Unpairing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circular Dichroism (CD); DNA Physical Chemistry; DNA Repair; DNA Replication; DNA-Protein Interaction; Enzyme Catalysis; Enzyme Mechanisms; Fluorescence; Fluorescence Correlation Spectroscopy; Nucleic Acid Enzymology	METAL-IONS; DNA; MECHANISM; CATALYSIS; NUCLEASE; RECOGNITION; SUPERFAMILY; SPECIFICITY; PROTEINS; CLEAVAGE	Background: Human flap endonuclease-1, the prototypical 5-nuclease, removes 5-flaps by incising one nucleotide into duplex DNA using a double nucleotide unpairing mechanism. Results: Alteration of the hFEN1 helical cap structure, but not removal of conserved basic residues, prevents substrate unpairing. Conclusion: The hFEN1 helical cap is required for substrate rearrangement. Significance: Mechanistic details of 5-nuclease catalysis are crucial for understanding DNA replication and repair. The prototypical 5-nuclease, flap endonuclease-1 (FEN1), catalyzes the essential removal of single-stranded flaps during DNA replication and repair. FEN1 hydrolyzes a specific phosphodiester bond one nucleotide into double-stranded DNA. This specificity arises from double nucleotide unpairing that places the scissile phosphate diester on active site divalent metal ions. Also related to FEN1 specificity is the helical arch, through which 5-flaps, but not continuous DNAs, can thread. The arch contains basic residues (Lys-93 and Arg-100 in human FEN1 (hFEN1)) that are conserved by all 5-nucleases and a cap region only present in enzymes that process DNAs with 5 termini. Proline mutations (L97P, L111P, L130P) were introduced into the hFEN1 helical arch. Each mutation was severely detrimental to reaction. However, all proteins were at least as stable as wild-type (WT) hFEN1 and bound substrate with comparable affinity. Moreover, all mutants produced complexes with 5-biotinylated substrate that, when captured with streptavidin, were resistant to challenge with competitor DNA. Removal of both conserved basic residues (K93A/R100A) was no more detrimental to reaction than the single mutation R100A, but much less severe than L97P. The ability of protein-Ca2+ to rearrange 2-aminopurine-containing substrates was monitored by low energy CD. Although L97P and K93A/R100A retained the ability to unpair substrates, the cap mutants L111P and L130P did not. Taken together, these data challenge current assumptions related to 5-nuclease family mechanism. Conserved basic amino acids are not required for double nucleotide unpairing and appear to act cooperatively, whereas the helical cap plays an unexpected role in hFEN1-substrate rearrangement.	[Patel, Nikesh; Exell, Jack C.; Jardine, Emma; Ombler, Ben; Finger, L. David; Ciani, Barbara; Grasby, Jane A.] Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England	University of Sheffield	Finger, LD (corresponding author), Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England.	d.finger@sheffield.ac.uk; b.ciani@sheffield.ac.uk; j.a.grasby@sheffield.ac.uk	Ciani, Barbara/A-1679-2012	Ciani, Barbara/0000-0001-7223-4154; Finger, L. David/0000-0002-2342-9569; Patel, Nikesh/0000-0001-6098-3633	Biotechnology and Biological Sciences Research Council [BB/J00300X, BB/K009079/1]; Biotechnology and Biological Sciences Research Council [BB/J00300X/1] Funding Source: researchfish; BBSRC [BB/K009079/1, BB/J00300X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council grants BB/J00300X (to J.A.G. and B.C.) and BB/K009079/1 (to J.A.G. and L.D.F.).	Beddows A, 2012, CHEM COMMUN, V48, P8895, DOI 10.1039/c2cc33400c; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger L David, 2012, Subcell Biochem, V62, P301, DOI 10.1007/978-94-007-4572-8_16; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lyamichev V, 1999, P NATL ACAD SCI USA, V96, P6143, DOI 10.1073/pnas.96.11.6143; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sobhy MA, 2013, CELL REP, V3, P1785, DOI 10.1016/j.celrep.2013.05.001; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; Tomlinson CG, 2011, J BIOL CHEM, V286, P30878, DOI 10.1074/jbc.M111.230391; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; WARREN JR, 1966, J PHYS CHEM-US, V70, P297, DOI 10.1021/j100873a507; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063	27	13	13	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34239	34248		10.1074/jbc.M113.509489	http://dx.doi.org/10.1074/jbc.M113.509489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126913	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000327250200066
J	Gupta, SC; Francis, SK; Nair, MS; Mo, YY; Aggarwal, BB				Gupta, Subash C.; Francis, Sajin K.; Nair, Mangalam S.; Mo, Yin-Yuan; Aggarwal, Bharat B.			Azadirone, a Limonoid Tetranortriterpene, Induces Death Receptors and Sensitizes Human Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) through a p53 Protein-independent Mechanism EVIDENCE FOR THE ROLE OF THE ROS-ERK-CHOP-DEATH RECEPTOR PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Apoptosis; Cancer Therapy; MAP Kinases (MAPKs); Reactive Oxygen Species (ROS); Trail; CHOP; Death Receptor; Limonoid	NF-KAPPA-B; MELIA-AZADIRACHTA L; DOWN-REGULATION; UP-REGULATION; APO2L/TRAIL-INDUCED APOPTOSIS; CHOLANGIOCARCINOMA CELLS; MEDIATED APOPTOSIS; ANTITUMOR-ACTIVITY; SURVIVAL PROTEINS; COLON-CARCINOMA	Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has shown efficacy in a phase 2 clinical trial, development of resistance to TRAIL by tumor cells is a major roadblock. We investigated whether azadirone, a limonoidal tetranortriterpene, can sensitize human tumor cells to TRAIL. Results indicate that azadirone sensitized cancer cells to TRAIL. The limonoid induced expression of death receptor (DR) 5 and DR4 but did not affect expression of decoy receptors in cancer cells. The induction of DRs was mediated through activation of ERK and through up-regulation of a transcription factor CCAAT enhancer-binding protein homologous protein (CHOP) as silencing of these signaling molecules abrogated the effect of azadirone. These effects of azadirone were cancer cell-specific. The CHOP binding site on the DR5 gene was required for induction of DR5 by azadirone. Up-regulation of DRs was mediated through the generation of reactive oxygen species (ROS) as ROS scavengers reduced the effect of azadirone on ERK activation, CHOP up-regulation, DR induction, and TRAIL sensitization. The induction of DRs by this limonoid was independent of p53, but sensitization to TRAIL was p53-dependent. The limonoid down-regulated the expression of cell survival proteins and up-regulated the proapoptotic proteins. The combination of azadirone with TRAIL was found to be additive at concentrations lower than IC50, whereas at higher concentrations, the combination was synergistic. Overall, this study indicates that azadirone can sensitize cancer cells to TRAIL through ROS-ERK-CHOP-mediated up-regulation of DR5 and DR4 signaling, down-regulation of cell survival proteins, and up-regulation of proapoptotic proteins.	[Gupta, Subash C.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA; [Francis, Sajin K.; Nair, Mangalam S.] Natl Inst Interdisciplinary Sci & Technol CSIR, Organ Chem Sect, Trivandrum 695019, Kerala, India; [Gupta, Subash C.; Mo, Yin-Yuan] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA	University of Texas System; UTMD Anderson Cancer Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); University of Mississippi; University of Mississippi Medical Center	Aggarwal, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Gupta, Subash/AAF-2563-2019; Mo, Yin-Yuan/R-8255-2019; Aggarwal, Bharat B/G-3388-2013	Gupta, Subash/0000-0002-0418-1940; 	National Institutes of Health [CA124787-01A2]; Malaysian Palm Oil Board; NATIONAL CANCER INSTITUTE [P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaysian Palm Oil Board; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant CA124787-01A2. This work was also supported by a grant from the Malaysian Palm Oil Board.	Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bouralexis S, 2003, BRIT J CANCER, V89, P206, DOI 10.1038/sj.bjc.6601021; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chianese G, 2010, J NAT PROD, V73, P1448, DOI 10.1021/np100325q; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Ekong D.E.U, 1967, CHEM COMMUN, DOI [10.1039/C1967000808A, DOI 10.1039/C1967000808A]; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Gupta SC, 2011, J BIOL CHEM, V286, P1134, DOI 10.1074/jbc.M110.191379; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kim EH, 2004, ONCOGENE, V23, P446, DOI 10.1038/sj.onc.1207025; Kim JH, 2012, ANTIOXID REDOX SIGN, V16, P413, DOI 10.1089/ars.2011.3982; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; LAVIE D, 1967, CHEM COMMUN, P278, DOI 10.1039/c19670000278; LAVIE D, 1971, TETRAHEDRON, V27, P3927, DOI 10.1016/S0040-4020(01)98254-7; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Nanduri S, 2003, BIOORG MED CHEM LETT, V13, P4111, DOI 10.1016/j.bmcl.2003.08.030; Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Paul R, 2011, CANCER BIOL THER, V12, P467, DOI 10.4161/cbt.12.6.16850; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Rodriguez B, 2003, MAGN RESON CHEM, V41, P206, DOI 10.1002/mrc.1159; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Schwinger M., 1984, P 2 INT NEEM C RAUIS, P181; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Siddiqui BS, 2006, NAT PROD RES, V20, P241, DOI 10.1080/14786410500059318; Siddiqui S, 1942, CURR SCI, V11, P278; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Suh WS, 2003, LEUKEMIA, V17, P2122, DOI 10.1038/sj.leu.2403112; Sung B, 2010, J BIOL CHEM, V285, P11498, DOI 10.1074/jbc.M109.090209; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Truneh A, 2000, J BIOL CHEM, V275, P23319, DOI 10.1074/jbc.M910438199; van Geelen CMM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-39; Velculescu VE, 1996, CLIN CHEM, V42, P858; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161	54	57	60	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32343	32356		10.1074/jbc.M113.455188	http://dx.doi.org/10.1074/jbc.M113.455188			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078627	Green Published, hybrid			2022-12-28	WOS:000328681700020
J	Chen, XH; Xu, ZJ; Zhang, LN; Liu, HC; Liu, X; Lou, M; Zhu, LJ; Huang, BD; Yang, CG; Zhu, WL; Shao, JM				Chen, Xinhuan; Xu, Zhijian; Zhang, Lingna; Liu, Hongchuan; Liu, Xia; Lou, Meng; Zhu, Lijun; Huang, Bingding; Yang, Cai-Guang; Zhu, Weiliang; Shao, Jimin			The Conserved Lys-95 Charged Residue Cluster Is Critical for the Homodimerization and Enzyme Activity of Human Ribonucleotide Reductase Small Subunit M2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; ESCHERICHIA-COLI; IN-VITRO; PROTEIN R2; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; ALLOSTERIC REGULATION; MOLECULAR-MECHANICS; ELECTRON-TRANSFER; DNA-REPLICATION	Ribonucleotide reductase (RR) catalyzes the reduction of ribonucleotides to deoxyribonucleotides for DNA synthesis. Human RR small subunit M2 exists in a homodimer form. However, the importance of the dimer form to the enzyme and the related mechanism remain unclear. In this study, we tried to identify the interfacial residues that may mediate the assembly of M2 homodimer by computational alanine scanning based on the x-ray crystal structure. Co-immunoprecipitation, size exclusion chromatography, and RR activity assays showed that the K95E mutation in M2 resulted in dimer disassembly and enzyme activity inhibition. In comparison, the charge-exchanging double mutation of K95E and E98K recovered the dimerization and activity. Structural comparisons suggested that a conserved cluster of charged residues, including Lys-95, Glu-98, Glu-105, and Glu-174, at the interface may function as an ionic lock for M2 homodimer. Although the measurements of the radical and iron contents showed that the monomer (the K95E mutant) was capable of generating the diiron and tyrosyl radical cofactor, co-immunoprecipitation and competitive enzyme inhibition assays indicated that the disassembly of M2 dimer reduced its interaction with the large subunit M1. In addition, the immunofluorescent and fusion protein-fluorescent imaging analyses showed that the dissociation of M2 dimer altered its subcellular localization. Finally, the transfection of the wild-type M2 but not the K95E mutant rescued the G(1)/S phase cell cycle arrest and cell growth inhibition caused by the siRNA knockdown of M2. Thus, the conserved Lys-95 charged residue cluster is critical for human RR M2 homodimerization, which is indispensable to constitute an active holoenzyme and function in cells.	[Chen, Xinhuan; Zhang, Lingna; Liu, Xia; Lou, Meng; Zhu, Lijun; Shao, Jimin] Zhejiang Univ, Dept Pathol & Pathophysiol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Xu, Zhijian; Liu, Hongchuan; Yang, Cai-Guang; Zhu, Weiliang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Huang, Bingding] German Canc Res Ctr, Genom & Prote Core Facil, D-69120 Heidelberg, Germany	Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Helmholtz Association; German Cancer Research Center (DKFZ)	Zhu, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	wlzhu@mail.shcnc.ac.cn; shaojimin@zju.edu.cn	Xu, Zhijian/Q-9834-2016	Xu, Zhijian/0000-0002-3063-8473	National Natural Science Foundation of China [81372138, 30873094, 81090421]; 863 National High Technology Research and Development Program of China [2012AA020206, 2012AA01A305]; Ministry of Education of China [J20100041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 81372138, 30873094, and 81090421; 863 National High Technology Research and Development Program of China Grants 2012AA020206 and 2012AA01A305; and Ministry of Education of China Grant J20100041.	Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DOBELN UV, 1976, J BIOL CHEM, V251, P3616; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; Kauppi B, 1996, J MOL BIOL, V262, P706, DOI 10.1006/jmbi.1996.0546; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Liu XY, 2005, BIOCHEM PHARMACOL, V70, P1288, DOI 10.1016/j.bcp.2005.08.005; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Narvaez AJ, 2006, J BIOL CHEM, V281, P26022, DOI 10.1074/jbc.M604598200; Nocentini G, 1996, CRIT REV ONCOL HEMAT, V22, P89, DOI 10.1016/1040-8428(95)00187-5; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Qi HY, 2012, J BIOL CHEM, V287, P12622, DOI 10.1074/jbc.M111.313429; Reddy G P, 1993, Crit Rev Eukaryot Gene Expr, V3, P255; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scott CP, 2001, BIOCHEMISTRY-US, V40, P1651, DOI 10.1021/bi002335z; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shao JM, 2005, BIOCHEM PHARMACOL, V69, P627, DOI 10.1016/j.bcp.2004.11.016; Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048; SJOBERG BM, 1987, J BIOL CHEM, V262, P9736; Strand KR, 2004, J BIOL CHEM, V279, P46794, DOI 10.1074/jbc.M407346200; Strand KR, 2002, J BIOL CHEM, V277, P34229, DOI 10.1074/jbc.M203358200; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; THELANDER M, 1985, J BIOL CHEM, V260, P2737; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Wu XR, 2008, MOL CELL BIOL, V28, P7156, DOI 10.1128/MCB.01388-08; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Xue LJ, 2003, CANCER RES, V63, P980; Zhang Y, 2013, J BIOL CHEM, V288, P13951, DOI 10.1074/jbc.M113.467001; Zhou BS, 1998, BIOCHEM PHARMACOL, V55, P1657, DOI 10.1016/S0006-2952(98)00042-2; Zhu LJ, 2009, BIOCHEM PHARMACOL, V78, P1178, DOI 10.1016/j.bcp.2009.06.103	58	5	5	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					909	920		10.1074/jbc.M113.524546	http://dx.doi.org/10.1074/jbc.M113.524546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24253041	Green Published, hybrid			2022-12-28	WOS:000330541200026
J	Kishikawa, J; Nakanishi, A; Furuike, S; Tamakoshi, M; Yokoyama, K				Kishikawa, Jun-ichi; Nakanishi, Atsuko; Furuike, Shou; Tamakoshi, Masatada; Yokoyama, Ken			Molecular Basis of ADP Inhibition of Vacuolar (V)-type ATPase/Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP Synthase; F1F0 ATPase; Membrane Proteins; Molecular Motors; Vacuolar ATPase; ADP Inhibition	PROKARYOTIC V-ATPASE; THERMUS-THERMOPHILUS; ENTEROCOCCUS-HIRAE; H+-ATPASE/SYNTHASE; CRYSTAL-STRUCTURE; NA+-ATPASE; ROTATION; F-1-ATPASE; V-1-ATPASE; HYDROLYSIS	Reduction of ATP hydrolysis activity of vacuolar-type ATPase/synthase (V0V1) as a result of ADP inhibition occurs as part of the normal mechanism of V0V1 of Thermus thermophilus but not V0V1 of Enterococcus hirae or eukaryotes. To investigate the molecular basis for this difference, domain-swapped chimeric V-1 consisting of both T. thermophilus and E. hirae enzymes were generated, and their function was analyzed. The data showed that the interaction between the nucleotide binding and C-terminal domains of the catalytic A subunit from E. hirae V-1 is central to increasing binding affinity of the chimeric V-1 for phosphate, resulting in reduction of the ADP inhibition. These findings together with a comparison of the crystal structures of T. thermophilus V-1 with E. hirae V-1 strongly suggest that the A subunit adopts a conformation in T. thermophilus V-1 different from that in E. hirae V-1. This key difference results in ADP inhibition of T. thermophilus V-1 by abolishing the binding affinity for phosphate during ATP hydrolysis.	[Kishikawa, Jun-ichi; Nakanishi, Atsuko; Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan; [Furuike, Shou] Osaka Med Coll, Dept Phys, Osaka 5698686, Japan; [Tamakoshi, Masatada] Tokyo Univ Pharm & Life Sci, Dept Appl Life Sci, Hachioji, Tokyo 1920392, Japan	Kyoto Sangyo University; Osaka Medical College; Tokyo University of Pharmacy & Life Sciences	Yokoyama, K (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 6038555, Japan.	yokoken@cc.kyoto-su.ac.jp	Yokoyama, Ken/AAJ-3582-2020	Yokoyama, Ken/0000-0002-6813-1096; Kishikawa, Jun-ichi/0000-0003-3913-7330	National Institutes of Health from NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Bernadette Byrne for critical reading of the manuscript and Dr. Takeshi Murata for the gift of pCemtp18. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41-GM103311 from the NIGMS).	Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2008, BIOPHYS J, V95, P761, DOI 10.1529/biophysj.107.123307; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Kettner C, 2003, FEBS LETT, V535, P119, DOI 10.1016/S0014-5793(02)03886-3; Kishikawa J, 2012, J BIOL CHEM, V287, P24597, DOI 10.1074/jbc.M112.367813; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	26	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					403	412		10.1074/jbc.M113.523498	http://dx.doi.org/10.1074/jbc.M113.523498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247239	Green Published, hybrid			2022-12-28	WOS:000329370900035
J	Broege, A; Pham, L; Jensen, ED; Emery, A; Huang, TH; Stemig, M; Beppu, H; Petryk, A; O'Connor, M; Mansky, K; Gopalakrishnan, R				Broege, Aaron; Pham, Lan; Jensen, Eric D.; Emery, Ann; Huang, Tsang-Hai; Stemig, Melissa; Beppu, Hideyuki; Petryk, Anna; O'Connor, Michael; Mansky, Kim; Gopalakrishnan, Raj			Bone Morphogenetic Proteins Signal Via SMAD and Mitogen-activated Protein (MAP) Kinase Pathways at Distinct Times during Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Bone Morphogenetic Protein (BMP); MAP Kinases (MAPKs); Osteoclast; Signal Transduction; BMPRII; Conditional Deletion	KAPPA-B LIGAND; RECEPTOR ACTIVATOR; DIFFERENTIATION; TAK1; CARTILAGE; SURVIVAL; EXPRESSION; DELETION; CELLS; GENE	To investigate the role of bone morphogenetic protein (BMP) signaling in osteoclastogenesis in vivo, we eliminated BMPRII in osteoclasts by creating a BMPRIIfl/fl;lysM-Cre mouse strain. Conditional knock-out (cKO) mice are osteopetrotic when compared with WT controls due to a decrease in osteoclast activity. Bone marrow macrophages (BMMs) isolated from cKO mice are severely inhibited in their capacity to differentiate into mature osteoclasts in the presence of M-CSF and receptor activator of NF-B (RANK) ligand. We also show that BMP noncanonical (MAPK) and canonical (SMAD) pathways are utilized at different stages of osteoclast differentiation. BMP2 induces p38 phosphorylation in pre-fusion osteoclasts and increases SMAD phosphorylation around osteoclast precursor fusion. Phosphorylation of MAPKs was decreased in differentiated BMMs from cKO animals. Treating BMMs with the SMAD inhibitor dorsomorphin confirms the requirement for the canonical pathway around the time of fusion. These results demonstrate the requirement for BMP signaling in osteoclasts for proper bone homeostasis and also explore the complex signaling mechanisms employed by BMP signaling during osteoclast differentiation.	[Broege, Aaron; Pham, Lan; Jensen, Eric D.; Emery, Ann; Stemig, Melissa; Gopalakrishnan, Raj] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Petryk, Anna; O'Connor, Michael] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Petryk, Anna] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mansky, Kim] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA; [Huang, Tsang-Hai] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 701, Taiwan; [Beppu, Hideyuki] Toyama Univ, Dept Clin & Mol Pathol, Toyama 9300887, Japan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Cheng Kung University; University of Toyama	Mansky, K (corresponding author), 16-262B Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.	kmansky@umn.edu; gopal007@umn.edu	O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506; Mansky, Kim/0000-0002-2826-5030	National Institutes of Health [R01AR056642, R01AR061352, R01DE016601]; University of Minnesota through NIDCR, National Institutes of Health [T32DE07288, T90DE022732]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056642, R01AR061352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE022732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016601, T32DE007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota through NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR056642 (to R. G.); R01AR061352 (to K. M. and E. D. J.); and R01DE016601 (to A. P.).; Supported by the University of Minnesota MinnCResT training grant through the NIDCR, National Institutes of Health Grants T32DE07288 and T90DE022732.	Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fong D, 2013, CELL SIGNAL, V25, P717, DOI 10.1016/j.cellsig.2012.12.003; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Greenblatt MB, 2010, ANN NY ACAD SCI, V1192, P385, DOI 10.1111/j.1749-6632.2009.05222.x; Gunnell LM, 2010, J BONE MINER RES, V25, P1784, DOI 10.1002/jbmr.79; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Jensen ED, 2010, J CELL BIOCHEM, V109, P672, DOI 10.1002/jcb.22462; KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Okamoto M, 2011, J BONE MINER RES, V26, P2511, DOI 10.1002/jbmr.477; Petryk A, 2004, DEV BIOL, V267, P374, DOI 10.1016/j.ydbio.2003.11.015; Pham L, 2011, J CELL BIOCHEM, V112, P793, DOI 10.1002/jcb.23003; Rodriguez JES, 2009, J BONE MINER RES, V24, P1917, DOI [10.1359/jbmr.090507, 10.1359/JBMR.090507]; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Takayanagi H, 2010, ANN NY ACAD SCI, V1192, P117, DOI 10.1111/j.1749-6632.2009.05303.x; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	25	47	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37230	37240		10.1074/jbc.M113.496950	http://dx.doi.org/10.1074/jbc.M113.496950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235143	hybrid, Green Published			2022-12-28	WOS:000329189700040
J	Pathak, P; Li, TG; Chiang, JYL				Pathak, Preeti; Li, Tiangang; Chiang, John Y. L. l			Retinoic Acid-related Orphan Receptor alpha Regulates Diurnal Rhythm and Fasting Induction of Sterol 12 alpha-Hydroxylase in Bile Acid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Diabetes; Lipid Metabolism; Nuclear Receptors; Obesity	CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLIC-ACID; ROR-ALPHA; GENE-EXPRESSION; PROFILING REVEALS; HUMAN HEPATOCYTES; CIRCADIAN-RHYTHM; RAT-LIVER; INSULIN; TRANSCRIPTION	Sterol 12-hydroxylase (CYP8B1) is required for cholic acid synthesis and plays a critical role in intestinal cholesterol absorption and pathogenesis of cholesterol gallstone, dyslipidemia, and diabetes. In this study we investigated the underlying mechanism of fasting induction and circadian rhythm of CYP8B1 by a cholesterol-activated nuclear receptor and core clock gene retinoic acid-related orphan receptor (ROR). Fasting stimulated, whereas restricted-feeding reduced expression of CYP8B1 mRNA and protein. However, fasting and feeding had little effect on the diurnal rhythm of ROR mRNA expression, but fasting increased ROR protein levels by cAMP-activated protein kinase A-mediated phosphorylation and stabilization of the protein. Adenovirus-mediated gene transduction of ROR to mice strongly induced CYP8B1 expression, and increased liver cholesterol and 12-hydroxylated bile acids in the bile acid pool and serum. A reporter assay identified a functional ROR response element in the CYP8B1 promoter. ROR recruited cAMP response element-binding protein-binding protein (CBP) to stimulate histone acetylation on the CYP8B1 gene promoter. In conclusion, ROR is a key regulator of diurnal rhythm and fasting induction of CYP8B1, which regulates bile acid composition and serum and liver cholesterol levels. Antagonizing ROR activity may be a therapeutic strategy for treating inflammatory diseases such as non-alcoholic fatty liver disease and type 2 diabetes.	[Pathak, Preeti; Li, Tiangang; Chiang, John Y. L. l] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Li, Tiangang] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	Northeast Ohio Medical University (NEOMED); University of Kansas; University of Kansas Medical Center	Chiang, JYL (corresponding author), Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA.		Chiang, John Y. L./G-2658-2011	Chiang, John Y. L./0000-0001-9360-7650	National Institutes of Health [DK44442, DK58379]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058379, R56DK044442, R37DK058379, R01DK044442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44442 and DK58379 (to J. Y. L. C.).	Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Han SX, 2009, DRUG METAB DISPOS, V37, P469, DOI 10.1124/dmd.108.025155; Ishida H, 2000, J BIOCHEM, V127, P57, DOI 10.1093/oxfordjournals.jbchem.a022584; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Li TG, 2007, GASTROENTEROLOGY, V133, P1660, DOI 10.1053/j.gastro.2007.08.042; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Li TG, 2009, BBA-MOL CELL BIOL L, V1791, P991, DOI 10.1016/j.bbalip.2009.05.004; LI YC, 1990, J BIOL CHEM, V265, P12012; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Murphy C, 2005, BBA-MOL CELL BIOL L, V1735, P167, DOI 10.1016/j.bbalip.2005.06.001; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; NOSHIRO M, 1990, J BIOL CHEM, V265, P10036; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Slatis K, 2010, J LIPID RES, V51, P3289, DOI 10.1194/jlr.M009308; Song KH, 2006, HEPATOLOGY, V43, P117, DOI 10.1002/hep.20919; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Wada T, 2008, MOL PHARMACOL, V73, P891, DOI 10.1124/mol.107.040741; Wang DQH, 1999, AM J PHYSIOL-GASTR L, V276, pG751, DOI 10.1152/ajpgi.1999.276.3.G751; Wang J, 2006, BIOCHEM BIOPH RES CO, V342, P1382, DOI 10.1016/j.bbrc.2006.02.108; Wang J, 2006, J LIPID RES, V47, P421, DOI 10.1194/jlr.M500441-JLR200; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641	42	37	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37154	37165		10.1074/jbc.M113.485987	http://dx.doi.org/10.1074/jbc.M113.485987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24226095	Green Published, hybrid			2022-12-28	WOS:000329189700034
J	Lee, SH; Zhu, CF; Peng, Y; Johnson, DT; Lehmann, L; Sun, ZJ				Lee, Suk Hyung; Zhu, Chunfang; Peng, Yue; Johnson, Daniel T.; Lehmann, Lynn; Sun, Zijie			Identification of a Novel Role of ZMIZ2 Protein in Regulating the Activity of the Wnt/beta-Catenin Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Catenin; Cell Signaling; Protein-Protein Interactions; Transcription Regulation; Wnt Signaling; PIAS-like Proteins; Wnt Ligand; ZMIZ2	PIAS-LIKE PROTEIN; RECEPTOR-MEDIATED TRANSCRIPTION; PROSTATE-CANCER CELLS; P53 TUMOR-SUPPRESSOR; BETA-CATENIN; ANDROGEN RECEPTOR; COLON-CARCINOMA; WNT; COMPLEX; EXPRESSION	Background: ZMIZ2 is a transcriptional coactivator, but its biological role has not been fully investigated. Results: We demonstrate a promotional role of ZMIZ2 in -catenin-mediated transcription and cell growth using a variety of biologically relevant in vitro and in vivo approaches. Conclusion: ZMIZ2 is a coactivator of the Wnt/-catenin signaling pathway. Significance: This study explores a novel mechanism for PIAS-like proteins in regulating Wnt signaling pathways. ZMIZ2, also named ZIMP7, is a protein inhibitor of activated STAT (PIAS)-like protein and a transcriptional coactivator. In this study, we investigated the interaction between ZMIZ2 and -catenin, a key regulator of the Wnt signaling pathway. We demonstrated that the expression of exogenous ZMIZ2 augments TCF (T cell factor) and -catenin-mediated transcription. In contrast, shRNA knockdown of ZMIZ2 expression specifically represses the enhancement of TCF/-catenin-mediated transcription by ZMIZ2. Using Wnt3a-conditioned medium, we demonstrated that ZMIZ2 can enhance Wnt ligand-induced TCF/-catenin-mediated transcription. We also showed a promotional role of ZMIZ2 in enhancing -catenin downstream target gene expression in human cells and in Zmiz2 null (Zmiz2(-/-)) mouse embryonic fibroblasts (MEFs). The regulatory role of Zmiz2 in Wnt-induced TCF/-catenin-mediated transcription can be restored in Zmiz2(-/-) MEFs that were infected with adenoviral expression vectors for Zmiz2. Moreover, enhancement of Zmiz2 on TCF/-catenin-mediated transcription was further demonstrated in Zmiz2 knockout and Axin2 reporter compound mice. Furthermore, the protein-protein interaction between ZMIZ2 and -catenin was identified by co-immunoprecipitation and in vitro protein pulldown assays. We also observed recruitment of endogenous ZMIZ2 onto the promoter region of the Axin 2 gene, a -catenin downstream target promoter, in a Wnt ligand-inducible manner. Finally, a promotional role of ZMIZ2 on cell growth was demonstrated in human cell lines and Zmiz2 knockout MEFs. Our findings demonstrate a novel interaction between ZMIZ2 and -catenin and elucidate a novel mechanism for PIAS-like proteins in regulating Wnt signaling pathways.	[Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Sun, Zijie] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Sun, ZJ (corresponding author), Stanford Univ, Sch Med, Dept Urol, S287,Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	National Cancer Institute Public Health Service [R01 CA070297, R01 CA151623, U01 CA166894]; NATIONAL CANCER INSTITUTE [R01CA070297, U01CA166894, R01CA151623] Funding Source: NIH RePORTER	National Cancer Institute Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Public Health Service Grants R01 CA070297, R01 CA151623, and U01 CA166894.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Beliakoff Jason, 2006, Nucl Recept Signal, V4, pe017; Chen GW, 2004, CHEM ENG J, V101, P101, DOI 10.1016/j.cej.2004.01.020; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chesire DR, 2000, PROSTATE, V45, P323, DOI 10.1002/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Farson D, 2001, HUM GENE THER, V12, P981, DOI 10.1089/104303401750195935; Gerstein AV, 2002, GENE CHROMOSOME CANC, V34, P9, DOI 10.1002/gcc.10037; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee J, 2007, NUCLEIC ACIDS RES, V35, P4523, DOI 10.1093/nar/gkm476; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li X, 2011, PLOS ONE, V6; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; Peng Y, 2010, J BIOL CHEM, V285, P11465, DOI 10.1074/jbc.M109.079327; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Polakis P, 2000, GENE DEV, V14, P1837; Rakowski LA, 2013, CANCER RES, V73, P930, DOI 10.1158/0008-5472.CAN-12-1389; Rodriguez-Magadan H, 2008, GENE EXPR PATTERNS, V8, P206, DOI 10.1016/j.modgep.2007.10.005; Rodriguez-Magadan H, 2010, GENE EXPR PATTERNS, V10, P16, DOI 10.1016/j.gep.2009.11.004; Rogers LM, 2013, J INVEST DERMATOL, V133, P1863, DOI 10.1038/jid.2013.77; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Soler G, 2008, LEUKEMIA, V22, P1278, DOI 10.1038/sj.leu.2405033; SUN ZJ, 1995, J BIOL CHEM, V270, P1462, DOI 10.1074/jbc.270.3.1462; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Voeller HJ, 1998, CANCER RES, V58, P2520; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200	61	15	16	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35913	35924		10.1074/jbc.M113.529727	http://dx.doi.org/10.1074/jbc.M113.529727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174533	Green Published, hybrid			2022-12-28	WOS:000329814700028
J	Wu, S; Zheng, SD; Huang, HL; Yan, LC; Yin, XF; Xu, HN; Zhang, KJ; Gui, JH; Chu, L; Liu, XY				Wu, Shuai; Zheng, Shui-Di; Huang, Hong-Ling; Yan, Li-Chong; Yin, Xiao-Fei; Xu, Hai-Neng; Zhang, Kang-Jian; Gui, Jing-Hua; Chu, Liang; Liu, Xin-Yuan			Lithium Down-regulates Histone Deacetylase 1 (HDAC1) and Induces Degradation of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Signaling; Histone Deacetylase; Histone Deacetylase Inhibitors; Huntington Disease; Neurodegeneration; MicroRNA; Autophagy	CELL-CYCLE ARREST; INDUCED NEURODEGENERATION; INHIBITS PROLIFERATION; LIVER PROLIFERATION; BINDING PROTEIN; AUTOPHAGY; DISEASE; CANCER; ACTIVATION; APOPTOSIS	Background: Lithium and valproic acid (VPA) exhibit a robust neuroprotective and anti-tumor effects in neural cells and tumor cells. Results: Lithium significantly down-regulates HDAC1 at the translational level by targeting HDAC1 mRNA. Conclusion: The decrease in HDAC1 is essential for the lithium-mediated, autophagic degradation of mutant huntingtin. Significance: This report is the first demonstration that HDAC1 decreases in response to lithium treatment. Lithium is an effective mood stabilizer that has been clinically used to treat bipolar disorder for several decades. Recent studies have suggested that lithium possesses robust neuroprotective and anti-tumor properties. Thus far, a large number of lithium targets have been discovered. Here, we report for the first time that HDAC1 is a target of lithium. Lithium significantly down-regulated HDAC1 at the translational level by targeting HDAC1 mRNA. We also showed that depletion of HDAC1 is essential for the neuroprotective effects of lithium and for the lithium-mediated degradation of mutant huntingtin through the autophagic pathway. Our studies explain the multiple functions of lithium and reveal a novel mechanism for the function of lithium in neurodegeneration.	[Wu, Shuai; Huang, Hong-Ling; Yan, Li-Chong; Yin, Xiao-Fei; Xu, Hai-Neng; Zhang, Kang-Jian; Chu, Liang; Liu, Xin-Yuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Zheng, Shui-Di; Gui, Jing-Hua; Liu, Xin-Yuan] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 10018, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Sci-Tech University	Chu, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Yueyang Rd, Shanghai 200031, Peoples R China.	lchu@sibcb.ac.cn; xyliu@sibcb.ac.cn	Liu, Xinyuan/HDM-5505-2022; Wu, Shuai/V-4605-2019; Xu, Haineng/A-4345-2016	Xu, Haineng/0000-0001-7195-4897; Gui, Jinghua/0000-0003-2474-500X; Wu, Shuai/0000-0002-3183-5081	National Nature Science Foundation of China [30623003]; National Basic Research Program of China (973 Program) [2010CB529901]; National Science and Technology Specific Project of Hepatitis and Hepatoma Related Program [2008ZX10002-023]; National Basic Research Committee of Science and Technology [06ZR14072, 074119508]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Technology Specific Project of Hepatitis and Hepatoma Related Program; National Basic Research Committee of Science and Technology	This work was supported by the National Nature Science Foundation of China (30623003), the National Basic Research Program of China (973 Program) (2010CB529901), the important National Science and Technology Specific Project of Hepatitis and Hepatoma Related Program (2008ZX10002-023), and the National Basic Research Committee of Science and Technology (06ZR14072 and 074119508).	Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Barrachina M, 2009, J NEUROPATH EXP NEUR, V68, P880, DOI 10.1097/NEN.0b013e3181af2e46; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Catalano MG, 2005, J CLIN ENDOCR METAB, V90, P1383, DOI 10.1210/jc.2004-1355; Chen HM, 2009, INT J NEUROPSYCHOPH, V12, P975, DOI 10.1017/S1461145709000029; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Fujimura K, 2008, EXP CELL RES, V314, P543, DOI 10.1016/j.yexcr.2007.10.024; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kaufmann L, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-15; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Licht RW, 2012, CNS NEUROSCI THER, V18, P219, DOI 10.1111/j.1755-5949.2011.00260.x; Macdonald A, 2008, INT J GERIATR PSYCH, V23, P704, DOI 10.1002/gps.1964; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nunes PV, 2007, BRIT J PSYCHIAT, V190, P359, DOI 10.1192/bjp.bp.106.029868; Oh M, 2008, BIOCHEM BIOPH RES CO, V369, P1179, DOI 10.1016/j.bbrc.2008.03.019; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; QUINN N, 1986, LANCET, V1, P1377; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rolli-Derkinderen M, 2003, J BIOL CHEM, V278, P18859, DOI 10.1074/jbc.M211696200; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Song L, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-20; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stump RJW, 2006, J PATHOL, V210, P249, DOI 10.1002/path.2049; Tang R, 2004, LEUKEMIA, V18, P1246, DOI 10.1038/sj.leu.2403390; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Varshochi R, 2005, J BIOL CHEM, V280, P3185, DOI 10.1074/jbc.M408063200; Vincent T, 2008, ONCOGENE, V27, P5254, DOI 10.1038/onc.2008.152; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang WV, 2005, APOPTOSIS, V10, P75, DOI 10.1007/s10495-005-6063-x; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	75	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35500	35510		10.1074/jbc.M113.479865	http://dx.doi.org/10.1074/jbc.M113.479865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165128	Green Published, hybrid			2022-12-28	WOS:000329867600045
J	Bharathi, SS; Zhang, YX; Mohsen, AW; Uppala, R; Balasubramani, M; Schreiber, E; Uechi, G; Beck, ME; Rardin, MJ; Vockley, J; Verdin, E; Gibson, BW; Hirschey, MD; Goetzman, ES				Bharathi, Sivakama S.; Zhang, Yuxun; Mohsen, Al-Walid; Uppala, Radha; Balasubramani, Manimalha; Schreiber, Emanuel; Uechi, Guy; Beck, Megan E.; Rardin, Matthew J.; Vockley, Jerry; Verdin, Eric; Gibson, Bradford W.; Hirschey, Matthew D.; Goetzman, Eric S.			Sirtuin 3 (SIRT3) Protein Regulates Long-chain Acyl-CoA Dehydrogenase by Deacetylating Conserved Lysines Near the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Transfer; Enzyme Catalysis; FAD; Fatty Acid Oxidation; Mitochondria; Posttranslational Modification; Sirtuins; Acyl-CoA Dehydrogenase; Lysine Acetylation	CALORIE RESTRICTION; ACETYLATION; METABOLISM; PROTEOMICS; ACETYLOME; MECHANISM; OXIDATION; ACYLATION; ENZYMES; PLAYS	Long-chain acyl-CoA dehydrogenase (LCAD) is a key mitochondrial fatty acid oxidation enzyme. We previously demonstrated increased LCAD lysine acetylation in SIRT3 knockout mice concomitant with reduced LCAD activity and reduced fatty acid oxidation. To study the effects of acetylation on LCAD and determine sirtuin 3 (SIRT3) target sites, we chemically acetylated recombinant LCAD. Acetylation impeded substrate binding and reduced catalytic efficiency. Deacetylation with recombinant SIRT3 partially restored activity. Residues Lys-318 and Lys-322 were identified as SIRT3-targeted lysines. Arginine substitutions at Lys-318 and Lys-322 prevented the acetylation-induced activity loss. Lys-318 and Lys-322 flank residues Arg-317 and Phe-320, which are conserved among all acyl-CoA dehydrogenases and coordinate the enzyme-bound FAD cofactor in the active site. We propose that acetylation at Lys-318/Lys-322 causes a conformational change which reduces hydride transfer from substrate to FAD. Medium-chain acyl-CoA dehydrogenase and acyl-CoA dehydrogenase 9, two related enzymes with lysines at positions equivalent to Lys-318/Lys-322, were also efficiently deacetylated by SIRT3 following chemical acetylation. These results suggest that acetylation/deacetylation at Lys-318/Lys-322 is a mode of regulating fatty acid oxidation. The same mechanism may regulate other acyl-CoA dehydrogenases.	[Bharathi, Sivakama S.; Zhang, Yuxun; Mohsen, Al-Walid; Uppala, Radha; Vockley, Jerry; Goetzman, Eric S.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Balasubramani, Manimalha; Schreiber, Emanuel; Uechi, Guy] Univ Pittsburgh, Genom & Prote Core Facil, Pittsburgh, PA 15224 USA; [Beck, Megan E.; Vockley, Jerry; Goetzman, Eric S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15224 USA; [Rardin, Matthew J.; Gibson, Bradford W.] Buck Inst Res Aging, Novato, CA 94945 USA; [Verdin, Eric] Gladstone Inst, San Francisco, CA 94158 USA; [Verdin, Eric] Univ Calif San Francisco, San Francisco, CA 94158 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Buck Institute for Research on Aging; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Duke University	Goetzman, ES (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA.	eric.goetzman@chp.edu	Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016; Verdin, Eric/AAB-7999-2019; Mohsen, Al-Walid/D-6577-2018	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Mohsen, Al-Walid/0000-0002-0096-5959; Hirschey, Matthew/0000-0003-4541-5376; Verdin, Eric/0000-0003-3703-3183	National Institutes of Health [R01 DK090242, R03 DK88870]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493, R01DK078775, R03DK088870, P30DK026743, R01DK090242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health Grants R01 DK090242 and R03 DK88870. To whom correspondence should be addressed. E-mail: eric.goetzman@chp.edu.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Goetzman ES, 2009, OBESITY, V17, P196, DOI 10.1038/oby.2008.467; Goetzman ES, 2005, J BIOL CHEM, V280, P4873, DOI 10.1074/jbc.M412640200; Guo X, 2008, ANAL CHEM, V80, P951, DOI 10.1021/ac701636w; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hirschey MD, 2009, METHOD ENZYMOL, V457, P137, DOI 10.1016/S0076-6879(09)05008-3; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kormanik K, 2012, MOL GENET METAB, V107, P684, DOI 10.1016/j.ymgme.2012.10.009; Landry J, 2003, METHODS, V31, P33, DOI 10.1016/S1046-2023(03)00085-9; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Swigonova Z, 2009, J MOL EVOL, V69, P176, DOI 10.1007/s00239-009-9263-0; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Toogood HS, 2004, J BIOL CHEM, V279, P32904, DOI 10.1074/jbc.M404884200; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Volchenboum SL, 2001, MOL GENET METAB, V74, P226, DOI 10.1006/mgme.2001.3234; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou YY, 2012, J BIOL CHEM, V287, P28307, DOI 10.1074/jbc.M112.384511	38	121	127	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33837	33847		10.1074/jbc.M113.510354	http://dx.doi.org/10.1074/jbc.M113.510354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121500	Green Published, hybrid			2022-12-28	WOS:000327250200028
J	Huang, SB; Okamoto, K; Yu, CR; Sinicrope, FA				Huang, Shengbing; Okamoto, Koichi; Yu, Chunrong; Sinicrope, Frank A.			p62/Sequestosome-1 Up-regulation Promotes ABT-263-induced Caspase-8 Aggregation/Activation on the Autophagosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Bcl-2 Family Proteins; Cancer Therapy; Caspase; BH3 Mimetic; p62; Sequestosome 1	INDUCED CELL-DEATH; PANCREATIC-CANCER CELLS; INDUCED APOPTOSIS; TARGETING AUTOPHAGY; MIMETIC ABT-737; TUMOR-CELLS; ACTIVATION; PROTEIN; INHIBITION; DEGRADATION	Autophagy and apoptosis regulate cancer cell viability in response to cytotoxic stress; however, their functional relationship remains unclear. p62/sequestosome 1 is a multifunctional protein and a signaling hub that shuttles ubiquitinated proteins to the lysosome during autophagy. Autophagy inhibition up-regulates p62, and prior data suggest that p62 may mediate apoptosis. Here, we demonstrate that p62 can regulate a caspase-8-dependent apoptosis in response to the BH3 mimetic agent, ABT-263. Up-regulation of p62 was shown to enhance ABT-263-induced caspase-8 activation that was Bax-dependent and resulted from mitochondrial amplification. Dependence upon caspase-8 was confirmed using caspase-8-deficient cells and by caspase-8 siRNA. Ectopic wild-type p62, but not p62 mutants with loss of ability to promote apoptosis, was shown to co-localize with caspase-8 and to promote its self-aggregation in ABT-263-treated cells, shown using a bimolecular fluorescence complementation assay. Endogenous p62 co-localized with caspase-8 in the presence of ABT-263 plus an autophagy inhibitor. Caspase-8 was shown to interact and co-localize with the autophagosome marker, LC3II. Knockdown of p62 attenuated binding between caspase-8 and LC3II, whereas p62 overexpression enhanced the co-localization of caspase-8 aggregates with LC3. LC3 knockdown did not affect interaction between caspase-8 and p62, suggesting that p62 may facilitate caspase-8 translocation to the autophagosomal membrane. A direct activator of caspase-8, i.e., TRAIL, alone or combined with ABT-263, induced caspase-8 aggregation and co-localization with p62 that was associated with a synergistic drug interaction. Together, these results demonstrate that up-regulation of p62 can mediate apoptosis via caspase-8 in the setting of autophagy inhibition.	[Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.] Mayo Canc Ctr, Rochester, MN 55905 USA; [Yu, Chunrong] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Roswell Park Cancer Institute	Sinicrope, FA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol & Med Oncol, 200 1st St SW, Rochester, MN 55905 USA.	sinicrope.frank@mayo.edu			National Institutes of Health [K05CA142885, R01CA132991, R01CA113681]; Mayo Cancer Center [CA15083]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; NATIONAL CANCER INSTITUTE [K05CA142885, P30CA015083, R01CA113681, R01CA132991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Cancer Center; Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K05CA142885, R01CA132991, and R01CA113681 (to F. A. S.). This work was also supported by Mayo Cancer Center Core Grant CA15083 and Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30DK084567.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Huang SB, 2008, CANCER RES, V68, P2944, DOI 10.1158/0008-5472.CAN-07-2508; Huang SB, 2011, J BIOL CHEM, V286, P40002, DOI 10.1074/jbc.M111.297432; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Huang SB, 2009, CLIN CANCER RES, V15, P150, DOI 10.1158/1078-0432.CCR-08-1575; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Malik SA, 2011, ONCOGENE, V30, P3918, DOI 10.1038/onc.2011.104; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mutlu A, 2012, BRIT J HAEMATOL, V159, P565, DOI 10.1111/bjh.12066; Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Periyasamy-Thandavan S, 2010, AUTOPHAGY, V6, P19, DOI 10.4161/auto.6.1.10323; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Song JH, 2008, J BIOL CHEM, V283, P25003, DOI 10.1074/jbc.M802511200; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Williams J. A., 2012, PLOS ONE, V7; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104	44	79	80	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33654	33666		10.1074/jbc.M113.518134	http://dx.doi.org/10.1074/jbc.M113.518134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121507	Green Published, hybrid			2022-12-28	WOS:000327250200014
J	Lee, KH; Jeong, J; Yoo, CG				Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu			Long-term Incubation with Proteasome Inhibitors (PIs) Induces I kappa B alpha Degradation via the Lysosomal Pathway in an I kappa B Kinase (IKK)-dependent and IKK-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Lung Cancer; Lysosomes; Proteasome; Signal Transduction; GSK-3; IKK; IB; Lysosome; Proteasome Inhibitor	RESPIRATORY EPITHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3; TUMOR-NECROSIS-FACTOR; LUNG-CANCER; THERAPEUTIC TARGET; INDUCED APOPTOSIS; ACTIVATION; PS-341; BORTEZOMIB; TRANSCRIPTION	Background: IB, a cytoplasmic inhibitor of NF-B, is degraded via the proteasome. Results: Paradoxically, proteasome inhibitors (PIs) induce IB degradation via the lysosome in an IKK-dependent and IKK-independent manner. Conclusion: PI-induced IB degradation results in NF-B activation that confers resistance to PI-induced cancer cell death. Significance: This provides a molecular mechanism to enhance the anti-cancer efficacy of PIs. Proteasome inhibitors (PIs) have been reported to induce apoptosis in many types of tumor. Their apoptotic activities have been suggested to be associated with the up-regulation of molecules implicated in pro-apoptotic cascades such as p53, p21(Waf1), and p27(Kip1). Moreover, the blocking of NF-B nuclear translocation via the stabilization of IB is an important mechanism of PI-induced apoptosis. However, we found that long-term incubation with PIs (PS-341 or MG132) increased NF-B-regulated gene expression such as COX-2, cIAP2, XIAP, and IL-8 in a dose- and time-dependent manner, which was mediated by phosphorylation of IB and its subsequent degradation via the alternative route, lysosome. Overexpression of the IB superrepressor (IB-SR) blocked PI-induced NF-B activation. Treatment with lysosomal inhibitors (ammonium chloride or chloroquine) or inhibitors of cathepsins (Z-FF-FMK or Z-FA-FMK) or knock-down of LC3B expression by siRNAs suppressed PI-induced IB degradation. Furthermore, we found that both IKK-dependent and IKK-independent pathways were required for PI-induced IB degradation. Pretreatment with IKK specific inhibitor, SC-514, partially suppressed IB degradation and IL-8 production by PIs. Blockade of IKK activity using insolubilization by heat shock (HS) and knock-down by siRNAs for IKK only delayed IB degradation up to 8 h after treatment with PIs. In addition, PIs induced Akt-dependent inactivation of GSK-3. Inactive GSK-3 accelerated PI-induced IB degradation. Overexpression of active GSK-3 (S9A) or knock-down of GSK-3 delayed PI-induced IB degradation. Collectively, our data demonstrate that long-term incubation with PIs activates NF-B, which is mediated by IB degradation via the lysosome in an IKK-dependent and IKK-independent manner.	[Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110799, South Korea; [Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Lung Inst, Med Res Ctr, Seoul 110799, South Korea; [Lee, Kyoung-Hee; Jeong, Jiyeong; Yoo, Chul-Gyu] Seoul Natl Univ Hosp, Clin Res Inst, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Yoo, CG (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, 101 Daehak Ro, Seoul 110744, South Korea.	cgyoo@snu.ac.kr			Seoul National University Hospital [0320030170]	Seoul National University Hospital	This work was supported by Grant 0320030170 from the Seoul National University Hospital.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Chen F, 1997, ARCH BIOCHEM BIOPHYS, V342, P383, DOI 10.1006/abbi.1997.0132; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Cusack JC, 2001, CANCER RES, V61, P3535; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; Denlinger CE, 2004, ANN THORAC SURG, V78, P1207, DOI 10.1016/j.athoracsur.2004.04.029; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; Eto M, 2005, CIRCULATION, V112, P1316, DOI 10.1161/CIRCULATIONAHA.105.564112; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOLDBERG AL, 1995, CHEM BIOL, V2, P503, DOI 10.1016/1074-5521(95)90182-5; Hideshima T, 2001, CANCER RES, V61, P3071; Kim JY, 2000, BIOCHEM BIOPH RES CO, V273, P140, DOI 10.1006/bbrc.2000.2909; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee KH, 2004, EXP CELL RES, V299, P49, DOI 10.1016/j.yexcr.2004.05.013; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Ling YH, 2003, CLIN CANCER RES, V9, P1145; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Nemeth ZH, 2004, MOL PHARMACOL, V65, P342, DOI 10.1124/mol.65.2.342; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Park GY, 2001, EUR RESPIR J, V18, P801, DOI 10.1183/09031936.01.00099801; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Richardson PG, 2005, CELL CYCLE, V4, P290; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; White DW, 1996, ONCOGENE, V13, P891; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416	36	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32777	32786		10.1074/jbc.M113.480921	http://dx.doi.org/10.1074/jbc.M113.480921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085292	Green Published, hybrid			2022-12-28	WOS:000328681700061
J	Zhang, YN; Eigenbrot, C; Zhou, LJ; Shia, S; Li, W; Quan, C; Tom, J; Moran, P; Di Lello, P; Skelton, NJ; Kong-Beltran, M; Peterson, A; Kirchhofer, D				Zhang, Yingnan; Eigenbrot, Charles; Zhou, Lijuan; Shia, Steven; Li, Wei; Quan, Clifford; Tom, Jeffrey; Moran, Paul; Di Lello, Paola; Skelton, Nicholas J.; Kong-Beltran, Monica; Peterson, Andrew; Kirchhofer, Daniel			Identification of a Small Peptide That Inhibits PCSK9 Protein Binding to the Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; LDL-RECEPTOR; SECRETED PCSK9; CHOLESTEROL; ANTIBODY; DEGRADATION; COMPLEX; DESIGN; RECOGNITION; ANTAGONISTS	PCSK9 (proprotein convertase subtilisin/kexin type 9) is a negative regulator of the hepatic LDL receptor, and clinical studies with PCSK9-inhibiting antibodies have demonstrated strong LDL-c-lowering effects. Here we screened phage-displayed peptide libraries and identified the 13-amino acid linear peptide Pep2-8 as the smallest PCSK9 inhibitor with a clearly defined mechanism of inhibition that has been described. Pep2-8 bound to PCSK9 with a K-D of 0.7 mu M but did not bind to other proprotein convertases. It fully restored LDL receptor surface levels and LDL particle uptake in PCSK9-treated HepG2 cells. The crystal structure of Pep2-8 bound to C-terminally truncated PCSK9 at 1.85 angstrom resolution showed that the peptide adopted a strand-turn-helix conformation, which is remarkably similar to its solution structure determined by NMR. Consistent with the functional binding site identified by an Ala scan of PCSK9, the structural Pep2-8 contact region of about 400 angstrom(2) largely overlapped with that contacted by the EGF(A) domain of the LDL receptor, suggesting a competitive inhibition mechanism. Consistent with this, Pep2-8 inhibited LDL receptor and EGF(A) domain binding to PCSK9 with IC50 values of 0.8 and 0.4 mu M, respectively. Remarkably, Pep2-8 mimicked secondary structural elements of the EGF(A) domain that interact with PCSK9, notably the beta-strand and a discontinuous short alpha-helix, and it engaged in the same beta-sheet hydrogen bonds as EGF(A) does. Although Pep2-8 itself may not be amenable to therapeutic applications, this study demonstrates the feasibility of developing peptidic inhibitors to functionally relevant sites on PCSK9.	[Zhang, Yingnan; Zhou, Lijuan; Li, Wei; Quan, Clifford; Tom, Jeffrey; Moran, Paul; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Eigenbrot, Charles; Shia, Steven; Di Lello, Paola] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Skelton, Nicholas J.] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Kong-Beltran, Monica; Peterson, Andrew] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kirchhofer, D (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	dak@gene.com	Zhou, Li/GSE-4531-2022		Department of Energy Office of Biological and Environmental Research; National Institutes of Health; NIGMS [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Diffraction data were collected at the Stanford Synchrotron Radiation Lightsource (SSRL), operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research, National Institutes of Health, NIGMS (including Grant P41GM103393), and National Center for Research Resources Grant P41RR001209.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andronati SA, 2004, CURR MED CHEM, V11, P1183, DOI 10.2174/0929867043365314; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; DeVay RM, 2013, J BIOL CHEM, V288, P10805, DOI 10.1074/jbc.M113.453373; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franklin MC, 2003, BIOCHEMISTRY-US, V42, P8223, DOI 10.1021/bi034227t; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Liang H, 2012, J PHARMACOL EXP THER, V340, P228, DOI 10.1124/jpet.111.187419; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Lowman HB, 1998, BIOCHEMISTRY-US, V37, P8870, DOI 10.1021/bi980426e; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer-Smith H, 2010, CURR MED CHEM, V17, P2168, DOI 10.2174/092986710791299948; Pan B, 2002, J MOL BIOL, V316, P769, DOI 10.1006/jmbi.2001.5370; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Schaffer ML, 2003, BIOCHEMISTRY-US, V42, P9324, DOI 10.1021/bi034386c; Seidah NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041865; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shan LX, 2008, BIOCHEM BIOPH RES CO, V375, P69, DOI 10.1016/j.bbrc.2008.07.106; Stanger K, 2012, NAT CHEM BIOL, V8, P655, DOI [10.1038/nchembio.967, 10.1038/NCHEMBIO.967]; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tveten K, 2012, HUM MOL GENET, V21, P1402, DOI 10.1093/hmg/ddr578; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto T, 2011, J BIOL CHEM, V286, P5464, DOI 10.1074/jbc.M110.199042; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang YN, 2012, J MOL BIOL, V422, P685, DOI 10.1016/j.jmb.2012.06.018; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	54	98	116	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					942	955		10.1074/jbc.M113.514067	http://dx.doi.org/10.1074/jbc.M113.514067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24225950	Green Published, hybrid			2022-12-28	WOS:000330541200029
J	Borgeling, Y; Schmolke, M; Viemann, D; Nordhoff, C; Roth, J; Ludwig, S				Boergeling, Yvonne; Schmolke, Mirco; Viemann, Dorothee; Nordhoff, Carolin; Roth, Johannes; Ludwig, Stephan			Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelium; Influenza Virus; Interferon; p38 MAPK; STAT Transcription Factor; JAK; STAT Signaling; Highly Pathogenic Avian Influenza Virus (HPAIV); Hypercytokinemia	NF-KAPPA-B; MAP KINASE; A VIRUS; TRANSCRIPTIONAL ACTIVATION; INDUCED PHOSPHORYLATION; SERINE PHOSPHORYLATION; ANTIVIRAL RESPONSES; REGULATORY FACTOR-3; EXPRESSION; INTERFERON	Highly pathogenic avian influenza viruses (HPAIV) induce severe inflammation in poultry and men. One characteristic of HPAIV infections is the induction of a cytokine burst that strongly contributes to viral pathogenicity. This cell-intrinsic hypercytokinemia seems to involve hyperinduction of p38 mitogen-activated protein kinase. Here we investigate the role of p38 MAPK signaling in the antiviral response against HPAIV in mice as well as in human endothelial cells, the latter being a primary source of cytokines during systemic infections. Global gene expression profiling of HPAIV-infected endothelial cells in the presence of the p38-specific inhibitor SB 202190 revealed that inhibition of p38 MAPK leads to reduced expression of IFN and other cytokines after H5N1 and H7N7 infection. More than 90% of all virus-induced genes were either partially or fully dependent on p38 signaling. Moreover, promoter analysis confirmed a direct impact of p38 on the IFN promoter activity. Furthermore, upon treatment with IFN or conditioned media from HPAIV-infected cells, p38 controls interferon-stimulated gene expression by coregulating STAT1 by phosphorylation at serine 727. In vivo inhibition of p38 MAPK greatly diminishes virus-induced cytokine expression concomitant with reduced viral titers, thereby protecting mice from lethal infection. These observations show that p38 MAPK acts on two levels of the antiviral IFN response. Initially the kinase regulates IFN induction and, at a later stage, p38 controls IFN signaling and thereby expression of IFN-stimulated genes. Thus, inhibition of MAP kinase p38 may be an antiviral strategy that protects mice from lethal influenza by suppressing excessive cytokine expression.	[Boergeling, Yvonne; Schmolke, Mirco; Nordhoff, Carolin; Ludwig, Stephan] Univ Munster, Ctr Mol Biol Inflammat, Inst Mol Virol, D-48149 Munster, Germany; [Boergeling, Yvonne; Ludwig, Stephan] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [Roth, Johannes; Ludwig, Stephan] Univ Munster, Cells Mot Cluster Excellence, D-48149 Munster, Germany; [Viemann, Dorothee; Roth, Johannes] Univ Munster, Inst Immunol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Ludwig, S (corresponding author), Ctr Mol Biol Inflammat, Inst Mol Virol, Von Esmarch Str 56, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Schmolke, Mirco/AAI-9081-2020	Schmolke, Mirco/0000-0002-2491-3029; Ludwig, Stephan/0000-0003-4490-3052; Viemann, Dorothee/0000-0002-9009-3559	Interdisciplinary Center for Clinical Research (IZKF) of the University of Muenster [Lud2/010/11]; Deutsche Forschungsgemeinschaft [Lu477/12-1, SFB 1009 TP B02]	Interdisciplinary Center for Clinical Research (IZKF) of the University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) of the University of Muenster (Lud2/010/11) and Deutsche Forschungsgemeinschaft Grants Lu477/12-1 and SFB 1009 TP B02.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Flati V, 1996, EMBO J, V15, P1566, DOI 10.1002/j.1460-2075.1996.tb00501.x; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Horvath CM, 1996, J VIROL, V70, P647, DOI 10.1128/JVI.70.1.647-650.1996; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kang YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000934; KATZE MG, 1984, MOL CELL BIOL, V4, P2198, DOI 10.1128/MCB.4.10.2198; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Klenk HD, 2005, THROMB HAEMOSTASIS, V94, P262, DOI 10.1160/TH05-04-0264; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Nencioni L, 2009, J BIOL CHEM, V284, P16004, DOI 10.1074/jbc.M900146200; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pilz A, 2003, EMBO REP, V4, P368, DOI 10.1038/sj.embor.embor802; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reimer T, 2007, J INTERF CYTOK RES, V27, P751, DOI 10.1089/jir.2007.0024; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Schmolke M, 2009, J IMMUNOL, V183, P5180, DOI 10.4049/jimmunol.0804198; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Uddin S, 2000, J BIOL CHEM, V275, P27634; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2011, J IMMUNOL, V186, P164, DOI 10.4049/jimmunol.0904170; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9	50	75	81	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					13	27		10.1074/jbc.M113.469239	http://dx.doi.org/10.1074/jbc.M113.469239			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24189062	Green Published, hybrid			2022-12-28	WOS:000329370900002
J	Bomberger, JM; Ely, KH; Bangia, N; Ye, SY; Green, KA; Green, WR; Enelow, RI; Stanton, BA				Bomberger, Jennifer M.; Ely, Kenneth H.; Bangia, Naveen; Ye, Siying; Green, Kathy A.; Green, William R.; Enelow, Richard I.; Stanton, Bruce A.			Pseudomonas aeruginosa Cif Protein Enhances the Ubiquitination and Proteasomal Degradation of the Transporter Associated with Antigen Processing (TAP) and Reduces Major Histocompatibility Complex (MHC) Class I Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Antigen Processing; Deubiquitination; Pseudomonas aeruginosa; Ubiquitination; TAP; Airway Epithelial Cell; Viral-Bacterial Co-infection	TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; PEPTIDE-LOADING COMPLEX; T-LYMPHOCYTE EPITOPE; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; DEUBIQUITINATING ENZYMES; HALF-LIFE; VIRUS; TAPASIN	Cif (PA2934), a bacterial virulence factor secreted in outer membrane vesicles by Pseudomonas aeruginosa, increases the ubiquitination and lysosomal degradation of some, but not all, plasma membrane ATP-binding cassette transporters (ABC), including the cystic fibrosis transmembrane conductance regulator and P-glycoprotein. The goal of this study was to determine whether Cif enhances the ubiquitination and degradation of the transporter associated with antigen processing (TAP1 and TAP2), members of the ABC transporter family that play an essential role in antigen presentation and intracellular pathogen clearance. Cif selectively increased the amount of ubiquitinated TAP1 and increased its degradation in the proteasome of human airway epithelial cells. This effect of Cif was mediated by reducing USP10 deubiquitinating activity, resulting in increased polyubiquitination and proteasomal degradation of TAP1. The reduction in TAP1 abundance decreased peptide antigen translocation into the endoplasmic reticulum, an effect that resulted in reduced antigen available to MHC class I molecules for presentation at the plasma membrane of airway epithelial cells and recognition by CD8(+) T cells. Cif is the first bacterial factor identified that inhibits TAP function and MHC class I antigen presentation.	[Bomberger, Jennifer M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Ely, Kenneth H.; Ye, Siying; Green, Kathy A.; Green, William R.; Enelow, Richard I.; Stanton, Bruce A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Bangia, Naveen] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Roswell Park Cancer Institute	Bomberger, JM (corresponding author), Univ Pittsburgh, 450 Technol Dr,416 Bridgeside Point 2, Pittsburgh, PA 15219 USA.	jbomb@pitt.edu	Ye, Siying/H-3156-2013	Ye, Siying/0000-0002-0882-1642; Bangia, Naveen/0000-0003-0631-2323	National Institutes of Health [R00HL098342, P30DK072506, 5T32DK007301, 2R01HL074175, R01-DK/HL45881]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175, R00HL098342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007301, P30DK072506, R01DK045881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R00HL098342 and P30DK072506 (to J. M. B.) and 5T32DK007301, 2R01HL074175, and R01-DK/HL45881 (to B. A. S).	Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn K, 1996, EMBO J, V15, P3247, DOI 10.1002/j.1460-2075.1996.tb00689.x; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bebok Z, 1998, AM J PHYSIOL-CELL PH, V275, pC599, DOI 10.1152/ajpcell.1998.275.2.C599; Beismann-Driemeyer S, 2004, ANGEW CHEM INT EDIT, V43, P4014, DOI 10.1002/anie.200300642; Belicha-Villanueva A, 2008, IMMUNOLOGY, V124, P112, DOI 10.1111/j.1365-2567.2007.02746.x; Bennett EM, 1999, J IMMUNOL, V162, P5049; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Deng YP, 1998, J IMMUNOL, V161, P1677; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hoiby N, 1998, Nord Med, V113, P328; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Iannello A, 2006, J LEUKOCYTE BIOL, V79, P16, DOI 10.1189/jlb.0705397; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Keusekotten K, 2006, J BIOL CHEM, V281, P17545, DOI 10.1074/jbc.M602360200; Kim V, 1997, VIROLOGY, V236, P221, DOI 10.1006/viro.1997.8747; Kim V, 1998, VIRAL IMMUNOL, V11, P197, DOI 10.1089/vim.1998.11.197; Kim V, 2000, J VIROL, V74, P3924, DOI 10.1128/JVI.74.8.3924-3928.2000; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000080; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Leonhardt RM, 2005, J IMMUNOL, V175, P5104, DOI 10.4049/jimmunol.175.8.5104; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Messaoudi I, 1999, J IMMUNOL, V163, P3286; Panter MS, 2012, J BIOL CHEM, V287, P31172, DOI 10.1074/jbc.M112.387704; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Petersen JL, 2003, J IMMUNOL, V171, P4473, DOI 10.4049/jimmunol.171.9.4473; Raghuraman G, 2002, J BIOL CHEM, V277, P41786, DOI 10.1074/jbc.M207128200; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Seliger B, 2001, CANCER RES, V61, P8647; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; van Ewijk BE, 2008, PEDIATRICS, V122, P1171, DOI 10.1542/peds.2007-3139; Verweij MC, 2008, J IMMUNOL, V181, P4894, DOI 10.4049/jimmunol.181.7.4894; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Wat Dennis, 2003, Paediatr Respir Rev, V4, P172, DOI 10.1016/S1526-0542(03)00059-9; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wilkinson TMA, 2006, AM J RESP CRIT CARE, V173, P871, DOI 10.1164/rccm.200509-1489OC; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; Ye S, 2008, AM J PHYSIOL-CELL PH, V295, pC807, DOI 10.1152/ajpcell.00234.2008; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Zarling AL, 2003, J IMMUNOL, V171, P5287, DOI 10.4049/jimmunol.171.10.5287; Zeidler R, 1997, BLOOD, V90, P2390; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhu KC, 1999, ONCOGENE, V18, P7740, DOI 10.1038/sj.onc.1203235	65	38	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					152	162		10.1074/jbc.M113.459271	http://dx.doi.org/10.1074/jbc.M113.459271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24247241	Green Published, hybrid			2022-12-28	WOS:000329370900014
J	Compeer, EB; Flinsenberg, TWH; Boon, L; Hoekstra, ME; Boes, M				Compeer, Ewoud B.; Flinsenberg, Thijs W. H.; Boon, Louis; Hoekstra, Mirjam E.; Boes, Marianne			Tubulation of Endosomal Structures in Human Dendritic Cells by Toll-like Receptor Ligation and Lymphocyte Contact Accompanies Antigen Cross-presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-Cell Interaction; Dendritic Cells; Endosomes; Intracellular Trafficking; T Cell Receptor; Toll-like Receptor (TLR); Live Cell Confocal Microscopy; Recycling; Tubulation; Cross-presentation	COMPLEX CLASS-I; MHC CLASS-I; PLASMA-MEMBRANE; T-CELLS; COMPARTMENTS; TRANSPORT; MATURATION; MOLECULES; SURFACE	Mouse dendritic cells (DCs) can rapidly extend their Class II MHC-positive late endosomal compartments into tubular structures, induced by Toll-like receptor (TLR) triggering. Within antigen-presenting DCs, tubular endosomes polarize toward antigen-specific CD4(+) T cells, which are considered beneficial for their activation. Here we describe that also in human DCs, TLR triggering induces tubular late endosomes, labeled by fluorescent LDL. TLR triggering was insufficient for induced tubulation of transferrin-positive endosomal recycling compartments (ERCs) in human monocyte-derived DCs. We studied endosomal remodeling in human DCs in co-cultures of DCs with CD8(+) T cells. Tubulation of ERCs within human DCs requires antigen-specific CD8(+) T cell interaction. Tubular remodeling of endosomes occurs within 30 min of T cell contact and involves ligation of HLA-A2 and ICAM-1 by T cell-expressed T cell receptor and LFA-1, respectively. Disintegration of microtubules or inhibition of endosomal recycling abolished tubular ERCs, which coincided with reduced antigen-dependent CD8(+) T cell activation. Based on these data, we propose that remodeling of transferrin-positive ERCs in human DCs involves both innate and T cell-derived signals.	[Compeer, Ewoud B.; Flinsenberg, Thijs W. H.; Hoekstra, Mirjam E.; Boes, Marianne] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat, Lab Translat Immunol, NL-3584 EA Utrecht, Netherlands; [Boon, Louis] Bioceros, NL-3584 CM Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Boes, M (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat, Lab Translat Immunol, NL-3584 EA Utrecht, Netherlands.	mboes@umcutrecht.nl	Boon, Laurence/HCI-3629-2022; Compeer, Ewoud Bernardus/E-8553-2015	Compeer, Ewoud Bernardus/0000-0002-3050-7633; Boes, Marianne/0000-0003-2590-1692; Boon, Louis/0000-0002-0937-9171; Flinsenberg, Thijs/0000-0003-4268-3279; Hoekstra, Mirjam/0000-0003-4434-9813	Wilhelmina Research Fund	Wilhelmina Research Fund	This work was supported by the Wilhelmina Research Fund (to M. B.).	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Barois N, 2002, TRAFFIC, V3, P894, DOI 10.1034/j.1600-0854.2002.31205.x; Bertho N, 2003, J IMMUNOL, V171, P5689, DOI 10.4049/jimmunol.171.11.5689; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boes M, 2003, J IMMUNOL, V171, P4081, DOI 10.4049/jimmunol.171.8.4081; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dustin ML, 2006, CURR OPIN IMMUNOL, V18, P512, DOI 10.1016/j.coi.2006.05.017; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Flinsenberg TWH, 2012, BLOOD, V120, P5163, DOI 10.1182/blood-2012-06-434498; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hasegawa S, 2001, GENE THER, V8, P1669, DOI 10.1038/sj.gt.3301573; Kaniuk NA, 2011, CELL MICROBIOL, V13, P1812, DOI 10.1111/j.1462-5822.2011.01663.x; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lebedeva T, 2004, IMMUNOLOGY, V113, P460, DOI 10.1111/j.1365-2567.2004.01985.x; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van Weert AWM, 2000, EUR J CELL BIOL, V79, P394, DOI 10.1078/0171-9335-00062; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vyas JM, 2007, J IMMUNOL, V178, P7199, DOI 10.4049/jimmunol.178.11.7199	32	13	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					520	528		10.1074/jbc.M113.511147	http://dx.doi.org/10.1074/jbc.M113.511147			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235148	Green Published, hybrid			2022-12-28	WOS:000329370900044
J	Pandey, A; Gordon, DM; Pain, J; Stemmler, TL; Dancis, A; Pain, D				Pandey, Alok; Gordon, Donna M.; Pain, Jayashree; Stemmler, Timothy L.; Dancis, Andrew; Pain, Debkumar			Frataxin Directly Stimulates Mitochondrial Cysteine Desulfurase by Exposing Substrate-binding Sites, and a Mutant Fe-S Cluster Scaffold Protein with Frataxin-bypassing Ability Acts Similarly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron-Sulfur Protein; Metal Homeostasis; Metals; Mitochondria; Mitochondrial Metabolism; Pyridoxal Phosphate; Sulfur; Yeast	YEAST FRATAXIN; INTERACTING PROTEIN; IRON; BIOGENESIS; HOMOLOG; DEFICIENCY; IDENTIFICATION; MECHANISM; ACONITASE; INSIGHTS	For iron-sulfur (Fe-S) cluster synthesis in mitochondria, the sulfur is derived from the amino acid cysteine by the cysteine desulfurase activity of Nfs1. The enzyme binds the substrate cysteine in the pyridoxal phosphate-containing site, and a persulfide is formed on the active site cysteine in a manner depending on the accessory protein Isd11. The persulfide is then transferred to the scaffold Isu, where it combines with iron to form the Fe-S cluster intermediate. Frataxin is implicated in the process, although it is unclear where and how, and deficiency causes Friedreich ataxia. Using purified proteins and isolated mitochondria, we show here that the yeast frataxin homolog (Yfh1) directly and specifically stimulates cysteine binding to Nfs1 by exposing substrate-binding sites. This novel function of frataxin does not require iron, Isu1, or Isd11. Once bound to Nfs1, the substrate cysteine is the source of the Nfs1 persulfide, but this step is independent of frataxin and strictly dependent on Isd11. Recently, a point mutation in Isu1 was found to bypass many frataxin functions. The data presented here show that the Isu1 suppressor mimics the frataxin effects on Nfs1, explaining the bypassing activity. We propose a regulatory mechanism for the Nfs1 persulfide-forming activity. Specifically, at least two separate conformational changes must occur in the enzyme for optimum activity as follows: one is mediated by frataxin interaction that exposes the buried substrate-binding sites, and the other is mediated by Isd11 interaction that brings the bound substrate cysteine and the active site cysteine in proximity for persulfide formation.	[Pandey, Alok; Gordon, Donna M.; Pain, Jayashree; Pain, Debkumar] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07101 USA; [Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Dancis, Andrew] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Wayne State University; University of Pennsylvania	Pain, D (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol & Physiol, 185 South Orange Ave,MSB I-669, Newark, NJ 07101 USA.	painde@njms.rutgers.edu			National Institutes of Health from NIA [RO1AG030504, RO1DK068139, R37DK053953]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139, R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	National Institutes of Health from NIA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AG030504 from NIA (to D. P.), RO1DK068139 (to T. L. S.), and R37DK053953 (to A. D.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chouchani ET, 2011, CURR OPIN CHEM BIOL, V15, P120, DOI 10.1016/j.cbpa.2010.11.003; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gordon DM, 2001, HUM MOL GENET, V10, P259, DOI 10.1093/hmg/10.3.259; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Lesuisse E, 2004, BIOCHEM J, V378, P599, DOI 10.1042/BJ20031387; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Naamati A, 2009, J BIOL CHEM, V284, P30200, DOI 10.1074/jbc.M109.034694; Pain J, 2010, J BIOL CHEM, V285, P39409, DOI 10.1074/jbc.M110.178947; Pandey A, 2012, BIOCHEM J, V448, P171, DOI 10.1042/BJ20120951; Pandey A, 2012, MITOCHONDRION, V12, P539, DOI 10.1016/j.mito.2012.07.103; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; SANCHEZ-CASIS G, 1976, Canadian Journal of Neurological Sciences, V3, P349; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Tsou AY, 2009, CNS DRUGS, V23, P213, DOI 10.2165/00023210-200923030-00003; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	41	70	71	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36773	36786		10.1074/jbc.M113.525857	http://dx.doi.org/10.1074/jbc.M113.525857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217246	Green Published, hybrid			2022-12-28	WOS:000329189700002
J	Kistler, AD; Singh, G; Altintas, MM; Yu, H; Fernandez, IC; Gu, CK; Wilson, C; Srivastava, SK; Dietrich, A; Walz, K; Kerjaschki, D; Ruiz, P; Dryer, S; Sever, S; Dinda, AK; Faul, C; Reiser, J				Kistler, Andreas D.; Singh, Geetika; Altintas, Mehmet M.; Yu, Hao; Fernandez, Isabel C.; Gu, Changkyu; Wilson, Cory; Srivastava, Sandeep Kumar; Dietrich, Alexander; Walz, Katherina; Kerjaschki, Dontscho; Ruiz, Phillip; Dryer, Stuart; Sever, Sanja; Dinda, Amit K.; Faul, Christian; Reiser, Jochen			Transient Receptor Potential Channel 6 (TRPC6) Protects Podocytes during Complement-mediated Glomerular Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; CaMKII; Complement; Kidney; Podocytes; TRP Channels; TRPC6; Membranous Nephropathy; Nephrotoxic Serum Nephritis	DECAY-ACCELERATING FACTOR; MEMBRANOUS NEPHROPATHY; SLIT DIAPHRAGM; ACTIN; INJURY; SYNAPTOPODIN; CONTRIBUTES; ACTIVATION; PODOCIN; CYTOSKELETON	Background: Activating mutations of the calcium channel TRPC6 lead to adult onset genetic kidney disease. Results: In acquired kidney diseases, increased TRPC6 expression protects kidney podocytes against complement-mediated injury. Conclusion: The effect, protective or nocuous, of TRPC6 in podocytes is context dependent. Significance: Pharmacologic inhibition of TRPC6 in acquired kidney disease may be detrimental. Gain-of-function mutations in the calcium channel TRPC6 lead to autosomal dominant focal segmental glomerulosclerosis and podocyte expression of TRPC6 is increased in some acquired human glomerular diseases, particularly in membranous nephropathy. These observations led to the hypothesis that TRPC6 overactivation is deleterious to podocytes through pathological calcium signaling, both in genetic and acquired diseases. Here, we show that the effects of TRPC6 on podocyte function are context-dependent. Overexpression of TRPC6 alone did not directly affect podocyte morphology and cytoskeletal structure. Unexpectedly, however, overexpression of TRPC6 protected podocytes from complement-mediated injury, whereas genetic or pharmacological TRPC6 inactivation increased podocyte susceptibility to complement. Mechanistically, this effect was mediated by Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation. Podocyte-specific TRPC6 transgenic mice showed stronger CaMKII activation, reduced podocyte foot process effacement and reduced levels of proteinuria during nephrotoxic serum nephritis, whereas TRPC6 null mice exhibited reduced CaMKII activation and higher levels of proteinuria compared with wild type littermates. Human membranous nephropathy biopsy samples showed podocyte staining for active CaMKII, which correlated with the degree of TRPC6 expression. Together, these data suggest a dual and context dependent role of TRPC6 in podocytes where acute activation protects from complement-mediated damage, but chronic overactivation leads to focal segmental glomerulosclerosis.	[Kistler, Andreas D.; Yu, Hao; Faul, Christian] Univ Miami, Dept Med, Div Nephrol & Hypertens, Miller Sch Med, Miami, FL 33136 USA; [Kistler, Andreas D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Singh, Geetika; Srivastava, Sandeep Kumar; Dinda, Amit K.] All India Inst Med Sci, Dept Pathol, New Delhi 110029, DL, India; [Altintas, Mehmet M.; Fernandez, Isabel C.; Reiser, Jochen] Rush Univ, Dept Med, Ctr Med, Chicago, IL 60612 USA; [Gu, Changkyu; Sever, Sanja] Harvard Univ, Sch Med, Dept Med, Nephrol Div, Charlestown, MA 02129 USA; [Gu, Changkyu; Sever, Sanja] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Wilson, Cory; Dryer, Stuart] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Dietrich, Alexander] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany; [Walz, Katherina] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL 33136 USA; [Kerjaschki, Dontscho] Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria; [Ruiz, Phillip] Univ Miami, Dept Surg, Miami, FL 33136 USA	University of Miami; University of Zurich; University Zurich Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Rush University; Harvard University; Harvard University; Massachusetts General Hospital; University of Houston System; University of Houston; University of Munich; University of Miami; Medical University of Vienna; University of Miami	Kistler, AD (corresponding author), Rush Univ, Dept Med, Ctr Med, 1735 W Harrison St,Cohn Res Bldg,Ste 724, Chicago, IL 60612 USA.	jochen_reiser@rush.edu	Dietrich, Alexander/G-8619-2013; srivastava, sandeep/ABH-3565-2022; Faul, Christian/AAG-7800-2022; Faul, Christian/AFL-7858-2022; Altintas, Mehmet Mete/ABI-5904-2020; Altintas, Mehmet Mete/T-5333-2018	Dietrich, Alexander/0000-0002-1168-8707; srivastava, sandeep/0000-0002-9965-2257; Faul, Christian/0000-0002-7512-0977; Faul, Christian/0000-0002-7512-0977; Altintas, Mehmet Mete/0000-0002-1871-6985; Kistler, Andreas/0000-0002-4114-9560; Wilson, Cory/0000-0003-3948-3831; SRIVASTAVA, SANDEEP/0000-0003-4484-0223	National Institutes of Health [DK073495, DK089394, DK101350]; Swiss National Science Foundation; Swiss Society for Medical and Biological Scholarships; Amgen-FROMO scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101350, R01DK089394, R01DK073495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society for Medical and Biological Scholarships; Amgen-FROMO scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants DK073495, DK089394, and DK101350 from the National Institutes of Health (to J. R.).; Supported by a grant from the Swiss National Science Foundation, a grant from the Swiss Society for Medical and Biological Scholarships, and an Amgen-FROMO scholarship. To whom correspondence may be addressed: University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland. Tel.: 41-44-255-13-89; Fax: 41-44-255-45-93.	Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; CYBULSKY AV, 1989, AM J PHYSIOL, V257, pF826, DOI 10.1152/ajprenal.1989.257.5.F826; CYBULSKY AV, 1990, KIDNEY INT, V38, P803, DOI 10.1038/ki.1990.274; Debiec H, 2011, NEW ENGL J MED, V364, P2101, DOI 10.1056/NEJMoa1013792; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; Glassock RJ, 2012, CURR OPIN NEPHROL HY, V21, P235, DOI 10.1097/MNH.0b013e3283522ea8; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Hebert MJ, 1998, NEPHROL DIAL TRANSPL, V13, P2799, DOI 10.1093/ndt/13.11.2799; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jefferson J Ashley, 2010, Drug Discov Today Dis Models, V7, P27, DOI 10.1016/j.ddmod.2010.11.001; Kerjaschki D, 1997, J CLIN INVEST, V100, P2303, DOI 10.1172/JCI119768; Kim EY, 2013, AM J PHYSIOL-CELL PH, V305, pC960, DOI 10.1152/ajpcell.00191.2013; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Laude AJ, 2009, FEBS J, V276, P1800, DOI 10.1111/j.1742-4658.2009.06927.x; Lavin PJ, 2008, CURR OPIN NEPHROL HY, V17, P386, DOI 10.1097/MNH.0b013e32830464f4; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lin F, 2002, LAB INVEST, V82, P563, DOI 10.1038/labinvest.3780451; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Moller CC, 2009, J AM SOC NEPHROL, V20, P950, DOI 10.1681/ASN.2008030329; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Ophascharoensuk V, 1998, KIDNEY INT, V54, P416, DOI 10.1046/j.1523-1755.1998.00003.x; Quigg RJ, 1998, J EXP MED, V188, P1321, DOI 10.1084/jem.188.7.1321; Quigg RJ, 1998, J IMMUNOL, V160, P4553; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Skelding KA, 2009, NEUROCHEM RES, V34, P1792, DOI 10.1007/s11064-009-9985-9; Takano T, 2000, AM J PATHOL, V156, P2091, DOI 10.1016/S0002-9440(10)65080-8; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; Turnberg D, 2003, J AM SOC NEPHROL, V14, P2271, DOI 10.1097/01.ASN.0000083901.47783.2E; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215	51	32	34	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36598	36609		10.1074/jbc.M113.488122	http://dx.doi.org/10.1074/jbc.M113.488122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194522	Green Published, hybrid			2022-12-28	WOS:000328883400040
J	Luoto, HH; Nordbo, E; Baykov, AA; Lahti, R; Malinen, AM				Luoto, Heidi H.; Nordbo, Erika; Baykov, Alexander A.; Lahti, Reijo; Malinen, Anssi M.			Membrane Na+-pyrophosphatases Can Transport Protons at Low Sodium Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Enzyme Kinetics; Enzyme Mechanisms; Membrane Energetics; Membrane Proteins; Molecular Evolution; Proton Transport; Sodium Transport; Membrane Pyrophosphatase; Pyrophosphate	H+-PYROPHOSPHATASE; ESCHERICHIA-COLI; ATP SYNTHASE; TRANSLOCATING PYROPHOSPHATASE; RHODOSPIRILLUM-RUBRUM; BINDING; IDENTIFICATION; RESIDUES; ENZYME; IONS	Background: Prokaryotic membrane Na+-PPases couple PPi hydrolysis with active Na+ transport. Results: Na+-PPases can transport both Na+ and H+ at Na+ concentrations <5 mm but only Na+ above this level. Conclusion: Na+-PPases are dual specificity transporters in which H+ transport activity is masked under physiological conditions. Significance: Inherent Na+/H+ promiscuity provides a basis for Na+-PPase evolution to H+-PPase. Membrane-bound Na+-pyrophosphatase (Na+-PPase), working in parallel with the corresponding ATP-energized pumps, catalyzes active Na+ transport in bacteria and archaea. Each approximate to 75-kDa subunit of homodimeric Na+-PPase forms an unusual funnel-like structure with a catalytic site in the cytoplasmic part and a hydrophilic gated channel in the membrane. Here, we show that at subphysiological Na+ concentrations (<5 mm), the Na+-PPases of Chlorobium limicola, four other bacteria, and one archaeon additionally exhibit an H+-pumping activity in inverted membrane vesicles prepared from recombinant Escherichia coli strains. H+ accumulation in vesicles was measured with fluorescent pH indicators. At pH 6.2-8.2, H+ transport activity was high at 0.1 mm Na+ but decreased progressively with increasing Na+ concentrations until virtually disappearing at 5 mm Na+. In contrast, Na-22(+) transport activity changed little over a Na+ concentration range of 0.05-10 mm. Conservative substitutions of gate Glu(242) and nearby Ser(243) and Asn(677) residues reduced the catalytic and transport functions of the enzyme but did not affect the Na+ dependence of H+ transport, whereas a Lys(681) substitution abolished H+ (but not Na+) transport. All four substitutions markedly decreased PPase affinity for the activating Na+ ion. These results are interpreted in terms of a model that assumes the presence of two Na+-binding sites in the channel: one associated with the gate and controlling all enzyme activities and the other located at a distance and controlling only H+ transport activity. The inherent H+ transport activity of Na+-PPase provides a rationale for its easy evolution toward specific H+ transport.	[Luoto, Heidi H.; Nordbo, Erika; Lahti, Reijo; Malinen, Anssi M.] Univ Turku, Dept Biochem, FIN-20014 Turku, Finland; [Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University	Malinen, AM (corresponding author), Univ Turku, Dept Biochem, Vatselankatu 2, FIN-20014 Turku, Finland.	anssi.malinen@utu.fi	Baykov, Alexander/AAH-5301-2021; Baykov, Alexander A/C-7981-2012	Baykov, Alexander/0000-0002-2495-8200; Malinen, Anssi/0000-0003-2987-2649; Artukka, Erika/0000-0003-0035-6923	Academy of Finland [139031]; Russian Foundation for Basic Research [12-04-01002]; Ministry of Education and the Academy of Finland	Academy of Finland(Academy of Finland); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and the Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland Grant 139031, Russian Foundation for Basic Research Grant 12-04-01002, and grants from the Ministry of Education and the Academy of Finland (to the National Graduate School in Informational and Structural Biology).	Baykov AA, 1996, EUR J BIOCHEM, V236, P121, DOI 10.1111/j.1432-1033.1996.00121.x; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Baykov AA, 2013, MICROBIOL MOL BIOL R, V77, P267, DOI 10.1128/MMBR.00003-13; Belogurov GA, 2005, BIOCHEMISTRY-US, V44, P2088, DOI 10.1021/bi048429g; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Belogurov GA, 2002, J BIOL CHEM, V277, P22209, DOI 10.1074/jbc.M202951200; Biegel E, 2011, J BIOL CHEM, V286, P6080, DOI 10.1074/jbc.M110.192823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASADIO R, 1991, EUR BIOPHYS J, V19, P189; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; Dzioba J, 2003, J BACTERIOL, V185, P674, DOI 10.1128/JB.185.2.674-678.2003; GordonWeeks R, 1996, PLANT PHYSIOL, V111, P195, DOI 10.1104/pp.111.1.195; HARA Y, 1986, J BIOCHEM, V99, P531, DOI 10.1093/oxfordjournals.jbchem.a135509; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P930, DOI 10.1016/j.bbabio.2007.03.014; Holm NG, 2011, ORIGINS LIFE EVOL B, V41, P483, DOI 10.1007/s11084-011-9235-4; Huang YT, 2013, J BIOL CHEM, V288, P19312, DOI 10.1074/jbc.M113.469353; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; LAUBINGER W, 1989, BIOCHEMISTRY-US, V28, P7194, DOI 10.1021/bi00444a010; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Luoto HH, 2013, P NATL ACAD SCI USA, V110, P1255, DOI 10.1073/pnas.1217816110; Luoto HH, 2011, J BIOL CHEM, V286, P21633, DOI 10.1074/jbc.M111.244483; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Nadson G.A., 1906, B JARD BOT ST PETERS, V6, P190; REIDLINGER J, 1994, EUR J BIOCHEM, V223, P275, DOI 10.1111/j.1432-1033.1994.tb18992.x; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ZHANG Y, 1995, J BIOL CHEM, V270, P87, DOI 10.1074/jbc.270.1.87; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153	33	24	27	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35489	35499		10.1074/jbc.M113.510909	http://dx.doi.org/10.1074/jbc.M113.510909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24158447	Green Published, hybrid			2022-12-28	WOS:000329867600044
J	Gotoh, A; Hidaka, M; Hirose, K; Uchida, T				Gotoh, Aina; Hidaka, Masafumi; Hirose, Keiko; Uchida, Takafumi			Gas7b (Growth Arrest Specific Protein 7b) Regulates Neuronal Cell Morphology by Enhancing Microtubule and Actin Filament Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Alzheimer Disease; Electron Microscopy (EM); Microtubules; Neurite Outgrowth	TUBULIN; PURIFICATION; MATURATION; DYNAMICS; MAP2	Background: Growth arrest specific protein 7b (Gas7b) protein levels are significantly reduced in the brain tissue of patients with Alzheimer disease. Results: Gas7b enhances microtubule bundling and microtubule cross-linking with the actin filament. Conclusion: Gas7b regulates neural cell morphology by altering the cytoskeletal organization. Significance: A decrease in Gas7b levels impairs neural cell function. Neurons undergo several morphological changes as a part of normal neuron maturation process. Alzheimer disease is associated with increased neuroproliferation and impaired neuronal maturation. In this study, we demonstrated that Gas7b (growth arrest specific protein 7b) expression in a neuronal cell line, Neuro 2A, induces cell maturation by facilitating formation of dendrite-like processes and/or filopodia projections and that Gas7b co-localizes with neurite microtubules. Molecular analysis was performed to evaluate whether Gas7b associates with actin filaments and microtubules, and the data revealed two novel roles of Gas7b in neurite outgrowth: we showed that Gas7b enhances bundling of several microtubule filaments and connects microtubules with actin filaments. These results suggest that Gas7b governs neural cell morphogenesis by enhancing the coordination between actin filaments and microtubules. We conclude that lower neuronal Gas7b levels may impact Alzheimer disease progression.	[Gotoh, Aina; Hidaka, Masafumi; Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 9818555, Japan; [Hirose, Keiko] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Tsukuba, Ibaraki 3058561, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST)	Uchida, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Aoba Ku, 1-1 Amamiya, Sendai, Miyagi 9818555, Japan.	uchidat@biochem.tohoku.ac.jp	; Hirose, Keiko/M-5429-2018	Uchida, Takafumi/0000-0003-3665-4906; Hirose, Keiko/0000-0003-4587-8346; Gotoh, Aina/0000-0002-0979-2265	JSPS [S 20228006, 11J07541]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [11J07541] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows and Scientific Research Kiban S 20228006 (to T. U.) and Research Fellowship from the JSPS for Young Scientists 11J07541 (to A. G.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akiyama H, 2009, J BIOL CHEM, V284, P32695, DOI 10.1074/jbc.M109.035998; Alberts B., 2008, MOL BIOL CEL, V5th ed.; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; BONNE D, 1985, J BIOL CHEM, V260, P2819; Bouslama-Oueghlani L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049015; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Halbach A, 2007, FEBS J, V274, P773, DOI 10.1111/j.1742-4658.2006.05622.x; HEUSELE C, 1987, EUR J BIOCHEM, V165, P613, DOI 10.1111/j.1432-1033.1987.tb11484.x; Hidaka M, 2012, J BIOCHEM, V151, P593, DOI 10.1093/jb/mvs038; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lortie K, 2005, BRAIN RES, V1036, P27, DOI 10.1016/j.brainres.2004.12.024; Lu PJ, 1999, NATURE, V399, P784; Noguchi TQP, 2007, J BIOL CHEM, V282, P27721, DOI 10.1074/jbc.M703165200; Ramjaun AR, 1999, J BIOL CHEM, V274, P19785, DOI 10.1074/jbc.274.28.19785; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; TAKEMURA R, 1992, J CELL SCI, V103, P953; Uchida T, 2009, J MOL BIOL, V391, P849, DOI 10.1016/j.jmb.2009.06.081; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	30	18	20	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34699	34706		10.1074/jbc.M113.513119	http://dx.doi.org/10.1074/jbc.M113.513119			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151073	Green Published, hybrid			2022-12-28	WOS:000329812800036
J	Condliffe, SB; Fratangeli, A; Munasinghe, NR; Saba, E; Passafaro, M; Montrasio, C; Ferrari, M; Rosa, P; Carrera, P				Condliffe, Steven B.; Fratangeli, Alessandra; Munasinghe, Nehan R.; Saba, Elena; Passafaro, Maria; Montrasio, Cristina; Ferrari, Maurizio; Rosa, Patrizia; Carrera, Paola			The E1015K Variant in the Synprint Region of the Ca(V)2.1 Channel Alters Channel Function and Is Associated with Different Migraine Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Genetics; Neurological Diseases; Protein-Protein Interactions; SNARE Proteins; Migraine	FAMILIAL HEMIPLEGIC MIGRAINE; GATED CALCIUM-CHANNELS; PROTEIN-INTERACTION SITE; EPISODIC ATAXIA TYPE-2; CA2+ CHANNEL; GLUTAMATERGIC NEURONS; SYNAPTIC PLASTICITY; ALPHA(1) SUBUNIT; N-TYPE; MUTATIONS	Mutations in the CACNA1A gene, which encodes the pore-forming 1A subunit of the Ca(V)2.1 voltage-gated calcium channel, cause a number of human neurologic diseases including familial hemiplegic migraine. We have analyzed the functional impact of the E1015K amino acid substitution located in the synprint domain of the 1A subunit. This variant was identified in two families with hemiplegic migraine and in one patient with migraine with aura. The wild type (WT) and the E1015K forms of the GFP-tagged 1A subunit were expressed in cultured hippocampal neurons and HEK cells to understand the role of the variant in the transport activity and physiology of Ca(V)2.1. The E1015K variant does not alter Ca(V)2.1 protein expression, and its transport to the cell surface and synaptic terminals is similar to that observed for WT channels. Electrophysiological data demonstrated that E1015K channels have increased current density and significantly altered inactivation properties compared with WT. Furthermore, the SNARE proteins syntaxin 1A and SNAP-25 were unable to modulate voltage-dependent inactivation of E1015K channels. Overall, our findings describe a genetic variant in the synprint site of the Ca(V)2.1 channel which is characterized by a gain-of-function and associated with both hemiplegic migraine and migraine with aura in patients.	[Condliffe, Steven B.; Munasinghe, Nehan R.] Univ Otago, Dept Physiol, Dunedin 9054, New Zealand; [Fratangeli, Alessandra; Saba, Elena; Passafaro, Maria; Rosa, Patrizia] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, CNR, Inst Neurosci, I-20129 Milan, Italy; [Montrasio, Cristina; Ferrari, Maurizio; Carrera, Paola] Hosp San Raffaele, Ctr Translat Genom & Bioinformat & Laboraf, I-20132 Milan, Italy; [Ferrari, Maurizio] Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Otago; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Condliffe, SB (corresponding author), Univ Otago, Dept Physiol, POB 56, Dunedin 9054, New Zealand.	steven.condliffe@otago.ac.nz; p.rosa@in.cnr.it; carrera.paola@hsr.it	Saba, Elena/ABH-9313-2020	Saba, Elena/0000-0002-8217-5968; Rosa, Patrizia/0000-0002-2590-6955; Carrera, Paola/0000-0001-7376-2119; Condliffe, Steven/0000-0002-5621-3924	University of Otago; Department of Physiology, University of Otago; Fondazione Cariplo Grants [2004.1600, 2012.0546]; Regione Lombardia Project [NUTEC 30263049]	University of Otago; Department of Physiology, University of Otago; Fondazione Cariplo Grants(Fondazione Cariplo); Regione Lombardia Project(Regione Lombardia)	This work was supported by a University of Otago research grant and the Department of Physiology, University of Otago (to S. B. C.), Fondazione Cariplo Grants 2004.1600 (to P. R. and P. C.) and 2012.0546, and Regione Lombardia Project NUTEC 30263049 (to P. R. and M. P.)	Adams PJ, 2010, P NATL ACAD SCI USA, V107, P18694, DOI 10.1073/pnas.1009500107; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Catterall WA, 2013, J BIOL CHEM, V288, P10742, DOI 10.1074/jbc.R112.411645; Cohen-Kutner M, 2010, CHANNELS, V4, P266, DOI 10.4161/chan.4.4.12130; Condliffe SB, 2011, CHANNELS, V5, P304, DOI 10.4161/chan.5.4.16228; Condliffe SB, 2010, J BIOL CHEM, V285, P24968, DOI 10.1074/jbc.M110.145813; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Garza-Lopez E, 2012, BBA-MOL BASIS DIS, V1822, P1238, DOI 10.1016/j.bbadis.2012.04.008; Hans M, 1999, J NEUROSCI, V19, P1610; Jarvis SE, 2007, CURR OPIN CELL BIOL, V19, P474, DOI 10.1016/j.ceb.2007.04.020; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Melliti K, 2003, J PHYSIOL-LONDON, V546, P337, DOI 10.1113/jphysiol.2002.026716; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Mullner C, 2004, J BIOL CHEM, V279, P51844, DOI 10.1074/jbc.M408756200; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; Serra SA, 2010, P NATL ACAD SCI USA, V107, P1672, DOI 10.1073/pnas.0908359107; Sheng ZH, 1996, NATURE, V379, P451, DOI 10.1038/379451a0; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tottene A, 2005, J BIOL CHEM, V280, P17678, DOI 10.1074/jbc.M501110200; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; van den Maagdenberg AMJM, 2002, J NEUROL, V249, P1515, DOI 10.1007/s00415-002-0860-8; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200; WITCHER DR, 1995, J BIOL CHEM, V270, P18088, DOI 10.1074/jbc.270.30.18088; Yokoyama CT, 2005, MOL CELL NEUROSCI, V28, P1, DOI 10.1016/j.mcn.2004.08.019; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	39	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33873	33883		10.1074/jbc.M113.497701	http://dx.doi.org/10.1074/jbc.M113.497701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108129	Green Published, hybrid			2022-12-28	WOS:000327250200031
J	Mantuano, E; Lam, MS; Gonias, SL				Mantuano, Elisabetta; Lam, Michael S.; Gonias, Steven L.			LRP1 Assembles Unique Co-receptor Systems to Initiate Cell Signaling in Response to Tissue-type Plasminogen Activator and Myelin-associated Glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; ERK; Lipoprotein-like Receptor (LRP); Protease Inhibitor; Tissue-type Plasminogen Activator (tPA)	RECEPTOR-RELATED PROTEIN; METHYL-D-ASPARTATE; BLOOD-BRAIN-BARRIER; LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; ALPHA-2-MACROGLOBULIN RECEPTOR; MOLECULAR DISSECTION; MEDIATED ACTIVATION; CALCIUM RESPONSES	In addition to functioning as an activator of fibrinolysis, tissue-type plasminogen activator (tPA) interacts with neurons and regulates multiple aspects of neuronal cell physiology. In this study, we examined the mechanism by which tPA initiates cell signaling in PC12 and N2a neuron-like cells. We demonstrate that enzymatically active and inactive tPA (EI-tPA) activate ERK1/2 in a biphasic manner. Rapid ERK1/2 activation is dependent on LDL receptor-related protein-1 (LRP1). In the second phase, ERK1/2 is activated by tPA independently of LRP1. The length of the LRP1-dependent phase varied inversely with the tPA concentration. Rapid ERK1/2 activation in response to EI-tPA and activated (2)-macroglobulin (M-2*) required the NMDA receptor and Trk receptors, which assemble with LRP1 into a single pathway. Assembly of this signaling system may have been facilitated by the bifunctional adapter protein, PSD-95, which associated with LRP1 selectively in cells treated with EI-tPA or M-2*. Myelin-associated glycoprotein binds to LRP1 with high affinity but failed to induce phosphorylation of TrkA or ERK1/2. Instead, myelin-associated glycoprotein recruited p75 neurotrophin receptor (p75NTR) into a complex with LRP1 and activated RhoA. p75NTR was not recruited by other LRP1 ligands, including EI-tPA and M-2*. Lactoferrin functioned as an LRP1 signaling antagonist, inhibiting Trk receptor phosphorylation and ERK1/2 activation in response to EI-tPA. These results demonstrate that LRP1-initiated cell signaling is ligand-dependent. Proteins that activate cell signaling by binding to LRP1 assemble different co-receptor systems. Ligand-specific co-receptor recruitment provides a mechanism by which one receptor, LRP1, may trigger different signaling responses.	[Mantuano, Elisabetta; Lam, Michael S.; Gonias, Steven L.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, Biomed Sci Bldg,9500 Gilman Dr,0612, La Jolla, CA 92093 USA.	sgonias@ucsd.edu	Mantuano, Elisabetta/C-1769-2015	Mantuano, Elisabetta/0000-0001-5728-9261; Lam, Michael/0000-0001-9670-0025	National Institutes of Health [HL-060551, NS-054671]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health R01 Grants HL-060551 and NS-054671.	Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Baron A, 2010, BIOL CELL, V102, P539, DOI 10.1042/BC20100072; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; Benchenane K, 2005, CIRCULATION, V111, P2241, DOI 10.1161/01.CIR.0000163542.48611.A2; BU GJ, 1994, BLOOD, V83, P3427; BU GJ, 1992, P NATL ACAD SCI USA, V89, P7427, DOI 10.1073/pnas.89.16.7427; Bukhari N, 2011, J NEUROSCI, V31, P14931, DOI 10.1523/JNEUROSCI.3339-11.2011; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; COLLEN D, 1987, J CELL BIOCHEM, V33, P77, DOI 10.1002/jcb.240330202; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Domeniconi M, 2010, HISTOL HISTOPATHOL, V25, P1207, DOI 10.14670/HH-25.1207; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fernandez-Castaneda A, 2013, J BIOL CHEM, V288, P4538, DOI 10.1074/jbc.M112.384693; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Gualandris A, 1996, J NEUROSCI, V16, P2220; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; HUSSAINI IM, 1990, J BIOL CHEM, V265, P19441; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Lee HY, 2007, J NEUROCHEM, V101, P1236, DOI 10.1111/j.1471-4159.2007.04417.x; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Nakajima C, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444364; NEY KA, 1985, BIOCHEMISTRY-US, V24, P4586, DOI 10.1021/bi00338a016; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; Perron JC, 1999, MOL CELL NEUROSCI, V13, P362, DOI 10.1006/mcne.1999.0753; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Rebeck GW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pe28; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; SANO M, 1995, BRAIN RES, V688, P213, DOI 10.1016/0006-8993(95)00558-8; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; THOMAS SM, 1991, MOL CELL BIOL, V11, P4739, DOI 10.1128/MCB.11.9.4739; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Vazhappilly R, 2010, NEUROCHEM INT, V56, P569, DOI 10.1016/j.neuint.2009.12.020; Webb DJ, 1995, EUR J BIOCHEM, V234, P714, DOI 10.1111/j.1432-1033.1995.714_a.x; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; Wu F, 2013, MOL CELL NEUROSCI, V52, P9, DOI 10.1016/j.mcn.2012.10.001; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	56	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34009	34018		10.1074/jbc.M113.509133	http://dx.doi.org/10.1074/jbc.M113.509133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24129569	Green Published, hybrid			2022-12-28	WOS:000327250200042
J	Ridlon, L; Skodova, I; Pan, SQ; Lukes, J; Maslov, DA				Ridlon, Lucie; Skodova, Ingrid; Pan, Songqin; Lukes, Julius; Maslov, Dmitri A.			The Importance of the 45 S Ribosomal Small Subunit-related Complex for Mitochondrial Translation in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Protein Synthesis; Ribonuclear Protein (RNP); Trypanosoma brucei; Trypanosome; Leish	PENTATRICOPEPTIDE REPEAT PROTEINS; INDUCIBLE EXPRESSION SYSTEM; RNA INTERFERENCE; KINETOPLAST DNA; LEISHMANIA; IDENTIFICATION; MECHANISM	Background: Trypanosome mitochondria contain a 45 S ribosomal SSU-related complex with no precedence in other systems. Results: A selective ablation of the 45 S complex was associated with synthesis inhibition of some mitochondrial polypeptides. Conclusion: The 45 S complex is a factor required for mitochondrial translation that may have selective effects on different mRNAs. Significance: The mechanisms of mitochondrial translation in trypanosomes have no counterparts in other eukaryotes. The mitochondrial 45 S SSU* complex in Trypanosoma brucei contains the 9 S SSU ribosomal RNA, a set of SSU ribosomal proteins, several pentatricopeptide repeat (PPR) proteins, and proteins not typically found in ribosomes, including rhodanese domain protein (Rhod) and a 200-kDa coiled-coil protein. To investigate the function of this complex, PPR29, Rhod, 200-kDa protein, and mitochondrial ribosomal protein S17 were knocked down by RNAi in procyclic T. brucei. A growth retardation phenotype, a reduction in the amount of the 45 S SSU* complexes, and the preferential inhibition of synthesis of the cytochrome c oxidase subunit I over apocytochrome b were observed as early as day 2 postinduction of RNAi. On the contrary, the down-regulation of mitochondrial ribosomal protein L3 drastically reduced the amount of the large subunit and indiscriminately inhibited mitochondrial translation. The relative amounts of translation-competent, long poly(AU)-tailed cytochrome c oxidase subunit I and edited apocytochrome b mRNAs were selectively reduced by ablation of the 45 S SSU* complex. The formation of the 80 S translation complexes, identified by association of the long-tailed mRNAs with the mitoribosomes, was also disrupted. On the other hand, the relative amount of long-tailed edited RPS12 mRNA was not substantially affected, and there was no noticeable effect on the RPS12 translation complexes. In bloodstream trypanosomes, the amount of the 45 S complexes was drastically reduced compared with procyclics. We propose that the 45 S SSU* complex represents a factor required for normal mitochondrial translation that may have selective effects on different mRNAs.	[Ridlon, Lucie; Skodova, Ingrid; Maslov, Dmitri A.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Ridlon, Lucie; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Budweis, Czech Republic; [Skodova, Ingrid] Comenius Univ, Fac Nat Sci, Bratislava 84215, Slovakia; [Pan, Songqin] Univ Calif Riverside, WM Keck Prote Lab, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Lukes, Julius] Ctr Biol, Inst Parasitol, Ceske Budejovice 37005, Budweis, Czech Republic	University of California System; University of California Riverside; University of South Bohemia Ceske Budejovice; Comenius University Bratislava; University of California System; University of California Riverside; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Maslov, DA (corresponding author), Univ Calif Riverside, Dept Biol, 900 Univ Ave, Riverside, CA 92531 USA.	maslov@ucr.edu	Lukes, Julius/H-6760-2012; Sveráková, Ingrid/AAE-2756-2019	Lukes, Julius/0000-0002-0578-6618; Sveráková, Ingrid/0000-0002-4004-3377	National Institutes of Health [AI088292]; Grant Agency of the Czech Republic [P305/11/2179]; Ministry of Education of the Czech Republic [AMVIS LH12104]; Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Praemium Academiae award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI088292 (to D. M.). This work was also supported by Grant Agency of the Czech Republic Grant P305/11/2179, Ministry of Education of the Czech Republic Grant AMVIS LH12104, and the Praemium Academiae award (to J. L.).	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; Alfonzo JD, 2009, BIOL CHEM, V390, P717, DOI 10.1515/BC.2009.101; Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizhev R, 2011, RES MICROBIOL, V162, P655, DOI 10.1016/j.resmic.2011.04.015; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; BENNE R, 1994, EUR J BIOCHEM, V221, P9, DOI 10.1111/j.1432-1033.1994.tb18710.x; BORST P, 1979, PLASMID, V2, P20, DOI 10.1016/0147-619X(79)90003-9; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; BRUN R, 1979, ACTA TROP, V36, P289; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; HAJDUK SL, 1993, FASEB J, V7, P54, DOI 10.1096/fasebj.7.1.8422975; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Hashimi H, 2013, TRENDS PARASITOL, V29, P91, DOI 10.1016/j.pt.2012.11.005; Herrmann JM, 2013, BBA-MOL CELL RES, V1833, P286, DOI 10.1016/j.bbamcr.2012.03.007; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Horvath A, 2002, J BIOL CHEM, V277, P7222, DOI 10.1074/jbc.M109715200; Kable ML, 1997, TRENDS BIOCHEM SCI, V22, P162, DOI 10.1016/S0968-0004(97)01041-4; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; Koslowsky Donna J, 2004, Methods Mol Biol, V265, P161; Koslowsky DJ, 2009, TRENDS PARASITOL, V25, P252, DOI 10.1016/j.pt.2009.03.008; Lipinski KA, 2011, MOL BIOL EVOL, V28, P2935, DOI 10.1093/molbev/msr120; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Maslov D. A., 2013, TRANSLATION MITOCHON, P133; Maslov DA, 2007, MOL BIOCHEM PARASIT, V152, P203, DOI 10.1016/j.molbiopara.2007.01.012; Maslov DA, 2006, MOL BIOCHEM PARASIT, V148, P69, DOI 10.1016/j.molbiopara.2006.02.021; Maslov Dmitri A., 2012, P215; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; Mingler MK, 2006, MOL BIOCHEM PARASIT, V150, P37, DOI 10.1016/j.molbiopara.2006.06.006; Nebohacova M, 2004, J BIOL CHEM, V279, P7819, DOI 10.1074/jbc.M311360200; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Pusnik M, 2012, EUKARYOT CELL, V11, P79, DOI 10.1128/EC.05213-11; Rackham O, 2012, BBA-GENE REGUL MECH, V1819, P1008, DOI 10.1016/j.bbagrm.2011.10.007; Sambrook J., 2001, MOL CLONING LAB MANU; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Sharma MR, 2009, P NATL ACAD SCI USA, V106, P9637, DOI 10.1073/pnas.0901631106; SIMPSON L, 1986, INT REV CYTOL, V99, P119; SIMPSON L, 1995, CELL, V81, P837, DOI 10.1016/0092-8674(95)90003-9; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Simpson L, 1993, RNA EDITING ALTERATI, P53; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Vickerman K., 1976, P35; Vickerman K., 1976, P1; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	55	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32963	32978		10.1074/jbc.M113.501874	http://dx.doi.org/10.1074/jbc.M113.501874			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089529	Green Published, hybrid			2022-12-28	WOS:000328841700014
J	Parker, BW; Schwessinger, EA; Jakob, U; Gray, MJ				Parker, Benjamin W.; Schwessinger, Emily A.; Jakob, Ursula; Gray, Michael J.			The RclR Protein Is a Reactive Chlorine-specific Transcription Factor in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Escherichia coli; Oxidative Stress; Redox Signaling; Transcription Regulation; Hypochlorous Acid (HOCl); Reactive Chlorine Species (RCS); YkgD	OXIDATIVE STRESS; HYPOCHLOROUS ACID; N-CHLOROTAURINE; REDOX-SWITCH; THIOL; MECHANISMS; REGULATOR; DEFENSE; SENSORS; BLEACH	Reactive chlorine species (RCS) such as hypochlorous acid are powerful antimicrobial oxidants. Used extensively for disinfection in household and industrial settings (i.e. as bleach), RCS are also naturally generated in high quantities during the innate immune response. Bacterial responses to RCS are complex and differ substantially from the well characterized responses to other physiologically relevant oxidants, like peroxide or superoxide. Several RCS-sensitive transcription factors have been identified in bacteria, but most of them respond to multiple stressors whose damaging effects overlap with those of RCS, including reactive oxygen species and electrophiles. We have now used in vivo genetic and in vitro biochemical methods to identify and demonstrate that Escherichia coli RclR (formerly YkgD) is a redox-regulated transcriptional activator of the AraC family, whose highly conserved cysteine residues are specifically sensitive to oxidation by RCS. Oxidation of these cysteines leads to strong, highly specific activation of expression of genes required for survival of RCS stress. These results demonstrate the existence of a widely conserved bacterial regulon devoted specifically to RCS resistance.	[Parker, Benjamin W.; Schwessinger, Emily A.; Jakob, Ursula; Gray, Michael J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Jakob, Ursula] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	ujakob@umich.edu; mikegray@umich.edu		Gray, Michael/0000-0002-7112-4188	National Institutes of Health [R01-GM065318, R21-AI097893]; National Research Service Award [F32GM096613]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM065318 and R21-AI097893 (to U.J.).; Supported by National Research Service Award F32GM096613.	ANDEREGG G, 1977, HELV CHIM ACTA, V60, P123, DOI 10.1002/hlca.19770600115; Antelmann H, 2008, EXPERT REV PROTEOMIC, V5, P77, DOI 10.1586/14789450.5.1.77; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bengtson P, 2009, ENVIRON MICROBIOL, V11, P1330, DOI 10.1111/j.1462-2920.2009.01915.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bryk R, 2002, SCIENCE, V295, P1073, DOI 10.1126/science.1067798; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gorodetsky AA, 2008, P NATL ACAD SCI USA, V105, P3684, DOI 10.1073/pnas.0800093105; Gottardi W, 2002, ARCH PHARM, V335, P411, DOI 10.1002/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen EH, 2005, J APPL MICROBIOL, V98, P581, DOI 10.1111/j.1365-2672.2004.02491.x; Holder D., 2007, P WATER ENV FED DISI, V11, P63; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Lee C, 2013, MOL MICROBIOL, V88, P395, DOI 10.1111/mmi.12192; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Nagl M, 2000, ANTIMICROB AGENTS CH, V44, P2507, DOI 10.1128/AAC.44.9.2507-2513.2000; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Okun D. A., 2005, WATER ENCY, P281; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Poole L. B., 2008, CURR PROTOC TOXICOL, V17, P12; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; Rutala WA, 1997, CLIN MICROBIOL REV, V10, P597, DOI 10.1128/CMR.10.4.597; Sambrook J., 1989, MOL CLONING LAB MANU; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Spiro S, 2012, ANTIOXID REDOX SIGN, V17, P1264, DOI 10.1089/ars.2012.4533; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Vazquez-Torres A, 2012, ANTIOXID REDOX SIGN, V17, P1201, DOI 10.1089/ars.2012.4522; Wang SY, 2009, APPL ENVIRON MICROB, V75, P6110, DOI 10.1128/AEM.00914-09; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	64	51	56	2	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32574	32584		10.1074/jbc.M113.503516	http://dx.doi.org/10.1074/jbc.M113.503516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24078635	Green Published, hybrid			2022-12-28	WOS:000328681700040
J	Pandey, MS; Weigel, PH				Pandey, Madhu S.; Weigel, Paul H.			Hyaluronic Acid Receptor for Endocytosis (HARE)-mediated Endocytosis of Hyaluronan, Heparin, Dermatan Sulfate, and Acetylated Low Density Lipoprotein (AcLDL), but Not Chondroitin Sulfate Types A, C, D, or E, Activates NF-kappa B-regulated Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Extracellular Matrix; Ligand-binding Protein; NF-B Transcription Factor; Scavenger Receptor; Luciferase; Stabilin-2	HEPATIC SINUSOIDAL ENDOTHELIUM; SCAVENGER RECEPTOR; RAT; STABILIN-2; PROTEIN; CLEARANCE; BINDING; IDENTIFICATION; CELLS; HARE	Background: HARE mediates systemic clearance of 14 ECM- or stress-derived ligands. Hyaluronan uptake activates NF-B. Results: Heparin, dermatan sulfate, and acetylated LDL also activated NF-B; chondroitin sulfates types A, C, D, and E did not. Conclusion: A subset of HARE ligands activates signaling and gene expression. Significance: HARE may be a systemic tissue-stress sensor that responds to abnormal ECM turnover and damage. The hyaluronan (HA) receptor for endocytosis (HARE; Stab2) clears 14 systemic ligands, including HA and heparin. Here, we used NF-B promoter-driven luciferase reporter assays to test HARE-mediated intracellular signaling during the uptake of eight ligands, whose binding sites in the HARE ectodomain were mapped by competition studies (Harris, E. N., and Weigel, P. H. (2008) Glycobiology 18, 638-648). Unique intermediate size Select-HA(TM), heparin, dermatan sulfate, and acetylated LDL stimulated dose-dependent HARE-mediated NF-B activation of luciferase expression, with half-maximal values of 10-25 nm. In contrast, chondroitin sulfate types A, C, D, and E did not stimulate NF-B activation. Moreover, degradation of endogenous IkB- (an NF-B inhibitor) was stimulated only by the signaling ligands. The stimulatory activities of pairwise combinations of the four signaling ligands were additive. The four nonstimulatory chondroitin sulfate types, which compete for HA binding, also effectively blocked HA-stimulated signaling. Clathrin siRNA decreased clathrin expression by approximate to 50% and completely eliminated NF-B-mediated signaling by all four ligands, indicating that activation of signaling complexes occurs after endocytosis. These results indicate that HARE not only binds and clears extracellular matrix degradation products (e.g. released normally or during infection, injury, tumorigenesis, or other stress situations) but that a subset of ligands also serves as signaling indicator ligands. HARE may be part of a systemic tissue-stress sensor feedback system that responds to abnormal tissue turnover or damage as a danger signal; the signaling indicator ligands would reflect the homeostatic status, whether normal or pathological, of tissue cells and biomatrix components.	[Pandey, Madhu S.; Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu			National Institutes of Health from NIGMS [GM69961]; Oklahoma Center for the Advancement of Science and Technology from the State of Oklahoma [HR10-074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069961] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Center for the Advancement of Science and Technology from the State of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69961 from NIGMS. This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR10-074 from the State of Oklahoma.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Baggenstoss BA, 2006, ANAL BIOCHEM, V352, P243, DOI 10.1016/j.ab.2006.01.019; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; ERIKSSON S, 1983, EXP CELL RES, V144, P223, DOI 10.1016/0014-4827(83)90458-5; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; FUKUDA S, 1986, VIRCHOWS ARCH B, V52, P1, DOI 10.1007/BF02889945; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017; Harris E. N., 2009, HEPATIC ENDOCYTOSIS, P210; Harris EN, 2008, GLYCOBIOLOGY, V18, P638, DOI 10.1093/glycob/cwn045; Harris EN, 2008, J BIOL CHEM, V283, P17341, DOI 10.1074/jbc.M710360200; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2009, AM J PHYSIOL-GASTR L, V296, pG1191, DOI 10.1152/ajpgi.90717.2008; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; Kim S, 2012, MOL CELL BIOL, V32, P2698, DOI 10.1128/MCB.06743-11; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Laurent T.C., 1991, DEGRADATION BIOACTIV, P249; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEBEL L, 1994, EUR J CLIN INVEST, V24, P621, DOI 10.1111/j.1365-2362.1994.tb01114.x; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641; Matsunaga T, 2003, BIOCHEM BIOPH RES CO, V303, P313, DOI 10.1016/S0006-291X(03)00308-5; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; OKA JA, 1988, J CELL BIOCHEM, V36, P169, DOI 10.1002/jcb.240360208; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Pandey MS, 2013, J BIOL CHEM, V288, P14068, DOI 10.1074/jbc.M112.442889; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2008, J BIOL CHEM, V283, P10593, DOI 10.1074/jbc.M709105200; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Qian H, 2009, BIOCHEM BIOPH RES CO, V390, P883, DOI 10.1016/j.bbrc.2009.10.068; RAJA RH, 1984, ANAL BIOCHEM, V139, P168, DOI 10.1016/0003-2697(84)90402-0; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; SMEDSROD B, 1988, CELL TISSUE RES, V253, P39; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Weigel P. H., 2012, STRUCTURE FUNCTION B, P293; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; YannarielloBrown J, 1997, GLYCOBIOLOGY, V7, P15, DOI 10.1093/glycob/7.1.15; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	53	30	31	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1756	1767		10.1074/jbc.M113.510339	http://dx.doi.org/10.1074/jbc.M113.510339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24247245	hybrid, Green Published			2022-12-28	WOS:000332401700046
J	Jeong, AL; Lee, S; Park, JS; Han, S; Jang, CY; Lim, JS; Lee, MS; Yang, Y				Jeong, Ae Lee; Lee, Sunyi; Park, Jeong Su; Han, Sora; Jang, Chang-Young; Lim, Jong-Seok; Lee, Myung Sok; Yang, Young			Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Protein Is Involved in Centrosome Separation through the Regulation of NIMA (Never In Mitosis Gene A)-related Kinase 2 (NEK2) Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Centrosome; Mitosis; Mitotic Spindle; PP2A; CIP2A; Centrosome Separation; NEK2	CELL-CYCLE; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC ROLE; POOR-PROGNOSIS; EXPRESSION; CHROMOSOME; PHOSPHORYLATION; ACTIVATION; SUBSTRATE; SENESCENCE	Cancerous inhibitor of protein phosphatase 2A (CIP2A) is overexpressed in most human cancers and has been described as being involved in the progression of several human malignancies via the inhibition of protein phosphatase 2A (PP2A) activity toward c-Myc. However, with the exception of this role, the cellular function of CIP2A remains poorly understood. On the basis of yeast two-hybrid and coimmunoprecipitation assays, we demonstrate here that NIMA (never in mitosis gene A)-related kinase 2 (NEK2) is a binding partner for CIP2A. CIP2A exhibited dynamic changes in distribution, including the cytoplasm and centrosome, depending on the cell cycle stage. When CIP2A was depleted, centrosome separation and the mitotic spindle dynamics were impaired, resulting in the activation of spindle assembly checkpoint signaling and, ultimately, extension of the cell division time. Our data imply that CIP2A strongly interacts with NEK2 during G(2)/M phase, thereby enhancing NEK2 kinase activity to facilitate centrosome separation in a PP1- and PP2A-independent manner. In conclusion, CIP2A is involved in cell cycle progression through centrosome separation and mitotic spindle dynamics.	[Jeong, Ae Lee; Lee, Sunyi; Park, Jeong Su; Han, Sora; Lim, Jong-Seok; Lee, Myung Sok; Yang, Young] Sookmyung Womens Univ, Dept Life Syst, Res Ctr Womens Dis, Coll Pharm, Seoul 140742, South Korea; [Jang, Chang-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 140742, South Korea	Sookmyung Women's University; Sookmyung Women's University	Yang, Y (corresponding author), Sookmyung Womens Univ, Dept Life Syst, Res Ctr Womens Dis, Seoul 140742, South Korea.	yyang@sookmyung.ac.kr		Lim, Jong-Seok/0000-0003-4024-6868; Yang, Young/0000-0003-4239-0804	National Research Foundation of Korea (NRF) [NRF-2012R1A2A1A03003709, 2011-0030074]; Korean government (Ministry of Science, ICT and Future Planning); Korea Health Industry Development Institute [B110053-1101-0000200]; Ministry of Health and Welfare	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Science, ICT and Future Planning); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by National Research Foundation of Korea (NRF) Grants NRF-2012R1A2A1A03003709 and 2011-0030074 funded by the Korean government (Ministry of Science, ICT and Future Planning) and by Grant B110053-1101-0000200 of the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bockelman C, 2011, BRIT J CANCER, V105, P989, DOI 10.1038/bjc.2011.346; Bockelman C, 2011, BRIT J CANCER, V104, P1890, DOI 10.1038/bjc.2011.167; Bockelman C, 2012, CANCER BIOL THER, V13, P289, DOI [10.4161/cbt.18922, 10.4161/cbt.13.5.18922]; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Choi YA, 2011, FEBS LETT, V585, P755, DOI 10.1016/j.febslet.2011.01.018; Coenen EA, 2011, LEUKEMIA RES, V35, P133, DOI 10.1016/j.leukres.2010.08.017; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Dong QZ, 2011, ANN SURG ONCOL, V18, P857, DOI 10.1245/s10434-010-1313-8; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Fang YY, 2012, TUMOR BIOL, V33, P2299, DOI 10.1007/s13277-012-0492-2; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Fletcher L, 2005, BBA-MOL CELL RES, V1744, P89, DOI 10.1016/j.bbamcr.2005.01.007; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hames RS, 2002, BIOCHEM J, V361, P77, DOI 10.1042/0264-6021:3610077; He H, 2012, DIAGN MOL PATHOL, V21, P143, DOI 10.1097/PDM.0b013e318249fd8b; Helps NR, 2000, BIOCHEM J, V349, P509, DOI 10.1042/0264-6021:3490509; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Huang LP, 2012, CANCER MED-US, V1, P76, DOI 10.1002/cam4.15; Huang LP, 2010, CANCER BIOMARK, V8, P309, DOI 10.3233/CBM-2011-0220; Huang PZ, 2012, BIOMARKERS, V17, P422, DOI 10.3109/1354750X.2012.680608; Jeong Y, 2007, J CELL SCI, V120, P2106, DOI 10.1242/jcs.03458; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katz J, 2010, CANCER BIOL THER, V10, P694, DOI 10.4161/cbt.10.7.12895; Khanna A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017979; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kim YH, 2002, BIOCHEM BIOPH RES CO, V290, P730, DOI 10.1006/bbrc.2001.6212; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Lin YC, 2012, ORAL ONCOL, V48, P585, DOI 10.1016/j.oraloncology.2012.01.012; Liu J, 2011, GYNECOL ONCOL, V122, P430, DOI 10.1016/j.ygyno.2011.04.031; Ma LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026310; Mardin BR, 2013, DEV CELL, V25, P229, DOI 10.1016/j.devcel.2013.03.012; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Mathiasen DP, 2012, ONCOGENE, V31, P390, DOI 10.1038/onc.2011.230; Mayor T, 2002, J CELL SCI, V115, P3275; Meraldi P, 2001, J CELL SCI, V114, P3749; Mi J, 2007, CANCER RES, V67, P1082, DOI 10.1158/0008-5472.CAN-06-3071; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Niemela M, 2012, ONCOGENE, V31, P4266, DOI 10.1038/onc.2011.599; Park J, 2013, BIOCHEM BIOPH RES CO, V431, P302, DOI 10.1016/j.bbrc.2012.12.106; PerezRoger I, 1997, ONCOGENE, V14, P2373, DOI 10.1038/sj.onc.1201197; Qu W, 2012, MED ONCOL, V29, P113, DOI 10.1007/s12032-010-9768-9; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Rhee K, 1997, DEVELOPMENT, V124, P2167; Silkworth WT, 2012, MOL BIOL CELL, V23, P401, DOI 10.1091/mbc.E11-02-0095; Sonn S, 2004, J CELL SCI, V117, P5557, DOI 10.1242/jcs.01476; Teng HW, 2012, J GASTROINTEST SURG, V16, P1037, DOI 10.1007/s11605-012-1828-3; Thadani R, 2012, CURR BIOL, V22, pR1012, DOI 10.1016/j.cub.2012.10.023; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Ventela S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033209; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wang L, 2013, TUMOR BIOL, V34, P2309, DOI 10.1007/s13277-013-0775-2; Wei R, 2011, MOL BIOL CELL, V22, P3584, DOI 10.1091/mbc.E11-01-0012; Westwood I, 2009, J MOL BIOL, V386, P476, DOI 10.1016/j.jmb.2008.12.033; Xue YJ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0406-6; Yi FX, 2013, MOL MED REP, V7, P1376, DOI 10.3892/mmr.2013.1357; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001	66	27	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					28	40		10.1074/jbc.M113.507954	http://dx.doi.org/10.1074/jbc.M113.507954			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24214971	Green Published, hybrid			2022-12-28	WOS:000329370900003
J	Linke-Winnebeck, C; Paterson, NG; Young, PG; Middleditch, MJ; Greenwood, DR; Witte, G; Baker, EN				Linke-Winnebeck, Christian; Paterson, Neil G.; Young, Paul G.; Middleditch, Martin J.; Greenwood, David R.; Witte, Gregor; Baker, Edward N.			Structural Model for Covalent Adhesion of the Streptococcus pyogenes Pilus through a Thioester Bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Adhesion; Bacterial Pathogenesis; Crystal Structure; Mass Spectrometry (MS); Post-translational Modification; Protein Cross-linking; Protein Domains; Streptococcus pyogenes; Bacterial Pilus; Thioester Domain	COMPLEMENT COMPONENT C3; RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; INTERNAL THIOESTER; BIOFILM FORMATION; ISOPEPTIDE BONDS; FCT REGION; PROTEIN; BINDING; MECHANISM	The human pathogen Streptococcus pyogenes produces pili that are essential for adhesion to host surface receptors. Cpa, the adhesin at the pilus tip, was recently shown to have a thioester-containing domain. The thioester bond is believed to be important in adhesion, implying a mechanism of covalent attachment analogous to that used by human complement factors. Here, we have characterized a second active thioester-containing domain on Cpa, the N-terminal domain of Cpa (CpaN). Expression of CpaN in Escherichia coli gave covalently linked dimers. These were shown by x-ray crystallography and mass spectrometry to comprise two CpaN molecules cross-linked by the polyamine spermidine following reaction with the thioester bonds. This cross-linked CpaN dimer provides a model for the covalent attachment of Cpa to target receptors and thus the streptococcal pilus to host cells. Similar thioester domains were identified in cell wall proteins of other Gram-positive pathogens, suggesting that thioester domains are more widely used and provide a mechanism of adhesion by covalent bonding to target molecules on host cells that mimics that used by the human complement system to eliminate pathogens.	[Linke-Winnebeck, Christian; Paterson, Neil G.; Young, Paul G.; Middleditch, Martin J.; Greenwood, David R.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Linke-Winnebeck, Christian; Paterson, Neil G.; Young, Paul G.; Middleditch, Martin J.; Greenwood, David R.; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Witte, Gregor] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Witte, Gregor] Univ Munich, Gene Ctr, D-81377 Munich, Germany	University of Auckland; University of Auckland; University of Munich; University of Munich	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 921019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz	Linke-Winnebeck, Christian/F-4091-2010; Linke-Winnebeck, Christian/P-1585-2019; Greenwood, David R/D-2375-2016; Witte, Gregor/B-4635-2011	Linke-Winnebeck, Christian/0000-0002-2306-247X; Linke-Winnebeck, Christian/0000-0002-2306-247X; Greenwood, David R/0000-0001-5280-042X; Witte, Gregor/0000-0003-0313-0962; Paterson, Neil/0000-0003-4292-6971; Baker, Edward/0000-0003-2456-7661	Marsden Fund of New Zealand; Health Research Council of New Zealand; Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; German Research Council (Deutsche Forschungsgemeinschaft) [GRK1721]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported in part by the Marsden Fund of New Zealand, the Health Research Council of New Zealand, and the Tertiary Education Commission of New Zealand through funding of the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by German Research Council (Deutsche Forschungsgemeinschaft) Grant GRK1721.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Alexander LEC, 2010, J MOL MED, V88, P371, DOI 10.1007/s00109-009-0566-9; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Blanc E., 2011, BUSTER VERSION 2 11; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; DeLano W.L, PYMOL MOL GRAPHICS S; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Gadjeva M, 1998, J IMMUNOL, V161, P985; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koller T, 2010, J MED MICROBIOL, V59, P442, DOI 10.1099/jmm.0.013581-0; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Krishnan V, 2013, ACTA CRYSTALLOGR D, V69, P1073, DOI 10.1107/S0907444913004642; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Law SKA, 1997, PROTEIN SCI, V6, P263; Lebedev A. A., 2012, CCP4 NEWSLETTER COMP; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Solovyova AS, 2010, EUR BIOPHYS J BIOPHY, V39, P469, DOI 10.1007/s00249-009-0432-2; Sugiyama S, 1996, PROTEIN SCI, V5, P1984, DOI 10.1002/pro.5560051004; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Tholl D, 1998, WORLD J MICROB BIOT, V14, P857, DOI 10.1023/A:1008829008065; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walden M., 2013, PROTEINS, DOI 10.1002/prot.24420; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHATMORE AM, 1994, MOL MICROBIOL, V11, P363, DOI 10.1111/j.1365-2958.1994.tb00316.x; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791	60	36	37	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					177	189		10.1074/jbc.M113.523761	http://dx.doi.org/10.1074/jbc.M113.523761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24220033	hybrid, Green Published			2022-12-28	WOS:000329370900016
J	Geng, J; Sivaramakrishnan, S; Raghavan, M				Geng, Jie; Sivaramakrishnan, Sivaraj; Raghavan, Malini			Analyses of Conformational States of the Transporter Associated with Antigen Processing (TAP) Protein in a Native Cellular Membrane Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Antigen Presentation; ATPases; Major Histocompatibility Complex (MHC); Peptide Transport; Transporters; Transporter Associated with Antigen Processing (TAP)	NUCLEOTIDE-BINDING DOMAINS; RESONANCE ENERGY-TRANSFER; P-GLYCOPROTEIN; ABC TRANSPORTER; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; PEPTIDE-BINDING; MALTOSE TRANSPORTER; MECHANISM; INTERMEDIATE	The transporter associated with antigen processing (TAP) plays a critical role in the MHC class I antigen presentation pathway. TAP translocates cellular peptides across the endoplasmic reticulum membrane in an ATP hydrolysis-dependent manner. We used FRET spectroscopy in permeabilized cells to delineate different conformational states of TAP in a native subcellular membrane environment. For these studies, we tagged the TAP1 and TAP2 subunits with enhanced cyan fluorescent protein and enhanced yellow fluorescent protein, respectively, C-terminally to their nucleotide binding domains (NBDs), and measured FRET efficiencies under different conditions. Our data indicate that both ATP and ADP enhance the FRET efficiencies but that neither induces a maximally closed NBD conformation. Additionally, peptide binding induces a large and significant increase in NBD proximity with a concentration dependence that is reflective of individual peptide affinities for TAP, revealing the underlying mechanism of peptide-stimulated ATPase activity of TAP. Maximal NBD closure is induced by the combination of peptide and non-hydrolysable ATP analogs. Thus, TAP1-TAP2 NBD dimers are not fully stabilized by nucleotides alone, and substrate binding plays a key role in inducing the transition state conformations of the NBD. Taken together, these findings show that at least three steps are involved in the transport of peptides across the endoplasmic reticulum membrane for antigen presentation, corresponding to three dynamically and structurally distinct conformational states of TAP. Our studies elucidate structural changes in the TAP NBD in response to nucleotides and substrate, providing new insights into the mechanism of ATP-binding cassette transporter function.	[Geng, Jie; Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Sch Med, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu	Geng, Jie/E-8552-2019	Geng, Jie/0000-0001-8722-2228	National Institutes of Health [AI044115]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health [DK020572]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044115, R56AI044115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI044115 (to M. R.) and utilized the DNA sequencing cores of the Michigan Diabetes Research and Training Center funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant DK020572.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Corradi V, 2012, J BIOL CHEM, V287, P28099, DOI 10.1074/jbc.M112.381251; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doshi R, 2013, J BIOL CHEM, V288, P21638, DOI 10.1074/jbc.M113.485714; Gaudet R, 2001, TECHNOL REV, V104, P20; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Hellmich UA, 2012, J AM CHEM SOC, V134, P5857, DOI 10.1021/ja211007t; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Lapinski PE, 2003, J BIOL CHEM, V278, P8229, DOI 10.1074/jbc.M208930200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Perria CL, 2006, J BIOL CHEM, V281, P39839, DOI 10.1074/jbc.M605492200; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Raghuraman G, 2002, J BIOL CHEM, V277, P41786, DOI 10.1074/jbc.M207128200; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Schmitt L, 2000, CHEMBIOCHEM, V1, P17; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; SINICROPE FA, 1992, J BIOL CHEM, V267, P24995; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Willemse M, 2007, NAT BIOTECHNOL, V25, P170, DOI 10.1038/nbt0207-170; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	48	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37039	37047		10.1074/jbc.M113.504696	http://dx.doi.org/10.1074/jbc.M113.504696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196954	hybrid, Green Published			2022-12-28	WOS:000329189700024
J	Lager, I; Yilmaz, JL; Zhou, XR; Jasieniecka, K; Kazachkov, M; Wang, P; Zou, JT; Weselake, R; Smith, MA; Bayon, S; Dyer, JM; Shockey, JM; Heinz, E; Green, A; Banas, A; Stymne, S				Lager, Ida; Yilmaz, Jenny Lindberg; Zhou, Xue-Rong; Jasieniecka, Katarzyna; Kazachkov, Michael; Wang, Peng; Zou, Jitao; Weselake, Randall; Smith, Mark A.; Bayon, Shen; Dyer, John M.; Shockey, Jay M.; Heinz, Ernst; Green, Allan; Banas, Antoni; Stymne, Sten			Plant Acyl-CoA: Lysophosphatidylcholine Acyltransferases (LPCATs) Have Different Specificities in Their Forward and Reverse Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Enzymes; Lipid Metabolism; Phosphatidylcholine; Plant Biochemistry; Lysophosphatidylcholine Acyltransferases; Phosphatidylcholine Metabolism; Plant Lipid Biochemistry; Enzyme	FATTY-ACIDS; DIACYLGLYCEROL ACYLTRANSFERASE; MICROSOMAL PREPARATIONS; BINDING-PROTEIN; MOLECULAR CHARACTERIZATION; TRIACYLGLYCEROL SYNTHESIS; DEVELOPING SEEDS; OLEOYL-COA; PHOSPHATIDYLCHOLINE; COTYLEDONS	Acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT) enzymes have central roles in acyl editing of phosphatidylcholine (PC). Plant LPCAT genes were expressed in yeast and characterized biochemically in microsomal preparations of the cells. Specificities for different acyl-CoAs were similar for seven LPCATs from five different species, including species accumulating hydroxylated acyl groups in their seed oil, with a preference for C-18-unsaturated acyl-CoA and low activity with palmitoyl-CoA and ricinoleoyl (12-hydroxyoctadec-9-enoyl)-CoA. We showed that Arabidopsis LPCAT1 and LPCAT2 enzymes catalyzed the acylation and de-acylation of both sn positions of PC, with a preference for the sn-2 position. When acyl specificities of the Arabidopsis LPCATs were measured in the reverse reaction, sn-2-bound oleoyl, linoleoyl, and linolenoyl groups from PC were transferred to acyl-CoA to a similar extent. However, a ricinoleoyl group at the sn-2-position of PC was removed 4-6-fold faster than an oleoyl group in the reverse reaction, despite poor utilization in the forward reaction. The data presented, taken together with earlier published reports on in vivo lipid metabolism, support the hypothesis that plant LPCAT enzymes play an important role in regulating the acyl-CoA composition in plant cells by transferring polyunsaturated and hydroxy fatty acids produced on PC directly to the acyl-CoA pool for further metabolism or catabolism.	[Lager, Ida; Stymne, Sten] Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden; [Yilmaz, Jenny Lindberg] Scandinavian Biotechnol Res AB, S-23053 Alnarp, Sweden; [Zhou, Xue-Rong; Green, Allan] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia; [Jasieniecka, Katarzyna; Banas, Antoni] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Jasieniecka, Katarzyna; Banas, Antoni] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Kazachkov, Michael; Zou, Jitao; Smith, Mark A.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Wang, Peng] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Wang, Peng] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Weselake, Randall] Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada; [Bayon, Shen] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Dyer, John M.] ARS, US Arid Land Agr Res Ctr, USDA, Maricopa, AZ 85138 USA; [Shockey, Jay M.] ARS, Commod Utilizat Res Unit, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Heinz, Ernst] Univ Hamburg, Bioctr Klein Flottbek & Bot Garden, D-22609 Hamburg, Germany	Swedish University of Agricultural Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; National Research Council Canada; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Alberta; Washington State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Hamburg	Lager, I (corresponding author), Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden.	Ida.Lager@slu.se	Zhou, Xue-Rong/D-4706-2009; Green, Allan/AAM-6856-2021; Green, Allan G/C-6572-2008	Zhou, Xue-Rong/0000-0003-3717-2984; Shockey, Jay/0000-0002-5057-5457; Banas, Antoni/0000-0001-9397-7627; Jasieniecka-Gazarkiewicz, Katarzyna/0000-0002-7682-188X; Wang, Peng/0000-0001-5960-6339	United States National Science Foundation Plant Genome Program [IOS 0701919]	United States National Science Foundation Plant Genome Program	The Momordica LPCAT was identified in the Edgar Cahoon laboratory from funding provided by the United States National Science Foundation Plant Genome Program IOS 0701919.	Arroyo-Caro J. M., 2013, LIPIDS IN PRESS, V48; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; BAFOR M, 1993, ARCH BIOCHEM BIOPHYS, V303, P145, DOI 10.1006/abbi.1993.1265; Banas A, 2005, J BIOL CHEM, V280, P34626, DOI 10.1074/jbc.M504459200; Banas A, 1997, PHYSIOLOGY, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF PLANT LIPIDS, P57; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broun P, 1997, PLANT PHYSIOL, V113, P933, DOI 10.1104/pp.113.3.933; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Engeseth N, 1996, PLANTA, V198, P238, DOI 10.1007/BF00206249; Engeseth NJ, 1996, ARCH BIOCHEM BIOPHYS, V331, P55, DOI 10.1006/abbi.1996.0282; KANDA P, 1981, J LIPID RES, V22, P877; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Arroyo-Caro JM, 2013, LIPIDS, V48, P663, DOI 10.1007/s11745-013-3797-z; Mavraganis I, 2010, APPL ENVIRON MICROB, V76, P1135, DOI 10.1128/AEM.02297-09; Milcamps A, 2005, J BIOL CHEM, V280, P5370, DOI 10.1074/jbc.M410276200; Pollard M, 1999, PLANT PHYSIOL, V121, P1217, DOI 10.1104/pp.121.4.1217; SANCHEZ M, 1973, BIOCHEM J, V132, P697, DOI 10.1042/bj1320697; SLACK CR, 1983, BIOCHIM BIOPHYS ACTA, V754, P10, DOI 10.1016/0005-2760(83)90076-0; SLACK CR, 1985, BIOCHIM BIOPHYS ACTA, V833, P438, DOI 10.1016/0005-2760(85)90101-8; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; Soboll S., 1976, USE ISOLATED LIVER C, P29; SPERLING P, 1993, EUR J BIOCHEM, V213, P965, DOI 10.1111/j.1432-1033.1993.tb17841.x; STAHL U, 1995, PLANT PHYSIOL, V107, P953, DOI 10.1104/pp.107.3.953; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; STOBART AK, 1985, BIOCHEM J, V232, P217, DOI 10.1042/bj2320217; STYMNE S, 1981, LIPIDS, V16, P298, DOI 10.1007/BF02534953; STYMNE S, 1978, EUR J BIOCHEM, V90, P223, DOI 10.1111/j.1432-1033.1978.tb12594.x; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Thomaeus S, 2001, PLANT SCI, V161, P997, DOI 10.1016/S0168-9452(01)00500-3; Tilton GB, 2004, J BIOL CHEM, V279, P7487, DOI 10.1074/jbc.M309532200; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; WITT W, 1984, BIOCHIM BIOPHYS ACTA, V795, P108, DOI 10.1016/0005-2760(84)90110-3; Yurchenko OP, 2009, PLANT BIOTECHNOL J, V7, P602, DOI 10.1111/j.1467-7652.2009.00427.x	45	94	99	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36902	36914		10.1074/jbc.M113.521815	http://dx.doi.org/10.1074/jbc.M113.521815			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24189065	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000329189700013
J	Sun, JW; He, HF; Pillai, S; Xiong, Y; Challa, S; Xu, LY; Chellappan, S; Yang, SY				Sun, Jianwei; He, Huifang; Pillai, Smitha; Xiong, Yin; Challa, Sridevi; Xu, Liyan; Chellappan, Srikumar; Yang, Shengyu			GATA3 Transcription Factor Abrogates Smad4 Transcription Factor-mediated Fascin Overexpression, Invadopodium Formation, and Breast Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Invasion; Cytoskeleton; GATA; Metastasis; SMAD Transcription Factor	EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; TUMOR-METASTASIS; MAMMARY-GLAND; EXPRESSION; GROWTH; DIFFERENTIATION; MIGRATION; PROTEIN; ACTIN	Transforming growth factor (TGF) is a potent and context-dependent regulator of tumor progression. TGF promotes the lung metastasis of basal-like (but not the luminal-like) breast cancer. Here, we demonstrated that fascin, a pro-metastasis actin bundling protein, was a direct target of the canonical TGF-Smad4 signaling pathway in basal-like breast cancer cells. TGF and Smad4 induced fascin overexpression by directly binding to a Smad binding element on the fascin promoter. We identified GATA3, a transcription factor crucial for mammary gland morphogenesis and luminal differentiation, as a negative regulator of TGF- and Smad4-induced fascin overexpression. When ectopically expressed in basal-like breast cancer cells, GATA-3 abrogated TGF- and Smad4-mediated overexpression of fascin and other TGF response genes, invadopodium formation, cell migration, and invasion, suggesting suppression of the canonical TGF-Smad signaling axis. Mechanistically, GATA3 abrogated the canonical TGF-Smad signaling by abolishing interactions between Smad4 and its DNA binding elements, potentially through physical interactions between the N-terminal of GATA3 and Smad3/4 proteins. Our findings provide mechanistic insight into how TGF-mediated cell motility and invasiveness are differentially regulated in breast cancer.	[Sun, Jianwei; He, Huifang; Pillai, Smitha; Chellappan, Srikumar; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Sun, Jianwei; He, Huifang; Yang, Shengyu] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA; [Xiong, Yin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Womens Oncol, Tampa, FL 33612 USA; [Challa, Sridevi] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Canc Biol Grad Program, Tampa, FL 33612 USA; [Xu, Liyan] Shantou Univ, Coll Med, Inst Oncol Pathol, Shantou 515041, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Shantou University	Yang, SY (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, 12902 Magnolia Dr SRB-2, Tampa, FL 33612 USA.	shengyu.yang@moffitt.org	xu, li/GNH-3667-2022	Pillai, Smitha/0000-0001-9718-5010; CHALLA, SRIDEVI/0000-0002-5308-9243	NCI, National Institutes of Health [P30-CA76292-14]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Minjung Kim and Jin Q. Cheng for reagents and cell lines, the Analytic Microscopy Core and Molecular Genomics core at Moffitt Cancer center for assistance with image acquisition and qPCR, and Rasa Hamilton for editorial assistance. The Analytic Microscopy Core and Molecular Genomics Core at Moffitt Cancer Center were supported in part by NCI, National Institutes of Health Grant P30-CA76292-14.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Blokzijl A, 2002, CURR BIOL, V12, P35, DOI 10.1016/S0960-9822(01)00623-6; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Chu IM, 2012, ONCOGENE, V31, P2017, DOI 10.1038/onc.2011.382; Chu I. M., 2013, PLOS ONE, V8; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fu H, 2009, ACTA BIOCH BIOPH SIN, V41, P648, DOI 10.1093/abbs/gmp053; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Kang YB, 2006, J CELL BIOCHEM, V98, P1380, DOI 10.1002/jcb.20928; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kress AK, 2011, BLOOD, V117, P3609, DOI 10.1182/blood-2010-09-305805; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Lu XF, 2010, CELL MOL LIFE SCI, V67, P3313, DOI 10.1007/s00018-010-0382-y; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; McGarrigle D, 2006, J BIOL CHEM, V281, P10583, DOI 10.1074/jbc.M513002200; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pillai Smitha, 2009, V523, P323, DOI 10.1007/978-1-59745-190-1_22; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Snyder M, 2011, J BIOL CHEM, V286, P38886, DOI 10.1074/jbc.M111.286245; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yang SY, 2013, J BIOL CHEM, V288, P274, DOI 10.1074/jbc.M112.427971; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Yoder BJ, 2005, CLIN CANCER RES, V11, P186	44	38	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36971	36982		10.1074/jbc.M113.506535	http://dx.doi.org/10.1074/jbc.M113.506535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24235142	Green Published, hybrid			2022-12-28	WOS:000329189700019
J	Cordero-Espinoza, L; Hagen, T				Cordero-Espinoza, Lucia; Hagen, Thilo			Increased Concentrations of Fructose 2,6-Bisphosphate Contribute to the Warburg Effect in Phosphatase and Tensin Homolog (PTEN)-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Fructose 2; 6-Bisphosphate; Glycolysis; Phosphofructokinase; Pten; APC; C-Cdh1; PFKFB3	PROTEIN-KINASE B; HEART 6-PHOSPHOFRUCTO-2-KINASE; AEROBIC GLYCOLYSIS; PTEN; APC/C-CDH1; INHIBITION; METABOLISM; ACTIVATION; ELEVATION; CANCERS	Background: PTEN deficiency leads to increased glycolytic flux characteristic of cancer cells. Results: PTEN-deficient cells have high concentrations of fructose 2,6-bisphosphate due to protein stabilization of PFKFB3 that results from impaired APC/C-Cdh1-dependent degradation. Conclusion: Elevated fructose 2,6-bisphosphate concentrations contribute to the increased rates of glycolysis and proliferation in PTEN-deficient cells. Significance: Fructose 2,6-bisphosphate might be a crucial mediator of tumorigenesis in PTEN-deficient cells. Unlike normal differentiated cells, tumor cells metabolize glucose via glycolysis under aerobic conditions, a hallmark of cancer known as the Warburg effect. Cells lacking the commonly mutated tumor suppressor PTEN exhibit a glycolytic phenotype reminiscent of the Warburg effect. This has been traditionally attributed to the hyperactivation of PI3K/Akt signaling that results from PTEN loss. Here, we propose a novel mechanism whereby the loss of PTEN negatively affects the activity of the E3 ligase APC/C-Cdh1, resulting in the stabilization of the enzyme PFKFB3 and increased synthesis of its product fructose 2,6-bisphosphate (F2,6P(2)). We discovered that when compared with wild-type cells, PTEN knock-out mouse embryonic fibroblasts (PTEN KO MEF) have 2-3-fold higher concentrations of F2,6P(2), the most potent allosteric activator of the glycolytic enzyme phosphofructokinase-1 (PFK-1). Reintroduction of either wild-type or phosphatase mutant PTEN in the PTEN KO cells effectively lowers F2,6P(2) to the wild-type levels and reduces their lactate production. PTEN KO cells were found to have high protein levels of PFKFB3, which directly contribute to the increased concentrations of F2,6P(2). PTEN enhances interaction between PFKFB3 and Cdh1, and overexpression of Cdh1 down-regulates the PFKFB3 protein level in wild-type, but not in PTEN-deficient cells. Importantly, we found that the degradation of endogenous PFKFB3 in PTEN KO cells occurs at a slower rate than in wild-type cells. Our results suggest an important role for F2,6P(2) in the metabolic reprogramming of PTEN-deficient cells that has important consequences for cell proliferation.	[Cordero-Espinoza, Lucia; Hagen, Thilo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	National University of Singapore	Hagen, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore.	bchth@nus.edu.sg		Cordero Espinoza, Lucia/0000-0002-2954-7654	Singapore Biomedical Research Council, A*Star [10/1/21/19/647]	Singapore Biomedical Research Council, A*Star	This work was supported by Grant 10/1/21/19/647 from the Singapore Biomedical Research Council, A*Star.	Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Blouin MJ, 2010, CANCER LETT, V289, P246, DOI 10.1016/j.canlet.2009.08.021; BROWN J, 1962, METABOLISM, V11, P1098; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lefebvre V, 1996, J BIOL CHEM, V271, P22289, DOI 10.1074/jbc.271.37.22289; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li M, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-2; NEELY JR, 1972, BIOCHEM J, V128, P147, DOI 10.1042/bj1280147; Pfleger CM, 2000, GENE DEV, V14, P655; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tandon P, 2011, P NATL ACAD SCI USA, V108, P2361, DOI 10.1073/pnas.1013629108; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	31	36	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36020	36028		10.1074/jbc.M113.510289	http://dx.doi.org/10.1074/jbc.M113.510289			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169697	Green Published, hybrid			2022-12-28	WOS:000329814700037
J	Lee, J; Kim, HJ; Roh, J; Seo, Y; Kim, M; Jun, HR; Pham, CD; Kwon, MH				Lee, Jiyeon; Kim, Hye-Jin; Roh, Jooho; Seo, Youngsil; Kim, Minjae; Jun, Hye-Ryeong; Pham, Chuong D.; Kwon, Myung-Hee			Functional Consequences of Complementarity-determining Region Deactivation in a Multifunctional Anti-nucleic Acid Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Antibody Engineering; Autoimmunity; Immunology; Molecular Biology; Anti-DNA Antibody; CDR Deactivation; Cell Penetration; DNA Hydrolysis; Multifunctional Antibody	DNA ANTIBODIES; HEPARAN-SULFATE; HIGH-AFFINITY; BINDING; CDR; CELLS; LOCALIZATION; HYDROLYSIS; PATHWAY	Background: A subset of anti-DNA antibodies have DNA-hydrolysis and/or cell-penetration activity. Results: Deactivation of different complementarity-determining regions (CDRs) in a multifunctional anti-nucleic acid antibody alters the properties of the antibody. Conclusion: CDR1 of the light chain plays a crucial role in maintaining the properties of 3D8 scFv. Significance: Single complete CDR deactivation allows exploration of the molecular features of multifunctional anti-DNA antibodies. Many murine monoclonal anti-DNA antibodies (Abs) derived from mice models for systemic lupus erythematosus have additional cell-penetration and/or nucleic acid-hydrolysis properties. Here, we examined the influence of deactivating each complementarity-determining region (CDR) within a multifunctional anti-nucleic acid antibody (Ab) that possesses these activities, the catalytic 3D8 single chain variable fragment (scFv). CDR-deactivated 3D8 scFv variants were generated by replacing all of the amino acids within each CDR with Gly/Ser residues. The structure of 3D8 scFv accommodated single complete CDR deactivations. Different functional activities of 3D8 scFv were affected differently depending on which CDR was deactivated. The only exception was CDR1, located within the light chain (LCDR1); deactivation of LCDR1 abolished all of the functional activities of 3D8 scFv. A hybrid Ab, HW6/3D8L1, in which the LCDR1 from an unrelated Ab (HW6) was replaced with the LCDR1 from 3D8, acquired all activities associated with the 3D8 scFv. These results suggest that the activity of a multifunctional 3D8 scFv Ab can be modulated by single complete CDR deactivation and that the LCDR1 plays a crucial role in maintaining Ab properties. This study presents a new approach for determining the role of individual CDRs in multifunctional Abs with important implications for the future of Ab engineering.	[Lee, Jiyeon; Kim, Hye-Jin; Roh, Jooho; Seo, Youngsil; Kim, Minjae; Jun, Hye-Ryeong; Pham, Chuong D.; Kwon, Myung-Hee] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon 443749, South Korea; [Kwon, Myung-Hee] Ajou Univ, Sch Med, Dept Microbiol, Suwon 443749, South Korea	Ajou University; Ajou University	Kwon, MH (corresponding author), Ajou Univ, Sch Med, Dept Microbiol, Woncheon Dong 5, Suwon 443749, South Korea.	kwonmh@ajou.ac.kr	Pham, Dinh-Chuong/L-8930-2018	Pham, Dinh-Chuong/0000-0002-3074-6941	Science Research Center Program of the National Research Foundation of Korea [20110030043]; Basic Science Research Program of the National Research Foundation of Korea [2011-0007358]; Department of Medical Sciences, the Graduate School, Ajou University	Science Research Center Program of the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Department of Medical Sciences, the Graduate School, Ajou University	This work was supported by the Science Research Center Program (20110030043) and the Basic Science Research Program (2011-0007358) of the National Research Foundation of Korea and a grant (2011) from the Department of Medical Sciences, the Graduate School, Ajou University.	BERDEN JHM, 1989, NEPHROLOGIE, V10, P127; Clark LA, 2009, PROTEIN ENG DES SEL, V22, P93, DOI 10.1093/protein/gzn072; Dobroff AS, 2010, TRANSL ONCOL, V3, P204, DOI 10.1593/tlo.09316; FAABER P, 1986, J CLIN INVEST, V77, P1824, DOI 10.1172/JCI112508; Gololobov GV, 1997, MOL IMMUNOL, V34, P1083, DOI 10.1016/S0161-5890(97)00129-6; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Jang EJ, 2009, IMMUNOL LETT, V124, P70, DOI 10.1016/j.imlet.2009.04.005; Jeong JG, 2011, BIOCHEM BIOPH RES CO, V406, P403, DOI 10.1016/j.bbrc.2011.02.054; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Kiss C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl681; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Krishnan MR, 2012, KIDNEY INT, V82, P184, DOI 10.1038/ki.2011.484; Lee EJ, 2007, BIOORGAN MED CHEM, V15, P2016, DOI 10.1016/j.bmc.2006.12.037; Lupinek C, 2009, J IMMUNOL, V182, P4817, DOI 10.4049/jimmunol.0800726; Murakami A, 2010, MOL IMMUNOL, V48, P48, DOI 10.1016/j.molimm.2010.09.013; Nicaise M, 2004, PROTEIN SCI, V13, P1882, DOI 10.1110/ps.03540504; Perchiacca JM, 2011, PROTEINS, V79, P2637, DOI 10.1002/prot.23085; Petrovskaya LE, 2012, BIOCHEMISTRY-MOSCOW+, V77, P62, DOI 10.1134/S0006297912010075; Pham CD, 2012, J IMMUNOL, V189, P5755, DOI 10.4049/jimmunol.1200804; Putterman C, 2004, AUTOIMMUN REV, V3, P97, DOI 10.1016/S1568-9972(03)00082-X; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Rahman A, 1998, SEMIN ARTHRITIS RHEU, V28, P141, DOI 10.1016/S0049-0172(98)80031-0; Schroeder K, 2013, AUTOIMMUNITY, V46, P121, DOI 10.3109/08916934.2012.748751; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Ternynck T, 1998, J AUTOIMMUN, V11, P511, DOI 10.1006/jaut.1998.0222; Timmerman P, 2010, J MOL RECOGNIT, V23, P559, DOI 10.1002/jmr.1017; Wellmann U, 2005, P NATL ACAD SCI USA, V102, P9258, DOI 10.1073/pnas.0500132102; Yanase K, 2005, J AUTOIMMUN, V24, P145, DOI 10.1016/j.jaut.2004.11.008; Zack DJ, 1996, J IMMUNOL, V157, P2082	31	7	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35877	35885		10.1074/jbc.M113.508499	http://dx.doi.org/10.1074/jbc.M113.508499			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24155236	Green Published, hybrid			2022-12-28	WOS:000329814700024
J	Patel, N; Barrientos, A; Landgraf, R				Patel, Nirav; Barrientos, Antoni; Landgraf, Ralf			The Growth Factor Receptor ERBB2 Regulates Mitochondria! Activity on a Signaling Time Scale	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucose Metabolism; Mitochondria; Receptor Tyrosine Kinase; Signal Transduction; Uncoupling Proteins	UNCOUPLING PROTEIN-2; PROTON TRANSPORT; OXYGEN-CONSUMPTION; OXIDATIVE STRESS; UCP2; EXPRESSION; METABOLISM; MEMBRANE; KINASE; GENE	Background: Overexpressed UCP2 and ERBB2 are oncogenic, but their functions at low expression are unclear. Results: ERBB2 regulates UCP2 levels at low and overexpression settings. The rapid regulation of mitochondria by ERBB2 requires UCP2, but not its transporter activity. Conclusion: At low levels, UCP2 integrates mitochondria into the acute (2 h) signaling response. Significance: This study links growth factor signaling, mitochondrial adaptability, and oncogenic deregulation. Overexpression of the ERBB2 receptor tyrosine kinase and the mitochondrial inner membrane protein UCP2 occurs frequently in aggressive cancers with dysfunctional mitochondria. Overexpressed ERBB2 signals constitutively and elevated UCP2 can uncouple mitochondria and alleviate oxidative stress. However, the physiological contributions of UCP2 and ERBB2 at the low expression levels that are typical of most tissues, as well as the path to oncogenic deregulation, are poorly understood. We now show that ERBB2 directly controls UCP2 levels, both at low physiological levels and oncogenic overexpression. At low levels of receptor and UCP2, ligand stimulation creates a distinct temporal response pattern driven by the opposing forces of translational suppression of the exceptionally short lived UCP2 protein and a time delayed transcriptional up-regulation. The latter becomes dominant through constitutive signaling by overexpressed ERBB2, resulting in high levels of UCP2 that contribute mitochondrial uncoupling. By contrast, ligand stimulation of non-overexpressed ERBB2 transiently removes UCP2 and paradoxically reduces the mitochondrial membrane potential, oxygen consumption, and OXPHOS on a signaling time scale. However, neither the transporter activity nor down-regulation of already low UCP2 levels drive this reduction in mitochondrial activity. Instead, UCP2 is required to establish mitochondria that are capable of responding to ligand. UCP2 knockdown impairs proliferation at high glucose but its absence specifically impairs ligand-induced growth when glucose levels fluctuate. These findings demonstrate the ability of growth factor signaling to control oxidative phosphorylation on a signaling time scale and point toward a non-transporter role for low levels of UCP2 in establishing dynamic response capability.	[Patel, Nirav; Barrientos, Antoni; Landgraf, Ralf] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; [Landgraf, Ralf] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA; [Barrientos, Antoni] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33101 USA	University of Miami; University of Miami; University of Miami	Landgraf, R (corresponding author), Box 016129 R-629, Miami, FL 33101 USA.	rlandgraf@med.miami.edu			National Institutes of Health [R01-CA98881]; NCI; Braman Family Breast Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA098881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Braman Family Breast Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA98881 (to R. L.) from the NCI and the Braman Family Breast Cancer Institute (to R. L.).	Andrews Zane B, 2010, Curr Aging Sci, V3, P102; Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Azzu V, 2008, BBA-BIOENERGETICS, V1777, P1378, DOI 10.1016/j.bbabio.2008.07.001; Ball WB, 2011, J IMMUNOL, V187, P1322, DOI 10.4049/jimmunol.1004237; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Bouillaud F, 2009, BBA-BIOENERGETICS, V1787, P377, DOI 10.1016/j.bbabio.2009.01.003; Bugger H, 2011, CANCER CHEMOTH PHARM, V67, P1381, DOI 10.1007/s00280-010-1441-7; Criscuolo F, 2006, BBA-BIOENERGETICS, V1757, P1284, DOI 10.1016/j.bbabio.2006.06.002; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Dalgaard LT, 2011, J OBES, V2011, DOI 10.1155/2011/340241; Dalgaard LT, 2012, BIOCHEM BIOPH RES CO, V417, P495, DOI 10.1016/j.bbrc.2011.11.148; Dhamrait SS, 2004, EUR HEART J, V25, P468, DOI 10.1016/j.ehj.2004.01.007; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2236; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Ewer MS, 1999, SEMIN ONCOL, V26, P96; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Gordon LI, 2009, J BIOL CHEM, V284, P2080, DOI 10.1074/jbc.M804570200; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; KLINGENBERG M, 1985, EMBO J, V4, P3087, DOI 10.1002/j.1460-2075.1985.tb04049.x; KORTENJANN M, 1995, ONCOGENE, V11, P2105; Landgraf R, 1998, BIOCHEMISTRY-US, V37, P3220, DOI 10.1021/bi972326z; Landgraf R, 2000, BIOCHEMISTRY-US, V39, P8503, DOI 10.1021/bi000953+; Lemmens K, 2011, AM J PHYSIOL-HEART C, V300, pH931, DOI 10.1152/ajpheart.00385.2010; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Pegram MD, 1997, ONCOGENE, V15, P537, DOI 10.1038/sj.onc.1201222; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Rohrbach S, 2005, BASIC RES CARDIOL, V100, P240, DOI 10.1007/s00395-005-0514-4; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Suarez E, 2001, J BIOL CHEM, V276, P18257, DOI 10.1074/jbc.M008100200; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Uray IP, 2002, J HEART LUNG TRANSPL, V21, P771, DOI 10.1016/S1053-2498(02)00390-X; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Warren CM, 2006, J BIOL CHEM, V281, P27306, DOI 10.1074/jbc.M512887200; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Yang J, 2012, J CLIN INVEST, V122, P600, DOI 10.1172/JCI58780; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou H, 2009, ARCH BIOCHEM BIOPHYS, V486, P88, DOI 10.1016/j.abb.2009.02.017	54	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35253	35265		10.1074/jbc.M113.478271	http://dx.doi.org/10.1074/jbc.M113.478271			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142693	Green Published, hybrid			2022-12-28	WOS:000329867600024
J	Rajagopal, S; Bassoni, DL; Campbell, JJ; Gerard, NP; Gerard, C; Wehrman, TS				Rajagopal, Sudarshan; Bassoni, Daniel L.; Campbell, James J.; Gerard, Norma P.; Gerard, Craig; Wehrman, Tom S.			Biased Agonism as a Mechanism for Differential Signaling by Chemokine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arrestin; Chemokines; G Protein-coupled Receptors (GPCR); G Proteins; Signaling; Biased Agonism	I RECEPTOR; PROTEIN; LIGAND; CXCR3; ASSAY; COMPLEMENTATION; RECRUITMENT; ACTIVATION; TRV120027; HEART	Background: Chemokines have been thought to act in a redundant fashion through their shared receptors. Results: Chemokines can display different efficacies for G proteins and -arrestins, resulting in different chemotactic profiles. Conclusion: Chemokines can behave as biased agonists at their receptors, leading to functionally distinct, not redundant, responses. Significance: Biased agonism plays an important role in biological signaling. Chemokines display considerable promiscuity with multiple ligands and receptors shared in common, a phenomenon that is thought to underlie their biochemical redundancy. Their receptors are part of a larger seven-transmembrane receptor superfamily, commonly referred to as G protein-coupled receptors, which have been demonstrated to be able to signal with different efficacies to their multiple downstream signaling pathways, a phenomenon referred to as biased agonism. Biased agonism has been primarily reported as a phenomenon of synthetic ligands, and the biologic prevalence and importance of such signaling are unclear. Here, to assess the presence of biased agonism that may underlie differential signaling by chemokines targeting the same receptor, we performed a detailed pharmacologic analysis of a set of chemokine receptors with multiple endogenous ligands using assays for G protein signaling, -arrestin recruitment, and receptor internalization. We found that chemokines targeting the same receptor can display marked differences in their efficacies for G protein- or -arrestin-mediated signaling or receptor internalization. This ligand bias correlates with changes in leukocyte migration, consistent with different mechanisms underlying the signaling downstream of these receptors induced by their ligands. These findings demonstrate that biased agonism is a common and likely evolutionarily conserved biological mechanism for generating qualitatively distinct patterns of signaling via the same receptor in response to different endogenous ligands.	[Rajagopal, Sudarshan] Duke Univ, Dept Med, Med Ctr, Durham, NC 27710 USA; [Bassoni, Daniel L.; Wehrman, Tom S.] DiscoveRx Corp, Fremont, CA 94538 USA; [Campbell, James J.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Gerard, Norma P.; Gerard, Craig] Childrens Hosp, Dept Pediat, Div Resp Dis, Boston, MA 02115 USA	Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Rajagopal, S (corresponding author), Duke Univ, Med Ctr, 2301 Erwin Rd,DUMC 3845, Durham, NC 27710 USA.	sudarshan.rajagopal@dm.duke.edu	Rajagopal, Sudarshan/G-8975-2013	Rajagopal, Sudarshan/0000-0002-3443-5040; Campbell, James/0000-0003-4252-5182	National Institutes of Health [HL07101-34]; T32 training grant [R21A1092388, R21A1097468, R01A1039795-14, 5R01HL51366-15]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051366, T32HL007101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097468, R21AI092388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL07101-34, a T32 training grant (to S. R.); R21A1092388 and R21A1097468 (to J. C.); and R01A1039795-14 and 5R01HL51366-15 (to C. G.). D. B. and T. W. are employees of DiscoveRx Corporation, which commercializes the PathHunter technology.	Bassoni Daniel L, 2012, Methods Mol Biol, V897, P171, DOI 10.1007/978-1-61779-909-9_8; Bassoni Daniel L, 2012, Methods Mol Biol, V897, P181, DOI 10.1007/978-1-61779-909-9_9; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Bradley J, 2009, METHODS MOL BIOL, V552, P171, DOI 10.1007/978-1-60327-317-6_12; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Drury LJ, 2011, P NATL ACAD SCI USA, V108, P17655, DOI 10.1073/pnas.1101133108; Eglen RM, 2002, ASSAY DRUG DEV TECHN, V1, P97, DOI 10.1089/154065802761001356; Ehlert FJ, 2008, N-S ARCH PHARMACOL, V377, P549, DOI 10.1007/s00210-008-0260-4; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Furchgott RF., 1966, ADV DRUG RES, V3, P21; Gesty-Palmer D, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000071; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Griffin MT, 2007, J PHARMACOL EXP THER, V321, P1193, DOI 10.1124/jpet.107.120857; GURWITZ D, 1994, EUR J PHARM-MOLEC PH, V267, P21, DOI 10.1016/0922-4106(94)90220-8; Hammer MM, 2007, FASEB J, V21, P3827, DOI 10.1096/fj.07-8777com; Hu SM, 2011, P NATL ACAD SCI USA, V108, pE1035, DOI 10.1073/pnas.1100156108; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Meiser A, 2008, J IMMUNOL, V180, P6713, DOI 10.4049/jimmunol.180.10.6713; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Olson KR, 2007, ASSAY DRUG DEV TECHN, V5, P137, DOI 10.1089/adt.2006.052; Power CA, 2003, J IMMUNOL METHODS, V273, P73, DOI 10.1016/S0022-1759(02)00419-2; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Watts AO, 2012, BIOCHEM BIOPH RES CO, V419, P412, DOI 10.1016/j.bbrc.2012.02.036; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	35	90	90	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35039	35048		10.1074/jbc.M113.479113	http://dx.doi.org/10.1074/jbc.M113.479113			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24145037	Green Published, hybrid			2022-12-28	WOS:000329867600006
J	Belugin, S; Diogenes, AR; Patil, MJ; Ginsburg, E; Henry, MA; Akopian, AN				Belugin, Sergei; Diogenes, Anibal R.; Patil, Mayur J.; Ginsburg, Erika; Henry, Michael A.; Akopian, Armen N.			Mechanisms of Transient Signaling via Short and Long Prolactin Receptor Isoforms in Female and Male Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neuroendocrinology; Pain; PI3-kinase (PI3K); Prolactin; Protein Kinase C (PKC)	PROTEIN-KINASE-C; DELTA-OPIOID-RECEPTOR; MESSENGER-RNA; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATORY HYPERALGESIA; TRIGEMINAL NOCICEPTORS; FUNCTIONAL COMPETENCE; INHIBITORY-ACTION; TRP CHANNELS; SHORT-FORM	Background: Prolactin regulates the activity of nociceptors in pain conditions. Results: Prolactin regulation of sensory neurons is acute and mediated via PI3K and PKCE following activation of prolactin receptor short isoform. Prolactin receptor short isoform actions are inhibited by the long isoform. Conclusion: Prolactin receptor short isoform mediates transient sensitization of nociceptors. Significance: The proposed mechanism could underlie prolactin involvement in hyperalgesia/pain. Prolactin (PRL) regulates activity of nociceptors and causes hyperalgesia in pain conditions. PRL enhances nociceptive responses by rapidly modulating channels in nociceptors. The molecular mechanisms underlying PRL-induced transient signaling in neurons are not well understood. Here we use a variety of cell biology and pharmacological approaches to show that PRL transiently enhanced capsaicin-evoked responses involve protein kinase C E (PKCE) or phosphatidylinositol 3-kinase (PI3K) pathways in female rat trigeminal (TG) neurons. We next reconstituted PRL-induced signaling in a heterologous expression system and TG neurons from PRL receptor (PRLR)-null mutant mice by expressing rat PRLR-long isoform (PRLR-L), PRLR-short isoform (PRLR-S), or a mix of both. Results show that PRLR-S, but not PRLR-L, is capable of mediating PRL-induced transient enhancement of capsaicin responses in both male and female TG neurons. However, co-expression of PRLR-L with PRLR-S (1:1 ratio) leads to the inhibition of the transient PRL actions. Co-expression of PRLR-L deletion mutants with PRLR-S indicated that the cytoplasmic site adjacent to the trans-membrane domain of PRLR-L was responsible for inhibitory effects of PRLR-L. Furthermore, in situ hybridization and immunohistochemistry data indicate that in normal conditions, PRLR-L is expressed mainly in glia with little expression in rat sensory neurons (3-5%) and human nerves. The predominant PRLR form in TG neurons/nerves from rats and humans is PRLR-S. Altogether, PRL-induced transient signaling in sensory neurons is governed by PI3K or PKCE, mediated via the PRLR-S isoform, and transient effects mediated by PRLR-S are inhibited by presence of PRLR-L in these cells.	[Belugin, Sergei; Diogenes, Anibal R.; Henry, Michael A.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Patil, Mayur J.; Akopian, Armen N.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Ginsburg, Erika] NCI, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Akopian, AN (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	akopian@uthscsa.edu	Belugin, Sergei/L-5005-2013	Belugin, Sergei/0000-0001-9006-7732	National Institutes of Health [DE017696]; Intramural Research Program of the NCI/National Institutes of Health; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DE017696 (to A.N.A.) and by the Intramural Research Program of the NCI/National Institutes of Health (to E.G.).	Ahonen TJ, 2002, ENDOCRINOLOGY, V143, P228, DOI 10.1210/en.143.1.228; Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Amaral MEC, 2004, J ENDOCRINOL, V183, P469, DOI 10.1677/joe.1.05547; Bakowska JC, 2003, MOL BRAIN RES, V116, P50, DOI 10.1016/S0169-328X(03)00213-4; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandman R, 2007, J BIOL CHEM, V282, P4113, DOI 10.1074/jbc.M608521200; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; BRIDGES RS, 1990, P NATL ACAD SCI USA, V87, P8003, DOI 10.1073/pnas.87.20.8003; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brown RSE, 2012, ENDOCRINOLOGY, V153, P2375, DOI 10.1210/en.2011-2005; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Clevenger CV, 2001, LUPUS, V10, P706, DOI 10.1191/096120301717164949; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; DAVIS JA, 1989, MOL ENDOCRINOL, V3, P674, DOI 10.1210/mend-3-4-674; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; DUDLEY CA, 1982, ENDOCRINOLOGY, V110, P677, DOI 10.1210/endo-110-2-677; FUKAZAWA H, 1994, FEBS LETT, V340, P155, DOI 10.1016/0014-5793(94)80127-4; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Ginsburg E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-678; Goffin V, 1996, CLIN ENDOCRINOL, V45, P247, DOI 10.1046/j.1365-2265.1996.00799.x; Gorski E, 1999, MOL UROL, V3, P17; Goupille O, 1997, MOL CELL ENDOCRINOL, V127, P155, DOI 10.1016/S0303-7207(97)04005-7; Gregus AM, 2012, P NATL ACAD SCI USA, V109, P6721, DOI 10.1073/pnas.1110460109; Gutzman JH, 2004, MOL ENDOCRINOL, V18, P3064, DOI 10.1210/me.2004-0187; Henry MA, 2006, PAIN, V124, P222, DOI 10.1016/j.pain.2006.05.028; Jeske NA, 2006, J BIOL CHEM, V281, P32879, DOI 10.1074/jbc.M603220200; KELLY PA, 1991, ENDOCR REV, V12, P235, DOI 10.1210/edrv-12-3-235; Kumar A, 1997, INT J IMMUNOPHARMACO, V19, P129, DOI 10.1016/S0192-0561(97)00022-2; Lim S, 2008, LIFE SCI, V82, P733, DOI 10.1016/j.lfs.2008.01.005; Lopshire JC, 1998, J NEUROSCI, V18, P6081; Lyons DJ, 2012, J NEUROSCI, V32, P8074, DOI 10.1523/JNEUROSCI.0129-12.2012; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mena F, 2013, NEUROSCIENCE, V248, P552, DOI 10.1016/j.neuroscience.2013.06.052; NOEL MB, 1993, PHYSIOL BEHAV, V54, P151, DOI 10.1016/0031-9384(93)90057-M; Ochoa-Amaya JE, 2011, NEUROIMMUNOMODULAT, V18, P245, DOI 10.1159/000323774; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Patil MJ, 2013, NEUROSCIENCE, V253, P132, DOI 10.1016/j.neuroscience.2013.08.035; Patil M. J., 2013, AM J PHYSL IN PRESS; Patil M, 2011, NEUROPHARMACOLOGY, V61, P778, DOI 10.1016/j.neuropharm.2011.05.024; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; Patwardhan AM, 2005, J NEUROSCI, V25, P8825, DOI 10.1523/JNEUROSCI.0160-05.2005; Patwardhan AM, 2006, PAIN, V125, P114, DOI 10.1016/j.pain.2006.05.007; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; Pi XJ, 1999, J MOL ENDOCRINOL, V23, P13, DOI 10.1677/jme.0.0230013; Pi XJ, 2002, J NEUROSCI RES, V67, P551, DOI 10.1002/jnr.10147; Qazi AM, 2006, MOL ENDOCRINOL, V20, P1912, DOI 10.1210/me.2005-0291; REINER Z, 1987, ACTA OTO-LARYNGOL, V103, P665; Scotland PE, 2011, EUR J NEUROSCI, V34, P745, DOI 10.1111/j.1460-9568.2011.07788.x; Sobhia ME, 2013, EXPERT OPIN THER PAT, V23, P1297, DOI 10.1517/13543776.2013.805205; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Xie YL, 2009, MOL CELL BIOL, V29, P2546, DOI 10.1128/MCB.01716-08; Yardeni Israel Z, 2007, Int J Surg, V5, P239, DOI 10.1016/j.ijsu.2006.09.008; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	63	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34943	34955		10.1074/jbc.M113.486571	http://dx.doi.org/10.1074/jbc.M113.486571			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142695	hybrid, Green Published			2022-12-28	WOS:000329812800060
J	Cook, I; Wang, T; Falany, CN; Leyh, TS				Cook, Ian; Wang, Ting; Falany, Charles N.; Leyh, Thomas S.			High Accuracy in Silico Sulfotransferase Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Enzyme Mechanisms; Metabolism; Molecular Dynamics; Sulfotransferase; Binding; In Silico; Phase II Metabolism; Reactivity	ORAL-CONTRACEPTIVE STEROIDS; PHENOL SULFOTRANSFERASE; SULFURYL TRANSFER; CRYSTAL-STRUCTURE; SULFATION; MECHANISM; DEHYDROEPIANDROSTERONE; INHIBITION; METABOLISM; EXPRESSION	Background: Human sulfotransferases (SULTs) regulate the bioactivities of hundreds of compounds in vivo. Results: The in silico models of SULTs developed here proved remarkably accurate in identifying SULT substrates in a 1,455-compound library containing all FDA-approved drugs. Conclusion: Highly accurate in silico SULT models are now available. Significance: The elision of mechanism and modeling can produce remarkably accurate in silico tools for the study of biology. Predicting enzymatic behavior in silico is an integral part of our efforts to understand biology. Hundreds of millions of compounds lie in targeted in silico libraries waiting for their metabolic potential to be discovered. In silico enzymes capable of accurately determining whether compounds can inhibit or react is often the missing piece in this endeavor. This problem has now been solved for the cytosolic sulfotransferases (SULTs). SULTs regulate the bioactivities of thousands of compoundsendogenous metabolites, drugs and other xenobioticsby transferring the sulfuryl moiety (SO3) from 3-phosphoadenosine 5-phosphosulfate to the hydroxyls and primary amines of these acceptors. SULT1A1 and 2A1 catalyze the majority of sulfation that occurs during human Phase II metabolism. Here, recent insights into the structure and dynamics of SULT binding and reactivity are incorporated into in silico models of 1A1 and 2A1 that are used to identify substrates and inhibitors in a structurally diverse set of 1,455 high value compounds: the FDA-approved small molecule drugs. The SULT1A1 models predict 76 substrates. Of these, 53 were known substrates. Of the remaining 23, 21 were tested, and all were sulfated. The SULT2A1 models predict 22 substrates, 14 of which are known substrates. Of the remaining 8, 4 were tested, and all are substrates. The models proved to be 100% accurate in identifying substrates and made no false predictions at K-d thresholds of 100 m. In total, 23 new drug substrates were identified, and new linkages to drug inhibitors are predicted. It now appears to be possible to accurately predict Phase II sulfonation in silico.	[Cook, Ian; Wang, Ting; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Falany, Charles N.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Sch Med Birmingham, Birmingham, AL 35294 USA	Yeshiva University; Albert Einstein College of Medicine; University of Alabama System; University of Alabama Birmingham	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tsleyh@gmail.com	Wang, Ting/J-7577-2015		National Institutes of Health [GM54469, GM38953]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054469, R29GM038953, R01GM038953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54469 and GM38953.	[Anonymous], 2011, NAT REV DRUG DISCOV; Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941; BAMFORTH KJ, 1992, EUR J PHARM-ENVIRON, V228, P15, DOI 10.1016/0926-6917(92)90006-X; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; BENSON GA, 1980, CHEM REV, V80, P151, DOI 10.1021/cr60324a002; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bode JW, 2004, J AM CHEM SOC, V126, P15317, DOI 10.1021/ja040968l; Cleland W W, 1979, Methods Enzymol, V63, P103; COMER KA, 1993, BIOCHEM J, V289, P233, DOI 10.1042/bj2890233; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Durrant JD, 2013, J MOL GRAPH MODEL, V44, P104, DOI 10.1016/j.jmgm.2013.05.006; Edavana VK, 2011, PHARMACOGN PERS MED, V4, P137, DOI 10.2147/PGPM.S25418; Ekins Sean, 2005, Expert Opin Drug Metab Toxicol, V1, P303, DOI 10.1517/17425255.1.2.303; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Falany JL, 2007, J STEROID BIOCHEM, V107, P202, DOI 10.1016/j.jsbmb.2007.03.046; FORADADA M, 1995, INT J PHARM, V124, P261, DOI 10.1016/0378-5173(95)00097-3; Ginsberg G, 2009, ENVIRON HEALTH PERSP, V117, P1639, DOI 10.1289/ehp.0901010; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang J, 2010, XENOBIOTICA, V40, P184, DOI 10.3109/00498250903514607; Klaassen CD, 1997, FASEB J, V11, P404, DOI 10.1096/fasebj.11.6.9194521; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kotov A, 1999, J STEROID BIOCHEM, V68, P137, DOI 10.1016/S0960-0760(99)00022-9; Kumari S, 2011, ANAL CHEM, V83, P5895, DOI 10.1021/ac2006137; Meloche CA, 2001, J STEROID BIOCHEM, V77, P261, DOI 10.1016/S0960-0760(01)00064-4; MITCHELL MC, 1983, CLIN PHARMACOL THER, V34, P48, DOI 10.1038/clpt.1983.127; Mitchell P B, 1994, Aust Fam Physician, V23, P1771; Mitchell PB, 1994, AUST FAM PHYSICIAN, V23, P1776; Nishimuta H, 2005, PHARM RES-DORDR, V22, P1406, DOI 10.1007/s11095-005-5263-y; Nishiyama Takahito, 2002, Drug Metab Pharmacokinet, V17, P221, DOI 10.2133/dmpk.17.221; Nowell S, 2006, ONCOGENE, V25, P1673, DOI 10.1038/sj.onc.1209376; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; ROGERS SM, 1987, BRIT J CLIN PHARMACO, V23, P721, DOI 10.1111/j.1365-2125.1987.tb03107.x; Rohn KJ, 2012, DRUG METAB DISPOS, V40, P1588, DOI 10.1124/dmd.112.045583; Shoichet BK, 2002, CURR OPIN CHEM BIOL, V6, P439, DOI 10.1016/S1367-5931(02)00339-3; Sorich MJ, 2008, CURR DRUG METAB, V9, P60, DOI 10.2174/138920008783331167; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Tang QX, 2010, J PHYS CHEM B, V114, P16131, DOI 10.1021/jp1055528; Thomas NL, 2003, XENOBIOTICA, V33, P1139, DOI 10.1080/00498250310001609192; Tyapochkin E, 2008, BIOCHEMISTRY-US, V47, P11894, DOI 10.1021/bi801211t; van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; VISSER TJ, 1994, CHEM-BIOL INTERACT, V92, P293, DOI 10.1016/0009-2797(94)90071-X; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weger BD, 2012, ACS CHEM BIOL, V7, P1178, DOI 10.1021/cb3000474; Weise AM, 2009, ANN PHARMACOTHER, V43, P761, DOI 10.1345/aph.1L528; WHITTEMORE RM, 1985, BIOCHEMISTRY-US, V24, P2477, DOI 10.1021/bi00331a013; Yang CH, 2011, J PHARM PHARMACOL, V63, P967, DOI 10.1111/j.2042-7158.2011.01298.x; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	59	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34494	34501		10.1074/jbc.M113.510974	http://dx.doi.org/10.1074/jbc.M113.510974			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129576	Green Published, hybrid			2022-12-28	WOS:000329812800019
J	Liang, WX; Deutscher, MP				Liang, Wenxing; Deutscher, Murray P.			Ribosomes Regulate the Stability and Action of the Exoribonuclease RNase R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli; Protein Stability; Ribonuclease; Ribosomes; RNA Metabolism	ESCHERICHIA-COLI; MESSENGER-RNA; STABLE RNA; NUCLEASE DOMAIN; STRUCTURED RNA; 10SA RNA; DEGRADATION; TMRNA; BACTERIA; STRESS	Background: Cells require mechanisms to regulate the potentially destructive action of RNases. Results: RNase R is largely bound to ribosomes in growing cells dependent on tmRNA-SmpB and nonstop mRNA. Conclusion: Ribosome binding stabilizes RNase R and sequesters it away from action on many functional RNAs. Significance: This work defines a previously unknown mechanism by which ribosomes regulate a deleterious enzyme. Ribonucleases play an important role in RNA metabolism. Yet, they are also potentially destructive enzymes whose activity must be controlled. Here we describe a novel regulatory mechanism affecting RNase R, a 3 to 5 exoribonuclease able to act on essentially all RNAs including those with extensive secondary structure. Most RNase R is sequestered on ribosomes in growing cells where it is stable and participates in trans-translation. In contrast, the free form of the enzyme, which is deleterious to cells, is extremely unstable, turning over with a half-life of 2 min. RNase R binding to ribosomes is dependent on transfer-messenger RNA (tmRNA)-SmpB, nonstop mRNA, and the modified form of ribosomal protein S12. Degradation of the free form of RNase R also requires tmRNA-SmpB, but this process is independent of ribosomes, indicating two distinct roles for tmRNA-SmpB. Inhibition of RNase R binding to ribosomes leads to slower growth and a massive increase in RNA degradation. These studies indicate a previously unknown role for ribosomes in cellular homeostasis.	[Liang, Wenxing; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA.	mdeutsch@med.miami.edu			National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Chen CL, 2010, RNA, V16, P667, DOI 10.1261/rna.1981010; Chen CL, 2005, J BIOL CHEM, V280, P34393, DOI 10.1074/jbc.C500333200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; COHEN L, 1977, J BACTERIOL, V129, P651, DOI 10.1128/JB.129.2.651-657.1977; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Komine Y, 1996, J BIOCHEM-TOKYO, V119, P463; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Liang WX, 2006, ARCH VIROL, V151, P2311, DOI 10.1007/s00705-006-0780-5; Liang WX, 2012, J BIOL CHEM, V287, P33472, DOI 10.1074/jbc.M112.375287; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Liang WX, 2010, J BIOL CHEM, V285, P29054, DOI 10.1074/jbc.C110.168641; Liang WX, 2009, CELL RES, V19, P307, DOI 10.1038/cr.2008.317; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Strader MB, 2013, J PROTEOME RES, V12, P1289, DOI 10.1021/pr3009435; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Sundermeier TR, 2007, J BIOL CHEM, V282, P34779, DOI 10.1074/jbc.M707256200; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Vincent HA, 2009, J BIOL CHEM, V284, P486, DOI 10.1074/jbc.M806468200; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	36	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34791	34798		10.1074/jbc.M113.519553	http://dx.doi.org/10.1074/jbc.M113.519553			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133211	Green Published, hybrid			2022-12-28	WOS:000329812800047
J	Bode, A; Wood, SE; Mullins, JGL; Keramidas, A; Cushion, TD; Thomas, RH; Pickrell, WO; Drew, CJG; Masri, A; Jones, EA; Vassallo, G; Born, AP; Alehan, F; Aharoni, S; Bannasch, G; Bartsch, M; Kara, B; Krause, A; Karam, EG; Matta, S; Jain, V; Mandel, H; Freilinger, M; Graham, GE; Hobson, E; Chatfield, S; Vincent-Delorme, C; Rahme, JE; Afawi, Z; Berkovic, SF; Howell, OW; Vanbellinghen, JF; Rees, MI; Chung, SK; Lynch, JW				Bode, Anna; Wood, Sian-Elin; Mullins, Jonathan G. L.; Keramidas, Angelo; Cushion, Thomas D.; Thomas, Rhys H.; Pickrell, William O.; Drew, Cheney J. G.; Masri, Amira; Jones, Elizabeth A.; Vassallo, Grace; Born, Alfred P.; Alehan, Fusun; Aharoni, Sharon; Bannasch, Gerald; Bartsch, Marius; Kara, Bulent; Krause, Amanda; Karam, Elie G.; Matta, Stephanie; Jain, Vivek; Mandel, Hanna; Freilinger, Michael; Graham, Gail E.; Hobson, Emma; Chatfield, Sue; Vincent-Delorme, Catherine; Rahme, Jubran E.; Afawi, Zaid; Berkovic, Samuel F.; Howell, Owain W.; Vanbellinghen, Jean-Francois; Rees, Mark I.; Chung, Seo-Kyung; Lynch, Joseph W.			New Hyperekplexia Mutations Provide Insight into Glycine Receptor Assembly, Trafficking, and Activation Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloride Channels; Cys-Loop Receptors; Glycine Receptors; Neurological Diseases; Patch Clamp Electrophysiology	CYS-LOOP RECEPTORS; STARTLE DISEASE; COMPOUND HETEROZYGOSITY; FUNCTIONAL-CHARACTERIZATION; SPORADIC HYPEREKPLEXIA; TRANSMEMBRANE SEGMENT; NONSENSE MUTATIONS; MISSENSE MUTATION; CHLORIDE CHANNELS; ALPHA-1 SUBUNIT	Hyperekplexia is a syndrome of readily provoked startle responses, alongside episodic and generalized hypertonia, that presents within the first month of life. Inhibitory glycine receptors are pentameric ligand-gated ion channels with a definitive and clinically well stratified linkage to hyperekplexia. Most hyperekplexia cases are caused by mutations in the 1 subunit of the human glycine receptor (hGlyR) gene (GLRA1). Here we analyzed 68 new unrelated hyperekplexia probands for GLRA1 mutations and identified 19 mutations, of which 9 were novel. Electrophysiological analysis demonstrated that the dominant mutations p.Q226E, p.V280M, and p.R414H induced spontaneous channel activity, indicating that this is a recurring mechanism in hGlyR pathophysiology. p.Q226E, at the top of TM1, most likely induced tonic activation via an enhanced electrostatic attraction to p.R271 at the top of TM2, suggesting a structural mechanism for channel activation. Receptors incorporating p.P230S (which is heterozygous with p.R65W) desensitized much faster than wild type receptors and represent a new TM1 site capable of modulating desensitization. The recessive mutations p.R72C, p.R218W, p.L291P, p.D388A, and p.E375X precluded cell surface expression unless co-expressed with 1 wild type subunits. The recessive p.E375X mutation resulted in subunit truncation upstream of the TM4 domain. Surprisingly, on the basis of three independent assays, we were able to infer that p.E375X truncated subunits are incorporated into functional hGlyRs together with unmutated 1 or 1 plus subunits. These aberrant receptors exhibit significantly reduced glycine sensitivity. To our knowledge, this is the first suggestion that subunits lacking TM4 domains might be incorporated into functional pentameric ligand-gated ion channel receptors.	[Bode, Anna; Keramidas, Angelo; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Bode, Anna; Keramidas, Angelo; Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Wood, Sian-Elin; Mullins, Jonathan G. L.; Cushion, Thomas D.; Thomas, Rhys H.; Pickrell, William O.; Drew, Cheney J. G.; Howell, Owain W.; Rees, Mark I.; Chung, Seo-Kyung] Swansea Univ, Dept Neurol Res & Mol Neurosci, Inst Life Sci, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Thomas, Rhys H.; Pickrell, William O.; Drew, Cheney J. G.; Howell, Owain W.; Rees, Mark I.; Chung, Seo-Kyung] Swansea Univ, Wales Epilepsy Res Network, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Masri, Amira] Univ Jordan, Dept Paediat, Div Child Neurol, Fac Med, Amman 11942, Jordan; [Jones, Elizabeth A.] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester M13 9WL, Lancs, England; [Vassallo, Grace] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Royal Manchester Childrens Hosp, Manchester M13 9WL, Lancs, England; [Jones, Elizabeth A.] Univ Manchester, Manchester Ctr Genom Med, Manchester Acad Hlth Sci Ctr, Inst Human Dev,Fac Med & Human Sci, Manchester M13 9WL, Lancs, England; [Born, Alfred P.] Rigshosp, Copenhagen Univ Hosp, Dept Pediat, DK-2100 Copenhagen, Denmark; [Alehan, Fusun] Basskent Univ, Div Child Neurol, Dept Pediat, Fac Med, TR-06990 Ankara, Turkey; [Aharoni, Sharon] Schneider Childrens Med Ctr Israel, Inst Pediat Neurol, IL-49202 Petah Tiqwa, Israel; [Aharoni, Sharon] Tel Aviv Univ, Sackler Fac Med, IL-69987 Tel Aviv, Israel; [Bannasch, Gerald] Affin Med Grp, Dept Neurol, Menasha, WI 54952 USA; [Bartsch, Marius] Johannes Gutenberg Univ Mainz, Dept Neonatol, Univ Med Ctr, D-55099 Mainz, Germany; [Kara, Bulent] Kocaeli Univ, Fac Med, Dept Pediat, Div Child Neurol, TR-41380 Kocaeli, Turkey; [Krause, Amanda] Univ Witwatersrand, Div Human Genet, Natl Hlth Lab Serv, ZA-2000 Johannesburg, South Africa; [Krause, Amanda] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, ZA-2000 Johannesburg, South Africa; [Karam, Elie G.; Matta, Stephanie] Balamand Univ, Dept Psychiat & Clin Psychol, St George Hosp Univ Med Ctr, Fac Med, Beirut 11002807, Lebanon; [Jain, Vivek] Royal Childrens Hosp, Royal Childrens Hosp Melbourne, Childrens Neurosci Ctr, Parkville, Vic 3052, Australia; [Mandel, Hanna] Technion Israel Inst Technol, Rambam Med Ctr, Meyer Childrens Hosp, Metab Unit,Fac Med, IL-31096 Haifa, Israel; [Freilinger, Michael] Med Univ Vienna, Dept Pediat & Adolescent Med, A-1090 Vienna, Austria; [Graham, Gail E.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Hobson, Emma] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [Chatfield, Sue] Bradford Royal Infirm, Neonatal Unit, Bradford BD9 6RJ, W Yorkshire, England; [Vincent-Delorme, Catherine] Ctr Hosp Arras, F-62000 Arras, France; [Rahme, Jubran E.] Clalit Hlth Serv, IL-20200 Shfaram, Israel; [Afawi, Zaid] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-8410501 Beer Sheva, Israel; [Berkovic, Samuel F.] Austin Hlth, Epilepsy Res Ctr, Melbourne Brain Ctr, Heidelberg, Vic 3084, Australia; [Vanbellinghen, Jean-Francois] Inst Pathol & Genet ASBL IRSPG, B-6041 Gosselies, Belgium	University of Queensland; University of Queensland; Swansea University; Swansea University; University of Jordan; University of Manchester; Royal Manchester Children's Hospital; University of Manchester; University of Manchester; Rigshospitalet; University of Copenhagen; Tel Aviv University; Sackler Faculty of Medicine; Johannes Gutenberg University of Mainz; Kocaeli University; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; University Balamand; Royal Children's Hospital Melbourne; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Medical University of Vienna; University of Ottawa; Children's Hospital of Eastern Ontario; Chapel Allerton Hospital; Bradford Royal Infirmary; Clalit Health Services; Ben Gurion University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	masri, amira/C-4570-2015; Cushion, Thomas D/O-3986-2017; Krause, Amanda/AAQ-7038-2020; Rees, Mark I/J-3129-2012; Pickrell, William Owen/F-7110-2014; Afawi, Zaid/AAE-7848-2022; jiang, yu/HGU-0029-2022; Keramidas, Angelo/I-1704-2013; Chung, Seo-Kyung/I-3329-2017; Born, Alfred Peter/GVS-4083-2022; Thomas, Rhys/I-3840-2019; Chung, Seo-Kyung/AAT-4693-2021	masri, amira/0000-0001-6103-8713; Cushion, Thomas D/0000-0002-0040-0069; Krause, Amanda/0000-0002-7157-0807; Rees, Mark I/0000-0003-3570-5986; Pickrell, William Owen/0000-0003-4396-5657; Keramidas, Angelo/0000-0003-2846-052X; Chung, Seo-Kyung/0000-0002-5008-8384; Thomas, Rhys/0000-0003-2062-8623; Chung, Seo-Kyung/0000-0002-5008-8384; Howell, Owain/0000-0003-2157-9157; Mullins, Jonathan/0000-0003-0144-2962; Berkovic, Samuel/0000-0003-4580-841X; Wood, Sian/0000-0003-2353-7073	Australian Research Council (JWL); Waterloo Foundation (MIR); National Institute of Social Care and Health Research (NISCHR-RRG); Wales Gene Park (MIR); Epilepsy Research UK fellowship; National Health and Medical Research Council	Australian Research Council (JWL)(Australian Research Council); Waterloo Foundation (MIR); National Institute of Social Care and Health Research (NISCHR-RRG); Wales Gene Park (MIR); Epilepsy Research UK fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (JWL), Waterloo Foundation (MIR), the National Institute of Social Care and Health Research (NISCHR-RRG; to MIR, RHT and SKC), Wales Gene Park (MIR).; Supported by an Epilepsy Research UK fellowship.; Supported by the National Health and Medical Research Council. To whom correspondence should be addressed: Queensland Brain Institute, University of Queensland, Brisbane,	Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; Bellini G, 2007, NEUROLOGY, V68, P1947, DOI 10.1212/01.wnl.0000263193.75291.85; Brune W, 1996, AM J HUM GENET, V58, P989; Butler AS, 2009, NEUROPHARMACOLOGY, V56, P292, DOI 10.1016/j.neuropharm.2008.08.017; Chen XB, 2009, MOL MEMBR BIOL, V26, P321, DOI 10.1080/09687680903120319; Chung SK, 2013, HUM MOL GENET, V22, P927, DOI 10.1093/hmg/dds498; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Davies JS, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00008; del Giudice EM, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e71; Estrada-Mondragon A, 2010, P NATL ACAD SCI USA, V107, P17780, DOI 10.1073/pnas.1012540107; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Graham BA, 2006, J NEUROSCI, V26, P4880, DOI 10.1523/JNEUROSCI.3991-05.2006; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Humeny A, 2002, EUR J HUM GENET, V10, P188, DOI 10.1038/sj.ejhg.5200779; Islam R, 2012, BRIT J PHARMACOL, V165, P2707, DOI 10.1111/j.1476-5381.2011.01722.x; James VM, 2013, NEUROBIOL DIS, V52, P137, DOI 10.1016/j.nbd.2012.12.001; Kang JQ, 2010, J NEUROSCI, V30, P13895, DOI 10.1523/JNEUROSCI.2320-10.2010; Kling C, 1997, NEUROSCIENCE, V78, P411, DOI 10.1016/S0306-4522(96)00567-2; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; LANGOSCH D, 1994, EMBO J, V13, P4223, DOI 10.1002/j.1460-2075.1994.tb06742.x; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pons S, 2004, EUR J NEUROSCI, V20, P2022, DOI 10.1111/j.1460-9568.2004.03673.x; RAJENDRA S, 1994, J BIOL CHEM, V269, P18739; Rea R, 2002, EUR J NEUROSCI, V16, P186, DOI 10.1046/j.1460-9568.2002.02054.x; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Rees MI, 2001, HUM GENET, V109, P267, DOI 10.1007/s004390100569; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Saul B, 1999, J NEUROSCI, V19, P869; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Thomas RH, 2013, BRAIN, V136, P3085, DOI 10.1093/brain/awt207; Thomas RH, 2010, J PEDIATR NEUROL, V8, P11, DOI 10.3233/JPN-2010-0359; Unterer B, 2012, J BIOL CHEM, V287, P39205, DOI 10.1074/jbc.M112.376053; Vergouwe MN, 1999, ANN NEUROL, V46, P634, DOI 10.1002/1531-8249(199910)46:4<634::AID-ANA12>3.0.CO;2-9; Villmann C, 2009, J NEUROCHEM, V111, P837, DOI 10.1111/j.1471-4159.2009.06372.x; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Wang Q, 2011, J BIOL CHEM, V286, P38814, DOI 10.1074/jbc.M111.273631; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yang Z, 2012, BIOCHEMISTRY-US, V51, P5229, DOI 10.1021/bi300063m	55	32	33	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33745	33759		10.1074/jbc.M113.509240	http://dx.doi.org/10.1074/jbc.M113.509240			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24108130	Green Published, hybrid			2022-12-28	WOS:000327250200021
J	Opefi, CA; South, K; Reynolds, CA; Smith, SO; Reeves, PJ				Opefi, Chikwado A.; South, Kieron; Reynolds, Christopher A.; Smith, Steven O.; Reeves, Philip J.			Retinitis Pigmentosa Mutants Provide Insight into the Role of the N-terminal Cap in Rhodopsin Folding, Structure, and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled Receptor (GPCR); Membrane Proteins; Phototransduction; Protein Misfolding; Protein Stability; Retinal Degeneration; Retinoid; Rhodopsin	PROTEIN-COUPLED-RECEPTOR; SCHIFF-BASE STABILITY; OPSIN MUTANT; INTRADISCAL DOMAIN; CRYSTAL-STRUCTURE; QUALITY-CONTROL; EXPRESSION; GENE; ACTIVATION; FLUORESCENCE	Autosomal dominant retinitis pigmentosa (ADRP) mutants (T4K, N15S, T17M, V20G, P23A/H/L, and Q28H) in the N-terminal cap of rhodopsin misfold when expressed in mammalian cells. To gain insight into the causes of misfolding and to define the contributions of specific residues to receptor stability and function, we evaluated the responses of these mutants to 11-cis-retinal pharmacological chaperone rescue or disulfide bond-mediated repair. Pharmacological rescue restored folding in all mutants, but the purified mutant pigments in all cases were thermo-unstable and exhibited abnormal photobleaching, metarhodopsin II decay, and G protein activation. As a complementary approach, we superimposed this panel of ADRP mutants onto a rhodopsin background containing a juxtaposed cysteine pair (N2C/D282C) that forms a disulfide bond. This approach restored folding in T4K, N15S, V20G, P23A, and Q28H but not T17M, P23H, or P23L. ADRP mutant pigments obtained by disulfide bond repair exhibited enhanced stability, and some also displayed markedly improved photobleaching and signal transduction properties. Our major conclusion is that the N-terminal cap stabilizes opsin during biosynthesis and contributes to the dark-state stability of rhodopsin. Comparison of these two restorative approaches revealed that the correct position of the cap relative to the extracellular loops is also required for optimal photochemistry and efficient G protein activation.	[Opefi, Chikwado A.; South, Kieron; Reynolds, Christopher A.; Reeves, Philip J.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of Essex; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reeves, PJ (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	preeves@essex.ac.uk	Smith, Steven/HDM-9496-2022; Reynolds, Christopher/G-1036-2010	Reynolds, Christopher/0000-0001-9267-5141; South, Kieron/0000-0002-9141-3438	National Institutes of Health [R01 GM41412]; RP Fighting Blindness Grant [GR572]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RP Fighting Blindness Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM41412 (to S. O. S.). This work was also supported by RP Fighting Blindness Grant GR572 (to P. J. R.).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; ANUKANTH A, 1994, J BIOL CHEM, V269, P19738; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bosch-Presegue L, 2011, FEBS J, V278, P1493, DOI 10.1111/j.1742-4658.2011.08066.x; Cha KW, 2000, P NATL ACAD SCI USA, V97, P3016, DOI 10.1073/pnas.97.7.3016; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Fanelli F, 2010, FASEB J, V24, P3196, DOI 10.1096/fj.09-151084; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, VISION RES, V43, P2991, DOI 10.1016/j.visres.2003.08.010; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Janz JM, 2001, BIOCHEMISTRY-US, V40, P7219, DOI 10.1021/bi002937i; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; MIN KC, 1993, J BIOL CHEM, V268, P9400; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OMAHONEY JV, 1994, DNA CELL BIOL, V13, P1227, DOI 10.1089/dna.1994.13.1227; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pattabiraman N, 1995, J MOL RECOGNIT, V8, P334, DOI 10.1002/jmr.300080603; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; RICHARDS FM, 1993, Q REV BIOPHYS, V26, P423, DOI 10.1017/S0033583500002845; Ridge KD, 1996, J BIOL CHEM, V271, P7860, DOI 10.1074/jbc.271.13.7860; RIDGE KD, 1995, BIOCHEMISTRY-US, V34, P3261, DOI 10.1021/bi00010a016; Saliba RS, 2002, J CELL SCI, V115, P2907; Shichida Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P70, DOI 10.1562/2006-03-22-IR-854; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100	57	29	30	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33912	33926		10.1074/jbc.M113.483032	http://dx.doi.org/10.1074/jbc.M113.483032			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24106275	Green Published, hybrid			2022-12-28	WOS:000327250200034
J	Sa-Moura, B; Funakoshi, M; Tomko, RJ; Dohmen, RJ; Wu, ZP; Peng, JM; Hochstrasser, M				Sa-Moura, Bebiana; Funakoshi, Minoru; Tomko, Robert J., Jr.; Dohmen, R. Juergen; Wu, Zhiping; Peng, Junmin; Hochstrasser, Mark			A Conserved Protein with AN1 Zinc Finger and Ubiquitin-like Domains Modulates Cdc48 (p97) Function in the Ubiquitin-Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; ER-associated Degradation; Proteasome; Ubiquitin; Yeast; Zinc Finger; Cdc48; Cuz1	AAA ATPASE P97/VCP; TRANSCRIPTION FACTOR; GLOBAL ANALYSIS; ER; DEGRADATION; COMPLEX; STRESS; LINKS; UBX2; CDC48(UFD1/NPL4)	Regulated protein degradation mediated by the ubiquitin-proteasome system (UPS) is critical to eukaryotic protein homeostasis. Often vital to degradation of protein substrates is their disassembly, unfolding, or extraction from membranes. These processes are catalyzed by the conserved AAA-ATPase Cdc48 (also known as p97). Here we characterize the Cuz1 protein (Cdc48-associated UBL/zinc finger protein-1), encoded by a previously uncharacterized arsenite-inducible gene in budding yeast. Cuz1, like its human ortholog ZFAND1, has both an AN1-type zinc finger (Zf_AN1) and a divergent ubiquitin-like domain (UBL). We show that Cuz1 modulates Cdc48 function in the UPS. The two proteins directly interact, and the Cuz1 UBL, but not Zf_AN1, is necessary for binding to the Cdc48 N-terminal domain. Cuz1 also associates, albeit more weakly, with the proteasome, and the UBL is dispensable for this interaction. Cuz1-proteasome interaction is strongly enhanced by exposure of cells to the environmental toxin arsenite, and in a proteasome mutant, loss of Cuz1 enhances arsenite sensitivity. Whereas loss of Cuz1 alone causes only minor UPS degradation defects, its combination with mutations in the Cdc48(Npl4-Ufd1) complex leads to much greater impairment. Cuz1 helps limit the accumulation of ubiquitin conjugates on both the proteasome and Cdc48, suggesting a possible role in the transfer of ubiquitylated substrates from Cdc48 to the proteasome or in their release from these complexes.	[Sa-Moura, Bebiana; Funakoshi, Minoru; Tomko, Robert J., Jr.; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Sa-Moura, Bebiana] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099002 Oporto, Portugal; [Dohmen, R. Juergen] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Wu, Zhiping; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Dept Biol Struct, Memphis, TN 38105 USA; [Wu, Zhiping; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Dept Dev Neurobiol, Memphis, TN 38105 USA	Yale University; Universidade do Porto; University of Cologne; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hochstrasser, M (corresponding author), 266 Whitney Ave, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu	Dohmen, R. Jürgen/AAD-6649-2022; Peng, Junmin/N-2614-2018	Dohmen, R. Jürgen/0000-0002-5756-6780; Peng, Junmin/0000-0003-0472-7648; Hochstrasser, Mark/0000-0002-1131-5484; Tomko Jr., Robert/0000-0003-2515-1078; Sa-Moura, Bebiana/0000-0003-2943-8818	National Institutes of Health [GM083050, GM046904]; American Cancer Society; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083050, R01GM046904, R37GM046904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083050 and GM046904 (to M. H.).; Supported in part by an American Cancer Society postdoctoral fellowship.; Supported by the American Lebanese Syrian Associated Charities.	Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; [Anonymous], 1991, Methods Enzymol, V194, P1; Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108; Barthelme D, 2013, P NATL ACAD SCI USA, V110, P3327, DOI 10.1073/pnas.1300408110; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Burroughs AM, 2011, MOL BIOSYST, V7, P2261, DOI 10.1039/c1mb05061c; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Chia WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050490; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hochstrasser M, 2012, METHODS MOL BIOL, V832, P349, DOI 10.1007/978-1-61779-474-2_24; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Isakov E, 2011, J BIOL CHEM, V286, P30274, DOI 10.1074/jbc.M111.240309; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; PETERS JM, 1994, J BIOL CHEM, V269, P7709; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vij S, 2008, FUNCT INTEGR GENOMIC, V8, P301, DOI 10.1007/s10142-008-0078-7; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	73	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33682	33696		10.1074/jbc.M113.521088	http://dx.doi.org/10.1074/jbc.M113.521088			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121501	Green Published, hybrid			2022-12-28	WOS:000327250200016
J	Seung, D; Thalmann, M; Sparla, F; Hachem, M; Lee, SK; Issakidis-Bourguet, E; Svensson, B; Zeeman, SC; Santelia, D				Seung, David; Thalmann, Matthias; Sparla, Francesca; Abou Hachem, Maher; Lee, Sang Kyu; Issakidis-Bourguet, Emmanuelle; Svensson, Birte; Zeeman, Samuel C.; Santelia, Diana			Arabidopsis thaliana AMY3 Is a Unique Redox- regulated Chloroplastic alpha-Amylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Carbohydrate Metabolism; Plant Biochemistry; Redox Regulation; Thioredoxin; -Amylase; Amylopectin; Starch	STARCH DEGRADATION; BETA-AMYLASE; PLASTIDIAL THIOREDOXINS; BINDING MODES; BREAKDOWN; PHOSPHOGLUCAN; METABOLISM; ENZYMES; SPECIFICITY; SENSITIVITY	alpha-Amylases are glucan hydrolases that cleave -1,4-glucosidic bonds in starch. In vascular plants, -amylases can be classified into three subfamilies. Arabidopsis has one member of each subfamily. Among them, only AtAMY3 is localized in the chloroplast. We expressed and purified AtAMY3 from Escherichia coli and carried out a biochemical characterization of the protein to find factors that regulate its activity. Recombinant AtAMY3 was active toward both insoluble starch granules and soluble substrates, with a strong preference for -limit dextrin over amylopectin. Activity was shown to be dependent on a conserved aspartic acid residue (Asp(666)), identified as the catalytic nucleophile in other plant -amylases such as the barley AMY1. AtAMY3 released small linear and branched glucans from Arabidopsis starch granules, and the proportion of branched glucans increased after the predigestion of starch with a -amylase. Optimal rates of starch digestion in vitro was achieved when both AtAMY3 and -amylase activities were present, suggesting that the two enzymes work synergistically at the granule surface. We also found that AtAMY3 has unique properties among other characterized plant -amylases, with a pH optimum of 7.5-8, appropriate for activity in the chloroplast stroma. AtAMY3 is also redox-regulated, and the inactive oxidized form of AtAMY3 could be reactivated by reduced thioredoxins. Site-directed mutagenesis combined with mass spectrometry analysis showed that a disulfide bridge between Cys(499) and Cys(587) is central to this regulation. This work provides new insights into how -amylase activity may be regulated in the chloroplast.	[Seung, David; Thalmann, Matthias; Lee, Sang Kyu; Zeeman, Samuel C.; Santelia, Diana] ETH, Inst Agr Sci, CH-8092 Zurich, Switzerland; [Sparla, Francesca] Univ Bologna, Dept Expt Evolutionary Biol, I-40126 Bologna, Italy; [Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Issakidis-Bourguet, Emmanuelle] Univ Paris 11, CNRS, UMR 8618, Inst Biol Plantes, F-91405 Orsay, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bologna; Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Santelia, D (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	dsantelia@botinst.uzh.ch	Santelia, Diana/AAQ-3967-2020; Abou Hachem, Maher/M-4772-2019; Seung, David/D-8811-2013	Abou Hachem, Maher/0000-0001-8250-1842; Seung, David/0000-0003-3905-3647; Issakidis-Bourguet, Emmanuelle/0000-0002-6144-4364; Sparla, Francesca/0000-0002-2103-4870; Zeeman, Samuel/0000-0002-2791-0915; Svensson, Birte/0000-0002-2993-8196; Thalmann, Matthias/0000-0002-6260-1448	Swiss-South African Joint Research Program [IZ LS Z3122916]; SNSF Marie Heim-Vogtlin [PMPDP3_139645]; Novartis-ETH Zurich Excellence Scholarship	Swiss-South African Joint Research Program; SNSF Marie Heim-Vogtlin; Novartis-ETH Zurich Excellence Scholarship	This work was supported by the Swiss-South African Joint Research Program Grant IZ LS Z3122916 (to D. Santelia and S. C. Z.), SNSF Marie Heim-Vogtlin Grant PMPDP3_139645 (to D. Santelia), and a Novartis-ETH Zurich Excellence Scholarship (to D. Seung).	Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; Bak-Jensen KS, 2004, J BIOL CHEM, V279, P10093, DOI 10.1074/jbc.M312825200; Brandes HK, 1996, J BIOL CHEM, V271, P3333; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Delatte T, 2006, J BIOL CHEM, V281, P12050, DOI 10.1074/jbc.M513661200; Ficarra R, 2002, J PHARMACEUT BIOMED, V29, P989, DOI 10.1016/S0731-7085(02)00139-5; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Glaring MA, 2012, PLANT PHYSIOL BIOCH, V58, P89, DOI 10.1016/j.plaphy.2012.06.017; Glaring MA, 2011, FEBS J, V278, P1175, DOI 10.1111/j.1742-4658.2011.08043.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HELDT HW, 1973, BIOCHIM BIOPHYS ACTA, V314, P224, DOI 10.1016/0005-2728(73)90137-0; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Kaplan F, 2006, PHYSIOL PLANTARUM, V126, P120, DOI [10.1111/j.1399-3054.2006.00604.x, 10.1111/j.1399-3054.2005.00604.x]; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Kuriki T, 1999, J BIOSCI BIOENG, V87, P557, DOI 10.1016/S1389-1723(99)80114-5; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MCCLEARY BV, 1987, J CEREAL SCI, V6, P237, DOI 10.1016/S0733-5210(87)80061-9; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mikkelsen R, 2005, P NATL ACAD SCI USA, V102, P1785, DOI 10.1073/pnas.0406674102; Mikkelsen R, 2006, BIOCHEMISTRY-US, V45, P4674, DOI 10.1021/bi051712a; Mori H, 2001, EUR J BIOCHEM, V268, P6545, DOI 10.1046/j.0014-2956.2001.02609.x; Nielsen JW, 2012, ARCH BIOCHEM BIOPHYS, V528, P1, DOI 10.1016/j.abb.2012.08.005; OKITA TW, 1979, PLANT PHYSIOL, V64, P187, DOI 10.1104/pp.64.2.187; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Scialdone A, 2013, ELIFE, V2, DOI 10.7554/eLife.00669; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Silver DM, 2013, FEBS J, V280, P538, DOI 10.1111/j.1742-4658.2012.08546.x; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; SOGAARD M, 1993, CARBOHYD POLYM, V21, P137, DOI 10.1016/0144-8617(93)90008-R; Sokolov LN, 2006, P NATL ACAD SCI USA, V103, P9732, DOI 10.1073/pnas.0603329103; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stanley D, 2002, BIOLOGIA, V57, P137; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Streb S, 2012, J BIOL CHEM, V287, P41745, DOI 10.1074/jbc.M112.395244; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valerio C, 2011, J EXP BOT, V62, P545, DOI 10.1093/jxb/erq288; Weise SE, 2006, PLANT PHYSIOL, V141, P879, DOI 10.1104/pp.106.081174; WILLIAMS JF, 1973, CROP SCI, V13, P612, DOI 10.2135/cropsci1973.0011183X001300060008x; Wong JH, 2002, P NATL ACAD SCI USA, V99, P16325, DOI 10.1073/pnas.212641999; Yu TS, 2005, J BIOL CHEM, V280, P9773, DOI 10.1074/jbc.M413638200; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; ZIEGLER P, 1988, PLANT PHYSIOL, V86, P659, DOI 10.1104/pp.86.3.659; Ziegler P, 1999, J CEREAL SCI, V29, P195, DOI 10.1006/jcrs.1998.0238	57	68	72	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33620	33633		10.1074/jbc.M113.514794	http://dx.doi.org/10.1074/jbc.M113.514794			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24089528	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000327250200011
J	Wang, JY; Zhang, Y; Weng, WH; Qiao, YX; Ma, LF; Xiao, WF; Yu, YC; Pan, QH; Sun, FY				Wang, Jiayi; Zhang, Yue; Weng, Wenhao; Qiao, Yongxia; Ma, Lifang; Xiao, Weifan; Yu, Yongchun; Pan, Qiuhui; Sun, Fenyong			Impaired Phosphorylation and Ubiquitination by p70 S6 Kinase (p70S6K) and Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promote Tribbles Homolog 2 (TRIB2) Stability and Carcinogenic Property in Liver Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Gene Regulation; Hepatocellular Carcinoma; Phosphorylation; Post-translational Modification	LIGASE SMURF1; C/EBP-ALPHA; DEGRADATION; ACTIVATION; RAPAMYCIN; DOMAIN; TUMORIGENESIS; LOCALIZATION; CONTRIBUTES; RESISTANCE	Tribbles homolog 2 (TRIB2) is critical for both solid and non-solid malignancies. Recently, TRIB2 was identified as a liver cancer-specific Wnt/-catenin signaling downstream target and is functionally important for liver cancer cell survival and transformation. TRIB2 functions as a protein that interacts with E3 ubiquitin ligases and thereby modulates protein stability of downstream effectors. However, the regulation underlying TRIB2 protein stability per se has not yet been reported. In this study, we found that TRIB2 was up-regulated and exhibited high stability in liver cancer cells compared with other cells. We performed a structure-function analysis of TRIB2 and identified a domain (amino acids 1-5) at the N terminus that interacted with the E3 ubiquitin ligase Smurf1 and was critical for protein stability. Deletion of this domain extended TRIB2 half-life time accompanied with a more significant malignant property compared with wild type TRIB2. Furthermore, Smurf1-mediated ubiquitination required phosphorylation of TRIB2 by p70 S6 kinase (p70S6K) via another domain (amino acids 69-85) that is also essential for correct TRIB2 subcellular localization. Mutation of Ser-83 diminished p70S6K-induced phosphorylation of TRIB2. Moreover, the high stability of TRIB2 may be due to the fact that both p70S6K and Smurf1 were down-regulated and negatively correlated with TRIB2 expression in both liver cancer tissues and established liver cancer cell lines. Taken together, impaired phosphorylation and ubiquitination by p70S6K and Smurf1 increase the protein stability of TRIB2 in liver cancer and thus may be helpful in the development of diagnosis and treatment strategies against this malignant disease.	[Wang, Jiayi; Weng, Wenhao; Ma, Lifang; Sun, Fenyong] Tongji Univ, Dept Clin Lab Med, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Zhang, Yue; Xiao, Weifan; Yu, Yongchun; Pan, Qiuhui] Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Qiao, Yongxia] Shanghai Jiao Tong Univ, Sch Publ Hlth, Sch Med, Shanghai 200025, Peoples R China	Tongji University; Tongji University; Shanghai Jiao Tong University	Pan, QH (corresponding author), Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	panqiuhui@263.net; sunfenyong@126.com		Wang, Jiayi/0000-0003-1688-2864	973 Program [2011CBA01100, 2012CB966900]; Natural Science Foundation of China [81272292, 81071524, 81201884]; 5810 Training Program from Shanghai Tenth People's Hospital	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 5810 Training Program from Shanghai Tenth People's Hospital	This work was supported by 973 Program Grants 2011CBA01100 and 2012CB966900; Natural Science Foundation of China Grants 81272292, 81071524, and 81201884; and the 5810 Training Program (to J. W.) from Shanghai Tenth People's Hospital.	Chen YL, 2013, J PATHOL, V229, P486, DOI 10.1002/path.4130; COFFER PJ, 1994, BIOCHEM BIOPH RES CO, V198, P780, DOI 10.1006/bbrc.1994.1112; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57; Guo X, 2011, J BIOL CHEM, V286, P18037, DOI 10.1074/jbc.M111.225615; Hannon MM, 2012, BRIT J HAEMATOL, V158, P626, DOI 10.1111/j.1365-2141.2012.09222.x; Iwanami A, 2013, P NATL ACAD SCI USA, V110, P4339, DOI 10.1073/pnas.1217602110; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Soond SM, 2011, ONCOGENE, V30, P2451, DOI 10.1038/onc.2010.617; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Totary-Jain H, 2013, J BIOL CHEM, V288, P6034, DOI 10.1074/jbc.M112.416446; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Xie P, 2011, BIOCHEM BIOPH RES CO, V407, P254, DOI 10.1016/j.bbrc.2011.03.016; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zanella F, 2010, ONCOGENE, V29, P2973, DOI 10.1038/onc.2010.58; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	29	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33667	33681		10.1074/jbc.M113.503292	http://dx.doi.org/10.1074/jbc.M113.503292			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24089522	Green Published, hybrid			2022-12-28	WOS:000327250200015
J	Wu, M; Bu, LT; Vuong, TV; Wilson, DB; Crowley, MF; Sandgren, M; Stahlberg, J; Beckham, GT; Hansson, H				Wu, Miao; Bu, Lintao; Vuong, Thu V.; Wilson, David B.; Crowley, Michael F.; Sandgren, Mats; Stahlberg, Jerry; Beckham, Gregg T.; Hansson, Henrik			Loop Motions Important to Product Expulsion in the Thermobifida fusca Glycoside Hydrolase Family 6 Cellobiohydrolase from Structural and Computational Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellulase; Enzyme Structure; Glycoside Hydrolases; Molecular Dynamics; X-ray Crystallography; Thermobifida fusca; Cellobiohydrolase	SITE-DIRECTED MUTATION; MOLECULAR-DYNAMICS; TRICHODERMA-REESEI; HUMICOLA-INSOLENS; CRYSTAL-STRUCTURE; LIGNOCELLULOSIC BIOMASS; PROCESSIVE CELLULASE; DEGRADING ENZYMES; CATALYTIC CORE; FORCE-FIELDS	Background: Family 6 glycoside hydrolases represent an important, diverse enzyme class in cellulolytic organisms. Results: We solved structures of two Thermobifida fusca Cel6B (TfuCel6B) cellobiohydrolase mutants and examined ligand dynamics and product release with simulation. Conclusion: These results suggest mechanisms for product release in TfuCel6B. Significance: This study further elucidates the mechanism of a unique cellobiohydrolase with an extended, enclosed active site tunnel. Cellobiohydrolases (CBHs) are typically major components of natural enzyme cocktails for biomass degradation. Their active sites are enclosed in a tunnel, enabling processive hydrolysis of cellulose chains. Glycoside hydrolase Family 6 (GH6) CBHs act from nonreducing ends by an inverting mechanism and are present in many cellulolytic fungi and bacteria. The bacterial Thermobifida fusca Cel6B (TfuCel6B) exhibits a longer and more enclosed active site tunnel than its fungal counterparts. Here, we determine the structures of two TfuCel6B mutants co-crystallized with cellobiose, D274A (catalytic acid), and the double mutant D226A/S232A, which targets the putative catalytic base and a conserved serine that binds the nucleophilic water. The ligand binding and the structure of the active site are retained when compared with the wild type structure, supporting the hypothesis that these residues are directly involved in catalysis. One structure exhibits crystallographic waters that enable construction of a model of the alpha-anomer product after hydrolysis. Interestingly, the product sites of TfuCel6B are completely enclosed by an "exit loop" not present in fungal GH6 CBHs and by an extended "bottom loop". From the structures, we hypothesize that either of the loops enclosing the product subsites in the TfuCel6B active site tunnel must open substantially for product release. With simulation, we demonstrate that both loops can readily open to allow product release with equal probability in solution or when the enzyme is engaged on cellulose. Overall, this study reveals new structural details of GH6 CBHs likely important for functional differences among enzymes from this important family.	[Wu, Miao; Sandgren, Mats; Stahlberg, Jerry; Hansson, Henrik] Swedish Univ Agr Sci, Dept Mol Biol, SE-75007 Uppsala, Sweden; [Bu, Lintao; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Vuong, Thu V.; Wilson, David B.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Cornell University	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; Henrik.Hansson@slu.se	; Stahlberg, Jerry/D-4163-2013; crowley, michael/A-4852-2013	Hansson, Henrik/0000-0002-6003-2982; Stahlberg, Jerry/0000-0003-4059-8580; Sandgren, Mats/0000-0002-2358-4534; crowley, michael/0000-0001-5163-9398	Texas Advanced Computing Center Stampede cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) [MCB090159]; National Renewable Energy Laboratory (NREL) Computational Sciences Center; Department of Energy Efficiency and Renewable Energy (EERE) [DE-AC36-08GO28308]	Texas Advanced Computing Center Stampede cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE); National Renewable Energy Laboratory (NREL) Computational Sciences Center; Department of Energy Efficiency and Renewable Energy (EERE)(United States Department of Energy (DOE))	Computer time for this research was provided by the Texas Advanced Computing Center Stampede cluster under National Science Foundation Extreme Science and Engineering Discovery Environment (XSEDE) Grant number MCB090159 and the National Renewable Energy Laboratory (NREL) Computational Sciences Center supported by the Department of Energy Efficiency and Renewable Energy (EERE) under Contract DE-AC36-08GO28308.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hummer G, 2001, P NATL ACAD SCI USA, V98, P3658, DOI 10.1073/pnas.071034098; Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung H, 2003, BIOTECHNOL BIOENG, V84, P151, DOI 10.1002/bit.10743; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; REESE ET, 1976, BIOTECHNOL BIOENG, P9; Ribeiro DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050571; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sandgren M, 2013, J MOL BIOL, V425, P622, DOI 10.1016/j.jmb.2012.11.039; SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Tamura M, 2012, FEBS J, V279, P1871, DOI 10.1111/j.1742-4658.2012.08568.x; Teeri TT, 1998, BIOCHEM SOC T, V26, P173, DOI 10.1042/bst0260173; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Varrot A, 2003, CHEM COMMUN, P946, DOI 10.1039/b301592k; Varrot A, 2002, ACTA CRYSTALLOGR D, V58, P2201, DOI 10.1107/S0907444902017006; Varrot A, 1999, BIOCHEM J, V337, P297, DOI 10.1042/0264-6021:3370297; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vuong TV, 2010, BIOTECHNOL BIOENG, V107, P195, DOI 10.1002/bit.22838; Vuong TV, 2009, APPL ENVIRON MICROB, V75, P6655, DOI 10.1128/AEM.01260-09; Vuong TV, 2009, FEBS J, V276, P4261, DOI 10.1111/j.1742-4658.2009.07097.x; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	79	23	23	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33107	33117		10.1074/jbc.M113.502765	http://dx.doi.org/10.1074/jbc.M113.502765			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085303	Green Published, hybrid			2022-12-28	WOS:000328841700026
J	Chan, SW; Lim, CJ; Guo, FS; Tan, I; Leung, T; Hong, WJ				Chan, Siew Wee; Lim, Chun Jye; Guo, Fusheng; Tan, Ivan; Leung, Thomas; Hong, Wanjin			Actin-binding and Cell Proliferation Activities of Angiomotin Family Members Are Regulated by Hippo Pathway-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Proliferation; Phosphorylation; Protein Kinases; Signal Transduction; Angiomotin; Hippo Pathway; LATS Kinase	TUMOR-SUPPRESSOR; BREAST-CANCER; MIGRATION; PROTEINS; TAZ; P130-ANGIOMOTIN; ANGIOGENESIS; EXPRESSION; INVASION; KINASES	Whether the Hippo pathway has downstream targets other than YAP and TAZ is unknown. In this report, we have identified angiomotin (Amot) family members as novel substrates of Hippo core kinases. The N-terminal regions of Amot proteins contain a conserved HXRXXS consensus site for LATS1/2-mediated phosphorylation. Phospho-specific antibodies showed that Hippo core kinases could mediate phosphorylation of endogenous as well as exogenous Amot family members. Knockdown of LATS1 and LATS2 endogenously reduced the phosphorylation of Amots detected by the phospho-specific antibodies. Mutation of the serine to alanine within this HXRXXS site in Amot and AmotL2 established that this site was essential for Hippo core kinase-mediated phosphorylation. Wild-type and non-phosphorylated Amot (Amot-S175A) were targeted to actin filaments, whereas phospho-mimic Amot (Amot-S175D) failed to be localized with actin. Overexpression of LATS2 caused dissociation of Amot from actin but not Amot-S175A. Mapping of the actin-binding site of Amot showed that serine 175 of Amot was important for the actin-binding activity. Amot-S175A promoted, whereas Amot and Amot-S175D inhibited, cell proliferation. These results collectively suggest that the Hippo pathway negatively regulates the actin-binding activity of Amot family members through direct phosphorylation.	[Chan, Siew Wee; Lim, Chun Jye; Guo, Fusheng; Tan, Ivan; Leung, Thomas; Hong, Wanjin] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Hong, Wanjin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Chan, SW (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbcsw@imcb.a-star.edu.sg; mcbhwj@imcb.a-star.edu.sg			Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A*STAR), Singapore.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Bossuyt W., 2013, ONCOGENE, DOI 10.1038/onc.2013.82; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Jiang WG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-16; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	24	69	70	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37296	37307		10.1074/jbc.M113.527598	http://dx.doi.org/10.1074/jbc.M113.527598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24225952	Green Published, hybrid			2022-12-28	WOS:000329189700046
J	Hirata, R; Nihei, C; Nakano, A				Hirata, Ryogo; Nihei, Coh-ichi; Nakano, Akihiko			Isoform-selective Oligomer Formation of Saccharomyces cerevisiae p24 Family Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Golgi; Membrane Trafficking; Protein Assembly; Protein Sorting; Yeast	COPII-COATED VESICLES; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; RETRIEVAL RECEPTOR; GOLGI-APPARATUS; QUALITY-CONTROL; CARGO BINDING; TRANSPORT; IDENTIFICATION; COMPLEX	p24 family proteins are evolutionarily conserved transmembrane proteins involved in the early secretory pathway. Saccharomyces cerevisiae has 8 known p24 proteins that are classified into four subfamilies (p24, -, -, and -). Emp24 and Erv25 are the sole members of p24 and -, respectively, and deletion of either destabilizes the remaining p24 proteins, resulting in p24 null phenotype (p24). We studied genetic and physical interactions of p24 (Erp1, -5, and -6) and (Erp2, -3, and -4). Deletion of the major p24 (Erp1) partially inhibited p24 activity as reported previously. A second mutation in either Erp5 or Erp6 aggravated the erp1 phenotype, and the triple mutation gave a full p24 phenotype. Similar genetic interactions were observed among the major p24 (Erp2) and the other two members. All the p24/ isoforms interacted with both p24 and -. Interaction between p24 and - was isoform-selective, and five major / pairs were detected. These results suggest that the yeast p24 proteins form functionally redundant complexes. We also identified Rrt6 as a novel p24 isoform. Rrt6 shows only limited sequence identity (approximate to 15%) to known p24 proteins but was found to have structural properties characteristic of p24. Rrt6 was induced when cells were grown on glycerol and form an additional complex with Erp3, Erp5, and Emp24. This complex was mainly localized to the Golgi, whereas the p24 complex containing Erv25, instead of Rrt6 but otherwise with the same isoform composition, was found mostly in the ER.	[Hirata, Ryogo; Nihei, Coh-ichi; Nakano, Akihiko] RIKEN, Ctr Adv Photon, Live Cell Mol Imaging Res Team, Wako, Saitama 3510198, Japan; [Hirata, Ryogo] RIKEN, Biol Chem Lab, Wako, Saitama 3510198, Japan; [Nakano, Akihiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; University of Tokyo	Hirata, R (corresponding author), RIKEN, Biol Chem Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	rhirata@riken.jp	Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/A-6420-2016; Hirata, Ryogo/C-7424-2017	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bioarchitect Project of RIKEN; Extreme Photonics Project of RIKEN; Cellular Systems Biology Project of RIKEN; Grants-in-Aid for Scientific Research [20001009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bioarchitect Project of RIKEN; Extreme Photonics Project of RIKEN; Cellular Systems Biology Project of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Specially Promoted Research, grants-in-aid for Scientific Research, and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Bioarchitect, the Extreme Photonics, and the Cellular Systems Biology Projects of RIKEN.	Anantharaman V, 2002, GENOME BIOL, V3; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Bouw G, 2004, MOL BIOL CELL, V15, P1244, DOI 10.1091/mbc.E03-08-0600; Brachmann CB, 1998, YEAST, V14, P115; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Bue CA, 2009, J BIOL CHEM, V284, P24049, DOI 10.1074/jbc.M109.022590; Buechling T, 2011, EMBO REP, V12, P1265, DOI 10.1038/embor.2011.212; Burke D., 2000, METHODS YEAST GENETI, P171; Montesinos JC, 2012, J EXP BOT, V63, P4243, DOI 10.1093/jxb/ers112; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Ciufo LF, 2000, J BIOL CHEM, V275, P8382, DOI 10.1074/jbc.275.12.8382; Copic A, 2012, SCIENCE, V335, P1359, DOI 10.1126/science.1215909; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Finnigan GC, 2011, MOL BIOL CELL, V22, P3176, DOI 10.1091/mbc.E11-03-0244; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Graham LA, 1998, J CELL BIOL, V142, P39, DOI 10.1083/jcb.142.1.39; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Herzig Y, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001329; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hontz RD, 2009, GENETICS, V182, P105, DOI 10.1534/genetics.108.100313; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lavieu G, 2013, ELIFE, V2, DOI 10.7554/eLife.00558; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Luo WB, 2011, J NEUROCHEM, V117, P71, DOI 10.1111/j.1471-4159.2011.07173.x; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Noda Y, 2010, J BIOL CHEM, V285, P15420, DOI 10.1074/jbc.M109.086272; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popoff V., 2011, COLD SPRING HARB PER, V3; Port F, 2011, EMBO REP, V12, P1144, DOI 10.1038/embor.2011.165; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; Rizzo R, 2013, J CELL BIOL, V201, P1027, DOI 10.1083/jcb.201211147; Roberts GG, 2009, YEAST, V26, P95, DOI 10.1002/yea.1655; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Rotter J, 2002, J CELL SCI, V115, P1049; Sacher M, 1997, J BIOL CHEM, V272, P17134, DOI 10.1074/jbc.272.27.17134; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Shi YF, 2011, MOL BIOL CELL, V22, P4093, DOI 10.1091/mbc.E11-05-0440; SIKORSKI RS, 1989, GENETICS, V122, P19; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Strating JRPM, 2009, MOL BIOL EVOL, V26, P1707, DOI 10.1093/molbev/msp099; Strating JRPM, 2009, BIOL CELL, V101, P207, DOI 10.1042/BC20080075; Strating JRPM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000704; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Weidler M, 2000, BIOCHEM BIOPH RES CO, V271, P401, DOI 10.1006/bbrc.2000.2511; Yang JS, 2011, NAT CELL BIOL, V13, P996, DOI 10.1038/ncb2273; Zhang LL, 2010, FEBS LETT, V584, P2298, DOI 10.1016/j.febslet.2010.03.041; Zheng CL, 2013, J BIOL CHEM, V288, P20499, DOI 10.1074/jbc.M113.461434	79	13	13	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37057	37070		10.1074/jbc.M113.518340	http://dx.doi.org/10.1074/jbc.M113.518340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217251	hybrid, Green Published			2022-12-28	WOS:000329189700026
J	Goto, T; Sato, A; Adachi, S; Iemura, S; Natsume, T; Shibuya, H				Goto, Toshiyasu; Sato, Atsushi; Adachi, Shungo; Iemura, Shun-ichiro; Natsume, Tohru; Shibuya, Hiroshi			IQGAP1 Protein Regulates Nuclear Localization of beta-Catenin via Importin-beta 5 Protein in Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Nuclear Translocation; Nuclear Transport; Signal Transduction; Wnt Pathway; Wnt Signaling; Dvl; IQGAP; Ran; Importin	SMALL GTPASES; BINDING; TRANSPORT; IMPORT; TARGET; AXIS; CALMODULIN; INDUCTION; RECEPTOR; PATHWAY	Background: The molecular mechanisms underlying the -catenin nuclear localization remain unclear. Results: IQGAP1 is a regulator of -catenin nuclear localization. Conclusion: Importin-5 and Ran contribute to the nuclear localization of -catenin. Significance: Novel molecular mechanisms were found in Wnt signaling. In the canonical Wnt signaling pathway, the translocation of -catenin is important for the activation of target genes in the nucleus. However, the molecular mechanisms underlying its nuclear localization remain unclear. In the present study, we found IQGAP1 to be a regulator of -catenin function via importin-5. In Xenopus embryos, depletion of IQGAP1 reduced Wnt-induced nuclear accumulation of -catenin and expression of Wnt target genes during early embryogenesis. Depletion of endogenous importin-5 associated with IQGAP1 also reduced expression of Wnt target genes and the nuclear localization of IQGAP1 and -catenin. Moreover, a small GTPase, Ran1, contributes to the nuclear translocation of -catenin and the activation of Wnt target genes. These results suggest that IQGAP1 functions as a regulator of translocation of -catenin in the canonical Wnt signaling pathway.	[Goto, Toshiyasu; Sato, Atsushi; Shibuya, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Adachi, Shungo; Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST)	Shibuya, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan.	shibuya.mcb@mri.tmd.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Carnac G, 1996, DEVELOPMENT, V122, P3055; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Glinka A, 1996, MECH DEVELOP, V60, P221, DOI 10.1016/S0925-4773(96)00624-7; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goto T., 2013, PLOS ONE, V8; Gumbiner BM, 1997, CURR BIOL, V7, pR443, DOI 10.1016/S0960-9822(06)00214-4; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119	40	30	33	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36351	36360		10.1074/jbc.M113.520528	http://dx.doi.org/10.1074/jbc.M113.520528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196961	hybrid, Green Published			2022-12-28	WOS:000328883400017
J	Leslie, KL; Song, GJ; Barrick, S; Wehbi, VL; Vilardaga, JP; Bauer, PM; Bisello, A				Leslie, Kristen L.; Song, Gyun Jee; Barrick, Stacey; Wehbi, Vanessa L.; Vilardaga, Jean-Pierre; Bauer, Philip M.; Bisello, Alessandro			Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) and Nuclear Factor-kappa B (NF-kappa B) A FEED-FORWARD LOOP FOR SYSTEMIC AND VASCULAR INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Macrophages; NF-Kappa B (NF-KB); Scaffold Proteins; Vascular Biology; Vascular Smooth Muscle Cells; EBP50; NHERF1; PDZ Domain; PKC Zeta	SMOOTH-MUSCLE-CELLS; KINASE-C-ZETA; TUMOR-NECROSIS-FACTOR; CARDIOVASCULAR-DISEASE; MACROPHAGE ACTIVATION; REGULATORY FACTOR; HUMAN MONOCYTES; PKC-ZETA; PROTEIN; RECEPTOR	Background: EBP50 is a scaffolding protein that is critical during vascular remodeling. Results: EBP50 expression is induced by inflammatory stimuli and potentiates NF-B activation and inflammation. Conclusion: EBP50 and NF-B participate in a feed-forward loop leading to increased macrophage activation and enhanced response of vascular cells to inflammation. Significance: This work reveals a novel mechanism regulating systemic and vascular inflammation. The interaction between vascular cells and macrophages is critical during vascular remodeling. Here we report that the scaffolding protein, ezrin-binding phosphoprotein 50 (EBP50), is a central regulator of macrophage and vascular smooth muscle cells (VSMC) function. EBP50 is up-regulated in intimal VSMC following endoluminal injury and promotes neointima formation. However, the mechanisms underlying these effects are not fully understood. Because of the fundamental role that inflammation plays in vascular diseases, we hypothesized that EBP50 mediates macrophage activation and the response of vessels to inflammation. Indeed, EBP50 expression increased in primary macrophages and VSMC, and in the aorta of mice, upon treatment with LPS or TNF. This increase was nuclear factor-B (NF-B)-dependent. Conversely, activation of NF-B was impaired in EBP50-null VSMC and macrophages. We found that inflammatory stimuli promote the formation of an EBP50-PKC complex at the cell membrane that induces NF-B signaling. Macrophage activation and vascular inflammation after acute LPS treatment were reduced in EBP50-null cells and mice as compared with WT. Furthermore, macrophage recruitment to vascular lesions was significantly reduced in EBP50 knock-out mice. Thus, EBP50 and NF-B participate in a feed-forward loop leading to increased macrophage activation and enhanced response of vascular cells to inflammation.	[Bisello, Alessandro] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wehbi, Vanessa L.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA; [Bauer, Philip M.; Bisello, Alessandro] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bisello, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1358 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	alb138@pitt.edu	Barrick, Stacey/J-1595-2015	Barrick, Stacey/0000-0002-4837-3741	Vascular Medicine Institute, University of Pittsburgh; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; National Institutes of Health [UL1 RR024153, UL1TR000005, T32GM08424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072501] Funding Source: NIH RePORTER	Vascular Medicine Institute, University of Pittsburgh; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a Pilot Project Program in Hemostasis and Vascular Biology, Vascular Medicine Institute, University of Pittsburgh, supported by grants from the Institute for Transfusion Medicine and the Hemophilia Society of Western Pennsylvania and by National Institutes of Health Grants UL1 RR024153 and UL1TR000005 (to A. B.).; Supported by the National Institutes of Health Predoctoral Training Grant T32GM08424.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Breuss JM, 2002, CIRCULATION, V105, P633, DOI 10.1161/hc0502.102966; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; Dagvadorj J, 2009, INNATE IMMUN, V15, P217, DOI 10.1177/1753425909103738; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Ediger TR, 2002, MOL ENDOCRINOL, V16, P1828, DOI 10.1210/me.2001-0290; Ediger TR, 1999, ENDOCRINOLOGY, V140, P2976, DOI 10.1210/en.140.7.2976; Estell K, 2003, MOL CELL BIOL, V23, P594, DOI 10.1128/MCB.23.2.594-606.2003; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Landry DB, 1997, AM J PATHOL, V151, P1085; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lingnau M, 2007, HUM IMMUNOL, V68, P730, DOI 10.1016/j.humimm.2007.06.004; Luscinskas FW, 1996, ANNU REV MED, V47, P413, DOI 10.1146/annurev.med.47.1.413; Manes S, 2010, FASEB J, V24, P3381, DOI 10.1096/fj.09-153106; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salyer S, 2011, AM J PHYSIOL-CELL PH, V300, pC425, DOI 10.1152/ajpcell.00357.2010; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Song GJ, 2012, J MOL CELL CARDIOL, V53, P809, DOI 10.1016/j.yjmcc.2012.08.022; Song GJ, 2012, ARTERIOSCL THROM VAS, V32, P33, DOI 10.1161/ATVBAHA.111.235200; Song GJ, 2010, J MOL CELL CARDIOL, V49, P1012, DOI 10.1016/j.yjmcc.2010.08.025; Song J, 2007, HISTOPATHOLOGY, V51, P40, DOI 10.1111/j.1365-2559.2007.02730.x; Stemmer-Rachamimov AO, 2001, AM J PATHOL, V158, P57, DOI 10.1016/S0002-9440(10)63944-2; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762; Yin G, 2011, BRIT J DERMATOL, V164, P1043, DOI 10.1111/j.1365-2133.2010.10192.x	49	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36426	36436		10.1074/jbc.M113.483339	http://dx.doi.org/10.1074/jbc.M113.483339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196963	Green Published, hybrid			2022-12-28	WOS:000328883400024
J	Yao, JW; Maxwell, JB; Rock, CO				Yao, Jiangwei; Maxwell, John B.; Rock, Charles O.			Resistance to AFN-1252 Arises from Missense Mutations in Staphylococcus aureus Enoyl-acyl Carrier Protein Reductase (FabI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acyl Carrier Protein; Antibiotic Resistance; Antibiotics Action; Drug Resistance; Fatty Acid Synthase; Staphylococcus aureus; FabI; Enoyl-ACP Reductase	FATTY-ACID SYNTHESIS; IN-VITRO ACTIVITY; ESCHERICHIA-COLI; TRICLOSAN RESISTANCE; INHIBITOR AFN-1252; RESIDENCE TIME; ACP REDUCTASE; MECHANISM; COMPLEX; ENZYME	Background: AFN-1252 is a FabI inhibitor developed to treat Staphylococcus aureus. Results: AFN-1252 resistance arises from a single missense mutation that produces a FabI(M99T) protein. Conclusion: The interaction between Met-99 and AFN-1252 accounts for the staphylococcal selectivity of the drug. Significance: The AFN-1252-resistant strains remain susceptible to drug concentrations typically achieved in antibiotic therapy. AFN-1252 is a potent antibiotic against Staphylococcus aureus that targets the enoyl-acyl carrier protein reductase (FabI). A thorough screen for AFN-1252-resistant strains was undertaken to identify the spectrum of mechanisms for acquired resistance. A missense mutation in fabI predicted to encode FabI(M99T) was isolated 49 times, and a single isolate was predicted to encode FabI(Y147H). AFN-1252 only bound to the NADPH form of FabI, and the close interactions between the drug and Met-99 and Tyr-147 explained how the mutations would result in resistant enzymes. The clone expressing FabI(Y147H) had a pronounced growth defect that was rescued by exogenous fatty acid supplementation, and the purified protein had less than 5% of the enzymatic activity of FabI. FabI(Y147F) was also catalytically defective but retained its sensitivity to AFN-1252, illustrating the importance of the conserved Tyr-147 hydroxyl group in FabI function. The strains expressing FabI(M99T) exhibited normal growth, and the biochemical properties of the purified protein were indistinguishable from those of FabI. The AFN-1252 K<sub arrange="stack">i<sup arrange="stack">app increased from 4 nm in FabI to 69 nm in FabI(M99T), accounting for the increased resistance of the corresponding mutant strain. The low activity of FabI(Y147H) precluded an accurate K-i measurement. The strain expressing FabI(Y147H) was also resistant to triclosan; however, the strain expressing FabI(M99T) was more susceptible. Strains with higher levels of AFN-1252 resistance were not obtained. The AFN-1252-resistant strains remained sensitive to submicromolar concentrations of AFN-1252, which blocked growth through inhibition of fatty acid biosynthesis at the FabI step.	[Yao, Jiangwei; Maxwell, John B.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org		Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R25CA023944, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM034496 (to C. O. R.) and CA21765 (Cancer Center Support Grant). This work was also supported by the American Lebanese Syrian Associated Charities.	Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenwald NP, 2003, J HOSP INFECT, V55, P141, DOI 10.1016/S0195-6701(03)00222-6; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Escaich S, 2011, ANTIMICROB AGENTS CH, V55, P4692, DOI 10.1128/AAC.01248-10; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Kaplan N, 2013, J CHEMOTHERAPY, V25, P18, DOI 10.1179/1973947812Y.0000000063; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Karlowsky JA, 2007, ANTIMICROB AGENTS CH, V51, P1580, DOI 10.1128/AAC.01254-06; Karlowsky JA, 2009, ANTIMICROB AGENTS CH, V53, P3544, DOI 10.1128/AAC.00400-09; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lee HH, 2007, PROTEINS, V69, P691, DOI 10.1002/prot.21586; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Massengo-Tiasse RP, 2009, CELL MOL LIFE SCI, V66, P1507, DOI 10.1007/s00018-009-8704-7; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McAllister KA, 2006, J BACTERIOL, V188, P4737, DOI 10.1128/JB.01917-05; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Park HS, 2007, INT J ANTIMICROB AG, V30, P446, DOI 10.1016/j.ijantimicag.2007.07.006; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2008, MOL MICROBIOL, V68, P987, DOI 10.1111/j.1365-2958.2008.06202.x; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a	47	35	35	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36261	36271		10.1074/jbc.M113.512905	http://dx.doi.org/10.1074/jbc.M113.512905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189061	Green Published, hybrid			2022-12-28	WOS:000328883400010
J	Griffin, MJ; Zhou, YM; Kang, SN; Zhang, XL; Mikkelsen, TS; Rosen, ED				Griffin, Michael J.; Zhou, Yiming; Kang, Sona; Zhang, Xiaolan; Mikkelsen, Tarjei S.; Rosen, Evan D.			Early B-cell Factor-1 (EBF1) Is a Key Regulator of Metabolic and Inflammatory Signaling Pathways in Mature Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Chromatin Immunoprecipitation (ChiP); Inflammation; Signal Transduction; Transcription; Developmental Factors; B Lymphocyte; EBF1; Insulin Signaling	GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTORS; FINGER PROTEIN; CLONING; DIFFERENTIATION; IDENTIFICATION; ESTABLISHMENT; ACTIVATION; NETWORK	Background: EBF1 is critical for early adipogenesis, yet its targets/function in mature fat cells are unknown. Results: EBF1 binds to and/or regulates many core genes in metabolic and inflammatory signaling pathways, and loss of EBF1 results in impaired insulin and inflammatory signaling. Conclusion: EBF1 regulates signaling pathways in adipocytes. Significance: We have defined a major regulator of metabolism and signal transduction in adipose cells. EBF1 plays a crucial role in early adipogenesis; however, despite high expression in mature adipocytes, its function in these cells is currently unknown. To identify direct and indirect EBF1 targets in fat, we undertook a combination of transcriptional profiling of EBF1-deficient adipocytes and genome-wide EBF1 location analysis. Our results indicate that many components of metabolic and inflammatory pathways are positively and directly regulated by EBF1, including PI3K/AKT, MAPK, and STAT1 signaling. Accordingly, we observed significant reduction of multiple signaling events in EBF1 knockdown cells as well as a reduction in insulin-stimulated glucose uptake and lipogenesis. Inflammatory signaling, gene expression, and secretion of inflammatory cytokines were also significantly affected by loss of EBF1 in adipocytes, although ChIP-sequencing results suggest that these actions are indirect. We also found that EBF1 occupies some 35,000 sites in adipocytes, most of which occur in enhancers. Significantly, comparison with three other published EBF1 ChIP-sequencing data sets in B-cells reveals both gene- and cell type-specific patterns of EBF1 binding. These results advance our understanding of the transcriptional mechanisms regulating signaling pathways in mature fat cells and indicate that EBF1 functions as a key integrator of signal transduction, inflammation, and metabolism.	[Griffin, Michael J.; Zhou, Yiming; Kang, Sona; Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Griffin, Michael J.; Rosen, Evan D.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Xiaolan; Mikkelsen, Tarjei S.; Rosen, Evan D.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rosen, ED (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Metab & Diabet, Boston, MA 02215 USA.	erosen@bidmc.harvard.edu	Mikkelsen, Tarjei S/A-1306-2007	Mikkelsen, Tarjei S/0000-0002-8133-3135; Griffin, Michael/0000-0003-4252-2803	National Institutes of Health [R01 DK078061, F32 DK082161]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078061, F32DK082161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078061 (to E. D. R.) and F32 DK082161 (to M. J. G.).	Balhoff JP, 1998, BIOCHEM BIOPH RES CO, V247, P894, DOI 10.1006/bbrc.1998.8890; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dowell P, 2002, J BIOL CHEM, V277, P1712, DOI 10.1074/jbc.M108589200; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fretz JA, 2010, ENDOCRINOLOGY, V151, P1611, DOI 10.1210/en.2009-0987; Gisler R, 2000, BLOOD, V96, P1457, DOI 10.1182/blood.V96.4.1457.h8001457_1457_1464; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hesslein DGT, 2009, BONE, V44, P537, DOI 10.1016/j.bone.2008.11.021; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Karczewski KJ, 2011, P NATL ACAD SCI USA, V108, P13353, DOI 10.1073/pnas.1103105108; Lee HS, 2009, CYTOKINE, V46, P160, DOI 10.1016/j.cyto.2008.12.025; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Loots Gabriela G., 2007, V395, P237; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Lukin K, 2011, EUR J IMMUNOL, V41, P1787, DOI 10.1002/eji.201041137; Maier H, 2004, NAT IMMUNOL, V5, P1069, DOI 10.1038/ni1119; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; MILATOVICH A, 1994, MAMM GENOME, V5, P211, DOI 10.1007/BF00360547; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Sigvardsson M, 2002, MOL CELL BIOL, V22, P8539, DOI 10.1128/MCB.22.24.8539-8551.2002; Skurk T, 2009, HORM METAB RES, V41, P183, DOI 10.1055/s-0028-1093345; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364	47	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35925	35939		10.1074/jbc.M113.491936	http://dx.doi.org/10.1074/jbc.M113.491936			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24174531	Green Published, hybrid			2022-12-28	WOS:000329814700029
J	Murray, DS; Chinnam, N; Tonthat, NK; Whitfill, T; Wray, LV; Fisher, SH; Schumacher, MA				Murray, David S.; Chinnam, Nagababu; Tonthat, Nam Ky; Whitfill, Travis; Wray, Lewis V., Jr.; Fisher, Susan H.; Schumacher, Maria A.			Structures of the Bacillus subtilis Glutamine Synthetase Dodecamer Reveal Large Intersubunit Catalytic Conformational Changes Linked to a Unique Feedback Inhibition Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cooperativity; Enzyme Catalysis; Enzyme Inactivation; Enzyme Mechanisms; Enzyme Structure; Glutamine	AMINO-ACID AVAILABILITY; ESCHERICHIA-COLI; GENE-EXPRESSION; METHIONINE SULFOXIMINE; KINETIC PROPERTIES; CRYSTAL-STRUCTURES; NITROGEN; ENZYME; MYCOBACTERIA; COMPLEXES	Background:B. subtilis GS catalyzes the production of glutamine, a key metabolite in nitrogen assimilation. Results:B. subtilis GS forms a dodecamer that undergoes large intersubunit conformational changes during catalysis. Conclusion:B. subtilis GS structures reveal a heretofore unseen active site restructuring that is linked to a novel feedback regulatory mechanism. Significance: The GS specific regulatory/catalytic mechanism may be used to target Gram-positive pathogens. Glutamine synthetase (GS), which catalyzes the production of glutamine, plays essential roles in nitrogen metabolism. There are two main bacterial GS isoenzymes, GSI- and GSI-. GSI- enzymes, which have not been structurally characterized, are uniquely feedback-inhibited by Gln. To gain insight into GSI- function, we performed biochemical and cellular studies and obtained structures for all GSI- catalytic and regulatory states. GSI- forms a massive 600-kDa dodecameric machine. Unlike other characterized GS, the Bacillus subtilis enzyme undergoes dramatic intersubunit conformational alterations during formation of the transition state. Remarkably, these changes are required for active site construction. Feedback inhibition arises from a hydrogen bond network between Gln, the catalytic glutamate, and the GSI--specific residue, Arg(62), from an adjacent subunit. Notably, Arg(62) must be ejected for proper active site reorganization. Consistent with these findings, an R62A mutation abrogates Gln feedback inhibition but does not affect catalysis. Thus, these data reveal a heretofore unseen restructuring of an enzyme active site that is coupled with an isoenzyme-specific regulatory mechanism. This GSI--specific regulatory network could be exploited for inhibitor design against Gram-positive pathogens.	[Murray, David S.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chinnam, Nagababu; Tonthat, Nam Ky; Whitfill, Travis; Schumacher, Maria A.] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Wray, Lewis V., Jr.; Fisher, Susan H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Oregon Health & Science University; Duke University; Boston University	Schumacher, MA (corresponding author), Duke Univ, Sch Med, Dept Biochem, DUMC, 255 Nanaline H Duke,Box 3711, Durham, NC 27710 USA.	Maria.Schumacher@duke.edu	chinnam, Nagababu/AFS-2420-2022; Chinnam, Nagababu/ABF-5512-2021	chinnam, Nagababu/0000-0001-8925-5365; Chinnam, Nagababu/0000-0001-8925-5365; Whitfill, Travis/0000-0002-3277-4380	National Institutes of Health Grants [GM074815, GM051127]; M. D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280, R01GM051127, R01GM074815] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM074815 (to M. A. S.) and GM051127 (to S. H. F.). This work was also supported by an M. D. Anderson Trust Fellowship and Burroughs Wellcome Career Development Award (to M. A. S.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALMASSY RJ, 1986, NATURE, V323, P304, DOI 10.1038/323304a0; ATKINSON MR, 1990, J BACTERIOL, V172, P4758, DOI 10.1128/jb.172.9.4758-4765.1990; BROWN JR, 1994, J MOL EVOL, V38, P566; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DEUEL TF, 1970, J BIOL CHEM, V245, P5195; DEUEL TF, 1974, J BIOL CHEM, V249, P257; DEUEL TF, 1970, J BIOL CHEM, V245, P5206; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Ferson AE, 1996, MOL MICROBIOL, V22, P693, DOI 10.1046/j.1365-2958.1996.d01-1720.x; FISHER SH, 1984, J BACTERIOL, V157, P612, DOI 10.1128/JB.157.2.612-621.1984; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Fisher SH, 2002, J BACTERIOL, V184, P2148, DOI 10.1128/JB.184.8.2148-2154.2002; Fisher SH, 2008, P NATL ACAD SCI USA, V105, P1014, DOI 10.1073/pnas.0709949105; Fisher SH, 2009, J BACTERIOL, V191, P2485, DOI 10.1128/JB.01734-08; Gawronski JD, 2004, ANAL BIOCHEM, V327, P114, DOI 10.1016/j.ab.2003.12.024; Gill HS, 2001, BIOCHEMISTRY-US, V40, P1903, DOI 10.1021/bi002438h; Harth G, 1999, J EXP MED, V189, P1425, DOI 10.1084/jem.189.9.1425; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krajewski WW, 2008, J MOL BIOL, V375, P217, DOI 10.1016/j.jmb.2007.10.029; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P11184, DOI 10.1021/bi00203a014; MAGASANIK B, 1993, J CELL BIOCHEM, V51, P34, DOI 10.1002/jcb.240510108; Mehta R, 2004, J BIOL CHEM, V279, P22477, DOI 10.1074/jbc.M401652200; MIDELFORT CF, 1976, J BIOL CHEM, V251, P5881; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nilsson MT, 2009, J MOL BIOL, V393, P504, DOI 10.1016/j.jmb.2009.08.028; PESOLE G, 1991, P NATL ACAD SCI USA, V88, P522, DOI 10.1073/pnas.88.2.522; Purich DL, 1998, ADV ENZYMOL RAMB, V72, P9; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; RHEE SG, 1981, J BIOL CHEM, V256, P644; SCHREIER HJ, 1989, J MOL BIOL, V210, P51, DOI 10.1016/0022-2836(89)90290-8; SHAPIRO BM, 1968, J BIOL CHEM, V243, P3769; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; van Rooyen JM, 2011, STRUCTURE, V19, P471, DOI 10.1016/j.str.2011.02.001; WEDLER FC, 1972, J BIOL CHEM, V247, P993; WEDLER FC, 1976, J BIOL CHEM, V251, P7530; WEISBROD RE, 1973, J BIOL CHEM, V248, P3997; Wray LV, 2008, MOL MICROBIOL, V68, P277, DOI 10.1111/j.1365-2958.2008.06162.x; Wray LV, 2010, J BACTERIOL, V192, P5018, DOI 10.1128/JB.00509-10; Wray LV, 1996, P NATL ACAD SCI USA, V93, P8841, DOI 10.1073/pnas.93.17.8841; Wray LV, 2005, J BIOL CHEM, V280, P33298, DOI 10.1074/jbc.M504957200; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4	47	29	30	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35801	35811		10.1074/jbc.M113.519496	http://dx.doi.org/10.1074/jbc.M113.519496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24158439	Green Published, hybrid			2022-12-28	WOS:000329814700018
J	Islam, M; Gor, J; Perkins, SJ; Ishikawa, Y; Bachinger, HP; Hohenester, E				Islam, Mehwaesh; Gor, Jayesh; Perkins, Stephen J.; Ishikawa, Yoshihiro; Baechinger, Hans Peter; Hohenester, Erhard			The Concave Face of Decorin Mediates Reversible Dimerization and Collagen Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix; Protein-Protein Interactions; Proteoglycan; Site-directed Mutagenesis	LEUCINE-RICH REPEAT; CRYSTAL-STRUCTURE; I COLLAGEN; TENDON COLLAGEN; CORE PROTEIN; X-RAY; FIBRILLOGENESIS; PROTEOGLYCANS; BIGLYCAN; SCATTERING	Background: In the crystal structure of decorin, the concave faces of two monomers interact to form a tight dimer. Results: The decorin dimer in solution is in equilibrium with stable monomers, and mutations on the concave face abolish collagen binding. Conclusion: Decorin binds collagen as a monomer. Significance: These findings help resolve the controversy about the functional oligomeric state of decorin. Decorin, the prototypical small leucine-rich proteoglycan, binds to collagen and thereby regulates collagen assembly into fibrils. The crystal structure of the decorin core protein revealed a tight dimer formed by the association of two monomers via their concave faces (Scott, P. G., McEwan, P. A., Dodd, C. M., Bergmann, E. M., Bishop, P. N., and Bella, J. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 15633-15638). Whether decorin binds collagen as a dimer has been controversial. Using analytical ultracentrifugation, we determined a dissociation constant of 1.37 +/- 0.30 m for the mouse decorin dimer. Dimerization could be abolished by engineering glycosylation sites into the dimer interface; other interface mutants remained dimeric. The monomeric mutants were as stable as wild-type decorin in thermal unfolding experiments. Mutations on the concave face of decorin abolished collagen binding regardless of whether the mutant proteins retained the ability to dimerize or not. We conclude that the concave face of decorin mediates collagen binding and that the dimer therefore must dissociate to bind collagen.	[Islam, Mehwaesh; Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Imperial College London; University of London; University College London; Oregon Health & Science University	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	e.hohenester@imperial.ac.uk		Islam, Mehwaesh/0000-0003-1025-9852; Ishikawa, Yoshihiro/0000-0003-2013-0518	Shriners Hospital; Wellcome Trust Senior Fellowship in Basic Biomedical Science [083942/Z/07/Z]; BBSRC [BB/E013104/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish	Shriners Hospital; Wellcome Trust Senior Fellowship in Basic Biomedical Science(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from Shriners Hospital (to H. P. B.) and a Wellcome Trust Senior Fellowship in Basic Biomedical Science 083942/Z/07/Z (to E. H.).	Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Boehm MK, 1996, J MOL BIOL, V259, P718, DOI 10.1006/jmbi.1996.0353; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Kajander T, 2011, J MOL BIOL, V413, P1001, DOI 10.1016/j.jmb.2011.09.032; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; Le Goff MM, 2003, J BIOL CHEM, V278, P45280, DOI 10.1074/jbc.M303117200; LIU J, 1994, J BIOL CHEM, V269, P28366; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; PRINGLE GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1405, DOI 10.1177/38.10.1698203; Raspanti M, 2007, BIOMACROMOLECULES, V8, P2087, DOI 10.1021/bm070091t; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCOTT JE, 1981, BIOCHEM J, V197, P213, DOI 10.1042/bj1970213; Scott PG, 2006, J BIOL CHEM, V281, P13324, DOI 10.1074/jbc.M513470200; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Scott PG, 2003, J BIOL CHEM, V278, P18353, DOI 10.1074/jbc.M211936200; Seiradake E, 2009, EMBO REP, V10, P736, DOI 10.1038/embor.2009.95; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	40	25	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35526	35533		10.1074/jbc.M113.504530	http://dx.doi.org/10.1074/jbc.M113.504530			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24169694	hybrid, Green Published			2022-12-28	WOS:000329867600047
J	Chen, M; Zhang, WW; Lu, X; Hoggatt, AM; Gunst, SJ; Kassab, GS; Tune, JD; Herring, BP				Chen, Meng; Zhang, Wenwu; Lu, Xiao; Hoggatt, April M.; Gunst, Susan J.; Kassab, Ghassan S.; Tune, Johnathan D.; Herring, B. Paul			Regulation of 130-kDa Smooth Muscle Myosin Light Chain Kinase Expression by an Intronic CArG Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Calmodulin-dependent Protein Kinase (CaMK); Contractile Protein; Intestine; Myosin; Smooth Muscle; Serum Response Factor	SERUM RESPONSE FACTOR; BARRIER DYSFUNCTION; TELOKIN EXPRESSION; PROMOTER ACTIVITY; DISTINCT ROLES; DEFICIENT MICE; IN-VIVO; PHOSPHORYLATION; ACTIVATION; PROTEIN	Background: Mechanisms regulating transcription of MLCK are poorly defined. Results: Deleting a CArG element from the mylk1 gene specifically decreased expression of the 130-kDa smMLCK isoform, resulting in decreased intestinal contractility and proliferation. Conclusion: The 130-kDa smMLCK isoform has functions that cannot be compensated for by the 220-kDa MLCK. Significance: Floxed mylk1 mice permit specific functions of the 130-kDa smMLCK to be determined. The mylk1 gene encodes a 220-kDa nonmuscle myosin light chain kinase (MLCK), a 130-kDa smooth muscle MLCK (smMLCK), as well as the non-catalytic product telokin. Together, these proteins play critical roles in regulating smooth muscle contractility. Changes in their expression are associated with many pathological conditions; thus, it is important to understand the mechanisms regulating expression of mylk1 gene transcripts. Previously, we reported a highly conserved CArG box, which binds serum response factor, in intron 15 of mylk1. Because this CArG element is near the promoter that drives transcription of the 130-kDa smMLCK, we examined its role in regulating expression of this transcript. Results show that deletion of the intronic CArG region from a -galactosidase reporter gene abolished transgene expression in mice in vivo. Deletion of the CArG region from the endogenous mylk1 gene, specifically in smooth muscle cells, decreased expression of the 130-kDa smMLCK by 40% without affecting expression of the 220-kDa MLCK or telokin. This reduction in 130-kDa smMLCK expression resulted in decreased phosphorylation of myosin light chains, attenuated smooth muscle contractility, and a 24% decrease in small intestine length that was associated with a significant reduction of Ki67-positive smooth muscle cells. Overall, these data show that the CArG element in intron 15 of the mylk1 gene is necessary for maximal expression of the 130-kDa smMLCK and that the 130-kDa smMLCK isoform is specifically required to regulate smooth muscle contractility and small intestine smooth muscle cell proliferation.	[Chen, Meng; Zhang, Wenwu; Lu, Xiao; Hoggatt, April M.; Gunst, Susan J.; Kassab, Ghassan S.; Tune, Johnathan D.; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Herring, BP (corresponding author), Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	pherring@iupui.edu		Gunst, Susan/0000-0001-9836-4782; Tune, Johnathan/0000-0003-2959-0801	National Institutes of Health [HL085212]; American Heart Association (Midwest Affiliate); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Midwest Affiliate)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085212 (to B. P. H.).; Supported by a predoctoral fellowship from the American Heart Association (Midwest Affiliate).	Basu S, 2013, J BIOL CHEM, V288, P11191, DOI 10.1074/jbc.M112.442996; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen M, 2013, J BIOL CHEM, V288, P6397, DOI 10.1074/jbc.M112.409474; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; de Lange WJ, 2008, PHYSIOL GENOMICS, V35, P1, DOI 10.1152/physiolgenomics.90284.2008; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Guo MZ, 2012, SHOCK, V38, P436, DOI 10.1097/SHK.0b013e318268c731; Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9; Han YJ, 2006, MOL BIOL CELL, V17, P4039, DOI 10.1091/mbc.E06-04-0353; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; He WQ, 2011, AM J PHYSIOL-HEART C, V301, pH584, DOI 10.1152/ajpheart.01212.2010; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Herring BP, 2001, AM J PHYSIOL-CELL PH, V280, pC12, DOI 10.1152/ajpcell.2001.280.1.C12; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; Iida Y, 1997, AM J PHYSIOL-ENDOC M, V273, pE782, DOI 10.1152/ajpendo.1997.273.4.E782; Kamm K E, 1987, Prog Clin Biol Res, V245, P183; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Khromov AS, 2006, P NATL ACAD SCI USA, V103, P2440, DOI 10.1073/pnas.0508566103; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Lu XA, 2011, AM J PHYSIOL-HEART C, V300, pH94, DOI 10.1152/ajpheart.00708.2010; Maksym GN, 2005, CAN J PHYSIOL PHARM, V83, P913, DOI 10.1139/Y05-091; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Matsuzaki K, 2003, BIOCHEM BIOPH RES CO, V306, P32, DOI 10.1016/S0006-291X(03)00910-0; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Schmidt JT, 2002, J NEUROBIOL, V52, P175, DOI 10.1002/neu.10083; Shen L, 2006, J CELL SCI, V119, P2095, DOI 10.1242/jcs.02915; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tian Y, 2013, MOL MED REP, V8, P294, DOI 10.3892/mmr.2013.1473; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Touw K, 2007, AM J PHYSIOL-CELL PH, V292, pC1024, DOI 10.1152/ajpcell.00445.2006; Touw K, 2012, AM J PHYSIOL-GASTR L, V302, pG66, DOI 10.1152/ajpgi.00183.2011; Usatyuk PV, 2012, J BIOL CHEM, V287, P9360, DOI 10.1074/jbc.M111.294546; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yu Y, 2012, FEBS J, V279, P1485, DOI 10.1111/j.1742-4658.2012.08541.x; Zhang M, 2011, MOL CELL BIOL, V31, P2618, DOI 10.1128/MCB.01338-10	51	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34647	34657		10.1074/jbc.M113.510362	http://dx.doi.org/10.1074/jbc.M113.510362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24151072	hybrid, Green Published			2022-12-28	WOS:000329812800032
J	Gangula, NR; Maddika, S				Gangula, Narmadha Reddy; Maddika, Subbareddy			WD Repeat Protein WDR48 in Complex with Deubiquitinase USP12 Suppresses Akt-dependent Cell Survival Signaling by Stabilizing PH Domain Leucine-rich Repeat Protein Phosphatase 1 (PHLPP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Apoptosis; Protein Stability; Tumor Suppressor Gene; Ubiquitin; PHLPP; USP12; WDR48	TUMOR-SUPPRESSOR; CANCER	Background: PHLPP1 is a tumor suppressor phosphatase. Results: WDR48 in complex with USP12 controls cell survival signaling by deubiquitinating PHLPP1. Conclusion: WDR48 acts as a potential tumor suppressor by positively regulating PHLPP1 stability. Significance: WDR48 was identified as novel PHLPP1 regulator, which is critical in understanding its role as tumor suppressor in human cancers. PHLPP1 (PH domain leucine-rich repeat protein phosphatase 1) is a protein-serine/threonine phosphatase and a negative regulator of the PI3-kinase/Akt pathway. Although its function as a suppressor of tumor cell growth has been established, the mechanism of its regulation is not completely understood. In this study, by utilizing the tandem affinity purification approach we have identified WDR48 and USP12 as novel PHLPP1-associated proteins. The WDR48USP12 complex deubiquitinates PHLPP1 and thereby enhances its protein stability. Similar to PHLPP1 function, WDR48 and USP12 negatively regulate Akt activation and thus promote cellular apoptosis. Functionally, we show that WDR48 and USP12 suppress proliferation of tumor cells. Importantly, we found a WDR48 somatic mutation (L580F) that is defective in stabilizing PHLPP1 in colorectal cancers, supporting a WDR48 role in tumor suppression. Together, our results reveal WDR48 and USP12 as novel PHLPP1 regulators and potential suppressors of tumor cell survival.	[Gangula, Narmadha Reddy; Maddika, Subbareddy] CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Maddika, S (corresponding author), CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India.	humsreddy@cdfd.org.inu			Wellcome Trust/DBT India Alliance Intermediate Fellowship [500230/Z/11/Z]	Wellcome Trust/DBT India Alliance Intermediate Fellowship	This work was supported by Wellcome Trust/DBT India Alliance Intermediate Fellowship Grant 500230/Z/11/Z (to S. M.).	Andreozzi F, 2011, DIABETOLOGIA, V54, P1879, DOI 10.1007/s00125-011-2116-6; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Gao GL, 2013, MOL BIOL REP, V40, P2947, DOI 10.1007/s11033-012-2363-8; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel A, 2003, CANCER RES, V63, P1608; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Li X, 2013, ONCOGENE, V32, P471, DOI 10.1038/onc.2012.66; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Moretti J, 2012, J BIOL CHEM, V287, P29429, DOI 10.1074/jbc.M112.366807; Patael-Karasik Y, 2000, CANCER GENET CYTOGEN, V121, P26, DOI 10.1016/S0165-4608(00)00224-7; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Shimizu K, 2010, MOL BIOSYST, V6, P38, DOI 10.1039/b911410f; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Torring N, 2007, BRIT J CANCER, V96, P499, DOI 10.1038/sj.bjc.6603476; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zhang ZQ, 2012, J CANCER RES CLIN, V138, P1231, DOI 10.1007/s00432-012-1193-3	26	48	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34545	34554		10.1074/jbc.M113.503383	http://dx.doi.org/10.1074/jbc.M113.503383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24145035	Green Published, hybrid			2022-12-28	WOS:000329812800023
J	Ma, N; Liao, BJ; Zhang, H; Wang, LL; Shan, YL; Xue, YT; Huang, K; Chen, SB; Zhou, XX; Chen, Y; Pei, DQ; Pan, GJ				Ma, Ning; Liao, Baojian; Zhang, Hui; Wang, Linli; Shan, Yongli; Xue, Yanting; Huang, Ke; Chen, Shubin; Zhou, Xiaoxiao; Chen, Yang; Pei, Duanqing; Pan, Guangjin			Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free beta-Thalassemia Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cell Therapy; Hemoglobin; Homologous Recombination; Induced Pluripotent Stem (iPS) Cell; -Thalassemia; HBB; TALEN; Gene Correction; iPS	HOMOLOGOUS RECOMBINATION; KNOCKOUT; MUTATION; PATIENT; VECTOR	Background: Gene editing in human patient-specific iPSCs is critical for regenerative medicine. Results: Nonintegrating -thalassemia iPSCs corrected by TALENs display undetectable off targets and can be differentiated into erythroblasts expressing normal -globin. Conclusion: TALENs can be used for HBB correction efficiently in -thalassemia iPSCs with different types. Significance: Our study extends TALENs for gene correction in patient-specific iPSCs and may have applications in cell therapy. -Thalassemia (-Thal) is a group of life-threatening blood disorders caused by either point mutations or deletions of nucleotides in -globin gene (HBB). It is estimated that 4.5% of the population in the world carry -Thal mutants (1), posing a persistent threat to public health. The generation of patient-specific induced pluripotent stem cells (iPSCs) and subsequent correction of the disease-causing mutations offer an ideal therapeutic solution to this problem. However, homologous recombination-based gene correction in human iPSCs remains largely inefficient. Here, we describe a robust process combining efficient generation of integration-free -Thal iPSCs from the cells of patients and transcription activator-like effector nuclease (TALEN)-based universal correction of HBB mutations in situ. We generated integration-free and gene-corrected iPSC lines from two patients carrying different types of homozygous mutations and showed that these iPSCs are pluripotent and have normal karyotype. We showed that the correction process did not generate TALEN-induced off targeting mutations by sequencing. More importantly, the gene-corrected -Thal iPS cell lines from each patient can be induced to differentiate into hematopoietic progenitor cells and then further to erythroblasts expressing normal -globin. Our studies provide an efficient and universal strategy to correct different types of -globin mutations in -Thal iPSCs for disease modeling and applications.	[Ma, Ning; Liao, Baojian; Zhang, Hui; Wang, Linli; Shan, Yongli; Xue, Yanting; Huang, Ke; Chen, Shubin; Zhou, Xiaoxiao; Chen, Yang; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Ma, Ning; Liao, Baojian; Zhang, Hui; Wang, Linli; Shan, Yongli; Xue, Yanting; Huang, Ke; Chen, Shubin; Zhou, Xiaoxiao; Chen, Yang; Pei, Duanqing; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Xue, Yanting] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Kaiyuan Ave Sci Pk, Guangzhou 510530, Guangdong, Peoples R China.	pan_guangjin@gibh.ac.cn	Liao, Baojian/AAI-6286-2021; Wang, Linli/R-5688-2018	Wang, Linli/0000-0002-8380-6135; Pan, Guangjin/0000-0002-2378-7198	National Basic Research Program of China, 973 Program of China [2012CB966503]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA01020202]; 973 Program of China [2011CB965204]; National S&T Major Special Project on Major New Drug Innovation [2011ZX09102-010]; National Natural Science Foundation of China [31200970, 91213304]; Bureau of Science and Technology of Guangzhou Municipality, China [2010U1-E00521]; Hundred Talents Program of the Chinese Academy of Science	National Basic Research Program of China, 973 Program of China(National Basic Research Program of China); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 Program of China(National Basic Research Program of China); National S&T Major Special Project on Major New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Guangzhou Municipality, China; Hundred Talents Program of the Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China, 973 Program of China Grant 2012CB966503, "Strategic Priority Research Program" of the Chinese Academy of Sciences Grant XDA01020202, 973 Program of China Grant 2011CB965204, National S&T Major Special Project on Major New Drug Innovation Grant 2011ZX09102-010, National Natural Science Foundation of China Grants 31200970 and 91213304, Bureau of Science and Technology of Guangzhou Municipality, China, Grant 2010U1-E00521 and funds from the Hundred Talents Program of the Chinese Academy of Science (to G. P.).	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Gong L, 2000, BRIT J HAEMATOL, V111, P351, DOI 10.1046/j.1365-2141.2000.02311.x; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; KIMURA A, 1983, J BIOL CHEM, V258, P2748; Li M, 2011, CELL RES, V21, P1740, DOI 10.1038/cr.2011.186; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Tuzmen S, 2001, BLOOD REV, V15, P19, DOI 10.1054/blre.2001.0147; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	35	114	128	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34671	34679		10.1074/jbc.M113.496174	http://dx.doi.org/10.1074/jbc.M113.496174			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24155235	Green Published, hybrid			2022-12-28	WOS:000329812800034
J	Stefan, CP; Cunningham, KW				Stefan, Christopher P.; Cunningham, Kyle W.			Kch1 Family Proteins Mediate Essential Responses to Endoplasmic Reticulum Stresses in the Yeasts Saccharomyces cerevisiae and Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium Channels; Cell Death; ER Stress; Potassium Transport; Antifungals	PLASMA-MEMBRANE PROTEIN; SODIUM LEAK CHANNELS; CA2+ INFLUX; CALCINEURIN INHIBITORS; TRANSCRIPTION FACTOR; NONAPOPTOTIC DEATH; SECRETORY PATHWAY; CALCIUM-CHANNELS; ER STRESS; GENE	Background: Fungal cells require Ca2+ influx and signaling to survive some antifungal assaults. Results: High affinity Ca2+ influx systems in yeasts required the Kch1 K+ transporters for full activation in response to ER stressors but not clinical antifungals. Conclusion: Kch1 family proteins regulate Ca2+ influx in many yeast species. Significance: Targeting fungal K+ transporters or Ca2+ channels may improve efficacy of existing antifungals in narrow situations. The activation of a high affinity Ca2+ influx system (HACS) in the plasma membrane is required for survival of yeast cells exposed to natural or synthetic inhibitors of essential processes (secretory protein folding or sterol biosynthesis) in the endoplasmic reticulum (ER). The mechanisms linking ER stress to HACS activation are not known. Here we show that Kch1, a recently identified low affinity K+ transporter in the plasma membrane of Saccharomyces cerevisiae, is up-regulated in response to several ER stressors and necessary for HACS activation. The activation of HACS required extracellular K+ and was also dependent on the high affinity K+ transporters Trk1 and Trk2. However, a paralog of Kch1 termed Kch2 was not expressed and not necessary for HACS activation in these conditions. The pathogenic yeast Candida albicans carries only one homolog of Kch1/Kch2, and homozygous knock-out mutants were similarly deficient in the activation of HACS during the responses to tunicamycin. However, the Kch1 homolog was not necessary for HACS activation or cell survival in response to several clinical antifungals (azoles, allylamines, echinocandins) that target the ER or cell wall. Thus, Kch1 family proteins represent a conserved linkage between HACS and only certain classes of ER stress in these yeasts.	[Stefan, Christopher P.; Cunningham, Kyle W.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Cunningham, KW (corresponding author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.	kwc@jhu.edu	Stefan, Christopher/V-5970-2019	Stefan, Christopher/0000-0003-4891-447X	National Institutes of Health [NS057023, NS074072]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074072, R21NS057023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Research Awards NS057023 and NS074072 (to K.W.C.).	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bihler H, 1998, FEBS LETT, V432, P59, DOI 10.1016/S0014-5793(98)00832-1; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Bonilla Myriam, 2002, Sci STKE, V2002, ppe17; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Clancy CJ, 2006, ANTIMICROB AGENTS CH, V50, P2569, DOI 10.1128/AAC.00291-06; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; CYERT MS, 1991, P NATL ACAD SCI USA, V88, P7376, DOI 10.1073/pnas.88.16.7376; Del Poeta M, 2000, ANTIMICROB AGENTS CH, V44, P739, DOI 10.1128/AAC.44.3.739-746.2000; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; GABER RF, 1988, MOL CELL BIOL, V8, P2848, DOI 10.1128/MCB.8.7.2848; Gijsen VMGJ, 2012, ANN TRANSPL, V17, P111; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gregory MA, 2010, CANCER CELL, V18, P74, DOI 10.1016/j.ccr.2010.04.025; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haro R, 2002, BBA-BIOMEMBRANES, V1564, P114, DOI 10.1016/S0005-2736(02)00408-X; Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1990, J BIOL CHEM, V265, P13391; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2004, FEBS LETT, V576, P291, DOI 10.1016/j.febslet.2004.09.021; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kim H, 2012, J BIOL CHEM, V287, P19029, DOI 10.1074/jbc.M112.363390; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; KO CH, 1990, GENETICS, V125, P305; Kusio-Kobialka M, 2012, CELL CYCLE, V11, P4069, DOI 10.4161/cc.22387; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; Liebeskind BJ, 2012, MOL BIOL EVOL, V29, P3613, DOI 10.1093/molbev/mss182; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Macario AJL, 2002, AGEING RES REV, V1, P295, DOI 10.1016/S1568-1637(01)00005-8; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2932, DOI 10.1128/AAC.44.11.2932-2938.2000; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2373, DOI 10.1128/AAC.44.9.2373-2381.2000; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Morrison Vicki A, 2006, Expert Rev Anti Infect Ther, V4, P325, DOI 10.1586/14787210.4.2.325; Moser NJ, 1996, MOL CELL BIOL, V16, P4824; Muller EM, 2003, J BIOL CHEM, V278, P38461, DOI 10.1074/jbc.M304089200; Muller EM, 2001, GENETICS, V159, P1527; Onyewu C, 2003, ANTIMICROB AGENTS CH, V47, P956, DOI 10.1128/AAC.47.3.956-964.2003; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Pallet N, 2010, PHARMACOGENOMICS, V11, P1491, DOI 10.2217/PGS.10.137; Pena A, 2010, J BIOENERG BIOMEMBR, V42, P419, DOI 10.1007/s10863-010-9311-x; Reedy J. L., 2010, Fungal Genetics and Biology, V47, P107, DOI 10.1016/j.fgb.2009.09.002; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Sherman F., 1986, METHODS YEAST GENETI; SLAYMAN CL, 1973, J MEMBRANE BIOL, V14, P305, DOI 10.1007/BF01868083; SLAYMAN CL, 1965, J GEN PHYSIOL, V49, P69, DOI 10.1085/jgp.49.1.69; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P1664, DOI 10.1128/AAC.48.5.1664-1669.2004; Strayle J, 1999, EMBO J, V18, P4733, DOI 10.1093/emboj/18.17.4733; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	70	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34861	34870		10.1074/jbc.M113.508705	http://dx.doi.org/10.1074/jbc.M113.508705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142703	hybrid, Green Published			2022-12-28	WOS:000329812800053
J	Unno, M; Ardevol, A; Rovira, C; Ikeda-Saito, M				Unno, Masaki; Ardevol, Albert; Rovira, Carme; Ikeda-Saito, Masao			Structures of the Substrate-free and Product-bound Forms of HmuO, a Heme Oxygenase from Corynebacterium diphtheriae X-RAY CRYSTALLOGRAPHY AND MOLECULAR DYNAMICS INVESTIGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Structure; Heme; Heme Oxygenase; Molecular Dynamics; X-ray Crystallography; Bacterial Iron Acquisition	GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; DEGRADATION; IRON; MECHANISM; COMPLEX; BINDING; ACQUISITION; PROTEINS; SYSTEM	Background: Heme oxygenase (HO) converts heme to biliverdin, carbon monoxide, and Fe2+. Results: HO crystal structures were determined for substrate-free Fe3+-biliverdin and biliverdin forms, as well as intermediates of the last two. Conclusion: HO reaction center is built with substrate-induced conformational changes, and Fe2+ is released without major structural changes. Significance: Elucidation of these HO structures is fundamental for understanding its enzyme mechanism. Heme oxygenase catalyzes the degradation of heme to biliverdin, iron, and carbon monoxide. Here, we present crystal structures of the substrate-free, Fe3+-biliverdin-bound, and biliverdin-bound forms of HmuO, a heme oxygenase from Corynebacterium diphtheriae, refined to 1.80, 1.90, and 1.85 resolution, respectively. In the substrate-free structure, the proximal and distal helices, which tightly bracket the substrate heme in the substrate-bound heme complex, move apart, and the proximal helix is partially unwound. These features are supported by the molecular dynamic simulations. The structure implies that the heme binding fixes the enzyme active site structure, including the water hydrogen bond network critical for heme degradation. The biliverdin groups assume the helical conformation and are located in the heme pocket in the crystal structures of the Fe3+-biliverdin-bound and the biliverdin-bound HmuO, prepared by in situ heme oxygenase reaction from the heme complex crystals. The proximal His serves as the Fe3+-biliverdin axial ligand in the former complex and forms a hydrogen bond through a bridging water molecule with the biliverdin pyrrole nitrogen atoms in the latter complex. In both structures, salt bridges between one of the biliverdin propionate groups and the Arg and Lys residues further stabilize biliverdin at the HmuO heme pocket. Additionally, the crystal structure of a mixture of two intermediates between the Fe3+-biliverdin and biliverdin complexes has been determined at 1.70 resolution, implying a possible route for iron exit.	[Unno, Masaki; Ikeda-Saito, Masao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Unno, Masaki] Ibaraki Univ, Frontier Res Ctr Appl Atom Sci, Naka, Ibaraki 3191106, Japan; [Unno, Masaki] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Unno, Masaki; Ikeda-Saito, Masao] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Ardevol, Albert] Comp Simulat & Modeling Lab, Barcelona 08028, Spain; [Rovira, Carme] Univ Barcelona, Dept Quim Organ, E-08028 Barcelona, Spain; [Rovira, Carme] Univ Barcelona, Inst Quim Teor & Computac, E-08028 Barcelona, Spain; [Rovira, Carme] Inst Catalana Recerca & Estudis Avancats, Barcelona 08020, Spain	Tohoku University; Ibaraki University; Ibaraki University; RIKEN; University of Barcelona; University of Barcelona; University of Barcelona; ICREA	Ikeda-Saito, M (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan.	mis2@tagen.tohoku.ac.jp	Ikeda-Saito, Masao/A-5992-2008; Ikeda-Saito, Masao/K-2703-2015; Rovira, Carme/K-5195-2014; Ardevol, Albert/I-4401-2012	Rovira, Carme/0000-0003-1477-5010; Ardevol, Albert/0000-0003-2614-5526	Japan Society for Promotion of Science [21350087, 2412006, 24350081, 18770080, 22770096, 24570122]; Management Expenses Grant for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Spanish Ministry of Economy and Competitiveness [CTQ2011-25871]; Generalitat de Catalunya [2009SGR-1309]; European Molecular Biology Organization; ICREA Funding Source: Custom; Grants-in-Aid for Scientific Research [24120001, 24570122] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Management Expenses Grant for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); ICREA(ICREA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research 21350087, 2412006, and 24350081 (to M.I.-S.) and 18770080, 22770096, and 24570122 (to M. U.) from the Japan Society for Promotion of Science, the Management Expenses Grant for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Spanish Ministry of Economy and Competitiveness Grant CTQ2011-25871, and Generalitat de Catalunya Grant 2009SGR-1309.; Supported by a long term fellowship from the European Molecular Biology Organization.	Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barker KD, 2012, J BIOL CHEM, V287, P18342, DOI 10.1074/jbc.M112.359265; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chu GC, 1999, J BIOL CHEM, V274, P21319, DOI 10.1074/jbc.274.30.21319; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DeLano W.L, PYMOL MOL GRAPHICS S; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Du ZM, 2010, J INORG BIOCHEM, V104, P1063, DOI 10.1016/j.jinorgbio.2010.06.003; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; Ikeda-Saito M, 2003, ACS SYM SER, V858, P97; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lad L, 2004, BIOCHEMISTRY-US, V43, P3793, DOI 10.1021/bi035451l; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Lai WZ, 2010, J AM CHEM SOC, V132, P12960, DOI 10.1021/ja104674q; Li YM, 2003, J BIOL CHEM, V278, P6651, DOI 10.1074/jbc.M211249200; Liu Y, 2000, J BIOL CHEM, V275, P5297, DOI 10.1074/jbc.275.8.5297; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marechal JD, 2008, EUR BIOPHYS J BIOPHY, V37, P1157, DOI 10.1007/s00249-008-0279-y; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t; Matsui T, 2010, ACCOUNTS CHEM RES, V43, P240, DOI 10.1021/ar9001685; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Pereira PJB, 2001, NAT STRUCT BIOL, V8, P215, DOI 10.1038/84948; Pietrucci F, 2009, J CHEM THEORY COMPUT, V5, P2197, DOI 10.1021/ct900202f; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Sawai H, 2012, J BIOL CHEM, V287, P30755, DOI 10.1074/jbc.M112.370916; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; Sheldrick W. S., 1976, J CHEM SOC PERK T, V2, P1453; Sugishima M, 2003, J BIOL CHEM, V278, P32352, DOI 10.1074/jbc.M303682200; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Unno M, 2004, J BIOL CHEM, V279, P21055, DOI 10.1074/jbc.M400491200; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Unno M, 2012, J INORG BIOCHEM, V113, P102, DOI 10.1016/j.jinorgbio.2012.04.012; WAGNER UG, 1995, J MOL BIOL, V247, P326, DOI 10.1006/jmbi.1994.0142; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; YOSHIDA T, 1978, J BIOL CHEM, V253, P4230; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	63	15	15	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34443	34458		10.1074/jbc.M113.486936	http://dx.doi.org/10.1074/jbc.M113.486936			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24106279	Green Published, hybrid			2022-12-28	WOS:000329812800015
J	Ahsberg, J; Ungerback, J; Strid, T; Welinder, E; Stjernberg, J; Larsson, M; Qian, H; Sigvardsson, M				Ahsberg, Josefine; Ungerback, Jonas; Strid, Tobias; Welinder, Eva; Stjernberg, Jenny; Larsson, Malin; Qian, Hong; Sigvardsson, Mikael			Early B-cell Factor 1 Regulates the Expansion of B-cell Progenitors in a Dose-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Differentiation; Immunology; Lymphocyte; Transcription Factors	COMMON LYMPHOID PROGENITORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTORS; FACTOR EBF; FACTOR PAX5; EXPRESSION; E2A; DIFFERENTIATION; GENES; COMMITMENT	Transcription factor doses are of importance for normal and malignant B-lymphocyte development; however, the understanding of underlying mechanisms and functional consequences of reduced transcription factor levels is limited. We have analyzed progenitor and B-lineage compartments in mice carrying heterozygote mutations in the E2a, Ebf1, or Pax5 gene. Although lymphoid progenitors from Ebf1 or Pax5 heterozygote mice were specified and lineage-restricted in a manner comparable with Wt progenitors, this process was severely impaired in E2a heterozygote mutant mice. This defect was not significantly enhanced upon combined deletion of E2a with Ebf1 or Pax5. Analysis of the pre-B-cell compartment in Ebf1 heterozygote mice revealed a reduction in cell numbers. These cells expressed Pax5 and other B-lineage-associated genes, and global gene expression analysis suggested that the reduction of the pre-B-cell compartment was a result of impaired pre-B-cell expansion. This idea was supported by a reduction in IL2R-expressing late pre-B-cells as well as by cell cycle analysis and by the finding that the complexity of the VDJ rearrangement patterns was comparable in Wt and Ebf1(+/-) pre-B-cells, although the number of progenitors was reduced. Heterozygote deletion of Ebf1 resulted in impaired response to IL7 in vitro and reduced expression levels of pre-BCR on the cell surface, providing possible explanations for the observed stage-specific reduction in cellular expansion. Thus, transcription factor doses are critical for specification as well as expansion of B-lymphoid progenitors, providing increased insight into the molecular regulation of B-cell development.	[Ahsberg, Josefine; Ungerback, Jonas; Strid, Tobias; Welinder, Eva; Stjernberg, Jenny; Qian, Hong; Sigvardsson, Mikael] Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med,Univ Lab 1, SE-58185 Linkoping, Sweden; [Larsson, Malin] Linkoping Univ, IFM Bioinformat, SE-58185 Linkoping, Sweden; [Qian, Hong] Karolinska Inst Huddinge, Dept Med, Ctr Hematol & Regenerat Med, SE-17177 Stockholm, Sweden	Linkoping University; Linkoping University; Karolinska Institutet	Sigvardsson, M (corresponding author), Linkoping Univ, Fac Hlth Sci, Expt Hematopoiesis Unit, Dept Clin & Expt Med,Univ Lab 1, Level 13, SE-58185 Linkoping, Sweden.	mikael.sigvardsson@liu.se	Qian, Hong/D-5588-2014	Qian, Hong/0000-0002-2512-9199; Sigvardsson, Mikael/0000-0001-8527-7276	Swedish Cancer Society; Swedish Research Council; Hemato-Linne; Faculty of Medicine at Linkoping University	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Hemato-Linne; Faculty of Medicine at Linkoping University	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council through project grants, and Hemato-Linne and the Faculty of Medicine at Linkoping University.	CHEN JZ, 1994, INT IMMUNOL, V6, P1265, DOI 10.1093/intimm/6.8.1265; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Gyory I, 2012, GENE DEV, V26, P668, DOI 10.1101/gad.187328.112; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; hsberg J., 2010, J BIOL CHEM, V285, P36275; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lukin K, 2011, EUR J IMMUNOL, V41, P1787, DOI 10.1002/eji.201041137; Lukin K, 2010, P NATL ACAD SCI USA, V107, P7869, DOI 10.1073/pnas.1003525107; Mansson R, 2008, BLOOD, V112, P1048, DOI 10.1182/blood-2007-11-125385; Mansson R, 2012, P NATL ACAD SCI USA, V109, P21028, DOI 10.1073/pnas.1211427109; Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398; Martensson IL, 1997, J EXP MED, V185, P653, DOI 10.1084/jem.185.4.653; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257; Sandoval GJ, 2013, J IMMUNOL, V190, P2485, DOI 10.4049/jimmunol.1203208; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Simmons S, 2012, BLOOD, V120, P3688, DOI 10.1182/blood-2012-03-414821; Smith EMK, 2002, J IMMUNOL, V169, P261, DOI 10.4049/jimmunol.169.1.261; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Welinder E, 2011, SEMIN IMMUNOL, V23, P335, DOI 10.1016/j.smim.2011.08.005; Welinder E, 2011, P NATL ACAD SCI USA, V108, P17402, DOI 10.1073/pnas.1111766108; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yang Q, 2008, J IMMUNOL, V181, P5885, DOI 10.4049/jimmunol.181.9.5885; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zandi S, 2012, P NATL ACAD SCI USA, V109, P15871, DOI 10.1073/pnas.1210144109; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	48	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33449	33461		10.1074/jbc.M113.506261	http://dx.doi.org/10.1074/jbc.M113.506261			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24078629	Green Published, hybrid			2022-12-28	WOS:000328841700057
J	Brindle, NPJ; Sale, JE; Arakawa, H; Buerstedde, JM; Nuamchit, T; Sharma, S; Steele, KH				Brindle, Nicholas P. J.; Sale, Julian E.; Arakawa, Hiroshi; Buerstedde, Jean-Marie; Nuamchit, Teonchit; Sharma, Shikha; Steele, Kathryn H.			Directed Evolution of an Angiopoietin-2 Ligand Trap by Somatic Hypermutation and Cell Surface Display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cell Surface Receptor; Directed Evolution; Endothelial Cell; Ligand-binding Protein; Protein Engineering	AFFINITY MATURATION; TIE2 RECEPTOR; TUMOR-GROWTH; ANGIOGENESIS; METASTASIS; PROTEIN; INHIBITION; ANTIBODIES	Background: The ligand angiopoietin2 contributes to vascular diseases. Results: A new directed evolution method was used to create a specific angiopoietin2-binding protein from a nonspecific angiopoietin receptor. Conclusion: The receptor binding specificity can be switched with just three residue changes. Significance: The new protein has therapeutic potential, and the directed evolution method has advantages for evolving mammalian proteins. Tie2 is a receptor tyrosine kinase that is essential for the development and maintenance of blood vessels through binding the soluble ligands angiopoietin 1 (Ang1) and 2 (Ang2). Ang1 is constitutively produced by perivascular cells and is protective of the adult vasculature. Ang2 plays an important role in blood vessel formation and is normally expressed during development. However, its re-expression in disease states, including cancer and sepsis, results in destabilization of blood vessels contributing to the pathology of these conditions. Ang2 is thus an attractive therapeutic target. Here we report the directed evolution of a ligand trap for Ang2 by harnessing the B cell somatic hypermutation machinery and coupling this to selectable cell surface display of a Tie2 ectodomain. Directed evolution produced an unexpected combination of mutations resulting in loss of Ang1 binding but maintenance of Ang2 binding. A soluble form of the evolved ectodomain binds Ang2 but not Ang1. Furthermore, the soluble evolved ectodomain blocks Ang2 effects on endothelial cells without interfering with Ang1 activity. Our study has created a novel Ang2 ligand trap and provided proof of concept for combining surface display and exogenous gene diversification in B cells for evolution of a non-immunoglobulin target.	[Brindle, Nicholas P. J.; Nuamchit, Teonchit; Sharma, Shikha; Steele, Kathryn H.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 9HN, Leics, England; [Brindle, Nicholas P. J.] Univ Leicester, Depts Biochem, Leicester LE1 9HN, Leics, England; [Sale, Julian E.] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England; [Arakawa, Hiroshi] European Inst Oncol, Italian Fdn Canc Res Inst Mol Oncol, I-20139 Milan, Italy; [Buerstedde, Jean-Marie] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA	University of Leicester; University of Leicester; MRC Laboratory Molecular Biology; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Yale University	Brindle, NPJ (corresponding author), Univ Leicester, Depts Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	npjb1@le.ac.uk		Brindle, Nicholas/0000-0002-4221-677X; Sale, Julian/0000-0002-5031-3780	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E019404/1]; Wellcome Trust [097828/z/11/z, 097828/z/11/a]; Medical Research Council [U105178808]; BBSRC [BB/E019404/1] Funding Source: UKRI; MRC [MC_U105178808] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E019404/1] Funding Source: researchfish; Medical Research Council [MC_U105178808] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/E019404/1 (to N. P. J. B.), Wellcome Trust Grants 097828/z/11/z and 097828/z/11/a (to N. P. J. B.), and Medical Research Council Grant U105178808 (to J. E. S.).	Arakawa H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm616; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Macdonald PR, 2006, J BIOL CHEM, V281, P28408, DOI 10.1074/jbc.M605219200; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; Tabruyn SP, 2010, AM J PATHOL, V177, P3233, DOI 10.2353/ajpath.2010.100059; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; White RR, 2003, P NATL ACAD SCI USA, V100, P5028, DOI 10.1073/pnas.0831159100; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	27	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33205	33212		10.1074/jbc.M113.510578	http://dx.doi.org/10.1074/jbc.M113.510578			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24106271	Green Published, hybrid			2022-12-28	WOS:000328841700035
J	Gu, JP; Congdon, EE; Sigurdsson, EM				Gu, Jiaping; Congdon, Erin E.; Sigurdsson, Einar M.			Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Endosomes; Immunotherapy; Lysosomes; Phosphorylation; Tau; Alzheimer Disease; Autophagosomes	CENTRAL-NERVOUS-SYSTEM; AMYLOID-BETA 25-35; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; MOUSE MODEL; TRANSGENIC MICE; PASSIVE-IMMUNIZATION; CEREBROSPINAL-FLUID; IMMUNOTHERAPY; PROPAGATION	Background: Tau immunotherapy is an emerging approach to treat Alzheimer disease. Results: Two novel Tau antibodies targeting the 396/404 region are primarily taken up by neurons and reduce Tau pathology. Conclusion: Receptor-mediated endocytosis and the intracellular endosome/autophagosome/lysosome system are likely involved in antibody-mediated clearance of pathological Tau. Significance: This study provides valuable insight into development of Tau immunotherapy. Aggregated Tau proteins are hallmarks of Alzheimer disease and other tauopathies. Recent studies from our group and others have demonstrated that both active and passive immunizations reduce Tau pathology and prevent cognitive decline in transgenic mice. To determine the efficacy and safety of targeting the prominent 396/404 region, we developed two novel monoclonal antibodies (mAbs) with distinct binding profiles for phospho and non-phospho epitopes. The two mAbs significantly reduced hyperphosphorylated soluble Tau in long term brain slice cultures without apparent toxicity, suggesting the therapeutic importance of targeting the 396/404 region. In mechanistic studies, we found that neurons were the primary cell type that internalized the mAbs, whereas a small amount of mAbs was taken up by microglia cells. Within neurons, the two mAbs were highly colocalized with distinct pathological Tau markers, indicating their affinity toward different stages or forms of pathological Tau. Moreover, the mAbs were largely co-localized with endosomal/lysosomal markers, and partially co-localized with autophagy pathway markers. Additionally, the Fab fragments of the mAbs were able to enter neurons, but unlike the whole antibodies, the fragments were not specifically localized in pathological neurons. In summary, our Tau mAbs were safe and efficient to clear pathological Tau in a brain slice model. Fc-receptor-mediated endocytosis and the endosome/autophagosome/lysosome system are likely to have a critical role in antibody-mediated clearance of Tau pathology.	[Gu, Jiaping; Congdon, Erin E.; Sigurdsson, Einar M.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; [Sigurdsson, Einar M.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	New York University; New York University	Sigurdsson, EM (corresponding author), 550 1st Ave MSB 459, New York, NY 10016 USA.	einar.sigurdsson@nyumc.org		Congdon, Erin/0000-0001-8322-6176; Sigurdsson, Einar/0000-0003-1451-0952	National Institutes of Health [NS077239, AG032611, AG020197]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032611, R01AG020197, P30AG008051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS077239, AG032611, and AG020197. E. M. Sigurdsson is an inventor on New York University patents on Tau immunotherapy. New York University technology on Tau immunotherapy is licensed to and is being co-developed with H. Lundbeck A/S.	Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; d'Abramo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062402; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Delacourte A, 2002, NEUROLOGY, V59, P398, DOI 10.1212/WNL.59.3.398; DIETZSCHOLD B, 1992, P NATL ACAD SCI USA, V89, P7252, DOI 10.1073/pnas.89.15.7252; Donovan LE, 2012, PROTEOM CLIN APPL, V6, P201, DOI 10.1002/prca.201100068; Duff K, 2002, J MOL NEUROSCI, V19, P317, DOI 10.1385/JMN:19:3:317; FABIAN RH, 1987, NEUROLOGY, V37, P1780, DOI 10.1212/WNL.37.11.1780; Farlow M, 2012, ALZHEIMERS DEMENT, V8, P261, DOI 10.1016/j.jalz.2011.09.224; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gong CX, 2001, BRAIN RES PROTOC, V6, P134, DOI 10.1016/S1385-299X(00)00046-5; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Krishnamurthy Pavan K, 2011, Front Psychiatry, V2, P59, DOI 10.3389/fpsyt.2011.00059; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu L, 2012, PLOS ONE, V7; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Panza F, 2011, CURR ALZHEIMER RES, V8, P808, DOI 10.2174/156720511798192718; Pearson R C, 1989, Rev Neurosci, V2, P101, DOI 10.1515/REVNEURO.1989.2.2.101; Ribe EM, 2005, NEUROBIOL DIS, V20, P814, DOI 10.1016/j.nbd.2005.05.027; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Siemers ER, 2010, CLIN NEUROPHARMACOL, V33, P67, DOI 10.1097/WNF.0b013e3181cb577a; Sigurdsson EM, 2009, CURR ALZHEIMER RES, V6, P446, DOI 10.2174/156720509789207930; Sigurdsson EM, 1996, NEUROBIOL AGING, V17, P893, DOI 10.1016/S0197-4580(96)00169-8; Sigurdsson EM, 1997, NEUROBIOL AGING, V18, P591, DOI 10.1016/S0197-4580(97)00154-1; Tampellini D, 2007, J BIOL CHEM, V282, P18895, DOI 10.1074/jbc.M700373200; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1	57	113	125	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33081	33095		10.1074/jbc.M113.494922	http://dx.doi.org/10.1074/jbc.M113.494922			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24089520	Green Published, hybrid			2022-12-28	WOS:000328841700024
J	Acharya, BR; Espenel, C; Kreitzer, G				Acharya, Bipul R.; Espenel, Cedric; Kreitzer, Geri			Direct Regulation of Microtubule Dynamics by KIF17 Motor and Tail Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytoskeleton; Epithelial Cell; Kinesin; Microtubules; Protein Domains	MOLECULAR-WEIGHT PROTEINS; KINESIN; TUBULIN; LENGTH; EB1; DEPOLYMERASE; MECHANISM; TRANSPORT; BINDING; MCAK	KIF17 is a kinesin-2 family motor that interacts with EB1 at microtubule (MT) plus-ends and contributes to MT stabilization in epithelial cells. The mechanism by which KIF17 affects MTs and how its activity is regulated are not yet known. Here, we show that EB1 and the KIF17 autoinhibitory tail domain (KIF17-Tail) interacted competitively with the KIF17 catalytic motor domain (K370). Both EB1 and KIF17-Tail decreased the K-0.5MT of K370, with opposing effects on MT-stimulated ATPase activity. Importantly, K370 had independent effects on MT dynamic instability, resulting in formation of long MTs without affecting polymerization rate or total polymer mass. K370 also inhibited MT depolymerization induced by dilution in vitro and by nocodazole in cells, suggesting that it acts by protecting MT plus-ends. Interestingly, KIF17-Tail bound MTs and tubulin dimers, delaying initial MT polymerization in vitro and MT regrowth in cells. However, neither EB1 nor KIF17-Tail affected K370-mediated MT polymerization or stabilization significantly in vitro, and EB1 was dispensable for MT stabilization by K370 in cells. Thus, although EB1 and KIF17-Tail may coordinate KIF17 catalytic activity, our data reveal a novel and direct role for KIF17 in regulating MT dynamics.	[Acharya, Bipul R.; Espenel, Cedric; Kreitzer, Geri] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA	Cornell University	Kreitzer, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, 1300 York Ave, New York, NY 10021 USA.	gek2006@med.cornell.edu	ACHARYA, BIPUL/C-9733-2017; Acharya, Bipul/AAW-6685-2020	ACHARYA, BIPUL/0000-0002-2819-0120; Acharya, Bipul/0000-0001-9670-1204; espenel, cedric/0000-0002-8246-2879	National Institutes of Health [R01 GM087575]; Irma T. Hirschl Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM087575 (to G. K.). This work was also supported by the Irma T. Hirschl Trust (to G. K.).	Boehlke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062165; BORISY GG, 1975, ANN NY ACAD SCI, V253, P107, DOI 10.1111/j.1749-6632.1975.tb19196.x; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Daire V, 2011, ARCH BIOCHEM BIOPHYS, V510, P83, DOI 10.1016/j.abb.2011.02.012; Daire V, 2009, J BIOL CHEM, V284, P31992, DOI 10.1074/jbc.M109.007906; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Drummond DR, 2011, SEMIN CELL DEV BIOL, V22, P927, DOI 10.1016/j.semcdb.2011.09.021; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Espenel C., 2013, J CELL BIOL IN PRESS; Gardner MK, 2008, TRENDS CELL BIOL, V18, P307, DOI 10.1016/j.tcb.2008.05.003; Gardner MK, 2011, CELL, V147, P1092, DOI 10.1016/j.cell.2011.10.037; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hammond JW, 2010, J CELL BIOL, V189, P1013, DOI 10.1083/jcb.201001057; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Insinna C, 2009, DEV DYNAM, V238, P2211, DOI 10.1002/dvdy.21956; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Lee T, 2008, ONCOGENE, V27, P2494, DOI 10.1038/sj.onc.1210867; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; MURPHY DB, 1975, P NATL ACAD SCI USA, V72, P2696, DOI 10.1073/pnas.72.7.2696; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; RODIONOV VI, 1990, J BIOL CHEM, V265, P5702; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Scholey JM, 2012, VISION RES, V75, P44, DOI 10.1016/j.visres.2012.06.015; Seeger MA, 2010, J BIOL CHEM, V285, P8155, DOI 10.1074/jbc.M109.068247; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Stout JR, 2011, MOL BIOL CELL, V22, P3070, DOI 10.1091/mbc.E11-04-0363; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Su XL, 2012, TRENDS CELL BIOL, V22, P567, DOI 10.1016/j.tcb.2012.08.003; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; ten Hoopen R, 2012, CURR BIOL, V22, P1075, DOI 10.1016/j.cub.2012.04.059; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; WEISENBERG RC, 1981, BIOCHEM BIOPH RES CO, V102, P924, DOI 10.1016/0006-291X(81)91626-0; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585; Zhu ZQC, 2009, J BIOL CHEM, V284, P32651, DOI 10.1074/jbc.M109.013466	46	14	14	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32302	32313		10.1074/jbc.M113.494989	http://dx.doi.org/10.1074/jbc.M113.494989			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24072717	Green Published, hybrid			2022-12-28	WOS:000328681700017
J	Andre, J; Kerry, L; Qi, X; Hawkins, E; Drizyte, K; Ginger, ML; McKean, PG				Andre, Jane; Kerry, Louise; Qi, Xin; Hawkins, Erica; Drizyte, Kristina; Ginger, Michael L.; McKean, Paul G.			An Alternative Model for the Role of RP2 Protein in Flagellum Assembly in the African Trypanosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centriole; Cilia; Protein Targeting; Trypanosoma Brucei; Tubulin; GTPase-activating Protein; Axoneme	TRANSITION ZONE; BASAL BODY; INTRAFLAGELLAR TRANSPORT; FUNCTIONAL GENOMICS; PROTEOMIC ANALYSIS; ATTACHMENT ZONE; ALPHA-TUBULIN; MEMBRANE; BRUCEI; CILIA	The tubulin cofactor C domain-containing protein TbRP2 is a basal body (centriolar) protein essential for axoneme formation in the flagellate protist Trypanosoma brucei, the causal agent of African sleeping sickness. Here, we show how TbRP2 is targeted and tethered at mature basal bodies and provide novel insight into TbRP2 function. Regarding targeting, understanding how several hundred proteins combine to build a microtubule axoneme is a fundamental challenge in eukaryotic cell biology. We show that basal body localization of TbRP2 is mediated by twinned, N-terminal TOF (TON1, OFD1, and FOP) and LisH motifs, motifs that otherwise facilitate localization of only a few conserved proteins at microtubule-organizing centers in animals, plants, and flagellate protists. Regarding TbRP2 function, there is a debate as to whether the flagellar assembly function of specialized, centriolar tubulin cofactor C domain-containing proteins is processing tubulin, the major component of axonemes, or general vesicular trafficking in a flagellum assembly context. Here we report that TbRP2 is required for the recruitment of T. brucei orthologs of MKS1 and MKS6, proteins that, in animal cells, are part of a complex that assembles at the base of the flagellum to regulate protein composition and cilium function. We also identify that TbRP2 is detected by YL1/2, an antibody classically used to detect -tubulin. Together, these data suggest a general processing role for TbRP2 in trypanosome flagellum assembly and challenge the notion that TbRP2 functions solely in assessing tubulin quality prior to tubulin incorporation into the elongating axoneme.	[Andre, Jane; Kerry, Louise; Qi, Xin; Hawkins, Erica; Drizyte, Kristina; Ginger, Michael L.; McKean, Paul G.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England	Lancaster University	Ginger, ML (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.	m.ginger@lancaster.ac.uk; p.mckean@lancaster.ac.uk		Hawkins, Erica/0000-0002-9839-6212; McKean, Paul Gerard/0000-0002-0445-0741; Drizyte-Miller, Kristina/0000-0001-7049-2934; Ginger, Michael/0000-0002-9643-8482; Harmer, Jane/0000-0003-1247-4468	Biological and Biotechnological Sciences Research Council of the UK [BBG0210581, BBF0109311]; Royal Society Research Fellowship; BBSRC [BB/G021058/1, BB/F010931/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021058/1, BB/F010931/1] Funding Source: researchfish	Biological and Biotechnological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Research Fellowship(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biological and Biotechnological Sciences Research Council of the UK Grants BBG0210581 and BBF0109311 (to P. G. M. and M. L. G.) and a Royal Society Research Fellowship (to M. L. G.).	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Aubusson-Fleury A, 2012, J CELL SCI, V125, P4395, DOI 10.1242/jcs.108639; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Azimzadeh J, 2008, PLANT CELL, V20, P2146, DOI 10.1105/tpc.107.056812; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Davidge JA, 2006, J CELL SCI, V119, P3935, DOI 10.1242/jcs.03203; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lee J. K., 2013, PLOS ONE, V8; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lukes J, 2009, P NATL ACAD SCI USA, V106, P9963, DOI 10.1073/pnas.0901004106; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Mikolajka A, 2006, J MOL BIOL, V359, P863, DOI 10.1016/j.jmb.2006.03.070; Mori R, 2013, MOL BIOL CELL, V24, P1713, DOI 10.1091/mbc.E12-11-0792; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Rovini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065694; Schwarz N, 2012, HUM MOL GENET, V21, P863, DOI 10.1093/hmg/ddr520; Sedjai F, 2010, J CELL SCI, V123, P2391, DOI 10.1242/jcs.065045; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Stephan A, 2007, TRAFFIC, V8, P1323, DOI 10.1111/j.1600-0854.2007.00611.x; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Tran KD, 2013, J BIOL CHEM, V288, P22721, DOI 10.1074/jbc.M113.483461; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wang WJ, 2013, NAT CELL BIOL, V15, P591, DOI 10.1038/ncb2739; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; WEHLAND J, 1984, EMBO J, V3, P1295, DOI 10.1002/j.1460-2075.1984.tb01965.x; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1995, PARASITOLOGY, V111, P77, DOI 10.1017/S0031182000064623; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111	54	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					464	475		10.1074/jbc.M113.509521	http://dx.doi.org/10.1074/jbc.M113.509521			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24257747	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000329370900040
J	Aquilano, K; Baldelli, S; Ciriolo, MR				Aquilano, Katia; Baldelli, Sara; Ciriolo, Maria R.			Nuclear Recruitment of Neuronal Nitric-oxide Synthase by alpha-Syntrophin Is Crucial for the Induction of Mitochondrial Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Myogenesis; Nitric-oxide Synthase; S-Nitrosylation; Scaffold Proteins	CU,ZN SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; NEUROBLASTOMA-CELLS; MUSCULAR-DYSTROPHY; SIGNALING PATHWAYS; LOCALIZATION; PGC-1-ALPHA; EXPRESSION; PROTEINS; ARGININE	Neuronal nitric-oxide synthase (nNOS) has various splicing variants and different subcellular localizations. nNOS can be found also in the nucleus; however, its exact role in this compartment is still not completely defined. In this report, we demonstrate that the PDZ domain allows the recruitment of nNOS to nuclei, thus favoring local NO production, nuclear protein S-nitrosylation, and induction of mitochondrial biogenesis. In particular, overexpression of PDZ-containing nNOS (nNOS) increases S-nitrosylated CREB with consequent augmented binding on cAMP response element consensus sequence on peroxisome proliferator-activated receptor co-activator (PGC)-1 promoter. The resulting PGC-1 induction is accompanied by the expression of mitochondrial genes (e.g., TFAM, MtCO1) and increased mitochondrial mass. Importantly, full active nNOS lacking PDZ domain (nNOS) does not localize in nuclei and fails in inducing the expression of PGC-1. Moreover, we substantiate that the mitochondrial biogenesis normally accompanying myogenesis is associated with nuclear translocation of nNOS. We demonstrate that -Syntrophin, which resides in nuclei of myocytes, functions as the upstream mediator of nuclear nNOS translocation and nNOS-dependent mitochondrial biogenesis. Overall, our results indicate that altered nNOS splicing and nuclear localization could be contributing factors in human muscular diseases associated with mitochondrial impairment.	[Aquilano, Katia; Ciriolo, Maria R.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Baldelli, Sara] Univ Telemat Roma San Raffaele, I-00166 Rome, Italy; [Ciriolo, Maria R.] IRCCS San Raffaele La Pisana, I-00166 Rome, Italy	University of Rome Tor Vergata; Universita Telematica San Raffaele; IRCCS San Raffaele Pisana	Aquilano, K (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci 1, I-00133 Rome, Italy.	katia.aquilano@uniroma2.it; ciriolo@bio.uniroma2.it	Ciriolo, Maria Rosa/K-6572-2016; AQUILANO, KATIA/K-8888-2016; BALDELLI, SARA/G-4318-2015	AQUILANO, KATIA/0000-0002-5905-9870; BALDELLI, SARA/0000-0001-7003-3172	MIUR PRIN	MIUR PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was partially supported by grants from MIUR PRIN 2009.	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Aquilano K, 2013, CURR MOL MED, V13, P140, DOI 10.2174/156652413804486241; Aquilano K, 2003, J NEUROCHEM, V85, P1324, DOI 10.1046/j.1471-4159.2003.01783.x; Aquilano K, 2006, FASEB J, V20, P1683, DOI 10.1096/fj.05-5225fje; Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615; Aquilano K, 2011, J CELL SCI, V124, P1043, DOI 10.1242/jcs.077149; Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje; BACHS O, 1992, BIOCHIM BIOPHYS ACTA, V1113, P259, DOI 10.1016/0304-4157(92)90041-8; Baldelli S, 2008, INT J BIOCHEM CELL B, V40, P2660, DOI 10.1016/j.biocel.2008.05.013; Baldelli S, 2013, BBA-GEN SUBJECTS, V1830, P4137, DOI 10.1016/j.bbagen.2013.04.006; Baldelli S, 2011, INT J BIOCHEM CELL B, V43, P163, DOI 10.1016/j.biocel.2010.10.016; Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Bhat HF, 2013, CELL MOL LIFE SCI, V70, P2533, DOI 10.1007/s00018-012-1233-9; Bossy-Wetzel E, 2003, CELL DEATH DIFFER, V10, P757, DOI 10.1038/sj.cdd.4401244; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Buono R, 2012, STEM CELLS, V30, P197, DOI 10.1002/stem.783; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Chakrabarti S, 2012, J LEUKOCYTE BIOL, V91, P947, DOI 10.1189/jlb.1011513; Ciani E, 2002, J NEUROCHEM, V81, P218, DOI 10.1046/j.1471-4159.2002.00857.x; Constantin B., 2013, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbamem.2013.08.023; Corso-Diaz X, 2010, J NEUROCHEM, V114, P864, DOI 10.1111/j.1471-4159.2010.06813.x; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018; El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; Elzaouk L, 2004, BBA-GEN SUBJECTS, V1670, P56, DOI 10.1016/j.bbagen.2003.10.015; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frandsen U, 1996, BIOCHEM BIOPH RES CO, V227, P88, DOI 10.1006/bbrc.1996.1472; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hedderick ELF, 2011, NEUROLOGY, V76, P960, DOI 10.1212/WNL.0b013e31821043c8; Hernandez-Aguilera A., 2013, MEDIATORS INFLAMM, V2013; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Larsson B, 1998, BIOCHEM BIOPH RES CO, V251, P898, DOI 10.1006/bbrc.1998.9578; Lee MA, 1997, J CLIN INVEST, V100, P1507, DOI 10.1172/JCI119673; Lettieri Barbato D, 2012, INT J CELL BIOL, V2012; Lettieri Barbato D., 2013, CELL DEATH DIFFER, DOI 10.1038/cdd.2013137; Lira VA, 2010, J PHYSIOL-LONDON, V588, P3551, DOI 10.1113/jphysiol.2010.194035; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024; Meinen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044148; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Pagliei B, 2013, BIOCHEM PHARMACOL, V85, P335, DOI 10.1016/j.bcp.2012.11.007; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Percival JM, 2010, J CLIN INVEST, V120, P816, DOI 10.1172/JCI40736; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Pifarre P, 2009, INT J BIOCHEM CELL B, V41, P1719, DOI 10.1016/j.biocel.2009.02.022; Qu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052788; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; Rotilio G, 2003, IUBMB LIFE, V55, P629, DOI 10.1080/15216540310001628717; Saur D, 2000, GASTROENTEROLOGY, V118, P849, DOI 10.1016/S0016-5085(00)70171-5; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Sullivan JC, 2003, ACTA PHYSIOL SCAND, V179, P115, DOI 10.1046/j.1365-201X.2003.01181.x; Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06; Tengan CH, 2007, BIOCHEM BIOPH RES CO, V359, P771, DOI 10.1016/j.bbrc.2007.05.184; Tengan CH, 2012, INT J MOL SCI, V13, P17160, DOI 10.3390/ijms131217160; Thomas GD, 2003, CIRC RES, V92, P554, DOI 10.1161/01.RES.0000061570.83105.52; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	72	40	41	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					365	378		10.1074/jbc.M113.506733	http://dx.doi.org/10.1074/jbc.M113.506733			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24235139	Green Published, hybrid			2022-12-28	WOS:000329370900032
J	Rogowski, A; Basle, A; Farinas, CS; Solovyova, A; Mortimer, JC; Dupree, P; Gilbert, HJ; Bolam, DN				Rogowski, Artur; Basle, Arnaud; Farinas, Cristiane S.; Solovyova, Alexandra; Mortimer, Jennifer C.; Dupree, Paul; Gilbert, Harry J.; Bolam, David N.			Evidence That GH115 alpha-Glucuronidase Activity, Which Is Required to Degrade Plant Biomass, Is Dependent on Conformational Flexibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergy; Enzyme Structure; Glycoside Hydrolases; Plant Cell Wall; X-ray Crystallography	CARBOHYDRATE-BINDING MODULES; STRUCTURAL BASIS; FAMILY; SUBSTRATE; POLYSACCHARIDE; BIOCHEMISTRY; RECOGNITION; SPECIFICITY; XYLANASE; REVEALS	The microbial degradation of the plant cell wall is an important biological process that is highly relevant to environmentally significant industries such as the bioenergy and biorefining sectors. A major component of the wall is glucuronoxylan, a 1,4-linked xylose polysaccharide that is decorated with -linked glucuronic and/or methylglucuronic acid (GlcA/MeGlcA). Recently three members of a glycoside hydrolase family, GH115, were shown to hydrolyze MeGlcA side chains from the internal regions of xylan, an activity that has not previously been described. Here we show that a dominant member of the human microbiota, Bacteroides ovatus, contains a GH115 enzyme, BoAgu115A, which displays glucuronoxylan -(4-O-methyl)-glucuronidase activity. The enzyme is significantly more active against substrates in which the xylose decorated with GlcA/MeGlcA is flanked by one or more xylose residues. The crystal structure of BoAgu115A revealed a four-domain protein in which the active site, comprising a pocket that abuts a cleft-like structure, is housed in the second domain that adopts a TIM barrel-fold. The third domain, a five-helical bundle, and the C-terminal -sandwich domain make inter-chain contacts leading to protein dimerization. Informed by the structure of the enzyme in complex with GlcA in its open ring form, in conjunction with mutagenesis studies, the potential substrate binding and catalytically significant amino acids were identified. Based on the catalytic importance of residues located on a highly flexible loop, the enzyme is required to undergo a substantial conformational change to form a productive Michaelis complex with glucuronoxylan.	[Rogowski, Artur; Basle, Arnaud; Solovyova, Alexandra; Gilbert, Harry J.; Bolam, David N.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Farinas, Cristiane S.; Mortimer, Jennifer C.; Dupree, Paul] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Newcastle University - UK; University of Cambridge	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk; david.bolam@ncl.ac.uk	Farinas, Cristiane/B-2576-2014; Mortimer, Jenny/A-8043-2008; Dupree, Paul/T-2568-2018; Mortimer, Jenny C/AAY-6648-2021	Farinas, Cristiane/0000-0002-9985-190X; Mortimer, Jenny/0000-0001-6624-636X; Dupree, Paul/0000-0001-9270-6286; Mortimer, Jenny C/0000-0001-6624-636X; Bolam, David/0000-0003-0314-3122; Solovyova, Alexandra/0000-0002-5682-7037; Basle, Arnaud/0000-0002-4899-3086	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G016240/1]; BBSRC Sustainable Bioenergy Centre (BSBEC) Cell Wall Sugars Programme; Wellcome Trust [WT097907MA]; Biotechnology and Biological Sciences Research Council [BB/G016186/1, BB/G016240/1] Funding Source: researchfish; BBSRC [BB/G016240/1, BB/G016186/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Sustainable Bioenergy Centre (BSBEC) Cell Wall Sugars Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/G016240/1 BBSRC Sustainable Bioenergy Centre (BSBEC) Cell Wall Sugars Programme and Wellcome Trust Grant WT097907MA.	BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brett C. T., 1996, TPOICS PLANT FUNCTIO; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujimoto Z, 2011, ACTA CRYSTALLOGR F, V67, P68, DOI 10.1107/S1744309110043721; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; Goubet F, 2002, ANAL BIOCHEM, V300, P53, DOI 10.1006/abio.2001.5444; Hehemann JH, 2012, J BIOL CHEM, V287, P13985, DOI 10.1074/jbc.M112.345645; Hidaka M, 2009, J BIOL CHEM, V284, P7273, DOI 10.1074/jbc.M808525200; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Kolenova K, 2010, FEBS LETT, V584, P4063, DOI 10.1016/j.febslet.2010.08.031; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Nagy T, 2003, J BIOL CHEM, V278, P20286, DOI 10.1074/jbc.M302205200; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Ryabova O, 2009, FEBS LETT, V583, P1457, DOI 10.1016/j.febslet.2009.03.057; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Tenkanen M, 2000, J BIOTECHNOL, V78, P149, DOI 10.1016/S0168-1656(99)00240-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vardakou M, 2008, J MOL BIOL, V375, P1293, DOI 10.1016/j.jmb.2007.11.007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	42	43	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					53	64		10.1074/jbc.M113.525295	http://dx.doi.org/10.1074/jbc.M113.525295			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24214982	hybrid, Green Published			2022-12-28	WOS:000329370900005
J	Rudell, JC; Borges, LS; Rudell, JB; Beck, KA; Ferns, MJ				Rudell, Jolene Chang; Borges, Lucia S.; Rudell, John B.; Beck, Kenneth A.; Ferns, Michael J.			Determinants in the beta and delta Subunit Cytoplasmic Loop Regulate Golgi Trafficking and Surface Expression of the Muscle Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Golgi; Nicotinic Acetylcholine Receptors; Protein Motifs; Skeletal Muscle; Trafficking; Neuromuscular Junction	ALPHA-SUBUNIT; PROTEIN; RAPSYN; MEMBRANE; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; ASSOCIATION; DEGRADATION; UBIQUITIN	The molecular determinants that govern nicotinic acetylcholine receptor (AChR) assembly and trafficking are poorly defined, and those identified operate largely during initial receptor biogenesis in the endoplasmic reticulum. To identify determinants that regulate later trafficking steps, we performed an unbiased screen using chimeric proteins consisting of CD4 fused to the muscle AChR subunit cytoplasmic loops. In C2 mouse muscle cells, we found that CD4- and subunit loops were expressed at very low levels on the cell surface, whereas the other subunit loops were robustly expressed on the plasma membrane. The low surface expression of CD4- and loops was due to their pronounced retention in the Golgi apparatus and also to their rapid internalization from the plasma membrane. Both retention and recovery were mediated by the proximal 25-28 amino acids in each loop and were dependent on an ordered sequence of charged and hydrophobic residues. Indeed, K353L and K351L mutations increased surface trafficking of the CD4-subunit loops by >6-fold and also decreased their internalization from the plasma membrane. Similarly, combined K353L and K351L mutations increased the surface levels of assembled AChR expressed in HEK cells to 138% of wild-type levels. This was due to increased trafficking to the plasma membrane and not decreased AChR turnover. These findings identify novel Golgi retention signals in the and subunit loops that regulate surface trafficking of assembled AChR and may help prevent surface expression of unassembled subunits. Together, these results define molecular determinants that govern a Golgi-based regulatory step in nicotinic AChR trafficking.	[Rudell, Jolene Chang; Borges, Lucia S.; Rudell, John B.; Ferns, Michael J.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Beck, Kenneth A.] Univ Calif Davis, Dept Cell Biol & Anat, Davis, CA 95616 USA; [Ferns, Michael J.] Univ Calif Davis, Dept Anesthesiol & Pain Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ferns, MJ (corresponding author), Univ Calif Davis, Dept Physiol & Membrane Biol, 1 Shields Ave, Davis, CA 95616 USA.	mjferns@ucdavis.edu		Ferns, Michael/0000-0002-1545-3024; Rudell, Jolene/0000-0003-3022-4649	Muscular Dystrophy Association [134412]; University of California Davis Physician Scientist Training Program award	Muscular Dystrophy Association(Muscular Dystrophy Association); University of California Davis Physician Scientist Training Program award	This work was supported by Muscular Dystrophy Association Grant 134412 (to M. J. F.) and a University of California Davis Physician Scientist Training Program award (to J. C. R.).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borges LS, 2008, J NEUROSCI, V28, P11468, DOI 10.1523/JNEUROSCI.2508-08.2008; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; Engel AG, 2003, MUSCLE NERVE, V27, P4, DOI 10.1002/mus.10269; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Lu ZM, 2001, MOL BIOL CELL, V12, P795, DOI 10.1091/mbc.12.4.795; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Marchand S, 2000, J NEUROSCI, V20, P521, DOI 10.1523/JNEUROSCI.20-02-00521.2000; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Park JY, 2012, J NEUROSCI, V32, P7356, DOI 10.1523/JNEUROSCI.0397-12.2012; Phillips WD, 1997, MOL CELL NEUROSCI, V10, P16, DOI 10.1006/mcne.1997.0634; Ramanathan VK, 1999, J BIOL CHEM, V274, P20513, DOI 10.1074/jbc.274.29.20513; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Rezvani K, 2009, J NEUROSCI, V29, P6883, DOI 10.1523/JNEUROSCI.4723-08.2009; SALPETER MM, 1993, ANN NY ACAD SCI, V681, P155, DOI 10.1111/j.1749-6632.1993.tb22881.x; Valkova C, 2011, P NATL ACAD SCI USA, V108, P621, DOI 10.1073/pnas.1001624108; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; ZHOU J, 1995, J NEUROCHEM, V65, P1146	31	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					203	214		10.1074/jbc.M113.502328	http://dx.doi.org/10.1074/jbc.M113.502328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24240098	Green Published, hybrid			2022-12-28	WOS:000329370900018
J	Bretz, NP; Ridinger, J; Rupp, AK; Rimbach, K; Keller, S; Rupp, C; Marme, F; Umansky, L; Umansky, V; Eigenbrod, T; Sammar, M; Altevogt, P				Bretz, Niko P.; Ridinger, Johannes; Rupp, Anne-Kathleen; Rimbach, Katharina; Keller, Sascha; Rupp, Christian; Marme, Frederik; Umansky, Ludmila; Umansky, Viktor; Eigenbrod, Tatjana; Sammar, Marei; Altevogt, Peter			Body Fluid Exosomes Promote Secretion of Inflammatory Cytokines in Monocytic Cells via Toll-like Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine Induction; Exosomes; NFB Transcription Factor; STAT3; Toll-like receptor (TLR); Amniotic Fluid; Malignant Ascites	TUMOR-DERIVED EXOSOMES; RELEASED MICROVESICLES; GROWTH; BIOGENESIS; MECHANISM; DIFFERENTIATION; EXPRESSION; MICRORNAS; VESICLES; IMMUNITY	Background: Exosomes, secreted from cells, have immunomodulatory capacities. Results: NFB- and STAT3-mediated cytokine release is triggered by various types of ex vivo exosomes in a TLR-dependent fashion. Conclusion: Exosomes have inherent signaling capacities important for global inflammatory responses. Significance: Detailed knowledge about intercellular communication in cancer and inflammatory diseases is crucial for development of new therapeutic approaches. Tumor-derived exosomes have been shown to induce various immunomodulatory effects. However, the underlying signaling pathways are poorly understood. Here, we analyzed the effects of ex vivo-derived exosomes on monocytic cell differentiation/activation using THP-1 cells as model. We isolated exosomes from various body fluids such as amniotic fluid, liver cirrhosis ascites, and malignant ascites of ovarian cancer patients. We observed that exosomes were internalized by THP-1 cells and induced the production of IL-1, TNF-, and IL-6. Analysis of the signaling pathways revealed a fast triggering of NFB and a delayed activation of STAT3. Pharmacologic and antibody-blocking experiments showed that the initial production of IL-6 was instrumental for subsequent activation of STAT3. Importantly, triggering of cell signaling was not a unique property of tumor exosomes but was also observed with exosomes of noncancerous origin. Exosomal signaling was TLR-dependent as the knockdown of Toll-like receptor 2 (TLR2) and TLR4 blocked NFB and STAT3 activation. Similar results were obtained with TLR-neutralizing antibodies. Exosomes also triggered the release of cytokines from mouse bone marrow-derived dendritic cells or macrophages. This process was MyD88-dependent, further supporting a role of TLR signaling. Our results suggest that exosomes trigger TLR-dependent signaling pathways in monocytic precursor cells but possibly also in other immune cells. This process could be important for the induction of immunosuppressive mechanisms during cancer progression and inflammatory diseases.	[Bretz, Niko P.; Ridinger, Johannes; Rupp, Anne-Kathleen; Keller, Sascha; Umansky, Ludmila; Altevogt, Peter] German Canc Res Ctr, Tumor Immunol Programme, D-69120 Heidelberg, Germany; [Rimbach, Katharina; Eigenbrod, Tatjana] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, D-69120 Heidelberg, Germany; [Rupp, Christian] Heidelberg Univ, Dept Internal Med Gastroenterol Infect Dis & Into, D-69120 Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Clin Gynecol, D-69120 Heidelberg, Germany; [Marme, Frederik] Heidelberg Univ, Clin Obstet, D-69120 Heidelberg, Germany; [Umansky, Viktor] German Canc Res Ctr, Skin Canc Unit, D-69120 Heidelberg, Germany; [Umansky, Viktor] Heidelberg Univ, Dept Dermatol Venereol & Allergol, Univ Med Ctr Mannheim, D-68135 Mannheim, Germany; [Sammar, Marei] ORT Braude Coll, Dept Biotechnol Engn, IL-21661 Kamiel, Israel	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Altevogt, P (corresponding author), German Canc Res Ctr, Tumor Immunol Programme, D015,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.altevogt@dkfz.de	Sammar, Marei/Q-1410-2019; Rupp, Christian/E-7652-2019	Rupp, Christian/0000-0003-2808-9230	Deutsche Krebshilfe Project [109745]; Deutsches Krebsforschungszentrum/Tumorzentrum Collaborative Program	Deutsche Krebshilfe Project; Deutsches Krebsforschungszentrum/Tumorzentrum Collaborative Program	This work was supported by Deutsche Krebshilfe Project 109745 and by the Deutsches Krebsforschungszentrum/Tumorzentrum Collaborative Program (to P. A. and F. M.).	Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Clayton A, 2012, ONCOIMMUNOLOGY, V1, P78, DOI 10.4161/onci.1.1.17826; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Hendrix A, 2010, CANCER RES, V70, P9533, DOI 10.1158/0008-5472.CAN-10-3248; Ji H, 2013, PROTEOMICS, V13, P1672, DOI 10.1002/pmic.201200562; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Keller S, 2009, CANCER LETT, V278, P73, DOI 10.1016/j.canlet.2008.12.028; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Marton A, 2012, IMMUNOL LETT, V148, P34, DOI 10.1016/j.imlet.2012.07.006; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Rupp AK, 2011, GYNECOL ONCOL, V122, P437, DOI 10.1016/j.ygyno.2011.04.035; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Viaud S, 2010, CANCER RES, V70, P1281, DOI 10.1158/0008-5472.CAN-09-3276; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Whiteside TL, 2005, BRIT J CANCER, V92, P209, DOI 10.1038/sj.bjc.6602360; Xiang XY, 2010, AM J PATHOL, V177, P1606, DOI 10.2353/ajpath.2010.100245; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867	47	173	177	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36691	36702		10.1074/jbc.M113.512806	http://dx.doi.org/10.1074/jbc.M113.512806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24225954	Green Published, hybrid			2022-12-28	WOS:000328883400047
J	Hotzy, J; Schneider, N; Kovermann, P; Fahlke, C				Hotzy, Jasmin; Schneider, Nicole; Kovermann, Peter; Fahlke, Christoph			Mutating a Conserved Proline Residue within the Trimerization Domain Modifies Na+ Binding to Excitatory Amino Acid Transporters and Associated Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anion Transport; Ataxia; Glutamate; Neurological Diseases; Neurotransmitter Transport; Voltage Clamp Fluorometry	NEURONAL GLUTAMATE TRANSPORTER; ANION CHANNELS; EPISODIC ATAXIA; SUBSTRATE; EAAC1; CURRENTS; SODIUM; TRANSLOCATION; MECHANISM; CYCLE	Background: The mutation P290R in the excitatory amino acid transporter 1 (EAAT1) causes episodic ataxia type 6. Results: Voltage clamp fluorometry demonstrates changes in the time course of EAAT3 fluorescence signals by the homologous P259R mutation. Conclusion: P259R alters EAAT3 transport functions by decelerating conformational changes associated with sodium binding. Significance: Studying naturally occurring mutations promises identification of unexpected determinants of transporter functions. Excitatory amino acid transporters (EAATs) are crucial for glutamate homeostasis in the mammalian central nervous system. They are not only secondary active glutamate transporters but also function as anion channels, and different EAATs vary considerably in glutamate transport rates and associated anion current amplitudes. A naturally occurring mutation, which was identified in a patient with episodic ataxia type 6 and that predicts the substitution of a highly conserved proline at position 290 by arginine (P290R), was recently shown to reduce glutamate uptake and to increase anion conduction by hEAAT1. We here used voltage clamp fluorometry to define how the homologous P259R mutation modifies the functional properties of hEAAT3. P259R inverts the voltage dependence, changes the sodium dependence, and alters the time dependence of hEAAT3 fluorescence signals. Kinetic analysis of fluorescence signals indicate that P259R decelerates a conformational change associated with sodium binding to the glutamate-free mutant transporters. This alteration in the glutamate uptake cycle accounts for the experimentally observed changes in glutamate transport and anion conduction by P259R hEAAT3.	[Hotzy, Jasmin; Schneider, Nicole; Kovermann, Peter; Fahlke, Christoph] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Schneider, Nicole; Kovermann, Peter; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52428 Julich, Germany; [Schneider, Nicole; Fahlke, Christoph] Zentrum Syst Neurowissensch Hannover, D-30559 Hannover, Germany	Hannover Medical School; Helmholtz Association; Research Center Julich	Fahlke, C (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, Wilhelm Johnen Str, D-52428 Julich, Germany.	c.fahlke@fz-juelich.de	Kovermann, Peter/AAF-4411-2020; Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Kovermann, Peter/0000-0001-5296-4918	Deutsche Forschungsgemeinschaft [FA301/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/9 to C. F.).	Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; Bergles DE, 2002, J NEUROSCI, V22, P10153; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Hotzy J, 2012, J BIOL CHEM, V287, P20016, DOI 10.1074/jbc.M112.344077; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kovermann P, 2010, J BIOL CHEM, V285, P23676, DOI 10.1074/jbc.M110.126557; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Machtens JP, 2011, CHANNELS, V5, P468, DOI 10.4161/chan.5.6.17453; Machtens JP, 2011, J BIOL CHEM, V286, P23780, DOI 10.1074/jbc.M110.207514; Melzer N, 2005, P NATL ACAD SCI USA, V102, P19214, DOI 10.1073/pnas.0508837103; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Winter N, 2012, BRAIN, V135, P3416, DOI 10.1093/brain/aws255; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	29	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36492	36501		10.1074/jbc.M113.489385	http://dx.doi.org/10.1074/jbc.M113.489385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214974	hybrid, Green Published			2022-12-28	WOS:000328883400030
J	Huang, X; Pan, QM; Sun, DN; Chen, W; Shen, AJ; Huang, M; Ding, J; Geng, MY				Huang, Xun; Pan, Qiuming; Sun, Danni; Chen, Wei; Shen, Aijun; Huang, Min; Ding, Jian; Geng, Meiyu			O-GlcNAcylation of Cofilin Promotes Breast Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Invasion; Cell Motility; Cofilin; O-GlcNAcylation; Invadopodia; OGT	N-ACETYLGLUCOSAMINE; PHOSPHORYLATION; METASTASIS; GLCNAC; ADF/COFILIN; MIGRATION; DYNAMICS; GROWTH; SENSOR	Background:O-GlcNAcylation plays important roles in breast cancer metastasis, but the underlying mechanism is not fully known. Results: Cofilin is O-GlcNAcylated at Ser-108, which is required for its proper localization in invadopodia and is implicated in promoting breast cancer cell invasion. Conclusion:O-GlcNAcylation plays an important role in fine-tuning the regulation of cofilin. Significance: These findings reveal the implications of aberrant cofilin O-GlcNAcylation in cancer metastasis. O-GlcNAcylation is a post-translational modification that regulates a broad range of nuclear and cytoplasmic proteins and is emerging as a key regulator of various biological processes. Previous studies have shown that increased levels of global O-GlcNAcylation and O-GlcNAc transferase (OGT) are linked to the incidence of metastasis in breast cancer patients, but the molecular basis behind this is not fully known. In this study, we have determined that the actin-binding protein cofilin is O-GlcNAcylated by OGT and mainly, if not completely, mediates OGT modulation of cell mobility. O-GlcNAcylation at Ser-108 of cofilin is required for its proper localization in invadopodia at the leading edge of breast cancer cells during three-dimensional cell invasion. Loss of O-GlcNAcylation of cofilin leads to destabilization of invadopodia and impairs cell invasion, although the actin-severing activity or lamellipodial localization is not affected. Our study provides insights into the mechanism of post-translational modification in fine-tuning the regulation of cofilin activity and suggests its important implications in cancer metastasis.	[Huang, Xun; Pan, Qiuming; Sun, Danni; Shen, Aijun; Huang, Min; Ding, Jian; Geng, Meiyu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China; [Chen, Wei] China Pharmaceut Univ, Ctr Drug Discovery, State Key Lab Nat Med, Nanjing 210009, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; China Pharmaceutical University	Ding, J (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China.	jding@simm.ac.cn; mygeng@simm.ac.cn	Huang, xun/AAM-3093-2020		Natural Science Foundation of China [81021062]; National Natural Science Foundation of China [91229204, 81302791]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China for Innovation Research Group Grant 81021062 and National Natural Science Foundation of China Grants 91229204 and 81302791.	Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carrillo LD, 2011, J BIOL CHEM, V286, P6650, DOI 10.1074/jbc.M110.191627; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Klemke M, 2010, EMBO J, V29, P2915, DOI 10.1038/emboj.2010.153; Li R, 2013, CLIN EXP METASTAS, V30, P483, DOI 10.1007/s10585-012-9553-6; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; McConnell BV, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-75; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038701; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	35	51	53	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36418	36425		10.1074/jbc.M113.495713	http://dx.doi.org/10.1074/jbc.M113.495713			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214978	Green Published, hybrid			2022-12-28	WOS:000328883400023
J	Tang, WK; Xia, D				Tang, Wai Kwan; Xia, Di			Altered Intersubunit Communication Is the Molecular Basis for Functional Defects of Pathogenic p97 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Crystal Structure; Genetic Diseases; Molecular Chaperone; Mutant; ATPase Activity; IBMPFD; Communication; p97; VCP; Prebound ADP	ATPASE ACTIVITY; AAA ATPASE; PAGET-DISEASE; CONFORMATIONAL-CHANGES; NUCLEOTIDE-BINDING; PROTEIN VCP; MUTATIONS; MECHANISM; P97/VCP; BONE	Background: Single-point mutations in AAA chaperone p97 cause multiple disorders, but the molecular basis remains unknown. Results: Significant differences in structural and biochemical properties between wild type and pathogenic p97 were revealed. Conclusion: Mutations altered the communication among subunits within a hexameric p97, resulting in p97 molecules with defective function. Significance: Mechanistic insights into the function of p97 are provided. The human AAA ATPase p97 is a molecular chaperone essential in cellular proteostasis. Single amino acid substitutions in p97 have been linked to a clinical multiple-disorder condition known as inclusion body myopathy associated with Paget's disease of the bone and frontotemporal dementia. How the mutations affect the molecular mechanism that governs the function of p97 remains unclear. Here, we show that within the hexameric ring of a mutant p97, D1 domains fail to regulate their respective nucleotide-binding states, as evidenced by the lower amount of prebound ADP, weaker ADP binding affinity, full occupancy of adenosine-5-O-(3-thiotriphosphate) binding, and elevated overall ATPase activity, indicating a loss of communication among subunits. Defective communication between subunits is further illustrated by altered conformation in the side chain of residue Phe-360 that probes into the nucleotide-binding pocket from a neighboring subunit. Consequently, conformations of N domains in a hexameric ring of a mutant p97 become uncoordinated, thus impacting its ability to process substrate.	[Tang, Wai Kwan; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xia, D (corresponding author), NCI, Cell Biol Lab, NIH, 37 Convent Dr,Bldg 37,Rm 2122C, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Tang, Wai Kwan/A-6158-2012		National Institutes of Health Intramural Research Program (NCI, Center for Cancer Research); NATIONAL CANCER INSTITUTE [ZIABC010600] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program (NCI, Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program (NCI, Center for Cancer Research).	Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Gu JM, 2013, BONE, V52, P9, DOI 10.1016/j.bone.2012.09.012; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Nishikori S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201400; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tang W. K., 2012, NEUROMUSCULAR DISORD, P155; Tang WK, 2012, J STRUCT BIOL, V179, P83, DOI 10.1016/j.jsb.2012.04.024; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tang WK, 2009, ACTA CRYSTALLOGR F, V65, P1166, DOI 10.1107/S174430910904055X; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	45	54	54	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36624	36635		10.1074/jbc.M113.488924	http://dx.doi.org/10.1074/jbc.M113.488924			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196964	hybrid, Green Published			2022-12-28	WOS:000328883400042
J	Pessentheiner, AR; Pelzmann, HJ; Walenta, E; Schweiger, M; Groschner, LN; Graier, WF; Kolb, D; Uno, K; Miyazaki, T; Nitta, A; Rieder, D; Prokesch, A; Bogner-Strauss, JG				Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Walenta, Evelyn; Schweiger, Martina; Groschner, Lukas N.; Graier, Wolfgang F.; Kolb, Dagmar; Uno, Kyosuke; Miyazaki, Toh; Nitta, Atsumi; Rieder, Dietmar; Prokesch, Andreas; Bogner-Strauss, Juliane G.			NAT8L (N-Acetyltransferase 8-Like) Accelerates Lipid Turnover and Increases Energy Expenditure in Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Adipose Tissue Metabolism; Aspartate; Fatty Acid Metabolism; Lipid Metabolism; Brown Adipocytes; N-Acetylaspartate; N-Acetyltransferase 8-like; Energy Expenditure	FATTY-ACID OXIDATION; ACTIVATED-RECEPTOR-ALPHA; ADIPOSE-TISSUE; PPAR-ALPHA; MOUSE-LIVER; ACETYLASPARTATE; GENE; MITOCHONDRIA; METABOLISM; MUSCLE	Background: NAT8L (N-acetyltransferase 8-like) synthesizes N-acetylaspartate and is required for myelination in the brain. Its function in other tissues was undefined. Results:Nat8l is highly expressed in adipose tissues and impacts adipogenic marker gene expression, lipid turnover, and energy metabolism in brown adipocytes. Conclusion:Nat8l expression influences cellular bioenergetics in adipocytes. Significance: These findings establish a novel pathway in brown adipocyte metabolism. NAT8L (N-acetyltransferase 8-like) catalyzes the formation of N-acetylaspartate (NAA) from acetyl-CoA and aspartate. In the brain, NAA delivers the acetate moiety for synthesis of acetyl-CoA that is further used for fatty acid generation. However, its function in other tissues remained elusive. Here, we show for the first time that Nat8l is highly expressed in adipose tissues and murine and human adipogenic cell lines and is localized in the mitochondria of brown adipocytes. Stable overexpression of Nat8l in immortalized brown adipogenic cells strongly increases glucose incorporation into neutral lipids, accompanied by increased lipolysis, indicating an accelerated lipid turnover. Additionally, mitochondrial mass and number as well as oxygen consumption are elevated upon Nat8l overexpression. Concordantly, expression levels of brown marker genes, such as Prdm16, Cidea, Pgc1, Ppar, and particularly UCP1, are markedly elevated in these cells. Treatment with a PPAR antagonist indicates that the increase in UCP1 expression and oxygen consumption is PPAR-dependent. Nat8l knockdown in brown adipocytes has no impact on cellular triglyceride content, lipogenesis, or oxygen consumption, but lipolysis and brown marker gene expression are increased; the latter is also observed in BAT of Nat8l-KO mice. Interestingly, the expression of ATP-citrate lyase is increased in Nat8l-silenced adipocytes and BAT of Nat8l-KO mice, indicating a compensatory mechanism to sustain the acetyl-CoA pool once Nat8l levels are reduced. Taken together, our data show that Nat8l impacts on the brown adipogenic phenotype and suggests the existence of the NAT8L-driven NAA metabolism as a novel pathway to provide cytosolic acetyl-CoA for lipid synthesis in adipocytes.	[Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Walenta, Evelyn; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Pessentheiner, Ariane R.; Pelzmann, Helmut J.; Prokesch, Andreas; Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Schweiger, Martina] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Groschner, Lukas N.; Graier, Wolfgang F.] Med Univ Graz, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Inst Cell Biol Histol & Embryol, A-8010 Graz, Austria; [Kolb, Dagmar] Med Univ Graz, Med Res Ctr, Core Facil Ultrastruct Anal, A-8010 Graz, Austria; [Uno, Kyosuke; Miyazaki, Toh; Nitta, Atsumi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Fac Pharmaceut Sci, Dept Pharmaceut Therapy & Neuropharmacol, Toyama 9300194, Japan; [Rieder, Dietmar] Med Univ Innsbruck, Bioctr, Div Bioinformat, A-6020 Innsbruck, Austria	Graz University of Technology; Graz University of Technology; University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Toyama; Medical University of Innsbruck	Bogner-Strauss, JG (corresponding author), Petersgasse 14-5, A-8010 Graz, Austria.	juliane.bogner-strauss@tugraz.at	Rieder, Dietmar/AAB-2609-2022; Graier, Wolfgang F./B-7052-2008; Groschner, Lukas/AHD-6319-2022; Groschner, Lukas/J-9398-2012; Nitta, Atsumi/AAF-4211-2019; PROKESCH, ANDREAS/B-6786-2019	Rieder, Dietmar/0000-0003-1754-690X; Graier, Wolfgang F./0000-0003-1871-3298; Groschner, Lukas/0000-0002-4325-0232; Groschner, Lukas/0000-0002-4325-0232; Pessentheiner, Ariane/0000-0002-5010-9528; Bogner-Strauss, Juliane/0000-0003-2459-0124; Schweiger, Martina/0000-0002-3419-1007; PROKESCH, ANDREAS/0000-0002-8487-7103	Austrian Science Fund FWF [DK-MCD W01226, P24143]; Program for Next Generation World-leading Researchers [LS047]; Smoking Research Foundation Grant for Biomedical Research; Austrian Science Fund (FWF) [P 24143] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Program for Next Generation World-leading Researchers; Smoking Research Foundation Grant for Biomedical Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF Grants DK-MCD W01226 and P24143, by Program for Next Generation World-leading Researchers Grant LS047, and by a Smoking Research Foundation Grant for Biomedical Research.	Aflaki E, 2011, J BIOL CHEM, V286, P7418, DOI 10.1074/jbc.M110.175703; Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Ariyannur PS, 2008, BRAIN RES, V1227, P34, DOI 10.1016/j.brainres.2008.06.040; Ariyannur PS, 2010, BRAIN RES, V1335, P1, DOI 10.1016/j.brainres.2010.04.008; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bogner-Strauss JG, 2010, CELL MOL LIFE SCI, V67, P4049, DOI 10.1007/s00018-010-0424-5; Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014; Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786; Burlina AP, 2006, ADV EXP MED BIOL, V576, P283; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DADAMO AF, 1966, J NEUROCHEM, V13, P961, DOI 10.1111/j.1471-4159.1966.tb10292.x; DARNLEY AC, 1988, BIOCHEM J, V253, P351, DOI 10.1042/bj2530351; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Furukawa-Hibi Y, 2012, NEUROSCI LETT, V526, P79, DOI 10.1016/j.neulet.2012.08.028; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Huang JS, 2012, FASEB J, V26, P628, DOI 10.1096/fj.11-194019; Ji S, 2008, MOL GENET METAB, V93, P314, DOI 10.1016/j.ymgme.2007.10.006; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; MA SWY, 1986, CAN J PHYSIOL PHARM, V64, P609, DOI 10.1139/y86-101; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Peng L, 2004, MECH AGEING DEV, V125, P337, DOI 10.1016/j.mad.2004.01.002; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SUGDEN MC, 1982, BIOSCIENCE REP, V2, P289, DOI 10.1007/BF01115114; Tahay G, 2012, BIOCHEM J, V441, P105, DOI 10.1042/BJ20111179; Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Wiame E, 2010, BIOCHEM J, V425, P127, DOI 10.1042/BJ20091024; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	49	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36040	36051		10.1074/jbc.M113.491324	http://dx.doi.org/10.1074/jbc.M113.491324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24155240	Green Published, hybrid			2022-12-28	WOS:000329814700039
J	Yacoub, D; Benslimane, N; Al-Zoobi, L; Hassan, G; Nadiri, A; Mourad, W				Yacoub, Daniel; Benslimane, Nadir; Al-Zoobi, Loubna; Hassan, Ghada; Nadiri, Amal; Mourad, Walid			CD154 Is Released from T-cells by a Disintegrin and Metalloproteinase Domain-containing Protein 10 (ADAM10) and ADAM17 in a CD40 Protein-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Inflammation; Integrins; Molecular Biology; Receptors; CD154; CD40; T-cells	MATRIX METALLOPROTEINASE-2; ALPHA-5-BETA-1 INTEGRIN; LIPID RAFTS; LIGAND; RECEPTOR; PKC; CLEAVAGE; BINDING	Background: CD154 is released from T-cells in a manner that remains elusive. Results: CD154 is released from Jurkat E6.1 T-cells by ADAM10 and ADAM17 upon its interaction with CD40 exclusively. Conclusion: The cleavage of CD154 is mediated through specific signaling events that bypass many other CD154 signaling events. Significance: These data may lead to the generation of novel targets for the treatment of CD154-associated disorders. CD154 (CD40 ligand) is a type II transmembrane protein that belongs to the tumor necrosis factor superfamily. The soluble form of CD154 (sCD154), which results from the shedding of membrane-bound CD154, plays a key role in the production of proinflammatory cytokines and has been linked to various autoimmune and vascular disorders. Therefore, elucidating the mechanisms by which CD154 is released from the cell surface following its interaction with its various receptors is of primordial importance. Using co-culture experiments, we show that CD154 is shed predominantly upon its engagement with CD40. Indeed, only CD40 (both membrane-bound and soluble) and not 51 or M2 is involved in the cleavage and release of CD154 from Jurkat E6.1 T-cells. Interestingly, CD154 is cleaved independently of the formation of cell surface CD40 homodimers and independently of its association into lipid rafts. In contrast, we found that the protein kinase C (PKC) signaling family and the matrix metalloproteinases ADAM10 and ADAM17 are intimately involved in this process. In conclusion, our data indicate that CD154 is released from T-cells by ADAM10 and ADAM17 upon CD40 ligation. These findings add significant insights into the mechanisms by which CD154 is down-regulated and may lead to the generation of novel therapeutic targets for the treatment of CD154-associated disorders.	[Yacoub, Daniel; Benslimane, Nadir; Al-Zoobi, Loubna; Hassan, Ghada; Nadiri, Amal; Mourad, Walid] Hop St Luc, Ctr Hosp Univ Montreal, Lab Immunol Cellulaire & Mol, Montreal, PQ H2X 1P1, Canada	Universite de Montreal	Mourad, W (corresponding author), Hop St Luc, Ctr Hosp Univ Montreal, Pavillon Edward Asselin 415,264 Rene Levesque Est, Montreal, PQ H2X 1P1, Canada.	mw.mourad@umontreal.ca		Hassan, Ghada S./0000-0002-1391-5248; Mourad, Walid/0000-0002-1859-9387	Canadian Institutes of Health Research (IRSC); Canadian Arthritis Network (CAN)	Canadian Institutes of Health Research (IRSC)(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network (CAN)	This work was supported by the Canadian Institutes of Health Research (IRSC) and the Canadian Arthritis Network (CAN).	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Benslimane N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043070; Choi WS, 2010, J THROMB HAEMOST, V8, P1364, DOI 10.1111/j.1538-7836.2010.03837.x; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; El Fakhry Y, 2010, EUR J IMMUNOL, V40, P770, DOI 10.1002/eji.200939646; Gil C, 2007, FEBS LETT, V581, P1851, DOI 10.1016/j.febslet.2007.03.080; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Henn V, 2001, BLOOD, V98, P1047, DOI 10.1182/blood.V98.4.1047; Jin Yinzhu, 2001, Journal of Medical and Dental Sciences, V48, P23; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ludewig B, 1996, EUR J IMMUNOL, V26, P3137, DOI 10.1002/eji.1830261246; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Matthies KMG, 2006, CELL IMMUNOL, V241, P47, DOI 10.1016/j.cellimm.2006.08.001; Menchen L, 2009, GUT, V58, P920, DOI 10.1136/gut.2008.150318; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Pietravalle F, 1996, J BIOL CHEM, V271, P5965, DOI 10.1074/jbc.271.11.5965; Reinboldt S, 2009, PLATELETS, V20, P441, DOI 10.1080/09537100903096684; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Santos-Martinez MJ, 2008, THROMB RES, V121, P535, DOI 10.1016/j.thromres.2007.06.002; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Wang Y, 2011, J BIOL CHEM, V286, P38980, DOI 10.1074/jbc.M111.277087; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; YELLIN MJ, 1994, J IMMUNOL, V153, P666; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	34	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36083	36093		10.1074/jbc.M113.506220	http://dx.doi.org/10.1074/jbc.M113.506220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189063	Green Published, hybrid			2022-12-28	WOS:000329814700043
J	Zhou, Y; Maxwell, KN; Sezgin, E; Lu, M; Liang, H; Hancock, JF; Dial, EJ; Lichtenberger, LM; Levental, I				Zhou, Yong; Maxwell, Kelsey N.; Sezgin, Erdinc; Lu, Maryia; Liang, Hong; Hancock, John F.; Dial, Elizabeth J.; Lichtenberger, Lenard M.; Levental, Ilya			Bile Acids Modulate Signaling by Functional Perturbation of Plasma Membrane Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bile Acid; Lipid Raft; Membrane Bilayer; Membrane Biophysics; Membrane Lipids; Membrane Structure; Ras	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LIPID RAFTS; MODEL MEMBRANES; CELL-MEMBRANES; RAS PROTEINS; H-RAS; SPATIOTEMPORAL ORGANIZATION; PHOSPHOLIPID TRANSFER; K-RAS; VESICLES	Background: Bile acids (BAs) affect cellular membranes. Results: BAs stabilize domains in plasma membranes, leading to reorganization of membrane proteins and signaling perturbations. Conclusion: BAs affect cell function by modulating the stability of plasma membrane nanodomains. Significance: These results suggest mechanisms for regulation of functional membrane domains and nonreceptor-mediated BA signaling. Eukaryotic cell membranes are organized into functional lipid and protein domains, the most widely studied being membrane rafts. Although rafts have been associated with numerous plasma membrane functions, the mechanisms by which these domains themselves are regulated remain undefined. Bile acids (BAs), whose primary function is the solubilization of dietary lipids for digestion and absorption, can affect cells by interacting directly with membranes. To investigate whether these interactions affected domain organization in biological membranes, we assayed the effects of BAs on biomimetic synthetic liposomes, isolated plasma membranes, and live cells. At cytotoxic concentrations, BAs dissolved synthetic and cell-derived membranes and disrupted live cell plasma membranes, implicating plasma membrane damage as the mechanism for BA cellular toxicity. At subtoxic concentrations, BAs dramatically stabilized domain separation in Giant Plasma Membrane Vesicles without affecting protein partitioning between coexisting domains. Domain stabilization was the result of BA binding to and disordering the nonraft domain, thus promoting separation by enhancing domain immiscibility. Consistent with the physical changes observed in synthetic and isolated biological membranes, BAs reorganized intact cell membranes, as evaluated by the spatial distribution of membrane-anchored Ras isoforms. Nanoclustering of K-Ras, related to nonraft membrane domains, was enhanced in intact plasma membranes, whereas the organization of H-Ras was unaffected. BA-induced changes in Ras lateral segregation potentiated EGF-induced signaling through MAPK, confirming the ability of BAs to influence cell signal transduction by altering the physical properties of the plasma membrane. These observations suggest general, membrane-mediated mechanisms by which biological amphiphiles can produce their cellular effects.	[Zhou, Yong; Maxwell, Kelsey N.; Lu, Maryia; Liang, Hong; Hancock, John F.; Dial, Elizabeth J.; Lichtenberger, Lenard M.; Levental, Ilya] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Sezgin, Erdinc] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Texas System; University of Texas Health Science Center Houston; Max Planck Society	Zhou, Y (corresponding author), Suite R382,6431 Fannin St, Houston, TX 77030 USA.	yong.zhou@uth.tmc.edu; ilya.levental@uth.tmc.edu	Levental, Ilya/F-4707-2011; Sezgin, Erdinc/R-1980-2018	Levental, Ilya/0000-0002-1206-9545; Sezgin, Erdinc/0000-0002-4915-388X; Zhou, Yong/0000-0002-0214-8151; Hancock, John/0000-0003-0542-4710	National Institutes of Health [0GM066717]; Texas Medical Center Digestive Diseases Center [P30 DK56338]; Cancer Prevention and Research Institute of Texas Grant [R1215]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Medical Center Digestive Diseases Center; Cancer Prevention and Research Institute of Texas Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant 0GM066717 (to. J. F. H.). This work was also supported by Pilot and Feasibility Grant P30 DK56338 from the Texas Medical Center Digestive Diseases Center (to Y. Z.) and Cancer Prevention and Research Institute of Texas Grant R1215 (to I. L.). L. M. L. is a founder and shareholder of PLx Pharma Inc., Houston TX.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Akare S, 2005, BBA-MOL CELL BIOL L, V1735, P59, DOI 10.1016/j.bbalip.2005.04.006; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; CABRAL DJ, 1987, BIOCHEMISTRY-US, V26, P1801, DOI 10.1021/bi00381a002; Caron RW, 2005, MOL CANCER THER, V4, P257; Choi JA, 2004, ONCOGENE, V23, P9, DOI 10.1038/sj.onc.1206982; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Esposito C, 2007, BIOPHYS J, V93, P3169, DOI 10.1529/biophysj.107.111922; FULLINGTON DA, 1990, BIOCHEMISTRY-US, V29, P879, DOI 10.1021/bi00456a005; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; HOFMANN AF, 1967, ANNU REV MED, V18, P333, DOI 10.1146/annurev.me.18.020167.002001; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Inder Kerry, 2008, Commun Integr Biol, V1, P178; Jean-Louis S, 2006, J BIOL CHEM, V281, P14948, DOI 10.1074/jbc.M506710200; Johnson SA, 2010, BBA-BIOMEMBRANES, V1798, P1427, DOI 10.1016/j.bbamem.2010.03.009; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; LaRocca T. J., 2013, PLOS PATHOG, V9; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; MAZER NA, 1980, BIOCHEMISTRY-US, V19, P601, DOI 10.1021/bi00545a001; Mello-Vieira J, 2013, BBA-BIOMEMBRANES, V1828, P2152, DOI 10.1016/j.bbamem.2013.05.021; NICHOLS JW, 1986, BIOCHEMISTRY-US, V25, P4596, DOI 10.1021/bi00364a021; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Powell AA, 2001, BIOCHEM J, V356, P481, DOI 10.1042/0264-6021:3560481; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; RODA A, 1983, J BIOL CHEM, V258, P6362; Scotti E, 2007, CELL MOL LIFE SCI, V64, P2477, DOI 10.1007/s00018-007-7280-y; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHOEMAKER DG, 1990, BIOCHEMISTRY-US, V29, P5837, DOI 10.1021/bi00476a027; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Simons K, 2011, COLD SPRING HARB PER, V3; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2003, BIOPHYS J, V84, P725, DOI 10.1016/S0006-3495(03)74891-7; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Young RM, 2005, J BIOL CHEM, V280, P1230, DOI 10.1074/jbc.M408339200; Zhao J, 2013, BIOPHYS J, V104, P825, DOI 10.1016/j.bpj.2012.12.047; Zhou Y, 2012, J BIOL CHEM, V287, P16586, DOI 10.1074/jbc.M112.348490; Zhou Y, 2010, J BIOL CHEM, V285, P35188, DOI 10.1074/jbc.M110.141200; Zhou Y, 2010, AM J PHYSIOL-GASTR L, V298, pG722, DOI 10.1152/ajpgi.00387.2009; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008811; Zhou Y, 2009, BBA-BIOMEMBRANES, V1788, P507, DOI 10.1016/j.bbamem.2008.12.008; Zollner G, 2009, BRIT J PHARMACOL, V156, P7, DOI 10.1111/j.1476-5381.2008.00030.x	62	64	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35660	35670		10.1074/jbc.M113.519116	http://dx.doi.org/10.1074/jbc.M113.519116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24165125	hybrid, Green Published			2022-12-28	WOS:000329814700005
J	Gellert, M; Venz, S; Mitlohner, J; Cott, C; Hanschmann, EM; Lillig, CH				Gellert, Manuela; Venz, Simone; Mitloehner, Jessica; Cott, Catherine; Hanschmann, Eva-Maria; Lillig, Christopher Horst			Identification of a Dithiol-disulfide Switch in Collapsin Response Mediator Protein 2 (CRMP2) That Is Toggled in a Model of Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Neurodifferentiation; Redox Regulation; Redox Signaling; Thiol; CRMP2; Glutaredoxin; Neuronal Differentiation; Redox Switch	HUMAN GLUTAREDOXIN-2; EXPRESSION PATTERN; SIGNALING PATHWAYS; AXON GUIDANCE; THIOREDOXIN; MITOCHONDRIAL; MECHANISMS; THIOLTRANSFERASE; PHOSPHORYLATION; INVOLVEMENT	Background: Cytosolic glutaredoxin 2 (Grx2) is essential for neuronal development in zebrafish; collapsin response mediator protein 2 (CRMP2) was identified as Grx2 substrate. Results: Oxidation of CRMP2 by hydrogen peroxide induces an intermolecular disulfide, changes in -helical content, and hydrophobicity. Conclusion: The dithiol-disulfide redox switch defines two conformations of CRMP2. Significance: This switch may be functional during axonal outgrowth. Vertebrate-specific glutaredoxin 2 (Grx2) is expressed in at least two isoforms, mitochondrial Grx2a and cytosolic Grx2c. We have previously shown that cytosolic Grx2 is essential for embryonic development of the brain. In particular, we identified collapsin response mediator protein 2 (CRMP2/DPYSL2), a mediator of the semaphorin-plexin signaling pathway, as redox-regulated target of Grx2c and demonstrated that this regulation is required for normal axonal outgrowth. In this study, we demonstrate the molecular mechanism of this regulation, a specific and reversible intermolecular Cys-504-Cys-504 dithiol-disulfide switch in homotetrameric CRMP2. This switch determines two conformations of the quaternary CRMP2 complex that controls axonal outgrowth and thus neuronal development.	[Gellert, Manuela; Venz, Simone; Mitloehner, Jessica; Hanschmann, Eva-Maria; Lillig, Christopher Horst] Ernst Moritz Arndt Univ Greifswald, Univ Med, Inst Med Biochem & Mol Biol, D-17475 Greifswald, Germany; [Cott, Catherine] Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Freiburg	Lillig, CH (corresponding author), Univ Med Greifswald, Inst Med Biochem & Mol Biol, J03 33 Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany.	horst@lillig.de	Lillig, Christopher Horst/AAD-7098-2019; Hanschmann, Eva-Maria/AAS-9261-2021	Lillig, Christopher Horst/0000-0003-2509-5117; Gellert, Manuela/0000-0002-2545-7125	Deutsche Forschungsgemeinschaft [DFG SFB593-N01]; Science Networks (Forschungsverbunde) Neuroscience and Molecular Medicine, University Medicine Greifswald	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Science Networks (Forschungsverbunde) Neuroscience and Molecular Medicine, University Medicine Greifswald	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SFB593-N01) and start-up funding by the Science Networks (Forschungsverbunde) Neuroscience and Molecular Medicine, University Medicine Greifswald.	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Berndt C, 2007, AM J PHYSIOL-HEART C, V292, pH1227, DOI 10.1152/ajpheart.01162.2006; Beydoun A, 2009, EXPERT REV NEUROTHER, V9, P33, DOI 10.1586/14737175.9.1.33; Brautigam L, 2011, P NATL ACAD SCI USA, V108, P20532, DOI 10.1073/pnas.1110085108; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; Deo RC, 2004, EMBO J, V23, P9, DOI 10.1038/sj.emboj.7600021; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Giridharan SSP, 2012, J CELL SCI, V125, P614, DOI 10.1242/jcs.089367; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; Hou ST, 2009, J NEUROCHEM, V111, P870, DOI 10.1111/j.1471-4159.2009.06375.x; Hudemann C, 2009, ANTIOXID REDOX SIGN, V11, P1, DOI 10.1089/ars.2008.2068; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2013, ANTIOXID REDOX SIGN, V18, P1654, DOI 10.1089/ars.2012.5007; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Morinaka A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001127; Nadella M, 2005, P NATL ACAD SCI USA, V102, P16830, DOI 10.1073/pnas.0504838102; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Patrakitkomjorn S, 2008, J BIOL CHEM, V283, P9399, DOI 10.1074/jbc.M708206200; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Schutte LD, 2013, BBA-GEN SUBJECTS, V1830, P4999, DOI 10.1016/j.bbagen.2013.07.009; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Uchida Y, 2009, J BIOL CHEM, V284, P27393, DOI 10.1074/jbc.M109.000240; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang LH, 1997, J NEUROCHEM, V69, P2261	48	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35117	35125		10.1074/jbc.M113.521443	http://dx.doi.org/10.1074/jbc.M113.521443			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133216	hybrid, Green Published			2022-12-28	WOS:000329867600013
J	Ogura, Y; Mishra, V; Hindi, SM; Kuang, SH; Kumar, A				Ogura, Yuji; Mishra, Vivek; Hindi, Sajedah M.; Kuang, Shihuan; Kumar, Ashok			Proinflammatory Cytokine Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) Suppresses Satellite Cell Self-renewal through Inversely Modulating Notch and NF-kappa B Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine Action; Inflammation; NF-B; Notch Pathway; Signaling; Skeletal Muscle; Stem Cells; Tumor Necrosis Factor (TNF); TWEAK; Satellite Cells; Self-renewal; Notch	SKELETAL-MUSCLE; REGULATORY FACTORS; TARGETED ABLATION; CROSS-TALK; MYOD; ACTIVATION; EXPRESSION; PROMOTES; PAX7; REGENERATION	Background: TNF-like weak inducer of apoptosis (TWEAK) cytokine is an important regulator of inflammation and skeletal muscle mass. Results: TWEAK represses Pax7 expression and Notch signaling and activates NF-B in satellite cells. Conclusion: TWEAK suppresses satellite cell self-renewal through reciprocally regulating Notch and NF-B signaling. Significance: Inhibition of TWEAK can be used as a therapeutic approach to maintain the satellite cell pool in skeletal muscle. Satellite cell self-renewal is an essential process to maintaining the robustness of skeletal muscle regenerative capacity. However, extrinsic factors that regulate self-renewal of satellite cells are not well understood. Here, we demonstrate that TWEAK cytokine reduces the proportion of Pax7(+)/MyoD(-) cells (an index of self-renewal) on myofiber explants and represses multiple components of Notch signaling in satellite cell cultures. The number of Pax7(+) cells is significantly increased in skeletal muscle of TWEAK knock-out (KO) mice compared with wild-type in response to injury. Furthermore, Notch signaling is significantly elevated in cultured satellite cells and in regenerating myofibers of TWEAK-KO mice. Forced activation of Notch signaling through overexpression of the Notch1 intracellular domain (N1ICD) rescued the TWEAK-mediated inhibition of satellite cell self-renewal. TWEAK also activates the NF-B transcription factor in satellite cells and inhibition of NF-B significantly improved the number of Pax7(+) cells in TWEAK-treated cultures. Furthermore, our results demonstrate that a reciprocal interaction between NF-B and Notch signaling governs the inhibitory effect of TWEAK on satellite cell self-renewal. Collectively, our study demonstrates that TWEAK suppresses satellite cell self-renewal through activating NF-B and repressing Notch signaling.	[Ogura, Yuji; Mishra, Vivek; Hindi, Sajedah M.; Kumar, Ashok] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA; [Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of Louisville; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kumar, A (corresponding author), 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu		Kuang, Shihuan/0000-0001-9180-3180; Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [RO1AR059810, RO1AG029623]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652, R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AR059810 and RO1AG029623 (to A. K.).	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Acharyya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012479; Bhatnagar S, 2012, CURR MOL MED, V12, P3, DOI 10.2174/156652412798376107; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; GUO K, 1995, MOL CELL BIOL, V15, P3823; GUTTRIDGE DC, 2000, SCIENCE, V289, P2363, DOI [10.1126/sci-ence.289.5488.2363, DOI 10.1126/SCI-ENCE.289.5488.2363, DOI 10.1126/science.289.5488.2363, DOI 10.1126/SCIENCE.289.5488.2363]; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He W. A., 2013, J CLIN INVEST, DOI 10.1172/JCI68523; Hindi SM, 2012, MOL CELL BIOL, V32, P4833, DOI 10.1128/MCB.00717-12; Kitamoto T, 2010, STEM CELLS, V28, P2205, DOI 10.1002/stem.547; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Relaix F, 2009, CURR OPIN CELL BIOL, V21, P748, DOI 10.1016/j.ceb.2009.10.002; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; von Maltzahn J, 2012, P NATL ACAD SCI USA, V109, P20614, DOI 10.1073/pnas.1215765109; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	56	33	40	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35159	35169		10.1074/jbc.M113.517300	http://dx.doi.org/10.1074/jbc.M113.517300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151074	Green Published, hybrid			2022-12-28	WOS:000329867600017
J	Park, KH; Kim, BJ; Shawl, AI; Han, MK; Lee, HC; Kim, UH				Park, Kwang-Hyun; Kim, Byung-Ju; Shawl, Asif Iqbal; Han, Myung-Kwan; Lee, Hon Cheung; Kim, Uh-Hyun			Autocrine/Paracrine Function of Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) for Glucose Homeostasis in Pancreatic beta-Cells and Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Beta Cell; Calcium Signaling; Diabetes; NAADP	CYCLIC-ADP-RIBOSE; CA2+; CALCIUM; CD38; HYDROLYSIS; AGONIST; CYCLASE; ACINAR; 2ND-MESSENGER; ACTIVATION	Background: External application of a Ca2+-mobilizing messenger, NAADP, to -cells activates intracellular Ca2+ changes and stimulates insulin secretion. Results: NAADP is transported into adipocytes and -cells in a glucose-dependent manner and is also released from pancreatic islets upon stimulation by high glucose. Conclusion: NAADP functions in an auto-/paracrine manner to regulate glucose homeostasis. Significance: NAADP can be exploited as a potential antidiabetic agent. Nicotinic acid adenine dinucleotide phosphate (NAADP) is a second messenger for mobilizing Ca2+ from intracellular stores in various cell types. Extracellular application of NAADP has been shown to elicit intracellular Ca2+ signals, indicating that it is readily transported into cells. However, little is known about the functional role of this NAADP uptake system. Here, we show that NAADP is effectively transported into selected cell types involved in glucose homeostasis, such as adipocytes and pancreatic -cells, but not the acinar cells, in a high glucose-dependent manner. NAADP uptake was inhibitable by Ned-19, a NAADP mimic; dipyridamole, a nucleoside inhibitor; or NaN3, a metabolic inhibitor or under Ca2+-free conditions. Furthermore, NAADP was found to be released from pancreatic islets upon stimulation by high glucose. Consistently, administration of NAADP to type 2 diabetic mice improved glucose tolerance. We propose that NAADP is functioning as an autocrine/paracrine hormone important in glucose homeostasis. NAADP is thus a potential antidiabetic agent with therapeutic relevance.	[Park, Kwang-Hyun; Kim, Byung-Ju; Shawl, Asif Iqbal; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Park, Kwang-Hyun; Kim, Byung-Ju; Shawl, Asif Iqbal; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Ca2, Signaling Network, Jeonju 561180, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 561180, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Cardiovasc Res, Jeonju 561180, South Korea; [Lee, Hon Cheung] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Shenzhen 518055, Peoples R China	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Peking University; University Town of Shenzhen	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Keumam Dong San 2-20, Jeonju 561180, South Korea.	uhkim@chonbuk.ac.kr	Lee, Hon Cheung/C-4329-2009	Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190	National Research Foundation [2012R1A3A2026453]; Korean government; Research Grants Council of Hong Kong [768408, 769309, 770610, 770111, 769912]	National Research Foundation; Korean government(Korean Government); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by National Research Foundation Grant 2012R1A3A2026453 funded by the Korean government (to U.-H. K.) and by Research Grants Council of Hong Kong Grants 768408, 769309, 770610, 770111, and 769912 (to H. C. L).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Billington RA, 2000, BIOCHEM BIOPH RES CO, V276, P112, DOI 10.1006/bbrc.2000.3444; Billington RA, 2006, FASEB J, V20, P521, DOI 10.1096/fj.05-5058fje; Billington RA, 2002, J PHYSIOL-LONDON, V544, P107, DOI 10.1113/jphysiol.2002.030098; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2002, DIABETES, V51, pS349, DOI 10.2337/diabetes.51.2007.S349; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Galione A, 2009, PFLUG ARCH EUR J PHY, V458, P869, DOI 10.1007/s00424-009-0682-y; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; KIM UH, 1993, BIOCHIM BIOPHYS ACTA, V1178, P121, DOI 10.1016/0167-4889(93)90001-6; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; McClain DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE973, DOI 10.1152/ajpendo.00549.2004; Moreschi I, 2008, CELL CALCIUM, V43, P344, DOI 10.1016/j.ceca.2007.06.006; Mushtaq M, 2011, J BIOL CHEM, V286, P12952, DOI 10.1074/jbc.M110.207100; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Shawl AI, 2009, ISLETS, V1, P216, DOI 10.4161/isl.1.3.9646; SHIBATA A, 1976, DIABETES, V25, P667, DOI 10.2337/diabetes.25.8.667; Singaravelu K, 2006, CELL CALCIUM, V39, P143, DOI 10.1016/j.ceca.2005.10.001; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200	37	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35548	35558		10.1074/jbc.M113.489278	http://dx.doi.org/10.1074/jbc.M113.489278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165120	Green Published, hybrid			2022-12-28	WOS:000329867600049
J	Tukey, DS; Ziff, EB				Tukey, David S.; Ziff, Edward B.			Ca2+-permeable AMPA (alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Receptors and Dopamine D1 Receptors Regulate GluA1 Trafficking in Striatal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dopamine; Glutamate; Glutamate Receptors; Neurons; Synaptic Plasticity; Dopamine; AMPA Receptor; Striatum; Nucleus Accumbens; GluA1; Medium Spiny Neurons; cGKII; cGMP	LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; MEDIUM SPINY NEURONS; D-ASPARTATE RECEPTOR; RECORDED IN-VIVO; SYNAPTIC PLASTICITY; ADENYLYL-CYCLASE; GUANYLYL CYCLASE; MEMBRANE EXCITABILITY; STIMULATION INCREASES	Regulation of striatal medium spiny neuron synapses underlies forms of motivated behavior and pathological drug seeking. A primary mechanism for increasing synaptic strength is the trafficking of -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) into the postsynapse, a process mediated by GluA1 AMPAR subunit phosphorylation. We have examined the role of converging glutamate and dopamine inputs in regulating biochemical cascades upstream of GluA1 phosphorylation. We focused on the role of Ca2+-permeable AMPARs (CPARs), which lack the GluA2 AMPAR subunit. Under conditions that prevented depolarization, stimulation of CPARs activated neuronal nitric oxide synthase and production of cGMP. CPAR-dependent cGMP production was sufficient to induce synaptic insertion of GluA1, detected by confocal microscopy, through a mechanism dependent on GluA1 Ser-845 phosphorylation. Dopamine D1 receptors, in contrast, stimulate GluA1 extra synaptic insertion. Simultaneous activation of dopamine D1 receptors and CPARs induced additive increases in GluA1 membrane insertion, but only CPAR stimulation augmented CPAR-dependent GluA1 synaptic insertion. This incorporation into the synapse proceeded through a sequential two-step mechanism; that is, cGMP-dependent protein kinase II facilitated membrane insertion and/or retention, and protein kinase C activity was necessary for synaptic insertion. These data suggest a feed-forward mechanism for synaptic priming whereby an initial stimulus acting independently of voltage-gated conductance increases striatal neuron excitability, facilitating greater neuronal excitation by a subsequent stimulus.	[Tukey, David S.; Ziff, Edward B.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University	Ziff, EB (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave, New York, NY 10016 USA.	edward.ziff@nyumc.org		Ziff, Edward/0000-0001-7389-8649	National Institutes of Health [R01NS06192, R01MH67229]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067229, F31MH076617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS06192 (CPAR studies) and R01MH67229 (cGKII studies) (to E. B. Z.)	Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P651, DOI 10.1152/jn.1990.63.4.651; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Carra KD, 2010, NEUROSCIENCE, V165, P1074, DOI 10.1016/j.neuroscience.2009.11.015; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Cooper DMF, 1998, J BIOL CHEM, V273, P27703, DOI 10.1074/jbc.273.42.27703; Corona JC, 2007, NEUROPHARMACOLOGY, V52, P1219, DOI 10.1016/j.neuropharm.2006.12.008; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kheirbek MA, 2008, J NEUROSCI, V28, P11401, DOI 10.1523/JNEUROSCI.4115-08.2008; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mahajan SS, 2007, MOL CELL NEUROSCI, V35, P470, DOI 10.1016/j.mcn.2007.04.006; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Marcoli M, 2006, NEUROCHEM INT, V49, P683, DOI 10.1016/j.neuint.2006.06.009; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; MONS N, 1994, MOL BRAIN RES, V22, P236, DOI 10.1016/0169-328X(94)90052-3; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340; Sammut S, 2006, NEUROPSYCHOPHARMACOL, V31, P493, DOI 10.1038/sj.npp.1300826; Sammut S, 2010, NEUROPHARMACOLOGY, V58, P624, DOI 10.1016/j.neuropharm.2009.11.011; Schotanus SM, 2008, EUR J NEUROSCI, V27, P1957, DOI 10.1111/j.1460-9568.2008.06173.x; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Serulle Y, 2008, CHANNELS, V2, P230, DOI 10.4161/chan.2.4.6391; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Tukey DS, 2013, J NEUROSCI, V33, P6123, DOI 10.1523/JNEUROSCI.4806-12.2013; Vikman KS, 2008, J PHYSIOL-LONDON, V586, P515, DOI 10.1113/jphysiol.2007.145581; West AR, 2004, J NEUROSCI, V24, P1924, DOI 10.1523/JNEUROSCI.4470-03.2004; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; YUNG KKL, 1995, NEUROSCIENCE, V65, P709, DOI 10.1016/0306-4522(94)00536-E; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	64	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35297	35306		10.1074/jbc.M113.516690	http://dx.doi.org/10.1074/jbc.M113.516690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24133208	hybrid, Green Published			2022-12-28	WOS:000329867600028
J	Chattopadhyay, MK; Tabor, H				Chattopadhyay, Manas K.; Tabor, Herbert			Polyamines Are Critical for the Induction of the Glutamate Decarboxylase-dependent Acid Resistance System in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cyclic AMP (cAMP); Decarboxylase; Gene Expression; Glutamate; Microarray; Polyamines; Putrescine; Spermidine	SMALL-RNA; GADE YHIE; GENES; RPOS; EXPRESSION; PROTEIN; STRESS; REGULATORS; ACTIVATOR; GROWTH	As part of our studies on the biological functions of polyamines, we have used a mutant of Escherichia coli that lacks all the genes for polyamine biosynthesis for a global transcriptional analysis on the effect of added polyamines. The most striking early response to the polyamine addition is the increased expression of the genes for the glutamate-dependent acid resistance system (GDAR) that is important for the survival of the bacteria when passing through the acid environment of the stomach. Not only were the two genes for glutamate decarboxylases (gadA and gadB) and the gene for glutamate--aminobutyrate antiporter (gadC) induced by the polyamine addition, but the various genes involved in the regulation of this system were also induced. We confirmed the importance of polyamines for the induction of the GDAR system by direct measurement of glutamate decarboxylase activity and acid survival. The effect of deletions of the regulatory genes on the GDAR system and the effects of overproduction of two of these genes were also studied. Strikingly, overproduction of the alternative sigma factor rpoS and of the regulatory gene gadE resulted in very high levels of glutamate decarboxylase and almost complete protection against acid stress even in the absence of any polyamines. Thus, these data show that a major function of polyamines in E. coli is protection against acid stress by increasing the synthesis of glutamate decarboxylase, presumably by increasing the levels of the rpoS and gadE regulators.	[Chattopadhyay, Manas K.; Tabor, Herbert] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chattopadhyay, MK (corresponding author), NIDDK, NIH, 8 Ctr Dr,Bldg 8,Rm 219, Bethesda, MD 20892 USA.	manasc@intra.niddk.nih.gov			National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024709] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NIDDK.	ALEXANDER DM, 1994, MOL MICROBIOL, V11, P1059, DOI 10.1111/j.1365-2958.1994.tb00383.x; Atlung T, 2002, MOL GENET GENOMICS, V266, P873, DOI 10.1007/s00438-001-0610-0; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castanie-Cornet MP, 2010, NUCLEIC ACIDS RES, V38, P3546, DOI 10.1093/nar/gkq097; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Castanie-Cornet MP, 2001, MICROBIOL-UK, V147, P709, DOI 10.1099/00221287-147-3-709; Chattopadhyay MK, 2013, FEMS MICROBIOL LETT, V338, P132, DOI 10.1111/1574-6968.12035; Chattopadhyay MK, 2009, J BACTERIOL, V191, P5549, DOI 10.1128/JB.00381-09; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S A, 1998, Guttmacher Rep Public Policy, V1, P1; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; De Biase D, 2012, MOL MICROBIOL, V86, P770, DOI 10.1111/mmi.12020; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Gale EF, 1940, BIOCHEM J, V34, P846, DOI 10.1042/bj0340846; Giangrossi M, 2005, J BIOL CHEM, V280, P21498, DOI 10.1074/jbc.M413255200; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; HENGGEARONIS R, 1993, CELL, V72, P165, DOI 10.1016/0092-8674(93)90655-A; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hommais F, 2004, MICROBIOL-SGM, V150, P61, DOI 10.1099/mic.0.26659-0; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Jung IL, 2003, J BIOL CHEM, V278, P22846, DOI 10.1074/jbc.M212055200; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Kanjee U, 2011, EMBO J, V30, P931, DOI 10.1038/emboj.2011.5; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; Kurihara S, 2009, FEMS MICROBIOL LETT, V294, P97, DOI 10.1111/j.1574-6968.2009.01552.x; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Lu PL, 2013, CELL RES, V23, P635, DOI 10.1038/cr.2013.13; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Ma Z, 2002, J BACTERIOL, V184, P7001, DOI 10.1128/JB.184.24.7001-7012.2002; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; MILLER JH, 1992, SHORT COURSE BACTERI, P268; Opdyke JA, 2004, J BACTERIOL, V186, P6698, DOI 10.1128/JB.186.20.6698-6705.2004; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Richard H, 2007, MICROBIOL-SGM, V153, P3154, DOI 10.1099/mic.0.2007/007575-0; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Sayed AK, 2007, MICROBIOL-SGM, V153, P2584, DOI 10.1099/mic.0.2007/007005-0; Sayed AK, 2009, MOL MICROBIOL, V71, P1435, DOI 10.1111/j.1365-2958.2009.06614.x; Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x; SMITH DK, 1992, J BACTERIOL, V174, P5820, DOI 10.1128/jb.174.18.5820-5826.1992; StimHerndon KP, 1996, MICROBIOL-UK, V142, P1311, DOI 10.1099/13500872-142-5-1311; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR H, 1982, P NATL ACAD SCI-BIOL, V79, P7087, DOI 10.1073/pnas.79.23.7087; Tkachenko AG, 2006, BIOCHEMISTRY-MOSCOW+, V71, P185, DOI 10.1134/S0006297906020118; Tramonti A, 2002, J BACTERIOL, V184, P2603, DOI 10.1128/JB.184.10.2603-2613.2002; Tramonti A, 2008, MOL MICROBIOL, V70, P965, DOI 10.1111/j.1365-2958.2008.06458.x; Tucker DL, 2003, J BACTERIOL, V185, P3190, DOI 10.1128/JB.185.10.3190-3201.2003; Vecerek B, 2010, NUCLEIC ACIDS RES, V38, P1284, DOI 10.1093/nar/gkp1125; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Waterman SR, 1996, INFECT IMMUN, V64, P2808, DOI 10.1128/IAI.64.7.2808-2811.1996; Waterman SR, 2003, J BACTERIOL, V185, P4644, DOI 10.1128/JB.185.15.4644-4647.2003; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Yoshida M, 2002, J BIOL CHEM, V277, P37139, DOI 10.1074/jbc.M206668200; Yoshida M, 2001, J BIOL CHEM, V276, P16289, DOI 10.1074/jbc.M011059200	63	26	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33559	33570		10.1074/jbc.M113.510552	http://dx.doi.org/10.1074/jbc.M113.510552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097985	hybrid, Green Published			2022-12-28	WOS:000327250200006
J	Nascimento, AFZ; Trindade, DM; Tonoli, CCC; de Giuseppe, PO; Assis, LHP; Honorato, RV; de Oliveira, PSL; Mahajan, P; Burgess-Brown, NA; von Delft, F; Larson, RE; Murakami, MT				Nascimento, Andrey F. Z.; Trindade, Daniel M.; Tonoli, Celisa C. C.; de Giuseppe, Priscila O.; Assis, Leandro H. P.; Honorato, Rodrigo V.; de Oliveira, Paulo S. L.; Mahajan, Pravin; Burgess-Brown, Nicola A.; von Delft, Frank; Larson, Roy E.; Murakami, Mario T.			Structural Insights into Functional Overlapping and Differentiation among Myosin V Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Crystal Structure; Intracellular Trafficking; Molecular Motors; Myosin; Myosin V; Cargo-binding Domain; Molecular Plasticity; Redox Dimerization	GLOBULAR TAIL DOMAIN; PROTEIN-STRUCTURE; BIOLOGICAL MACROMOLECULES; MOLECULAR REPLACEMENT; MODEL; RESOLUTION; REFINEMENT; MUTATIONS; DISEASE; RILPL2	Background: MyoVs are molecular motors widely distributed in eukaryotic cells responsible for membrane trafficking and intracellular transport. Results: The cargo-binding domain from human MyoV paralogs was structurally and biophysically characterized. Conclusion: We identified singular structural changes and molecular events conferring functional differentiation and modulating cargo binding. Significance: This work provides structural insights into cargo recognition and regulatory mechanisms in MyoVs. Myosin V (MyoV) motors have been implicated in the intracellular transport of diverse cargoes including vesicles, organelles, RNA-protein complexes, and regulatory proteins. Here, we have solved the cargo-binding domain (CBD) structures of the three human MyoV paralogs (Va, Vb, and Vc), revealing subtle structural changes that drive functional differentiation and a novel redox mechanism controlling the CBD dimerization process, which is unique for the MyoVc subclass. Moreover, the cargo- and motor-binding sites were structurally assigned, indicating the conservation of residues involved in the recognition of adaptors for peroxisome transport and providing high resolution insights into motor domain inhibition by CBD. These results contribute to understanding the structural requirements for cargo transport, autoinhibition, and regulatory mechanisms in myosin V motors.	[Nascimento, Andrey F. Z.; Trindade, Daniel M.; Tonoli, Celisa C. C.; de Giuseppe, Priscila O.; Assis, Leandro H. P.; Honorato, Rodrigo V.; de Oliveira, Paulo S. L.; Murakami, Mario T.] Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil; [Mahajan, Pravin; Burgess-Brown, Nicola A.; von Delft, Frank] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Larson, Roy E.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cellular & Mol Biol, BR-14049900 Sao Paulo, Brazil	University of Oxford; Universidade de Sao Paulo	Murakami, MT (corresponding author), Natl Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, Giuseppe Maximo Scolfaro St 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Murakami, Mario T/C-2087-2012; Trindade, Daniel Maragno/J-6085-2012; Oliveira, Paulo S/K-5588-2013; Honorato, Rodrigo/H-9773-2013; Murakami, Mario T/F-5640-2016; Nascimento, Andrey Fabricio Ziem/M-1740-2016; Honorato, Rodrigo Vargas/AAY-9375-2020; Oliveira de Giuseppe, Priscila/GLR-1319-2022; Paula Assis, Leandro Henrique/Q-6823-2016	Trindade, Daniel Maragno/0000-0002-8005-8784; Honorato, Rodrigo/0000-0001-5267-3002; Murakami, Mario T/0000-0002-0405-8010; Nascimento, Andrey Fabricio Ziem/0000-0003-4692-5263; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Oliveira de Giuseppe, Priscila/0000-0003-2094-7325; Paula Assis, Leandro Henrique/0000-0002-0610-9483; Tonoli, Celisa/0000-0003-2580-5588; Mahajan, Pravin/0000-0002-6073-9363; von Delft, Frank/0000-0003-0378-0017	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/08312-6, 07/59939-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [478059/2009-4, 486841/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 09/08312-6 (to M.T.M.) and 07/59939-3 (to R.E.L.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 478059/2009-4 and 486841/2012-0, and grants from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P11767; Chen YF, 2009, CANCER RES, V69, P8585, DOI 10.1158/0008-5472.CAN-09-2284; Correia SS, 2008, NAT NEUROSCI, V11, P457, DOI 10.1038/nn2063; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Dong WJ, 2013, DIGEST DIS SCI, V58, P2038, DOI 10.1007/s10620-013-2600-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGLE LJ, 1994, GENOMICS, V19, P407, DOI 10.1006/geno.1994.1088; Eves PT, 2012, J CELL BIOL, V198, P69, DOI 10.1083/jcb.201201024; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hammersley AP, 1997, J SYNCHROTRON RADIAT, V4, P67, DOI 10.1107/S0909049596015087; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lan LX, 2010, INT J CANCER, V126, P53, DOI 10.1002/ijc.24641; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lise MF, 2009, J CELL SCI, V122, P3810, DOI 10.1242/jcs.050344; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Olkkonen VM, 2006, J CELL SCI, V119, P5031, DOI 10.1242/jcs.03303; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pashkova N, 2005, J CELL BIOL, V168, P359, DOI 10.1083/jcb.200407146; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; Pranchevicius MCS, 2008, CELL MOTIL CYTOSKEL, V65, P441, DOI 10.1002/cm.20269; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schaub JR, 2013, MOL BIOL CELL, V24, P453, DOI 10.1091/mbc.E12-08-0598; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sellers JR, 2008, BIOCHEM BIOPH RES CO, V369, P176, DOI 10.1016/j.bbrc.2007.11.109; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taylor KA, 2007, CURR OPIN CELL BIOL, V19, P67, DOI 10.1016/j.ceb.2006.12.014; Terwilliger Thomas C., 2012, Journal of Structural and Functional Genomics, V13, P81, DOI 10.1007/s10969-012-9129-3; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang TL, 2004, MOL BIOL CELL, V15, P815, DOI 10.1091/mbc.E03-06-0413; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	66	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34131	34145		10.1074/jbc.M113.507202	http://dx.doi.org/10.1074/jbc.M113.507202			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24097982	Green Published, hybrid			2022-12-28	WOS:000327250200057
J	Pei, SS; Minhajuddin, M; Callahan, KP; Balys, M; Ashton, JM; Neering, SJ; Lagadinou, ED; Corbett, C; Ye, HB; Liesveld, JL; O'Dwyer, KM; Li, Z; Shi, L; Greninger, P; Settleman, J; Benes, C; Hagen, FK; Munger, J; Crooks, PA; Becker, MW; Jordan, CT				Pei, Shanshan; Minhajuddin, Mohammad; Callahan, Kevin P.; Balys, Marlene; Ashton, John M.; Neering, Sarah J.; Lagadinou, Eleni D.; Corbett, Cheryl; Ye, Haobin; Liesveld, Jane L.; O'Dwyer, Kristen M.; Li, Zheng; Shi, Lei; Greninger, Patricia; Settleman, Jeffrey; Benes, Cyril; Hagen, Fred K.; Munger, Joshua; Crooks, Peter A.; Becker, Michael W.; Jordan, Craig T.			Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cancer Stem Cells; Leukemia; Redox Regulation; Tumor Metabolism; CD34+; Glutathione; Human; Parthenolide	LIGASE CATALYTIC SUBUNIT; SESQUITERPENE LACTONE; KAPPA-B; CANCER-CELLS; STEM-CELLS; PARTHENOLIDE; EXPRESSION; MECHANISM; APOPTOSIS; PROTEIN	The development of strategies to eradicate primary human acute myelogenous leukemia (AML) cells is a major challenge to the leukemia research field. In particular, primitive leukemia cells, often termed leukemia stem cells, are typically refractory to many forms of therapy. To investigate improved strategies for targeting of human AML cells we compared the molecular mechanisms regulating oxidative state in primitive (CD34(+)) leukemic versus normal specimens. Our data indicate that CD34(+) AML cells have elevated expression of multiple glutathione pathway regulatory proteins, presumably as a mechanism to compensate for increased oxidative stress in leukemic cells. Consistent with this observation, CD34(+) AML cells have lower levels of reduced glutathione and increased levels of oxidized glutathione compared with normal CD34(+) cells. These findings led us to hypothesize that AML cells will be hypersensitive to inhibition of glutathione metabolism. To test this premise, we identified compounds such as parthenolide (PTL) or piperlongumine that induce almost complete glutathione depletion and severe cell death in CD34(+) AML cells. Importantly, these compounds only induce limited and transient glutathione depletion as well as significantly less toxicity in normal CD34(+) cells. We further determined that PTL perturbs glutathione homeostasis by a multifactorial mechanism, which includes inhibiting key glutathione metabolic enzymes (GCLC and GPX1), as well as direct depletion of glutathione. These findings demonstrate that primitive leukemia cells are uniquely sensitive to agents that target aberrant glutathione metabolism, an intrinsic property of primary human AML cells.	[Pei, Shanshan; Jordan, Craig T.] Univ Rochester, Sch Med, Dept Biomed Genet, Rochester, NY 14642 USA; [Callahan, Kevin P.; Balys, Marlene; Ashton, John M.; Neering, Sarah J.; Lagadinou, Eleni D.; Corbett, Cheryl; Liesveld, Jane L.; O'Dwyer, Kristen M.; Becker, Michael W.] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA; [Ye, Haobin] Univ Rochester, Sch Med, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Hagen, Fred K.; Munger, Joshua] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Pei, Shanshan; Minhajuddin, Mohammad; Ye, Haobin; Jordan, Craig T.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Li, Zheng; Shi, Lei] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei] Cornell Univ, Weill Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Greninger, Patricia; Settleman, Jeffrey; Benes, Cyril] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Greninger, Patricia; Settleman, Jeffrey; Benes, Cyril] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Crooks, Peter A.] Univ Arkansas, Dept Pharmaceut Sci, Little Rock, AR 72205 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Cornell University; Cornell University; Harvard University; Massachusetts General Hospital; Harvard University; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Jordan, CT (corresponding author), 12700 E 19th Ave, Aurora, CO 80045 USA.	craig.jordan@ucdenver.edu	PEI, SHANSHAN/D-8200-2016; Munger, Joshua/ABA-6395-2020; Shi, Lei/AAV-1321-2020; Minhajuddin, Mohammad/AAC-9227-2022; Shi, Xian-Lei/Q-2330-2015; jordan, craig/D-7666-2014	PEI, SHANSHAN/0000-0001-9619-2614; Shi, Lei/0000-0002-4137-096X; Shi, Xian-Lei/0000-0003-4703-6601; Ashton, John/0000-0001-9875-5994; jordan, craig/0000-0003-0869-3465; Munger, Joshua/0000-0001-5379-9440; Becker, Michael/0000-0001-9890-8815	National Institutes of Health [R01AI081773]; Leukemia and Lymphoma Society [6230-11]; Department of Defense [W81XWH-07-1-0601]; New York State Stem Cell Foundation [C024964, R01-CA158275]; NATIONAL CANCER INSTITUTE [R01CA158275] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081773, R56AI081773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Department of Defense(United States Department of Defense); New York State Stem Cell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI081773 (to J.M.), Leukemia and Lymphoma Society Grant 6230-11 (to C.T.J.), Department of Defense Grant W81XWH-07-1-0601 (to C.T.J.), New York State Stem Cell Foundation Grant C024964 (to C.T.J.) and R01-CA158275 (to P.A.C.).	Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Akerboom T P, 1981, Methods Enzymol, V77, P373; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Asahi M, 1997, J BIOL CHEM, V272, P19152, DOI 10.1074/jbc.272.31.19152; Ashton JM, 2012, CELL STEM CELL, V11, P359, DOI 10.1016/j.stem.2012.05.024; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; Costello RT, 2000, CANCER RES, V60, P4403; Couzin J, 2002, SCIENCE, V298, P522, DOI 10.1126/science.298.5593.522; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Er TK, 2007, CLIN BIOCHEM, V40, P1015, DOI 10.1016/j.clinbiochem.2007.05.013; FernandezCheca JC, 1997, AM J PHYSIOL-GASTR L, V273, pG7, DOI 10.1152/ajpgi.1997.273.1.G7; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Fraser JA, 2003, J BIOL CHEM, V278, P46369, DOI 10.1074/jbc.M308035200; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hamilton D, 2003, BLOOD, V102, P725, DOI 10.1182/blood-2002-11-3622; Hassane DC, 2008, BLOOD, V111, P5654, DOI 10.1182/blood-2007-11-126003; Jeudy S, 2006, PROTEINS, V62, P302, DOI 10.1002/prot.20710; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kratzer R, 2004, BIOCHEMISTRY-US, V43, P4944, DOI 10.1021/bi035833r; Krause DS, 1996, BLOOD, V87, P1; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Liu ZF, 2009, J PHARMACOL EXP THER, V329, P505, DOI 10.1124/jpet.108.147934; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Mathema VB, 2012, INFLAMMATION, V35, P560, DOI 10.1007/s10753-011-9346-0; MULLENBACH GT, 1987, NUCLEIC ACIDS RES, V15, P5484, DOI 10.1093/nar/15.13.5484; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nasim S, 2011, BIOORGAN MED CHEM, V19, P1515, DOI 10.1016/j.bmc.2010.12.045; Kreuger MRO, 2012, ANTI-CANCER DRUG, V23, P883, DOI 10.1097/CAD.0b013e328356cad9; Pajak B, 2008, FOLIA HISTOCHEM CYTO, V46, P129, DOI 10.2478/v10042-008-0019-2; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Rushworth SA, 2011, CANCER RES, V71, P1999, DOI 10.1158/0008-5472.CAN-10-3018; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; SAUERBREY A, 1994, BRIT J CANCER, V70, P1144, DOI 10.1038/bjc.1994.462; SCHISSELBAUER JC, 1990, CANCER RES, V50, P3562; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sobhakumari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048175; Sobota R, 2000, BIOCHEM BIOPH RES CO, V267, P329, DOI 10.1006/bbrc.1999.1948; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Trachootham D, 2008, BLOOD, V112, P1912, DOI 10.1182/blood-2008-04-149815; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tu ZH, 1998, BIOCHEM J, V336, P675, DOI 10.1042/bj3360675; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Weiwer M, 2012, BIOORG MED CHEM LETT, V22, P1822, DOI 10.1016/j.bmcl.2011.09.047; Xia CL, 1996, BIOCHEM J, V313, P155, DOI 10.1042/bj3130155; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005	60	125	134	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33542	33558		10.1074/jbc.M113.511170	http://dx.doi.org/10.1074/jbc.M113.511170			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24089526	Green Published, hybrid			2022-12-28	WOS:000327250200005
J	Wang, R; McGrath, BC; Kopp, RF; Roe, MW; Tang, X; Chen, G; Cavener, DR				Wang, Rong; McGrath, Barbara C.; Kopp, Richard F.; Roe, Michael W.; Tang, Xin; Chen, Gong; Cavener, Douglas R.			Insulin Secretion and Ca2+ Dynamics in beta-Cells Are Regulated by PERK (EIF2AK3) in Concert with Calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium Imaging; Diabetes; ER Stress; Insulin Secretion; Calcium Dynamics; PERK; Sarcoplasmic Endoplasmic Reticulum-Calcium ATPase; Store-operated Calcium Entry	ENDOPLASMIC-RETICULUM STRESS; STORE-OPERATED INFLUX; TRANSLATIONAL CONTROL; EIF2-ALPHA KINASE; CALCIUM; ACTIVATION; MICE; INHIBITOR; TRANSLOCATION; DYSFUNCTION	Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) (EIF2AK3) is essential for normal development and function of the insulin-secreting -cell. Although genetic ablation of PERK in -cells results in permanent neonatal diabetes in humans and mice, the underlying mechanisms remain unclear. Here, we used a newly developed and highly specific inhibitor of PERK to determine the immediate effects of acute ablation of PERK activity. We found that inhibition of PERK in human and rodent -cells causes a rapid inhibition of secretagogue-stimulated subcellular Ca2+ signaling and insulin secretion. These dysfunctions stem from alterations in store-operated Ca2+ entry and sarcoplasmic endoplasmic reticulum Ca2+-ATPase activity. We also found that PERK regulates calcineurin, and pharmacological inhibition of calcineurin results in similar defects on stimulus-secretion coupling. Our findings suggest that interplay between calcineurin and PERK regulates -cell Ca2+ signaling and insulin secretion, and that loss of this interaction may have profound implications in insulin secretion defects associated with diabetes.	[Wang, Rong; McGrath, Barbara C.; Tang, Xin; Chen, Gong; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA; [Kopp, Richard F.; Roe, Michael W.] SUNY Upstate Med Univ, Dept Med Cell & Dev Biol, Syracuse, NY 13210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cavener, DR (corresponding author), 101 LSB, University Pk, PA 16802 USA.	drc9@psu.edu	Tang, Xin/E-8191-2016; Wang, Rong/M-4503-2019	Kopp, Richard/0000-0001-8190-1748	National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140, R01DK092616] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Richard Ordway and Dr. Fumiko Kawasaki for advice and technical assistance with the FRET-based Ca<SUP>2+</SUP> imaging experiments. We thank Dr. Jeff Axten and Dr. Rakesh Kumar for providing the GSK414 PERK inhibitor and discussions about the effects of PERK inhibition. We thank the National Institutes of Health NIDDK-funded Integrated Islet Distribution Program (IIDP) at City of Hope for providing human pancreatic islets. We thank Cavener Lab members Elyse Munoz, Carrie Lewis, Jingjie Hu, and Siying Zhu for technical assistance and Dr. Fumihiko Urano, Dr. Christopher Newgard, Dr. Jun-Ichi Miyazaki, and Dr. Jonathan Lytton for providing experimental materials.	Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bollo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011925; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cavener DR, 2010, TRENDS ENDOCRIN MET, V21, P714, DOI 10.1016/j.tem.2010.08.005; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dyachok O, 2001, J CELL SCI, V114, P2179; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Feng DR, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-61; GILL DL, 2004, SCI STKE, pPE39, DOI DOI 10.1126/ST5E.2432004PE39; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heit JJ, 2007, BIOESSAYS, V29, P1011, DOI 10.1002/bies.20644; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; Jacobson D. A., 2007, V179, P409; Kitamura T, 2001, MOL CELL BIOL, V21, P5624, DOI 10.1128/MCB.21.16.5624-5630.2001; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu YJ, 1997, CELL CALCIUM, V22, P277, DOI 10.1016/S0143-4160(97)90066-X; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Moore CE, 2011, MOL ENDOCRINOL, V25, P315, DOI 10.1210/me.2010-0309; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Ravier MA, 2011, DIABETES, V60, P2533, DOI 10.2337/db10-1543; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Roe Michael Wm., 2006, V319, P37; Rubio-Cabezas O, 2009, J CLIN ENDOCR METAB, V94, P4162, DOI 10.1210/jc.2009-1137; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Senee V, 2004, DIABETES, V53, P1876, DOI 10.2337/diabetes.53.7.1876; Shaw JA, 2012, NEUROSCIENCE, V203, P144, DOI 10.1016/j.neuroscience.2011.12.010; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Tong L, 2007, IUBMB LIFE, V59, P402, DOI 10.1080/15216540701411244; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; Uchida K, 2011, ENDOCR J, V58, P1021, DOI 10.1507/endocrj.EJ11-0130; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	56	65	66	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33824	33836		10.1074/jbc.M113.503664	http://dx.doi.org/10.1074/jbc.M113.503664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24114838	Green Published, hybrid			2022-12-28	WOS:000327250200027
J	Hirota, Y; Tsugawa, N; Nakagawa, K; Suhara, Y; Tanaka, K; Uchino, Y; Takeuchi, A; Sawada, N; Kamao, M; Wada, A; Okitsu, T; Okano, T				Hirota, Yoshihisa; Tsugawa, Naoko; Nakagawa, Kimie; Suhara, Yoshitomo; Tanaka, Kiyoshi; Uchino, Yuri; Takeuchi, Atsuko; Sawada, Natsumi; Kamao, Maya; Wada, Akimori; Okitsu, Takashi; Okano, Toshio			Menadione (Vitamin K-3) Is a Catabolic Product of Oral Phylloquinone (Vitamin K-1) in the Intestine and a Circulating Precursor of Tissue Menaquinone-4 (Vitamin K-2) in Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzymes; Intestine; Metabolism; Rat; Vitamin K; UBIAD1; Conversion; Menadione; Menaquinone-4; Phylloquinone	CELL-LINES; CONVERSION; METABOLISM; CANNULATION	Background: Menadione is an intermediate in phylloquinone to menaquinone-4 conversion in mammals. Results: Menadione is released from phylloquinone in the intestine and converted to menaquinone-4 in tissues after being reduced. Conclusion: Menadione is a catabolic product of phylloquinone and circulating precursor of tissue menaquinone-4. Significance: Determining how phylloquinone is metabolized in the body is crucial for understanding vitamin K biology. Mice have the ability to convert dietary phylloquinone (vitamin K-1) into menaquinone-4 (vitamin K-2) and store the latter in tissues. A prenyltransferase enzyme, UbiA prenyltransferase domain-containing 1 (UBIAD1), is involved in this conversion. There is evidence that UBIAD1 has a weak side chain cleavage activity for phylloquinone but a strong prenylation activity for menadione (vitamin K-3), which has long been postulated as an intermediate in this conversion. Further evidence indicates that when intravenously administered in mice phylloquinone can enter into tissues but is not converted further to menaquinone-4. These findings raise the question whether phylloquinone is absorbed and delivered to tissues in its original form and converted to menaquinone-4 or whether it is converted to menadione in the intestine followed by delivery of menadione to tissues and subsequent conversion to menaquinone-4. To answer this question, we conducted cannulation experiments using stable isotope tracer technology in rats. We confirmed that the second pathway is correct on the basis of structural assignments and measurements of phylloquinone-derived menadione using high resolution MS analysis and a bioassay using recombinant UBIAD1 protein. Furthermore, high resolution MS and H-1 NMR analyses of the product generated from the incubation of menadione with recombinant UBIAD1 revealed that the hydroquinone, but not the quinone form of menadione, was an intermediate of the conversion. Taken together, these results provide unequivocal evidence that menadione is a catabolic product of oral phylloquinone and a major source of tissue menaquinone-4.	[Hirota, Yoshihisa; Tsugawa, Naoko; Nakagawa, Kimie; Uchino, Yuri; Sawada, Natsumi; Kamao, Maya; Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Kobe, Hyogo 6588558, Japan; [Wada, Akimori; Okitsu, Takashi] Kobe Pharmaceut Univ, Dept Bioorgan Chem, Kobe, Hyogo 6588558, Japan; [Takeuchi, Atsuko] Kobe Pharmaceut Univ, Analyt Ctr, Kobe, Hyogo 6588558, Japan; [Suhara, Yoshitomo] Shibaura Inst Technol, Dept Biosci & Engn, Saitama 3308570, Japan; [Tanaka, Kiyoshi] Kyoto Womens Univ, Dept Food & Nutr, Kyoto 6058501, Japan	Kobe Pharmaceutical University; Kobe Pharmaceutical University; Kobe Pharmaceutical University; Shibaura Institute of Technology; Kyoto Womens University	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	t-okano@kobepharma-u.ac.jp	Okitsu, Takashi/V-9676-2019; Hirota, Yoshihisa/R-6741-2019	Okitsu, Takashi/0000-0001-5836-4470; Hirota, Yoshihisa/0000-0002-6462-9479; Suhara, Yoshitomo/0000-0002-4770-2910	Japan Society for the Promotion of Science (JSPS) [23390022, 23790110];  [24-7941]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by Grant-in-aid for Scientific Research (B) 23390022 (to T. O.), Grant-in-aid for Scientific Research (Young Scientists-B) 23790110 (to K. N.) from the Japan Society for the Promotion of Science (JSPS), and Grant-in-aid for JSPS Fellows 24-7941 (to Y. H.).	Al Rajabi A, 2012, J NUTR, V142, P841, DOI 10.3945/jn.111.155804; Al Rajabi A, 2010, J CHROMATOGR B, V878, P2457, DOI 10.1016/j.jchromb.2010.07.016; Davidson RT, 1998, J NUTR, V128, P220, DOI 10.1093/jn/128.2.220; Ionac M, 2003, MICROSURG, V23, P239, DOI 10.1002/micr.10136; MEDINSKY MA, 1983, TOXICOL APPL PHARM, V68, P359, DOI 10.1016/0041-008X(83)90279-X; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Okano T, 2008, J BIOL CHEM, V283, P11270, DOI 10.1074/jbc.M702971200; Ronden JE, 1998, BBA-GEN SUBJECTS, V1379, P69, DOI 10.1016/S0304-4165(97)00089-5; Shearer MJ, 2012, ADV NUTR, V3, P182, DOI 10.3945/an.111.001800; SPEEK AJ, 1984, J CHROMATOGR, V301, P441, DOI 10.1016/S0021-9673(01)89217-7; Strubbe JH, 1999, PHYSIOL BEHAV, V65, P885; Suhara Y, 2010, BIOORGAN MED CHEM, V18, P3116, DOI 10.1016/j.bmc.2010.03.035; Suhara Y, 2009, BIOORG MED CHEM LETT, V19, P1054, DOI 10.1016/j.bmcl.2009.01.021; Suhara Y, 2006, BIOORGAN MED CHEM, V14, P6601, DOI 10.1016/j.bmc.2006.06.004; TAGGART WV, 1969, BIOCHEMISTRY-US, V8, P1141, DOI 10.1021/bi00831a047; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Yang J, 2005, LAB ANIM-UK, V39, P259, DOI 10.1258/0023677054307033	17	78	81	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33071	33080		10.1074/jbc.M113.477356	http://dx.doi.org/10.1074/jbc.M113.477356			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24085302	Green Published, hybrid			2022-12-28	WOS:000328841700023
J	Berkyurek, AC; Suetake, I; Arita, K; Takeshita, K; Nakagawa, A; Shirakawa, M; Tajima, S				Berkyurek, Ahmet Can; Suetake, Isao; Arita, Kyohei; Takeshita, Kohei; Nakagawa, Atsushi; Shirakawa, Masahiro; Tajima, Shoji			The DNA Methyltransferase Dnmt1 Directly Interacts with the SET and RING Finger-associated (SRA) Domain of the Multifunctional Protein Uhrf1 to Facilitate Accession of the Catalytic Center to Hemi-methylated DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; DNA Methyltransferase; Epigenetics; Gene Regulation; Gene Silencing	CYTOSINE-5 METHYLTRANSFERASES; MAINTENANCE; REPLICATION; SEQUENCE; BINDS; RECOGNITION; COMPLEX; SITES	Dnmt1 is responsible for the maintenance DNA methylation during replication to propagate methylation patterns to the next generation. The replication foci targeting sequence (RFTS), which plugs the catalytic pocket, is necessary for recruitment of Dnmt1 to the replication site. In the present study we found that the DNA methylation activity of Dnmt1 was DNA length-dependent and scarcely methylated 12-bp short hemi-methylated DNA. Contrarily, the RFTS-deleted Dnmt1 and Dnmt1 mutants that destroyed the hydrogen bonds between the RFTS and catalytic domain showed significant DNA methylation activity even toward 12-bp hemi-methylated DNA. The DNA methylation activity of the RFTS-deleted Dnmt1 toward 12-bp hemi-methylated DNA was strongly inhibited on the addition of RFTS, but to a lesser extent by Dnmt1 harboring the mutations that impair the hydrogen bond formation. The SRA domain of Uhrf1, which is a prerequisite factor for maintenance methylation and selectively binds to hemi-methylated DNA, stimulated the DNA methylation activity of Dnmt1. The SRA to Dnmt1 concentration ratio was the determinant for the maximum stimulation. In addition, a mutant SRA, which had lost the DNA binding activity but was able to bind to Dnmt1, stimulated the DNA methylation activity of Dnmt1. The results indicate that the DNA methylation activity of Dnmt1 was stimulated on the direct interaction of the SRA and Dnmt1. The SRA facilitated acceptance of the 12-bp fluorocytosine-containing DNA by the catalytic center. We propose that the SRA removes the RFTS plug from the catalytic pocket to facilitate DNA acceptance by the catalytic center.	[Berkyurek, Ahmet Can; Suetake, Isao; Takeshita, Kohei; Nakagawa, Atsushi; Tajima, Shoji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Arita, Kyohei] Yokohama City Univ, Grad Sch Nanobiosci, Div Macromol Crystallog, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Suetake, Isao; Shirakawa, Masahiro] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	Osaka University; Yokohama City University; Kyoto University; Japan Science & Technology Agency (JST)	Tajima, S (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tajima@protein.osaka-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Suetake, Isao/D-4326-2009; Arita, Kyohei/AAJ-6402-2020; Nakagawa, Atsushi/M-5731-2019; Suetake, Isao/G-3144-2013	Nakagawa, Atsushi/0000-0002-1700-7861; Suetake, Isao/0000-0002-1246-8474; Arita, Kyohei/0000-0002-9762-8405; Nakagawa, Atsushi/0000-0002-1700-7861; 	Japan Society for the Promotion of Science; CREST by Japan Science and Technology Agency; Japanese Government; Grants-in-Aid for Scientific Research [24116515, 24651214, 24570153, 24113711] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST by Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research B (to S. T.) and scientific research C (to I. S.) from the Japan Society for the Promotion of Science, and CREST by Japan Science and Technology Agency (to M. S. and I. S.).; Supported by a Japanese Government scholarship program.	Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Brank AS, 2002, PROTEIN EXPRES PURIF, V25, P31, DOI 10.1006/prep.2001.1606; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Suetake I, 2006, J BIOCHEM, V140, P763, DOI 10.1093/jb/mvj210; Sugiyama Y, 2010, BIOCHEM J, V427, P489, DOI 10.1042/BJ20091856; Syeda F, 2011, J BIOL CHEM, V286, P15344, DOI 10.1074/jbc.M110.209882; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200	23	80	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					379	386		10.1074/jbc.M113.523209	http://dx.doi.org/10.1074/jbc.M113.523209			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24253042	Green Published, hybrid			2022-12-28	WOS:000329370900033
J	Kim, C; Yun, N; Lee, YM; Jeong, JY; Baek, JY; Song, HY; Ju, C; Youdim, MBH; Jin, BK; Kim, WK; Oh, YJ				Kim, Chiho; Yun, Nuri; Lee, Young Mook; Jeong, Jae Y.; Baek, Jeong Y.; Song, Hwa Young; Ju, Chung; Youdim, Moussa B. H.; Jin, Byung K.; Kim, Won-Ki; Oh, Young J.			Gel-based Protease Proteomics for Identifying the Novel Calpain Substrates in Dopaminergic Neuronal Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calpain; Neurodegeneration; Parkinson Disease; Protein Degradation; Proteomics; Substrates	PROTEOLYTIC CLEAVAGE; PROTECTIVE ROLE; WILD-TYPE; DEATH; CASPASE; MECHANISMS; OPTINEURIN; ACTIVATION; DISEASE; GENE	Background: It is important to assess contribution of calpain activation and identify substrates affected during neurodegeneration. Results: Gel-based protease proteomics identified novel substrates that were cleaved in neurotoxin-treated culture and rat brain disease models. Conclusion: These novel calpain substrates may confer protection against neurodegeneration. Significance: Our findings contribute to better deciphering the molecular mechanism underlying the progression of protease-mediated neurodegeneration. Calpains are a family of calcium-dependent cysteine proteases that are ubiquitously expressed in mammals and play critical roles in neuronal death by catalyzing substrate proteolysis. Here, we developed two-dimensional gel electrophoresis-based protease proteomics to identify putative calpain substrates. To accomplish this, cellular lysates from neuronal cells were first separated by pI, and the immobilized sample on a gel strip was incubated with a recombinant calpain and separated by molecular weight. Among 25 altered protein spots that were differentially expressed by at least 2-fold, we confirmed that arsenical pump-driving ATPase, optineurin, and peripherin were cleaved by calpain using in vitro and in vivo cleavage assays. Furthermore, we found that all of these substrates were cleaved in MN9D cells treated with either ionomycin or 1-methyl-4-phenylpyridinium, both of which cause a calcium-mediated calpain activation. Their cleavage was blocked by calcium chelator or calpain inhibitors. In addition, calpain-mediated cleavage of these substrates and its inhibition by calpeptin were confirmed in a middle cerebral artery occlusion model of cerebral ischemia, as well as a stereotaxic brain injection model of Parkinson disease. Transient overexpression of each protein was shown to attenuate 1-methyl-4-phenylpyridinium-induced cell death, indicating that these substrates may confer protection of varying magnitudes against dopaminergic injury. Taken together, the data indicate that our protease proteomic method has the potential to be applicable for identifying proteolytic substrates affected by diverse proteases. Moreover, the results described here will help us decipher the molecular mechanisms underlying the progression of neurodegenerative disorders where protease activation is critically involved.	[Kim, Chiho; Yun, Nuri; Youdim, Moussa B. H.; Oh, Young J.] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea; [Lee, Young Mook] Univ Colorado, Div Clin Pharmacol, Dept Med, Hlth Sci Ctr, Denver, CO 80262 USA; [Jeong, Jae Y.; Baek, Jeong Y.; Jin, Byung K.] Kyung Hee Univ, Dept Biochem & Mol Biol, Dept Neurosci, Neurodegenerat Control Res Ctr,Sch Med, Seoul 130701, South Korea; [Song, Hwa Young; Ju, Chung; Kim, Won-Ki] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea	Yonsei University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Kyung Hee University; Korea University; Korea University Medicine (KU Medicine)	Kim, WK (corresponding author), Anamdong 5 Ga, Seoul 136705, South Korea.	wonki@korea.ac.kr; yjoh@yonsei.ac.kr		Yun, Nuri/0000-0003-1853-1304	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012-0000496]; World Class University Grant [R33-10014]; Bio & Medical Technology Development Program Grant through the National Research Foundation of Korea [2011-0019440]; Ministry of Science and Technology	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University Grant; Bio & Medical Technology Development Program Grant through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2012-0000496 and World Class University Grant R33-10014 (to Y. J. O.). This work was also supported by Bio & Medical Technology Development Program Grant 2011-0019440 through the National Research Foundation of Korea funded by the Ministry of Science and Technology (to W. K. K.).	Agard NJ, 2009, CURR OPIN CHEM BIOL, V13, P503, DOI 10.1016/j.cbpa.2009.07.026; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Bevers MB, 2009, J NEUROCHEM, V108, P1237, DOI 10.1111/j.1471-4159.2008.05860.x; Bozoky Z, 2009, ARCH BIOCHEM BIOPHYS, V481, P219, DOI 10.1016/j.abb.2008.11.011; Brule C, 2010, BIOCHIMIE, V92, P1923, DOI 10.1016/j.biochi.2010.09.003; Caberoy NB, 2011, MOLECULES, V16, P1739, DOI 10.3390/molecules16021739; Camins A, 2009, CURR DRUG METAB, V10, P433, DOI 10.2174/138920009788898028; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Choi IY, 2011, AM J PATHOL, V179, P2042, DOI 10.1016/j.ajpath.2011.07.006; Choi WS, 2008, BIOCHEM BIOPH RES CO, V371, P127, DOI 10.1016/j.bbrc.2008.04.020; Choi WS, 2001, J NEUROCHEM, V77, P1531, DOI 10.1046/j.1471-4159.2001.00368.x; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Cryns VL, 1997, J BIOL CHEM, V272, P29449, DOI 10.1074/jbc.272.47.29449; Cuerrier D, 2005, J BIOL CHEM, V280, P40632, DOI 10.1074/jbc.M506870200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; Demon D, 2009, TRENDS BIOTECHNOL, V27, P680, DOI 10.1016/j.tibtech.2009.09.007; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Han BS, 2003, J NEUROSCI, V23, P5069; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Kamada S, 1998, P NATL ACAD SCI USA, V95, P8532, DOI 10.1073/pnas.95.15.8532; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kedzierski W, 2001, P NATL ACAD SCI USA, V98, P7718, DOI 10.1073/pnas.141124198; Kim HE, 2001, BIOCHEM BIOPH RES CO, V286, P659, DOI 10.1006/bbrc.2001.5446; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee YM, 2008, J BIOL CHEM, V283, P9986, DOI 10.1074/jbc.M800426200; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MOLINARI M, 1995, J BIOL CHEM, V270, P2032, DOI 10.1074/jbc.270.5.2032; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nakanishi H, 2003, MOL NEUROBIOL, V27, P163, DOI 10.1385/MN:27:2:163; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Peng S, 2011, MOL BIOL REP, V38, P905, DOI 10.1007/s11033-010-0183-2; Ray SK, 2011, NEUROTHERAPEUTICS, V8, P180, DOI 10.1007/s13311-011-0037-1; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Samantaray S, 2008, CNS NEUROL DISORD-DR, V7, P305, DOI 10.2174/187152708784936680; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Tamada Y, 2005, BRAIN RES, V1050, P148, DOI 10.1016/j.brainres.2005.05.048; TISA LS, 1990, J BIOL CHEM, V265, P190; TROY CM, 1990, BRAIN RES, V529, P232, DOI 10.1016/0006-8993(90)90832-V; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wood DE, 1999, J BIOL CHEM, V274, P8309, DOI 10.1074/jbc.274.12.8309; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	57	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36717	36732		10.1074/jbc.M113.492876	http://dx.doi.org/10.1074/jbc.M113.492876			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24235151	Green Published, hybrid			2022-12-28	WOS:000328883400049
J	Regadas, I; Matos, MR; Monteiro, FA; Gomez-Skarmeta, JL; Lima, D; Bessa, J; Casares, F; Reguenga, C				Regadas, Isabel; Matos, Mariana Raimundo; Monteiro, Filipe Almeida; Luis Gomez-Skarmeta, Jose; Lima, Deolinda; Bessa, Jose; Casares, Fernando; Reguenga, Carlos			Several Cis-regulatory Elements Control mRNA Stability, Translation Efficiency, and Expression Pattern of Prrxl1 (Paired Related Homeobox Protein-like 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Neurodevelopment; Pain; Promoters; Transcription; Developmental Factors; 5-UTR; Phox2b; Prrxl1; Alternative Promoters; Sensory Neurons	DORSAL SPINAL-CORD; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; SENSORY NEURONS; ALTERNATIVE PROMOTERS; BINDING-PROTEINS; CELL; PHOX2B; TRANSCRIPTION; ZEBRAFISH	Background: The mechanisms that control the Prrxl1 expression are poorly understood. Results: Several regulatory elements present in Prrxl1 alternative promoters are functionally characterized, including a binding motif for Phox2b required for Prrxl1 expression in visceral sensory neurons. Conclusion: We define diverse regulatory modules, which control the spatiotemporal expression of Prrxl1 in nociceptive neurons. Significance: A new mechanism involved in the ganglion specific action of Prrxl1 is described. The homeodomain transcription factor Prrxl1/DRG11 has emerged as a crucial molecule in the establishment of the pain circuitry, in particular spinal cord targeting of dorsal root ganglia (DRG) axons and differentiation of nociceptive glutamatergic spinal cord neurons. Despite Prrxl1 importance in the establishment of the DRG-spinal nociceptive circuit, the molecular mechanisms that regulate its expression along development remain largely unknown. Here, we show that Prrxl1 transcription is regulated by three alternative promoters (named P1, P2, and P3), which control the expression of three distinct Prrxl1 5-UTR variants, named 5-UTR-A, 5-UTR-B, and 5-UTR-C. These 5-UTR sequences confer distinct mRNA stability and translation efficiency to the Prrxl1 transcript. The most conserved promoter (P3) contains a TATA-box and displays in vivo enhancer activity in a pattern that overlaps with the zebrafish Prrxl1 homologue, drgx. Regulatory modules present in this sequence were identified and characterized, including a binding site for Phox2b. Concomitantly, we demonstrate that zebrafish Phox2b is required for the expression of drgx in the facial, glossopharyngeal, and vagal cranial ganglia.	[Regadas, Isabel; Matos, Mariana Raimundo; Monteiro, Filipe Almeida; Lima, Deolinda; Reguenga, Carlos] Univ Porto, Dept Biol Expt, Fac Med Porto, P-4200319 Oporto, Portugal; [Regadas, Isabel; Matos, Mariana Raimundo; Monteiro, Filipe Almeida; Lima, Deolinda; Bessa, Jose; Reguenga, Carlos] Univ Porto, Inst Biol Mol & Celular, P-4150 Oporto, Portugal; [Luis Gomez-Skarmeta, Jose; Bessa, Jose; Casares, Fernando] CABD Consejo Super Invest Cient UPO Junta Andaluc, Seville 41013, Spain	Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD)	Reguenga, C (corresponding author), Fac Med Porto, Dept Expt Biol, 4th Floor, P-4200319 Oporto, Portugal.	cregueng@med.up.pt	Casares, Fernando/M-5451-2019; Monteiro, Filipe Almeida/N-8479-2018; Gomez-Skarmeta, Jose Luis/B-5268-2014; Bessa, Jose/I-8084-2013	Casares, Fernando/0000-0002-2181-3858; Monteiro, Filipe Almeida/0000-0003-0670-3658; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Lima, Deolinda/0000-0002-5723-0777; Bessa, Jose/0000-0002-8591-7138; Reguenga, Carlos/0000-0003-1219-9961	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/65300/2009, PTDC/SAU-OBD/099886/2008]; COMPETE [COMP-01-0124-FEDER-011262]; Universidade do Porto/Banco Santander Totta (Projectos Pluridisciplinares)	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; Universidade do Porto/Banco Santander Totta (Projectos Pluridisciplinares)	This work was supported by the Fundacao para a Ciencia e a Tecnologia (SFRH/BD/65300/2009 (to I. R.) and PTDC/SAU-OBD/099886/2008), COMPETE: FCOMP-01-0124-FEDER-011262, and Universidade do Porto/Banco Santander Totta (Projectos Pluridisciplinares).	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Akamatsu W, 1999, P NATL ACAD SCI USA, V96, P9885, DOI 10.1073/pnas.96.17.9885; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Banday AR, 2011, MOL CELL BIOCHEM, V357, P263, DOI 10.1007/s11010-011-0897-z; Bessa J, 2008, DEVELOPMENT, V135, P799, DOI 10.1242/dev.011932; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; D'Autreaux F, 2011, P NATL ACAD SCI USA, V108, P20018, DOI 10.1073/pnas.1110416108; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Ding YQ, 2004, DEVELOPMENT, V131, P3693, DOI 10.1242/dev.01250; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Elworthy S, 2005, MECH DEVELOP, V122, P659, DOI 10.1016/j.mod.2004.12.008; Gauss KA, 2006, GENE, V366, P169, DOI 10.1016/j.gene.2005.09.012; GEBALLE AP, 1994, TRENDS BIOCHEM SCI, V19, P159, DOI 10.1016/0968-0004(94)90277-1; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Grandien K, 1997, INT J BIOCHEM CELL B, V29, P1343, DOI 10.1016/S1357-2725(97)89967-0; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kim JD, 2011, MOL CELLS, V31, P141, DOI 10.1007/s10059-011-0018-6; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Knight RD, 2005, DEVELOPMENT, V132, P3127, DOI 10.1242/dev.01879; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; McCormick LJ, 2007, GENE EXPR PATTERNS, V7, P289, DOI 10.1016/j.modgep.2006.09.003; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Mobarak CD, 2000, MOL BIOL CELL, V11, P3191, DOI 10.1091/mbc.11.9.3191; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicholas SB, 1998, AM J PHYSIOL-HEART C, V274, pH217, DOI 10.1152/ajpheart.1998.274.1.H217; Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Qian Y, 2002, GENE DEV, V16, P1220, DOI 10.1101/gad.982802; Rebelo S, 2007, DEV DYNAM, V236, P2653, DOI 10.1002/dvdy.21271; Rebelo S, 2006, MOL CELL NEUROSCI, V33, P236, DOI 10.1016/j.mcn.2006.07.013; Rebelo S, 2010, DEV DYNAM, V239, P1684, DOI 10.1002/dvdy.22305; Rebelo S, 2009, INT J DEV BIOL, V53, P1089, DOI 10.1387/ijdb.072507sr; Riquet FB, 2001, J BIOL CHEM, V276, P38665, DOI 10.1074/jbc.M009881200; Rogozin IB, 2001, BIOINFORMATICS, V17, P890, DOI 10.1093/bioinformatics/17.10.890; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wildner H, 2006, DEVELOPMENT, V133, P2105, DOI 10.1242/dev.02345; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yang CY, 1998, J NEUROCHEM, V71, P1813; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	65	10	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36285	36301		10.1074/jbc.M113.491993	http://dx.doi.org/10.1074/jbc.M113.491993			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24214975	Green Published, hybrid			2022-12-28	WOS:000328883400012
J	Suzuki, Y; Yamamura, H; Ohya, S; Imaizumi, Y				Suzuki, Yoshiaki; Yamamura, Hisao; Ohya, Susumu; Imaizumi, Yuji			Caveolin-1 Facilitates the Direct Coupling between Large Conductance Ca2+-activated K+ (BKCa) and Cav1.2 Ca2+ Channels and Their Clustering to Regulate Membrane Excitability in Vascular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Caveolin; Fluorescence Resonance Energy Transfer (FRET); Imaging; Single Molecule Biophysics; Vascular Smooth Muscle Cells; L-type Voltage-dependent Calcium Channel; Large Conductance Calcium-activated Potassium Channel; Total Internal Reflection Fluorescent Microscopy	SMOOTH-MUSCLE-CELLS; PIG VAS-DEFERENS; ARTERIAL; PROTEIN; RELEASE; ACTIVATION; RELAXATION; EXPRESSION; SINGLE; DEPOLARIZATION	Background: The contribution of caveolae to physiological interaction between two major ion channels, large conductance Ca2+-activated K+ (BKCa) and Ca2+ (Cav1.2) channels, is unknown in vascular myocytes. Results: The loss of caveola by caveolin-1 deficiency reduced BKCa-Cav1.2 coupling, Cav1.2 clustering, and membrane excitability regulation. Conclusion: Caveolin-1 provides platform for BKCa-Cav1.2 molecular complex. Significance: Caveolin-1-BKCa-Cav1.2 in caveola forms a novel Ca2+ signal domain for arterial tonus regulation. L-type voltage-dependent Ca2+ channels (LVDCC) and large conductance Ca2+-activated K+ channels (BKCa) are the major factors defining membrane excitability in vascular smooth muscle cells (VSMCs). The Ca2+ release from sarcoplasmic reticulum through ryanodine receptor significantly contributes to BKCa activation in VSMCs. In this study direct coupling between LVDCC (Cav1.2) and BKCa and the role of caveoline-1 on their interaction in mouse mesenteric artery SMCs were examined. The direct activation of BKCa by Ca2+ influx through coupling LVDCC was demonstrated by patch clamp recordings in freshly isolated VSMCs. Using total internal reflection fluorescence microscopy, it was found that a large part of yellow fluorescent protein-tagged BKCa co-localized with the cyan fluorescent protein-tagged Cav1.2 expressed in the plasma membrane of primary cultured mouse VSMCs and that the two molecules often exhibited FRET. It is notable that each BK subunit of a tetramer in BKCa can directly interact with Cav1.2 and promotes Cav1.2 cluster in the molecular complex. Furthermore, caveolin-1 deficiency in knock-out (KO) mice significantly reduced not only the direct coupling between BKCa and Cav1.2 but also the functional coupling between BKCa and ryanodine receptor in VSMCs. The measurement of single cell shortening by 40 mm K+ revealed enhanced contractility in VSMCs from KO mice than wild type. Taken together, caveolin-1 facilitates the accumulation/clustering of BKCa-LVDCC complex in caveolae, which effectively regulates spatiotemporal Ca2+ dynamics including the negative feedback, to control the arterial excitability and contractility.	[Suzuki, Yoshiaki; Yamamura, Hisao; Ohya, Susumu; Imaizumi, Yuji] Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Ohya, Susumu] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol, Kyoto 6078414, Japan	Nagoya City University; Kyoto Pharmaceutical University	Imaizumi, Y (corresponding author), Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Ohya, Susumu/AAB-3618-2020; Suzuki, Yoshiaki/ABH-5320-2020; Imaizumi, Yuji/AAF-6585-2020	Ohya, Susumu/0000-0002-5765-0667; Suzuki, Yoshiaki/0000-0002-7879-6059; 	Ministry of Education, Culture, Sports, Science, and Technology [20056027, 23136512]; Japan Society for the Promotion of Science [23390020, 226641]; Grants-in-Aid for Scientific Research [23390020, 25460111] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 20056027 and 23136512 (to Y. I.) from the Ministry of Education, Culture, Sports, Science, and Technology, Grant-in-aid for Scientific Research (B) 23390020 (to Y. I.), and Grant-in-aid for Japan Society for the Promotion of Science Fellows 226641 (to Y. S.) from the Japan Society for the Promotion of Science.	Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Cheng XY, 2006, AM J PHYSIOL-HEART C, V290, pH2309, DOI 10.1152/ajpheart.01226.2005; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Collier ML, 2000, J GEN PHYSIOL, V115, P653, DOI 10.1085/jgp.115.5.653; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Daniel EE, 2006, J CELL MOL MED, V10, P529, DOI 10.1111/j.1582-4934.2006.tb00418.x; Dinardo MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040235; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Guia A, 1999, CIRC RES, V84, P1032, DOI 10.1161/01.RES.84.9.1032; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; Hotta S, 2007, J PHARMACOL SCI, V103, P121, DOI 10.1254/jphs.SC0060213; Imaizumi Y, 1998, J PHYSIOL-LONDON, V510, P705, DOI 10.1111/j.1469-7793.1998.705bj.x; IMAIZUMI Y, 1989, J PHYSIOL-LONDON, V411, P131, DOI 10.1113/jphysiol.1989.sp017565; ITOH T, 1983, J PHYSIOL-LONDON, V337, P609, DOI 10.1113/jphysiol.1983.sp014645; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Loane DJ, 2007, J CELL SCI, V120, P985, DOI 10.1242/jcs.03399; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Morimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC388, DOI 10.1152/ajpcell.00409.2005; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Naraghi M, 1997, J NEUROSCI, V17, P6961; Navedo MF, 2007, AM J PHYSIOL-HEART C, V293, pH1359, DOI 10.1152/ajpheart.00450.2007; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Navedo MF, 2010, CIRC RES, V106, P748, DOI 10.1161/CIRCRESAHA.109.213363; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nuno DW, 2012, AM J PHYSIOL-REG I, V303, pR959, DOI 10.1152/ajpregu.00667.2011; Ohba T, 2013, J PHARMACOL EXP THER, V347, P145, DOI 10.1124/jpet.113.205138; Ohi Y, 2001, J PHYSIOL-LONDON, V534, P313, DOI 10.1111/j.1469-7793.2001.t01-3-00313.x; Ohya S, 2001, PFLUG ARCH EUR J PHY, V441, P611, DOI 10.1007/s004240000463; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Rodrigues GJ, 2010, EUR J PHARMACOL, V627, P251, DOI 10.1016/j.ejphar.2009.11.010; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Santana LF, 2009, J MOL CELL CARDIOL, V47, P436, DOI 10.1016/j.yjmcc.2009.07.008; Shakirova Y, 2006, AM J PHYSIOL-CELL PH, V291, pC1326, DOI 10.1152/ajpcell.00046.2006; Suzuki Y, 2013, BIOCHEM BIOPH RES CO, V430, P1169, DOI 10.1016/j.bbrc.2012.12.015; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Weston AH, 2010, BRIT J PHARMACOL, V160, P836, DOI 10.1111/j.1476-5381.2010.00657.x; Yamamura H, 2012, BIOCHEM BIOPH RES CO, V427, P54, DOI 10.1016/j.bbrc.2012.08.145; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011	53	43	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36750	36761		10.1074/jbc.M113.511485	http://dx.doi.org/10.1074/jbc.M113.511485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24202214	Green Published, hybrid			2022-12-28	WOS:000328883400052
J	Hofmeister-Brix, A; Kollmann, K; Langer, S; Schultz, J; Lenzen, S; Baltrusch, S				Hofmeister-Brix, Anke; Kollmann, Katrin; Langer, Sara; Schultz, Julia; Lenzen, Sigurd; Baltrusch, Simone			Identification of the Ubiquitin-like Domain of Midnolin as a New Glucokinase Interaction Partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence Resonance Energy Transfer (FRET); Glucokinase; Insulin Secretion; Insulin Synthesis; Pancreatic Islets; Parkin; Ubiquitin; Midnolin; Two-hybrid System; Ubiquitin-like Domain	PANCREATIC BETA-CELLS; INSULIN-PRODUCING CELLS; SWISS-MODEL; REGULATORY PROTEIN; DIFFERENTIAL EXPRESSION; GLUCOSE-HOMEOSTASIS; PROTEASOME SYSTEM; GENE-EXPRESSION; RAT-LIVER; B-CELLS	Background: Glucokinase activity is regulated on the posttranslational level in pancreatic beta cells. Results: Searching a pancreatic islet yeast two-hybrid library, the ubiquitin-like domain of midnolin was identified to bind and inhibit glucokinase at low glucose, thereby reducing insulin secretion. Conclusion: Midnolin is a new glucokinase interaction partner. Significance: This is the first report demonstrating midnolin protein expression in pancreatic beta cells. Glucokinase acts as a glucose sensor in pancreatic beta cells. Its posttranslational regulation is important but not yet fully understood. Therefore, a pancreatic islet yeast two-hybrid library was produced and searched for glucokinase-binding proteins. A protein sequence containing a full-length ubiquitin-like domain was identified to interact with glucokinase. Mammalian two-hybrid and fluorescence resonance energy transfer analyses confirmed the interaction between glucokinase and the ubiquitin-like domain in insulin-secreting MIN6 cells and revealed the highest binding affinity at low glucose. Overexpression of parkin, an ubiquitin E3 ligase exhibiting an ubiquitin-like domain with high homology to the identified, diminished insulin secretion in MIN6 cells but had only some effect on glucokinase activity. Overexpression of the elucidated ubiquitin-like domain or midnolin, containing exactly this ubiquitin-like domain, significantly reduced both intrinsic glucokinase activity and glucose-induced insulin secretion. Midnolin has been to date classified as a nucleolar protein regulating mouse development. However, we could not confirm localization of midnolin in nucleoli. Fluorescence microscopy analyses revealed localization of midnolin in nucleus and cytoplasm and co-localization with glucokinase in pancreatic beta cells. In addition we could show that midnolin gene expression in pancreatic islets is up-regulated at low glucose and that the midnolin protein is highly expressed in pancreatic beta cells and also in liver, muscle, and brain of the adult mouse and cell lines of human and rat origin. Thus, the results of our study suggest that midnolin plays a role in cellular signaling of adult tissues and regulates glucokinase enzyme activity in pancreatic beta cells.	[Hofmeister-Brix, Anke; Kollmann, Katrin; Langer, Sara; Lenzen, Sigurd; Baltrusch, Simone] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany; [Schultz, Julia; Baltrusch, Simone] Univ Rostock, Inst Med Biochem & Mol Biol, D-18057 Rostock, Germany	Hannover Medical School; University of Rostock	Baltrusch, S (corresponding author), Univ Rostock, Inst Med Biochem & Mol Biol, D-18057 Rostock, Germany.	simone.baltrusch@med.uni-rostock.de			Innovative Medicines Initiative Joint Undertaking Grant [155005]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA)	Innovative Medicines Initiative Joint Undertaking Grant; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA)	The work was supported by Innovative Medicines Initiative Joint Undertaking Grant 155005 (Innovative Medicines Initiative for Diabetes), the resources of which are composed of financial contributions from the European Union Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies in kind contribution.	Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; Arden C, 2004, DIABETES, V53, P2346, DOI 10.2337/diabetes.53.9.2346; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baltrusch S, 2005, DIABETES, V54, P2829, DOI 10.2337/diabetes.54.10.2829; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Baltrusch S, 2006, DIABETES, V55, pS55, DOI 10.2337/db06-S008; Baltrusch S, 2007, DIABETES, V56, P1305, DOI 10.2337/db06-0894; BEERS EP, 1993, J BIOL CHEM, V268, P21645; Bjorkhaug L, 2007, J BIOL CHEM, V282, P22757, DOI 10.1074/jbc.M700517200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORNISHBOWDEN A, 1986, BIOCHEM J, V240, P293, DOI 10.1042/bj2400293; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Ding SY, 2011, J BIOL CHEM, V286, P16768, DOI 10.1074/jbc.M110.192799; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Hofmeister-Brix A, 2013, BIOCHEM J, V456, P173, DOI 10.1042/BJ20130262; Huynh DP, 2001, DEV BRAIN RES, V130, P173, DOI 10.1016/S0165-3806(01)00234-6; IYNEDJIAN PB, 1986, P NATL ACAD SCI USA, V83, P1998, DOI 10.1073/pnas.83.7.1998; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KORANYI LI, 1992, DIABETES, V41, P807, DOI 10.2337/diabetes.41.7.807; Kuhn K, 2004, DEV BRAIN RES, V149, P131, DOI 10.1016/j.devbrainres.2004.02.001; Langer S, 2010, MOL ENDOCRINOL, V24, P1988, DOI 10.1210/me.2010-0115; Larion M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001452; LENZEN S, 1988, BIOCHEM PHARMACOL, V37, P371, DOI 10.1016/0006-2952(88)90201-8; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; Markwardt ML, 2012, MOL ENDOCRINOL, V26, P1617, DOI 10.1210/me.2012-1183; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; Matschinsky FM, 2006, DIABETES, V55, P1; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Negahdar M, 2012, BBA-MOL BASIS DIS, V1822, P1705, DOI 10.1016/j.bbadis.2012.07.005; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Schmitt H, 2011, DIABETOLOGIA, V54, P1744, DOI 10.1007/s00125-011-2133-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; SIBROWSKI W, 1984, J BIOL CHEM, V259, P343; Smith WE, 2007, MOL ENDOCRINOL, V21, P1478, DOI 10.1210/me.2006-0356; TIEDGE M, 1995, BIOCHEM J, V308, P139, DOI 10.1042/bj3080139; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tsukahara M, 2000, GENE, V254, P45, DOI 10.1016/S0378-1119(00)00259-6; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walters KJ, 2004, BBA-MOL CELL RES, V1695, P73, DOI 10.1016/j.bbamcr.2004.10.005; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yang F, 2007, GENE EXPR PATTERNS, V7, P131, DOI 10.1016/j.modgep.2006.06.002; YIN L, 1992, DIABETES, V41, P792; Zielak AE, 2008, MOL REPROD DEV, V75, P904, DOI 10.1002/mrd.20819	63	31	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35824	35839		10.1074/jbc.M113.526632	http://dx.doi.org/10.1074/jbc.M113.526632			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187134	hybrid, Green Published			2022-12-28	WOS:000329814700020
J	Chung, JH; Karkhanis, V; Tae, S; Yan, FT; Smith, P; Ayers, LW; Agostinelli, C; Pileri, S; Denis, GV; Baiocchi, RA; Sif, S				Chung, Jihyun; Karkhanis, Vrajesh; Tae, Sookil; Yan, Fengting; Smith, Porsha; Ayers, Leona W.; Agostinelli, Claudio; Pileri, Stefano; Denis, Gerald V.; Baiocchi, Robert A.; Sif, Said			Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Cyclin D1; Leukemia; Lymphoma; Retinoblastoma (Rb); PRC2; PRMT5; RB1; RBL2	TARGET GENES; P53 ACTIVITY; CYCLIN D1; EXPRESSION; EZH2; PROLIFERATION; METHYLATION; APOPTOSIS; TRANSCRIPTION; INTERACTS	Background: PRMT5, PRC2, and cyclin D1 are overexpressed in non-Hodgkin lymphoma (NHL). Results: PRMT5 expression inversely correlates with levels of hypophospho-RB1 and RBL2. Conclusion: PRMT5 inhibition reactivates RB1 and RBL2 and silences PRC2 and cyclin D1. Significance: PRMT5 inhibition results in NHL growth arrest and cell death. Epigenetic regulation mediated by lysine- and arginine-specific enzymes plays an essential role in tumorigenesis, and enhanced expression of the type II protein arginine methyltransferase PRMT5 as well as the polycomb repressor complex PRC2 has been associated with increased cell proliferation and survival. Here, we show that PRMT5 is overexpressed in three different types of non-Hodgkin lymphoma cell lines and clinical samples as well as in mouse primary lymphoma cells and that it up-regulates PRC2 expression through inactivation of the retinoblastoma proteins RB1 and RBL2. Although PRMT5 epigenetically controls RBL2 expression, it indirectly promotes RB1 phosphorylation through enhanced cyclin D1 expression. Furthermore, we demonstrate that PRMT5 knockdown in non-Hodgkin lymphoma cell lines and mouse primary lymphoma cells leads to RBL2 derepression and RB1 reactivation, which in turn inhibit PRC2 expression and trigger derepression of its CASP10, DAP1, HOXA5, and HRK pro-apoptotic target genes. We also show that reduced PRMT5 expression leads to cyclin D1 transcriptional repression via loss of TP53K372 methylation, which results in decreased BCL3 expression and enhanced recruitment of NF-B p52-HDAC1 repressor complexes to the cyclin D1 promoter. These findings indicate that PRMT5 is a master epigenetic regulator that governs expression of its own target genes and those regulated by PRC2 and that its inhibition could offer a promising therapeutic strategy for lymphoma patients.	[Chung, Jihyun; Karkhanis, Vrajesh; Tae, Sookil; Sif, Said] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Ayers, Leona W.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Yan, Fengting; Smith, Porsha; Baiocchi, Robert A.] Ohio State Univ, Coll Med, Div Hematol, Columbus, OH 43210 USA; [Agostinelli, Claudio; Pileri, Stefano] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Hematopathol Unit, I-40126 Bologna, Italy; [Denis, Gerald V.] Boston Univ, Sch Med, Canc Res Ctr, Boston, MA 02118 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Bologna; Boston University	Sif, S (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	sif.1@osu.edu	Sif, Said/AAE-5554-2019	Sif, Said/0000-0001-6268-1145; Denis, Gerald/0000-0001-9886-0401; Agostinelli, Claudio/0000-0002-4945-1422	National Institutes of Health from NCI [R01 CA116093]; Leukemia Research Foundation MCL Initiative; Associazione Italiana per la Ricerca sul Cancro (AIRC) [10007]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA116093, R29CA075107, R03CA102889] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000091] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation MCL Initiative; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA116093 from NCI (to S. S.). This work was also supported by the Leukemia Research Foundation MCL Initiative and Associazione Italiana per la Ricerca sul Cancro (AIRC) 5X100 Grant 10007 (to S. P.).	Agostinelli C, 2012, HISTOPATHOLOGY, V61, P33, DOI 10.1111/j.1365-2559.2012.04198.x; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen HX, 2004, MOL CELL BIOL, V24, P924, DOI 10.1128/MCB.24.2.924-935.2004; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; FISHER RI, 1995, BLOOD, V85, P1075, DOI 10.1182/blood.V85.4.1075.bloodjournal8541075; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schug J., 2008, CURR PROTOC BIOINFOR, V21, DOI DOI 10.1002/0471250953.BI0206S21; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Swerdlow SH, 2008, WHO CLASSIFICATION T, P229; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; TEODOROVIC I, 1995, J CLIN ONCOL, V13, P2819, DOI 10.1200/JCO.1995.13.11.2819; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	50	68	78	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35534	35547		10.1074/jbc.M113.510669	http://dx.doi.org/10.1074/jbc.M113.510669			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24189068	Green Published, hybrid			2022-12-28	WOS:000329867600048
J	Hattori, T; Kishino, T; Stephen, S; Eberspaecher, H; Maki, S; Takigawa, M; de Crombrugghe, B; Yasuda, H				Hattori, Takako; Kishino, Tetsuya; Stephen, Shelley; Eberspaecher, Heidi; Maki, Sayumi; Takigawa, Masaharu; de Crombrugghe, Benoit; Yasuda, Hideyo			E6-AP/UBE3A Protein Acts as a Ubiquitin Ligase toward SOX9 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondrocytes; E3 Ubiquitin Ligase; Protein Degradation; Proteomics; Ubiquitin; Ubiquitination; E6-AP; SOX9; UBE3A	CHONDROCYTE-SPECIFIC ENHANCER; AUTOSOMAL SEX REVERSAL; CAMPOMELIC DYSPLASIA; GENE; CARTILAGE; TRANSCRIPTION; EXPRESSION; COLLAGEN; DIFFERENTIATION; IDENTIFICATION	Background: Although the ubiquitin-proteasome pathway is thought to regulate the level of SOX9, the ubiquitin ligase involved has not yet been determined. Results: E6-AP/UBE3A was found to bind and ubiquitinate SOX9. Conclusion: E6-AP/UBE3A functions as a ubiquitin ligase toward SOX9 both in vitro and in vivo. Significance: These data provide the regulatory mechanism of the SOX9 level in chondrocytes by ubiquitin ligase. SOX9 is a transcription factor that acts as a key regulator at various stages of cartilage differentiation. There is ample evidence that intracellular SOX9 protein levels are tightly regulated both by sumoylation and by degradation through the ubiquitin-proteasome pathway. Using a proteomics approach, here we report the identification of a SOX9-binding protein, E6-AP/UBE3A, that may act as a ubiquitin ligase toward Sox9. E6-AP bound SOX9 through the region consisting mostly of its high mobility group domain in vitro. In nuclear lysates, FLAG-tagged E6-AP coprecipitated with Sox9 and its high mobility group domain. This finding was estimated using nuclear lysates from a chondrocytic cell line that endogenously expresses E6-AP and SOX9. Accordingly, ectopically expressed E6-AP and SOX9 colocalized in the nucleus. We show that E6-AP ubiquitinates SOX9 in vitro and in vivo and that SOX9 levels are enhanced after addition of the proteasome inhibitor bortezomib. Similar, siRNA knockdown of E6-AP and the E2 ligase Ubc9 increased cellular SOX9 amounts, supporting the notion that SOX9 may be ubiquitinated in hypertrophic chondrocytes by E6-AP and degraded by proteasomes. This is in accordance with the distribution of SOX9 levels, which are high in proliferating and prehypertrophic chondrocytes but low in hypertrophic chondrocytes, whereas E6-AP levels are high in hypertrophic chondrocytes and low in prehypertrophic chondrocytes. Furthermore, E6-AP-deficient mice showed SOX9 accumulation in chondrocytes and the brain. These findings support the concept that E6-AP regulates SOX9 levels in developing cartilage by acting as a ubiquitin ligase.	[Hattori, Takako; Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Kita Ku, Okayama 7008525, Japan; [Kishino, Tetsuya] Nagasaki Univ, Div Funct Genom, Ctr Frontier Life Sci, Nagasaki 852852, Japan; [Hattori, Takako; Stephen, Shelley; Eberspaecher, Heidi; de Crombrugghe, Benoit; Yasuda, Hideyo] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Maki, Sayumi; Yasuda, Hideyo] Nippon Flour Mills Co Ltd, Cent Lab, Biosci Lab, Atsugi, Kanagawa 2430041, Japan	Okayama University; Nagasaki University; University of Texas System; UTMD Anderson Cancer Center	Hattori, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	hattorit@md.okayama-u.ac.jp; h-yasuda@yk9.so-net.ne.jp			National Institutes of Health [RO1AR309854]; Ministry of Education, Culture, and Sports, Japan [21592359, 25462888]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, and Sports, Japan	This work was supported, in whole or in part, by National Institutes of Health grant RO1AR309854 (to B. d. C.).This work was also supported by Scientific Research Grants 21592359 and 25462888 from the Ministry of Education, Culture, and Sports, Japan (to T. H., M. T., and H. Y.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, MATRIX BIOL, V23, P499, DOI 10.1016/j.matbio.2004.10.002; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Ciechanover A, 1990, Semin Cell Biol, V1, P415; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dikic I, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-22; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Oh CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010113; Riemer S, 2002, J CELL BIOCHEM, V86, P688, DOI 10.1002/jcb.10260; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	43	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35138	35148		10.1074/jbc.M113.486795	http://dx.doi.org/10.1074/jbc.M113.486795			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24155239	Green Published, hybrid			2022-12-28	WOS:000329867600015
J	Mulligan, C; Mindell, JA				Mulligan, Christopher; Mindell, Joseph A.			Mechanism of Transport Modulation by an Extracellular Loop in an Archaeal Excitatory Amino Acid Transporter (EAAT) Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Chemical Modification; Glutamate; Membrane Transport; Reconstitution of Membrane Transporters; Transporters; Protein Cross-linking	DEPENDENT ASPARTATE TRANSPORTER; GLUTAMATE TRANSPORTER; PYROCOCCUS-HORIKOSHII; CRYSTAL-STRUCTURE; TRANSLOCATION; BINDING; SODIUM; STOICHIOMETRY; SUBSTRATE; EXCHANGE	Background: The extracellular loop, 3L4, plays an important, unknown role in the transport cycle of the glutamate transporter homolog, Glt(Ph). Results: Cleaving 3L4 differentially affects transport cycle steps. Conclusion: 3L4 discriminates between substrate-loaded and empty states of the transporter. Significance: Empty and loaded forms of the transport domain have structurally distinguishable forms, reflecting essential features of the transport mechanism. Secondary transporters in the excitatory amino acid transporter family terminate glutamatergic synaptic transmission by catalyzing Na+-dependent removal of glutamate from the synaptic cleft. Recent structural studies of the aspartate-specific archaeal homolog, Glt(Ph), suggest that transport is achieved by a rigid body, piston-like movement of the transport domain, which houses the substrate-binding site, between the extracellular and cytoplasmic sides of the membrane. This transport domain is connected to an immobile scaffold by three loops, one of which, the 3-4 loop (3L4), undergoes substrate-sensitive conformational change. Proteolytic cleavage of the 3L4 was found to abolish transport activity indicating an essential function for this loop in the transport mechanism. Here, we demonstrate that despite the presence of fully cleaved 3L4, Glt(Ph) is still able to sample conformations relevant for transport. Optimized reconstitution conditions reveal that fully cleaved Glt(Ph) retains some transport activity. Analysis of the kinetics and temperature dependence of transport accompanied by direct measurements of substrate binding reveal that this decreased transport activity is not due to alteration of the substrate binding characteristics but is caused by the significantly reduced turnover rate. By measuring solute counterflow activity and cross-link formation rates, we demonstrate that cleaving 3L4 severely and specifically compromises one or more steps contributing to the movement of the substrate-loaded transport domain between the outward- and inward-facing conformational states, sparing the equivalent step(s) during the movement of the empty transport domain. These results reveal a hitherto unknown role for the 3L4 in modulating an essential step in the transport process.	[Mulligan, Christopher; Mindell, Joseph A.] NINDS, Membrane Transport Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mindell, JA (corresponding author), NINDS, Membrane Transport Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov	Mindell, Joseph/P-4461-2017	Mindell, Joseph/0000-0002-6952-8247; Mulligan, Christopher/0000-0001-5157-4651	Intramural Research Program of the National Institutes of Health, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003014] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institutes of Health, NINDS.	ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Compton ELR, 2010, P NATL ACAD SCI USA, V107, P12840, DOI 10.1073/pnas.1003046107; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Georgieva ER, 2013, NAT STRUCT MOL BIOL, V20, P215, DOI 10.1038/nsmb.2494; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, J BACTERIOL, V192, P2900, DOI 10.1128/JB.00136-10; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Hanelt I, 2013, NAT STRUCT MOL BIOL, V20, P210, DOI 10.1038/nsmb.2471; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3691, DOI 10.1021/bi00584a009; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; LOLKEMA JS, 1991, BIOCHEMISTRY-US, V30, P1284, DOI 10.1021/bi00219a018; Mim C, 2007, BIOCHEMISTRY-US, V46, P9007, DOI 10.1021/bi7005465; Reyes N, 2013, NAT STRUCT MOL BIOL, V20, P634, DOI 10.1038/nsmb.2548; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	27	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35266	35276		10.1074/jbc.M113.508408	http://dx.doi.org/10.1074/jbc.M113.508408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24155238	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000329867600025
J	Tipton, AR; Ji, WB; Sturt-Gillespie, B; Bekier, ME; Wang, KX; Taylor, WR; Liu, ST				Tipton, Aaron R.; Ji, Wenbin; Sturt-Gillespie, Brianne; Bekier, Michael E., II; Wang, Kexi; Taylor, William R.; Liu, Song-Tao			Monopolar Spindle 1 (MPS1) Kinase Promotes Production of Closed MAD2 (C-MAD2) Conformer and Assembly of the Mitotic Checkpoint Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; E3 Ubiquitin Ligase; Mitosis; Protein Complexes; Protein Kinases; BUBR1; MAD2; MPS1 Kinase; Mitotic Checkpoint Complex (MCC); Spindle Assembly Checkpoint	AURORA-B; ANAPHASE; CDC20; KINETOCHORES; BUBR1; INHIBITION; BINDING; MITOSIS; APC/C; COMPLEX/CYCLOSOME	Background: How MPS1 kinase functions during mitotic checkpoint signaling is not fully understood. Results: C-MAD2 expression rescues premature mitotic exit caused by MPS1 inhibition without localizing at kinetochores. Conclusion: MPS1 functions primarily to enhance C-MAD2 production and subsequent formation of the mitotic checkpoint complex. Significance: The results underscore the importance of MPS1 kinase in maintaining kinetochore localization and catalytic efficiency of the MAD1C-MAD2 core. MPS1 kinase is an essential component of the spindle assembly checkpoint (SAC), but its functioning mechanisms are not fully understood. We have shown recently that direct interaction between BUBR1 and MAD2 is critical for assembly and function of the human mitotic checkpoint complex (MCC), the SAC effector. Here we report that inhibition of MPS1 kinase activity by reversine disrupts BUBR1-MAD2 as well as CDC20-MAD2 interactions, causing premature activation of the anaphase-promoting complex/cyclosome. The effect of MPS1 inhibition is likely due to reduction of closed MAD2 (C-MAD2), as expressing a MAD2 mutant (MAD2(L13A)) that is locked in the C conformation rescued the checkpoint defects. In the presence of reversine, exogenous C-MAD2 does not localize to unattached kinetochores but is still incorporated into the MCC. Contrary to a previous report, we found that sustained MPS1 activity is required for maintaining both the MAD1C-MAD2 complex and open MAD2 (O-MAD2) at unattached kinetochores to facilitate C-MAD2 production. Additionally, mitotic phosphorylation of BUBR1 is also affected by MPS1 inhibition but seems dispensable for MCC assembly. Our results support the notion that MPS1 kinase promotes C-MAD2 production and subsequent MCC assembly to activate the SAC.	[Tipton, Aaron R.; Ji, Wenbin; Sturt-Gillespie, Brianne; Bekier, Michael E., II; Wang, Kexi; Taylor, William R.; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579	deArce Memorial Fund; Ohio Cancer Research Associates; National Science Foundation [MCB-1052413]	deArce Memorial Fund; Ohio Cancer Research Associates; National Science Foundation(National Science Foundation (NSF))	This work was supported by the deArce Memorial Fund, by Ohio Cancer Research Associates, and by National Science Foundation Grant MCB-1052413 (to S.T.L).	Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Campbell MS, 2001, J CELL SCI, V114, P953; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Diaz-Martinez LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-23; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Hagan RS, 2011, MOL BIOL CELL, V22, P4236, DOI 10.1091/mbc.E11-03-0216; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jia LY, 2011, MOL BIOL CELL, V22, P4227, DOI 10.1091/mbc.E11-05-0389; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lau DTC, 2012, CURR BIOL, V22, P180, DOI 10.1016/j.cub.2011.12.029; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Mariani L, 2012, CURR BIOL, V22, P1900, DOI 10.1016/j.cub.2012.08.028; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Miniowitz-Shemtov S, 2010, P NATL ACAD SCI USA, V107, P5351, DOI 10.1073/pnas.1001875107; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050	52	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35149	35158		10.1074/jbc.M113.522375	http://dx.doi.org/10.1074/jbc.M113.522375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151075	hybrid, Green Published			2022-12-28	WOS:000329867600016
J	Viswanatha, R; Wayt, J; Ohouo, PY; Smolka, MB; Bretscher, A				Viswanatha, Raghuvir; Wayt, Jessica; Ohouo, Patrice Y.; Smolka, Marcus B.; Bretscher, Anthony			Interactome Analysis Reveals Ezrin Can Adopt Multiple Conformational States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Cytoskeleton; Ezrin; Phosphorylation; Plasma Membrane; Proteomics	GDP DISSOCIATION INHIBITOR; RETINAL-PIGMENT EPITHELIUM; SCAFFOLDING PROTEIN EBP50; H EXCHANGER NHE1; ERM PROTEINS; ACTIN CYTOSKELETON; STRUCTURAL BASIS; CYTOPLASMIC DOMAIN; CELL-MIGRATION; BINDING-SITE	Background: Ezrin is a conformationally regulated microfilament-membrane linker restricted to the apical aspect of epithelial cells. Results: Quantitative mass spectrometry identified proteins that associate with different ezrin conformations; the interactors include novel apical microvilli-associated proteins, with classes perceiving ezrin's conformation differentially. Conclusion: Different proteins selectively associate with three distinct conformational states of ezrin. Significance: This study extends the conformational activation model of ezrin and identifies new interacting partners. Ezrin, a member of the ezrin-radixin-moesin family (ERM), is an essential regulator of the structure of microvilli on the apical aspect of epithelial cells. Ezrin provides a linkage between membrane-associated proteins and F-actin, oscillating between active/open and inactive/closed states, and is regulated in part by phosphorylation of a C-terminal threonine. In the open state, ezrin can bind a number of ligands, but in the closed state the ligand-binding sites are inaccessible. In vitro analysis has proposed that there may be a third hyperactivated form of ezrin. To gain a better understanding of ezrin, we conducted an unbiased proteomic analysis of ezrin-binding proteins in an epithelial cell line, Jeg-3. We refined our list of interactors by comparing the interactomes using quantitative mass spectrometry between wild-type ezrin, closed ezrin, open ezrin, and hyperactivated ezrin. The analysis reveals several novel interactors confirmed by their localization to microvilli, as well as a significant class of proteins that bind closed ezrin. Taken together, the data indicate that ezrin can exist in three different conformational states, and different ligands perceive ezrin conformational states differently.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Bretscher, Anthony] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Bretscher, A (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, 257 Weill Hall, Ithaca, NY 14853 USA.	apb5@cornell.edu			National Institutes of Health [GM-036652, 5T32GM007273]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273, R01GM036652, R01GM097272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-036652 (to A. B.).; Supported in part by National Institutes of Health Training Grant 5T32GM007273.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Ben-Aissa K, 2012, J BIOL CHEM, V287, P16311, DOI 10.1074/jbc.M111.304881; Berryman M, 2000, MOL BIOL CELL, V11, P1509, DOI 10.1091/mbc.11.5.1509; Berryman MA, 2003, CELL MOTIL CYTOSKEL, V56, P159, DOI 10.1002/cm.10141; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Bonilha VL, 2001, INVEST OPHTH VIS SCI, V42, P3274; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; Bretscher A, 1997, J CELL SCI, V110, P3011; Cannon JL, 2011, MOL BIOL CELL, V22, P954, DOI 10.1091/mbc.E10-07-0586; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Chambers DN, 2005, BIOCHEMISTRY-US, V44, P3926, DOI 10.1021/bi0480382; Chirivino D, 2011, MOL BIOL CELL, V22, P375, DOI 10.1091/mbc.E10-09-0796; Chuang JZ, 2010, MOL BIOL CELL, V21, P3017, DOI 10.1091/mbc.E09-10-0907; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dominguez-Luis M, 2011, EUR J IMMUNOL, V41, P3436, DOI 10.1002/eji.201141764; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; GARY R, 1993, P NATL ACAD SCI USA, V90, P10846, DOI 10.1073/pnas.90.22.10846; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100; Granes F, 2000, J CELL SCI, V113, P1267; Granes F, 2003, FEBS LETT, V547, P212, DOI 10.1016/S0014-5793(03)00712-9; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Henning MS, 2011, VIROLOGY, V415, P114, DOI 10.1016/j.virol.2011.04.006; Hipfner DR, 2004, GENE DEV, V18, P2243, DOI 10.1101/gad.303304; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; Hughes SC, 2010, J CELL SCI, V123, P1099, DOI 10.1242/jcs.059469; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; Luo Y, 2012, ONCOGENE, V31, P306, DOI 10.1038/onc.2011.244; Martin M, 2006, EUR J CELL BIOL, V85, P769, DOI 10.1016/j.ejcb.2006.02.013; Matsui K, 2011, J PROTEOME RES, V10, P3983, DOI 10.1021/pr200577d; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Neisch AL, 2013, MOL BIOL CELL, V24, P1420, DOI 10.1091/mbc.E12-11-0800; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Ognibene M, 2011, J BIOL CHEM, V286, P29973, DOI 10.1074/jbc.M111.270785; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Orlando RA, 2001, J AM SOC NEPHROL, V12, P1589, DOI 10.1681/ASN.V1281589; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Sakurai T, 2008, J NEUROSCI RES, V86, P2602, DOI 10.1002/jnr.21705; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Snapp KR, 2002, BLOOD, V99, P4494, DOI 10.1182/blood.V99.12.4494; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Sperka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027511; Spertini C, 2012, J BIOL CHEM, V287, P10693, DOI 10.1074/jbc.M111.318022; Sullivan A, 2003, EXP CELL RES, V284, P224, DOI 10.1016/S0014-4827(02)00054-X; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wang Z, 2011, INVEST OPHTH VIS SCI, V52, P5079, DOI 10.1167/iovs.10-6998; Yang HS, 2006, CANCER RES, V66, P2708, DOI 10.1158/0008-5472.CAN-05-3141; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 2002, J CELL SCI, V115, P2569; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zaarour RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037490; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	105	33	34	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35437	35451		10.1074/jbc.M113.505669	http://dx.doi.org/10.1074/jbc.M113.505669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24151071	Green Published, hybrid			2022-12-28	WOS:000329867600040
J	Wijeyesakere, SJ; Rizvi, SM; Raghavan, M				Wijeyesakere, Sanjeeva J.; Rizvi, Syed M.; Raghavan, Malini			Glycan-dependent and -independent Interactions Contribute to Cellular Substrate Recruitment by Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Fluorescence Resonance Energy Transfer (FRET); Glycosylation; Molecular Chaperone; Protein Folding; Calreticulin; ERp57	MOLECULAR CHAPERONE; MUTATIONAL ANALYSIS; BINDING; CALNEXIN; INSIGHT; LECTIN; ERP57; ROLES	Background: We investigated the different modes of calreticulin-substrate binding. Results: Calreticulin binds glycosylated and nonglycosylated proteins with similar affinities but distinct kinetics and P-domain conformations. Conclusion: Successful substrate recruitment by calreticulin requires glycan and P-domain-dependent interactions. Significance: Elucidation of the distinct modes of calreticulin binding to substrate glycan and polypeptide components and their combined contributions to substrate recruitment in cells. Calreticulin is an endoplasmic reticulum chaperone with specificity for monoglucosylated glycoproteins. Calreticulin also inhibits precipitation of nonglycosylated proteins and thus contains generic protein-binding sites, but their location and contributions to substrate folding are unknown. We show that calreticulin binds glycosylated and nonglycosylated proteins with similar affinities but distinct interaction kinetics. Although both interactions involve the glycan-binding site or its vicinity, the arm-like proline-rich (P-) domain of calreticulin contributes to binding non/deglycosylated proteins. Correspondingly, ensemble FRET spectroscopy measurements indicate that glycosylated and nonglycosylated proteins induce open and closed P-domain conformations, respectively. The co-chaperone ERp57 influences substrate-binding kinetics and induces a closed P-domain conformation. Together with analysis of the interactions of calreticulin with cellular proteins, these findings indicate that the recruitment of monoglucosylated proteins to calreticulin is kinetically driven, whereas the P-domain and co-chaperone contribute to stable substrate binding. Substrate sequestration in the cleft between the glycan-binding site and P-domain is a likely mechanism for calreticulin-assisted protein folding.	[Wijeyesakere, Sanjeeva J.; Rizvi, Syed M.; Raghavan, Malini] Univ Michigan, Sch Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu			National Institutes of Health [AI066131, AI044115, DK020572]; American Heart Association [12POST8810006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI044115, R01AI044115, R01AI066131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants (AI066131 and AI044115 to M. R.). This work was also supported by an American Heart Association grant (12POST8810006 to S. J. W.) and utilized the DNA sequencing cores of the Michigan Diabetes Research and Training Center funded by a National Institutes of Health grant (DK020572).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Garboczi DN, 1996, J IMMUNOL, V157, P5403; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Kapoor M, 2004, BIOCHEMISTRY-US, V43, P97, DOI 10.1021/bi0355286; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mollegaard KM, 2011, BBA-PROTEINS PROTEOM, V1814, P889, DOI 10.1016/j.bbapap.2011.03.015; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; OHTA M, 1991, GLYCOCONJUGATE J, V8, P400, DOI 10.1007/BF00731292; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Raghavan M, 2013, TRENDS IMMUNOL, V34, P13, DOI 10.1016/j.it.2012.08.002; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Wijeyesakere SJ, 2011, J BIOL CHEM, V286, P8771, DOI 10.1074/jbc.M110.169193; Yan Q, 2010, BIOCHEMISTRY-US, V49, P3685, DOI 10.1021/bi902067f; Zapun A, 1999, STRUCT FOLD DES, V7, pR173, DOI 10.1016/S0969-2126(99)80112-9	38	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35104	35116		10.1074/jbc.M113.507921	http://dx.doi.org/10.1074/jbc.M113.507921			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24100026	Green Published, hybrid			2022-12-28	WOS:000329867600012
J	Liu, L; Souto, J; Liao, WB; Jiang, YP; Li, YQ; Nishinakamura, R; Huang, SM; Rosengart, T; Yang, VW; Schuster, M; Ma, YP; Yang, JC				Liu, Li; Souto, Joseph; Liao, Wenbin; Jiang, Yongping; Li, Yangqiu; Nishinakamura, Ryuichi; Huang, Suming; Rosengart, Todd; Yang, Vincent W.; Schuster, Michael; Ma, Yupo; Yang, Jianchang			Histone Lysine-specific Demethylase 1 (LSD1) Protein Is Involved in Sal-like Protein 4 (SALL4)-mediated Transcriptional Repression in Hematopoietic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Marrow; DNA Methylation; Hematopoiesis; Repressor Protein; Stem Cells; Histone Demethylation; Mi-2 center dot NuRD Complex; SALL Family; Hematopoietic Progenitor	STEM/PROGENITOR CELLS; OKIHIRO-SYNDROME; GENE-EXPRESSION; PLURIPOTENCY; REGULATOR; MURINE; DIFFERENTIATION; PROLIFERATION; HOMOLOG; PATHWAY	Background: SALL4 plays important roles in regulating the growth of hematopoietic progenitor cells. Results: SALL4 dynamically recruits histone demethylase LSD1 to specific target genes. LSD1 negatively regulates SALL4-mediated gene expression by affecting local chromatin structure. Conclusion: Multiple epigenetic modifiers cooperatively modulate SALL4-mediated gene repression. Significance: This report provides a novel mechanism by which stem cell gene SALL4 controls hematopoietic progenitor cell properties. The stem cell protein SALL4 plays a critical role in hematopoiesis by regulating the cell fate. In primitive hematopoietic precursors, it activates or represses important genes via recruitment of various epigenetic factors such as DNA methyltransferases, and histone deacylases. Here, we demonstrate that LSD1, a histone lysine demethylase, also participates in the trans-repressive effects of SALL4. Based on luciferase assays, the amine oxidase domain of LSD1 is important in suppressing SALL4-mediated reporter transcription. In freshly isolated adult mouse bone marrows, both SALL4 and LSD1 proteins are preferentially expressed in undifferentiated progenitor cells and co-localize in the nuclei. Further sequential chromatin immunoprecipitation assay confirmed that these two factors share the same binding sites at the promoter regions of important hematopoietic regulatory genes including EBF1, GATA1, and TNF. In addition, studies from both gain- and loss-of-function models revealed that SALL4 dynamically controls the binding levels of LSD1, which is accompanied by a reversely changed histone 3 dimethylated lysine 4 at the same promoter regions. Finally, shRNA-mediated knockdown of LSD1 in hematopoietic precursor cells resulted in altered SALL4 downstream gene expression and increased cellular activity. Thus, our data revealed that histone demethylase LSD1 may negatively regulate SALL4-mediated transcription, and the dynamic regulation of SALL4-associated epigenetic factors cooperatively modulates early hematopoietic precursor proliferation.	[Liu, Li; Souto, Joseph; Yang, Jianchang] SUNY Stony Brook, Dept Surg, Stony Brook, NY 11790 USA; [Liao, Wenbin; Ma, Yupo; Yang, Jianchang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11790 USA; [Yang, Vincent W.; Schuster, Michael] SUNY Stony Brook, Dept Med, Stony Brook, NY 11790 USA; [Jiang, Yongping] Chinese Acad Med Sci, Biopharmaceut Res Ctr, Suzhou 215126, Peoples R China; [Jiang, Yongping] Peking Union Med Coll, Suzhou 215126, Peoples R China; [Li, Yangqiu] Jinan Univ, Inst Hematol, Guangzhou 510632, Guangdong, Peoples R China; [Nishinakamura, Ryuichi] Kumamoto Univ, Dept Kidney Dev, Kumamoto 8600862, Japan; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32611 USA; [Rosengart, Todd] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Jinan University; Kumamoto University; State University System of Florida; University of Florida; Baylor College of Medicine	Ma, YP (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11790 USA.	yupo.ma@stonybrookmedicine.edu; jianchang.yang@stonybrookmedicine.edu			National Institutes of Health [R01HL087948, R01 HL090589]; American Cancer Society Research Scholar Grant [RSG-12-216-01-LIB]; State New Drug Research Development [2011ZX09401-027, 2011ZX09102-010-04, 12C26213202208]; New York State Stem Cell Science (NYSTEM) [C028114, C026716]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948, R01HL090589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); State New Drug Research Development; New York State Stem Cell Science (NYSTEM); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL087948 (to Y. M.) and R01 HL090589 (to S. H.). This work was also supported by American Cancer Society Research Scholar Grant RSG-12-216-01-LIB (to J. Y.); State New Drug Research & Development Grants 2011ZX09401-027, 2011ZX09102-010-04, and 12C26213202208 (to Y. J.); and New York State Stem Cell Science (NYSTEM) Grants C028114 and C026716 (to the Stony Brook Stem Cell Center).	Aguila JR, 2011, BLOOD, V118, P576, DOI 10.1182/blood-2011-01-333641; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Du T, 2010, P NATL ACAD SCI USA, V107, P15904, DOI 10.1073/pnas.1010741107; Forneris F, 2005, FEBS LETT, V579, P2203, DOI 10.1016/j.febslet.2005.03.015; Gao C, 2013, TRANSFUSION, V53, P1037, DOI 10.1111/j.1537-2995.2012.03888.x; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Kerenyi MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00633; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Li AL, 2013, J CLIN INVEST, V123, P4195, DOI 10.1172/JCI62891; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Maier H, 2002, SEMIN IMMUNOL, V14, P415, DOI 10.1016/S1044532302000763; Oikawa T, 2009, GASTROENTEROLOGY, V136, P1000, DOI 10.1053/j.gastro.2008.11.018; Okuma E, 2000, LEUKEMIA, V14, P612, DOI 10.1038/sj.leu.2401716; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Satoh Y, 2008, J BIOL CHEM, V283, P30045, DOI 10.1074/jbc.M804768200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Vasilatos SN, 2013, CARCINOGENESIS, V34, P1196, DOI 10.1093/carcin/bgt033; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang JC, 2012, CURR OPIN HEMATOL, V19, P287, DOI 10.1097/MOH.0b013e328353c684; Yang JC, 2012, J BIOL CHEM, V287, P1996, DOI 10.1074/jbc.M111.308734; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	33	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34719	34728		10.1074/jbc.M113.506568	http://dx.doi.org/10.1074/jbc.M113.506568			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24163373	Green Published, hybrid			2022-12-28	WOS:000329812800038
J	Tadokoro, H; Umezu, T; Ohyashiki, K; Hirano, T; Ohyashiki, JH				Tadokoro, Hiroko; Umezu, Tomohiro; Ohyashiki, Kazuma; Hirano, Toshihiko; Ohyashiki, Junko H.			Exosomes Derived from Hypoxic Leukemia Cells Enhance Tube Formation in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Cell-cell Interaction; Exosomes; Hypoxia; MicroRNA	MICROENVIRONMENTAL REGULATION; CANCER; ANGIOGENESIS; MICRORNAS; MICROVESICLES; MECHANISMS; PROTEINS; TARGET; VEGF	Background: We recently showed communication between leukemia and endothelial cells and induction of angiogenesis via exosomes. Results: Hypoxic leukemia cells secrete exosomal miRNA, which enhances tube formation in endothelial cells. Conclusion: Exosomal miRNA from a tumor itself helps modulate the microenvironment of the tumor. Significance: This study provides novel insight into the role of exosomes in cancer development. Hypoxia plays an important role during the evolution of cancer cells and their microenvironment. Emerging evidence suggests communication between cancer cells and their microenvironment occurs via exosomes. This study aimed to clarify whether hypoxia affects angiogenic function through exosomes secreted from leukemia cells. We used the human leukemia cell line K562 for exosome-generating cells and human umbilical vein endothelial cells (HUVECs) for exosome target cells. Exosomes derived from K562 cells cultured under normoxic (20%) or hypoxic (1%) conditions for 24 h were isolated and quantitated by nanoparticle tracking analysis. These exosomes were then cocultured with HUVECs to evaluate angiogenic activity. The exosomes secreted from K562 cells in hypoxic conditions significantly enhanced tube formation by HUVECs compared with exosomes produced in normoxic conditions. Using a TaqMan low-density miRNA array, we found a subset of miRNAs, including miR-210, were significantly increased in exosomes secreted from hypoxic K562 cells. We demonstrated that cancer cells and their exosomes have altered miRNA profiles under hypoxic conditions. Although exosomes contain various molecular constituents such as proteins and mRNAs, altered exosomal compartments under hypoxic conditions, including miR-210, affected the behavior of endothelial cells. Our results suggest that exosomal miRNA derived from cancer cells under hypoxic conditions may partly affect angiogenic activity in endothelial cells.	[Tadokoro, Hiroko; Hirano, Toshihiko] Tokyo Univ Pharm & Life Sci, Dept Clin Pharmacol, Tokyo 1920392, Japan; [Umezu, Tomohiro; Ohyashiki, Kazuma] Tokyo Med Univ, Dept Mol Sci, Tokyo 1600023, Japan; [Ohyashiki, Kazuma] Tokyo Med Univ, Dept Internal Med 1, Tokyo 1600023, Japan; [Tadokoro, Hiroko; Umezu, Tomohiro; Ohyashiki, Junko H.] Tokyo Med Univ, Inst Med Sci, Tokyo 1600023, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Ohyashiki, JH (corresponding author), Tokyo Med Univ, Inst Med Sci, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	junko@hh.iij4u.or.jp	Umezu, Tomohiro/AAK-9711-2020	Umezu, Tomohiro/0000-0002-0123-8921	Private University Strategic Research Based Support Project Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science, and Technology) (Tokyo, Japan)	Private University Strategic Research Based Support Project Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science, and Technology) (Tokyo, Japan)	This work was supported by the Private University Strategic Research Based Support Project Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets from MEXT (Ministry of Education, Culture, Sports, Science, and Technology) (Tokyo, Japan).	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Camussi G, 2011, AM J CANCER RES, V1, P98; Corrado C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042310; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kvasnicka HM, 2004, BLOOD, V103, P3549, DOI 10.1182/blood-2003-08-2734; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Taverna S, 2012, INT J CANCER, V130, P2033, DOI 10.1002/ijc.26217; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722	36	263	281	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34343	34351		10.1074/jbc.M113.480822	http://dx.doi.org/10.1074/jbc.M113.480822			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133215	hybrid, Green Published			2022-12-28	WOS:000329812800006
J	Decker, C; Hesker, P; Zhang, KH; Faccio, R				Decker, Corinne; Hesker, Pamela; Zhang, Kaihua; Faccio, Roberta			Targeted Inhibition of Phospholipase C gamma 2 Adaptor Function Blocks Osteoclastogenesis and Protects from Pathological Osteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Cell Differentiation; Osteoclast; Phospholipase C; Signaling; Gab2; PLC gamma 2; RANK; Bone Erosion; Osteolysis	T-CELL-ACTIVATION; INFLAMMATORY ARTHRITIS; MURINE MODEL; IDENTIFICATION; MECHANISMS; PLC-GAMMA-2; PROTEINS; RECEPTOR; KINASE; BONE	Phospholipase C 2 (PLC2) is a critical regulator of innate immune cells and osteoclasts (OCs) during inflammatory arthritis. Both the catalytic domain and the adaptor motifs of PLC2 are required for OC formation and function. Due to the high homology between the catalytic domains of PLC2 and the ubiquitously expressed PLC1, molecules encompassing the adaptor motifs of PLC2 were designed to test the hypothesis that uncoupling the adaptor and catalytic functions of PLC2 could specifically inhibit osteoclastogenesis and bone erosion. Wild-type (WT) bone marrow macrophages (BMM) that overexpress the tandem Src homology 2 (SH2) domains of PLC2 (SH2(N+C)) failed to form mature OCs and resorb bone in vitro. Activation of the receptor activator of NF-B (RANK) signaling pathway, which is critical for OC development, was impaired in cells expressing SH2(N+C). Arrest in OC differentiation was evidenced by a reduction of p38 and I-B phosphorylation as well as decreased NFATc1 and c-Fos/c-Jun levels. Consistent with our hypothesis, SH2(N+C) abrogated formation of the RANK-Gab2 complex, which mediates NF-B and AP-1 activation following RANK ligand (RANKL) stimulation. Furthermore, the ability of SH2(N+C) to prevent inflammatory osteolysis was examined in vivo following RANKL or LPS injections over the calvaria. Both models induced osteolysis in the control group, whereas the SH2(N+C)-treated cohort was largely protected from bone erosion. Collectively, these data indicate that inflammatory osteolysis can be abrogated by treatment with a molecule composed of the tandem SH2 domains of PLC gamma 2.	[Decker, Corinne; Hesker, Pamela; Zhang, Kaihua; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL)	Faccio, R (corresponding author), Washington Univ, Sch Med, Dept Orthopaed Surg, Musculoskeletal Res Ctr, St Louis, MO 63110 USA.	faccior@wustl.edu			National Institutes of Health [P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053628, P30AR057235, T32AR060719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The Washington University Center for Musculoskeletal Research was supported by National Institutes of Health Grant P30 AR057235.	Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Cremasco V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008909; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Faccio R, 2010, ANN NY ACAD SCI, V1192, P124, DOI 10.1111/j.1749-6632.2009.05217.x; Goldring SR, 2000, ARTHRITIS RES, V2, P33, DOI 10.1186/ar67; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Taguchi Y, 2012, J BONE MINER METAB, V30, P543, DOI 10.1007/s00774-012-0353-5; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takayanagi H, 2012, NAT REV RHEUMATOL, V8, P684, DOI 10.1038/nrrheum.2012.167; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Turner T, 1997, CLIN CANCER RES, V3, P2275; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Wei S, 2008, PATHOL RES PRACT, V204, P695, DOI 10.1016/j.prp.2008.07.002	23	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33634	33641		10.1074/jbc.M113.477281	http://dx.doi.org/10.1074/jbc.M113.477281			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24081142	Green Published, hybrid			2022-12-28	WOS:000327250200012
J	Deyev, IE; Mitrofanova, AV; Zhevlenev, ES; Radionov, N; Berchatova, AA; Popova, NV; Serova, OV; Petrenko, AG				Deyev, Igor E.; Mitrofanova, Alla V.; Zhevlenev, Egor S.; Radionov, Nikita; Berchatova, Anastasiya A.; Popova, Nadezhda V.; Serova, Oxana V.; Petrenko, Alexander G.			Structural Determinants of the Insulin Receptor-related Receptor Activation by Alkali	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Insulin; Membrane Proteins; Phosphorylation; Receptor Tyrosine Kinase; Site-directed Mutagenesis; Alkaline pH	ALANINE SCANNING MUTAGENESIS; EPIDERMAL-GROWTH-FACTOR; LIGAND-BINDING-SITE; TYROSINE KINASES; SPECIFICITY; FAMILY; SENSOR	IRR is a member of the insulin receptor (IR) family that does not have any known agonist of a peptide nature but can be activated by mildly alkaline medium and was thus proposed to function as an extracellular pH sensor. IRR activation by alkali is defined by its N-terminal extracellular region. To reveal key structural elements involved in alkali sensing, we developed an in vitro method to quantify activity of IRR and its mutants. Replacing the IRR L1C domains (residues 1-333) or L2 domain (residues 334-462) or both with the homologous fragments of IR reduced the receptor activity to 35, 64, and 7% percent, respectively. Within L1C domains, five amino acid residues (Leu-135, Gly-188, Arg-244, and vicinal His-318 and Lys-319) were identified as IRR-specific by species conservation analysis of the IR family. These residues are exposed and located in junctions between secondary structure folds. The quintuple mutation of these residues to alanine had the same negative effect as the entire L1C domain replacement, whereas none of the single mutations was as effective. Separate mutations of these five residues and of L2 produced partial negative effects that were additive. The pH dependence of cell-expressed mutants (L1C and L2 swap, L2 plus triple LGR mutation, and L2 plus quintuple LGRHK mutation) was shifted toward alkalinity and, in contrast with IRR, did not show significant positive cooperativity. Our data suggest that IRR activation is not based on a single residue deprotonation in the IRR ectodomain but rather involves synergistic conformational changes at multiple points.	[Deyev, Igor E.; Mitrofanova, Alla V.; Zhevlenev, Egor S.; Radionov, Nikita; Berchatova, Anastasiya A.; Popova, Nadezhda V.; Serova, Oxana V.; Petrenko, Alexander G.] Russian Acad Sci, Lab Receptor Cell Biol, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Deyev, IE (corresponding author), Inst Bioorgan Chem, Lab Receptor Cell Biol, GSP-7,Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	deyevie@ibch.ru	Mitrofanova, Alla/L-1590-2019; Popova, Nadezhda/ABD-7185-2021; Popova, Nadezhda/AAJ-8312-2020; Deyev, Igor E/L-5841-2016; Deyev, Igor E/CAJ-5868-2022	Mitrofanova, Alla/0000-0001-5065-9522; Popova, Nadezhda/0000-0002-6761-589X; Popova, Nadezhda/0000-0002-6761-589X; Deyev, Igor E/0000-0002-2041-808X; Deyev, Igor E/0000-0002-2041-808X; Petrenko, Alexander/0000-0002-6689-6546; Serova, Oxana/0000-0002-4941-8913	Russian Foundation for Basic Research [10-04-01794-a, 11-04-12151-ofi-m-2011, 12-04-01817-a, 12-04-33190, 12-04-32099]; Basic Sciences to Medicine Program of the Russian Academy of Sciences; Russian Federation [MK-127.2012.4]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Basic Sciences to Medicine Program of the Russian Academy of Sciences; Russian Federation(Russian Federation)	This work was supported by the Russian Foundation for Basic Research (Grants 10-04-01794-a, 11-04-12151-ofi-m-2011, 12-04-01817-a, 12-04-33190, and 12-04-32099), Basic Sciences to Medicine Program of the Russian Academy of Sciences, and by the President of the Russian Federation (Grant MK-127.2012.4).	BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; Deev I E, 2006, Dokl Biochem Biophys, V408, P184, DOI 10.1134/S1607672906030203; Deyev IE, 2011, ACTA NATURAE, V3, P114, DOI 10.32607/20758251-2011-3-4-114-117; Deyev IE, 2011, CELL METAB, V13, P679, DOI 10.1016/j.cmet.2011.03.022; Deyev IE, 2010, BIOCHIMIE, V92, P418, DOI 10.1016/j.biochi.2010.01.015; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; GRIGORESCU F, 1983, J BIOL CHEM, V258, P3708; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Klammt J, 2005, BIOCHEM BIOPH RES CO, V327, P557, DOI 10.1016/j.bbrc.2004.12.039; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Mynarcik DC, 1997, J BIOL CHEM, V272, P2077; NAKAE J, 1995, J BIOL CHEM, V270, P22017, DOI 10.1074/jbc.270.37.22017; Petrenko AG, 2013, BBA-PROTEINS PROTEOM, V1834, P2170, DOI 10.1016/j.bbapap.2012.11.011; Renteria ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003667; Rouard M, 1999, J BIOL CHEM, V274, P18487, DOI 10.1074/jbc.274.26.18487; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHUMACHER R, 1991, J BIOL CHEM, V266, P19288; SHIER P, 1989, J BIOL CHEM, V264, P14605; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012	28	21	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33884	33893		10.1074/jbc.M113.483172	http://dx.doi.org/10.1074/jbc.M113.483172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24121506	hybrid, Green Published			2022-12-28	WOS:000327250200032
J	Popovic, M; Zaja, R; Fent, K; Smital, T				Popovic, Marta; Zaja, Roko; Fent, Karl; Smital, Tvrtko			Molecular Characterization of Zebrafish Oatp1d1 (Slco1d1), a Novel Organic Anion-transporting Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Metabolism; Membrane Proteins; Membrane Transport; Organic Anion Channels; Zebrafish; New Slco Transporter in zebrafish; New Slco Transporter in Zebrafish; Molecular Characterization	THYROID-HORMONE TRANSPORTERS; CHOLESTEROL IN-VITRO; XENOBIOTIC TRANSPORTERS; OATP/SLCO SUPERFAMILY; IDENTIFICATION; PROTEIN; MEMBRANE; SUBSTRATE; FAMILY; CELLS	The organic anion-transporting polypeptide (OATP/Oatp) superfamily includes a group of polyspecific transporters that mediate transport of large amphipathic, mostly anionic molecules across cell membranes of eukaryotes. OATPs/Oatps are involved in the disposition and elimination of numerous physiological and foreign compounds. However, in non-mammalian species, the functional properties of Oatps remain unknown. We aimed to elucidate the role of Oatp1d1 in zebrafish to gain insights into the functional and structural evolution of the OATP1/Oatp1 superfamily. We show that diversification of the OATP1/Oatp1 family occurs after the emergence of jawed fish and that the OATP1A/Oatp1a and OATP1B/Oatp1b subfamilies appeared at the root of tetrapods. The Oatp1d subfamily emerged in teleosts and is absent in tetrapods. The zebrafish Oatp1d1 is similar to mammalian OATP1A/Oatp1a and OATP1B/Oatp1b members, with the main physiological role in transport and balance of steroid hormones. Oatp1d1 activity is dependent upon pH gradient, which could indicate bicarbonate exchange as a mode of transport. Our analysis of evolutionary conservation and structural properties revealed that (i) His-79 in intracellular loop 3 is conserved within OATP1/Oatp1 family and is crucial for the transport activity; (ii) N-glycosylation impacts membrane targeting and is conserved within the OATP1/Oatp1 family with Asn-122, Asn-133, Asn-499, and Asn-512 residues involved; (iii) the evolutionarily conserved cholesterol recognition interaction amino acid consensus motif is important for membrane localization; and (iv) Oatp1d1 is present in dimeric and possibly oligomeric form in the cell membrane. In conclusion, we describe the first detailed characterization of a new Oatp transporter in zebrafish, offering important insights into the functional evolution of the OATP1/Oatp1 family and the physiological role of Oatp1d1.	[Popovic, Marta; Zaja, Roko; Smital, Tvrtko] Rudjer Boskovic Inst, Div Marine & Environm Res, Lab Mol Ecotoxicol, Zagreb 10000, Croatia; [Fent, Karl] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland; [Fent, Karl] Swiss Fed Inst Technol ETHZ, Dept Environm Syst Sci, CH-8092 Zurich, Switzerland	Rudjer Boskovic Institute; FHNW University of Applied Sciences & Arts Northwestern Switzerland; Swiss Federal Institutes of Technology Domain; ETH Zurich	Smital, T (corresponding author), Rudjer Boskovic Inst, Div Marine & Environm Res, Lab Mol Ecotoxicol, Bijenicka 54, Zagreb 10000, Croatia.	smital@irb.hr		Zaja, Roko/0000-0003-3944-0153; Popovic, Marta/0000-0002-9464-5824	Ministry for Science, Technology, and Sports of the Republic of Croatia [098-0982934-2745]; Swiss National Science Foundation (SNSF) [SCOPES-IZ73ZO_128025/1]	Ministry for Science, Technology, and Sports of the Republic of Croatia; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by Ministry for Science, Technology, and Sports of the Republic of Croatia Project 098-0982934-2745 and by Swiss National Science Foundation (SNSF) Grant SCOPES-IZ73ZO_128025/1.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Badagnani I, 2006, J PHARMACOL EXP THER, V318, P521, DOI 10.1124/jpet.106.104364; BENDAYAN R, 1994, J AM SOC NEPHROL, V5, P75; Boyarsky G, 1996, FASEB J, V10, P1205, DOI 10.1096/fasebj.10.10.8751723; Cai SY, 2002, AM J PHYSIOL-GASTR L, V282, pG702, DOI 10.1152/ajpgi.00458.2001; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Froschauer A, 2006, CURR GENOMICS, V7, P43, DOI 10.2174/138920206776389766; Fujiwara K, 2001, ENDOCRINOLOGY, V142, P2005, DOI 10.1210/en.142.5.2005; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gui CS, 2009, PHARMACOL RES, V60, P50, DOI 10.1016/j.phrs.2009.03.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanggi E, 2006, MOL PHARMACOL, V70, P806, DOI 10.1124/mol.105.019547; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hagey LR, 2010, ZOOL SCI, V27, P565, DOI 10.2108/zsj.27.565; Hirano M, 2006, DRUG METAB DISPOS, V34, P1229, DOI 10.1124/dmd.106.009290; Hong M, 2005, J BIOL CHEM, V280, P32285, DOI 10.1074/jbc.M501447200; Hong M, 2001, J PHARMACOL EXP THER, V296, P141; Horschitz S, 2008, NEUROCHEM INT, V52, P770, DOI 10.1016/j.neuint.2007.09.005; Huber RD, 2007, AM J PHYSIOL-CELL PH, V292, pC795, DOI 10.1152/ajpcell.00597.2005; Jafurulla M, 2011, BIOCHEM BIOPH RES CO, V404, P569, DOI 10.1016/j.bbrc.2010.12.031; James MO, 2011, J STEROID BIOCHEM, V127, P167, DOI 10.1016/j.jsbmb.2010.10.003; Keller T, 2011, J BIOL CHEM, V286, P37874, DOI 10.1074/jbc.M111.289330; Kindla J, 2011, DRUG METAB DISPOS, V39, P1047, DOI 10.1124/dmd.110.037622; Klaassen CD, 2008, TOXICOL SCI, V101, P186, DOI 10.1093/toxsci/kfm214; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Lee TK, 2003, AM J PHYSIOL-GASTR L, V285, pG371, DOI 10.1152/ajpgi.00358.2002; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; Leuthold S, 2009, AM J PHYSIOL-CELL PH, V296, pC570, DOI 10.1152/ajpcell.00436.2008; Li LQ, 2000, MOL PHARMACOL, V58, P335, DOI 10.1124/mol.58.2.335; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martinez-Becerra P, 2011, MOL PHARMACOL, V79, P596, DOI 10.1124/mol.110.069971; Meier-Abt F, 2005, J MEMBRANE BIOL, V208, P213, DOI 10.1007/s00232-005-7004-x; Meier-Abt F, 2007, TOXICOL APPL PHARM, V218, P274, DOI 10.1016/j.taap.2006.11.015; Molina H, 2008, BBA-BIOMEMBRANES, V1778, P1283, DOI 10.1016/j.bbamem.2008.01.020; Nakao N, 2006, ENDOCRINOLOGY, V147, P1067, DOI 10.1210/en.2005-1090; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Pippal JB, 2011, MOL CELL ENDOCRINOL, V332, P58, DOI 10.1016/j.mce.2010.09.014; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; Popovic M, 2010, COMP BIOCHEM PHYS A, V155, P327, DOI 10.1016/j.cbpa.2009.11.011; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Roth M, 2011, J PHARMACOL EXP THER, V339, P624, DOI 10.1124/jpet.111.184564; Satlin LM, 1997, J BIOL CHEM, V272, P26340, DOI 10.1074/jbc.272.42.26340; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tom R., 2008, CSH PROTOC; Tschantz WR, 2008, PROTEIN EXPRES PURIF, V57, P163, DOI 10.1016/j.pep.2007.10.007; van der Deure WM, 2010, J MOL ENDOCRINOL, V44, P1, DOI 10.1677/JME-09-0042; Wang PJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1052, DOI 10.1152/ajpgi.00584.2007; Westholm DE, 2009, ENDOCRINOLOGY, V150, P5153, DOI 10.1210/en.2009-0769; Xiao YH, 2007, BIOTECHNOL LETT, V29, P925, DOI 10.1007/s10529-007-9327-4; Yamazaki M, 2005, XENOBIOTICA, V35, P737, DOI 10.1080/00498250500136676; Yao J., 2012, PLOS ONE, V7	56	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33894	33911		10.1074/jbc.M113.518506	http://dx.doi.org/10.1074/jbc.M113.518506			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126916	Green Published, hybrid			2022-12-28	WOS:000327250200033
J	Shah, CA; Bei, L; Wang, H; Platanias, LC; Eklund, EA				Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.			The Leukemia-associated Mll-Ell Oncoprotein Induces Fibroblast Growth Factor 2 (Fgf2)-dependent Cytokine Hypersensitivity in Myeloid Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Fibroblast Growth Factor (FGF); Gene Transcription; Growth Factors; Leukemia; hox; mll	BONE-MARROW-CELLS; GENE-EXPRESSION; IN-VITRO; ACTIVATES TRANSCRIPTION; ENCODING GP91(PHOX); DNA-BINDING; HOX; DIFFERENTIATION; SUBPOPULATIONS; OVEREXPRESSION	The subset of acute myeloid leukemias (AML) with chromosomal translocations involving the MLL gene have a poor prognosis (referred to as 11q23-AML). The MLL fusion proteins that are expressed in 11q23-AML facilitate transcription of a set of HOX genes, including HOXA9 and HOXA10. Because Hox proteins are transcription factors, this suggests the possibility that Hox target genes mediate the adverse effects of MLL fusion proteins in leukemia. Identifying such Hox target genes might provide insights to the pathogenesis and treatment of 11q23-AML. In the current study we found that Mll-Ell (an MLL fusion protein) induced transcriptional activation of the FGF2 gene in a HoxA9- and HoxA10-dependent manner. FGF2 encodes fibroblast growth factor 2 (also referred to as basic fibroblast growth factor). Fgf2 influences proliferation and survival of hematopoietic stem cells and myeloid progenitor cells, and increased Fgf2-expression has been described in AMLs. We determined that expression of Mll-Ell in myeloid progenitor cells resulted in autocrine production of Fgf2 and Fgf2-dependent cytokine hypersensitivity. Therefore, our results implicated increased Fgf2 expression in progenitor proliferation and expansion in 11q23-AML. Because small molecule inhibitors of Fgf-receptors are in human clinical trials, this suggested a potential therapeutic approach to this treatment refractory leukemia.	[Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Shah, Chirag A.; Bei, Ling; Wang, Hao; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Adm Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [HL87717, CA155566, CA77816]; Veterans Affairs Merit Reviews; Mander Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA174205, R01CA077816, R01CA155566] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Reviews(US Department of Veterans Affairs); Mander Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL87717 (to E.A.E.), CA155566 (to L.C.P.), and CA77816 (to L.C.P.). This work was also supported by Veterans Affairs Merit Reviews (to E.A.E. and L.C.P.), the Mander Foundation (to E.A.E.), and the Director's Research Fund of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University (to E.A.E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bei L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402172; Bei L, 2011, J BIOL CHEM, V286, P19047, DOI 10.1074/jbc.M110.213983; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eklund E. A., 2011, Critical Reviews in Oncogenesis, V16, P65; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Lindsey S, 2005, J IMMUNOL, V175, P5269, DOI 10.4049/jimmunol.175.8.5269; Lindsey S, 2007, J BIOL CHEM, V282, P2237, DOI 10.1074/jbc.M608642200; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roche J, 2004, LEUKEMIA, V18, P1059, DOI 10.1038/sj.leu.2403366; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Schwind S, 2011, BLOOD, V118, P4188, DOI 10.1182/blood-2011-06-357764; Shah CA, 2012, J BIOL CHEM, V287, P18230, DOI 10.1074/jbc.M111.328401; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2011, J BIOL CHEM, V286, P16832, DOI 10.1074/jbc.M110.213975; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; WILSON EL, 1991, BLOOD, V77, P954; Yoon SY, 2000, ACTA HAEMATOL-BASEL, V104, P151, DOI 10.1159/000046507	46	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32490	32505		10.1074/jbc.M113.496109	http://dx.doi.org/10.1074/jbc.M113.496109			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089521	Green Published, hybrid			2022-12-28	WOS:000328681700033
J	Lee, MJ; Gravelat, FN; Cerone, RP; Baptista, SD; Campoli, PV; Choe, SI; Kravtsov, I; Vinogradov, E; Creuzenet, C; Liu, H; Berghuis, AM; Latge, JP; Filler, SG; Fontaine, T; Sheppard, DC				Lee, Mark J.; Gravelat, Fabrice N.; Cerone, Robert P.; Baptista, Stefanie D.; Campoli, Paolo V.; Choe, Se-In; Kravtsov, Ilia; Vinogradov, Evgeny; Creuzenet, Carole; Liu, Hong; Berghuis, Albert M.; Latge, Jean-Paul; Filler, Scott G.; Fontaine, Thierry; Sheppard, Donald C.			Overlapping and Distinct Roles of Aspergillus fumigatus UDP-glucose 4-Epimerases in Galactose Metabolism and the Synthesis of Galactose-containing Cell Wall Polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Cell Wall; Galactose Metabolism; Glycobiology; Mycology; Polysaccharide	N-ACETYLGLUCOSAMINE; PSEUDOMONAS-AERUGINOSA; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; C4 EPIMERASE; BIOSYNTHESIS; GALACTOFURANOSE; IDENTIFICATION; EXPRESSION; DATABASE	Background:Aspergillus fumigatus produces two galactose-containing exopolysaccharides, galactomannan and galactosaminogalactan. Results: Galactosaminogalactan synthesis requires the UDP-glucose 4-epimerases, Uge5 and Uge3, whereas galactomannan synthesis requires Uge5 alone. Conclusion: Epimerases in A. fumigatus play both distinct and overlapping roles in exopolysaccharide synthesis. Significance: Uncovering the biosynthetic pathways of galactosaminogalactan will be crucial in developing therapeutics targeting this exopolysaccharide. The cell wall of Aspergillus fumigatus contains two galactose-containing polysaccharides, galactomannan and galactosaminogalactan, whose biosynthetic pathways are not well understood. The A. fumigatus genome contains three genes encoding putative UDP-glucose 4-epimerases, uge3, uge4, and uge5. We undertook this study to elucidate the function of these epimerases. We found that uge4 is minimally expressed and is not required for the synthesis of galactose-containing exopolysaccharides or galactose metabolism. Uge5 is the dominant UDP-glucose 4-epimerase in A. fumigatus and is essential for normal growth in galactose-based medium. Uge5 is required for synthesis of the galactofuranose (Galf) component of galactomannan and contributes galactose to the synthesis of galactosaminogalactan. Uge3 can mediate production of both UDP-galactose and UDP-N-acetylgalactosamine (GalNAc) and is required for the production of galactosaminogalactan but not galactomannan. In the absence of Uge5, Uge3 activity is sufficient for growth on galactose and the synthesis of galactosaminogalactan containing lower levels of galactose but not the synthesis of Galf. A double deletion of uge5 and uge3 blocked growth on galactose and synthesis of both Galf and galactosaminogalactan. This study is the first survey of glucose epimerases in A. fumigatus and contributes to our understanding of the role of these enzymes in metabolism and cell wall synthesis.	[Lee, Mark J.; Gravelat, Fabrice N.; Cerone, Robert P.; Baptista, Stefanie D.; Campoli, Paolo V.; Choe, Se-In; Kravtsov, Ilia; Sheppard, Donald C.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Vinogradov, Evgeny] CNR, Ottawa, ON K1A 0R6, Canada; [Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [Liu, Hong; Filler, Scott G.] Harbor UCLA Med Ctr, Los Angeles Biomed Med Inst, Div Infect Dis, Torrance, CA 90502 USA; [Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada; [Latge, Jean-Paul; Fontaine, Thierry] Inst Pasteur, Aspergillus Unit, F-75724 Paris, France	McGill University; National Research Council Canada; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; McGill University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sheppard, DC (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Rue Univ, Montreal, PQ H3A 2B4, Canada.	don.sheppard@mcgill.ca	Berghuis, Albert M/A-6495-2008; Fontaine, Thierry/F-8227-2011; Fontaine, thierry/Q-2201-2018; Sheppard, Donald/B-4637-2008	Fontaine, thierry/0000-0002-8184-789X; Sheppard, Donald/0000-0001-8877-880X; Berghuis, Albert/0000-0002-2663-025X; Gravelat, Fabrice/0000-0003-2416-9380	National Institutes of Health [R01AI073829]; Canadian Institutes of Health Research; Research Institute of the McGill University Health Center; Fonds de Recherche du Quebec-Sante; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Institute of the McGill University Health Center; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI073829. This work was also supported by operating funds from the Canadian Institutes of Health Research.; Supported by a studentship from the Research Institute of the McGill University Health Center.; Supported by a Chercheur-Boursier award from the Fonds de Recherche du Quebec-Sante. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, McGill University, 3775 Rue University, Montreal, Quebec H3A 2B4, Canada. Tel.: 514-398-1759; Fax: 514-398-7052; E-mail: don.sheppard@mcgill.ca.	Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Al Abdallah Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049959; Alam MK, 2013, BOTANY, V91, P467, DOI 10.1139/cjb-2012-0270; Alam MK, 2012, FUNGAL GENET BIOL, V49, P1033, DOI 10.1016/j.fgb.2012.08.010; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Campoli P., 2013, J INFECT DIS, DOI 10.1093/infdis/jit358; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Choe SI, 2012, APPL ENVIRON MICROB, V78, P3855, DOI 10.1128/AEM.07771-11; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Demendi M, 2005, BIOCHEM J, V389, P173, DOI 10.1042/BJ20050263; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Garcia-Vidal C, 2008, CLIN INFECT DIS, V47, P1041, DOI 10.1086/591969; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gravelat FN, 2008, INFECT IMMUN, V76, P3632, DOI 10.1128/IAI.01483-07; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gravelat Fabrice N, 2012, Methods Mol Biol, V845, P119, DOI 10.1007/978-1-61779-539-8_8; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Gu XG, 2011, MICROBIOL-SGM, V157, P260, DOI 10.1099/mic.0.040758-0; Guan S, 2001, J BACTERIOL, V183, P3318, DOI 10.1128/JB.183.11.3318-3327.2001; Hartmann T, 2010, APPL ENVIRON MICROB, V76, P6313, DOI 10.1128/AEM.00882-10; Henry C, 2012, EUKARYOT CELL, V11, P26, DOI 10.1128/EC.05270-11; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Johnson AE, 1998, BIOCHEMISTRY-US, V37, P5746, DOI 10.1021/bi972984j; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Luong ML, 2010, DIAGN MICR INFEC DIS, V68, P132, DOI 10.1016/j.diagmicrobio.2010.03.017; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Mellado E, 2003, FUNGAL GENET BIOL, V38, P98, DOI 10.1016/S1087-1845(02)00516-9; Mikusova K, 2006, J BACTERIOL, V188, P6592, DOI 10.1128/JB.00489-06; Oppenheimer M, 2010, ARCH BIOCHEM BIOPHYS, V502, P31, DOI 10.1016/j.abb.2010.06.035; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Paul BC, 2011, EUKARYOT CELL, V10, P646, DOI 10.1128/EC.00304-10; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Shaw MP, 2003, MOL BIOCHEM PARASIT, V126, P173, DOI 10.1016/S0166-6851(02)00243-8; Slepak T, 2005, MOL GENET METAB, V86, P360, DOI 10.1016/j.ymgme.2005.08.002; Stoco PH, 2012, EXP PARASITOL, V130, P246, DOI 10.1016/j.exppara.2011.12.005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Timson DJ., 2007, DYN BIOCH PROCE BIOT, V1, P63, DOI DOI 10.1046/j.1365-8711.2003.06497.x; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wing C, 2006, ORG BIOMOL CHEM, V4, P3945, DOI 10.1039/b609455d	65	70	72	4	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1243	1256		10.1074/jbc.M113.522516	http://dx.doi.org/10.1074/jbc.M113.522516			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24257745	hybrid, Green Published			2022-12-28	WOS:000332401700005
J	Michel, CH; Kumar, S; Pinotsi, D; Tunnacliffe, A; St George-Hyslop, P; Mandelkow, E; Mandelkow, EM; Kaminski, CF; Schierle, GSK				Michel, Claire H.; Kumar, Satish; Pinotsi, Dorothea; Tunnacliffe, Alan; St George-Hyslop, Peter; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski			Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALPHA-SYNUCLEIN; TRANSMISSION; AGGREGATION; PROPAGATION; ENDOCYTOSIS; EXOCYTOSIS; TAUOPATHY; MODEL	Understanding the formation and propagation of aggregates of the Alzheimer disease-associated Tau protein in vivo is vital for the development of therapeutics for this devastating disorder. Using our recently developed live-cell aggregation sensor in neuron-like cells, we demonstrate that different variants of exogenous monomeric Tau, namely full-length Tau (hTau40) and the Tau-derived construct K18 comprising the repeat domain, initially accumulate in endosomal compartments, where they form fibrillar seeds that subsequently induce the aggregation of endogenous Tau. Using superresolution imaging, we confirm that fibrils consisting of endogenous and exogenous Tau are released from cells and demonstrate their potential to spread Tau pathology. Our data indicate a greater pathological risk and potential toxicity than hitherto suspected for extracellular soluble Tau.	[Michel, Claire H.; Pinotsi, Dorothea; Tunnacliffe, Alan; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England; [Kumar, Satish; Mandelkow, Eckhard; Mandelkow, Eva-Maria] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Kumar, Satish; Mandelkow, Eckhard; Mandelkow, Eva-Maria] DESY, MPI Neurol Res, Hamburg Outstn, D-22607 Hamburg, Germany; [St George-Hyslop, Peter] Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 0XY, England; [St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Mandelkow, Eckhard; Mandelkow, Eva-Maria] Ctr Adv European Studies & Res, D-53175 Bonn, Germany	University of Cambridge; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Toronto; Center of Advanced European Studies & Research (CAESAR)	Kaminski, CF (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Pembroke St, Cambridge CB2 3RA, England.	cfk23@cam.ac.uk; gsk20@cam.ac.uk	Kumar, Satish/AAF-3112-2019; Kaminski, Clemens/G-7488-2016	Kumar, Satish/0000-0002-2993-3694; Kaminski, Clemens/0000-0002-5194-0962; Tunnacliffe, Alan/0000-0001-8570-125X; St George-Hyslop, Peter/0000-0003-0796-7209	Wellcome Trust [089703/Z/09/Z]; Medical Research Council [089703/Z/09/Z, MR/K015850/1, G09022243]; Alzheimer's Research UK [ARUK-EG2012A-1, ARUK-ESG2012-1]; Engineering and Physical Sciences Research Council [EP/H018301/1]; European Research Council [AdG 233232]; Alzheimers Research UK [ARUK-EG2012A-1, ARUK-ESG2012-1] Funding Source: researchfish; Medical Research Council [G0902243, MR/K02292X/1, MC_G1000734] Funding Source: researchfish; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K02292X/1, MR/K015850/1, G0902243, MC_G1000734] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust and Medical Research Council joint funding Grant 089703/Z/09/Z, by Medical Research Council Grants MR/K015850/1 and G09022243, by Alzheimer's Research UK Grants ARUK-EG2012A-1 and ARUK-ESG2012-1, by Engineering and Physical Sciences Research Council Grant EP/H018301/1, and by European Research Council Grant AdG 233232.	Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Frank JH, 2007, J MICROSC-OXFORD, V227, P203, DOI 10.1111/j.1365-2818.2007.01803.x; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Karch CM, 2012, J BIOL CHEM, V287, P42751, DOI 10.1074/jbc.M112.380642; Karch CM, 2013, NEUROBIOL AGING, V34, P374, DOI 10.1016/j.neurobiolaging.2012.05.003; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Niles WD, 1999, J MEMBRANE BIOL, V167, P85, DOI 10.1007/s002329900474; Pinotsi D, 2013, CHEMBIOCHEM, V14, P846, DOI 10.1002/cbic.201300103; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Rees E. J., 2012, OPTICAL NANOSCOPY, V1, P1, DOI DOI 10.1186/2192-2853-1-12; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3	42	110	115	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					956	967		10.1074/jbc.M113.515445	http://dx.doi.org/10.1074/jbc.M113.515445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24235150	hybrid, Green Published			2022-12-28	WOS:000330541200030
J	Muller, PAJ; Trinidad, AG; Caswell, PT; Norman, JC; Vousden, KH				Muller, Patricia A. J.; Trinidad, Antonio G.; Caswell, Patrick T.; Norman, Jim C.; Vousden, Karen H.			Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Motility; Dicer; MicroRNA; p63; Cell Scattering; Mutant p53	CELL-MIGRATION; DOWN-REGULATION; TAP63; P63; METASTASIS; INTEGRIN; CANCER; PROLIFERATION; MODULATION; EXPRESSION	The control and processing of microRNAs (miRs) is critical in the regulation of all cellular responses. Previous studies have suggested that a reduction in the expression of certain miRs, or an overall decrease in miR processing through the partial depletion of Dicer, can promote enhanced metastatic potential. We show here that Dicer depletion can promote the invasive behavior of cells that is reflected in enhanced recycling and activation of the growth factor receptors Met and EGF receptor. These responses are also seen in response to the expression of tumor-derived mutant p53s, and we show that mutant p53 can down-regulate Dicer expression through both direct inhibition of the TAp63-mediated transcriptional activation of Dicer and a TAp63-independent control of Dicer protein expression. Our results delineate a clear relationship between mutant p53, TAp63, and Dicer that might contribute to the metastatic function of mutant p53 but, interestingly, also reveal TAp63-independent functions of mutant p53 in controlling Dicer activity.	[Muller, Patricia A. J.; Trinidad, Antonio G.; Norman, Jim C.; Vousden, Karen H.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland; [Caswell, Patrick T.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	Beatson Institute; University of Manchester	Muller, PAJ (corresponding author), MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	PM292@le.ac.uk	Muller, Patricia AJ/AAH-1888-2019; Caswell, Patrick/N-3063-2015	Muller, Patricia AJ/0000-0002-0926-1499; Caswell, Patrick/0000-0002-2633-2324; NORMAN, Jim/0000-0002-0098-3014	Cancer Research UK; AICR (Association For International Cancer Research); Breast Cancer Campaign; Wellcome Trust/The Royal Society; Medical Research Council; MRC [MC_UP_1203/3] Funding Source: UKRI; Cancer Research UK [18274] Funding Source: researchfish; Medical Research Council [MC_UP_1203/3] Funding Source: researchfish; Wellcome Trust [101242/A/13/Z] Funding Source: researchfish; Breast Cancer Campaign [2011NovPR12] Funding Source: researchfish; Worldwide Cancer Research [11-0626] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR (Association For International Cancer Research); Breast Cancer Campaign; Wellcome Trust/The Royal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Campaign; Worldwide Cancer Research	This work was supported by Cancer Research UK and the AICR (Association For International Cancer Research) and Breast Cancer Campaign (to K. H. V. and J. C. N.) and by the Wellcome Trust/The Royal Society and the Medical Research Council to (P. A. J. M.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Chang L, 2012, RNA BIOL, V9, P1247, DOI 10.4161/rna.21821; Chicas A, 2000, BIOCHEM BIOPH RES CO, V279, P383, DOI 10.1006/bbrc.2000.3965; Damiani MT, 2004, TRAFFIC, V5, P785, DOI 10.1111/j.1600-0854.2004.00220.x; Deng Y, 2013, STEM CELLS DEV, V22, P2278, DOI 10.1089/scd.2012.0686; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Han L, 2010, INT J ONCOL, V37, P299, DOI 10.3892/ijo_00000678; Kuang Y, 2013, ONCOL LETT, V5, P1149, DOI 10.3892/ol.2013.1158; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Tanaka T, 2011, ONCOL REP, V26, P1329, DOI 10.3892/or.2011.1401; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.97; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wiesen JL, 2009, MOL IMMUNOL, V46, P1222, DOI 10.1016/j.molimm.2008.11.012; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	50	56	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					122	132		10.1074/jbc.M113.502138	http://dx.doi.org/10.1074/jbc.M113.502138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24220032	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000329370900011
J	Chin, YKY; Headey, SJ; Mohanty, B; Patil, R; McEwan, PA; Swarbrick, JD; Mulhern, TD; Emsley, J; Simpson, JS; Scanlon, MJ				Chin, Yanni K. -Y.; Headey, Stephen J.; Mohanty, Biswaranjan; Patil, Rahul; McEwan, Paul A.; Swarbrick, James D.; Mulhern, Terrence D.; Emsley, Jonas; Simpson, Jamie S.; Scanlon, Martin J.			The Structure of Integrin alpha 1I Domain in Complex with a Collagen-mimetic Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Extracellular Matrix; Integrins; NMR; Protein Structure; Protein-Protein Interactions	ANGLE SCATTERING DATA; NMR STRUCTURE DETERMINATION; I-DOMAIN; BINDING-SITE; A-DOMAIN; DIVALENT-CATION; RECOGNITION; ALPHA(1)BETA(1); ACTIVATION; DYNAMICS	We have determined the structure of the human integrin 1I domain bound to a triple-helical collagen peptide. The structure of the 1I-peptide complex was investigated using data from NMR, small angle x-ray scattering, and size exclusion chromatography that were used to generate and validate a model of the complex using the data-driven docking program, HADDOCK (High Ambiguity Driven Biomolecular Docking). The structure revealed that the 1I domain undergoes a major conformational change upon binding of the collagen peptide. This involves a large movement in the C-terminal helix of the I domain that has been suggested to be the mechanism by which signals are propagated in the intact integrin receptor. The structure suggests a basis for the different binding selectivity observed for the 1I and 2I domains. Mutational data identify residues that contribute to the conformational change observed. Furthermore, small angle x-ray scattering data suggest that at low collagen peptide concentrations the complex exists in equilibrium between a 1:1 and 2:1 1I-peptide complex.	[Chin, Yanni K. -Y.; Headey, Stephen J.; Mohanty, Biswaranjan; Patil, Rahul; Swarbrick, James D.; Simpson, Jamie S.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Australian Res Council, Ctr Excellence Coherent Xray Sci, Parkville, Vic 3052, Australia; [McEwan, Paul A.; Emsley, Jonas] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England; [Mulhern, Terrence D.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia	Monash University; Monash University; University of Nottingham; University of Melbourne	Scanlon, MJ (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	martin.scanlon@monash.edu	emsley, jonas/A-8509-2016; Simpson, Jamie/ABC-7083-2020; Mohanty, Biswaranjan/E-2080-2018; Chin, Yanni/D-2139-2017; Simpson, Jamie S/A-1700-2012	emsley, jonas/0000-0002-8949-8030; Simpson, Jamie/0000-0002-8894-422X; Mohanty, Biswaranjan/0000-0002-6921-343X; Chin, Yanni/0000-0002-3367-6897; Simpson, Jamie S/0000-0002-8894-422X; Scanlon, Martin/0000-0002-9230-7506; Headey, Stephen/0000-0001-8015-7064; Mulhern, Terrence/0000-0002-1609-7498; mcewan, paul/0000-0001-6097-1528	Monash-Nottingham Research Fund	Monash-Nottingham Research Fund	This work was supported in part by a grant from the Monash-Nottingham Research Fund.	Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chin Y. K., 2013, BIOMOL NMR ASSIGN, DOI 10.1007/s12104-013-9465-7; Connors WL, 2007, J BIOL CHEM, V282, P14675, DOI 10.1074/jbc.M700759200; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Goddard T., 2001, SPARKY; Gullberg D, 2003, MOL B INT U, P67; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; Gunn NJ, 2011, ACTA CRYSTALLOGR F, V67, P336, DOI 10.1107/S1744309110053728; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lahti M, 2011, J BIOL CHEM, V286, P43343, DOI 10.1074/jbc.M111.261909; Lambert LJ, 2008, J BIOL CHEM, V283, P16665, DOI 10.1074/jbc.M710483200; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Nymalm Y, 2004, J BIOL CHEM, V279, P7962, DOI 10.1074/jbc.M312912200; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Serrano P, 2010, ACTA CRYSTALLOGR F, V66, P1393, DOI 10.1107/S1744309110033658; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi M, 2012, J BIOL CHEM, V287, P35139, DOI 10.1074/jbc.M112.358648; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Tulla M, 2008, EXP CELL RES, V314, P1734, DOI 10.1016/j.yexcr.2008.01.025; Vanderslice P, 2006, EXPERT OPIN INV DRUG, V15, P1235, DOI 10.1517/13543784.15.10.1235; Weinreb PH, 2012, J BIOL CHEM, V287, P32897, DOI 10.1074/jbc.M112.354365; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yang W, 2004, P NATL ACAD SCI USA, V101, P2906, DOI 10.1073/pnas.0307340101	58	21	21	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36796	36809		10.1074/jbc.M113.480251	http://dx.doi.org/10.1074/jbc.M113.480251			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24187131	Green Published, hybrid			2022-12-28	WOS:000329189700004
J	Feinberg, H; Rowntree, TJW; Tan, SLW; Drickamer, K; Weis, WI; Taylor, ME				Feinberg, Hadar; Rowntree, Thomas J. W.; Tan, Shawn L. W.; Drickamer, Kurt; Weis, William I.; Taylor, Maureen E.			Common Polymorphisms in Human Langerin Change Specificity for Glycan Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate-binding Protein; Crystal Structure; Genetic Polymorphism; Glycobiology; Lectin; CD207; Sulfated Glycans	C-TYPE LECTIN; CARBOHYDRATE-RECOGNITION; HIV-1 TRANSMISSION; STRUCTURAL BASIS; DC-SIGN; CELLS; BIOSYNTHESIS; ANTIGENS; RECEPTOR; VIRUS	Langerin, a C-type lectin on Langerhans cells, mediates carbohydrate-dependent uptake of pathogens in the first step of antigen presentation to the adaptive immune system. Langerin binds a diverse range of carbohydrates including high mannose structures, fucosylated blood group antigens, and glycans with terminal 6-sulfated galactose. Mutagenesis and quantitative binding assays indicate that salt bridges between the sulfate group and two lysine residues compensate for the nonoptimal binding of galactose at the primary Ca2+ site. A commonly occurring single nucleotide polymorphism (SNP) in human langerin results in change of one of these lysine residues, Lys-313, to isoleucine. Glycan array screening reveals that this amino acid change abolishes binding to oligosaccharides with terminal 6SO(4)-Gal and enhances binding to oligosaccharides with terminal GlcNAc residues. Structural analysis shows that enhanced binding to GlcNAc may result from Ile-313 packing against the N-acetyl group. The K313I polymorphism is tightly linked to another SNP that results in the change N288D, which reduces affinity for glycan ligands by destabilizing the Ca2+-binding site. Langerin with Asp-288 and Ile-313 shows no binding to 6SO(4)-Gal-terminated glycans and increased binding to GlcNAc-terminated structures, but overall decreased binding to glycans. Altered langerin function in individuals with the linked N288D and K313I polymorphisms may affect susceptibility to infection by microorganisms.	[Rowntree, Thomas J. W.; Tan, Shawn L. W.; Drickamer, Kurt; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94306 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94306 USA	Imperial College London; Stanford University; Stanford University	Taylor, ME (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	maureen.taylor@imperial.ac.uk	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Drickamer, Kurt/0000-0001-5026-5996	National Institutes of Health [GM62116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Consortium for Functional Glycomics was supported by Grant GM62116 from the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSSON M, 1989, CARBOHYD RES, V185, P211, DOI 10.1016/0008-6215(89)80036-9; Chabrol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050722; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; de Jong MAWP, 2010, TRENDS IMMUNOL, V31, P452, DOI 10.1016/j.it.2010.08.002; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; de Jong MAWP, 2010, J LEUKOCYTE BIOL, V87, P637, DOI 10.1189/jlb.0809577; de Jong MAWP, 2010, MOL IMMUNOL, V47, P1216, DOI 10.1016/j.molimm.2009.12.016; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Hiraoka N, 2007, GLYCOBIOLOGY, V17, P277, DOI 10.1093/glycob/cwl077; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Idoyaga J, 2008, J IMMUNOL, V180, P3647, DOI 10.4049/jimmunol.180.6.3647; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Stoitzner P, 2011, EUR J IMMUNOL, V41, P2526, DOI 10.1002/eji.201141934; Tateno H, 2010, J BIOL CHEM, V285, P6390, DOI 10.1074/jbc.M109.041863; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; van der Vlist M, 2011, EUR J IMMUNOL, V41, P2619, DOI 10.1002/eji.201041305; Varki A., 2009, ESSENTIALS GLYCOBIOL; Ward EM, 2006, J BIOL CHEM, V281, P15450, DOI 10.1074/jbc.M511502200; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	30	38	39	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36762	36771		10.1074/jbc.M113.528000	http://dx.doi.org/10.1074/jbc.M113.528000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24217250	hybrid, Green Published			2022-12-28	WOS:000329189700001
J	Hurlburt, BK; Offermann, LR; McBride, JK; Majorek, KA; Maleki, SJ; Chruszcz, M				Hurlburt, Barry K.; Offermann, Lesa R.; McBride, Jane K.; Majorek, Karolina A.; Maleki, Soheila J.; Chruszcz, Maksymilian			Structure and Function of the Peanut Panallergen Ara h 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergen; Antigen; Crystal Structure; Flavonoids; Fluorescence; Peanut	BET V 1; BIRCH POLLEN ALLERGEN; PATHOGENESIS-RELATED PROTEINS; X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; MAJOR ALLERGEN; RIBONUCLEASE-ACTIVITY; FOOD ALLERGENS; NUCLEIC-ACIDS	The incidence of peanut allergy continues to rise in the United States and Europe. Whereas exposure to the major allergens Ara h 1, 2, 3, and 6 can cause fatal anaphylaxis, exposure to the minor allergens usually does not. Ara h 8 is a minor allergen. Importantly, it is the minor food allergens that are thought to be responsible for oral allergy syndrome (OAS), in which sensitization to airborne allergens causes a Type 2 allergic reaction to ingested foods. Furthermore, it is believed that similar protein structure rather than a similar linear sequence is the cause of OAS. Bet v 1 from birch pollen is a common sensitizing agent, and OAS results when patients consume certain fruits, vegetables, tree nuts, and peanuts. Here, we report the three-dimensional structure of Ara h 8, a Bet v 1 homolog. The overall fold is very similar to that of Bet v 1, Api g 1 (celery), Gly m 4 (soy), and Pru av 1 (cherry). Ara h 8 binds the isoflavones quercetin and apigenin as well as resveratrol avidly.	[Hurlburt, Barry K.; McBride, Jane K.; Maleki, Soheila J.] ARS, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Offermann, Lesa R.; Chruszcz, Maksymilian] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Majorek, Karolina A.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	United States Department of Agriculture (USDA); University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Virginia	Hurlburt, BK (corresponding author), ARS, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA.	barry.hurlburt@ars.usda.gov; chruszcz@mailbox.sc.edu	Chruszcz, Maksymilian/E-6407-2011	Chruszcz, Maksymilian/0000-0001-7521-5485	United States Department of Agriculture, Agricultural Research Service; University of South Carolina	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of South Carolina	This work was supported by the United States Department of Agriculture, Agricultural Research Service, and internal funds from the University of South Carolina.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asarnoj A, 2010, ALLERGY, V65, P213, DOI 10.1111/j.1398-9995.2009.02138.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; Berkner H, 2009, BIOSCIENCE REP, V29, P183, DOI 10.1042/BSR20080117; Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Casanal A, 2013, ACTA CRYSTALLOGR F, V69, P510, DOI 10.1107/S1744309113006945; Chruszcz M, 2013, MOL IMMUNOL, V56, P794, DOI 10.1016/j.molimm.2013.07.004; D'Avino R, 2011, ALLERGY, V66, P870, DOI 10.1111/j.1398-9995.2011.02555.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027; Fernandes H, 2013, FEBS J, V280, P1169, DOI 10.1111/febs.12114; Fernandes H, 2009, FEBS J, V276, P1596, DOI 10.1111/j.1742-4658.2009.06892.x; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; GOLDBERG ME, 1990, FEBS LETT, V263, P51, DOI 10.1016/0014-5793(90)80703-L; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Hecker J, 2012, ALLERGY, V67, P1530, DOI 10.1111/all.12045; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; Koistinen KM, 2002, PLANT CELL ENVIRON, V25, P707, DOI 10.1046/j.1365-3040.2002.00858.x; Kondo Yasuto, 2009, Allergology International, V58, P485, DOI 10.2332/allergolint.09-RAI-0136; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; Mittag D, 2005, CLIN EXP ALLERGY, V35, P1049, DOI 10.1111/j.1365-2222.2005.02309.x; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Mittag D, 2004, J ALLERGY CLIN IMMUN, V113, P148, DOI 10.1016/j.jaci.2003.09.030; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Mogensen JE, 2007, BIOCHEMISTRY-US, V46, P3356, DOI 10.1021/bi062058h; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200; Osmark P, 1998, PLANT MOL BIOL, V38, P1243, DOI 10.1023/A:1006060224012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pasternak O, 2005, ACTA CRYSTALLOGR D, V61, P99, DOI 10.1107/S0907444904028173; Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119; Riecken S, 2008, BIOL CHEM, V389, P415, DOI 10.1515/BC.2008.038; Samanta A., 2011, CARBON, V100, P12; Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054; Schweimer K, 1999, APPL MAGN RESON, V17, P449, DOI 10.1007/BF03162177; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Swoboda I, 1996, PHYSIOL PLANTARUM, V96, P433, DOI 10.1111/j.1399-3054.1996.tb00455.x; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P603, DOI 10.1016/j.jaci.2010.09.010; Watari H, 1997, P NATL ACAD SCI USA, V94, P8462, DOI 10.1073/pnas.94.16.8462; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419	58	32	34	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36890	36901		10.1074/jbc.M113.517797	http://dx.doi.org/10.1074/jbc.M113.517797			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24253038	Green Published, hybrid			2022-12-28	WOS:000329189700012
J	Cobbold, SA; Vaughan, AM; Lewis, IA; Painter, HJ; Camargo, N; Perlman, DH; Fishbaugher, M; Healer, J; Cowman, AF; Kappe, SHI; Llinas, M				Cobbold, Simon A.; Vaughan, Ashley M.; Lewis, Ian A.; Painter, Heather J.; Camargo, Nelly; Perlman, David H.; Fishbaugher, Matthew; Healer, Julie; Cowman, Alan F.; Kappe, Stefan H. I.; Llinas, Manuel			Kinetic Flux Profiling Elucidates Two Independent Acetyl-CoA Biosynthetic Pathways in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Glycolysis; Malaria; Phosphoenolpyruvate Carboxykinase; Plasmodium; Pyruvate Dehydrogenase Complex; Tricarboxylic Acid (TCA) Cycle; Acetate	MALARIA PARASITE; PYRUVATE-DEHYDROGENASE; METABOLIC PATHWAYS; MITOCHONDRIAL METABOLISM; ACID DEHYDROGENASE; LACTATE PRODUCTION; TRANSPORT; COMPLEX; ERYTHROCYTES; INFECTION	Background: The acetyl-CoA biosynthetic pathways of the malaria parasite are unclear. Results: C-13-Labeling experiments in parasites lacking a functional pyruvate dehydrogenase (PDH) complex show that the PDH does not contribute significantly to the acetyl-CoA pool. Conclusion: The majority of acetyl-CoA biosynthesis in the parasite derives from a PDH-like enzyme and acetyl-CoA synthetase. Significance: The two routes for acetyl-CoA synthesis appear to have separate functions. The malaria parasite Plasmodium falciparum depends on glucose to meet its energy requirements during blood-stage development. Although glycolysis is one of the best understood pathways in the parasite, it is unclear if glucose metabolism appreciably contributes to the acetyl-CoA pools required for tricarboxylic acid metabolism (TCA) cycle and fatty acid biosynthesis. P. falciparum possesses a pyruvate dehydrogenase (PDH) complex that is localized to the apicoplast, a specialized quadruple membrane organelle, suggesting that separate acetyl-CoA pools are likely. Herein, we analyze PDH-deficient parasites using rapid stable-isotope labeling and show that PDH does not appreciably contribute to acetyl-CoA synthesis, tricarboxylic acid metabolism, or fatty acid synthesis in blood stage parasites. Rather, we find that acetyl-CoA demands are supplied through a PDH-like enzyme and provide evidence that the branched-chain keto acid dehydrogenase (BCKDH) complex is performing this function. We also show that acetyl-CoA synthetase can be a significant contributor to acetyl-CoA biosynthesis. Interestingly, the PDH-like pathway contributes glucose-derived acetyl-CoA to the TCA cycle in a stage-independent process, whereas anapleurotic carbon enters the TCA cycle via a stage-dependent phosphoenolpyruvate carboxylase/phosphoenolpyruvate carboxykinase process that decreases as the parasite matures. Although PDH-deficient parasites have no blood-stage growth defect, they are unable to progress beyond the oocyst phase of the parasite mosquito stage.	[Llinas, Manuel] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA; [Llinas, Manuel] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16802 USA; [Cobbold, Simon A.; Lewis, Ian A.; Painter, Heather J.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Perlman, David H.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Vaughan, Ashley M.; Camargo, Nelly; Fishbaugher, Matthew; Kappe, Stefan H. I.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Healer, Julie; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Princeton University; Princeton University; Center for Infectious Disease Research; Walter & Eliza Hall Institute; University of Washington; University of Washington Seattle	Llinas, M (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA.	manuel@psu.edu		Cobbold, Simon/0000-0002-9927-8998; Lewis, Ian A./0000-0002-5753-499X	National Institutes of Health Director's New Innovators Award [1DP2OD001315-01]; Center for Quantitative Biology [R56 AI080685, P50 GM071508]; Burroughs Welcome Fund; National Health and Medical Research Council (NHMRC) of Australia; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001315] Funding Source: NIH RePORTER	National Institutes of Health Director's New Innovators Award; Center for Quantitative Biology; Burroughs Welcome Fund(Burroughs Wellcome Fund); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovators Award 1DP2OD001315-01) (to M. L.) and Grants R56 AI080685 (to S. H. I. K.) and P50 GM071508 (Center for Quantitative Biology; to M. L.). This work was also supported through generous support from the Burroughs Welcome Fund (to M. L.) and National Health and Medical Research Council (NHMRC) of Australia and Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institutes Infrastructure Support Scheme (to A. F. C.).	Amador-Noguez D, 2011, APPL ENVIRON MICROB, V77, P7984, DOI 10.1128/AEM.05374-11; ATAMNA H, 1994, MOL BIOCHEM PARASIT, V67, P79, DOI 10.1016/0166-6851(94)90098-1; Beier John C., 1998, P49; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Botte CY, 2013, P NATL ACAD SCI USA, V110, P7506, DOI 10.1073/pnas.1301251110; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Cobbold SA, 2011, INT J PARASITOL, V41, P125, DOI 10.1016/j.ijpara.2010.09.001; CRANMER SL, 1995, J BIOL CHEM, V270, P15045, DOI 10.1074/jbc.270.25.15045; Cui LW, 2010, EUKARYOT CELL, V9, P1138, DOI 10.1128/EC.00036-10; Dechamps S, 2010, INT J PARASITOL, V40, P1347, DOI 10.1016/j.ijpara.2010.05.008; Elliott JL, 2001, BIOCHEM J, V355, P733, DOI 10.1042/bj3550733; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Frltzler JM, 2007, EUKARYOT CELL, V6, P2018, DOI 10.1128/EC.00210-07; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Heath C, 2007, FEBS J, V274, P5406, DOI 10.1111/j.1742-4658.2007.06067.x; Kamphorst JJ, 2011, ANAL CHEM, V83, P9114, DOI 10.1021/ac202220b; KANAANI J, 1991, J CELL PHYSIOL, V149, P469, DOI 10.1002/jcp.1041490316; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lee S, 2011, EUKARYOT CELL, V10, P1043, DOI 10.1128/EC.05071-11; Lentner C., 1992, GEIGY SCI TABLES, V1, P167; Lewis IA, 2007, ANAL CHEM, V79, P9385, DOI 10.1021/ac071583z; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Mehta Monika, 2006, Journal of Vector Borne Diseases, V43, P95; Mi-ichi F, 2006, PARASITOLOGY, V133, P399, DOI 10.1017/S0031182006000540; Miao J, 2013, MOL MICROBIOL, V89, P660, DOI 10.1111/mmi.12303; Mogi T, 2010, PARASITOL INT, V59, P305, DOI 10.1016/j.parint.2010.04.005; Olszewski Kellen L, 2013, Methods Mol Biol, V923, P259; Olszewski KL, 2011, MOL BIOCHEM PARASIT, V175, P95, DOI 10.1016/j.molbiopara.2010.09.001; PAXTON R, 1982, J BIOL CHEM, V257, P4433; PAXTON R, 1986, BIOCHEM J, V234, P295, DOI 10.1042/bj2340295; Pei Y, 2010, MOL MICROBIOL, V75, P957, DOI 10.1111/j.1365-2958.2009.07034.x; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; PFALLER MA, 1982, EXP PARASITOL, V54, P391, DOI 10.1016/0014-4894(82)90048-0; Polonais V, 2010, BIOL CELL, V102, P435, DOI 10.1042/BC20100005; Ralph SA, 2005, MOL MICROBIOL, V55, P1, DOI 10.1111/j.1365-2958.2004.04314.x; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; ROTH EF, 1982, BIOCHEM BIOPH RES CO, V109, P355, DOI 10.1016/0006-291X(82)91728-4; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Seeber F, 2008, TRENDS PARASITOL, V24, P468, DOI 10.1016/j.pt.2008.07.004; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDERJAGT DL, 1990, MOL BIOCHEM PARASIT, V42, P277, DOI 10.1016/0166-6851(90)90171-H; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]; Yoshii Y, 2009, NUCL MED BIOL, V36, P771, DOI 10.1016/j.nucmedbio.2009.05.006; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698; ZOLG JW, 1984, IN VITRO CELL DEV B, V20, P205, DOI 10.1007/BF02618189	57	53	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36338	36350		10.1074/jbc.M113.503557	http://dx.doi.org/10.1074/jbc.M113.503557			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24163372	hybrid, Green Published			2022-12-28	WOS:000328883400016
J	Daly, NL; Thorstholm, L; Greenwood, KP; King, GJ; Rosengren, KJ; Heras, B; Martin, JL; Craik, DJ				Daly, Norelle L.; Thorstholm, Louise; Greenwood, Kathryn P.; King, Gordon J.; Rosengren, K. Johan; Heras, Begona; Martin, Jennifer L.; Craik, David J.			Structural Insights into the Role of the Cyclic Backbone in a Squash Trypsin Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NMR; Peptide Conformation; Peptide Interactions; Protease Inhibitor; Structural Biology; Cyclic Peptides; Cyclotides	MAGNETIC-RESONANCE RELAXATION; X-RAY-DIFFRACTION; CIRCULAR PROTEINS; PLANT CYCLOTIDES; KNOTTED PROTEINS; MCOTI-II; PEPTIDES; FRAGMENTS; DYNAMICS; DESIGN	Background: MCoTI-II is a potent serine protease inhibitor with a cyclic protein backbone. Results: Its three-dimensional structure and dynamics in complex with trypsin were determined using x-ray and NMR methods. Conclusion: The cyclic backbone of MCoTI-II participates in favorable interactions with trypsin. Significance: We demonstrate a new role for backbone cyclization in enhancing enzyme inhibitory activity. MCoTI-II is a head-to-tail cyclic peptide with potent trypsin inhibitory activity and, on the basis of its exceptional proteolytic stability, is a valuable template for the design of novel drug leads. Insights into inhibitor dynamics and interactions with biological targets are critical for drug design studies, particularly for protease targets. Here, we show that the cyclization and active site loops of MCoTI-II are flexible in solution, but when bound to trypsin, the active site loop converges to a single well defined conformation. This finding of reduced flexibility on binding is in contrast to a recent study on the homologous peptide MCoTI-I, which suggested that regions of the peptide are more flexible upon binding to trypsin. We provide a possible explanation for this discrepancy based on degradation of the complex over time. Our study also unexpectedly shows that the cyclization loop, not present in acyclic homologues, facilitates potent trypsin inhibitory activity by engaging in direct binding interactions with trypsin.	[Daly, Norelle L.; Thorstholm, Louise; Greenwood, Kathryn P.; King, Gordon J.; Heras, Begona; Martin, Jennifer L.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns 4878, Australia; [Daly, Norelle L.] James Cook Univ, Sch Pharm & Mol Sci, Cairns 4878, Australia; [Heras, Begona] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia	University of Queensland; University of Queensland; James Cook University; James Cook University; La Trobe University	Craik, DJ (corresponding author), Univ Queensland, St Lucia, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Greenwood, Kathryn/U-6965-2017; King, Gordon/J-8718-2014; Craik, David/B-1695-2010; Rosengren, K. Johan/P-4450-2016; Heras, Begona/H-8686-2014; Martin, Jennifer L./A-6039-2010	Greenwood, Kathryn/0000-0002-1556-0065; Craik, David/0000-0003-0007-6796; Rosengren, K. Johan/0000-0002-5007-8434; Heras, Begona/0000-0003-3469-7988; King, Gordon/0000-0001-5592-5789; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council [DP0984390]; National Health and Medical Research Council of Australia [APP1028509]	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council (DP0984390) and the National Health and Medical Research Council of Australia (APP1028509).	Aboye TL, 2012, J MED CHEM, V55, P10729, DOI 10.1021/jm301468k; Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Avrutina O, 2005, BIOL CHEM, V386, P1301, DOI 10.1515/BC.2005.148; BODE W, 1989, FEBS LETT, V242, P285, DOI 10.1016/0014-5793(89)80486-7; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Craik DJ, 2007, MOL BIOSYST, V3, P257, DOI 10.1039/b616856f; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Creighton T.E., 1992, PROTEINS STRUCTURES; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; JARVIS JA, 1993, BIOCHEM BIOPH RES CO, V192, P991, DOI 10.1006/bbrc.1993.1514; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Ji YB, 2013, J AM CHEM SOC, V135, P11623, DOI 10.1021/ja405108p; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIPARI G, 1981, BIOCHEMISTRY-US, V20, P6250, DOI 10.1021/bi00524a053; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paesen GC, 2007, J MOL BIOL, V368, P1172, DOI 10.1016/j.jmb.2007.03.011; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Puttamadappa SS, 2010, ANGEW CHEM INT EDIT, V49, P7030, DOI 10.1002/anie.201002906; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 1999, J AM CHEM SOC, V121, P4316, DOI 10.1021/ja984480u; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	42	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36141	36148		10.1074/jbc.M113.528240	http://dx.doi.org/10.1074/jbc.M113.528240			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24169696	hybrid, Green Published			2022-12-28	WOS:000329814700048
J	Mowrey, DD; Liu, Q; Bondarenko, V; Chen, Q; Seyoum, E; Xu, Y; Wu, J; Tang, P				Mowrey, David D.; Liu, Qiang; Bondarenko, Vasyl; Chen, Qiang; Seyoum, Edom; Xu, Yan; Wu, Jie; Tang, Pei			Insights into Distinct Modulation of alpha 7 and alpha 7 beta 2 Nicotinic Acetylcholine Receptors by the Volatile Anesthetic Isoflurane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anesthetics; Cys-loop Receptors; Electrophysiology; Nicotinic Acetylcholine Receptors; NMR; Protein Dynamics; 7; 72; Isoflurane	GATED ION-CHANNEL; X-RAY-STRUCTURE; ALPHA-4-BETA-2 NACHR; GENERAL-ANESTHETICS; MICE LACKING; CONFORMATIONAL TRANSITIONS; TRANSMEMBRANE DOMAINS; MOLECULAR-DYNAMICS; GABA(A) RECEPTOR; AMINO-ACIDS	Background: What determines hypersensitivity or insensitivity of 2-containing or 7 nAChRs to volatile anesthetics remains unclear. Results: Isoflurane binds to the EC end of the TM domain, modulates channel dynamics, and inhibits channel current in 2 not 7. Conclusion: The dynamic and structural differences between 2 and 7 affect isoflurane binding and inhibition. Significance: Both structure and dynamics are critical for drug action. Nicotinic acetylcholine receptors (nAChRs) are targets of general anesthetics, but functional sensitivity to anesthetic inhibition varies dramatically among different subtypes of nAChRs. Potential causes underlying different functional responses to anesthetics remain elusive. Here we show that in contrast to the 7 nAChR, the 72 nAChR is highly susceptible to inhibition by the volatile anesthetic isoflurane in electrophysiology measurements. Isoflurane-binding sites in 2 and 7 were found at the extracellular and intracellular end of their respective transmembrane domains using NMR. Functional relevance of the identified 2 site was validated via point mutations and subsequent functional measurements. Consistent with their functional responses to isoflurane, 2 but not 7 showed pronounced dynamics changes, particularly for the channel gate residue Leu-249(9). These results suggest that anesthetic binding alone is not sufficient to generate functional impact; only those sites that can modulate channel dynamics upon anesthetic binding will produce functional effects.	[Mowrey, David D.; Bondarenko, Vasyl; Chen, Qiang; Seyoum, Edom; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Mowrey, David D.; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Liu, Qiang; Wu, Jie] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Tang, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, 2049 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	tangp@upmc.edu	Liu, Qiang/HHZ-3181-2022	Tang, Pei/0000-0002-2869-2737; Seyoum, Edom/0000-0003-1357-1235	National Institutes of Health Grants [R01GM56257, R01GM66358, R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056257, R01GM066358, R37GM049202] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM56257 and R01GM66358 (to P. T.) and R37GM049202 (to Y. X.).	Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2013, BBA-BIOMEMBRANES, V1828, P398, DOI 10.1016/j.bbamem.2012.09.014; Bondarenko V, 2012, BBA-BIOMEMBRANES, V1818, P1261, DOI 10.1016/j.bbamem.2012.02.008; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Dascal N., 2001, CURR PROTOC NEUROSCI; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Downie DL, 2002, J BIOL CHEM, V277, P10367, DOI 10.1074/jbc.M107847200; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; Flood P, 2002, ANESTH ANALG, V95, P83, DOI 10.1097/00000539-200207000-00015; Goddard T. D., 2001, SPARKY 3; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Liu LT, 2010, J PHYS CHEM B, V114, P626, DOI 10.1021/jp908944e; Liu LT, 2009, J PHYS CHEM B, V113, P12581, DOI 10.1021/jp9039513; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mori T, 2001, MOL PHARMACOL, V59, P732, DOI 10.1124/mol.59.4.732; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Mowrey D, 2010, J PHYS CHEM B, V114, P7649, DOI 10.1021/jp1009675; Mowrey DD, 2013, STRUCTURE, V21, P1897, DOI 10.1016/j.str.2013.07.014; Nickalls RWD, 2003, BRIT J ANAESTH, V91, P170, DOI 10.1093/bja/aeg132; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Palma E, 1999, J BIOL CHEM, V274, P18335, DOI 10.1074/jbc.274.26.18335; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Varga Z, 2005, INT J QUANTUM CHEM, V105, P302, DOI 10.1002/qua.20706; Velisetty P, 2012, J BIOL CHEM, V287, P36864, DOI 10.1074/jbc.M112.401067; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu J, 2004, J PHARMACOL EXP THER, V311, P80, DOI 10.1124/jpet.104.070417; Xu W, 1999, J NEUROSCI, V19, P9298; Xu Y, 2000, BIOPHYS J, V78, P746, DOI 10.1016/S0006-3495(00)76632-X; Yamashita M, 2005, ANESTHESIOLOGY, V102, P76, DOI 10.1097/00000542-200501000-00015; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Zhao LK, 2003, J PHARMACOL EXP THER, V305, P1132, DOI 10.1124/jpet.103.048777	55	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35793	35800		10.1074/jbc.M113.508333	http://dx.doi.org/10.1074/jbc.M113.508333			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24194515	hybrid, Green Published			2022-12-28	WOS:000329814700017
J	Wilcoxen, J; Hille, R				Wilcoxen, Jarett; Hille, Russ			The Hydrogenase Activity of the Molybdenum/Copper-containing Carbon Monoxide Dehydrogenase of Oligotropha carboxidovorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbon Monoxide; Copper; Enzyme Kinetics; Hydrogenase; Kinetics; Molybdenum; CO Dehydrogenase	CO-DEHYDROGENASE; XANTHINE-OXIDASE; PSEUDOMONAS-CARBOXYDOVORANS; COPPER; MECHANISM; OXIDATION; SITE; OXIDOREDUCTASE; REDUCTION; CLUSTER	Background: CO dehydrogenase oxidizes CO to CO2 under aerobic conditions. Results: CO dehydrogenase also oxidizes H-2, eliciting a new EPR signal. Conclusion: CO dehydrogenase is an effective hydrogenase, and the EPR signal observed provides new mechanistic information. Significance: We have gained a deeper understanding of the chemistry catalyzed by this enzyme and new information concerning the mechanism of H-2 oxidation. The reaction of the air-tolerant CO dehydrogenase from Oligotropha carboxidovorans with H-2 has been examined. Like the Ni-Fe CO dehydrogenase, the enzyme can be reduced by H-2 with a limiting rate constant of 5.3 s(-1) and a dissociation constant K-d of 525 m; both k(red) and k(red)/K-d, reflecting the breakdown of the Michaelis complex and the reaction of free enzyme with free substrate in the low [S] regime, respectively, are largely pH-independent. During the reaction with H-2, a new EPR signal arising from the Mo/Cu-containing active site of the enzyme is observed which is distinct from the signal seen when the enzyme is reduced by CO, with greater g anisotropy and larger hyperfine coupling to the active site Cu-63,Cu-65. The signal also exhibits hyperfine coupling to at least two solvent-exchangeable protons of bound substrate that are rapidly exchanged with solvent. Proton coupling is also evident in the EPR signal seen with the dithionite-reduced native enzyme, and this coupling is lost in the presence of bicarbonate. We attribute the coupled protons in the dithionite-reduced enzyme to coordinated water at the copper site in the native enzyme and conclude that bicarbonate is able to displace this water from the copper coordination sphere. On the basis of our results, a mechanism for H-2 oxidation is proposed which involves initial binding of H-2 to the copper of the binuclear center, displacing the bound water, followed by sequential deprotonation through a copper-hydride intermediate to reduce the binuclear center.	[Wilcoxen, Jarett; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1462 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu	Wilcoxen, Jarett M/F-9794-2013	Wilcoxen, Jarett M/0000-0003-2220-0815	Department of Energy [13ER16411]	Department of Energy(United States Department of Energy (DOE))	This work was supported by Department of Energy Grant 13ER16411 (to R. H.).	BHATNAGAR L, 1987, FEMS MICROBIOL LETT, V41, P337; BRAY RC, 1969, BIOCHEM J, V114, P725, DOI 10.1042/bj1140725; CYPIONKA H, 1983, J BACTERIOL, V156, P1178, DOI 10.1128/JB.156.3.1178-1187.1983; Dobbek H, 2002, P NATL ACAD SCI USA, V99, P15971, DOI 10.1073/pnas.212640899; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Frohman DJ, 2013, INORG CHEM, V52, P816, DOI 10.1021/ic301941k; Gourlay C, 2006, J AM CHEM SOC, V128, P2164, DOI 10.1021/ja056500f; HILLE R, 1993, BIOCHEMISTRY-US, V32, P3973, DOI 10.1021/bi00066a018; Hille R, 2001, J BIOL CHEM, V276, P31193, DOI 10.1074/jbc.M100673200; Hofmann M, 2005, J BIOL INORG CHEM, V10, P490, DOI 10.1007/s00775-005-0661-5; Hulley EB, 2013, J AM CHEM SOC, V135, P11736, DOI 10.1021/ja405755j; Kemper PR, 1998, J AM CHEM SOC, V120, P13494, DOI 10.1021/ja9822658; Leger C, 2002, BIOCHEMISTRY-US, V41, P15736, DOI 10.1021/bi026586e; MAHONEY WS, 1988, J AM CHEM SOC, V110, P291, DOI 10.1021/ja00209a048; Menon S, 1996, BIOCHEMISTRY-US, V35, P15814, DOI 10.1021/bi9615598; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; MEYER O, 1980, J BACTERIOL, V141, P74, DOI 10.1128/JB.141.1.74-80.1980; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; Moersdorf Gerhard, 1992, Biodegradation, V3, P61; Moser R, 2010, J AM CHEM SOC, V132, P7852, DOI 10.1021/ja102689e; OLSON JS, 1974, J BIOL CHEM, V249, P4363; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Resch M, 2005, J BIOL INORG CHEM, V10, P518, DOI 10.1007/s00775-005-0006-4; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; Santiago B, 1996, FEMS MICROBIOL LETT, V136, P157; Siegbahn PEM, 2005, J COMPUT CHEM, V26, P888, DOI 10.1002/jcc.20230; Siegbahn PEM, 2007, CHEM REV, V107, P4414, DOI 10.1021/cr050185y; Speight J.G., 2004, LANGES HDB CHEM; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Wang N, 2013, DALTON T, V42, P12059, DOI 10.1039/c3dt51371h; Wilcoxen J, 2011, J AM CHEM SOC, V133, P12934, DOI 10.1021/ja205073j; Wilcoxen J, 2011, BIOCHEMISTRY-US, V50, P1910, DOI 10.1021/bi1017182; Zhang B, 2010, J BIOL CHEM, V285, P12571, DOI 10.1074/jbc.M109.076851	33	24	24	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36052	36060		10.1074/jbc.M113.522441	http://dx.doi.org/10.1074/jbc.M113.522441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24165123	hybrid, Green Published			2022-12-28	WOS:000329814700040
J	Amatsu, S; Sugawara, Y; Matsumura, T; Kitadokoro, K; Fujinaga, Y				Amatsu, Sho; Sugawara, Yo; Matsumura, Takuhiro; Kitadokoro, Kengo; Fujinaga, Yukako			Crystal Structure of Clostridium botulinum Whole Hemagglutinin Reveals a Huge Triskelion-shaped Molecular Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Botulinum Toxin; Carbohydrate-binding Protein; Crystal Structure; E-cadherin; Epithelial Cell; Protein Complexes; Bacterial Pathogenesis; Hemagglutinin	C PROGENITOR TOXIN; SUGAR-BINDING SITES; X-RAY-DIFFRACTION; EPITHELIAL BARRIER; HA PROTEINS; SIALIC-ACID; NEUROTOXIN; SUBCOMPONENT; CELLS; INTERNALIZATION	Clostridium botulinum HA is a component of the large botulinum neurotoxin complex and is critical for its oral toxicity. HA plays multiple roles in toxin penetration in the gastrointestinal tract, including protection from the digestive environment, binding to the intestinal mucosal surface, and disruption of the epithelial barrier. At least two properties of HA contribute to these roles: the sugar-binding activity and the barrier-disrupting activity that depends on E-cadherin binding of HA. HA consists of three different proteins, HA1, HA2, and HA3, whose structures have been partially solved and are made up mainly of -strands. Here, we demonstrate structural and functional reconstitution of whole HA and present the complete structure of HA of serotype B determined by x-ray crystallography at 3.5 resolution. This structure reveals whole HA to be a huge triskelion-shaped molecule. Our results suggest that whole HA is functionally and structurally separable into two parts: HA1, involved in recognition of cell-surface carbohydrates, and HA2-HA3, involved in paracellular barrier disruption by E-cadherin binding.	[Amatsu, Sho; Kitadokoro, Kengo] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Sugawara, Yo; Matsumura, Takuhiro; Fujinaga, Yukako] Osaka Univ, Lab Infect Cell Biol, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan	Kyoto Institute of Technology; Osaka University	Kitadokoro, K (corresponding author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Biomol Engn, Sakyo Ku, Matsugasakigosyokaido Cho, Kyoto 6068585, Japan.	kengo@kit.ac.jp; yukafuji@biken.osaka-u.ac.jp		Kitadokoro, Kengo/0000-0001-5969-7939; Amatsu, Sho/0000-0003-0692-264X	Academia Sinica; National Synchrotron Radiation Research Center (Taiwan)	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan)	We thank Dr. E. Yamashita and Prof. A. Nakagawa (SPring-8 beamline BL44XU) for help with the x-ray data collection. Diffraction data were collected at Osaka University beamline BL44XU at SPring-8 (equipped with a Rayonix MX300-HE detector), which is financially supported by Academia Sinica and the National Synchrotron Radiation Research Center (Taiwan). We also thank Asami Sano, Takayuki Yoshimura, and Kaoru Sasaki for technical assistance.	Arimitsu H, 2003, INFECT IMMUN, V71, P1599, DOI 10.1128/IAI.71.3.1599-1603.2003; Arimitsu H, 2008, MICROB PATHOGENESIS, V45, P142, DOI 10.1016/j.micpath.2008.04.007; Arndt JW, 2005, J MOL BIOL, V346, P1083, DOI 10.1016/j.jmb.2004.12.039; Benefield DA, 2013, P NATL ACAD SCI USA, V110, P5630, DOI [10.1073/pnas.1222139110, 10.1073/pnas.12222139110]; Briggs DC, 2011, J MOL BIOL, V413, P138, DOI 10.1016/j.jmb.2011.07.066; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Fujinaga Y, 2004, MICROBIOL-SGM, V150, P1529, DOI 10.1099/mic.0.26805-0; Fujinaga Y, 1997, MICROBIOL-UK, V143, P3841, DOI 10.1099/00221287-143-12-3841; Fujinaga Y, 2000, FEBS LETT, V467, P179, DOI 10.1016/S0014-5793(00)01147-9; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Gu SY, 2012, SCIENCE, V335, P977, DOI 10.1126/science.1214270; Hasegawa K, 2007, J BIOL CHEM, V282, P24777, DOI 10.1074/jbc.M703446200; Hill KK, 2013, CURR TOP MICROBIOL, V364, P1, DOI 10.1007/978-3-642-33570-9_1; Inoue K, 2003, MICROBIOL-SGM, V149, P3361, DOI 10.1099/mic.0.26586-0; Inui K, 2010, J VET MED SCI, V72, P1251, DOI 10.1292/jvms.10-0090; Ito H, 2011, FEMS IMMUNOL MED MIC, V61, P323, DOI 10.1111/j.1574-695X.2011.00779.x; JANCARIK J, 1991, J MOL BIOL, V221, P31, DOI 10.1016/0022-2836(91)80198-4; Jin YJ, 2009, MICROBIOL-SGM, V155, P35, DOI 10.1099/mic.0.021246-0; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; Kojima S, 2005, BIOCHEM BIOPH RES CO, V331, P571, DOI 10.1016/j.bbrc.2005.04.007; Kouguchi H, 2002, J BIOL CHEM, V277, P2650, DOI 10.1074/jbc.M106762200; Matsumura T, 2008, CELL MICROBIOL, V10, P355, DOI 10.1111/j.1462-5822.2007.01048.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2008, J MOL BIOL, V376, P854, DOI 10.1016/j.jmb.2007.12.031; Nakamura T, 2011, ARCH BIOCHEM BIOPHYS, V512, P69, DOI 10.1016/j.abb.2011.05.012; Nakamura T, 2009, J MOL BIOL, V385, P1193, DOI 10.1016/j.jmb.2008.11.039; Nishikawa A, 2004, BIOCHEM BIOPH RES CO, V319, P327, DOI 10.1016/j.bbrc.2004.04.183; Niwa K, 2007, FEMS IMMUNOL MED MIC, V49, P346, DOI 10.1111/j.1574-695X.2006.00205.x; Niwa K, 2010, VET MICROBIOL, V141, P312, DOI 10.1016/j.vetmic.2009.09.008; Oguma K, 1999, J TOXICOL-TOXIN REV, V18, P17, DOI 10.3109/15569549909036015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poulain B, 2008, BOTULINUM J, V1, P14, DOI DOI 10.1504/TBJ.2008.018951; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Sugawara Y, 2011, CELL ADHES MIGR, V5, P34, DOI 10.4161/cam.5.1.13574; Sugawara Y, 2010, J CELL BIOL, V189, P691, DOI 10.1083/jcb.200910119; Uotsu N, 2006, BBA-MOL CELL RES, V1763, P120, DOI 10.1016/j.bbamcr.2005.11.014; Yamashita S, 2012, FEBS LETT, V586, P2404, DOI 10.1016/j.febslet.2012.05.055	42	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35617	35625		10.1074/jbc.M113.521179	http://dx.doi.org/10.1074/jbc.M113.521179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24165130	Green Published, hybrid			2022-12-28	WOS:000329867600055
J	Shan, Z; Han, QL; Nie, J; Cao, XZ; Chen, ZJ; Yin, SY; Gao, YY; Lin, F; Zhou, XH; Xu, K; Fan, HM; Qian, ZK; Sun, B; Zhong, J; Li, B; Tsun, A				Shan, Zhao; Han, Qinglin; Nie, Jia; Cao, Xuezhi; Chen, Zuojia; Yin, Shuying; Gao, Yayi; Lin, Fang; Zhou, Xiaohui; Xu, Ke; Fan, Huimin; Qian, Zhikang; Sun, Bing; Zhong, Jin; Li, Bin; Tsun, Andy			Negative Regulation of Interferon-induced Transmembrane Protein 3 by SET7-mediated Lysine Monomethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; Host Defense; Host-pathogen Interactions; Post-translational Modification; Protein Methylation; Antiviral Host Restriction Factors; IFITM3; Lysine Methylation; SET7	INFLUENZA-A VIRUS; WEST NILE VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; METHYLATION; IFITM3; METHYLTRANSFERASE; RESISTANCE	Background: IFITM3 is a general antiviral host restriction factor against RNA viruses. Results: SET7-mediated monomethylation of IFITM3 at Lys-88 negatively affected its antiviral activity toward vesicular stomatitis virus (VSV) and influenza A virus (IAV) infection. Conclusion: The monomethylation of antiviral host restriction factors may perturb their function. Significance: Targeting the SET7 pathway could provide new antiviral therapeutic strategies. Although lysine methylation is classically known to regulate histone function, its role in modulating antiviral restriction factor activity remains uncharacterized. Interferon-induced transmembrane protein 3 (IFITM3) was found monomethylated on its lysine 88 residue (IFITM3-K88me1) to reduce its antiviral activity, mediated by the lysine methyltransferase SET7. Vesicular stomatitis virus and influenza A virus infection increased IFITM3-K88me1 levels by promoting the interaction between IFITM3 and SET7, suggesting that this pathway could be hijacked to support infection; conversely, IFN- reduced IFITM3-K88me1 levels. These findings may have important implications in the design of therapeutics targeting protein methylation against infectious diseases.	[Shan, Zhao; Nie, Jia; Chen, Zuojia; Yin, Shuying; Gao, Yayi; Lin, Fang; Li, Bin; Tsun, Andy] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Mol Immunol,Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Cao, Xuezhi; Zhong, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Viral Hepatitis,Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Han, Qinglin; Xu, Ke; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Mol Virol,Inst Pasteur Shanghai, Shanghai 200031, Peoples R China; [Qian, Zhikang] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Mol Virol & Immunol, Units Herpesvirus & Mol Virol Res,Inst Pasteur Sh, Shanghai 200031, Peoples R China; [Zhou, Xiaohui; Fan, Huimin] Tongji Univ, Sch Med, Shanghai East Hosp, Shanghai 200120, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Li, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Life Sci Res Bldg,320 Yueyang Rd, Shanghai 200031, Peoples R China.	binli@sibs.ac.cn; andy@sibs.ac.cn	lI, Bin/AAR-4966-2021; Chen, Zuojia/AAM-9465-2020; Zhong, Jin/M-6859-2018	lI, Bin/0000-0002-7640-8884; Zhong, Jin/0000-0002-3554-1275; Cao, Xuezhi/0000-0002-3602-4560	National Natural Science Foundation of China [30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, 81271835]; National Institutes of Health NSFC Collaborative [81161120417]; Shanghai "Rising Star" Program [10QA1407900]; Novo Nordisk-Chinese Academy of Sciences Foundation; National Science and Technology Major Project [2012ZX10002007-003, 2013ZX10003009-002]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2010KIP205, 2012KIP204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health NSFC Collaborative; Shanghai "Rising Star" Program; Novo Nordisk-Chinese Academy of Sciences Foundation; National Science and Technology Major Project; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, and 81271835; National Institutes of Health NSFC Collaborative Grant 81161120417;Shanghai "Rising Star" Program Grant 10QA1407900;the Novo Nordisk-Chinese Academy of Sciences Foundation; and National Science and Technology Major Project Grants 2012ZX10002007-003 and 2013ZX10003009-002. This work was also supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences and Chinese Academy of Sciences Grants 2010KIP205 and 2012KIP204.	Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Boritz E, 1999, J VIROL, V73, P6937, DOI 10.1128/JVI.73.8.6937-6945.1999; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; He YL, 2012, ACTA BIOCH BIOPH SIN, V44, P70, DOI 10.1093/abbs/gmr109; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Kitao Hiroyuki, 2006, Subcell Biochem, V40, P409; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Xu C, 2012, J GEN VIROL, V93, P531, DOI 10.1099/vir.0.036434-0; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	32	31	33	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35093	35103		10.1074/jbc.M113.511949	http://dx.doi.org/10.1074/jbc.M113.511949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24129573	hybrid, Green Published			2022-12-28	WOS:000329867600011
J	Yu, ZH; Zhao, XP; Huang, LQ; Zhang, T; Yang, FJ; Xie, L; Song, SL; Miao, P; Zhao, L; Sun, XG; Liu, JJ; Huang, G				Yu, Zhenhai; Zhao, Xiaoping; Huang, Liangqian; Zhang, Teng; Yang, Fajun; Xie, Lei; Song, Shaoli; Miao, Ping; Zhao, Li; Sun, Xiaoguang; Liu, Jianjun; Huang, Gang			Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Proliferation; Glycolysis; Phosphorylation; Pyruvate Kinase	HYPOXIA-INDUCIBLE FACTOR-1; ROUS-SARCOMA-VIRUS; SERINE/THREONINE KINASES; GENE-TRANSCRIPTION; PROTEIN-KINASE; TUMOR-GROWTH; TUMORIGENESIS; METABOLISM; ACTIVATION; EXPRESSION	Pyruvate kinase M2 (PKM2) is a key player in the Warburg effect of cancer cells. However, the mechanisms of regulating PKM2 are not fully elucidated. Here, we identified the protein-serine/threonine kinase PIM2, a known oncogene, as a novel binding partner of PKM2. The interaction between PIM2 and PKM2 was confirmed by multiple biochemical approaches in vitro and in cultured cells. Importantly, we found that PIM2 could directly phosphorylate PKM2 on the Thr-454 residue, resulting in an increase of PKM2 protein levels. Compared with wild type, PKM2 with the phosphorylation-defective mutation displayed a reduced effect on glycolysis, co-activating HIF-1 and -catenin, and cell proliferation, while enhancing mitochondrial respiration of cancer cells. These findings demonstrate that PIM2-dependent phosphorylation of PKM2 is critical for regulating the Warburg effect in cancer, highlighting PIM2 as a potential therapeutic target.	[Yu, Zhenhai; Huang, Gang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zhao, Xiaoping; Zhang, Teng; Xie, Lei; Song, Shaoli; Miao, Ping; Zhao, Li; Sun, Xiaoguang; Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Renji Hosp, Dept Nucl Med, Sch Med, Shanghai 200127, Peoples R China; [Huang, Liangqian; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Inst Hlth Sci,Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Yang, Fajun] Albert Einstein Coll Med, Dept Med & Dev & Mol Biol, Bronx, NY 10461 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Yeshiva University; Albert Einstein College of Medicine	Liu, JJ (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Nucl Med, Sch Med, Shanghai 200127, Peoples R China.	ljjsh@133sh.com; huang2802@163.com	song, sl/GRS-1884-2022		973 Project [201203932604]; New Drug Discovery Project [2012ZX09506-001-005]; Shanghai Leading Academic Discipline Project [S30203]; National Natural Science Foundation of China [81071180, 81001008, 81372195]; Shanghai Pujiang Program [13PJ1406000]; Science and Technology Commission of Shanghai Municipality [134119a5600]	973 Project(National Basic Research Program of China); New Drug Discovery Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by research grants from 973 Project 201203932604, New Drug Discovery Project 2012ZX09506-001-005, Shanghai Leading Academic Discipline Project S30203, National Natural Science Foundation of China 81071180, 81001008, and 81372195, Shanghai Pujiang Program 13PJ1406000, and Science and Technology Commission of Shanghai Municipality 134119a5600.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Bettaieb A, 2013, J BIOL CHEM, V288, P17360, DOI 10.1074/jbc.M112.441469; Blanco-Aparicio C, 2013, BIOCHEM PHARMACOL, V85, P629, DOI 10.1016/j.bcp.2012.09.018; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Ding G, 2013, FEBS LETT, V587, P930, DOI 10.1016/j.febslet.2013.02.020; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Le Mellay V, 2002, ADV ENZYME REGUL, V42, P317, DOI 10.1016/S0065-2571(01)00036-X; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; NETZKER R, 1992, J BIOL CHEM, V267, P6421; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; PRESEK P, 1980, CANCER RES, V40, P1733; PRESEK P, 1988, FEBS LETT, V242, P194, DOI 10.1016/0014-5793(88)81014-7; Schatz JH, 2011, CELL CYCLE, V10, P3830, DOI 10.4161/cc.10.22.18288; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Tang S., 2013, PLOS ONE, V8; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Wong N., 2013, INT J CELL BIOL, V2013; Xue HP, 2011, INT J BIOCHEM CELL B, V43, P348, DOI 10.1016/j.biocel.2010.11.002; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yan SH, 1999, IUBMB LIFE, V48, P409; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	42	62	65	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35406	35416		10.1074/jbc.M113.508226	http://dx.doi.org/10.1074/jbc.M113.508226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24142698	Green Published, hybrid			2022-12-28	WOS:000329867600037
J	Grishin, AA; Cuny, H; Hung, A; Clark, RJ; Brust, A; Akondi, K; Alewood, PF; Craik, DJ; Adams, DJ				Grishin, Anton A.; Cuny, Hartmut; Hung, Andrew; Clark, Richard J.; Brust, Andreas; Akondi, Kalyana; Alewood, Paul F.; Craik, David J.; Adams, David J.			Identifying Key Amino Acid Residues That Affect alpha-Conotoxin AuIB Inhibition of alpha 3 beta 4 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Molecular Docking; Molecular Modeling; Nicotinic Acetylcholine Receptors; NMR; Peptide Chemical Synthesis; Site-directed Mutagenesis; Xenopus Oocyte; Cyonotoxin	COMPETITIVE ANTAGONIST; CALCIUM-CHANNELS; STRUCTURAL DETERMINANTS; SUBUNIT INTERFACES; BINDING-PROTEIN; CHEMICAL-SHIFTS; SENSORY NEURONS; CONUS VENOMS; RICH SOURCE; VC1.1	Background: -Conotoxin AuIB interacts with 34 nAChRs and GABA(B) receptors, but structural determinants of these interactions are unknown. Results: Using alanine scanning mutagenesis and molecular dynamics, we identified residues crucial for AuIB34 nAChR interaction. Conclusion: We identified the key residues that mediate AuIB34 nAChR interaction. Significance: Ability to direct -conotoxin binding to nAChRs or GABA(B) receptors will improve analgesic conopeptides. -Conotoxin AuIB is a selective 34 nicotinic acetylcholine receptor (nAChR) subtype inhibitor. Its analgesic properties are believed to result from it activating GABA(B) receptors and subsequently inhibiting Ca(V)2.2 voltage-gated calcium channels. The structural determinants that mediate diverging AuIB activity at these targets are unknown. We performed alanine scanning mutagenesis of AuIB and 34 nAChR, homology modeling, and molecular dynamics simulations to identify the structural determinants of the AuIB34 nAChR interaction. Two alanine-substituted AuIB analogues, [P6A]AuIB and [F9A]AuIB, did not inhibit the 34 nAChR. NMR and CD spectroscopy studies demonstrated that [F9A]AuIB retains its native globular structure, so its activity loss is probably due to loss of specific toxin-receptor residue pairwise contacts. Compared with AuIB, the concentration-response curve for inhibition of 34 by [F9A]AuIB shifted rightward more than 10-fold, and its subtype selectivity profile changed. Homology modeling and molecular dynamics simulations suggest that Phe-9 of AuIB interacts with a two-residue binding pocket on the 4 nAChR subunit. This hypothesis was confirmed by site-directed mutagenesis of the 4-Trp-59 and 4-Lys-61 residues of loop D, which form a putative binding pocket. AuIB analogues with Phe-9 substitutions corroborated the finding of a binding pocket on the 4 subunit and gave further insight into how AuIB Phe-9 interacts with the 4 subunit. In summary, we identified critical residues that mediate interactions between AuIB and its cognate nAChR subtype. These findings might help improve the design of analgesic conopeptides that selectively avoid nAChR receptors while targeting receptors involved with nociception.	[Grishin, Anton A.; Cuny, Hartmut; Hung, Andrew; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3083, Australia; [Clark, Richard J.; Brust, Andreas; Akondi, Kalyana; Alewood, Paul F.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Royal Melbourne Institute of Technology (RMIT); University of Queensland	Adams, DJ (corresponding author), RMIT Univ, Hlth Innovat Res Inst, POB 71, Bundoora, Vic 3083, Australia.	david.adams@rmit.edu.au	Alewood, Paul F/J-2412-2014; Craik, David/B-1695-2010; Adams, David/J-9125-2014; Adams, David John/K-3578-2019; Clark, Richard J/G-8848-2012	Craik, David/0000-0003-0007-6796; Adams, David/0000-0002-7030-2288; Adams, David John/0000-0002-7030-2288; Clark, Richard J/0000-0002-6807-5426; Brust, Andreas/0000-0003-4238-5706; Cuny, Hartmut/0000-0002-1551-2354; Hung, Andrew/0000-0003-3569-2951; Alewood, Paul/0000-0001-7454-6522	National Health and Medical Research Council [569927]; Australian Research Council [DP 1093115]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council Program Grant 569927 and Australian Research Council Discovery Grant DP 1093115.	Adams DJ, 2013, BBA-BIOMEMBRANES, V1828, P1619, DOI 10.1016/j.bbamem.2013.01.019; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Callaghan B, 2010, CHANNELS, V4, P51, DOI 10.4161/chan.4.1.10281; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; CUNY H, 2012, P AUST PHYSL SOC, V43, pP65; Cuny H, 2012, J BIOL CHEM, V287, P23948, DOI 10.1074/jbc.M112.342998; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutton JL, 2002, J BIOL CHEM, V277, P48849, DOI 10.1074/jbc.M208842200; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Gay EA, 2007, MOL PHARMACOL, V72, P838, DOI 10.1124/mol.107.035527; Gehrmann J, 1999, J MED CHEM, V42, P2364, DOI 10.1021/jm990114p; Goddard D., 2008, SPARKY 3; Grishin AA, 2010, J BIOL CHEM, V285, P22254, DOI 10.1074/jbc.M110.111880; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Harvey SC, 1996, J NEUROSCI, V16, P3798; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Innocent N, 2008, J PHARMACOL EXP THER, V327, P529, DOI 10.1124/jpet.108.142943; Inserra MC, 2013, BIOCHEM PHARMACOL, V86, P791, DOI 10.1016/j.bcp.2013.07.016; Janes RW, 2005, CURR OPIN PHARMACOL, V5, P280, DOI 10.1016/j.coph.2005.01.013; Kapono CA, 2013, TOXICON, V70, P170, DOI 10.1016/j.toxicon.2013.04.022; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Lee C, 2012, BMB REP, V45, P275, DOI 10.5483/BMBRep.2012.45.5.275; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Luo SQ, 1998, J NEUROSCI, V18, P8571; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Marx UC, 2006, MAGN RESON CHEM, V44, pS41, DOI 10.1002/mrc.1821; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Parker MJ, 2001, J PHARMACOL EXP THER, V299, P385; Pereira EFR, 1996, J PHARMACOL EXP THER, V278, P1472; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Quiram PA, 1999, J BIOL CHEM, V274, P19517, DOI 10.1074/jbc.274.28.19517; Rogers JP, 1999, BIOCHEMISTRY-US, V38, P3874, DOI 10.1021/bi9826254; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Samanta U, 1999, ACTA CRYSTALLOGR D, V55, P1421, DOI 10.1107/S090744499900726X; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Lierop BJ, 2013, ACS CHEM BIOL, V8, P1815, DOI 10.1021/cb4002393; Williams DK, 2009, J PHARMACOL EXP THER, V330, P40, DOI 10.1124/jpet.109.151225; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu J, 2004, J BIOL CHEM, V279, P37842, DOI 10.1074/jbc.M400335200; Xie Y, 2001, J BIOL CHEM, V276, P2417, DOI 10.1074/jbc.M009085200; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Young GT, 2007, MOL PHARMACOL, V71, P389, DOI 10.1124/ml.106.030809; Yu RL, 2013, J MED CHEM, V56, P3557, DOI 10.1021/jm400041h; Yu RL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002011	78	39	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34428	34442		10.1074/jbc.M113.512582	http://dx.doi.org/10.1074/jbc.M113.512582			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24100032	Green Published, hybrid			2022-12-28	WOS:000329812800014
J	Kang, T; Lu, W; Xu, W; Anderson, L; Bacanamwo, M; Thompson, W; Chen, YE; Liu, D				Kang, Ting; Lu, Wan; Xu, Wei; Anderson, Leonard; Bacanamwo, Methode; Thompson, Winston; Chen, Y. Eugene; Liu, Dong			MicroRNA-27 (miR-27) Targets Prohibitin and Impairs Adipocyte Differentiation and Mitochondria! Function in Human Adipose-derived Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Cell Differentiation; MicroRNA; Mitochondria; Stem Cells; miR-27; Prohibitin	TUMOR-SUPPRESSOR; ADIPOGENESIS; EXPRESSION; MIR-128; OVEREXPRESSION; IDENTIFICATION; MAINTAINS; APOPTOSIS; OBESITY; PROFILE	Background: Prohibitin is essential in adipocyte differentiation and mitochondrial functions, but the regulative mechanisms of prohibitin by microRNA remain unclear. Results: miR-27 negatively regulates adipogenesis by targeting prohibitin and impairing mitochondrial biogenesis, structure, and activity. Conclusion: miR-27 targets prohibitin and suppresses adipocyte differentiation. Significance: Manipulation of miR-27 may offer opportunities for the therapeutic modulation of adipogenesis in obesity. Prohibitin (PHB) has been reported to play a crucial role in adipocyte differentiation and mitochondrial function. However, the regulative mechanism of PHB during adipogenesis remains unclear. In this study, we determined that the levels of both microRNA (miR)-27a and miR-27b were down-regulated following adipogenic induction of human adipose-derived stem cells, whereas the mRNA level of PHB was up-regulated. Overexpression of miR-27a or miR-27b inhibited PHB expression and adipocyte differentiation. Using PHB 3-UTR luciferase reporter assay, we observed that miR-27a and miR-27b directly targeted PHB in human adipose-derived stem cells. A compensation of PHB partially restored the adipogenesis inhibited by miR-27. Moreover, we demonstrated the novel finding that ectopic expression of miR-27a or miR-27b impaired mitochondrial biogenesis, structure integrity, and complex I activity accompanied by excessive reactive oxygen species production. Our data suggest that miR-27 is an anti-adipogenic microRNA partly by targeting PHB and impairing mitochondrial function. Pharmacological modulation of miR-27 function may provide a new therapeutic strategy for the treatment of obesity.	[Kang, Ting; Lu, Wan; Anderson, Leonard; Bacanamwo, Methode; Liu, Dong] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Xu, Wei; Thompson, Winston] Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA; [Liu, Dong] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Kang, Ting] Nanchang Univ, Div Cardiol, Affiliated Hosp 1, Nanchang 330006, Peoples R China; [Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	Morehouse School of Medicine; Morehouse School of Medicine; Morehouse School of Medicine; Nanchang University; University of Michigan System; University of Michigan	Liu, D (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, 720 Westview Dr SW, Atlanta, GA 30310 USA.	dliu@msm.edu			National Institutes of Health [G12RR003034, SC2GM099629]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM099629] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants G12RR003034 and SC2GM099629 (to D. L.).	Adlakha YK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.46; Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317; Ande SR, 2012, INT J OBESITY, V36, P1236, DOI 10.1038/ijo.2011.227; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Cho JA, 2011, J GENET, V90, P81, DOI 10.1007/s12041-011-0041-6; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Gesta S, 2011, P NATL ACAD SCI USA, V108, P2771, DOI 10.1073/pnas.1019704108; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034315; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Martinelli R, 2010, OBESITY, V18, P2170, DOI 10.1038/oby.2009.474; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; McGregor RA, 2011, CURR MOL MED, V11, P304; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang KH, 2010, KAOHSIUNG J MED SCI, V26, P113, DOI 10.1016/S1607-551X(10)70017-6; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007; Zhu YH, 2011, CLIN CANCER RES, V17, P7105, DOI 10.1158/1078-0432.CCR-11-0071	52	128	135	1	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34394	34402		10.1074/jbc.M113.514372	http://dx.doi.org/10.1074/jbc.M113.514372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133204	hybrid, Green Published			2022-12-28	WOS:000329812800011
J	Xu, JK; Patrick, BA; Jaiswal, AK				Xu, Junkang; Patrick, Brad Allen; Jaiswal, Anil K.			NRH:Quinone Oxidoreductase 2 (NQO2) Protein Competes with the 20 S Proteasome to Stabilize Transcription Factor CCAAT Enhancer-binding Protein alpha (C/EBP alpha), Leading to Protection against gamma Radiation-induced Myeloproliferative Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemoprevention; Protein Degradation; Protein Stability; Protein-Protein Interactions; Signal Transduction; 20 S Proteasome; C; EBP; Myeloproliferative Diseases; NQO2	ACUTE MYELOID-LEUKEMIA; DT-DIAPHORASE; GENE PROMOTER; MICE LEADS; DEGRADATION; DISRUPTION; PU.1; NRH-QUINONE-OXIDOREDUCTASE-2; EXPRESSION; MUTATIONS	Background: NQO2 protects against radiation-induced myeloproliferative disease, but the mechanism remains unknown. Results: Radiation-induced NQO2, independent of NQO1, competes with the 20 S proteasome for interaction with C/EBP region Ser-268 to Val-279 to stabilize C/EBP, leading to protection against myeloproliferative disease. Conclusion: NQO2 stabilizes C/EBP against 20 S degradation to protect against myeloproliferative disease. Significance: Stress-responsive NQO2 functions as an endogenous factor against myeloproliferative diseases. NRH:quinone oxidoreductase 2 (NQO2) is a flavoprotein that protects cells against radiation and chemical-induced oxidative stress. Disruption of the NQO2 gene in mice leads to radiation-induced myeloproliferative diseases. In this report, we showed that the 20 S proteasome and NQO2 both interact with myeloid differentiation factor CCAAT-enhancer-binding protein (C/EBP). The interaction of the 20 S proteasome with C/EBP led to the degradation of C/EBP. NQO2, in the presence of its cofactor NRH, protected C/EBP against 20 S degradation. Deletion and site-directed mutagenesis demonstrated that NQO2 and 20 S competed for the same binding region of S(268)GAGAGKAKKSV(279) in C/EBP. Exposure of mice and HL-60 cells to radiation enhanced the levels of NQO2, which led to an increased NQO2 interaction with C/EBP and decreased 20 S interaction with C/EBP. NQO2 stabilization of C/EBP was independent of NQO1, even though both interacted with the same C/EBP domain. NQO2(-/-) mice, deficient in NQO2, failed to stabilize C/EBP. This contributed to the development of radiation-induced myeloproliferative disease in NQO2(-/-) mice.	[Xu, Junkang; Patrick, Brad Allen; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu			National Institutes of Health [RO1 ES007943]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES007943 (to A. K J.).	Bianchet MA, 1999, BIOCHEM SOC T, V27, P610, DOI 10.1042/bst0270610; Chen S, 2000, FREE RADICAL BIO MED, V29, P276, DOI 10.1016/S0891-5849(00)00308-7; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Gong X, 2007, CANCER RES, V67, P5380, DOI 10.1158/0008-5472.CAN-07-0323; Iskander K, 2008, CANCER RES, V68, P7915, DOI 10.1158/0008-5472.CAN-08-0766; Iskander K, 2009, CLIN CANCER RES, V15, P1534, DOI 10.1158/1078-0432.CCR-08-1783; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Long DJ, 2002, J BIOL CHEM, V277, P46131, DOI 10.1074/jbc.M208675200; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Patrick BA, 2011, ONCOGENE, V30, P1098, DOI 10.1038/onc.2010.491; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; SCOTT LM, 1992, BLOOD, V80, P1725; Smith MT, 2002, BLOOD, V100, P4590, DOI 10.1182/blood-2001-12-0264; Wang W, 2004, FREE RADICAL BIO MED, V37, P1231, DOI 10.1016/j.freeradbiomed.2004.06.042; Wang W, 2008, J GERONTOL A-BIOL, V63, P127, DOI 10.1093/gerona/63.2.127; Xu JK, 2012, J BIOL CHEM, V287, P41608, DOI 10.1074/jbc.M112.387738; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Zhao QJ, 1997, P NATL ACAD SCI USA, V94, P1669, DOI 10.1073/pnas.94.5.1669	20	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34799	34808		10.1074/jbc.M113.495580	http://dx.doi.org/10.1074/jbc.M113.495580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24142791	Green Published, hybrid			2022-12-28	WOS:000329812800048
J	Shao, JF; He, K; Wang, H; Ho, WS; Ren, XL; An, XM; Wong, MK; Yan, B; Xie, DY; Stamatoyannopoulos, J; Zhao, ZY				Shao, Jiaofang; He, Kan; Wang, Hao; Ho, Wing Sze; Ren, Xiaoliang; An, Xiaomeng; Wong, Ming Kin; Yan, Bin; Xie, Dongying; Stamatoyannopoulos, John; Zhao, Zhongying			Collaborative Regulation of Development but Independent Control of Metabolism by Two Epidermis-specific Transcription Factors in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Cell Differentiation; Chromatin Immunoprecipitation (ChIP); Epithelium; Gene Expression; Gene Regulation	NUCLEAR HORMONE-RECEPTORS; GENE-EXPRESSION; INTEGRATIVE ANALYSIS; CELL FATE; LINEAGE; GENOME; NHR-25; DIFFERENTIATION; EMBRYOGENESIS; PROLIFERATION	Cell fate specification is typically initiated by a master regulator, which is relayed by tissue-specific regulatory proteins (usually transcription factors) for further enforcement of cell identities, but how the factors are coordinated among each other to finish up the specification remains poorly understood. Caenorhabditis elegans epidermis specification is initiated by a master regulator, ELT-1, that activates its targets, NHR-25 and ELT-3, two epidermis-specific transcription factors that are important for development but not for initial specification of epidermis, thus providing a unique paradigm for illustrating how the tissue-specific regulatory proteins work together to enforce cell fate specification. Here we addressed the question through contrasting genome-wide in vivo binding targets between NHR-25 and ELT-3. We demonstrate that the two factors bind discrete but conserved DNA motifs, most of which remain in proximity, suggesting formation of a complex between the two. In agreement with this, gene ontology analysis of putative target genes suggested differential regulation of metabolism but coordinated control of epidermal development between the two factors, which is supported by quantitative analysis of expression of their specific or common targets in the presence or absence of either protein. Functional validation of a subset of the target genes showed both activating and inhibitory roles of NHR-25 and ELT-3 in regulating their targets. We further demonstrated differential control of specification of AB and C lineage-derived epidermis. The results allow us to assemble a comprehensive gene network underlying C. elegans epidermis development that is likely to be widely used across species and provides insights into how tissue-specific transcription factors coordinate with one another to enforce cell fate specification initiated by its master regulator.	[Shao, Jiaofang; He, Kan; Ho, Wing Sze; Ren, Xiaoliang; An, Xiaomeng; Wong, Ming Kin; Yan, Bin; Xie, Dongying; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Wang, Hao; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Hong Kong Baptist University; University of Washington; University of Washington Seattle	Stamatoyannopoulos, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	jstam@u.washington.edu; zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015; He, Kan/AAG-6325-2020; Zhao, Zhongying/ABF-9458-2021	Zhao, Zhongying/0000-0003-2743-9008; /0000-0002-2168-3379; He, Kan/0000-0002-3385-7129	Collaborative Research Fund of the Research Grants Council in Hong Kong; Hong Kong Baptist University	Collaborative Research Fund of the Research Grants Council in Hong Kong; Hong Kong Baptist University	This work was supported by the Collaborative Research Fund of the Research Grants Council in Hong Kong and a faculty research grant from Hong Kong Baptist University.	Asahina M, 2000, GENES CELLS, V5, P711, DOI 10.1046/j.1365-2443.2000.00361.x; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baugh LR, 2005, DEVELOPMENT, V132, P1843, DOI 10.1242/dev.01782; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; CHEN L, 1992, SCIENCE, V256, P240, DOI 10.1126/science.1314423; CHEN LS, 1994, DEVELOPMENT, V120, P1631; Chen Z, 2004, MOL CELL BIOL, V24, P7345, DOI 10.1128/MCB.24.17.7345-7358.2004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Djabrayan NJV, 2012, GENE DEV, V26, P2386, DOI 10.1101/gad.199588.112; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gilleard JS, 2001, MOL CELL BIOL, V21, P2533, DOI 10.1128/MCB.21.7.2533-2544.2001; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Gissendanner CR, 2000, DEV BIOL, V221, P259, DOI 10.1006/dbio.2000.9679; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hajduskova M, 2009, J CELL SCI, V122, P3051, DOI 10.1242/jcs.052373; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Kuntz SG, 2012, GENOME RES, V22, P1907, DOI 10.1101/gr.133306.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maduro MF, 2009, BBA-GENE REGUL MECH, V1789, P250, DOI 10.1016/j.bbagrm.2008.07.013; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Murray JI, 2006, NAT PROTOC, V1, P1468, DOI 10.1038/nprot.2006.222; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nelson MD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002010; Niu W, 2011, GENOME RES, V21, P245, DOI 10.1101/gr.114587.110; Page BD, 1997, GENE DEV, V11, P1651, DOI 10.1101/gad.11.13.1651; Priess James R, 2005, WormBook, P1; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Sluder AE, 1999, GENOME RES, V9, P103; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Strong CD, 2006, J CELL BIOL, V175, P661, DOI 10.1083/jcb.200605057; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Tonsaker T, 2012, MECH AGEING DEV, V133, P50, DOI 10.1016/j.mad.2011.09.006; Ulvklo C, 2012, DEVELOPMENT, V139, P678, DOI 10.1242/dev.074500; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Walston TD, 2006, SEMIN CELL DEV BIOL, V17, P204, DOI 10.1016/j.semcdb.2006.04.005; Yamada M, 2000, DEVELOPMENT, V127, P5083; Yanai I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.6; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao G, 2012, G3-GENES GENOM GENET, V2, P469, DOI 10.1534/g3.111.001081; Zhao ZY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001089; Zhong M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000848	58	16	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33411	33426		10.1074/jbc.M113.487975	http://dx.doi.org/10.1074/jbc.M113.487975			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097988	hybrid, Green Published			2022-12-28	WOS:000328841700054
J	Villa, N; Do, A; Hershey, JWB; Fraser, CS				Villa, Nancy; Do, Angelie; Hershey, John W. B.; Fraser, Christopher S.			Human Eukaryotic Initiation Factor 4G (eIF4G) Protein Binds to eIF3c, -d, and -e to Promote mRNA Recruitment to the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; Protein Cross-linking; Protein-Protein Interactions; Ribosomes; Translation; Initiation; eIF3; eIF4G	PHOTO-CROSS-LINKING; TRANSLATION FACTOR EIF3; HELICASE ACTIVITY; ESCHERICHIA-COLI; IN-VIVO; DEPENDENT STIMULATION; MASS-SPECTROMETRY; CORE DOMAIN; AMINO-ACID; SUBUNIT	Background: The interaction between eukaryotic initiation factor 4G (eIF4G) and eIF3 promotes translation initiation in mammals. Results: Human eIF3 subunits -c, -d, and -e interact with two subdomains in eIF4G. Conclusion: Multiple contacts between eIF3 and eIF4G are required for mRNA recruitment to the human ribosome. Significance: Characterizing the eIF3-eIF4G interface might reveal a new regulatory mechanism and provide novel therapeutic targets. Recruitment of mRNA to the 40S ribosomal subunit requires the coordinated interaction of a large number of translation initiation factors. In mammals, the direct interaction between eukaryotic initiation factor 4G (eIF4G) and eIF3 is thought to act as the molecular bridge between the mRNA cap-binding complex and the 40S subunit. A discrete approximate to 90 amino acid domain in eIF4G is responsible for binding to eIF3, but the identity of the eIF3 subunit(s) involved is less clear. The eIF3e subunit has been shown to directly bind eIF4G, but the potential role of other eIF3 subunits in stabilizing this interaction has not been investigated. It is also not clear if the eIF4A helicase plays a role in stabilizing the interaction between eIF4G and eIF3. Here, we have used a fluorescence anisotropy assay to demonstrate that eIF4G binds to eIF3 independently of eIF4A binding to the middle region of eIF4G. By using a site-specific cross-linking approach, we unexpectedly show that the eIF4G-binding surface in eIF3 is comprised of the -c, -d and -e subunits. Screening multiple cross-linker positions reveals that eIF4G contains two distinct eIF3-binding subdomains within the previously identified eIF3-binding domain. Finally, by employing an eIF4G-dependent translation assay, we establish that both of these subdomains are required for efficient mRNA recruitment to the ribosome and stimulate translation. Our study reveals unexpected complexity to the eIF3-eIF4G interaction that provides new insight into the regulation of mRNA recruitment to the human ribosome.	[Villa, Nancy; Do, Angelie; Fraser, Christopher S.] Univ Calif Davis, Dept Mol & Cell Biol, Coll Biol Sci, Davis, CA 95616 USA; [Hershey, John W. B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Fraser, CS (corresponding author), Univ Calif Davis, Dept Mol & Cell Biol, Coll Biol Sci, Davis, CA 95616 USA.	csfraser@ucdavis.edu			National Institutes of Health [R01GM092927]; NIGMS [T32 GM007377]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377, R01GM092927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM092927 and Training Grant T32 GM007377 from the NIGMS (to N. V.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; De Gregorio E, 2001, RNA, V7, P106, DOI 10.1017/S1355838201000577; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Fraser CS, 2007, MOL CELL, V26, P811, DOI 10.1016/j.molcel.2007.05.019; Fraser CS, 2009, PROG MOL BIOL TRANSL, V90, P1, DOI 10.1016/S1877-1173(09)90001-1; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hashem Y, 2013, CELL, V153, P1108, DOI 10.1016/j.cell.2013.04.036; Hinnebusch AG, 2012, COLD SPRING HARB PER, V4; Hinton TM, 2007, J BIOL CHEM, V282, P1695, DOI 10.1074/jbc.M602780200; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; KAUER JC, 1986, J BIOL CHEM, V261, P695; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Morino S, 2000, MOL CELL BIOL, V20, P468, DOI 10.1128/MCB.20.2.468-477.2000; Morris-Desbois C, 2001, J BIOL CHEM, V276, P45988, DOI 10.1074/jbc.M104966200; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Ozawa K, 2013, NUCLEIC ACIDS RES, V41, P5354, DOI 10.1093/nar/gkt162; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Prevot D, 2003, EMBO J, V22, P1909, DOI 10.1093/emboj/cdg175; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Searfoss A, 2001, MOL CELL BIOL, V21, P4900, DOI 10.1128/MCB.21.15.4900-4908.2001; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; WEEKS KM, 1992, BIOCHEMISTRY-US, V31, P10281, DOI 10.1021/bi00157a015; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yu DM, 2013, J BACTERIOL, V195, P2817, DOI 10.1128/JB.02269-12; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	47	92	96	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					32932	32940		10.1074/jbc.M113.517011	http://dx.doi.org/10.1074/jbc.M113.517011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24092755	Green Published, hybrid			2022-12-28	WOS:000328841700011
J	Minagawa, Y; Ueno, H; Hara, M; Ishizuka-Katsura, Y; Ohsawa, N; Terada, T; Shirouzu, M; Yokoyama, S; Yamato, I; Muneyuki, E; Noji, H; Murata, T; Iino, R				Minagawa, Yoshihiro; Ueno, Hiroshi; Hara, Mayu; Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Yamato, Ichiro; Muneyuki, Eiro; Noji, Hiroyuki; Murata, Takeshi; Iino, Ryota			Basic Properties of Rotary Dynamics of the Molecular Motor Enterococcus hirae V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Enzyme Mechanisms; Molecular Motors; Single-molecule Biophysics; Vacuolar ATPase; V-1-ATPase; V0V1	THERMUS-THERMOPHILUS; PROTON PUMPS; C-SUBUNIT; ROTATION; F-1-ATPASE; ATPASE; RESOLUTION; MECHANISM; CATALYSIS; PURIFICATION	Background: The chemomechanical coupling scheme of the rotary motor V-1-ATPase is incompletely understood. Results:Enterococcus hirae V-1-ATPase (EhV(1)) showed 120 degrees steps of rotation without substeps, as commonly seen with F-1-ATPase. Conclusion: The basic properties of rotary dynamics of EhV(1) are similar to those of Thermus thermophilus V-1-ATPase. Significance: This study revealed the common properties of V-1-ATPases as rotary molecular motors, distinct from those of F-1-ATPases. V-ATPases are rotary molecular motors that generally function as proton pumps. We recently solved the crystal structures of the V-1 moiety of Enterococcus hirae V-ATPase (EhV(1)) and proposed a model for its rotation mechanism. Here, we characterized the rotary dynamics of EhV(1) using single-molecule analysis employing a load-free probe. EhV(1) rotated in a counterclockwise direction, exhibiting two distinct rotational states, namely clear and unclear, suggesting unstable interactions between the rotor and stator. The clear state was analyzed in detail to obtain kinetic parameters. The rotation rates obeyed Michaelis-Menten kinetics with a maximal rotation rate (V-max) of 107 revolutions/s and a Michaelis constant (K-m) of 154 m at 26 degrees C. At all ATP concentrations tested, EhV(1) showed only three pauses separated by 120 degrees/turn, and no substeps were resolved, as was the case with Thermus thermophilus V-1-ATPase (TtV(1)). At 10 m ATP (?K-m), the distribution of the durations of the ATP-waiting pause fit well with a single-exponential decay function. The second-order binding rate constant for ATP was 2.3 x 10(6) m(-1) s(-1). At 40 mm ATP (?K-m), the distribution of the durations of the catalytic pause was reproduced by a consecutive reaction with two time constants of 2.6 and 0.5 ms. These kinetic parameters were similar to those of TtV(1). Our results identify the common properties of rotary catalysis of V-1-ATPases that are distinct from those of F-1-ATPases and will further our understanding of the general mechanisms of rotary molecular motors.	[Minagawa, Yoshihiro; Hara, Mayu; Noji, Hiroyuki; Iino, Ryota] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Ueno, Hiroshi; Muneyuki, Eiro] Chuo Univ, Fac Sci & Engn, Dept Phys, Tokyo 1128551, Japan; [Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yamato, Ichiro] Tokyo Univ Sci, Dept Biol Sci & Technol, Tokyo 1258585, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Murata, Takeshi] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Chiba 2638522, Japan	University of Tokyo; Chuo University; RIKEN; Tokyo University of Science; Chiba University; Japan Science & Technology Agency (JST)	Murata, T (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan.	t.murata@faculty.chiba-u.jp; iino@appchem.t.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Iino, Ryota/B-7746-2011; Murata, Takeshi/J-6181-2017; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; Iino, Ryota/0000-0003-0110-5704; Murata, Takeshi/0000-0002-5748-4670; 	Ministry of Education, Culture, Sports, Science and Technology of Japan;  [24651167];  [23370047]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was supported in part by Grants-in-aid for Scientific Research 24651167 (to R. I.) and 23370047 (to T. M.) and the Target Proteins Research Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Iino R, 2013, IUBMB LIFE, V65, P238, DOI 10.1002/iub.1120; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; KAKINUMA Y, 1994, J BIOCHEM-TOKYO, V116, P1302, DOI 10.1093/oxfordjournals.jbchem.a124679; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Murata T, 1997, J BIOL CHEM, V272, P24885, DOI 10.1074/jbc.272.40.24885; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Uner NE, 2012, J BIOL CHEM, V287, P28327, DOI 10.1074/jbc.M112.381194; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	27	42	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32700	32707		10.1074/jbc.M113.506329	http://dx.doi.org/10.1074/jbc.M113.506329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24089518	Green Published, hybrid			2022-12-28	WOS:000328681700054
J	Yumimoto, K; Muneoka, T; Tsuboi, T; Nakayama, KI				Yumimoto, Kanae; Muneoka, Tetsuya; Tsuboi, Tomohiro; Nakayama, Keiichi I.			Substrate Binding Promotes Formation of the Skp1-Cul1-Fbxl3 (SCFFbxl3) Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Protein Assembly; Protein Degradation; Ubiquitin Ligase; Ubiquitylation	F-BOX PROTEIN; UBIQUITIN LIGASE; CIRCADIAN CLOCK; NEDD8 MODIFICATION; BETA-TRCP; SCF; DEGRADATION; CUL1; ACTIVATION; CRYPTOCHROMES	Background: The Skp1-Cul1-Fbxl3 (SCFFbxl3) complex regulates oscillation of the circadian clock by targeting Cry proteins for degradation. Results: Fbxl3 interacts with Skp1 and Cul1 only in the presence of its substrate Cry1 in vivo. Conclusion: Association of Cry1 with Fbxl3 is essential for SCFFbxl3 complex formation in vivo. Significance: Our findings provide important insight into the regulation of SCF ubiquitin ligase activity and circadian rhythmicity. The Skp1-Cul1-F-box protein (SCF) complex is one of the most well characterized types of ubiquitin ligase (E3), with the E3 activity of the complex being regulated in part at the level of complex formation. Fbxl3 is an F-box protein that is responsible for the ubiquitylation and consequent degradation of cryptochromes (Crys) and thus regulates oscillation of the circadian clock. Here we show that formation of the SCFFbxl3 complex is regulated by substrate binding in vivo. Fbxl3 did not associate with Skp1 and Cul1 to a substantial extent in transfected mammalian cells. Unexpectedly, however, formation of the SCFFbxl3 complex was markedly promoted by forced expression of its substrate Cry1 in these cells. A mutant form of Fbxl3 that does not bind to Cry1 was unable to form an SCF complex, suggesting that interaction of Cry1 with Fbxl3 is essential for formation of SCFFbxl3. In contrast, recombinant Fbxl3 associated with recombinant Skp1 and Cul1 in vitro even in the absence of recombinant Cry1. Domain-swap analysis revealed that the COOH-terminal leucine-rich repeat domain of Fbxl3 attenuates the interaction of Skp1, suggesting that a yet unknown protein associated with the COOH-terminal domain of Fbxl3 and inhibited SCF complex formation. Our results thus provide important insight into the regulation of both SCF ubiquitin ligase activity and circadian rhythmicity.	[Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Hatakeyama S, 1997, J BIOL CHEM, V272, P15085, DOI 10.1074/jbc.272.24.15085; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tsunematsu R, 2006, MOL CELL BIOL, V26, P6157, DOI 10.1128/MCB.00595-06; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	56	17	21	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32766	32776		10.1074/jbc.M113.511303	http://dx.doi.org/10.1074/jbc.M113.511303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24085301	Green Published, hybrid			2022-12-28	WOS:000328681700060
J	Boerma, LJ; Xia, G; Qui, C; Cox, BD; Chalmers, MJ; Smith, CD; Lobo-Ruppert, S; Griffin, PR; Muccio, DD; Renfrow, MB				Boerma, LeeAnn J.; Xia, Gang; Qui, Cheng; Cox, Bryan D.; Chalmers, Michael J.; Smith, Craig D.; Lobo-Ruppert, Susan; Griffin, Patrick R.; Muccio, Donald D.; Renfrow, Matthew B.			Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor alpha Ligand Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RXR-ALPHA; MAMMARY-CARCINOMA; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; SELECTIVE LIGAND; STRUCTURAL BASIS; HYDROGEN/DEUTERIUM EXCHANGE; NEOPLASTIC TRANSFORMATION; 9-CIS-RETINOIC ACID; LGD1069 TARGRETIN	Retinoid X receptors (RXRs) are obligate partners for several other nuclear receptors, and they play a key role in several signaling processes. Despite being a promiscuous heterodimer partner, this nuclear receptor is a target of therapeutic intervention through activation using selective RXR agonists (rexinoids). Agonist binding to RXR initiates a large conformational change in the receptor that allows for coactivator recruitment to its surface and enhanced transcription. Here we reveal the structural and dynamical changes produced when a coactivator peptide binds to the human RXR alpha ligand binding domain containing two clinically relevant rexinoids, Targretin and 9-cis-UAB30. Our results show that the structural changes are very similar for each rexinoid and similar to those for the pan-agonist 9-cis-retinoic acid. The four structural changes involve key residues on helix 3, helix 4, and helix 11 that move from a solvent-exposed environment to one that interacts extensively with helix 12. Hydrogen-deuterium exchange mass spectrometry reveals that the dynamics of helices 3, 11, and 12 are significantly decreased when the two rexinoids are bound to the receptor. When the pan-agonist 9-cis-retinoic acid is bound to the receptor, only the dynamics of helices 3 and 11 are reduced. The four structural changes are conserved in all x-ray structures of the RXR ligand-binding domain in the presence of agonist and coactivator peptide. They serve as hallmarks for how RXR changes conformation and dynamics in the presence of agonist and coactivator to initiate signaling.	[Boerma, LeeAnn J.; Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Xia, Gang; Qui, Cheng; Cox, Bryan D.; Muccio, Donald D.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Smith, Craig D.] Univ Alabama Birmingham, Dept Vis Sci, Birmingham, AL 35294 USA; [Lobo-Ruppert, Susan] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Chalmers, Michael J.; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Scripps Research Institute; State University System of Florida; University of Florida	Muccio, DD (corresponding author), Univ Alabama Birmingham, Dept Chem, 901 14th St South, Birmingham, AL 35294 USA.	muccio@uab.edu; renfrow@uab.edu		Renfrow, Matthew B./0000-0002-4193-7305; Chalmers, Michael/0000-0002-2139-6089	National Institutes of Health [2 P50 CA089019, 5 P50 CA089019, RR17261]; Alabama Drug Discovery Alliance; Komen Foundation [BCTR 20000690]; NATIONAL CANCER INSTITUTE [P50CA089019, P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270, S10RR017261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alabama Drug Discovery Alliance; Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2 P50 CA089019 (to D. D. M.), 5 P50 CA089019 (to M. B. R.), RR17261 (to M. B. R.). This work was also supported by a grant from the Alabama Drug Discovery Alliance (to M. B. R.) and Komen Foundation Grant BCTR 20000690 (to D. D. M.).	ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Atigadda VR, 2003, J MED CHEM, V46, P3766, DOI 10.1021/jm030095q; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bischoff ED, 1999, J NATL CANCER I, V91, P2118, DOI 10.1093/jnci/91.24.2118; Bischoff ED, 1998, CANCER RES, V58, P479; BOEHM MF, 1994, J MED CHEM, V37, P2930, DOI 10.1021/jm00044a014; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Chalmers MJ, 2011, INT J MASS SPECTROM, V302, P59, DOI 10.1016/j.ijms.2010.08.002; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Dai SY, 2008, P NATL ACAD SCI USA, V105, P7171, DOI 10.1073/pnas.0710802105; DAWSON MI, 1995, J MED CHEM, V38, P3368, DOI 10.1021/jm00017a021; Duvic M, 2001, ARCH DERMATOL, V137, P581; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Egea PF, 2001, ACTA CRYSTALLOGR D, V57, P434, DOI 10.1107/S0907444901000385; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Ghosh JC, 2002, P NATL ACAD SCI USA, V99, P5842, DOI 10.1073/pnas.092043399; Gottardis MM, 1996, CANCER RES, V56, P5566; Grubbs CJ, 2006, CARCINOGENESIS, V27, P1232, DOI 10.1093/carcin/bgi308; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Jiang W, 2009, CANCER BIOL THER, V8, P285, DOI 10.4161/cbt.8.3.7486; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kang S, 2008, J MOL BIOL, V381, P772, DOI 10.1016/j.jmb.2008.03.004; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P14263, DOI 10.1021/bi00043a034; KERSTEN S, 1995, BIOCHEMISTRY-US, V34, P13717, DOI 10.1021/bi00042a001; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kolesar JM, 2010, CANCER PREV RES, V3, P1565, DOI 10.1158/1940-6207.CAPR-10-0149; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; KROENKE K, 1990, ARCH INTERN MED, V150, P1685, DOI 10.1001/archinte.150.8.1685; le Maire A, 2010, CELL MOL LIFE SCI, V67, P1219, DOI 10.1007/s00018-009-0249-2; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Lin BC, 1997, MOL CELL BIOL, V17, P6131, DOI 10.1128/MCB.17.10.6131; Lindeblad M, 2011, DRUG CHEM TOXICOL, V34, P300, DOI 10.3109/01480545.2010.536771; Lippert WP, 2009, CHEMMEDCHEM, V4, P1143, DOI 10.1002/cmdc.200900090; Love JD, 2002, J BIOL CHEM, V277, P11385, DOI 10.1074/jbc.M110869200; Lu JY, 2006, BIOCHEMISTRY-US, V45, P1629, DOI 10.1021/bi051474j; Lubet RA, 2005, CARCINOGENESIS, V26, P441, DOI 10.1093/carcin/bgh338; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Muccio DD, 1998, J MED CHEM, V41, P1679, DOI 10.1021/jm970635h; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Santin EP, 2009, J MED CHEM, V52, P3150, DOI 10.1021/jm900096q; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Rocha GM, 2001, P NATL ACAD SCI USA, V98, P5317, DOI 10.1073/pnas.091057698; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Vedell PT, 2013, MOL PHARMACOL, V83, P698, DOI 10.1124/mol.112.082404; Xia G, 2011, BIOCHEMISTRY-US, V50, P93, DOI 10.1021/bi101288y; Yan XG, 2004, BIOCHEMISTRY-US, V43, P909, DOI 10.1021/bi030183c; Yasmin R, 2010, J MOL BIOL, V397, P1121, DOI 10.1016/j.jmb.2010.02.030; Zhang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028253; Zhang HT, 2011, J BIOL CHEM, V286, P24593, DOI 10.1074/jbc.M111.245498; Zhang HT, 2011, J MOL BIOL, V407, P13, DOI 10.1016/j.jmb.2011.01.032; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031811	65	40	40	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					814	826		10.1074/jbc.M113.476861	http://dx.doi.org/10.1074/jbc.M113.476861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24187139	Green Published, hybrid			2022-12-28	WOS:000330541200019
J	Chavez, JA; Siddique, MM; Wang, ST; Ching, JH; Shayman, JA; Summers, SA				Chavez, Jose A.; Siddique, M. Mobin; Wang, Siew Tein; Ching, Jianhong; Shayman, James A.; Summers, Scott A.			Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATURATED FATTY-ACIDS; MEMBRANE MICRODOMAIN DISORDER; SKELETAL-MUSCLE CELLS; HUMAN ADIPOSE-TISSUE; GANGLIOSIDE GM3; 3T3-L1 ADIPOCYTES; RESISTANCE; SENSITIVITY; SYNTHASE; MICE	Inhibitors of sphingolipid synthesis protect mice from diet induced-insulin resistance, and sphingolipids such as ceramides and glucosylated-ceramides (e.g., GM3) are putative nutritional intermediates linking obesity to diabetes risk. Herein we investigated the role of each of these sphingolipids in muscle and adipose tissue and conclude that they are independent and separable antagonists of insulin signaling. Of particular note, ceramides antagonize insulin signaling in both myotubes and adipocytes, whereas glucosyceramides are only efficacious in adipocytes: 1) In myotubes exposed to saturated fats, inhibitors of enzymes required for ceramide synthesis enhance insulin signaling, but those targeting glucosylceramide synthase have no effect. 2) Exogenous ceramides antagonize insulin signaling in myotubes, whereas ganglioside precursors do not. 3) Overexpression of glucosylceramide synthase in myotubes induces glucosylceramide but enhances insulin signaling. In contrast, glucosylated ceramides have profound effects in adipocytes. For example, either ganglioside addition or human glucosylceramide synthase overexpression suppresses insulin signaling in adipocytes. These data have important mechanistic implications for understanding how these sphingolipids contribute to energy sensing and the disruption of anabolism under conditions of nutrient oversupply.	[Chavez, Jose A.; Summers, Scott A.] Duke Univ Med Ctr, Stedman Ctr Nutr & Metab Res, Durham, NC 27710 USA; [Siddique, M. Mobin; Wang, Siew Tein; Ching, Jianhong; Summers, Scott A.] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Dis, Singapore 169857, Singapore; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Duke University; National University of Singapore; University of Michigan System; University of Michigan	Summers, SA (corresponding author), Duke NUS Grad Med Sch, Program Cardiovasc & Metab Dis, 8 Coll Rd 8-15, Singapore 169857, Singapore.	scott.summers@duke-nus.edu.sg	/AAE-5384-2020	Wang, Siew Tein/0000-0001-6306-2100	National Institutes of Health [R01DK081456-01]; National Medical Research Council [IRG09may004]; Singapore Ministry of Education Academic Research Fund Grant [MOE2009-T2-2-016]; Duke-NUS Signature Research Program; Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055823, P30DK020572, R01DK081456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore Ministry of Education Academic Research Fund Grant(Ministry of Education, Singapore); Duke-NUS Signature Research Program; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK081456-01 (to S. A. S.). This work was also supported by National Medical Research Council Grant IRG09may004 (to S. A. S.), Singapore Ministry of Education Academic Research Fund Grant MOE2009-T2-2-016 (to S. A. S.), and the Duke-NUS Signature Research Program funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore (to S. A. S.).	Abe A, 1998, J BIOL CHEM, V273, P8467, DOI 10.1074/jbc.273.14.8467; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Aerts JM, 2011, ADV EXP MED BIOL, V721, P99, DOI 10.1007/978-1-4614-0650-1_7; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Blachnio-Zabielska AU, 2012, J CELL PHYSIOL, V227, P550, DOI 10.1002/jcp.22745; Blachnio-Zabielska AU, 2012, OBESITY, V20, P2341, DOI 10.1038/oby.2012.126; Blachnio-Zabielska AU, 2012, LIPIDS, V47, P1131, DOI 10.1007/s11745-012-3722-x; Brozinick J. T., 2012, INT J OBES LOND, V37, P1064; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chocian G, 2010, MOL CELL BIOCHEM, V340, P125, DOI 10.1007/s11010-010-0409-6; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Deevska GM, 2011, BIOCHIMIE, V93, P32, DOI 10.1016/j.biochi.2010.05.016; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gill JMR, 2009, DIABETOLOGIA, V52, P2475, DOI 10.1007/s00125-009-1546-x; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Inokuchi J, 2007, YAKUGAKU ZASSHI, V127, P579, DOI 10.1248/yakushi.127.579; Inokuchi J, 2011, P JPN ACAD B-PHYS, V87, P179, DOI 10.2183/pjab.87.179; Jennemann R, 2010, HEPATOLOGY, V51, P1799, DOI 10.1002/hep.23545; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kristensen D, 2013, ACTA DIABETOL, V50, P705, DOI 10.1007/s00592-012-0379-0; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Skovbro M, 2008, DIABETOLOGIA, V51, P1253, DOI 10.1007/s00125-008-1014-z; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Watson ML, 2009, BIOCHEM J, V417, P791, DOI 10.1042/BJ20081149; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	51	88	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					723	734		10.1074/jbc.M113.522847	http://dx.doi.org/10.1074/jbc.M113.522847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24214972	hybrid, Green Published			2022-12-28	WOS:000330541200012
J	Okamoto-Terry, H; Umeki, K; Nakanishi-Matsui, M; Futai, M				Okamoto-Terry, Haruko; Umeki, Kaori; Nakanishi-Matsui, Mayumi; Futai, Masamitsu			Glu-44 in the Amino-terminal alpha-Helix of Yeast Vacuolar ATPase E Subunit (Vma4p) Has a Role for VoV1 Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Confocal Microscopy; Enzyme Catalysis; Protein Assembly; Yeast; V-ATPase	H+-ATPASE; V-ATPASE; MUTATIONAL ANALYSIS; PROTON PUMPS; G VMA10P; STATOR; ACIDIFICATION; DOMAIN; ISOFORM; GLUCOSE	Background: The V-ATPase is inactivated by reversible disassembly upon glucose starvation. Results: Glu-44 of the V-ATPase E subunit was identified by alanine scanning mutagenesis with reduced disassembly under glucose starvation. Conclusion: Mutations to Glu-44 of the E subunit disrupt normal disassembly of the V-ATPase and affect catalytic activity. Significance: Interactions with the E subunit in the V-ATPase are important for controlling disassembly and catalytic activity. The proton (H+) pumping vacuolar-type ATPase (V-ATPase) is a rotary enzyme that plays a pivotal role in forming intracellular acidic compartments in eukaryotic cells. In Saccharomyces cerevisiae, the membrane extrinsic catalytic V-1 and the transmembrane proton-pumping V-o complexes have been shown to reversibly dissociate upon removal of glucose from the medium. However, the basis of this disassembly is largely unknown. In the earlier study, we have found that the amino-terminal -helical domain between Lys-33 and Lys-83 of yeast E subunit (Vma4p) in the peripheral stalk of the V-1 complex has a role in glucose-dependent VoV1 assembly. Results of alanine-scanning mutagenesis within the domain revealed that the Vma4p Glu-44 is a key residue in VoV1 disassembly. Biochemical analysis on Vma4p Glu-44 to Ala, Asn, Asp, and Gln substitutions indicated that Glu-44 has a role in V-ATPase catalysis. These results suggest that Glu-44 is one of the key functional residues for subunit interaction in the V-ATPase stalk complex that allows both efficient rotation catalysis and assembly.	[Okamoto-Terry, Haruko; Umeki, Kaori; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Futai Special Lab, Yahaba, Iwate 0283694, Japan	Iwate Medical University	Okamoto-Terry, H (corresponding author), Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Futai Special Lab, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	hokamoto@iwate-med.ac.jp; futaim@iwate-med.ac.jp	Okamoto, Haruko/AAG-9512-2021	Okamoto, Haruko/0000-0001-5981-6571	Japanese Society for the Promotion of Science [23570171]; Japan Science and Technology Agency; Hayashi Memorial Foundation for Female Natural Scientists	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants-in-aid from Japanese Society for the Promotion of Science 23570171 (to H. O.-T.) and supported in part by a grant for Research Seeds Quest Program from Japan Science and Technology Agency (to M. F.) and by the Hayashi Memorial Foundation for Female Natural Scientists (to M. N.-M.).	Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Compton MA, 2006, J BIOL CHEM, V281, P15312, DOI 10.1074/jbc.M600890200; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Flannery AR, 2008, J BIOL CHEM, V283, P29099, DOI 10.1074/jbc.M803280200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Hayashi K, 2008, BBA-BIOENERGETICS, V1777, P1370, DOI 10.1016/j.bbabio.2008.06.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2005, J BIOENERG BIOMEMBR, V37, P399, DOI 10.1007/s10863-005-9479-7; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; Nakanishi-Matsui M., 2012, ROLES REGULATORY MEC, P53; Okamoto H., 2013, VACUOLAR TYPE ATPASE, P2719; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P447, DOI 10.1007/s10863-011-9379-y; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P187, DOI 10.1007/s10863-011-9342-y; Schnitzer D, 2011, PLANT CELL PHYSIOL, V52, P946, DOI 10.1093/pcp/pcr044; Stewart AG, 2012, STRUCTURE, V20, P1799, DOI 10.1016/j.str.2012.10.003; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	39	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36236	36243		10.1074/jbc.M113.506741	http://dx.doi.org/10.1074/jbc.M113.506741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196958	Green Published, hybrid			2022-12-28	WOS:000328883400006
J	Turpeinen, H; Oksanen, A; Kivinen, V; Kukkurainen, S; Uusimaki, A; Ramet, M; Parikka, M; Hytonen, VP; Nykter, M; Pesu, M				Turpeinen, Hannu; Oksanen, Anna; Kivinen, Virpi; Kukkurainen, Sampo; Uusimaki, Annemari; Ramet, Mika; Parikka, Mataleena; Hytonen, Vesa P.; Nykter, Matti; Pesu, Marko			Proprotein Convertase Subtilisin/Kexin Type 7 (PCSK7) Is Essential for the Zebrafish Development and Bioavailability of Transforming Growth Factor beta 1a (TGF beta 1a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Gene Expression; Homology Modeling; Protease; Transforming Growth Factor (TGF); PC7; Otolith; PCSK7; Proprotein Convertase; Zebrafish	CRYSTAL-STRUCTURE; SITE-1 PROTEASE; FURIN; EXPRESSION; MICE; PC7; CLEAVAGE; CELLS; EMBRYOGENESIS; DISRUPTION	Background: The in vivo importance of PCSK7 in the vertebrates is currently poorly understood. Results: Inhibiting PCSK7 in zebrafish results in various developmental defects and dysregulation of gene expressions. Conclusion: PCSK7 is essential for zebrafish development and regulates the expression and proteolytic cleavage of TGF1a. Significance: PCSK inhibitors are considered future therapeutics for human diseases; understanding the biological role of PCSK7 is therefore critical. Proprotein convertase subtilisin/kexin (PCSK) enzymes convert proproteins into bioactive end products. Although other PCSK enzymes are known to be essential for biological processes ranging from cholesterol metabolism to host defense, the in vivo importance of the evolutionarily ancient PCSK7 has remained enigmatic. Here, we quantified the expressions of all pcsk genes during the 1st week of fish development and in several tissues. pcsk7 expression was ubiquitous and evident already during the early development. To compare mammalian and zebrafish PCSK7, we prepared homology models, which demonstrated remarkable structural conservation. When the PCSK7 function in developing larvae was inhibited, we found that PCSK7-deficient fish have defects in various organs, including the brain, eye, and otic vesicle, and these result in mortality within 7 days postfertilization. A genome-wide analysis of PCSK7-dependent gene expression showed that, in addition to developmental processes, several immune system-related pathways are also regulated by PCSK7. Specifically, the PCSK7 contributed to the mRNA expression and proteolytic cleavage of the cytokine TGF1a. Consequently, tgf1a morphant fish displayed phenotypical similarities with pcsk7 morphants, underscoring the importance of this cytokine in the zebrafish development. Targeting PCSK activity has emerged as a strategy for treating human diseases. Our results suggest that inhibiting PCSK7 might interfere with normal vertebrate development.	[Turpeinen, Hannu; Oksanen, Anna; Kukkurainen, Sampo; Uusimaki, Annemari; Ramet, Mika; Parikka, Mataleena; Hytonen, Vesa P.; Pesu, Marko] Univ Tampere, Inst Biomed Technol, FI-33520 Tampere, Finland; [Turpeinen, Hannu; Oksanen, Anna; Kukkurainen, Sampo; Uusimaki, Annemari; Ramet, Mika; Parikka, Mataleena; Hytonen, Vesa P.; Pesu, Marko] BioMediTech, Tampere 33520, Finland; [Kivinen, Virpi; Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, Tampere 33720, Finland; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere 33521, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu 90029, Finland; [Ramet, Mika] Univ Oulu, Dept Pediat, Med Res Ctr, Oulu 90014, Finland; [Hytonen, Vesa P.; Pesu, Marko] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere 33520, Finland	Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; Pirkanmaa Hospital District	Turpeinen, H (corresponding author), Univ Tampere, Inst Biomed Technol, BioMediTech, FinnMedi 2,5th Fl,Biokatu 8, FI-33520 Tampere, Finland.	hannu.turpeinen@uta.fi	Hytonen, Vesa P./E-8855-2013; Pesu, Marko/L-6344-2013; Parikka, Mataleena/D-4364-2014	Hytonen, Vesa P./0000-0002-9357-1480; Pesu, Marko/0000-0002-7541-3921; Parikka, Mataleena/0000-0001-5555-3815; Nykter, Matti/0000-0001-6956-2843; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [128623, 135980, 121003, 140978, 132877]; European Community; Emil Aaltonen Foundation; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Tampere Graduate Program in Biomedicine and Biotechnology; Finnish Cultural Foundation; Finnish Foundation for Technology Promotion; Laboratoriolaaketieteen edistamissaatio; Tampere University Hospital [9M080, 9N056]	Academy of Finland(Academy of Finland); European Community(European Commission); Emil Aaltonen Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Tampere Graduate Program in Biomedicine and Biotechnology; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Technology Promotion; Laboratoriolaaketieteen edistamissaatio; Tampere University Hospital	This work was supported by Academy of Finland Projects 128623, 135980 (to M. Pesu), 121003 (to M. Parikka), 140978 (to V. H.), and 132877 (to M. N.); a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (to M. Pesu); the Emil Aaltonen Foundation (to M. Pesu); the Sigrid Juselius Foundation (to M. Pesu); the Tampere Tuberculosis Foundation (to M. Pesu); the Tampere Graduate Program in Biomedicine and Biotechnology (to A. O. and S. K.); the Finnish Cultural Foundation (to A. O. and V. K.); the Finnish Foundation for Technology Promotion (to V. K.); Laboratoriolaaketieteen edistamissaatio (to A. O.); and Competitive Research Funding of the Tampere University Hospital Grants 9M080 and 9N056 (to M. Pesu).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Blanchette F, 1997, J CLIN INVEST, V99, P1974, DOI 10.1172/JCI119365; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; Chitramuthu BP, 2011, METHODS MOL BIOL, V768, P273, DOI 10.1007/978-1-61779-204-5_15; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Constam DB, 2000, GENE DEV, V14, P1146; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; Declercq J, 2012, J BIOL CHEM, V287, P9052, DOI 10.1074/jbc.M111.306407; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Freeman JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-195; Gagnon J, 2011, LIFE SCI, V88, P212, DOI 10.1016/j.lfs.2010.11.010; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; MARCINKIEWICZ M, 1993, P NATL ACAD SCI USA, V90, P4922, DOI 10.1073/pnas.90.11.4922; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; Mbikay M, 2010, FEBS LETT, V584, P701, DOI 10.1016/j.febslet.2009.12.018; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Pesu M, 2006, BLOOD, V108, P983, DOI 10.1182/blood-2005-09-3824; Poirier S, 2006, J NEUROCHEM, V98, P838, DOI 10.1111/j.1471-4159.2006.03928.x; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Senturker S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039380; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Stawowy P, 2001, J HISTOCHEM CYTOCHEM, V49, P323, DOI 10.1177/002215540104900306; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Turpeinen H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-618; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Wheatley JL, 2007, P NATL ACAD SCI USA, V104, P6626, DOI 10.1073/pnas.0701983104; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599; Zhu XR, 1998, J BIOL CHEM, V273, P1158, DOI 10.1074/jbc.273.2.1158	59	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36610	36623		10.1074/jbc.M113.453183	http://dx.doi.org/10.1074/jbc.M113.453183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24178295	Green Published, hybrid			2022-12-28	WOS:000328883400041
J	Turegun, B; Kast, DJ; Dominguez, R				Turegun, Bengi; Kast, David J.; Dominguez, Roberto			Subunit Rtt102 Controls the Conformation of the Arp7/9 Heterodimer and Its Interactions with Nucleotide and the Catalytic Subunit of SWI/SNF Remodelers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; ATP; Chromatin Remodeling; Isothermal Titration Calorimetry; Protein-Protein interactions; X-ray Scattering; Actin-related Proteins; Nucleotide Binding	ACTIN-RELATED PROTEINS; X-RAY-SCATTERING; NUCLEAR ACTIN; BIOLOGICAL MACROMOLECULES; SACCHAROMYCES-CEREVISIAE; CHROMATIN; NUCLEOSOME; COMPLEX; CORE; SWI2/SNF2	Background: The function of subunit Rtt102 of SWI/SNF remodelers is largely unknown. Results: Rtt102 induces a conformational change in the Arp7/9 heterodimer, promoting nucleotide binding and restricting binding of Arp7/9 to a shorter segment of the HSA domain. Conclusion: Rtt102 stabilizes the structure of Arp7/9-containing remodelers. Significance: This work establishes Rtt102 as a modulator of SWI/SNF remodeler structure through effects on the Arp7/9 heterodimer. Chromatin-remodeling complexes are assembled around a catalytic subunit that contains a central ATPase domain and flanking sequences that recruit auxiliary subunits. The catalytic subunits of SWI/SNF remodelers recruit Arp7/9 through a helicase/SANT-associated (HSA) domain N-terminal to the ATPase domain. Arp7/9-containing remodelers also carry the auxiliary subunit Rtt102, but the role of this subunit is poorly understood. Here, we show that Rtt102 binds with nanomolar affinity to the Arp7/9 heterodimer and modulates its conformation and interactions with the ATPase subunit and nucleotide. When bound to Rtt102, Arp7/9 interacts with a shorter segment of the HSA domain. Structural analysis by small-angle x-ray scattering further shows that when bound to Rtt102, the complex of Arp7/9 with the catalytic subunit assumes a more stable compact conformation. We also found that Arp7, Arp9, and Arp7/9 interact very weakly with ATP, but Rtt102 promotes high-affinity ATP binding to a single site in the heterodimer. Collectively, the results establish a function for subunit Rtt102 as a stabilizing factor for the Arp7/9 heterodimer, enhancing its interaction with nucleotide and controlling the conformation of SWI/SNF remodelers in an Arp7/9-dependent manner.	[Turegun, Bengi; Kast, David J.; Dominguez, Roberto] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Turegun, Bengi] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Dominguez, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, 728 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu	Kast, David/O-2388-2016	Kast, David/0000-0002-1031-1211	National Science Foundation Grant [DMR-0936384]; National Institutes of Health Grant from NIGMS [GM103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM073791] Funding Source: NIH RePORTER	National Science Foundation Grant(National Science Foundation (NSF)); National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Gillilan (MacCHESS) for help with SAXS data collection and Adam Zwolak for assistance with SAXS data analysis. We thank Dr. Les Dutton for access to the CD spectrophotometer instrument. Data collection at CHESS beamline F2 was supported by National Science Foundation Grant DMR-0936384 (to CHESS) and National Institutes of Health Grant GM103485 from NIGMS (to MacCHESS).	Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Bingham JB, 1999, CURR BIOL, V9, P223, DOI 10.1016/S0960-9822(99)80095-5; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; He X, 2008, BIOCHEMISTRY-US, V47, P7025, DOI 10.1021/bi702304p; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Kast DJ, 2011, EMBO J, V30, P2097, DOI 10.1038/emboj.2011.150; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Lee KK, 2004, BIOCHEM SOC T, V32, P899, DOI 10.1042/BST0320899; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Nishimoto N, 2012, J CELL SCI, V125, P3870, DOI 10.1242/jcs.104349; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Toft KN, 2008, ANAL CHEM, V80, P3648, DOI 10.1021/ac800011y; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	51	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35758	35768		10.1074/jbc.M113.514083	http://dx.doi.org/10.1074/jbc.M113.514083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189066	hybrid, Green Published			2022-12-28	WOS:000329814700014
J	Wu, XW; Qi, J; Bradner, JE; Xiao, GT; Chen, LF				Wu, Xuewei; Qi, Jun; Bradner, James E.; Xiao, Gutian; Chen, Lin-Feng			Bromodomain and Extraterminal (BET) Protein Inhibition Suppresses Human T Cell Leukemia Virus 1 (HTLV-1) Tax Protein-mediated Tumorigenesis by Inhibiting Nuclear Factor kappa B (NF-kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Leukemia; NF-B; Signaling; Transcription; Brd4; HTLV-1; JQ1; TAX; Acetylation	LYMPHOTROPIC VIRUS; GENE-EXPRESSION; RAT FIBROBLASTS; DOWN-REGULATION; TRANSFORMATION; BRD4; PHOSPHORYLATION; ACETYLATION; ACTIVATION; MECHANISMS	Background: The HTLV-1 oncoprotein Tax induces sustained NF-B activation for cell survival and proliferation gene expression. Results: Recruitment of Brd4 to acetylated RelA is essential for Tax-mediated NF-B target gene expression and cell proliferation. Conclusion: Blocking the binding of Brd4 to acetylated RelA by JQ1 suppresses Tax-mediated NF-B activation and tumorigenesis. Significance: Inhibiting Brd4 could be a potential therapeutic strategy for diseases associated with HTLV-1 infection. The etiology of human T cell leukemia virus 1 (HTLV-1)-mediated adult T cell leukemia is associated with the ability of viral oncoprotein Tax to induce sustained NF-B activation and the expression of many NF-B target genes. Acetylation of the RelA subunit of NF-B and the subsequent recruitment of bromodomain-containing factor Brd4 are important for the expression of NF-B target genes in response to various stimuli. However, their contributions to Tax-mediated NF-B target gene expression and tumorigenesis remain unclear. Here we report that Tax induced the acetylation of lysine 310 of RelA and the binding of Brd4 to acetylated RelA to facilitate Tax-mediated transcriptional activation of NF-B. Depletion of Brd4 down-regulated Tax-mediated NF-B target gene expression and cell proliferation. Inhibiting the interaction of Brd4 and acetylated RelA with the bromodomain extraterminal protein inhibitor JQ1 suppressed the proliferation of Tax-expressing rat fibroblasts and Tax-positive HTLV-1-infected cells and Tax-mediated cell transformation and tumorigenesis. Moreover, JQ1 attenuated the Tax-mediated transcriptional activation of NF-B, triggering the polyubiquitination and proteasome-mediated degradation of constitutively active nuclear RelA. Our results identify Brd4 as a key regulator for Tax-mediated NF-B gene expression and suggest that targeting epigenetic regulators such as Brd4 with the bromodomain extraterminal protein inhibitor might be a potential therapeutic strategy for cancers and other diseases associated with HTLV-1 infection.	[Wu, Xuewei; Chen, Lin-Feng] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Chen, Lin-Feng] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Qi, Jun; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xiao, Gutian] Univ Pittsburgh, Med Ctr, Inst Canc, Pittsburgh, PA 15213 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Dana-Farber Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, LF (corresponding author), Univ Illinois, Coll Med, Dept Biochem, MC 714, Urbana, IL 61801 USA.	lfchen@life.illinois.edu			National Institutes of Health [DK-085158, DK-093865, CA116616]; University of Illinois at Urbana-Champaign; NATIONAL CANCER INSTITUTE [R01CA116616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085158, R21DK093865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Urbana-Champaign; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported, in whole or in part, by National Institutes of Health Grants DK-085158, DK-093865 (to L. F. C.), and CA116616 (to G. T. X.). This work was also supported by funds provided by the University of Illinois at Urbana-Champaign (to L. F. C.).	Bex F, 1998, METHODS, V16, P83, DOI 10.1006/meth.1998.0646; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; Choi KC, 2009, MOL CANCER RES, V7, P2011, DOI 10.1158/1541-7786.MCR-09-0239; Chung CW, 2012, PROGR MED CHEM, V51, P1, DOI 10.1016/B978-0-12-396493-9.00001-7; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; DEPPER JM, 1984, J IMMUNOL, V133, P1691; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GREENE WC, 1989, IMMUNOL TODAY, V10, P272, DOI 10.1016/0167-5699(89)90141-2; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Kwon H, 2005, J BIOL CHEM, V280, P35713, DOI 10.1074/jbc.M504848200; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Matsumoto K, 1997, J VIROL, V71, P4445, DOI 10.1128/JVI.71.6.4445-4451.1997; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; McBride AA, 2004, TRENDS MICROBIOL, V12, P527, DOI 10.1016/j.tim.2004.10.002; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Peloponese JM, 2006, IMMUNOL RES, V34, P1, DOI 10.1385/IR:34:1:1; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qu ZX, 2011, VIRUSES-BASEL, V3, P714, DOI 10.3390/v3060714; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; SMITH MR, 1991, J CLIN INVEST, V87, P761, DOI 10.1172/JCI115078; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Taylor GP, 2005, ONCOGENE, V24, P6047, DOI 10.1038/sj.onc.1208979; Taylor JM, 2008, APOPTOSIS, V13, P733, DOI 10.1007/s10495-008-0208-7; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Waldmann TA, 2007, ONCOGENE, V26, P3699, DOI 10.1038/sj.onc.1210368; Waldmann TA, 2002, J CLIN IMMUNOL, V22, P51, DOI 10.1023/A:1014416616687; WANO Y, 1988, P NATL ACAD SCI USA, V85, P9733, DOI 10.1073/pnas.85.24.9733; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zhao LL, 2013, J MED CHEM, V56, P3833, DOI 10.1021/jm301793a; Zimmerman B, 2010, VET PATHOL, V47, P677, DOI 10.1177/0300985810370009; Zou Z., 2013, ONCOGENE; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	53	30	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36094	36105		10.1074/jbc.M113.485029	http://dx.doi.org/10.1074/jbc.M113.485029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189064	Green Published, hybrid			2022-12-28	WOS:000329814700044
J	Eckenroth, BE; Towle-Weicksel, JB; Sweasy, JB; Doublie, S				Eckenroth, Brian E.; Towle-Weicksel, Jamie B.; Sweasy, Joann B.; Doublie, Sylvie			The E295K Cancer Variant of Human Polymerase beta Favors the Mismatch Conformational Pathway during Nucleotide Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; DNA Polymerase; DNA Repair; Mutagenesis; Protein Conformation	HIV-1 REVERSE-TRANSCRIPTASE; BASE EXCISION-REPAIR; CRYSTAL-STRUCTURES; KLENOW FRAGMENT; FINGERS SUBDOMAIN; KINETIC ANALYSES; DNA-REPLICATION; GASTRIC-CANCER; FIDELITY; MECHANISM	Background: Human DNA polymerase is mutated in a high percentage of cancers with specific variants impacting enzymatic activity and/or fidelity. Results: In the E295K carcinoma variant, dCTP competes with cognate dTTP with dA as templating base. Conclusion: Structures verify that the E295K variant favors the mismatch over cognate dNTP. Significance: Relevant mutations may have the potential to lower the mismatch energy barrier to catalysis. DNA polymerase (pol ) is responsible for gap filling synthesis during repair of damaged DNA as part of the base excision repair pathway. Human pol mutations were recently identified in a high percentage (approximate to 30%) of tumors. Characterization of specific cancer variants is particularly useful to further the understanding of the general mechanism of pol while providing context to disease contribution. We showed that expression of the carcinoma variant E295K induces cellular transformation. The poor polymerase activity exhibited by the variant was hypothesized to be caused by the destabilization of proper active site assembly by the glutamate to lysine mutation. Here, we show that this variant exhibits an unusual preference for binding dCTP opposite a templating adenine over the cognate dTTP. Biochemical studies indicate that the noncognate competes with the cognate nucleotide for binding to the polymerase active site with the noncognate incorporation a function of higher affinity and not increased activity. In the crystal structure of the variant bound to dA:dCTP, the fingers domain closes around the mismatched base pair. Nucleotide incorporation is hindered because key residues in the polymerase active site are not properly positioned for nucleotidyl transfer. In contrast to the noncognate dCTP, neither the cognate dTTP nor its nonhydrolyzable analog induced fingers closure, as isomorphous difference Fourier maps show that the cognate nucleotides are bound to the open state of the polymerase. Comparison with published structures provides insight into the structural rearrangements within pol that occur during the process of nucleotide discrimination.	[Eckenroth, Brian E.; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Towle-Weicksel, Jamie B.; Sweasy, Joann B.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	University of Vermont; Yale University	Sweasy, JB (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St,POB 208040, New Haven, CT 06520 USA.	joann.sweasy@yale.edu; sdoublie@uvm.edu		Doublie, Sylvie/0000-0002-6294-5304; Eckenroth, Brian/0000-0003-4818-311X	National Institutes of Health from NCI [R01 CA080830]; NATIONAL CANCER INSTITUTE [R01CA080830] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA080830 from NCI (to J.B.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Berlow RB, 2012, J MOL BIOL, V419, P171, DOI 10.1016/j.jmb.2012.03.013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P6751, DOI 10.1021/bi049975c; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Hariharan C, 2006, BIOCHEMISTRY-US, V45, P2836, DOI 10.1021/bi051644s; Iwanaga A, 1999, MUTAT RES-DNA REPAIR, V435, P121, DOI 10.1016/S0921-8777(99)00036-1; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kraynov VS, 1997, BIOCHEM J, V323, P103, DOI 10.1042/bj3230103; Kraynov VS, 2000, BIOCHEMISTRY-US, V39, P16008, DOI 10.1021/bi0008480; Lang TM, 2007, MOL CELL BIOL, V27, P5587, DOI 10.1128/MCB.01883-06; Li YL, 2012, J AM CHEM SOC, V134, P9999, DOI 10.1021/ja300361r; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Radhakrishnan R, 2006, BIOCHEMISTRY-US, V45, P15142, DOI 10.1021/bi061353z; Rothwell PJ, 2013, J BIOL CHEM, V288, P13575, DOI 10.1074/jbc.M112.432690; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Rould Mark A, 2007, Methods Mol Biol, V364, P159; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Schlick T, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1287-7; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; STEITZ TA, 1993, COLD SPRING HARB SYM, V58, P495, DOI 10.1101/SQB.1993.058.01.056; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TOPAL MD, 1976, NATURE, V263, P289, DOI 10.1038/263289a0; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Yang LJ, 2002, J MOL BIOL, V317, P651, DOI 10.1006/jmbi.2002.5450; Yang LJ, 2002, J MOL BIOL, V321, P459, DOI 10.1016/S0022-2836(02)00617-4; Zhang H, 2007, NUCLEIC ACIDS RES, V35, P6052, DOI 10.1093/nar/gkm587; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	56	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34850	34860		10.1074/jbc.M113.510891	http://dx.doi.org/10.1074/jbc.M113.510891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24133209	Green Published, hybrid			2022-12-28	WOS:000329812800052
J	Ngo, B; Hu, CM; Guo, XE; Ngo, B; Wei, R; Zhu, JW; Lee, WH				Ngo, Bryan; Hu, Chun-Mei; Guo, Xuning Emily; Ngo, Brittany; Wei, Randy; Zhu, Jiewen; Lee, Wen-Hwa			Complementary Interhelical Interactions between Three Buried Glu-Lys Pairs within Three Heptad Repeats Are Essential for Hec1-Nuf2 Heterodimerization and Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinetochore; Mitosis; Protein-Protein Interactions; Site-directed Mutagenesis; Western Blotting; Coiled-Coil; Hec1; Heptad Repeat; NDC80; Nuf2	KINETOCHORE-MICROTUBULE ATTACHMENT; FAITHFUL CHROMOSOME SEGREGATION; COILED-COIL FORMATION; NDC80 COMPLEX; SACCHAROMYCES-CEREVISIAE; PROTEIN SUMOYLATION; POLAR RESIDUES; STRUCTURAL SPECIFICITY; CORTEXILLIN I; SALT-BRIDGES	Background: Hec1 and Nuf2 are components of the NDC80 complex essential for faithful chromosome segregation. Results: Three contiguous heptad repeats with buried interhelical Glu-Lys pairs are required for Hec1-Nuf2 dimerization, NDC80 complex formation, and mitotic progression. Conclusion: Interhelical electrostatic and hydrophobic interactions define specificity and stability requirements for Hec1-Nuf2 dimerization. Significance: The results elucidate how Hec1-Nuf2 dimerize and provide insight into NDC80 complex formation. Hec1 and Nuf2, core components of the NDC80 complex, are essential for kinetochore-microtubule attachment and chromosome segregation. It has been shown that both Hec1 and Nuf2 utilize their coiled-coil domains to form a functional dimer; however, details of the consequential significance and structural requirements to form the dimerization interface have yet to be elucidated. Here, we showed that Hec1 required three contiguous heptad repeats from Leu-324 to Leu-352, but not the entire first coiled-coil domain, to ensure overall stability of the NDC80 complex through direct interaction with Nuf2. Substituting the hydrophobic core residues, Leu-331, Val-338, and Ile-345, of Hec1 with alanine completely eliminated Nuf2 binding and blocked mitotic progression. Moreover, unlike most coiled-coil proteins, where the buried positions are composed of hydrophobic residues, Hec1 possessed an unusual distribution of glutamic acid residues, Glu-334, Glu-341, and Glu-348, buried within the interior dimerization interface, which complement with three Nuf2 lysine residues: Lys-227, Lys-234, and Lys-241. Substituting these corresponding residues with alanine diminished the binding affinity between Hec1 and Nuf2, compromised NDC80 complex formation, and adversely affected mitotic progression. Taken together, these findings demonstrated that three buried glutamic acid-lysine pairs, in concert with hydrophobic interactions of core residues, provide the major specificity and stability requirements for Hec1-Nuf2 dimerization and NDC80 complex formation.	[Ngo, Bryan; Hu, Chun-Mei; Guo, Xuning Emily; Ngo, Brittany; Wei, Randy; Zhu, Jiewen; Lee, Wen-Hwa] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, 240D Med Sci Bldg, Irvine, CA 92697 USA.	whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014; Zhu, Jiewen/P-8220-2018; Zhu, Jiewen/D-8487-2013	Zhu, Jiewen/0000-0002-6742-8138; Zhu, Jiewen/0000-0002-6742-8138; Ngo, Bryan/0000-0002-7733-2658	National Institutes of Health [CA107568]; NATIONAL CANCER INSTITUTE [R01CA107568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA107568 (to W. H. L).	Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Campbell KM, 2002, BIOCHEMISTRY-US, V41, P7169, DOI 10.1021/bi025559l; Campbell KM, 2002, BIOCHEMISTRY-US, V41, P4866, DOI 10.1021/bi0159276; Chen Y, 1997, J BIOL CHEM, V272, P24081, DOI 10.1074/jbc.272.38.24081; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Chen YM, 2002, J BIOL CHEM, V277, P49408, DOI 10.1074/jbc.M207069200; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McClain DL, 2002, J MOL BIOL, V324, P257, DOI 10.1016/S0022-2836(02)01072-0; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Wei R, 2011, MOL BIOL CELL, V22, P3584, DOI 10.1091/mbc.E11-01-0012; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wu GK, 2008, MOL CELL BIOL, V28, P3652, DOI 10.1128/MCB.01923-07; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zheng L, 1999, MOL CELL BIOL, V19, P5417; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	44	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34403	34413		10.1074/jbc.M113.490524	http://dx.doi.org/10.1074/jbc.M113.490524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24129578	Green Published, hybrid			2022-12-28	WOS:000329812800012
J	Sidharthan, NP; Minchin, RF; Butcher, NJ				Sidharthan, Neelima P.; Minchin, Rodney F.; Butcher, Neville J.			Cytosolic Sulfotransferase 1A3 Is Induced by Dopamine and Protects Neuronal Cells from Dopamine Toxicity ROLE OF D1 RECEPTOR-N-METHYL-D-ASPARTATE RECEPTOR COUPLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Dopamine Receptors; ERK; Glutamate Receptors Ionotropic (AMPA; NMDA); Metabolism; Sulfotransferase	CATECHOL-O-METHYLTRANSFERASE; ELEMENT-BINDING PROTEIN; NMDA-RECEPTOR; CALCINEURIN-NFAT; GENE-EXPRESSION; ACTIVATING TRANSCRIPTION; OXIDATIVE STRESS; SULT1A3; BRAIN; ALPHA	Background: Dopaminergic neurons are susceptible to dopamine-induced toxicity. Results: Dopamine induces the cytosolic sulfotransferase SULT1A3 via a dopamine D1-NMDA receptor-coupled mechanism. Conclusion: Induction of SULT1A3 significantly protects cells from dopamine neurotoxicity. Significance: The dysregulation of SULT1A3 expression may be a risk factor for neurodegenerative diseases involving dopamine. Dopamine neurotoxicity is associated with several neurodegenerative diseases, and neurons utilize several mechanisms, including uptake and metabolism, to protect them from injury. Metabolism of dopamine involves three enzymes: monoamine oxidase, catechol O-methyltransferase, and sulfotransferase. In primates but not lower order animals, a sulfotransferase (SULT1A3) is present that can rapidly metabolize dopamine to dopamine sulfate. Here, we show that SULT1A3 and a closely related protein SULT1A1 are highly inducible by dopamine. This involves activation of the D1 and NMDA receptors. Both ERK1/2 phosphorylation and calcineurin activation are required for induction. Pharmacological agents that inhibited induction or siRNA targeting SULT1A3 significantly increased the susceptibility of cells to dopamine toxicity. Taken together, these results show that dopamine can induce its own metabolism and protect neuron-like cells from damage, suggesting that SULT1A3 activity may be a risk factor for dopamine-dependent neurodegenerative diseases.	[Sidharthan, Neelima P.; Minchin, Rodney F.; Butcher, Neville J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland	Minchin, RF (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	r.minchin@uq.edu.au		Nair, Neelima/0000-0003-1729-2575; Minchin, Rodney/0000-0002-3178-4835; Butcher, Neville/0000-0002-0709-5589	National Health and Medical Research Council of Australia [GNT1005899]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Grant GNT1005899.	Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Avramovich-Tirosh Y, 2007, J NEUROCHEM, V100, P490, DOI 10.1111/j.1471-4159.2006.04258.x; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Blum K, 2012, J PSYCHOACTIVE DRUGS, V44, P134, DOI 10.1080/02791072.2012.685407; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Butcher NJ, 2010, MOL PHARMACOL, V78, P503, DOI 10.1124/mol.110.063404; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; CEDARBAUM JM, 1991, NEUROLOGY, V41, P1567, DOI 10.1212/WNL.41.10.1567; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gandhi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037564; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Hempel N, 2004, MOL PHARMACOL, V66, P1690, DOI 10.1124/mol.104.003350; Hildebrandt HAT, 2004, BIOCHEM BIOPH RES CO, V321, P870, DOI 10.1016/j.bbrc.2004.07.038; Jassen AK, 2006, MOL PHARMACOL, V70, P71, DOI 10.1124/mol.105.021998; Jeon Sung-Man, 2010, Exp Neurobiol, V19, P155, DOI 10.5607/en.2010.19.3.155; Kaphzan H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000138; Kurogi K, 2012, BIOCHEM PHARMACOL, V84, P1186, DOI 10.1016/j.bcp.2012.08.009; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; Richard K, 2001, J CLIN ENDOCR METAB, V86, P2734, DOI 10.1210/jc.86.6.2734; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sai Y, 2008, TOXICOL IN VITRO, V22, P1461, DOI 10.1016/j.tiv.2008.04.019; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; Snyder GL, 1998, J NEUROSCI, V18, P10297; Tayebati SK, 2011, CURR NEUROVASC RES, V8, P246; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Thomae BA, 2003, J NEUROCHEM, V87, P809, DOI 10.1046/j.1471-4159.2003.02027.x; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Wu J, 2012, MOL NEUROBIOL, V45, P605, DOI 10.1007/s12035-012-8278-5; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yan MH, 2002, J PHARMACOL EXP THER, V301, P315, DOI 10.1124/jpet.301.1.315; ZHU XY, 1993, BIOCHEM BIOPH RES CO, V195, P120, DOI 10.1006/bbrc.1993.2018; ZIV I, 1994, NEUROSCI LETT, V170, P136, DOI 10.1016/0304-3940(94)90258-5	51	24	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2013	288	48					34364	34374		10.1074/jbc.M113.493239	http://dx.doi.org/10.1074/jbc.M113.493239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FH	24136195	Green Published, hybrid			2022-12-28	WOS:000329812800008
J	Matsubayashi, M; Teramoto-Kimata, I; Uni, S; Lillehoj, HS; Matsuda, H; Furuya, M; Tani, H; Sasai, K				Matsubayashi, Makoto; Teramoto-Kimata, Isao; Uni, Shigehiko; Lillehoj, Hyun S.; Matsuda, Haruo; Furuya, Masaru; Tani, Hiroyuki; Sasai, Kazumi			Elongation Factor-1 alpha Is a Novel Protein Associated with Host Cell Invasion and a Potential Protective Antigen of Cryptosporidium parvum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-penetrating Peptides; Cytoskeleton; Electron Microscopy (EM); Protozoan; Transcription Elongation Factors; Translation Elongation Factors; Western Blotting	SEA-URCHIN EGGS; FACTOR-I ALPHA; MONOCLONAL-ANTIBODY; TOXOPLASMA INVASION; ACTIN CYTOSKELETON; BINDING PROTEIN; FACTOR 1A; IDENTIFICATION; SPOROZOITES; EIMERIA	Background: Apicomplexan parasites, including Cryptosporidium, possess organelles associated with host cell invasion. Results: A chicken-derived monoclonal antibody inhibited host cell invasion by C. parvum. The corresponding antigen, which localizes to the apical region of the parasite, was identified as elongation factor-1 (EF-1). Conclusion: EF-1 mediates cryptosporidial cytoskeletal complex critical for host cell invasion. Significance: The findings suggest that cryptosporidial EF-1 could serve as a novel anti-infective target antigen. The phylum Apicomplexa comprises obligate intracellular parasites that infect vertebrates. All invasive forms of Apicomplexa possess an apical complex, a unique assembly of organelles localized to the anterior end of the cell and involved in host cell invasion. Previously, we generated a chicken monoclonal antibody (mAb), 6D-12-G10, with specificity for an antigen located in the apical cytoskeleton of Eimeria acervulina sporozoites. This antigen was highly conserved among Apicomplexan parasites, including other Eimeria spp., Toxoplasma, Neospora, and Cryptosporidium. In the present study, we identified the apical cytoskeletal antigen of Cryptosporidium parvum (C. parvum) and further characterized this antigen in C. parvum to assess its potential as a target molecule against cryptosporidiosis. Indirect immunofluorescence demonstrated that the reactivity of 6D-12-G10 with C. parvum sporozoites was similar to those of anti-- and anti--tubulins antibodies. Immunoelectron microscopy with the 6D-12-G10 mAb detected the antigen both on the sporozoite surface and underneath the inner membrane at the apical region of zoites. The 6D-12-G10 mAb significantly inhibited in vitro host cell invasion by C. parvum. MALDI-TOF/MS and LC-MS/MS analysis of tryptic peptides revealed that the mAb 6D-12-G10 target antigen was elongation factor-1 (EF-1). These results indicate that C. parvum EF-1 plays an essential role in mediating host cell entry by the parasite and, as such, could be a candidate vaccine antigen against cryptosporidiosis.	[Matsubayashi, Makoto] Osaka Yuhigaoka Gakuen Jr Coll, Dept Food & Nutr, Tennoji Ku, Osaka 5430073, Japan; [Matsubayashi, Makoto] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 3050856, Japan; [Teramoto-Kimata, Isao; Uni, Shigehiko] Osaka City Univ, Grad Sch Med, Dept Parasitol, Abeno Ku, Osaka 5458585, Japan; [Uni, Shigehiko] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Lillehoj, Hyun S.] USDA, Anim Biosci & Biotechnol Lab, Beltsville Agr Res Ctr, Beltsville, MD 20705 USA; [Matsuda, Haruo] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Mol & Appl Biosci, Immunobiol Lab, Higashihiroshima 7398528, Japan; [Furuya, Masaru; Tani, Hiroyuki; Sasai, Kazumi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Dept Vet Internal Med, Izumisano, Osaka 5988531, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University; Universiti Malaya; United States Department of Agriculture (USDA); Hiroshima University; Immuno-Biological Laboratories Co. Ltd.; Osaka Metropolitan University	Sasai, K (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Vet Sci, Dept Vet Internal Med, Izumisano, Osaka 5988531, Japan.	ksasai@vet.osakafu-u.ac.jp	uni, shigehiko/A-8940-2012; Sasai, Kazumi/GLV-2527-2022	Furuya, Masaru/0000-0003-3276-7903	Public Trust for Home Economics Research Support Fund; Ministry of Education, Culture, Sports, Science and Technology and from the Urakami Foundation [22700773];  [23580445]; Grants-in-Aid for Scientific Research [23580445] Funding Source: KAKEN	Public Trust for Home Economics Research Support Fund; Ministry of Education, Culture, Sports, Science and Technology and from the Urakami Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Public Trust for Home Economics Research Support Fund (to M.M.), Grants-in-aid for Scientific Research 23580445 (to K.S., H.T., M.F., and M.M.) and 22700773 (to M.M.) from the Ministry of Education, Culture, Sports, Science and Technology and from the Urakami Foundation (to K.S., H.T., and M.M.).	Abe N, 2002, J VET MED SCI, V64, P165, DOI 10.1292/jvms.64.165; Arrowood MJ, 2002, CLIN MICROBIOL REV, V15, P390, DOI 10.1128/CMR.15.3.390-400.2002; Beeley J. G., 1985, LAB TECHNIQUES BIOCH, V16, p[160, 279]; Blanch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066436; Bonafonte MT, 1997, BBA-GENE STRUCT EXPR, V1351, P256, DOI 10.1016/S0167-4781(97)00013-4; Brown WC, 1999, PARASITOL TODAY, V15, P275, DOI 10.1016/S0169-4758(99)01471-4; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Chappell C. L., 2003, CRYPTOSPORIDIUM MOL, P19; Chen XM, 2002, NEW ENGL J MED, V346, P1723, DOI 10.1056/NEJMra013170; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Doyle A, 2011, J STRUCT BIOL, V176, P370, DOI 10.1016/j.jsb.2011.09.004; DURSO NA, 1994, PLANT CELL, V6, P1699, DOI 10.2307/3869901; Fayer R., 1997, CRYPTOSPORIDIUM CRYP; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; HAMER DH, 1994, INFECT IMMUN, V62, P2208, DOI 10.1128/IAI.62.6.2208-2213.1994; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Kristensen R, 2005, MYCOL RES, V109, P173, DOI 10.1017/S0953756204002114; KURIYAMA R, 1990, J CELL SCI, V95, P231; Lovett JL, 2000, MOL BIOCHEM PARASIT, V107, P33, DOI 10.1016/S0166-6851(99)00228-5; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; Matsubayashi M, 2008, PARASITOLOGY, V135, P295, DOI 10.1017/S003118200700385X; Matsubayashi M, 2005, VET PARASITOL, V128, P47, DOI 10.1016/j.vetpar.2004.11.004; Matsubayashi M, 2011, INT J PARASITOL, V41, P287, DOI 10.1016/j.ijpara.2010.09.009; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OHTA K, 1990, J BIOL CHEM, V265, P3240; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Ransom-Hodgkins WD, 2009, MOL GENET GENOMICS, V281, P391, DOI 10.1007/s00438-008-0418-2; REYNAUD CA, 1985, CELL, V40, P283, DOI 10.1016/0092-8674(85)90142-4; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; Ridgley EL, 1996, MOL BIOCHEM PARASIT, V79, P119, DOI 10.1016/0166-6851(96)02639-4; Riggs MW, 1999, INFECT IMMUN, V67, P1317, DOI 10.1128/IAI.67.3.1317-1322.1999; RIGGS MW, 1997, CRYPTOSPORIDIUM CRYP, P129; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Sasai K, 1996, J PARASITOL, V82, P82, DOI 10.2307/3284120; Sasai K, 1998, J PARASITOL, V84, P654, DOI 10.2307/3284748; Schaefer DA, 2000, INFECT IMMUN, V68, P2608, DOI 10.1128/IAI.68.5.2608-2616.2000; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SONG CS, 1985, J IMMUNOL, V135, P3354; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tomley FM, 1996, MOL BIOCHEM PARASIT, V79, P195, DOI 10.1016/0166-6851(96)02662-X; Toueille M, 2007, PLANT PHYSIOL BIOCH, V45, P113, DOI 10.1016/j.plaphy.2007.01.006; Vinkenoog R, 1998, MOL BIOCHEM PARASIT, V94, P1, DOI 10.1016/S0166-6851(98)00035-8; WEILL JC, 1987, SCIENCE, V238, P1094, DOI 10.1126/science.3317827; Wetzel DM, 2005, INFECT IMMUN, V73, P5379, DOI 10.1128/IAI.73.9.5379-5387.2005; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YANG WN, 1993, J BIOL CHEM, V268, P392	46	31	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					34111	34120		10.1074/jbc.M113.515544	http://dx.doi.org/10.1074/jbc.M113.515544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24085304	Green Published, hybrid			2022-12-28	WOS:000327250200055
J	Rastogi, R; Jiang, ZL; Ahmad, N; Rosati, R; Liu, YS; Beuret, L; Monks, R; Charron, J; Birnbaum, MJ; Samavati, L				Rastogi, Ruchi; Jiang, Zhongliang; Ahmad, Nisar; Rosati, Rita; Liu, Yusen; Beuret, Laurent; Monks, Robert; Charron, Jean; Birnbaum, Morris J.; Samavati, Lobelia			Rapamycin Induces Mitogen-activated Protein (MAP) Kinase Phosphatase-1 (MKP-1) Expression through Activation of Protein Kinase B and Mitogen-activated Protein Kinase Kinase Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Dual Specificity Phosphoprotein Phosphatase; MAP Kinases (MAPKs); mTOR Complex (mTORC); Signal Transduction	DUAL-SPECIFICITY PHOSPHATASE-1; MAMMALIAN TARGET; INFLAMMATORY RESPONSE; IMMUNE-RESPONSES; CROSS-TALK; T-CELLS; PHOSPHORYLATION; MTOR; AKT; MACROPHAGES	Mitogen-activated protein kinase phosphatase-1 (MKP-1), also known as dual specificity phosphatase-1 (DUSP-1), plays a crucial role in the deactivation of MAPKs. Several drugs with immune-suppressive properties modulate MKP-1 expression as part of their mechanism of action. We investigated the effect of mTOR inhibition through rapamycin and a dual mTOR inhibitor (AZD2014) on MKP-1 expression. Low dose rapamycin led to a rapid activation of both AKT and ERK pathways with a subsequent increase in MKP-1 expression. Rapamycin treatment led to phosphorylation of CREB, transcription factor 1 (ATF1), and ATF2, three transcription factors that bind to the cyclic AMP-responsive elements on the Mkp-1 promoter. Inhibition of either the MEK/ERK or the AKT pathway attenuated rapamycin-mediated MKP-1 induction. AZD2014 did not activate AKT but activated the ERK pathway, leading to a moderate MKP-1 induction. Using bone marrow-derived macrophages (BMDMs) derived from wild-type (WT) mice or mice deficient in AKT1 and AKT2 isoforms or BMDM from targeted deficiency in MEK1 and MEK2, we show that rapamycin treatment led to an increased MKP1 expression in BMDM from WT but failed to do so in BMDMs lacking the AKT1 isoform or MEK1 and MEK2. Importantly, rapamycin pretreatment inhibited LPS-mediated p38 activation and decreased nitric oxide and IL-6 production. Our work provides a conceptual framework for the observed immune modulatory effect of mTOR inhibition.	[Rastogi, Ruchi; Jiang, Zhongliang; Ahmad, Nisar; Rosati, Rita; Samavati, Lobelia] Wayne State Univ, Dept Med, Div Pulm Crit Care & Sleep Med, Sch Med, Detroit, MI 48201 USA; [Rastogi, Ruchi; Jiang, Zhongliang; Ahmad, Nisar; Rosati, Rita; Samavati, Lobelia] Detroit Med Ctr, Detroit, MI 48201 USA; [Liu, Yusen] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Beuret, Laurent; Charron, Jean] Univ Laval, Ctr Rech Canc, CRCHU Q, Hotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; [Monks, Robert; Birnbaum, Morris J.] Univ Penn, Dept Med, Sch Med, Philadelphia, PA 19104 USA; [Samavati, Lobelia] Wayne State Univ, Ctr Mol Med & Genet, Sch Med, Detroit, MI 48201 USA	Wayne State University; Detroit Medical Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Laval University; University of Pennsylvania; Wayne State University	Samavati, L (corresponding author), Wayne State Univ, Dept Med, Div Pulm Crit Care & Sleep Med, Sch Med, 3990 John R,3 Hudson, Detroit, MI 48201 USA.	lsamavat@med.wayne.edu	Charron, Jean/A-9792-2013	Charron, Jean/0000-0002-5133-0056; Liu, Yusen/0000-0002-0994-0109; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health [R01 HL113508, R01 DK56886]; Department of Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine; Center for Molecular Medicine and Genetics, Wayne State University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL113508(to L. S.) and R01 DK56886(to M. J. B.). This work was also supported by the Department of Medicine and the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine (to L. S.).	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Bauerfeld CP, 2012, J IMMUNOL, V188, P2847, DOI 10.4049/jimmunol.1102157; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bissonauth V, 2006, DEVELOPMENT, V133, P3429, DOI 10.1242/dev.02526; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buck M, 2007, AM J PHYSIOL-CELL PH, V293, pC1788, DOI 10.1152/ajpcell.00141.2007; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Carloni S, 2010, AUTOPHAGY, V6, P366, DOI 10.4161/auto.6.3.11261; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chaturvedi D, 2009, ONCOGENE, V28, P1187, DOI 10.1038/onc.2008.490; Chen CC, 1999, MOL PHARMACOL, V55, P481; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gunzl P, 2010, J LEUKOCYTE BIOL, V88, P1259, DOI 10.1189/jlb.0110001; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Huang J, 2011, J CHEMOTHERAPY, V23, P221, DOI 10.1179/joc.2011.23.4.221; Janes MR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe25; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Johansson-Haque K, 2008, J MOL ENDOCRINOL, V41, P239, DOI 10.1677/JME-08-0015; Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607; Kristiansen M, 2010, J NEUROSCI, V30, P10820, DOI 10.1523/JNEUROSCI.2824-10.2010; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Liu RM, 2010, J BIOL CHEM, V285, P16239, DOI 10.1074/jbc.M110.111732; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; Moua T, 2012, AM J RESP CRIT CARE, V186, P389, DOI 10.1164/ajrccm.186.4.389; Mushaben EM, 2011, J IMMUNOL, V187, P5756, DOI 10.4049/jimmunol.1102133; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Rastogi R, 2011, AM J RESP CRIT CARE, V183, P500, DOI 10.1164/rccm.201005-0792OC; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Sanchez-Tillo E, 2006, J IMMUNOL, V176, P6594, DOI 10.4049/jimmunol.176.11.6594; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Staples CJ, 2010, J BIOL CHEM, V285, P25928, DOI 10.1074/jbc.M110.117911; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Wang XX, 2007, J IMMUNOL, V178, P5312, DOI 10.4049/jimmunol.178.8.5312; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao YQ, 2002, J BIOL CHEM, V277, P14884, DOI 10.1074/jbc.M111718200; Zhang YL, 2009, J BIOL CHEM, V284, P30815, DOI 10.1074/jbc.M109.052472; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	58	37	39	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2013	288	47					33966	33977		10.1074/jbc.M113.492702	http://dx.doi.org/10.1074/jbc.M113.492702			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	255OR	24126911	Green Published, hybrid			2022-12-28	WOS:000327250200038
J	Litvinov, RI; Yarovoi, SV; Rauova, L; Barsegov, V; Sachais, BS; Rux, AH; Hinds, JL; Arepally, GM; Cines, DB; Weisel, JW				Litvinov, Rustem I.; Yarovoi, Serge V.; Rauova, Lubica; Barsegov, Valeri; Sachais, Bruce S.; Rux, Ann H.; Hinds, Jillian L.; Arepally, Gowthami M.; Cines, Douglas B.; Weisel, John W.			Distinct Specificity and Single-molecule Kinetics Characterize the Interaction of Pathogenic and Non-pathogenic Antibodies against Platelet Factor 4-Heparin Complexes with Platelet Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Heparin-binding Protein; Platelets; Single Molecule Biophysics; Thrombosis	HEPARIN-INDUCED THROMBOCYTOPENIA; KNOB-HOLE INTERACTIONS; FORCE SPECTROSCOPY; BINDING; HIT; POLYMERIZATION; DISSOCIATION; ACTIVATION; STRENGTH; PEPTIDE	Background: Heparin-treated patients often develop antibodies, but only a subset cause heparin-induced thrombocytopenia. Results: In a single-molecule assay, a pathogenic monoclonal antibody bound more strongly to cross-linked platelet factor 4 than a non-pathogenic antibody. Conclusion: Oligomerization of platelet factor 4 may enhance binding of pathogenic antibodies. Significance: A molecular basis for specificity of pathogenic antibodies in heparin-induced thrombocytopenia is provided. Heparin-induced thrombocytopenia (HIT) is a thrombotic complication of heparin therapy mediated by antibodies to complexes between platelet factor 4 (PF4) and heparin or cellular glycosaminoglycans. However, only a fraction of patients with anti-PF4-heparin antibodies develop HIT, implying that only a subset of these antibodies is pathogenic. The basis for the pathogenic potential of anti-PF4-heparin antibodies remains unclear. To elucidate the intrinsic PF4-binding properties of HIT-like monoclonal antibody (KKO) versus non-pathogenic antibody (RTO) at the single-molecule level, we utilized optical trap-based force spectroscopy to measure the strength and probability of binding of surface-attached antibodies with oligomeric PF4 to simulate interactions on cells. To mimic the effect of heparin in bringing PF4 complexes into proximity, we chemically cross-linked PF4 tetramers using glutaraldehyde. Analysis of the force histograms revealed that KKO-PF4 interactions had approximate to 10-fold faster on-rates than RTO-PF4, and apparent equilibrium dissociation constants differed approximate to 10-fold with similar force-free off-rates (k(off) = 0.0031 and 0.0029 s(-1)). Qualitatively similar results were obtained for KKO and RTO interacting with PF4-heparin complexes. In contrast to WT PF4, KKO and RTO showed lower and similar binding probabilities to cross-linked PF4(K50E), which forms few if any oligomers. Thus, formation of stable PF4 polymers results in much stronger interactions with the pathogenic antibody without a significant effect on the binding of the non-pathogenic antibody. These results suggest a fundamental difference in the antigen-binding mechanisms between model pathogenic and non-pathogenic anti-PF4 antibodies that might underlie their distinct pathophysiological behaviors.	[Litvinov, Rustem I.; Yarovoi, Serge V.; Sachais, Bruce S.; Rux, Ann H.; Hinds, Jillian L.; Cines, Douglas B.; Weisel, John W.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Yarovoi, Serge V.; Sachais, Bruce S.; Rux, Ann H.; Hinds, Jillian L.; Cines, Douglas B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Rauova, Lubica] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Arepally, Gowthami M.] Duke Univ, Div Hematol, Dept Med, Durham, NC 27710 USA; [Barsegov, Valeri] Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; University of Massachusetts System; University of Massachusetts Lowell	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, 421 Curie Blvd,1154 BRB 2-3, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu	Litvinov, Rustem/E-5291-2011; Barsegov, Valeri/A-6203-2014	Litvinov, Rustem/0000-0003-0643-1496; Barsegov, Valeri/0000-0003-1994-3917; Cines, Douglas/0000-0001-5986-504X	National Institutes of Health [HL078726/HL078726-S1, HL099973/HL090774, HL084006, HL110860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL090774, R01HL084006, RC1HL099973, R01HL078726, R01HL090774, P01HL110860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL078726/HL078726-S1 (to B. S. S.), HL099973/HL090774 (to J. W. W.), HL084006 (to D. B. C.), and HL110860 (to B. S. S., L. R., G. M. A., D. B. C., and J. W. W.).	AMIRAL J, 1995, THROMB HAEMOSTASIS, V73, P21; Arepally GM, 2000, BLOOD, V95, P1533, DOI 10.1182/blood.V95.5.1533.005k01_1533_1540; Arepally GM, 2006, NEW ENGL J MED, V355, P809, DOI 10.1056/NEJMcp052967; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; CHILKOTI A, 1995, J AM CHEM SOC, V117, P10622, DOI 10.1021/ja00148a003; Cines DB, 2007, J CLIN APHERESIS, V22, P31, DOI 10.1002/jca.20109; Cuker A, 2013, BLOOD, V121, P3727, DOI 10.1182/blood-2013-01-479576; Cuker A, 2012, BLOOD, V119, P2209, DOI 10.1182/blood-2011-11-376293; Evans EB, 1999, BIOPHYS CHEM, V82, P83, DOI 10.1016/S0301-4622(99)00108-8; Gorkun OV, 2006, BIOCHEMISTRY-US, V45, P14843, DOI 10.1021/bi061430q; Greinacher A, 2005, THROMB HAEMOSTASIS, V94, P132, DOI 10.1160/TH04-12-0825; Greinacher A, 2006, ARTERIOSCL THROM VAS, V26, P2386, DOI 10.1161/01.ATV.0000238350.89477.88; Jaax ME, 2013, BLOOD, V122, P272, DOI 10.1182/blood-2013-01-478966; Litvinov RI, 2003, J BIOL CHEM, V278, P51285, DOI 10.1074/jbc.M304581200; Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2004, BLOOD, V104, P3979, DOI 10.1182/blood-2004-04-1411; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Litvinov RI, 2012, J BIOL CHEM, V287, P35275, DOI 10.1074/jbc.M112.404848; Litvinov RI, 2011, BIOPHYS J, V100, P165, DOI 10.1016/j.bpj.2010.11.019; MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357; Pouplard C, 2001, BLOOD, V97, P3300, DOI 10.1182/blood.V97.10.3300; Rauova L, 2006, BLOOD, V107, P2346, DOI 10.1182/blood-2005-08-3122; Rauova L, 2005, BLOOD, V105, P131, DOI 10.1182/blood-2004-04-1544; Reilly MP, 2001, BLOOD, V98, P2442, DOI 10.1182/blood.V98.8.2442; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; Sachais BS, 2012, BLOOD, V120, P1137, DOI 10.1182/blood-2012-01-407262; Sachais BS, 2012, BLOOD, V119, P5955, DOI 10.1182/blood-2012-01-406801; Shandler SJ, 2011, J AM CHEM SOC, V133, P12378, DOI 10.1021/ja204215f; Sun JEP, 2012, INTEGR BIOL-UK, V4, P84, DOI 10.1039/c1ib00085c; Warkentin TE, 2011, J THROMB HAEMOST, V9, P105, DOI 10.1111/j.1538-7836.2011.04322.x; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; Warkentin TE, 2005, J LAB CLIN MED, V146, P341, DOI 10.1016/j.lab.2005.08.003; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	36	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2013	288	46					33060	33070		10.1074/jbc.M113.481598	http://dx.doi.org/10.1074/jbc.M113.481598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TH	24097975	hybrid, Green Published			2022-12-28	WOS:000328841700022
J	Arachiche, A; Mumaw, MM; de la Fuente, M; Nieman, MT				Arachiche, Amal; Mumaw, Michele M.; de la Fuente, Maria; Nieman, Marvin T.			Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by alpha-Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioluminescence Resonance Energy Transfer (BRET); G-protein-coupled Receptors (GPCR); Protein-Protein Interactions; Receptor Regulation; Thrombin; PAR1; PAR4; Protease-activated Receptor	COUPLED RECEPTORS; SWISS-MODEL; CRYSTAL-STRUCTURE; HUMAN PLATELETS; RHODOPSIN; OLIGOMERIZATION; SPECIFICITY; TRANSDUCIN; COMPLEX; EXISTS	Thrombin is a potent platelet agonist that activates platelets and other cells of the cardiovascular system by cleaving its G-protein-coupled receptors, protease-activated receptor 1 (PAR1), PAR4, or both. We now show that cleaving PAR1 and PAR4 with -thrombin induces heterodimer formation. PAR1-PAR4 heterodimers were not detected when unstimulated; however, when the cells were stimulated with 10 nm -thrombin, we were able to detect a strong interaction between PAR1 and PAR4 by bioluminescence resonance energy transfer. In contrast, activating the receptors without cleavage using PAR1 and PAR4 agonist peptides (TFLLRN and AYPGKF, respectively) did not enhance heterodimer formation. Preventing PAR1 or PAR4 cleavage with point mutations or hirugen also prevented the induction of heterodimers. To further characterize the PAR1-PAR4 interactions, we mapped the heterodimer interface by introducing point mutations in transmembrane helix 4 of PAR1 or PAR4 that prevented heterodimer formation. Finally, we show that mutations in PAR1 or PAR4 at the heterodimer interface prevented PAR1-assisted cleavage of PAR4. These data demonstrate that PAR1 and PAR4 require allosteric changes induced via receptor cleavage by -thrombin to mediate heterodimer formation, and we have determined the PAR1-PAR4 heterodimer interface. Our findings show that PAR1 and PAR4 have dynamic interactions on the cell surface that should be taken into account when developing and characterizing PAR antagonists.	[Arachiche, Amal; Mumaw, Michele M.; de la Fuente, Maria; Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Nieman, MT (corresponding author), 10900 Euclid Ave,305C Wood Bldg, Cleveland, OH 44106 USA.	nieman@case.edu			National Institutes of Health [HL098217]; American Heart Association (AHA) [0865441D]; AHA Scientist Development Grant [10SDG2600021]; American Society for Hematology Scholar Award; Cytometry and Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center Grant [P30CA043703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); AHA Scientist Development Grant(American Heart Association); American Society for Hematology Scholar Award; Cytometry and Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL098217 (to M. N.). This work was also supported by American Heart Association (AHA) Beginning Grant-in-aid 0865441D, AHA Scientist Development Grant 10SDG2600021, an American Society for Hematology Scholar Award (to M. N.), and by the Cytometry and Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center Grant P30CA043703.	Arachiche A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055740; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Birdsall NJM, 2010, TRENDS PHARMACOL SCI, V31, P499, DOI 10.1016/j.tips.2010.08.003; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, THROMB HAEMOSTASIS, V87, P722, DOI 10.1055/s-0037-1613071; de la Fuente M, 2012, J BIOL CHEM, V287, P10414, DOI 10.1074/jbc.M112.341438; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Huntington JA, 2012, BBA-PROTEINS PROTEOM, V1824, P246, DOI 10.1016/j.bbapap.2011.07.005; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; LIU LW, 1991, J BIOL CHEM, V266, P16977; Lodowski DT, 2007, J STRUCT BIOL, V158, P455, DOI 10.1016/j.jsb.2007.01.017; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nieman MT, 2007, BIOCHEMISTRY-US, V46, P8603, DOI 10.1021/bi700597p; Nieman MT, 2008, BIOCHEMISTRY-US, V47, P13279, DOI 10.1021/bi801334s; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soh UJK, 2011, P NATL ACAD SCI USA, V108, pE1372, DOI 10.1073/pnas.1112482108; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; Wang HX, 2009, BIOCHEMISTRY-US, V48, P7132, DOI 10.1021/bi900424h; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	49	58	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2013	288	45					32553	32562		10.1074/jbc.M113.472373	http://dx.doi.org/10.1074/jbc.M113.472373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275MQ	24097976	Green Published, hybrid			2022-12-28	WOS:000328681700038
